MSH	ensembl_id	lApprovedUS.EU	Phase.Latest	First.Added	NelsonStatus	symbol
Abortion, Spontaneous	ENSG00000119535	FALSE	unknown	NA	Absent	CSF3R
Acidosis	ENSG00000151617	FALSE	Phase I Clinical Trial	2012-10-27	Absent	EDNRA
Acne Vulgaris	ENSG00000012779	FALSE	Phase II Clinical Trial	NA	Unused	ALOX5
Acne Vulgaris	ENSG00000026508	FALSE	Approved	NA	Unused	CD44
Acne Vulgaris	ENSG00000057252	FALSE	unknown	2009-07-01	Unused	SOAT1
Acne Vulgaris	ENSG00000065989	FALSE	Preclinical	2005-05-24	Absent	PDE4A
Acne Vulgaris	ENSG00000067182	FALSE	Approved	NA	Absent	TNFRSF1A
Acne Vulgaris	ENSG00000073756	FALSE	Approved	2000-03-29	Unused	PTGS2
Acne Vulgaris	ENSG00000076555	FALSE	Phase II Clinical Trial	2011-01-18	Absent	ACACB
Acne Vulgaris	ENSG00000077092	TRUE	Approved	1990-06-15	Approved	RARB
Acne Vulgaris	ENSG00000082175	TRUE	Approved	1991-09-15	Approved	PGR
Acne Vulgaris	ENSG00000091831	TRUE	Approved	1996-12-15	Approved	ESR1
Acne Vulgaris	ENSG00000095303	FALSE	Approved	2000-03-29	Unused	PTGS1
Acne Vulgaris	ENSG00000095596	FALSE	Preclinical	2014-12-31	Absent	CYP26A1
Acne Vulgaris	ENSG00000099194	FALSE	Phase II Clinical Trial	2009-07-01	Unused	SCD
Acne Vulgaris	ENSG00000101425	FALSE	Preclinical	2002-01-17	Unused	BPI
Acne Vulgaris	ENSG00000101846	FALSE	Phase I Clinical Trial	2003-11-19	Unused	STS
Acne Vulgaris	ENSG00000105329	FALSE	Approved	NA	Absent	TGFB1
Acne Vulgaris	ENSG00000109163	FALSE	Preclinical	1995-12-15	Unused	GNRHR
Acne Vulgaris	ENSG00000109320	FALSE	Preclinical	2015-10-23	Absent	NFKB1
Acne Vulgaris	ENSG00000111144	FALSE	unknown	2012-01-11	Absent	LTA4H
Acne Vulgaris	ENSG00000111319	TRUE	Approved	NA	Approved	SCNN1A
Acne Vulgaris	ENSG00000111424	TRUE	Approved	1994-08-15	Approved	VDR
Acne Vulgaris	ENSG00000112062	FALSE	Approved	NA	Absent	MAPK14
Acne Vulgaris	ENSG00000112115	FALSE	Phase II Clinical Trial	2013-04-16	Absent	IL17A
Acne Vulgaris	ENSG00000113161	FALSE	Preclinical	2008-02-11	Unused	HMGCR
Acne Vulgaris	ENSG00000113580	FALSE	Phase I Clinical Trial	NA	Unused	NR3C1
Acne Vulgaris	ENSG00000113749	FALSE	Preclinical	2009-09-29	Unused	HRH2
Acne Vulgaris	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Acne Vulgaris	ENSG00000116478	FALSE	Phase II Clinical Trial	2005-07-11	Unused	HDAC1
Acne Vulgaris	ENSG00000125538	FALSE	Preclinical	2006-01-18	Phase II Clinical Trial	IL1B
Acne Vulgaris	ENSG00000131759	TRUE	Approved	1991-02-15	Approved	RARA
Acne Vulgaris	ENSG00000140009	FALSE	Phase I Clinical Trial	2009-05-18	Unused	ESR2
Acne Vulgaris	ENSG00000142319	FALSE	Preclinical	2009-09-29	Unused	SLC6A3
Acne Vulgaris	ENSG00000145545	FALSE	Preclinical	1993-03-15	Unused	SRD5A1
Acne Vulgaris	ENSG00000151623	TRUE	Approved	NA	Approved	NR3C2
Acne Vulgaris	ENSG00000166825	FALSE	Phase II Clinical Trial	2007-09-25	Unused	ANPEP
Acne Vulgaris	ENSG00000169083	FALSE	Approved	1991-09-15	Unused	AR
Acne Vulgaris	ENSG00000172819	TRUE	Approved	1991-02-15	Approved	RARG
Acne Vulgaris	ENSG00000175445	FALSE	Phase I Clinical Trial	NA	Unused	LPL
Acne Vulgaris	ENSG00000176136	FALSE	Phase II Clinical Trial	2009-06-23	Phase II Clinical Trial	MC5R
Acne Vulgaris	ENSG00000196591	FALSE	Phase II Clinical Trial	2005-07-11	Unused	HDAC2
Acne Vulgaris	ENSG00000196611	FALSE	Preclinical	1995-06-15	Unused	MMP1
Acne Vulgaris	ENSG00000196639	FALSE	Preclinical	2009-09-29	Unused	HRH1
Acne Vulgaris	ENSG00000197635	FALSE	Phase II Clinical Trial	2007-09-25	Unused	DPP4
Acne Vulgaris	ENSG00000228716	TRUE	Approved	1999-03-08	Approved	DHFR
Acne Vulgaris	ENSG00000258839	FALSE	Phase II Clinical Trial	2011-04-01	Phase II Clinical Trial	MC1R
Acne Vulgaris	ENSG00000277893	FALSE	Phase II Clinical Trial	2013-09-27	Absent	SRD5A2
Acne Vulgaris	ENSG00000278540	FALSE	Phase II Clinical Trial	2011-01-18	Absent	ACACA
Acromegaly	ENSG00000017427	FALSE	Phase II Clinical Trial	2004-08-17	Phase II Clinical Trial	IGF1
Acromegaly	ENSG00000106128	FALSE	Phase I Clinical Trial	2015-07-27	Absent	GHRHR
Acromegaly	ENSG00000112964	TRUE	Approved	1993-06-15	Approved	GHR
Acromegaly	ENSG00000121853	FALSE	Preclinical	2003-07-07	Unused	GHSR
Acromegaly	ENSG00000132671	FALSE	Phase II Clinical Trial	1998-09-15	Phase II Clinical Trial	SSTR4
Acromegaly	ENSG00000135914	TRUE	Approved	NA	Approved	HTR2B
Acromegaly	ENSG00000139874	TRUE	Approved	2002-11-27	Phase III Clinical Trial	SSTR1
Acromegaly	ENSG00000140443	FALSE	unknown	NA	Unused	IGF1R
Acromegaly	ENSG00000149295	TRUE	Approved	2016-01-28	Approved	DRD2
Acromegaly	ENSG00000162009	TRUE	Approved	1998-09-15	Phase III Clinical Trial	SSTR5
Acromegaly	ENSG00000180616	TRUE	Approved	1998-08-15	Phase III Clinical Trial	SSTR2
Acromegaly	ENSG00000278195	TRUE	Approved	2002-11-27	Phase III Clinical Trial	SSTR3
Acute Chest Syndrome	ENSG00000069764	FALSE	unknown	1998-04-15	Unused	PLA2G10
Acute Chest Syndrome	ENSG00000146070	FALSE	unknown	1998-04-15	Unused	PLA2G7
Acute Chest Syndrome	ENSG00000184381	FALSE	unknown	1998-04-15	Unused	PLA2G6
Acute Chest Syndrome	ENSG00000188257	FALSE	unknown	1998-04-15	Unused	PLA2G2A
Acute Coronary Syndrome	ENSG00000005381	FALSE	Phase I Clinical Trial	2012-08-10	Absent	MPO
Acute Coronary Syndrome	ENSG00000005421	FALSE	Preclinical	2010-04-30	Absent	PON1
Acute Coronary Syndrome	ENSG00000005961	TRUE	Approved	1991-08-15	Approved	ITGA2B
Acute Coronary Syndrome	ENSG00000012779	FALSE	unknown	1994-10-15	Unused	ALOX5
Acute Coronary Syndrome	ENSG00000057593	FALSE	unknown	1992-03-15	Unused	F7
Acute Coronary Syndrome	ENSG00000073756	FALSE	Phase I Clinical Trial	2011-08-25	Phase I Clinical Trial	PTGS2
Acute Coronary Syndrome	ENSG00000087237	FALSE	Phase III Clinical Trial	2001-08-21	Absent	CETP
Acute Coronary Syndrome	ENSG00000088053	FALSE	Phase II Clinical Trial	2004-01-23	Phase II Clinical Trial	GP6
Acute Coronary Syndrome	ENSG00000095303	FALSE	Phase I Clinical Trial	2011-08-25	Phase I Clinical Trial	PTGS1
Acute Coronary Syndrome	ENSG00000101981	FALSE	Phase II Clinical Trial	2004-01-19	Phase II Clinical Trial	F9
Acute Coronary Syndrome	ENSG00000109320	FALSE	unknown	1994-09-15	Unused	NFKB1
Acute Coronary Syndrome	ENSG00000110799	FALSE	unknown	2003-07-09	Unused	VWF
Acute Coronary Syndrome	ENSG00000112062	FALSE	Phase III Clinical Trial	2006-05-19	Absent	MAPK14
Acute Coronary Syndrome	ENSG00000113161	FALSE	unknown	1997-02-15	Phase III Clinical Trial	HMGCR
Acute Coronary Syndrome	ENSG00000117525	FALSE	Phase I Clinical Trial	1992-03-15	Unused	F3
Acute Coronary Syndrome	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Acute Coronary Syndrome	ENSG00000118137	FALSE	Phase III Clinical Trial	2006-04-04	Phase II Clinical Trial	APOA1
Acute Coronary Syndrome	ENSG00000122861	FALSE	Preclinical	2013-05-22	Absent	PLAU
Acute Coronary Syndrome	ENSG00000125538	FALSE	unknown	2006-01-18	Phase II Clinical Trial	IL1B
Acute Coronary Syndrome	ENSG00000126218	TRUE	Approved	1992-03-15	Approved	F10
Acute Coronary Syndrome	ENSG00000130203	FALSE	Preclinical	2010-04-30	Preclinical	APOE
Acute Coronary Syndrome	ENSG00000131408	FALSE	Preclinical	2014-07-21	Absent	NR1H2
Acute Coronary Syndrome	ENSG00000143839	FALSE	Phase II Clinical Trial	2000-11-23	Phase II Clinical Trial	REN
Acute Coronary Syndrome	ENSG00000144891	FALSE	Phase III Clinical Trial	1992-05-15	Phase III Clinical Trial	AGTR1
Acute Coronary Syndrome	ENSG00000146070	FALSE	unknown	2000-11-07	Phase III Clinical Trial	PLA2G7
Acute Coronary Syndrome	ENSG00000150782	FALSE	Phase I Clinical Trial	2011-03-26	Unused	IL18
Acute Coronary Syndrome	ENSG00000159640	FALSE	Phase II Clinical Trial	2003-06-05	Unused	ACE
Acute Coronary Syndrome	ENSG00000164111	FALSE	Preclinical	2008-08-15	Preclinical	ANXA5
Acute Coronary Syndrome	ENSG00000169174	FALSE	Phase II Clinical Trial	2009-10-13	Phase II Clinical Trial	PCSK9
Acute Coronary Syndrome	ENSG00000169313	TRUE	Approved	1993-08-15	Approved	P2RY12
Acute Coronary Syndrome	ENSG00000171105	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	INSR
Acute Coronary Syndrome	ENSG00000174175	FALSE	unknown	2006-11-27	Absent	SELP
Acute Coronary Syndrome	ENSG00000180210	TRUE	Approved	1991-02-15	Approved	F2
Acute Coronary Syndrome	ENSG00000181104	FALSE	Phase II Clinical Trial	2003-03-03	Unused	F2R
Acute Coronary Syndrome	ENSG00000185245	FALSE	Phase II Clinical Trial	2009-10-08	Phase II Clinical Trial	GP1BA
Acute Coronary Syndrome	ENSG00000196611	FALSE	unknown	1995-06-15	Unused	MMP1
Acute Coronary Syndrome	ENSG00000205542	FALSE	Phase I Clinical Trial	2012-03-22	Absent	TMSB4X
Acute Coronary Syndrome	ENSG00000213398	FALSE	Phase II Clinical Trial	NA	Absent	LCAT
Acute Coronary Syndrome	ENSG00000259207	TRUE	Approved	1991-08-15	Approved	ITGB3
Acute Coronary Syndrome	ENSG00000269858	FALSE	Preclinical	2008-05-27	Preclinical	EGLN2
Acute Lung Injury	ENSG00000007908	FALSE	Phase I Clinical Trial	1994-02-15	Phase I Clinical Trial	SELE
Acute Lung Injury	ENSG00000019991	FALSE	unknown	2009-01-13	Absent	HGF
Acute Lung Injury	ENSG00000067182	FALSE	Phase II Clinical Trial	2009-11-16	Phase II Clinical Trial	TNFRSF1A
Acute Lung Injury	ENSG00000082781	FALSE	Preclinical	NA	Unused	ITGB5
Acute Lung Injury	ENSG00000091879	FALSE	Preclinical	2006-11-07	Unused	ANGPT2
Acute Lung Injury	ENSG00000106799	FALSE	Preclinical	2003-07-10	Unused	TGFBR1
Acute Lung Injury	ENSG00000112062	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	MAPK14
Acute Lung Injury	ENSG00000114812	FALSE	Phase I Clinical Trial	2003-12-09	Phase I Clinical Trial	VIPR1
Acute Lung Injury	ENSG00000117525	FALSE	Phase II Clinical Trial	2003-04-08	Phase II Clinical Trial	F3
Acute Lung Injury	ENSG00000128271	FALSE	unknown	1998-08-15	Phase I Clinical Trial	ADORA2A
Acute Lung Injury	ENSG00000130234	FALSE	Phase II Clinical Trial	2007-07-13	Phase II Clinical Trial	ACE2
Acute Lung Injury	ENSG00000130368	FALSE	Preclinical	2010-09-20	Preclinical	MAS1
Acute Lung Injury	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Acute Lung Injury	ENSG00000138448	FALSE	Preclinical	NA	Unused	ITGAV
Acute Lung Injury	ENSG00000142166	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	IFNAR1
Acute Lung Injury	ENSG00000149021	FALSE	Preclinical	2009-07-17	Absent	SCGB1A1
Acute Lung Injury	ENSG00000159110	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	IFNAR2
Acute Lung Injury	ENSG00000163737	FALSE	Preclinical	2009-12-01	Preclinical	PF4
Acute Lung Injury	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Acute Lung Injury	ENSG00000166311	FALSE	Preclinical	2009-10-20	Unused	SMPD1
Acute Lung Injury	ENSG00000168209	FALSE	unknown	2003-10-14	Preclinical	DDIT4
Acute Lung Injury	ENSG00000169429	FALSE	unknown	2005-10-17	Preclinical	CXCL8
Acute Lung Injury	ENSG00000170458	FALSE	unknown	1999-01-25	Unused	CD14
Acute Lung Injury	ENSG00000174175	FALSE	Phase I Clinical Trial	1994-02-15	Phase I Clinical Trial	SELP
Acute Lung Injury	ENSG00000188404	FALSE	Phase I Clinical Trial	1994-02-15	Phase I Clinical Trial	SELL
Acute Lung Injury	ENSG00000197249	FALSE	Preclinical	2009-12-01	Absent	SERPINA1
Acute Lung Injury	ENSG00000197561	FALSE	Approved	1991-08-15	Unused	ELANE
Acute Lung Injury	ENSG00000261371	FALSE	Preclinical	2010-04-29	Absent	PECAM1
Acute Lung Injury	ENSG00000271503	FALSE	Preclinical	2009-12-01	Preclinical	CCL5
Addison Disease	ENSG00000057252	FALSE	Phase II Clinical Trial	NA	Absent	SOAT1
Addison Disease	ENSG00000113580	TRUE	Approved	2014-11-28	Approved	NR3C1
Addison Disease	ENSG00000120088	FALSE	Phase II Clinical Trial	2007-03-15	Absent	CRHR1
Addison Disease	ENSG00000169083	FALSE	unknown	1997-09-15	Unused	AR
Addison Disease	ENSG00000185231	FALSE	Approved	2013-09-03	Absent	MC2R
Adenomatous Polyposis Coli	ENSG00000073756	TRUE	Approved	1996-10-15	Approved	PTGS2
Adenomatous Polyposis Coli	ENSG00000104267	FALSE	unknown	2006-08-11	Absent	CA2
Adenomatous Polyposis Coli	ENSG00000113712	FALSE	Preclinical	2014-08-02	Absent	CSNK1A1
Adenomatous Polyposis Coli	ENSG00000115758	FALSE	Phase III Clinical Trial	1996-05-15	Phase III Clinical Trial	ODC1
Adenomatous Polyposis Coli	ENSG00000116478	FALSE	unknown	2003-02-03	Unused	HDAC1
Adenomatous Polyposis Coli	ENSG00000138735	FALSE	unknown	1994-12-15	Unused	PDE5A
Adenomatous Polyposis Coli	ENSG00000159640	FALSE	Preclinical	2016-12-28	Absent	ACE
Adenomatous Polyposis Coli	ENSG00000168036	FALSE	Phase II Clinical Trial	2007-06-04	Unused	CTNNB1
Adenomatous Polyposis Coli	ENSG00000186642	FALSE	unknown	1994-12-15	Unused	PDE2A
Adenomatous Polyposis Coli	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-11-15	Absent	PDCD1
Adenomatous Polyposis Coli	ENSG00000196591	FALSE	unknown	2003-02-03	Unused	HDAC2
Adenoviridae Infections	ENSG00000100312	FALSE	unknown	2002-03-20	Absent	ACR
Adenoviridae Infections	ENSG00000113580	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	NR3C1
Adenoviridae Infections	ENSG00000114378	FALSE	unknown	2002-03-20	Absent	HYAL1
Adenoviridae Infections	ENSG00000128052	FALSE	Preclinical	2017-12-19	Absent	KDR
Adrenal Gland Neoplasms	ENSG00000037280	FALSE	Phase I Clinical Trial	2003-08-12	Absent	FLT4
Adrenal Gland Neoplasms	ENSG00000057252	FALSE	Phase I Clinical Trial	NA	Absent	SOAT1
Adrenal Gland Neoplasms	ENSG00000066468	FALSE	Phase I Clinical Trial	2009-10-16	Absent	FGFR2
Adrenal Gland Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase I Clinical Trial	TNFRSF1A
Adrenal Gland Neoplasms	ENSG00000068078	FALSE	Phase I Clinical Trial	2009-10-16	Absent	FGFR3
Adrenal Gland Neoplasms	ENSG00000077782	FALSE	Phase I Clinical Trial	2009-10-16	Absent	FGFR1
Adrenal Gland Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Adrenal Gland Neoplasms	ENSG00000102755	FALSE	unknown	2003-12-08	Unused	FLT1
Adrenal Gland Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2015-09-21	Absent	PIK3CG
Adrenal Gland Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	TGFBR1
Adrenal Gland Neoplasms	ENSG00000112715	FALSE	Phase I Clinical Trial	2003-08-12	Unused	VEGFA
Adrenal Gland Neoplasms	ENSG00000116016	FALSE	Preclinical	2015-07-29	Absent	EPAS1
Adrenal Gland Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	1997-05-15	Unused	CDK2
Adrenal Gland Neoplasms	ENSG00000128052	FALSE	Phase I Clinical Trial	2003-08-12	Unused	KDR
Adrenal Gland Neoplasms	ENSG00000131724	FALSE	unknown	1996-10-15	Absent	IL13RA1
Adrenal Gland Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Adrenal Gland Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK9
Adrenal Gland Neoplasms	ENSG00000136931	FALSE	Preclinical	2010-09-02	Preclinical	NR5A1
Adrenal Gland Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2006-04-25	Unused	IGF1R
Adrenal Gland Neoplasms	ENSG00000141736	FALSE	Phase I Clinical Trial	2003-08-12	Unused	ERBB2
Adrenal Gland Neoplasms	ENSG00000146648	FALSE	Phase I Clinical Trial	2003-08-12	Unused	EGFR
Adrenal Gland Neoplasms	ENSG00000166851	FALSE	Preclinical	2008-04-11	Absent	PLK1
Adrenal Gland Neoplasms	ENSG00000167658	FALSE	unknown	1996-10-15	Absent	EEF2
Adrenal Gland Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Adrenal Gland Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Absent	CD248
Adrenal Gland Neoplasms	ENSG00000178568	FALSE	unknown	2003-12-08	Unused	ERBB4
Adrenal Gland Neoplasms	ENSG00000196411	FALSE	Phase I Clinical Trial	2003-08-12	Unused	EPHB4
Adrenal Gland Neoplasms	ENSG00000197122	FALSE	Phase I Clinical Trial	2003-08-12	Unused	SRC
Adrenal Gland Neoplasms	ENSG00000198900	FALSE	unknown	2007-03-28	Unused	TOP1
Adrenoleukodystrophy	ENSG00000101986	FALSE	Phase III Clinical Trial	2005-01-10	Phase II Clinical Trial	ABCD1
Adrenoleukodystrophy	ENSG00000121966	FALSE	unknown	2000-06-06	Unused	CXCR4
Adrenoleukodystrophy	ENSG00000132170	FALSE	Phase III Clinical Trial	NA	Absent	PPARG
Adrenoleukodystrophy	ENSG00000151090	FALSE	Preclinical	2005-04-25	Absent	THRB
Adrenoleukodystrophy	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Adrenoleukodystrophy	ENSG00000160791	FALSE	unknown	2000-06-06	Unused	CCR5
Adrenoleukodystrophy	ENSG00000171862	FALSE	Preclinical	1999-02-15	Absent	PTEN
Adrenoleukodystrophy	ENSG00000197272	FALSE	Phase III Clinical Trial	2004-08-03	Phase III Clinical Trial	IL27
Adrenoleukodystrophy	ENSG00000198793	FALSE	Preclinical	1999-02-15	Absent	MTOR
Afibrinogenemia	ENSG00000171557	TRUE	Approved	1999-07-08	Approved	FGG
Afibrinogenemia	ENSG00000171560	TRUE	Approved	1999-07-08	Approved	FGA
Afibrinogenemia	ENSG00000171564	TRUE	Approved	1999-07-08	Approved	FGB
Afibrinogenemia	ENSG00000180210	FALSE	Approved	NA	Absent	F2
Agammaglobulinemia	ENSG00000010671	FALSE	Preclinical	2011-05-23	Unused	BTK
Agranulocytosis	ENSG00000198223	TRUE	Approved	NA	Approved	CSF2RA
AIDS Dementia Complex	ENSG00000111537	FALSE	Preclinical	2003-10-06	Unused	IFNG
AIDS Dementia Complex	ENSG00000169403	FALSE	unknown	NA	Unused	PTAFR
AIDS Dementia Complex	ENSG00000172216	FALSE	Preclinical	1994-11-15	Unused	CEBPB
AIDS Dementia Complex	ENSG00000176884	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	GRIN1
AIDS Dementia Complex	ENSG00000197919	FALSE	Preclinical	2003-10-06	Unused	IFNA1
Akathisia, Drug-Induced	ENSG00000128271	FALSE	unknown	1995-06-15	Unused	ADORA2A
Alagille Syndrome	ENSG00000012504	FALSE	Phase II Clinical Trial	1999-03-17	Absent	NR1H4
Albinism	ENSG00000258839	FALSE	Preclinical	2003-06-05	Absent	MC1R
Alcohol-Induced Disorders, Nervous System	ENSG00000111275	FALSE	Phase II Clinical Trial	2007-10-31	Phase II Clinical Trial	ALDH2
Alcoholic Intoxication	ENSG00000111275	FALSE	Preclinical	2014-08-27	Absent	ALDH2
Alcoholism	ENSG00000011677	TRUE	Approved	2009-07-16	Approved	GABRA3
Alcoholism	ENSG00000022355	TRUE	Approved	2009-07-16	Approved	GABRA1
Alcoholism	ENSG00000065989	FALSE	Phase II Clinical Trial	NA	Absent	PDE4A
Alcoholism	ENSG00000069535	FALSE	Preclinical	2012-07-03	Absent	MAOB
Alcoholism	ENSG00000069696	FALSE	Phase II Clinical Trial	1989-12-15	Unused	DRD4
Alcoholism	ENSG00000080644	FALSE	unknown	2010-11-08	Unused	CHRNA3
Alcoholism	ENSG00000082556	TRUE	Approved	1999-04-21	Approved	OPRK1
Alcoholism	ENSG00000087085	FALSE	Preclinical	2002-07-03	Unused	ACHE
Alcoholism	ENSG00000101180	TRUE	Approved	2005-10-18	Unused	HRH3
Alcoholism	ENSG00000102468	FALSE	Phase II Clinical Trial	1989-12-15	Phase II Clinical Trial	HTR2A
Alcoholism	ENSG00000103546	FALSE	Preclinical	2002-02-26	Unused	SLC6A2
Alcoholism	ENSG00000105650	FALSE	Phase II Clinical Trial	NA	Absent	PDE4C
Alcoholism	ENSG00000108576	TRUE	Approved	2002-02-26	Approved	SLC6A4
Alcoholism	ENSG00000111275	FALSE	Phase I Clinical Trial	2007-01-29	Unused	ALDH2
Alcoholism	ENSG00000112038	TRUE	Approved	1999-04-21	Approved	OPRM1
Alcoholism	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Absent	PDE10A
Alcoholism	ENSG00000113448	FALSE	Phase II Clinical Trial	NA	Absent	PDE4D
Alcoholism	ENSG00000115353	FALSE	Phase II Clinical Trial	1999-06-01	Unused	TACR1
Alcoholism	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRD1
Alcoholism	ENSG00000117971	FALSE	unknown	2010-11-08	Unused	CHRNB4
Alcoholism	ENSG00000118432	FALSE	unknown	1994-02-15	Unused	CNR1
Alcoholism	ENSG00000120907	FALSE	Phase I Clinical Trial	2007-04-02	Unused	ADRA1A
Alcoholism	ENSG00000121764	FALSE	Preclinical	2012-03-22	Preclinical	HCRTR1
Alcoholism	ENSG00000121853	FALSE	Preclinical	2004-03-12	Unused	GHSR
Alcoholism	ENSG00000125510	FALSE	Phase II Clinical Trial	2009-10-01	Phase I Clinical Trial	OPRL1
Alcoholism	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Absent	PDE11A
Alcoholism	ENSG00000132170	FALSE	Preclinical	2009-09-28	Preclinical	PPARG
Alcoholism	ENSG00000133019	FALSE	Phase I Clinical Trial	2007-04-02	Unused	CHRM3
Alcoholism	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Alcoholism	ENSG00000142319	FALSE	Preclinical	2002-02-26	Unused	SLC6A3
Alcoholism	ENSG00000147246	FALSE	Phase II Clinical Trial	1989-12-15	Unused	HTR2C
Alcoholism	ENSG00000149295	FALSE	Phase III Clinical Trial	1989-12-15	Phase II Clinical Trial	DRD2
Alcoholism	ENSG00000150594	FALSE	unknown	NA	Unused	ADRA2A
Alcoholism	ENSG00000151577	FALSE	Phase II Clinical Trial	1989-12-15	Unused	DRD3
Alcoholism	ENSG00000151834	TRUE	Approved	2009-07-16	Approved	GABRA2
Alcoholism	ENSG00000153956	FALSE	Phase II Clinical Trial	2002-11-25	Absent	CACNA2D1
Alcoholism	ENSG00000155511	FALSE	Phase II Clinical Trial	2011-05-26	Phase II Clinical Trial	GRIA1
Alcoholism	ENSG00000158748	FALSE	Phase I Clinical Trial	2007-04-02	Unused	HTR6
Alcoholism	ENSG00000166736	FALSE	Phase II Clinical Trial	2007-04-02	Phase II Clinical Trial	HTR3A
Alcoholism	ENSG00000168539	FALSE	Phase I Clinical Trial	2007-04-02	Unused	CHRM1
Alcoholism	ENSG00000168959	FALSE	Phase II Clinical Trial	2013-05-04	Absent	GRM5
Alcoholism	ENSG00000169836	FALSE	unknown	2009-03-06	Unused	TACR3
Alcoholism	ENSG00000171132	FALSE	Preclinical	2008-04-02	Unused	PRKCE
Alcoholism	ENSG00000176884	FALSE	Phase II Clinical Trial	1998-12-15	Unused	GRIN1
Alcoholism	ENSG00000178394	FALSE	Phase III Clinical Trial	1992-10-15	Phase II Clinical Trial	HTR1A
Alcoholism	ENSG00000179142	FALSE	Preclinical	2009-07-16	Preclinical	CYP11B2
Alcoholism	ENSG00000180720	FALSE	Phase I Clinical Trial	2007-04-02	Unused	CHRM4
Alcoholism	ENSG00000181072	FALSE	Phase I Clinical Trial	2007-04-02	Unused	CHRM2
Alcoholism	ENSG00000183873	FALSE	Phase II Clinical Trial	2011-05-26	Phase II Clinical Trial	SCN5A
Alcoholism	ENSG00000184588	FALSE	Phase II Clinical Trial	NA	Absent	PDE4B
Alcoholism	ENSG00000184845	FALSE	Phase III Clinical Trial	1989-12-15	Phase II Clinical Trial	DRD1
Alcoholism	ENSG00000186297	TRUE	Approved	2009-07-16	Approved	GABRA5
Alcoholism	ENSG00000189221	FALSE	Preclinical	2002-07-03	Unused	MAOA
Alcoholism	ENSG00000196277	FALSE	Preclinical	2011-04-26	Unused	GRM7
Alcoholism	ENSG00000196517	FALSE	Phase II Clinical Trial	2006-03-27	Unused	SLC6A9
Alcoholism	ENSG00000196639	FALSE	unknown	2002-04-03	Phase II Clinical Trial	HRH1
Alcoholism	ENSG00000198049	FALSE	Phase II Clinical Trial	2010-01-18	Preclinical	AVPR1B
Alcoholism	ENSG00000240972	FALSE	Phase II Clinical Trial	NA	Absent	MIF
Alkaptonuria	ENSG00000158104	FALSE	Phase II Clinical Trial	1992-11-15	Absent	HPD
Alopecia	ENSG00000017427	FALSE	Preclinical	2014-05-12	Absent	IGF1
Alopecia	ENSG00000069431	FALSE	Pre-registration	2016-11-08	Absent	ABCC9
Alopecia	ENSG00000100985	FALSE	Preclinical	1995-01-15	Unused	MMP9
Alopecia	ENSG00000105639	FALSE	Preclinical	2008-08-11	Absent	JAK3
Alopecia	ENSG00000105976	FALSE	Preclinical	2007-07-04	Unused	MET
Alopecia	ENSG00000106799	FALSE	Preclinical	2012-11-16	Preclinical	TGFBR1
Alopecia	ENSG00000111424	FALSE	Phase I Clinical Trial	2012-05-17	Phase I Clinical Trial	VDR
Alopecia	ENSG00000112115	FALSE	unknown	NA	Phase II Clinical Trial	IL17A
Alopecia	ENSG00000115232	FALSE	unknown	NA	Phase II Clinical Trial	ITGA4
Alopecia	ENSG00000121361	FALSE	Pre-registration	1992-11-15	Unused	KCNJ8
Alopecia	ENSG00000122420	FALSE	Phase II Clinical Trial	1991-07-15	Phase II Clinical Trial	PTGFR
Alopecia	ENSG00000123374	FALSE	Preclinical	1999-05-06	Unused	CDK2
Alopecia	ENSG00000137752	FALSE	unknown	NA	Phase II Clinical Trial	CASP1
Alopecia	ENSG00000138448	FALSE	unknown	NA	Phase II Clinical Trial	ITGAV
Alopecia	ENSG00000141510	FALSE	Preclinical	1999-09-22	Unused	TP53
Alopecia	ENSG00000143839	FALSE	Pre-registration	2016-11-08	Absent	REN
Alopecia	ENSG00000145545	TRUE	Approved	1994-02-15	Approved	SRD5A1
Alopecia	ENSG00000146648	FALSE	Preclinical	1996-09-15	Unused	EGFR
Alopecia	ENSG00000150782	FALSE	unknown	NA	Phase II Clinical Trial	IL18
Alopecia	ENSG00000152266	FALSE	Preclinical	2016-05-18	Absent	PTH
Alopecia	ENSG00000164078	FALSE	Preclinical	2007-07-04	Unused	MST1R
Alopecia	ENSG00000169083	FALSE	Phase II Clinical Trial	1993-09-15	Phase II Clinical Trial	AR
Alopecia	ENSG00000183134	FALSE	Phase II Clinical Trial	2007-02-22	Absent	PTGDR2
Alopecia	ENSG00000196611	FALSE	Preclinical	1995-01-15	Unused	MMP1
Alopecia	ENSG00000205542	FALSE	Preclinical	1995-01-15	Unused	TMSB4X
Alopecia	ENSG00000259207	FALSE	unknown	NA	Phase II Clinical Trial	ITGB3
Alopecia	ENSG00000277893	TRUE	Approved	1994-02-15	Approved	SRD5A2
Alopecia Areata	ENSG00000096968	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK2
Alopecia Areata	ENSG00000100453	FALSE	Preclinical	2013-03-12	Absent	GZMB
Alopecia Areata	ENSG00000105397	FALSE	Phase II Clinical Trial	2014-12-09	Absent	TYK2
Alopecia Areata	ENSG00000105639	FALSE	Phase II Clinical Trial	2008-08-11	Absent	JAK3
Alopecia Areata	ENSG00000111537	FALSE	Preclinical	1997-01-15	Unused	IFNG
Alopecia Areata	ENSG00000145839	FALSE	Preclinical	2014-10-28	Absent	IL9
Alopecia Areata	ENSG00000147168	FALSE	Preclinical	2014-10-28	Absent	IL2RG
Alopecia Areata	ENSG00000152266	FALSE	Preclinical	2016-05-18	Absent	PTH
Alopecia Areata	ENSG00000159110	FALSE	Preclinical	2014-12-16	Absent	IFNAR2
Alopecia Areata	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK1
Alopecia Areata	ENSG00000164136	FALSE	Preclinical	2014-10-28	Absent	IL15
Alopecia Areata	ENSG00000196262	FALSE	Phase II Clinical Trial	2003-07-14	Unused	PPIA
Alopecia Areata	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
alpha 1-Antitrypsin Deficiency	ENSG00000026508	FALSE	Phase I Clinical Trial	NA	Unused	CD44
alpha 1-Antitrypsin Deficiency	ENSG00000100448	FALSE	Preclinical	NA	Unused	CTSG
alpha 1-Antitrypsin Deficiency	ENSG00000135744	TRUE	Approved	2014-10-13	Absent	AGT
alpha 1-Antitrypsin Deficiency	ENSG00000163737	FALSE	Preclinical	2009-12-01	Absent	PF4
alpha 1-Antitrypsin Deficiency	ENSG00000172819	FALSE	unknown	2001-01-23	Absent	RARG
alpha 1-Antitrypsin Deficiency	ENSG00000197249	TRUE	Approved	1995-02-15	Approved	SERPINA1
alpha 1-Antitrypsin Deficiency	ENSG00000197561	TRUE	Approved	1996-12-15	Approved	ELANE
alpha 1-Antitrypsin Deficiency	ENSG00000271503	FALSE	Preclinical	2009-12-01	Absent	CCL5
alpha-Mannosidosis	ENSG00000104774	FALSE	Phase III Clinical Trial	2001-12-14	Phase III Clinical Trial	MAN2B1
Alphavirus Infections	ENSG00000158859	FALSE	Phase II Clinical Trial	2015-09-03	Absent	ADAMTS4
Alstrom Syndrome	ENSG00000166603	FALSE	Phase II Clinical Trial	2009-01-09	Absent	MC4R
Alzheimer Disease	ENSG00000004487	FALSE	Phase I Clinical Trial	2010-07-08	Preclinical	KDM1A
Alzheimer Disease	ENSG00000006210	FALSE	Preclinical	2010-02-25	Absent	CX3CL1
Alzheimer Disease	ENSG00000006283	FALSE	Phase III Clinical Trial	2008-10-23	Phase II Clinical Trial	CACNA1G
Alzheimer Disease	ENSG00000007171	FALSE	unknown	1996-08-15	Unused	NOS2
Alzheimer Disease	ENSG00000010810	FALSE	Phase III Clinical Trial	2016-10-05	Absent	FYN
Alzheimer Disease	ENSG00000011083	FALSE	Phase II Clinical Trial	2003-06-27	Unused	SLC6A7
Alzheimer Disease	ENSG00000011677	FALSE	Phase II Clinical Trial	1998-11-15	Unused	GABRA3
Alzheimer Disease	ENSG00000012779	FALSE	Preclinical	1996-08-15	Unused	ALOX5
Alzheimer Disease	ENSG00000017797	FALSE	Preclinical	2015-05-25	Absent	RALBP1
Alzheimer Disease	ENSG00000019991	FALSE	unknown	2001-01-31	Unused	HGF
Alzheimer Disease	ENSG00000022355	FALSE	Phase II Clinical Trial	1998-11-15	Unused	GABRA1
Alzheimer Disease	ENSG00000025434	FALSE	Preclinical	2008-06-30	Unused	NR1H3
Alzheimer Disease	ENSG00000034152	FALSE	Preclinical	1997-02-15	Unused	MAP2K3
Alzheimer Disease	ENSG00000043591	FALSE	Preclinical	2014-11-20	Unused	ADRB1
Alzheimer Disease	ENSG00000050748	FALSE	unknown	2001-01-23	Absent	MAPK9
Alzheimer Disease	ENSG00000063176	FALSE	Preclinical	2013-01-22	Preclinical	SPHK2
Alzheimer Disease	ENSG00000064300	FALSE	Phase I Clinical Trial	1995-08-15	Phase I Clinical Trial	NGFR
Alzheimer Disease	ENSG00000065559	FALSE	Preclinical	1997-02-15	Unused	MAP2K4
Alzheimer Disease	ENSG00000065989	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4A
Alzheimer Disease	ENSG00000067182	FALSE	Preclinical	2009-06-09	Phase I Clinical Trial	TNFRSF1A
Alzheimer Disease	ENSG00000068078	FALSE	Phase III Clinical Trial	2016-08-25	Phase III Clinical Trial	FGFR3
Alzheimer Disease	ENSG00000069535	FALSE	Phase II Clinical Trial	1992-01-15	Phase II Clinical Trial	MAOB
Alzheimer Disease	ENSG00000069696	FALSE	Phase II Clinical Trial	1989-12-15	Unused	DRD4
Alzheimer Disease	ENSG00000070019	FALSE	Preclinical	2017-01-27	Absent	GUCY2C
Alzheimer Disease	ENSG00000070748	FALSE	Phase II Clinical Trial	2007-03-12	Phase II Clinical Trial	CHAT
Alzheimer Disease	ENSG00000073756	FALSE	Preclinical	1996-08-15	Unused	PTGS2
Alzheimer Disease	ENSG00000074416	FALSE	Preclinical	2015-09-02	Absent	MGLL
Alzheimer Disease	ENSG00000077782	FALSE	unknown	2004-06-16	Unused	FGFR1
Alzheimer Disease	ENSG00000079459	FALSE	Preclinical	1995-06-15	Unused	FDFT1
Alzheimer Disease	ENSG00000080815	FALSE	Phase I Clinical Trial	1997-05-15	Unused	PSEN1
Alzheimer Disease	ENSG00000080824	FALSE	Preclinical	2007-11-27	Unused	HSP90AA1
Alzheimer Disease	ENSG00000082701	FALSE	Phase II Clinical Trial	2003-05-02	Phase II Clinical Trial	GSK3B
Alzheimer Disease	ENSG00000085377	FALSE	Phase II Clinical Trial	1994-05-15	Unused	PREP
Alzheimer Disease	ENSG00000085563	FALSE	Preclinical	1999-10-27	Unused	ABCB1
Alzheimer Disease	ENSG00000087085	TRUE	Approved	1989-06-15	Approved	ACHE
Alzheimer Disease	ENSG00000089041	FALSE	Preclinical	2014-12-19	Absent	P2RX7
Alzheimer Disease	ENSG00000089250	FALSE	Preclinical	2003-08-01	Unused	NOS1
Alzheimer Disease	ENSG00000091831	FALSE	Preclinical	1995-05-15	Unused	ESR1
Alzheimer Disease	ENSG00000094631	FALSE	Preclinical	2016-09-29	Absent	HDAC6
Alzheimer Disease	ENSG00000095303	FALSE	Preclinical	1996-08-15	Unused	PTGS1
Alzheimer Disease	ENSG00000095596	FALSE	Preclinical	2014-12-31	Absent	CYP26A1
Alzheimer Disease	ENSG00000095970	FALSE	Preclinical	2017-11-16	Absent	TREM2
Alzheimer Disease	ENSG00000100030	FALSE	Preclinical	2004-03-30	Unused	MAPK1
Alzheimer Disease	ENSG00000100292	FALSE	Preclinical	2014-08-22	Absent	HMOX1
Alzheimer Disease	ENSG00000101126	FALSE	Phase II Clinical Trial	1999-04-21	Unused	ADNP
Alzheimer Disease	ENSG00000101180	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	HRH3
Alzheimer Disease	ENSG00000101204	FALSE	Phase II Clinical Trial	2000-12-12	Phase II Clinical Trial	CHRNA4
Alzheimer Disease	ENSG00000101444	FALSE	Preclinical	2010-08-28	Unused	AHCY
Alzheimer Disease	ENSG00000101557	FALSE	Preclinical	2011-04-27	Preclinical	USP14
Alzheimer Disease	ENSG00000101856	FALSE	Phase II Clinical Trial	2014-11-25	Absent	PGRMC1
Alzheimer Disease	ENSG00000102468	TRUE	Approved	1989-12-15	Phase III Clinical Trial	HTR2A
Alzheimer Disease	ENSG00000103546	FALSE	unknown	1997-10-15	Unused	SLC6A2
Alzheimer Disease	ENSG00000105464	FALSE	Preclinical	2011-07-28	Absent	GRIN2D
Alzheimer Disease	ENSG00000105639	FALSE	Preclinical	2012-08-17	Absent	JAK3
Alzheimer Disease	ENSG00000105650	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4C
Alzheimer Disease	ENSG00000105723	FALSE	Preclinical	2011-07-22	Absent	GSK3A
Alzheimer Disease	ENSG00000106144	FALSE	Preclinical	2001-09-12	Absent	CASP2
Alzheimer Disease	ENSG00000106366	FALSE	Phase I Clinical Trial	2006-07-24	Unused	SERPINE1
Alzheimer Disease	ENSG00000106804	FALSE	Preclinical	2015-11-23	Absent	C5
Alzheimer Disease	ENSG00000107643	FALSE	unknown	2001-01-23	Absent	MAPK8
Alzheimer Disease	ENSG00000108576	FALSE	Approved	1997-10-15	Unused	SLC6A4
Alzheimer Disease	ENSG00000109163	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	GNRHR
Alzheimer Disease	ENSG00000109320	FALSE	Preclinical	2009-05-27	Absent	NFKB1
Alzheimer Disease	ENSG00000109339	FALSE	Preclinical	2001-01-23	Absent	MAPK10
Alzheimer Disease	ENSG00000110090	FALSE	unknown	2013-01-15	Phase I Clinical Trial	CPT1A
Alzheimer Disease	ENSG00000110887	FALSE	Phase I Clinical Trial	2007-08-22	Unused	DAO
Alzheimer Disease	ENSG00000111276	FALSE	Preclinical	2003-08-26	Absent	CDKN1B
Alzheimer Disease	ENSG00000111640	FALSE	unknown	1998-10-15	Unused	GAPDH
Alzheimer Disease	ENSG00000112033	FALSE	Phase II Clinical Trial	2007-10-17	Absent	PPARD
Alzheimer Disease	ENSG00000112062	FALSE	Phase II Clinical Trial	1997-06-15	Unused	MAPK14
Alzheimer Disease	ENSG00000112164	FALSE	Phase I Clinical Trial	2015-10-06	Absent	GLP1R
Alzheimer Disease	ENSG00000112541	FALSE	Preclinical	2009-03-31	Unused	PDE10A
Alzheimer Disease	ENSG00000113161	FALSE	Phase III Clinical Trial	1991-07-15	Unused	HMGCR
Alzheimer Disease	ENSG00000113263	FALSE	Preclinical	2012-08-17	Absent	ITK
Alzheimer Disease	ENSG00000113441	FALSE	Preclinical	2005-06-13	Unused	LNPEP
Alzheimer Disease	ENSG00000113448	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4D
Alzheimer Disease	ENSG00000113575	FALSE	Phase II Clinical Trial	2007-08-17	Unused	PPP2CA
Alzheimer Disease	ENSG00000113580	FALSE	unknown	2002-02-05	Phase II Clinical Trial	NR3C1
Alzheimer Disease	ENSG00000113600	FALSE	Phase I Clinical Trial	2014-09-25	Absent	C9
Alzheimer Disease	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	PDGFRB
Alzheimer Disease	ENSG00000114200	TRUE	Approved	1999-04-21	Approved	BCHE
Alzheimer Disease	ENSG00000114859	FALSE	Preclinical	2005-12-31	Unused	CLCN2
Alzheimer Disease	ENSG00000115252	FALSE	Preclinical	2007-06-26	Unused	PDE1A
Alzheimer Disease	ENSG00000115457	FALSE	Phase I Clinical Trial	2010-10-19	Absent	IGFBP2
Alzheimer Disease	ENSG00000115594	FALSE	Preclinical	2009-06-09	Preclinical	IL1R1
Alzheimer Disease	ENSG00000115828	FALSE	Phase II Clinical Trial	2008-07-01	Phase I Clinical Trial	QPCT
Alzheimer Disease	ENSG00000116106	FALSE	Preclinical	2017-10-03	Absent	EPHA4
Alzheimer Disease	ENSG00000116288	FALSE	Preclinical	2013-12-17	Absent	PARK7
Alzheimer Disease	ENSG00000116329	FALSE	Phase III Clinical Trial	2008-01-16	Absent	OPRD1
Alzheimer Disease	ENSG00000116478	FALSE	Preclinical	2017-01-23	Absent	HDAC1
Alzheimer Disease	ENSG00000116678	FALSE	Preclinical	2009-08-04	Preclinical	LEPR
Alzheimer Disease	ENSG00000117594	FALSE	Phase II Clinical Trial	2009-09-15	Absent	HSD11B1
Alzheimer Disease	ENSG00000118271	FALSE	unknown	2006-02-01	Unused	TTR
Alzheimer Disease	ENSG00000118432	FALSE	Phase II Clinical Trial	2003-11-17	Phase II Clinical Trial	CNR1
Alzheimer Disease	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Alzheimer Disease	ENSG00000120217	FALSE	Preclinical	2017-06-20	Absent	CD274
Alzheimer Disease	ENSG00000120907	TRUE	Approved	1995-05-15	Approved	ADRA1A
Alzheimer Disease	ENSG00000120948	FALSE	Preclinical	2014-12-30	Absent	TARDBP
Alzheimer Disease	ENSG00000121807	FALSE	Preclinical	2011-02-08	Absent	CCR2
Alzheimer Disease	ENSG00000121966	FALSE	unknown	1995-12-15	Unused	CXCR4
Alzheimer Disease	ENSG00000125384	FALSE	Preclinical	2012-04-03	Preclinical	PTGER2
Alzheimer Disease	ENSG00000125538	FALSE	unknown	2009-06-09	Phase I Clinical Trial	IL1B
Alzheimer Disease	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Alzheimer Disease	ENSG00000128271	FALSE	Preclinical	2008-07-24	Unused	ADORA2A
Alzheimer Disease	ENSG00000128272	FALSE	Phase II Clinical Trial	1991-05-15	Unused	ATF4
Alzheimer Disease	ENSG00000130203	FALSE	Preclinical	1994-11-15	Unused	APOE
Alzheimer Disease	ENSG00000131408	FALSE	Preclinical	2008-06-30	Unused	NR1H2
Alzheimer Disease	ENSG00000131471	FALSE	Preclinical	2015-07-30	Absent	AOC3
Alzheimer Disease	ENSG00000131759	FALSE	Preclinical	2013-03-13	Absent	RARA
Alzheimer Disease	ENSG00000132170	FALSE	Phase III Clinical Trial	1989-09-15	Phase II Clinical Trial	PPARG
Alzheimer Disease	ENSG00000132703	FALSE	unknown	1995-07-15	Absent	APCS
Alzheimer Disease	ENSG00000133019	FALSE	Phase II Clinical Trial	1996-06-15	Phase I Clinical Trial	CHRM3
Alzheimer Disease	ENSG00000134259	FALSE	Phase II Clinical Trial	1992-07-15	Phase II Clinical Trial	NGF
Alzheimer Disease	ENSG00000134318	FALSE	Preclinical	2014-08-11	Absent	ROCK2
Alzheimer Disease	ENSG00000134640	FALSE	Phase III Clinical Trial	2000-07-11	Unused	MTNR1B
Alzheimer Disease	ENSG00000135312	FALSE	Phase II Clinical Trial	1998-01-15	Unused	HTR1B
Alzheimer Disease	ENSG00000135519	FALSE	unknown	2008-05-13	Absent	KCNH3
Alzheimer Disease	ENSG00000135914	FALSE	Phase II Clinical Trial	2008-01-15	Absent	HTR2B
Alzheimer Disease	ENSG00000136156	FALSE	Preclinical	2008-08-13	Unused	ITM2B
Alzheimer Disease	ENSG00000136160	FALSE	Phase II Clinical Trial	2016-04-28	Absent	EDNRB
Alzheimer Disease	ENSG00000136634	FALSE	Preclinical	2017-03-17	Absent	IL10
Alzheimer Disease	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Alzheimer Disease	ENSG00000137752	FALSE	Preclinical	1995-06-15	Unused	CASP1
Alzheimer Disease	ENSG00000138039	FALSE	unknown	2005-12-06	Unused	LHCGR
Alzheimer Disease	ENSG00000138794	FALSE	Preclinical	2013-01-03	Preclinical	CASP6
Alzheimer Disease	ENSG00000139625	FALSE	Preclinical	2006-02-22	Unused	MAP3K12
Alzheimer Disease	ENSG00000140009	FALSE	Phase II Clinical Trial	2009-05-18	Absent	ESR2
Alzheimer Disease	ENSG00000140443	FALSE	Phase I Clinical Trial	2010-10-19	Absent	IGF1R
Alzheimer Disease	ENSG00000140538	FALSE	Preclinical	2016-10-25	Absent	NTRK3
Alzheimer Disease	ENSG00000141551	FALSE	Phase I Clinical Trial	2013-01-03	Preclinical	CSNK1D
Alzheimer Disease	ENSG00000141655	FALSE	Preclinical	2016-06-21	Absent	TNFRSF11A
Alzheimer Disease	ENSG00000141867	FALSE	Phase I Clinical Trial	2005-03-04	Phase I Clinical Trial	BRD4
Alzheimer Disease	ENSG00000142168	FALSE	Preclinical	2007-10-12	Unused	SOD1
Alzheimer Disease	ENSG00000142192	FALSE	Phase III Clinical Trial	1989-12-15	Phase III Clinical Trial	APP
Alzheimer Disease	ENSG00000142208	FALSE	Preclinical	2005-12-19	Unused	AKT1
Alzheimer Disease	ENSG00000142319	FALSE	Preclinical	1997-10-15	Unused	SLC6A3
Alzheimer Disease	ENSG00000143171	FALSE	Phase I Clinical Trial	2013-05-02	Absent	RXRG
Alzheimer Disease	ENSG00000143258	FALSE	Preclinical	NA	Unused	USP21
Alzheimer Disease	ENSG00000143384	FALSE	Preclinical	2007-09-07	Unused	MCL1
Alzheimer Disease	ENSG00000143799	FALSE	Phase II Clinical Trial	2003-06-17	Unused	PARP1
Alzheimer Disease	ENSG00000143801	FALSE	Preclinical	1997-05-15	Unused	PSEN2
Alzheimer Disease	ENSG00000145335	FALSE	Phase I Clinical Trial	2013-05-08	Absent	SNCA
Alzheimer Disease	ENSG00000145632	FALSE	Preclinical	2016-09-15	Absent	PLK2
Alzheimer Disease	ENSG00000145708	FALSE	unknown	1993-06-15	Unused	CRHBP
Alzheimer Disease	ENSG00000145864	FALSE	Preclinical	2013-02-26	Preclinical	GABRB2
Alzheimer Disease	ENSG00000145936	FALSE	Preclinical	1995-10-15	Unused	KCNMB1
Alzheimer Disease	ENSG00000146070	FALSE	Phase II Clinical Trial	2003-02-28	Phase II Clinical Trial	PLA2G7
Alzheimer Disease	ENSG00000146216	FALSE	Preclinical	2014-05-26	Absent	TTBK1
Alzheimer Disease	ENSG00000146648	FALSE	Preclinical	2014-06-11	Absent	EGFR
Alzheimer Disease	ENSG00000146674	FALSE	Preclinical	2008-01-04	Preclinical	IGFBP3
Alzheimer Disease	ENSG00000147246	FALSE	Phase II Clinical Trial	1989-12-15	Unused	HTR2C
Alzheimer Disease	ENSG00000147955	FALSE	Phase III Clinical Trial	1995-12-15	Phase II Clinical Trial	SIGMAR1
Alzheimer Disease	ENSG00000148053	FALSE	Preclinical	2016-10-25	Preclinical	NTRK2
Alzheimer Disease	ENSG00000148344	FALSE	Phase I Clinical Trial	2006-12-19	Phase I Clinical Trial	PTGES
Alzheimer Disease	ENSG00000148408	FALSE	Preclinical	1993-06-15	Unused	CACNA1B
Alzheimer Disease	ENSG00000148680	FALSE	Phase II Clinical Trial	1995-05-15	Unused	HTR7
Alzheimer Disease	ENSG00000149294	FALSE	Preclinical	2004-06-16	Unused	NCAM1
Alzheimer Disease	ENSG00000149295	TRUE	Approved	1989-12-15	Approved	DRD2
Alzheimer Disease	ENSG00000150594	FALSE	Preclinical	1999-03-24	Unused	ADRA2A
Alzheimer Disease	ENSG00000151067	FALSE	Phase III Clinical Trial	2008-10-23	Phase II Clinical Trial	CACNA1C
Alzheimer Disease	ENSG00000151577	FALSE	Phase III Clinical Trial	1989-12-15	Unused	DRD3
Alzheimer Disease	ENSG00000151834	FALSE	Phase II Clinical Trial	1998-11-15	Unused	GABRA2
Alzheimer Disease	ENSG00000152207	FALSE	Preclinical	2015-11-12	Absent	CYSLTR2
Alzheimer Disease	ENSG00000155511	FALSE	Phase II Clinical Trial	1994-02-15	Unused	GRIA1
Alzheimer Disease	ENSG00000157404	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	KIT
Alzheimer Disease	ENSG00000157540	FALSE	Preclinical	2012-08-22	Preclinical	DYRK1A
Alzheimer Disease	ENSG00000158748	FALSE	Phase II Clinical Trial	1999-01-15	Phase II Clinical Trial	HTR6
Alzheimer Disease	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Alzheimer Disease	ENSG00000159164	FALSE	Phase II Clinical Trial	2012-11-26	Phase II Clinical Trial	SV2A
Alzheimer Disease	ENSG00000159267	FALSE	Preclinical	2007-05-21	Unused	HLCS
Alzheimer Disease	ENSG00000160191	FALSE	Phase II Clinical Trial	2005-09-12	Unused	PDE9A
Alzheimer Disease	ENSG00000160712	FALSE	Preclinical	2004-04-05	Unused	IL6R
Alzheimer Disease	ENSG00000160716	FALSE	Phase II Clinical Trial	2000-12-12	Phase II Clinical Trial	CHRNB2
Alzheimer Disease	ENSG00000160791	FALSE	Preclinical	1995-12-15	Unused	CCR5
Alzheimer Disease	ENSG00000161509	FALSE	Preclinical	2011-07-28	Absent	GRIN2C
Alzheimer Disease	ENSG00000162711	FALSE	Preclinical	2013-03-28	Absent	NLRP3
Alzheimer Disease	ENSG00000163131	FALSE	Preclinical	2009-01-20	Preclinical	CTSS
Alzheimer Disease	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Alzheimer Disease	ENSG00000163485	FALSE	Preclinical	1990-12-15	Unused	ADORA1
Alzheimer Disease	ENSG00000164078	FALSE	Preclinical	2015-04-27	Absent	MST1R
Alzheimer Disease	ENSG00000164082	FALSE	Phase II Clinical Trial	2003-11-12	Phase I Clinical Trial	GRM2
Alzheimer Disease	ENSG00000164270	FALSE	Phase II Clinical Trial	1997-06-15	Phase II Clinical Trial	HTR4
Alzheimer Disease	ENSG00000164305	FALSE	Preclinical	1997-03-15	Unused	CASP3
Alzheimer Disease	ENSG00000164362	FALSE	Phase II Clinical Trial	2002-06-26	Absent	TERT
Alzheimer Disease	ENSG00000164733	FALSE	Preclinical	1996-11-15	Unused	CTSB
Alzheimer Disease	ENSG00000164867	FALSE	unknown	2000-02-24	Unused	NOS3
Alzheimer Disease	ENSG00000164885	FALSE	Preclinical	2006-02-22	Unused	CDK5
Alzheimer Disease	ENSG00000165029	FALSE	Preclinical	2011-06-23	Preclinical	ABCA1
Alzheimer Disease	ENSG00000166206	FALSE	Preclinical	2013-02-26	Preclinical	GABRB3
Alzheimer Disease	ENSG00000166573	FALSE	Preclinical	1993-11-15	Unused	GALR1
Alzheimer Disease	ENSG00000167186	FALSE	Preclinical	2006-09-11	Unused	COQ7
Alzheimer Disease	ENSG00000167325	FALSE	unknown	2002-07-08	Unused	RRM1
Alzheimer Disease	ENSG00000167720	FALSE	Preclinical	2000-03-01	Unused	SRR
Alzheimer Disease	ENSG00000168412	FALSE	Phase III Clinical Trial	2000-07-11	Unused	MTNR1A
Alzheimer Disease	ENSG00000168522	FALSE	Phase I Clinical Trial	1999-01-15	Phase I Clinical Trial	FNTA
Alzheimer Disease	ENSG00000168539	FALSE	Pre-registration	1990-03-15	Phase II Clinical Trial	CHRM1
Alzheimer Disease	ENSG00000168610	FALSE	Preclinical	2010-10-07	Phase II Clinical Trial	STAT3
Alzheimer Disease	ENSG00000168959	FALSE	Preclinical	2006-09-20	Unused	GRM5
Alzheimer Disease	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Alzheimer Disease	ENSG00000169083	FALSE	Phase II Clinical Trial	1996-04-15	Unused	AR
Alzheimer Disease	ENSG00000169403	FALSE	Preclinical	1996-08-15	Unused	PTAFR
Alzheimer Disease	ENSG00000171049	FALSE	Preclinical	2003-02-21	Unused	FPR2
Alzheimer Disease	ENSG00000171105	FALSE	Phase III Clinical Trial	2003-07-23	Unused	INSR
Alzheimer Disease	ENSG00000171132	FALSE	Phase II Clinical Trial	2009-05-01	Absent	PRKCE
Alzheimer Disease	ENSG00000171497	FALSE	Preclinical	2015-10-20	Absent	PPID
Alzheimer Disease	ENSG00000171631	FALSE	Phase I Clinical Trial	2012-09-25	Absent	P2RY6
Alzheimer Disease	ENSG00000171720	FALSE	Preclinical	2011-01-21	Unused	HDAC3
Alzheimer Disease	ENSG00000171848	FALSE	unknown	2002-07-08	Unused	RRM2
Alzheimer Disease	ENSG00000171867	FALSE	Preclinical	1994-08-15	Unused	PRNP
Alzheimer Disease	ENSG00000172071	FALSE	Preclinical	NA	Absent	EIF2AK3
Alzheimer Disease	ENSG00000172350	FALSE	Preclinical	1999-06-23	Unused	ABCG4
Alzheimer Disease	ENSG00000173198	FALSE	Phase I Clinical Trial	NA	Absent	CYSLTR1
Alzheimer Disease	ENSG00000173250	FALSE	Preclinical	2009-06-27	Absent	GPR151
Alzheimer Disease	ENSG00000174417	FALSE	Phase III Clinical Trial	1990-01-15	Unused	TRHR
Alzheimer Disease	ENSG00000175344	FALSE	Phase II Clinical Trial	1997-10-15	Phase II Clinical Trial	CHRNA7
Alzheimer Disease	ENSG00000175899	FALSE	Preclinical	1999-05-11	Unused	A2M
Alzheimer Disease	ENSG00000176884	TRUE	Approved	1995-07-15	Approved	GRIN1
Alzheimer Disease	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Alzheimer Disease	ENSG00000178394	FALSE	Phase III Clinical Trial	1991-07-15	Phase III Clinical Trial	HTR1A
Alzheimer Disease	ENSG00000178568	FALSE	Preclinical	2010-10-27	Absent	ERBB4
Alzheimer Disease	ENSG00000179097	FALSE	Preclinical	2013-11-19	Absent	HTR1F
Alzheimer Disease	ENSG00000179546	FALSE	Phase II Clinical Trial	2008-01-15	Absent	HTR1D
Alzheimer Disease	ENSG00000179934	FALSE	Preclinical	2011-02-08	Absent	CCR8
Alzheimer Disease	ENSG00000180720	FALSE	Phase III Clinical Trial	1995-03-15	Unused	CHRM4
Alzheimer Disease	ENSG00000180739	FALSE	Preclinical	2016-01-28	Absent	S1PR5
Alzheimer Disease	ENSG00000181072	FALSE	Phase II Clinical Trial	1996-10-15	Phase I Clinical Trial	CHRM2
Alzheimer Disease	ENSG00000181773	FALSE	Preclinical	2006-01-26	Unused	GPR3
Alzheimer Disease	ENSG00000182687	FALSE	Preclinical	1993-11-15	Unused	GALR2
Alzheimer Disease	ENSG00000184160	FALSE	Phase II Clinical Trial	1999-03-24	Phase II Clinical Trial	ADRA2C
Alzheimer Disease	ENSG00000184588	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	PDE4B
Alzheimer Disease	ENSG00000184845	FALSE	Phase III Clinical Trial	1989-12-15	Phase III Clinical Trial	DRD1
Alzheimer Disease	ENSG00000185231	FALSE	unknown	NA	Unused	MC2R
Alzheimer Disease	ENSG00000186088	FALSE	Phase I Clinical Trial	2004-11-19	Absent	GSAP
Alzheimer Disease	ENSG00000186297	FALSE	Phase II Clinical Trial	1998-11-15	Unused	GABRA5
Alzheimer Disease	ENSG00000186318	FALSE	Phase III Clinical Trial	1999-07-20	Phase III Clinical Trial	BACE1
Alzheimer Disease	ENSG00000186350	FALSE	Phase I Clinical Trial	2013-05-02	Absent	RXRA
Alzheimer Disease	ENSG00000186642	FALSE	Preclinical	2009-03-31	Unused	PDE2A
Alzheimer Disease	ENSG00000186868	FALSE	Phase III Clinical Trial	2006-07-26	Phase III Clinical Trial	MAPT
Alzheimer Disease	ENSG00000186951	FALSE	Phase I Clinical Trial	2008-05-12	Phase I Clinical Trial	PPARA
Alzheimer Disease	ENSG00000187266	FALSE	unknown	2005-12-06	Unused	EPOR
Alzheimer Disease	ENSG00000188389	FALSE	Preclinical	2017-06-20	Absent	PDCD1
Alzheimer Disease	ENSG00000188822	FALSE	Preclinical	2017-11-30	Absent	CNR2
Alzheimer Disease	ENSG00000188906	FALSE	Preclinical	2009-03-23	Unused	LRRK2
Alzheimer Disease	ENSG00000189221	FALSE	Preclinical	2011-08-20	Unused	MAOA
Alzheimer Disease	ENSG00000196218	FALSE	Preclinical	2012-09-07	Absent	RYR1
Alzheimer Disease	ENSG00000196517	FALSE	Phase II Clinical Trial	2008-05-13	Unused	SLC6A9
Alzheimer Disease	ENSG00000196549	FALSE	Preclinical	2014-06-17	Absent	MME
Alzheimer Disease	ENSG00000196591	FALSE	Preclinical	2014-01-10	Absent	HDAC2
Alzheimer Disease	ENSG00000196639	FALSE	Phase III Clinical Trial	2002-04-03	Phase III Clinical Trial	HRH1
Alzheimer Disease	ENSG00000197386	FALSE	Phase II Clinical Trial	2003-06-17	Absent	HTT
Alzheimer Disease	ENSG00000198223	FALSE	Phase II Clinical Trial	NA	Absent	CSF2RA
Alzheimer Disease	ENSG00000198400	FALSE	Preclinical	2009-11-09	Unused	NTRK1
Alzheimer Disease	ENSG00000198408	FALSE	Preclinical	2010-08-11	Preclinical	OGA
Alzheimer Disease	ENSG00000198822	FALSE	Phase I Clinical Trial	2003-11-12	Phase I Clinical Trial	GRM3
Alzheimer Disease	ENSG00000213923	FALSE	Phase I Clinical Trial	2015-05-18	Absent	CSNK1E
Alzheimer Disease	ENSG00000240972	FALSE	Preclinical	2012-06-15	Absent	MIF
Alzheimer Disease	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Alzheimer Disease	ENSG00000273079	FALSE	Preclinical	1997-12-15	Phase I Clinical Trial	GRIN2B
Alzheimer Disease	ENSG00000274286	FALSE	Preclinical	1999-03-24	Unused	ADRA2B
Amblyopia	ENSG00000108576	FALSE	Phase II Clinical Trial	2010-10-09	Absent	SLC6A4
Amenorrhea	ENSG00000082175	TRUE	Approved	1989-10-15	Approved	PGR
Amenorrhea	ENSG00000109163	FALSE	Preclinical	1995-12-15	Unused	GNRHR
Amenorrhea	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Amino Acid Metabolism, Inborn Errors	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Amino Acid Metabolism, Inborn Errors	ENSG00000132437	FALSE	Phase II Clinical Trial	2016-02-04	Absent	DDC
Amino Acid Metabolism, Inborn Errors	ENSG00000198793	FALSE	Preclinical	2016-07-22	Absent	MTOR
Amnesia	ENSG00000011677	FALSE	unknown	2004-01-05	Unused	GABRA3
Amnesia	ENSG00000022355	FALSE	unknown	2004-01-05	Unused	GABRA1
Amnesia	ENSG00000085377	FALSE	Preclinical	1995-09-15	Unused	PREP
Amnesia	ENSG00000147246	FALSE	Preclinical	1992-11-15	Unused	HTR2C
Amnesia	ENSG00000147955	FALSE	Preclinical	2013-10-03	Absent	SIGMAR1
Amnesia	ENSG00000149295	FALSE	unknown	NA	Unused	DRD2
Amnesia	ENSG00000151834	FALSE	unknown	2004-01-05	Unused	GABRA2
Amnesia	ENSG00000164270	FALSE	Preclinical	1992-11-15	Unused	HTR4
Amnesia	ENSG00000168539	FALSE	Preclinical	1997-10-15	Unused	CHRM1
Amnesia	ENSG00000174417	FALSE	Preclinical	1992-08-15	Unused	TRHR
Amnesia	ENSG00000185231	FALSE	unknown	NA	Unused	MC2R
Amnesia	ENSG00000186297	FALSE	unknown	2004-01-05	Unused	GABRA5
Amnesia	ENSG00000273079	FALSE	Preclinical	1997-12-15	Absent	GRIN2B
Amyloidosis	ENSG00000004468	FALSE	Phase III Clinical Trial	2005-05-13	Absent	CD38
Amyloidosis	ENSG00000093010	FALSE	Phase II Clinical Trial	2012-11-29	Absent	COMT
Amyloidosis	ENSG00000105639	FALSE	Preclinical	2012-08-17	Absent	JAK3
Amyloidosis	ENSG00000109320	FALSE	Phase III Clinical Trial	1997-11-15	Phase III Clinical Trial	NFKB1
Amyloidosis	ENSG00000113263	FALSE	Preclinical	2012-08-17	Absent	ITK
Amyloidosis	ENSG00000118271	TRUE	Approved	2005-06-13	Approved	TTR
Amyloidosis	ENSG00000132703	FALSE	Phase II Clinical Trial	1995-07-15	Phase I Clinical Trial	APCS
Amyloidosis	ENSG00000142192	FALSE	Preclinical	2010-08-06	Unused	APP
Amyloidosis	ENSG00000145335	FALSE	Preclinical	2016-10-12	Absent	SNCA
Amyloidosis	ENSG00000145826	FALSE	Preclinical	2017-11-30	Absent	LECT2
Amyloidosis	ENSG00000166710	FALSE	Preclinical	2004-05-24	Unused	B2M
Amyloidosis	ENSG00000186868	FALSE	Preclinical	2016-10-12	Absent	MAPT
Amyotrophic Lateral Sclerosis	ENSG00000000971	FALSE	Phase I Clinical Trial	2013-04-18	Absent	CFH
Amyotrophic Lateral Sclerosis	ENSG00000004139	FALSE	Preclinical	2017-11-02	Absent	SARM1
Amyotrophic Lateral Sclerosis	ENSG00000010810	FALSE	Pre-registration	NA	Absent	FYN
Amyotrophic Lateral Sclerosis	ENSG00000017427	FALSE	Phase I Clinical Trial	2003-08-08	Unused	IGF1
Amyotrophic Lateral Sclerosis	ENSG00000017797	FALSE	Preclinical	2015-05-25	Absent	RALBP1
Amyotrophic Lateral Sclerosis	ENSG00000019991	FALSE	Phase II Clinical Trial	2004-11-23	Absent	HGF
Amyotrophic Lateral Sclerosis	ENSG00000039537	FALSE	Preclinical	NA	Absent	C6
Amyotrophic Lateral Sclerosis	ENSG00000065989	FALSE	Phase II Clinical Trial	NA	Absent	PDE4A
Amyotrophic Lateral Sclerosis	ENSG00000068078	FALSE	Pre-registration	NA	Absent	FGFR3
Amyotrophic Lateral Sclerosis	ENSG00000069535	FALSE	Preclinical	2011-08-20	Unused	MAOB
Amyotrophic Lateral Sclerosis	ENSG00000074416	FALSE	Preclinical	2014-12-12	Absent	MGLL
Amyotrophic Lateral Sclerosis	ENSG00000075043	TRUE	Approved	1992-08-15	Absent	KCNQ2
Amyotrophic Lateral Sclerosis	ENSG00000080824	FALSE	Phase I Clinical Trial	2009-10-24	Unused	HSP90AA1
Amyotrophic Lateral Sclerosis	ENSG00000082701	FALSE	Preclinical	2011-07-27	Unused	GSK3B
Amyotrophic Lateral Sclerosis	ENSG00000087085	FALSE	unknown	2001-09-14	Unused	ACHE
Amyotrophic Lateral Sclerosis	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Amyotrophic Lateral Sclerosis	ENSG00000100697	FALSE	Preclinical	NA	Absent	DICER1
Amyotrophic Lateral Sclerosis	ENSG00000102245	FALSE	Preclinical	2004-02-09	Preclinical	CD40LG
Amyotrophic Lateral Sclerosis	ENSG00000104321	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPA1
Amyotrophic Lateral Sclerosis	ENSG00000105639	FALSE	Preclinical	1999-07-20	Unused	JAK3
Amyotrophic Lateral Sclerosis	ENSG00000105650	FALSE	Phase II Clinical Trial	NA	Absent	PDE4C
Amyotrophic Lateral Sclerosis	ENSG00000107611	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	CUBN
Amyotrophic Lateral Sclerosis	ENSG00000108342	FALSE	Preclinical	NA	Absent	CSF3
Amyotrophic Lateral Sclerosis	ENSG00000109320	FALSE	Preclinical	2009-05-27	Absent	NFKB1
Amyotrophic Lateral Sclerosis	ENSG00000110324	FALSE	Preclinical	2010-08-16	Preclinical	IL10RA
Amyotrophic Lateral Sclerosis	ENSG00000111640	FALSE	Phase II Clinical Trial	1998-10-15	Unused	GAPDH
Amyotrophic Lateral Sclerosis	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Absent	PDE10A
Amyotrophic Lateral Sclerosis	ENSG00000112715	FALSE	Phase II Clinical Trial	1998-12-15	Unused	VEGFA
Amyotrophic Lateral Sclerosis	ENSG00000113448	FALSE	Phase II Clinical Trial	NA	Absent	PDE4D
Amyotrophic Lateral Sclerosis	ENSG00000113580	FALSE	Phase II Clinical Trial	2012-04-20	Preclinical	NR3C1
Amyotrophic Lateral Sclerosis	ENSG00000113721	FALSE	Pre-registration	NA	Absent	PDGFRB
Amyotrophic Lateral Sclerosis	ENSG00000114854	FALSE	Phase II Clinical Trial	2015-07-02	Absent	TNNC1
Amyotrophic Lateral Sclerosis	ENSG00000115310	FALSE	Phase II Clinical Trial	2009-04-08	Phase III Clinical Trial	RTN4
Amyotrophic Lateral Sclerosis	ENSG00000115457	FALSE	Phase II Clinical Trial	2010-10-19	Absent	IGFBP2
Amyotrophic Lateral Sclerosis	ENSG00000115594	FALSE	unknown	1989-06-15	Unused	IL1R1
Amyotrophic Lateral Sclerosis	ENSG00000116044	FALSE	Preclinical	2010-04-24	Preclinical	NFE2L2
Amyotrophic Lateral Sclerosis	ENSG00000116106	FALSE	Preclinical	2015-11-18	Absent	EPHA4
Amyotrophic Lateral Sclerosis	ENSG00000116329	FALSE	Phase I Clinical Trial	2008-01-16	Phase I Clinical Trial	OPRD1
Amyotrophic Lateral Sclerosis	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Amyotrophic Lateral Sclerosis	ENSG00000119535	FALSE	Preclinical	2003-04-24	Phase I Clinical Trial	CSF3R
Amyotrophic Lateral Sclerosis	ENSG00000120948	FALSE	Phase I Clinical Trial	2013-03-02	Preclinical	TARDBP
Amyotrophic Lateral Sclerosis	ENSG00000121966	FALSE	Phase II Clinical Trial	2000-06-06	Phase II Clinical Trial	CXCR4
Amyotrophic Lateral Sclerosis	ENSG00000122756	FALSE	unknown	1995-12-15	Unused	CNTFR
Amyotrophic Lateral Sclerosis	ENSG00000128052	FALSE	Phase I Clinical Trial	1997-09-15	Absent	KDR
Amyotrophic Lateral Sclerosis	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Absent	PDE11A
Amyotrophic Lateral Sclerosis	ENSG00000132170	FALSE	Preclinical	2017-06-15	Absent	PPARG
Amyotrophic Lateral Sclerosis	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Amyotrophic Lateral Sclerosis	ENSG00000134569	FALSE	Preclinical	2016-07-28	Absent	LRP4
Amyotrophic Lateral Sclerosis	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Amyotrophic Lateral Sclerosis	ENSG00000138379	FALSE	Preclinical	2007-05-29	Unused	MSTN
Amyotrophic Lateral Sclerosis	ENSG00000139625	FALSE	Phase I Clinical Trial	2016-01-21	Absent	MAP3K12
Amyotrophic Lateral Sclerosis	ENSG00000140443	FALSE	Phase II Clinical Trial	2010-10-19	Phase II Clinical Trial	IGF1R
Amyotrophic Lateral Sclerosis	ENSG00000141655	FALSE	Preclinical	2016-05-05	Absent	TNFRSF11A
Amyotrophic Lateral Sclerosis	ENSG00000142168	FALSE	Phase II Clinical Trial	2002-07-01	Phase I Clinical Trial	SOD1
Amyotrophic Lateral Sclerosis	ENSG00000147894	FALSE	Preclinical	2017-08-14	Absent	C9orf72
Amyotrophic Lateral Sclerosis	ENSG00000147955	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	SIGMAR1
Amyotrophic Lateral Sclerosis	ENSG00000148053	FALSE	Preclinical	NA	Unused	NTRK2
Amyotrophic Lateral Sclerosis	ENSG00000148344	FALSE	Phase I Clinical Trial	2006-12-19	Phase I Clinical Trial	PTGES
Amyotrophic Lateral Sclerosis	ENSG00000149295	FALSE	Phase II Clinical Trial	2012-07-26	Phase II Clinical Trial	DRD2
Amyotrophic Lateral Sclerosis	ENSG00000150281	FALSE	Preclinical	2002-06-18	Unused	CTF1
Amyotrophic Lateral Sclerosis	ENSG00000153956	FALSE	Phase III Clinical Trial	1998-08-15	Unused	CACNA2D1
Amyotrophic Lateral Sclerosis	ENSG00000155511	FALSE	Phase II Clinical Trial	1996-08-15	Unused	GRIA1
Amyotrophic Lateral Sclerosis	ENSG00000157404	FALSE	Pre-registration	NA	Absent	KIT
Amyotrophic Lateral Sclerosis	ENSG00000160791	FALSE	Phase II Clinical Trial	2000-06-06	Phase II Clinical Trial	CCR5
Amyotrophic Lateral Sclerosis	ENSG00000168539	FALSE	Preclinical	1994-09-15	Preclinical	CHRM1
Amyotrophic Lateral Sclerosis	ENSG00000168621	FALSE	Preclinical	2010-12-07	Preclinical	GDNF
Amyotrophic Lateral Sclerosis	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Amyotrophic Lateral Sclerosis	ENSG00000171105	FALSE	Preclinical	2009-07-31	Absent	INSR
Amyotrophic Lateral Sclerosis	ENSG00000171119	FALSE	Preclinical	NA	Unused	NRTN
Amyotrophic Lateral Sclerosis	ENSG00000174417	FALSE	unknown	NA	Absent	TRHR
Amyotrophic Lateral Sclerosis	ENSG00000176884	FALSE	Phase I Clinical Trial	1999-01-15	Phase I Clinical Trial	GRIN1
Amyotrophic Lateral Sclerosis	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Amyotrophic Lateral Sclerosis	ENSG00000178394	FALSE	unknown	1991-07-15	Unused	HTR1A
Amyotrophic Lateral Sclerosis	ENSG00000178607	FALSE	Preclinical	2015-02-05	Absent	ERN1
Amyotrophic Lateral Sclerosis	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Amyotrophic Lateral Sclerosis	ENSG00000184156	TRUE	Approved	1992-08-15	Absent	KCNQ3
Amyotrophic Lateral Sclerosis	ENSG00000184588	FALSE	Phase II Clinical Trial	2001-12-03	Unused	PDE4B
Amyotrophic Lateral Sclerosis	ENSG00000184845	FALSE	Phase II Clinical Trial	2012-07-26	Phase II Clinical Trial	DRD1
Amyotrophic Lateral Sclerosis	ENSG00000185122	FALSE	Preclinical	2015-12-30	Absent	HSF1
Amyotrophic Lateral Sclerosis	ENSG00000185267	FALSE	Preclinical	2012-10-23	Absent	CDNF
Amyotrophic Lateral Sclerosis	ENSG00000188822	FALSE	Preclinical	2017-06-15	Absent	CNR2
Amyotrophic Lateral Sclerosis	ENSG00000189221	FALSE	Preclinical	2011-08-20	Unused	MAOA
Amyotrophic Lateral Sclerosis	ENSG00000196262	FALSE	Preclinical	2002-01-07	Preclinical	PPIA
Amyotrophic Lateral Sclerosis	ENSG00000196689	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPV1
Amyotrophic Lateral Sclerosis	ENSG00000197442	FALSE	Preclinical	2016-02-03	Absent	MAP3K5
Amyotrophic Lateral Sclerosis	ENSG00000197971	FALSE	Phase II Clinical Trial	NA	Unused	MBP
Amyotrophic Lateral Sclerosis	ENSG00000198822	FALSE	Preclinical	2013-10-15	Absent	GRM3
Amyotrophic Lateral Sclerosis	ENSG00000239732	FALSE	unknown	2001-09-14	Unused	TLR9
Amyotrophic Lateral Sclerosis	ENSG00000240972	FALSE	Phase II Clinical Trial	NA	Absent	MIF
Amyotrophic Lateral Sclerosis	ENSG00000254087	FALSE	Pre-registration	NA	Absent	LYN
Anaphylaxis	ENSG00000183625	FALSE	unknown	2004-09-17	Unused	CCR3
Anemia	ENSG00000039537	FALSE	Preclinical	NA	Absent	C6
Anemia	ENSG00000077238	FALSE	unknown	NA	Unused	IL4R
Anemia	ENSG00000082175	FALSE	unknown	2000-08-31	Unused	PGR
Anemia	ENSG00000085063	FALSE	Preclinical	2002-05-14	Unused	CD59
Anemia	ENSG00000090534	FALSE	unknown	2016-08-26	Absent	THPO
Anemia	ENSG00000096968	FALSE	Preclinical	2012-05-03	Preclinical	JAK2
Anemia	ENSG00000100462	FALSE	Preclinical	NA	Absent	PRMT5
Anemia	ENSG00000105697	FALSE	Phase I Clinical Trial	2009-11-09	Phase II Clinical Trial	HAMP
Anemia	ENSG00000106804	TRUE	Approved	1993-08-15	Approved	C5
Anemia	ENSG00000107611	TRUE	Approved	1992-09-15	Approved	CUBN
Anemia	ENSG00000107779	FALSE	Preclinical	2015-06-17	Absent	BMPR1A
Anemia	ENSG00000108342	FALSE	Approved	2014-05-26	Absent	CSF3
Anemia	ENSG00000110680	FALSE	unknown	2008-07-09	Unused	CALCA
Anemia	ENSG00000111275	FALSE	Preclinical	2014-08-27	Absent	ALDH2
Anemia	ENSG00000114739	FALSE	Preclinical	2012-01-20	Absent	ACVR2B
Anemia	ENSG00000115170	FALSE	Preclinical	2015-06-17	Absent	ACVR1
Anemia	ENSG00000116478	FALSE	Preclinical	2004-08-23	Unused	HDAC1
Anemia	ENSG00000118702	FALSE	Preclinical	2007-08-18	Unused	GHRH
Anemia	ENSG00000119535	FALSE	Approved	1991-08-15	Unused	CSF3R
Anemia	ENSG00000121966	FALSE	unknown	2009-03-27	Phase II Clinical Trial	CXCR4
Anemia	ENSG00000122641	FALSE	Preclinical	2012-01-20	Absent	INHBA
Anemia	ENSG00000125730	FALSE	Phase I Clinical Trial	2008-08-04	Unused	C3
Anemia	ENSG00000127241	FALSE	Preclinical	2015-10-28	Absent	MASP1
Anemia	ENSG00000129521	FALSE	Preclinical	2011-09-05	Preclinical	EGLN3
Anemia	ENSG00000130368	FALSE	Preclinical	2010-09-20	Preclinical	MAS1
Anemia	ENSG00000130427	FALSE	Preclinical	1993-05-15	Unused	EPO
Anemia	ENSG00000135766	FALSE	Preclinical	2011-09-05	Preclinical	EGLN1
Anemia	ENSG00000138449	FALSE	Phase II Clinical Trial	2011-04-08	Phase I Clinical Trial	SLC40A1
Anemia	ENSG00000139567	FALSE	Phase II Clinical Trial	2009-01-15	Phase II Clinical Trial	ACVRL1
Anemia	ENSG00000141867	FALSE	Preclinical	2005-03-04	Absent	BRD4
Anemia	ENSG00000143479	FALSE	Phase I Clinical Trial	2007-03-15	Unused	DYRK3
Anemia	ENSG00000143627	FALSE	unknown	2015-10-16	Absent	PKLR
Anemia	ENSG00000147099	FALSE	Preclinical	2004-08-23	Unused	HDAC8
Anemia	ENSG00000149131	FALSE	unknown	NA	Absent	SERPING1
Anemia	ENSG00000157404	FALSE	Approved	1990-11-15	Unused	KIT
Anemia	ENSG00000158169	FALSE	Phase II Clinical Trial	1995-08-15	Unused	FANCC
Anemia	ENSG00000167658	FALSE	Preclinical	1990-06-15	Unused	EEF2
Anemia	ENSG00000168487	FALSE	Preclinical	2012-05-03	Preclinical	BMP1
Anemia	ENSG00000168509	FALSE	Preclinical	2006-12-11	Unused	HJV
Anemia	ENSG00000169083	TRUE	Approved	NA	Approved	AR
Anemia	ENSG00000169418	FALSE	Preclinical	1995-06-15	Unused	NPR1
Anemia	ENSG00000171608	FALSE	unknown	2010-05-26	Unused	PIK3CD
Anemia	ENSG00000171720	FALSE	Preclinical	2004-08-23	Unused	HDAC3
Anemia	ENSG00000171791	FALSE	Preclinical	2001-05-30	Phase II Clinical Trial	BCL2
Anemia	ENSG00000177575	FALSE	Phase I Clinical Trial	NA	Preclinical	CD163
Anemia	ENSG00000178467	FALSE	Preclinical	2013-10-03	Absent	P4HTM
Anemia	ENSG00000182578	FALSE	Preclinical	1991-08-15	Unused	CSF1R
Anemia	ENSG00000185291	FALSE	Phase I Clinical Trial	1991-08-15	Unused	IL3RA
Anemia	ENSG00000187266	TRUE	Approved	1989-09-15	Approved	EPOR
Anemia	ENSG00000196262	FALSE	unknown	NA	Approved	PPIA
Anemia	ENSG00000196591	FALSE	Preclinical	2004-08-23	Unused	HDAC2
Anemia	ENSG00000197766	FALSE	Phase II Clinical Trial	2014-08-26	Absent	CFD
Anemia	ENSG00000198223	FALSE	Preclinical	1997-09-15	Approved	CSF2RA
Anemia	ENSG00000244734	FALSE	Preclinical	1994-06-15	Unused	HBB
Anemia	ENSG00000269858	FALSE	Preclinical	2003-07-02	Unused	EGLN2
Anemia, Aplastic	ENSG00000010610	FALSE	unknown	2005-10-18	Unused	CD4
Anemia, Aplastic	ENSG00000010671	TRUE	Approved	2007-12-12	Absent	BTK
Anemia, Aplastic	ENSG00000012223	FALSE	unknown	1994-08-15	Absent	LTF
Anemia, Aplastic	ENSG00000019582	FALSE	Phase I Clinical Trial	2005-02-25	Phase I Clinical Trial	CD74
Anemia, Aplastic	ENSG00000026103	FALSE	Phase II Clinical Trial	1998-12-15	Unused	FAS
Anemia, Aplastic	ENSG00000064012	FALSE	unknown	1999-01-15	Unused	CASP8
Anemia, Aplastic	ENSG00000065675	FALSE	Preclinical	2010-06-23	Unused	PRKCQ
Anemia, Aplastic	ENSG00000066468	FALSE	Phase II Clinical Trial	1996-06-15	Unused	FGFR2
Anemia, Aplastic	ENSG00000088832	TRUE	Approved	NA	Approved	FKBP1A
Anemia, Aplastic	ENSG00000090339	FALSE	Preclinical	2014-08-18	Absent	ICAM1
Anemia, Aplastic	ENSG00000096968	FALSE	Phase III Clinical Trial	2006-12-01	Absent	JAK2
Anemia, Aplastic	ENSG00000100385	FALSE	Phase I Clinical Trial	NA	Absent	IL2RB
Anemia, Aplastic	ENSG00000101017	FALSE	unknown	2004-10-05	Phase I Clinical Trial	CD40
Anemia, Aplastic	ENSG00000101425	FALSE	unknown	1989-12-15	Unused	BPI
Anemia, Aplastic	ENSG00000101868	TRUE	Approved	1998-12-15	Phase III Clinical Trial	POLA1
Anemia, Aplastic	ENSG00000101916	FALSE	unknown	2012-03-16	Absent	TLR8
Anemia, Aplastic	ENSG00000105639	FALSE	unknown	2006-07-25	Absent	JAK3
Anemia, Aplastic	ENSG00000106804	FALSE	unknown	2012-02-08	Absent	C5
Anemia, Aplastic	ENSG00000108342	FALSE	Phase I Clinical Trial	2016-06-01	Absent	CSF3
Anemia, Aplastic	ENSG00000109320	FALSE	Preclinical	2001-03-14	Unused	NFKB1
Anemia, Aplastic	ENSG00000109471	FALSE	Preclinical	2015-11-20	Absent	IL2
Anemia, Aplastic	ENSG00000110876	FALSE	Phase I Clinical Trial	2002-08-22	Absent	SELPLG
Anemia, Aplastic	ENSG00000112149	FALSE	Preclinical	2015-09-30	Absent	CD83
Anemia, Aplastic	ENSG00000113580	FALSE	Phase III Clinical Trial	2001-09-28	Phase III Clinical Trial	NR3C1
Anemia, Aplastic	ENSG00000114013	FALSE	Phase I Clinical Trial	1992-11-15	Unused	CD86
Anemia, Aplastic	ENSG00000115232	FALSE	Phase II Clinical Trial	1995-10-15	Absent	ITGA4
Anemia, Aplastic	ENSG00000115594	FALSE	unknown	1989-06-15	Unused	IL1R1
Anemia, Aplastic	ENSG00000115718	FALSE	unknown	2007-05-03	Unused	PROC
Anemia, Aplastic	ENSG00000116824	FALSE	unknown	1989-08-15	Unused	CD2
Anemia, Aplastic	ENSG00000117400	TRUE	Approved	2002-07-31	Absent	MPL
Anemia, Aplastic	ENSG00000117560	FALSE	unknown	2004-01-19	Phase I Clinical Trial	FASLG
Anemia, Aplastic	ENSG00000117586	FALSE	Preclinical	2014-01-31	Absent	TNFSF4
Anemia, Aplastic	ENSG00000119535	FALSE	Approved	2008-10-08	Absent	CSF3R
Anemia, Aplastic	ENSG00000120217	FALSE	Preclinical	2017-05-08	Absent	CD274
Anemia, Aplastic	ENSG00000121594	FALSE	Phase I Clinical Trial	1992-11-15	Unused	CD80
Anemia, Aplastic	ENSG00000121807	FALSE	Preclinical	NA	Absent	CCR2
Anemia, Aplastic	ENSG00000121966	FALSE	Phase II Clinical Trial	2009-03-27	Absent	CXCR4
Anemia, Aplastic	ENSG00000132693	FALSE	unknown	2006-05-02	Phase I Clinical Trial	CRP
Anemia, Aplastic	ENSG00000134318	FALSE	Phase II Clinical Trial	2005-05-24	Absent	ROCK2
Anemia, Aplastic	ENSG00000134460	FALSE	Phase III Clinical Trial	1991-10-15	Unused	IL2RA
Anemia, Aplastic	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Anemia, Aplastic	ENSG00000136634	FALSE	Preclinical	2012-11-19	Absent	IL10
Anemia, Aplastic	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Anemia, Aplastic	ENSG00000137462	FALSE	Preclinical	2007-01-30	Preclinical	TLR2
Anemia, Aplastic	ENSG00000139626	FALSE	Phase II Clinical Trial	1995-10-15	Absent	ITGB7
Anemia, Aplastic	ENSG00000142677	FALSE	Phase II Clinical Trial	2011-06-28	Absent	IL22RA1
Anemia, Aplastic	ENSG00000143799	FALSE	Preclinical	2016-10-17	Absent	PARP1
Anemia, Aplastic	ENSG00000150594	FALSE	Phase III Clinical Trial	2016-02-10	Absent	ADRA2A
Anemia, Aplastic	ENSG00000158473	FALSE	Phase II Clinical Trial	2007-07-16	Absent	CD1D
Anemia, Aplastic	ENSG00000160255	FALSE	unknown	NA	Unused	ITGB2
Anemia, Aplastic	ENSG00000160791	FALSE	Phase II Clinical Trial	1999-02-17	Absent	CCR5
Anemia, Aplastic	ENSG00000160801	FALSE	Preclinical	1996-11-15	Unused	PTH1R
Anemia, Aplastic	ENSG00000162434	FALSE	Phase III Clinical Trial	2006-12-01	Absent	JAK1
Anemia, Aplastic	ENSG00000162924	FALSE	Preclinical	2015-01-30	Absent	REL
Anemia, Aplastic	ENSG00000163599	FALSE	unknown	1999-06-30	Unused	CTLA4
Anemia, Aplastic	ENSG00000163606	FALSE	Preclinical	2015-10-16	Absent	CD200R1
Anemia, Aplastic	ENSG00000164362	FALSE	Preclinical	2010-05-18	Absent	TERT
Anemia, Aplastic	ENSG00000165025	FALSE	Phase II Clinical Trial	2006-07-25	Absent	SYK
Anemia, Aplastic	ENSG00000167658	FALSE	Phase II Clinical Trial	2008-03-26	Phase I Clinical Trial	EEF2
Anemia, Aplastic	ENSG00000169245	FALSE	unknown	2008-01-14	Absent	CXCL10
Anemia, Aplastic	ENSG00000170989	FALSE	Phase II Clinical Trial	2005-09-29	Absent	S1PR1
Anemia, Aplastic	ENSG00000172270	FALSE	unknown	NA	Unused	BSG
Anemia, Aplastic	ENSG00000173762	FALSE	Phase II Clinical Trial	1989-06-15	Phase I Clinical Trial	CD7
Anemia, Aplastic	ENSG00000174130	FALSE	Preclinical	2007-01-30	Preclinical	TLR6
Anemia, Aplastic	ENSG00000178562	FALSE	Preclinical	2009-06-29	Preclinical	CD28
Anemia, Aplastic	ENSG00000185291	FALSE	unknown	NA	Absent	IL3RA
Anemia, Aplastic	ENSG00000185436	FALSE	Preclinical	2016-10-17	Absent	IFNLR1
Anemia, Aplastic	ENSG00000185559	FALSE	Preclinical	1997-05-15	Unused	DLK1
Anemia, Aplastic	ENSG00000186827	FALSE	Preclinical	2015-09-23	Absent	TNFRSF4
Anemia, Aplastic	ENSG00000187266	TRUE	Approved	2001-10-16	Absent	EPOR
Anemia, Aplastic	ENSG00000196262	TRUE	Approved	2010-07-13	Absent	PPIA
Anemia, Aplastic	ENSG00000196664	FALSE	unknown	2012-03-16	Absent	TLR7
Anemia, Aplastic	ENSG00000196839	FALSE	unknown	NA	Unused	ADA
Anemia, Aplastic	ENSG00000197249	FALSE	Phase III Clinical Trial	2007-10-09	Preclinical	SERPINA1
Anemia, Aplastic	ENSG00000197561	FALSE	Phase II Clinical Trial	2017-12-13	Absent	ELANE
Anemia, Aplastic	ENSG00000197635	FALSE	Phase III Clinical Trial	2004-02-24	Phase II Clinical Trial	DPP4
Anemia, Aplastic	ENSG00000198223	TRUE	Approved	1990-03-15	Absent	CSF2RA
Anemia, Aplastic	ENSG00000198793	FALSE	Preclinical	1992-12-15	Unused	MTOR
Anemia, Aplastic	ENSG00000198805	FALSE	unknown	2004-01-05	Unused	PNP
Anemia, Aplastic	ENSG00000213918	FALSE	Preclinical	2014-11-21	Absent	DNASE1
Anemia, Aplastic	ENSG00000239732	FALSE	unknown	2012-03-16	Absent	TLR9
Anemia, Aplastic	ENSG00000272398	FALSE	Phase II Clinical Trial	NA	Absent	CD24
Anemia, Hemolytic	ENSG00000104783	FALSE	Phase I Clinical Trial	NA	Absent	KCNN4
Anemia, Hemolytic, Autoimmune	ENSG00000104870	FALSE	Phase II Clinical Trial	2016-03-22	Absent	FCGRT
Anemia, Hemolytic, Autoimmune	ENSG00000113580	TRUE	Approved	2015-09-04	Absent	NR3C1
Anemia, Hemolytic, Autoimmune	ENSG00000122025	FALSE	Phase II Clinical Trial	2003-10-31	Absent	FLT3
Anemia, Hemolytic, Autoimmune	ENSG00000125730	FALSE	Phase II Clinical Trial	2011-12-03	Preclinical	C3
Anemia, Hemolytic, Autoimmune	ENSG00000150337	FALSE	unknown	1992-02-15	Unused	FCGR1A
Anemia, Hemolytic, Autoimmune	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Absent	SYK
Anemia, Hemolytic, Autoimmune	ENSG00000182326	FALSE	Phase III Clinical Trial	2012-05-21	Absent	C1S
Anemia, Hemolytic, Autoimmune	ENSG00000197766	FALSE	Preclinical	2016-04-18	Absent	CFD
Anemia, Iron-Deficiency	ENSG00000105697	FALSE	Preclinical	2013-08-24	Absent	HAMP
Anemia, Pernicious	ENSG00000107611	TRUE	Approved	1992-09-15	Approved	CUBN
Anemia, Sickle Cell	ENSG00000004487	FALSE	Phase I Clinical Trial	2015-09-02	Absent	KDM1A
Anemia, Sickle Cell	ENSG00000007908	FALSE	Phase III Clinical Trial	2005-05-25	Phase II Clinical Trial	SELE
Anemia, Sickle Cell	ENSG00000055118	FALSE	Preclinical	NA	Absent	KCNH2
Anemia, Sickle Cell	ENSG00000070019	FALSE	Phase II Clinical Trial	2014-02-19	Absent	GUCY2C
Anemia, Sickle Cell	ENSG00000104783	FALSE	unknown	NA	Unused	KCNN4
Anemia, Sickle Cell	ENSG00000105221	FALSE	Preclinical	2008-11-12	Absent	AKT2
Anemia, Sickle Cell	ENSG00000113580	FALSE	Preclinical	NA	Absent	NR3C1
Anemia, Sickle Cell	ENSG00000116044	FALSE	Preclinical	2014-05-03	Absent	NFE2L2
Anemia, Sickle Cell	ENSG00000116478	FALSE	Preclinical	2011-06-30	Preclinical	HDAC1
Anemia, Sickle Cell	ENSG00000121879	FALSE	Preclinical	2008-11-12	Absent	PIK3CA
Anemia, Sickle Cell	ENSG00000121989	FALSE	Preclinical	NA	Unused	ACVR2A
Anemia, Sickle Cell	ENSG00000123454	FALSE	unknown	1989-06-15	Phase II Clinical Trial	DBH
Anemia, Sickle Cell	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Unused	IL1B
Anemia, Sickle Cell	ENSG00000128271	FALSE	Phase I Clinical Trial	2000-04-03	Unused	ADORA2A
Anemia, Sickle Cell	ENSG00000130816	FALSE	unknown	NA	Unused	DNMT1
Anemia, Sickle Cell	ENSG00000135218	FALSE	Preclinical	1995-03-15	Unused	CD36
Anemia, Sickle Cell	ENSG00000139567	FALSE	unknown	2009-01-15	Absent	ACVRL1
Anemia, Sickle Cell	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
Anemia, Sickle Cell	ENSG00000160191	FALSE	Phase II Clinical Trial	2008-07-28	Absent	PDE9A
Anemia, Sickle Cell	ENSG00000164867	FALSE	Preclinical	2015-10-16	Absent	NOS3
Anemia, Sickle Cell	ENSG00000167325	FALSE	Phase III Clinical Trial	NA	Unused	RRM1
Anemia, Sickle Cell	ENSG00000169313	FALSE	Phase III Clinical Trial	1993-08-15	Absent	P2RY12
Anemia, Sickle Cell	ENSG00000170425	FALSE	Preclinical	2012-08-02	Preclinical	ADORA2B
Anemia, Sickle Cell	ENSG00000171759	FALSE	unknown	1989-06-15	Phase II Clinical Trial	PAH
Anemia, Sickle Cell	ENSG00000174175	FALSE	Phase III Clinical Trial	2005-05-25	Phase II Clinical Trial	SELP
Anemia, Sickle Cell	ENSG00000181090	FALSE	Preclinical	2018-01-12	Absent	EHMT1
Anemia, Sickle Cell	ENSG00000187045	FALSE	Preclinical	2012-01-18	Preclinical	TMPRSS6
Anemia, Sickle Cell	ENSG00000188404	FALSE	Phase III Clinical Trial	2005-05-25	Phase II Clinical Trial	SELL
Anemia, Sickle Cell	ENSG00000196591	FALSE	Preclinical	2011-06-30	Preclinical	HDAC2
Anemia, Sickle Cell	ENSG00000244734	FALSE	Phase II Clinical Trial	1992-12-15	Phase II Clinical Trial	HBB
Aneurysm	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Aneurysm	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Aneurysm	ENSG00000100504	FALSE	Preclinical	2011-10-20	Preclinical	PYGL
Aneurysm	ENSG00000113161	FALSE	Preclinical	2009-11-09	Unused	HMGCR
Aneurysm	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Absent	IL1B
Aneurysm	ENSG00000142166	FALSE	Phase II Clinical Trial	NA	Absent	IFNAR1
Aneurysm	ENSG00000159110	FALSE	Phase II Clinical Trial	NA	Absent	IFNAR2
Aneurysm	ENSG00000160255	FALSE	unknown	1991-03-15	Unused	ITGB2
Aneurysm	ENSG00000163131	FALSE	Phase I Clinical Trial	NA	Absent	CTSS
Aneurysm	ENSG00000169896	FALSE	unknown	1991-03-15	Unused	ITGAM
Angelman Syndrome	ENSG00000114062	FALSE	Preclinical	2015-05-14	Absent	UBE3A
Angelman Syndrome	ENSG00000187730	FALSE	Phase II Clinical Trial	NA	Absent	GABRD
Angina Pectoris	ENSG00000005961	FALSE	Phase II Clinical Trial	1991-10-15	Unused	ITGA2B
Angina Pectoris	ENSG00000006071	FALSE	Preclinical	2000-09-21	Unused	ABCC8
Angina Pectoris	ENSG00000006283	TRUE	Approved	1989-09-15	Approved	CACNA1G
Angina Pectoris	ENSG00000006638	FALSE	Preclinical	NA	Unused	TBXA2R
Angina Pectoris	ENSG00000011677	FALSE	unknown	NA	Unused	GABRA3
Angina Pectoris	ENSG00000019991	FALSE	Phase II Clinical Trial	2004-11-23	Phase II Clinical Trial	HGF
Angina Pectoris	ENSG00000022355	FALSE	unknown	NA	Unused	GABRA1
Angina Pectoris	ENSG00000043591	TRUE	Approved	1993-11-15	Approved	ADRB1
Angina Pectoris	ENSG00000059377	FALSE	Preclinical	1992-11-15	Unused	TBXAS1
Angina Pectoris	ENSG00000064989	FALSE	unknown	NA	Unused	CALCRL
Angina Pectoris	ENSG00000067900	FALSE	Phase II Clinical Trial	2007-03-13	Absent	ROCK1
Angina Pectoris	ENSG00000069431	TRUE	Approved	1990-09-15	Approved	ABCC9
Angina Pectoris	ENSG00000070019	FALSE	Phase III Clinical Trial	NA	Unused	GUCY2C
Angina Pectoris	ENSG00000070915	TRUE	Approved	2011-09-29	Approved	SLC12A3
Angina Pectoris	ENSG00000073756	FALSE	Phase III Clinical Trial	NA	Unused	PTGS2
Angina Pectoris	ENSG00000075073	FALSE	unknown	1991-09-15	Unused	TACR2
Angina Pectoris	ENSG00000075388	FALSE	Phase III Clinical Trial	1998-01-15	Phase III Clinical Trial	FGF4
Angina Pectoris	ENSG00000082175	FALSE	Phase I Clinical Trial	2006-11-15	Unused	PGR
Angina Pectoris	ENSG00000090020	FALSE	Preclinical	2002-04-10	Unused	SLC9A1
Angina Pectoris	ENSG00000095303	TRUE	Approved	1995-10-15	Unused	PTGS1
Angina Pectoris	ENSG00000099822	TRUE	Approved	1991-02-15	Approved	HCN2
Angina Pectoris	ENSG00000100300	FALSE	unknown	NA	Unused	TSPO
Angina Pectoris	ENSG00000106366	FALSE	Preclinical	1991-11-15	Unused	SERPINE1
Angina Pectoris	ENSG00000107562	FALSE	Preclinical	2009-03-25	Absent	CXCL12
Angina Pectoris	ENSG00000112715	FALSE	Preclinical	1994-02-15	Unused	VEGFA
Angina Pectoris	ENSG00000113161	FALSE	Approved	2011-09-28	Unused	HMGCR
Angina Pectoris	ENSG00000115353	FALSE	unknown	1991-09-15	Unused	TACR1
Angina Pectoris	ENSG00000117525	FALSE	Phase I Clinical Trial	2003-04-08	Unused	F3
Angina Pectoris	ENSG00000117601	FALSE	Preclinical	2002-11-04	Unused	SERPINC1
Angina Pectoris	ENSG00000117984	FALSE	Preclinical	NA	Unused	CTSD
Angina Pectoris	ENSG00000118137	FALSE	unknown	NA	Unused	APOA1
Angina Pectoris	ENSG00000120907	FALSE	unknown	NA	Unused	ADRA1A
Angina Pectoris	ENSG00000121361	TRUE	Approved	1990-09-15	Approved	KCNJ8
Angina Pectoris	ENSG00000123454	FALSE	Preclinical	NA	Unused	DBH
Angina Pectoris	ENSG00000126218	FALSE	Preclinical	1990-08-15	Unused	F10
Angina Pectoris	ENSG00000128052	FALSE	unknown	1997-09-15	Absent	KDR
Angina Pectoris	ENSG00000132329	FALSE	unknown	NA	Unused	RAMP1
Angina Pectoris	ENSG00000136160	FALSE	Preclinical	1997-10-15	Unused	EDNRB
Angina Pectoris	ENSG00000138622	TRUE	Approved	1991-02-15	Approved	HCN4
Angina Pectoris	ENSG00000138735	FALSE	Preclinical	1991-09-15	Unused	PDE5A
Angina Pectoris	ENSG00000141744	FALSE	Preclinical	NA	Unused	PNMT
Angina Pectoris	ENSG00000143630	TRUE	Approved	1991-02-15	Approved	HCN3
Angina Pectoris	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Angina Pectoris	ENSG00000144891	FALSE	Approved	2011-09-28	Unused	AGTR1
Angina Pectoris	ENSG00000148408	FALSE	unknown	NA	Unused	CACNA1B
Angina Pectoris	ENSG00000151067	TRUE	Approved	1989-06-15	Approved	CACNA1C
Angina Pectoris	ENSG00000151617	FALSE	Preclinical	1992-12-15	Unused	EDNRA
Angina Pectoris	ENSG00000151834	FALSE	unknown	NA	Unused	GABRA2
Angina Pectoris	ENSG00000152256	FALSE	Preclinical	2008-07-29	Unused	PDK1
Angina Pectoris	ENSG00000154229	FALSE	Preclinical	1991-05-15	Unused	PRKCA
Angina Pectoris	ENSG00000158125	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	XDH
Angina Pectoris	ENSG00000159640	FALSE	Approved	2011-09-29	Unused	ACE
Angina Pectoris	ENSG00000160013	FALSE	unknown	1992-11-15	Unused	PTGIR
Angina Pectoris	ENSG00000163485	FALSE	Phase III Clinical Trial	1991-06-15	Unused	ADORA1
Angina Pectoris	ENSG00000164588	TRUE	Approved	1991-02-15	Approved	HCN1
Angina Pectoris	ENSG00000164867	FALSE	unknown	2002-12-11	Unused	NOS3
Angina Pectoris	ENSG00000165197	FALSE	Phase II Clinical Trial	2008-06-21	Phase II Clinical Trial	VEGFD
Angina Pectoris	ENSG00000165471	FALSE	Preclinical	2000-03-29	Unused	MBL2
Angina Pectoris	ENSG00000169252	TRUE	Approved	NA	Approved	ADRB2
Angina Pectoris	ENSG00000169403	FALSE	Preclinical	1990-01-15	Unused	PTAFR
Angina Pectoris	ENSG00000172572	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	PDE3A
Angina Pectoris	ENSG00000173511	FALSE	Preclinical	1997-07-15	Unused	VEGFB
Angina Pectoris	ENSG00000178726	FALSE	unknown	NA	Unused	THBD
Angina Pectoris	ENSG00000180210	FALSE	Preclinical	2002-11-04	Unused	F2
Angina Pectoris	ENSG00000181104	FALSE	Preclinical	1991-11-15	Unused	F2R
Angina Pectoris	ENSG00000183873	TRUE	Approved	2003-07-29	Approved	SCN5A
Angina Pectoris	ENSG00000186297	FALSE	unknown	NA	Unused	GABRA5
Angina Pectoris	ENSG00000187486	FALSE	Preclinical	1990-09-15	Unused	KCNJ11
Angina Pectoris	ENSG00000188778	TRUE	Approved	NA	Approved	ADRB3
Angina Pectoris	ENSG00000198668	FALSE	Preclinical	1991-02-15	Unused	CALM1
Angina Pectoris	ENSG00000259207	FALSE	Phase II Clinical Trial	1991-10-15	Unused	ITGB3
Angina Pectoris	ENSG00000274286	FALSE	Preclinical	2001-07-26	Unused	ADRA2B
Angina, Unstable	ENSG00000005961	TRUE	Approved	1991-08-15	Approved	ITGA2B
Angina, Unstable	ENSG00000006283	TRUE	Approved	1989-09-15	Unused	CACNA1G
Angina, Unstable	ENSG00000012779	FALSE	unknown	1994-10-15	Unused	ALOX5
Angina, Unstable	ENSG00000043591	TRUE	Approved	NA	Approved	ADRB1
Angina, Unstable	ENSG00000057593	FALSE	Preclinical	1991-04-15	Unused	F7
Angina, Unstable	ENSG00000069431	TRUE	Approved	NA	Approved	ABCC9
Angina, Unstable	ENSG00000104368	FALSE	Preclinical	1994-07-15	Unused	PLAT
Angina, Unstable	ENSG00000117525	FALSE	unknown	1992-03-15	Unused	F3
Angina, Unstable	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Angina, Unstable	ENSG00000121361	TRUE	Approved	NA	Approved	KCNJ8
Angina, Unstable	ENSG00000126218	TRUE	Approved	1992-03-15	Approved	F10
Angina, Unstable	ENSG00000138448	TRUE	Approved	2012-07-20	Approved	ITGAV
Angina, Unstable	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Angina, Unstable	ENSG00000160255	TRUE	Approved	2012-07-20	Approved	ITGB2
Angina, Unstable	ENSG00000169252	TRUE	Approved	NA	Approved	ADRB2
Angina, Unstable	ENSG00000169313	TRUE	Approved	1998-08-15	Approved	P2RY12
Angina, Unstable	ENSG00000180210	TRUE	Approved	1991-02-15	Approved	F2
Angina, Unstable	ENSG00000185245	FALSE	Phase II Clinical Trial	2001-03-30	Phase II Clinical Trial	GP1BA
Angina, Unstable	ENSG00000259207	TRUE	Approved	1991-08-15	Approved	ITGB3
Angioedema	ENSG00000131187	FALSE	Phase I Clinical Trial	2015-12-15	Absent	F12
Angioedema	ENSG00000149131	FALSE	Preclinical	NA	Preclinical	SERPING1
Angioedema	ENSG00000164344	FALSE	Phase II Clinical Trial	1999-01-15	Absent	KLKB1
Angioedema	ENSG00000168398	FALSE	Phase III Clinical Trial	1989-08-15	Approved	BDKRB2
Angioedemas, Hereditary	ENSG00000131187	FALSE	Phase I Clinical Trial	2010-02-23	Absent	F12
Angioedemas, Hereditary	ENSG00000149131	TRUE	Approved	2011-05-18	Approved	SERPING1
Angioedemas, Hereditary	ENSG00000164344	TRUE	Approved	1999-01-15	Absent	KLKB1
Angioedemas, Hereditary	ENSG00000168398	TRUE	Approved	1989-08-15	Approved	BDKRB2
Anorexia	ENSG00000082175	TRUE	Approved	NA	Approved	PGR
Anorexia	ENSG00000116678	FALSE	Preclinical	2008-11-13	Preclinical	LEPR
Anorexia	ENSG00000118432	FALSE	unknown	1995-10-15	Approved	CNR1
Anorexia	ENSG00000121853	FALSE	Pre-registration	2004-11-09	Phase III Clinical Trial	GHSR
Anorexia	ENSG00000132911	FALSE	Preclinical	2012-07-17	Preclinical	NMUR2
Anorexia	ENSG00000147246	FALSE	Preclinical	2012-09-28	Preclinical	HTR2C
Anorexia	ENSG00000148053	FALSE	Preclinical	2014-04-22	Absent	NTRK2
Anorexia	ENSG00000163394	FALSE	unknown	1993-01-15	Unused	CCKAR
Anorexia	ENSG00000164128	FALSE	Preclinical	1997-12-15	Unused	NPY1R
Anorexia	ENSG00000164129	FALSE	Preclinical	1997-12-15	Unused	NPY5R
Anorexia	ENSG00000166603	FALSE	Preclinical	2000-11-17	Unused	MC4R
Anorexia	ENSG00000171596	FALSE	Preclinical	2012-07-17	Preclinical	NMUR1
Anorexia	ENSG00000187871	FALSE	Preclinical	2016-11-22	Absent	GFRAL
Anorexia	ENSG00000188822	FALSE	unknown	1995-10-15	Unused	CNR2
Anorexia	ENSG00000196396	FALSE	unknown	2000-04-18	Preclinical	PTPN1
Anorexia Nervosa	ENSG00000069696	FALSE	unknown	1990-09-15	Unused	DRD4
Anorexia Nervosa	ENSG00000102468	FALSE	unknown	1990-09-15	Unused	HTR2A
Anorexia Nervosa	ENSG00000106113	FALSE	Preclinical	2000-11-13	Unused	CRHR2
Anorexia Nervosa	ENSG00000121853	FALSE	Phase III Clinical Trial	2003-07-02	Phase II Clinical Trial	GHSR
Anthrax	ENSG00000115353	FALSE	Preclinical	2003-08-19	Absent	TACR1
Anthrax	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Anthrax	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Anthrax	ENSG00000154133	FALSE	Preclinical	2010-12-13	Unused	ROBO4
Anthrax	ENSG00000169604	TRUE	Approved	2003-03-20	Approved	ANTXR1
Anthrax	ENSG00000197249	FALSE	unknown	2009-06-04	Preclinical	SERPINA1
Anthrax	ENSG00000203710	TRUE	Approved	2000-10-04	Phase II Clinical Trial	CR1
Antiphospholipid Syndrome	ENSG00000106804	FALSE	Preclinical	1993-08-15	Preclinical	C5
Antiphospholipid Syndrome	ENSG00000131187	FALSE	Preclinical	2015-12-09	Absent	F12
Antithrombin III Deficiency	ENSG00000117601	TRUE	Approved	1990-01-15	Approved	SERPINC1
Antithrombin III Deficiency	ENSG00000126218	FALSE	Approved	2017-09-04	Absent	F10
Antithrombin III Deficiency	ENSG00000180210	TRUE	Approved	2008-05-07	Approved	F2
Anus Neoplasms	ENSG00000086205	FALSE	unknown	2008-03-04	Absent	FOLH1
Anus Neoplasms	ENSG00000106991	FALSE	unknown	2006-05-01	Phase I Clinical Trial	ENG
Anus Neoplasms	ENSG00000120217	FALSE	Phase I Clinical Trial	2011-04-27	Absent	CD274
Anus Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Absent	MCL1
Anus Neoplasms	ENSG00000147889	FALSE	Phase II Clinical Trial	2011-11-11	Phase II Clinical Trial	CDKN2A
Anus Neoplasms	ENSG00000149554	FALSE	Phase I Clinical Trial	2010-03-02	Absent	CHEK1
Anus Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Anus Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Absent	PLK1
Anus Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Anus Neoplasms	ENSG00000183765	FALSE	Phase I Clinical Trial	2010-03-02	Absent	CHEK2
Anus Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Anus Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2009-03-09	Absent	MTOR
Anus Neoplasms	ENSG00000198900	FALSE	Phase I Clinical Trial	NA	Unused	TOP1
Anxiety	ENSG00000004948	FALSE	Preclinical	2009-04-27	Unused	CALCR
Anxiety	ENSG00000011677	TRUE	Approved	1989-06-15	Approved	GABRA3
Anxiety	ENSG00000022355	TRUE	Approved	1989-06-15	Approved	GABRA1
Anxiety	ENSG00000043591	TRUE	Approved	2010-08-02	Unused	ADRB1
Anxiety	ENSG00000065989	FALSE	Preclinical	2009-11-06	Unused	PDE4A
Anxiety	ENSG00000069696	FALSE	Preclinical	1998-07-15	Unused	DRD4
Anxiety	ENSG00000072315	FALSE	Phase I Clinical Trial	2010-07-08	Preclinical	TRPC5
Anxiety	ENSG00000075073	FALSE	Preclinical	1993-01-15	Unused	TACR2
Anxiety	ENSG00000080293	FALSE	unknown	1999-03-23	Unused	SCTR
Anxiety	ENSG00000082556	FALSE	Preclinical	2012-10-25	Preclinical	OPRK1
Anxiety	ENSG00000087085	FALSE	Preclinical	2001-09-14	Unused	ACHE
Anxiety	ENSG00000089041	FALSE	Preclinical	2008-09-30	Unused	P2RX7
Anxiety	ENSG00000089250	FALSE	Preclinical	2009-05-27	Preclinical	NOS1
Anxiety	ENSG00000100300	FALSE	Preclinical	1997-07-15	Unused	TSPO
Anxiety	ENSG00000101180	FALSE	Preclinical	2013-10-30	Absent	HRH3
Anxiety	ENSG00000101204	FALSE	Preclinical	2003-01-15	Unused	CHRNA4
Anxiety	ENSG00000102468	TRUE	Approved	1991-06-15	Unused	HTR2A
Anxiety	ENSG00000103546	TRUE	Approved	1990-09-15	Approved	SLC6A2
Anxiety	ENSG00000105650	FALSE	Preclinical	2009-11-06	Unused	PDE4C
Anxiety	ENSG00000106113	TRUE	Approved	1994-02-15	Approved	CRHR2
Anxiety	ENSG00000108576	TRUE	Approved	1989-10-15	Approved	SLC6A4
Anxiety	ENSG00000109158	FALSE	Preclinical	2007-11-14	Unused	GABRA4
Anxiety	ENSG00000110148	FALSE	Phase II Clinical Trial	1991-06-15	Unused	CCKBR
Anxiety	ENSG00000112038	FALSE	Phase II Clinical Trial	2008-12-29	Phase II Clinical Trial	OPRM1
Anxiety	ENSG00000112541	FALSE	Preclinical	NA	Preclinical	PDE10A
Anxiety	ENSG00000113327	FALSE	unknown	2004-11-03	Unused	GABRG2
Anxiety	ENSG00000113448	FALSE	Preclinical	2009-11-06	Unused	PDE4D
Anxiety	ENSG00000113749	FALSE	Preclinical	1995-10-15	Unused	HRH2
Anxiety	ENSG00000115353	FALSE	Phase I Clinical Trial	1991-04-15	Unused	TACR1
Anxiety	ENSG00000116329	FALSE	Preclinical	2005-01-28	Unused	OPRD1
Anxiety	ENSG00000117480	FALSE	Preclinical	2003-04-16	Unused	FAAH
Anxiety	ENSG00000118432	FALSE	Preclinical	2014-11-21	Absent	CNR1
Anxiety	ENSG00000120088	TRUE	Approved	1994-02-15	Approved	CRHR1
Anxiety	ENSG00000120907	FALSE	unknown	2007-11-05	Unused	ADRA1A
Anxiety	ENSG00000121764	FALSE	Phase I Clinical Trial	2010-03-11	Unused	HCRTR1
Anxiety	ENSG00000124493	FALSE	Preclinical	2004-05-24	Preclinical	GRM4
Anxiety	ENSG00000125510	FALSE	Preclinical	1999-04-28	Phase I Clinical Trial	OPRL1
Anxiety	ENSG00000126010	FALSE	Preclinical	1997-11-15	Unused	GRPR
Anxiety	ENSG00000128271	FALSE	Preclinical	1998-08-15	Unused	ADORA2A
Anxiety	ENSG00000128285	FALSE	Preclinical	2002-07-24	Unused	MCHR1
Anxiety	ENSG00000128310	FALSE	unknown	2005-11-15	Unused	GALR3
Anxiety	ENSG00000128655	FALSE	Preclinical	NA	Preclinical	PDE11A
Anxiety	ENSG00000129167	FALSE	unknown	NA	Unused	TPH1
Anxiety	ENSG00000131203	FALSE	Preclinical	2008-04-16	Unused	IDO1
Anxiety	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Anxiety	ENSG00000132437	FALSE	Preclinical	1990-07-15	Unused	DDC
Anxiety	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Anxiety	ENSG00000133107	FALSE	Phase I Clinical Trial	2010-07-08	Absent	TRPC4
Anxiety	ENSG00000134640	FALSE	Preclinical	1996-06-15	Unused	MTNR1B
Anxiety	ENSG00000135312	FALSE	Preclinical	1990-06-15	Unused	HTR1B
Anxiety	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Anxiety	ENSG00000135914	FALSE	Preclinical	1993-07-15	Unused	HTR2B
Anxiety	ENSG00000136869	FALSE	Preclinical	NA	Absent	TLR4
Anxiety	ENSG00000137252	FALSE	Preclinical	2010-03-11	Unused	HCRTR2
Anxiety	ENSG00000140009	FALSE	Preclinical	2007-12-04	Unused	ESR2
Anxiety	ENSG00000140443	FALSE	Preclinical	2006-11-01	Unused	IGF1R
Anxiety	ENSG00000141744	FALSE	Preclinical	NA	Unused	PNMT
Anxiety	ENSG00000142319	TRUE	Approved	2007-10-31	Approved	SLC6A3
Anxiety	ENSG00000144285	FALSE	Preclinical	1989-11-15	Unused	SCN1A
Anxiety	ENSG00000145864	FALSE	Preclinical	2005-06-01	Unused	GABRB2
Anxiety	ENSG00000147246	TRUE	Approved	1990-11-15	Unused	HTR2C
Anxiety	ENSG00000147955	FALSE	Phase I Clinical Trial	1990-04-15	Unused	SIGMAR1
Anxiety	ENSG00000148408	FALSE	Preclinical	1992-01-15	Unused	CACNA1B
Anxiety	ENSG00000148680	FALSE	unknown	1996-01-15	Unused	HTR7
Anxiety	ENSG00000149295	FALSE	Phase III Clinical Trial	1992-10-15	Unused	DRD2
Anxiety	ENSG00000150594	FALSE	Phase I Clinical Trial	2010-08-04	Phase I Clinical Trial	ADRA2A
Anxiety	ENSG00000151067	FALSE	Preclinical	NA	Unused	CACNA1C
Anxiety	ENSG00000151577	FALSE	Phase III Clinical Trial	2005-10-25	Unused	DRD3
Anxiety	ENSG00000151834	TRUE	Approved	1989-06-15	Approved	GABRA2
Anxiety	ENSG00000152822	FALSE	Preclinical	2005-10-03	Phase I Clinical Trial	GRM1
Anxiety	ENSG00000153253	FALSE	Preclinical	1989-11-15	Unused	SCN3A
Anxiety	ENSG00000155511	FALSE	Preclinical	1995-07-15	Unused	GRIA1
Anxiety	ENSG00000157103	FALSE	Phase III Clinical Trial	1990-09-15	Unused	SLC6A1
Anxiety	ENSG00000157219	FALSE	Preclinical	2017-02-28	Absent	HTR5A
Anxiety	ENSG00000158748	FALSE	Phase II Clinical Trial	2003-08-20	Unused	HTR6
Anxiety	ENSG00000160716	FALSE	Preclinical	2003-01-15	Unused	CHRNB2
Anxiety	ENSG00000163394	FALSE	Preclinical	1996-03-15	Unused	CCKAR
Anxiety	ENSG00000164082	FALSE	Phase II Clinical Trial	1996-10-15	Phase II Clinical Trial	GRM2
Anxiety	ENSG00000164270	FALSE	Preclinical	1993-12-15	Unused	HTR4
Anxiety	ENSG00000166148	FALSE	Preclinical	2001-06-14	Phase I Clinical Trial	AVPR1A
Anxiety	ENSG00000166206	FALSE	Preclinical	2004-11-03	Unused	GABRB3
Anxiety	ENSG00000166603	FALSE	Preclinical	2004-09-06	Unused	MC4R
Anxiety	ENSG00000166736	FALSE	Preclinical	1989-06-15	Unused	HTR3A
Anxiety	ENSG00000168412	FALSE	Preclinical	1996-06-15	Unused	MTNR1A
Anxiety	ENSG00000168959	FALSE	Phase I Clinical Trial	2002-09-10	Phase I Clinical Trial	GRM5
Anxiety	ENSG00000169083	TRUE	Approved	NA	Approved	AR
Anxiety	ENSG00000169252	TRUE	Approved	2010-08-02	Unused	ADRB2
Anxiety	ENSG00000169432	FALSE	Preclinical	2007-03-09	Absent	SCN9A
Anxiety	ENSG00000174417	FALSE	Preclinical	2009-06-26	Unused	TRHR
Anxiety	ENSG00000175344	FALSE	Preclinical	1996-06-15	Unused	CHRNA7
Anxiety	ENSG00000176884	FALSE	Preclinical	1989-08-15	Unused	GRIN1
Anxiety	ENSG00000178394	TRUE	Approved	1989-06-15	Approved	HTR1A
Anxiety	ENSG00000179546	FALSE	Preclinical	1992-07-15	Unused	HTR1D
Anxiety	ENSG00000180914	FALSE	Preclinical	2009-07-27	Unused	OXTR
Anxiety	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Anxiety	ENSG00000184588	FALSE	Preclinical	2009-11-06	Unused	PDE4B
Anxiety	ENSG00000184845	FALSE	Preclinical	2017-02-28	Unused	DRD1
Anxiety	ENSG00000185313	FALSE	Preclinical	2007-03-09	Absent	SCN10A
Anxiety	ENSG00000186297	TRUE	Approved	1989-06-15	Approved	GABRA5
Anxiety	ENSG00000186642	FALSE	Preclinical	2009-09-18	Unused	PDE2A
Anxiety	ENSG00000188822	FALSE	Preclinical	2007-06-05	Unused	CNR2
Anxiety	ENSG00000189221	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	MAOA
Anxiety	ENSG00000196277	FALSE	Preclinical	NA	Absent	GRM7
Anxiety	ENSG00000196639	FALSE	unknown	NA	Unused	HRH1
Anxiety	ENSG00000197635	FALSE	Preclinical	2004-11-22	Unused	DPP4
Anxiety	ENSG00000198049	FALSE	Preclinical	2001-09-04	Unused	AVPR1B
Anxiety	ENSG00000198822	FALSE	unknown	1996-10-15	Unused	GRM3
Anxiety	ENSG00000240972	FALSE	Preclinical	NA	Preclinical	MIF
Anxiety	ENSG00000282608	FALSE	Preclinical	1998-08-15	Unused	ADORA3
Anxiety Disorders	ENSG00000011677	FALSE	Approved	1993-04-15	Unused	GABRA3
Anxiety Disorders	ENSG00000022355	FALSE	Approved	1993-04-15	Unused	GABRA1
Anxiety Disorders	ENSG00000069696	FALSE	Phase II Clinical Trial	1989-12-15	Unused	DRD4
Anxiety Disorders	ENSG00000080644	FALSE	unknown	2005-12-06	Absent	CHRNA3
Anxiety Disorders	ENSG00000100300	FALSE	Phase II Clinical Trial	2000-03-29	Unused	TSPO
Anxiety Disorders	ENSG00000101204	FALSE	unknown	2005-12-06	Unused	CHRNA4
Anxiety Disorders	ENSG00000102468	FALSE	Phase II Clinical Trial	1989-12-15	Unused	HTR2A
Anxiety Disorders	ENSG00000103546	TRUE	Approved	1996-07-15	Approved	SLC6A2
Anxiety Disorders	ENSG00000108576	TRUE	Approved	1995-03-15	Approved	SLC6A4
Anxiety Disorders	ENSG00000109158	FALSE	Phase II Clinical Trial	2007-04-27	Unused	GABRA4
Anxiety Disorders	ENSG00000110148	FALSE	Phase II Clinical Trial	1997-06-15	Unused	CCKBR
Anxiety Disorders	ENSG00000117971	FALSE	unknown	2005-12-06	Absent	CHRNB4
Anxiety Disorders	ENSG00000120088	FALSE	unknown	2006-12-14	Unused	CRHR1
Anxiety Disorders	ENSG00000134640	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	MTNR1B
Anxiety Disorders	ENSG00000135312	FALSE	unknown	2003-12-22	Phase III Clinical Trial	HTR1B
Anxiety Disorders	ENSG00000142319	TRUE	Approved	2004-02-11	Approved	SLC6A3
Anxiety Disorders	ENSG00000144285	FALSE	Phase II Clinical Trial	NA	Unused	SCN1A
Anxiety Disorders	ENSG00000145864	FALSE	Preclinical	2013-02-26	Preclinical	GABRB2
Anxiety Disorders	ENSG00000147246	FALSE	Phase III Clinical Trial	1989-12-15	Phase III Clinical Trial	HTR2C
Anxiety Disorders	ENSG00000148680	FALSE	unknown	2003-12-22	Phase III Clinical Trial	HTR7
Anxiety Disorders	ENSG00000149295	FALSE	Pre-registration	1989-12-15	Unused	DRD2
Anxiety Disorders	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Anxiety Disorders	ENSG00000151577	FALSE	Phase II Clinical Trial	1989-12-15	Unused	DRD3
Anxiety Disorders	ENSG00000151834	FALSE	Approved	1993-04-15	Unused	GABRA2
Anxiety Disorders	ENSG00000153253	FALSE	Phase II Clinical Trial	NA	Unused	SCN3A
Anxiety Disorders	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Anxiety Disorders	ENSG00000155511	FALSE	Preclinical	2010-11-17	Absent	GRIA1
Anxiety Disorders	ENSG00000158748	FALSE	Phase II Clinical Trial	2009-06-17	Unused	HTR6
Anxiety Disorders	ENSG00000160716	FALSE	unknown	2005-12-06	Unused	CHRNB2
Anxiety Disorders	ENSG00000164082	FALSE	Phase III Clinical Trial	2004-06-29	Unused	GRM2
Anxiety Disorders	ENSG00000166148	FALSE	Phase I Clinical Trial	2006-07-10	Absent	AVPR1A
Anxiety Disorders	ENSG00000166206	FALSE	Preclinical	2013-02-26	Preclinical	GABRB3
Anxiety Disorders	ENSG00000166736	FALSE	Phase I Clinical Trial	2005-12-12	Phase I Clinical Trial	HTR3A
Anxiety Disorders	ENSG00000168412	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	MTNR1A
Anxiety Disorders	ENSG00000175344	FALSE	Phase II Clinical Trial	2007-05-30	Absent	CHRNA7
Anxiety Disorders	ENSG00000178394	TRUE	Approved	1995-03-15	Approved	HTR1A
Anxiety Disorders	ENSG00000179546	FALSE	unknown	2003-12-22	Absent	HTR1D
Anxiety Disorders	ENSG00000184845	FALSE	Pre-registration	1989-12-15	Unused	DRD1
Anxiety Disorders	ENSG00000186297	FALSE	Approved	1993-04-15	Unused	GABRA5
Anxiety Disorders	ENSG00000188778	FALSE	unknown	1998-02-15	Unused	ADRB3
Anxiety Disorders	ENSG00000196277	FALSE	Preclinical	2008-06-09	Preclinical	GRM7
Anxiety Disorders	ENSG00000196639	FALSE	Pre-registration	2002-04-03	Unused	HRH1
Anxiety Disorders	ENSG00000198049	FALSE	Phase II Clinical Trial	2001-09-04	Unused	AVPR1B
Anxiety Disorders	ENSG00000198822	FALSE	Phase III Clinical Trial	2004-06-29	Unused	GRM3
Anxiety, Separation	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Aortic Valve Stenosis	ENSG00000109320	FALSE	Phase I Clinical Trial	2015-05-05	Absent	NFKB1
Aortic Valve Stenosis	ENSG00000113161	FALSE	unknown	1997-02-15	Phase III Clinical Trial	HMGCR
Aortic Valve Stenosis	ENSG00000118137	FALSE	Phase I Clinical Trial	2008-10-17	Phase I Clinical Trial	APOA1
Apnea	ENSG00000066230	FALSE	Phase II Clinical Trial	2005-06-21	Unused	SLC9A3
Apnea	ENSG00000101180	FALSE	Phase I Clinical Trial	2010-06-15	Phase I Clinical Trial	HRH3
Apnea	ENSG00000114200	FALSE	Preclinical	NA	Absent	BCHE
Apnea	ENSG00000118432	FALSE	Phase II Clinical Trial	2010-12-23	Absent	CNR1
Apnea	ENSG00000128271	TRUE	Approved	NA	Approved	ADORA2A
Apnea	ENSG00000130037	FALSE	Phase I Clinical Trial	2004-02-06	Unused	KCNA5
Apnea	ENSG00000134640	FALSE	Phase III Clinical Trial	2000-07-11	Unused	MTNR1B
Apnea	ENSG00000150594	FALSE	Phase II Clinical Trial	2005-10-18	Unused	ADRA2A
Apnea	ENSG00000155511	FALSE	Phase II Clinical Trial	2008-03-19	Phase II Clinical Trial	GRIA1
Apnea	ENSG00000166736	FALSE	Phase II Clinical Trial	2004-02-04	Unused	HTR3A
Apnea	ENSG00000168412	FALSE	Phase III Clinical Trial	2000-07-11	Unused	MTNR1A
Apnea	ENSG00000171385	FALSE	Phase I Clinical Trial	2004-02-06	Unused	KCND3
Argininosuccinic Aciduria	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Argininosuccinic Aciduria	ENSG00000126522	FALSE	Preclinical	2016-06-27	Absent	ASL
Arrhythmias, Cardiac	ENSG00000006283	FALSE	Preclinical	1999-04-28	Unused	CACNA1G
Arrhythmias, Cardiac	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Unused	TBXA2R
Arrhythmias, Cardiac	ENSG00000010322	FALSE	Preclinical	2006-11-03	Unused	NISCH
Arrhythmias, Cardiac	ENSG00000043591	TRUE	Approved	1989-11-15	Approved	ADRB1
Arrhythmias, Cardiac	ENSG00000053918	FALSE	Phase II Clinical Trial	1994-06-15	Unused	KCNQ1
Arrhythmias, Cardiac	ENSG00000055118	TRUE	Approved	1989-09-15	Unused	KCNH2
Arrhythmias, Cardiac	ENSG00000059377	FALSE	unknown	NA	Unused	TBXAS1
Arrhythmias, Cardiac	ENSG00000069431	FALSE	Preclinical	1996-07-15	Unused	ABCC9
Arrhythmias, Cardiac	ENSG00000082556	FALSE	Preclinical	NA	Unused	OPRK1
Arrhythmias, Cardiac	ENSG00000090020	FALSE	Preclinical	1995-12-15	Unused	SLC9A1
Arrhythmias, Cardiac	ENSG00000099822	FALSE	Phase III Clinical Trial	1991-02-15	Unused	HCN2
Arrhythmias, Cardiac	ENSG00000100097	FALSE	Preclinical	NA	Preclinical	LGALS1
Arrhythmias, Cardiac	ENSG00000103546	FALSE	Preclinical	NA	Unused	SLC6A2
Arrhythmias, Cardiac	ENSG00000108576	FALSE	Preclinical	NA	Unused	SLC6A4
Arrhythmias, Cardiac	ENSG00000111319	FALSE	Preclinical	NA	Unused	SCNN1A
Arrhythmias, Cardiac	ENSG00000112038	FALSE	Preclinical	NA	Unused	OPRM1
Arrhythmias, Cardiac	ENSG00000116329	FALSE	Preclinical	NA	Unused	OPRD1
Arrhythmias, Cardiac	ENSG00000118515	FALSE	Preclinical	2017-03-23	Absent	SGK1
Arrhythmias, Cardiac	ENSG00000120907	FALSE	unknown	NA	Unused	ADRA1A
Arrhythmias, Cardiac	ENSG00000121361	FALSE	Preclinical	1996-07-15	Unused	KCNJ8
Arrhythmias, Cardiac	ENSG00000123700	FALSE	Preclinical	2007-06-11	Unused	KCNJ2
Arrhythmias, Cardiac	ENSG00000126351	FALSE	Preclinical	NA	Unused	THRA
Arrhythmias, Cardiac	ENSG00000130037	FALSE	Preclinical	1997-02-15	Unused	KCNA5
Arrhythmias, Cardiac	ENSG00000131981	FALSE	Preclinical	NA	Preclinical	LGALS3
Arrhythmias, Cardiac	ENSG00000138622	FALSE	Phase III Clinical Trial	1991-02-15	Unused	HCN4
Arrhythmias, Cardiac	ENSG00000143630	FALSE	Phase III Clinical Trial	1991-02-15	Unused	HCN3
Arrhythmias, Cardiac	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Arrhythmias, Cardiac	ENSG00000151067	FALSE	Phase II Clinical Trial	1989-06-15	Unused	CACNA1C
Arrhythmias, Cardiac	ENSG00000163399	TRUE	Approved	1992-10-15	Approved	ATP1A1
Arrhythmias, Cardiac	ENSG00000163485	FALSE	Preclinical	1995-05-15	Unused	ADORA1
Arrhythmias, Cardiac	ENSG00000164270	FALSE	Preclinical	1994-05-15	Unused	HTR4
Arrhythmias, Cardiac	ENSG00000164588	FALSE	Phase III Clinical Trial	1991-02-15	Unused	HCN1
Arrhythmias, Cardiac	ENSG00000169252	TRUE	Approved	1989-11-15	Approved	ADRB2
Arrhythmias, Cardiac	ENSG00000169403	FALSE	Preclinical	NA	Unused	PTAFR
Arrhythmias, Cardiac	ENSG00000169432	FALSE	Preclinical	1992-10-15	Unused	SCN9A
Arrhythmias, Cardiac	ENSG00000181072	FALSE	Preclinical	1992-12-15	Unused	CHRM2
Arrhythmias, Cardiac	ENSG00000183023	FALSE	Preclinical	2005-06-07	Unused	SLC8A1
Arrhythmias, Cardiac	ENSG00000183873	TRUE	Approved	1989-06-15	Approved	SCN5A
Arrhythmias, Cardiac	ENSG00000184408	FALSE	Phase II Clinical Trial	1997-02-15	Unused	KCND2
Arrhythmias, Cardiac	ENSG00000198626	FALSE	Preclinical	2008-07-04	Absent	RYR2
Arrhythmias, Cardiac	ENSG00000204174	FALSE	Preclinical	2006-11-03	Absent	NPY4R
Arthritis	ENSG00000004948	FALSE	Preclinical	2008-03-20	Unused	CALCR
Arthritis	ENSG00000006638	FALSE	Preclinical	NA	Unused	TBXA2R
Arthritis	ENSG00000007171	FALSE	Preclinical	1997-12-15	Unused	NOS2
Arthritis	ENSG00000007312	FALSE	Preclinical	2009-06-03	Unused	CD79B
Arthritis	ENSG00000007908	FALSE	Preclinical	1992-03-15	Unused	SELE
Arthritis	ENSG00000010610	FALSE	Preclinical	1999-01-15	Unused	CD4
Arthritis	ENSG00000010671	FALSE	Preclinical	2015-02-19	Absent	BTK
Arthritis	ENSG00000012779	FALSE	Phase II Clinical Trial	1989-06-15	Unused	ALOX5
Arthritis	ENSG00000013725	FALSE	unknown	1991-08-15	Unused	CD6
Arthritis	ENSG00000023445	FALSE	Preclinical	1997-02-15	Unused	BIRC3
Arthritis	ENSG00000026103	FALSE	Preclinical	2002-09-13	Unused	FAS
Arthritis	ENSG00000026508	FALSE	Approved	1992-09-15	Unused	CD44
Arthritis	ENSG00000027697	FALSE	unknown	NA	Unused	IFNGR1
Arthritis	ENSG00000034152	FALSE	Preclinical	1997-02-15	Unused	MAP2K3
Arthritis	ENSG00000035862	FALSE	Preclinical	1991-02-15	Unused	TIMP2
Arthritis	ENSG00000050628	FALSE	Preclinical	2016-09-20	Absent	PTGER3
Arthritis	ENSG00000053918	FALSE	Preclinical	2001-05-10	Unused	KCNQ1
Arthritis	ENSG00000055118	FALSE	Preclinical	2001-05-10	Unused	KCNH2
Arthritis	ENSG00000056736	FALSE	Preclinical	2015-06-19	Absent	IL17RB
Arthritis	ENSG00000064989	FALSE	Preclinical	1998-07-15	Unused	CALCRL
Arthritis	ENSG00000065559	FALSE	Preclinical	1997-02-15	Unused	MAP2K4
Arthritis	ENSG00000065675	FALSE	Preclinical	2005-05-31	Unused	PRKCQ
Arthritis	ENSG00000065989	FALSE	Preclinical	1994-10-15	Unused	PDE4A
Arthritis	ENSG00000066056	FALSE	Preclinical	NA	Unused	TIE1
Arthritis	ENSG00000067182	FALSE	Preclinical	1999-06-23	Unused	TNFRSF1A
Arthritis	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Arthritis	ENSG00000071054	FALSE	Preclinical	2008-10-17	Unused	MAP4K4
Arthritis	ENSG00000072571	FALSE	Preclinical	2014-10-14	Absent	HMMR
Arthritis	ENSG00000073756	TRUE	Approved	1992-07-15	Approved	PTGS2
Arthritis	ENSG00000075073	FALSE	Preclinical	1996-11-15	Unused	TACR2
Arthritis	ENSG00000082781	FALSE	Preclinical	2001-01-30	Unused	ITGB5
Arthritis	ENSG00000083457	FALSE	Preclinical	2007-05-22	Unused	ITGAE
Arthritis	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Arthritis	ENSG00000089041	FALSE	Preclinical	2008-08-26	Unused	P2RX7
Arthritis	ENSG00000090339	FALSE	Preclinical	1990-07-15	Unused	ICAM1
Arthritis	ENSG00000090382	FALSE	Preclinical	NA	Unused	LYZ
Arthritis	ENSG00000091831	FALSE	Preclinical	1996-04-15	Unused	ESR1
Arthritis	ENSG00000095303	TRUE	Approved	1992-07-15	Approved	PTGS1
Arthritis	ENSG00000099953	FALSE	Preclinical	1999-09-01	Unused	MMP11
Arthritis	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Arthritis	ENSG00000100739	FALSE	Preclinical	1997-10-15	Unused	BDKRB1
Arthritis	ENSG00000100985	FALSE	Preclinical	1999-09-01	Unused	MMP9
Arthritis	ENSG00000101017	FALSE	Preclinical	2007-05-01	Unused	CD40
Arthritis	ENSG00000101444	FALSE	unknown	NA	Unused	AHCY
Arthritis	ENSG00000102245	FALSE	Preclinical	2004-08-31	Unused	CD40LG
Arthritis	ENSG00000102755	FALSE	Preclinical	2000-03-01	Unused	FLT1
Arthritis	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Arthritis	ENSG00000104365	FALSE	Preclinical	2004-04-20	Unused	IKBKB
Arthritis	ENSG00000105639	FALSE	Preclinical	2009-06-10	Unused	JAK3
Arthritis	ENSG00000105650	FALSE	Preclinical	1994-10-15	Unused	PDE4C
Arthritis	ENSG00000107831	FALSE	Preclinical	2003-05-20	Unused	FGF8
Arthritis	ENSG00000108342	FALSE	Preclinical	2006-02-21	Unused	CSF3
Arthritis	ENSG00000108691	FALSE	Preclinical	2007-07-06	Unused	CCL2
Arthritis	ENSG00000109320	FALSE	Preclinical	2001-10-18	Unused	NFKB1
Arthritis	ENSG00000109471	FALSE	Preclinical	1993-04-15	Unused	IL2
Arthritis	ENSG00000109610	FALSE	Preclinical	1992-12-15	Unused	SOD3
Arthritis	ENSG00000110195	FALSE	Preclinical	2007-05-30	Unused	FOLR1
Arthritis	ENSG00000110944	FALSE	Preclinical	2006-07-13	Unused	IL23A
Arthritis	ENSG00000112062	FALSE	Phase I Clinical Trial	1995-11-15	Unused	MAPK14
Arthritis	ENSG00000112096	FALSE	Preclinical	1992-11-15	Unused	SOD2
Arthritis	ENSG00000112115	FALSE	Preclinical	2016-02-29	Absent	IL17A
Arthritis	ENSG00000113302	FALSE	unknown	2001-05-03	Unused	IL12B
Arthritis	ENSG00000113448	FALSE	Preclinical	1994-10-15	Unused	PDE4D
Arthritis	ENSG00000113580	TRUE	Approved	1990-12-15	Approved	NR3C1
Arthritis	ENSG00000114013	FALSE	Preclinical	1992-09-15	Unused	CD86
Arthritis	ENSG00000115085	FALSE	Preclinical	2005-10-18	Unused	ZAP70
Arthritis	ENSG00000115138	FALSE	Preclinical	2000-12-07	Unused	POMC
Arthritis	ENSG00000115232	FALSE	Preclinical	1992-01-15	Unused	ITGA4
Arthritis	ENSG00000115275	FALSE	Preclinical	NA	Unused	MOGS
Arthritis	ENSG00000115353	FALSE	Preclinical	1992-03-15	Unused	TACR1
Arthritis	ENSG00000115414	FALSE	Preclinical	1997-04-15	Unused	FN1
Arthritis	ENSG00000115590	FALSE	Preclinical	1994-10-15	Unused	IL1R2
Arthritis	ENSG00000115594	FALSE	Preclinical	1990-12-15	Unused	IL1R1
Arthritis	ENSG00000115828	FALSE	unknown	2008-07-01	Unused	QPCT
Arthritis	ENSG00000116711	FALSE	Preclinical	2005-01-21	Unused	PLA2G4A
Arthritis	ENSG00000116824	FALSE	Preclinical	1989-08-15	Unused	CD2
Arthritis	ENSG00000117560	FALSE	Preclinical	2000-03-29	Unused	FASLG
Arthritis	ENSG00000118113	FALSE	Preclinical	1998-08-15	Unused	MMP8
Arthritis	ENSG00000118137	FALSE	Preclinical	2003-10-13	Unused	APOA1
Arthritis	ENSG00000119535	FALSE	Preclinical	2006-02-21	Unused	CSF3R
Arthritis	ENSG00000121594	FALSE	Preclinical	1992-09-15	Unused	CD80
Arthritis	ENSG00000121807	FALSE	Preclinical	1997-08-15	Unused	CCR2
Arthritis	ENSG00000121879	FALSE	unknown	2005-05-10	Unused	PIK3CA
Arthritis	ENSG00000121966	FALSE	Preclinical	2007-05-18	Unused	CXCR4
Arthritis	ENSG00000124334	FALSE	Preclinical	1990-03-15	Unused	IL9R
Arthritis	ENSG00000127241	FALSE	Preclinical	2015-10-28	Absent	MASP1
Arthritis	ENSG00000128271	FALSE	Preclinical	2006-08-21	Unused	ADORA2A
Arthritis	ENSG00000131471	FALSE	Preclinical	2010-04-01	Absent	AOC3
Arthritis	ENSG00000132170	FALSE	Preclinical	2002-06-28	Unused	PPARG
Arthritis	ENSG00000132329	FALSE	Preclinical	1998-07-15	Unused	RAMP1
Arthritis	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Arthritis	ENSG00000134460	FALSE	Preclinical	1990-12-15	Unused	IL2RA
Arthritis	ENSG00000134470	FALSE	Preclinical	2001-04-12	Unused	IL15RA
Arthritis	ENSG00000136244	FALSE	Preclinical	2010-07-09	Unused	IL6
Arthritis	ENSG00000136689	FALSE	Preclinical	1990-06-15	Unused	IL1RN
Arthritis	ENSG00000136807	FALSE	Preclinical	2008-08-28	Unused	CDK9
Arthritis	ENSG00000137752	FALSE	Preclinical	1993-11-15	Unused	CASP1
Arthritis	ENSG00000138448	FALSE	Preclinical	2001-01-30	Unused	ITGAV
Arthritis	ENSG00000139219	FALSE	Preclinical	1995-02-15	Unused	COL2A1
Arthritis	ENSG00000139610	FALSE	Preclinical	1993-01-15	Unused	CELA1
Arthritis	ENSG00000140443	FALSE	Preclinical	2008-11-13	Unused	IGF1R
Arthritis	ENSG00000143365	FALSE	Preclinical	2010-01-07	Preclinical	RORC
Arthritis	ENSG00000143387	FALSE	Preclinical	1997-10-15	Unused	CTSK
Arthritis	ENSG00000146648	FALSE	Preclinical	2008-11-13	Unused	EGFR
Arthritis	ENSG00000148344	FALSE	Preclinical	2005-01-24	Preclinical	PTGES
Arthritis	ENSG00000149295	FALSE	Preclinical	1996-01-15	Unused	DRD2
Arthritis	ENSG00000149968	FALSE	Preclinical	1991-01-15	Unused	MMP3
Arthritis	ENSG00000150093	FALSE	Preclinical	1992-01-15	Unused	ITGB1
Arthritis	ENSG00000151694	FALSE	Preclinical	1995-05-15	Unused	ADAM17
Arthritis	ENSG00000154229	FALSE	Preclinical	1992-03-15	Unused	PRKCA
Arthritis	ENSG00000154736	FALSE	Preclinical	2009-03-15	Unused	ADAMTS5
Arthritis	ENSG00000156738	FALSE	Preclinical	2016-11-21	Absent	MS4A1
Arthritis	ENSG00000159110	FALSE	Preclinical	NA	Unused	IFNAR2
Arthritis	ENSG00000159339	FALSE	Preclinical	2017-02-22	Absent	PADI4
Arthritis	ENSG00000160013	FALSE	Preclinical	1993-11-15	Unused	PTGIR
Arthritis	ENSG00000160255	FALSE	Preclinical	1994-06-15	Unused	ITGB2
Arthritis	ENSG00000160712	FALSE	Phase II Clinical Trial	1992-08-15	Unused	IL6R
Arthritis	ENSG00000161905	FALSE	Preclinical	1997-08-15	Unused	ALOX15
Arthritis	ENSG00000162434	FALSE	Phase I Clinical Trial	2009-12-08	Absent	JAK1
Arthritis	ENSG00000162692	FALSE	Preclinical	1989-06-15	Unused	VCAM1
Arthritis	ENSG00000163131	FALSE	Preclinical	1998-06-15	Unused	CTSS
Arthritis	ENSG00000163464	FALSE	Preclinical	1990-01-15	Unused	CXCR1
Arthritis	ENSG00000163702	FALSE	Preclinical	2007-08-10	Unused	IL17RC
Arthritis	ENSG00000163736	FALSE	Preclinical	NA	Unused	PPBP
Arthritis	ENSG00000163823	FALSE	Preclinical	2001-08-11	Unused	CCR1
Arthritis	ENSG00000164251	FALSE	Preclinical	2003-04-08	Unused	F2RL1
Arthritis	ENSG00000164362	FALSE	Preclinical	1999-12-01	Unused	TERT
Arthritis	ENSG00000165025	FALSE	Phase I Clinical Trial	2009-06-10	Unused	SYK
Arthritis	ENSG00000166501	FALSE	Preclinical	1992-03-15	Unused	PRKCB
Arthritis	ENSG00000166710	FALSE	Preclinical	2000-11-08	Unused	B2M
Arthritis	ENSG00000167658	FALSE	unknown	1991-08-15	Unused	EEF2
Arthritis	ENSG00000168685	FALSE	Preclinical	1990-01-15	Unused	IL7R
Arthritis	ENSG00000168811	FALSE	unknown	2001-05-03	Unused	IL12A
Arthritis	ENSG00000168918	FALSE	Preclinical	2008-10-27	Preclinical	INPP5D
Arthritis	ENSG00000168961	FALSE	Preclinical	2007-08-10	Unused	LGALS9
Arthritis	ENSG00000169403	FALSE	Preclinical	1990-02-15	Unused	PTAFR
Arthritis	ENSG00000170989	FALSE	Preclinical	2011-09-12	Unused	S1PR1
Arthritis	ENSG00000173083	FALSE	Preclinical	2000-08-04	Unused	HPSE
Arthritis	ENSG00000173198	FALSE	Preclinical	1994-07-15	Unused	CYSLTR1
Arthritis	ENSG00000174175	FALSE	Preclinical	1995-11-15	Unused	SELP
Arthritis	ENSG00000176890	FALSE	Preclinical	1992-09-15	Unused	TYMS
Arthritis	ENSG00000177272	FALSE	Preclinical	2009-03-13	Unused	KCNA3
Arthritis	ENSG00000178562	FALSE	Preclinical	1992-09-15	Unused	CD28
Arthritis	ENSG00000180871	FALSE	Preclinical	1991-09-15	Unused	CXCR2
Arthritis	ENSG00000181092	FALSE	Preclinical	2004-09-20	Unused	ADIPOQ
Arthritis	ENSG00000183813	FALSE	Preclinical	2007-08-22	Unused	CCR4
Arthritis	ENSG00000184588	FALSE	Preclinical	1994-10-15	Unused	PDE4B
Arthritis	ENSG00000184845	FALSE	Preclinical	1996-01-15	Unused	DRD1
Arthritis	ENSG00000186810	FALSE	Preclinical	1997-03-15	Unused	CXCR3
Arthritis	ENSG00000187210	FALSE	Preclinical	1999-01-15	Unused	GCNT1
Arthritis	ENSG00000188822	FALSE	Preclinical	2008-04-28	Unused	CNR2
Arthritis	ENSG00000197249	FALSE	Preclinical	2008-03-11	Unused	SERPINA1
Arthritis	ENSG00000197405	FALSE	Preclinical	1994-05-15	Unused	C5AR1
Arthritis	ENSG00000197561	FALSE	Preclinical	1989-06-15	Unused	ELANE
Arthritis	ENSG00000198793	FALSE	Preclinical	2016-09-19	Absent	MTOR
Arthritis	ENSG00000198805	FALSE	Preclinical	1989-07-15	Unused	PNP
Arthritis	ENSG00000204628	FALSE	Preclinical	1995-06-15	Unused	RACK1
Arthritis	ENSG00000213903	FALSE	Phase I Clinical Trial	1995-06-15	Unused	LTB4R
Arthritis	ENSG00000228716	FALSE	Preclinical	1992-09-15	Unused	DHFR
Arthritis	ENSG00000240972	FALSE	Preclinical	2004-11-01	Unused	MIF
Arthritis	ENSG00000259207	FALSE	Preclinical	2001-01-30	Unused	ITGB3
Arthritis	ENSG00000271503	FALSE	Preclinical	1997-11-15	Unused	CCL5
Arthritis	ENSG00000276045	FALSE	Preclinical	NA	Absent	ORAI1
Arthritis, Gouty	ENSG00000073756	TRUE	Approved	1996-10-15	Approved	PTGS2
Arthritis, Gouty	ENSG00000095303	FALSE	Approved	2014-02-24	Unused	PTGS1
Arthritis, Gouty	ENSG00000125538	TRUE	Approved	2003-12-08	Approved	IL1B
Arthritis, Gouty	ENSG00000158125	FALSE	unknown	NA	Unused	XDH
Arthritis, Gouty	ENSG00000170989	FALSE	Phase I Clinical Trial	2011-09-21	Absent	S1PR1
Arthritis, Gouty	ENSG00000197249	FALSE	Preclinical	2013-03-22	Absent	SERPINA1
Arthritis, Juvenile	ENSG00000073756	TRUE	Approved	1996-10-15	Approved	PTGS2
Arthritis, Juvenile	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Arthritis, Juvenile	ENSG00000102967	FALSE	unknown	NA	Unused	DHODH
Arthritis, Juvenile	ENSG00000105639	FALSE	Phase III Clinical Trial	2003-06-25	Phase III Clinical Trial	JAK3
Arthritis, Juvenile	ENSG00000106804	FALSE	Phase I Clinical Trial	2017-04-12	Absent	C5
Arthritis, Juvenile	ENSG00000112115	FALSE	unknown	2006-02-01	Absent	IL17A
Arthritis, Juvenile	ENSG00000113580	TRUE	Approved	2013-07-09	Approved	NR3C1
Arthritis, Juvenile	ENSG00000114013	TRUE	Approved	1992-11-15	Approved	CD86
Arthritis, Juvenile	ENSG00000115590	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	IL1R2
Arthritis, Juvenile	ENSG00000115594	TRUE	Approved	1995-08-15	Approved	IL1R1
Arthritis, Juvenile	ENSG00000121594	TRUE	Approved	1992-11-15	Approved	CD80
Arthritis, Juvenile	ENSG00000125538	TRUE	Approved	2003-12-08	Phase III Clinical Trial	IL1B
Arthritis, Juvenile	ENSG00000136244	FALSE	Preclinical	2007-08-23	Absent	IL6
Arthritis, Juvenile	ENSG00000139219	FALSE	Preclinical	1993-04-15	Unused	COL2A1
Arthritis, Juvenile	ENSG00000150782	FALSE	Preclinical	2015-04-01	Absent	IL18
Arthritis, Juvenile	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Arthritis, Juvenile	ENSG00000160712	TRUE	Approved	1996-05-15	Approved	IL6R
Arthritis, Juvenile	ENSG00000162434	FALSE	Phase III Clinical Trial	2003-06-25	Phase III Clinical Trial	JAK1
Arthritis, Juvenile	ENSG00000176890	TRUE	Approved	NA	Approved	TYMS
Arthritis, Juvenile	ENSG00000213903	FALSE	Phase I Clinical Trial	2017-04-12	Absent	LTB4R
Arthritis, Juvenile	ENSG00000228716	TRUE	Approved	2010-04-29	Approved	DHFR
Arthritis, Psoriatic	ENSG00000005844	FALSE	Phase II Clinical Trial	1996-06-15	Unused	ITGAL
Arthritis, Psoriatic	ENSG00000013725	FALSE	unknown	2007-09-10	Unused	CD6
Arthritis, Psoriatic	ENSG00000065989	TRUE	Approved	2004-01-28	Phase III Clinical Trial	PDE4A
Arthritis, Psoriatic	ENSG00000067182	TRUE	Approved	2004-01-28	Phase III Clinical Trial	TNFRSF1A
Arthritis, Psoriatic	ENSG00000076706	FALSE	unknown	2013-01-11	Absent	MCAM
Arthritis, Psoriatic	ENSG00000096968	FALSE	Preclinical	2007-10-10	Absent	JAK2
Arthritis, Psoriatic	ENSG00000101017	FALSE	Phase I Clinical Trial	2006-12-06	Unused	CD40
Arthritis, Psoriatic	ENSG00000102967	TRUE	Approved	NA	Approved	DHODH
Arthritis, Psoriatic	ENSG00000105397	FALSE	Phase I Clinical Trial	2015-08-28	Absent	TYK2
Arthritis, Psoriatic	ENSG00000105639	TRUE	Approved	2003-06-25	Phase III Clinical Trial	JAK3
Arthritis, Psoriatic	ENSG00000105650	TRUE	Approved	2004-01-28	Phase III Clinical Trial	PDE4C
Arthritis, Psoriatic	ENSG00000110876	FALSE	Phase II Clinical Trial	2002-08-22	Absent	SELPLG
Arthritis, Psoriatic	ENSG00000110944	FALSE	Phase III Clinical Trial	2009-05-22	Absent	IL23A
Arthritis, Psoriatic	ENSG00000112115	TRUE	Approved	2006-02-01	Phase III Clinical Trial	IL17A
Arthritis, Psoriatic	ENSG00000112116	FALSE	Phase II Clinical Trial	2012-03-21	Absent	IL17F
Arthritis, Psoriatic	ENSG00000113302	TRUE	Approved	2003-04-30	Approved	IL12B
Arthritis, Psoriatic	ENSG00000113448	TRUE	Approved	2004-01-28	Phase III Clinical Trial	PDE4D
Arthritis, Psoriatic	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Arthritis, Psoriatic	ENSG00000114013	TRUE	Approved	1992-11-15	Phase II Clinical Trial	CD86
Arthritis, Psoriatic	ENSG00000115009	FALSE	unknown	2009-03-25	Absent	CCL20
Arthritis, Psoriatic	ENSG00000116824	FALSE	unknown	1989-08-15	Unused	CD2
Arthritis, Psoriatic	ENSG00000121594	TRUE	Approved	1992-11-15	Phase II Clinical Trial	CD80
Arthritis, Psoriatic	ENSG00000134318	FALSE	unknown	2005-05-24	Absent	ROCK2
Arthritis, Psoriatic	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Arthritis, Psoriatic	ENSG00000139219	FALSE	Preclinical	2016-11-23	Absent	COL2A1
Arthritis, Psoriatic	ENSG00000143365	FALSE	Preclinical	2012-06-15	Preclinical	RORC
Arthritis, Psoriatic	ENSG00000162434	TRUE	Approved	2003-06-25	Phase III Clinical Trial	JAK1
Arthritis, Psoriatic	ENSG00000162594	FALSE	Preclinical	2009-07-14	Unused	IL23R
Arthritis, Psoriatic	ENSG00000162891	FALSE	Phase I Clinical Trial	2001-01-17	Unused	IL20
Arthritis, Psoriatic	ENSG00000168811	FALSE	Preclinical	2015-09-10	Absent	IL12A
Arthritis, Psoriatic	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Arthritis, Psoriatic	ENSG00000177663	TRUE	Approved	2008-03-04	Phase II Clinical Trial	IL17RA
Arthritis, Psoriatic	ENSG00000184588	TRUE	Approved	2004-01-28	Phase III Clinical Trial	PDE4B
Arthritis, Psoriatic	ENSG00000198851	FALSE	Preclinical	2003-07-03	Unused	CD3E
Arthritis, Psoriatic	ENSG00000228716	FALSE	unknown	2008-03-27	Absent	DHFR
Arthritis, Rheumatoid	ENSG00000004468	FALSE	Phase I Clinical Trial	2014-08-20	Absent	CD38
Arthritis, Rheumatoid	ENSG00000005844	FALSE	Phase II Clinical Trial	1996-06-15	Unused	ITGAL
Arthritis, Rheumatoid	ENSG00000006210	FALSE	Phase II Clinical Trial	2010-02-25	Absent	CX3CL1
Arthritis, Rheumatoid	ENSG00000006327	FALSE	Phase II Clinical Trial	2008-10-17	Phase II Clinical Trial	TNFRSF12A
Arthritis, Rheumatoid	ENSG00000007171	FALSE	Preclinical	1999-09-22	Unused	NOS2
Arthritis, Rheumatoid	ENSG00000007312	FALSE	Phase I Clinical Trial	2014-03-26	Absent	CD79B
Arthritis, Rheumatoid	ENSG00000007908	FALSE	Preclinical	1999-09-01	Unused	SELE
Arthritis, Rheumatoid	ENSG00000010610	FALSE	Phase II Clinical Trial	1993-05-15	Phase II Clinical Trial	CD4
Arthritis, Rheumatoid	ENSG00000010671	FALSE	Phase II Clinical Trial	2004-08-23	Phase I Clinical Trial	BTK
Arthritis, Rheumatoid	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Arthritis, Rheumatoid	ENSG00000012779	FALSE	Phase II Clinical Trial	1994-07-15	Unused	ALOX5
Arthritis, Rheumatoid	ENSG00000013725	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CD6
Arthritis, Rheumatoid	ENSG00000017797	FALSE	Phase II Clinical Trial	2014-12-01	Absent	RALBP1
Arthritis, Rheumatoid	ENSG00000019991	FALSE	Preclinical	2016-06-01	Absent	HGF
Arthritis, Rheumatoid	ENSG00000026103	FALSE	Phase II Clinical Trial	2003-03-04	Phase II Clinical Trial	FAS
Arthritis, Rheumatoid	ENSG00000026508	FALSE	Preclinical	2000-10-10	Unused	CD44
Arthritis, Rheumatoid	ENSG00000027697	TRUE	Approved	1991-09-15	Approved	IFNGR1
Arthritis, Rheumatoid	ENSG00000041982	FALSE	Preclinical	2007-05-29	Unused	TNC
Arthritis, Rheumatoid	ENSG00000059377	FALSE	Phase III Clinical Trial	1993-06-15	Unused	TBXAS1
Arthritis, Rheumatoid	ENSG00000060982	FALSE	Preclinical	2011-07-09	Unused	BCAT1
Arthritis, Rheumatoid	ENSG00000065675	FALSE	Preclinical	2008-07-08	Unused	PRKCQ
Arthritis, Rheumatoid	ENSG00000065989	FALSE	Phase II Clinical Trial	1996-03-15	Phase II Clinical Trial	PDE4A
Arthritis, Rheumatoid	ENSG00000067182	FALSE	Phase II Clinical Trial	2003-11-18	Phase II Clinical Trial	TNFRSF1A
Arthritis, Rheumatoid	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	FGFR3
Arthritis, Rheumatoid	ENSG00000072694	FALSE	Phase I Clinical Trial	2006-07-31	Phase II Clinical Trial	FCGR2B
Arthritis, Rheumatoid	ENSG00000073756	TRUE	Approved	1989-05-15	Approved	PTGS2
Arthritis, Rheumatoid	ENSG00000077238	FALSE	Preclinical	1999-01-15	Unused	IL4R
Arthritis, Rheumatoid	ENSG00000080824	FALSE	Preclinical	2007-09-04	Unused	HSP90AA1
Arthritis, Rheumatoid	ENSG00000081051	FALSE	unknown	2001-02-27	Unused	AFP
Arthritis, Rheumatoid	ENSG00000081985	FALSE	Preclinical	2002-11-14	Unused	IL12RB2
Arthritis, Rheumatoid	ENSG00000082701	FALSE	unknown	2007-09-14	Unused	GSK3B
Arthritis, Rheumatoid	ENSG00000087085	FALSE	Phase I Clinical Trial	1994-11-15	Unused	ACHE
Arthritis, Rheumatoid	ENSG00000088832	TRUE	Approved	1989-10-15	Approved	FKBP1A
Arthritis, Rheumatoid	ENSG00000089022	FALSE	Phase II Clinical Trial	2006-01-24	Unused	MAPKAPK5
Arthritis, Rheumatoid	ENSG00000089041	FALSE	Phase II Clinical Trial	2001-12-04	Unused	P2RX7
Arthritis, Rheumatoid	ENSG00000089250	FALSE	Preclinical	1994-08-15	Unused	NOS1
Arthritis, Rheumatoid	ENSG00000090339	FALSE	Phase II Clinical Trial	1990-09-15	Unused	ICAM1
Arthritis, Rheumatoid	ENSG00000091831	FALSE	unknown	1999-05-19	Unused	ESR1
Arthritis, Rheumatoid	ENSG00000091879	FALSE	unknown	2009-11-23	Unused	ANGPT2
Arthritis, Rheumatoid	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Arthritis, Rheumatoid	ENSG00000094631	FALSE	Phase I Clinical Trial	2009-08-13	Unused	HDAC6
Arthritis, Rheumatoid	ENSG00000095303	TRUE	Approved	1989-05-15	Approved	PTGS1
Arthritis, Rheumatoid	ENSG00000096968	TRUE	Approved	2006-12-01	Phase III Clinical Trial	JAK2
Arthritis, Rheumatoid	ENSG00000096996	FALSE	Preclinical	2002-11-14	Unused	IL12RB1
Arthritis, Rheumatoid	ENSG00000099985	FALSE	Phase II Clinical Trial	2007-03-15	Unused	OSM
Arthritis, Rheumatoid	ENSG00000100030	FALSE	Preclinical	1998-01-15	Unused	MAPK1
Arthritis, Rheumatoid	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Arthritis, Rheumatoid	ENSG00000100453	FALSE	Preclinical	2013-03-12	Absent	GZMB
Arthritis, Rheumatoid	ENSG00000100644	FALSE	Phase I Clinical Trial	1997-04-15	Phase I Clinical Trial	HIF1A
Arthritis, Rheumatoid	ENSG00000100739	FALSE	Preclinical	2012-07-12	Preclinical	BDKRB1
Arthritis, Rheumatoid	ENSG00000100906	FALSE	Preclinical	2014-02-24	Absent	NFKBIA
Arthritis, Rheumatoid	ENSG00000100985	FALSE	Phase II Clinical Trial	2013-03-05	Absent	MMP9
Arthritis, Rheumatoid	ENSG00000101017	FALSE	Phase II Clinical Trial	2002-09-12	Absent	CD40
Arthritis, Rheumatoid	ENSG00000101868	FALSE	Phase I Clinical Trial	1995-03-15	Unused	POLA1
Arthritis, Rheumatoid	ENSG00000101916	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR8
Arthritis, Rheumatoid	ENSG00000102245	FALSE	Phase I Clinical Trial	2007-04-21	Unused	CD40LG
Arthritis, Rheumatoid	ENSG00000102524	FALSE	Phase III Clinical Trial	1999-07-13	Phase II Clinical Trial	TNFSF13B
Arthritis, Rheumatoid	ENSG00000102967	TRUE	Approved	1999-01-15	Approved	DHODH
Arthritis, Rheumatoid	ENSG00000104267	FALSE	unknown	2006-08-11	Phase I Clinical Trial	CA2
Arthritis, Rheumatoid	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Arthritis, Rheumatoid	ENSG00000104365	FALSE	Phase II Clinical Trial	2006-01-18	Unused	IKBKB
Arthritis, Rheumatoid	ENSG00000104921	FALSE	Preclinical	1997-10-15	Unused	FCER2
Arthritis, Rheumatoid	ENSG00000105329	FALSE	Phase II Clinical Trial	2007-10-09	Unused	TGFB1
Arthritis, Rheumatoid	ENSG00000105397	FALSE	Preclinical	2007-07-30	Unused	TYK2
Arthritis, Rheumatoid	ENSG00000105639	TRUE	Approved	2003-06-25	Approved	JAK3
Arthritis, Rheumatoid	ENSG00000105650	FALSE	Phase II Clinical Trial	1996-03-15	Phase II Clinical Trial	PDE4C
Arthritis, Rheumatoid	ENSG00000105675	TRUE	Approved	2005-10-28	Approved	ATP4A
Arthritis, Rheumatoid	ENSG00000105810	FALSE	Preclinical	2015-01-13	Absent	CDK6
Arthritis, Rheumatoid	ENSG00000105851	FALSE	Phase II Clinical Trial	2006-07-28	Phase I Clinical Trial	PIK3CG
Arthritis, Rheumatoid	ENSG00000106113	FALSE	unknown	1994-04-15	Unused	CRHR2
Arthritis, Rheumatoid	ENSG00000106348	FALSE	Approved	1989-12-15	Unused	IMPDH1
Arthritis, Rheumatoid	ENSG00000106366	FALSE	Phase II Clinical Trial	2006-08-29	Unused	SERPINE1
Arthritis, Rheumatoid	ENSG00000106804	FALSE	Preclinical	1993-08-15	Unused	C5
Arthritis, Rheumatoid	ENSG00000107968	FALSE	Preclinical	2003-06-09	Unused	MAP3K8
Arthritis, Rheumatoid	ENSG00000108691	FALSE	Phase II Clinical Trial	1992-01-15	Phase I Clinical Trial	CCL2
Arthritis, Rheumatoid	ENSG00000109163	FALSE	Phase II Clinical Trial	2010-08-04	Absent	GNRHR
Arthritis, Rheumatoid	ENSG00000109320	FALSE	Phase II Clinical Trial	1996-01-15	Phase II Clinical Trial	NFKB1
Arthritis, Rheumatoid	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Arthritis, Rheumatoid	ENSG00000110324	FALSE	Phase II Clinical Trial	2009-07-30	Phase I Clinical Trial	IL10RA
Arthritis, Rheumatoid	ENSG00000110448	FALSE	unknown	NA	Unused	CD5
Arthritis, Rheumatoid	ENSG00000110492	FALSE	Preclinical	2010-04-27	Unused	MDK
Arthritis, Rheumatoid	ENSG00000110719	FALSE	Preclinical	2002-11-21	Unused	TCIRG1
Arthritis, Rheumatoid	ENSG00000110876	FALSE	Preclinical	2002-08-22	Absent	SELPLG
Arthritis, Rheumatoid	ENSG00000110944	FALSE	Phase II Clinical Trial	2002-11-14	Phase II Clinical Trial	IL23A
Arthritis, Rheumatoid	ENSG00000111142	FALSE	unknown	2003-02-04	Unused	METAP2
Arthritis, Rheumatoid	ENSG00000111321	FALSE	Phase II Clinical Trial	2000-07-12	Unused	LTBR
Arthritis, Rheumatoid	ENSG00000111537	FALSE	Approved	1992-04-15	Unused	IFNG
Arthritis, Rheumatoid	ENSG00000112062	FALSE	Phase II Clinical Trial	1997-12-15	Phase I Clinical Trial	MAPK14
Arthritis, Rheumatoid	ENSG00000112115	FALSE	Phase III Clinical Trial	2001-07-24	Phase III Clinical Trial	IL17A
Arthritis, Rheumatoid	ENSG00000112116	FALSE	Phase II Clinical Trial	2011-12-12	Absent	IL17F
Arthritis, Rheumatoid	ENSG00000112486	FALSE	Preclinical	2012-02-10	Absent	CCR6
Arthritis, Rheumatoid	ENSG00000112715	FALSE	Preclinical	2010-11-25	Unused	VEGFA
Arthritis, Rheumatoid	ENSG00000113263	FALSE	Phase II Clinical Trial	2012-02-22	Absent	ITK
Arthritis, Rheumatoid	ENSG00000113302	FALSE	Phase III Clinical Trial	1997-06-15	Phase II Clinical Trial	IL12B
Arthritis, Rheumatoid	ENSG00000113448	FALSE	Phase II Clinical Trial	1996-03-15	Phase II Clinical Trial	PDE4D
Arthritis, Rheumatoid	ENSG00000113580	TRUE	Approved	1989-05-15	Approved	NR3C1
Arthritis, Rheumatoid	ENSG00000113594	FALSE	Preclinical	1996-09-15	Unused	LIFR
Arthritis, Rheumatoid	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	PDGFRB
Arthritis, Rheumatoid	ENSG00000114013	TRUE	Approved	1992-11-15	Approved	CD86
Arthritis, Rheumatoid	ENSG00000114812	FALSE	Preclinical	2008-09-26	Preclinical	VIPR1
Arthritis, Rheumatoid	ENSG00000115008	FALSE	Preclinical	2007-11-13	Unused	IL1A
Arthritis, Rheumatoid	ENSG00000115009	FALSE	unknown	2009-03-25	Absent	CCL20
Arthritis, Rheumatoid	ENSG00000115085	FALSE	Phase II Clinical Trial	1995-02-15	Unused	ZAP70
Arthritis, Rheumatoid	ENSG00000115232	FALSE	Phase II Clinical Trial	1991-12-15	Unused	ITGA4
Arthritis, Rheumatoid	ENSG00000115353	FALSE	Preclinical	1995-06-15	Unused	TACR1
Arthritis, Rheumatoid	ENSG00000115541	FALSE	unknown	2002-09-04	Unused	HSPE1
Arthritis, Rheumatoid	ENSG00000115590	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	IL1R2
Arthritis, Rheumatoid	ENSG00000115594	TRUE	Approved	1989-06-15	Approved	IL1R1
Arthritis, Rheumatoid	ENSG00000115884	FALSE	unknown	2006-07-11	Preclinical	SDC1
Arthritis, Rheumatoid	ENSG00000116044	FALSE	Phase II Clinical Trial	2003-10-13	Phase II Clinical Trial	NFE2L2
Arthritis, Rheumatoid	ENSG00000116478	FALSE	Preclinical	2006-12-20	Unused	HDAC1
Arthritis, Rheumatoid	ENSG00000116711	FALSE	Phase II Clinical Trial	2007-07-09	Unused	PLA2G4A
Arthritis, Rheumatoid	ENSG00000117281	FALSE	Preclinical	2004-10-20	Unused	CD160
Arthritis, Rheumatoid	ENSG00000117525	FALSE	Preclinical	2003-04-08	Unused	F3
Arthritis, Rheumatoid	ENSG00000117560	FALSE	Preclinical	1997-03-15	Unused	FASLG
Arthritis, Rheumatoid	ENSG00000117594	FALSE	Preclinical	2006-07-25	Unused	HSD11B1
Arthritis, Rheumatoid	ENSG00000118137	FALSE	unknown	2005-07-04	Absent	APOA1
Arthritis, Rheumatoid	ENSG00000118432	FALSE	Preclinical	2017-02-17	Unused	CNR1
Arthritis, Rheumatoid	ENSG00000118785	FALSE	Phase II Clinical Trial	2006-03-29	Unused	SPP1
Arthritis, Rheumatoid	ENSG00000120088	FALSE	unknown	1994-04-15	Unused	CRHR1
Arthritis, Rheumatoid	ENSG00000120659	TRUE	Approved	1997-07-15	Phase II Clinical Trial	TNFSF11
Arthritis, Rheumatoid	ENSG00000120889	FALSE	Phase I Clinical Trial	1997-04-15	Phase I Clinical Trial	TNFRSF10B
Arthritis, Rheumatoid	ENSG00000121594	TRUE	Approved	1992-11-15	Approved	CD80
Arthritis, Rheumatoid	ENSG00000121764	FALSE	Phase I Clinical Trial	2002-06-07	Unused	HCRTR1
Arthritis, Rheumatoid	ENSG00000121807	FALSE	Phase I Clinical Trial	1995-10-15	Unused	CCR2
Arthritis, Rheumatoid	ENSG00000121858	FALSE	Preclinical	2008-11-20	Preclinical	TNFSF10
Arthritis, Rheumatoid	ENSG00000121966	FALSE	Phase II Clinical Trial	1996-07-15	Unused	CXCR4
Arthritis, Rheumatoid	ENSG00000122025	FALSE	Phase I Clinical Trial	1993-05-15	Phase III Clinical Trial	FLT3
Arthritis, Rheumatoid	ENSG00000122194	FALSE	Preclinical	2002-06-24	Unused	PLG
Arthritis, Rheumatoid	ENSG00000123146	FALSE	Preclinical	2007-01-10	Unused	ADGRE5
Arthritis, Rheumatoid	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK2
Arthritis, Rheumatoid	ENSG00000124089	FALSE	Preclinical	2014-07-15	Absent	MC3R
Arthritis, Rheumatoid	ENSG00000124102	FALSE	Preclinical	NA	Unused	PI3
Arthritis, Rheumatoid	ENSG00000124391	FALSE	unknown	2008-11-28	Absent	IL17C
Arthritis, Rheumatoid	ENSG00000124731	FALSE	Preclinical	2012-01-19	Absent	TREM1
Arthritis, Rheumatoid	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Arthritis, Rheumatoid	ENSG00000125571	FALSE	Phase III Clinical Trial	2001-07-24	Absent	IL37
Arthritis, Rheumatoid	ENSG00000125910	FALSE	unknown	2009-01-15	Absent	S1PR4
Arthritis, Rheumatoid	ENSG00000126934	FALSE	Preclinical	2006-05-01	Phase II Clinical Trial	MAP2K2
Arthritis, Rheumatoid	ENSG00000128245	FALSE	Preclinical	2011-08-20	Preclinical	YWHAH
Arthritis, Rheumatoid	ENSG00000128271	FALSE	Preclinical	2003-10-08	Unused	ADORA2A
Arthritis, Rheumatoid	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Arthritis, Rheumatoid	ENSG00000131471	FALSE	Phase I Clinical Trial	2000-08-17	Phase I Clinical Trial	AOC3
Arthritis, Rheumatoid	ENSG00000131747	FALSE	unknown	1993-05-15	Unused	TOP2A
Arthritis, Rheumatoid	ENSG00000132170	FALSE	Phase II Clinical Trial	1995-03-15	Unused	PPARG
Arthritis, Rheumatoid	ENSG00000132693	FALSE	unknown	2006-05-02	Phase II Clinical Trial	CRP
Arthritis, Rheumatoid	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK7
Arthritis, Rheumatoid	ENSG00000134258	FALSE	Phase I Clinical Trial	2008-07-10	Preclinical	VTCN1
Arthritis, Rheumatoid	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Arthritis, Rheumatoid	ENSG00000134489	FALSE	Phase I Clinical Trial	2009-07-28	Absent	HRH4
Arthritis, Rheumatoid	ENSG00000134545	FALSE	Phase I Clinical Trial	2006-11-24	Phase I Clinical Trial	KLRC1
Arthritis, Rheumatoid	ENSG00000135047	FALSE	Preclinical	1997-01-15	Unused	CTSL
Arthritis, Rheumatoid	ENSG00000135446	FALSE	Preclinical	2015-01-13	Absent	CDK4
Arthritis, Rheumatoid	ENSG00000136244	FALSE	Phase III Clinical Trial	2006-08-21	Phase III Clinical Trial	IL6
Arthritis, Rheumatoid	ENSG00000136634	FALSE	Preclinical	2000-09-29	Phase I Clinical Trial	IL10
Arthritis, Rheumatoid	ENSG00000136689	FALSE	Phase II Clinical Trial	2002-07-08	Unused	IL1RN
Arthritis, Rheumatoid	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK9
Arthritis, Rheumatoid	ENSG00000136869	FALSE	Phase II Clinical Trial	2006-08-17	Preclinical	TLR4
Arthritis, Rheumatoid	ENSG00000137252	FALSE	Phase I Clinical Trial	2002-06-07	Unused	HCRTR2
Arthritis, Rheumatoid	ENSG00000137462	FALSE	Phase II Clinical Trial	2006-02-15	Absent	TLR2
Arthritis, Rheumatoid	ENSG00000137752	FALSE	Preclinical	1993-10-15	Unused	CASP1
Arthritis, Rheumatoid	ENSG00000137809	FALSE	Preclinical	2008-07-29	Unused	ITGA11
Arthritis, Rheumatoid	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Arthritis, Rheumatoid	ENSG00000138684	FALSE	Phase II Clinical Trial	2010-06-21	Absent	IL21
Arthritis, Rheumatoid	ENSG00000139219	FALSE	Preclinical	1993-04-15	Unused	COL2A1
Arthritis, Rheumatoid	ENSG00000139567	FALSE	unknown	2007-05-30	Preclinical	ACVRL1
Arthritis, Rheumatoid	ENSG00000139626	FALSE	Phase II Clinical Trial	1991-12-15	Unused	ITGB7
Arthritis, Rheumatoid	ENSG00000140009	FALSE	Phase I Clinical Trial	2003-08-20	Unused	ESR2
Arthritis, Rheumatoid	ENSG00000140443	FALSE	Phase I Clinical Trial	2005-05-13	Unused	IGF1R
Arthritis, Rheumatoid	ENSG00000140937	FALSE	Phase II Clinical Trial	NA	Preclinical	CDH11
Arthritis, Rheumatoid	ENSG00000141510	FALSE	unknown	1995-01-15	Unused	TP53
Arthritis, Rheumatoid	ENSG00000142677	FALSE	Phase II Clinical Trial	2006-10-10	Unused	IL22RA1
Arthritis, Rheumatoid	ENSG00000143365	FALSE	Phase I Clinical Trial	2012-06-15	Preclinical	RORC
Arthritis, Rheumatoid	ENSG00000143387	FALSE	Phase I Clinical Trial	2001-07-17	Unused	CTSK
Arthritis, Rheumatoid	ENSG00000144381	FALSE	Preclinical	2003-11-12	Unused	HSPD1
Arthritis, Rheumatoid	ENSG00000148344	FALSE	unknown	2006-12-19	Unused	PTGES
Arthritis, Rheumatoid	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Arthritis, Rheumatoid	ENSG00000149295	FALSE	Preclinical	2007-06-25	Unused	DRD2
Arthritis, Rheumatoid	ENSG00000149968	FALSE	Preclinical	NA	Unused	MMP3
Arthritis, Rheumatoid	ENSG00000150093	FALSE	Phase II Clinical Trial	1991-12-15	Unused	ITGB1
Arthritis, Rheumatoid	ENSG00000150782	FALSE	Preclinical	1999-05-04	Unused	IL18
Arthritis, Rheumatoid	ENSG00000151694	FALSE	Phase II Clinical Trial	1996-12-15	Unused	ADAM17
Arthritis, Rheumatoid	ENSG00000156738	TRUE	Approved	1993-09-15	Approved	MS4A1
Arthritis, Rheumatoid	ENSG00000157404	FALSE	Phase III Clinical Trial	2003-11-21	Phase III Clinical Trial	KIT
Arthritis, Rheumatoid	ENSG00000158517	FALSE	Preclinical	2003-05-20	Unused	NCF1
Arthritis, Rheumatoid	ENSG00000158859	FALSE	Preclinical	2007-02-06	Unused	ADAMTS4
Arthritis, Rheumatoid	ENSG00000159110	FALSE	Phase II Clinical Trial	NA	Unused	IFNAR2
Arthritis, Rheumatoid	ENSG00000159339	FALSE	Preclinical	2015-10-07	Absent	PADI4
Arthritis, Rheumatoid	ENSG00000159958	FALSE	Phase II Clinical Trial	2010-10-21	Absent	TNFRSF13C
Arthritis, Rheumatoid	ENSG00000160013	FALSE	unknown	NA	Unused	PTGIR
Arthritis, Rheumatoid	ENSG00000160211	FALSE	Phase II Clinical Trial	1995-12-15	Unused	G6PD
Arthritis, Rheumatoid	ENSG00000160223	FALSE	Phase I Clinical Trial	2015-12-03	Absent	ICOSLG
Arthritis, Rheumatoid	ENSG00000160712	TRUE	Approved	1990-08-15	Approved	IL6R
Arthritis, Rheumatoid	ENSG00000160791	FALSE	Phase II Clinical Trial	1996-07-15	Unused	CCR5
Arthritis, Rheumatoid	ENSG00000160951	TRUE	Approved	2007-04-13	Approved	PTGER1
Arthritis, Rheumatoid	ENSG00000161955	FALSE	Phase III Clinical Trial	2000-05-03	Phase II Clinical Trial	TNFSF13
Arthritis, Rheumatoid	ENSG00000162298	FALSE	Preclinical	2011-10-14	Preclinical	SYVN1
Arthritis, Rheumatoid	ENSG00000162434	TRUE	Approved	2003-06-25	Approved	JAK1
Arthritis, Rheumatoid	ENSG00000162594	FALSE	Preclinical	2010-12-15	Unused	IL23R
Arthritis, Rheumatoid	ENSG00000162692	FALSE	Preclinical	2001-04-12	Unused	VCAM1
Arthritis, Rheumatoid	ENSG00000162711	FALSE	Preclinical	2013-03-28	Absent	NLRP3
Arthritis, Rheumatoid	ENSG00000162747	FALSE	Preclinical	2006-07-31	Unused	FCGR3B
Arthritis, Rheumatoid	ENSG00000162889	FALSE	Preclinical	2011-09-06	Unused	MAPKAPK2
Arthritis, Rheumatoid	ENSG00000162891	FALSE	Phase II Clinical Trial	2001-01-17	Phase II Clinical Trial	IL20
Arthritis, Rheumatoid	ENSG00000163131	FALSE	Preclinical	2001-03-22	Unused	CTSS
Arthritis, Rheumatoid	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Arthritis, Rheumatoid	ENSG00000163220	FALSE	Phase I Clinical Trial	2002-06-05	Unused	S100A9
Arthritis, Rheumatoid	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Arthritis, Rheumatoid	ENSG00000163464	FALSE	Preclinical	1997-03-15	Unused	CXCR1
Arthritis, Rheumatoid	ENSG00000163485	FALSE	Preclinical	2016-06-03	Absent	ADORA1
Arthritis, Rheumatoid	ENSG00000163599	FALSE	Phase I Clinical Trial	2008-01-30	Phase I Clinical Trial	CTLA4
Arthritis, Rheumatoid	ENSG00000163600	FALSE	unknown	2007-04-05	Unused	ICOS
Arthritis, Rheumatoid	ENSG00000163606	FALSE	Preclinical	2009-02-16	Unused	CD200R1
Arthritis, Rheumatoid	ENSG00000163823	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	CCR1
Arthritis, Rheumatoid	ENSG00000164136	FALSE	unknown	1999-05-26	Unused	IL15
Arthritis, Rheumatoid	ENSG00000164251	FALSE	Preclinical	2011-08-30	Unused	F2RL1
Arthritis, Rheumatoid	ENSG00000164305	FALSE	Phase I Clinical Trial	1997-04-15	Phase I Clinical Trial	CASP3
Arthritis, Rheumatoid	ENSG00000164342	FALSE	Preclinical	2012-03-07	Absent	TLR3
Arthritis, Rheumatoid	ENSG00000164400	FALSE	Phase II Clinical Trial	1999-09-02	Phase II Clinical Trial	CSF2
Arthritis, Rheumatoid	ENSG00000164733	FALSE	Preclinical	1997-01-15	Unused	CTSB
Arthritis, Rheumatoid	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase III Clinical Trial	SYK
Arthritis, Rheumatoid	ENSG00000165168	FALSE	Preclinical	2012-11-13	Preclinical	CYBB
Arthritis, Rheumatoid	ENSG00000165731	FALSE	unknown	2007-01-10	Unused	RET
Arthritis, Rheumatoid	ENSG00000166224	FALSE	Phase II Clinical Trial	2006-11-03	Phase II Clinical Trial	SGPL1
Arthritis, Rheumatoid	ENSG00000166825	FALSE	unknown	2007-09-25	Unused	ANPEP
Arthritis, Rheumatoid	ENSG00000166888	FALSE	Preclinical	2016-11-17	Absent	STAT6
Arthritis, Rheumatoid	ENSG00000167658	FALSE	unknown	NA	Unused	EEF2
Arthritis, Rheumatoid	ENSG00000168398	FALSE	Preclinical	2012-07-12	Preclinical	BDKRB2
Arthritis, Rheumatoid	ENSG00000168610	FALSE	Preclinical	2016-06-23	Absent	STAT3
Arthritis, Rheumatoid	ENSG00000168811	FALSE	Phase III Clinical Trial	1997-06-15	Unused	IL12A
Arthritis, Rheumatoid	ENSG00000169032	FALSE	Preclinical	1998-01-15	Phase II Clinical Trial	MAP2K1
Arthritis, Rheumatoid	ENSG00000169245	FALSE	Phase II Clinical Trial	2003-01-07	Phase II Clinical Trial	CXCL10
Arthritis, Rheumatoid	ENSG00000169429	FALSE	unknown	2005-10-17	Unused	CXCL8
Arthritis, Rheumatoid	ENSG00000169442	FALSE	Phase II Clinical Trial	NA	Unused	CD52
Arthritis, Rheumatoid	ENSG00000170989	FALSE	Phase I Clinical Trial	2009-01-15	Unused	S1PR1
Arthritis, Rheumatoid	ENSG00000171132	FALSE	Preclinical	2008-07-08	Unused	PRKCE
Arthritis, Rheumatoid	ENSG00000171522	FALSE	Phase II Clinical Trial	2012-01-17	Unused	PTGER4
Arthritis, Rheumatoid	ENSG00000171608	FALSE	Phase II Clinical Trial	2008-07-18	Phase I Clinical Trial	PIK3CD
Arthritis, Rheumatoid	ENSG00000171855	FALSE	Phase I Clinical Trial	2006-06-26	Unused	IFNB1
Arthritis, Rheumatoid	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Unused	PTEN
Arthritis, Rheumatoid	ENSG00000172819	FALSE	Phase I Clinical Trial	2015-05-20	Absent	RARG
Arthritis, Rheumatoid	ENSG00000173511	FALSE	Preclinical	1997-07-15	Unused	VEGFB
Arthritis, Rheumatoid	ENSG00000175344	FALSE	Preclinical	NA	Unused	CHRNA7
Arthritis, Rheumatoid	ENSG00000175591	FALSE	unknown	2002-08-19	Unused	P2RY2
Arthritis, Rheumatoid	ENSG00000176387	FALSE	Preclinical	2006-07-25	Unused	HSD11B2
Arthritis, Rheumatoid	ENSG00000176890	TRUE	Approved	1996-05-15	Approved	TYMS
Arthritis, Rheumatoid	ENSG00000177272	FALSE	Preclinical	2008-04-16	Preclinical	KCNA3
Arthritis, Rheumatoid	ENSG00000177455	FALSE	Preclinical	2007-01-22	Phase II Clinical Trial	CD19
Arthritis, Rheumatoid	ENSG00000177575	FALSE	Preclinical	2009-10-28	Unused	CD163
Arthritis, Rheumatoid	ENSG00000177606	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	JUN
Arthritis, Rheumatoid	ENSG00000177663	FALSE	Phase II Clinical Trial	2008-03-04	Unused	IL17RA
Arthritis, Rheumatoid	ENSG00000178562	FALSE	Phase II Clinical Trial	2011-07-13	Unused	CD28
Arthritis, Rheumatoid	ENSG00000180739	FALSE	unknown	2009-01-15	Absent	S1PR5
Arthritis, Rheumatoid	ENSG00000180871	FALSE	Preclinical	1997-03-15	Unused	CXCR2
Arthritis, Rheumatoid	ENSG00000182578	FALSE	Preclinical	2003-11-21	Unused	CSF1R
Arthritis, Rheumatoid	ENSG00000182866	FALSE	Preclinical	1998-10-15	Unused	LCK
Arthritis, Rheumatoid	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Arthritis, Rheumatoid	ENSG00000184371	FALSE	unknown	2006-12-21	Unused	CSF1
Arthritis, Rheumatoid	ENSG00000184381	FALSE	unknown	2005-08-02	Unused	PLA2G6
Arthritis, Rheumatoid	ENSG00000184588	FALSE	Phase II Clinical Trial	1996-03-15	Phase II Clinical Trial	PDE4B
Arthritis, Rheumatoid	ENSG00000185231	TRUE	Approved	NA	Approved	MC2R
Arthritis, Rheumatoid	ENSG00000185291	FALSE	Preclinical	2011-05-17	Preclinical	IL3RA
Arthritis, Rheumatoid	ENSG00000185338	FALSE	Preclinical	2012-10-16	Preclinical	SOCS1
Arthritis, Rheumatoid	ENSG00000186818	FALSE	Preclinical	2004-10-20	Unused	LILRB4
Arthritis, Rheumatoid	ENSG00000187266	FALSE	Approved	2017-07-13	Absent	EPOR
Arthritis, Rheumatoid	ENSG00000188257	FALSE	Preclinical	1994-08-15	Unused	PLA2G2A
Arthritis, Rheumatoid	ENSG00000188822	FALSE	Preclinical	2017-02-17	Absent	CNR2
Arthritis, Rheumatoid	ENSG00000189403	FALSE	Preclinical	2003-08-06	Unused	HMGB1
Arthritis, Rheumatoid	ENSG00000196262	TRUE	Approved	NA	Approved	PPIA
Arthritis, Rheumatoid	ENSG00000196352	FALSE	Preclinical	1995-06-15	Unused	CD55
Arthritis, Rheumatoid	ENSG00000196591	FALSE	Preclinical	2006-12-20	Unused	HDAC2
Arthritis, Rheumatoid	ENSG00000196611	FALSE	Phase III Clinical Trial	1990-08-15	Unused	MMP1
Arthritis, Rheumatoid	ENSG00000196664	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR7
Arthritis, Rheumatoid	ENSG00000196689	FALSE	unknown	1994-05-15	Unused	TRPV1
Arthritis, Rheumatoid	ENSG00000196776	FALSE	Preclinical	2008-06-26	Unused	CD47
Arthritis, Rheumatoid	ENSG00000196839	FALSE	unknown	NA	Unused	ADA
Arthritis, Rheumatoid	ENSG00000197122	FALSE	Preclinical	1996-06-15	Unused	SRC
Arthritis, Rheumatoid	ENSG00000197249	FALSE	Phase II Clinical Trial	1993-08-15	Unused	SERPINA1
Arthritis, Rheumatoid	ENSG00000197272	FALSE	unknown	2004-08-03	Unused	IL27
Arthritis, Rheumatoid	ENSG00000197405	FALSE	Phase II Clinical Trial	2003-06-16	Phase II Clinical Trial	C5AR1
Arthritis, Rheumatoid	ENSG00000197561	FALSE	Preclinical	1992-06-15	Unused	ELANE
Arthritis, Rheumatoid	ENSG00000197635	FALSE	unknown	2007-09-25	Unused	DPP4
Arthritis, Rheumatoid	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Arthritis, Rheumatoid	ENSG00000197919	FALSE	unknown	1997-01-15	Unused	IFNA1
Arthritis, Rheumatoid	ENSG00000198001	FALSE	Phase II Clinical Trial	2011-03-28	Unused	IRAK4
Arthritis, Rheumatoid	ENSG00000198223	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	CSF2RA
Arthritis, Rheumatoid	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Unused	MTOR
Arthritis, Rheumatoid	ENSG00000198805	FALSE	Phase I Clinical Trial	1992-12-15	Unused	PNP
Arthritis, Rheumatoid	ENSG00000198851	FALSE	Phase I Clinical Trial	2002-11-07	Phase I Clinical Trial	CD3E
Arthritis, Rheumatoid	ENSG00000203710	FALSE	unknown	1999-02-14	Unused	CR1
Arthritis, Rheumatoid	ENSG00000203747	FALSE	Preclinical	2006-07-31	Unused	FCGR3A
Arthritis, Rheumatoid	ENSG00000213809	FALSE	Phase I Clinical Trial	2006-11-24	Unused	KLRK1
Arthritis, Rheumatoid	ENSG00000213903	FALSE	Phase II Clinical Trial	1993-02-15	Unused	LTB4R
Arthritis, Rheumatoid	ENSG00000213949	FALSE	Phase II Clinical Trial	2002-11-29	Phase I Clinical Trial	ITGA1
Arthritis, Rheumatoid	ENSG00000228716	TRUE	Approved	1994-08-15	Approved	DHFR
Arthritis, Rheumatoid	ENSG00000239732	FALSE	Phase II Clinical Trial	1993-07-15	Phase I Clinical Trial	TLR9
Arthritis, Rheumatoid	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Arthritis, Rheumatoid	ENSG00000242252	FALSE	Preclinical	2016-07-12	Absent	BGLAP
Arthritis, Rheumatoid	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Arthritis, Rheumatoid	ENSG00000258839	FALSE	Preclinical	2008-07-14	Unused	MC1R
Arthritis, Rheumatoid	ENSG00000259207	FALSE	Preclinical	1997-02-15	Unused	ITGB3
Arthritis, Rheumatoid	ENSG00000262406	FALSE	unknown	2000-10-19	Absent	MMP12
Arthritis, Rheumatoid	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Arthritis, Rheumatoid	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Arthritis, Rheumatoid	ENSG00000271503	FALSE	Preclinical	2000-11-07	Unused	CCL5
Arthritis, Rheumatoid	ENSG00000272398	FALSE	Preclinical	NA	Absent	CD24
Arthritis, Rheumatoid	ENSG00000275302	FALSE	Preclinical	2000-11-07	Unused	CCL4
Arthritis, Rheumatoid	ENSG00000276409	FALSE	Preclinical	1996-12-15	Unused	CCL14
Arthritis, Rheumatoid	ENSG00000277632	FALSE	Preclinical	2000-11-07	Unused	CCL3
Arthritis, Rheumatoid	ENSG00000282608	FALSE	Phase III Clinical Trial	2001-07-24	Phase II Clinical Trial	ADORA3
Ascites	ENSG00000026508	FALSE	Preclinical	2013-12-05	Absent	CD44
Ascites	ENSG00000102854	FALSE	Phase I Clinical Trial	1999-04-21	Unused	MSLN
Ascites	ENSG00000112715	FALSE	Phase II Clinical Trial	2000-08-30	Unused	VEGFA
Ascites	ENSG00000119888	TRUE	Approved	NA	Approved	EPCAM
Ascites	ENSG00000121858	FALSE	Preclinical	2018-01-10	Absent	TNFSF10
Ascites	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Ascites	ENSG00000143226	TRUE	Approved	NA	Absent	FCGR2A
Ascites	ENSG00000150337	TRUE	Approved	NA	Absent	FCGR1A
Ascites	ENSG00000162747	TRUE	Approved	NA	Absent	FCGR3B
Ascites	ENSG00000167658	FALSE	Phase I Clinical Trial	1999-04-21	Unused	EEF2
Ascites	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Ascites	ENSG00000196611	FALSE	unknown	NA	Unused	MMP1
Ascites	ENSG00000198851	TRUE	Approved	NA	Absent	CD3E
Ascites	ENSG00000203747	TRUE	Approved	NA	Absent	FCGR3A
Aspergillosis	ENSG00000102967	FALSE	Phase I Clinical Trial	2013-06-28	Absent	DHODH
Aspergillosis	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Asthma	ENSG00000001626	FALSE	Preclinical	1994-10-15	Unused	CFTR
Asthma	ENSG00000004468	FALSE	Preclinical	2014-08-22	Absent	CD38
Asthma	ENSG00000005381	FALSE	Preclinical	2016-02-17	Absent	MPO
Asthma	ENSG00000006638	FALSE	Approved	1989-06-15	Unused	TBXA2R
Asthma	ENSG00000007171	FALSE	Phase II Clinical Trial	1999-09-22	Unused	NOS2
Asthma	ENSG00000007908	FALSE	Preclinical	1994-02-15	Phase II Clinical Trial	SELE
Asthma	ENSG00000010610	FALSE	Preclinical	1999-01-15	Unused	CD4
Asthma	ENSG00000010671	FALSE	Preclinical	2004-08-23	Unused	BTK
Asthma	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Asthma	ENSG00000012223	FALSE	Preclinical	1994-08-15	Phase II Clinical Trial	LTF
Asthma	ENSG00000012779	TRUE	Approved	1989-07-15	Approved	ALOX5
Asthma	ENSG00000016490	FALSE	Phase I Clinical Trial	2001-02-26	Unused	CLCA1
Asthma	ENSG00000025434	FALSE	Preclinical	2002-04-17	Unused	NR1H3
Asthma	ENSG00000027697	FALSE	Phase II Clinical Trial	1996-12-15	Unused	IFNGR1
Asthma	ENSG00000043591	FALSE	Phase II Clinical Trial	1995-06-15	Phase II Clinical Trial	ADRB1
Asthma	ENSG00000050748	FALSE	unknown	2001-01-23	Absent	MAPK9
Asthma	ENSG00000056736	FALSE	Preclinical	NA	Absent	IL17RB
Asthma	ENSG00000059377	FALSE	Approved	1991-06-15	Unused	TBXAS1
Asthma	ENSG00000064989	FALSE	Phase II Clinical Trial	1998-07-15	Unused	CALCRL
Asthma	ENSG00000065675	FALSE	Preclinical	2008-05-13	Unused	PRKCQ
Asthma	ENSG00000065989	FALSE	Approved	1991-09-15	Unused	PDE4A
Asthma	ENSG00000067182	FALSE	Preclinical	1999-06-23	Unused	TNFRSF1A
Asthma	ENSG00000067900	FALSE	Preclinical	1998-10-15	Unused	ROCK1
Asthma	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	FGFR3
Asthma	ENSG00000069431	FALSE	Phase II Clinical Trial	1989-06-15	Unused	ABCC9
Asthma	ENSG00000069764	FALSE	Preclinical	1998-04-15	Unused	PLA2G10
Asthma	ENSG00000071054	FALSE	Preclinical	2008-10-17	Unused	MAP4K4
Asthma	ENSG00000072694	FALSE	Phase I Clinical Trial	2012-01-28	Absent	FCGR2B
Asthma	ENSG00000073756	FALSE	Preclinical	1998-05-15	Unused	PTGS2
Asthma	ENSG00000075073	FALSE	Phase II Clinical Trial	1991-01-15	Unused	TACR2
Asthma	ENSG00000077238	FALSE	Phase III Clinical Trial	1989-12-15	Phase II Clinical Trial	IL4R
Asthma	ENSG00000077782	FALSE	Preclinical	2009-03-03	Unused	FGFR1
Asthma	ENSG00000079459	FALSE	Preclinical	1990-06-15	Unused	FDFT1
Asthma	ENSG00000080293	FALSE	Phase II Clinical Trial	2001-12-04	Unused	SCTR
Asthma	ENSG00000083457	FALSE	Preclinical	2007-05-22	Unused	ITGAE
Asthma	ENSG00000085662	FALSE	Preclinical	2011-02-22	Unused	AKR1B1
Asthma	ENSG00000088832	FALSE	Preclinical	2008-07-16	Unused	FKBP1A
Asthma	ENSG00000088926	FALSE	unknown	2012-08-07	Absent	F11
Asthma	ENSG00000091181	TRUE	Approved	1989-07-15	Phase II Clinical Trial	IL5RA
Asthma	ENSG00000091879	FALSE	Preclinical	2006-11-07	Unused	ANGPT2
Asthma	ENSG00000092009	FALSE	Phase II Clinical Trial	2003-08-14	Unused	CMA1
Asthma	ENSG00000095303	FALSE	Preclinical	1998-05-15	Unused	PTGS1
Asthma	ENSG00000096968	FALSE	Preclinical	2017-02-15	Absent	JAK2
Asthma	ENSG00000100030	FALSE	Preclinical	2001-07-02	Unused	MAPK1
Asthma	ENSG00000100368	FALSE	Phase II Clinical Trial	2003-03-27	Phase II Clinical Trial	CSF2RB
Asthma	ENSG00000100448	FALSE	Preclinical	2003-08-14	Unused	CTSG
Asthma	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Asthma	ENSG00000100739	FALSE	Preclinical	1997-10-15	Unused	BDKRB1
Asthma	ENSG00000100985	FALSE	unknown	1995-01-15	Unused	MMP9
Asthma	ENSG00000101017	FALSE	Preclinical	1997-01-15	Unused	CD40
Asthma	ENSG00000101180	FALSE	Preclinical	1991-05-15	Unused	HRH3
Asthma	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Asthma	ENSG00000103222	FALSE	Preclinical	NA	Unused	ABCC1
Asthma	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Asthma	ENSG00000104321	FALSE	Phase II Clinical Trial	2009-11-09	Phase II Clinical Trial	TRPA1
Asthma	ENSG00000104365	FALSE	Preclinical	2004-02-12	Unused	IKBKB
Asthma	ENSG00000104783	FALSE	Phase I Clinical Trial	NA	Unused	KCNN4
Asthma	ENSG00000104921	FALSE	Phase II Clinical Trial	1995-08-15	Unused	FCER2
Asthma	ENSG00000105329	FALSE	Approved	NA	Unused	TGFB1
Asthma	ENSG00000105639	FALSE	Preclinical	2003-06-25	Unused	JAK3
Asthma	ENSG00000105650	FALSE	Approved	1991-09-15	Unused	PDE4C
Asthma	ENSG00000105675	FALSE	Phase II Clinical Trial	1989-09-15	Phase III Clinical Trial	ATP4A
Asthma	ENSG00000105851	FALSE	Phase I Clinical Trial	2006-07-28	Phase II Clinical Trial	PIK3CG
Asthma	ENSG00000106018	FALSE	Preclinical	2006-07-17	Unused	VIPR2
Asthma	ENSG00000106113	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CRHR2
Asthma	ENSG00000106366	FALSE	Preclinical	2006-08-29	Unused	SERPINE1
Asthma	ENSG00000106804	FALSE	Phase II Clinical Trial	1993-08-15	Phase II Clinical Trial	C5
Asthma	ENSG00000107317	FALSE	Preclinical	2006-10-17	Unused	PTGDS
Asthma	ENSG00000107485	FALSE	Phase II Clinical Trial	2011-11-01	Phase II Clinical Trial	GATA3
Asthma	ENSG00000107643	FALSE	unknown	2001-01-23	Absent	MAPK8
Asthma	ENSG00000108576	FALSE	Preclinical	NA	Unused	SLC6A4
Asthma	ENSG00000108691	FALSE	Phase I Clinical Trial	2003-12-08	Unused	CCL2
Asthma	ENSG00000108839	FALSE	Preclinical	1993-01-15	Unused	ALOX12
Asthma	ENSG00000109320	FALSE	Preclinical	1994-03-15	Unused	NFKB1
Asthma	ENSG00000109339	FALSE	unknown	2001-01-23	Absent	MAPK10
Asthma	ENSG00000109991	FALSE	Phase I Clinical Trial	2006-02-13	Absent	P2RX3
Asthma	ENSG00000110148	FALSE	Preclinical	2016-08-25	Absent	CCKBR
Asthma	ENSG00000110944	FALSE	Phase II Clinical Trial	2012-04-17	Absent	IL23A
Asthma	ENSG00000111144	FALSE	Preclinical	2005-03-13	Unused	LTA4H
Asthma	ENSG00000111319	FALSE	unknown	1990-02-15	Unused	SCNN1A
Asthma	ENSG00000112038	FALSE	Preclinical	1993-09-15	Unused	OPRM1
Asthma	ENSG00000112062	FALSE	Phase II Clinical Trial	2001-09-11	Unused	MAPK14
Asthma	ENSG00000112096	FALSE	Preclinical	1992-11-15	Unused	SOD2
Asthma	ENSG00000112115	FALSE	Phase II Clinical Trial	2006-02-01	Phase II Clinical Trial	IL17A
Asthma	ENSG00000112486	FALSE	Preclinical	2012-02-10	Absent	CCR6
Asthma	ENSG00000112541	FALSE	Approved	NA	Unused	PDE10A
Asthma	ENSG00000113263	FALSE	Preclinical	2011-08-29	Unused	ITK
Asthma	ENSG00000113448	FALSE	Approved	1991-09-15	Unused	PDE4D
Asthma	ENSG00000113520	FALSE	Phase II Clinical Trial	1998-07-15	Phase II Clinical Trial	IL4
Asthma	ENSG00000113525	TRUE	Approved	1993-03-15	Phase III Clinical Trial	IL5
Asthma	ENSG00000113580	TRUE	Approved	1991-01-15	Approved	NR3C1
Asthma	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	PDGFRB
Asthma	ENSG00000114812	FALSE	Phase II Clinical Trial	1991-11-15	Unused	VIPR1
Asthma	ENSG00000115085	FALSE	Preclinical	1995-02-15	Unused	ZAP70
Asthma	ENSG00000115138	FALSE	Preclinical	2000-12-07	Unused	POMC
Asthma	ENSG00000115232	FALSE	Phase II Clinical Trial	1992-01-15	Unused	ITGA4
Asthma	ENSG00000115252	FALSE	Preclinical	1993-06-15	Unused	PDE1A
Asthma	ENSG00000115353	FALSE	Phase II Clinical Trial	1991-01-15	Unused	TACR1
Asthma	ENSG00000115414	FALSE	Preclinical	1997-04-15	Unused	FN1
Asthma	ENSG00000115415	FALSE	unknown	2003-09-01	Unused	STAT1
Asthma	ENSG00000115594	FALSE	unknown	1989-06-15	Unused	IL1R1
Asthma	ENSG00000115602	FALSE	Phase II Clinical Trial	1999-10-20	Unused	IL1RL1
Asthma	ENSG00000116678	FALSE	Preclinical	1996-12-15	Unused	LEPR
Asthma	ENSG00000116711	FALSE	Phase I Clinical Trial	2005-01-21	Phase I Clinical Trial	PLA2G4A
Asthma	ENSG00000116824	FALSE	Preclinical	1989-08-15	Unused	CD2
Asthma	ENSG00000117013	FALSE	Preclinical	2012-05-03	Preclinical	KCNQ4
Asthma	ENSG00000117586	FALSE	Preclinical	2007-03-23	Phase II Clinical Trial	TNFSF4
Asthma	ENSG00000118137	FALSE	Preclinical	2018-01-04	Absent	APOA1
Asthma	ENSG00000118432	FALSE	Preclinical	2017-02-22	Absent	CNR1
Asthma	ENSG00000119535	FALSE	Preclinical	1996-12-15	Unused	CSF3R
Asthma	ENSG00000120088	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CRHR1
Asthma	ENSG00000121361	FALSE	Phase II Clinical Trial	1989-06-15	Unused	KCNJ8
Asthma	ENSG00000121807	FALSE	Preclinical	2007-01-29	Phase II Clinical Trial	CCR2
Asthma	ENSG00000121966	FALSE	Preclinical	1997-07-15	Unused	CXCR4
Asthma	ENSG00000122420	FALSE	unknown	NA	Unused	PTGFR
Asthma	ENSG00000123496	FALSE	Preclinical	2002-07-30	Unused	IL13RA2
Asthma	ENSG00000124107	FALSE	Preclinical	2003-08-14	Unused	SLPI
Asthma	ENSG00000124334	FALSE	Preclinical	2002-09-09	Unused	IL9R
Asthma	ENSG00000125384	FALSE	Preclinical	1997-11-15	Unused	PTGER2
Asthma	ENSG00000125538	FALSE	Phase I Clinical Trial	2003-12-08	Unused	IL1B
Asthma	ENSG00000125730	FALSE	unknown	2007-03-26	Preclinical	C3
Asthma	ENSG00000125910	FALSE	Phase II Clinical Trial	1997-12-15	Unused	S1PR4
Asthma	ENSG00000128052	FALSE	Preclinical	1998-12-15	Unused	KDR
Asthma	ENSG00000128271	TRUE	Approved	1991-03-15	Approved	ADORA2A
Asthma	ENSG00000128655	FALSE	Approved	NA	Unused	PDE11A
Asthma	ENSG00000131196	FALSE	Preclinical	1997-06-15	Unused	NFATC1
Asthma	ENSG00000131408	FALSE	Preclinical	2002-04-17	Unused	NR1H2
Asthma	ENSG00000131471	FALSE	Phase I Clinical Trial	2008-08-15	Preclinical	AOC3
Asthma	ENSG00000131724	FALSE	Phase II Clinical Trial	1998-08-15	Unused	IL13RA1
Asthma	ENSG00000132170	FALSE	Preclinical	2011-08-05	Unused	PPARG
Asthma	ENSG00000132329	FALSE	Phase II Clinical Trial	1998-07-15	Unused	RAMP1
Asthma	ENSG00000132437	FALSE	Phase I Clinical Trial	2011-01-18	Absent	DDC
Asthma	ENSG00000132703	FALSE	Preclinical	2009-07-24	Preclinical	APCS
Asthma	ENSG00000132965	FALSE	Phase II Clinical Trial	1989-07-15	Phase II Clinical Trial	ALOX5AP
Asthma	ENSG00000133019	TRUE	Approved	1990-10-15	Approved	CHRM3
Asthma	ENSG00000134216	FALSE	Phase I Clinical Trial	2014-12-23	Absent	CHIA
Asthma	ENSG00000134318	FALSE	Preclinical	2003-10-29	Unused	ROCK2
Asthma	ENSG00000134460	FALSE	Approved	1992-04-15	Unused	IL2RA
Asthma	ENSG00000134489	FALSE	Phase II Clinical Trial	2001-05-10	Phase I Clinical Trial	HRH4
Asthma	ENSG00000134853	FALSE	Preclinical	1998-12-15	Unused	PDGFRA
Asthma	ENSG00000135914	FALSE	Preclinical	2003-05-30	Preclinical	HTR2B
Asthma	ENSG00000135919	FALSE	Preclinical	1992-03-15	Unused	SERPINE2
Asthma	ENSG00000136160	FALSE	Phase II Clinical Trial	1993-12-15	Phase II Clinical Trial	EDNRB
Asthma	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-08-23	Absent	IL6
Asthma	ENSG00000136869	FALSE	Approved	2009-06-04	Preclinical	TLR4
Asthma	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Asthma	ENSG00000138684	FALSE	Preclinical	2014-10-29	Absent	IL21
Asthma	ENSG00000138735	FALSE	Phase II Clinical Trial	1990-10-15	Phase II Clinical Trial	PDE5A
Asthma	ENSG00000138792	FALSE	Preclinical	1991-02-15	Unused	ENPEP
Asthma	ENSG00000139626	FALSE	Phase II Clinical Trial	1999-08-26	Unused	ITGB7
Asthma	ENSG00000140443	FALSE	unknown	2002-06-06	Preclinical	IGF1R
Asthma	ENSG00000142168	FALSE	Phase III Clinical Trial	NA	Absent	SOD1
Asthma	ENSG00000143365	FALSE	Preclinical	2012-06-15	Absent	RORC
Asthma	ENSG00000145777	FALSE	Phase III Clinical Trial	2008-09-29	Phase I Clinical Trial	TSLP
Asthma	ENSG00000145839	FALSE	Phase II Clinical Trial	1998-01-15	Unused	IL9
Asthma	ENSG00000146070	FALSE	Phase I Clinical Trial	1997-08-15	Phase I Clinical Trial	PLA2G7
Asthma	ENSG00000146648	FALSE	Preclinical	1998-12-15	Unused	EGFR
Asthma	ENSG00000147246	FALSE	unknown	NA	Unused	HTR2C
Asthma	ENSG00000149021	FALSE	Preclinical	1997-08-15	Unused	SCGB1A1
Asthma	ENSG00000149295	FALSE	Phase II Clinical Trial	1994-06-15	Unused	DRD2
Asthma	ENSG00000149451	FALSE	Preclinical	1997-05-15	Unused	ADAM33
Asthma	ENSG00000150093	FALSE	Phase II Clinical Trial	1992-01-15	Unused	ITGB1
Asthma	ENSG00000151067	FALSE	Preclinical	1991-09-15	Unused	CACNA1C
Asthma	ENSG00000151617	FALSE	Phase II Clinical Trial	1991-04-15	Phase II Clinical Trial	EDNRA
Asthma	ENSG00000152207	FALSE	Preclinical	2014-12-02	Absent	CYSLTR2
Asthma	ENSG00000154229	FALSE	Preclinical	1992-06-15	Unused	PRKCA
Asthma	ENSG00000157404	FALSE	Phase III Clinical Trial	2013-12-07	Phase III Clinical Trial	KIT
Asthma	ENSG00000158125	FALSE	Preclinical	1998-11-15	Unused	XDH
Asthma	ENSG00000158859	FALSE	Preclinical	2015-09-03	Absent	ADAMTS4
Asthma	ENSG00000160013	FALSE	Phase I Clinical Trial	1998-09-15	Unused	PTGIR
Asthma	ENSG00000160255	FALSE	Preclinical	2011-03-31	Unused	ITGB2
Asthma	ENSG00000160712	FALSE	Preclinical	1996-12-15	Unused	IL6R
Asthma	ENSG00000160791	FALSE	Preclinical	1997-07-15	Unused	CCR5
Asthma	ENSG00000162434	FALSE	Preclinical	2003-06-25	Unused	JAK1
Asthma	ENSG00000162692	FALSE	Phase I Clinical Trial	1989-06-15	Unused	VCAM1
Asthma	ENSG00000162889	FALSE	Preclinical	2015-09-15	Absent	MAPKAPK2
Asthma	ENSG00000163106	FALSE	Phase I Clinical Trial	2008-02-12	Unused	HPGDS
Asthma	ENSG00000163131	FALSE	Preclinical	1998-06-15	Unused	CTSS
Asthma	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Asthma	ENSG00000163464	FALSE	Preclinical	1991-09-15	Unused	CXCR1
Asthma	ENSG00000163485	TRUE	Approved	1991-03-15	Approved	ADORA1
Asthma	ENSG00000163737	FALSE	Preclinical	2009-12-01	Preclinical	PF4
Asthma	ENSG00000164251	FALSE	Preclinical	2003-04-08	Unused	F2RL1
Asthma	ENSG00000164342	FALSE	Phase II Clinical Trial	2010-09-08	Absent	TLR3
Asthma	ENSG00000164400	FALSE	unknown	2004-10-18	Unused	CSF2
Asthma	ENSG00000165025	FALSE	Phase II Clinical Trial	1992-06-15	Phase II Clinical Trial	SYK
Asthma	ENSG00000166090	FALSE	Preclinical	2015-06-19	Absent	IL25
Asthma	ENSG00000166888	FALSE	Preclinical	1999-04-28	Unused	STAT6
Asthma	ENSG00000167658	FALSE	Preclinical	1997-12-15	Unused	EEF2
Asthma	ENSG00000167748	FALSE	Preclinical	2008-06-23	Preclinical	KLK1
Asthma	ENSG00000168229	FALSE	Phase II Clinical Trial	1999-11-02	Phase II Clinical Trial	PTGDR
Asthma	ENSG00000168398	FALSE	Phase I Clinical Trial	1989-08-15	Unused	BDKRB2
Asthma	ENSG00000168539	TRUE	Approved	1990-10-15	Approved	CHRM1
Asthma	ENSG00000168610	FALSE	unknown	2015-02-13	Absent	STAT3
Asthma	ENSG00000168615	FALSE	Preclinical	2002-08-14	Unused	ADAM9
Asthma	ENSG00000168918	FALSE	Phase II Clinical Trial	2007-10-29	Phase II Clinical Trial	INPP5D
Asthma	ENSG00000168961	FALSE	Preclinical	2007-08-10	Unused	LGALS9
Asthma	ENSG00000169083	FALSE	unknown	1996-11-15	Unused	AR
Asthma	ENSG00000169194	FALSE	Phase III Clinical Trial	2003-05-20	Phase III Clinical Trial	IL13
Asthma	ENSG00000169245	FALSE	unknown	2008-01-14	Absent	CXCL10
Asthma	ENSG00000169252	TRUE	Approved	1989-05-15	Approved	ADRB2
Asthma	ENSG00000169385	FALSE	Preclinical	1990-05-15	Unused	RNASE2
Asthma	ENSG00000169397	FALSE	Preclinical	1990-05-15	Unused	RNASE3
Asthma	ENSG00000169403	FALSE	Pre-registration	1989-07-15	Unused	PTAFR
Asthma	ENSG00000169418	FALSE	Phase I Clinical Trial	1990-02-15	Phase I Clinical Trial	NPR1
Asthma	ENSG00000169432	FALSE	Phase II Clinical Trial	2002-03-06	Unused	SCN9A
Asthma	ENSG00000169836	FALSE	Preclinical	1994-11-15	Unused	TACR3
Asthma	ENSG00000169896	FALSE	Preclinical	2011-03-31	Unused	ITGAM
Asthma	ENSG00000170425	FALSE	Phase I Clinical Trial	2000-06-28	Unused	ADORA2B
Asthma	ENSG00000170890	FALSE	Preclinical	NA	Unused	PLA2G1B
Asthma	ENSG00000170989	FALSE	Phase II Clinical Trial	1997-12-15	Unused	S1PR1
Asthma	ENSG00000171408	FALSE	Preclinical	2004-07-06	Unused	PDE7B
Asthma	ENSG00000171522	FALSE	Preclinical	2004-09-06	Unused	PTGER4
Asthma	ENSG00000171608	FALSE	Phase II Clinical Trial	2004-01-20	Phase II Clinical Trial	PIK3CD
Asthma	ENSG00000171855	FALSE	Preclinical	2008-08-28	Preclinical	IFNB1
Asthma	ENSG00000171860	FALSE	Preclinical	2001-08-21	Unused	C3AR1
Asthma	ENSG00000172156	FALSE	Preclinical	1996-03-15	Unused	CCL11
Asthma	ENSG00000172236	FALSE	Phase II Clinical Trial	1993-10-15	Unused	TPSAB1
Asthma	ENSG00000172243	FALSE	Preclinical	2017-05-30	Absent	CLEC7A
Asthma	ENSG00000172572	FALSE	Phase III Clinical Trial	1990-10-15	Phase II Clinical Trial	PDE3A
Asthma	ENSG00000173198	TRUE	Approved	1989-06-15	Approved	CYSLTR1
Asthma	ENSG00000174080	FALSE	Preclinical	2001-03-05	Unused	CTSF
Asthma	ENSG00000174175	FALSE	Preclinical	1994-02-15	Phase II Clinical Trial	SELP
Asthma	ENSG00000175344	FALSE	Preclinical	2009-03-11	Unused	CHRNA7
Asthma	ENSG00000175591	FALSE	unknown	2002-08-19	Unused	P2RY2
Asthma	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Asthma	ENSG00000177663	FALSE	Phase II Clinical Trial	2008-03-04	Phase II Clinical Trial	IL17RA
Asthma	ENSG00000178573	FALSE	Preclinical	1996-09-15	Unused	MAF
Asthma	ENSG00000180210	FALSE	Preclinical	1997-12-15	Unused	F2
Asthma	ENSG00000180720	TRUE	Approved	1998-03-15	Approved	CHRM4
Asthma	ENSG00000180739	FALSE	Phase II Clinical Trial	1997-12-15	Unused	S1PR5
Asthma	ENSG00000180871	FALSE	Preclinical	1991-09-15	Unused	CXCR2
Asthma	ENSG00000181072	TRUE	Approved	1998-03-15	Approved	CHRM2
Asthma	ENSG00000181408	FALSE	Phase I Clinical Trial	1999-09-22	Phase I Clinical Trial	UTS2R
Asthma	ENSG00000181634	FALSE	Preclinical	2010-09-29	Unused	TNFSF15
Asthma	ENSG00000183134	FALSE	Phase III Clinical Trial	2003-04-01	Phase II Clinical Trial	PTGDR2
Asthma	ENSG00000183625	FALSE	Phase II Clinical Trial	1996-03-15	Phase II Clinical Trial	CCR3
Asthma	ENSG00000183813	FALSE	Phase I Clinical Trial	2003-05-20	Phase II Clinical Trial	CCR4
Asthma	ENSG00000184033	FALSE	Preclinical	2004-04-05	Unused	CTAG1B
Asthma	ENSG00000184381	FALSE	Preclinical	1998-04-15	Unused	PLA2G6
Asthma	ENSG00000184451	FALSE	Preclinical	2015-07-21	Absent	CCR10
Asthma	ENSG00000184502	FALSE	unknown	NA	Unused	GAST
Asthma	ENSG00000184588	FALSE	Approved	1991-09-15	Unused	PDE4B
Asthma	ENSG00000184845	FALSE	Preclinical	NA	Unused	DRD1
Asthma	ENSG00000185149	FALSE	unknown	1999-06-02	Unused	NPY2R
Asthma	ENSG00000185760	FALSE	Preclinical	2012-05-03	Preclinical	KCNQ5
Asthma	ENSG00000186652	FALSE	Preclinical	1990-05-15	Unused	PRG2
Asthma	ENSG00000187210	FALSE	Preclinical	1999-01-15	Unused	GCNT1
Asthma	ENSG00000187266	FALSE	Preclinical	1996-12-15	Unused	EPOR
Asthma	ENSG00000188257	FALSE	Preclinical	1994-08-15	Unused	PLA2G2A
Asthma	ENSG00000188404	FALSE	Preclinical	1994-02-15	Phase II Clinical Trial	SELL
Asthma	ENSG00000188778	FALSE	Preclinical	1995-06-15	Unused	ADRB3
Asthma	ENSG00000188822	FALSE	Preclinical	2017-02-22	Absent	CNR2
Asthma	ENSG00000196262	FALSE	Preclinical	2002-03-11	Unused	PPIA
Asthma	ENSG00000196611	FALSE	unknown	1995-01-15	Unused	MMP1
Asthma	ENSG00000196639	TRUE	Approved	1990-09-15	Approved	HRH1
Asthma	ENSG00000196664	FALSE	Phase II Clinical Trial	2004-02-17	Phase II Clinical Trial	TLR7
Asthma	ENSG00000196689	FALSE	Preclinical	2005-09-12	Unused	TRPV1
Asthma	ENSG00000197122	FALSE	Preclinical	1996-06-15	Unused	SRC
Asthma	ENSG00000197249	FALSE	Preclinical	1999-05-11	Unused	SERPINA1
Asthma	ENSG00000197405	FALSE	Phase II Clinical Trial	1994-05-15	Unused	C5AR1
Asthma	ENSG00000197561	FALSE	Preclinical	1995-11-15	Unused	ELANE
Asthma	ENSG00000197646	FALSE	Preclinical	2009-02-16	Unused	PDCD1LG2
Asthma	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Asthma	ENSG00000198001	FALSE	Preclinical	NA	Absent	IRAK4
Asthma	ENSG00000198223	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	CSF2RA
Asthma	ENSG00000198668	FALSE	unknown	NA	Unused	CALM1
Asthma	ENSG00000204628	FALSE	Preclinical	1995-06-15	Unused	RACK1
Asthma	ENSG00000204671	FALSE	Preclinical	2004-07-20	Unused	IL31
Asthma	ENSG00000205268	FALSE	Preclinical	2004-07-06	Unused	PDE7A
Asthma	ENSG00000205542	FALSE	unknown	1995-01-15	Unused	TMSB4X
Asthma	ENSG00000213316	FALSE	Phase I Clinical Trial	2008-08-27	Preclinical	LTC4S
Asthma	ENSG00000213694	FALSE	Phase II Clinical Trial	1997-12-15	Unused	S1PR3
Asthma	ENSG00000213903	FALSE	Preclinical	1991-12-15	Unused	LTB4R
Asthma	ENSG00000239732	FALSE	Phase II Clinical Trial	1998-10-15	Phase I Clinical Trial	TLR9
Asthma	ENSG00000240972	FALSE	Approved	2004-01-13	Unused	MIF
Asthma	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Asthma	ENSG00000258839	FALSE	Preclinical	1997-08-15	Unused	MC1R
Asthma	ENSG00000259207	FALSE	Preclinical	1997-02-15	Unused	ITGB3
Asthma	ENSG00000262406	FALSE	Phase I Clinical Trial	2011-04-01	Unused	MMP12
Asthma	ENSG00000271503	FALSE	Preclinical	1997-11-15	Unused	CCL5
Asthma	ENSG00000275302	FALSE	unknown	2004-01-20	Unused	CCL4
Asthma	ENSG00000276045	FALSE	Preclinical	NA	Absent	ORAI1
Asthma	ENSG00000277443	FALSE	Preclinical	NA	Unused	MARCKS
Asthma	ENSG00000277632	FALSE	unknown	2004-01-20	Unused	CCL3
Asthma	ENSG00000282608	FALSE	Preclinical	1998-06-15	Unused	ADORA3
Asthma, Aspirin-Induced	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Absent	TBXA2R
Ataxia Telangiectasia	ENSG00000107984	FALSE	Preclinical	2014-01-10	Absent	DKK1
Ataxia Telangiectasia	ENSG00000113580	FALSE	Phase III Clinical Trial	2015-10-07	Phase II Clinical Trial	NR3C1
Atherosclerosis	ENSG00000001630	FALSE	Phase II Clinical Trial	1991-03-15	Unused	CYP51A1
Atherosclerosis	ENSG00000005421	FALSE	Preclinical	2001-01-23	Unused	PON1
Atherosclerosis	ENSG00000005961	FALSE	Preclinical	1993-06-15	Unused	ITGA2B
Atherosclerosis	ENSG00000006638	FALSE	Preclinical	1991-01-15	Unused	TBXA2R
Atherosclerosis	ENSG00000007908	FALSE	unknown	NA	Unused	SELE
Atherosclerosis	ENSG00000012779	FALSE	Phase II Clinical Trial	1994-10-15	Unused	ALOX5
Atherosclerosis	ENSG00000015520	FALSE	Preclinical	2010-05-13	Unused	NPC1L1
Atherosclerosis	ENSG00000017797	FALSE	Preclinical	2018-01-10	Absent	RALBP1
Atherosclerosis	ENSG00000019991	FALSE	Phase III Clinical Trial	2001-01-31	Phase III Clinical Trial	HGF
Atherosclerosis	ENSG00000025434	FALSE	Phase I Clinical Trial	2000-09-01	Phase I Clinical Trial	NR1H3
Atherosclerosis	ENSG00000026103	FALSE	Preclinical	2013-09-11	Absent	FAS
Atherosclerosis	ENSG00000050748	FALSE	Preclinical	2005-08-01	Unused	MAPK9
Atherosclerosis	ENSG00000053918	FALSE	unknown	NA	Unused	KCNQ1
Atherosclerosis	ENSG00000055118	FALSE	unknown	NA	Unused	KCNH2
Atherosclerosis	ENSG00000057252	FALSE	Phase III Clinical Trial	1990-07-15	Unused	SOAT1
Atherosclerosis	ENSG00000059377	FALSE	unknown	NA	Unused	TBXAS1
Atherosclerosis	ENSG00000069431	FALSE	Preclinical	1990-05-15	Unused	ABCC9
Atherosclerosis	ENSG00000069764	FALSE	Preclinical	2016-09-19	Absent	PLA2G10
Atherosclerosis	ENSG00000071054	FALSE	Preclinical	2008-10-17	Unused	MAP4K4
Atherosclerosis	ENSG00000073756	FALSE	Phase II Clinical Trial	1996-10-15	Phase II Clinical Trial	PTGS2
Atherosclerosis	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-03-26	Phase II Clinical Trial	FGFR1
Atherosclerosis	ENSG00000078098	FALSE	Preclinical	2008-06-23	Preclinical	FAP
Atherosclerosis	ENSG00000079459	FALSE	Preclinical	1990-07-15	Unused	FDFT1
Atherosclerosis	ENSG00000083444	FALSE	Preclinical	1993-12-15	Unused	PLOD1
Atherosclerosis	ENSG00000084674	FALSE	Phase II Clinical Trial	1992-02-15	Unused	APOB
Atherosclerosis	ENSG00000085662	TRUE	Approved	1993-09-15	Unused	AKR1B1
Atherosclerosis	ENSG00000087237	FALSE	Phase III Clinical Trial	1993-06-15	Phase III Clinical Trial	CETP
Atherosclerosis	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Atherosclerosis	ENSG00000090339	FALSE	Preclinical	1997-01-15	Unused	ICAM1
Atherosclerosis	ENSG00000091831	FALSE	Preclinical	1999-05-11	Unused	ESR1
Atherosclerosis	ENSG00000095303	FALSE	Approved	2008-09-12	Unused	PTGS1
Atherosclerosis	ENSG00000099194	FALSE	Phase II Clinical Trial	2007-08-21	Unused	SCD
Atherosclerosis	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Atherosclerosis	ENSG00000100504	FALSE	Preclinical	2011-10-20	Preclinical	PYGL
Atherosclerosis	ENSG00000100644	FALSE	Phase II Clinical Trial	1999-02-01	Unused	HIF1A
Atherosclerosis	ENSG00000101017	FALSE	Preclinical	2013-09-11	Absent	CD40
Atherosclerosis	ENSG00000101384	FALSE	Preclinical	2001-03-26	Unused	JAG1
Atherosclerosis	ENSG00000101916	FALSE	Preclinical	2006-07-28	Preclinical	TLR8
Atherosclerosis	ENSG00000102245	FALSE	Preclinical	2001-12-04	Unused	CD40LG
Atherosclerosis	ENSG00000102468	FALSE	Phase I Clinical Trial	2013-09-04	Absent	HTR2A
Atherosclerosis	ENSG00000104549	FALSE	Preclinical	1991-06-15	Unused	SQLE
Atherosclerosis	ENSG00000105976	FALSE	Preclinical	2001-07-03	Unused	MET
Atherosclerosis	ENSG00000106366	FALSE	Preclinical	2001-01-30	Unused	SERPINE1
Atherosclerosis	ENSG00000107798	FALSE	Preclinical	2003-11-19	Unused	LIPA
Atherosclerosis	ENSG00000108839	FALSE	Preclinical	1990-10-15	Unused	ALOX12
Atherosclerosis	ENSG00000111144	FALSE	Phase I Clinical Trial	2013-05-08	Absent	LTA4H
Atherosclerosis	ENSG00000111537	FALSE	Preclinical	2014-12-16	Absent	IFNG
Atherosclerosis	ENSG00000112033	FALSE	Phase I Clinical Trial	2004-01-16	Phase I Clinical Trial	PPARD
Atherosclerosis	ENSG00000112062	FALSE	Phase II Clinical Trial	1998-02-15	Phase II Clinical Trial	MAPK14
Atherosclerosis	ENSG00000112096	FALSE	Preclinical	1997-09-15	Unused	SOD2
Atherosclerosis	ENSG00000112164	FALSE	unknown	2008-02-14	Unused	GLP1R
Atherosclerosis	ENSG00000112715	FALSE	Preclinical	1994-02-15	Unused	VEGFA
Atherosclerosis	ENSG00000113161	TRUE	Approved	1989-05-15	Approved	HMGCR
Atherosclerosis	ENSG00000113580	FALSE	Preclinical	NA	Unused	NR3C1
Atherosclerosis	ENSG00000115008	FALSE	Preclinical	2007-03-28	Unused	IL1A
Atherosclerosis	ENSG00000115232	FALSE	Preclinical	1992-01-15	Unused	ITGA4
Atherosclerosis	ENSG00000115828	FALSE	Preclinical	2008-08-28	Unused	QPCT
Atherosclerosis	ENSG00000116711	FALSE	Preclinical	1996-04-15	Unused	PLA2G4A
Atherosclerosis	ENSG00000117298	FALSE	Preclinical	1996-10-15	Unused	ECE1
Atherosclerosis	ENSG00000117525	FALSE	Phase I Clinical Trial	2003-04-08	Unused	F3
Atherosclerosis	ENSG00000117594	FALSE	Phase II Clinical Trial	2006-01-23	Unused	HSD11B1
Atherosclerosis	ENSG00000117601	TRUE	Approved	NA	Approved	SERPINC1
Atherosclerosis	ENSG00000118113	FALSE	Preclinical	2001-10-16	Unused	MMP8
Atherosclerosis	ENSG00000118137	FALSE	Phase II Clinical Trial	1989-10-15	Phase II Clinical Trial	APOA1
Atherosclerosis	ENSG00000118432	FALSE	Phase III Clinical Trial	1994-02-15	Unused	CNR1
Atherosclerosis	ENSG00000120907	FALSE	unknown	NA	Unused	ADRA1A
Atherosclerosis	ENSG00000121361	FALSE	Preclinical	1990-05-15	Unused	KCNJ8
Atherosclerosis	ENSG00000121807	FALSE	Phase I Clinical Trial	1993-03-15	Unused	CCR2
Atherosclerosis	ENSG00000121853	FALSE	Preclinical	2003-07-03	Unused	GHSR
Atherosclerosis	ENSG00000122861	FALSE	Preclinical	2000-03-29	Unused	PLAU
Atherosclerosis	ENSG00000122884	FALSE	Preclinical	1993-12-15	Unused	P4HA1
Atherosclerosis	ENSG00000125538	FALSE	Phase III Clinical Trial	2003-12-08	Phase III Clinical Trial	IL1B
Atherosclerosis	ENSG00000126218	TRUE	Approved	2001-01-09	Approved	F10
Atherosclerosis	ENSG00000128052	FALSE	Preclinical	1999-04-21	Unused	KDR
Atherosclerosis	ENSG00000128271	FALSE	Preclinical	2016-07-29	Absent	ADORA2A
Atherosclerosis	ENSG00000130164	FALSE	Preclinical	1992-06-15	Unused	LDLR
Atherosclerosis	ENSG00000130203	FALSE	Preclinical	1999-01-15	Unused	APOE
Atherosclerosis	ENSG00000131408	FALSE	Phase I Clinical Trial	2000-09-01	Phase I Clinical Trial	NR1H2
Atherosclerosis	ENSG00000131473	FALSE	Preclinical	1992-10-15	Unused	ACLY
Atherosclerosis	ENSG00000132170	TRUE	Approved	1989-09-15	Unused	PPARG
Atherosclerosis	ENSG00000132693	FALSE	Phase II Clinical Trial	2006-05-02	Phase I Clinical Trial	CRP
Atherosclerosis	ENSG00000132703	FALSE	Preclinical	1995-06-15	Unused	APCS
Atherosclerosis	ENSG00000134318	FALSE	Preclinical	2005-05-24	Preclinical	ROCK2
Atherosclerosis	ENSG00000135218	FALSE	Preclinical	2003-07-03	Unused	CD36
Atherosclerosis	ENSG00000135744	FALSE	Preclinical	2014-11-04	Absent	AGT
Atherosclerosis	ENSG00000136160	FALSE	Preclinical	1993-12-15	Unused	EDNRB
Atherosclerosis	ENSG00000136634	FALSE	Preclinical	2000-10-26	Unused	IL10
Atherosclerosis	ENSG00000136869	FALSE	Phase II Clinical Trial	2006-08-17	Absent	TLR4
Atherosclerosis	ENSG00000137462	FALSE	Phase II Clinical Trial	2006-08-17	Absent	TLR2
Atherosclerosis	ENSG00000137752	FALSE	Preclinical	1994-04-15	Unused	CASP1
Atherosclerosis	ENSG00000138379	FALSE	Preclinical	2017-11-03	Absent	MSTN
Atherosclerosis	ENSG00000138448	FALSE	Preclinical	1996-10-15	Unused	ITGAV
Atherosclerosis	ENSG00000138675	FALSE	Preclinical	1993-04-15	Unused	FGF5
Atherosclerosis	ENSG00000138685	FALSE	Preclinical	1994-12-15	Unused	FGF2
Atherosclerosis	ENSG00000138823	FALSE	Preclinical	1998-01-15	Unused	MTTP
Atherosclerosis	ENSG00000139610	FALSE	Preclinical	2004-08-20	Unused	CELA1
Atherosclerosis	ENSG00000141510	FALSE	Preclinical	1999-04-28	Unused	TP53
Atherosclerosis	ENSG00000141867	FALSE	Phase III Clinical Trial	2005-03-04	Phase II Clinical Trial	BRD4
Atherosclerosis	ENSG00000142798	FALSE	Phase I Clinical Trial	2003-12-01	Unused	HSPG2
Atherosclerosis	ENSG00000142871	FALSE	Preclinical	2000-07-19	Unused	CYR61
Atherosclerosis	ENSG00000143171	FALSE	Preclinical	2008-07-10	Absent	RXRG
Atherosclerosis	ENSG00000143839	FALSE	Phase III Clinical Trial	1998-03-15	Phase III Clinical Trial	REN
Atherosclerosis	ENSG00000144381	FALSE	Preclinical	2001-08-10	Unused	HSPD1
Atherosclerosis	ENSG00000144891	FALSE	Phase III Clinical Trial	1992-05-15	Unused	AGTR1
Atherosclerosis	ENSG00000146070	FALSE	Phase II Clinical Trial	1996-11-15	Phase III Clinical Trial	PLA2G7
Atherosclerosis	ENSG00000146648	FALSE	Preclinical	1996-09-15	Unused	EGFR
Atherosclerosis	ENSG00000150093	FALSE	Preclinical	1992-01-15	Unused	ITGB1
Atherosclerosis	ENSG00000150782	FALSE	Preclinical	1999-05-04	Unused	IL18
Atherosclerosis	ENSG00000151067	TRUE	Approved	1993-06-15	Approved	CACNA1C
Atherosclerosis	ENSG00000151090	FALSE	Preclinical	2001-01-03	Unused	THRB
Atherosclerosis	ENSG00000151617	FALSE	Preclinical	1996-12-15	Unused	EDNRA
Atherosclerosis	ENSG00000153563	FALSE	Preclinical	2013-05-22	Absent	CD8A
Atherosclerosis	ENSG00000154188	FALSE	unknown	2007-10-22	Unused	ANGPT1
Atherosclerosis	ENSG00000154229	FALSE	Preclinical	1994-10-15	Unused	PRKCA
Atherosclerosis	ENSG00000157227	FALSE	Preclinical	2001-02-02	Unused	MMP14
Atherosclerosis	ENSG00000158769	FALSE	Preclinical	2009-09-30	Unused	F11R
Atherosclerosis	ENSG00000158874	FALSE	Preclinical	1989-10-15	Unused	APOA2
Atherosclerosis	ENSG00000159640	FALSE	Preclinical	1991-02-15	Unused	ACE
Atherosclerosis	ENSG00000160013	FALSE	Preclinical	1998-09-15	Unused	PTGIR
Atherosclerosis	ENSG00000160285	FALSE	Preclinical	1994-07-15	Unused	LSS
Atherosclerosis	ENSG00000160868	FALSE	Preclinical	1993-05-15	Unused	CYP3A4
Atherosclerosis	ENSG00000160951	FALSE	Phase II Clinical Trial	2010-11-12	Unused	PTGER1
Atherosclerosis	ENSG00000161905	FALSE	Preclinical	1993-01-15	Unused	ALOX15
Atherosclerosis	ENSG00000162692	FALSE	Preclinical	1996-02-15	Unused	VCAM1
Atherosclerosis	ENSG00000163131	FALSE	Phase I Clinical Trial	2011-02-02	Unused	CTSS
Atherosclerosis	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Atherosclerosis	ENSG00000163719	FALSE	Preclinical	2016-10-24	Absent	MTMR14
Atherosclerosis	ENSG00000163823	FALSE	Phase I Clinical Trial	1998-03-15	Unused	CCR1
Atherosclerosis	ENSG00000164362	FALSE	Preclinical	1999-12-01	Unused	TERT
Atherosclerosis	ENSG00000164687	FALSE	Preclinical	2016-10-21	Absent	FABP5
Atherosclerosis	ENSG00000165029	FALSE	Phase II Clinical Trial	2001-01-30	Unused	ABCA1
Atherosclerosis	ENSG00000165197	FALSE	Phase II Clinical Trial	1998-06-15	Unused	VEGFD
Atherosclerosis	ENSG00000165471	FALSE	Preclinical	2000-03-29	Unused	MBL2
Atherosclerosis	ENSG00000166073	FALSE	Preclinical	2016-11-02	Absent	GPR176
Atherosclerosis	ENSG00000166501	FALSE	Preclinical	1995-09-15	Unused	PRKCB
Atherosclerosis	ENSG00000167910	FALSE	Phase II Clinical Trial	1991-07-15	Unused	CYP7A1
Atherosclerosis	ENSG00000168229	FALSE	Preclinical	2008-12-15	Unused	PTGDR
Atherosclerosis	ENSG00000168522	FALSE	Preclinical	1994-11-15	Unused	FNTA
Atherosclerosis	ENSG00000169083	FALSE	Preclinical	1991-02-15	Unused	AR
Atherosclerosis	ENSG00000169174	FALSE	Phase I Clinical Trial	2007-05-09	Unused	PCSK9
Atherosclerosis	ENSG00000169313	TRUE	Approved	2008-05-01	Approved	P2RY12
Atherosclerosis	ENSG00000169418	FALSE	Preclinical	1995-06-15	Unused	NPR1
Atherosclerosis	ENSG00000169432	FALSE	Preclinical	NA	Unused	SCN9A
Atherosclerosis	ENSG00000170323	FALSE	Preclinical	2016-10-21	Absent	FABP4
Atherosclerosis	ENSG00000170425	FALSE	Preclinical	2016-07-28	Absent	ADORA2B
Atherosclerosis	ENSG00000170835	FALSE	Phase II Clinical Trial	1992-06-15	Unused	CEL
Atherosclerosis	ENSG00000171105	FALSE	Preclinical	2004-08-02	Unused	INSR
Atherosclerosis	ENSG00000171298	FALSE	unknown	NA	Unused	GAA
Atherosclerosis	ENSG00000171509	FALSE	Phase II Clinical Trial	2007-10-23	Absent	RXFP1
Atherosclerosis	ENSG00000171557	FALSE	Preclinical	2001-03-26	Unused	FGG
Atherosclerosis	ENSG00000171560	FALSE	Preclinical	2001-03-26	Unused	FGA
Atherosclerosis	ENSG00000171564	FALSE	Preclinical	2001-03-26	Unused	FGB
Atherosclerosis	ENSG00000172572	FALSE	Phase II Clinical Trial	2005-10-31	Phase II Clinical Trial	PDE3A
Atherosclerosis	ENSG00000173083	FALSE	Preclinical	1994-12-15	Unused	HPSE
Atherosclerosis	ENSG00000173198	FALSE	unknown	NA	Unused	CYSLTR1
Atherosclerosis	ENSG00000173391	FALSE	Preclinical	2014-08-28	Absent	OLR1
Atherosclerosis	ENSG00000174175	FALSE	Preclinical	2008-08-19	Unused	SELP
Atherosclerosis	ENSG00000175344	FALSE	Preclinical	2014-04-16	Absent	CHRNA7
Atherosclerosis	ENSG00000175445	TRUE	Approved	1990-06-15	Approved	LPL
Atherosclerosis	ENSG00000175535	FALSE	Preclinical	NA	Unused	PNLIP
Atherosclerosis	ENSG00000178394	FALSE	Preclinical	NA	Unused	HTR1A
Atherosclerosis	ENSG00000180210	TRUE	Approved	1995-11-15	Approved	F2
Atherosclerosis	ENSG00000180871	FALSE	Preclinical	2000-04-05	Unused	CXCR2
Atherosclerosis	ENSG00000181092	FALSE	Preclinical	2004-09-20	Unused	ADIPOQ
Atherosclerosis	ENSG00000181104	FALSE	unknown	2001-04-10	Unused	F2R
Atherosclerosis	ENSG00000181631	FALSE	Preclinical	2016-02-26	Absent	P2RY13
Atherosclerosis	ENSG00000182492	FALSE	Preclinical	2009-07-24	Preclinical	BGN
Atherosclerosis	ENSG00000182782	TRUE	Approved	2003-04-14	Approved	HCAR2
Atherosclerosis	ENSG00000183484	FALSE	Preclinical	2016-11-02	Absent	GPR132
Atherosclerosis	ENSG00000183873	FALSE	Preclinical	NA	Unused	SCN5A
Atherosclerosis	ENSG00000185149	FALSE	Preclinical	2005-05-31	Unused	NPY2R
Atherosclerosis	ENSG00000186951	TRUE	Approved	1997-11-15	Approved	PPARA
Atherosclerosis	ENSG00000187210	FALSE	Preclinical	2004-05-05	Unused	GCNT1
Atherosclerosis	ENSG00000189403	FALSE	Preclinical	2008-07-12	Unused	HMGB1
Atherosclerosis	ENSG00000196549	FALSE	Preclinical	1996-10-15	Unused	MME
Atherosclerosis	ENSG00000196664	FALSE	Preclinical	2006-07-28	Preclinical	TLR7
Atherosclerosis	ENSG00000197122	FALSE	Preclinical	1997-10-15	Unused	SRC
Atherosclerosis	ENSG00000198670	FALSE	Phase II Clinical Trial	1989-06-15	Unused	LPA
Atherosclerosis	ENSG00000198911	FALSE	Preclinical	2008-11-27	Preclinical	SREBF2
Atherosclerosis	ENSG00000213398	FALSE	Phase II Clinical Trial	1999-04-28	Phase I Clinical Trial	LCAT
Atherosclerosis	ENSG00000213903	FALSE	Preclinical	2007-08-19	Unused	LTB4R
Atherosclerosis	ENSG00000219073	FALSE	Preclinical	NA	Unused	CELA3B
Atherosclerosis	ENSG00000239732	FALSE	Preclinical	2006-07-28	Preclinical	TLR9
Atherosclerosis	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Atherosclerosis	ENSG00000255398	FALSE	Phase I Clinical Trial	2005-10-31	Unused	HCAR3
Atherosclerosis	ENSG00000259207	FALSE	Preclinical	1993-06-15	Unused	ITGB3
Atherosclerosis	ENSG00000271503	FALSE	Preclinical	1997-11-15	Unused	CCL5
Atrial Fibrillation	ENSG00000043591	TRUE	Approved	1990-08-15	Approved	ADRB1
Atrial Fibrillation	ENSG00000053918	FALSE	unknown	1993-06-15	Unused	KCNQ1
Atrial Fibrillation	ENSG00000055118	TRUE	Approved	1989-08-15	Approved	KCNH2
Atrial Fibrillation	ENSG00000090020	FALSE	unknown	2001-08-08	Absent	SLC9A1
Atrial Fibrillation	ENSG00000096717	FALSE	Phase I Clinical Trial	2015-10-13	Absent	SIRT1
Atrial Fibrillation	ENSG00000099822	FALSE	Phase II Clinical Trial	2006-08-29	Unused	HCN2
Atrial Fibrillation	ENSG00000104783	FALSE	Preclinical	2012-04-24	Preclinical	KCNN4
Atrial Fibrillation	ENSG00000106211	FALSE	Preclinical	2009-12-23	Unused	HSPB1
Atrial Fibrillation	ENSG00000117601	FALSE	unknown	1994-10-15	Unused	SERPINC1
Atrial Fibrillation	ENSG00000120457	FALSE	Phase II Clinical Trial	1999-11-17	Phase II Clinical Trial	KCNJ5
Atrial Fibrillation	ENSG00000126218	TRUE	Approved	2001-01-09	Unused	F10
Atrial Fibrillation	ENSG00000130037	FALSE	Phase II Clinical Trial	2002-10-08	Phase I Clinical Trial	KCNA5
Atrial Fibrillation	ENSG00000132693	FALSE	Phase II Clinical Trial	2006-05-02	Phase II Clinical Trial	CRP
Atrial Fibrillation	ENSG00000138622	FALSE	Phase II Clinical Trial	2006-08-29	Unused	HCN4
Atrial Fibrillation	ENSG00000143630	FALSE	Phase II Clinical Trial	2006-08-29	Unused	HCN3
Atrial Fibrillation	ENSG00000144891	FALSE	unknown	1992-03-15	Unused	AGTR1
Atrial Fibrillation	ENSG00000151067	TRUE	Approved	1994-04-15	Approved	CACNA1C
Atrial Fibrillation	ENSG00000157388	FALSE	Preclinical	2005-08-19	Unused	CACNA1D
Atrial Fibrillation	ENSG00000162989	FALSE	Phase II Clinical Trial	1999-11-17	Phase II Clinical Trial	KCNJ3
Atrial Fibrillation	ENSG00000163399	FALSE	Preclinical	1998-12-15	Unused	ATP1A1
Atrial Fibrillation	ENSG00000163485	FALSE	Phase II Clinical Trial	1998-03-15	Unused	ADORA1
Atrial Fibrillation	ENSG00000164270	FALSE	Preclinical	1993-12-15	Unused	HTR4
Atrial Fibrillation	ENSG00000164588	FALSE	Phase II Clinical Trial	2006-08-29	Unused	HCN1
Atrial Fibrillation	ENSG00000169252	TRUE	Approved	NA	Approved	ADRB2
Atrial Fibrillation	ENSG00000171385	FALSE	Phase II Clinical Trial	2002-03-08	Unused	KCND3
Atrial Fibrillation	ENSG00000180210	FALSE	Preclinical	2001-02-28	Unused	F2
Atrial Fibrillation	ENSG00000183873	TRUE	Approved	1990-07-15	Approved	SCN5A
Atrial Fibrillation	ENSG00000186951	FALSE	Phase I Clinical Trial	2015-10-13	Absent	PPARA
Atrial Fibrillation	ENSG00000198626	FALSE	Phase II Clinical Trial	1997-05-15	Unused	RYR2
Atrophic Vaginitis	ENSG00000082175	TRUE	Approved	NA	Absent	PGR
Atrophic Vaginitis	ENSG00000091831	TRUE	Approved	1990-10-15	Absent	ESR1
Atrophic Vaginitis	ENSG00000169083	TRUE	Approved	2008-07-22	Absent	AR
Atrophic Vaginitis	ENSG00000180914	FALSE	Phase II Clinical Trial	2011-09-29	Absent	OXTR
Attention Deficit Disorder with Hyperactivity	ENSG00000069696	FALSE	Phase II Clinical Trial	1995-03-15	Unused	DRD4
Attention Deficit Disorder with Hyperactivity	ENSG00000073756	FALSE	Preclinical	2012-11-14	Absent	PTGS2
Attention Deficit Disorder with Hyperactivity	ENSG00000075043	FALSE	unknown	1992-08-15	Unused	KCNQ2
Attention Deficit Disorder with Hyperactivity	ENSG00000082556	FALSE	Preclinical	2012-11-14	Absent	OPRK1
Attention Deficit Disorder with Hyperactivity	ENSG00000087085	FALSE	Phase II Clinical Trial	1989-06-15	Phase II Clinical Trial	ACHE
Attention Deficit Disorder with Hyperactivity	ENSG00000095303	FALSE	Preclinical	2012-11-14	Absent	PTGS1
Attention Deficit Disorder with Hyperactivity	ENSG00000101180	FALSE	Phase II Clinical Trial	1997-06-15	Phase I Clinical Trial	HRH3
Attention Deficit Disorder with Hyperactivity	ENSG00000101204	FALSE	Phase II Clinical Trial	2003-01-15	Phase II Clinical Trial	CHRNA4
Attention Deficit Disorder with Hyperactivity	ENSG00000102468	FALSE	Phase II Clinical Trial	1992-10-15	Phase II Clinical Trial	HTR2A
Attention Deficit Disorder with Hyperactivity	ENSG00000103546	TRUE	Approved	1997-07-15	Approved	SLC6A2
Attention Deficit Disorder with Hyperactivity	ENSG00000105464	FALSE	Preclinical	2011-11-15	Preclinical	GRIN2D
Attention Deficit Disorder with Hyperactivity	ENSG00000108576	FALSE	Pre-registration	1998-06-15	Phase II Clinical Trial	SLC6A4
Attention Deficit Disorder with Hyperactivity	ENSG00000112038	FALSE	Preclinical	2012-11-14	Absent	OPRM1
Attention Deficit Disorder with Hyperactivity	ENSG00000115252	FALSE	Preclinical	2007-06-26	Unused	PDE1A
Attention Deficit Disorder with Hyperactivity	ENSG00000116329	FALSE	Preclinical	2012-11-14	Absent	OPRD1
Attention Deficit Disorder with Hyperactivity	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Attention Deficit Disorder with Hyperactivity	ENSG00000128272	FALSE	Phase II Clinical Trial	1991-05-15	Unused	ATF4
Attention Deficit Disorder with Hyperactivity	ENSG00000135312	FALSE	Phase II Clinical Trial	2003-12-22	Phase II Clinical Trial	HTR1B
Attention Deficit Disorder with Hyperactivity	ENSG00000135519	FALSE	Phase I Clinical Trial	2008-05-13	Absent	KCNH3
Attention Deficit Disorder with Hyperactivity	ENSG00000137252	FALSE	Phase II Clinical Trial	2015-01-06	Absent	HCRTR2
Attention Deficit Disorder with Hyperactivity	ENSG00000142319	TRUE	Approved	1997-03-15	Approved	SLC6A3
Attention Deficit Disorder with Hyperactivity	ENSG00000148680	FALSE	Phase II Clinical Trial	2003-12-22	Absent	HTR7
Attention Deficit Disorder with Hyperactivity	ENSG00000149295	FALSE	Phase III Clinical Trial	1992-10-15	Phase II Clinical Trial	DRD2
Attention Deficit Disorder with Hyperactivity	ENSG00000150594	TRUE	Approved	2007-07-16	Approved	ADRA2A
Attention Deficit Disorder with Hyperactivity	ENSG00000151577	FALSE	Phase II Clinical Trial	2008-07-22	Phase II Clinical Trial	DRD3
Attention Deficit Disorder with Hyperactivity	ENSG00000155511	FALSE	Phase II Clinical Trial	1994-02-15	Unused	GRIA1
Attention Deficit Disorder with Hyperactivity	ENSG00000158748	FALSE	Phase II Clinical Trial	2008-07-22	Preclinical	HTR6
Attention Deficit Disorder with Hyperactivity	ENSG00000160716	FALSE	Phase II Clinical Trial	2003-01-15	Phase II Clinical Trial	CHRNB2
Attention Deficit Disorder with Hyperactivity	ENSG00000165646	TRUE	Approved	1999-06-15	Absent	SLC18A2
Attention Deficit Disorder with Hyperactivity	ENSG00000169676	FALSE	Phase III Clinical Trial	2008-03-05	Phase II Clinical Trial	DRD5
Attention Deficit Disorder with Hyperactivity	ENSG00000175344	FALSE	Phase II Clinical Trial	1997-10-15	Unused	CHRNA7
Attention Deficit Disorder with Hyperactivity	ENSG00000176884	FALSE	Preclinical	NA	Absent	GRIN1
Attention Deficit Disorder with Hyperactivity	ENSG00000178394	FALSE	Phase II Clinical Trial	1992-10-15	Phase II Clinical Trial	HTR1A
Attention Deficit Disorder with Hyperactivity	ENSG00000179546	FALSE	Phase II Clinical Trial	2003-12-22	Absent	HTR1D
Attention Deficit Disorder with Hyperactivity	ENSG00000184156	FALSE	unknown	1992-08-15	Unused	KCNQ3
Attention Deficit Disorder with Hyperactivity	ENSG00000184160	TRUE	Approved	2007-07-16	Approved	ADRA2C
Attention Deficit Disorder with Hyperactivity	ENSG00000184845	FALSE	Preclinical	2007-06-26	Unused	DRD1
Attention Deficit Disorder with Hyperactivity	ENSG00000189221	FALSE	unknown	1999-08-11	Absent	MAOA
Attention Deficit Disorder with Hyperactivity	ENSG00000274286	TRUE	Approved	2007-07-16	Approved	ADRA2B
Autistic Disorder	ENSG00000064651	FALSE	Phase II Clinical Trial	2014-02-22	Absent	SLC12A2
Autistic Disorder	ENSG00000069696	FALSE	Phase I Clinical Trial	2008-07-22	Absent	DRD4
Autistic Disorder	ENSG00000074803	FALSE	Phase II Clinical Trial	2014-02-22	Absent	SLC12A1
Autistic Disorder	ENSG00000080293	FALSE	Preclinical	1999-03-23	Unused	SCTR
Autistic Disorder	ENSG00000102468	TRUE	Approved	1992-10-15	Approved	HTR2A
Autistic Disorder	ENSG00000108576	FALSE	Pre-registration	NA	Phase III Clinical Trial	SLC6A4
Autistic Disorder	ENSG00000109158	FALSE	Preclinical	2013-06-12	Absent	GABRA4
Autistic Disorder	ENSG00000117480	FALSE	Preclinical	2012-08-08	Absent	FAAH
Autistic Disorder	ENSG00000124493	FALSE	Preclinical	2004-05-24	Absent	GRM4
Autistic Disorder	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Autistic Disorder	ENSG00000134640	FALSE	Phase III Clinical Trial	2001-11-14	Phase I Clinical Trial	MTNR1B
Autistic Disorder	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Autistic Disorder	ENSG00000144285	FALSE	Phase II Clinical Trial	NA	Unused	SCN1A
Autistic Disorder	ENSG00000147246	FALSE	Phase I Clinical Trial	2012-08-22	Phase I Clinical Trial	HTR2C
Autistic Disorder	ENSG00000147955	FALSE	Preclinical	2007-02-02	Absent	SIGMAR1
Autistic Disorder	ENSG00000148680	FALSE	Phase III Clinical Trial	1996-01-15	Phase III Clinical Trial	HTR7
Autistic Disorder	ENSG00000149295	TRUE	Approved	1992-10-15	Approved	DRD2
Autistic Disorder	ENSG00000150594	FALSE	Phase II Clinical Trial	2010-08-04	Phase I Clinical Trial	ADRA2A
Autistic Disorder	ENSG00000151247	FALSE	Preclinical	2014-03-06	Absent	EIF4E
Autistic Disorder	ENSG00000151577	FALSE	Phase I Clinical Trial	2008-07-22	Absent	DRD3
Autistic Disorder	ENSG00000153253	FALSE	Phase II Clinical Trial	NA	Unused	SCN3A
Autistic Disorder	ENSG00000155511	FALSE	Phase II Clinical Trial	1994-02-15	Unused	GRIA1
Autistic Disorder	ENSG00000158748	FALSE	Phase I Clinical Trial	2008-07-22	Absent	HTR6
Autistic Disorder	ENSG00000166148	FALSE	Phase II Clinical Trial	2011-08-18	Phase I Clinical Trial	AVPR1A
Autistic Disorder	ENSG00000168412	FALSE	Phase III Clinical Trial	2001-11-14	Phase I Clinical Trial	MTNR1A
Autistic Disorder	ENSG00000168539	FALSE	Preclinical	2010-01-08	Preclinical	CHRM1
Autistic Disorder	ENSG00000168959	FALSE	Preclinical	2005-10-04	Preclinical	GRM5
Autistic Disorder	ENSG00000176884	FALSE	Phase II Clinical Trial	2007-08-08	Phase II Clinical Trial	GRIN1
Autistic Disorder	ENSG00000178394	TRUE	Approved	1992-10-15	Approved	HTR1A
Autistic Disorder	ENSG00000180914	FALSE	Phase II Clinical Trial	2005-02-07	Phase I Clinical Trial	OXTR
Autistic Disorder	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Autistic Disorder	ENSG00000183454	FALSE	Preclinical	2011-11-15	Preclinical	GRIN2A
Autistic Disorder	ENSG00000186297	FALSE	Preclinical	2012-11-27	Absent	GABRA5
Autistic Disorder	ENSG00000187730	FALSE	Preclinical	2013-06-12	Absent	GABRD
Autoimmune Diseases	ENSG00000006210	FALSE	Preclinical	2006-02-07	Absent	CX3CL1
Autoimmune Diseases	ENSG00000006327	FALSE	Preclinical	2012-11-19	Preclinical	TNFRSF12A
Autoimmune Diseases	ENSG00000007312	FALSE	Preclinical	2010-10-27	Preclinical	CD79B
Autoimmune Diseases	ENSG00000010671	FALSE	Phase I Clinical Trial	2011-09-02	Phase I Clinical Trial	BTK
Autoimmune Diseases	ENSG00000012124	FALSE	Preclinical	2015-06-30	Absent	CD22
Autoimmune Diseases	ENSG00000019582	FALSE	Preclinical	2015-10-12	Absent	CD74
Autoimmune Diseases	ENSG00000026103	FALSE	Preclinical	NA	Preclinical	FAS
Autoimmune Diseases	ENSG00000051180	FALSE	Preclinical	2016-06-29	Absent	RAD51
Autoimmune Diseases	ENSG00000065675	FALSE	Preclinical	2013-02-25	Preclinical	PRKCQ
Autoimmune Diseases	ENSG00000067182	FALSE	Preclinical	2016-06-01	Absent	TNFRSF1A
Autoimmune Diseases	ENSG00000072694	FALSE	Phase II Clinical Trial	2007-12-11	Preclinical	FCGR2B
Autoimmune Diseases	ENSG00000074966	FALSE	Preclinical	2015-01-28	Absent	TXK
Autoimmune Diseases	ENSG00000082556	FALSE	Approved	2012-09-01	Absent	OPRK1
Autoimmune Diseases	ENSG00000088832	FALSE	Preclinical	2011-05-18	Preclinical	FKBP1A
Autoimmune Diseases	ENSG00000089041	FALSE	Preclinical	2011-08-16	Preclinical	P2RX7
Autoimmune Diseases	ENSG00000089685	FALSE	Preclinical	2015-10-07	Absent	BIRC5
Autoimmune Diseases	ENSG00000089692	FALSE	Preclinical	2015-04-10	Absent	LAG3
Autoimmune Diseases	ENSG00000090339	FALSE	Preclinical	2014-08-18	Absent	ICAM1
Autoimmune Diseases	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Autoimmune Diseases	ENSG00000092445	FALSE	Preclinical	2014-09-16	Absent	TYRO3
Autoimmune Diseases	ENSG00000094631	FALSE	Phase I Clinical Trial	2015-07-17	Absent	HDAC6
Autoimmune Diseases	ENSG00000096968	FALSE	Preclinical	2007-07-30	Preclinical	JAK2
Autoimmune Diseases	ENSG00000100385	FALSE	Phase I Clinical Trial	NA	Absent	IL2RB
Autoimmune Diseases	ENSG00000100784	FALSE	Preclinical	2014-08-25	Absent	RPS6KA5
Autoimmune Diseases	ENSG00000101017	FALSE	Preclinical	2008-06-04	Absent	CD40
Autoimmune Diseases	ENSG00000101916	FALSE	Phase I Clinical Trial	2011-10-28	Preclinical	TLR8
Autoimmune Diseases	ENSG00000102524	FALSE	Phase I Clinical Trial	2016-01-25	Absent	TNFSF13B
Autoimmune Diseases	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Autoimmune Diseases	ENSG00000104783	FALSE	Preclinical	2016-09-26	Absent	KCNN4
Autoimmune Diseases	ENSG00000104870	FALSE	Phase I Clinical Trial	2011-11-19	Preclinical	FCGRT
Autoimmune Diseases	ENSG00000105246	FALSE	Preclinical	2016-03-17	Absent	EBI3
Autoimmune Diseases	ENSG00000105329	FALSE	Preclinical	2016-11-11	Absent	TGFB1
Autoimmune Diseases	ENSG00000105397	FALSE	Preclinical	2007-07-30	Preclinical	TYK2
Autoimmune Diseases	ENSG00000105639	FALSE	Preclinical	2007-07-30	Preclinical	JAK3
Autoimmune Diseases	ENSG00000105851	FALSE	Preclinical	2012-05-04	Preclinical	PIK3CG
Autoimmune Diseases	ENSG00000106804	FALSE	Preclinical	2009-03-27	Absent	C5
Autoimmune Diseases	ENSG00000106952	FALSE	Preclinical	2005-06-20	Absent	TNFSF8
Autoimmune Diseases	ENSG00000107611	FALSE	Preclinical	2001-02-02	Preclinical	CUBN
Autoimmune Diseases	ENSG00000107738	FALSE	Preclinical	2015-04-10	Absent	VSIR
Autoimmune Diseases	ENSG00000109339	FALSE	Preclinical	2014-10-18	Absent	MAPK10
Autoimmune Diseases	ENSG00000110448	FALSE	Preclinical	2016-12-28	Unused	CD5
Autoimmune Diseases	ENSG00000112038	FALSE	Approved	2012-09-01	Absent	OPRM1
Autoimmune Diseases	ENSG00000112115	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	IL17A
Autoimmune Diseases	ENSG00000112116	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	IL17F
Autoimmune Diseases	ENSG00000112164	FALSE	Preclinical	NA	Absent	GLP1R
Autoimmune Diseases	ENSG00000112486	FALSE	Preclinical	NA	Preclinical	CCR6
Autoimmune Diseases	ENSG00000113263	FALSE	Phase II Clinical Trial	2011-05-06	Phase I Clinical Trial	ITK
Autoimmune Diseases	ENSG00000113302	FALSE	Phase II Clinical Trial	2008-06-18	Absent	IL12B
Autoimmune Diseases	ENSG00000113520	FALSE	Preclinical	2014-10-29	Absent	IL4
Autoimmune Diseases	ENSG00000113525	FALSE	Preclinical	2016-09-02	Absent	IL5
Autoimmune Diseases	ENSG00000113916	FALSE	Preclinical	2017-01-03	Absent	BCL6
Autoimmune Diseases	ENSG00000115085	FALSE	Preclinical	2014-04-29	Absent	ZAP70
Autoimmune Diseases	ENSG00000116824	FALSE	Preclinical	2002-11-07	Unused	CD2
Autoimmune Diseases	ENSG00000117560	FALSE	Preclinical	2011-02-14	Preclinical	FASLG
Autoimmune Diseases	ENSG00000120217	FALSE	Preclinical	2014-12-17	Absent	CD274
Autoimmune Diseases	ENSG00000121807	FALSE	Preclinical	2011-08-30	Unused	CCR2
Autoimmune Diseases	ENSG00000121966	FALSE	Preclinical	2011-08-24	Preclinical	CXCR4
Autoimmune Diseases	ENSG00000122025	FALSE	Preclinical	2006-11-28	Unused	FLT3
Autoimmune Diseases	ENSG00000123358	FALSE	Preclinical	2013-10-30	Absent	NR4A1
Autoimmune Diseases	ENSG00000125538	FALSE	Preclinical	2012-07-12	Unused	IL1B
Autoimmune Diseases	ENSG00000125571	FALSE	Preclinical	2011-10-20	Absent	IL37
Autoimmune Diseases	ENSG00000128271	FALSE	Preclinical	2016-07-29	Absent	ADORA2A
Autoimmune Diseases	ENSG00000131759	FALSE	unknown	2011-11-25	Phase II Clinical Trial	RARA
Autoimmune Diseases	ENSG00000134318	FALSE	Preclinical	2015-06-10	Absent	ROCK2
Autoimmune Diseases	ENSG00000134460	FALSE	Phase I Clinical Trial	2013-05-30	Absent	IL2RA
Autoimmune Diseases	ENSG00000134470	FALSE	Preclinical	NA	Absent	IL15RA
Autoimmune Diseases	ENSG00000134489	FALSE	Preclinical	2007-07-30	Absent	HRH4
Autoimmune Diseases	ENSG00000135046	FALSE	Preclinical	2014-04-25	Absent	ANXA1
Autoimmune Diseases	ENSG00000135047	FALSE	Preclinical	2009-01-21	Preclinical	CTSL
Autoimmune Diseases	ENSG00000135077	FALSE	Preclinical	2015-04-10	Absent	HAVCR2
Autoimmune Diseases	ENSG00000136244	FALSE	Preclinical	2009-10-12	Absent	IL6
Autoimmune Diseases	ENSG00000136634	FALSE	Preclinical	2012-11-19	Preclinical	IL10
Autoimmune Diseases	ENSG00000136869	FALSE	Preclinical	2015-01-05	Absent	TLR4
Autoimmune Diseases	ENSG00000137745	FALSE	Preclinical	2012-07-26	Preclinical	MMP13
Autoimmune Diseases	ENSG00000138684	FALSE	Phase I Clinical Trial	2014-10-29	Absent	IL21
Autoimmune Diseases	ENSG00000141867	FALSE	Preclinical	2013-10-01	Absent	BRD4
Autoimmune Diseases	ENSG00000143171	FALSE	Phase I Clinical Trial	2008-07-10	Absent	RXRG
Autoimmune Diseases	ENSG00000143365	FALSE	Phase I Clinical Trial	2011-12-26	Preclinical	RORC
Autoimmune Diseases	ENSG00000143387	FALSE	Preclinical	2009-01-21	Preclinical	CTSK
Autoimmune Diseases	ENSG00000144381	FALSE	Preclinical	2015-09-01	Absent	HSPD1
Autoimmune Diseases	ENSG00000145839	FALSE	Preclinical	2014-10-29	Absent	IL9
Autoimmune Diseases	ENSG00000147099	FALSE	Preclinical	2007-07-10	Absent	HDAC8
Autoimmune Diseases	ENSG00000153208	FALSE	Preclinical	2014-09-16	Absent	MERTK
Autoimmune Diseases	ENSG00000153234	FALSE	Preclinical	2013-10-30	Absent	NR4A2
Autoimmune Diseases	ENSG00000156234	FALSE	Preclinical	2006-06-20	Absent	CXCL13
Autoimmune Diseases	ENSG00000156738	FALSE	Preclinical	2014-07-12	Preclinical	MS4A1
Autoimmune Diseases	ENSG00000159110	FALSE	Approved	2016-12-27	Absent	IFNAR2
Autoimmune Diseases	ENSG00000159339	FALSE	Preclinical	2015-10-07	Absent	PADI4
Autoimmune Diseases	ENSG00000160113	FALSE	Preclinical	2016-06-16	Absent	NR2F6
Autoimmune Diseases	ENSG00000160223	FALSE	Preclinical	2017-04-25	Absent	ICOSLG
Autoimmune Diseases	ENSG00000160712	FALSE	Preclinical	2005-09-12	Preclinical	IL6R
Autoimmune Diseases	ENSG00000160791	FALSE	Preclinical	2011-08-30	Phase I Clinical Trial	CCR5
Autoimmune Diseases	ENSG00000161955	FALSE	Preclinical	2016-05-30	Absent	TNFSF13
Autoimmune Diseases	ENSG00000162302	FALSE	Preclinical	2014-08-25	Absent	RPS6KA4
Autoimmune Diseases	ENSG00000162434	FALSE	Preclinical	2007-07-30	Preclinical	JAK1
Autoimmune Diseases	ENSG00000162594	FALSE	Preclinical	2015-12-14	Absent	IL23R
Autoimmune Diseases	ENSG00000162711	FALSE	Preclinical	2013-03-28	Absent	NLRP3
Autoimmune Diseases	ENSG00000163131	FALSE	Phase I Clinical Trial	2009-01-21	Unused	CTSS
Autoimmune Diseases	ENSG00000163599	FALSE	Preclinical	2012-11-19	Preclinical	CTLA4
Autoimmune Diseases	ENSG00000164342	FALSE	Preclinical	2015-02-03	Absent	TLR3
Autoimmune Diseases	ENSG00000164399	FALSE	Preclinical	2016-09-02	Absent	IL3
Autoimmune Diseases	ENSG00000164400	FALSE	Preclinical	2016-09-02	Absent	CSF2
Autoimmune Diseases	ENSG00000164733	FALSE	Preclinical	2009-01-21	Preclinical	CTSB
Autoimmune Diseases	ENSG00000165025	FALSE	Preclinical	2012-07-26	Preclinical	SYK
Autoimmune Diseases	ENSG00000167601	FALSE	Preclinical	2014-09-16	Absent	AXL
Autoimmune Diseases	ENSG00000167658	FALSE	Preclinical	2008-03-26	Absent	EEF2
Autoimmune Diseases	ENSG00000168685	FALSE	Phase I Clinical Trial	2013-03-09	Absent	IL7R
Autoimmune Diseases	ENSG00000168811	FALSE	Preclinical	2016-03-17	Absent	IL12A
Autoimmune Diseases	ENSG00000168918	FALSE	Preclinical	2008-10-28	Preclinical	INPP5D
Autoimmune Diseases	ENSG00000170989	FALSE	Preclinical	2009-05-08	Unused	S1PR1
Autoimmune Diseases	ENSG00000171522	FALSE	Phase I Clinical Trial	2008-07-04	Phase I Clinical Trial	PTGER4
Autoimmune Diseases	ENSG00000172349	FALSE	Preclinical	2015-08-06	Absent	IL16
Autoimmune Diseases	ENSG00000172819	FALSE	Phase I Clinical Trial	2013-08-01	Absent	RARG
Autoimmune Diseases	ENSG00000173083	FALSE	Preclinical	2013-12-03	Absent	HPSE
Autoimmune Diseases	ENSG00000173762	FALSE	Preclinical	2008-03-26	Absent	CD7
Autoimmune Diseases	ENSG00000174059	FALSE	Preclinical	2015-06-10	Absent	CD34
Autoimmune Diseases	ENSG00000174080	FALSE	Preclinical	2009-01-21	Preclinical	CTSF
Autoimmune Diseases	ENSG00000177272	FALSE	Preclinical	2005-06-17	Preclinical	KCNA3
Autoimmune Diseases	ENSG00000177455	FALSE	Phase II Clinical Trial	2007-07-19	Unused	CD19
Autoimmune Diseases	ENSG00000177663	FALSE	Phase I Clinical Trial	2015-08-10	Absent	IL17RA
Autoimmune Diseases	ENSG00000178562	FALSE	Preclinical	2017-04-25	Absent	CD28
Autoimmune Diseases	ENSG00000178607	FALSE	Preclinical	2010-03-31	Preclinical	ERN1
Autoimmune Diseases	ENSG00000180739	FALSE	Preclinical	2017-02-09	Absent	S1PR5
Autoimmune Diseases	ENSG00000180871	FALSE	Preclinical	2017-12-20	Absent	CXCR2
Autoimmune Diseases	ENSG00000181847	FALSE	Preclinical	NA	Absent	TIGIT
Autoimmune Diseases	ENSG00000182326	FALSE	Preclinical	2016-06-27	Absent	C1S
Autoimmune Diseases	ENSG00000182578	FALSE	Preclinical	2007-06-12	Unused	CSF1R
Autoimmune Diseases	ENSG00000183813	FALSE	Preclinical	2009-06-10	Absent	CCR4
Autoimmune Diseases	ENSG00000184216	FALSE	Preclinical	2016-08-02	Absent	IRAK1
Autoimmune Diseases	ENSG00000184584	FALSE	Preclinical	2016-02-11	Absent	TMEM173
Autoimmune Diseases	ENSG00000185291	FALSE	Preclinical	2007-03-13	Absent	IL3RA
Autoimmune Diseases	ENSG00000185339	FALSE	Preclinical	2001-02-02	Preclinical	TCN2
Autoimmune Diseases	ENSG00000186827	FALSE	Phase I Clinical Trial	2013-02-01	Preclinical	TNFRSF4
Autoimmune Diseases	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-12-17	Absent	PDCD1
Autoimmune Diseases	ENSG00000189403	FALSE	Preclinical	2017-07-21	Absent	HMGB1
Autoimmune Diseases	ENSG00000196083	FALSE	Preclinical	2017-06-21	Absent	IL1RAP
Autoimmune Diseases	ENSG00000196664	FALSE	Phase I Clinical Trial	2009-12-23	Preclinical	TLR7
Autoimmune Diseases	ENSG00000197919	FALSE	Preclinical	2016-04-08	Absent	IFNA1
Autoimmune Diseases	ENSG00000198001	FALSE	Preclinical	2014-05-26	Absent	IRAK4
Autoimmune Diseases	ENSG00000198793	FALSE	Preclinical	2014-07-04	Absent	MTOR
Autoimmune Diseases	ENSG00000198829	FALSE	Preclinical	NA	Absent	SUCNR1
Autoimmune Diseases	ENSG00000213694	FALSE	Preclinical	2010-07-02	Unused	S1PR3
Autoimmune Diseases	ENSG00000213809	FALSE	Preclinical	2006-11-24	Absent	KLRK1
Autoimmune Diseases	ENSG00000239732	FALSE	Preclinical	2012-03-16	Absent	TLR9
Autoimmune Diseases	ENSG00000240972	FALSE	Preclinical	2011-04-21	Absent	MIF
Autoimmune Diseases	ENSG00000271503	FALSE	unknown	2009-06-04	Absent	CCL5
Bacterial Infections	ENSG00000065989	FALSE	Phase I Clinical Trial	2005-05-24	Absent	PDE4A
Bacterial Infections	ENSG00000070915	FALSE	Preclinical	NA	Unused	SLC12A3
Bacterial Infections	ENSG00000113161	FALSE	Preclinical	2010-06-02	Absent	HMGCR
Bacterial Infections	ENSG00000115020	FALSE	Preclinical	2013-08-29	Absent	PIKFYVE
Bacterial Infections	ENSG00000131747	FALSE	Preclinical	1991-07-15	Unused	TOP2A
Bacterial Infections	ENSG00000165527	FALSE	Preclinical	2016-10-04	Absent	ARF6
Bacterial Infections	ENSG00000228716	FALSE	Preclinical	NA	Unused	DHFR
Bardet-Biedl Syndrome	ENSG00000166603	FALSE	Phase II Clinical Trial	2009-01-09	Absent	MC4R
Barrett Esophagus	ENSG00000073756	FALSE	Phase II Clinical Trial	1996-10-15	Phase II Clinical Trial	PTGS2
Barrett Esophagus	ENSG00000110148	FALSE	Phase II Clinical Trial	NA	Absent	CCKBR
Barrett Esophagus	ENSG00000115758	FALSE	Phase I Clinical Trial	1996-05-15	Unused	ODC1
Barrett Esophagus	ENSG00000138735	FALSE	Preclinical	1994-12-15	Unused	PDE5A
Barrett Esophagus	ENSG00000172936	FALSE	unknown	2000-03-01	Unused	MYD88
Barrett Esophagus	ENSG00000175104	FALSE	unknown	2000-03-01	Unused	TRAF6
Barrett Esophagus	ENSG00000184216	FALSE	unknown	2000-03-01	Unused	IRAK1
Barrett Esophagus	ENSG00000186642	FALSE	Preclinical	1994-12-15	Unused	PDE2A
Barrett Esophagus	ENSG00000196664	FALSE	Phase I Clinical Trial	NA	Unused	TLR7
Basal Cell Nevus Syndrome	ENSG00000128602	FALSE	Phase III Clinical Trial	2008-11-24	Unused	SMO
Basal Cell Nevus Syndrome	ENSG00000172819	FALSE	Preclinical	2012-06-14	Absent	RARG
Behcet Syndrome	ENSG00000065989	FALSE	Pre-registration	2004-01-28	Phase II Clinical Trial	PDE4A
Behcet Syndrome	ENSG00000067182	FALSE	Pre-registration	2004-01-28	Phase II Clinical Trial	TNFRSF1A
Behcet Syndrome	ENSG00000072062	FALSE	Preclinical	2007-03-14	Unused	PRKACA
Behcet Syndrome	ENSG00000105650	FALSE	Pre-registration	2004-01-28	Phase II Clinical Trial	PDE4C
Behcet Syndrome	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Behcet Syndrome	ENSG00000112115	FALSE	Phase III Clinical Trial	2006-02-01	Phase III Clinical Trial	IL17A
Behcet Syndrome	ENSG00000113448	FALSE	Pre-registration	2004-01-28	Phase II Clinical Trial	PDE4D
Behcet Syndrome	ENSG00000125538	FALSE	Phase III Clinical Trial	2003-12-08	Phase III Clinical Trial	IL1B
Behcet Syndrome	ENSG00000135047	FALSE	Preclinical	1997-01-15	Unused	CTSL
Behcet Syndrome	ENSG00000140538	FALSE	Preclinical	2007-03-14	Unused	NTRK3
Behcet Syndrome	ENSG00000143365	FALSE	Phase I Clinical Trial	2013-05-30	Absent	RORC
Behcet Syndrome	ENSG00000148053	FALSE	Preclinical	2007-03-14	Unused	NTRK2
Behcet Syndrome	ENSG00000154229	FALSE	Preclinical	2007-03-14	Unused	PRKCA
Behcet Syndrome	ENSG00000159110	FALSE	Phase I Clinical Trial	2003-07-30	Unused	IFNAR2
Behcet Syndrome	ENSG00000164733	FALSE	Preclinical	1997-01-15	Unused	CTSB
Behcet Syndrome	ENSG00000184588	FALSE	Pre-registration	2004-01-28	Phase II Clinical Trial	PDE4B
Behcet Syndrome	ENSG00000185532	FALSE	Preclinical	2007-03-14	Unused	PRKG1
Behcet Syndrome	ENSG00000189403	FALSE	Preclinical	2007-03-14	Unused	HMGB1
Behcet Syndrome	ENSG00000213903	FALSE	unknown	1990-07-15	Unused	LTB4R
Biliary Atresia	ENSG00000012504	FALSE	Phase II Clinical Trial	2004-08-13	Absent	NR1H4
Biliary Dyskinesia	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Biliary Dyskinesia	ENSG00000163394	FALSE	Preclinical	1995-11-15	Unused	CCKAR
Biliary Dyskinesia	ENSG00000168539	TRUE	Approved	1989-05-15	Approved	CHRM1
Biliary Dyskinesia	ENSG00000180720	TRUE	Approved	1989-05-15	Approved	CHRM4
Biliary Dyskinesia	ENSG00000181072	TRUE	Approved	1989-05-15	Approved	CHRM2
Biliary Tract Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FLT4
Biliary Tract Neoplasms	ENSG00000047936	FALSE	Preclinical	2012-08-16	Absent	ROS1
Biliary Tract Neoplasms	ENSG00000060491	FALSE	Preclinical	NA	Absent	OGFR
Biliary Tract Neoplasms	ENSG00000063176	FALSE	Phase II Clinical Trial	2006-06-05	Absent	SPHK2
Biliary Tract Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2006-02-24	Absent	ERBB3
Biliary Tract Neoplasms	ENSG00000066468	FALSE	Phase III Clinical Trial	2003-07-22	Absent	FGFR2
Biliary Tract Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2003-07-22	Absent	FGFR3
Biliary Tract Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Biliary Tract Neoplasms	ENSG00000073756	FALSE	Preclinical	2008-03-11	Absent	PTGS2
Biliary Tract Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Biliary Tract Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	2003-07-22	Absent	FGFR1
Biliary Tract Neoplasms	ENSG00000080824	FALSE	Preclinical	2011-10-27	Unused	HSP90AA1
Biliary Tract Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Biliary Tract Neoplasms	ENSG00000086205	FALSE	Phase II Clinical Trial	2008-03-04	Absent	FOLH1
Biliary Tract Neoplasms	ENSG00000091831	FALSE	unknown	2010-02-19	Absent	ESR1
Biliary Tract Neoplasms	ENSG00000094631	FALSE	Phase I Clinical Trial	2009-08-13	Absent	HDAC6
Biliary Tract Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	ABL1
Biliary Tract Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Biliary Tract Neoplasms	ENSG00000100644	FALSE	unknown	1997-04-15	Unused	HIF1A
Biliary Tract Neoplasms	ENSG00000101180	FALSE	Preclinical	2005-05-16	Unused	HRH3
Biliary Tract Neoplasms	ENSG00000101266	FALSE	Phase II Clinical Trial	2007-05-23	Absent	CSNK2A1
Biliary Tract Neoplasms	ENSG00000101966	FALSE	unknown	2006-05-17	Phase I Clinical Trial	XIAP
Biliary Tract Neoplasms	ENSG00000102312	FALSE	Preclinical	2015-06-23	Absent	PORCN
Biliary Tract Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FLT1
Biliary Tract Neoplasms	ENSG00000103257	FALSE	Preclinical	NA	Absent	SLC7A5
Biliary Tract Neoplasms	ENSG00000105329	FALSE	Preclinical	2008-03-11	Absent	TGFB1
Biliary Tract Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2014-07-14	Absent	CEACAM5
Biliary Tract Neoplasms	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Biliary Tract Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	2003-07-18	Phase I Clinical Trial	MET
Biliary Tract Neoplasms	ENSG00000106991	FALSE	unknown	2006-05-01	Phase I Clinical Trial	ENG
Biliary Tract Neoplasms	ENSG00000107159	FALSE	Phase II Clinical Trial	1999-09-08	Unused	CA9
Biliary Tract Neoplasms	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Absent	DKK1
Biliary Tract Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Unused	NFKB1
Biliary Tract Neoplasms	ENSG00000111679	FALSE	Preclinical	2016-11-08	Absent	PTPN6
Biliary Tract Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Biliary Tract Neoplasms	ENSG00000114378	FALSE	Phase II Clinical Trial	NA	Absent	HYAL1
Biliary Tract Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Biliary Tract Neoplasms	ENSG00000115008	FALSE	unknown	2009-12-07	Absent	IL1A
Biliary Tract Neoplasms	ENSG00000116478	FALSE	Phase I Clinical Trial	2008-02-19	Absent	HDAC1
Biliary Tract Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG1
Biliary Tract Neoplasms	ENSG00000120156	FALSE	Phase I Clinical Trial	2004-06-18	Unused	TEK
Biliary Tract Neoplasms	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-06-20	Absent	CD274
Biliary Tract Neoplasms	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Biliary Tract Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	2009-09-01	Absent	PIK3CA
Biliary Tract Neoplasms	ENSG00000122025	FALSE	Phase I Clinical Trial	2004-06-18	Unused	FLT3
Biliary Tract Neoplasms	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Biliary Tract Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K2
Biliary Tract Neoplasms	ENSG00000128052	FALSE	Phase II Clinical Trial	1999-12-09	Phase II Clinical Trial	KDR
Biliary Tract Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	2001-07-18	Unused	TOP2A
Biliary Tract Neoplasms	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Absent	PDHA1
Biliary Tract Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	2002-08-05	Phase II Clinical Trial	LGALS3
Biliary Tract Neoplasms	ENSG00000134489	FALSE	Preclinical	2005-05-16	Unused	HRH4
Biliary Tract Neoplasms	ENSG00000134853	FALSE	unknown	2004-03-24	Phase I Clinical Trial	PDGFRA
Biliary Tract Neoplasms	ENSG00000136160	FALSE	Phase II Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Biliary Tract Neoplasms	ENSG00000136807	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK9
Biliary Tract Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Biliary Tract Neoplasms	ENSG00000138413	FALSE	Phase III Clinical Trial	2010-04-19	Absent	IDH1
Biliary Tract Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Biliary Tract Neoplasms	ENSG00000141736	FALSE	Phase III Clinical Trial	2000-05-18	Phase II Clinical Trial	ERBB2
Biliary Tract Neoplasms	ENSG00000142208	FALSE	Preclinical	2010-11-10	Absent	AKT1
Biliary Tract Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1993-07-15	Phase II Clinical Trial	EGFR
Biliary Tract Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Biliary Tract Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Biliary Tract Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	KIT
Biliary Tract Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2009-04-21	Absent	BRAF
Biliary Tract Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Biliary Tract Neoplasms	ENSG00000164305	FALSE	unknown	1997-04-15	Unused	CASP3
Biliary Tract Neoplasms	ENSG00000164400	FALSE	Phase I Clinical Trial	2008-07-04	Phase I Clinical Trial	CSF2
Biliary Tract Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Biliary Tract Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1999-12-09	Phase II Clinical Trial	RET
Biliary Tract Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Biliary Tract Neoplasms	ENSG00000167325	FALSE	unknown	1991-07-15	Unused	RRM1
Biliary Tract Neoplasms	ENSG00000167601	FALSE	Phase I Clinical Trial	2004-06-18	Unused	AXL
Biliary Tract Neoplasms	ENSG00000167658	FALSE	unknown	2004-03-03	Unused	EEF2
Biliary Tract Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Unused	FNTA
Biliary Tract Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Biliary Tract Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K1
Biliary Tract Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Biliary Tract Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2011-04-18	Phase I Clinical Trial	PTK2
Biliary Tract Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Biliary Tract Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Biliary Tract Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Biliary Tract Neoplasms	ENSG00000171848	FALSE	unknown	1991-07-15	Unused	RRM2
Biliary Tract Neoplasms	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Biliary Tract Neoplasms	ENSG00000178568	FALSE	Phase III Clinical Trial	2002-05-30	Phase II Clinical Trial	ERBB4
Biliary Tract Neoplasms	ENSG00000182054	FALSE	Phase II Clinical Trial	NA	Absent	IDH2
Biliary Tract Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-08-14	Absent	CSF1R
Biliary Tract Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	BCR
Biliary Tract Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Biliary Tract Neoplasms	ENSG00000188641	FALSE	Approved	2016-06-16	Absent	DPYD
Biliary Tract Neoplasms	ENSG00000196591	FALSE	Phase I Clinical Trial	2008-02-19	Absent	HDAC2
Biliary Tract Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Biliary Tract Neoplasms	ENSG00000198363	FALSE	Preclinical	2008-09-08	Unused	ASPH
Biliary Tract Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Biliary Tract Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2009-03-09	Absent	MTOR
Biliary Tract Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Phase I Clinical Trial	TOP1
Biliary Tract Neoplasms	ENSG00000198964	FALSE	Phase II Clinical Trial	2008-11-07	Absent	SGMS1
Binge-Eating Disorder	ENSG00000043591	FALSE	Preclinical	2014-10-31	Absent	ADRB1
Binge-Eating Disorder	ENSG00000082556	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRK1
Binge-Eating Disorder	ENSG00000103546	FALSE	Phase III Clinical Trial	2004-02-11	Absent	SLC6A2
Binge-Eating Disorder	ENSG00000108576	FALSE	Phase III Clinical Trial	2004-02-11	Unused	SLC6A4
Binge-Eating Disorder	ENSG00000112038	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRM1
Binge-Eating Disorder	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-29	Unused	OPRD1
Binge-Eating Disorder	ENSG00000121764	FALSE	Preclinical	2012-03-22	Preclinical	HCRTR1
Binge-Eating Disorder	ENSG00000125510	FALSE	unknown	2009-10-01	Absent	OPRL1
Binge-Eating Disorder	ENSG00000142319	FALSE	Phase III Clinical Trial	2004-02-11	Absent	SLC6A3
Binge-Eating Disorder	ENSG00000146399	FALSE	Preclinical	NA	Absent	TAAR1
Binge-Eating Disorder	ENSG00000151577	FALSE	Phase I Clinical Trial	2007-03-15	Unused	DRD3
Binge-Eating Disorder	ENSG00000165646	FALSE	Phase II Clinical Trial	2015-11-27	Absent	SLC18A2
Binge-Eating Disorder	ENSG00000171408	FALSE	Preclinical	2009-01-09	Preclinical	PDE7B
Binge-Eating Disorder	ENSG00000205268	FALSE	Preclinical	2009-01-09	Preclinical	PDE7A
Bipolar Disorder	ENSG00000069696	TRUE	Approved	1989-12-15	Approved	DRD4
Bipolar Disorder	ENSG00000075043	FALSE	unknown	1992-08-15	Unused	KCNQ2
Bipolar Disorder	ENSG00000082556	FALSE	Phase III Clinical Trial	2009-07-15	Unused	OPRK1
Bipolar Disorder	ENSG00000091831	FALSE	Phase II Clinical Trial	2010-03-29	Absent	ESR1
Bipolar Disorder	ENSG00000102468	TRUE	Approved	1989-12-15	Approved	HTR2A
Bipolar Disorder	ENSG00000103546	FALSE	Phase II Clinical Trial	2002-03-28	Phase II Clinical Trial	SLC6A2
Bipolar Disorder	ENSG00000108576	TRUE	Approved	2000-07-04	Approved	SLC6A4
Bipolar Disorder	ENSG00000112038	FALSE	Phase III Clinical Trial	2013-01-09	Absent	OPRM1
Bipolar Disorder	ENSG00000112541	FALSE	Phase II Clinical Trial	2007-01-08	Unused	PDE10A
Bipolar Disorder	ENSG00000116329	FALSE	Phase III Clinical Trial	2013-01-09	Absent	OPRD1
Bipolar Disorder	ENSG00000120907	TRUE	Approved	NA	Approved	ADRA1A
Bipolar Disorder	ENSG00000133019	TRUE	Approved	2000-07-04	Approved	CHRM3
Bipolar Disorder	ENSG00000134640	FALSE	unknown	2000-07-11	Phase III Clinical Trial	MTNR1B
Bipolar Disorder	ENSG00000135914	FALSE	Phase II Clinical Trial	2003-08-20	Unused	HTR2B
Bipolar Disorder	ENSG00000142192	FALSE	unknown	2004-12-22	Phase II Clinical Trial	APP
Bipolar Disorder	ENSG00000142319	FALSE	Preclinical	2002-03-28	Unused	SLC6A3
Bipolar Disorder	ENSG00000144285	TRUE	Approved	1995-04-15	Approved	SCN1A
Bipolar Disorder	ENSG00000147246	TRUE	Approved	1989-12-15	Approved	HTR2C
Bipolar Disorder	ENSG00000148680	TRUE	Approved	1996-01-15	Approved	HTR7
Bipolar Disorder	ENSG00000149295	TRUE	Approved	1989-12-15	Approved	DRD2
Bipolar Disorder	ENSG00000151577	TRUE	Approved	1989-12-15	Approved	DRD3
Bipolar Disorder	ENSG00000153253	TRUE	Approved	1995-04-15	Approved	SCN3A
Bipolar Disorder	ENSG00000153956	FALSE	Phase III Clinical Trial	NA	Unused	CACNA2D1
Bipolar Disorder	ENSG00000154229	FALSE	Preclinical	2012-09-25	Preclinical	PRKCA
Bipolar Disorder	ENSG00000155511	FALSE	Phase III Clinical Trial	NA	Unused	GRIA1
Bipolar Disorder	ENSG00000158748	TRUE	Approved	2008-07-22	Approved	HTR6
Bipolar Disorder	ENSG00000159164	FALSE	Phase II Clinical Trial	NA	Unused	SV2A
Bipolar Disorder	ENSG00000164082	FALSE	Phase I Clinical Trial	2010-11-29	Absent	GRM2
Bipolar Disorder	ENSG00000165646	FALSE	Preclinical	2012-02-24	Absent	SLC18A2
Bipolar Disorder	ENSG00000166736	TRUE	Approved	NA	Approved	HTR3A
Bipolar Disorder	ENSG00000168412	FALSE	unknown	2000-07-11	Phase III Clinical Trial	MTNR1A
Bipolar Disorder	ENSG00000168539	TRUE	Approved	2000-07-04	Approved	CHRM1
Bipolar Disorder	ENSG00000168959	FALSE	Preclinical	2015-05-28	Absent	GRM5
Bipolar Disorder	ENSG00000169432	FALSE	unknown	2007-10-10	Unused	SCN9A
Bipolar Disorder	ENSG00000178394	TRUE	Approved	1992-10-15	Approved	HTR1A
Bipolar Disorder	ENSG00000179097	TRUE	Approved	2000-07-04	Absent	HTR1F
Bipolar Disorder	ENSG00000179546	TRUE	Approved	1992-10-15	Approved	HTR1D
Bipolar Disorder	ENSG00000180720	TRUE	Approved	2000-07-04	Approved	CHRM4
Bipolar Disorder	ENSG00000181072	TRUE	Approved	2000-07-04	Approved	CHRM2
Bipolar Disorder	ENSG00000183873	FALSE	Phase III Clinical Trial	NA	Unused	SCN5A
Bipolar Disorder	ENSG00000184156	FALSE	unknown	1992-08-15	Unused	KCNQ3
Bipolar Disorder	ENSG00000184845	TRUE	Approved	1989-12-15	Approved	DRD1
Bipolar Disorder	ENSG00000196639	TRUE	Approved	2002-04-03	Approved	HRH1
Bipolar Disorder	ENSG00000198049	FALSE	unknown	2001-09-04	Unused	AVPR1B
Blepharitis	ENSG00000113580	TRUE	Approved	2005-11-04	Approved	NR3C1
Blepharitis	ENSG00000122420	FALSE	Preclinical	2016-06-17	Absent	PTGFR
Blindness	ENSG00000116745	FALSE	unknown	2007-05-01	Absent	RPE65
Blindness	ENSG00000118137	FALSE	unknown	2005-07-04	Absent	APOA1
Blood Coagulation Disorders	ENSG00000005961	FALSE	Preclinical	2005-06-07	Unused	ITGA2B
Blood Coagulation Disorders	ENSG00000006638	FALSE	Preclinical	1991-09-15	Unused	TBXA2R
Blood Coagulation Disorders	ENSG00000057593	FALSE	Preclinical	2004-03-28	Unused	F7
Blood Coagulation Disorders	ENSG00000064989	FALSE	Preclinical	NA	Unused	CALCRL
Blood Coagulation Disorders	ENSG00000072062	FALSE	Preclinical	NA	Unused	PRKACA
Blood Coagulation Disorders	ENSG00000080293	FALSE	Phase II Clinical Trial	NA	Unused	SCTR
Blood Coagulation Disorders	ENSG00000080618	FALSE	Preclinical	2004-03-28	Unused	CPB2
Blood Coagulation Disorders	ENSG00000088926	FALSE	Preclinical	2005-03-13	Unused	F11
Blood Coagulation Disorders	ENSG00000096968	FALSE	Preclinical	2009-12-22	Unused	JAK2
Blood Coagulation Disorders	ENSG00000101425	FALSE	Preclinical	1995-02-15	Unused	BPI
Blood Coagulation Disorders	ENSG00000104368	FALSE	Approved	1989-11-15	Unused	PLAT
Blood Coagulation Disorders	ENSG00000105388	FALSE	Preclinical	2009-04-23	Unused	CEACAM5
Blood Coagulation Disorders	ENSG00000106366	FALSE	Preclinical	1991-12-15	Unused	SERPINE1
Blood Coagulation Disorders	ENSG00000108342	FALSE	Preclinical	2009-10-30	Unused	CSF3
Blood Coagulation Disorders	ENSG00000112964	TRUE	Approved	NA	Approved	GHR
Blood Coagulation Disorders	ENSG00000115718	FALSE	Preclinical	1992-08-15	Unused	PROC
Blood Coagulation Disorders	ENSG00000117400	FALSE	Preclinical	2008-09-15	Unused	MPL
Blood Coagulation Disorders	ENSG00000117525	FALSE	Preclinical	2004-03-28	Unused	F3
Blood Coagulation Disorders	ENSG00000117601	TRUE	Approved	1990-06-15	Approved	SERPINC1
Blood Coagulation Disorders	ENSG00000119535	FALSE	Preclinical	2009-04-23	Unused	CSF3R
Blood Coagulation Disorders	ENSG00000120156	FALSE	Preclinical	1995-08-15	Unused	TEK
Blood Coagulation Disorders	ENSG00000121966	FALSE	Preclinical	2017-12-20	Absent	CXCR4
Blood Coagulation Disorders	ENSG00000121989	FALSE	Preclinical	1990-10-15	Unused	ACVR2A
Blood Coagulation Disorders	ENSG00000122194	FALSE	Preclinical	1990-06-15	Unused	PLG
Blood Coagulation Disorders	ENSG00000122861	FALSE	Approved	1989-12-15	Unused	PLAU
Blood Coagulation Disorders	ENSG00000124491	FALSE	Preclinical	NA	Unused	F13A1
Blood Coagulation Disorders	ENSG00000126218	FALSE	Pre-registration	1989-10-15	Phase I Clinical Trial	F10
Blood Coagulation Disorders	ENSG00000131187	FALSE	Preclinical	1991-05-15	Unused	F12
Blood Coagulation Disorders	ENSG00000135218	FALSE	Preclinical	1989-11-15	Unused	CD36
Blood Coagulation Disorders	ENSG00000135919	FALSE	Preclinical	NA	Unused	SERPINE2
Blood Coagulation Disorders	ENSG00000137070	FALSE	Preclinical	2008-07-01	Unused	IL11RA
Blood Coagulation Disorders	ENSG00000146648	FALSE	Preclinical	NA	Unused	EGFR
Blood Coagulation Disorders	ENSG00000148400	FALSE	Preclinical	2012-03-06	Preclinical	NOTCH1
Blood Coagulation Disorders	ENSG00000151623	FALSE	Preclinical	2004-03-16	Unused	NR3C2
Blood Coagulation Disorders	ENSG00000151694	FALSE	Preclinical	2012-01-02	Unused	ADAM17
Blood Coagulation Disorders	ENSG00000156738	FALSE	Preclinical	2009-04-23	Unused	MS4A1
Blood Coagulation Disorders	ENSG00000157404	FALSE	Preclinical	1993-06-15	Unused	KIT
Blood Coagulation Disorders	ENSG00000160013	FALSE	Phase I Clinical Trial	2005-06-01	Unused	PTGIR
Blood Coagulation Disorders	ENSG00000160712	FALSE	Preclinical	1998-03-15	Unused	IL6R
Blood Coagulation Disorders	ENSG00000163737	FALSE	Preclinical	1991-03-15	Unused	PF4
Blood Coagulation Disorders	ENSG00000166148	TRUE	Approved	1991-08-15	Approved	AVPR1A
Blood Coagulation Disorders	ENSG00000167711	FALSE	Preclinical	2017-11-22	Unused	SERPINF2
Blood Coagulation Disorders	ENSG00000169313	FALSE	Preclinical	2004-03-03	Unused	P2RY12
Blood Coagulation Disorders	ENSG00000171557	FALSE	Phase II Clinical Trial	1991-01-15	Unused	FGG
Blood Coagulation Disorders	ENSG00000171560	FALSE	Phase II Clinical Trial	1991-01-15	Unused	FGA
Blood Coagulation Disorders	ENSG00000171564	FALSE	Phase II Clinical Trial	1991-01-15	Unused	FGB
Blood Coagulation Disorders	ENSG00000174175	FALSE	Preclinical	1990-02-15	Unused	SELP
Blood Coagulation Disorders	ENSG00000178726	FALSE	Preclinical	1991-12-15	Unused	THBD
Blood Coagulation Disorders	ENSG00000180210	FALSE	Pre-registration	1989-08-15	Unused	F2
Blood Coagulation Disorders	ENSG00000180871	FALSE	Preclinical	2017-12-20	Absent	CXCR2
Blood Coagulation Disorders	ENSG00000181104	FALSE	Preclinical	1992-03-15	Unused	F2R
Blood Coagulation Disorders	ENSG00000184500	FALSE	Preclinical	1995-06-15	Unused	PROS1
Blood Coagulation Disorders	ENSG00000185010	FALSE	unknown	2013-11-06	Absent	F8
Blood Coagulation Disorders	ENSG00000185245	FALSE	Preclinical	NA	Unused	GP1BA
Blood Coagulation Disorders	ENSG00000185291	FALSE	unknown	1991-01-15	Unused	IL3RA
Blood Coagulation Disorders	ENSG00000185532	FALSE	Preclinical	NA	Unused	PRKG1
Blood Coagulation Disorders	ENSG00000187010	FALSE	Phase I Clinical Trial	1989-12-15	Unused	RHD
Blood Coagulation Disorders	ENSG00000187266	FALSE	Approved	2016-12-27	Absent	EPOR
Blood Coagulation Disorders	ENSG00000197122	FALSE	Preclinical	NA	Unused	SRC
Blood Coagulation Disorders	ENSG00000197249	FALSE	Preclinical	2016-12-27	Absent	SERPINA1
Blood Coagulation Disorders	ENSG00000197561	FALSE	Preclinical	NA	Unused	ELANE
Blood Coagulation Disorders	ENSG00000197635	FALSE	Preclinical	2005-07-19	Unused	DPP4
Blood Coagulation Disorders	ENSG00000198049	TRUE	Approved	1991-08-15	Approved	AVPR1B
Blood Coagulation Disorders	ENSG00000198223	FALSE	unknown	1991-01-15	Unused	CSF2RA
Blood Coagulation Disorders	ENSG00000244734	FALSE	Preclinical	1992-12-15	Unused	HBB
Blood Coagulation Disorders	ENSG00000259207	FALSE	Preclinical	2005-06-07	Unused	ITGB3
Bone Cysts	ENSG00000160801	FALSE	Phase I Clinical Trial	NA	Unused	PTH1R
Bone Diseases	ENSG00000004948	FALSE	Phase II Clinical Trial	1993-11-15	Unused	CALCR
Bone Diseases	ENSG00000036828	FALSE	Preclinical	1996-08-15	Unused	CASR
Bone Diseases	ENSG00000065320	FALSE	Preclinical	2015-07-27	Absent	NTN1
Bone Diseases	ENSG00000107984	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DKK1
Bone Diseases	ENSG00000115457	FALSE	Preclinical	2014-12-04	Absent	IGFBP2
Bone Diseases	ENSG00000120659	FALSE	Preclinical	2003-09-09	Unused	TNFSF11
Bone Diseases	ENSG00000125384	FALSE	Preclinical	2004-05-27	Unused	PTGER2
Bone Diseases	ENSG00000125845	FALSE	Phase III Clinical Trial	2001-06-06	Unused	BMP2
Bone Diseases	ENSG00000135047	FALSE	Preclinical	1996-07-15	Unused	CTSL
Bone Diseases	ENSG00000144668	FALSE	Preclinical	2007-07-23	Unused	ITGA9
Bone Diseases	ENSG00000160801	FALSE	Preclinical	1996-08-15	Unused	PTH1R
Bone Diseases	ENSG00000161011	FALSE	Preclinical	2015-03-13	Absent	SQSTM1
Bone Diseases	ENSG00000162337	FALSE	Preclinical	2004-01-19	Unused	LRP5
Bone Diseases	ENSG00000164733	FALSE	Preclinical	1996-07-15	Unused	CTSB
Bone Diseases	ENSG00000167941	FALSE	Preclinical	2009-05-18	Phase I Clinical Trial	SOST
Bone Diseases	ENSG00000171522	FALSE	Preclinical	2008-09-08	Unused	PTGER4
Bone Diseases	ENSG00000173250	FALSE	Preclinical	2004-07-23	Absent	GPR151
Bone Diseases	ENSG00000182578	FALSE	unknown	2010-03-25	Unused	CSF1R
Bone Diseases	ENSG00000197046	FALSE	Preclinical	2011-02-11	Preclinical	SIGLEC15
Bone Diseases	ENSG00000206549	FALSE	Preclinical	2011-02-11	Unused	PRSS50
Bone Diseases, Metabolic	ENSG00000007171	FALSE	unknown	1996-08-15	Unused	NOS2
Bone Diseases, Metabolic	ENSG00000073756	FALSE	unknown	1996-08-15	Unused	PTGS2
Bone Diseases, Metabolic	ENSG00000095303	FALSE	unknown	1996-08-15	Unused	PTGS1
Bone Diseases, Metabolic	ENSG00000120659	TRUE	Approved	1997-07-15	Approved	TNFSF11
Bone Diseases, Metabolic	ENSG00000138448	FALSE	Preclinical	2000-03-29	Unused	ITGAV
Bone Diseases, Metabolic	ENSG00000143387	FALSE	Phase II Clinical Trial	2005-08-10	Unused	CTSK
Bone Diseases, Metabolic	ENSG00000167941	FALSE	Phase II Clinical Trial	2009-05-18	Phase II Clinical Trial	SOST
Bone Diseases, Metabolic	ENSG00000182578	FALSE	Preclinical	2009-01-27	Preclinical	CSF1R
Bone Diseases, Metabolic	ENSG00000259207	FALSE	Preclinical	2000-03-29	Unused	ITGB3
Bone Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGB5
Bone Neoplasms	ENSG00000086205	FALSE	unknown	2002-05-01	Unused	FOLH1
Bone Neoplasms	ENSG00000087494	FALSE	Preclinical	2000-10-04	Unused	PTHLH
Bone Neoplasms	ENSG00000097007	FALSE	unknown	2002-11-12	Unused	ABL1
Bone Neoplasms	ENSG00000101384	FALSE	Preclinical	2018-01-05	Absent	JAG1
Bone Neoplasms	ENSG00000105329	FALSE	Preclinical	2006-10-13	Preclinical	TGFB1
Bone Neoplasms	ENSG00000105976	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	MET
Bone Neoplasms	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Bone Neoplasms	ENSG00000111424	FALSE	Phase I Clinical Trial	2007-09-21	Absent	VDR
Bone Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGB6
Bone Neoplasms	ENSG00000120156	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	TEK
Bone Neoplasms	ENSG00000120659	FALSE	Phase II Clinical Trial	2005-07-06	Phase III Clinical Trial	TNFSF11
Bone Neoplasms	ENSG00000122025	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	FLT3
Bone Neoplasms	ENSG00000128052	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	KDR
Bone Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2005-01-07	Unused	SMO
Bone Neoplasms	ENSG00000131747	FALSE	unknown	NA	Preclinical	TOP2A
Bone Neoplasms	ENSG00000135047	FALSE	unknown	2002-07-17	Unused	CTSL
Bone Neoplasms	ENSG00000136943	FALSE	Preclinical	2002-07-17	Unused	CTSV
Bone Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGAV
Bone Neoplasms	ENSG00000140443	FALSE	unknown	2005-08-05	Unused	IGF1R
Bone Neoplasms	ENSG00000143387	FALSE	Preclinical	1995-08-15	Phase II Clinical Trial	CTSK
Bone Neoplasms	ENSG00000150093	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGB1
Bone Neoplasms	ENSG00000152266	FALSE	Preclinical	2005-07-25	Unused	PTH
Bone Neoplasms	ENSG00000157404	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	KIT
Bone Neoplasms	ENSG00000163131	FALSE	Preclinical	2009-01-21	Preclinical	CTSS
Bone Neoplasms	ENSG00000163430	FALSE	Preclinical	2015-10-08	Absent	FSTL1
Bone Neoplasms	ENSG00000164733	FALSE	Preclinical	2009-01-21	Preclinical	CTSB
Bone Neoplasms	ENSG00000165731	FALSE	Preclinical	2004-08-09	Phase III Clinical Trial	RET
Bone Neoplasms	ENSG00000168522	FALSE	Preclinical	NA	Preclinical	FNTA
Bone Neoplasms	ENSG00000169083	FALSE	Preclinical	2003-12-01	Unused	AR
Bone Neoplasms	ENSG00000182578	FALSE	Phase I Clinical Trial	2004-03-31	Unused	CSF1R
Bone Neoplasms	ENSG00000184371	FALSE	unknown	2008-09-30	Unused	CSF1
Bone Neoplasms	ENSG00000188379	FALSE	Approved	2017-07-13	Absent	IFNA2
Bone Neoplasms	ENSG00000197122	FALSE	Phase I Clinical Trial	2001-10-15	Phase I Clinical Trial	SRC
Bone Neoplasms	ENSG00000198793	FALSE	Preclinical	2003-03-13	Phase II Clinical Trial	MTOR
Bone Neoplasms	ENSG00000198900	FALSE	Preclinical	2007-02-28	Unused	TOP1
Bone Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGB3
Bradycardia	ENSG00000168539	FALSE	Phase III Clinical Trial	NA	Unused	CHRM1
Bradycardia	ENSG00000170989	FALSE	Preclinical	2014-07-21	Absent	S1PR1
Brain Diseases, Metabolic, Inborn	ENSG00000182054	FALSE	Preclinical	2016-10-04	Absent	IDH2
Brain Edema	ENSG00000106113	FALSE	Phase II Clinical Trial	1994-04-15	Phase III Clinical Trial	CRHR2
Brain Edema	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Brain Edema	ENSG00000120088	FALSE	Phase II Clinical Trial	1994-04-15	Phase III Clinical Trial	CRHR1
Brain Edema	ENSG00000126895	FALSE	Phase II Clinical Trial	1993-11-15	Unused	AVPR2
Brain Edema	ENSG00000151617	FALSE	Phase I Clinical Trial	2012-10-27	Absent	EDNRA
Brain Edema	ENSG00000166148	FALSE	Preclinical	NA	Unused	AVPR1A
Brain Edema	ENSG00000198049	FALSE	Preclinical	NA	Unused	AVPR1B
Brain Injuries	ENSG00000106144	FALSE	Preclinical	2012-09-28	Absent	CASP2
Brain Injuries	ENSG00000134640	FALSE	Preclinical	2013-05-04	Absent	MTNR1B
Brain Injuries	ENSG00000168412	FALSE	Preclinical	2013-05-04	Absent	MTNR1A
Brain Ischemia	ENSG00000004478	FALSE	Phase I Clinical Trial	2007-03-21	Unused	FKBP4
Brain Ischemia	ENSG00000005421	FALSE	Preclinical	2008-11-28	Unused	PON1
Brain Ischemia	ENSG00000005961	FALSE	Phase II Clinical Trial	1991-01-15	Unused	ITGA2B
Brain Ischemia	ENSG00000006071	FALSE	Phase II Clinical Trial	2010-06-10	Phase II Clinical Trial	ABCC8
Brain Ischemia	ENSG00000007171	FALSE	Preclinical	1998-10-15	Unused	NOS2
Brain Ischemia	ENSG00000007908	FALSE	Preclinical	1995-06-15	Unused	SELE
Brain Ischemia	ENSG00000011677	FALSE	unknown	1999-12-13	Preclinical	GABRA3
Brain Ischemia	ENSG00000012779	FALSE	unknown	1994-10-15	Unused	ALOX5
Brain Ischemia	ENSG00000017427	FALSE	Preclinical	1998-06-15	Unused	IGF1
Brain Ischemia	ENSG00000022355	FALSE	Preclinical	1999-12-13	Preclinical	GABRA1
Brain Ischemia	ENSG00000059377	FALSE	Phase II Clinical Trial	1989-11-15	Unused	TBXAS1
Brain Ischemia	ENSG00000064012	FALSE	Preclinical	2002-06-26	Unused	CASP8
Brain Ischemia	ENSG00000064300	FALSE	unknown	1997-05-15	Unused	NGFR
Brain Ischemia	ENSG00000065989	TRUE	Approved	NA	Approved	PDE4A
Brain Ischemia	ENSG00000067182	FALSE	unknown	2007-11-12	Unused	TNFRSF1A
Brain Ischemia	ENSG00000069431	FALSE	Preclinical	1995-08-15	Unused	ABCC9
Brain Ischemia	ENSG00000069535	FALSE	Phase II Clinical Trial	2011-09-13	Unused	MAOB
Brain Ischemia	ENSG00000069764	FALSE	unknown	1998-04-15	Unused	PLA2G10
Brain Ischemia	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Brain Ischemia	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Brain Ischemia	ENSG00000077782	FALSE	Phase I Clinical Trial	2007-07-16	Unused	FGFR1
Brain Ischemia	ENSG00000078018	FALSE	Preclinical	2013-06-28	Absent	MAP2
Brain Ischemia	ENSG00000080618	FALSE	Phase II Clinical Trial	2007-10-15	Phase I Clinical Trial	CPB2
Brain Ischemia	ENSG00000082175	FALSE	Preclinical	2008-08-29	Unused	PGR
Brain Ischemia	ENSG00000082556	FALSE	unknown	1990-10-15	Unused	OPRK1
Brain Ischemia	ENSG00000082701	FALSE	Phase I Clinical Trial	2003-01-24	Unused	GSK3B
Brain Ischemia	ENSG00000086991	FALSE	Preclinical	2016-10-28	Absent	NOX4
Brain Ischemia	ENSG00000087085	FALSE	unknown	2009-07-21	Unused	ACHE
Brain Ischemia	ENSG00000088053	FALSE	Phase II Clinical Trial	2004-01-23	Phase II Clinical Trial	GP6
Brain Ischemia	ENSG00000088832	FALSE	Phase I Clinical Trial	NA	Unused	FKBP1A
Brain Ischemia	ENSG00000089250	FALSE	Preclinical	1994-08-15	Unused	NOS1
Brain Ischemia	ENSG00000091831	FALSE	Preclinical	1997-12-15	Unused	ESR1
Brain Ischemia	ENSG00000092439	FALSE	Preclinical	2011-09-28	Absent	TRPM7
Brain Ischemia	ENSG00000095303	TRUE	Approved	1995-05-15	Approved	PTGS1
Brain Ischemia	ENSG00000100380	FALSE	Preclinical	2011-01-03	Unused	ST13
Brain Ischemia	ENSG00000100985	FALSE	unknown	1995-01-15	Preclinical	MMP9
Brain Ischemia	ENSG00000101126	FALSE	Preclinical	2007-02-12	Preclinical	ADNP
Brain Ischemia	ENSG00000101916	FALSE	Preclinical	2008-04-01	Unused	TLR8
Brain Ischemia	ENSG00000101981	FALSE	Phase I Clinical Trial	1997-10-15	Unused	F9
Brain Ischemia	ENSG00000103546	FALSE	Approved	2003-07-29	Unused	SLC6A2
Brain Ischemia	ENSG00000104368	TRUE	Approved	1989-07-15	Approved	PLAT
Brain Ischemia	ENSG00000105650	TRUE	Approved	NA	Approved	PDE4C
Brain Ischemia	ENSG00000105675	TRUE	Approved	NA	Approved	ATP4A
Brain Ischemia	ENSG00000105695	FALSE	Phase II Clinical Trial	2007-11-05	Phase II Clinical Trial	MAG
Brain Ischemia	ENSG00000105701	FALSE	Preclinical	2007-05-21	Unused	FKBP8
Brain Ischemia	ENSG00000106144	FALSE	Preclinical	2001-09-12	Unused	CASP2
Brain Ischemia	ENSG00000106804	FALSE	unknown	2005-01-31	Unused	C5
Brain Ischemia	ENSG00000108342	FALSE	Preclinical	2012-12-01	Absent	CSF3
Brain Ischemia	ENSG00000108576	FALSE	Phase III Clinical Trial	2003-07-29	Phase I Clinical Trial	SLC6A4
Brain Ischemia	ENSG00000109320	FALSE	Preclinical	1990-06-15	Unused	NFKB1
Brain Ischemia	ENSG00000109339	FALSE	Preclinical	2004-03-28	Unused	MAPK10
Brain Ischemia	ENSG00000110492	FALSE	Preclinical	2009-05-19	Unused	MDK
Brain Ischemia	ENSG00000110799	FALSE	Preclinical	2003-07-09	Unused	VWF
Brain Ischemia	ENSG00000110881	FALSE	Preclinical	2008-04-02	Unused	ASIC1
Brain Ischemia	ENSG00000112062	FALSE	Preclinical	2007-11-12	Unused	MAPK14
Brain Ischemia	ENSG00000112715	FALSE	Preclinical	2003-07-02	Unused	VEGFA
Brain Ischemia	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Brain Ischemia	ENSG00000113448	TRUE	Approved	2004-02-04	Approved	PDE4D
Brain Ischemia	ENSG00000114854	FALSE	Phase I Clinical Trial	1991-05-15	Unused	TNNC1
Brain Ischemia	ENSG00000114859	FALSE	unknown	2005-12-31	Unused	CLCN2
Brain Ischemia	ENSG00000115232	FALSE	Phase II Clinical Trial	1991-12-15	Unused	ITGA4
Brain Ischemia	ENSG00000115353	FALSE	Preclinical	1995-12-15	Unused	TACR1
Brain Ischemia	ENSG00000115457	FALSE	Phase II Clinical Trial	2010-10-19	Absent	IGFBP2
Brain Ischemia	ENSG00000115718	FALSE	Phase II Clinical Trial	1996-07-15	Phase I Clinical Trial	PROC
Brain Ischemia	ENSG00000117298	FALSE	Preclinical	1996-10-15	Unused	ECE1
Brain Ischemia	ENSG00000117560	FALSE	unknown	2004-01-19	Unused	FASLG
Brain Ischemia	ENSG00000117601	FALSE	Phase III Clinical Trial	1994-10-15	Unused	SERPINC1
Brain Ischemia	ENSG00000118137	FALSE	Phase I Clinical Trial	2006-04-04	Unused	APOA1
Brain Ischemia	ENSG00000118432	FALSE	unknown	1998-12-15	Unused	CNR1
Brain Ischemia	ENSG00000119535	FALSE	Preclinical	2003-04-24	Unused	CSF3R
Brain Ischemia	ENSG00000120088	FALSE	Preclinical	1999-03-23	Unused	CRHR1
Brain Ischemia	ENSG00000121361	FALSE	Preclinical	1995-08-15	Unused	KCNJ8
Brain Ischemia	ENSG00000121653	FALSE	Phase I Clinical Trial	2003-08-26	Unused	MAPK8IP1
Brain Ischemia	ENSG00000121853	FALSE	Preclinical	2015-10-22	Absent	GHSR
Brain Ischemia	ENSG00000121966	FALSE	Phase I Clinical Trial	2004-06-22	Unused	CXCR4
Brain Ischemia	ENSG00000122194	FALSE	Phase II Clinical Trial	1991-05-15	Phase II Clinical Trial	PLG
Brain Ischemia	ENSG00000122585	FALSE	unknown	NA	Unused	NPY
Brain Ischemia	ENSG00000122861	FALSE	Phase III Clinical Trial	1994-06-15	Phase I Clinical Trial	PLAU
Brain Ischemia	ENSG00000124493	FALSE	Preclinical	NA	Absent	GRM4
Brain Ischemia	ENSG00000125538	FALSE	unknown	2006-01-18	Preclinical	IL1B
Brain Ischemia	ENSG00000126218	TRUE	Approved	1991-11-15	Approved	F10
Brain Ischemia	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Brain Ischemia	ENSG00000127533	FALSE	Phase I Clinical Trial	2015-01-23	Absent	F2RL3
Brain Ischemia	ENSG00000129521	FALSE	Phase II Clinical Trial	2008-09-16	Absent	EGLN3
Brain Ischemia	ENSG00000130368	FALSE	Preclinical	2010-09-20	Absent	MAS1
Brain Ischemia	ENSG00000131187	FALSE	Preclinical	2010-02-23	Unused	F12
Brain Ischemia	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Brain Ischemia	ENSG00000132535	FALSE	Preclinical	2015-06-10	Absent	DLG4
Brain Ischemia	ENSG00000133019	FALSE	Preclinical	2007-02-02	Unused	CHRM3
Brain Ischemia	ENSG00000134318	FALSE	unknown	2005-05-24	Preclinical	ROCK2
Brain Ischemia	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Brain Ischemia	ENSG00000136160	FALSE	Phase II Clinical Trial	1995-03-15	Unused	EDNRB
Brain Ischemia	ENSG00000136869	FALSE	Preclinical	2008-04-01	Unused	TLR4
Brain Ischemia	ENSG00000138039	FALSE	unknown	2005-12-06	Phase II Clinical Trial	LHCGR
Brain Ischemia	ENSG00000138448	FALSE	Phase II Clinical Trial	NA	Unused	ITGAV
Brain Ischemia	ENSG00000138685	FALSE	Phase II Clinical Trial	2011-04-04	Absent	FGF2
Brain Ischemia	ENSG00000138735	FALSE	Phase II Clinical Trial	2008-09-30	Absent	PDE5A
Brain Ischemia	ENSG00000139626	FALSE	Phase II Clinical Trial	1991-12-15	Absent	ITGB7
Brain Ischemia	ENSG00000140443	FALSE	Phase II Clinical Trial	2010-10-19	Absent	IGF1R
Brain Ischemia	ENSG00000141510	FALSE	Preclinical	2000-10-04	Unused	TP53
Brain Ischemia	ENSG00000142192	FALSE	Preclinical	NA	Absent	APP
Brain Ischemia	ENSG00000143799	FALSE	Phase II Clinical Trial	2002-11-05	Phase I Clinical Trial	PARP1
Brain Ischemia	ENSG00000144285	FALSE	Phase II Clinical Trial	1998-07-15	Unused	SCN1A
Brain Ischemia	ENSG00000144891	FALSE	unknown	1999-10-05	Unused	AGTR1
Brain Ischemia	ENSG00000145050	FALSE	Preclinical	NA	Absent	MANF
Brain Ischemia	ENSG00000145936	FALSE	Phase III Clinical Trial	1997-07-15	Unused	KCNMB1
Brain Ischemia	ENSG00000146070	FALSE	unknown	1998-04-15	Unused	PLA2G7
Brain Ischemia	ENSG00000147955	FALSE	Phase II Clinical Trial	1996-05-15	Unused	SIGMAR1
Brain Ischemia	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Brain Ischemia	ENSG00000148408	FALSE	Phase II Clinical Trial	1992-05-15	Unused	CACNA1B
Brain Ischemia	ENSG00000149131	FALSE	Preclinical	2012-09-27	Phase I Clinical Trial	SERPING1
Brain Ischemia	ENSG00000150093	FALSE	Phase II Clinical Trial	1991-12-15	Unused	ITGB1
Brain Ischemia	ENSG00000151067	TRUE	Approved	1989-07-15	Approved	CACNA1C
Brain Ischemia	ENSG00000151617	FALSE	Phase II Clinical Trial	1994-10-15	Unused	EDNRA
Brain Ischemia	ENSG00000151694	FALSE	Preclinical	2003-12-01	Unused	ADAM17
Brain Ischemia	ENSG00000151834	FALSE	unknown	1999-12-13	Preclinical	GABRA2
Brain Ischemia	ENSG00000153253	FALSE	Phase II Clinical Trial	1998-07-15	Unused	SCN3A
Brain Ischemia	ENSG00000155511	FALSE	Phase II Clinical Trial	1993-01-15	Unused	GRIA1
Brain Ischemia	ENSG00000156427	FALSE	unknown	2002-05-08	Unused	FGF18
Brain Ischemia	ENSG00000157168	FALSE	unknown	1989-06-15	Absent	NRG1
Brain Ischemia	ENSG00000159640	FALSE	Preclinical	1996-10-15	Unused	ACE
Brain Ischemia	ENSG00000160255	FALSE	Phase III Clinical Trial	1992-11-15	Unused	ITGB2
Brain Ischemia	ENSG00000160323	FALSE	unknown	2007-10-18	Unused	ADAMTS13
Brain Ischemia	ENSG00000162692	FALSE	Preclinical	NA	Unused	VCAM1
Brain Ischemia	ENSG00000163485	FALSE	Preclinical	1994-01-15	Unused	ADORA1
Brain Ischemia	ENSG00000163932	FALSE	Phase I Clinical Trial	2004-09-29	Unused	PRKCD
Brain Ischemia	ENSG00000164082	FALSE	Preclinical	2008-10-16	Absent	GRM2
Brain Ischemia	ENSG00000164305	FALSE	Preclinical	1998-05-15	Unused	CASP3
Brain Ischemia	ENSG00000164690	FALSE	Preclinical	2004-07-21	Unused	SHH
Brain Ischemia	ENSG00000164867	FALSE	Preclinical	1998-10-15	Unused	NOS3
Brain Ischemia	ENSG00000164885	FALSE	Preclinical	2005-03-13	Unused	CDK5
Brain Ischemia	ENSG00000165025	FALSE	Preclinical	2016-09-26	Absent	SYK
Brain Ischemia	ENSG00000165029	FALSE	Preclinical	2014-09-10	Absent	ABCA1
Brain Ischemia	ENSG00000165646	FALSE	unknown	2010-04-15	Absent	SLC18A2
Brain Ischemia	ENSG00000166670	FALSE	Preclinical	2014-01-23	Absent	MMP10
Brain Ischemia	ENSG00000167325	FALSE	unknown	2002-07-08	Unused	RRM1
Brain Ischemia	ENSG00000167397	FALSE	Phase II Clinical Trial	2004-10-13	Unused	VKORC1
Brain Ischemia	ENSG00000167711	FALSE	Phase I Clinical Trial	2013-11-28	Absent	SERPINF2
Brain Ischemia	ENSG00000167720	FALSE	Preclinical	2000-03-01	Unused	SRR
Brain Ischemia	ENSG00000168398	FALSE	Preclinical	1997-03-15	Unused	BDKRB2
Brain Ischemia	ENSG00000168539	FALSE	Preclinical	2007-02-02	Preclinical	CHRM1
Brain Ischemia	ENSG00000168621	FALSE	Preclinical	2001-09-27	Unused	GDNF
Brain Ischemia	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Brain Ischemia	ENSG00000169252	FALSE	Preclinical	1996-08-15	Unused	ADRB2
Brain Ischemia	ENSG00000169313	TRUE	Approved	1993-08-15	Approved	P2RY12
Brain Ischemia	ENSG00000169403	FALSE	Preclinical	1989-11-15	Unused	PTAFR
Brain Ischemia	ENSG00000169418	FALSE	Preclinical	1995-06-15	Unused	NPR1
Brain Ischemia	ENSG00000169432	FALSE	Phase II Clinical Trial	1998-07-15	Unused	SCN9A
Brain Ischemia	ENSG00000169896	FALSE	Phase II Clinical Trial	1992-11-15	Unused	ITGAM
Brain Ischemia	ENSG00000170989	FALSE	Preclinical	2006-12-07	Absent	S1PR1
Brain Ischemia	ENSG00000171105	FALSE	Preclinical	2008-11-28	Unused	INSR
Brain Ischemia	ENSG00000171497	FALSE	Preclinical	2009-07-28	Preclinical	PPID
Brain Ischemia	ENSG00000171557	FALSE	unknown	NA	Unused	FGG
Brain Ischemia	ENSG00000171560	FALSE	unknown	NA	Unused	FGA
Brain Ischemia	ENSG00000171564	FALSE	unknown	NA	Unused	FGB
Brain Ischemia	ENSG00000171848	FALSE	unknown	2002-07-08	Unused	RRM2
Brain Ischemia	ENSG00000171862	FALSE	Preclinical	2015-09-17	Absent	PTEN
Brain Ischemia	ENSG00000172572	FALSE	unknown	2013-09-05	Absent	PDE3A
Brain Ischemia	ENSG00000174175	FALSE	unknown	1995-06-15	Unused	SELP
Brain Ischemia	ENSG00000174417	FALSE	unknown	1990-01-15	Unused	TRHR
Brain Ischemia	ENSG00000175567	FALSE	Preclinical	2001-10-18	Unused	UCP2
Brain Ischemia	ENSG00000175899	FALSE	unknown	2001-05-29	Unused	A2M
Brain Ischemia	ENSG00000176884	FALSE	Pre-registration	1990-06-15	Phase I Clinical Trial	GRIN1
Brain Ischemia	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Brain Ischemia	ENSG00000178394	FALSE	unknown	1996-08-15	Unused	HTR1A
Brain Ischemia	ENSG00000180210	TRUE	Approved	1995-11-15	Approved	F2
Brain Ischemia	ENSG00000180739	FALSE	Preclinical	2006-12-07	Absent	S1PR5
Brain Ischemia	ENSG00000181072	FALSE	Preclinical	2007-02-02	Unused	CHRM2
Brain Ischemia	ENSG00000181104	FALSE	Preclinical	1991-11-15	Unused	F2R
Brain Ischemia	ENSG00000182782	FALSE	unknown	NA	Approved	HCAR2
Brain Ischemia	ENSG00000184381	FALSE	unknown	1998-04-15	Unused	PLA2G6
Brain Ischemia	ENSG00000184588	TRUE	Approved	NA	Approved	PDE4B
Brain Ischemia	ENSG00000185010	FALSE	Phase II Clinical Trial	2000-10-30	Unused	F8
Brain Ischemia	ENSG00000186297	FALSE	Phase II Clinical Trial	1999-12-13	Preclinical	GABRA5
Brain Ischemia	ENSG00000187266	FALSE	Phase II Clinical Trial	1996-10-15	Phase II Clinical Trial	EPOR
Brain Ischemia	ENSG00000188257	FALSE	unknown	1998-04-15	Unused	PLA2G2A
Brain Ischemia	ENSG00000188822	FALSE	unknown	1998-12-15	Unused	CNR2
Brain Ischemia	ENSG00000189403	FALSE	Preclinical	2013-11-28	Absent	HMGB1
Brain Ischemia	ENSG00000196262	FALSE	Preclinical	NA	Absent	PPIA
Brain Ischemia	ENSG00000196277	FALSE	Preclinical	NA	Absent	GRM7
Brain Ischemia	ENSG00000196549	FALSE	Preclinical	1996-10-15	Unused	MME
Brain Ischemia	ENSG00000196611	FALSE	unknown	1995-01-15	Preclinical	MMP1
Brain Ischemia	ENSG00000196664	FALSE	Preclinical	2008-04-01	Unused	TLR7
Brain Ischemia	ENSG00000197122	FALSE	Preclinical	2001-02-20	Unused	SRC
Brain Ischemia	ENSG00000198668	FALSE	Phase I Clinical Trial	1995-10-15	Unused	CALM1
Brain Ischemia	ENSG00000198763	FALSE	Preclinical	2012-09-14	Absent	MT-ND2
Brain Ischemia	ENSG00000203710	FALSE	Preclinical	NA	Unused	CR1
Brain Ischemia	ENSG00000205542	FALSE	unknown	1995-01-15	Preclinical	TMSB4X
Brain Ischemia	ENSG00000213903	FALSE	unknown	NA	Unused	LTB4R
Brain Ischemia	ENSG00000239732	FALSE	Preclinical	2008-04-01	Unused	TLR9
Brain Ischemia	ENSG00000259207	FALSE	Phase II Clinical Trial	1991-01-15	Unused	ITGB3
Brain Ischemia	ENSG00000269858	FALSE	Phase II Clinical Trial	2003-07-02	Unused	EGLN2
Brain Ischemia	ENSG00000273079	FALSE	unknown	1995-12-15	Unused	GRIN2B
Brain Ischemia	ENSG00000282608	FALSE	Phase II Clinical Trial	1999-02-17	Unused	ADORA3
Brain Neoplasms	ENSG00000003402	FALSE	Preclinical	2016-10-25	Absent	CFLAR
Brain Neoplasms	ENSG00000004487	FALSE	Preclinical	2016-03-18	Absent	KDM1A
Brain Neoplasms	ENSG00000007062	FALSE	Phase I Clinical Trial	2008-07-11	Preclinical	PROM1
Brain Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2014-01-01	Absent	BTK
Brain Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Brain Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Unused	HGF
Brain Neoplasms	ENSG00000025434	FALSE	unknown	2014-11-13	Absent	NR1H3
Brain Neoplasms	ENSG00000026025	FALSE	Phase II Clinical Trial	2012-02-29	Phase II Clinical Trial	VIM
Brain Neoplasms	ENSG00000026103	FALSE	Phase III Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Brain Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT4
Brain Neoplasms	ENSG00000041982	FALSE	Phase I Clinical Trial	2006-04-19	Unused	TNC
Brain Neoplasms	ENSG00000043591	FALSE	unknown	2007-01-23	Absent	ADRB1
Brain Neoplasms	ENSG00000047936	FALSE	Preclinical	2006-12-05	Absent	ROS1
Brain Neoplasms	ENSG00000051180	FALSE	unknown	2004-10-05	Unused	RAD51
Brain Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2011-10-28	Phase II Clinical Trial	PIK3CB
Brain Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Brain Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2009-07-06	Phase I Clinical Trial	ERBB3
Brain Neoplasms	ENSG00000065989	FALSE	Preclinical	NA	Absent	PDE4A
Brain Neoplasms	ENSG00000066044	FALSE	Preclinical	2016-09-22	Absent	ELAVL1
Brain Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Brain Neoplasms	ENSG00000067182	FALSE	Phase III Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Brain Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR3
Brain Neoplasms	ENSG00000070501	TRUE	Approved	2015-10-19	Approved	POLB
Brain Neoplasms	ENSG00000071054	FALSE	Preclinical	2012-10-25	Absent	MAP4K4
Brain Neoplasms	ENSG00000072274	FALSE	Phase III Clinical Trial	1994-12-15	Unused	TFRC
Brain Neoplasms	ENSG00000073756	FALSE	unknown	2007-01-23	Phase II Clinical Trial	PTGS2
Brain Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Brain Neoplasms	ENSG00000077238	FALSE	Phase II Clinical Trial	1996-06-15	Unused	IL4R
Brain Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Brain Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2006-05-05	Phase I Clinical Trial	HSP90AA1
Brain Neoplasms	ENSG00000081181	FALSE	Preclinical	2017-06-28	Absent	ARG2
Brain Neoplasms	ENSG00000081985	FALSE	Phase II Clinical Trial	NA	Unused	IL12RB2
Brain Neoplasms	ENSG00000082701	FALSE	Preclinical	NA	Absent	GSK3B
Brain Neoplasms	ENSG00000082781	FALSE	Phase III Clinical Trial	1998-06-15	Phase III Clinical Trial	ITGB5
Brain Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Brain Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Brain Neoplasms	ENSG00000086205	FALSE	Preclinical	2014-05-20	Absent	FOLH1
Brain Neoplasms	ENSG00000087586	FALSE	unknown	2004-05-20	Phase I Clinical Trial	AURKA
Brain Neoplasms	ENSG00000089685	FALSE	Phase II Clinical Trial	2008-01-15	Absent	BIRC5
Brain Neoplasms	ENSG00000090339	FALSE	Preclinical	2004-07-19	Preclinical	ICAM1
Brain Neoplasms	ENSG00000090554	FALSE	Preclinical	2009-07-01	Unused	FLT3LG
Brain Neoplasms	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Brain Neoplasms	ENSG00000091831	FALSE	Phase II Clinical Trial	1999-03-23	Unused	ESR1
Brain Neoplasms	ENSG00000091879	FALSE	unknown	2006-10-16	Unused	ANGPT2
Brain Neoplasms	ENSG00000092969	FALSE	Phase III Clinical Trial	2001-06-12	Phase III Clinical Trial	TGFB2
Brain Neoplasms	ENSG00000095015	FALSE	Preclinical	2007-08-10	Absent	MAP3K1
Brain Neoplasms	ENSG00000095303	FALSE	unknown	2008-06-03	Phase II Clinical Trial	PTGS1
Brain Neoplasms	ENSG00000096968	FALSE	Preclinical	2004-05-20	Phase I Clinical Trial	JAK2
Brain Neoplasms	ENSG00000096996	FALSE	Phase II Clinical Trial	2011-01-21	Unused	IL12RB1
Brain Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	ABL1
Brain Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Brain Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDGFB
Brain Neoplasms	ENSG00000100644	FALSE	Preclinical	1997-04-15	Unused	HIF1A
Brain Neoplasms	ENSG00000100823	FALSE	Phase II Clinical Trial	2000-07-19	Phase II Clinical Trial	APEX1
Brain Neoplasms	ENSG00000101868	TRUE	Approved	1996-09-15	Approved	POLA1
Brain Neoplasms	ENSG00000101966	FALSE	Preclinical	2016-10-25	Absent	XIAP
Brain Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	2000-07-05	Phase III Clinical Trial	FLT1
Brain Neoplasms	ENSG00000102967	FALSE	unknown	1994-12-15	Unused	DHODH
Brain Neoplasms	ENSG00000103257	FALSE	Phase I Clinical Trial	2016-11-04	Absent	SLC7A5
Brain Neoplasms	ENSG00000103855	FALSE	Phase II Clinical Trial	2009-09-16	Phase I Clinical Trial	CD276
Brain Neoplasms	ENSG00000104365	FALSE	Preclinical	2003-04-22	Unused	IKBKB
Brain Neoplasms	ENSG00000105221	FALSE	Preclinical	2011-12-19	Absent	AKT2
Brain Neoplasms	ENSG00000105650	FALSE	Preclinical	NA	Absent	PDE4C
Brain Neoplasms	ENSG00000105810	FALSE	Phase I Clinical Trial	2009-12-10	Preclinical	CDK6
Brain Neoplasms	ENSG00000105835	FALSE	unknown	2003-04-22	Unused	NAMPT
Brain Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2004-08-09	Phase II Clinical Trial	MET
Brain Neoplasms	ENSG00000106113	FALSE	Phase II Clinical Trial	1994-04-15	Phase II Clinical Trial	CRHR2
Brain Neoplasms	ENSG00000106278	FALSE	Preclinical	2001-10-18	Unused	PTPRZ1
Brain Neoplasms	ENSG00000106799	FALSE	Phase II Clinical Trial	2003-09-17	Phase II Clinical Trial	TGFBR1
Brain Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Brain Neoplasms	ENSG00000107562	FALSE	Phase I Clinical Trial	2007-04-10	Absent	CXCL12
Brain Neoplasms	ENSG00000108443	FALSE	Preclinical	2008-10-22	Absent	RPS6KB1
Brain Neoplasms	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Brain Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1990-06-15	Phase I Clinical Trial	NFKB1
Brain Neoplasms	ENSG00000109471	FALSE	Phase II Clinical Trial	1997-06-15	Unused	IL2
Brain Neoplasms	ENSG00000110092	FALSE	Preclinical	2016-11-01	Absent	CCND1
Brain Neoplasms	ENSG00000110492	FALSE	Preclinical	2014-05-20	Absent	MDK
Brain Neoplasms	ENSG00000111142	FALSE	unknown	1998-07-15	Absent	METAP2
Brain Neoplasms	ENSG00000112541	FALSE	Preclinical	NA	Absent	PDE10A
Brain Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Approved	VEGFA
Brain Neoplasms	ENSG00000113070	FALSE	Phase II Clinical Trial	2004-02-04	Absent	HBEGF
Brain Neoplasms	ENSG00000113083	FALSE	Preclinical	2013-04-24	Absent	LOX
Brain Neoplasms	ENSG00000113302	FALSE	Preclinical	2001-10-02	Unused	IL12B
Brain Neoplasms	ENSG00000113448	FALSE	Preclinical	NA	Absent	PDE4D
Brain Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Brain Neoplasms	ENSG00000113575	FALSE	Preclinical	2008-02-29	Preclinical	PPP2CA
Brain Neoplasms	ENSG00000113580	FALSE	Phase I Clinical Trial	2007-01-19	Phase I Clinical Trial	NR3C1
Brain Neoplasms	ENSG00000113594	FALSE	Preclinical	2017-04-13	Absent	LIFR
Brain Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Brain Neoplasms	ENSG00000113749	FALSE	unknown	2008-06-03	Phase II Clinical Trial	HRH2
Brain Neoplasms	ENSG00000113851	FALSE	Phase I Clinical Trial	2011-08-26	Absent	CRBN
Brain Neoplasms	ENSG00000114013	FALSE	Phase I Clinical Trial	2002-01-11	Unused	CD86
Brain Neoplasms	ENSG00000115053	FALSE	Preclinical	2003-03-13	Unused	NCL
Brain Neoplasms	ENSG00000115414	FALSE	Phase II Clinical Trial	1995-10-15	Phase II Clinical Trial	FN1
Brain Neoplasms	ENSG00000115758	FALSE	Phase III Clinical Trial	NA	Absent	ODC1
Brain Neoplasms	ENSG00000116016	FALSE	Preclinical	2011-08-02	Absent	EPAS1
Brain Neoplasms	ENSG00000116044	FALSE	Preclinical	2007-04-27	Unused	NFE2L2
Brain Neoplasms	ENSG00000116478	FALSE	Preclinical	2003-12-09	Absent	HDAC1
Brain Neoplasms	ENSG00000117560	FALSE	Phase II Clinical Trial	2004-01-19	Phase II Clinical Trial	FASLG
Brain Neoplasms	ENSG00000118432	FALSE	Phase II Clinical Trial	1998-08-15	Absent	CNR1
Brain Neoplasms	ENSG00000118513	FALSE	Preclinical	2013-03-20	Absent	MYB
Brain Neoplasms	ENSG00000118520	FALSE	Preclinical	2017-06-28	Absent	ARG1
Brain Neoplasms	ENSG00000119630	FALSE	Phase II Clinical Trial	2003-07-24	Phase II Clinical Trial	PGF
Brain Neoplasms	ENSG00000120088	FALSE	Phase II Clinical Trial	1994-04-15	Phase II Clinical Trial	CRHR1
Brain Neoplasms	ENSG00000120156	FALSE	Preclinical	2004-08-09	Phase II Clinical Trial	TEK
Brain Neoplasms	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Brain Neoplasms	ENSG00000120889	FALSE	Preclinical	1997-04-15	Unused	TNFRSF10B
Brain Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Brain Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Brain Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	2001-04-09	Preclinical	CXCR4
Brain Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Brain Neoplasms	ENSG00000122194	FALSE	Phase I Clinical Trial	1998-06-15	Unused	PLG
Brain Neoplasms	ENSG00000122861	FALSE	unknown	1993-05-15	Unused	PLAU
Brain Neoplasms	ENSG00000123374	FALSE	unknown	2007-02-06	Preclinical	CDK2
Brain Neoplasms	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Brain Neoplasms	ENSG00000123496	FALSE	Phase II Clinical Trial	2006-12-01	Phase II Clinical Trial	IL13RA2
Brain Neoplasms	ENSG00000124102	FALSE	Preclinical	2015-11-20	Absent	PI3
Brain Neoplasms	ENSG00000124486	FALSE	Preclinical	2015-10-20	Absent	USP9X
Brain Neoplasms	ENSG00000125378	FALSE	Phase I Clinical Trial	NA	Absent	BMP4
Brain Neoplasms	ENSG00000126602	FALSE	Preclinical	2013-09-14	Absent	TRAP1
Brain Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2006-10-23	Absent	MAP2K2
Brain Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	KDR
Brain Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2008-06-19	Phase II Clinical Trial	SMO
Brain Neoplasms	ENSG00000128655	FALSE	Preclinical	NA	Absent	PDE11A
Brain Neoplasms	ENSG00000129484	FALSE	Phase II Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Brain Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Absent	IDO1
Brain Neoplasms	ENSG00000131724	FALSE	Preclinical	1996-10-15	Unused	IL13RA1
Brain Neoplasms	ENSG00000131747	TRUE	Approved	1989-08-15	Approved	TOP2A
Brain Neoplasms	ENSG00000132155	FALSE	Preclinical	1992-11-15	Phase II Clinical Trial	RAF1
Brain Neoplasms	ENSG00000132646	FALSE	Preclinical	2011-03-30	Absent	PCNA
Brain Neoplasms	ENSG00000132906	FALSE	Preclinical	2004-01-30	Unused	CASP9
Brain Neoplasms	ENSG00000133703	FALSE	unknown	1992-11-15	Unused	KRAS
Brain Neoplasms	ENSG00000134250	FALSE	Phase I Clinical Trial	2012-09-29	Absent	NOTCH2
Brain Neoplasms	ENSG00000134323	FALSE	Preclinical	NA	Absent	MYCN
Brain Neoplasms	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Brain Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	PDGFRA
Brain Neoplasms	ENSG00000135218	FALSE	Preclinical	2010-11-18	Unused	CD36
Brain Neoplasms	ENSG00000135446	FALSE	Phase I Clinical Trial	2007-02-06	Preclinical	CDK4
Brain Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2004-11-29	Phase I Clinical Trial	EDNRB
Brain Neoplasms	ENSG00000136235	FALSE	unknown	1999-12-10	Unused	GPNMB
Brain Neoplasms	ENSG00000136810	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	TXN
Brain Neoplasms	ENSG00000136869	FALSE	Preclinical	NA	Absent	TLR4
Brain Neoplasms	ENSG00000136997	FALSE	Preclinical	NA	Absent	MYC
Brain Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Brain Neoplasms	ENSG00000138413	FALSE	Phase I Clinical Trial	2010-04-19	Preclinical	IDH1
Brain Neoplasms	ENSG00000138448	FALSE	Phase III Clinical Trial	1998-06-15	Phase III Clinical Trial	ITGAV
Brain Neoplasms	ENSG00000138798	FALSE	Preclinical	2007-07-03	Unused	EGF
Brain Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Brain Neoplasms	ENSG00000139567	FALSE	unknown	2007-05-30	Absent	ACVRL1
Brain Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	1998-07-15	Phase I Clinical Trial	IGF1R
Brain Neoplasms	ENSG00000140538	FALSE	Preclinical	2012-03-14	Absent	NTRK3
Brain Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1995-01-15	Unused	TP53
Brain Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	1990-09-15	Phase II Clinical Trial	ERBB2
Brain Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD4
Brain Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Unused	AKT1
Brain Neoplasms	ENSG00000142627	FALSE	Phase II Clinical Trial	2010-11-30	Absent	EPHA2
Brain Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	MCL1
Brain Neoplasms	ENSG00000143437	FALSE	Preclinical	2015-07-29	Absent	ARNT
Brain Neoplasms	ENSG00000143799	FALSE	Phase II Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Brain Neoplasms	ENSG00000144476	FALSE	Preclinical	2005-06-29	Preclinical	ACKR3
Brain Neoplasms	ENSG00000145545	FALSE	Preclinical	2016-10-25	Absent	SRD5A1
Brain Neoplasms	ENSG00000145936	FALSE	Preclinical	2005-10-28	Unused	KCNMB1
Brain Neoplasms	ENSG00000146648	FALSE	Approved	1993-07-15	Approved	EGFR
Brain Neoplasms	ENSG00000146904	FALSE	Preclinical	2016-12-02	Absent	EPHA1
Brain Neoplasms	ENSG00000147099	FALSE	Preclinical	2015-08-31	Absent	HDAC8
Brain Neoplasms	ENSG00000147889	FALSE	Preclinical	2009-07-17	Unused	CDKN2A
Brain Neoplasms	ENSG00000149294	FALSE	Phase I Clinical Trial	1992-11-15	Unused	NCAM1
Brain Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	1995-09-15	Unused	DRD2
Brain Neoplasms	ENSG00000149311	FALSE	Phase I Clinical Trial	2017-05-18	Absent	ATM
Brain Neoplasms	ENSG00000150093	FALSE	Preclinical	2001-11-05	Phase II Clinical Trial	ITGB1
Brain Neoplasms	ENSG00000150630	FALSE	unknown	2007-07-02	Preclinical	VEGFC
Brain Neoplasms	ENSG00000151617	FALSE	Phase I Clinical Trial	2004-11-29	Phase I Clinical Trial	EDNRA
Brain Neoplasms	ENSG00000151702	FALSE	Preclinical	2016-01-22	Absent	FLI1
Brain Neoplasms	ENSG00000153208	FALSE	unknown	2012-12-21	Absent	MERTK
Brain Neoplasms	ENSG00000154229	FALSE	unknown	1991-01-15	Unused	PRKCA
Brain Neoplasms	ENSG00000155511	FALSE	Phase II Clinical Trial	1996-08-15	Unused	GRIA1
Brain Neoplasms	ENSG00000156113	FALSE	Preclinical	2005-10-28	Unused	KCNMA1
Brain Neoplasms	ENSG00000157404	FALSE	Phase III Clinical Trial	1999-03-17	Phase III Clinical Trial	KIT
Brain Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	BRAF
Brain Neoplasms	ENSG00000159110	TRUE	Approved	2005-10-11	Approved	IFNAR2
Brain Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Brain Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Brain Neoplasms	ENSG00000161011	FALSE	Preclinical	2015-11-04	Absent	SQSTM1
Brain Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Phase II Clinical Trial	ITGA5
Brain Neoplasms	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Brain Neoplasms	ENSG00000163399	FALSE	Preclinical	2008-10-22	Absent	ATP1A1
Brain Neoplasms	ENSG00000163513	FALSE	Preclinical	2016-02-11	Absent	TGFBR2
Brain Neoplasms	ENSG00000163599	FALSE	unknown	1998-09-15	Unused	CTLA4
Brain Neoplasms	ENSG00000163737	FALSE	unknown	NA	Unused	PF4
Brain Neoplasms	ENSG00000164078	FALSE	unknown	2012-12-21	Unused	MST1R
Brain Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	1997-04-15	Unused	CASP3
Brain Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	TLR3
Brain Neoplasms	ENSG00000164362	FALSE	Preclinical	2005-07-22	Unused	TERT
Brain Neoplasms	ENSG00000164400	FALSE	Phase I Clinical Trial	1999-12-01	Phase I Clinical Trial	CSF2
Brain Neoplasms	ENSG00000165304	FALSE	Preclinical	2010-01-25	Preclinical	MELK
Brain Neoplasms	ENSG00000165675	FALSE	Preclinical	2016-10-25	Absent	ENOX2
Brain Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Brain Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Brain Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2011-11-22	Absent	AXL
Brain Neoplasms	ENSG00000167658	FALSE	Phase III Clinical Trial	1994-12-15	Unused	EEF2
Brain Neoplasms	ENSG00000168283	FALSE	Preclinical	2010-06-08	Absent	BMI1
Brain Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	2011-04-18	Unused	FNTA
Brain Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2005-04-25	Absent	STAT3
Brain Neoplasms	ENSG00000168811	FALSE	Preclinical	2001-10-02	Unused	IL12A
Brain Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2006-10-23	Absent	MAP2K1
Brain Neoplasms	ENSG00000169136	FALSE	Preclinical	2016-07-14	Absent	ATF5
Brain Neoplasms	ENSG00000169194	FALSE	Phase I Clinical Trial	2007-01-19	Phase I Clinical Trial	IL13
Brain Neoplasms	ENSG00000169252	FALSE	unknown	2007-01-23	Absent	ADRB2
Brain Neoplasms	ENSG00000169429	FALSE	unknown	2001-08-28	Unused	CXCL8
Brain Neoplasms	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Brain Neoplasms	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Brain Neoplasms	ENSG00000170430	FALSE	Phase II Clinical Trial	1998-06-15	Unused	MGMT
Brain Neoplasms	ENSG00000170525	FALSE	Preclinical	2008-04-04	Unused	PFKFB3
Brain Neoplasms	ENSG00000171094	FALSE	Phase I Clinical Trial	2006-12-05	Phase I Clinical Trial	ALK
Brain Neoplasms	ENSG00000171552	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BCL2L1
Brain Neoplasms	ENSG00000171791	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BCL2
Brain Neoplasms	ENSG00000171848	FALSE	Preclinical	NA	Absent	RRM2
Brain Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Brain Neoplasms	ENSG00000172062	FALSE	Preclinical	2014-06-26	Absent	SMN1
Brain Neoplasms	ENSG00000173039	FALSE	unknown	NA	Unused	RELA
Brain Neoplasms	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Brain Neoplasms	ENSG00000173250	FALSE	Preclinical	2017-07-06	Absent	GPR151
Brain Neoplasms	ENSG00000173546	FALSE	Preclinical	2010-05-21	Preclinical	CSPG4
Brain Neoplasms	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Brain Neoplasms	ENSG00000176884	FALSE	Phase I Clinical Trial	1990-06-15	Phase I Clinical Trial	GRIN1
Brain Neoplasms	ENSG00000176890	FALSE	Phase III Clinical Trial	1992-06-15	Phase II Clinical Trial	TYMS
Brain Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB4
Brain Neoplasms	ENSG00000178999	FALSE	unknown	2004-05-20	Phase I Clinical Trial	AURKB
Brain Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Absent	CDH5
Brain Neoplasms	ENSG00000182054	FALSE	Phase II Clinical Trial	2011-11-14	Absent	IDH2
Brain Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2008-08-14	Phase II Clinical Trial	CSF1R
Brain Neoplasms	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Brain Neoplasms	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Brain Neoplasms	ENSG00000184033	FALSE	Phase I Clinical Trial	2013-02-01	Absent	CTAG1B
Brain Neoplasms	ENSG00000184588	FALSE	Preclinical	NA	Absent	PDE4B
Brain Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	2012-05-14	Absent	WT1
Brain Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2016-04-21	Absent	MUC1
Brain Neoplasms	ENSG00000185664	FALSE	Preclinical	2016-07-21	Absent	PMEL
Brain Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Brain Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Brain Neoplasms	ENSG00000188822	FALSE	Preclinical	2005-01-31	Unused	CNR2
Brain Neoplasms	ENSG00000196352	FALSE	Preclinical	2004-07-19	Preclinical	CD55
Brain Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Absent	EPHB4
Brain Neoplasms	ENSG00000196557	FALSE	Phase I Clinical Trial	NA	Absent	CACNA1H
Brain Neoplasms	ENSG00000196591	FALSE	Preclinical	2003-12-09	Absent	HDAC2
Brain Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Brain Neoplasms	ENSG00000198363	FALSE	Preclinical	2000-06-23	Unused	ASPH
Brain Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Preclinical	NTRK1
Brain Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Phase II Clinical Trial	MTOR
Brain Neoplasms	ENSG00000198805	FALSE	Preclinical	1997-04-15	Unused	PNP
Brain Neoplasms	ENSG00000198822	FALSE	Preclinical	2013-09-26	Absent	GRM3
Brain Neoplasms	ENSG00000198900	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	TOP1
Brain Neoplasms	ENSG00000198964	FALSE	Phase II Clinical Trial	2008-11-07	Absent	SGMS1
Brain Neoplasms	ENSG00000205927	FALSE	Preclinical	2013-11-05	Absent	OLIG2
Brain Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Brain Neoplasms	ENSG00000239732	FALSE	Preclinical	2016-05-11	Unused	TLR9
Brain Neoplasms	ENSG00000240972	FALSE	Preclinical	NA	Absent	MIF
Brain Neoplasms	ENSG00000253729	FALSE	unknown	2006-11-29	Preclinical	PRKDC
Brain Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Brain Neoplasms	ENSG00000259207	FALSE	Phase III Clinical Trial	1998-06-15	Phase III Clinical Trial	ITGB3
Brain Neoplasms	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Breast Neoplasms	ENSG00000000938	FALSE	Phase I Clinical Trial	2007-10-29	Absent	FGR
Breast Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	CFLAR
Breast Neoplasms	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Breast Neoplasms	ENSG00000004487	FALSE	Preclinical	2016-04-19	Absent	KDM1A
Breast Neoplasms	ENSG00000006283	FALSE	Preclinical	2009-02-12	Unused	CACNA1G
Breast Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Breast Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Breast Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Breast Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Breast Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Breast Neoplasms	ENSG00000012048	FALSE	Preclinical	1993-07-15	Unused	BRCA1
Breast Neoplasms	ENSG00000014257	FALSE	Phase I Clinical Trial	1997-10-15	Unused	ACPP
Breast Neoplasms	ENSG00000017427	FALSE	unknown	2009-06-23	Phase II Clinical Trial	IGF1
Breast Neoplasms	ENSG00000023445	FALSE	unknown	2005-11-21	Absent	BIRC3
Breast Neoplasms	ENSG00000025434	FALSE	Phase I Clinical Trial	2014-11-13	Absent	NR1H3
Breast Neoplasms	ENSG00000026025	FALSE	Preclinical	2012-02-29	Absent	VIM
Breast Neoplasms	ENSG00000026103	FALSE	Preclinical	2004-04-28	Absent	FAS
Breast Neoplasms	ENSG00000026508	FALSE	Phase I Clinical Trial	1992-09-15	Unused	CD44
Breast Neoplasms	ENSG00000030582	FALSE	Preclinical	2004-02-24	Unused	GRN
Breast Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT4
Breast Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-08-27	Absent	CDH1
Breast Neoplasms	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-05-29	Phase II Clinical Trial	TNC
Breast Neoplasms	ENSG00000047936	FALSE	Phase II Clinical Trial	2010-05-17	Absent	ROS1
Breast Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2015-07-15	Absent	TNFRSF9
Breast Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Breast Neoplasms	ENSG00000051341	FALSE	Preclinical	2017-03-02	Absent	POLQ
Breast Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CB
Breast Neoplasms	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Breast Neoplasms	ENSG00000058085	FALSE	Preclinical	2009-02-12	Unused	LAMC2
Breast Neoplasms	ENSG00000062038	FALSE	Phase I Clinical Trial	2014-07-16	Absent	CDH3
Breast Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Breast Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	ERBB3
Breast Neoplasms	ENSG00000065559	FALSE	Preclinical	1998-01-15	Unused	MAP2K4
Breast Neoplasms	ENSG00000065675	FALSE	Preclinical	2016-10-31	Absent	PRKCQ
Breast Neoplasms	ENSG00000065978	FALSE	Preclinical	2017-02-06	Absent	YBX1
Breast Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FGFR2
Breast Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase II Clinical Trial	TNFRSF1A
Breast Neoplasms	ENSG00000067225	FALSE	Preclinical	2011-05-04	Preclinical	PKM
Breast Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Breast Neoplasms	ENSG00000069399	FALSE	Preclinical	2014-05-23	Absent	BCL3
Breast Neoplasms	ENSG00000069667	FALSE	Preclinical	2011-01-18	Absent	RORA
Breast Neoplasms	ENSG00000070018	FALSE	Preclinical	2006-11-13	Unused	LRP6
Breast Neoplasms	ENSG00000070501	FALSE	unknown	1995-06-15	Unused	POLB
Breast Neoplasms	ENSG00000071242	FALSE	Preclinical	2017-05-25	Absent	RPS6KA2
Breast Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Breast Neoplasms	ENSG00000072571	FALSE	Preclinical	2014-10-14	Absent	HMMR
Breast Neoplasms	ENSG00000073756	FALSE	Phase II Clinical Trial	2003-02-20	Unused	PTGS2
Breast Neoplasms	ENSG00000074181	FALSE	Phase I Clinical Trial	2014-05-06	Phase I Clinical Trial	NOTCH3
Breast Neoplasms	ENSG00000074590	FALSE	Preclinical	2007-05-16	Absent	NUAK1
Breast Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Breast Neoplasms	ENSG00000075891	FALSE	Preclinical	2011-09-22	Unused	PAX2
Breast Neoplasms	ENSG00000077092	FALSE	Preclinical	NA	Absent	RARB
Breast Neoplasms	ENSG00000077238	FALSE	Phase I Clinical Trial	1996-06-15	Unused	IL4R
Breast Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Breast Neoplasms	ENSG00000078098	FALSE	unknown	1998-07-15	Unused	FAP
Breast Neoplasms	ENSG00000078142	FALSE	Preclinical	2012-11-20	Absent	PIK3C3
Breast Neoplasms	ENSG00000079277	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK1
Breast Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	HSP90AA1
Breast Neoplasms	ENSG00000081051	FALSE	Preclinical	NA	Unused	AFP
Breast Neoplasms	ENSG00000081985	FALSE	Phase II Clinical Trial	2011-06-06	Absent	IL12RB2
Breast Neoplasms	ENSG00000082175	TRUE	Approved	1997-07-15	Approved	PGR
Breast Neoplasms	ENSG00000082781	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGB5
Breast Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Breast Neoplasms	ENSG00000083312	FALSE	unknown	2005-06-27	Unused	TNPO1
Breast Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Breast Neoplasms	ENSG00000085063	FALSE	Preclinical	2007-03-06	Unused	CD59
Breast Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Breast Neoplasms	ENSG00000085563	FALSE	Phase III Clinical Trial	1992-05-15	Unused	ABCB1
Breast Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Absent	FOLH1
Breast Neoplasms	ENSG00000086548	FALSE	Preclinical	2005-05-04	Absent	CEACAM6
Breast Neoplasms	ENSG00000087494	FALSE	Preclinical	2015-10-19	Absent	PTHLH
Breast Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKA
Breast Neoplasms	ENSG00000089685	FALSE	Phase II Clinical Trial	2002-04-29	Phase I Clinical Trial	BIRC5
Breast Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2004-06-08	Phase II Clinical Trial	LAG3
Breast Neoplasms	ENSG00000090339	FALSE	Phase I Clinical Trial	2004-07-19	Phase I Clinical Trial	ICAM1
Breast Neoplasms	ENSG00000091831	TRUE	Approved	1989-11-15	Approved	ESR1
Breast Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Breast Neoplasms	ENSG00000092969	FALSE	Phase I Clinical Trial	2011-10-19	Phase I Clinical Trial	TGFB2
Breast Neoplasms	ENSG00000094631	FALSE	Preclinical	2017-08-17	Absent	HDAC6
Breast Neoplasms	ENSG00000095015	FALSE	unknown	2007-08-10	Preclinical	MAP3K1
Breast Neoplasms	ENSG00000095596	FALSE	Preclinical	2004-03-29	Unused	CYP26A1
Breast Neoplasms	ENSG00000096968	FALSE	Phase II Clinical Trial	2006-12-01	Unused	JAK2
Breast Neoplasms	ENSG00000096996	FALSE	Phase II Clinical Trial	2011-01-21	Preclinical	IL12RB1
Breast Neoplasms	ENSG00000097007	FALSE	Phase I Clinical Trial	1999-03-17	Unused	ABL1
Breast Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2014-03-07	Absent	CDC7
Breast Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Breast Neoplasms	ENSG00000099810	FALSE	Preclinical	2014-12-17	Absent	MTAP
Breast Neoplasms	ENSG00000099875	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK2
Breast Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Breast Neoplasms	ENSG00000100311	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	PDGFB
Breast Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	NA	Absent	ST13
Breast Neoplasms	ENSG00000100385	FALSE	Phase II Clinical Trial	2012-05-28	Absent	IL2RB
Breast Neoplasms	ENSG00000100429	FALSE	Phase III Clinical Trial	2006-05-08	Phase II Clinical Trial	HDAC10
Breast Neoplasms	ENSG00000100644	FALSE	unknown	1997-04-15	Phase I Clinical Trial	HIF1A
Breast Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2010-07-20	Absent	CD40
Breast Neoplasms	ENSG00000101266	FALSE	Phase I Clinical Trial	2007-05-23	Phase I Clinical Trial	CSNK2A1
Breast Neoplasms	ENSG00000101336	FALSE	Phase I Clinical Trial	2007-10-29	Absent	HCK
Breast Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Breast Neoplasms	ENSG00000101846	FALSE	Phase II Clinical Trial	1996-11-15	Unused	STS
Breast Neoplasms	ENSG00000101868	FALSE	Phase I Clinical Trial	1993-08-15	Phase I Clinical Trial	POLA1
Breast Neoplasms	ENSG00000101916	FALSE	unknown	2008-06-17	Phase I Clinical Trial	TLR8
Breast Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	XIAP
Breast Neoplasms	ENSG00000102245	FALSE	unknown	2001-06-01	Preclinical	CD40LG
Breast Neoplasms	ENSG00000102312	FALSE	Phase I Clinical Trial	2011-05-14	Phase I Clinical Trial	PORCN
Breast Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Breast Neoplasms	ENSG00000102854	FALSE	Preclinical	2016-03-02	Preclinical	MSLN
Breast Neoplasms	ENSG00000103222	FALSE	Preclinical	1992-05-15	Unused	ABCC1
Breast Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Breast Neoplasms	ENSG00000104432	FALSE	unknown	2001-06-01	Preclinical	IL7
Breast Neoplasms	ENSG00000104763	FALSE	Preclinical	NA	Absent	ASAH1
Breast Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	1996-02-15	Phase I Clinical Trial	CGB3
Breast Neoplasms	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKC
Breast Neoplasms	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE1
Breast Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Breast Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1993-06-15	Phase II Clinical Trial	CEACAM5
Breast Neoplasms	ENSG00000105810	TRUE	Approved	1996-05-15	Phase III Clinical Trial	CDK6
Breast Neoplasms	ENSG00000105851	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	PIK3CG
Breast Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Breast Neoplasms	ENSG00000106128	FALSE	Preclinical	1996-07-15	Unused	GHRHR
Breast Neoplasms	ENSG00000106211	FALSE	Phase I Clinical Trial	2004-09-24	Phase I Clinical Trial	HSPB1
Breast Neoplasms	ENSG00000106268	FALSE	Preclinical	2015-03-23	Absent	NUDT1
Breast Neoplasms	ENSG00000106462	FALSE	Preclinical	2010-12-03	Preclinical	EZH2
Breast Neoplasms	ENSG00000106546	FALSE	unknown	1999-04-13	Unused	AHR
Breast Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	TGFBR1
Breast Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Breast Neoplasms	ENSG00000107562	FALSE	unknown	2003-04-10	Unused	CXCL12
Breast Neoplasms	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Breast Neoplasms	ENSG00000108424	FALSE	unknown	2005-06-27	Unused	KPNB1
Breast Neoplasms	ENSG00000108443	FALSE	Phase II Clinical Trial	2003-03-20	Phase I Clinical Trial	RPS6KB1
Breast Neoplasms	ENSG00000108654	FALSE	Phase II Clinical Trial	2006-08-30	Absent	DDX5
Breast Neoplasms	ENSG00000108679	FALSE	Preclinical	2014-07-22	Absent	LGALS3BP
Breast Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Breast Neoplasms	ENSG00000108786	FALSE	Preclinical	2000-02-09	Unused	HSD17B1
Breast Neoplasms	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Breast Neoplasms	ENSG00000109163	TRUE	Approved	1990-10-15	Approved	GNRHR
Breast Neoplasms	ENSG00000109193	FALSE	Preclinical	2004-01-20	Unused	SULT1E1
Breast Neoplasms	ENSG00000109320	FALSE	Preclinical	1997-11-15	Unused	NFKB1
Breast Neoplasms	ENSG00000109471	FALSE	unknown	1998-06-15	Unused	IL2
Breast Neoplasms	ENSG00000110092	FALSE	Preclinical	1999-06-02	Phase I Clinical Trial	CCND1
Breast Neoplasms	ENSG00000110195	FALSE	Phase II Clinical Trial	2003-02-24	Phase I Clinical Trial	FOLR1
Breast Neoplasms	ENSG00000110330	FALSE	unknown	2005-11-21	Absent	BIRC2
Breast Neoplasms	ENSG00000110484	FALSE	Preclinical	1999-01-15	Unused	SCGB2A2
Breast Neoplasms	ENSG00000111142	FALSE	Preclinical	2011-07-21	Absent	METAP2
Breast Neoplasms	ENSG00000111424	FALSE	Phase II Clinical Trial	1993-07-15	Unused	VDR
Breast Neoplasms	ENSG00000111640	FALSE	Preclinical	2013-07-26	Absent	GAPDH
Breast Neoplasms	ENSG00000111679	FALSE	Preclinical	2016-11-08	Absent	PTPN6
Breast Neoplasms	ENSG00000112062	FALSE	Phase I Clinical Trial	2008-09-05	Phase I Clinical Trial	MAPK14
Breast Neoplasms	ENSG00000112486	FALSE	Preclinical	2002-03-13	Unused	CCR6
Breast Neoplasms	ENSG00000112655	FALSE	Phase I Clinical Trial	2014-08-25	Absent	PTK7
Breast Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Approved	VEGFA
Breast Neoplasms	ENSG00000112742	FALSE	Phase I Clinical Trial	2013-05-04	Absent	TTK
Breast Neoplasms	ENSG00000113302	FALSE	unknown	1995-09-15	Unused	IL12B
Breast Neoplasms	ENSG00000113328	FALSE	Phase II Clinical Trial	2003-08-05	Phase II Clinical Trial	CCNG1
Breast Neoplasms	ENSG00000113494	FALSE	Phase I Clinical Trial	2009-12-10	Phase I Clinical Trial	PRLR
Breast Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Breast Neoplasms	ENSG00000113575	FALSE	Preclinical	2015-07-15	Absent	PPP2CA
Breast Neoplasms	ENSG00000113580	FALSE	Phase II Clinical Trial	2001-02-27	Unused	NR3C1
Breast Neoplasms	ENSG00000113594	FALSE	Preclinical	2017-12-22	Absent	LIFR
Breast Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Breast Neoplasms	ENSG00000113851	FALSE	Phase I Clinical Trial	2011-08-26	Absent	CRBN
Breast Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Breast Neoplasms	ENSG00000114013	FALSE	unknown	1997-07-15	Unused	CD86
Breast Neoplasms	ENSG00000114378	FALSE	Phase II Clinical Trial	NA	Absent	HYAL1
Breast Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Breast Neoplasms	ENSG00000114812	FALSE	Preclinical	2014-01-21	Absent	VIPR1
Breast Neoplasms	ENSG00000115053	FALSE	Phase II Clinical Trial	2008-07-31	Phase II Clinical Trial	NCL
Breast Neoplasms	ENSG00000115353	FALSE	Preclinical	2015-10-27	Absent	TACR1
Breast Neoplasms	ENSG00000115414	FALSE	Phase I Clinical Trial	2004-02-11	Unused	FN1
Breast Neoplasms	ENSG00000115419	FALSE	Phase II Clinical Trial	2013-05-02	Absent	GLS
Breast Neoplasms	ENSG00000115457	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP2
Breast Neoplasms	ENSG00000115461	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP5
Breast Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase I Clinical Trial	ODC1
Breast Neoplasms	ENSG00000115884	FALSE	Phase II Clinical Trial	2006-07-11	Absent	SDC1
Breast Neoplasms	ENSG00000116016	FALSE	unknown	2003-08-01	Absent	EPAS1
Breast Neoplasms	ENSG00000116106	FALSE	Phase I Clinical Trial	2014-03-06	Absent	EPHA4
Breast Neoplasms	ENSG00000116478	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Breast Neoplasms	ENSG00000116678	FALSE	Preclinical	2008-04-21	Unused	LEPR
Breast Neoplasms	ENSG00000116711	FALSE	Preclinical	2013-10-03	Absent	PLA2G4A
Breast Neoplasms	ENSG00000117020	FALSE	Phase I Clinical Trial	2013-11-01	Absent	AKT3
Breast Neoplasms	ENSG00000117525	FALSE	Phase I Clinical Trial	2007-09-05	Unused	F3
Breast Neoplasms	ENSG00000117632	FALSE	unknown	2008-07-04	Phase I Clinical Trial	STMN1
Breast Neoplasms	ENSG00000118513	FALSE	Preclinical	2013-03-20	Absent	MYB
Breast Neoplasms	ENSG00000118515	FALSE	Preclinical	2014-01-11	Absent	SGK1
Breast Neoplasms	ENSG00000118785	FALSE	Preclinical	2011-08-02	Unused	SPP1
Breast Neoplasms	ENSG00000119535	FALSE	Phase I Clinical Trial	2011-10-19	Phase I Clinical Trial	CSF3R
Breast Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	EPCAM
Breast Neoplasms	ENSG00000120156	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	TEK
Breast Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Breast Neoplasms	ENSG00000120659	FALSE	Phase II Clinical Trial	2013-07-19	Absent	TNFSF11
Breast Neoplasms	ENSG00000120885	FALSE	Phase II Clinical Trial	2001-12-07	Unused	CLU
Breast Neoplasms	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Breast Neoplasms	ENSG00000121594	FALSE	unknown	2001-06-01	Preclinical	CD80
Breast Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Breast Neoplasms	ENSG00000121879	FALSE	Phase III Clinical Trial	1992-08-15	Phase III Clinical Trial	PIK3CA
Breast Neoplasms	ENSG00000121966	FALSE	Phase I Clinical Trial	2001-04-09	Unused	CXCR4
Breast Neoplasms	ENSG00000122025	FALSE	Phase III Clinical Trial	1993-05-15	Phase III Clinical Trial	FLT3
Breast Neoplasms	ENSG00000122861	FALSE	Phase II Clinical Trial	1993-05-15	Phase II Clinical Trial	PLAU
Breast Neoplasms	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK2
Breast Neoplasms	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Breast Neoplasms	ENSG00000124102	FALSE	Preclinical	2015-11-20	Phase I Clinical Trial	PI3
Breast Neoplasms	ENSG00000124486	FALSE	Preclinical	2015-10-20	Absent	USP9X
Breast Neoplasms	ENSG00000124731	FALSE	Preclinical	2012-01-19	Preclinical	TREM1
Breast Neoplasms	ENSG00000124762	FALSE	Preclinical	1996-05-15	Unused	CDKN1A
Breast Neoplasms	ENSG00000126010	FALSE	Preclinical	2008-11-13	Unused	GRPR
Breast Neoplasms	ENSG00000126266	FALSE	Preclinical	2006-08-09	Unused	FFAR1
Breast Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K2
Breast Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	KDR
Breast Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Breast Neoplasms	ENSG00000128602	FALSE	Phase I Clinical Trial	2004-07-21	Phase I Clinical Trial	SMO
Breast Neoplasms	ENSG00000129484	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP2
Breast Neoplasms	ENSG00000130037	FALSE	Preclinical	2015-08-14	Absent	KCNA5
Breast Neoplasms	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK4
Breast Neoplasms	ENSG00000130948	FALSE	Preclinical	2009-05-12	Unused	HSD17B3
Breast Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Phase II Clinical Trial	IDO1
Breast Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase I Clinical Trial	PPT1
Breast Neoplasms	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Breast Neoplasms	ENSG00000131759	FALSE	Preclinical	NA	Unused	RARA
Breast Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	2002-08-05	Unused	LGALS3
Breast Neoplasms	ENSG00000132155	FALSE	Phase III Clinical Trial	1992-11-15	Phase III Clinical Trial	RAF1
Breast Neoplasms	ENSG00000132170	FALSE	Preclinical	2002-01-29	Unused	PPARG
Breast Neoplasms	ENSG00000132383	FALSE	Preclinical	1998-06-15	Phase I Clinical Trial	RPA1
Breast Neoplasms	ENSG00000132906	FALSE	Preclinical	2001-10-17	Unused	CASP9
Breast Neoplasms	ENSG00000132964	FALSE	Phase I Clinical Trial	2010-07-12	Absent	CDK8
Breast Neoplasms	ENSG00000133019	FALSE	Preclinical	2007-02-13	Unused	CHRM3
Breast Neoplasms	ENSG00000133703	FALSE	unknown	1992-11-15	Unused	KRAS
Breast Neoplasms	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-01-15	Unused	CDK7
Breast Neoplasms	ENSG00000134243	FALSE	Preclinical	2016-12-27	Absent	SORT1
Breast Neoplasms	ENSG00000134250	FALSE	Phase I Clinical Trial	2012-09-29	Phase I Clinical Trial	NOTCH2
Breast Neoplasms	ENSG00000134258	FALSE	Preclinical	2007-01-22	Unused	VTCN1
Breast Neoplasms	ENSG00000134323	FALSE	Preclinical	2017-02-07	Absent	MYCN
Breast Neoplasms	ENSG00000134460	FALSE	Approved	2003-08-18	Unused	IL2RA
Breast Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	1996-12-15	Phase II Clinical Trial	PDGFRA
Breast Neoplasms	ENSG00000135218	FALSE	Phase I Clinical Trial	2001-03-14	Unused	CD36
Breast Neoplasms	ENSG00000135387	FALSE	Preclinical	2012-04-16	Preclinical	CAPRIN1
Breast Neoplasms	ENSG00000135404	FALSE	Preclinical	2003-04-15	Unused	CD63
Breast Neoplasms	ENSG00000135446	TRUE	Approved	1996-05-15	Phase III Clinical Trial	CDK4
Breast Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Breast Neoplasms	ENSG00000136235	FALSE	Phase II Clinical Trial	1999-12-10	Phase II Clinical Trial	GPNMB
Breast Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2001-11-07	Unused	IL10
Breast Neoplasms	ENSG00000136807	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CDK9
Breast Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Breast Neoplasms	ENSG00000136869	FALSE	Phase I Clinical Trial	2012-08-06	Absent	TLR4
Breast Neoplasms	ENSG00000136997	FALSE	Preclinical	2000-02-10	Unused	MYC
Breast Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Breast Neoplasms	ENSG00000137193	FALSE	Preclinical	2009-02-13	Preclinical	PIM1
Breast Neoplasms	ENSG00000137845	FALSE	Phase I Clinical Trial	2003-09-17	Unused	ADAM10
Breast Neoplasms	ENSG00000137869	TRUE	Approved	1990-05-15	Approved	CYP19A1
Breast Neoplasms	ENSG00000138039	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	LHCGR
Breast Neoplasms	ENSG00000138061	FALSE	unknown	NA	Unused	CYP1B1
Breast Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Breast Neoplasms	ENSG00000138448	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGAV
Breast Neoplasms	ENSG00000138735	FALSE	unknown	1994-12-15	Unused	PDE5A
Breast Neoplasms	ENSG00000138798	FALSE	Phase I Clinical Trial	2000-01-05	Unused	EGF
Breast Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Breast Neoplasms	ENSG00000139567	FALSE	unknown	2007-05-30	Absent	ACVRL1
Breast Neoplasms	ENSG00000139618	FALSE	Preclinical	1996-02-15	Unused	BRCA2
Breast Neoplasms	ENSG00000140009	TRUE	Approved	2001-12-06	Approved	ESR2
Breast Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	1997-10-15	Phase II Clinical Trial	IGF1R
Breast Neoplasms	ENSG00000140465	FALSE	unknown	1999-04-13	Unused	CYP1A1
Breast Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2010-05-17	Absent	NTRK3
Breast Neoplasms	ENSG00000140545	FALSE	unknown	1997-04-15	Unused	MFGE8
Breast Neoplasms	ENSG00000140937	FALSE	Preclinical	2003-05-16	Unused	CDH11
Breast Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1993-10-15	Unused	TP53
Breast Neoplasms	ENSG00000141736	TRUE	Approved	1990-09-15	Approved	ERBB2
Breast Neoplasms	ENSG00000141741	FALSE	Preclinical	2004-07-19	Unused	MIEN1
Breast Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Absent	BRD4
Breast Neoplasms	ENSG00000142168	FALSE	Phase II Clinical Trial	2002-07-01	Unused	SOD1
Breast Neoplasms	ENSG00000142208	FALSE	Phase III Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Breast Neoplasms	ENSG00000142627	FALSE	Phase II Clinical Trial	2006-09-11	Unused	EPHA2
Breast Neoplasms	ENSG00000142871	FALSE	Preclinical	2016-03-14	Absent	CYR61
Breast Neoplasms	ENSG00000143147	FALSE	Preclinical	2015-03-18	Absent	GPR161
Breast Neoplasms	ENSG00000143171	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRG
Breast Neoplasms	ENSG00000143217	FALSE	Phase I Clinical Trial	2004-10-18	Unused	NECTIN4
Breast Neoplasms	ENSG00000143226	FALSE	Phase II Clinical Trial	2004-07-27	Absent	FCGR2A
Breast Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	1997-01-15	Phase I Clinical Trial	MCL1
Breast Neoplasms	ENSG00000143387	FALSE	Preclinical	2014-10-07	Absent	CTSK
Breast Neoplasms	ENSG00000143537	FALSE	Preclinical	2015-06-24	Absent	ADAM15
Breast Neoplasms	ENSG00000143799	TRUE	Approved	2000-06-26	Phase III Clinical Trial	PARP1
Breast Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	SRD5A1
Breast Neoplasms	ENSG00000145632	FALSE	Preclinical	2009-11-21	Absent	PLK2
Breast Neoplasms	ENSG00000146049	FALSE	Preclinical	2015-02-24	Absent	KAAG1
Breast Neoplasms	ENSG00000146242	FALSE	Phase I Clinical Trial	1999-06-10	Phase II Clinical Trial	TPBG
Breast Neoplasms	ENSG00000146648	TRUE	Approved	1993-02-15	Approved	EGFR
Breast Neoplasms	ENSG00000146674	FALSE	Phase I Clinical Trial	2002-09-16	Unused	IGFBP3
Breast Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	EPHA1
Breast Neoplasms	ENSG00000147155	FALSE	unknown	1993-01-15	Unused	EBP
Breast Neoplasms	ENSG00000147257	FALSE	Phase I Clinical Trial	2014-12-01	Absent	GPC3
Breast Neoplasms	ENSG00000147437	FALSE	Phase I Clinical Trial	1990-08-15	Phase I Clinical Trial	GNRH1
Breast Neoplasms	ENSG00000147955	FALSE	Preclinical	1993-01-15	Unused	SIGMAR1
Breast Neoplasms	ENSG00000148400	FALSE	Phase I Clinical Trial	2009-02-06	Unused	NOTCH1
Breast Neoplasms	ENSG00000148795	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	CYP17A1
Breast Neoplasms	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-02	Unused	PAK1
Breast Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Breast Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	1991-09-15	Phase I Clinical Trial	CHEK1
Breast Neoplasms	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Breast Neoplasms	ENSG00000150337	FALSE	Phase II Clinical Trial	1992-02-15	Unused	FCGR1A
Breast Neoplasms	ENSG00000151012	FALSE	Preclinical	2014-10-01	Absent	SLC7A11
Breast Neoplasms	ENSG00000151617	FALSE	Phase I Clinical Trial	2002-11-12	Phase II Clinical Trial	EDNRA
Breast Neoplasms	ENSG00000151694	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	ADAM17
Breast Neoplasms	ENSG00000153563	FALSE	unknown	2007-07-23	Unused	CD8A
Breast Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Breast Neoplasms	ENSG00000154229	FALSE	Preclinical	1991-01-15	Unused	PRKCA
Breast Neoplasms	ENSG00000155111	FALSE	Phase I Clinical Trial	2017-02-28	Absent	CDK19
Breast Neoplasms	ENSG00000155760	FALSE	Phase I Clinical Trial	2010-06-19	Absent	FZD7
Breast Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase I Clinical Trial	EEF1A1
Breast Neoplasms	ENSG00000156709	FALSE	Phase I Clinical Trial	2005-07-19	Phase II Clinical Trial	AIFM1
Breast Neoplasms	ENSG00000157036	FALSE	unknown	2009-12-08	Unused	EXOG
Breast Neoplasms	ENSG00000157168	FALSE	Preclinical	2002-07-08	Unused	NRG1
Breast Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	KIT
Breast Neoplasms	ENSG00000157764	FALSE	unknown	2001-04-03	Phase II Clinical Trial	BRAF
Breast Neoplasms	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Breast Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1990-07-15	Unused	GART
Breast Neoplasms	ENSG00000160180	FALSE	Preclinical	2012-07-17	Preclinical	TFF3
Breast Neoplasms	ENSG00000160182	FALSE	Preclinical	2012-07-17	Preclinical	TFF1
Breast Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Breast Neoplasms	ENSG00000160712	FALSE	unknown	NA	Phase II Clinical Trial	IL6R
Breast Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR4
Breast Neoplasms	ENSG00000160932	FALSE	Phase I Clinical Trial	2014-03-18	Absent	LY6E
Breast Neoplasms	ENSG00000161011	FALSE	Phase II Clinical Trial	2015-11-04	Absent	SQSTM1
Breast Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Breast Neoplasms	ENSG00000162337	FALSE	Preclinical	2006-11-13	Preclinical	LRP5
Breast Neoplasms	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK1
Breast Neoplasms	ENSG00000162747	FALSE	Phase II Clinical Trial	2004-07-27	Absent	FCGR3B
Breast Neoplasms	ENSG00000162892	FALSE	unknown	1999-07-07	Unused	IL24
Breast Neoplasms	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Breast Neoplasms	ENSG00000163430	FALSE	Preclinical	2015-10-08	Absent	FSTL1
Breast Neoplasms	ENSG00000163464	FALSE	Phase II Clinical Trial	1999-01-15	Absent	CXCR1
Breast Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	1998-09-15	Phase I Clinical Trial	CTLA4
Breast Neoplasms	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Breast Neoplasms	ENSG00000163785	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RYK
Breast Neoplasms	ENSG00000163823	FALSE	Phase I Clinical Trial	2007-06-13	Unused	CCR1
Breast Neoplasms	ENSG00000163932	FALSE	Phase I Clinical Trial	2002-10-14	Unused	PRKCD
Breast Neoplasms	ENSG00000164136	FALSE	Preclinical	2014-01-23	Absent	IL15
Breast Neoplasms	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Unused	CASP3
Breast Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	TLR3
Breast Neoplasms	ENSG00000164362	FALSE	Phase II Clinical Trial	2005-07-22	Phase II Clinical Trial	TERT
Breast Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Breast Neoplasms	ENSG00000164885	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK5
Breast Neoplasms	ENSG00000165025	FALSE	Phase I Clinical Trial	2013-12-06	Absent	SYK
Breast Neoplasms	ENSG00000165125	FALSE	Preclinical	2011-08-04	Preclinical	TRPV6
Breast Neoplasms	ENSG00000165304	FALSE	Phase I Clinical Trial	2010-01-25	Preclinical	MELK
Breast Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	ENOX2
Breast Neoplasms	ENSG00000165731	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	RET
Breast Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Breast Neoplasms	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Breast Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Breast Neoplasms	ENSG00000166598	FALSE	Preclinical	2003-02-17	Unused	HSP90B1
Breast Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Preclinical	ANPEP
Breast Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	1997-12-15	Phase I Clinical Trial	PLK1
Breast Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1997-03-15	Unused	RRM1
Breast Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Phase II Clinical Trial	AXL
Breast Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1993-05-15	Unused	EEF2
Breast Neoplasms	ENSG00000168036	FALSE	Preclinical	2005-09-12	Unused	CTNNB1
Breast Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	1995-04-15	Phase II Clinical Trial	FNTA
Breast Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Unused	STAT3
Breast Neoplasms	ENSG00000168811	FALSE	unknown	1995-09-15	Unused	IL12A
Breast Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K1
Breast Neoplasms	ENSG00000169083	FALSE	Phase III Clinical Trial	2002-08-02	Phase I Clinical Trial	AR
Breast Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Breast Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2002-10-29	Unused	PTK2
Breast Neoplasms	ENSG00000169403	FALSE	unknown	1996-01-15	Unused	PTAFR
Breast Neoplasms	ENSG00000169710	FALSE	Preclinical	2008-06-20	Unused	FASN
Breast Neoplasms	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Breast Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Breast Neoplasms	ENSG00000170145	FALSE	Preclinical	2012-08-17	Preclinical	SIK2
Breast Neoplasms	ENSG00000170312	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK1
Breast Neoplasms	ENSG00000170430	FALSE	unknown	1998-06-15	Unused	MGMT
Breast Neoplasms	ENSG00000170525	FALSE	unknown	2014-01-27	Absent	PFKFB3
Breast Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Breast Neoplasms	ENSG00000170961	FALSE	Preclinical	NA	Unused	HAS2
Breast Neoplasms	ENSG00000170965	FALSE	Preclinical	2007-06-08	Unused	PLAC1
Breast Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2010-05-17	Absent	ALK
Breast Neoplasms	ENSG00000171509	FALSE	Preclinical	2011-10-20	Preclinical	RXFP1
Breast Neoplasms	ENSG00000171552	FALSE	Preclinical	NA	Absent	BCL2L1
Breast Neoplasms	ENSG00000171608	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	PIK3CD
Breast Neoplasms	ENSG00000171791	FALSE	Preclinical	1992-03-15	Unused	BCL2
Breast Neoplasms	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Breast Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Breast Neoplasms	ENSG00000172201	FALSE	Preclinical	2001-01-05	Unused	ID4
Breast Neoplasms	ENSG00000173153	FALSE	Phase II Clinical Trial	2004-02-03	Unused	ESRRA
Breast Neoplasms	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Breast Neoplasms	ENSG00000173546	FALSE	Preclinical	2004-01-13	Unused	CSPG4
Breast Neoplasms	ENSG00000173638	FALSE	Preclinical	1996-12-15	Phase II Clinical Trial	SLC19A1
Breast Neoplasms	ENSG00000174437	FALSE	Preclinical	2016-12-16	Absent	ATP2A2
Breast Neoplasms	ENSG00000174775	FALSE	unknown	NA	Unused	HRAS
Breast Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Unused	CD248
Breast Neoplasms	ENSG00000175054	FALSE	Phase II Clinical Trial	2013-04-30	Absent	ATR
Breast Neoplasms	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE2
Breast Neoplasms	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Breast Neoplasms	ENSG00000176444	FALSE	Preclinical	2017-08-30	Absent	CLK2
Breast Neoplasms	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Breast Neoplasms	ENSG00000177606	TRUE	Approved	2009-05-27	Approved	JUN
Breast Neoplasms	ENSG00000177885	FALSE	Preclinical	NA	Preclinical	GRB2
Breast Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Breast Neoplasms	ENSG00000178568	TRUE	Approved	2002-05-30	Phase III Clinical Trial	ERBB4
Breast Neoplasms	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKB
Breast Neoplasms	ENSG00000180210	FALSE	unknown	2005-05-04	Unused	F2
Breast Neoplasms	ENSG00000180871	FALSE	Phase II Clinical Trial	1999-01-15	Absent	CXCR2
Breast Neoplasms	ENSG00000180914	FALSE	unknown	2005-02-07	Unused	OXTR
Breast Neoplasms	ENSG00000181104	FALSE	Preclinical	2000-09-06	Unused	F2R
Breast Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	CSF1R
Breast Neoplasms	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Breast Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Breast Neoplasms	ENSG00000182944	FALSE	Preclinical	2011-12-03	Absent	EWSR1
Breast Neoplasms	ENSG00000183087	FALSE	Preclinical	2016-02-16	Absent	GAS6
Breast Neoplasms	ENSG00000183735	FALSE	Preclinical	2010-07-30	Preclinical	TBK1
Breast Neoplasms	ENSG00000183765	FALSE	Phase II Clinical Trial	2010-03-02	Absent	CHEK2
Breast Neoplasms	ENSG00000183873	FALSE	Preclinical	2011-06-23	Unused	SCN5A
Breast Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	CTAG1B
Breast Neoplasms	ENSG00000184047	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	DIABLO
Breast Neoplasms	ENSG00000184292	FALSE	Phase III Clinical Trial	2007-03-06	Unused	TACSTD2
Breast Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Phase I Clinical Trial	CSF1
Breast Neoplasms	ENSG00000184584	FALSE	Preclinical	2017-04-18	Absent	TMEM173
Breast Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	1999-06-15	Phase II Clinical Trial	WT1
Breast Neoplasms	ENSG00000185043	FALSE	Preclinical	2017-04-04	Absent	CIB1
Breast Neoplasms	ENSG00000185291	FALSE	unknown	1990-03-15	Unused	IL3RA
Breast Neoplasms	ENSG00000185483	FALSE	Phase I Clinical Trial	2015-01-02	Absent	ROR1
Breast Neoplasms	ENSG00000185499	FALSE	Phase III Clinical Trial	1994-08-15	Phase II Clinical Trial	MUC1
Breast Neoplasms	ENSG00000185591	FALSE	Preclinical	2011-12-03	Absent	SP1
Breast Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Absent	PRAME
Breast Neoplasms	ENSG00000185896	FALSE	Phase I Clinical Trial	2015-10-19	Absent	LAMP1
Breast Neoplasms	ENSG00000186088	FALSE	Phase II Clinical Trial	2007-01-08	Absent	GSAP
Breast Neoplasms	ENSG00000186350	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRA
Breast Neoplasms	ENSG00000186642	FALSE	unknown	1994-12-15	Unused	PDE2A
Breast Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Breast Neoplasms	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Breast Neoplasms	ENSG00000187514	FALSE	Approved	2014-01-22	Absent	PTMA
Breast Neoplasms	ENSG00000187554	FALSE	Phase I Clinical Trial	2006-08-01	Absent	TLR5
Breast Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Breast Neoplasms	ENSG00000188641	FALSE	Approved	1993-07-15	Phase II Clinical Trial	DPYD
Breast Neoplasms	ENSG00000196083	FALSE	Phase II Clinical Trial	NA	Absent	IL1RAP
Breast Neoplasms	ENSG00000196352	FALSE	Phase I Clinical Trial	2004-07-19	Phase I Clinical Trial	CD55
Breast Neoplasms	ENSG00000196396	FALSE	Preclinical	2000-04-18	Absent	PTPN1
Breast Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	EPHB4
Breast Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Breast Neoplasms	ENSG00000196664	FALSE	Preclinical	2016-12-27	Unused	TLR7
Breast Neoplasms	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Breast Neoplasms	ENSG00000197081	FALSE	Phase II Clinical Trial	2009-01-13	Phase II Clinical Trial	IGF2R
Breast Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	SRC
Breast Neoplasms	ENSG00000197408	FALSE	unknown	NA	Phase II Clinical Trial	CYP2B6
Breast Neoplasms	ENSG00000197992	FALSE	Preclinical	2013-07-05	Absent	CLEC9A
Breast Neoplasms	ENSG00000198223	FALSE	Phase II Clinical Trial	2011-09-23	Preclinical	CSF2RA
Breast Neoplasms	ENSG00000198363	FALSE	Preclinical	2007-12-07	Absent	ASPH
Breast Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Absent	NTRK1
Breast Neoplasms	ENSG00000198625	FALSE	Preclinical	2014-05-08	Absent	MDM4
Breast Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Approved	MTOR
Breast Neoplasms	ENSG00000198805	FALSE	Preclinical	1997-04-15	Unused	PNP
Breast Neoplasms	ENSG00000198851	FALSE	Phase II Clinical Trial	2004-07-27	Absent	CD3E
Breast Neoplasms	ENSG00000198900	TRUE	Approved	1993-07-15	Approved	TOP1
Breast Neoplasms	ENSG00000203747	FALSE	Phase II Clinical Trial	2004-07-27	Absent	FCGR3A
Breast Neoplasms	ENSG00000203859	TRUE	Approved	NA	Approved	HSD3B2
Breast Neoplasms	ENSG00000213694	FALSE	Preclinical	2011-03-15	Preclinical	S1PR3
Breast Neoplasms	ENSG00000221867	FALSE	unknown	NA	Unused	MAGEA3
Breast Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Phase II Clinical Trial	DHFR
Breast Neoplasms	ENSG00000239732	FALSE	unknown	1998-10-15	Unused	TLR9
Breast Neoplasms	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Breast Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Breast Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Breast Neoplasms	ENSG00000258947	FALSE	Preclinical	2016-01-27	Absent	TUBB3
Breast Neoplasms	ENSG00000259207	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGB3
Breast Neoplasms	ENSG00000263528	FALSE	Preclinical	2010-07-30	Preclinical	IKBKE
Breast Neoplasms	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Breast Neoplasms	ENSG00000276045	FALSE	Preclinical	2014-10-02	Absent	ORAI1
Bronchiectasis	ENSG00000100985	FALSE	Preclinical	1995-01-15	Preclinical	MMP9
Bronchiectasis	ENSG00000109861	FALSE	Phase I Clinical Trial	2014-02-11	Absent	CTSC
Bronchiectasis	ENSG00000111319	FALSE	Preclinical	2007-08-18	Unused	SCNN1A
Bronchiectasis	ENSG00000148180	FALSE	Preclinical	NA	Absent	GSN
Bronchiectasis	ENSG00000171608	FALSE	Phase I Clinical Trial	2011-09-02	Absent	PIK3CD
Bronchiectasis	ENSG00000180871	FALSE	Phase II Clinical Trial	2006-02-08	Absent	CXCR2
Bronchiectasis	ENSG00000196611	FALSE	Preclinical	1995-01-15	Preclinical	MMP1
Bronchiectasis	ENSG00000197249	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	SERPINA1
Bronchiectasis	ENSG00000197561	FALSE	Phase II Clinical Trial	2006-02-08	Unused	ELANE
Bronchiectasis	ENSG00000198223	FALSE	unknown	NA	Absent	CSF2RA
Bronchiectasis	ENSG00000205542	FALSE	Preclinical	1995-01-15	Preclinical	TMSB4X
Bronchiolitis Obliterans	ENSG00000106804	FALSE	Phase I Clinical Trial	2017-04-12	Absent	C5
Bronchiolitis Obliterans	ENSG00000109320	FALSE	Preclinical	2001-03-14	Unused	NFKB1
Bronchiolitis Obliterans	ENSG00000113580	FALSE	unknown	2014-09-19	Absent	NR3C1
Bronchiolitis Obliterans	ENSG00000134460	FALSE	Preclinical	2001-03-14	Unused	IL2RA
Bronchiolitis Obliterans	ENSG00000149021	FALSE	Preclinical	2009-07-17	Absent	SCGB1A1
Bronchiolitis Obliterans	ENSG00000163235	FALSE	unknown	NA	Phase I Clinical Trial	TGFA
Bronchiolitis Obliterans	ENSG00000169429	FALSE	unknown	NA	Phase I Clinical Trial	CXCL8
Bronchiolitis Obliterans	ENSG00000196262	FALSE	Phase I Clinical Trial	NA	Phase III Clinical Trial	PPIA
Bronchiolitis Obliterans	ENSG00000197919	FALSE	Phase II Clinical Trial	2017-06-01	Absent	IFNA1
Bronchiolitis Obliterans	ENSG00000213903	FALSE	Phase I Clinical Trial	2017-04-12	Absent	LTB4R
Bronchitis, Chronic	ENSG00000043591	FALSE	Preclinical	2004-07-26	Preclinical	ADRB1
Bronchitis, Chronic	ENSG00000065989	FALSE	unknown	1992-06-15	Unused	PDE4A
Bronchitis, Chronic	ENSG00000073756	FALSE	Preclinical	1998-05-15	Unused	PTGS2
Bronchitis, Chronic	ENSG00000075073	FALSE	Preclinical	1995-02-15	Unused	TACR2
Bronchitis, Chronic	ENSG00000095303	FALSE	Preclinical	1998-05-15	Unused	PTGS1
Bronchitis, Chronic	ENSG00000100985	FALSE	unknown	1995-01-15	Unused	MMP9
Bronchitis, Chronic	ENSG00000105650	FALSE	unknown	1992-06-15	Unused	PDE4C
Bronchitis, Chronic	ENSG00000109320	FALSE	unknown	1998-03-15	Unused	NFKB1
Bronchitis, Chronic	ENSG00000113448	FALSE	unknown	1992-06-15	Unused	PDE4D
Bronchitis, Chronic	ENSG00000113580	FALSE	Phase III Clinical Trial	2002-03-25	Unused	NR3C1
Bronchitis, Chronic	ENSG00000115353	FALSE	Phase II Clinical Trial	1993-01-15	Unused	TACR1
Bronchitis, Chronic	ENSG00000128271	TRUE	Approved	NA	Approved	ADORA2A
Bronchitis, Chronic	ENSG00000133019	TRUE	Approved	2000-03-08	Approved	CHRM3
Bronchitis, Chronic	ENSG00000163485	TRUE	Approved	1992-08-15	Approved	ADORA1
Bronchitis, Chronic	ENSG00000169252	TRUE	Approved	1994-08-15	Approved	ADRB2
Bronchitis, Chronic	ENSG00000169403	FALSE	unknown	1990-04-15	Unused	PTAFR
Bronchitis, Chronic	ENSG00000169429	FALSE	Preclinical	1995-02-15	Unused	CXCL8
Bronchitis, Chronic	ENSG00000173198	FALSE	Preclinical	1995-11-15	Unused	CYSLTR1
Bronchitis, Chronic	ENSG00000175591	FALSE	Phase II Clinical Trial	NA	Unused	P2RY2
Bronchitis, Chronic	ENSG00000184588	FALSE	unknown	1992-06-15	Unused	PDE4B
Bronchitis, Chronic	ENSG00000196611	FALSE	unknown	1995-01-15	Unused	MMP1
Bronchitis, Chronic	ENSG00000197561	FALSE	Preclinical	1994-06-15	Unused	ELANE
Bronchitis, Chronic	ENSG00000205542	FALSE	unknown	1995-01-15	Unused	TMSB4X
Bronchopulmonary Dysplasia	ENSG00000072571	FALSE	Preclinical	2014-10-14	Absent	HMMR
Bronchopulmonary Dysplasia	ENSG00000140443	FALSE	Phase II Clinical Trial	NA	Absent	IGF1R
Bronchopulmonary Dysplasia	ENSG00000142168	FALSE	Phase III Clinical Trial	NA	Unused	SOD1
Bronchopulmonary Dysplasia	ENSG00000149021	FALSE	Phase II Clinical Trial	2011-02-22	Phase II Clinical Trial	SCGB1A1
Bronchopulmonary Dysplasia	ENSG00000163464	FALSE	Preclinical	2015-07-02	Absent	CXCR1
Bronchopulmonary Dysplasia	ENSG00000180871	FALSE	Preclinical	2015-07-02	Absent	CXCR2
Bronchopulmonary Dysplasia	ENSG00000197249	FALSE	unknown	1999-05-11	Absent	SERPINA1
Bronchopulmonary Dysplasia	ENSG00000197561	FALSE	unknown	NA	Absent	ELANE
Brucellosis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Bulimia	ENSG00000082556	FALSE	Phase II Clinical Trial	2009-12-04	Preclinical	OPRK1
Bulimia	ENSG00000108576	TRUE	Approved	2001-10-16	Approved	SLC6A4
Bulimia	ENSG00000112038	FALSE	Phase II Clinical Trial	2009-12-04	Preclinical	OPRM1
Bulimia	ENSG00000118432	FALSE	unknown	1995-10-15	Unused	CNR1
Bulimia	ENSG00000120088	FALSE	Preclinical	1996-09-15	Unused	CRHR1
Bulimia	ENSG00000147246	FALSE	unknown	2001-10-16	Unused	HTR2C
Bulimia	ENSG00000164128	FALSE	Preclinical	1996-06-15	Unused	NPY1R
Bulimia	ENSG00000164270	FALSE	unknown	1996-01-15	Unused	HTR4
Bulimia	ENSG00000166736	FALSE	unknown	1996-01-15	Unused	HTR3A
Bulimia	ENSG00000188822	FALSE	unknown	1995-10-15	Unused	CNR2
Burkholderia Infections	ENSG00000115353	FALSE	Preclinical	2003-08-19	Preclinical	TACR1
Burkholderia Infections	ENSG00000115590	FALSE	Preclinical	2016-11-17	Absent	IL1R2
Burkholderia Infections	ENSG00000187554	FALSE	Preclinical	2009-01-22	Unused	TLR5
Burns	ENSG00000017427	FALSE	Phase II Clinical Trial	2011-10-05	Absent	IGF1
Burns	ENSG00000072571	FALSE	Preclinical	1998-07-15	Unused	HMMR
Burns	ENSG00000073756	FALSE	unknown	2000-03-29	Absent	PTGS2
Burns	ENSG00000077782	FALSE	Approved	2007-03-06	Unused	FGFR1
Burns	ENSG00000090339	FALSE	Preclinical	2002-04-23	Unused	ICAM1
Burns	ENSG00000095303	FALSE	unknown	2000-03-29	Absent	PTGS1
Burns	ENSG00000101425	FALSE	unknown	1989-12-15	Unused	BPI
Burns	ENSG00000105329	FALSE	Preclinical	NA	Unused	TGFB1
Burns	ENSG00000112964	FALSE	Approved	NA	Absent	GHR
Burns	ENSG00000113721	FALSE	Phase II Clinical Trial	2008-02-06	Phase II Clinical Trial	PDGFRB
Burns	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Burns	ENSG00000115718	FALSE	Phase I Clinical Trial	2008-09-30	Unused	PROC
Burns	ENSG00000122884	FALSE	Preclinical	2001-02-06	Unused	P4HA1
Burns	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Burns	ENSG00000134853	FALSE	Phase II Clinical Trial	2008-02-06	Phase II Clinical Trial	PDGFRA
Burns	ENSG00000140443	FALSE	unknown	NA	Unused	IGF1R
Burns	ENSG00000146648	FALSE	Approved	2002-05-09	Unused	EGFR
Burns	ENSG00000168398	FALSE	Phase I Clinical Trial	1989-08-15	Unused	BDKRB2
Burns	ENSG00000169083	FALSE	unknown	1996-11-15	Unused	AR
Burns	ENSG00000173083	FALSE	Preclinical	1990-06-15	Unused	HPSE
Burns	ENSG00000176884	FALSE	Preclinical	2002-05-03	Preclinical	GRIN1
Burns	ENSG00000198223	FALSE	unknown	NA	Absent	CSF2RA
Bursitis	ENSG00000006638	TRUE	Approved	NA	Approved	TBXA2R
Bursitis	ENSG00000073756	TRUE	Approved	1996-12-15	Approved	PTGS2
Bursitis	ENSG00000095303	TRUE	Approved	1996-12-15	Approved	PTGS1
Bursitis	ENSG00000112038	TRUE	Approved	NA	Approved	OPRM1
Bursitis	ENSG00000169432	FALSE	Phase III Clinical Trial	2010-08-13	Phase III Clinical Trial	SCN9A
Bursitis	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Cachexia	ENSG00000043591	FALSE	Preclinical	2007-01-23	Phase II Clinical Trial	ADRB1
Cachexia	ENSG00000069696	FALSE	Preclinical	2007-06-04	Unused	DRD4
Cachexia	ENSG00000073756	FALSE	unknown	2007-01-23	Unused	PTGS2
Cachexia	ENSG00000082175	TRUE	Approved	2007-07-05	Approved	PGR
Cachexia	ENSG00000102468	FALSE	Preclinical	2007-06-04	Unused	HTR2A
Cachexia	ENSG00000105639	FALSE	Preclinical	2015-07-01	Absent	JAK3
Cachexia	ENSG00000106128	TRUE	Approved	1996-05-15	Phase II Clinical Trial	GHRHR
Cachexia	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Cachexia	ENSG00000111424	FALSE	Phase I Clinical Trial	2013-03-20	Absent	VDR
Cachexia	ENSG00000111537	FALSE	Preclinical	1997-04-15	Unused	IFNG
Cachexia	ENSG00000112033	FALSE	Phase I Clinical Trial	2006-06-10	Absent	PPARD
Cachexia	ENSG00000112964	TRUE	Approved	1998-06-15	Approved	GHR
Cachexia	ENSG00000114739	FALSE	Phase II Clinical Trial	2010-07-02	Preclinical	ACVR2B
Cachexia	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Cachexia	ENSG00000116678	FALSE	Preclinical	2000-10-02	Unused	LEPR
Cachexia	ENSG00000118432	TRUE	Approved	2002-06-14	Approved	CNR1
Cachexia	ENSG00000118702	FALSE	Preclinical	2007-08-18	Unused	GHRH
Cachexia	ENSG00000121853	FALSE	Pre-registration	1998-10-15	Phase III Clinical Trial	GHSR
Cachexia	ENSG00000121966	FALSE	Phase I Clinical Trial	1995-12-15	Phase II Clinical Trial	CXCR4
Cachexia	ENSG00000121989	FALSE	Preclinical	2015-09-17	Phase II Clinical Trial	ACVR2A
Cachexia	ENSG00000130368	FALSE	Preclinical	2016-02-10	Absent	MAS1
Cachexia	ENSG00000130513	FALSE	Preclinical	2013-11-09	Absent	GDF15
Cachexia	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Cachexia	ENSG00000138379	FALSE	Phase II Clinical Trial	1997-04-15	Phase I Clinical Trial	MSTN
Cachexia	ENSG00000140564	FALSE	Preclinical	2015-02-06	Absent	FURIN
Cachexia	ENSG00000143839	FALSE	Preclinical	2000-10-04	Unused	REN
Cachexia	ENSG00000147246	FALSE	Preclinical	2007-06-04	Unused	HTR2C
Cachexia	ENSG00000147955	FALSE	unknown	1995-12-15	Unused	SIGMAR1
Cachexia	ENSG00000148053	FALSE	Phase I Clinical Trial	2010-12-20	Absent	NTRK2
Cachexia	ENSG00000149295	FALSE	Preclinical	2007-06-04	Unused	DRD2
Cachexia	ENSG00000157017	FALSE	Preclinical	2015-09-25	Absent	GHRL
Cachexia	ENSG00000158022	FALSE	Preclinical	2012-08-08	Preclinical	TRIM63
Cachexia	ENSG00000158748	FALSE	Preclinical	2007-06-04	Unused	HTR6
Cachexia	ENSG00000159640	FALSE	Phase III Clinical Trial	2002-05-22	Unused	ACE
Cachexia	ENSG00000160712	FALSE	Preclinical	2005-09-12	Preclinical	IL6R
Cachexia	ENSG00000160791	FALSE	Phase I Clinical Trial	1995-12-15	Phase II Clinical Trial	CCR5
Cachexia	ENSG00000166603	FALSE	Preclinical	1997-03-15	Unused	MC4R
Cachexia	ENSG00000166736	FALSE	Preclinical	2007-06-04	Unused	HTR3A
Cachexia	ENSG00000168539	FALSE	Preclinical	2007-06-04	Unused	CHRM1
Cachexia	ENSG00000168610	FALSE	unknown	2015-02-13	Absent	STAT3
Cachexia	ENSG00000169083	TRUE	Approved	1995-10-15	Approved	AR
Cachexia	ENSG00000169252	FALSE	Phase II Clinical Trial	2007-01-23	Phase II Clinical Trial	ADRB2
Cachexia	ENSG00000172046	FALSE	Preclinical	2012-08-08	Preclinical	USP19
Cachexia	ENSG00000184845	FALSE	Preclinical	2007-06-04	Unused	DRD1
Cachexia	ENSG00000187871	FALSE	Preclinical	2016-11-22	Absent	GFRAL
Cachexia	ENSG00000188822	FALSE	Phase I Clinical Trial	2006-02-07	Absent	CNR2
Cachexia	ENSG00000196218	FALSE	Preclinical	2008-07-04	Absent	RYR1
Caliciviridae Infections	ENSG00000107201	FALSE	unknown	2008-07-29	Absent	DDX58
Caliciviridae Infections	ENSG00000167207	FALSE	unknown	2008-07-29	Absent	NOD2
Candidiasis	ENSG00000012223	FALSE	unknown	1996-06-15	Unused	LTF
Candidiasis	ENSG00000113580	FALSE	Phase II Clinical Trial	2008-03-31	Unused	NR3C1
Candidiasis	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Candidiasis	ENSG00000172236	FALSE	unknown	1996-06-15	Unused	TPSAB1
Candidiasis	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Candidiasis	ENSG00000187514	FALSE	Preclinical	NA	Unused	PTMA
Candidiasis	ENSG00000203710	FALSE	Preclinical	2005-11-04	Unused	CR1
Candidiasis	ENSG00000205649	FALSE	Phase II Clinical Trial	1998-03-15	Unused	HTN3
Candidiasis	ENSG00000228716	FALSE	Preclinical	NA	Unused	DHFR
Candidiasis	ENSG00000258839	FALSE	Phase II Clinical Trial	2002-11-21	Unused	MC1R
Capillary Leak Syndrome	ENSG00000149131	FALSE	Preclinical	NA	Preclinical	SERPING1
Capillary Leak Syndrome	ENSG00000168398	FALSE	unknown	1989-08-15	Unused	BDKRB2
Capillary Leak Syndrome	ENSG00000196396	FALSE	Preclinical	2009-06-04	Preclinical	PTPN1
Carbamoyl-Phosphate Synthase I Deficiency Disease	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Carbohydrate Metabolism, Inborn Errors	ENSG00000090402	TRUE	Approved	NA	Approved	SI
Carcinoid Tumor	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Carcinoid Tumor	ENSG00000037280	FALSE	unknown	2001-04-03	Unused	FLT4
Carcinoid Tumor	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Carcinoid Tumor	ENSG00000068078	FALSE	unknown	2001-04-03	Absent	FGFR3
Carcinoid Tumor	ENSG00000077782	FALSE	Phase I Clinical Trial	2001-04-03	Absent	FGFR1
Carcinoid Tumor	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Carcinoid Tumor	ENSG00000100644	FALSE	unknown	1997-04-15	Unused	HIF1A
Carcinoid Tumor	ENSG00000102755	FALSE	unknown	2001-04-03	Unused	FLT1
Carcinoid Tumor	ENSG00000105976	FALSE	Phase I Clinical Trial	2004-06-18	Phase I Clinical Trial	MET
Carcinoid Tumor	ENSG00000110148	FALSE	Phase II Clinical Trial	NA	Absent	CCKBR
Carcinoid Tumor	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase III Clinical Trial	VEGFA
Carcinoid Tumor	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Carcinoid Tumor	ENSG00000113721	FALSE	unknown	2001-04-03	Unused	PDGFRB
Carcinoid Tumor	ENSG00000115053	FALSE	unknown	2004-03-31	Unused	NCL
Carcinoid Tumor	ENSG00000120156	FALSE	Phase I Clinical Trial	2004-06-18	Phase I Clinical Trial	TEK
Carcinoid Tumor	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Carcinoid Tumor	ENSG00000122025	FALSE	Phase I Clinical Trial	2004-06-18	Phase I Clinical Trial	FLT3
Carcinoid Tumor	ENSG00000126934	FALSE	Phase I Clinical Trial	2007-01-30	Absent	MAP2K2
Carcinoid Tumor	ENSG00000128052	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	KDR
Carcinoid Tumor	ENSG00000131747	TRUE	Approved	NA	Unused	TOP2A
Carcinoid Tumor	ENSG00000132155	FALSE	unknown	2006-01-11	Phase I Clinical Trial	RAF1
Carcinoid Tumor	ENSG00000134853	FALSE	unknown	2001-04-03	Unused	PDGFRA
Carcinoid Tumor	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Carcinoid Tumor	ENSG00000139874	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR1
Carcinoid Tumor	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Carcinoid Tumor	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Carcinoid Tumor	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Carcinoid Tumor	ENSG00000157404	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	KIT
Carcinoid Tumor	ENSG00000157764	FALSE	unknown	2001-04-03	Phase I Clinical Trial	BRAF
Carcinoid Tumor	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Carcinoid Tumor	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Carcinoid Tumor	ENSG00000162009	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR5
Carcinoid Tumor	ENSG00000164305	FALSE	unknown	1997-04-15	Unused	CASP3
Carcinoid Tumor	ENSG00000165731	FALSE	unknown	2004-08-09	Phase I Clinical Trial	RET
Carcinoid Tumor	ENSG00000166851	FALSE	Phase I Clinical Trial	2008-04-11	Absent	PLK1
Carcinoid Tumor	ENSG00000167601	FALSE	Phase I Clinical Trial	2004-06-18	Unused	AXL
Carcinoid Tumor	ENSG00000169032	FALSE	Phase I Clinical Trial	2007-01-30	Absent	MAP2K1
Carcinoid Tumor	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Carcinoid Tumor	ENSG00000180616	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR2
Carcinoid Tumor	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Carcinoid Tumor	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Phase III Clinical Trial	MTOR
Carcinoid Tumor	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Carcinoid Tumor	ENSG00000278195	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR3
Carcinoma, Merkel Cell	ENSG00000004487	FALSE	Preclinical	2008-07-31	Absent	KDM1A
Carcinoma, Merkel Cell	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-05-29	Absent	TNC
Carcinoma, Merkel Cell	ENSG00000049249	FALSE	Phase I Clinical Trial	2011-01-31	Absent	TNFRSF9
Carcinoma, Merkel Cell	ENSG00000081985	FALSE	Phase II Clinical Trial	2011-06-06	Phase II Clinical Trial	IL12RB2
Carcinoma, Merkel Cell	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Carcinoma, Merkel Cell	ENSG00000096996	FALSE	Phase II Clinical Trial	2011-06-06	Phase II Clinical Trial	IL12RB1
Carcinoma, Merkel Cell	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Carcinoma, Merkel Cell	ENSG00000116478	FALSE	Preclinical	2008-07-31	Absent	HDAC1
Carcinoma, Merkel Cell	ENSG00000120217	TRUE	Approved	2013-01-23	Absent	CD274
Carcinoma, Merkel Cell	ENSG00000134460	FALSE	Phase II Clinical Trial	2007-05-29	Absent	IL2RA
Carcinoma, Merkel Cell	ENSG00000136869	FALSE	Phase I Clinical Trial	2014-02-19	Absent	TLR4
Carcinoma, Merkel Cell	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Carcinoma, Merkel Cell	ENSG00000139874	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR1
Carcinoma, Merkel Cell	ENSG00000147099	FALSE	Preclinical	2008-07-31	Absent	HDAC8
Carcinoma, Merkel Cell	ENSG00000149294	FALSE	Phase I Clinical Trial	NA	Phase II Clinical Trial	NCAM1
Carcinoma, Merkel Cell	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Carcinoma, Merkel Cell	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Carcinoma, Merkel Cell	ENSG00000162009	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR5
Carcinoma, Merkel Cell	ENSG00000171720	FALSE	Preclinical	2008-07-31	Absent	HDAC3
Carcinoma, Merkel Cell	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Preclinical	SSTR2
Carcinoma, Merkel Cell	ENSG00000188389	FALSE	Phase I Clinical Trial	2011-02-17	Absent	PDCD1
Carcinoma, Merkel Cell	ENSG00000196591	FALSE	Preclinical	2008-07-31	Absent	HDAC2
Carcinoma, Merkel Cell	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Carcinoma, Merkel Cell	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Carcinoma, Merkel Cell	ENSG00000278195	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR3
Carcinoma, Neuroendocrine	ENSG00000026103	FALSE	Phase I Clinical Trial	2002-06-26	Phase I Clinical Trial	FAS
Carcinoma, Neuroendocrine	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase I Clinical Trial	FLT4
Carcinoma, Neuroendocrine	ENSG00000044574	FALSE	Phase I Clinical Trial	2009-07-23	Phase I Clinical Trial	HSPA5
Carcinoma, Neuroendocrine	ENSG00000047936	FALSE	Phase I Clinical Trial	2014-11-03	Absent	ROS1
Carcinoma, Neuroendocrine	ENSG00000051180	FALSE	unknown	2004-10-05	Unused	RAD51
Carcinoma, Neuroendocrine	ENSG00000067182	FALSE	Phase I Clinical Trial	2002-06-26	Phase I Clinical Trial	TNFRSF1A
Carcinoma, Neuroendocrine	ENSG00000077782	FALSE	Phase III Clinical Trial	2007-08-14	Absent	FGFR1
Carcinoma, Neuroendocrine	ENSG00000080824	FALSE	Phase I Clinical Trial	2005-02-11	Absent	HSP90AA1
Carcinoma, Neuroendocrine	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Carcinoma, Neuroendocrine	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Carcinoma, Neuroendocrine	ENSG00000091879	FALSE	unknown	2010-10-29	Absent	ANGPT2
Carcinoma, Neuroendocrine	ENSG00000100311	FALSE	unknown	1994-06-15	Unused	PDGFB
Carcinoma, Neuroendocrine	ENSG00000102755	FALSE	Phase III Clinical Trial	2002-03-21	Phase I Clinical Trial	FLT1
Carcinoma, Neuroendocrine	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Carcinoma, Neuroendocrine	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Carcinoma, Neuroendocrine	ENSG00000106128	FALSE	Phase I Clinical Trial	2015-07-27	Absent	GHRHR
Carcinoma, Neuroendocrine	ENSG00000108443	FALSE	Phase I Clinical Trial	2009-04-27	Unused	RPS6KB1
Carcinoma, Neuroendocrine	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Carcinoma, Neuroendocrine	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Carcinoma, Neuroendocrine	ENSG00000115008	FALSE	unknown	2009-12-07	Phase II Clinical Trial	IL1A
Carcinoma, Neuroendocrine	ENSG00000121879	FALSE	Phase II Clinical Trial	2008-11-12	Absent	PIK3CA
Carcinoma, Neuroendocrine	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase I Clinical Trial	FLT3
Carcinoma, Neuroendocrine	ENSG00000123374	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK2
Carcinoma, Neuroendocrine	ENSG00000126934	FALSE	Phase I Clinical Trial	2007-01-30	Absent	MAP2K2
Carcinoma, Neuroendocrine	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase I Clinical Trial	KDR
Carcinoma, Neuroendocrine	ENSG00000129484	FALSE	Phase II Clinical Trial	2006-08-16	Absent	PARP2
Carcinoma, Neuroendocrine	ENSG00000132155	FALSE	unknown	1994-06-15	Unused	RAF1
Carcinoma, Neuroendocrine	ENSG00000132671	FALSE	Preclinical	1998-09-15	Preclinical	SSTR4
Carcinoma, Neuroendocrine	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Carcinoma, Neuroendocrine	ENSG00000134853	FALSE	unknown	2002-03-21	Phase I Clinical Trial	PDGFRA
Carcinoma, Neuroendocrine	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK9
Carcinoma, Neuroendocrine	ENSG00000139874	FALSE	Phase II Clinical Trial	2010-07-30	Phase II Clinical Trial	SSTR1
Carcinoma, Neuroendocrine	ENSG00000140538	FALSE	Phase I Clinical Trial	2014-11-03	Absent	NTRK3
Carcinoma, Neuroendocrine	ENSG00000143799	FALSE	Phase II Clinical Trial	2006-08-16	Absent	PARP1
Carcinoma, Neuroendocrine	ENSG00000146648	FALSE	Phase I Clinical Trial	2005-01-28	Phase I Clinical Trial	EGFR
Carcinoma, Neuroendocrine	ENSG00000148053	FALSE	Phase I Clinical Trial	2014-11-03	Absent	NTRK2
Carcinoma, Neuroendocrine	ENSG00000149294	FALSE	unknown	NA	Phase I Clinical Trial	NCAM1
Carcinoma, Neuroendocrine	ENSG00000157404	FALSE	Phase II Clinical Trial	2002-03-21	Phase I Clinical Trial	KIT
Carcinoma, Neuroendocrine	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Carcinoma, Neuroendocrine	ENSG00000162009	FALSE	Phase II Clinical Trial	1998-09-15	Phase II Clinical Trial	SSTR5
Carcinoma, Neuroendocrine	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Carcinoma, Neuroendocrine	ENSG00000165731	FALSE	unknown	1994-06-15	Phase I Clinical Trial	RET
Carcinoma, Neuroendocrine	ENSG00000169032	FALSE	Phase I Clinical Trial	2007-01-30	Absent	MAP2K1
Carcinoma, Neuroendocrine	ENSG00000169398	FALSE	unknown	2007-01-08	Unused	PTK2
Carcinoma, Neuroendocrine	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Carcinoma, Neuroendocrine	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Carcinoma, Neuroendocrine	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Carcinoma, Neuroendocrine	ENSG00000179776	FALSE	unknown	2000-12-11	Absent	CDH5
Carcinoma, Neuroendocrine	ENSG00000180176	TRUE	Approved	NA	Absent	TH
Carcinoma, Neuroendocrine	ENSG00000180616	FALSE	Phase II Clinical Trial	1998-09-15	Phase II Clinical Trial	SSTR2
Carcinoma, Neuroendocrine	ENSG00000182578	FALSE	Phase III Clinical Trial	2007-08-14	Absent	CSF1R
Carcinoma, Neuroendocrine	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Carcinoma, Neuroendocrine	ENSG00000188389	FALSE	Phase II Clinical Trial	2011-02-17	Absent	PDCD1
Carcinoma, Neuroendocrine	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Carcinoma, Neuroendocrine	ENSG00000198400	FALSE	Phase I Clinical Trial	2014-11-03	Absent	NTRK1
Carcinoma, Neuroendocrine	ENSG00000198668	FALSE	unknown	2003-12-09	Absent	CALM1
Carcinoma, Neuroendocrine	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Unused	MTOR
Carcinoma, Neuroendocrine	ENSG00000198900	FALSE	Preclinical	2016-05-02	Absent	TOP1
Carcinoma, Neuroendocrine	ENSG00000278195	FALSE	Phase II Clinical Trial	2010-07-30	Phase II Clinical Trial	SSTR3
Carcinoma, Non-Small-Cell Lung	ENSG00000003402	FALSE	Phase II Clinical Trial	2016-10-25	Absent	CFLAR
Carcinoma, Non-Small-Cell Lung	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Carcinoma, Non-Small-Cell Lung	ENSG00000006638	FALSE	Preclinical	NA	Unused	TBXA2R
Carcinoma, Non-Small-Cell Lung	ENSG00000010610	FALSE	Phase II Clinical Trial	2015-12-02	Absent	CD4
Carcinoma, Non-Small-Cell Lung	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Carcinoma, Non-Small-Cell Lung	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Carcinoma, Non-Small-Cell Lung	ENSG00000012223	FALSE	unknown	1994-08-15	Phase III Clinical Trial	LTF
Carcinoma, Non-Small-Cell Lung	ENSG00000012779	FALSE	unknown	1993-10-15	Unused	ALOX5
Carcinoma, Non-Small-Cell Lung	ENSG00000019991	FALSE	Phase II Clinical Trial	2006-04-28	Absent	HGF
Carcinoma, Non-Small-Cell Lung	ENSG00000023445	FALSE	Phase I Clinical Trial	2005-11-21	Absent	BIRC3
Carcinoma, Non-Small-Cell Lung	ENSG00000025434	FALSE	Phase I Clinical Trial	2014-11-13	Absent	NR1H3
Carcinoma, Non-Small-Cell Lung	ENSG00000026103	FALSE	Phase I Clinical Trial	2002-06-26	Phase I Clinical Trial	FAS
Carcinoma, Non-Small-Cell Lung	ENSG00000026508	FALSE	Phase I Clinical Trial	1992-11-15	Absent	CD44
Carcinoma, Non-Small-Cell Lung	ENSG00000037280	TRUE	Approved	1994-06-15	Phase III Clinical Trial	FLT4
Carcinoma, Non-Small-Cell Lung	ENSG00000041982	FALSE	Phase I Clinical Trial	2007-05-29	Phase II Clinical Trial	TNC
Carcinoma, Non-Small-Cell Lung	ENSG00000044574	FALSE	Phase I Clinical Trial	2009-07-23	Phase I Clinical Trial	HSPA5
Carcinoma, Non-Small-Cell Lung	ENSG00000047936	TRUE	Approved	2006-12-05	Absent	ROS1
Carcinoma, Non-Small-Cell Lung	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Unused	TNFRSF9
Carcinoma, Non-Small-Cell Lung	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Carcinoma, Non-Small-Cell Lung	ENSG00000051382	FALSE	Phase II Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CB
Carcinoma, Non-Small-Cell Lung	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Carcinoma, Non-Small-Cell Lung	ENSG00000058085	FALSE	Preclinical	2009-02-12	Unused	LAMC2
Carcinoma, Non-Small-Cell Lung	ENSG00000062038	FALSE	Phase I Clinical Trial	2012-11-23	Absent	CDH3
Carcinoma, Non-Small-Cell Lung	ENSG00000065361	FALSE	Phase II Clinical Trial	1994-09-15	Phase II Clinical Trial	ERBB3
Carcinoma, Non-Small-Cell Lung	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Carcinoma, Non-Small-Cell Lung	ENSG00000067182	FALSE	Phase I Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Carcinoma, Non-Small-Cell Lung	ENSG00000068024	FALSE	Phase II Clinical Trial	2002-06-10	Absent	HDAC4
Carcinoma, Non-Small-Cell Lung	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase I Clinical Trial	FGFR3
Carcinoma, Non-Small-Cell Lung	ENSG00000070501	FALSE	Phase I Clinical Trial	1996-08-15	Unused	POLB
Carcinoma, Non-Small-Cell Lung	ENSG00000073756	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	PTGS2
Carcinoma, Non-Small-Cell Lung	ENSG00000077092	FALSE	unknown	NA	Phase II Clinical Trial	RARB
Carcinoma, Non-Small-Cell Lung	ENSG00000077238	FALSE	Phase I Clinical Trial	1996-06-15	Unused	IL4R
Carcinoma, Non-Small-Cell Lung	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Carcinoma, Non-Small-Cell Lung	ENSG00000078098	FALSE	Phase I Clinical Trial	1998-07-15	Unused	FAP
Carcinoma, Non-Small-Cell Lung	ENSG00000079385	FALSE	Phase I Clinical Trial	2015-01-09	Absent	CEACAM1
Carcinoma, Non-Small-Cell Lung	ENSG00000080824	FALSE	Phase II Clinical Trial	2004-02-03	Phase III Clinical Trial	HSP90AA1
Carcinoma, Non-Small-Cell Lung	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Carcinoma, Non-Small-Cell Lung	ENSG00000082781	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGB5
Carcinoma, Non-Small-Cell Lung	ENSG00000082898	FALSE	Preclinical	2012-06-02	Absent	XPO1
Carcinoma, Non-Small-Cell Lung	ENSG00000083312	FALSE	unknown	2005-06-27	Unused	TNPO1
Carcinoma, Non-Small-Cell Lung	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Carcinoma, Non-Small-Cell Lung	ENSG00000085563	FALSE	unknown	1997-01-15	Unused	ABCB1
Carcinoma, Non-Small-Cell Lung	ENSG00000086205	FALSE	Approved	2008-03-04	Phase II Clinical Trial	FOLH1
Carcinoma, Non-Small-Cell Lung	ENSG00000086548	FALSE	Phase II Clinical Trial	2005-05-04	Absent	CEACAM6
Carcinoma, Non-Small-Cell Lung	ENSG00000087245	FALSE	unknown	1997-01-15	Unused	MMP2
Carcinoma, Non-Small-Cell Lung	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Carcinoma, Non-Small-Cell Lung	ENSG00000089327	FALSE	Preclinical	2011-01-25	Absent	FXYD5
Carcinoma, Non-Small-Cell Lung	ENSG00000089685	FALSE	Phase II Clinical Trial	2002-04-29	Phase II Clinical Trial	BIRC5
Carcinoma, Non-Small-Cell Lung	ENSG00000089692	FALSE	Phase II Clinical Trial	2012-10-31	Absent	LAG3
Carcinoma, Non-Small-Cell Lung	ENSG00000090339	FALSE	Phase II Clinical Trial	2004-07-19	Absent	ICAM1
Carcinoma, Non-Small-Cell Lung	ENSG00000091879	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Carcinoma, Non-Small-Cell Lung	ENSG00000092445	FALSE	Preclinical	NA	Absent	TYRO3
Carcinoma, Non-Small-Cell Lung	ENSG00000092969	FALSE	Phase III Clinical Trial	1997-02-15	Phase III Clinical Trial	TGFB2
Carcinoma, Non-Small-Cell Lung	ENSG00000094631	FALSE	Phase I Clinical Trial	2015-03-31	Absent	HDAC6
Carcinoma, Non-Small-Cell Lung	ENSG00000095596	FALSE	unknown	NA	Unused	CYP26A1
Carcinoma, Non-Small-Cell Lung	ENSG00000096968	FALSE	Phase II Clinical Trial	2003-01-24	Unused	JAK2
Carcinoma, Non-Small-Cell Lung	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Carcinoma, Non-Small-Cell Lung	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	ABL1
Carcinoma, Non-Small-Cell Lung	ENSG00000097046	FALSE	Phase I Clinical Trial	2016-10-12	Absent	CDC7
Carcinoma, Non-Small-Cell Lung	ENSG00000100030	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MAPK1
Carcinoma, Non-Small-Cell Lung	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase III Clinical Trial	PDGFB
Carcinoma, Non-Small-Cell Lung	ENSG00000100385	FALSE	Phase II Clinical Trial	2007-03-01	Unused	IL2RB
Carcinoma, Non-Small-Cell Lung	ENSG00000100429	FALSE	Phase II Clinical Trial	2006-05-08	Phase II Clinical Trial	HDAC10
Carcinoma, Non-Small-Cell Lung	ENSG00000100644	FALSE	Phase II Clinical Trial	2003-08-01	Phase II Clinical Trial	HIF1A
Carcinoma, Non-Small-Cell Lung	ENSG00000100985	FALSE	Phase I Clinical Trial	1997-01-15	Unused	MMP9
Carcinoma, Non-Small-Cell Lung	ENSG00000101017	FALSE	Phase II Clinical Trial	1998-07-15	Unused	CD40
Carcinoma, Non-Small-Cell Lung	ENSG00000101266	FALSE	unknown	2007-05-23	Preclinical	CSNK2A1
Carcinoma, Non-Small-Cell Lung	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Carcinoma, Non-Small-Cell Lung	ENSG00000101868	FALSE	Phase II Clinical Trial	1993-08-15	Phase II Clinical Trial	POLA1
Carcinoma, Non-Small-Cell Lung	ENSG00000101966	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	XIAP
Carcinoma, Non-Small-Cell Lung	ENSG00000102096	FALSE	Preclinical	2013-06-12	Absent	PIM2
Carcinoma, Non-Small-Cell Lung	ENSG00000102468	FALSE	Phase II Clinical Trial	2014-04-16	Absent	HTR2A
Carcinoma, Non-Small-Cell Lung	ENSG00000102755	TRUE	Approved	1994-03-15	Phase III Clinical Trial	FLT1
Carcinoma, Non-Small-Cell Lung	ENSG00000102854	FALSE	Phase I Clinical Trial	1999-04-21	Phase I Clinical Trial	MSLN
Carcinoma, Non-Small-Cell Lung	ENSG00000102882	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MAPK3
Carcinoma, Non-Small-Cell Lung	ENSG00000102967	FALSE	unknown	1994-12-15	Unused	DHODH
Carcinoma, Non-Small-Cell Lung	ENSG00000103222	FALSE	Preclinical	2011-09-28	Preclinical	ABCC1
Carcinoma, Non-Small-Cell Lung	ENSG00000103522	FALSE	unknown	2001-01-25	Phase I Clinical Trial	IL21R
Carcinoma, Non-Small-Cell Lung	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Carcinoma, Non-Small-Cell Lung	ENSG00000103876	FALSE	Preclinical	2002-04-29	Unused	FAH
Carcinoma, Non-Small-Cell Lung	ENSG00000104689	FALSE	Phase III Clinical Trial	1998-08-15	Phase II Clinical Trial	TNFRSF10A
Carcinoma, Non-Small-Cell Lung	ENSG00000104827	FALSE	Preclinical	2007-10-03	Unused	CGB3
Carcinoma, Non-Small-Cell Lung	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKC
Carcinoma, Non-Small-Cell Lung	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Carcinoma, Non-Small-Cell Lung	ENSG00000105329	FALSE	Preclinical	2003-04-10	Unused	TGFB1
Carcinoma, Non-Small-Cell Lung	ENSG00000105388	FALSE	Phase II Clinical Trial	1997-04-15	Phase I Clinical Trial	CEACAM5
Carcinoma, Non-Small-Cell Lung	ENSG00000105810	FALSE	Phase III Clinical Trial	1996-05-15	Unused	CDK6
Carcinoma, Non-Small-Cell Lung	ENSG00000105851	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	PIK3CG
Carcinoma, Non-Small-Cell Lung	ENSG00000105976	TRUE	Approved	2001-12-18	Approved	MET
Carcinoma, Non-Small-Cell Lung	ENSG00000106211	FALSE	Phase II Clinical Trial	2004-09-24	Phase I Clinical Trial	HSPB1
Carcinoma, Non-Small-Cell Lung	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Carcinoma, Non-Small-Cell Lung	ENSG00000106991	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	ENG
Carcinoma, Non-Small-Cell Lung	ENSG00000107738	FALSE	Phase I Clinical Trial	2011-10-03	Absent	VSIR
Carcinoma, Non-Small-Cell Lung	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Phase I Clinical Trial	DKK1
Carcinoma, Non-Small-Cell Lung	ENSG00000108424	FALSE	unknown	2005-06-27	Unused	KPNB1
Carcinoma, Non-Small-Cell Lung	ENSG00000108443	FALSE	Phase II Clinical Trial	2003-03-20	Unused	RPS6KB1
Carcinoma, Non-Small-Cell Lung	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Carcinoma, Non-Small-Cell Lung	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Carcinoma, Non-Small-Cell Lung	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Carcinoma, Non-Small-Cell Lung	ENSG00000109320	FALSE	Phase II Clinical Trial	1997-11-15	Phase I Clinical Trial	NFKB1
Carcinoma, Non-Small-Cell Lung	ENSG00000109471	FALSE	Phase I Clinical Trial	2013-12-09	Phase III Clinical Trial	IL2
Carcinoma, Non-Small-Cell Lung	ENSG00000110195	FALSE	Phase II Clinical Trial	2003-02-24	Phase II Clinical Trial	FOLR1
Carcinoma, Non-Small-Cell Lung	ENSG00000110330	FALSE	Phase I Clinical Trial	2005-11-21	Absent	BIRC2
Carcinoma, Non-Small-Cell Lung	ENSG00000111424	FALSE	unknown	2002-05-28	Unused	VDR
Carcinoma, Non-Small-Cell Lung	ENSG00000112038	FALSE	Preclinical	2011-05-12	Unused	OPRM1
Carcinoma, Non-Small-Cell Lung	ENSG00000112062	FALSE	Phase I Clinical Trial	2008-09-05	Phase I Clinical Trial	MAPK14
Carcinoma, Non-Small-Cell Lung	ENSG00000112655	FALSE	Phase I Clinical Trial	2014-08-25	Absent	PTK7
Carcinoma, Non-Small-Cell Lung	ENSG00000112715	TRUE	Approved	1993-05-15	Approved	VEGFA
Carcinoma, Non-Small-Cell Lung	ENSG00000113070	FALSE	Phase I Clinical Trial	2002-06-13	Phase I Clinical Trial	HBEGF
Carcinoma, Non-Small-Cell Lung	ENSG00000113163	FALSE	Preclinical	2016-09-08	Absent	COL4A3BP
Carcinoma, Non-Small-Cell Lung	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Carcinoma, Non-Small-Cell Lung	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Carcinoma, Non-Small-Cell Lung	ENSG00000113580	FALSE	Preclinical	2011-07-01	Unused	NR3C1
Carcinoma, Non-Small-Cell Lung	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Carcinoma, Non-Small-Cell Lung	ENSG00000114013	FALSE	unknown	2002-01-11	Unused	CD86
Carcinoma, Non-Small-Cell Lung	ENSG00000114378	FALSE	Phase II Clinical Trial	NA	Absent	HYAL1
Carcinoma, Non-Small-Cell Lung	ENSG00000114383	FALSE	Phase II Clinical Trial	2003-05-02	Phase I Clinical Trial	TUSC2
Carcinoma, Non-Small-Cell Lung	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Carcinoma, Non-Small-Cell Lung	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Carcinoma, Non-Small-Cell Lung	ENSG00000115053	FALSE	unknown	2003-03-13	Unused	NCL
Carcinoma, Non-Small-Cell Lung	ENSG00000115221	FALSE	unknown	2002-11-26	Unused	ITGB6
Carcinoma, Non-Small-Cell Lung	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-02-11	Unused	FN1
Carcinoma, Non-Small-Cell Lung	ENSG00000115419	FALSE	Phase II Clinical Trial	2013-05-02	Absent	GLS
Carcinoma, Non-Small-Cell Lung	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Carcinoma, Non-Small-Cell Lung	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Carcinoma, Non-Small-Cell Lung	ENSG00000116044	FALSE	Phase I Clinical Trial	2008-10-15	Unused	NFE2L2
Carcinoma, Non-Small-Cell Lung	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Phase II Clinical Trial	HDAC1
Carcinoma, Non-Small-Cell Lung	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Preclinical	F3
Carcinoma, Non-Small-Cell Lung	ENSG00000117601	FALSE	Phase III Clinical Trial	NA	Unused	SERPINC1
Carcinoma, Non-Small-Cell Lung	ENSG00000118520	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG1
Carcinoma, Non-Small-Cell Lung	ENSG00000119535	FALSE	Phase I Clinical Trial	2011-10-19	Phase I Clinical Trial	CSF3R
Carcinoma, Non-Small-Cell Lung	ENSG00000119888	FALSE	Phase II Clinical Trial	1995-12-15	Phase I Clinical Trial	EPCAM
Carcinoma, Non-Small-Cell Lung	ENSG00000120156	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	TEK
Carcinoma, Non-Small-Cell Lung	ENSG00000120217	TRUE	Approved	2008-01-16	Phase I Clinical Trial	CD274
Carcinoma, Non-Small-Cell Lung	ENSG00000120659	FALSE	Phase II Clinical Trial	1997-07-15	Absent	TNFSF11
Carcinoma, Non-Small-Cell Lung	ENSG00000120885	FALSE	Phase III Clinical Trial	2001-12-07	Phase III Clinical Trial	CLU
Carcinoma, Non-Small-Cell Lung	ENSG00000120889	FALSE	Phase III Clinical Trial	2001-08-23	Phase II Clinical Trial	TNFRSF10B
Carcinoma, Non-Small-Cell Lung	ENSG00000121858	FALSE	Phase II Clinical Trial	2006-07-10	Unused	TNFSF10
Carcinoma, Non-Small-Cell Lung	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Carcinoma, Non-Small-Cell Lung	ENSG00000121966	FALSE	Preclinical	2009-03-27	Absent	CXCR4
Carcinoma, Non-Small-Cell Lung	ENSG00000122025	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT3
Carcinoma, Non-Small-Cell Lung	ENSG00000122194	FALSE	unknown	1995-05-15	Unused	PLG
Carcinoma, Non-Small-Cell Lung	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK2
Carcinoma, Non-Small-Cell Lung	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Carcinoma, Non-Small-Cell Lung	ENSG00000124731	FALSE	Preclinical	2012-01-19	Preclinical	TREM1
Carcinoma, Non-Small-Cell Lung	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Carcinoma, Non-Small-Cell Lung	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Carcinoma, Non-Small-Cell Lung	ENSG00000125538	FALSE	Preclinical	2003-12-08	Absent	IL1B
Carcinoma, Non-Small-Cell Lung	ENSG00000126010	FALSE	unknown	2008-11-13	Unused	GRPR
Carcinoma, Non-Small-Cell Lung	ENSG00000126218	FALSE	Phase III Clinical Trial	NA	Unused	F10
Carcinoma, Non-Small-Cell Lung	ENSG00000126934	TRUE	Approved	1999-04-14	Phase II Clinical Trial	MAP2K2
Carcinoma, Non-Small-Cell Lung	ENSG00000128052	TRUE	Approved	1994-06-15	Phase III Clinical Trial	KDR
Carcinoma, Non-Small-Cell Lung	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Carcinoma, Non-Small-Cell Lung	ENSG00000128602	FALSE	Phase I Clinical Trial	2006-10-19	Phase I Clinical Trial	SMO
Carcinoma, Non-Small-Cell Lung	ENSG00000128917	FALSE	Phase II Clinical Trial	2005-09-14	Phase I Clinical Trial	DLL4
Carcinoma, Non-Small-Cell Lung	ENSG00000128951	FALSE	Phase II Clinical Trial	2012-06-07	Absent	DUT
Carcinoma, Non-Small-Cell Lung	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Carcinoma, Non-Small-Cell Lung	ENSG00000130037	FALSE	Preclinical	2015-08-14	Absent	KCNA5
Carcinoma, Non-Small-Cell Lung	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK4
Carcinoma, Non-Small-Cell Lung	ENSG00000130816	FALSE	Preclinical	2005-12-02	Unused	DNMT1
Carcinoma, Non-Small-Cell Lung	ENSG00000131203	FALSE	Phase III Clinical Trial	2008-01-23	Absent	IDO1
Carcinoma, Non-Small-Cell Lung	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Carcinoma, Non-Small-Cell Lung	ENSG00000131747	FALSE	Approved	1990-07-15	Unused	TOP2A
Carcinoma, Non-Small-Cell Lung	ENSG00000131759	FALSE	unknown	NA	Phase II Clinical Trial	RARA
Carcinoma, Non-Small-Cell Lung	ENSG00000132155	FALSE	Phase I Clinical Trial	1992-11-15	Phase III Clinical Trial	RAF1
Carcinoma, Non-Small-Cell Lung	ENSG00000132170	FALSE	Phase II Clinical Trial	1993-10-15	Phase II Clinical Trial	PPARG
Carcinoma, Non-Small-Cell Lung	ENSG00000132646	FALSE	Preclinical	2011-03-30	Preclinical	PCNA
Carcinoma, Non-Small-Cell Lung	ENSG00000133703	FALSE	Preclinical	1992-11-15	Unused	KRAS
Carcinoma, Non-Small-Cell Lung	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-01-15	Unused	CDK7
Carcinoma, Non-Small-Cell Lung	ENSG00000134318	FALSE	Preclinical	2016-03-17	Absent	ROCK2
Carcinoma, Non-Small-Cell Lung	ENSG00000134460	FALSE	Phase III Clinical Trial	2000-11-07	Unused	IL2RA
Carcinoma, Non-Small-Cell Lung	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Carcinoma, Non-Small-Cell Lung	ENSG00000134853	TRUE	Approved	1994-12-15	Phase III Clinical Trial	PDGFRA
Carcinoma, Non-Small-Cell Lung	ENSG00000135218	FALSE	Phase I Clinical Trial	2001-03-14	Unused	CD36
Carcinoma, Non-Small-Cell Lung	ENSG00000135318	FALSE	Preclinical	2015-07-23	Absent	NT5E
Carcinoma, Non-Small-Cell Lung	ENSG00000135446	FALSE	Phase III Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK4
Carcinoma, Non-Small-Cell Lung	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-14	Unused	MDM2
Carcinoma, Non-Small-Cell Lung	ENSG00000136160	FALSE	Phase II Clinical Trial	2016-04-28	Preclinical	EDNRB
Carcinoma, Non-Small-Cell Lung	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Carcinoma, Non-Small-Cell Lung	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Carcinoma, Non-Small-Cell Lung	ENSG00000136807	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CDK9
Carcinoma, Non-Small-Cell Lung	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Carcinoma, Non-Small-Cell Lung	ENSG00000136826	FALSE	Phase I Clinical Trial	2004-05-21	Absent	KLF4
Carcinoma, Non-Small-Cell Lung	ENSG00000136869	FALSE	Phase I Clinical Trial	2012-08-06	Absent	TLR4
Carcinoma, Non-Small-Cell Lung	ENSG00000136997	FALSE	Phase I Clinical Trial	2004-05-21	Absent	MYC
Carcinoma, Non-Small-Cell Lung	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Carcinoma, Non-Small-Cell Lung	ENSG00000137193	FALSE	Preclinical	2013-06-12	Absent	PIM1
Carcinoma, Non-Small-Cell Lung	ENSG00000137845	FALSE	unknown	2003-09-17	Unused	ADAM10
Carcinoma, Non-Small-Cell Lung	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Carcinoma, Non-Small-Cell Lung	ENSG00000138448	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGAV
Carcinoma, Non-Small-Cell Lung	ENSG00000138685	FALSE	unknown	1993-05-15	Absent	FGF2
Carcinoma, Non-Small-Cell Lung	ENSG00000138735	FALSE	unknown	1994-12-15	Unused	PDE5A
Carcinoma, Non-Small-Cell Lung	ENSG00000138755	FALSE	Preclinical	2005-01-27	Unused	CXCL9
Carcinoma, Non-Small-Cell Lung	ENSG00000138798	FALSE	Approved	1996-05-15	Unused	EGF
Carcinoma, Non-Small-Cell Lung	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Carcinoma, Non-Small-Cell Lung	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Carcinoma, Non-Small-Cell Lung	ENSG00000140538	FALSE	Phase III Clinical Trial	2009-05-20	Absent	NTRK3
Carcinoma, Non-Small-Cell Lung	ENSG00000140545	FALSE	unknown	1997-04-15	Unused	MFGE8
Carcinoma, Non-Small-Cell Lung	ENSG00000141510	FALSE	Preclinical	1993-10-15	Unused	TP53
Carcinoma, Non-Small-Cell Lung	ENSG00000141736	TRUE	Approved	1990-09-15	Approved	ERBB2
Carcinoma, Non-Small-Cell Lung	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Absent	BRD4
Carcinoma, Non-Small-Cell Lung	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Carcinoma, Non-Small-Cell Lung	ENSG00000142627	FALSE	Phase III Clinical Trial	2006-09-11	Unused	EPHA2
Carcinoma, Non-Small-Cell Lung	ENSG00000143171	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRG
Carcinoma, Non-Small-Cell Lung	ENSG00000143217	FALSE	Phase I Clinical Trial	2004-10-18	Absent	NECTIN4
Carcinoma, Non-Small-Cell Lung	ENSG00000143226	FALSE	Phase II Clinical Trial	NA	Absent	FCGR2A
Carcinoma, Non-Small-Cell Lung	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Carcinoma, Non-Small-Cell Lung	ENSG00000143384	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	MCL1
Carcinoma, Non-Small-Cell Lung	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Phase III Clinical Trial	PARP1
Carcinoma, Non-Small-Cell Lung	ENSG00000145545	FALSE	Phase II Clinical Trial	2016-10-25	Absent	SRD5A1
Carcinoma, Non-Small-Cell Lung	ENSG00000146242	FALSE	Phase I Clinical Trial	1998-09-15	Unused	TPBG
Carcinoma, Non-Small-Cell Lung	ENSG00000146648	TRUE	Approved	1990-05-15	Approved	EGFR
Carcinoma, Non-Small-Cell Lung	ENSG00000146674	FALSE	Phase I Clinical Trial	2008-01-04	Unused	IGFBP3
Carcinoma, Non-Small-Cell Lung	ENSG00000147381	FALSE	Preclinical	2007-03-19	Unused	MAGEA4
Carcinoma, Non-Small-Cell Lung	ENSG00000148053	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK2
Carcinoma, Non-Small-Cell Lung	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK1
Carcinoma, Non-Small-Cell Lung	ENSG00000149295	FALSE	Phase II Clinical Trial	1995-09-15	Unused	DRD2
Carcinoma, Non-Small-Cell Lung	ENSG00000149554	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	CHEK1
Carcinoma, Non-Small-Cell Lung	ENSG00000149968	FALSE	unknown	1997-01-15	Unused	MMP3
Carcinoma, Non-Small-Cell Lung	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Carcinoma, Non-Small-Cell Lung	ENSG00000150337	FALSE	Phase II Clinical Trial	NA	Absent	FCGR1A
Carcinoma, Non-Small-Cell Lung	ENSG00000151247	FALSE	unknown	2004-09-22	Phase II Clinical Trial	EIF4E
Carcinoma, Non-Small-Cell Lung	ENSG00000151617	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	EDNRA
Carcinoma, Non-Small-Cell Lung	ENSG00000151694	FALSE	unknown	2003-09-17	Unused	ADAM17
Carcinoma, Non-Small-Cell Lung	ENSG00000153208	FALSE	Phase I Clinical Trial	2012-12-21	Absent	MERTK
Carcinoma, Non-Small-Cell Lung	ENSG00000154188	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Carcinoma, Non-Small-Cell Lung	ENSG00000154229	FALSE	Preclinical	1991-01-15	Unused	PRKCA
Carcinoma, Non-Small-Cell Lung	ENSG00000155760	FALSE	Phase I Clinical Trial	2010-06-19	Absent	FZD7
Carcinoma, Non-Small-Cell Lung	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Carcinoma, Non-Small-Cell Lung	ENSG00000157036	FALSE	unknown	2009-12-08	Phase II Clinical Trial	EXOG
Carcinoma, Non-Small-Cell Lung	ENSG00000157404	FALSE	Phase III Clinical Trial	2000-07-05	Phase III Clinical Trial	KIT
Carcinoma, Non-Small-Cell Lung	ENSG00000157764	TRUE	Approved	2001-04-03	Phase II Clinical Trial	BRAF
Carcinoma, Non-Small-Cell Lung	ENSG00000157765	FALSE	Phase I Clinical Trial	2011-06-03	Absent	SLC34A2
Carcinoma, Non-Small-Cell Lung	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Carcinoma, Non-Small-Cell Lung	ENSG00000159131	TRUE	Approved	1990-07-15	Approved	GART
Carcinoma, Non-Small-Cell Lung	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Carcinoma, Non-Small-Cell Lung	ENSG00000160932	FALSE	Phase I Clinical Trial	2014-03-18	Absent	LY6E
Carcinoma, Non-Small-Cell Lung	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Carcinoma, Non-Small-Cell Lung	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-11-24	Absent	JAK1
Carcinoma, Non-Small-Cell Lung	ENSG00000162747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3B
Carcinoma, Non-Small-Cell Lung	ENSG00000163399	FALSE	Preclinical	2011-01-25	Absent	ATP1A1
Carcinoma, Non-Small-Cell Lung	ENSG00000163464	FALSE	Preclinical	2005-01-27	Unused	CXCR1
Carcinoma, Non-Small-Cell Lung	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	HDAC11
Carcinoma, Non-Small-Cell Lung	ENSG00000163558	FALSE	Preclinical	2015-03-24	Absent	PRKCI
Carcinoma, Non-Small-Cell Lung	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	CTLA4
Carcinoma, Non-Small-Cell Lung	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Carcinoma, Non-Small-Cell Lung	ENSG00000163823	FALSE	Phase I Clinical Trial	2007-06-13	Unused	CCR1
Carcinoma, Non-Small-Cell Lung	ENSG00000164078	FALSE	Phase II Clinical Trial	2001-12-18	Approved	MST1R
Carcinoma, Non-Small-Cell Lung	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Unused	CASP3
Carcinoma, Non-Small-Cell Lung	ENSG00000164342	FALSE	Preclinical	NA	Absent	TLR3
Carcinoma, Non-Small-Cell Lung	ENSG00000164362	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TERT
Carcinoma, Non-Small-Cell Lung	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Unused	CSF2
Carcinoma, Non-Small-Cell Lung	ENSG00000164885	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK5
Carcinoma, Non-Small-Cell Lung	ENSG00000165025	FALSE	Phase I Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Carcinoma, Non-Small-Cell Lung	ENSG00000165675	FALSE	Phase II Clinical Trial	2016-10-25	Absent	ENOX2
Carcinoma, Non-Small-Cell Lung	ENSG00000165731	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	RET
Carcinoma, Non-Small-Cell Lung	ENSG00000166483	FALSE	Phase II Clinical Trial	2008-04-09	Absent	WEE1
Carcinoma, Non-Small-Cell Lung	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Carcinoma, Non-Small-Cell Lung	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Carcinoma, Non-Small-Cell Lung	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	PLK1
Carcinoma, Non-Small-Cell Lung	ENSG00000167325	FALSE	Phase I Clinical Trial	1991-07-15	Unused	RRM1
Carcinoma, Non-Small-Cell Lung	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Absent	AXL
Carcinoma, Non-Small-Cell Lung	ENSG00000167658	FALSE	Phase II Clinical Trial	1990-05-15	Unused	EEF2
Carcinoma, Non-Small-Cell Lung	ENSG00000168398	FALSE	Preclinical	2008-06-03	Unused	BDKRB2
Carcinoma, Non-Small-Cell Lung	ENSG00000168522	FALSE	Phase II Clinical Trial	1996-01-15	Unused	FNTA
Carcinoma, Non-Small-Cell Lung	ENSG00000168610	FALSE	Phase III Clinical Trial	2010-05-18	Phase I Clinical Trial	STAT3
Carcinoma, Non-Small-Cell Lung	ENSG00000168685	FALSE	Preclinical	2017-06-12	Absent	IL7R
Carcinoma, Non-Small-Cell Lung	ENSG00000169032	TRUE	Approved	1999-04-14	Phase II Clinical Trial	MAP2K1
Carcinoma, Non-Small-Cell Lung	ENSG00000169398	FALSE	Phase II Clinical Trial	2008-11-11	Unused	PTK2
Carcinoma, Non-Small-Cell Lung	ENSG00000169403	FALSE	Preclinical	2008-01-22	Unused	PTAFR
Carcinoma, Non-Small-Cell Lung	ENSG00000169710	FALSE	Phase I Clinical Trial	2009-09-18	Absent	FASN
Carcinoma, Non-Small-Cell Lung	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Carcinoma, Non-Small-Cell Lung	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Carcinoma, Non-Small-Cell Lung	ENSG00000170312	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK1
Carcinoma, Non-Small-Cell Lung	ENSG00000170425	FALSE	Preclinical	2015-05-27	Absent	ADORA2B
Carcinoma, Non-Small-Cell Lung	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Carcinoma, Non-Small-Cell Lung	ENSG00000170820	FALSE	Preclinical	2012-09-18	Absent	FSHR
Carcinoma, Non-Small-Cell Lung	ENSG00000171094	TRUE	Approved	2006-12-05	Approved	ALK
Carcinoma, Non-Small-Cell Lung	ENSG00000171552	FALSE	unknown	2005-11-21	Phase II Clinical Trial	BCL2L1
Carcinoma, Non-Small-Cell Lung	ENSG00000171608	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	PIK3CD
Carcinoma, Non-Small-Cell Lung	ENSG00000171720	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	HDAC3
Carcinoma, Non-Small-Cell Lung	ENSG00000171791	FALSE	unknown	1992-03-15	Phase II Clinical Trial	BCL2
Carcinoma, Non-Small-Cell Lung	ENSG00000171848	FALSE	unknown	1991-07-15	Unused	RRM2
Carcinoma, Non-Small-Cell Lung	ENSG00000171862	FALSE	unknown	2005-08-22	Phase II Clinical Trial	PTEN
Carcinoma, Non-Small-Cell Lung	ENSG00000172270	FALSE	Phase I Clinical Trial	2015-01-08	Absent	BSG
Carcinoma, Non-Small-Cell Lung	ENSG00000172819	FALSE	unknown	2002-06-26	Unused	RARG
Carcinoma, Non-Small-Cell Lung	ENSG00000172889	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	EGFL7
Carcinoma, Non-Small-Cell Lung	ENSG00000173083	FALSE	unknown	1997-09-15	Unused	HPSE
Carcinoma, Non-Small-Cell Lung	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Carcinoma, Non-Small-Cell Lung	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Carcinoma, Non-Small-Cell Lung	ENSG00000174775	FALSE	Preclinical	2007-07-24	Unused	HRAS
Carcinoma, Non-Small-Cell Lung	ENSG00000174807	FALSE	unknown	2004-10-18	Unused	CD248
Carcinoma, Non-Small-Cell Lung	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-07-22	Absent	ATR
Carcinoma, Non-Small-Cell Lung	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Carcinoma, Non-Small-Cell Lung	ENSG00000176601	FALSE	Preclinical	2017-05-12	Absent	MAP3K19
Carcinoma, Non-Small-Cell Lung	ENSG00000176890	TRUE	Approved	1991-10-15	Approved	TYMS
Carcinoma, Non-Small-Cell Lung	ENSG00000177606	FALSE	Phase II Clinical Trial	2007-10-08	Unused	JUN
Carcinoma, Non-Small-Cell Lung	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Carcinoma, Non-Small-Cell Lung	ENSG00000178568	FALSE	Phase III Clinical Trial	2002-05-30	Phase III Clinical Trial	ERBB4
Carcinoma, Non-Small-Cell Lung	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Carcinoma, Non-Small-Cell Lung	ENSG00000179295	FALSE	Phase I Clinical Trial	2017-04-17	Absent	PTPN11
Carcinoma, Non-Small-Cell Lung	ENSG00000179776	FALSE	unknown	2000-12-11	Unused	CDH5
Carcinoma, Non-Small-Cell Lung	ENSG00000180210	FALSE	Phase III Clinical Trial	NA	Unused	F2
Carcinoma, Non-Small-Cell Lung	ENSG00000180616	FALSE	Phase I Clinical Trial	1999-09-02	Absent	SSTR2
Carcinoma, Non-Small-Cell Lung	ENSG00000180871	FALSE	Preclinical	2005-01-27	Unused	CXCR2
Carcinoma, Non-Small-Cell Lung	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	CSF1R
Carcinoma, Non-Small-Cell Lung	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Carcinoma, Non-Small-Cell Lung	ENSG00000182871	FALSE	Approved	NA	Unused	COL18A1
Carcinoma, Non-Small-Cell Lung	ENSG00000183765	FALSE	Phase I Clinical Trial	2010-03-02	Phase II Clinical Trial	CHEK2
Carcinoma, Non-Small-Cell Lung	ENSG00000183813	FALSE	Phase I Clinical Trial	2003-05-20	Absent	CCR4
Carcinoma, Non-Small-Cell Lung	ENSG00000184033	FALSE	Phase II Clinical Trial	2004-05-24	Phase II Clinical Trial	CTAG1B
Carcinoma, Non-Small-Cell Lung	ENSG00000184047	FALSE	Phase I Clinical Trial	2005-11-21	Absent	DIABLO
Carcinoma, Non-Small-Cell Lung	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Carcinoma, Non-Small-Cell Lung	ENSG00000184371	FALSE	Phase II Clinical Trial	2010-08-09	Phase I Clinical Trial	CSF1
Carcinoma, Non-Small-Cell Lung	ENSG00000184697	FALSE	unknown	2011-02-25	Absent	CLDN6
Carcinoma, Non-Small-Cell Lung	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase III Clinical Trial	WT1
Carcinoma, Non-Small-Cell Lung	ENSG00000185483	FALSE	Phase I Clinical Trial	2015-01-02	Absent	ROR1
Carcinoma, Non-Small-Cell Lung	ENSG00000185499	FALSE	Phase III Clinical Trial	1992-07-15	Phase III Clinical Trial	MUC1
Carcinoma, Non-Small-Cell Lung	ENSG00000185686	FALSE	Phase II Clinical Trial	2010-07-16	Phase I Clinical Trial	PRAME
Carcinoma, Non-Small-Cell Lung	ENSG00000185825	FALSE	Preclinical	2001-09-24	Unused	BCAP31
Carcinoma, Non-Small-Cell Lung	ENSG00000186350	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRA
Carcinoma, Non-Small-Cell Lung	ENSG00000186642	FALSE	unknown	1994-12-15	Unused	PDE2A
Carcinoma, Non-Small-Cell Lung	ENSG00000186716	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	BCR
Carcinoma, Non-Small-Cell Lung	ENSG00000186827	FALSE	unknown	2014-08-23	Absent	TNFRSF4
Carcinoma, Non-Small-Cell Lung	ENSG00000187079	FALSE	Preclinical	2014-11-05	Absent	TEAD1
Carcinoma, Non-Small-Cell Lung	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Carcinoma, Non-Small-Cell Lung	ENSG00000187514	FALSE	Phase II Clinical Trial	NA	Unused	PTMA
Carcinoma, Non-Small-Cell Lung	ENSG00000187764	FALSE	Phase II Clinical Trial	2006-06-20	Absent	SEMA4D
Carcinoma, Non-Small-Cell Lung	ENSG00000188389	TRUE	Approved	2005-05-12	Phase III Clinical Trial	PDCD1
Carcinoma, Non-Small-Cell Lung	ENSG00000188641	FALSE	Approved	2012-06-07	Absent	DPYD
Carcinoma, Non-Small-Cell Lung	ENSG00000196083	FALSE	Phase II Clinical Trial	NA	Absent	IL1RAP
Carcinoma, Non-Small-Cell Lung	ENSG00000196352	FALSE	Phase II Clinical Trial	2004-07-19	Absent	CD55
Carcinoma, Non-Small-Cell Lung	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Phase III Clinical Trial	EPHB4
Carcinoma, Non-Small-Cell Lung	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Carcinoma, Non-Small-Cell Lung	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Phase III Clinical Trial	SRC
Carcinoma, Non-Small-Cell Lung	ENSG00000198223	FALSE	unknown	1994-08-15	Phase III Clinical Trial	CSF2RA
Carcinoma, Non-Small-Cell Lung	ENSG00000198355	FALSE	Preclinical	2013-06-12	Absent	PIM3
Carcinoma, Non-Small-Cell Lung	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Phase I Clinical Trial	NTRK1
Carcinoma, Non-Small-Cell Lung	ENSG00000198668	FALSE	Phase II Clinical Trial	2003-12-09	Absent	CALM1
Carcinoma, Non-Small-Cell Lung	ENSG00000198681	FALSE	Preclinical	2016-10-07	Absent	MAGEA1
Carcinoma, Non-Small-Cell Lung	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Carcinoma, Non-Small-Cell Lung	ENSG00000198851	FALSE	Phase II Clinical Trial	2016-09-13	Absent	CD3E
Carcinoma, Non-Small-Cell Lung	ENSG00000198900	FALSE	Phase III Clinical Trial	1990-07-15	Phase III Clinical Trial	TOP1
Carcinoma, Non-Small-Cell Lung	ENSG00000198964	FALSE	unknown	2008-11-07	Absent	SGMS1
Carcinoma, Non-Small-Cell Lung	ENSG00000203747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3A
Carcinoma, Non-Small-Cell Lung	ENSG00000213281	FALSE	Preclinical	2007-07-24	Preclinical	NRAS
Carcinoma, Non-Small-Cell Lung	ENSG00000213903	FALSE	unknown	1993-10-15	Unused	LTB4R
Carcinoma, Non-Small-Cell Lung	ENSG00000221867	FALSE	Phase II Clinical Trial	1998-07-15	Phase III Clinical Trial	MAGEA3
Carcinoma, Non-Small-Cell Lung	ENSG00000228716	TRUE	Approved	1992-06-15	Approved	DHFR
Carcinoma, Non-Small-Cell Lung	ENSG00000239732	FALSE	Phase III Clinical Trial	1998-10-15	Phase II Clinical Trial	TLR9
Carcinoma, Non-Small-Cell Lung	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Carcinoma, Non-Small-Cell Lung	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Carcinoma, Non-Small-Cell Lung	ENSG00000253729	FALSE	Phase II Clinical Trial	1999-03-31	Unused	PRKDC
Carcinoma, Non-Small-Cell Lung	ENSG00000254087	TRUE	Approved	2001-10-30	Phase III Clinical Trial	LYN
Carcinoma, Non-Small-Cell Lung	ENSG00000258947	FALSE	Preclinical	2009-02-10	Unused	TUBB3
Carcinoma, Non-Small-Cell Lung	ENSG00000259207	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGB3
Carcinoma, Non-Small-Cell Lung	ENSG00000277443	FALSE	Preclinical	NA	Absent	MARCKS
Carcinoma, Non-Small-Cell Lung	ENSG00000278540	FALSE	Preclinical	2014-04-05	Absent	ACACA
Carcinoma, Renal Cell	ENSG00000100644	FALSE	Phase I Clinical Trial	2013-11-05	Absent	HIF1A
Carcinoma, Renal Cell	ENSG00000105697	FALSE	Phase II Clinical Trial	2010-02-17	Absent	HAMP
Carcinoma, Renal Cell	ENSG00000115590	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	IL1R2
Carcinoma, Renal Cell	ENSG00000115594	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	IL1R1
Carcinoma, Renal Cell	ENSG00000129521	FALSE	Phase III Clinical Trial	2008-09-16	Absent	EGLN3
Carcinoma, Renal Cell	ENSG00000130427	FALSE	Phase I Clinical Trial	1996-09-15	Unused	EPO
Carcinoma, Renal Cell	ENSG00000139567	FALSE	unknown	2009-01-15	Phase I Clinical Trial	ACVRL1
Carcinoma, Renal Cell	ENSG00000153162	FALSE	Phase II Clinical Trial	2013-04-25	Absent	BMP6
Carcinoma, Renal Cell	ENSG00000167941	FALSE	Phase II Clinical Trial	2011-08-12	Absent	SOST
Carcinoma, Renal Cell	ENSG00000171791	FALSE	unknown	2001-05-30	Phase II Clinical Trial	BCL2
Carcinoma, Renal Cell	ENSG00000187266	TRUE	Approved	1991-03-15	Approved	EPOR
Carcinoma, Renal Cell	ENSG00000198223	FALSE	Preclinical	1997-09-15	Unused	CSF2RA
Carcinoma, Renal Cell	ENSG00000269858	FALSE	Phase III Clinical Trial	2003-07-02	Phase II Clinical Trial	EGLN2
Carcinoma, Squamous Cell	ENSG00000121879	FALSE	Phase I Clinical Trial	NA	Absent	PIK3CA
Carcinoma, Squamous Cell	ENSG00000141867	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD4
Carcinoma, Squamous Cell	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Carcinoma, Transitional Cell	ENSG00000112062	FALSE	unknown	2000-10-25	Unused	MAPK14
Carcinoma, Transitional Cell	ENSG00000138735	FALSE	unknown	2005-05-24	Unused	PDE5A
Cardiomyopathies	ENSG00000005961	FALSE	unknown	1996-12-15	Unused	ITGA2B
Cardiomyopathies	ENSG00000006638	FALSE	Preclinical	1997-06-15	Unused	TBXA2R
Cardiomyopathies	ENSG00000010322	FALSE	Preclinical	2006-11-03	Unused	NISCH
Cardiomyopathies	ENSG00000075388	FALSE	Preclinical	1998-01-15	Unused	FGF4
Cardiomyopathies	ENSG00000079459	FALSE	Preclinical	1995-05-15	Unused	FDFT1
Cardiomyopathies	ENSG00000112715	FALSE	Preclinical	1997-11-15	Unused	VEGFA
Cardiomyopathies	ENSG00000114812	FALSE	Phase I Clinical Trial	2010-11-16	Absent	VIPR1
Cardiomyopathies	ENSG00000116016	FALSE	Preclinical	2002-11-06	Unused	EPAS1
Cardiomyopathies	ENSG00000116329	FALSE	Preclinical	2002-07-02	Unused	OPRD1
Cardiomyopathies	ENSG00000117601	FALSE	unknown	1989-11-15	Unused	SERPINC1
Cardiomyopathies	ENSG00000118271	FALSE	Preclinical	2015-08-25	Absent	TTR
Cardiomyopathies	ENSG00000121361	FALSE	unknown	1997-12-15	Unused	KCNJ8
Cardiomyopathies	ENSG00000128271	FALSE	Preclinical	1999-04-28	Unused	ADORA2A
Cardiomyopathies	ENSG00000138685	FALSE	Preclinical	2000-12-07	Unused	FGF2
Cardiomyopathies	ENSG00000142168	FALSE	Phase II Clinical Trial	NA	Unused	SOD1
Cardiomyopathies	ENSG00000151067	FALSE	Approved	1999-09-14	Unused	CACNA1C
Cardiomyopathies	ENSG00000158828	FALSE	Preclinical	2015-03-18	Absent	PINK1
Cardiomyopathies	ENSG00000163485	FALSE	Preclinical	1995-05-15	Unused	ADORA1
Cardiomyopathies	ENSG00000173198	FALSE	Preclinical	1997-06-15	Unused	CYSLTR1
Cardiomyopathies	ENSG00000180210	FALSE	unknown	1991-02-15	Unused	F2
Cardiomyopathies	ENSG00000180772	FALSE	Preclinical	2015-11-12	Absent	AGTR2
Cardiomyopathies	ENSG00000184381	FALSE	Preclinical	1998-12-15	Unused	PLA2G6
Cardiomyopathies	ENSG00000187266	FALSE	Preclinical	2003-07-02	Unused	EPOR
Cardiomyopathies	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Cardiomyopathies	ENSG00000204174	FALSE	Preclinical	2006-11-03	Absent	NPY4R
Cardiomyopathies	ENSG00000259207	FALSE	unknown	1996-12-15	Unused	ITGB3
Cardiomyopathies	ENSG00000269858	FALSE	Preclinical	2003-07-02	Unused	EGLN2
Cardiomyopathies	ENSG00000282608	FALSE	Preclinical	1999-04-28	Unused	ADORA3
Cardiomyopathy, Dilated	ENSG00000099822	FALSE	Preclinical	1993-10-15	Absent	HCN2
Cardiomyopathy, Dilated	ENSG00000112062	FALSE	Phase II Clinical Trial	2003-11-21	Absent	MAPK14
Cardiomyopathy, Dilated	ENSG00000135424	FALSE	Preclinical	NA	Preclinical	ITGA7
Cardiomyopathy, Dilated	ENSG00000138622	FALSE	Preclinical	1993-10-15	Absent	HCN4
Cardiomyopathy, Dilated	ENSG00000143630	FALSE	Preclinical	1993-10-15	Absent	HCN3
Cardiomyopathy, Dilated	ENSG00000152818	FALSE	Preclinical	NA	Preclinical	UTRN
Cardiomyopathy, Dilated	ENSG00000164588	FALSE	Preclinical	1993-10-15	Absent	HCN1
Cardiomyopathy, Dilated	ENSG00000173250	FALSE	Phase I Clinical Trial	2016-11-11	Absent	GPR151
Cardiomyopathy, Dilated	ENSG00000173402	FALSE	Preclinical	NA	Preclinical	DAG1
Cardiomyopathy, Dilated	ENSG00000198947	FALSE	Preclinical	NA	Preclinical	DMD
Cardiomyopathy, Hypertrophic	ENSG00000110090	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CPT1A
Cardiomyopathy, Hypertrophic	ENSG00000126934	FALSE	unknown	2006-05-01	Phase II Clinical Trial	MAP2K2
Cardiomyopathy, Hypertrophic	ENSG00000157184	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CPT2
Cardiomyopathy, Hypertrophic	ENSG00000169032	FALSE	unknown	2006-05-01	Phase II Clinical Trial	MAP2K1
Cardiovascular Diseases	ENSG00000005381	FALSE	Phase I Clinical Trial	2016-02-17	Absent	MPO
Cardiovascular Diseases	ENSG00000005961	FALSE	Preclinical	1991-11-15	Unused	ITGA2B
Cardiovascular Diseases	ENSG00000006638	FALSE	Preclinical	1989-06-15	Unused	TBXA2R
Cardiovascular Diseases	ENSG00000007171	FALSE	Preclinical	1995-11-15	Unused	NOS2
Cardiovascular Diseases	ENSG00000007908	FALSE	Preclinical	1992-03-15	Unused	SELE
Cardiovascular Diseases	ENSG00000007952	FALSE	Preclinical	2015-03-26	Absent	NOX1
Cardiovascular Diseases	ENSG00000012779	FALSE	Preclinical	2010-06-11	Unused	ALOX5
Cardiovascular Diseases	ENSG00000026103	FALSE	Preclinical	1999-10-05	Unused	FAS
Cardiovascular Diseases	ENSG00000030110	FALSE	Preclinical	1997-07-15	Absent	BAK1
Cardiovascular Diseases	ENSG00000035862	FALSE	Preclinical	1991-02-15	Unused	TIMP2
Cardiovascular Diseases	ENSG00000043591	TRUE	Approved	1993-07-15	Approved	ADRB1
Cardiovascular Diseases	ENSG00000050628	FALSE	Preclinical	2016-09-20	Absent	PTGER3
Cardiovascular Diseases	ENSG00000053918	FALSE	Preclinical	2001-06-12	Unused	KCNQ1
Cardiovascular Diseases	ENSG00000057252	FALSE	unknown	1991-07-15	Unused	SOAT1
Cardiovascular Diseases	ENSG00000057593	FALSE	Preclinical	2005-01-26	Unused	F7
Cardiovascular Diseases	ENSG00000059377	FALSE	Phase II Clinical Trial	1992-09-15	Unused	TBXAS1
Cardiovascular Diseases	ENSG00000060491	FALSE	unknown	NA	Unused	OGFR
Cardiovascular Diseases	ENSG00000064989	FALSE	Preclinical	1991-02-15	Unused	CALCRL
Cardiovascular Diseases	ENSG00000065534	FALSE	Phase I Clinical Trial	NA	Unused	MYLK
Cardiovascular Diseases	ENSG00000065989	FALSE	Preclinical	1990-06-15	Unused	PDE4A
Cardiovascular Diseases	ENSG00000066230	FALSE	Preclinical	2015-07-15	Absent	SLC9A3
Cardiovascular Diseases	ENSG00000067560	FALSE	Preclinical	2004-08-13	Unused	RHOA
Cardiovascular Diseases	ENSG00000069431	FALSE	Preclinical	1989-07-15	Unused	ABCC9
Cardiovascular Diseases	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Cardiovascular Diseases	ENSG00000069764	FALSE	Preclinical	2007-09-22	Unused	PLA2G10
Cardiovascular Diseases	ENSG00000070019	FALSE	Phase I Clinical Trial	2014-02-19	Absent	GUCY2C
Cardiovascular Diseases	ENSG00000072062	FALSE	Preclinical	2002-07-10	Unused	PRKACA
Cardiovascular Diseases	ENSG00000073756	FALSE	Preclinical	2009-11-09	Unused	PTGS2
Cardiovascular Diseases	ENSG00000077782	FALSE	Preclinical	NA	Unused	FGFR1
Cardiovascular Diseases	ENSG00000079459	FALSE	Preclinical	1998-10-15	Unused	FDFT1
Cardiovascular Diseases	ENSG00000087237	FALSE	Preclinical	2011-12-13	Preclinical	CETP
Cardiovascular Diseases	ENSG00000089250	FALSE	Preclinical	1998-10-15	Unused	NOS1
Cardiovascular Diseases	ENSG00000089692	FALSE	Preclinical	2016-08-23	Absent	LAG3
Cardiovascular Diseases	ENSG00000090339	FALSE	Preclinical	1990-07-15	Unused	ICAM1
Cardiovascular Diseases	ENSG00000091831	FALSE	Preclinical	1999-05-11	Unused	ESR1
Cardiovascular Diseases	ENSG00000092009	FALSE	Preclinical	2002-04-10	Unused	CMA1
Cardiovascular Diseases	ENSG00000095303	FALSE	Preclinical	2004-02-04	Unused	PTGS1
Cardiovascular Diseases	ENSG00000095321	FALSE	Preclinical	1993-01-15	Unused	CRAT
Cardiovascular Diseases	ENSG00000100985	FALSE	Preclinical	2011-09-29	Absent	MMP9
Cardiovascular Diseases	ENSG00000101109	FALSE	Preclinical	2011-03-02	Unused	STK4
Cardiovascular Diseases	ENSG00000102468	FALSE	Preclinical	1990-07-15	Unused	HTR2A
Cardiovascular Diseases	ENSG00000104368	FALSE	Approved	2017-03-07	Unused	PLAT
Cardiovascular Diseases	ENSG00000105329	FALSE	Preclinical	NA	Absent	TGFB1
Cardiovascular Diseases	ENSG00000105650	FALSE	Preclinical	1990-06-15	Unused	PDE4C
Cardiovascular Diseases	ENSG00000105894	FALSE	Preclinical	2002-02-11	Unused	PTN
Cardiovascular Diseases	ENSG00000106018	FALSE	Preclinical	2014-01-21	Absent	VIPR2
Cardiovascular Diseases	ENSG00000106366	FALSE	unknown	1994-08-15	Unused	SERPINE1
Cardiovascular Diseases	ENSG00000106804	FALSE	Preclinical	2004-04-26	Unused	C5
Cardiovascular Diseases	ENSG00000107562	FALSE	Phase I Clinical Trial	2012-03-21	Absent	CXCL12
Cardiovascular Diseases	ENSG00000108691	FALSE	unknown	2010-01-15	Absent	CCL2
Cardiovascular Diseases	ENSG00000108839	FALSE	Preclinical	NA	Unused	ALOX12
Cardiovascular Diseases	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Cardiovascular Diseases	ENSG00000109610	FALSE	Preclinical	1992-12-15	Unused	SOD3
Cardiovascular Diseases	ENSG00000110090	FALSE	Preclinical	1993-04-15	Unused	CPT1A
Cardiovascular Diseases	ENSG00000111142	FALSE	unknown	2010-07-01	Preclinical	METAP2
Cardiovascular Diseases	ENSG00000112062	FALSE	Preclinical	NA	Unused	MAPK14
Cardiovascular Diseases	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Cardiovascular Diseases	ENSG00000112164	FALSE	unknown	2015-08-19	Absent	GLP1R
Cardiovascular Diseases	ENSG00000113161	FALSE	Preclinical	1994-07-15	Unused	HMGCR
Cardiovascular Diseases	ENSG00000113389	FALSE	Preclinical	2017-03-03	Absent	NPR3
Cardiovascular Diseases	ENSG00000113448	FALSE	Preclinical	1990-06-15	Unused	PDE4D
Cardiovascular Diseases	ENSG00000113749	FALSE	Preclinical	NA	Unused	HRH2
Cardiovascular Diseases	ENSG00000114378	FALSE	Preclinical	NA	Unused	HYAL1
Cardiovascular Diseases	ENSG00000114854	FALSE	Preclinical	2016-03-15	Absent	TNNC1
Cardiovascular Diseases	ENSG00000115252	FALSE	Phase I Clinical Trial	2007-06-26	Unused	PDE1A
Cardiovascular Diseases	ENSG00000116016	FALSE	Preclinical	2002-03-18	Unused	EPAS1
Cardiovascular Diseases	ENSG00000116044	FALSE	Preclinical	2013-08-22	Absent	NFE2L2
Cardiovascular Diseases	ENSG00000116478	FALSE	Preclinical	2007-12-18	Unused	HDAC1
Cardiovascular Diseases	ENSG00000117298	FALSE	Preclinical	1989-07-15	Unused	ECE1
Cardiovascular Diseases	ENSG00000117525	FALSE	Preclinical	2005-01-26	Unused	F3
Cardiovascular Diseases	ENSG00000117560	FALSE	Preclinical	1999-10-05	Unused	FASLG
Cardiovascular Diseases	ENSG00000117601	FALSE	Preclinical	NA	Unused	SERPINC1
Cardiovascular Diseases	ENSG00000118137	FALSE	Preclinical	2003-10-13	Unused	APOA1
Cardiovascular Diseases	ENSG00000118513	FALSE	Preclinical	1992-06-15	Unused	MYB
Cardiovascular Diseases	ENSG00000118523	FALSE	unknown	1999-09-14	Unused	CTGF
Cardiovascular Diseases	ENSG00000119535	FALSE	Phase I Clinical Trial	2012-03-21	Absent	CSF3R
Cardiovascular Diseases	ENSG00000120088	FALSE	unknown	2009-01-07	Unused	CRHR1
Cardiovascular Diseases	ENSG00000120156	FALSE	Preclinical	1995-08-15	Unused	TEK
Cardiovascular Diseases	ENSG00000120907	TRUE	Approved	NA	Approved	ADRA1A
Cardiovascular Diseases	ENSG00000120915	FALSE	Preclinical	2016-10-27	Absent	EPHX2
Cardiovascular Diseases	ENSG00000121361	FALSE	Preclinical	1989-07-15	Unused	KCNJ8
Cardiovascular Diseases	ENSG00000121653	FALSE	Preclinical	2003-08-26	Unused	MAPK8IP1
Cardiovascular Diseases	ENSG00000121691	FALSE	Preclinical	1989-12-15	Unused	CAT
Cardiovascular Diseases	ENSG00000121807	FALSE	Preclinical	2009-09-15	Preclinical	CCR2
Cardiovascular Diseases	ENSG00000121966	FALSE	Preclinical	2008-09-04	Unused	CXCR4
Cardiovascular Diseases	ENSG00000122420	FALSE	Preclinical	NA	Unused	PTGFR
Cardiovascular Diseases	ENSG00000122585	FALSE	Phase II Clinical Trial	1999-12-09	Unused	NPY
Cardiovascular Diseases	ENSG00000122861	FALSE	Preclinical	2000-03-29	Unused	PLAU
Cardiovascular Diseases	ENSG00000125538	FALSE	Preclinical	2012-11-05	Preclinical	IL1B
Cardiovascular Diseases	ENSG00000126218	FALSE	Phase I Clinical Trial	NA	Unused	F10
Cardiovascular Diseases	ENSG00000126895	FALSE	Preclinical	1995-08-15	Unused	AVPR2
Cardiovascular Diseases	ENSG00000127533	FALSE	Phase I Clinical Trial	2014-03-05	Absent	F2RL3
Cardiovascular Diseases	ENSG00000128271	FALSE	Preclinical	1989-06-15	Unused	ADORA2A
Cardiovascular Diseases	ENSG00000129484	FALSE	unknown	2000-06-26	Unused	PARP2
Cardiovascular Diseases	ENSG00000130164	FALSE	Preclinical	1994-06-15	Unused	LDLR
Cardiovascular Diseases	ENSG00000130203	FALSE	unknown	NA	Unused	APOE
Cardiovascular Diseases	ENSG00000130368	FALSE	Preclinical	2008-03-25	Unused	MAS1
Cardiovascular Diseases	ENSG00000131471	FALSE	Preclinical	2016-02-17	Absent	AOC3
Cardiovascular Diseases	ENSG00000131747	FALSE	Preclinical	1991-07-15	Unused	TOP2A
Cardiovascular Diseases	ENSG00000131981	FALSE	Preclinical	2013-08-19	Absent	LGALS3
Cardiovascular Diseases	ENSG00000132329	FALSE	Preclinical	1991-02-15	Unused	RAMP1
Cardiovascular Diseases	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Cardiovascular Diseases	ENSG00000132693	FALSE	unknown	2003-02-12	Unused	CRP
Cardiovascular Diseases	ENSG00000132906	FALSE	Preclinical	1999-04-14	Unused	CASP9
Cardiovascular Diseases	ENSG00000132965	FALSE	unknown	2007-04-13	Unused	ALOX5AP
Cardiovascular Diseases	ENSG00000133105	FALSE	Preclinical	2008-05-20	Unused	RXFP2
Cardiovascular Diseases	ENSG00000134318	FALSE	Preclinical	2003-10-29	Unused	ROCK2
Cardiovascular Diseases	ENSG00000134853	FALSE	Preclinical	NA	Unused	PDGFRA
Cardiovascular Diseases	ENSG00000135124	FALSE	Preclinical	2015-06-24	Absent	P2RX4
Cardiovascular Diseases	ENSG00000135744	FALSE	Preclinical	2017-06-14	Absent	AGT
Cardiovascular Diseases	ENSG00000136160	FALSE	Preclinical	1989-07-15	Unused	EDNRB
Cardiovascular Diseases	ENSG00000137752	FALSE	Preclinical	1998-09-15	Unused	CASP1
Cardiovascular Diseases	ENSG00000138379	FALSE	Preclinical	2002-06-17	Unused	MSTN
Cardiovascular Diseases	ENSG00000138448	FALSE	Preclinical	1998-10-15	Unused	ITGAV
Cardiovascular Diseases	ENSG00000138675	FALSE	Preclinical	1993-04-15	Unused	FGF5
Cardiovascular Diseases	ENSG00000138735	FALSE	Phase III Clinical Trial	1994-09-15	Unused	PDE5A
Cardiovascular Diseases	ENSG00000139610	FALSE	Preclinical	NA	Unused	CELA1
Cardiovascular Diseases	ENSG00000139687	FALSE	Preclinical	2002-08-20	Unused	RB1
Cardiovascular Diseases	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Cardiovascular Diseases	ENSG00000141505	FALSE	Phase I Clinical Trial	2016-12-01	Absent	ASGR1
Cardiovascular Diseases	ENSG00000141744	FALSE	Preclinical	NA	Unused	PNMT
Cardiovascular Diseases	ENSG00000143799	FALSE	Preclinical	2000-06-26	Unused	PARP1
Cardiovascular Diseases	ENSG00000143839	FALSE	Preclinical	1991-12-15	Unused	REN
Cardiovascular Diseases	ENSG00000144285	FALSE	Preclinical	1993-06-15	Unused	SCN1A
Cardiovascular Diseases	ENSG00000144891	FALSE	Preclinical	1992-07-15	Unused	AGTR1
Cardiovascular Diseases	ENSG00000145423	FALSE	Preclinical	1998-12-15	Unused	SFRP2
Cardiovascular Diseases	ENSG00000145936	FALSE	Preclinical	1995-08-15	Unused	KCNMB1
Cardiovascular Diseases	ENSG00000146469	FALSE	Preclinical	NA	Unused	VIP
Cardiovascular Diseases	ENSG00000146648	FALSE	Preclinical	NA	Unused	EGFR
Cardiovascular Diseases	ENSG00000147246	FALSE	Preclinical	1995-08-15	Unused	HTR2C
Cardiovascular Diseases	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Cardiovascular Diseases	ENSG00000149295	FALSE	Preclinical	1994-08-15	Unused	DRD2
Cardiovascular Diseases	ENSG00000149451	FALSE	Preclinical	2002-07-19	Unused	ADAM33
Cardiovascular Diseases	ENSG00000150594	FALSE	Preclinical	1995-12-15	Unused	ADRA2A
Cardiovascular Diseases	ENSG00000151067	FALSE	Phase I Clinical Trial	1989-06-15	Unused	CACNA1C
Cardiovascular Diseases	ENSG00000151617	FALSE	Preclinical	1989-07-15	Unused	EDNRA
Cardiovascular Diseases	ENSG00000151623	FALSE	Preclinical	1992-12-15	Unused	NR3C2
Cardiovascular Diseases	ENSG00000151729	FALSE	Preclinical	2002-11-05	Unused	SLC25A4
Cardiovascular Diseases	ENSG00000153253	FALSE	Preclinical	1993-06-15	Unused	SCN3A
Cardiovascular Diseases	ENSG00000154229	FALSE	Preclinical	1992-03-15	Unused	PRKCA
Cardiovascular Diseases	ENSG00000155011	FALSE	Preclinical	2012-04-18	Preclinical	DKK2
Cardiovascular Diseases	ENSG00000156026	FALSE	Preclinical	2017-07-17	Absent	MCU
Cardiovascular Diseases	ENSG00000157227	FALSE	Preclinical	2001-02-02	Unused	MMP14
Cardiovascular Diseases	ENSG00000158125	FALSE	Preclinical	1991-11-15	Unused	XDH
Cardiovascular Diseases	ENSG00000159640	FALSE	Phase I Clinical Trial	1993-03-15	Unused	ACE
Cardiovascular Diseases	ENSG00000159899	FALSE	Preclinical	2008-06-20	Preclinical	NPR2
Cardiovascular Diseases	ENSG00000160013	FALSE	Phase I Clinical Trial	1990-12-15	Unused	PTGIR
Cardiovascular Diseases	ENSG00000160255	FALSE	Preclinical	1994-06-15	Unused	ITGB2
Cardiovascular Diseases	ENSG00000160691	FALSE	Preclinical	2007-07-23	Unused	SHC1
Cardiovascular Diseases	ENSG00000160791	FALSE	Preclinical	2009-09-15	Preclinical	CCR5
Cardiovascular Diseases	ENSG00000160951	FALSE	Phase I Clinical Trial	1994-04-15	Unused	PTGER1
Cardiovascular Diseases	ENSG00000163399	FALSE	Phase I Clinical Trial	1996-07-15	Unused	ATP1A1
Cardiovascular Diseases	ENSG00000163485	FALSE	Preclinical	1991-11-15	Unused	ADORA1
Cardiovascular Diseases	ENSG00000163737	FALSE	Preclinical	2009-12-01	Preclinical	PF4
Cardiovascular Diseases	ENSG00000164128	FALSE	Preclinical	1996-01-15	Unused	NPY1R
Cardiovascular Diseases	ENSG00000164251	FALSE	Preclinical	2011-06-02	Absent	F2RL1
Cardiovascular Diseases	ENSG00000164266	FALSE	Preclinical	1999-06-02	Unused	SPINK1
Cardiovascular Diseases	ENSG00000164270	FALSE	Preclinical	1995-03-15	Unused	HTR4
Cardiovascular Diseases	ENSG00000164305	FALSE	Preclinical	2000-05-10	Unused	CASP3
Cardiovascular Diseases	ENSG00000164867	FALSE	Preclinical	1998-10-15	Unused	NOS3
Cardiovascular Diseases	ENSG00000165471	FALSE	Preclinical	2004-01-06	Unused	MBL2
Cardiovascular Diseases	ENSG00000166148	FALSE	Preclinical	NA	Unused	AVPR1A
Cardiovascular Diseases	ENSG00000166501	FALSE	Preclinical	1995-09-15	Unused	PRKCB
Cardiovascular Diseases	ENSG00000166603	FALSE	Preclinical	1998-08-15	Unused	MC4R
Cardiovascular Diseases	ENSG00000167601	FALSE	Preclinical	2007-10-29	Unused	AXL
Cardiovascular Diseases	ENSG00000168522	FALSE	Preclinical	1998-10-15	Unused	FNTA
Cardiovascular Diseases	ENSG00000169174	FALSE	Preclinical	2015-08-19	Absent	PCSK9
Cardiovascular Diseases	ENSG00000169252	FALSE	Preclinical	1989-09-15	Unused	ADRB2
Cardiovascular Diseases	ENSG00000169313	FALSE	Preclinical	2001-12-04	Unused	P2RY12
Cardiovascular Diseases	ENSG00000169403	FALSE	Preclinical	1989-07-15	Unused	PTAFR
Cardiovascular Diseases	ENSG00000169418	FALSE	Preclinical	2008-06-20	Preclinical	NPR1
Cardiovascular Diseases	ENSG00000170989	FALSE	Phase I Clinical Trial	2016-11-01	Absent	S1PR1
Cardiovascular Diseases	ENSG00000171049	FALSE	Preclinical	NA	Absent	FPR2
Cardiovascular Diseases	ENSG00000171388	FALSE	Phase I Clinical Trial	2017-01-31	Absent	APLN
Cardiovascular Diseases	ENSG00000171509	FALSE	Preclinical	2008-05-20	Unused	RXFP1
Cardiovascular Diseases	ENSG00000171552	FALSE	Preclinical	2003-06-02	Unused	BCL2L1
Cardiovascular Diseases	ENSG00000171791	FALSE	Preclinical	2001-02-28	Unused	BCL2
Cardiovascular Diseases	ENSG00000171862	FALSE	Preclinical	1999-07-06	Unused	PTEN
Cardiovascular Diseases	ENSG00000172572	TRUE	Approved	1991-12-15	Unused	PDE3A
Cardiovascular Diseases	ENSG00000173175	FALSE	Preclinical	2011-03-01	Unused	ADCY5
Cardiovascular Diseases	ENSG00000173198	FALSE	Preclinical	1994-07-15	Unused	CYSLTR1
Cardiovascular Diseases	ENSG00000173250	FALSE	Preclinical	2017-12-18	Absent	GPR151
Cardiovascular Diseases	ENSG00000174175	FALSE	Preclinical	1993-05-15	Unused	SELP
Cardiovascular Diseases	ENSG00000175445	FALSE	Preclinical	2012-11-23	Preclinical	LPL
Cardiovascular Diseases	ENSG00000175591	FALSE	Preclinical	2017-08-21	Absent	P2RY2
Cardiovascular Diseases	ENSG00000176884	TRUE	Approved	NA	Approved	GRIN1
Cardiovascular Diseases	ENSG00000177606	FALSE	Preclinical	2001-11-13	Unused	JUN
Cardiovascular Diseases	ENSG00000178394	FALSE	Preclinical	1989-09-15	Unused	HTR1A
Cardiovascular Diseases	ENSG00000179142	FALSE	Preclinical	2008-05-21	Unused	CYP11B2
Cardiovascular Diseases	ENSG00000180210	FALSE	Preclinical	1995-06-15	Unused	F2
Cardiovascular Diseases	ENSG00000180772	FALSE	Preclinical	1994-09-15	Unused	AGTR2
Cardiovascular Diseases	ENSG00000180914	FALSE	Preclinical	1995-08-15	Unused	OXTR
Cardiovascular Diseases	ENSG00000181072	FALSE	Preclinical	1991-02-15	Unused	CHRM2
Cardiovascular Diseases	ENSG00000181104	FALSE	Preclinical	1991-11-15	Unused	F2R
Cardiovascular Diseases	ENSG00000181408	FALSE	Preclinical	1999-09-22	Unused	UTS2R
Cardiovascular Diseases	ENSG00000182782	FALSE	Preclinical	2000-12-05	Unused	HCAR2
Cardiovascular Diseases	ENSG00000183023	FALSE	Preclinical	1998-12-15	Unused	SLC8A1
Cardiovascular Diseases	ENSG00000183873	FALSE	Preclinical	2003-07-29	Absent	SCN5A
Cardiovascular Diseases	ENSG00000184588	FALSE	Preclinical	1990-06-15	Unused	PDE4B
Cardiovascular Diseases	ENSG00000184845	FALSE	Preclinical	1990-08-15	Unused	DRD1
Cardiovascular Diseases	ENSG00000185532	FALSE	Preclinical	NA	Unused	PRKG1
Cardiovascular Diseases	ENSG00000186951	FALSE	Preclinical	2009-08-26	Unused	PPARA
Cardiovascular Diseases	ENSG00000187266	FALSE	Preclinical	2002-02-25	Unused	EPOR
Cardiovascular Diseases	ENSG00000187486	FALSE	Preclinical	1990-09-15	Unused	KCNJ11
Cardiovascular Diseases	ENSG00000188404	FALSE	Preclinical	1996-03-15	Unused	SELL
Cardiovascular Diseases	ENSG00000188778	FALSE	Preclinical	1995-06-15	Unused	ADRB3
Cardiovascular Diseases	ENSG00000189403	FALSE	Preclinical	2007-09-22	Unused	HMGB1
Cardiovascular Diseases	ENSG00000196411	FALSE	Preclinical	2006-08-21	Unused	EPHB4
Cardiovascular Diseases	ENSG00000196549	FALSE	Preclinical	1990-09-15	Unused	MME
Cardiovascular Diseases	ENSG00000196591	FALSE	Preclinical	2007-12-18	Unused	HDAC2
Cardiovascular Diseases	ENSG00000196639	FALSE	Preclinical	2007-12-10	Unused	HRH1
Cardiovascular Diseases	ENSG00000197122	FALSE	Preclinical	1997-10-15	Unused	SRC
Cardiovascular Diseases	ENSG00000197249	FALSE	Preclinical	2009-12-01	Absent	SERPINA1
Cardiovascular Diseases	ENSG00000197405	FALSE	Preclinical	2003-10-15	Unused	C5AR1
Cardiovascular Diseases	ENSG00000197442	FALSE	Preclinical	2010-12-23	Unused	MAP3K5
Cardiovascular Diseases	ENSG00000197561	FALSE	Preclinical	1993-08-15	Unused	ELANE
Cardiovascular Diseases	ENSG00000197635	FALSE	Phase I Clinical Trial	2012-03-21	Absent	DPP4
Cardiovascular Diseases	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Cardiovascular Diseases	ENSG00000198049	FALSE	Preclinical	NA	Unused	AVPR1B
Cardiovascular Diseases	ENSG00000198670	FALSE	Preclinical	2015-10-15	Absent	LPA
Cardiovascular Diseases	ENSG00000198793	FALSE	Preclinical	2003-05-28	Unused	MTOR
Cardiovascular Diseases	ENSG00000203710	FALSE	Preclinical	1992-11-15	Unused	CR1
Cardiovascular Diseases	ENSG00000213398	FALSE	Preclinical	2008-04-08	Unused	LCAT
Cardiovascular Diseases	ENSG00000213903	FALSE	Preclinical	NA	Unused	LTB4R
Cardiovascular Diseases	ENSG00000214274	FALSE	Preclinical	NA	Unused	ANG
Cardiovascular Diseases	ENSG00000215644	FALSE	Preclinical	2008-03-04	Absent	GCGR
Cardiovascular Diseases	ENSG00000219073	FALSE	Preclinical	NA	Unused	CELA3B
Cardiovascular Diseases	ENSG00000240972	FALSE	Preclinical	2009-12-01	Preclinical	MIF
Cardiovascular Diseases	ENSG00000259207	FALSE	Preclinical	1991-11-15	Unused	ITGB3
Cardiovascular Diseases	ENSG00000271503	FALSE	Preclinical	2009-12-01	Preclinical	CCL5
Cardiovascular Diseases	ENSG00000274286	FALSE	Preclinical	1991-03-15	Unused	ADRA2B
Cardiovascular Diseases	ENSG00000282608	FALSE	Preclinical	1995-06-15	Unused	ADORA3
Cataplexy	ENSG00000101180	FALSE	Phase III Clinical Trial	2005-10-18	Phase III Clinical Trial	HRH3
Cataplexy	ENSG00000103546	FALSE	unknown	NA	Absent	SLC6A2
Cataplexy	ENSG00000108576	FALSE	unknown	NA	Absent	SLC6A4
Cataract	ENSG00000014216	FALSE	Preclinical	2016-04-28	Absent	CAPN1
Cataract	ENSG00000073756	TRUE	Approved	2008-01-15	Approved	PTGS2
Cataract	ENSG00000085662	FALSE	Phase II Clinical Trial	1989-11-15	Unused	AKR1B1
Cataract	ENSG00000095303	TRUE	Approved	2008-01-15	Approved	PTGS1
Cataract	ENSG00000106799	FALSE	Preclinical	2004-08-11	Unused	TGFBR1
Cataract	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Cataract	ENSG00000116044	FALSE	Phase II Clinical Trial	2014-01-07	Absent	NFE2L2
Cataract	ENSG00000120907	TRUE	Approved	2008-01-15	Phase III Clinical Trial	ADRA1A
Cataract	ENSG00000131747	FALSE	Preclinical	2016-09-21	Absent	TOP2A
Cataract	ENSG00000162909	FALSE	Preclinical	2016-04-28	Absent	CAPN2
Cataract	ENSG00000163513	FALSE	Preclinical	2004-08-11	Unused	TGFBR2
Cataract	ENSG00000170214	TRUE	Approved	2008-01-15	Phase III Clinical Trial	ADRA1B
Cataract	ENSG00000171873	TRUE	Approved	2008-01-15	Phase III Clinical Trial	ADRA1D
Cataract	ENSG00000180720	FALSE	Phase III Clinical Trial	2014-04-07	Absent	CHRM4
Celiac Disease	ENSG00000085377	FALSE	Phase II Clinical Trial	2006-12-11	Phase II Clinical Trial	PREP
Celiac Disease	ENSG00000117525	FALSE	unknown	2003-04-08	Preclinical	F3
Celiac Disease	ENSG00000138684	FALSE	Preclinical	2014-10-29	Absent	IL21
Celiac Disease	ENSG00000163131	FALSE	Phase I Clinical Trial	2014-11-22	Absent	CTSS
Celiac Disease	ENSG00000164136	FALSE	Phase II Clinical Trial	1999-05-26	Absent	IL15
Celiac Disease	ENSG00000165025	FALSE	Preclinical	1992-06-15	Unused	SYK
Celiac Disease	ENSG00000173585	FALSE	Phase II Clinical Trial	2003-07-07	Phase II Clinical Trial	CCR9
Celiac Disease	ENSG00000186827	FALSE	Preclinical	2013-02-05	Absent	TNFRSF4
Celiac Disease	ENSG00000198793	FALSE	Preclinical	2015-05-14	Absent	MTOR
Celiac Disease	ENSG00000198851	FALSE	unknown	2002-11-07	Unused	CD3E
Celiac Disease	ENSG00000198959	FALSE	Phase I Clinical Trial	2008-02-14	Unused	TGM2
Central Nervous System Neoplasms	ENSG00000047936	FALSE	Phase I Clinical Trial	2009-05-20	Absent	ROS1
Central Nervous System Neoplasms	ENSG00000116478	FALSE	Preclinical	2015-01-21	Absent	HDAC1
Central Nervous System Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	2013-07-09	Absent	PIK3CA
Central Nervous System Neoplasms	ENSG00000128052	FALSE	Phase I Clinical Trial	1997-11-15	Absent	KDR
Central Nervous System Neoplasms	ENSG00000135914	TRUE	Approved	NA	Approved	HTR2B
Central Nervous System Neoplasms	ENSG00000140443	FALSE	unknown	2005-08-05	Unused	IGF1R
Central Nervous System Neoplasms	ENSG00000140538	FALSE	Phase I Clinical Trial	2009-05-20	Absent	NTRK3
Central Nervous System Neoplasms	ENSG00000148053	FALSE	Phase I Clinical Trial	2009-05-20	Absent	NTRK2
Central Nervous System Neoplasms	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Central Nervous System Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	1998-09-15	Absent	CTLA4
Central Nervous System Neoplasms	ENSG00000168522	FALSE	unknown	1997-06-15	Phase I Clinical Trial	FNTA
Central Nervous System Neoplasms	ENSG00000170430	FALSE	unknown	1998-06-15	Unused	MGMT
Central Nervous System Neoplasms	ENSG00000171094	FALSE	Phase I Clinical Trial	2009-05-20	Absent	ALK
Central Nervous System Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Central Nervous System Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Central Nervous System Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Central Nervous System Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK1
Central Nervous System Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	MTOR
Cerebral Amyloid Angiopathy	ENSG00000142192	FALSE	Phase II Clinical Trial	2004-11-12	Absent	APP
Cerebral Hemorrhage	ENSG00000057593	FALSE	Phase III Clinical Trial	2004-12-07	Unused	F7
Cerebral Hemorrhage	ENSG00000067182	FALSE	unknown	2009-06-09	Preclinical	TNFRSF1A
Cerebral Hemorrhage	ENSG00000074416	FALSE	Phase I Clinical Trial	NA	Absent	MGLL
Cerebral Hemorrhage	ENSG00000115263	FALSE	unknown	2004-03-05	Phase II Clinical Trial	GCG
Cerebral Hemorrhage	ENSG00000125538	FALSE	unknown	2009-06-09	Preclinical	IL1B
Cerebral Hemorrhage	ENSG00000126218	FALSE	Phase I Clinical Trial	2013-07-12	Absent	F10
Cerebral Hemorrhage	ENSG00000138039	FALSE	unknown	2005-12-06	Unused	LHCGR
Cerebral Hemorrhage	ENSG00000140443	FALSE	Phase II Clinical Trial	NA	Absent	IGF1R
Cerebral Hemorrhage	ENSG00000170989	FALSE	Preclinical	2006-12-07	Absent	S1PR1
Cerebral Hemorrhage	ENSG00000180739	FALSE	Preclinical	2006-12-07	Absent	S1PR5
Cerebral Hemorrhage	ENSG00000187266	FALSE	unknown	2005-12-06	Unused	EPOR
Cerebral Infarction	ENSG00000005961	FALSE	unknown	2001-12-19	Unused	ITGA2B
Cerebral Infarction	ENSG00000006283	FALSE	Phase I Clinical Trial	2001-01-10	Unused	CACNA1G
Cerebral Infarction	ENSG00000006638	FALSE	Preclinical	1996-06-15	Unused	TBXA2R
Cerebral Infarction	ENSG00000059377	FALSE	Phase II Clinical Trial	NA	Unused	TBXAS1
Cerebral Infarction	ENSG00000065989	TRUE	Approved	NA	Approved	PDE4A
Cerebral Infarction	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Cerebral Infarction	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Cerebral Infarction	ENSG00000102468	FALSE	unknown	1989-11-15	Unused	HTR2A
Cerebral Infarction	ENSG00000104368	FALSE	Preclinical	1994-07-15	Unused	PLAT
Cerebral Infarction	ENSG00000105650	TRUE	Approved	NA	Approved	PDE4C
Cerebral Infarction	ENSG00000112541	FALSE	Approved	NA	Unused	PDE10A
Cerebral Infarction	ENSG00000113448	TRUE	Approved	NA	Approved	PDE4D
Cerebral Infarction	ENSG00000128655	FALSE	Approved	NA	Unused	PDE11A
Cerebral Infarction	ENSG00000131471	FALSE	Preclinical	2015-06-09	Absent	AOC3
Cerebral Infarction	ENSG00000136160	FALSE	Preclinical	1997-10-15	Unused	EDNRB
Cerebral Infarction	ENSG00000136869	FALSE	Approved	NA	Absent	TLR4
Cerebral Infarction	ENSG00000148408	FALSE	Preclinical	2000-03-22	Unused	CACNA1B
Cerebral Infarction	ENSG00000150093	FALSE	Preclinical	2001-07-23	Unused	ITGB1
Cerebral Infarction	ENSG00000151617	FALSE	Preclinical	1997-10-15	Unused	EDNRA
Cerebral Infarction	ENSG00000164171	FALSE	Preclinical	2001-07-23	Unused	ITGA2
Cerebral Infarction	ENSG00000169313	TRUE	Approved	NA	Approved	P2RY12
Cerebral Infarction	ENSG00000171557	FALSE	unknown	NA	Unused	FGG
Cerebral Infarction	ENSG00000171560	FALSE	unknown	NA	Unused	FGA
Cerebral Infarction	ENSG00000171564	FALSE	unknown	NA	Unused	FGB
Cerebral Infarction	ENSG00000172572	TRUE	Approved	2008-10-20	Approved	PDE3A
Cerebral Infarction	ENSG00000173198	FALSE	Preclinical	1996-06-15	Unused	CYSLTR1
Cerebral Infarction	ENSG00000176884	FALSE	unknown	1998-08-15	Unused	GRIN1
Cerebral Infarction	ENSG00000180210	FALSE	Preclinical	1997-03-15	Unused	F2
Cerebral Infarction	ENSG00000184588	TRUE	Approved	NA	Approved	PDE4B
Cerebral Infarction	ENSG00000240972	FALSE	Approved	NA	Unused	MIF
Cerebral Infarction	ENSG00000259207	FALSE	unknown	2001-12-19	Unused	ITGB3
Cerebral Infarction	ENSG00000273079	FALSE	unknown	NA	Unused	GRIN2B
Cerebral Palsy	ENSG00000004948	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CALCR
Cerebral Palsy	ENSG00000118432	FALSE	Phase III Clinical Trial	1998-08-15	Absent	CNR1
Chagas Disease	ENSG00000068903	FALSE	Preclinical	2015-08-26	Absent	SIRT2
Charcot-Marie-Tooth Disease	ENSG00000082556	FALSE	Phase III Clinical Trial	2009-06-15	Absent	OPRK1
Charcot-Marie-Tooth Disease	ENSG00000087074	FALSE	Preclinical	2014-04-30	Absent	PPP1R15A
Charcot-Marie-Tooth Disease	ENSG00000094631	FALSE	Preclinical	2009-08-13	Absent	HDAC6
Charcot-Marie-Tooth Disease	ENSG00000104321	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPA1
Charcot-Marie-Tooth Disease	ENSG00000112038	FALSE	Phase III Clinical Trial	2009-06-15	Absent	OPRM1
Charcot-Marie-Tooth Disease	ENSG00000140538	FALSE	Preclinical	2016-10-25	Absent	NTRK3
Charcot-Marie-Tooth Disease	ENSG00000148053	FALSE	Preclinical	2016-10-25	Absent	NTRK2
Charcot-Marie-Tooth Disease	ENSG00000196689	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPV1
Chickenpox	ENSG00000164342	FALSE	Preclinical	2017-05-26	Absent	TLR3
Chikungunya Fever	ENSG00000158859	FALSE	Preclinical	2015-09-03	Absent	ADAMTS4
Chlamydia Infections	ENSG00000010610	FALSE	Phase III Clinical Trial	1993-07-15	Unused	CD4
Chlamydia Infections	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Cholangitis	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Cholangitis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Cholangitis	ENSG00000160867	FALSE	Phase II Clinical Trial	2012-03-30	Absent	FGFR4
Cholangitis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Cholangitis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Cholangitis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Cholangitis, Sclerosing	ENSG00000012504	FALSE	Phase II Clinical Trial	1999-03-17	Absent	NR1H4
Cholangitis, Sclerosing	ENSG00000073756	FALSE	Preclinical	2008-03-11	Absent	PTGS2
Cholangitis, Sclerosing	ENSG00000105329	FALSE	Preclinical	2008-03-11	Absent	TGFB1
Cholangitis, Sclerosing	ENSG00000115232	FALSE	Preclinical	1995-10-15	Absent	ITGA4
Cholangitis, Sclerosing	ENSG00000121807	FALSE	Phase II Clinical Trial	NA	Absent	CCR2
Cholangitis, Sclerosing	ENSG00000131471	FALSE	Phase II Clinical Trial	2006-06-01	Absent	AOC3
Cholangitis, Sclerosing	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Absent	LOXL2
Cholangitis, Sclerosing	ENSG00000139626	FALSE	Preclinical	1995-10-15	Absent	ITGB7
Cholangitis, Sclerosing	ENSG00000160791	FALSE	Phase II Clinical Trial	NA	Absent	CCR5
Cholecystitis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Cholecystitis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Cholecystitis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Cholecystitis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Cholelithiasis	ENSG00000099194	FALSE	Phase II Clinical Trial	2007-08-21	Unused	SCD
Cholelithiasis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Cholelithiasis	ENSG00000163394	FALSE	unknown	2000-02-06	Unused	CCKAR
Cholelithiasis	ENSG00000165029	FALSE	Phase II Clinical Trial	2007-08-21	Unused	ABCA1
Cholelithiasis	ENSG00000167910	FALSE	Phase II Clinical Trial	2007-08-21	Unused	CYP7A1
Cholelithiasis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Cholelithiasis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Cholelithiasis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Cholestasis, Intrahepatic	ENSG00000005471	FALSE	Preclinical	2015-10-01	Absent	ABCB4
Cholestasis, Intrahepatic	ENSG00000012504	FALSE	Phase II Clinical Trial	1999-03-17	Absent	NR1H4
Cholestasis, Intrahepatic	ENSG00000125255	FALSE	Preclinical	2008-04-18	Absent	SLC10A2
Chordoma	ENSG00000037280	FALSE	Phase I Clinical Trial	2003-08-12	Absent	FLT4
Chordoma	ENSG00000082898	FALSE	Phase I Clinical Trial	2012-06-02	Absent	XPO1
Chordoma	ENSG00000112715	FALSE	Phase I Clinical Trial	2003-08-12	Absent	VEGFA
Chordoma	ENSG00000128052	FALSE	Phase I Clinical Trial	2003-08-12	Absent	KDR
Chordoma	ENSG00000141736	FALSE	Phase I Clinical Trial	2003-08-12	Absent	ERBB2
Chordoma	ENSG00000146648	FALSE	Phase I Clinical Trial	2003-08-12	Absent	EGFR
Chordoma	ENSG00000196411	FALSE	Phase I Clinical Trial	2003-08-12	Absent	EPHB4
Chordoma	ENSG00000197122	FALSE	Phase I Clinical Trial	2003-08-12	Absent	SRC
Chordoma	ENSG00000198900	FALSE	unknown	NA	Absent	TOP1
Chorioretinitis	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Choroidal Neovascularization	ENSG00000106804	FALSE	Phase II Clinical Trial	2007-04-30	Absent	C5
Choroidal Neovascularization	ENSG00000179776	FALSE	Phase II Clinical Trial	2000-12-11	Phase II Clinical Trial	CDH5
Choroideremia	ENSG00000188419	FALSE	Phase II Clinical Trial	2014-02-06	Absent	CHM
Chronic Kidney Disease-Mineral and Bone Disorder	ENSG00000111424	TRUE	Approved	1989-07-15	Approved	VDR
Churg-Strauss Syndrome	ENSG00000113525	TRUE	Approved	1997-05-15	Absent	IL5
Churg-Strauss Syndrome	ENSG00000197405	FALSE	unknown	2006-07-25	Absent	C5AR1
Citrullinemia	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Citrullinemia	ENSG00000130707	FALSE	Preclinical	2016-09-09	Absent	ASS1
Clostridium Infections	ENSG00000012223	FALSE	unknown	NA	Phase II Clinical Trial	LTF
Cluster Headache	ENSG00000073756	FALSE	unknown	2009-01-15	Absent	PTGS2
Cluster Headache	ENSG00000082556	FALSE	unknown	2009-01-15	Phase III Clinical Trial	OPRK1
Cluster Headache	ENSG00000095303	FALSE	unknown	2009-01-15	Phase III Clinical Trial	PTGS1
Cluster Headache	ENSG00000110680	FALSE	Phase III Clinical Trial	2004-11-12	Unused	CALCA
Cluster Headache	ENSG00000112038	FALSE	unknown	2009-01-15	Phase III Clinical Trial	OPRM1
Cluster Headache	ENSG00000116329	FALSE	unknown	2009-01-15	Phase III Clinical Trial	OPRD1
Cluster Headache	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR1
Cluster Headache	ENSG00000155511	FALSE	unknown	NA	Unused	GRIA1
Cluster Headache	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR5
Cluster Headache	ENSG00000179546	TRUE	Approved	2004-11-03	Approved	HTR1D
Cluster Headache	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR2
Cluster Headache	ENSG00000183873	FALSE	unknown	NA	Unused	SCN5A
Cluster Headache	ENSG00000196639	FALSE	unknown	2009-01-15	Phase III Clinical Trial	HRH1
Cluster Headache	ENSG00000196689	FALSE	Phase III Clinical Trial	2005-01-28	Phase III Clinical Trial	TRPV1
Cluster Headache	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR3
Coagulation Protein Disorders	ENSG00000122194	FALSE	Pre-registration	NA	Absent	PLG
Cocaine-Related Disorders	ENSG00000011677	FALSE	Phase I Clinical Trial	2009-07-16	Phase I Clinical Trial	GABRA3
Cocaine-Related Disorders	ENSG00000022355	FALSE	Phase I Clinical Trial	2009-07-16	Phase I Clinical Trial	GABRA1
Cocaine-Related Disorders	ENSG00000069535	FALSE	unknown	1995-12-15	Unused	MAOB
Cocaine-Related Disorders	ENSG00000082556	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRK1
Cocaine-Related Disorders	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Cocaine-Related Disorders	ENSG00000103546	FALSE	Phase II Clinical Trial	1998-06-15	Unused	SLC6A2
Cocaine-Related Disorders	ENSG00000108576	FALSE	Phase II Clinical Trial	1998-06-15	Unused	SLC6A4
Cocaine-Related Disorders	ENSG00000111275	FALSE	Preclinical	2007-01-29	Absent	ALDH2
Cocaine-Related Disorders	ENSG00000112038	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRM1
Cocaine-Related Disorders	ENSG00000114200	FALSE	Phase II Clinical Trial	2001-09-07	Unused	BCHE
Cocaine-Related Disorders	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-29	Phase II Clinical Trial	OPRD1
Cocaine-Related Disorders	ENSG00000121764	FALSE	Preclinical	2012-03-22	Absent	HCRTR1
Cocaine-Related Disorders	ENSG00000123454	FALSE	Phase II Clinical Trial	1996-12-15	Phase II Clinical Trial	DBH
Cocaine-Related Disorders	ENSG00000142319	FALSE	Phase II Clinical Trial	1994-12-15	Unused	SLC6A3
Cocaine-Related Disorders	ENSG00000147955	FALSE	Preclinical	1990-04-15	Unused	SIGMAR1
Cocaine-Related Disorders	ENSG00000149295	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DRD2
Cocaine-Related Disorders	ENSG00000151577	FALSE	Preclinical	1998-08-15	Unused	DRD3
Cocaine-Related Disorders	ENSG00000151834	FALSE	Phase I Clinical Trial	2009-07-16	Phase I Clinical Trial	GABRA2
Cocaine-Related Disorders	ENSG00000155511	FALSE	Preclinical	2002-11-15	Absent	GRIA1
Cocaine-Related Disorders	ENSG00000164082	FALSE	Preclinical	2017-10-04	Absent	GRM2
Cocaine-Related Disorders	ENSG00000164129	FALSE	Preclinical	2010-10-01	Unused	NPY5R
Cocaine-Related Disorders	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Absent	GRM5
Cocaine-Related Disorders	ENSG00000171408	FALSE	Preclinical	2009-01-09	Preclinical	PDE7B
Cocaine-Related Disorders	ENSG00000178394	FALSE	Phase II Clinical Trial	NA	Absent	HTR1A
Cocaine-Related Disorders	ENSG00000179142	FALSE	Phase I Clinical Trial	2009-07-16	Phase I Clinical Trial	CYP11B2
Cocaine-Related Disorders	ENSG00000184845	FALSE	Phase II Clinical Trial	1995-06-15	Unused	DRD1
Cocaine-Related Disorders	ENSG00000186297	FALSE	Phase I Clinical Trial	2009-07-16	Phase I Clinical Trial	GABRA5
Cocaine-Related Disorders	ENSG00000187554	FALSE	Preclinical	2017-01-09	Absent	TLR5
Cocaine-Related Disorders	ENSG00000189221	FALSE	unknown	NA	Unused	MAOA
Cocaine-Related Disorders	ENSG00000205268	FALSE	Preclinical	2009-01-09	Preclinical	PDE7A
Colic	ENSG00000075073	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	TACR2
Colitis	ENSG00000012223	FALSE	Preclinical	NA	Absent	LTF
Colitis	ENSG00000012779	FALSE	Preclinical	1995-02-15	Unused	ALOX5
Colitis	ENSG00000059377	FALSE	unknown	1995-02-15	Unused	TBXAS1
Colitis	ENSG00000073756	FALSE	Preclinical	1998-12-15	Unused	PTGS2
Colitis	ENSG00000095303	FALSE	Preclinical	1998-12-15	Unused	PTGS1
Colitis	ENSG00000100739	FALSE	Preclinical	2008-07-03	Unused	BDKRB1
Colitis	ENSG00000104783	FALSE	Preclinical	2014-05-08	Absent	KCNN4
Colitis	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Colitis	ENSG00000112062	FALSE	Preclinical	2010-05-28	Unused	MAPK14
Colitis	ENSG00000113302	FALSE	Preclinical	1996-09-15	Unused	IL12B
Colitis	ENSG00000113580	TRUE	Approved	2001-02-15	Approved	NR3C1
Colitis	ENSG00000116678	FALSE	Preclinical	2008-11-13	Preclinical	LEPR
Colitis	ENSG00000116824	FALSE	Preclinical	2011-06-23	Unused	CD2
Colitis	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Colitis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Colitis	ENSG00000163394	FALSE	Preclinical	1995-11-15	Unused	CCKAR
Colitis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Colitis	ENSG00000168811	FALSE	Preclinical	1996-09-15	Unused	IL12A
Colitis	ENSG00000169218	FALSE	unknown	1998-12-15	Unused	RSPO1
Colitis	ENSG00000172236	FALSE	Preclinical	NA	Absent	TPSAB1
Colitis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Colitis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Colitis	ENSG00000198793	FALSE	Preclinical	2008-10-29	Unused	MTOR
Colitis	ENSG00000269858	FALSE	Preclinical	2014-02-25	Absent	EGLN2
Colitis, Ulcerative	ENSG00000007908	FALSE	Phase II Clinical Trial	2006-05-31	Unused	SELE
Colitis, Ulcerative	ENSG00000012223	FALSE	unknown	2012-12-07	Absent	LTF
Colitis, Ulcerative	ENSG00000012779	FALSE	Phase II Clinical Trial	1994-10-15	Unused	ALOX5
Colitis, Ulcerative	ENSG00000017797	FALSE	Phase II Clinical Trial	2014-12-01	Absent	RALBP1
Colitis, Ulcerative	ENSG00000027075	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCH
Colitis, Ulcerative	ENSG00000056736	FALSE	Preclinical	NA	Absent	IL17RB
Colitis, Ulcerative	ENSG00000059377	FALSE	Phase II Clinical Trial	2014-07-30	Absent	TBXAS1
Colitis, Ulcerative	ENSG00000063176	FALSE	Preclinical	2006-06-05	Absent	SPHK2
Colitis, Ulcerative	ENSG00000065325	FALSE	unknown	2008-09-17	Preclinical	GLP2R
Colitis, Ulcerative	ENSG00000065675	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCQ
Colitis, Ulcerative	ENSG00000065989	FALSE	Phase III Clinical Trial	1996-01-15	Unused	PDE4A
Colitis, Ulcerative	ENSG00000066468	FALSE	unknown	1998-04-15	Unused	FGFR2
Colitis, Ulcerative	ENSG00000067182	FALSE	Phase II Clinical Trial	2004-01-28	Absent	TNFRSF1A
Colitis, Ulcerative	ENSG00000070019	FALSE	Phase II Clinical Trial	2003-07-23	Phase I Clinical Trial	GUCY2C
Colitis, Ulcerative	ENSG00000073756	TRUE	Approved	1991-08-15	Approved	PTGS2
Colitis, Ulcerative	ENSG00000078579	FALSE	unknown	2002-02-01	Unused	FGF20
Colitis, Ulcerative	ENSG00000082556	FALSE	Preclinical	2012-09-01	Preclinical	OPRK1
Colitis, Ulcerative	ENSG00000083457	FALSE	Phase III Clinical Trial	2007-03-23	Phase II Clinical Trial	ITGAE
Colitis, Ulcerative	ENSG00000087085	FALSE	Phase II Clinical Trial	2001-09-14	Phase II Clinical Trial	ACHE
Colitis, Ulcerative	ENSG00000088832	TRUE	Approved	NA	Approved	FKBP1A
Colitis, Ulcerative	ENSG00000090339	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	ICAM1
Colitis, Ulcerative	ENSG00000095303	TRUE	Approved	1991-08-15	Approved	PTGS1
Colitis, Ulcerative	ENSG00000095321	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CRAT
Colitis, Ulcerative	ENSG00000096717	FALSE	Phase I Clinical Trial	2008-10-21	Phase I Clinical Trial	SIRT1
Colitis, Ulcerative	ENSG00000096968	FALSE	Phase I Clinical Trial	2007-10-10	Absent	JAK2
Colitis, Ulcerative	ENSG00000099866	FALSE	Phase III Clinical Trial	2007-01-10	Phase II Clinical Trial	MADCAM1
Colitis, Ulcerative	ENSG00000100985	FALSE	Phase II Clinical Trial	2013-03-05	Absent	MMP9
Colitis, Ulcerative	ENSG00000101017	FALSE	Phase I Clinical Trial	2014-03-07	Absent	CD40
Colitis, Ulcerative	ENSG00000101665	FALSE	Phase II Clinical Trial	2008-11-28	Absent	SMAD7
Colitis, Ulcerative	ENSG00000102967	FALSE	Phase I Clinical Trial	2002-11-13	Phase II Clinical Trial	DHODH
Colitis, Ulcerative	ENSG00000104783	FALSE	Preclinical	2013-12-05	Absent	KCNN4
Colitis, Ulcerative	ENSG00000105397	FALSE	Phase II Clinical Trial	2014-12-09	Absent	TYK2
Colitis, Ulcerative	ENSG00000105639	FALSE	Pre-registration	2003-06-25	Phase III Clinical Trial	JAK3
Colitis, Ulcerative	ENSG00000105650	FALSE	Phase III Clinical Trial	1996-01-15	Unused	PDE4C
Colitis, Ulcerative	ENSG00000107485	FALSE	Phase II Clinical Trial	2014-05-07	Absent	GATA3
Colitis, Ulcerative	ENSG00000109320	FALSE	Phase II Clinical Trial	1994-09-15	Phase II Clinical Trial	NFKB1
Colitis, Ulcerative	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Colitis, Ulcerative	ENSG00000110324	FALSE	Phase II Clinical Trial	2007-03-02	Absent	IL10RA
Colitis, Ulcerative	ENSG00000110944	FALSE	Phase II Clinical Trial	2010-04-07	Absent	IL23A
Colitis, Ulcerative	ENSG00000111321	FALSE	Phase II Clinical Trial	2007-07-20	Unused	LTBR
Colitis, Ulcerative	ENSG00000111424	FALSE	Preclinical	2005-05-15	Unused	VDR
Colitis, Ulcerative	ENSG00000112038	FALSE	Preclinical	2012-09-01	Preclinical	OPRM1
Colitis, Ulcerative	ENSG00000112115	FALSE	Phase II Clinical Trial	2012-03-21	Phase II Clinical Trial	IL17A
Colitis, Ulcerative	ENSG00000112116	FALSE	Phase II Clinical Trial	2012-03-21	Absent	IL17F
Colitis, Ulcerative	ENSG00000113302	FALSE	Phase III Clinical Trial	1996-09-15	Phase II Clinical Trial	IL12B
Colitis, Ulcerative	ENSG00000113448	FALSE	Phase III Clinical Trial	1996-01-15	Unused	PDE4D
Colitis, Ulcerative	ENSG00000113580	TRUE	Approved	1992-11-15	Approved	NR3C1
Colitis, Ulcerative	ENSG00000114013	FALSE	Preclinical	1992-11-15	Phase III Clinical Trial	CD86
Colitis, Ulcerative	ENSG00000115009	FALSE	Phase I Clinical Trial	2009-03-25	Absent	CCL20
Colitis, Ulcerative	ENSG00000115232	TRUE	Approved	1991-12-15	Phase III Clinical Trial	ITGA4
Colitis, Ulcerative	ENSG00000115353	FALSE	unknown	1993-01-15	Unused	TACR1
Colitis, Ulcerative	ENSG00000115541	FALSE	unknown	2002-09-04	Unused	HSPE1
Colitis, Ulcerative	ENSG00000116044	FALSE	Preclinical	2013-07-19	Absent	NFE2L2
Colitis, Ulcerative	ENSG00000117601	FALSE	unknown	2007-03-14	Phase II Clinical Trial	SERPINC1
Colitis, Ulcerative	ENSG00000121594	FALSE	Preclinical	1992-11-15	Phase III Clinical Trial	CD80
Colitis, Ulcerative	ENSG00000121807	FALSE	Preclinical	1999-05-19	Unused	CCR2
Colitis, Ulcerative	ENSG00000122025	FALSE	Preclinical	2009-10-29	Unused	FLT3
Colitis, Ulcerative	ENSG00000124172	FALSE	Phase II Clinical Trial	2014-05-15	Absent	ATP5F1E
Colitis, Ulcerative	ENSG00000124491	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	F13A1
Colitis, Ulcerative	ENSG00000125571	FALSE	Preclinical	2016-06-14	Absent	IL37
Colitis, Ulcerative	ENSG00000125735	FALSE	unknown	2009-05-14	Phase I Clinical Trial	TNFSF14
Colitis, Ulcerative	ENSG00000125910	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR4
Colitis, Ulcerative	ENSG00000126262	FALSE	Phase II Clinical Trial	2009-06-29	Preclinical	FFAR2
Colitis, Ulcerative	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Colitis, Ulcerative	ENSG00000129167	FALSE	Phase II Clinical Trial	2007-02-05	Phase II Clinical Trial	TPH1
Colitis, Ulcerative	ENSG00000130234	FALSE	unknown	2007-07-31	Phase II Clinical Trial	ACE2
Colitis, Ulcerative	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Colitis, Ulcerative	ENSG00000132170	FALSE	Phase III Clinical Trial	1995-03-15	Unused	PPARG
Colitis, Ulcerative	ENSG00000132434	FALSE	Preclinical	2014-05-15	Absent	LANCL2
Colitis, Ulcerative	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Colitis, Ulcerative	ENSG00000134460	FALSE	Phase II Clinical Trial	1992-04-15	Unused	IL2RA
Colitis, Ulcerative	ENSG00000136634	FALSE	Preclinical	2001-02-08	Unused	IL10
Colitis, Ulcerative	ENSG00000136869	FALSE	Phase II Clinical Trial	2006-08-17	Absent	TLR4
Colitis, Ulcerative	ENSG00000137070	FALSE	unknown	2003-05-19	Unused	IL11RA
Colitis, Ulcerative	ENSG00000137462	FALSE	Phase II Clinical Trial	2006-08-17	Absent	TLR2
Colitis, Ulcerative	ENSG00000139572	FALSE	unknown	2013-01-15	Absent	GPR84
Colitis, Ulcerative	ENSG00000139626	TRUE	Approved	1991-12-15	Phase III Clinical Trial	ITGB7
Colitis, Ulcerative	ENSG00000142677	FALSE	Phase II Clinical Trial	2011-07-28	Absent	IL22RA1
Colitis, Ulcerative	ENSG00000146070	FALSE	Preclinical	2016-11-25	Absent	PLA2G7
Colitis, Ulcerative	ENSG00000148344	FALSE	unknown	2006-12-19	Unused	PTGES
Colitis, Ulcerative	ENSG00000150093	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	ITGB1
Colitis, Ulcerative	ENSG00000154229	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCA
Colitis, Ulcerative	ENSG00000159110	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IFNAR2
Colitis, Ulcerative	ENSG00000160712	FALSE	Phase II Clinical Trial	1998-08-15	Unused	IL6R
Colitis, Ulcerative	ENSG00000160791	FALSE	Phase I Clinical Trial	1999-05-19	Unused	CCR5
Colitis, Ulcerative	ENSG00000162434	FALSE	Pre-registration	2003-06-25	Phase III Clinical Trial	JAK1
Colitis, Ulcerative	ENSG00000163464	FALSE	Phase I Clinical Trial	2004-10-12	Unused	CXCR1
Colitis, Ulcerative	ENSG00000163599	FALSE	unknown	2008-01-30	Absent	CTLA4
Colitis, Ulcerative	ENSG00000163932	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCD
Colitis, Ulcerative	ENSG00000164171	FALSE	Phase I Clinical Trial	2006-02-13	Phase II Clinical Trial	ITGA2
Colitis, Ulcerative	ENSG00000164251	FALSE	Preclinical	NA	Preclinical	F2RL1
Colitis, Ulcerative	ENSG00000164342	FALSE	Preclinical	2010-09-08	Absent	TLR3
Colitis, Ulcerative	ENSG00000166501	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCB
Colitis, Ulcerative	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Colitis, Ulcerative	ENSG00000168610	FALSE	Phase II Clinical Trial	2013-12-20	Absent	STAT3
Colitis, Ulcerative	ENSG00000168685	FALSE	Preclinical	2011-07-13	Absent	IL7R
Colitis, Ulcerative	ENSG00000168811	FALSE	Preclinical	1996-09-15	Unused	IL12A
Colitis, Ulcerative	ENSG00000169194	FALSE	Phase II Clinical Trial	2003-05-20	Phase II Clinical Trial	IL13
Colitis, Ulcerative	ENSG00000169245	FALSE	Phase I Clinical Trial	2003-01-07	Phase II Clinical Trial	CXCL10
Colitis, Ulcerative	ENSG00000169403	TRUE	Approved	1998-09-15	Approved	PTAFR
Colitis, Ulcerative	ENSG00000170820	FALSE	Preclinical	2007-11-05	Unused	FSHR
Colitis, Ulcerative	ENSG00000170989	FALSE	Phase III Clinical Trial	2009-01-15	Phase II Clinical Trial	S1PR1
Colitis, Ulcerative	ENSG00000171132	FALSE	Phase II Clinical Trial	2005-01-26	Phase II Clinical Trial	PRKCE
Colitis, Ulcerative	ENSG00000171522	FALSE	Phase II Clinical Trial	NA	Unused	PTGER4
Colitis, Ulcerative	ENSG00000172156	FALSE	Phase II Clinical Trial	2000-08-02	Preclinical	CCL11
Colitis, Ulcerative	ENSG00000172236	FALSE	unknown	1998-07-15	Unused	TPSAB1
Colitis, Ulcerative	ENSG00000172936	FALSE	unknown	2000-03-01	Unused	MYD88
Colitis, Ulcerative	ENSG00000173039	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	RELA
Colitis, Ulcerative	ENSG00000173585	FALSE	Phase I Clinical Trial	2003-07-07	Phase II Clinical Trial	CCR9
Colitis, Ulcerative	ENSG00000175104	FALSE	unknown	2000-03-01	Unused	TRAF6
Colitis, Ulcerative	ENSG00000178568	FALSE	Preclinical	2015-10-23	Absent	ERBB4
Colitis, Ulcerative	ENSG00000180210	FALSE	Phase III Clinical Trial	1996-01-15	Unused	F2
Colitis, Ulcerative	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Colitis, Ulcerative	ENSG00000180739	FALSE	Phase III Clinical Trial	2009-01-15	Absent	S1PR5
Colitis, Ulcerative	ENSG00000180871	FALSE	Phase I Clinical Trial	2004-10-12	Unused	CXCR2
Colitis, Ulcerative	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Colitis, Ulcerative	ENSG00000181634	FALSE	Phase II Clinical Trial	2013-11-21	Absent	TNFSF15
Colitis, Ulcerative	ENSG00000184216	FALSE	unknown	2000-03-01	Unused	IRAK1
Colitis, Ulcerative	ENSG00000184588	FALSE	Phase III Clinical Trial	1996-01-15	Unused	PDE4B
Colitis, Ulcerative	ENSG00000186827	FALSE	Phase II Clinical Trial	2013-02-01	Absent	TNFRSF4
Colitis, Ulcerative	ENSG00000188404	FALSE	unknown	NA	Unused	SELL
Colitis, Ulcerative	ENSG00000196262	FALSE	Phase II Clinical Trial	2010-01-29	Phase II Clinical Trial	PPIA
Colitis, Ulcerative	ENSG00000197249	FALSE	unknown	NA	Unused	SERPINA1
Colitis, Ulcerative	ENSG00000197329	FALSE	Preclinical	2017-04-04	Absent	PELI1
Colitis, Ulcerative	ENSG00000197405	FALSE	Preclinical	2003-06-24	Unused	C5AR1
Colitis, Ulcerative	ENSG00000198793	FALSE	unknown	NA	Unused	MTOR
Colitis, Ulcerative	ENSG00000198851	FALSE	Preclinical	2004-02-24	Absent	CD3E
Colitis, Ulcerative	ENSG00000204174	FALSE	Phase II Clinical Trial	2006-07-31	Absent	NPY4R
Colitis, Ulcerative	ENSG00000213903	FALSE	unknown	1990-07-15	Unused	LTB4R
Colitis, Ulcerative	ENSG00000213949	FALSE	unknown	2002-11-29	Absent	ITGA1
Colitis, Ulcerative	ENSG00000239732	FALSE	Phase III Clinical Trial	1993-07-15	Phase III Clinical Trial	TLR9
Colitis, Ulcerative	ENSG00000240972	FALSE	Preclinical	2004-01-13	Preclinical	MIF
Color Vision Defects	ENSG00000122756	FALSE	Phase I Clinical Trial	2000-05-31	Phase I Clinical Trial	CNTFR
Color Vision Defects	ENSG00000144191	FALSE	Phase II Clinical Trial	2017-01-04	Absent	CNGA3
Color Vision Defects	ENSG00000170289	FALSE	Phase II Clinical Trial	2009-05-04	Preclinical	CNGB3
Colorectal Neoplasms	ENSG00000003402	FALSE	Preclinical	2015-05-11	Absent	CFLAR
Colorectal Neoplasms	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Colorectal Neoplasms	ENSG00000006283	FALSE	Preclinical	2009-02-12	Unused	CACNA1G
Colorectal Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Colorectal Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Colorectal Neoplasms	ENSG00000007171	FALSE	unknown	1993-06-15	Unused	NOS2
Colorectal Neoplasms	ENSG00000007908	FALSE	Preclinical	2015-03-23	Absent	SELE
Colorectal Neoplasms	ENSG00000010278	FALSE	Preclinical	2012-05-05	Absent	CD9
Colorectal Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Colorectal Neoplasms	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Colorectal Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Colorectal Neoplasms	ENSG00000019582	FALSE	Preclinical	2000-04-26	Unused	CD74
Colorectal Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Unused	HGF
Colorectal Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Phase II Clinical Trial	BIRC3
Colorectal Neoplasms	ENSG00000025708	TRUE	Approved	1998-06-15	Unused	TYMP
Colorectal Neoplasms	ENSG00000026508	FALSE	Phase III Clinical Trial	1995-05-15	Phase III Clinical Trial	CD44
Colorectal Neoplasms	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Colorectal Neoplasms	ENSG00000030110	FALSE	Preclinical	1999-01-15	Absent	BAK1
Colorectal Neoplasms	ENSG00000037280	FALSE	Pre-registration	1994-06-15	Phase III Clinical Trial	FLT4
Colorectal Neoplasms	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-06-05	Unused	TNC
Colorectal Neoplasms	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Colorectal Neoplasms	ENSG00000047936	FALSE	Phase I Clinical Trial	2006-12-05	Absent	ROS1
Colorectal Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2005-11-15	Absent	TNFRSF9
Colorectal Neoplasms	ENSG00000051382	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CB
Colorectal Neoplasms	ENSG00000057593	FALSE	unknown	1992-03-15	Unused	F7
Colorectal Neoplasms	ENSG00000058085	FALSE	Preclinical	1997-04-15	Unused	LAMC2
Colorectal Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Colorectal Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	ERBB3
Colorectal Neoplasms	ENSG00000065559	FALSE	Preclinical	1998-01-15	Unused	MAP2K4
Colorectal Neoplasms	ENSG00000066044	FALSE	Preclinical	2011-04-18	Unused	ELAVL1
Colorectal Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Colorectal Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase II Clinical Trial	TNFRSF1A
Colorectal Neoplasms	ENSG00000067225	FALSE	Preclinical	2011-05-04	Preclinical	PKM
Colorectal Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase I Clinical Trial	FGFR3
Colorectal Neoplasms	ENSG00000070019	FALSE	Phase I Clinical Trial	2001-12-04	Phase I Clinical Trial	GUCY2C
Colorectal Neoplasms	ENSG00000070501	FALSE	Phase II Clinical Trial	1996-08-15	Unused	POLB
Colorectal Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Colorectal Neoplasms	ENSG00000073008	FALSE	Preclinical	2004-12-07	Unused	PVR
Colorectal Neoplasms	ENSG00000073756	FALSE	Phase II Clinical Trial	1993-06-15	Unused	PTGS2
Colorectal Neoplasms	ENSG00000074181	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH3
Colorectal Neoplasms	ENSG00000074590	FALSE	Preclinical	2007-05-16	Absent	NUAK1
Colorectal Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Colorectal Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Phase I Clinical Trial	FGFR1
Colorectal Neoplasms	ENSG00000078098	FALSE	Phase II Clinical Trial	1998-07-15	Unused	FAP
Colorectal Neoplasms	ENSG00000079277	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK1
Colorectal Neoplasms	ENSG00000079385	FALSE	Phase I Clinical Trial	2015-01-09	Absent	CEACAM1
Colorectal Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	HSP90AA1
Colorectal Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Colorectal Neoplasms	ENSG00000082781	FALSE	Phase II Clinical Trial	2001-11-05	Phase II Clinical Trial	ITGB5
Colorectal Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Colorectal Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Colorectal Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Colorectal Neoplasms	ENSG00000085563	FALSE	unknown	2007-03-26	Phase I Clinical Trial	ABCB1
Colorectal Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Absent	FOLH1
Colorectal Neoplasms	ENSG00000087088	FALSE	unknown	2002-06-26	Unused	BAX
Colorectal Neoplasms	ENSG00000087245	FALSE	unknown	2001-07-18	Phase I Clinical Trial	MMP2
Colorectal Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Colorectal Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Phase I Clinical Trial	BIRC5
Colorectal Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2012-10-31	Absent	LAG3
Colorectal Neoplasms	ENSG00000090339	FALSE	Preclinical	2001-02-21	Unused	ICAM1
Colorectal Neoplasms	ENSG00000091831	FALSE	Preclinical	1998-11-15	Unused	ESR1
Colorectal Neoplasms	ENSG00000091879	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Colorectal Neoplasms	ENSG00000092969	FALSE	Phase II Clinical Trial	1997-02-15	Phase II Clinical Trial	TGFB2
Colorectal Neoplasms	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Colorectal Neoplasms	ENSG00000095303	FALSE	Phase II Clinical Trial	1996-04-15	Unused	PTGS1
Colorectal Neoplasms	ENSG00000096717	FALSE	unknown	2006-01-16	Unused	SIRT1
Colorectal Neoplasms	ENSG00000096968	FALSE	Phase II Clinical Trial	2003-01-24	Unused	JAK2
Colorectal Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Colorectal Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	ABL1
Colorectal Neoplasms	ENSG00000097046	FALSE	Phase II Clinical Trial	2016-03-08	Absent	CDC7
Colorectal Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Colorectal Neoplasms	ENSG00000099875	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK2
Colorectal Neoplasms	ENSG00000100030	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MAPK1
Colorectal Neoplasms	ENSG00000100097	FALSE	Phase I Clinical Trial	2011-11-25	Absent	LGALS1
Colorectal Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Colorectal Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDGFB
Colorectal Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	NA	Absent	ST13
Colorectal Neoplasms	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Colorectal Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	2003-08-01	Phase I Clinical Trial	HIF1A
Colorectal Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2016-11-14	Absent	CD40
Colorectal Neoplasms	ENSG00000101412	FALSE	unknown	2001-02-02	Unused	E2F1
Colorectal Neoplasms	ENSG00000101868	FALSE	Phase II Clinical Trial	1993-08-15	Phase I Clinical Trial	POLA1
Colorectal Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	2008-10-17	Phase II Clinical Trial	XIAP
Colorectal Neoplasms	ENSG00000102245	FALSE	unknown	2001-06-01	Phase II Clinical Trial	CD40LG
Colorectal Neoplasms	ENSG00000102312	FALSE	Phase II Clinical Trial	2011-05-14	Absent	PORCN
Colorectal Neoplasms	ENSG00000102755	FALSE	Pre-registration	1991-02-15	Phase III Clinical Trial	FLT1
Colorectal Neoplasms	ENSG00000102854	FALSE	Preclinical	NA	Preclinical	MSLN
Colorectal Neoplasms	ENSG00000102882	FALSE	Phase I Clinical Trial	2011-05-26	Absent	MAPK3
Colorectal Neoplasms	ENSG00000103222	FALSE	unknown	2001-07-18	Phase I Clinical Trial	ABCC1
Colorectal Neoplasms	ENSG00000103522	FALSE	unknown	2001-01-25	Unused	IL21R
Colorectal Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Colorectal Neoplasms	ENSG00000104267	FALSE	unknown	2006-08-11	Absent	CA2
Colorectal Neoplasms	ENSG00000104365	FALSE	Preclinical	1996-04-15	Unused	IKBKB
Colorectal Neoplasms	ENSG00000104432	FALSE	unknown	2001-06-01	Phase II Clinical Trial	IL7
Colorectal Neoplasms	ENSG00000104689	FALSE	Phase II Clinical Trial	1998-08-15	Unused	TNFRSF10A
Colorectal Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	1996-02-15	Phase I Clinical Trial	CGB3
Colorectal Neoplasms	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-01-31	Phase II Clinical Trial	AURKC
Colorectal Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Colorectal Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1993-05-15	Phase II Clinical Trial	CEACAM5
Colorectal Neoplasms	ENSG00000105397	FALSE	Preclinical	NA	Absent	TYK2
Colorectal Neoplasms	ENSG00000105639	FALSE	Preclinical	2017-07-24	Absent	JAK3
Colorectal Neoplasms	ENSG00000105675	FALSE	Preclinical	NA	Unused	ATP4A
Colorectal Neoplasms	ENSG00000105810	FALSE	Phase II Clinical Trial	2007-05-16	Absent	CDK6
Colorectal Neoplasms	ENSG00000105835	FALSE	Phase I Clinical Trial	2014-01-22	Absent	NAMPT
Colorectal Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CG
Colorectal Neoplasms	ENSG00000105953	FALSE	Phase I Clinical Trial	2008-07-26	Absent	OGDH
Colorectal Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	1996-01-15	Phase II Clinical Trial	MET
Colorectal Neoplasms	ENSG00000106268	FALSE	Preclinical	2015-03-23	Absent	NUDT1
Colorectal Neoplasms	ENSG00000106348	FALSE	Preclinical	2001-06-06	Unused	IMPDH1
Colorectal Neoplasms	ENSG00000106546	FALSE	unknown	1999-04-13	Phase I Clinical Trial	AHR
Colorectal Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	TGFBR1
Colorectal Neoplasms	ENSG00000106804	FALSE	Preclinical	2008-10-08	Unused	C5
Colorectal Neoplasms	ENSG00000106991	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	ENG
Colorectal Neoplasms	ENSG00000107159	FALSE	Preclinical	NA	Preclinical	CA9
Colorectal Neoplasms	ENSG00000107562	FALSE	Phase II Clinical Trial	2007-04-10	Absent	CXCL12
Colorectal Neoplasms	ENSG00000107854	FALSE	Preclinical	2017-04-12	Absent	TNKS2
Colorectal Neoplasms	ENSG00000108654	FALSE	Preclinical	2006-08-30	Absent	DDX5
Colorectal Neoplasms	ENSG00000108691	FALSE	Phase II Clinical Trial	2010-01-15	Unused	CCL2
Colorectal Neoplasms	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Colorectal Neoplasms	ENSG00000109163	FALSE	Preclinical	1999-07-06	Unused	GNRHR
Colorectal Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1993-06-15	Phase I Clinical Trial	NFKB1
Colorectal Neoplasms	ENSG00000109471	FALSE	Phase I Clinical Trial	1992-12-15	Unused	IL2
Colorectal Neoplasms	ENSG00000110195	FALSE	unknown	NA	Phase I Clinical Trial	FOLR1
Colorectal Neoplasms	ENSG00000110324	FALSE	Preclinical	2014-10-14	Absent	IL10RA
Colorectal Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Phase II Clinical Trial	BIRC2
Colorectal Neoplasms	ENSG00000110492	FALSE	Preclinical	2009-05-19	Unused	MDK
Colorectal Neoplasms	ENSG00000111142	FALSE	Phase I Clinical Trial	1998-07-15	Unused	METAP2
Colorectal Neoplasms	ENSG00000111424	FALSE	Phase II Clinical Trial	1993-07-15	Unused	VDR
Colorectal Neoplasms	ENSG00000111679	FALSE	Preclinical	2005-08-19	Unused	PTPN6
Colorectal Neoplasms	ENSG00000112062	FALSE	Phase I Clinical Trial	2008-09-05	Absent	MAPK14
Colorectal Neoplasms	ENSG00000112115	FALSE	Phase II Clinical Trial	2001-07-24	Absent	IL17A
Colorectal Neoplasms	ENSG00000112715	TRUE	Approved	1991-02-15	Approved	VEGFA
Colorectal Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2002-06-13	Unused	HBEGF
Colorectal Neoplasms	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Colorectal Neoplasms	ENSG00000113302	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12B
Colorectal Neoplasms	ENSG00000113328	FALSE	Phase II Clinical Trial	2003-08-05	Unused	CCNG1
Colorectal Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Colorectal Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	1996-05-15	Unused	PPP2CA
Colorectal Neoplasms	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Colorectal Neoplasms	ENSG00000113712	FALSE	Preclinical	2017-07-14	Absent	CSNK1A1
Colorectal Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	1991-02-15	Phase II Clinical Trial	PDGFRB
Colorectal Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Colorectal Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Colorectal Neoplasms	ENSG00000115008	FALSE	Pre-registration	2009-12-07	Phase II Clinical Trial	IL1A
Colorectal Neoplasms	ENSG00000115053	FALSE	unknown	2004-03-31	Unused	NCL
Colorectal Neoplasms	ENSG00000115221	FALSE	Phase II Clinical Trial	2002-11-26	Phase II Clinical Trial	ITGB6
Colorectal Neoplasms	ENSG00000115353	FALSE	unknown	2001-07-18	Phase I Clinical Trial	TACR1
Colorectal Neoplasms	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-02-11	Unused	FN1
Colorectal Neoplasms	ENSG00000115758	FALSE	Phase III Clinical Trial	1994-03-15	Phase II Clinical Trial	ODC1
Colorectal Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Colorectal Neoplasms	ENSG00000116128	FALSE	Preclinical	2000-11-13	Unused	BCL9
Colorectal Neoplasms	ENSG00000116329	FALSE	unknown	2001-07-18	Phase I Clinical Trial	OPRD1
Colorectal Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Phase II Clinical Trial	HDAC1
Colorectal Neoplasms	ENSG00000117091	FALSE	unknown	2001-02-21	Unused	CD48
Colorectal Neoplasms	ENSG00000117525	FALSE	Phase I Clinical Trial	1992-03-15	Unused	F3
Colorectal Neoplasms	ENSG00000118137	FALSE	unknown	2005-07-04	Unused	APOA1
Colorectal Neoplasms	ENSG00000118513	FALSE	Preclinical	2013-03-20	Absent	MYB
Colorectal Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG1
Colorectal Neoplasms	ENSG00000119535	FALSE	Phase I Clinical Trial	2011-10-19	Phase I Clinical Trial	CSF3R
Colorectal Neoplasms	ENSG00000119630	FALSE	Preclinical	2003-07-24	Phase II Clinical Trial	PGF
Colorectal Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1995-12-15	Phase I Clinical Trial	EPCAM
Colorectal Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	TEK
Colorectal Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Colorectal Neoplasms	ENSG00000120885	FALSE	unknown	2007-10-05	Absent	CLU
Colorectal Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	2001-08-23	Phase II Clinical Trial	TNFRSF10B
Colorectal Neoplasms	ENSG00000121594	FALSE	unknown	2001-02-21	Phase II Clinical Trial	CD80
Colorectal Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Colorectal Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase III Clinical Trial	PIK3CA
Colorectal Neoplasms	ENSG00000121966	FALSE	Preclinical	2001-04-09	Preclinical	CXCR4
Colorectal Neoplasms	ENSG00000122025	FALSE	Phase III Clinical Trial	1991-02-15	Phase II Clinical Trial	FLT3
Colorectal Neoplasms	ENSG00000122194	FALSE	unknown	1995-05-15	Unused	PLG
Colorectal Neoplasms	ENSG00000122861	FALSE	Preclinical	1993-05-15	Unused	PLAU
Colorectal Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK2
Colorectal Neoplasms	ENSG00000124107	FALSE	Preclinical	2006-08-25	Unused	SLPI
Colorectal Neoplasms	ENSG00000124762	FALSE	Preclinical	1996-05-15	Unused	CDKN1A
Colorectal Neoplasms	ENSG00000125378	FALSE	Preclinical	NA	Absent	BMP4
Colorectal Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Colorectal Neoplasms	ENSG00000125571	FALSE	Phase II Clinical Trial	2001-07-24	Absent	IL37
Colorectal Neoplasms	ENSG00000126218	FALSE	unknown	1992-03-15	Unused	F10
Colorectal Neoplasms	ENSG00000126934	FALSE	Phase III Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K2
Colorectal Neoplasms	ENSG00000128052	TRUE	Approved	1991-02-15	Phase III Clinical Trial	KDR
Colorectal Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Colorectal Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Phase II Clinical Trial	SMO
Colorectal Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2005-09-14	Phase I Clinical Trial	DLL4
Colorectal Neoplasms	ENSG00000129484	FALSE	Phase II Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Colorectal Neoplasms	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK4
Colorectal Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	2005-12-02	Unused	DNMT1
Colorectal Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Colorectal Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Colorectal Neoplasms	ENSG00000131724	FALSE	Preclinical	2002-01-09	Unused	IL13RA1
Colorectal Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1990-07-15	Phase II Clinical Trial	TOP2A
Colorectal Neoplasms	ENSG00000131828	FALSE	Phase I Clinical Trial	2008-07-26	Absent	PDHA1
Colorectal Neoplasms	ENSG00000131981	FALSE	Pre-registration	2002-08-05	Approved	LGALS3
Colorectal Neoplasms	ENSG00000132155	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	RAF1
Colorectal Neoplasms	ENSG00000132170	FALSE	Phase II Clinical Trial	2002-01-29	Phase II Clinical Trial	PPARG
Colorectal Neoplasms	ENSG00000132383	FALSE	Preclinical	1998-06-15	Unused	RPA1
Colorectal Neoplasms	ENSG00000132906	FALSE	Preclinical	2004-01-30	Unused	CASP9
Colorectal Neoplasms	ENSG00000132964	FALSE	Preclinical	2010-07-12	Absent	CDK8
Colorectal Neoplasms	ENSG00000133019	FALSE	Preclinical	2007-02-13	Unused	CHRM3
Colorectal Neoplasms	ENSG00000133703	FALSE	Preclinical	1992-11-15	Unused	KRAS
Colorectal Neoplasms	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Phase II Clinical Trial	LOXL2
Colorectal Neoplasms	ENSG00000134057	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	CCNB1
Colorectal Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Colorectal Neoplasms	ENSG00000134243	FALSE	Preclinical	2016-12-27	Absent	SORT1
Colorectal Neoplasms	ENSG00000134250	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH2
Colorectal Neoplasms	ENSG00000134460	FALSE	Approved	2000-11-07	Unused	IL2RA
Colorectal Neoplasms	ENSG00000134853	TRUE	Approved	1996-12-15	Approved	PDGFRA
Colorectal Neoplasms	ENSG00000135218	FALSE	Phase I Clinical Trial	2001-03-14	Unused	CD36
Colorectal Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	2007-02-06	Phase I Clinical Trial	CDK4
Colorectal Neoplasms	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-11-21	Absent	MDM2
Colorectal Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Colorectal Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Colorectal Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK9
Colorectal Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	2000-05-11	Unused	TXN
Colorectal Neoplasms	ENSG00000136826	FALSE	Phase I Clinical Trial	2004-05-21	Absent	KLF4
Colorectal Neoplasms	ENSG00000136856	FALSE	Preclinical	2004-11-24	Absent	SLC2A8
Colorectal Neoplasms	ENSG00000136943	FALSE	Preclinical	2001-12-19	Unused	CTSV
Colorectal Neoplasms	ENSG00000136997	FALSE	Phase I Clinical Trial	2004-05-21	Unused	MYC
Colorectal Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Colorectal Neoplasms	ENSG00000137845	FALSE	unknown	2003-09-17	Unused	ADAM10
Colorectal Neoplasms	ENSG00000138039	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	LHCGR
Colorectal Neoplasms	ENSG00000138061	FALSE	unknown	NA	Unused	CYP1B1
Colorectal Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Colorectal Neoplasms	ENSG00000138448	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGAV
Colorectal Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Colorectal Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Colorectal Neoplasms	ENSG00000139292	FALSE	Phase I Clinical Trial	2011-11-01	Absent	LGR5
Colorectal Neoplasms	ENSG00000139567	FALSE	unknown	2007-05-30	Absent	ACVRL1
Colorectal Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR1
Colorectal Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Colorectal Neoplasms	ENSG00000140465	FALSE	unknown	1999-04-13	Phase I Clinical Trial	CYP1A1
Colorectal Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK3
Colorectal Neoplasms	ENSG00000140545	FALSE	unknown	1997-04-15	Unused	MFGE8
Colorectal Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1993-10-15	Phase II Clinical Trial	TP53
Colorectal Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	1990-09-15	Phase II Clinical Trial	ERBB2
Colorectal Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Colorectal Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase III Clinical Trial	AKT1
Colorectal Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Colorectal Neoplasms	ENSG00000143167	FALSE	Phase II Clinical Trial	2007-08-13	Unused	GPA33
Colorectal Neoplasms	ENSG00000143226	FALSE	unknown	NA	Absent	FCGR2A
Colorectal Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Colorectal Neoplasms	ENSG00000143799	FALSE	Phase II Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Colorectal Neoplasms	ENSG00000144744	FALSE	unknown	2007-04-27	Phase I Clinical Trial	UBA3
Colorectal Neoplasms	ENSG00000144891	FALSE	Preclinical	2016-12-29	Absent	AGTR1
Colorectal Neoplasms	ENSG00000146242	FALSE	Phase II Clinical Trial	1999-06-10	Phase II Clinical Trial	TPBG
Colorectal Neoplasms	ENSG00000146374	FALSE	Phase I Clinical Trial	2012-10-11	Absent	RSPO3
Colorectal Neoplasms	ENSG00000146648	TRUE	Approved	1992-03-15	Approved	EGFR
Colorectal Neoplasms	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Colorectal Neoplasms	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC8
Colorectal Neoplasms	ENSG00000147437	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	GNRH1
Colorectal Neoplasms	ENSG00000147889	FALSE	Preclinical	2000-11-29	Unused	CDKN2A
Colorectal Neoplasms	ENSG00000147955	FALSE	Preclinical	2007-02-13	Unused	SIGMAR1
Colorectal Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK2
Colorectal Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Colorectal Neoplasms	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK1
Colorectal Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Colorectal Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	2007-04-23	Phase I Clinical Trial	CHEK1
Colorectal Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Colorectal Neoplasms	ENSG00000150337	FALSE	unknown	1992-02-15	Unused	FCGR1A
Colorectal Neoplasms	ENSG00000150630	FALSE	unknown	2007-07-02	Preclinical	VEGFC
Colorectal Neoplasms	ENSG00000151247	FALSE	Preclinical	2016-02-02	Absent	EIF4E
Colorectal Neoplasms	ENSG00000151694	FALSE	unknown	2003-09-17	Unused	ADAM17
Colorectal Neoplasms	ENSG00000154188	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Colorectal Neoplasms	ENSG00000154229	FALSE	Phase I Clinical Trial	1991-01-15	Phase I Clinical Trial	PRKCA
Colorectal Neoplasms	ENSG00000154310	FALSE	Preclinical	2015-06-15	Absent	TNIK
Colorectal Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Colorectal Neoplasms	ENSG00000157036	FALSE	unknown	2009-12-08	Phase II Clinical Trial	EXOG
Colorectal Neoplasms	ENSG00000157404	TRUE	Approved	1991-02-15	Approved	KIT
Colorectal Neoplasms	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	BRAF
Colorectal Neoplasms	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Colorectal Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-02-15	Unused	GART
Colorectal Neoplasms	ENSG00000160180	FALSE	Preclinical	2012-07-17	Preclinical	TFF3
Colorectal Neoplasms	ENSG00000160182	FALSE	Preclinical	2012-07-17	Preclinical	TFF1
Colorectal Neoplasms	ENSG00000160712	FALSE	unknown	NA	Phase II Clinical Trial	IL6R
Colorectal Neoplasms	ENSG00000160791	FALSE	Phase II Clinical Trial	2010-01-15	Absent	CCR5
Colorectal Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2003-07-22	Absent	FGFR4
Colorectal Neoplasms	ENSG00000161638	FALSE	unknown	2000-02-02	Phase I Clinical Trial	ITGA5
Colorectal Neoplasms	ENSG00000161955	FALSE	Preclinical	2012-02-27	Absent	TNFSF13
Colorectal Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR5
Colorectal Neoplasms	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK1
Colorectal Neoplasms	ENSG00000162747	FALSE	unknown	NA	Absent	FCGR3B
Colorectal Neoplasms	ENSG00000162892	FALSE	unknown	1999-07-07	Unused	IL24
Colorectal Neoplasms	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Colorectal Neoplasms	ENSG00000163430	FALSE	Preclinical	2015-10-08	Absent	FSTL1
Colorectal Neoplasms	ENSG00000163513	FALSE	unknown	2002-06-26	Unused	TGFBR2
Colorectal Neoplasms	ENSG00000163517	FALSE	Phase I Clinical Trial	2010-08-16	Phase I Clinical Trial	HDAC11
Colorectal Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	1998-09-15	Phase II Clinical Trial	CTLA4
Colorectal Neoplasms	ENSG00000163737	FALSE	unknown	NA	Unused	PF4
Colorectal Neoplasms	ENSG00000164078	FALSE	Phase I Clinical Trial	2001-12-18	Phase I Clinical Trial	MST1R
Colorectal Neoplasms	ENSG00000164136	FALSE	Preclinical	2014-01-23	Absent	IL15
Colorectal Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Colorectal Neoplasms	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Phase I Clinical Trial	CASP3
Colorectal Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Absent	TLR3
Colorectal Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2002-06-26	Unused	TERT
Colorectal Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1999-12-01	Phase II Clinical Trial	CSF2
Colorectal Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Colorectal Neoplasms	ENSG00000165025	FALSE	unknown	2003-10-31	Phase II Clinical Trial	SYK
Colorectal Neoplasms	ENSG00000165197	FALSE	Preclinical	2008-10-17	Unused	VEGFD
Colorectal Neoplasms	ENSG00000165280	FALSE	Preclinical	2013-11-18	Absent	VCP
Colorectal Neoplasms	ENSG00000165392	FALSE	Phase I Clinical Trial	2015-06-10	Absent	WRN
Colorectal Neoplasms	ENSG00000165731	TRUE	Approved	1994-06-15	Approved	RET
Colorectal Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Colorectal Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Colorectal Neoplasms	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Colorectal Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	1997-12-15	Phase I Clinical Trial	PLK1
Colorectal Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1991-07-15	Unused	RRM1
Colorectal Neoplasms	ENSG00000167601	FALSE	Phase I Clinical Trial	2004-06-18	Unused	AXL
Colorectal Neoplasms	ENSG00000167658	FALSE	Preclinical	1994-06-15	Unused	EEF2
Colorectal Neoplasms	ENSG00000168036	FALSE	Phase I Clinical Trial	2005-09-12	Phase I Clinical Trial	CTNNB1
Colorectal Neoplasms	ENSG00000168522	FALSE	unknown	1995-06-15	Unused	FNTA
Colorectal Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Colorectal Neoplasms	ENSG00000168615	FALSE	Preclinical	2007-02-27	Unused	ADAM9
Colorectal Neoplasms	ENSG00000168811	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12A
Colorectal Neoplasms	ENSG00000169032	FALSE	Phase III Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K1
Colorectal Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Colorectal Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Phase I Clinical Trial	PTK2
Colorectal Neoplasms	ENSG00000169403	FALSE	Preclinical	1991-07-15	Unused	PTAFR
Colorectal Neoplasms	ENSG00000169710	FALSE	Preclinical	2017-05-09	Absent	FASN
Colorectal Neoplasms	ENSG00000169919	FALSE	unknown	2001-07-18	Phase I Clinical Trial	GUSB
Colorectal Neoplasms	ENSG00000170312	FALSE	Phase I Clinical Trial	2005-03-14	Phase I Clinical Trial	CDK1
Colorectal Neoplasms	ENSG00000170430	FALSE	unknown	1998-06-15	Unused	MGMT
Colorectal Neoplasms	ENSG00000170525	FALSE	unknown	2014-01-27	Absent	PFKFB3
Colorectal Neoplasms	ENSG00000170558	FALSE	Phase I Clinical Trial	1999-06-30	Unused	CDH2
Colorectal Neoplasms	ENSG00000171016	FALSE	Preclinical	2004-04-14	Unused	PYGO1
Colorectal Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2006-12-05	Phase I Clinical Trial	ALK
Colorectal Neoplasms	ENSG00000171522	FALSE	Phase I Clinical Trial	2015-07-31	Absent	PTGER4
Colorectal Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CD
Colorectal Neoplasms	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Colorectal Neoplasms	ENSG00000171791	FALSE	Preclinical	1992-03-15	Unused	BCL2
Colorectal Neoplasms	ENSG00000171848	FALSE	unknown	1991-07-15	Unused	RRM2
Colorectal Neoplasms	ENSG00000171855	FALSE	unknown	2000-08-17	Unused	IFNB1
Colorectal Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Colorectal Neoplasms	ENSG00000172889	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	EGFL7
Colorectal Neoplasms	ENSG00000173153	FALSE	Preclinical	2006-09-15	Unused	ESRRA
Colorectal Neoplasms	ENSG00000173273	FALSE	Preclinical	2017-04-12	Absent	TNKS
Colorectal Neoplasms	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Colorectal Neoplasms	ENSG00000174437	FALSE	Preclinical	2016-12-16	Absent	ATP2A2
Colorectal Neoplasms	ENSG00000174775	FALSE	unknown	NA	Unused	HRAS
Colorectal Neoplasms	ENSG00000174807	FALSE	Phase II Clinical Trial	2004-10-18	Phase II Clinical Trial	CD248
Colorectal Neoplasms	ENSG00000176890	TRUE	Approved	1990-03-15	Approved	TYMS
Colorectal Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Colorectal Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Phase II Clinical Trial	ERBB4
Colorectal Neoplasms	ENSG00000178726	FALSE	Phase II Clinical Trial	NA	Absent	THBD
Colorectal Neoplasms	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Colorectal Neoplasms	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Colorectal Neoplasms	ENSG00000179583	FALSE	Preclinical	2000-04-26	Unused	CIITA
Colorectal Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Phase II Clinical Trial	CDH5
Colorectal Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR2
Colorectal Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	CSF1R
Colorectal Neoplasms	ENSG00000182782	FALSE	Preclinical	2011-09-29	Absent	HCAR2
Colorectal Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Phase II Clinical Trial	COL18A1
Colorectal Neoplasms	ENSG00000183765	FALSE	Phase I Clinical Trial	2010-03-02	Absent	CHEK2
Colorectal Neoplasms	ENSG00000183873	FALSE	Preclinical	2011-06-23	Unused	SCN5A
Colorectal Neoplasms	ENSG00000184047	FALSE	Phase I Clinical Trial	2008-11-24	Phase I Clinical Trial	DIABLO
Colorectal Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-03-06	Unused	TACSTD2
Colorectal Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2010-08-09	Phase I Clinical Trial	CSF1
Colorectal Neoplasms	ENSG00000184489	FALSE	Preclinical	2002-04-09	Unused	PTP4A3
Colorectal Neoplasms	ENSG00000184502	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	GAST
Colorectal Neoplasms	ENSG00000184584	FALSE	Preclinical	2017-04-18	Absent	TMEM173
Colorectal Neoplasms	ENSG00000184937	FALSE	Preclinical	2005-12-05	Phase II Clinical Trial	WT1
Colorectal Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	MUC1
Colorectal Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Absent	PRAME
Colorectal Neoplasms	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Colorectal Neoplasms	ENSG00000186350	FALSE	Preclinical	2015-11-18	Absent	RXRA
Colorectal Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Colorectal Neoplasms	ENSG00000186827	FALSE	unknown	2014-08-23	Absent	TNFRSF4
Colorectal Neoplasms	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Colorectal Neoplasms	ENSG00000187554	FALSE	Phase II Clinical Trial	2006-08-01	Absent	TLR5
Colorectal Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Phase II Clinical Trial	PDCD1
Colorectal Neoplasms	ENSG00000188641	FALSE	Approved	1993-07-15	Phase II Clinical Trial	DPYD
Colorectal Neoplasms	ENSG00000196083	FALSE	Phase II Clinical Trial	NA	Absent	IL1RAP
Colorectal Neoplasms	ENSG00000196154	FALSE	Preclinical	2011-09-15	Absent	S100A4
Colorectal Neoplasms	ENSG00000196352	FALSE	Preclinical	1994-06-15	Unused	CD55
Colorectal Neoplasms	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Colorectal Neoplasms	ENSG00000196411	FALSE	Phase I Clinical Trial	2003-08-12	Unused	EPHB4
Colorectal Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	2003-02-03	Phase II Clinical Trial	HDAC2
Colorectal Neoplasms	ENSG00000196628	FALSE	Preclinical	2007-10-03	Unused	TCF4
Colorectal Neoplasms	ENSG00000196776	FALSE	Phase II Clinical Trial	2016-02-25	Absent	CD47
Colorectal Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Colorectal Neoplasms	ENSG00000197157	FALSE	Preclinical	2017-02-14	Absent	SND1
Colorectal Neoplasms	ENSG00000197635	FALSE	unknown	2004-02-24	Unused	DPP4
Colorectal Neoplasms	ENSG00000198223	FALSE	Preclinical	2011-09-23	Preclinical	CSF2RA
Colorectal Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Phase I Clinical Trial	NTRK1
Colorectal Neoplasms	ENSG00000198625	FALSE	Preclinical	2014-05-08	Absent	MDM4
Colorectal Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Colorectal Neoplasms	ENSG00000198805	FALSE	Preclinical	1997-04-15	Unused	PNP
Colorectal Neoplasms	ENSG00000198851	FALSE	Phase I Clinical Trial	2007-04-11	Absent	CD3E
Colorectal Neoplasms	ENSG00000198900	TRUE	Approved	1990-07-15	Approved	TOP1
Colorectal Neoplasms	ENSG00000198964	FALSE	Phase II Clinical Trial	2008-11-07	Absent	SGMS1
Colorectal Neoplasms	ENSG00000203747	FALSE	unknown	NA	Absent	FCGR3A
Colorectal Neoplasms	ENSG00000213918	FALSE	Preclinical	1995-06-15	Unused	DNASE1
Colorectal Neoplasms	ENSG00000221867	FALSE	unknown	NA	Unused	MAGEA3
Colorectal Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Colorectal Neoplasms	ENSG00000239732	FALSE	Phase III Clinical Trial	2001-06-01	Phase III Clinical Trial	TLR9
Colorectal Neoplasms	ENSG00000240972	FALSE	Phase II Clinical Trial	2004-01-13	Absent	MIF
Colorectal Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Colorectal Neoplasms	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Colorectal Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PRKDC
Colorectal Neoplasms	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Colorectal Neoplasms	ENSG00000259207	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGB3
Colorectal Neoplasms	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Colorectal Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR3
Colorectal Neoplasms	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-07-24	Phase II Clinical Trial	ADORA3
Complex Regional Pain Syndromes	ENSG00000082556	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	OPRK1
Complex Regional Pain Syndromes	ENSG00000112038	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	OPRM1
Complex Regional Pain Syndromes	ENSG00000116329	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	OPRD1
Complex Regional Pain Syndromes	ENSG00000153956	FALSE	Phase II Clinical Trial	2007-09-12	Unused	CACNA2D1
Conduct Disorder	ENSG00000149295	FALSE	Phase III Clinical Trial	2008-03-05	Phase II Clinical Trial	DRD2
Conduct Disorder	ENSG00000169676	FALSE	Phase III Clinical Trial	2008-03-05	Phase II Clinical Trial	DRD5
Conjunctivitis	ENSG00000106804	FALSE	Preclinical	2005-01-31	Absent	C5
Conjunctivitis	ENSG00000122420	FALSE	Preclinical	2016-06-17	Absent	PTGFR
Conjunctivitis	ENSG00000134489	FALSE	Preclinical	2012-11-26	Preclinical	HRH4
Conjunctivitis	ENSG00000196639	FALSE	Preclinical	2012-11-26	Preclinical	HRH1
Conjunctivitis, Allergic	ENSG00000005844	FALSE	Phase II Clinical Trial	2007-03-12	Phase II Clinical Trial	ITGAL
Conjunctivitis, Allergic	ENSG00000065989	FALSE	Approved	2002-10-16	Unused	PDE4A
Conjunctivitis, Allergic	ENSG00000073756	TRUE	Approved	2010-12-15	Approved	PTGS2
Conjunctivitis, Allergic	ENSG00000077238	FALSE	Preclinical	1998-08-15	Unused	IL4R
Conjunctivitis, Allergic	ENSG00000088832	FALSE	Pre-registration	NA	Unused	FKBP1A
Conjunctivitis, Allergic	ENSG00000090339	FALSE	Phase II Clinical Trial	2007-03-12	Phase II Clinical Trial	ICAM1
Conjunctivitis, Allergic	ENSG00000095303	TRUE	Approved	2010-12-15	Approved	PTGS1
Conjunctivitis, Allergic	ENSG00000105329	FALSE	Approved	NA	Unused	TGFB1
Conjunctivitis, Allergic	ENSG00000105366	FALSE	Phase I Clinical Trial	2016-06-24	Absent	SIGLEC8
Conjunctivitis, Allergic	ENSG00000105650	FALSE	Approved	2002-10-16	Unused	PDE4C
Conjunctivitis, Allergic	ENSG00000112541	FALSE	Approved	NA	Unused	PDE10A
Conjunctivitis, Allergic	ENSG00000113448	FALSE	Approved	2002-10-16	Unused	PDE4D
Conjunctivitis, Allergic	ENSG00000113580	FALSE	Phase II Clinical Trial	1989-12-15	Phase II Clinical Trial	NR3C1
Conjunctivitis, Allergic	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Conjunctivitis, Allergic	ENSG00000115008	FALSE	Phase III Clinical Trial	2012-05-09	Absent	IL1A
Conjunctivitis, Allergic	ENSG00000115353	FALSE	Preclinical	1999-01-15	Unused	TACR1
Conjunctivitis, Allergic	ENSG00000122194	FALSE	Phase III Clinical Trial	NA	Preclinical	PLG
Conjunctivitis, Allergic	ENSG00000125538	FALSE	Phase III Clinical Trial	2012-05-09	Absent	IL1B
Conjunctivitis, Allergic	ENSG00000128271	FALSE	unknown	2005-07-05	Unused	ADORA2A
Conjunctivitis, Allergic	ENSG00000128655	FALSE	Approved	NA	Unused	PDE11A
Conjunctivitis, Allergic	ENSG00000132170	FALSE	unknown	1999-05-25	Absent	PPARG
Conjunctivitis, Allergic	ENSG00000134489	FALSE	Phase II Clinical Trial	2001-05-10	Unused	HRH4
Conjunctivitis, Allergic	ENSG00000136869	FALSE	Approved	NA	Absent	TLR4
Conjunctivitis, Allergic	ENSG00000150594	FALSE	Phase II Clinical Trial	2011-01-17	Phase II Clinical Trial	ADRA2A
Conjunctivitis, Allergic	ENSG00000160712	FALSE	Preclinical	1998-08-15	Unused	IL6R
Conjunctivitis, Allergic	ENSG00000165025	FALSE	Phase II Clinical Trial	2015-05-06	Absent	SYK
Conjunctivitis, Allergic	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Conjunctivitis, Allergic	ENSG00000172156	FALSE	unknown	2000-08-02	Phase II Clinical Trial	CCL11
Conjunctivitis, Allergic	ENSG00000172236	FALSE	Preclinical	2002-06-21	Unused	TPSAB1
Conjunctivitis, Allergic	ENSG00000172572	FALSE	Phase II Clinical Trial	2005-02-17	Unused	PDE3A
Conjunctivitis, Allergic	ENSG00000183134	FALSE	Phase II Clinical Trial	2005-06-01	Phase II Clinical Trial	PTGDR2
Conjunctivitis, Allergic	ENSG00000184588	FALSE	Approved	2002-10-16	Unused	PDE4B
Conjunctivitis, Allergic	ENSG00000196262	FALSE	Phase II Clinical Trial	2006-02-15	Absent	PPIA
Conjunctivitis, Allergic	ENSG00000196639	TRUE	Approved	1998-06-15	Approved	HRH1
Conjunctivitis, Allergic	ENSG00000240972	FALSE	Approved	NA	Unused	MIF
Constipation	ENSG00000001626	FALSE	Preclinical	2017-03-29	Absent	CFTR
Constipation	ENSG00000066230	FALSE	unknown	2011-05-03	Unused	SLC9A3
Constipation	ENSG00000070019	TRUE	Approved	2003-07-23	Approved	GUCY2C
Constipation	ENSG00000082556	TRUE	Approved	2001-08-09	Approved	OPRK1
Constipation	ENSG00000087085	FALSE	unknown	2000-03-01	Unused	ACHE
Constipation	ENSG00000100170	FALSE	Phase I Clinical Trial	2008-05-12	Absent	SLC5A1
Constipation	ENSG00000102539	FALSE	Phase I Clinical Trial	2014-05-20	Absent	MLNR
Constipation	ENSG00000104321	FALSE	Approved	2005-05-23	Absent	TRPA1
Constipation	ENSG00000110148	FALSE	Preclinical	1996-03-15	Unused	CCKBR
Constipation	ENSG00000112038	TRUE	Approved	1999-01-15	Approved	OPRM1
Constipation	ENSG00000114859	TRUE	Approved	2002-05-28	Approved	CLCN2
Constipation	ENSG00000116329	TRUE	Approved	2001-08-09	Approved	OPRD1
Constipation	ENSG00000121853	FALSE	Phase II Clinical Trial	2003-07-02	Phase I Clinical Trial	GHSR
Constipation	ENSG00000122420	FALSE	unknown	NA	Unused	PTGFR
Constipation	ENSG00000125255	FALSE	Approved	2008-04-18	Phase II Clinical Trial	SLC10A2
Constipation	ENSG00000140538	FALSE	unknown	1989-06-15	Unused	NTRK3
Constipation	ENSG00000145335	FALSE	Phase II Clinical Trial	2017-02-15	Absent	SNCA
Constipation	ENSG00000148053	FALSE	unknown	1989-06-15	Unused	NTRK2
Constipation	ENSG00000160867	FALSE	Phase II Clinical Trial	2012-03-30	Absent	FGFR4
Constipation	ENSG00000163394	FALSE	Preclinical	1995-01-15	Unused	CCKAR
Constipation	ENSG00000164270	TRUE	Approved	1995-07-15	Approved	HTR4
Constipation	ENSG00000166736	FALSE	unknown	1995-08-15	Unused	HTR3A
Constipation	ENSG00000168539	FALSE	unknown	2000-03-01	Unused	CHRM1
Constipation	ENSG00000175591	FALSE	Preclinical	2008-04-18	Preclinical	P2RY2
Constipation	ENSG00000181072	FALSE	unknown	2000-03-01	Unused	CHRM2
Corneal Injuries	ENSG00000101425	FALSE	Preclinical	NA	Absent	BPI
Corneal Injuries	ENSG00000105329	FALSE	unknown	2001-11-19	Absent	TGFB1
Corneal Injuries	ENSG00000112964	FALSE	Preclinical	NA	Absent	GHR
Corneal Injuries	ENSG00000113328	FALSE	Preclinical	2003-08-05	Absent	CCNG1
Corneal Injuries	ENSG00000114378	FALSE	unknown	2001-10-26	Absent	HYAL1
Corneal Injuries	ENSG00000115414	FALSE	Phase III Clinical Trial	NA	Absent	FN1
Corneal Injuries	ENSG00000146648	TRUE	Approved	NA	Absent	EGFR
Corneal Injuries	ENSG00000149968	FALSE	Preclinical	1994-07-15	Absent	MMP3
Corneal Injuries	ENSG00000156738	FALSE	unknown	1993-09-15	Absent	MS4A1
Corneal Injuries	ENSG00000163513	FALSE	unknown	2001-11-19	Absent	TGFBR2
Corneal Injuries	ENSG00000164111	FALSE	Phase II Clinical Trial	NA	Absent	ANXA5
Corneal Injuries	ENSG00000169047	FALSE	Phase III Clinical Trial	NA	Absent	IRS1
Corneal Injuries	ENSG00000175591	FALSE	Phase II Clinical Trial	NA	Absent	P2RY2
Corneal Injuries	ENSG00000205542	FALSE	unknown	2012-03-22	Absent	TMSB4X
Corneal Ulcer	ENSG00000064300	FALSE	Preclinical	2007-03-19	Unused	NGFR
Corneal Ulcer	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Corneal Ulcer	ENSG00000100985	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP9
Corneal Ulcer	ENSG00000105329	FALSE	Preclinical	2006-10-13	Preclinical	TGFB1
Corneal Ulcer	ENSG00000113580	FALSE	Phase II Clinical Trial	2002-07-31	Unused	NR3C1
Corneal Ulcer	ENSG00000149968	FALSE	Preclinical	1994-07-15	Unused	MMP3
Corneal Ulcer	ENSG00000154229	FALSE	Preclinical	2010-06-15	Preclinical	PRKCA
Corneal Ulcer	ENSG00000196611	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP1
Corneal Ulcer	ENSG00000205542	FALSE	unknown	1995-01-15	Phase II Clinical Trial	TMSB4X
Coronary Restenosis	ENSG00000005961	TRUE	Approved	1998-01-15	Approved	ITGA2B
Coronary Restenosis	ENSG00000007171	FALSE	Phase I Clinical Trial	1996-12-15	Unused	NOS2
Coronary Restenosis	ENSG00000007908	FALSE	unknown	2005-05-25	Unused	SELE
Coronary Restenosis	ENSG00000010322	FALSE	Preclinical	2006-11-03	Unused	NISCH
Coronary Restenosis	ENSG00000011677	FALSE	Pre-registration	NA	Unused	GABRA3
Coronary Restenosis	ENSG00000022355	FALSE	Pre-registration	NA	Unused	GABRA1
Coronary Restenosis	ENSG00000026508	FALSE	Phase II Clinical Trial	1994-08-15	Unused	CD44
Coronary Restenosis	ENSG00000059377	FALSE	Phase III Clinical Trial	1993-02-15	Unused	TBXAS1
Coronary Restenosis	ENSG00000065989	TRUE	Approved	1998-09-15	Approved	PDE4A
Coronary Restenosis	ENSG00000072062	FALSE	Preclinical	2005-12-13	Unused	PRKACA
Coronary Restenosis	ENSG00000072571	FALSE	Phase II Clinical Trial	1994-08-15	Unused	HMMR
Coronary Restenosis	ENSG00000073756	TRUE	Approved	1996-04-15	Approved	PTGS2
Coronary Restenosis	ENSG00000079459	FALSE	Preclinical	NA	Unused	FDFT1
Coronary Restenosis	ENSG00000085563	FALSE	unknown	2005-04-13	Unused	ABCB1
Coronary Restenosis	ENSG00000085662	FALSE	Preclinical	1997-08-15	Unused	AKR1B1
Coronary Restenosis	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Coronary Restenosis	ENSG00000088832	FALSE	Preclinical	2004-09-28	Unused	FKBP1A
Coronary Restenosis	ENSG00000090339	FALSE	Preclinical	1997-01-15	Unused	ICAM1
Coronary Restenosis	ENSG00000091831	FALSE	Phase II Clinical Trial	2002-12-16	Unused	ESR1
Coronary Restenosis	ENSG00000092009	FALSE	Preclinical	2002-11-22	Unused	CMA1
Coronary Restenosis	ENSG00000095303	TRUE	Approved	1996-04-15	Approved	PTGS1
Coronary Restenosis	ENSG00000100030	FALSE	Preclinical	NA	Unused	MAPK1
Coronary Restenosis	ENSG00000101109	FALSE	Preclinical	2011-03-01	Unused	STK4
Coronary Restenosis	ENSG00000101868	FALSE	Preclinical	1995-05-15	Unused	POLA1
Coronary Restenosis	ENSG00000102882	FALSE	Preclinical	NA	Unused	MAPK3
Coronary Restenosis	ENSG00000104365	FALSE	Preclinical	1996-04-15	Unused	IKBKB
Coronary Restenosis	ENSG00000105329	FALSE	Phase II Clinical Trial	NA	Unused	TGFB1
Coronary Restenosis	ENSG00000105650	TRUE	Approved	1998-09-15	Approved	PDE4C
Coronary Restenosis	ENSG00000106366	FALSE	Preclinical	1997-08-15	Unused	SERPINE1
Coronary Restenosis	ENSG00000106511	FALSE	Preclinical	1996-12-15	Unused	MEOX2
Coronary Restenosis	ENSG00000108691	FALSE	Phase II Clinical Trial	1992-01-15	Unused	CCL2
Coronary Restenosis	ENSG00000109320	FALSE	Phase I Clinical Trial	2001-07-18	Phase I Clinical Trial	NFKB1
Coronary Restenosis	ENSG00000110092	FALSE	Preclinical	1998-06-15	Unused	CCND1
Coronary Restenosis	ENSG00000111276	FALSE	Preclinical	1998-06-15	Unused	CDKN1B
Coronary Restenosis	ENSG00000112062	FALSE	Preclinical	1995-11-15	Unused	MAPK14
Coronary Restenosis	ENSG00000112715	FALSE	Preclinical	2000-10-10	Unused	VEGFA
Coronary Restenosis	ENSG00000113161	FALSE	Approved	2009-01-27	Approved	HMGCR
Coronary Restenosis	ENSG00000113448	TRUE	Approved	1998-09-15	Approved	PDE4D
Coronary Restenosis	ENSG00000113721	FALSE	Preclinical	2001-12-04	Unused	PDGFRB
Coronary Restenosis	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Coronary Restenosis	ENSG00000115252	FALSE	Preclinical	1995-06-15	Unused	PDE1A
Coronary Restenosis	ENSG00000117411	FALSE	Preclinical	2009-07-09	Unused	B4GALT2
Coronary Restenosis	ENSG00000117601	TRUE	Approved	1993-09-15	Approved	SERPINC1
Coronary Restenosis	ENSG00000118137	FALSE	unknown	NA	Unused	APOA1
Coronary Restenosis	ENSG00000118523	FALSE	Preclinical	1998-10-15	Unused	CTGF
Coronary Restenosis	ENSG00000118785	FALSE	Preclinical	1999-04-28	Unused	SPP1
Coronary Restenosis	ENSG00000121807	FALSE	Preclinical	1995-11-15	Unused	CCR2
Coronary Restenosis	ENSG00000123374	FALSE	Preclinical	1993-09-15	Unused	CDK2
Coronary Restenosis	ENSG00000126218	TRUE	Approved	1993-09-15	Approved	F10
Coronary Restenosis	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Coronary Restenosis	ENSG00000132170	FALSE	Phase II Clinical Trial	1995-03-15	Unused	PPARG
Coronary Restenosis	ENSG00000132646	FALSE	Phase II Clinical Trial	1993-09-15	Unused	PCNA
Coronary Restenosis	ENSG00000134853	FALSE	Preclinical	1991-11-15	Unused	PDGFRA
Coronary Restenosis	ENSG00000136160	FALSE	Preclinical	1998-10-15	Unused	EDNRB
Coronary Restenosis	ENSG00000136997	FALSE	Phase II Clinical Trial	1997-03-15	Unused	MYC
Coronary Restenosis	ENSG00000138448	TRUE	Approved	1996-06-15	Approved	ITGAV
Coronary Restenosis	ENSG00000138735	FALSE	Preclinical	1995-06-15	Unused	PDE5A
Coronary Restenosis	ENSG00000139687	FALSE	Preclinical	1995-05-15	Unused	RB1
Coronary Restenosis	ENSG00000140009	FALSE	Phase II Clinical Trial	2002-12-16	Unused	ESR2
Coronary Restenosis	ENSG00000140538	FALSE	Preclinical	2005-12-13	Unused	NTRK3
Coronary Restenosis	ENSG00000141510	FALSE	Preclinical	1999-04-28	Unused	TP53
Coronary Restenosis	ENSG00000144891	FALSE	Phase III Clinical Trial	1992-05-15	Unused	AGTR1
Coronary Restenosis	ENSG00000147889	FALSE	Preclinical	1998-06-15	Unused	CDKN2A
Coronary Restenosis	ENSG00000148053	FALSE	Preclinical	2005-12-13	Unused	NTRK2
Coronary Restenosis	ENSG00000151617	FALSE	Preclinical	1996-12-15	Unused	EDNRA
Coronary Restenosis	ENSG00000151834	FALSE	Pre-registration	NA	Unused	GABRA2
Coronary Restenosis	ENSG00000154229	FALSE	Preclinical	2005-12-13	Unused	PRKCA
Coronary Restenosis	ENSG00000157150	FALSE	Preclinical	2000-07-19	Unused	TIMP4
Coronary Restenosis	ENSG00000159899	FALSE	Preclinical	1991-08-15	Unused	NPR2
Coronary Restenosis	ENSG00000160013	FALSE	unknown	2010-08-20	Phase II Clinical Trial	PTGIR
Coronary Restenosis	ENSG00000160255	TRUE	Approved	2012-07-20	Approved	ITGB2
Coronary Restenosis	ENSG00000160951	FALSE	Preclinical	2004-10-11	Unused	PTGER1
Coronary Restenosis	ENSG00000161905	FALSE	Preclinical	1997-08-15	Unused	ALOX15
Coronary Restenosis	ENSG00000162692	FALSE	Preclinical	1997-01-15	Unused	VCAM1
Coronary Restenosis	ENSG00000164867	FALSE	Preclinical	1998-05-15	Unused	NOS3
Coronary Restenosis	ENSG00000165197	FALSE	Phase III Clinical Trial	1998-06-15	Unused	VEGFD
Coronary Restenosis	ENSG00000168522	FALSE	Preclinical	1997-06-15	Unused	FNTA
Coronary Restenosis	ENSG00000169403	FALSE	unknown	1996-01-15	Unused	PTAFR
Coronary Restenosis	ENSG00000170558	FALSE	Preclinical	NA	Unused	CDH2
Coronary Restenosis	ENSG00000174175	FALSE	unknown	2005-05-25	Unused	SELP
Coronary Restenosis	ENSG00000175899	FALSE	unknown	2001-05-29	Unused	A2M
Coronary Restenosis	ENSG00000177606	FALSE	Preclinical	2008-08-26	Unused	JUN
Coronary Restenosis	ENSG00000179776	FALSE	Preclinical	2000-12-11	Unused	CDH5
Coronary Restenosis	ENSG00000180210	TRUE	Approved	1993-09-15	Approved	F2
Coronary Restenosis	ENSG00000181104	FALSE	Preclinical	1999-09-08	Unused	F2R
Coronary Restenosis	ENSG00000184588	TRUE	Approved	1998-09-15	Approved	PDE4B
Coronary Restenosis	ENSG00000185532	FALSE	Preclinical	1997-04-15	Unused	PRKG1
Coronary Restenosis	ENSG00000186297	FALSE	Pre-registration	NA	Unused	GABRA5
Coronary Restenosis	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Coronary Restenosis	ENSG00000189403	FALSE	Preclinical	2005-12-13	Unused	HMGB1
Coronary Restenosis	ENSG00000196611	FALSE	Phase II Clinical Trial	NA	Unused	MMP1
Coronary Restenosis	ENSG00000198400	FALSE	Preclinical	2005-12-13	Unused	NTRK1
Coronary Restenosis	ENSG00000198793	TRUE	Approved	2004-12-20	Approved	MTOR
Coronary Restenosis	ENSG00000204174	FALSE	Preclinical	2006-11-03	Absent	NPY4R
Coronary Restenosis	ENSG00000259207	TRUE	Approved	1996-06-15	Approved	ITGB3
Coronary Thrombosis	ENSG00000005961	TRUE	Approved	2012-07-20	Approved	ITGA2B
Coronary Thrombosis	ENSG00000088053	FALSE	Preclinical	2004-12-06	Unused	GP6
Coronary Thrombosis	ENSG00000106366	FALSE	Preclinical	1991-11-15	Unused	SERPINE1
Coronary Thrombosis	ENSG00000106804	FALSE	unknown	2005-01-31	Unused	C5
Coronary Thrombosis	ENSG00000122861	TRUE	Approved	1995-02-15	Approved	PLAU
Coronary Thrombosis	ENSG00000138448	TRUE	Approved	2012-07-20	Approved	ITGAV
Coronary Thrombosis	ENSG00000160255	TRUE	Approved	2012-07-20	Approved	ITGB2
Coronary Thrombosis	ENSG00000169313	FALSE	Preclinical	2004-10-19	Unused	P2RY12
Coronary Thrombosis	ENSG00000172236	FALSE	Preclinical	1997-12-15	Unused	TPSAB1
Coronary Thrombosis	ENSG00000180210	FALSE	Preclinical	1997-12-15	Unused	F2
Coronary Thrombosis	ENSG00000181104	FALSE	Preclinical	2000-02-15	Unused	F2R
Coronary Thrombosis	ENSG00000259207	TRUE	Approved	2012-07-20	Approved	ITGB3
Coronavirus Infections	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Coronavirus Infections	ENSG00000133321	FALSE	Preclinical	2009-07-23	Absent	RARRES3
Coronavirus Infections	ENSG00000135047	FALSE	Preclinical	2014-03-10	Absent	CTSL
Coronavirus Infections	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Coronavirus Infections	ENSG00000159110	FALSE	Preclinical	2004-09-10	Unused	IFNAR2
Coronavirus Infections	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
Coronavirus Infections	ENSG00000196262	FALSE	Preclinical	NA	Absent	PPIA
Coronavirus Infections	ENSG00000196664	FALSE	Phase II Clinical Trial	1989-06-15	Unused	TLR7
Coronavirus Infections	ENSG00000197635	FALSE	Preclinical	2008-07-31	Absent	DPP4
Cough	ENSG00000059377	FALSE	Phase II Clinical Trial	NA	Unused	TBXAS1
Cough	ENSG00000069535	FALSE	unknown	1999-08-17	Unused	MAOB
Cough	ENSG00000073756	TRUE	Approved	NA	Absent	PTGS2
Cough	ENSG00000075073	FALSE	Preclinical	1997-04-15	Unused	TACR2
Cough	ENSG00000082556	TRUE	Approved	2014-09-09	Approved	OPRK1
Cough	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Cough	ENSG00000104321	FALSE	Phase II Clinical Trial	2010-09-01	Absent	TRPA1
Cough	ENSG00000109991	FALSE	Phase II Clinical Trial	2006-02-13	Phase II Clinical Trial	P2RX3
Cough	ENSG00000112038	TRUE	Approved	2010-03-05	Approved	OPRM1
Cough	ENSG00000115353	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	TACR1
Cough	ENSG00000116329	TRUE	Approved	1998-05-15	Approved	OPRD1
Cough	ENSG00000120907	FALSE	Phase I Clinical Trial	NA	Unused	ADRA1A
Cough	ENSG00000125510	FALSE	Preclinical	2007-08-19	Unused	OPRL1
Cough	ENSG00000144481	FALSE	Preclinical	2016-02-01	Absent	TRPM8
Cough	ENSG00000147955	FALSE	unknown	1999-01-15	Preclinical	SIGMAR1
Cough	ENSG00000169252	TRUE	Approved	NA	Approved	ADRB2
Cough	ENSG00000169432	FALSE	Preclinical	NA	Unused	SCN9A
Cough	ENSG00000169836	FALSE	Phase II Clinical Trial	1996-03-15	Unused	TACR3
Cough	ENSG00000170214	FALSE	Phase I Clinical Trial	NA	Unused	ADRA1B
Cough	ENSG00000171873	FALSE	Phase I Clinical Trial	NA	Unused	ADRA1D
Cough	ENSG00000175344	FALSE	Preclinical	2006-06-30	Absent	CHRNA7
Cough	ENSG00000176884	TRUE	Approved	1999-01-15	Approved	GRIN1
Cough	ENSG00000178623	FALSE	Phase II Clinical Trial	2015-01-09	Absent	GPR35
Cough	ENSG00000183873	FALSE	Preclinical	NA	Unused	SCN5A
Cough	ENSG00000188822	FALSE	Preclinical	2004-02-17	Unused	CNR2
Cough	ENSG00000189221	FALSE	unknown	1999-08-17	Unused	MAOA
Cough	ENSG00000196639	TRUE	Approved	2010-03-05	Approved	HRH1
Cough	ENSG00000196689	FALSE	Phase II Clinical Trial	2000-05-17	Unused	TRPV1
Craniocerebral Trauma	ENSG00000006071	FALSE	Phase II Clinical Trial	2010-06-10	Phase II Clinical Trial	ABCC8
Craniocerebral Trauma	ENSG00000007171	FALSE	Phase III Clinical Trial	2004-01-13	Phase II Clinical Trial	NOS2
Craniocerebral Trauma	ENSG00000014216	FALSE	Preclinical	1996-12-15	Unused	CAPN1
Craniocerebral Trauma	ENSG00000019582	FALSE	Preclinical	2010-02-11	Absent	CD74
Craniocerebral Trauma	ENSG00000022355	FALSE	Phase II Clinical Trial	2006-08-18	Unused	GABRA1
Craniocerebral Trauma	ENSG00000050748	FALSE	Preclinical	2015-09-18	Absent	MAPK9
Craniocerebral Trauma	ENSG00000057593	FALSE	Phase II Clinical Trial	NA	Unused	F7
Craniocerebral Trauma	ENSG00000064300	FALSE	Phase I Clinical Trial	2012-04-27	Phase I Clinical Trial	NGFR
Craniocerebral Trauma	ENSG00000065989	FALSE	Preclinical	NA	Preclinical	PDE4A
Craniocerebral Trauma	ENSG00000067182	FALSE	Preclinical	2009-06-09	Preclinical	TNFRSF1A
Craniocerebral Trauma	ENSG00000067560	FALSE	Preclinical	2004-08-10	Unused	RHOA
Craniocerebral Trauma	ENSG00000077782	FALSE	unknown	2004-06-16	Unused	FGFR1
Craniocerebral Trauma	ENSG00000078018	FALSE	unknown	2010-08-21	Unused	MAP2
Craniocerebral Trauma	ENSG00000082175	FALSE	Phase III Clinical Trial	2008-08-29	Phase III Clinical Trial	PGR
Craniocerebral Trauma	ENSG00000082556	FALSE	unknown	1990-10-15	Unused	OPRK1
Craniocerebral Trauma	ENSG00000086205	FALSE	Preclinical	2012-01-04	Preclinical	FOLH1
Craniocerebral Trauma	ENSG00000089250	FALSE	Phase III Clinical Trial	1995-11-15	Phase II Clinical Trial	NOS1
Craniocerebral Trauma	ENSG00000092439	FALSE	Preclinical	2011-09-28	Absent	TRPM7
Craniocerebral Trauma	ENSG00000100985	FALSE	Preclinical	1995-01-15	Preclinical	MMP9
Craniocerebral Trauma	ENSG00000102468	FALSE	unknown	2010-01-06	Preclinical	HTR2A
Craniocerebral Trauma	ENSG00000104368	FALSE	Preclinical	2008-12-03	Preclinical	PLAT
Craniocerebral Trauma	ENSG00000105650	FALSE	Preclinical	NA	Preclinical	PDE4C
Craniocerebral Trauma	ENSG00000105695	FALSE	unknown	2007-11-05	Unused	MAG
Craniocerebral Trauma	ENSG00000106113	FALSE	Preclinical	1994-04-15	Unused	CRHR2
Craniocerebral Trauma	ENSG00000106144	FALSE	Preclinical	2001-09-12	Preclinical	CASP2
Craniocerebral Trauma	ENSG00000109320	FALSE	Preclinical	1990-06-15	Unused	NFKB1
Craniocerebral Trauma	ENSG00000109339	FALSE	Preclinical	2015-09-18	Absent	MAPK10
Craniocerebral Trauma	ENSG00000110799	FALSE	unknown	2006-02-13	Unused	VWF
Craniocerebral Trauma	ENSG00000112541	FALSE	Preclinical	NA	Preclinical	PDE10A
Craniocerebral Trauma	ENSG00000112715	FALSE	Preclinical	1998-12-15	Unused	VEGFA
Craniocerebral Trauma	ENSG00000113161	FALSE	unknown	1997-02-15	Phase II Clinical Trial	HMGCR
Craniocerebral Trauma	ENSG00000113448	FALSE	Preclinical	NA	Preclinical	PDE4D
Craniocerebral Trauma	ENSG00000113494	FALSE	Phase II Clinical Trial	2007-07-06	Phase II Clinical Trial	PRLR
Craniocerebral Trauma	ENSG00000113721	FALSE	Preclinical	2005-02-22	Preclinical	PDGFRB
Craniocerebral Trauma	ENSG00000115232	FALSE	Preclinical	NA	Unused	ITGA4
Craniocerebral Trauma	ENSG00000115263	FALSE	unknown	2004-03-05	Unused	GCG
Craniocerebral Trauma	ENSG00000115594	FALSE	Preclinical	2009-06-09	Preclinical	IL1R1
Craniocerebral Trauma	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Craniocerebral Trauma	ENSG00000118432	FALSE	Preclinical	1998-12-15	Unused	CNR1
Craniocerebral Trauma	ENSG00000120088	FALSE	Preclinical	1994-04-15	Unused	CRHR1
Craniocerebral Trauma	ENSG00000125538	FALSE	Preclinical	2009-06-09	Preclinical	IL1B
Craniocerebral Trauma	ENSG00000128655	FALSE	Preclinical	NA	Preclinical	PDE11A
Craniocerebral Trauma	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Craniocerebral Trauma	ENSG00000130427	FALSE	Preclinical	2011-06-20	Preclinical	EPO
Craniocerebral Trauma	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Craniocerebral Trauma	ENSG00000136869	FALSE	Preclinical	NA	Absent	TLR4
Craniocerebral Trauma	ENSG00000138039	FALSE	Preclinical	2005-12-06	Unused	LHCGR
Craniocerebral Trauma	ENSG00000141655	FALSE	Preclinical	2016-06-21	Absent	TNFRSF11A
Craniocerebral Trauma	ENSG00000142168	FALSE	Preclinical	2016-06-21	Absent	SOD1
Craniocerebral Trauma	ENSG00000142192	FALSE	Preclinical	2003-06-17	Absent	APP
Craniocerebral Trauma	ENSG00000142319	FALSE	Preclinical	2005-12-13	Preclinical	SLC6A3
Craniocerebral Trauma	ENSG00000143799	FALSE	Preclinical	2013-06-28	Absent	PARP1
Craniocerebral Trauma	ENSG00000147955	FALSE	Phase II Clinical Trial	1996-05-15	Unused	SIGMAR1
Craniocerebral Trauma	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Craniocerebral Trauma	ENSG00000148408	FALSE	Preclinical	1992-05-15	Unused	CACNA1B
Craniocerebral Trauma	ENSG00000149131	FALSE	Preclinical	2014-10-08	Absent	SERPING1
Craniocerebral Trauma	ENSG00000149294	FALSE	Preclinical	2004-06-16	Unused	NCAM1
Craniocerebral Trauma	ENSG00000149295	FALSE	Phase II Clinical Trial	2005-04-06	Phase II Clinical Trial	DRD2
Craniocerebral Trauma	ENSG00000150093	FALSE	Preclinical	NA	Unused	ITGB1
Craniocerebral Trauma	ENSG00000151067	FALSE	Preclinical	2012-06-12	Preclinical	CACNA1C
Craniocerebral Trauma	ENSG00000155511	FALSE	unknown	2001-07-25	Unused	GRIA1
Craniocerebral Trauma	ENSG00000159640	FALSE	unknown	NA	Unused	ACE
Craniocerebral Trauma	ENSG00000162692	FALSE	Preclinical	NA	Unused	VCAM1
Craniocerebral Trauma	ENSG00000162909	FALSE	Preclinical	1996-12-15	Unused	CAPN2
Craniocerebral Trauma	ENSG00000163485	FALSE	Preclinical	1999-04-21	Unused	ADORA1
Craniocerebral Trauma	ENSG00000164305	FALSE	Preclinical	2013-01-03	Preclinical	CASP3
Craniocerebral Trauma	ENSG00000164733	FALSE	Preclinical	2013-11-29	Absent	CTSB
Craniocerebral Trauma	ENSG00000165646	FALSE	unknown	2010-04-15	Absent	SLC18A2
Craniocerebral Trauma	ENSG00000168398	FALSE	Preclinical	1997-03-15	Unused	BDKRB2
Craniocerebral Trauma	ENSG00000168621	FALSE	Preclinical	2009-08-03	Unused	GDNF
Craniocerebral Trauma	ENSG00000169245	FALSE	Preclinical	2002-12-04	Unused	CXCL10
Craniocerebral Trauma	ENSG00000171497	FALSE	Preclinical	2009-07-28	Unused	PPID
Craniocerebral Trauma	ENSG00000173198	FALSE	Preclinical	2014-03-06	Absent	CYSLTR1
Craniocerebral Trauma	ENSG00000174417	FALSE	unknown	1990-01-15	Unused	TRHR
Craniocerebral Trauma	ENSG00000175344	FALSE	Preclinical	2013-06-19	Absent	CHRNA7
Craniocerebral Trauma	ENSG00000175567	FALSE	Preclinical	2001-10-18	Unused	UCP2
Craniocerebral Trauma	ENSG00000176884	FALSE	Phase III Clinical Trial	1990-06-15	Unused	GRIN1
Craniocerebral Trauma	ENSG00000178394	FALSE	unknown	1996-08-15	Unused	HTR1A
Craniocerebral Trauma	ENSG00000184588	FALSE	Preclinical	2012-06-28	Preclinical	PDE4B
Craniocerebral Trauma	ENSG00000184845	FALSE	Phase II Clinical Trial	2005-04-06	Phase II Clinical Trial	DRD1
Craniocerebral Trauma	ENSG00000186297	FALSE	Preclinical	2013-06-19	Absent	GABRA5
Craniocerebral Trauma	ENSG00000186318	FALSE	Preclinical	2003-06-17	Absent	BACE1
Craniocerebral Trauma	ENSG00000186868	FALSE	Preclinical	2012-05-08	Absent	MAPT
Craniocerebral Trauma	ENSG00000187266	FALSE	Phase II Clinical Trial	2005-12-06	Phase II Clinical Trial	EPOR
Craniocerebral Trauma	ENSG00000188822	FALSE	Preclinical	1998-12-15	Unused	CNR2
Craniocerebral Trauma	ENSG00000196262	FALSE	Phase II Clinical Trial	2002-01-07	Phase I Clinical Trial	PPIA
Craniocerebral Trauma	ENSG00000196591	FALSE	Preclinical	2014-01-10	Absent	HDAC2
Craniocerebral Trauma	ENSG00000196611	FALSE	Preclinical	1995-01-15	Preclinical	MMP1
Craniocerebral Trauma	ENSG00000196639	FALSE	Preclinical	2014-03-06	Absent	HRH1
Craniocerebral Trauma	ENSG00000197386	FALSE	Preclinical	2003-06-17	Absent	HTT
Craniocerebral Trauma	ENSG00000205542	FALSE	Preclinical	1995-01-15	Preclinical	TMSB4X
Craniocerebral Trauma	ENSG00000240972	FALSE	Preclinical	NA	Preclinical	MIF
Craniocerebral Trauma	ENSG00000273079	FALSE	unknown	NA	Unused	GRIN2B
Creutzfeldt-Jakob Syndrome	ENSG00000075043	FALSE	unknown	NA	Absent	KCNQ2
Creutzfeldt-Jakob Syndrome	ENSG00000171867	FALSE	Phase I Clinical Trial	1994-08-15	Unused	PRNP
Creutzfeldt-Jakob Syndrome	ENSG00000172071	FALSE	Preclinical	NA	Absent	EIF2AK3
Creutzfeldt-Jakob Syndrome	ENSG00000184156	FALSE	unknown	NA	Absent	KCNQ3
Crigler-Najjar Syndrome	ENSG00000241635	FALSE	Preclinical	2014-01-17	Absent	NA
Crohn Disease	ENSG00000005961	FALSE	unknown	NA	Unused	ITGA2B
Crohn Disease	ENSG00000006210	FALSE	Phase II Clinical Trial	2010-02-25	Absent	CX3CL1
Crohn Disease	ENSG00000010610	FALSE	unknown	1990-06-15	Absent	CD4
Crohn Disease	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Crohn Disease	ENSG00000012779	FALSE	Phase II Clinical Trial	NA	Unused	ALOX5
Crohn Disease	ENSG00000059377	FALSE	unknown	2014-07-30	Absent	TBXAS1
Crohn Disease	ENSG00000065325	FALSE	Phase II Clinical Trial	1997-03-15	Phase II Clinical Trial	GLP2R
Crohn Disease	ENSG00000065989	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	PDE4A
Crohn Disease	ENSG00000067182	FALSE	Preclinical	2003-12-12	Phase II Clinical Trial	TNFRSF1A
Crohn Disease	ENSG00000067900	FALSE	Preclinical	2007-11-26	Unused	ROCK1
Crohn Disease	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Absent	FGFR3
Crohn Disease	ENSG00000073756	TRUE	Approved	1993-03-15	Approved	PTGS2
Crohn Disease	ENSG00000076662	FALSE	unknown	1992-11-15	Unused	ICAM3
Crohn Disease	ENSG00000077092	FALSE	unknown	NA	Phase II Clinical Trial	RARB
Crohn Disease	ENSG00000081985	FALSE	Preclinical	2002-11-14	Unused	IL12RB2
Crohn Disease	ENSG00000082556	FALSE	Approved	2007-02-13	Unused	OPRK1
Crohn Disease	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Crohn Disease	ENSG00000083457	FALSE	Phase III Clinical Trial	2007-03-23	Absent	ITGAE
Crohn Disease	ENSG00000087245	FALSE	unknown	2001-07-18	Unused	MMP2
Crohn Disease	ENSG00000090339	FALSE	Preclinical	1993-07-15	Unused	ICAM1
Crohn Disease	ENSG00000095303	TRUE	Approved	1993-03-15	Approved	PTGS1
Crohn Disease	ENSG00000096968	FALSE	Preclinical	2007-10-10	Absent	JAK2
Crohn Disease	ENSG00000096996	FALSE	Preclinical	2002-11-14	Unused	IL12RB1
Crohn Disease	ENSG00000099866	FALSE	Phase III Clinical Trial	1999-09-01	Phase II Clinical Trial	MADCAM1
Crohn Disease	ENSG00000100985	FALSE	Phase II Clinical Trial	2013-03-05	Absent	MMP9
Crohn Disease	ENSG00000101017	FALSE	Phase II Clinical Trial	2000-06-01	Unused	CD40
Crohn Disease	ENSG00000101425	FALSE	unknown	1989-12-15	Unused	BPI
Crohn Disease	ENSG00000101665	FALSE	Phase I Clinical Trial	2008-11-28	Absent	SMAD7
Crohn Disease	ENSG00000102245	FALSE	Phase II Clinical Trial	1993-11-15	Unused	CD40LG
Crohn Disease	ENSG00000102967	FALSE	Phase II Clinical Trial	2002-11-13	Phase II Clinical Trial	DHODH
Crohn Disease	ENSG00000103222	FALSE	unknown	2001-07-18	Unused	ABCC1
Crohn Disease	ENSG00000103522	FALSE	Phase I Clinical Trial	2008-04-24	Unused	IL21R
Crohn Disease	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Crohn Disease	ENSG00000104321	FALSE	Phase II Clinical Trial	2005-05-23	Absent	TRPA1
Crohn Disease	ENSG00000104783	FALSE	Preclinical	2013-12-05	Absent	KCNN4
Crohn Disease	ENSG00000105397	FALSE	Preclinical	2014-12-09	Absent	TYK2
Crohn Disease	ENSG00000105639	FALSE	Preclinical	2003-06-25	Phase II Clinical Trial	JAK3
Crohn Disease	ENSG00000105650	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	PDE4C
Crohn Disease	ENSG00000106348	FALSE	unknown	1989-12-15	Unused	IMPDH1
Crohn Disease	ENSG00000109320	FALSE	Preclinical	2001-07-18	Unused	NFKB1
Crohn Disease	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Crohn Disease	ENSG00000110324	FALSE	Phase I Clinical Trial	2007-03-02	Absent	IL10RA
Crohn Disease	ENSG00000110876	FALSE	Preclinical	2002-08-22	Preclinical	SELPLG
Crohn Disease	ENSG00000110944	FALSE	Phase III Clinical Trial	2002-11-14	Phase II Clinical Trial	IL23A
Crohn Disease	ENSG00000111321	FALSE	Phase II Clinical Trial	2007-07-20	Unused	LTBR
Crohn Disease	ENSG00000111537	FALSE	Phase II Clinical Trial	1992-04-15	Unused	IFNG
Crohn Disease	ENSG00000112033	FALSE	Preclinical	2004-08-02	Absent	PPARD
Crohn Disease	ENSG00000112038	FALSE	Approved	2007-02-13	Unused	OPRM1
Crohn Disease	ENSG00000112062	FALSE	Phase II Clinical Trial	1997-06-15	Phase I Clinical Trial	MAPK14
Crohn Disease	ENSG00000112115	FALSE	unknown	2006-02-01	Phase II Clinical Trial	IL17A
Crohn Disease	ENSG00000112964	FALSE	Phase II Clinical Trial	NA	Unused	GHR
Crohn Disease	ENSG00000113302	TRUE	Approved	1997-06-15	Phase III Clinical Trial	IL12B
Crohn Disease	ENSG00000113448	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	PDE4D
Crohn Disease	ENSG00000113580	TRUE	Approved	1993-08-15	Approved	NR3C1
Crohn Disease	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Absent	PDGFRB
Crohn Disease	ENSG00000114013	FALSE	Preclinical	1992-11-15	Unused	CD86
Crohn Disease	ENSG00000115232	TRUE	Approved	1991-12-15	Approved	ITGA4
Crohn Disease	ENSG00000115353	FALSE	unknown	2001-07-18	Unused	TACR1
Crohn Disease	ENSG00000116044	FALSE	Preclinical	2003-10-13	Unused	NFE2L2
Crohn Disease	ENSG00000116329	FALSE	unknown	2001-07-18	Unused	OPRD1
Crohn Disease	ENSG00000116678	FALSE	Preclinical	2008-11-13	Preclinical	LEPR
Crohn Disease	ENSG00000116824	FALSE	Phase I Clinical Trial	1989-08-15	Unused	CD2
Crohn Disease	ENSG00000117480	FALSE	Preclinical	2017-09-07	Absent	FAAH
Crohn Disease	ENSG00000117525	FALSE	Preclinical	2003-04-08	Preclinical	F3
Crohn Disease	ENSG00000121594	FALSE	Phase I Clinical Trial	1992-11-15	Unused	CD80
Crohn Disease	ENSG00000122025	FALSE	Preclinical	2009-10-29	Unused	FLT3
Crohn Disease	ENSG00000125571	FALSE	Preclinical	2016-06-14	Absent	IL37
Crohn Disease	ENSG00000125735	FALSE	Phase I Clinical Trial	2009-05-14	Phase I Clinical Trial	TNFSF14
Crohn Disease	ENSG00000125910	FALSE	Preclinical	2009-01-15	Absent	S1PR4
Crohn Disease	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Crohn Disease	ENSG00000131759	FALSE	unknown	NA	Phase II Clinical Trial	RARA
Crohn Disease	ENSG00000132170	FALSE	Phase I Clinical Trial	1995-03-15	Unused	PPARG
Crohn Disease	ENSG00000132434	FALSE	Preclinical	2014-05-15	Absent	LANCL2
Crohn Disease	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Crohn Disease	ENSG00000134318	FALSE	Preclinical	2007-11-26	Unused	ROCK2
Crohn Disease	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Crohn Disease	ENSG00000136634	FALSE	Preclinical	2001-02-08	Unused	IL10
Crohn Disease	ENSG00000136869	FALSE	Phase II Clinical Trial	2007-01-03	Phase II Clinical Trial	TLR4
Crohn Disease	ENSG00000137070	FALSE	unknown	2003-05-19	Unused	IL11RA
Crohn Disease	ENSG00000138378	FALSE	Preclinical	1999-10-05	Unused	STAT4
Crohn Disease	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Crohn Disease	ENSG00000138684	FALSE	Phase II Clinical Trial	2010-06-21	Absent	IL21
Crohn Disease	ENSG00000138735	FALSE	unknown	1999-01-08	Unused	PDE5A
Crohn Disease	ENSG00000139572	FALSE	Phase II Clinical Trial	2013-01-15	Absent	GPR84
Crohn Disease	ENSG00000139626	TRUE	Approved	1991-12-15	Approved	ITGB7
Crohn Disease	ENSG00000143365	FALSE	Phase I Clinical Trial	2016-05-02	Absent	RORC
Crohn Disease	ENSG00000146070	FALSE	Preclinical	2016-11-25	Absent	PLA2G7
Crohn Disease	ENSG00000150093	TRUE	Approved	1991-12-15	Approved	ITGB1
Crohn Disease	ENSG00000150782	FALSE	unknown	1999-05-04	Unused	IL18
Crohn Disease	ENSG00000156738	FALSE	unknown	2002-10-28	Unused	MS4A1
Crohn Disease	ENSG00000157404	FALSE	Phase III Clinical Trial	NA	Absent	KIT
Crohn Disease	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Crohn Disease	ENSG00000160255	FALSE	unknown	NA	Unused	ITGB2
Crohn Disease	ENSG00000160712	FALSE	Phase II Clinical Trial	1996-05-15	Unused	IL6R
Crohn Disease	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Crohn Disease	ENSG00000162434	FALSE	Phase III Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK1
Crohn Disease	ENSG00000163131	FALSE	Phase I Clinical Trial	2009-01-20	Absent	CTSS
Crohn Disease	ENSG00000163464	FALSE	Preclinical	1997-03-15	Unused	CXCR1
Crohn Disease	ENSG00000163599	FALSE	unknown	2008-01-30	Absent	CTLA4
Crohn Disease	ENSG00000163606	FALSE	Preclinical	2015-10-16	Absent	CD200R1
Crohn Disease	ENSG00000164171	FALSE	unknown	2006-02-13	Preclinical	ITGA2
Crohn Disease	ENSG00000166888	FALSE	Preclinical	2016-11-17	Absent	STAT6
Crohn Disease	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Crohn Disease	ENSG00000168685	FALSE	Preclinical	2011-07-13	Absent	IL7R
Crohn Disease	ENSG00000168811	FALSE	Phase II Clinical Trial	1997-06-15	Phase II Clinical Trial	IL12A
Crohn Disease	ENSG00000169083	FALSE	Phase II Clinical Trial	2006-07-07	Unused	AR
Crohn Disease	ENSG00000169194	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	IL13
Crohn Disease	ENSG00000169245	FALSE	Phase II Clinical Trial	2003-01-07	Phase II Clinical Trial	CXCL10
Crohn Disease	ENSG00000169403	FALSE	unknown	1998-09-15	Unused	PTAFR
Crohn Disease	ENSG00000169919	FALSE	unknown	2001-07-18	Unused	GUSB
Crohn Disease	ENSG00000170989	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR1
Crohn Disease	ENSG00000172156	FALSE	Phase II Clinical Trial	2000-08-02	Preclinical	CCL11
Crohn Disease	ENSG00000172936	FALSE	Preclinical	2000-03-01	Unused	MYD88
Crohn Disease	ENSG00000173585	FALSE	Phase III Clinical Trial	2003-07-07	Phase III Clinical Trial	CCR9
Crohn Disease	ENSG00000175104	FALSE	Preclinical	2000-03-01	Unused	TRAF6
Crohn Disease	ENSG00000175344	FALSE	Preclinical	NA	Unused	CHRNA7
Crohn Disease	ENSG00000176890	TRUE	Approved	NA	Absent	TYMS
Crohn Disease	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Crohn Disease	ENSG00000177663	FALSE	Phase II Clinical Trial	2008-03-04	Unused	IL17RA
Crohn Disease	ENSG00000178568	FALSE	Preclinical	2015-10-23	Absent	ERBB4
Crohn Disease	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Crohn Disease	ENSG00000180739	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR5
Crohn Disease	ENSG00000180871	FALSE	Preclinical	1997-03-15	Unused	CXCR2
Crohn Disease	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Crohn Disease	ENSG00000181634	FALSE	Phase I Clinical Trial	2013-11-21	Absent	TNFSF15
Crohn Disease	ENSG00000182578	FALSE	Phase I Clinical Trial	2010-01-25	Preclinical	CSF1R
Crohn Disease	ENSG00000184216	FALSE	Preclinical	2000-03-01	Unused	IRAK1
Crohn Disease	ENSG00000184588	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	PDE4B
Crohn Disease	ENSG00000186642	FALSE	unknown	1999-01-08	Unused	PDE2A
Crohn Disease	ENSG00000186951	FALSE	Preclinical	2004-08-02	Absent	PPARA
Crohn Disease	ENSG00000188404	FALSE	Phase II Clinical Trial	NA	Unused	SELL
Crohn Disease	ENSG00000188822	FALSE	Preclinical	2017-09-07	Absent	CNR2
Crohn Disease	ENSG00000189403	FALSE	Preclinical	2003-08-06	Unused	HMGB1
Crohn Disease	ENSG00000196689	FALSE	Phase I Clinical Trial	2005-01-31	Phase I Clinical Trial	TRPV1
Crohn Disease	ENSG00000197249	FALSE	unknown	NA	Unused	SERPINA1
Crohn Disease	ENSG00000197405	FALSE	Preclinical	2003-06-16	Unused	C5AR1
Crohn Disease	ENSG00000197971	FALSE	unknown	2005-04-05	Absent	MBP
Crohn Disease	ENSG00000198223	FALSE	Phase III Clinical Trial	2003-06-12	Unused	CSF2RA
Crohn Disease	ENSG00000198793	FALSE	Preclinical	NA	Unused	MTOR
Crohn Disease	ENSG00000198805	FALSE	unknown	2004-01-05	Unused	PNP
Crohn Disease	ENSG00000198851	FALSE	Phase II Clinical Trial	2004-02-24	Absent	CD3E
Crohn Disease	ENSG00000204174	FALSE	Phase II Clinical Trial	2006-07-31	Absent	NPY4R
Crohn Disease	ENSG00000213809	FALSE	Phase II Clinical Trial	2006-11-24	Unused	KLRK1
Crohn Disease	ENSG00000228716	TRUE	Approved	2008-03-27	Absent	DHFR
Crohn Disease	ENSG00000239732	FALSE	Preclinical	1993-07-15	Absent	TLR9
Crohn Disease	ENSG00000240972	FALSE	Preclinical	2004-01-13	Preclinical	MIF
Crohn Disease	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Crohn Disease	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Croup	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Cryopyrin-Associated Periodic Syndromes	ENSG00000115590	TRUE	Approved	1995-08-15	Approved	IL1R2
Cryopyrin-Associated Periodic Syndromes	ENSG00000115594	TRUE	Approved	1995-08-15	Approved	IL1R1
Cryopyrin-Associated Periodic Syndromes	ENSG00000125538	TRUE	Approved	2003-12-08	Approved	IL1B
Cryptococcosis	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Unused	IFNGR1
Cryptococcosis	ENSG00000140992	FALSE	unknown	2008-04-09	Absent	PDPK1
Cryptococcosis	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Cryptosporidiosis	ENSG00000241973	FALSE	Preclinical	2017-06-20	Absent	PI4KA
Cystic Fibrosis	ENSG00000001626	TRUE	Approved	1990-10-15	Approved	CFTR
Cystic Fibrosis	ENSG00000006283	FALSE	Preclinical	1991-09-15	Unused	CACNA1G
Cystic Fibrosis	ENSG00000012223	FALSE	Phase I Clinical Trial	NA	Preclinical	LTF
Cystic Fibrosis	ENSG00000012779	FALSE	Preclinical	1998-10-15	Absent	ALOX5
Cystic Fibrosis	ENSG00000016490	FALSE	unknown	2001-02-26	Unused	CLCA1
Cystic Fibrosis	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Unused	IFNGR1
Cystic Fibrosis	ENSG00000043591	FALSE	unknown	2004-07-26	Preclinical	ADRB1
Cystic Fibrosis	ENSG00000065989	FALSE	Phase II Clinical Trial	2007-06-06	Absent	PDE4A
Cystic Fibrosis	ENSG00000089250	FALSE	Preclinical	2015-08-19	Absent	NOS1
Cystic Fibrosis	ENSG00000100985	FALSE	Phase II Clinical Trial	1995-01-15	Preclinical	MMP9
Cystic Fibrosis	ENSG00000101557	FALSE	Preclinical	2011-04-27	Unused	USP14
Cystic Fibrosis	ENSG00000105650	FALSE	Phase II Clinical Trial	2007-06-06	Absent	PDE4C
Cystic Fibrosis	ENSG00000105851	FALSE	Preclinical	2017-05-03	Absent	PIK3CG
Cystic Fibrosis	ENSG00000109320	FALSE	unknown	1998-03-15	Unused	NFKB1
Cystic Fibrosis	ENSG00000111144	FALSE	Phase II Clinical Trial	2012-01-11	Phase I Clinical Trial	LTA4H
Cystic Fibrosis	ENSG00000111319	FALSE	Phase II Clinical Trial	1990-02-15	Unused	SCNN1A
Cystic Fibrosis	ENSG00000113448	FALSE	Phase II Clinical Trial	2007-06-06	Absent	PDE4D
Cystic Fibrosis	ENSG00000113580	FALSE	Preclinical	NA	Unused	NR3C1
Cystic Fibrosis	ENSG00000114812	FALSE	Preclinical	2010-11-16	Absent	VIPR1
Cystic Fibrosis	ENSG00000114859	FALSE	unknown	2002-09-25	Phase II Clinical Trial	CLCN2
Cystic Fibrosis	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK2
Cystic Fibrosis	ENSG00000130164	FALSE	unknown	1995-10-15	Unused	LDLR
Cystic Fibrosis	ENSG00000131759	FALSE	Phase I Clinical Trial	2015-06-17	Absent	RARA
Cystic Fibrosis	ENSG00000132170	FALSE	Preclinical	2011-08-05	Unused	PPARG
Cystic Fibrosis	ENSG00000133019	FALSE	Phase III Clinical Trial	1994-08-15	Phase III Clinical Trial	CHRM3
Cystic Fibrosis	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK7
Cystic Fibrosis	ENSG00000134489	FALSE	Preclinical	2012-07-21	Phase II Clinical Trial	HRH4
Cystic Fibrosis	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK9
Cystic Fibrosis	ENSG00000136810	FALSE	Preclinical	2012-08-06	Preclinical	TXN
Cystic Fibrosis	ENSG00000136960	FALSE	Preclinical	2013-04-01	Absent	ENPP2
Cystic Fibrosis	ENSG00000148154	FALSE	unknown	1989-06-15	Absent	UGCG
Cystic Fibrosis	ENSG00000148180	FALSE	Phase II Clinical Trial	1994-04-15	Unused	GSN
Cystic Fibrosis	ENSG00000149021	FALSE	unknown	1997-08-15	Absent	SCGB1A1
Cystic Fibrosis	ENSG00000160013	FALSE	Phase I Clinical Trial	2015-10-05	Absent	PTGIR
Cystic Fibrosis	ENSG00000160211	FALSE	unknown	1999-01-15	Unused	G6PD
Cystic Fibrosis	ENSG00000163464	FALSE	Phase II Clinical Trial	2004-10-12	Unused	CXCR1
Cystic Fibrosis	ENSG00000163737	FALSE	Preclinical	2009-12-01	Absent	PF4
Cystic Fibrosis	ENSG00000164270	FALSE	Preclinical	NA	Unused	HTR4
Cystic Fibrosis	ENSG00000167642	FALSE	Phase II Clinical Trial	2004-08-23	Unused	SPINT2
Cystic Fibrosis	ENSG00000169252	FALSE	unknown	2004-07-26	Preclinical	ADRB2
Cystic Fibrosis	ENSG00000169429	FALSE	Preclinical	1995-02-15	Unused	CXCL8
Cystic Fibrosis	ENSG00000170820	FALSE	Phase I Clinical Trial	2012-09-18	Preclinical	FSHR
Cystic Fibrosis	ENSG00000170835	FALSE	unknown	1998-06-15	Unused	CEL
Cystic Fibrosis	ENSG00000172572	FALSE	Phase II Clinical Trial	2007-06-06	Absent	PDE3A
Cystic Fibrosis	ENSG00000173083	FALSE	Preclinical	1999-02-15	Unused	HPSE
Cystic Fibrosis	ENSG00000175535	FALSE	Phase II Clinical Trial	2003-05-19	Absent	PNLIP
Cystic Fibrosis	ENSG00000175591	FALSE	Phase III Clinical Trial	2005-05-08	Unused	P2RY2
Cystic Fibrosis	ENSG00000180871	FALSE	Phase II Clinical Trial	2004-10-12	Unused	CXCR2
Cystic Fibrosis	ENSG00000182333	FALSE	Phase II Clinical Trial	1990-11-15	Unused	LIPF
Cystic Fibrosis	ENSG00000184588	FALSE	Phase II Clinical Trial	2007-06-06	Absent	PDE4B
Cystic Fibrosis	ENSG00000188257	FALSE	Phase I Clinical Trial	1997-11-15	Unused	PLA2G2A
Cystic Fibrosis	ENSG00000188822	FALSE	Phase II Clinical Trial	2011-05-13	Absent	CNR2
Cystic Fibrosis	ENSG00000196611	FALSE	unknown	1995-01-15	Preclinical	MMP1
Cystic Fibrosis	ENSG00000197249	FALSE	Phase II Clinical Trial	1996-07-15	Phase II Clinical Trial	SERPINA1
Cystic Fibrosis	ENSG00000197561	FALSE	Phase II Clinical Trial	1990-11-15	Unused	ELANE
Cystic Fibrosis	ENSG00000198223	FALSE	unknown	NA	Absent	CSF2RA
Cystic Fibrosis	ENSG00000205542	FALSE	Preclinical	1995-01-15	Unused	TMSB4X
Cystic Fibrosis	ENSG00000213903	FALSE	Phase I Clinical Trial	1998-07-15	Unused	LTB4R
Cystic Fibrosis	ENSG00000213918	TRUE	Approved	1990-07-15	Approved	DNASE1
Cystic Fibrosis	ENSG00000271503	FALSE	Preclinical	2009-12-01	Absent	CCL5
Cystic Fibrosis	ENSG00000277443	FALSE	Preclinical	NA	Unused	MARCKS
Cytomegalovirus Infections	ENSG00000090339	TRUE	Approved	1992-11-15	Unused	ICAM1
Cytomegalovirus Infections	ENSG00000109471	FALSE	Preclinical	1994-08-15	Unused	IL2
Cytomegalovirus Infections	ENSG00000128052	FALSE	Preclinical	2017-12-19	Absent	KDR
Cytomegalovirus Infections	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Cytomegalovirus Infections	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Cytomegalovirus Infections	ENSG00000146648	FALSE	Preclinical	NA	Absent	EGFR
Cytomegalovirus Infections	ENSG00000156738	FALSE	Preclinical	NA	Absent	MS4A1
Cytomegalovirus Infections	ENSG00000213809	FALSE	Preclinical	NA	Absent	KLRK1
Darier Disease	ENSG00000166224	FALSE	Phase II Clinical Trial	2017-12-04	Absent	SGPL1
Delayed Graft Function	ENSG00000019991	FALSE	Phase II Clinical Trial	2009-01-13	Absent	HGF
Delayed Graft Function	ENSG00000106804	FALSE	Phase III Clinical Trial	1993-08-15	Absent	C5
Delayed Graft Function	ENSG00000112715	FALSE	Preclinical	2003-07-02	Absent	VEGFA
Delayed Graft Function	ENSG00000116824	FALSE	unknown	1995-12-15	Absent	CD2
Delayed Graft Function	ENSG00000125730	FALSE	Preclinical	2011-09-15	Absent	C3
Delayed Graft Function	ENSG00000137462	FALSE	Phase II Clinical Trial	2006-02-15	Absent	TLR2
Delayed Graft Function	ENSG00000141510	FALSE	Phase III Clinical Trial	2003-10-14	Absent	TP53
Delayed Graft Function	ENSG00000149131	FALSE	Preclinical	NA	Absent	SERPING1
Delayed Graft Function	ENSG00000150281	FALSE	unknown	NA	Absent	CTF1
Delayed Graft Function	ENSG00000150782	FALSE	Phase II Clinical Trial	2009-12-18	Absent	IL18
Delayed Graft Function	ENSG00000163464	FALSE	Preclinical	1999-01-15	Absent	CXCR1
Delayed Graft Function	ENSG00000164111	FALSE	Phase II Clinical Trial	2003-11-10	Absent	ANXA5
Delayed Graft Function	ENSG00000169429	FALSE	unknown	2005-10-17	Absent	CXCL8
Delayed Graft Function	ENSG00000174175	FALSE	unknown	1999-02-15	Absent	SELP
Delayed Graft Function	ENSG00000180871	FALSE	Preclinical	1999-01-15	Absent	CXCR2
Delayed Graft Function	ENSG00000187266	FALSE	Preclinical	2003-07-02	Absent	EPOR
Delayed Graft Function	ENSG00000196776	FALSE	Preclinical	2014-05-27	Absent	CD47
Delayed Graft Function	ENSG00000269858	FALSE	Preclinical	2003-07-02	Absent	EGLN2
Dementia	ENSG00000004487	FALSE	Preclinical	2010-07-08	Preclinical	KDM1A
Dementia	ENSG00000022355	FALSE	Preclinical	2013-11-21	Absent	GABRA1
Dementia	ENSG00000068903	FALSE	Preclinical	2008-12-05	Unused	SIRT2
Dementia	ENSG00000069535	FALSE	Preclinical	2010-07-08	Preclinical	MAOB
Dementia	ENSG00000085377	FALSE	Phase I Clinical Trial	1994-06-15	Unused	PREP
Dementia	ENSG00000087085	TRUE	Approved	1989-06-15	Approved	ACHE
Dementia	ENSG00000101180	FALSE	Phase I Clinical Trial	2011-04-02	Absent	HRH3
Dementia	ENSG00000101204	FALSE	unknown	2003-01-15	Unused	CHRNA4
Dementia	ENSG00000102468	TRUE	Approved	2003-08-13	Absent	HTR2A
Dementia	ENSG00000112715	FALSE	Preclinical	2008-12-05	Unused	VEGFA
Dementia	ENSG00000113441	FALSE	Preclinical	1997-05-15	Unused	LNPEP
Dementia	ENSG00000114200	TRUE	Approved	2012-08-07	Approved	BCHE
Dementia	ENSG00000134259	FALSE	Preclinical	2001-08-01	Unused	NGF
Dementia	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Dementia	ENSG00000158748	FALSE	Phase II Clinical Trial	2004-02-18	Phase II Clinical Trial	HTR6
Dementia	ENSG00000160191	FALSE	Phase I Clinical Trial	2015-04-16	Absent	PDE9A
Dementia	ENSG00000160716	FALSE	unknown	2003-01-15	Unused	CHRNB2
Dementia	ENSG00000164082	FALSE	unknown	2009-02-20	Unused	GRM2
Dementia	ENSG00000168539	FALSE	Preclinical	1994-09-15	Unused	CHRM1
Dementia	ENSG00000175344	FALSE	unknown	2007-10-08	Unused	CHRNA7
Dementia	ENSG00000178394	FALSE	Preclinical	1998-09-15	Unused	HTR1A
Dementia	ENSG00000180720	FALSE	Preclinical	2014-11-18	Absent	CHRM4
Dementia	ENSG00000184845	TRUE	Approved	2015-04-24	Approved	DRD1
Dementia	ENSG00000186642	FALSE	Preclinical	2001-03-19	Unused	PDE2A
Dementia	ENSG00000186868	FALSE	Preclinical	2016-07-15	Absent	MAPT
Dementia	ENSG00000198822	FALSE	unknown	2009-02-20	Unused	GRM3
Dementia, Vascular	ENSG00000069535	FALSE	Preclinical	2007-08-28	Unused	MAOB
Dementia, Vascular	ENSG00000070019	FALSE	Preclinical	2017-01-27	Absent	GUCY2C
Dementia, Vascular	ENSG00000087085	FALSE	Phase III Clinical Trial	1989-06-15	Unused	ACHE
Dementia, Vascular	ENSG00000102468	TRUE	Approved	NA	Absent	HTR2A
Dementia, Vascular	ENSG00000106366	FALSE	Preclinical	2009-08-06	Absent	SERPINE1
Dementia, Vascular	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Dementia, Vascular	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Dementia, Vascular	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Dementia, Vascular	ENSG00000158748	FALSE	unknown	2004-02-18	Absent	HTR6
Dementia, Vascular	ENSG00000174417	FALSE	Phase II Clinical Trial	1990-01-15	Unused	TRHR
Dementia, Vascular	ENSG00000176884	FALSE	Phase III Clinical Trial	2008-01-16	Phase III Clinical Trial	GRIN1
Dementia, Vascular	ENSG00000184588	FALSE	unknown	2001-12-03	Unused	PDE4B
Dementia, Vascular	ENSG00000184845	TRUE	Approved	NA	Approved	DRD1
Dengue	ENSG00000133321	FALSE	Preclinical	2009-07-23	Absent	RARRES3
Dengue	ENSG00000140564	FALSE	Preclinical	2014-03-06	Absent	FURIN
Dengue	ENSG00000159640	FALSE	unknown	2003-07-16	Absent	ACE
Dengue	ENSG00000164342	FALSE	unknown	NA	Absent	TLR3
Dengue	ENSG00000169403	FALSE	Phase III Clinical Trial	2015-09-16	Absent	PTAFR
Dengue	ENSG00000171298	FALSE	Phase III Clinical Trial	2013-12-31	Absent	GAA
Dengue	ENSG00000260314	FALSE	Preclinical	2017-08-16	Absent	MRC1
Depression	ENSG00000004948	FALSE	Preclinical	2009-04-27	Unused	CALCR
Depression	ENSG00000010322	FALSE	Phase I Clinical Trial	1991-06-15	Unused	NISCH
Depression	ENSG00000011677	TRUE	Approved	1991-04-15	Approved	GABRA3
Depression	ENSG00000022355	TRUE	Approved	1991-04-15	Approved	GABRA1
Depression	ENSG00000059377	FALSE	unknown	NA	Unused	TBXAS1
Depression	ENSG00000060491	FALSE	unknown	NA	Unused	OGFR
Depression	ENSG00000064989	FALSE	Phase II Clinical Trial	2001-06-12	Unused	CALCRL
Depression	ENSG00000065989	FALSE	Phase I Clinical Trial	2003-02-15	Unused	PDE4A
Depression	ENSG00000067182	FALSE	Preclinical	2009-07-29	Preclinical	TNFRSF1A
Depression	ENSG00000069535	FALSE	Phase II Clinical Trial	1992-01-15	Unused	MAOB
Depression	ENSG00000069696	TRUE	Approved	1989-12-15	Approved	DRD4
Depression	ENSG00000070748	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	CHAT
Depression	ENSG00000072315	FALSE	Phase I Clinical Trial	2010-07-08	Preclinical	TRPC5
Depression	ENSG00000073756	FALSE	unknown	2000-05-24	Unused	PTGS2
Depression	ENSG00000075073	FALSE	Preclinical	1993-01-15	Unused	TACR2
Depression	ENSG00000078018	FALSE	unknown	2010-08-21	Unused	MAP2
Depression	ENSG00000082556	FALSE	Preclinical	2010-09-08	Unused	OPRK1
Depression	ENSG00000082701	FALSE	Preclinical	2004-08-16	Unused	GSK3B
Depression	ENSG00000087085	FALSE	Preclinical	1994-02-15	Unused	ACHE
Depression	ENSG00000089041	FALSE	Preclinical	2007-05-11	Unused	P2RX7
Depression	ENSG00000089250	FALSE	Preclinical	2009-05-27	Preclinical	NOS1
Depression	ENSG00000091831	FALSE	unknown	NA	Preclinical	ESR1
Depression	ENSG00000092009	FALSE	Preclinical	1995-02-15	Unused	CMA1
Depression	ENSG00000094631	FALSE	Preclinical	2017-01-31	Absent	HDAC6
Depression	ENSG00000100300	FALSE	Preclinical	1997-07-15	Unused	TSPO
Depression	ENSG00000101180	FALSE	Preclinical	1994-08-15	Unused	HRH3
Depression	ENSG00000101204	FALSE	Preclinical	2003-01-15	Unused	CHRNA4
Depression	ENSG00000102468	TRUE	Approved	1989-12-15	Approved	HTR2A
Depression	ENSG00000103546	TRUE	Approved	1989-07-15	Approved	SLC6A2
Depression	ENSG00000105464	FALSE	Preclinical	2011-07-28	Absent	GRIN2D
Depression	ENSG00000105650	FALSE	Phase I Clinical Trial	2003-02-15	Unused	PDE4C
Depression	ENSG00000106113	FALSE	Preclinical	1994-02-15	Unused	CRHR2
Depression	ENSG00000108576	TRUE	Approved	1989-06-15	Approved	SLC6A4
Depression	ENSG00000109158	FALSE	Preclinical	2007-11-14	Unused	GABRA4
Depression	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Depression	ENSG00000110090	FALSE	Phase I Clinical Trial	2013-01-15	Phase I Clinical Trial	CPT1A
Depression	ENSG00000110148	FALSE	unknown	1991-07-15	Unused	CCKBR
Depression	ENSG00000112038	FALSE	Phase I Clinical Trial	2002-07-02	Absent	OPRM1
Depression	ENSG00000112164	FALSE	Preclinical	2006-01-30	Unused	GLP1R
Depression	ENSG00000113161	FALSE	unknown	1997-02-15	Phase II Clinical Trial	HMGCR
Depression	ENSG00000113448	FALSE	Phase I Clinical Trial	2003-02-15	Unused	PDE4D
Depression	ENSG00000113580	FALSE	Phase II Clinical Trial	2001-02-27	Unused	NR3C1
Depression	ENSG00000113749	FALSE	Preclinical	NA	Unused	HRH2
Depression	ENSG00000115353	FALSE	Phase III Clinical Trial	1998-06-15	Unused	TACR1
Depression	ENSG00000116329	FALSE	Phase I Clinical Trial	1995-08-15	Unused	OPRD1
Depression	ENSG00000117480	FALSE	Preclinical	2004-03-02	Unused	FAAH
Depression	ENSG00000119973	FALSE	unknown	NA	Unused	PRLHR
Depression	ENSG00000120088	FALSE	Preclinical	1994-02-15	Unused	CRHR1
Depression	ENSG00000124493	FALSE	Preclinical	NA	Absent	GRM4
Depression	ENSG00000125510	FALSE	Preclinical	1999-06-10	Unused	OPRL1
Depression	ENSG00000126010	FALSE	Preclinical	1997-11-15	Unused	GRPR
Depression	ENSG00000128271	FALSE	Phase II Clinical Trial	1996-03-15	Phase I Clinical Trial	ADORA2A
Depression	ENSG00000128285	FALSE	Preclinical	2004-08-22	Unused	MCHR1
Depression	ENSG00000129167	FALSE	unknown	NA	Unused	TPH1
Depression	ENSG00000131203	FALSE	Preclinical	2008-04-16	Unused	IDO1
Depression	ENSG00000131747	FALSE	unknown	NA	Unused	TOP2A
Depression	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Depression	ENSG00000132329	FALSE	Phase II Clinical Trial	2001-06-12	Unused	RAMP1
Depression	ENSG00000132437	FALSE	Phase I Clinical Trial	NA	Unused	DDC
Depression	ENSG00000133019	TRUE	Approved	2000-07-04	Absent	CHRM3
Depression	ENSG00000133107	FALSE	Phase I Clinical Trial	2010-07-08	Absent	TRPC4
Depression	ENSG00000133731	FALSE	Preclinical	1993-01-15	Unused	IMPA1
Depression	ENSG00000134640	FALSE	Preclinical	1996-03-15	Unused	MTNR1B
Depression	ENSG00000135124	FALSE	Preclinical	2009-09-30	Unused	P2RX4
Depression	ENSG00000135312	FALSE	Phase II Clinical Trial	1992-12-15	Unused	HTR1B
Depression	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Depression	ENSG00000135914	FALSE	Phase II Clinical Trial	1997-11-15	Unused	HTR2B
Depression	ENSG00000137252	FALSE	Preclinical	2014-02-08	Absent	HCRTR2
Depression	ENSG00000140009	FALSE	Preclinical	2007-06-04	Unused	ESR2
Depression	ENSG00000140443	FALSE	Preclinical	2006-11-01	Unused	IGF1R
Depression	ENSG00000142319	TRUE	Approved	1989-07-15	Approved	SLC6A3
Depression	ENSG00000144339	FALSE	Preclinical	2009-05-22	Preclinical	TMEFF2
Depression	ENSG00000144724	FALSE	Preclinical	2009-08-25	Unused	PTPRG
Depression	ENSG00000146399	FALSE	Phase I Clinical Trial	2010-02-08	Unused	TAAR1
Depression	ENSG00000147246	TRUE	Approved	1989-12-15	Approved	HTR2C
Depression	ENSG00000147955	FALSE	Preclinical	1990-09-15	Unused	SIGMAR1
Depression	ENSG00000148053	FALSE	Preclinical	NA	Preclinical	NTRK2
Depression	ENSG00000148344	FALSE	Preclinical	2006-12-19	Absent	PTGES
Depression	ENSG00000148408	FALSE	Preclinical	1992-01-15	Unused	CACNA1B
Depression	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Depression	ENSG00000149177	FALSE	Preclinical	1996-10-15	Unused	PTPRJ
Depression	ENSG00000149295	TRUE	Approved	1989-12-15	Approved	DRD2
Depression	ENSG00000150594	TRUE	Approved	1990-11-15	Approved	ADRA2A
Depression	ENSG00000151067	FALSE	Preclinical	1992-08-15	Unused	CACNA1C
Depression	ENSG00000151577	TRUE	Approved	1989-12-15	Approved	DRD3
Depression	ENSG00000151834	TRUE	Approved	1991-04-15	Approved	GABRA2
Depression	ENSG00000153253	FALSE	Preclinical	2007-03-09	Absent	SCN3A
Depression	ENSG00000155511	FALSE	Phase I Clinical Trial	1995-07-15	Unused	GRIA1
Depression	ENSG00000157103	FALSE	Preclinical	1990-09-15	Unused	SLC6A1
Depression	ENSG00000157219	FALSE	Preclinical	2006-11-24	Unused	HTR5A
Depression	ENSG00000157540	FALSE	Preclinical	2008-07-17	Preclinical	DYRK1A
Depression	ENSG00000158748	FALSE	Preclinical	2006-03-27	Unused	HTR6
Depression	ENSG00000160712	FALSE	Preclinical	2001-03-19	Unused	IL6R
Depression	ENSG00000160716	FALSE	Preclinical	2003-01-15	Unused	CHRNB2
Depression	ENSG00000160951	FALSE	Preclinical	2009-09-30	Unused	PTGER1
Depression	ENSG00000161509	FALSE	Preclinical	2011-07-28	Absent	GRIN2C
Depression	ENSG00000163485	FALSE	Preclinical	1990-12-15	Unused	ADORA1
Depression	ENSG00000164082	FALSE	Preclinical	2003-11-12	Phase I Clinical Trial	GRM2
Depression	ENSG00000164128	FALSE	Phase I Clinical Trial	1996-05-15	Unused	NPY1R
Depression	ENSG00000164270	FALSE	unknown	NA	Unused	HTR4
Depression	ENSG00000166148	FALSE	Phase I Clinical Trial	2006-07-10	Phase I Clinical Trial	AVPR1A
Depression	ENSG00000166573	FALSE	Preclinical	1997-05-15	Unused	GALR1
Depression	ENSG00000166736	TRUE	Approved	1990-07-15	Approved	HTR3A
Depression	ENSG00000168412	FALSE	Preclinical	1996-03-15	Unused	MTNR1A
Depression	ENSG00000168539	TRUE	Approved	2000-07-04	Preclinical	CHRM1
Depression	ENSG00000168959	FALSE	Phase I Clinical Trial	2002-09-10	Unused	GRM5
Depression	ENSG00000169083	TRUE	Approved	NA	Approved	AR
Depression	ENSG00000169432	FALSE	Preclinical	2007-03-09	Absent	SCN9A
Depression	ENSG00000169836	FALSE	Preclinical	1998-09-15	Unused	TACR3
Depression	ENSG00000173250	FALSE	Preclinical	2001-01-23	Absent	GPR151
Depression	ENSG00000174417	FALSE	Preclinical	NA	Unused	TRHR
Depression	ENSG00000175344	FALSE	Phase II Clinical Trial	2010-06-08	Preclinical	CHRNA7
Depression	ENSG00000176884	FALSE	Preclinical	1996-07-15	Unused	GRIN1
Depression	ENSG00000178394	TRUE	Approved	1989-09-15	Approved	HTR1A
Depression	ENSG00000179097	TRUE	Approved	2000-07-04	Absent	HTR1F
Depression	ENSG00000179546	TRUE	Approved	1992-07-15	Approved	HTR1D
Depression	ENSG00000180720	TRUE	Approved	2000-07-04	Absent	CHRM4
Depression	ENSG00000181072	TRUE	Approved	2000-07-04	Preclinical	CHRM2
Depression	ENSG00000182687	FALSE	Preclinical	1997-05-15	Unused	GALR2
Depression	ENSG00000184160	FALSE	Phase I Clinical Trial	1990-11-15	Unused	ADRA2C
Depression	ENSG00000184588	FALSE	Phase I Clinical Trial	2003-02-15	Unused	PDE4B
Depression	ENSG00000184845	TRUE	Approved	1989-12-15	Approved	DRD1
Depression	ENSG00000185313	FALSE	Preclinical	2007-03-09	Absent	SCN10A
Depression	ENSG00000186297	TRUE	Approved	1991-04-15	Approved	GABRA5
Depression	ENSG00000186642	FALSE	Preclinical	2009-09-18	Unused	PDE2A
Depression	ENSG00000187266	FALSE	Preclinical	2009-11-16	Unused	EPOR
Depression	ENSG00000188778	FALSE	Preclinical	1996-03-15	Unused	ADRB3
Depression	ENSG00000189221	TRUE	Approved	1990-04-15	Approved	MAOA
Depression	ENSG00000196277	FALSE	Preclinical	2008-06-09	Preclinical	GRM7
Depression	ENSG00000196549	FALSE	Preclinical	1990-11-15	Unused	MME
Depression	ENSG00000196639	TRUE	Approved	2002-04-03	Approved	HRH1
Depression	ENSG00000197635	FALSE	Preclinical	2004-11-22	Unused	DPP4
Depression	ENSG00000197747	FALSE	Preclinical	2009-10-01	Unused	S100A10
Depression	ENSG00000198049	FALSE	Preclinical	2006-03-27	Unused	AVPR1B
Depression	ENSG00000198822	FALSE	Preclinical	2003-11-12	Phase I Clinical Trial	GRM3
Depression	ENSG00000273079	FALSE	Phase I Clinical Trial	2004-11-05	Phase II Clinical Trial	GRIN2B
Depression	ENSG00000274286	FALSE	Phase II Clinical Trial	1990-11-15	Unused	ADRA2B
Depressive Disorder	ENSG00000010810	FALSE	Phase II Clinical Trial	NA	Absent	FYN
Depressive Disorder	ENSG00000022355	FALSE	Phase III Clinical Trial	1996-01-15	Phase III Clinical Trial	GABRA1
Depressive Disorder	ENSG00000065989	FALSE	unknown	2009-11-06	Unused	PDE4A
Depressive Disorder	ENSG00000068078	FALSE	Phase II Clinical Trial	NA	Absent	FGFR3
Depressive Disorder	ENSG00000069535	TRUE	Approved	2002-04-16	Approved	MAOB
Depressive Disorder	ENSG00000069696	TRUE	Approved	2000-07-04	Phase III Clinical Trial	DRD4
Depressive Disorder	ENSG00000075073	FALSE	unknown	1993-01-15	Unused	TACR2
Depressive Disorder	ENSG00000080644	FALSE	Phase III Clinical Trial	2005-12-06	Absent	CHRNA3
Depressive Disorder	ENSG00000082175	FALSE	unknown	2008-03-11	Unused	PGR
Depressive Disorder	ENSG00000082556	FALSE	Pre-registration	2011-06-08	Phase II Clinical Trial	OPRK1
Depressive Disorder	ENSG00000089041	FALSE	Phase I Clinical Trial	2015-06-24	Absent	P2RX7
Depressive Disorder	ENSG00000093010	FALSE	Preclinical	2015-07-18	Absent	COMT
Depressive Disorder	ENSG00000101204	FALSE	Phase III Clinical Trial	2005-12-06	Unused	CHRNA4
Depressive Disorder	ENSG00000102468	TRUE	Approved	1990-12-15	Approved	HTR2A
Depressive Disorder	ENSG00000103546	TRUE	Approved	1998-06-15	Approved	SLC6A2
Depressive Disorder	ENSG00000105650	FALSE	unknown	2009-11-06	Unused	PDE4C
Depressive Disorder	ENSG00000106113	FALSE	Preclinical	2005-10-03	Unused	CRHR2
Depressive Disorder	ENSG00000108576	TRUE	Approved	1995-03-15	Approved	SLC6A4
Depressive Disorder	ENSG00000112038	FALSE	Pre-registration	2007-12-05	Phase II Clinical Trial	OPRM1
Depressive Disorder	ENSG00000112062	FALSE	Phase II Clinical Trial	2006-05-19	Phase II Clinical Trial	MAPK14
Depressive Disorder	ENSG00000113448	FALSE	unknown	2009-11-06	Unused	PDE4D
Depressive Disorder	ENSG00000113580	FALSE	Phase II Clinical Trial	2001-02-27	Unused	NR3C1
Depressive Disorder	ENSG00000113721	FALSE	Phase II Clinical Trial	NA	Absent	PDGFRB
Depressive Disorder	ENSG00000115353	FALSE	Phase II Clinical Trial	1999-06-01	Unused	TACR1
Depressive Disorder	ENSG00000116329	FALSE	Pre-registration	2005-01-28	Phase II Clinical Trial	OPRD1
Depressive Disorder	ENSG00000117480	FALSE	Phase II Clinical Trial	2003-04-16	Unused	FAAH
Depressive Disorder	ENSG00000117971	FALSE	Phase III Clinical Trial	2005-12-06	Absent	CHRNB4
Depressive Disorder	ENSG00000120088	FALSE	Phase II Clinical Trial	1994-06-15	Unused	CRHR1
Depressive Disorder	ENSG00000121764	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR1
Depressive Disorder	ENSG00000125510	FALSE	Phase II Clinical Trial	2009-10-01	Phase II Clinical Trial	OPRL1
Depressive Disorder	ENSG00000128310	FALSE	Phase II Clinical Trial	2005-11-15	Phase II Clinical Trial	GALR3
Depressive Disorder	ENSG00000133019	TRUE	Approved	2000-07-04	Absent	CHRM3
Depressive Disorder	ENSG00000134640	TRUE	Approved	2006-01-04	Approved	MTNR1B
Depressive Disorder	ENSG00000135312	TRUE	Approved	2003-12-22	Approved	HTR1B
Depressive Disorder	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-08-23	Absent	IL6
Depressive Disorder	ENSG00000137252	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR2
Depressive Disorder	ENSG00000142319	TRUE	Approved	1998-06-15	Approved	SLC6A3
Depressive Disorder	ENSG00000147246	TRUE	Approved	2000-07-04	Approved	HTR2C
Depressive Disorder	ENSG00000147955	FALSE	Phase II Clinical Trial	1990-09-15	Unused	SIGMAR1
Depressive Disorder	ENSG00000148053	FALSE	Preclinical	2017-06-16	Absent	NTRK2
Depressive Disorder	ENSG00000148680	TRUE	Approved	1996-01-15	Approved	HTR7
Depressive Disorder	ENSG00000149295	TRUE	Approved	1990-12-15	Approved	DRD2
Depressive Disorder	ENSG00000150594	TRUE	Approved	NA	Approved	ADRA2A
Depressive Disorder	ENSG00000151577	TRUE	Approved	2000-07-04	Phase III Clinical Trial	DRD3
Depressive Disorder	ENSG00000155511	FALSE	Phase II Clinical Trial	2004-10-04	Unused	GRIA1
Depressive Disorder	ENSG00000157404	FALSE	Phase II Clinical Trial	NA	Absent	KIT
Depressive Disorder	ENSG00000158748	FALSE	Phase II Clinical Trial	2008-07-22	Absent	HTR6
Depressive Disorder	ENSG00000160716	FALSE	Phase III Clinical Trial	2005-12-06	Unused	CHRNB2
Depressive Disorder	ENSG00000164082	FALSE	Phase II Clinical Trial	2003-11-12	Phase II Clinical Trial	GRM2
Depressive Disorder	ENSG00000166148	FALSE	unknown	2006-07-10	Phase I Clinical Trial	AVPR1A
Depressive Disorder	ENSG00000166736	TRUE	Approved	2005-12-12	Approved	HTR3A
Depressive Disorder	ENSG00000168412	TRUE	Approved	2006-01-04	Approved	MTNR1A
Depressive Disorder	ENSG00000168539	TRUE	Approved	1995-03-15	Unused	CHRM1
Depressive Disorder	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-11-04	Phase II Clinical Trial	GRM5
Depressive Disorder	ENSG00000175344	FALSE	Phase I Clinical Trial	2007-05-30	Absent	CHRNA7
Depressive Disorder	ENSG00000176884	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	GRIN1
Depressive Disorder	ENSG00000178394	TRUE	Approved	1992-10-15	Approved	HTR1A
Depressive Disorder	ENSG00000179097	TRUE	Approved	2000-07-04	Absent	HTR1F
Depressive Disorder	ENSG00000179546	TRUE	Approved	2003-12-22	Unused	HTR1D
Depressive Disorder	ENSG00000180720	TRUE	Approved	1995-03-15	Unused	CHRM4
Depressive Disorder	ENSG00000181072	TRUE	Approved	2000-07-04	Absent	CHRM2
Depressive Disorder	ENSG00000184588	FALSE	unknown	2009-11-06	Unused	PDE4B
Depressive Disorder	ENSG00000184845	TRUE	Approved	2000-07-04	Approved	DRD1
Depressive Disorder	ENSG00000188778	FALSE	unknown	1998-02-15	Unused	ADRB3
Depressive Disorder	ENSG00000189221	TRUE	Approved	1999-08-11	Approved	MAOA
Depressive Disorder	ENSG00000196639	TRUE	Approved	2002-04-03	Approved	HRH1
Depressive Disorder	ENSG00000198049	FALSE	Phase II Clinical Trial	2001-09-04	Phase II Clinical Trial	AVPR1B
Depressive Disorder	ENSG00000198793	FALSE	Preclinical	2014-07-04	Absent	MTOR
Depressive Disorder	ENSG00000198822	FALSE	Phase II Clinical Trial	2003-11-12	Phase II Clinical Trial	GRM3
Depressive Disorder	ENSG00000254087	FALSE	Phase II Clinical Trial	NA	Absent	LYN
Depressive Disorder	ENSG00000273079	FALSE	Phase II Clinical Trial	2006-01-23	Preclinical	GRIN2B
Dermatitis, Atopic	ENSG00000005844	FALSE	Preclinical	2003-08-14	Unused	ITGAL
Dermatitis, Atopic	ENSG00000007171	FALSE	Phase III Clinical Trial	2008-04-02	Phase II Clinical Trial	NOS2
Dermatitis, Atopic	ENSG00000007908	FALSE	Preclinical	1994-02-15	Unused	SELE
Dermatitis, Atopic	ENSG00000012779	FALSE	Preclinical	1991-04-15	Unused	ALOX5
Dermatitis, Atopic	ENSG00000025434	FALSE	Preclinical	2016-12-15	Absent	NR1H3
Dermatitis, Atopic	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Unused	IFNGR1
Dermatitis, Atopic	ENSG00000034152	FALSE	Preclinical	2011-10-06	Absent	MAP2K3
Dermatitis, Atopic	ENSG00000059377	TRUE	Approved	1993-11-15	Approved	TBXAS1
Dermatitis, Atopic	ENSG00000065989	TRUE	Approved	1993-08-15	Phase II Clinical Trial	PDE4A
Dermatitis, Atopic	ENSG00000067182	FALSE	Phase II Clinical Trial	2004-01-28	Absent	TNFRSF1A
Dermatitis, Atopic	ENSG00000072062	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	PRKACA
Dermatitis, Atopic	ENSG00000072694	FALSE	Phase I Clinical Trial	2012-01-28	Absent	FCGR2B
Dermatitis, Atopic	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Dermatitis, Atopic	ENSG00000075073	FALSE	Phase II Clinical Trial	1998-10-15	Unused	TACR2
Dermatitis, Atopic	ENSG00000077092	FALSE	unknown	2008-03-31	Absent	RARB
Dermatitis, Atopic	ENSG00000077238	TRUE	Approved	2005-12-10	Phase II Clinical Trial	IL4R
Dermatitis, Atopic	ENSG00000082556	FALSE	Phase II Clinical Trial	1994-05-15	Phase II Clinical Trial	OPRK1
Dermatitis, Atopic	ENSG00000088832	TRUE	Approved	1995-02-15	Approved	FKBP1A
Dermatitis, Atopic	ENSG00000090339	FALSE	unknown	1990-07-15	Unused	ICAM1
Dermatitis, Atopic	ENSG00000092009	FALSE	Phase II Clinical Trial	2008-05-14	Phase II Clinical Trial	CMA1
Dermatitis, Atopic	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Dermatitis, Atopic	ENSG00000096968	FALSE	Phase III Clinical Trial	2006-12-01	Absent	JAK2
Dermatitis, Atopic	ENSG00000100079	FALSE	Preclinical	2006-02-28	Unused	LGALS2
Dermatitis, Atopic	ENSG00000100097	FALSE	Phase I Clinical Trial	NA	Absent	LGALS1
Dermatitis, Atopic	ENSG00000100644	FALSE	unknown	2009-02-18	Preclinical	HIF1A
Dermatitis, Atopic	ENSG00000101204	FALSE	unknown	2010-10-07	Absent	CHRNA4
Dermatitis, Atopic	ENSG00000102967	FALSE	unknown	2002-11-13	Unused	DHODH
Dermatitis, Atopic	ENSG00000102970	FALSE	Preclinical	2010-05-14	Unused	CCL17
Dermatitis, Atopic	ENSG00000104365	FALSE	Phase I Clinical Trial	2009-08-13	Unused	IKBKB
Dermatitis, Atopic	ENSG00000104921	FALSE	Pre-registration	1992-08-15	Unused	FCER2
Dermatitis, Atopic	ENSG00000105329	FALSE	Approved	NA	Unused	TGFB1
Dermatitis, Atopic	ENSG00000105397	FALSE	Phase III Clinical Trial	2013-04-19	Absent	TYK2
Dermatitis, Atopic	ENSG00000105639	FALSE	Phase II Clinical Trial	2003-06-25	Absent	JAK3
Dermatitis, Atopic	ENSG00000105650	TRUE	Approved	1993-08-15	Phase II Clinical Trial	PDE4C
Dermatitis, Atopic	ENSG00000106546	FALSE	Phase II Clinical Trial	2004-01-28	Absent	AHR
Dermatitis, Atopic	ENSG00000107485	FALSE	Phase II Clinical Trial	2011-11-01	Preclinical	GATA3
Dermatitis, Atopic	ENSG00000109320	FALSE	Phase III Clinical Trial	1994-03-15	Phase II Clinical Trial	NFKB1
Dermatitis, Atopic	ENSG00000110148	FALSE	Preclinical	2016-08-25	Absent	CCKBR
Dermatitis, Atopic	ENSG00000111144	FALSE	Preclinical	2005-03-13	Unused	LTA4H
Dermatitis, Atopic	ENSG00000111424	FALSE	Phase II Clinical Trial	1991-04-15	Unused	VDR
Dermatitis, Atopic	ENSG00000112038	FALSE	unknown	2008-07-03	Unused	OPRM1
Dermatitis, Atopic	ENSG00000112062	FALSE	unknown	1999-06-30	Unused	MAPK14
Dermatitis, Atopic	ENSG00000112115	FALSE	Phase I Clinical Trial	2017-01-31	Phase II Clinical Trial	IL17A
Dermatitis, Atopic	ENSG00000113302	FALSE	Phase II Clinical Trial	2003-04-30	Absent	IL12B
Dermatitis, Atopic	ENSG00000113448	TRUE	Approved	1993-08-15	Phase II Clinical Trial	PDE4D
Dermatitis, Atopic	ENSG00000113520	FALSE	Phase I Clinical Trial	2017-01-31	Absent	IL4
Dermatitis, Atopic	ENSG00000113525	FALSE	Phase II Clinical Trial	1997-05-15	Unused	IL5
Dermatitis, Atopic	ENSG00000113580	TRUE	Approved	1993-01-15	Approved	NR3C1
Dermatitis, Atopic	ENSG00000115232	FALSE	Preclinical	1992-01-15	Phase II Clinical Trial	ITGA4
Dermatitis, Atopic	ENSG00000115353	FALSE	Phase II Clinical Trial	1997-02-15	Unused	TACR1
Dermatitis, Atopic	ENSG00000115594	FALSE	Phase I Clinical Trial	2017-01-31	Absent	IL1R1
Dermatitis, Atopic	ENSG00000115602	FALSE	Phase II Clinical Trial	2014-01-16	Absent	IL1RL1
Dermatitis, Atopic	ENSG00000116711	FALSE	Phase II Clinical Trial	2007-06-05	Unused	PLA2G4A
Dermatitis, Atopic	ENSG00000121807	FALSE	Preclinical	2011-09-30	Unused	CCR2
Dermatitis, Atopic	ENSG00000124089	FALSE	Phase I Clinical Trial	2004-03-16	Unused	MC3R
Dermatitis, Atopic	ENSG00000124391	FALSE	Phase I Clinical Trial	2008-11-28	Absent	IL17C
Dermatitis, Atopic	ENSG00000125384	FALSE	Preclinical	1992-01-15	Unused	PTGER2
Dermatitis, Atopic	ENSG00000126010	FALSE	Preclinical	1997-11-15	Unused	GRPR
Dermatitis, Atopic	ENSG00000128271	FALSE	Preclinical	2004-12-13	Unused	ADORA2A
Dermatitis, Atopic	ENSG00000131196	FALSE	Preclinical	1997-06-15	Unused	NFATC1
Dermatitis, Atopic	ENSG00000131408	FALSE	Phase II Clinical Trial	2014-07-11	Absent	NR1H2
Dermatitis, Atopic	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Dermatitis, Atopic	ENSG00000131724	FALSE	Phase II Clinical Trial	2005-12-10	Phase II Clinical Trial	IL13RA1
Dermatitis, Atopic	ENSG00000131759	FALSE	unknown	2008-03-31	Absent	RARA
Dermatitis, Atopic	ENSG00000131981	FALSE	Phase I Clinical Trial	NA	Absent	LGALS3
Dermatitis, Atopic	ENSG00000133110	FALSE	Preclinical	2016-11-25	Absent	POSTN
Dermatitis, Atopic	ENSG00000133710	FALSE	Preclinical	2007-09-03	Unused	SPINK5
Dermatitis, Atopic	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Dermatitis, Atopic	ENSG00000134489	FALSE	Phase II Clinical Trial	2007-07-30	Preclinical	HRH4
Dermatitis, Atopic	ENSG00000135047	FALSE	unknown	2009-01-20	Unused	CTSL
Dermatitis, Atopic	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Dermatitis, Atopic	ENSG00000135914	FALSE	Phase II Clinical Trial	2001-10-15	Unused	HTR2B
Dermatitis, Atopic	ENSG00000137752	FALSE	Preclinical	1994-04-15	Phase II Clinical Trial	CASP1
Dermatitis, Atopic	ENSG00000138448	FALSE	unknown	NA	Phase II Clinical Trial	ITGAV
Dermatitis, Atopic	ENSG00000140538	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	NTRK3
Dermatitis, Atopic	ENSG00000142677	FALSE	Preclinical	2012-12-07	Absent	IL22RA1
Dermatitis, Atopic	ENSG00000143171	FALSE	unknown	2008-03-31	Absent	RXRG
Dermatitis, Atopic	ENSG00000143387	FALSE	unknown	2009-01-20	Unused	CTSK
Dermatitis, Atopic	ENSG00000145777	FALSE	Phase II Clinical Trial	2008-09-29	Phase I Clinical Trial	TSLP
Dermatitis, Atopic	ENSG00000148053	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	NTRK2
Dermatitis, Atopic	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Dermatitis, Atopic	ENSG00000150782	FALSE	unknown	NA	Phase II Clinical Trial	IL18
Dermatitis, Atopic	ENSG00000151623	FALSE	Preclinical	NA	Unused	NR3C2
Dermatitis, Atopic	ENSG00000154229	FALSE	Phase II Clinical Trial	1992-03-15	Phase II Clinical Trial	PRKCA
Dermatitis, Atopic	ENSG00000160716	FALSE	unknown	2010-10-07	Absent	CHRNB2
Dermatitis, Atopic	ENSG00000162434	FALSE	Phase III Clinical Trial	2003-06-25	Absent	JAK1
Dermatitis, Atopic	ENSG00000163106	FALSE	Preclinical	2008-04-14	Unused	HPGDS
Dermatitis, Atopic	ENSG00000163131	FALSE	unknown	2009-01-20	Unused	CTSS
Dermatitis, Atopic	ENSG00000163464	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR1
Dermatitis, Atopic	ENSG00000164251	FALSE	Preclinical	2015-08-07	Preclinical	F2RL1
Dermatitis, Atopic	ENSG00000164733	FALSE	unknown	2009-01-20	Unused	CTSB
Dermatitis, Atopic	ENSG00000165025	FALSE	Phase I Clinical Trial	1992-06-15	Unused	SYK
Dermatitis, Atopic	ENSG00000166090	FALSE	Preclinical	2015-06-19	Absent	IL25
Dermatitis, Atopic	ENSG00000166333	FALSE	unknown	2010-06-08	Unused	ILK
Dermatitis, Atopic	ENSG00000166603	FALSE	Preclinical	2004-11-02	Preclinical	MC4R
Dermatitis, Atopic	ENSG00000168229	FALSE	Phase II Clinical Trial	2003-07-07	Unused	PTGDR
Dermatitis, Atopic	ENSG00000168610	FALSE	unknown	2010-10-07	Absent	STAT3
Dermatitis, Atopic	ENSG00000168615	FALSE	Preclinical	2002-08-14	Unused	ADAM9
Dermatitis, Atopic	ENSG00000168918	FALSE	Phase II Clinical Trial	2009-10-12	Absent	INPP5D
Dermatitis, Atopic	ENSG00000169035	FALSE	Preclinical	2003-03-05	Unused	KLK7
Dermatitis, Atopic	ENSG00000169194	FALSE	Phase III Clinical Trial	2003-05-20	Phase II Clinical Trial	IL13
Dermatitis, Atopic	ENSG00000169403	TRUE	Approved	1992-07-15	Approved	PTAFR
Dermatitis, Atopic	ENSG00000170989	FALSE	Phase I Clinical Trial	2011-09-21	Absent	S1PR1
Dermatitis, Atopic	ENSG00000172156	FALSE	Preclinical	2000-08-02	Absent	CCL11
Dermatitis, Atopic	ENSG00000172236	FALSE	Preclinical	2001-04-02	Unused	TPSAB1
Dermatitis, Atopic	ENSG00000172572	FALSE	Preclinical	1993-08-15	Unused	PDE3A
Dermatitis, Atopic	ENSG00000172936	FALSE	unknown	2000-03-01	Unused	MYD88
Dermatitis, Atopic	ENSG00000173198	FALSE	unknown	1993-07-15	Unused	CYSLTR1
Dermatitis, Atopic	ENSG00000174080	FALSE	unknown	2009-01-20	Unused	CTSF
Dermatitis, Atopic	ENSG00000174175	FALSE	Preclinical	1994-02-15	Unused	SELP
Dermatitis, Atopic	ENSG00000175104	FALSE	unknown	2000-03-01	Unused	TRAF6
Dermatitis, Atopic	ENSG00000175344	FALSE	unknown	2010-10-07	Absent	CHRNA7
Dermatitis, Atopic	ENSG00000176136	FALSE	Preclinical	2004-11-02	Preclinical	MC5R
Dermatitis, Atopic	ENSG00000177272	FALSE	Preclinical	2008-04-16	Preclinical	KCNA3
Dermatitis, Atopic	ENSG00000177606	FALSE	unknown	2008-03-31	Unused	JUN
Dermatitis, Atopic	ENSG00000178394	FALSE	Phase II Clinical Trial	1995-02-15	Unused	HTR1A
Dermatitis, Atopic	ENSG00000180871	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR2
Dermatitis, Atopic	ENSG00000182866	FALSE	Preclinical	2010-08-06	Phase II Clinical Trial	LCK
Dermatitis, Atopic	ENSG00000183134	FALSE	Phase II Clinical Trial	2005-06-01	Absent	PTGDR2
Dermatitis, Atopic	ENSG00000183625	FALSE	Preclinical	2001-02-09	Unused	CCR3
Dermatitis, Atopic	ENSG00000183813	FALSE	Preclinical	2005-10-03	Unused	CCR4
Dermatitis, Atopic	ENSG00000184216	FALSE	unknown	2000-03-01	Unused	IRAK1
Dermatitis, Atopic	ENSG00000184588	TRUE	Approved	1993-08-15	Phase II Clinical Trial	PDE4B
Dermatitis, Atopic	ENSG00000185532	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	PRKG1
Dermatitis, Atopic	ENSG00000186350	FALSE	unknown	2008-03-31	Absent	RXRA
Dermatitis, Atopic	ENSG00000186827	FALSE	Phase II Clinical Trial	2013-02-01	Absent	TNFRSF4
Dermatitis, Atopic	ENSG00000188404	FALSE	unknown	1994-02-15	Unused	SELL
Dermatitis, Atopic	ENSG00000188641	FALSE	unknown	NA	Unused	DPYD
Dermatitis, Atopic	ENSG00000188822	FALSE	unknown	2006-08-08	Unused	CNR2
Dermatitis, Atopic	ENSG00000189403	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	HMGB1
Dermatitis, Atopic	ENSG00000196262	TRUE	Approved	2003-07-21	Approved	PPIA
Dermatitis, Atopic	ENSG00000196639	TRUE	Approved	1993-06-15	Approved	HRH1
Dermatitis, Atopic	ENSG00000196689	FALSE	Phase III Clinical Trial	2006-12-14	Phase I Clinical Trial	TRPV1
Dermatitis, Atopic	ENSG00000197249	FALSE	Preclinical	2008-03-11	Unused	SERPINA1
Dermatitis, Atopic	ENSG00000198400	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	NTRK1
Dermatitis, Atopic	ENSG00000198668	FALSE	unknown	NA	Unused	CALM1
Dermatitis, Atopic	ENSG00000198793	FALSE	Preclinical	2003-07-23	Unused	MTOR
Dermatitis, Atopic	ENSG00000198851	FALSE	unknown	2004-02-24	Absent	CD3E
Dermatitis, Atopic	ENSG00000204671	FALSE	Phase II Clinical Trial	2004-07-20	Phase I Clinical Trial	IL31
Dermatitis, Atopic	ENSG00000213903	FALSE	Preclinical	1993-08-15	Unused	LTB4R
Dermatitis, Atopic	ENSG00000228716	FALSE	Phase I Clinical Trial	1999-03-08	Unused	DHFR
Dermatitis, Atopic	ENSG00000240972	FALSE	Preclinical	2012-06-15	Absent	MIF
Dermatitis, Atopic	ENSG00000258839	FALSE	Phase I Clinical Trial	2004-03-16	Unused	MC1R
Dermatitis, Atopic	ENSG00000259207	FALSE	unknown	NA	Phase II Clinical Trial	ITGB3
Dermatitis, Contact	ENSG00000065989	FALSE	unknown	2005-05-24	Unused	PDE4A
Dermatitis, Contact	ENSG00000073756	FALSE	Approved	NA	Unused	PTGS2
Dermatitis, Contact	ENSG00000088832	FALSE	Phase II Clinical Trial	1995-02-15	Phase II Clinical Trial	FKBP1A
Dermatitis, Contact	ENSG00000095303	FALSE	Approved	NA	Unused	PTGS1
Dermatitis, Contact	ENSG00000105650	FALSE	unknown	2005-05-24	Unused	PDE4C
Dermatitis, Contact	ENSG00000111424	FALSE	unknown	1991-04-15	Unused	VDR
Dermatitis, Contact	ENSG00000113448	FALSE	unknown	2005-05-24	Unused	PDE4D
Dermatitis, Contact	ENSG00000113580	TRUE	Approved	2005-11-09	Approved	NR3C1
Dermatitis, Contact	ENSG00000116711	FALSE	unknown	2007-06-05	Absent	PLA2G4A
Dermatitis, Contact	ENSG00000131471	FALSE	unknown	2011-11-11	Preclinical	AOC3
Dermatitis, Contact	ENSG00000169245	FALSE	Phase I Clinical Trial	2008-01-14	Phase I Clinical Trial	CXCL10
Dermatitis, Contact	ENSG00000184588	FALSE	unknown	2005-05-24	Unused	PDE4B
Dermatitis, Contact	ENSG00000188641	FALSE	unknown	NA	Unused	DPYD
Dermatitis, Contact	ENSG00000196639	FALSE	Preclinical	2001-02-12	Unused	HRH1
Dermatitis, Seborrheic	ENSG00000057252	FALSE	unknown	2009-07-01	Unused	SOAT1
Dermatitis, Seborrheic	ENSG00000091831	TRUE	Approved	NA	Approved	ESR1
Dermatitis, Seborrheic	ENSG00000099194	FALSE	Preclinical	2009-07-01	Unused	SCD
Dermatitis, Seborrheic	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Dermatitis, Seborrheic	ENSG00000145545	FALSE	Preclinical	2004-03-17	Absent	SRD5A1
Dermatitis, Seborrheic	ENSG00000169083	FALSE	Approved	2007-03-14	Unused	AR
Dermatitis, Seborrheic	ENSG00000176136	FALSE	Phase II Clinical Trial	2009-06-23	Unused	MC5R
Dermatitis, Seborrheic	ENSG00000196689	FALSE	Phase II Clinical Trial	2009-06-30	Absent	TRPV1
Dermatomyositis	ENSG00000088832	TRUE	Approved	NA	Absent	FKBP1A
Dermatomyositis	ENSG00000101916	FALSE	Phase II Clinical Trial	2012-03-16	Absent	TLR8
Dermatomyositis	ENSG00000106804	FALSE	unknown	1993-08-15	Absent	C5
Dermatomyositis	ENSG00000113580	TRUE	Approved	NA	Absent	NR3C1
Dermatomyositis	ENSG00000114013	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD86
Dermatomyositis	ENSG00000121594	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD80
Dermatomyositis	ENSG00000125538	FALSE	unknown	2006-01-18	Absent	IL1B
Dermatomyositis	ENSG00000142166	FALSE	Preclinical	2016-05-13	Absent	IFNAR1
Dermatomyositis	ENSG00000170989	FALSE	unknown	2006-12-07	Absent	S1PR1
Dermatomyositis	ENSG00000180739	FALSE	unknown	2006-12-07	Absent	S1PR5
Dermatomyositis	ENSG00000188822	FALSE	Phase II Clinical Trial	2011-05-13	Absent	CNR2
Dermatomyositis	ENSG00000196664	FALSE	Phase II Clinical Trial	2012-03-16	Absent	TLR7
Dermatomyositis	ENSG00000197919	FALSE	Phase II Clinical Trial	2003-12-12	Absent	IFNA1
Dermatomyositis	ENSG00000239732	FALSE	Phase II Clinical Trial	2012-03-16	Absent	TLR9
Dermatomyositis	ENSG00000239961	FALSE	Phase I Clinical Trial	2010-01-21	Absent	LILRA4
Diabetes Complications	ENSG00000006638	TRUE	Approved	NA	Approved	TBXA2R
Diabetes Complications	ENSG00000007908	FALSE	unknown	2005-05-25	Unused	SELE
Diabetes Complications	ENSG00000011465	FALSE	Preclinical	1991-06-15	Unused	DCN
Diabetes Complications	ENSG00000026508	FALSE	Preclinical	2008-02-20	Unused	CD44
Diabetes Complications	ENSG00000059377	FALSE	Preclinical	1994-08-15	Unused	TBXAS1
Diabetes Complications	ENSG00000065989	FALSE	unknown	NA	Unused	PDE4A
Diabetes Complications	ENSG00000069535	FALSE	Preclinical	2002-04-23	Unused	MAOB
Diabetes Complications	ENSG00000077782	FALSE	Approved	2007-03-06	Unused	FGFR1
Diabetes Complications	ENSG00000079435	FALSE	Preclinical	2005-02-01	Unused	LIPE
Diabetes Complications	ENSG00000080618	FALSE	Phase I Clinical Trial	2011-11-07	Phase I Clinical Trial	CPB2
Diabetes Complications	ENSG00000080824	FALSE	Preclinical	2001-12-11	Unused	HSP90AA1
Diabetes Complications	ENSG00000082781	FALSE	Preclinical	2001-01-30	Unused	ITGB5
Diabetes Complications	ENSG00000084674	FALSE	Phase I Clinical Trial	2007-05-23	Unused	APOB
Diabetes Complications	ENSG00000085662	TRUE	Approved	1989-07-15	Unused	AKR1B1
Diabetes Complications	ENSG00000088053	FALSE	Preclinical	2009-08-04	Absent	GP6
Diabetes Complications	ENSG00000100292	FALSE	Preclinical	2012-07-25	Unused	HMOX1
Diabetes Complications	ENSG00000102539	FALSE	unknown	1995-08-15	Unused	MLNR
Diabetes Complications	ENSG00000102755	FALSE	Preclinical	2000-03-01	Unused	FLT1
Diabetes Complications	ENSG00000104365	FALSE	unknown	2006-08-29	Unused	IKBKB
Diabetes Complications	ENSG00000105650	FALSE	unknown	NA	Unused	PDE4C
Diabetes Complications	ENSG00000106366	FALSE	unknown	2006-08-29	Unused	SERPINE1
Diabetes Complications	ENSG00000106799	FALSE	Preclinical	1991-06-15	Unused	TGFBR1
Diabetes Complications	ENSG00000108839	FALSE	Preclinical	1998-03-15	Unused	ALOX12
Diabetes Complications	ENSG00000111262	FALSE	Preclinical	1994-12-15	Unused	KCNA1
Diabetes Complications	ENSG00000112033	FALSE	unknown	2003-06-23	Unused	PPARD
Diabetes Complications	ENSG00000112715	FALSE	unknown	2001-08-08	Unused	VEGFA
Diabetes Complications	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Diabetes Complications	ENSG00000113448	FALSE	unknown	NA	Unused	PDE4D
Diabetes Complications	ENSG00000117594	FALSE	Preclinical	2006-04-11	Unused	HSD11B1
Diabetes Complications	ENSG00000118260	FALSE	Preclinical	2009-06-09	Unused	CREB1
Diabetes Complications	ENSG00000120156	FALSE	Preclinical	1995-08-15	Unused	TEK
Diabetes Complications	ENSG00000121807	FALSE	unknown	2007-04-10	Phase II Clinical Trial	CCR2
Diabetes Complications	ENSG00000121853	FALSE	unknown	2004-03-08	Unused	GHSR
Diabetes Complications	ENSG00000121966	FALSE	Preclinical	2008-09-04	Unused	CXCR4
Diabetes Complications	ENSG00000122756	FALSE	Preclinical	1991-09-15	Unused	CNTFR
Diabetes Complications	ENSG00000125538	FALSE	Preclinical	2003-12-08	Preclinical	IL1B
Diabetes Complications	ENSG00000126895	FALSE	unknown	2001-10-10	Unused	AVPR2
Diabetes Complications	ENSG00000128052	FALSE	Preclinical	2000-05-10	Unused	KDR
Diabetes Complications	ENSG00000130164	FALSE	Phase I Clinical Trial	2007-05-23	Unused	LDLR
Diabetes Complications	ENSG00000131471	FALSE	Preclinical	2017-06-20	Absent	AOC3
Diabetes Complications	ENSG00000132170	FALSE	Preclinical	1989-09-15	Approved	PPARG
Diabetes Complications	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Diabetes Complications	ENSG00000134259	FALSE	Preclinical	1999-06-23	Unused	NGF
Diabetes Complications	ENSG00000138448	FALSE	Preclinical	1998-11-15	Unused	ITGAV
Diabetes Complications	ENSG00000138685	FALSE	Preclinical	1994-06-15	Unused	FGF2
Diabetes Complications	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Diabetes Complications	ENSG00000140263	FALSE	Preclinical	2002-02-13	Unused	SORD
Diabetes Complications	ENSG00000142208	FALSE	Preclinical	2004-10-19	Unused	AKT1
Diabetes Complications	ENSG00000143839	FALSE	unknown	2000-11-23	Phase III Clinical Trial	REN
Diabetes Complications	ENSG00000144891	FALSE	Preclinical	2007-10-02	Unused	AGTR1
Diabetes Complications	ENSG00000146648	FALSE	Preclinical	NA	Unused	EGFR
Diabetes Complications	ENSG00000147262	FALSE	Preclinical	2005-07-27	Unused	GPR119
Diabetes Complications	ENSG00000149295	TRUE	Approved	1992-09-15	Approved	DRD2
Diabetes Complications	ENSG00000149968	FALSE	Preclinical	2002-09-03	Unused	MMP3
Diabetes Complications	ENSG00000151617	FALSE	Phase I Clinical Trial	2012-10-27	Absent	EDNRA
Diabetes Complications	ENSG00000152256	FALSE	Preclinical	2008-07-29	Unused	PDK1
Diabetes Complications	ENSG00000159640	TRUE	Approved	NA	Approved	ACE
Diabetes Complications	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Diabetes Complications	ENSG00000164270	TRUE	Approved	1992-09-15	Approved	HTR4
Diabetes Complications	ENSG00000166501	FALSE	Preclinical	2005-10-31	Unused	PRKCB
Diabetes Complications	ENSG00000166603	FALSE	Preclinical	2006-08-18	Unused	MC4R
Diabetes Complications	ENSG00000170425	FALSE	Preclinical	2004-03-31	Unused	ADORA2B
Diabetes Complications	ENSG00000171105	FALSE	Preclinical	2004-08-02	Unused	INSR
Diabetes Complications	ENSG00000172572	TRUE	Approved	2008-10-20	Approved	PDE3A
Diabetes Complications	ENSG00000174175	FALSE	unknown	2005-05-25	Unused	SELP
Diabetes Complications	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Diabetes Complications	ENSG00000176884	FALSE	unknown	2003-12-01	Unused	GRIN1
Diabetes Complications	ENSG00000181408	FALSE	Preclinical	2004-11-29	Unused	UTS2R
Diabetes Complications	ENSG00000182782	FALSE	Phase III Clinical Trial	NA	Approved	HCAR2
Diabetes Complications	ENSG00000183048	FALSE	Preclinical	2007-07-24	Unused	SLC25A10
Diabetes Complications	ENSG00000184588	FALSE	unknown	NA	Unused	PDE4B
Diabetes Complications	ENSG00000185231	FALSE	unknown	NA	Unused	MC2R
Diabetes Complications	ENSG00000186951	FALSE	Preclinical	2000-11-07	Unused	PPARA
Diabetes Complications	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Diabetes Complications	ENSG00000188822	FALSE	unknown	NA	Phase II Clinical Trial	CNR2
Diabetes Complications	ENSG00000196411	FALSE	Preclinical	2006-08-15	Unused	EPHB4
Diabetes Complications	ENSG00000197122	FALSE	Preclinical	2007-08-01	Unused	SRC
Diabetes Complications	ENSG00000198959	FALSE	Preclinical	2003-12-01	Unused	TGM2
Diabetes Complications	ENSG00000259207	FALSE	Preclinical	1998-11-15	Unused	ITGB3
Diabetes Insipidus	ENSG00000101200	FALSE	Preclinical	2002-08-09	Unused	AVP
Diabetes Insipidus	ENSG00000126895	TRUE	Approved	1998-10-15	Approved	AVPR2
Diabetes Insipidus	ENSG00000167580	FALSE	Preclinical	2008-08-09	Unused	AQP2
Diabetes Mellitus, Type 1	ENSG00000004948	TRUE	Approved	1992-02-15	Approved	CALCR
Diabetes Mellitus, Type 1	ENSG00000007372	FALSE	Preclinical	1998-07-15	Unused	PAX6
Diabetes Mellitus, Type 1	ENSG00000007952	FALSE	Preclinical	NA	Absent	NOX1
Diabetes Mellitus, Type 1	ENSG00000013725	FALSE	unknown	2007-09-10	Unused	CD6
Diabetes Mellitus, Type 1	ENSG00000022355	FALSE	Preclinical	2016-11-07	Absent	GABRA1
Diabetes Mellitus, Type 1	ENSG00000057252	FALSE	Preclinical	2013-09-05	Absent	SOAT1
Diabetes Mellitus, Type 1	ENSG00000064012	FALSE	Phase II Clinical Trial	1999-01-15	Phase II Clinical Trial	CASP8
Diabetes Mellitus, Type 1	ENSG00000077238	FALSE	Preclinical	2008-10-09	Preclinical	IL4R
Diabetes Mellitus, Type 1	ENSG00000082701	FALSE	Phase I Clinical Trial	2007-09-14	Unused	GSK3B
Diabetes Mellitus, Type 1	ENSG00000086991	FALSE	Preclinical	NA	Absent	NOX4
Diabetes Mellitus, Type 1	ENSG00000090339	FALSE	Preclinical	2014-08-18	Absent	ICAM1
Diabetes Mellitus, Type 1	ENSG00000100170	FALSE	Phase III Clinical Trial	2008-07-29	Phase II Clinical Trial	SLC5A1
Diabetes Mellitus, Type 1	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Diabetes Mellitus, Type 1	ENSG00000101017	FALSE	Preclinical	2017-07-31	Absent	CD40
Diabetes Mellitus, Type 1	ENSG00000101266	FALSE	Preclinical	2015-12-01	Absent	CSNK2A1
Diabetes Mellitus, Type 1	ENSG00000105675	FALSE	Phase III Clinical Trial	2013-09-21	Absent	ATP4A
Diabetes Mellitus, Type 1	ENSG00000106331	FALSE	Preclinical	1998-07-15	Unused	PAX4
Diabetes Mellitus, Type 1	ENSG00000106633	FALSE	Phase II Clinical Trial	2007-05-10	Phase I Clinical Trial	GCK
Diabetes Mellitus, Type 1	ENSG00000109320	FALSE	Preclinical	NA	Absent	NFKB1
Diabetes Mellitus, Type 1	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Diabetes Mellitus, Type 1	ENSG00000110148	FALSE	unknown	2001-08-09	Unused	CCKBR
Diabetes Mellitus, Type 1	ENSG00000110448	FALSE	unknown	NA	Unused	CD5
Diabetes Mellitus, Type 1	ENSG00000110876	FALSE	Preclinical	2002-08-22	Absent	SELPLG
Diabetes Mellitus, Type 1	ENSG00000111424	FALSE	Phase I Clinical Trial	2003-10-14	Unused	VDR
Diabetes Mellitus, Type 1	ENSG00000111537	FALSE	unknown	1997-01-15	Unused	IFNG
Diabetes Mellitus, Type 1	ENSG00000112062	FALSE	Preclinical	2007-08-21	Unused	MAPK14
Diabetes Mellitus, Type 1	ENSG00000112115	FALSE	Phase II Clinical Trial	2006-02-01	Absent	IL17A
Diabetes Mellitus, Type 1	ENSG00000112164	TRUE	Approved	1996-06-15	Phase III Clinical Trial	GLP1R
Diabetes Mellitus, Type 1	ENSG00000113302	FALSE	unknown	2003-04-30	Absent	IL12B
Diabetes Mellitus, Type 1	ENSG00000114013	FALSE	Preclinical	2017-07-31	Absent	CD86
Diabetes Mellitus, Type 1	ENSG00000115263	FALSE	Phase II Clinical Trial	2002-05-03	Preclinical	GCG
Diabetes Mellitus, Type 1	ENSG00000115594	FALSE	Preclinical	2009-06-09	Unused	IL1R1
Diabetes Mellitus, Type 1	ENSG00000116678	FALSE	Phase I Clinical Trial	1999-04-28	Phase I Clinical Trial	LEPR
Diabetes Mellitus, Type 1	ENSG00000116824	FALSE	unknown	1989-08-15	Unused	CD2
Diabetes Mellitus, Type 1	ENSG00000117594	FALSE	Preclinical	2004-01-20	Unused	HSD11B1
Diabetes Mellitus, Type 1	ENSG00000121594	FALSE	Preclinical	2017-07-31	Absent	CD80
Diabetes Mellitus, Type 1	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Diabetes Mellitus, Type 1	ENSG00000128683	FALSE	Preclinical	1999-06-30	Unused	GAD1
Diabetes Mellitus, Type 1	ENSG00000131724	FALSE	Preclinical	2008-10-09	Preclinical	IL13RA1
Diabetes Mellitus, Type 1	ENSG00000132170	FALSE	Phase II Clinical Trial	1995-03-15	Phase II Clinical Trial	PPARG
Diabetes Mellitus, Type 1	ENSG00000134460	FALSE	Phase II Clinical Trial	1992-04-15	Unused	IL2RA
Diabetes Mellitus, Type 1	ENSG00000136634	FALSE	Preclinical	2016-04-07	Absent	IL10
Diabetes Mellitus, Type 1	ENSG00000136750	FALSE	Phase II Clinical Trial	1999-06-30	Unused	GAD2
Diabetes Mellitus, Type 1	ENSG00000138684	FALSE	Phase II Clinical Trial	2010-06-21	Absent	IL21
Diabetes Mellitus, Type 1	ENSG00000139515	FALSE	Preclinical	2009-07-28	Unused	PDX1
Diabetes Mellitus, Type 1	ENSG00000140443	FALSE	unknown	NA	Phase II Clinical Trial	IGF1R
Diabetes Mellitus, Type 1	ENSG00000140675	FALSE	Pre-registration	2004-11-22	Phase III Clinical Trial	SLC5A2
Diabetes Mellitus, Type 1	ENSG00000141505	FALSE	Preclinical	2017-06-20	Absent	ASGR1
Diabetes Mellitus, Type 1	ENSG00000143365	FALSE	Preclinical	2012-06-15	Preclinical	RORC
Diabetes Mellitus, Type 1	ENSG00000143799	FALSE	unknown	2005-07-18	Unused	PARP1
Diabetes Mellitus, Type 1	ENSG00000144381	FALSE	Phase III Clinical Trial	2000-12-12	Phase III Clinical Trial	HSPD1
Diabetes Mellitus, Type 1	ENSG00000146648	FALSE	unknown	2001-08-09	Unused	EGFR
Diabetes Mellitus, Type 1	ENSG00000149294	FALSE	Preclinical	2006-09-11	Unused	NCAM1
Diabetes Mellitus, Type 1	ENSG00000159224	FALSE	Preclinical	2004-10-18	Preclinical	GIP
Diabetes Mellitus, Type 1	ENSG00000160867	FALSE	Phase I Clinical Trial	2012-03-30	Absent	FGFR4
Diabetes Mellitus, Type 1	ENSG00000163464	FALSE	Phase II Clinical Trial	2007-07-04	Absent	CXCR1
Diabetes Mellitus, Type 1	ENSG00000164305	FALSE	Preclinical	1997-03-15	Unused	CASP3
Diabetes Mellitus, Type 1	ENSG00000166598	FALSE	Preclinical	2001-05-22	Unused	HSP90B1
Diabetes Mellitus, Type 1	ENSG00000167658	FALSE	unknown	NA	Unused	EEF2
Diabetes Mellitus, Type 1	ENSG00000168685	FALSE	Phase I Clinical Trial	2011-07-13	Preclinical	IL7R
Diabetes Mellitus, Type 1	ENSG00000169252	FALSE	Phase II Clinical Trial	2010-03-25	Absent	ADRB2
Diabetes Mellitus, Type 1	ENSG00000171105	TRUE	Approved	1990-01-15	Approved	INSR
Diabetes Mellitus, Type 1	ENSG00000171298	TRUE	Approved	NA	Approved	GAA
Diabetes Mellitus, Type 1	ENSG00000172016	FALSE	Phase II Clinical Trial	2002-01-03	Phase II Clinical Trial	REG3A
Diabetes Mellitus, Type 1	ENSG00000173083	FALSE	Preclinical	2013-12-03	Absent	HPSE
Diabetes Mellitus, Type 1	ENSG00000174059	FALSE	Preclinical	2015-06-10	Absent	CD34
Diabetes Mellitus, Type 1	ENSG00000177272	FALSE	Preclinical	2008-04-16	Preclinical	KCNA3
Diabetes Mellitus, Type 1	ENSG00000178562	FALSE	Preclinical	2001-04-09	Unused	CD28
Diabetes Mellitus, Type 1	ENSG00000180871	FALSE	Phase II Clinical Trial	2007-07-04	Absent	CXCR2
Diabetes Mellitus, Type 1	ENSG00000181104	FALSE	Preclinical	2014-11-27	Absent	F2R
Diabetes Mellitus, Type 1	ENSG00000186951	FALSE	unknown	2003-07-10	Unused	PPARA
Diabetes Mellitus, Type 1	ENSG00000187486	FALSE	unknown	2000-11-28	Unused	KCNJ11
Diabetes Mellitus, Type 1	ENSG00000188778	FALSE	Preclinical	1999-01-15	Unused	ADRB3
Diabetes Mellitus, Type 1	ENSG00000189430	FALSE	Preclinical	2011-10-21	Preclinical	NCR1
Diabetes Mellitus, Type 1	ENSG00000196262	FALSE	Phase III Clinical Trial	2013-09-21	Absent	PPIA
Diabetes Mellitus, Type 1	ENSG00000197249	FALSE	Phase III Clinical Trial	2007-10-09	Phase II Clinical Trial	SERPINA1
Diabetes Mellitus, Type 1	ENSG00000197635	FALSE	Pre-registration	2013-02-04	Phase III Clinical Trial	DPP4
Diabetes Mellitus, Type 1	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
Diabetes Mellitus, Type 1	ENSG00000198851	FALSE	Phase III Clinical Trial	2002-11-07	Phase III Clinical Trial	CD3E
Diabetes Mellitus, Type 1	ENSG00000204174	FALSE	Preclinical	2002-11-13	Absent	NPY4R
Diabetes Mellitus, Type 1	ENSG00000213809	FALSE	unknown	2006-11-24	Unused	KLRK1
Diabetes Mellitus, Type 1	ENSG00000215644	FALSE	Phase II Clinical Trial	2007-08-16	Phase I Clinical Trial	GCGR
Diabetes Mellitus, Type 1	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Diabetes Mellitus, Type 1	ENSG00000242950	FALSE	Phase II Clinical Trial	2007-07-20	Absent	ERVW-1
Diabetes Mellitus, Type 1	ENSG00000254647	FALSE	Phase II Clinical Trial	1995-02-15	Phase I Clinical Trial	INS
Diabetes Mellitus, Type 2	ENSG00000004948	TRUE	Approved	1992-02-15	Approved	CALCR
Diabetes Mellitus, Type 2	ENSG00000006071	TRUE	Approved	1992-12-15	Approved	ABCC8
Diabetes Mellitus, Type 2	ENSG00000007372	FALSE	Preclinical	1999-05-25	Unused	PAX6
Diabetes Mellitus, Type 2	ENSG00000010310	FALSE	Phase II Clinical Trial	2003-08-13	Phase I Clinical Trial	GIPR
Diabetes Mellitus, Type 2	ENSG00000012504	FALSE	Preclinical	2004-02-03	Unused	NR1H4
Diabetes Mellitus, Type 2	ENSG00000043591	FALSE	Phase II Clinical Trial	2014-10-31	Absent	ADRB1
Diabetes Mellitus, Type 2	ENSG00000050628	FALSE	Preclinical	2017-09-21	Absent	PTGER3
Diabetes Mellitus, Type 2	ENSG00000059377	FALSE	Phase II Clinical Trial	2016-05-31	Phase II Clinical Trial	TBXAS1
Diabetes Mellitus, Type 2	ENSG00000062282	FALSE	Phase II Clinical Trial	2011-12-14	Preclinical	DGAT2
Diabetes Mellitus, Type 2	ENSG00000064989	FALSE	Preclinical	1997-09-15	Unused	CALCRL
Diabetes Mellitus, Type 2	ENSG00000065325	FALSE	Preclinical	2014-01-22	Absent	GLP2R
Diabetes Mellitus, Type 2	ENSG00000065989	FALSE	Phase I Clinical Trial	NA	Absent	PDE4A
Diabetes Mellitus, Type 2	ENSG00000068903	FALSE	Preclinical	2010-01-08	Unused	SIRT2
Diabetes Mellitus, Type 2	ENSG00000073756	FALSE	Phase I Clinical Trial	1996-04-15	Unused	PTGS2
Diabetes Mellitus, Type 2	ENSG00000074590	FALSE	Preclinical	2014-11-18	Absent	NUAK1
Diabetes Mellitus, Type 2	ENSG00000076555	FALSE	Phase II Clinical Trial	2006-07-17	Unused	ACACB
Diabetes Mellitus, Type 2	ENSG00000077238	FALSE	Preclinical	1999-01-15	Unused	IL4R
Diabetes Mellitus, Type 2	ENSG00000077463	FALSE	Preclinical	NA	Absent	SIRT6
Diabetes Mellitus, Type 2	ENSG00000077782	FALSE	Preclinical	2015-12-04	Absent	FGFR1
Diabetes Mellitus, Type 2	ENSG00000079277	FALSE	Preclinical	2007-11-13	Unused	MKNK1
Diabetes Mellitus, Type 2	ENSG00000082701	FALSE	Phase II Clinical Trial	2001-07-25	Unused	GSK3B
Diabetes Mellitus, Type 2	ENSG00000084734	FALSE	Preclinical	2013-11-13	Absent	GCKR
Diabetes Mellitus, Type 2	ENSG00000085662	TRUE	Approved	NA	Unused	AKR1B1
Diabetes Mellitus, Type 2	ENSG00000095303	FALSE	Phase I Clinical Trial	1996-04-15	Unused	PTGS1
Diabetes Mellitus, Type 2	ENSG00000096717	FALSE	Phase I Clinical Trial	2004-09-16	Phase II Clinical Trial	SIRT1
Diabetes Mellitus, Type 2	ENSG00000099194	FALSE	Phase II Clinical Trial	2007-04-03	Unused	SCD
Diabetes Mellitus, Type 2	ENSG00000100170	FALSE	Phase III Clinical Trial	2005-09-02	Phase II Clinical Trial	SLC5A1
Diabetes Mellitus, Type 2	ENSG00000100504	FALSE	Phase III Clinical Trial	1999-06-30	Unused	PYGL
Diabetes Mellitus, Type 2	ENSG00000101180	FALSE	Phase II Clinical Trial	2005-02-23	Phase I Clinical Trial	HRH3
Diabetes Mellitus, Type 2	ENSG00000103150	FALSE	Preclinical	2010-09-30	Unused	MLYCD
Diabetes Mellitus, Type 2	ENSG00000103546	FALSE	Phase II Clinical Trial	1997-10-15	Preclinical	SLC6A2
Diabetes Mellitus, Type 2	ENSG00000104365	FALSE	unknown	1996-04-15	Unused	IKBKB
Diabetes Mellitus, Type 2	ENSG00000105550	FALSE	Phase II Clinical Trial	2005-05-27	Unused	FGF21
Diabetes Mellitus, Type 2	ENSG00000105650	FALSE	Phase I Clinical Trial	NA	Absent	PDE4C
Diabetes Mellitus, Type 2	ENSG00000106018	FALSE	Preclinical	NA	Absent	VIPR2
Diabetes Mellitus, Type 2	ENSG00000106128	FALSE	unknown	1997-08-15	Phase II Clinical Trial	GHRHR
Diabetes Mellitus, Type 2	ENSG00000106331	FALSE	Preclinical	1999-05-25	Unused	PAX4
Diabetes Mellitus, Type 2	ENSG00000106633	FALSE	Phase III Clinical Trial	1998-06-15	Phase II Clinical Trial	GCK
Diabetes Mellitus, Type 2	ENSG00000108576	FALSE	Phase II Clinical Trial	1997-10-15	Preclinical	SLC6A4
Diabetes Mellitus, Type 2	ENSG00000109320	FALSE	Phase I Clinical Trial	2006-09-27	Phase II Clinical Trial	NFKB1
Diabetes Mellitus, Type 2	ENSG00000110090	FALSE	Phase II Clinical Trial	1996-10-15	Unused	CPT1A
Diabetes Mellitus, Type 2	ENSG00000110148	FALSE	Phase II Clinical Trial	2001-08-09	Unused	CCKBR
Diabetes Mellitus, Type 2	ENSG00000110244	FALSE	Preclinical	2012-05-25	Preclinical	APOA4
Diabetes Mellitus, Type 2	ENSG00000110245	FALSE	Phase II Clinical Trial	2009-05-01	Absent	APOC3
Diabetes Mellitus, Type 2	ENSG00000110395	FALSE	Preclinical	2003-09-24	Unused	CBL
Diabetes Mellitus, Type 2	ENSG00000110680	FALSE	Phase II Clinical Trial	2015-07-15	Absent	CALCA
Diabetes Mellitus, Type 2	ENSG00000111142	FALSE	Phase II Clinical Trial	1998-07-15	Absent	METAP2
Diabetes Mellitus, Type 2	ENSG00000111199	FALSE	Preclinical	2012-09-29	Preclinical	TRPV4
Diabetes Mellitus, Type 2	ENSG00000112033	FALSE	Phase III Clinical Trial	1996-06-15	Phase III Clinical Trial	PPARD
Diabetes Mellitus, Type 2	ENSG00000112062	FALSE	Preclinical	2008-02-14	Unused	MAPK14
Diabetes Mellitus, Type 2	ENSG00000112164	TRUE	Approved	1996-12-15	Approved	GLP1R
Diabetes Mellitus, Type 2	ENSG00000112541	FALSE	Preclinical	2015-09-03	Absent	PDE10A
Diabetes Mellitus, Type 2	ENSG00000112715	FALSE	Phase I Clinical Trial	2016-03-08	Absent	VEGFA
Diabetes Mellitus, Type 2	ENSG00000112964	FALSE	Preclinical	1998-12-15	Unused	GHR
Diabetes Mellitus, Type 2	ENSG00000113161	TRUE	Approved	2007-03-15	Approved	HMGCR
Diabetes Mellitus, Type 2	ENSG00000113448	FALSE	Phase I Clinical Trial	NA	Absent	PDE4D
Diabetes Mellitus, Type 2	ENSG00000113575	FALSE	Preclinical	2009-02-13	Unused	PPP2CA
Diabetes Mellitus, Type 2	ENSG00000113578	FALSE	Phase I Clinical Trial	2015-11-03	Absent	FGF1
Diabetes Mellitus, Type 2	ENSG00000113580	FALSE	Phase II Clinical Trial	2001-08-28	Phase I Clinical Trial	NR3C1
Diabetes Mellitus, Type 2	ENSG00000114739	FALSE	Phase II Clinical Trial	2010-07-02	Absent	ACVR2B
Diabetes Mellitus, Type 2	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Diabetes Mellitus, Type 2	ENSG00000115263	TRUE	Approved	1996-09-15	Approved	GCG
Diabetes Mellitus, Type 2	ENSG00000115590	FALSE	Phase II Clinical Trial	2004-03-25	Unused	IL1R2
Diabetes Mellitus, Type 2	ENSG00000115592	FALSE	Preclinical	2003-05-20	Unused	PRKAG3
Diabetes Mellitus, Type 2	ENSG00000115594	FALSE	Phase II Clinical Trial	2004-03-25	Unused	IL1R1
Diabetes Mellitus, Type 2	ENSG00000116678	FALSE	Preclinical	1995-08-15	Unused	LEPR
Diabetes Mellitus, Type 2	ENSG00000117009	FALSE	Preclinical	2016-10-14	Absent	KMO
Diabetes Mellitus, Type 2	ENSG00000117594	FALSE	Phase II Clinical Trial	2001-10-19	Phase II Clinical Trial	HSD11B1
Diabetes Mellitus, Type 2	ENSG00000118271	FALSE	Preclinical	2009-06-09	Unused	TTR
Diabetes Mellitus, Type 2	ENSG00000118432	FALSE	Phase III Clinical Trial	1994-02-15	Phase I Clinical Trial	CNR1
Diabetes Mellitus, Type 2	ENSG00000121351	FALSE	Phase II Clinical Trial	2001-05-15	Unused	IAPP
Diabetes Mellitus, Type 2	ENSG00000121807	FALSE	Phase II Clinical Trial	2002-11-14	Phase II Clinical Trial	CCR2
Diabetes Mellitus, Type 2	ENSG00000121853	FALSE	Phase I Clinical Trial	2004-11-24	Unused	GHSR
Diabetes Mellitus, Type 2	ENSG00000121966	FALSE	Phase I Clinical Trial	1996-07-15	Unused	CXCR4
Diabetes Mellitus, Type 2	ENSG00000122585	FALSE	Phase I Clinical Trial	2008-05-07	Unused	NPY
Diabetes Mellitus, Type 2	ENSG00000124253	FALSE	Phase II Clinical Trial	1995-10-15	Unused	PCK1
Diabetes Mellitus, Type 2	ENSG00000125255	FALSE	Phase II Clinical Trial	2011-02-04	Phase I Clinical Trial	SLC10A2
Diabetes Mellitus, Type 2	ENSG00000125378	FALSE	Preclinical	2007-08-22	Unused	BMP4
Diabetes Mellitus, Type 2	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase III Clinical Trial	IL1B
Diabetes Mellitus, Type 2	ENSG00000126262	FALSE	Preclinical	2009-06-29	Unused	FFAR2
Diabetes Mellitus, Type 2	ENSG00000126266	FALSE	Phase III Clinical Trial	2003-02-27	Phase III Clinical Trial	FFAR1
Diabetes Mellitus, Type 2	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Diabetes Mellitus, Type 2	ENSG00000128285	FALSE	Preclinical	2002-09-10	Unused	MCHR1
Diabetes Mellitus, Type 2	ENSG00000130368	FALSE	Preclinical	2010-09-20	Absent	MAS1
Diabetes Mellitus, Type 2	ENSG00000132170	TRUE	Approved	1989-09-15	Approved	PPARG
Diabetes Mellitus, Type 2	ENSG00000132329	FALSE	Preclinical	1997-09-15	Unused	RAMP1
Diabetes Mellitus, Type 2	ENSG00000132356	FALSE	Preclinical	2005-06-28	Unused	PRKAA1
Diabetes Mellitus, Type 2	ENSG00000132434	FALSE	Preclinical	2014-05-15	Absent	LANCL2
Diabetes Mellitus, Type 2	ENSG00000132693	FALSE	Preclinical	2006-09-11	Unused	CRP
Diabetes Mellitus, Type 2	ENSG00000132703	FALSE	unknown	1995-07-15	Absent	APCS
Diabetes Mellitus, Type 2	ENSG00000132855	FALSE	Phase II Clinical Trial	2015-03-18	Absent	ANGPTL3
Diabetes Mellitus, Type 2	ENSG00000133019	FALSE	unknown	2007-02-02	Unused	CHRM3
Diabetes Mellitus, Type 2	ENSG00000134318	FALSE	unknown	2005-05-24	Phase I Clinical Trial	ROCK2
Diabetes Mellitus, Type 2	ENSG00000134640	FALSE	Preclinical	2008-01-15	Absent	MTNR1B
Diabetes Mellitus, Type 2	ENSG00000134962	FALSE	Phase I Clinical Trial	2015-11-03	Absent	KLB
Diabetes Mellitus, Type 2	ENSG00000135914	FALSE	Preclinical	2008-01-15	Absent	HTR2B
Diabetes Mellitus, Type 2	ENSG00000136750	FALSE	Phase III Clinical Trial	NA	Unused	GAD2
Diabetes Mellitus, Type 2	ENSG00000138207	FALSE	Preclinical	2009-06-09	Unused	RBP4
Diabetes Mellitus, Type 2	ENSG00000138379	FALSE	Preclinical	2006-08-07	Unused	MSTN
Diabetes Mellitus, Type 2	ENSG00000138823	FALSE	Phase II Clinical Trial	2005-05-24	Phase II Clinical Trial	MTTP
Diabetes Mellitus, Type 2	ENSG00000139515	FALSE	Preclinical	1995-05-15	Unused	PDX1
Diabetes Mellitus, Type 2	ENSG00000140443	FALSE	Approved	NA	Unused	IGF1R
Diabetes Mellitus, Type 2	ENSG00000140675	TRUE	Approved	2000-07-20	Approved	SLC5A2
Diabetes Mellitus, Type 2	ENSG00000141485	FALSE	Preclinical	2014-05-13	Absent	SLC13A5
Diabetes Mellitus, Type 2	ENSG00000141867	FALSE	Phase III Clinical Trial	2005-03-04	Phase II Clinical Trial	BRD4
Diabetes Mellitus, Type 2	ENSG00000142319	FALSE	Phase II Clinical Trial	1997-10-15	Preclinical	SLC6A3
Diabetes Mellitus, Type 2	ENSG00000143171	FALSE	Preclinical	1992-09-15	Unused	RXRG
Diabetes Mellitus, Type 2	ENSG00000143799	FALSE	Phase II Clinical Trial	2002-03-12	Phase II Clinical Trial	PARP1
Diabetes Mellitus, Type 2	ENSG00000144891	FALSE	Phase III Clinical Trial	2006-07-21	Unused	AGTR1
Diabetes Mellitus, Type 2	ENSG00000146648	FALSE	unknown	2001-08-09	Unused	EGFR
Diabetes Mellitus, Type 2	ENSG00000147246	FALSE	unknown	NA	Phase II Clinical Trial	HTR2C
Diabetes Mellitus, Type 2	ENSG00000147262	FALSE	Phase II Clinical Trial	2005-08-02	Phase II Clinical Trial	GPR119
Diabetes Mellitus, Type 2	ENSG00000147955	FALSE	unknown	2007-02-02	Unused	SIGMAR1
Diabetes Mellitus, Type 2	ENSG00000148154	FALSE	Preclinical	2007-07-05	Unused	UGCG
Diabetes Mellitus, Type 2	ENSG00000149295	TRUE	Approved	1995-07-15	Approved	DRD2
Diabetes Mellitus, Type 2	ENSG00000150782	FALSE	Phase II Clinical Trial	2009-12-18	Phase I Clinical Trial	IL18
Diabetes Mellitus, Type 2	ENSG00000150907	FALSE	Preclinical	2010-09-20	Unused	FOXO1
Diabetes Mellitus, Type 2	ENSG00000151090	FALSE	unknown	2009-01-06	Unused	THRB
Diabetes Mellitus, Type 2	ENSG00000152256	FALSE	Phase I Clinical Trial	2014-04-09	Absent	PDK1
Diabetes Mellitus, Type 2	ENSG00000157184	FALSE	Phase I Clinical Trial	1995-10-15	Unused	CPT2
Diabetes Mellitus, Type 2	ENSG00000159224	FALSE	Preclinical	2015-06-09	Absent	GIP
Diabetes Mellitus, Type 2	ENSG00000159640	FALSE	Preclinical	2005-11-04	Unused	ACE
Diabetes Mellitus, Type 2	ENSG00000160691	FALSE	Preclinical	2015-09-23	Absent	SHC1
Diabetes Mellitus, Type 2	ENSG00000160791	FALSE	Phase II Clinical Trial	1996-07-15	Unused	CCR5
Diabetes Mellitus, Type 2	ENSG00000160867	FALSE	Phase II Clinical Trial	2012-03-30	Absent	FGFR4
Diabetes Mellitus, Type 2	ENSG00000162009	FALSE	Preclinical	NA	Absent	SSTR5
Diabetes Mellitus, Type 2	ENSG00000162692	FALSE	unknown	1996-02-15	Unused	VCAM1
Diabetes Mellitus, Type 2	ENSG00000162711	FALSE	Phase II Clinical Trial	2010-01-19	Absent	NLRP3
Diabetes Mellitus, Type 2	ENSG00000163394	FALSE	unknown	2006-12-21	Unused	CCKAR
Diabetes Mellitus, Type 2	ENSG00000163485	FALSE	Phase I Clinical Trial	2004-01-02	Unused	ADORA1
Diabetes Mellitus, Type 2	ENSG00000163631	FALSE	Phase I Clinical Trial	2012-03-09	Phase I Clinical Trial	ALB
Diabetes Mellitus, Type 2	ENSG00000164128	FALSE	Preclinical	2009-01-12	Unused	NPY1R
Diabetes Mellitus, Type 2	ENSG00000164756	FALSE	Preclinical	2009-11-27	Unused	SLC30A8
Diabetes Mellitus, Type 2	ENSG00000165029	FALSE	unknown	2007-08-21	Unused	ABCA1
Diabetes Mellitus, Type 2	ENSG00000165140	FALSE	Phase II Clinical Trial	1997-08-15	Unused	FBP1
Diabetes Mellitus, Type 2	ENSG00000166501	FALSE	Preclinical	2004-01-21	Unused	PRKCB
Diabetes Mellitus, Type 2	ENSG00000166603	FALSE	Preclinical	2000-07-19	Unused	MC4R
Diabetes Mellitus, Type 2	ENSG00000167085	FALSE	unknown	2010-12-22	Preclinical	PHB
Diabetes Mellitus, Type 2	ENSG00000167535	FALSE	Preclinical	2005-05-23	Unused	CACNB3
Diabetes Mellitus, Type 2	ENSG00000167910	FALSE	unknown	2007-08-21	Unused	CYP7A1
Diabetes Mellitus, Type 2	ENSG00000168078	FALSE	Preclinical	2017-03-14	Absent	PBK
Diabetes Mellitus, Type 2	ENSG00000168398	FALSE	Preclinical	2011-04-28	Absent	BDKRB2
Diabetes Mellitus, Type 2	ENSG00000168412	FALSE	Preclinical	2008-01-15	Absent	MTNR1A
Diabetes Mellitus, Type 2	ENSG00000169083	FALSE	Preclinical	1995-10-15	Phase II Clinical Trial	AR
Diabetes Mellitus, Type 2	ENSG00000169174	FALSE	Phase III Clinical Trial	2009-12-10	Absent	PCSK9
Diabetes Mellitus, Type 2	ENSG00000169194	FALSE	Preclinical	2004-01-21	Unused	IL13
Diabetes Mellitus, Type 2	ENSG00000170425	FALSE	Preclinical	2000-03-22	Unused	ADORA2B
Diabetes Mellitus, Type 2	ENSG00000171105	TRUE	Approved	1990-01-15	Approved	INSR
Diabetes Mellitus, Type 2	ENSG00000171132	FALSE	unknown	2002-11-15	Unused	PRKCE
Diabetes Mellitus, Type 2	ENSG00000171298	TRUE	Approved	1998-07-15	Approved	GAA
Diabetes Mellitus, Type 2	ENSG00000171862	FALSE	Preclinical	2004-07-13	Unused	PTEN
Diabetes Mellitus, Type 2	ENSG00000172016	FALSE	Preclinical	2002-01-03	Unused	REG3A
Diabetes Mellitus, Type 2	ENSG00000172938	FALSE	Preclinical	2015-12-23	Absent	MRGPRD
Diabetes Mellitus, Type 2	ENSG00000173083	FALSE	Preclinical	2013-12-03	Absent	HPSE
Diabetes Mellitus, Type 2	ENSG00000173153	FALSE	Preclinical	2012-05-23	Preclinical	ESRRA
Diabetes Mellitus, Type 2	ENSG00000173250	FALSE	Preclinical	2017-08-03	Absent	GPR151
Diabetes Mellitus, Type 2	ENSG00000173511	FALSE	Phase I Clinical Trial	2012-09-28	Preclinical	VEGFB
Diabetes Mellitus, Type 2	ENSG00000174437	FALSE	Preclinical	2014-02-26	Absent	ATP2A2
Diabetes Mellitus, Type 2	ENSG00000174697	FALSE	Preclinical	2006-09-11	Unused	LEP
Diabetes Mellitus, Type 2	ENSG00000175344	FALSE	Phase II Clinical Trial	2009-03-11	Unused	CHRNA7
Diabetes Mellitus, Type 2	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Diabetes Mellitus, Type 2	ENSG00000175535	TRUE	Approved	1995-10-15	Approved	PNLIP
Diabetes Mellitus, Type 2	ENSG00000177669	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MBOAT4
Diabetes Mellitus, Type 2	ENSG00000178394	FALSE	Preclinical	2008-01-15	Absent	HTR1A
Diabetes Mellitus, Type 2	ENSG00000179546	FALSE	Preclinical	2008-01-15	Absent	HTR1D
Diabetes Mellitus, Type 2	ENSG00000179921	FALSE	Phase II Clinical Trial	2005-05-25	Unused	GPBAR1
Diabetes Mellitus, Type 2	ENSG00000180530	FALSE	Preclinical	2003-05-06	Unused	NRIP1
Diabetes Mellitus, Type 2	ENSG00000180616	FALSE	Phase II Clinical Trial	1999-05-19	Unused	SSTR2
Diabetes Mellitus, Type 2	ENSG00000181072	FALSE	unknown	2007-02-02	Unused	CHRM2
Diabetes Mellitus, Type 2	ENSG00000181856	FALSE	Phase I Clinical Trial	1997-09-15	Unused	SLC2A4
Diabetes Mellitus, Type 2	ENSG00000182240	FALSE	Preclinical	2014-12-02	Absent	BACE2
Diabetes Mellitus, Type 2	ENSG00000182782	FALSE	Phase II Clinical Trial	2006-02-19	Phase II Clinical Trial	HCAR2
Diabetes Mellitus, Type 2	ENSG00000183840	FALSE	Preclinical	2010-06-04	Unused	GPR39
Diabetes Mellitus, Type 2	ENSG00000184502	FALSE	Phase II Clinical Trial	2007-11-07	Unused	GAST
Diabetes Mellitus, Type 2	ENSG00000184588	FALSE	Phase I Clinical Trial	NA	Absent	PDE4B
Diabetes Mellitus, Type 2	ENSG00000184845	TRUE	Approved	1995-07-15	Approved	DRD1
Diabetes Mellitus, Type 2	ENSG00000185000	FALSE	Phase II Clinical Trial	2006-06-20	Phase II Clinical Trial	DGAT1
Diabetes Mellitus, Type 2	ENSG00000185149	FALSE	Phase I Clinical Trial	2006-11-28	Unused	NPY2R
Diabetes Mellitus, Type 2	ENSG00000185950	FALSE	Preclinical	2003-09-09	Unused	IRS2
Diabetes Mellitus, Type 2	ENSG00000186188	FALSE	Preclinical	2011-11-11	Unused	FFAR4
Diabetes Mellitus, Type 2	ENSG00000186350	FALSE	Preclinical	1992-09-15	Unused	RXRA
Diabetes Mellitus, Type 2	ENSG00000186951	FALSE	Approved	1996-06-15	Unused	PPARA
Diabetes Mellitus, Type 2	ENSG00000187266	FALSE	unknown	2008-06-12	Unused	EPOR
Diabetes Mellitus, Type 2	ENSG00000187486	TRUE	Approved	1992-12-15	Approved	KCNJ11
Diabetes Mellitus, Type 2	ENSG00000187871	FALSE	Preclinical	2015-10-15	Absent	GFRAL
Diabetes Mellitus, Type 2	ENSG00000188778	FALSE	Phase I Clinical Trial	1994-11-15	Unused	ADRB3
Diabetes Mellitus, Type 2	ENSG00000188822	FALSE	Phase II Clinical Trial	2007-04-23	Phase II Clinical Trial	CNR2
Diabetes Mellitus, Type 2	ENSG00000196396	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	PTPN1
Diabetes Mellitus, Type 2	ENSG00000196498	FALSE	Preclinical	2009-06-09	Unused	NCOR2
Diabetes Mellitus, Type 2	ENSG00000196689	FALSE	Phase II Clinical Trial	2009-03-12	Absent	TRPV1
Diabetes Mellitus, Type 2	ENSG00000197249	FALSE	unknown	2009-06-04	Preclinical	SERPINA1
Diabetes Mellitus, Type 2	ENSG00000197635	TRUE	Approved	1998-06-15	Approved	DPP4
Diabetes Mellitus, Type 2	ENSG00000197891	FALSE	Phase II Clinical Trial	2000-02-02	Absent	SLC22A12
Diabetes Mellitus, Type 2	ENSG00000198851	FALSE	Preclinical	2004-02-24	Absent	CD3E
Diabetes Mellitus, Type 2	ENSG00000205542	FALSE	unknown	2010-01-14	Unused	TMSB4X
Diabetes Mellitus, Type 2	ENSG00000215644	FALSE	Phase II Clinical Trial	1994-09-15	Phase II Clinical Trial	GCGR
Diabetes Mellitus, Type 2	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Diabetes Mellitus, Type 2	ENSG00000254087	FALSE	Phase II Clinical Trial	2007-04-05	Preclinical	LYN
Diabetes Mellitus, Type 2	ENSG00000254647	FALSE	Phase II Clinical Trial	2008-10-27	Phase I Clinical Trial	INS
Diabetes Mellitus, Type 2	ENSG00000257008	FALSE	Phase I Clinical Trial	2011-08-31	Preclinical	GPR142
Diabetes Mellitus, Type 2	ENSG00000258839	FALSE	unknown	2005-12-18	Unused	MC1R
Diabetes Mellitus, Type 2	ENSG00000278195	FALSE	Preclinical	2012-04-04	Absent	SSTR3
Diabetes Mellitus, Type 2	ENSG00000278540	FALSE	Phase II Clinical Trial	2010-08-04	Unused	ACACA
Diabetes, Gestational	ENSG00000112164	FALSE	Phase III Clinical Trial	1997-07-15	Phase I Clinical Trial	GLP1R
Diabetes, Gestational	ENSG00000171105	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	INSR
Diabetic Cardiomyopathies	ENSG00000085662	FALSE	Phase III Clinical Trial	1991-07-15	Unused	AKR1B1
Diabetic Cardiomyopathies	ENSG00000118271	FALSE	Preclinical	2009-06-09	Unused	TTR
Diabetic Cardiomyopathies	ENSG00000138207	FALSE	Preclinical	2009-06-09	Unused	RBP4
Diabetic Cardiomyopathies	ENSG00000171105	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	INSR
Diabetic Foot	ENSG00000012223	FALSE	unknown	1994-08-15	Phase II Clinical Trial	LTF
Diabetic Foot	ENSG00000019991	FALSE	Phase III Clinical Trial	2004-11-23	Absent	HGF
Diabetic Foot	ENSG00000043591	FALSE	Phase II Clinical Trial	2010-05-06	Unused	ADRB1
Diabetic Foot	ENSG00000065989	FALSE	Preclinical	2005-05-24	Absent	PDE4A
Diabetic Foot	ENSG00000077782	FALSE	Phase III Clinical Trial	2005-09-14	Phase I Clinical Trial	FGFR1
Diabetic Foot	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Diabetic Foot	ENSG00000089250	FALSE	Phase III Clinical Trial	2015-08-19	Absent	NOS1
Diabetic Foot	ENSG00000100311	FALSE	Phase III Clinical Trial	2001-04-17	Unused	PDGFB
Diabetic Foot	ENSG00000100453	FALSE	Preclinical	2013-03-08	Absent	GZMB
Diabetic Foot	ENSG00000112062	FALSE	unknown	2000-10-25	Unused	MAPK14
Diabetic Foot	ENSG00000112715	FALSE	Preclinical	2011-02-08	Absent	VEGFA
Diabetic Foot	ENSG00000113721	TRUE	Approved	2007-03-20	Approved	PDGFRB
Diabetic Foot	ENSG00000115353	FALSE	Preclinical	NA	Absent	TACR1
Diabetic Foot	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-08-11	Unused	FN1
Diabetic Foot	ENSG00000115718	FALSE	Preclinical	2012-08-13	Absent	PROC
Diabetic Foot	ENSG00000117601	FALSE	Phase III Clinical Trial	2007-05-19	Phase III Clinical Trial	SERPINC1
Diabetic Foot	ENSG00000122194	FALSE	Preclinical	NA	Absent	PLG
Diabetic Foot	ENSG00000125538	FALSE	Preclinical	2017-03-02	Absent	IL1B
Diabetic Foot	ENSG00000126218	FALSE	Phase III Clinical Trial	2012-04-28	Phase III Clinical Trial	F10
Diabetic Foot	ENSG00000128052	FALSE	unknown	1997-09-15	Unused	KDR
Diabetic Foot	ENSG00000128271	FALSE	Phase II Clinical Trial	2002-07-03	Unused	ADORA2A
Diabetic Foot	ENSG00000129521	FALSE	Phase I Clinical Trial	2008-09-16	Absent	EGLN3
Diabetic Foot	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Diabetic Foot	ENSG00000134853	FALSE	unknown	2007-03-20	Unused	PDGFRA
Diabetic Foot	ENSG00000138735	FALSE	Preclinical	2017-06-19	Absent	PDE5A
Diabetic Foot	ENSG00000142677	FALSE	Phase I Clinical Trial	2015-01-31	Absent	IL22RA1
Diabetic Foot	ENSG00000146648	FALSE	Approved	1997-11-15	Unused	EGFR
Diabetic Foot	ENSG00000154229	FALSE	Phase II Clinical Trial	2007-01-02	Phase III Clinical Trial	PRKCA
Diabetic Foot	ENSG00000155011	FALSE	Preclinical	2012-04-18	Preclinical	DKK2
Diabetic Foot	ENSG00000160951	FALSE	Approved	1999-05-11	Unused	PTGER1
Diabetic Foot	ENSG00000163932	FALSE	Phase II Clinical Trial	2007-01-02	Phase III Clinical Trial	PRKCD
Diabetic Foot	ENSG00000180210	FALSE	Phase III Clinical Trial	2012-04-28	Phase III Clinical Trial	F2
Diabetic Foot	ENSG00000184160	FALSE	Phase I Clinical Trial	2015-09-04	Absent	ADRA2C
Diabetic Foot	ENSG00000187266	FALSE	Phase II Clinical Trial	2015-03-19	Absent	EPOR
Diabetic Foot	ENSG00000197461	FALSE	Phase III Clinical Trial	2001-04-17	Unused	PDGFA
Diabetic Foot	ENSG00000198223	FALSE	unknown	1994-08-15	Phase II Clinical Trial	CSF2RA
Diabetic Foot	ENSG00000269858	FALSE	Phase I Clinical Trial	2008-09-16	Absent	EGLN2
Diabetic Nephropathies	ENSG00000007171	FALSE	unknown	1989-10-15	Unused	NOS2
Diabetic Nephropathies	ENSG00000007952	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	NOX1
Diabetic Nephropathies	ENSG00000012504	FALSE	unknown	2005-05-26	Preclinical	NR1H4
Diabetic Nephropathies	ENSG00000017427	FALSE	Preclinical	2004-08-17	Absent	IGF1
Diabetic Nephropathies	ENSG00000019186	FALSE	Preclinical	2012-06-11	Preclinical	CYP24A1
Diabetic Nephropathies	ENSG00000059377	FALSE	Phase II Clinical Trial	2006-08-29	Absent	TBXAS1
Diabetic Nephropathies	ENSG00000065989	FALSE	Phase I Clinical Trial	NA	Absent	PDE4A
Diabetic Nephropathies	ENSG00000067182	FALSE	Phase I Clinical Trial	2005-06-27	Preclinical	TNFRSF1A
Diabetic Nephropathies	ENSG00000067900	FALSE	Phase I Clinical Trial	2007-03-13	Unused	ROCK1
Diabetic Nephropathies	ENSG00000070019	FALSE	Phase II Clinical Trial	2013-12-16	Absent	GUCY2C
Diabetic Nephropathies	ENSG00000071246	FALSE	Preclinical	2010-02-15	Unused	VASH1
Diabetic Nephropathies	ENSG00000082701	FALSE	unknown	2009-02-05	Absent	GSK3B
Diabetic Nephropathies	ENSG00000085662	FALSE	Preclinical	2011-01-14	Preclinical	AKR1B1
Diabetic Nephropathies	ENSG00000086991	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	NOX4
Diabetic Nephropathies	ENSG00000087245	FALSE	unknown	2002-12-06	Unused	MMP2
Diabetic Nephropathies	ENSG00000092009	FALSE	Phase II Clinical Trial	2014-03-18	Absent	CMA1
Diabetic Nephropathies	ENSG00000094631	FALSE	Preclinical	2009-08-13	Absent	HDAC6
Diabetic Nephropathies	ENSG00000096968	FALSE	unknown	2007-10-10	Phase II Clinical Trial	JAK2
Diabetic Nephropathies	ENSG00000100665	FALSE	Preclinical	2007-11-27	Unused	SERPINA4
Diabetic Nephropathies	ENSG00000100985	FALSE	unknown	2002-12-06	Unused	MMP9
Diabetic Nephropathies	ENSG00000102755	FALSE	Phase I Clinical Trial	2015-01-12	Absent	FLT1
Diabetic Nephropathies	ENSG00000105329	FALSE	Phase I Clinical Trial	2005-06-27	Preclinical	TGFB1
Diabetic Nephropathies	ENSG00000105650	FALSE	Phase I Clinical Trial	NA	Absent	PDE4C
Diabetic Nephropathies	ENSG00000106366	FALSE	Preclinical	2016-12-12	Absent	SERPINE1
Diabetic Nephropathies	ENSG00000106799	FALSE	Phase II Clinical Trial	2007-10-03	Phase II Clinical Trial	TGFBR1
Diabetic Nephropathies	ENSG00000108691	FALSE	Phase III Clinical Trial	1992-01-15	Unused	CCL2
Diabetic Nephropathies	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Diabetic Nephropathies	ENSG00000112062	FALSE	Phase I Clinical Trial	2005-06-27	Preclinical	MAPK14
Diabetic Nephropathies	ENSG00000112715	FALSE	unknown	1994-12-15	Unused	VEGFA
Diabetic Nephropathies	ENSG00000113448	FALSE	Phase I Clinical Trial	NA	Absent	PDE4D
Diabetic Nephropathies	ENSG00000113580	FALSE	Phase II Clinical Trial	2006-03-13	Phase II Clinical Trial	NR3C1
Diabetic Nephropathies	ENSG00000116044	FALSE	Phase II Clinical Trial	2005-05-27	Unused	NFE2L2
Diabetic Nephropathies	ENSG00000117298	FALSE	Preclinical	2011-07-27	Unused	ECE1
Diabetic Nephropathies	ENSG00000118113	FALSE	unknown	2002-12-06	Unused	MMP8
Diabetic Nephropathies	ENSG00000118523	FALSE	Phase II Clinical Trial	1999-09-14	Phase II Clinical Trial	CTGF
Diabetic Nephropathies	ENSG00000121807	FALSE	Phase II Clinical Trial	2003-02-24	Phase II Clinical Trial	CCR2
Diabetic Nephropathies	ENSG00000125538	FALSE	unknown	2006-01-18	Unused	IL1B
Diabetic Nephropathies	ENSG00000131471	FALSE	Phase II Clinical Trial	2013-02-04	Absent	AOC3
Diabetic Nephropathies	ENSG00000132671	FALSE	unknown	1998-09-15	Unused	SSTR4
Diabetic Nephropathies	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Diabetic Nephropathies	ENSG00000136160	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	EDNRB
Diabetic Nephropathies	ENSG00000137745	FALSE	unknown	2002-12-06	Unused	MMP13
Diabetic Nephropathies	ENSG00000137845	FALSE	unknown	2002-12-06	Unused	ADAM10
Diabetic Nephropathies	ENSG00000138448	FALSE	Phase II Clinical Trial	2012-09-14	Preclinical	ITGAV
Diabetic Nephropathies	ENSG00000138735	FALSE	Phase II Clinical Trial	2006-12-21	Phase II Clinical Trial	PDE5A
Diabetic Nephropathies	ENSG00000140675	FALSE	Phase III Clinical Trial	2005-04-01	Absent	SLC5A2
Diabetic Nephropathies	ENSG00000143839	FALSE	Phase II Clinical Trial	2004-01-13	Phase I Clinical Trial	REN
Diabetic Nephropathies	ENSG00000144891	TRUE	Approved	1989-11-15	Approved	AGTR1
Diabetic Nephropathies	ENSG00000146648	FALSE	Phase II Clinical Trial	2012-03-09	Absent	EGFR
Diabetic Nephropathies	ENSG00000149968	FALSE	unknown	2002-12-06	Unused	MMP3
Diabetic Nephropathies	ENSG00000151617	FALSE	Phase III Clinical Trial	1994-10-15	Phase III Clinical Trial	EDNRA
Diabetic Nephropathies	ENSG00000151623	FALSE	Phase III Clinical Trial	2006-01-11	Phase II Clinical Trial	NR3C2
Diabetic Nephropathies	ENSG00000151694	FALSE	unknown	2002-12-06	Unused	ADAM17
Diabetic Nephropathies	ENSG00000154646	FALSE	Phase I Clinical Trial	2015-05-22	Absent	TMPRSS15
Diabetic Nephropathies	ENSG00000158125	FALSE	Phase I Clinical Trial	2015-08-10	Absent	XDH
Diabetic Nephropathies	ENSG00000159640	TRUE	Approved	1989-05-15	Approved	ACE
Diabetic Nephropathies	ENSG00000160791	FALSE	Phase II Clinical Trial	2010-01-15	Phase II Clinical Trial	CCR5
Diabetic Nephropathies	ENSG00000161270	FALSE	Preclinical	2005-05-23	Unused	NPHS1
Diabetic Nephropathies	ENSG00000162009	FALSE	unknown	1998-09-15	Unused	SSTR5
Diabetic Nephropathies	ENSG00000162434	FALSE	unknown	2007-10-10	Phase II Clinical Trial	JAK1
Diabetic Nephropathies	ENSG00000162711	FALSE	unknown	2010-01-19	Absent	NLRP3
Diabetic Nephropathies	ENSG00000163235	FALSE	Phase II Clinical Trial	2012-03-09	Absent	TGFA
Diabetic Nephropathies	ENSG00000166501	FALSE	Phase II Clinical Trial	1996-06-15	Unused	PRKCB
Diabetic Nephropathies	ENSG00000170820	FALSE	Preclinical	2012-09-18	Absent	FSHR
Diabetic Nephropathies	ENSG00000170962	FALSE	unknown	2001-05-14	Unused	PDGFD
Diabetic Nephropathies	ENSG00000171517	FALSE	Preclinical	2017-08-08	Absent	LPAR3
Diabetic Nephropathies	ENSG00000171791	FALSE	Preclinical	2008-04-02	Preclinical	BCL2
Diabetic Nephropathies	ENSG00000173083	FALSE	Preclinical	2013-12-03	Absent	HPSE
Diabetic Nephropathies	ENSG00000173511	FALSE	Phase I Clinical Trial	2012-09-28	Absent	VEGFB
Diabetic Nephropathies	ENSG00000175445	FALSE	unknown	2000-09-01	Unused	LPL
Diabetic Nephropathies	ENSG00000179921	FALSE	unknown	2005-05-26	Preclinical	GPBAR1
Diabetic Nephropathies	ENSG00000180616	FALSE	unknown	1998-09-15	Unused	SSTR2
Diabetic Nephropathies	ENSG00000180772	FALSE	Phase I Clinical Trial	2012-02-22	Absent	AGTR2
Diabetic Nephropathies	ENSG00000181408	FALSE	Phase I Clinical Trial	2002-06-07	Unused	UTS2R
Diabetic Nephropathies	ENSG00000184588	FALSE	Phase I Clinical Trial	NA	Absent	PDE4B
Diabetic Nephropathies	ENSG00000196396	FALSE	Preclinical	2009-06-04	Preclinical	PTPN1
Diabetic Nephropathies	ENSG00000196549	FALSE	Phase I Clinical Trial	2002-06-19	Unused	MME
Diabetic Nephropathies	ENSG00000197442	FALSE	Phase I Clinical Trial	2014-03-17	Absent	MAP3K5
Diabetic Nephropathies	ENSG00000197891	FALSE	unknown	2010-01-19	Absent	SLC22A12
Diabetic Nephropathies	ENSG00000198001	FALSE	Preclinical	2011-09-05	Preclinical	IRAK4
Diabetic Nephropathies	ENSG00000198121	FALSE	Preclinical	2017-08-08	Absent	LPAR1
Diabetic Nephropathies	ENSG00000198829	FALSE	Preclinical	NA	Absent	SUCNR1
Diabetic Nephropathies	ENSG00000198959	FALSE	Preclinical	2012-11-27	Absent	TGM2
Diabetic Neuropathies	ENSG00000006638	FALSE	Preclinical	1996-02-15	Unused	TBXA2R
Diabetic Neuropathies	ENSG00000017427	FALSE	Preclinical	2007-09-24	Unused	IGF1
Diabetic Neuropathies	ENSG00000019991	FALSE	Phase III Clinical Trial	2004-11-23	Phase II Clinical Trial	HGF
Diabetic Neuropathies	ENSG00000059377	FALSE	Pre-registration	1993-06-15	Unused	TBXAS1
Diabetic Neuropathies	ENSG00000064300	FALSE	Phase II Clinical Trial	1998-06-15	Unused	NGFR
Diabetic Neuropathies	ENSG00000065989	FALSE	unknown	NA	Unused	PDE4A
Diabetic Neuropathies	ENSG00000069535	FALSE	unknown	1999-08-17	Unused	MAOB
Diabetic Neuropathies	ENSG00000075043	FALSE	unknown	2007-12-13	Phase II Clinical Trial	KCNQ2
Diabetic Neuropathies	ENSG00000080824	FALSE	Phase I Clinical Trial	2016-01-29	Absent	HSP90AA1
Diabetic Neuropathies	ENSG00000082556	FALSE	Approved	1999-04-13	Unused	OPRK1
Diabetic Neuropathies	ENSG00000085563	FALSE	unknown	1996-02-15	Unused	ABCB1
Diabetic Neuropathies	ENSG00000085662	FALSE	Approved	1990-06-15	Unused	AKR1B1
Diabetic Neuropathies	ENSG00000086205	FALSE	Preclinical	2007-04-27	Unused	FOLH1
Diabetic Neuropathies	ENSG00000087085	FALSE	unknown	2005-12-14	Unused	ACHE
Diabetic Neuropathies	ENSG00000087245	FALSE	Phase I Clinical Trial	2015-04-21	Absent	MMP2
Diabetic Neuropathies	ENSG00000092964	FALSE	unknown	2000-01-11	Phase III Clinical Trial	DPYSL2
Diabetic Neuropathies	ENSG00000100300	FALSE	Phase II Clinical Trial	2001-06-08	Unused	TSPO
Diabetic Neuropathies	ENSG00000100739	FALSE	Preclinical	2009-03-28	Unused	BDKRB1
Diabetic Neuropathies	ENSG00000100985	FALSE	Phase I Clinical Trial	2015-04-21	Absent	MMP9
Diabetic Neuropathies	ENSG00000101180	FALSE	Phase II Clinical Trial	2010-06-15	Phase II Clinical Trial	HRH3
Diabetic Neuropathies	ENSG00000101204	FALSE	unknown	1998-03-15	Unused	CHRNA4
Diabetic Neuropathies	ENSG00000101327	FALSE	unknown	2005-10-17	Absent	PDYN
Diabetic Neuropathies	ENSG00000102468	FALSE	unknown	1998-10-15	Unused	HTR2A
Diabetic Neuropathies	ENSG00000103546	TRUE	Approved	2000-01-19	Approved	SLC6A2
Diabetic Neuropathies	ENSG00000104321	FALSE	Phase II Clinical Trial	2009-06-22	Phase II Clinical Trial	TRPA1
Diabetic Neuropathies	ENSG00000105650	FALSE	unknown	NA	Unused	PDE4C
Diabetic Neuropathies	ENSG00000107611	FALSE	Approved	NA	Unused	CUBN
Diabetic Neuropathies	ENSG00000108576	TRUE	Approved	2000-01-19	Approved	SLC6A4
Diabetic Neuropathies	ENSG00000109320	FALSE	Phase III Clinical Trial	1999-03-23	Unused	NFKB1
Diabetic Neuropathies	ENSG00000111679	FALSE	Preclinical	2002-07-03	Unused	PTPN6
Diabetic Neuropathies	ENSG00000112038	TRUE	Approved	2001-08-09	Approved	OPRM1
Diabetic Neuropathies	ENSG00000112062	FALSE	Preclinical	2000-10-25	Unused	MAPK14
Diabetic Neuropathies	ENSG00000112096	FALSE	Preclinical	2009-07-02	Unused	SOD2
Diabetic Neuropathies	ENSG00000112541	FALSE	unknown	NA	Unused	PDE10A
Diabetic Neuropathies	ENSG00000112715	FALSE	Phase I Clinical Trial	1998-01-15	Unused	VEGFA
Diabetic Neuropathies	ENSG00000113448	FALSE	unknown	NA	Unused	PDE4D
Diabetic Neuropathies	ENSG00000115353	FALSE	unknown	1995-07-15	Unused	TACR1
Diabetic Neuropathies	ENSG00000116329	FALSE	Phase II Clinical Trial	2001-08-09	Phase II Clinical Trial	OPRD1
Diabetic Neuropathies	ENSG00000117594	FALSE	Phase II Clinical Trial	2013-05-14	Absent	HSD11B1
Diabetic Neuropathies	ENSG00000118432	FALSE	unknown	1998-08-15	Phase III Clinical Trial	CNR1
Diabetic Neuropathies	ENSG00000119535	FALSE	Phase II Clinical Trial	2010-05-26	Absent	CSF3R
Diabetic Neuropathies	ENSG00000120156	FALSE	Preclinical	2008-09-13	Unused	TEK
Diabetic Neuropathies	ENSG00000121764	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR1
Diabetic Neuropathies	ENSG00000121807	FALSE	Phase II Clinical Trial	2007-04-03	Unused	CCR2
Diabetic Neuropathies	ENSG00000124253	FALSE	Phase II Clinical Trial	2005-06-22	Unused	PCK1
Diabetic Neuropathies	ENSG00000125510	FALSE	Phase II Clinical Trial	2009-03-15	Phase II Clinical Trial	OPRL1
Diabetic Neuropathies	ENSG00000128271	FALSE	unknown	2003-05-23	Unused	ADORA2A
Diabetic Neuropathies	ENSG00000128655	FALSE	unknown	NA	Unused	PDE11A
Diabetic Neuropathies	ENSG00000128683	FALSE	Preclinical	2007-06-04	Preclinical	GAD1
Diabetic Neuropathies	ENSG00000131471	FALSE	unknown	2011-11-11	Preclinical	AOC3
Diabetic Neuropathies	ENSG00000134259	FALSE	Phase II Clinical Trial	2001-08-01	Phase II Clinical Trial	NGF
Diabetic Neuropathies	ENSG00000136869	FALSE	unknown	NA	Absent	TLR4
Diabetic Neuropathies	ENSG00000137252	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR2
Diabetic Neuropathies	ENSG00000138735	FALSE	unknown	2006-12-21	Absent	PDE5A
Diabetic Neuropathies	ENSG00000140443	FALSE	Phase II Clinical Trial	2000-08-24	Unused	IGF1R
Diabetic Neuropathies	ENSG00000140538	FALSE	unknown	1989-06-15	Unused	NTRK3
Diabetic Neuropathies	ENSG00000142319	FALSE	Phase III Clinical Trial	NA	Unused	SLC6A3
Diabetic Neuropathies	ENSG00000143799	FALSE	Preclinical	2003-06-17	Preclinical	PARP1
Diabetic Neuropathies	ENSG00000144285	FALSE	Phase III Clinical Trial	2000-01-11	Phase III Clinical Trial	SCN1A
Diabetic Neuropathies	ENSG00000144891	FALSE	unknown	1992-05-15	Unused	AGTR1
Diabetic Neuropathies	ENSG00000146013	FALSE	unknown	2000-06-16	Preclinical	GFRA3
Diabetic Neuropathies	ENSG00000147955	FALSE	Phase II Clinical Trial	1999-01-15	Phase III Clinical Trial	SIGMAR1
Diabetic Neuropathies	ENSG00000148053	FALSE	unknown	1989-06-15	Absent	NTRK2
Diabetic Neuropathies	ENSG00000148408	FALSE	Phase II Clinical Trial	2010-10-04	Absent	CACNA1B
Diabetic Neuropathies	ENSG00000150594	FALSE	Phase II Clinical Trial	2008-06-18	Phase II Clinical Trial	ADRA2A
Diabetic Neuropathies	ENSG00000153253	FALSE	Phase III Clinical Trial	2000-01-11	Phase III Clinical Trial	SCN3A
Diabetic Neuropathies	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Diabetic Neuropathies	ENSG00000154188	FALSE	Preclinical	2008-09-13	Unused	ANGPT1
Diabetic Neuropathies	ENSG00000155011	FALSE	Preclinical	2014-06-13	Absent	DKK2
Diabetic Neuropathies	ENSG00000155511	FALSE	unknown	2000-03-29	Phase III Clinical Trial	GRIA1
Diabetic Neuropathies	ENSG00000160712	FALSE	Phase II Clinical Trial	2015-09-22	Absent	IL6R
Diabetic Neuropathies	ENSG00000160716	FALSE	unknown	1998-03-15	Unused	CHRNB2
Diabetic Neuropathies	ENSG00000160951	FALSE	Approved	1999-05-11	Unused	PTGER1
Diabetic Neuropathies	ENSG00000166148	FALSE	unknown	1992-01-15	Unused	AVPR1A
Diabetic Neuropathies	ENSG00000166501	FALSE	Phase II Clinical Trial	1996-06-15	Unused	PRKCB
Diabetic Neuropathies	ENSG00000166825	FALSE	Phase II Clinical Trial	2008-10-06	Absent	ANPEP
Diabetic Neuropathies	ENSG00000167723	FALSE	Phase II Clinical Trial	2008-10-28	Phase II Clinical Trial	TRPV3
Diabetic Neuropathies	ENSG00000169432	FALSE	Phase III Clinical Trial	2007-08-17	Unused	SCN9A
Diabetic Neuropathies	ENSG00000171189	FALSE	Phase II Clinical Trial	2006-12-13	Unused	GRIK1
Diabetic Neuropathies	ENSG00000176884	FALSE	Phase III Clinical Trial	1997-04-15	Phase III Clinical Trial	GRIN1
Diabetic Neuropathies	ENSG00000178394	FALSE	Preclinical	2000-03-22	Phase II Clinical Trial	HTR1A
Diabetic Neuropathies	ENSG00000179295	FALSE	Preclinical	2002-07-03	Unused	PTPN11
Diabetic Neuropathies	ENSG00000180772	FALSE	unknown	2008-09-09	Phase I Clinical Trial	AGTR2
Diabetic Neuropathies	ENSG00000184156	FALSE	unknown	2007-12-13	Phase II Clinical Trial	KCNQ3
Diabetic Neuropathies	ENSG00000184160	FALSE	Phase II Clinical Trial	2008-06-18	Phase II Clinical Trial	ADRA2C
Diabetic Neuropathies	ENSG00000184588	FALSE	unknown	NA	Unused	PDE4B
Diabetic Neuropathies	ENSG00000188822	FALSE	unknown	2007-03-12	Unused	CNR2
Diabetic Neuropathies	ENSG00000189221	FALSE	unknown	1999-08-17	Unused	MAOA
Diabetic Neuropathies	ENSG00000196549	FALSE	Phase II Clinical Trial	2008-10-06	Absent	MME
Diabetic Neuropathies	ENSG00000196557	FALSE	Phase II Clinical Trial	2011-05-03	Absent	CACNA1H
Diabetic Neuropathies	ENSG00000196689	TRUE	Approved	1995-07-15	Approved	TRPV1
Diabetic Neuropathies	ENSG00000198049	FALSE	unknown	1992-01-15	Unused	AVPR1B
Diabetic Neuropathies	ENSG00000240972	FALSE	unknown	NA	Unused	MIF
Diabetic Neuropathies	ENSG00000273079	FALSE	Phase II Clinical Trial	2005-11-29	Unused	GRIN2B
Diabetic Neuropathies	ENSG00000274286	FALSE	Phase II Clinical Trial	2004-11-02	Phase II Clinical Trial	ADRA2B
Diabetic Retinopathy	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-07-15	Unused	TBXA2R
Diabetic Retinopathy	ENSG00000017427	FALSE	Phase I Clinical Trial	2004-08-17	Phase I Clinical Trial	IGF1
Diabetic Retinopathy	ENSG00000019991	FALSE	Preclinical	2001-07-18	Unused	HGF
Diabetic Retinopathy	ENSG00000026508	FALSE	unknown	1998-12-15	Unused	CD44
Diabetic Retinopathy	ENSG00000037280	FALSE	Preclinical	2005-04-19	Unused	FLT4
Diabetic Retinopathy	ENSG00000059377	FALSE	Phase II Clinical Trial	1991-07-15	Unused	TBXAS1
Diabetic Retinopathy	ENSG00000066468	FALSE	Preclinical	2005-04-19	Unused	FGFR2
Diabetic Retinopathy	ENSG00000067900	FALSE	Phase II Clinical Trial	2006-08-14	Absent	ROCK1
Diabetic Retinopathy	ENSG00000075043	FALSE	unknown	NA	Absent	KCNQ2
Diabetic Retinopathy	ENSG00000077782	FALSE	Preclinical	2005-04-19	Unused	FGFR1
Diabetic Retinopathy	ENSG00000082781	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGB5
Diabetic Retinopathy	ENSG00000085662	FALSE	unknown	1997-04-15	Unused	AKR1B1
Diabetic Retinopathy	ENSG00000086205	FALSE	unknown	1997-03-15	Unused	FOLH1
Diabetic Retinopathy	ENSG00000090339	FALSE	Preclinical	2005-06-29	Unused	ICAM1
Diabetic Retinopathy	ENSG00000100644	FALSE	Preclinical	2006-12-19	Unused	HIF1A
Diabetic Retinopathy	ENSG00000100665	FALSE	Preclinical	2007-11-27	Unused	SERPINA4
Diabetic Retinopathy	ENSG00000100739	FALSE	Phase II Clinical Trial	2009-02-12	Unused	BDKRB1
Diabetic Retinopathy	ENSG00000100823	FALSE	Preclinical	2010-12-27	Unused	APEX1
Diabetic Retinopathy	ENSG00000100985	FALSE	unknown	1995-01-15	Unused	MMP9
Diabetic Retinopathy	ENSG00000101425	FALSE	Preclinical	2001-05-01	Unused	BPI
Diabetic Retinopathy	ENSG00000102755	FALSE	Preclinical	2005-04-19	Unused	FLT1
Diabetic Retinopathy	ENSG00000107562	FALSE	unknown	2007-04-10	Unused	CXCL12
Diabetic Retinopathy	ENSG00000112096	FALSE	Preclinical	2009-02-18	Unused	SOD2
Diabetic Retinopathy	ENSG00000112715	TRUE	Approved	1993-05-15	Phase I Clinical Trial	VEGFA
Diabetic Retinopathy	ENSG00000113580	FALSE	Phase III Clinical Trial	2004-05-07	Unused	NR3C1
Diabetic Retinopathy	ENSG00000113721	FALSE	Preclinical	2004-02-09	Unused	PDGFRB
Diabetic Retinopathy	ENSG00000113889	FALSE	Preclinical	2004-12-13	Unused	KNG1
Diabetic Retinopathy	ENSG00000114378	TRUE	Approved	NA	Approved	HYAL1
Diabetic Retinopathy	ENSG00000115053	FALSE	Preclinical	2008-07-31	Absent	NCL
Diabetic Retinopathy	ENSG00000116745	FALSE	Phase II Clinical Trial	2008-06-17	Absent	RPE65
Diabetic Retinopathy	ENSG00000118432	FALSE	Preclinical	2016-12-30	Absent	CNR1
Diabetic Retinopathy	ENSG00000119630	TRUE	Approved	2003-07-24	Unused	PGF
Diabetic Retinopathy	ENSG00000120156	FALSE	Preclinical	2008-09-13	Unused	TEK
Diabetic Retinopathy	ENSG00000121966	FALSE	Phase I Clinical Trial	2004-06-22	Phase I Clinical Trial	CXCR4
Diabetic Retinopathy	ENSG00000122194	FALSE	Phase II Clinical Trial	2000-10-30	Phase II Clinical Trial	PLG
Diabetic Retinopathy	ENSG00000128052	FALSE	Preclinical	1992-03-15	Unused	KDR
Diabetic Retinopathy	ENSG00000130427	FALSE	Phase I Clinical Trial	2014-11-04	Absent	EPO
Diabetic Retinopathy	ENSG00000131471	FALSE	Phase II Clinical Trial	2008-08-22	Absent	AOC3
Diabetic Retinopathy	ENSG00000132155	FALSE	unknown	2001-04-20	Preclinical	RAF1
Diabetic Retinopathy	ENSG00000132386	FALSE	unknown	1996-11-15	Unused	SERPINF1
Diabetic Retinopathy	ENSG00000132671	FALSE	Preclinical	1998-09-15	Preclinical	SSTR4
Diabetic Retinopathy	ENSG00000132703	FALSE	Preclinical	2012-03-16	Preclinical	APCS
Diabetic Retinopathy	ENSG00000133110	FALSE	Preclinical	2016-11-25	Absent	POSTN
Diabetic Retinopathy	ENSG00000138448	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGAV
Diabetic Retinopathy	ENSG00000138685	FALSE	Phase II Clinical Trial	1993-05-15	Absent	FGF2
Diabetic Retinopathy	ENSG00000140443	FALSE	Preclinical	2014-12-29	Absent	IGF1R
Diabetic Retinopathy	ENSG00000143799	FALSE	Preclinical	2009-02-18	Unused	PARP1
Diabetic Retinopathy	ENSG00000144891	FALSE	Phase III Clinical Trial	1992-10-15	Phase III Clinical Trial	AGTR1
Diabetic Retinopathy	ENSG00000150093	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGB1
Diabetic Retinopathy	ENSG00000154188	FALSE	Phase II Clinical Trial	2008-09-13	Unused	ANGPT1
Diabetic Retinopathy	ENSG00000159640	FALSE	unknown	NA	Unused	ACE
Diabetic Retinopathy	ENSG00000161638	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGA5
Diabetic Retinopathy	ENSG00000162009	FALSE	Preclinical	1998-09-15	Preclinical	SSTR5
Diabetic Retinopathy	ENSG00000164171	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGA2
Diabetic Retinopathy	ENSG00000164344	FALSE	Preclinical	2017-10-17	Absent	KLKB1
Diabetic Retinopathy	ENSG00000165025	FALSE	unknown	2006-12-19	Unused	SYK
Diabetic Retinopathy	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Diabetic Retinopathy	ENSG00000166501	FALSE	Phase III Clinical Trial	1996-06-15	Unused	PRKCB
Diabetic Retinopathy	ENSG00000168209	FALSE	Preclinical	2003-10-14	Unused	DDIT4
Diabetic Retinopathy	ENSG00000169047	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IRS1
Diabetic Retinopathy	ENSG00000170989	FALSE	Preclinical	2011-11-22	Preclinical	S1PR1
Diabetic Retinopathy	ENSG00000171105	FALSE	unknown	NA	Approved	INSR
Diabetic Retinopathy	ENSG00000174807	FALSE	Preclinical	2004-10-18	Preclinical	CD248
Diabetic Retinopathy	ENSG00000175445	FALSE	Phase II Clinical Trial	2000-09-01	Phase II Clinical Trial	LPL
Diabetic Retinopathy	ENSG00000177606	FALSE	Preclinical	2006-07-25	Unused	JUN
Diabetic Retinopathy	ENSG00000179776	FALSE	unknown	2000-12-11	Unused	CDH5
Diabetic Retinopathy	ENSG00000180616	FALSE	Preclinical	1998-09-15	Preclinical	SSTR2
Diabetic Retinopathy	ENSG00000182220	FALSE	Preclinical	2017-09-28	Absent	ATP6AP2
Diabetic Retinopathy	ENSG00000182871	FALSE	unknown	2002-08-29	Preclinical	COL18A1
Diabetic Retinopathy	ENSG00000184156	FALSE	unknown	NA	Absent	KCNQ3
Diabetic Retinopathy	ENSG00000185149	FALSE	Preclinical	2003-09-15	Unused	NPY2R
Diabetic Retinopathy	ENSG00000187210	FALSE	Preclinical	2004-05-05	Unused	GCNT1
Diabetic Retinopathy	ENSG00000188822	FALSE	Preclinical	2016-12-30	Absent	CNR2
Diabetic Retinopathy	ENSG00000196396	FALSE	Phase II Clinical Trial	2009-06-04	Preclinical	PTPN1
Diabetic Retinopathy	ENSG00000196611	FALSE	unknown	1995-01-15	Unused	MMP1
Diabetic Retinopathy	ENSG00000205542	FALSE	unknown	1995-01-15	Unused	TMSB4X
Diabetic Retinopathy	ENSG00000259207	FALSE	Phase II Clinical Trial	2011-12-02	Phase I Clinical Trial	ITGB3
Diarrhea	ENSG00000001626	TRUE	Approved	1992-11-15	Approved	CFTR
Diarrhea	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Diarrhea	ENSG00000012504	FALSE	Phase II Clinical Trial	2004-08-13	Absent	NR1H4
Diarrhea	ENSG00000044012	FALSE	Preclinical	1997-05-15	Unused	GUCA2B
Diarrhea	ENSG00000053918	FALSE	Preclinical	2001-05-10	Unused	KCNQ1
Diarrhea	ENSG00000055118	FALSE	Preclinical	2001-05-10	Unused	KCNH2
Diarrhea	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Diarrhea	ENSG00000102539	FALSE	Preclinical	2004-08-20	Preclinical	MLNR
Diarrhea	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Diarrhea	ENSG00000103546	FALSE	unknown	NA	Unused	SLC6A2
Diarrhea	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Diarrhea	ENSG00000112038	FALSE	Phase I Clinical Trial	1991-08-15	Unused	OPRM1
Diarrhea	ENSG00000115353	FALSE	unknown	2001-07-18	Preclinical	TACR1
Diarrhea	ENSG00000116329	FALSE	Phase I Clinical Trial	1991-08-15	Unused	OPRD1
Diarrhea	ENSG00000125510	FALSE	Preclinical	2009-02-09	Unused	OPRL1
Diarrhea	ENSG00000150594	FALSE	Preclinical	NA	Unused	ADRA2A
Diarrhea	ENSG00000163399	FALSE	Preclinical	NA	Unused	ATP1A1
Diarrhea	ENSG00000164342	FALSE	Preclinical	2017-05-24	Absent	TLR3
Diarrhea	ENSG00000169403	FALSE	unknown	1990-09-15	Unused	PTAFR
Diarrhea	ENSG00000169919	FALSE	Approved	1995-09-15	Unused	GUSB
Diarrhea	ENSG00000185149	FALSE	Preclinical	2009-11-30	Unused	NPY2R
Diarrhea	ENSG00000196549	TRUE	Approved	NA	Approved	MME
Diarrhea	ENSG00000198668	FALSE	Phase III Clinical Trial	NA	Unused	CALM1
Diarrhea	ENSG00000274286	FALSE	Preclinical	NA	Unused	ADRA2B
DiGeorge Syndrome	ENSG00000187514	FALSE	unknown	NA	Absent	PTMA
Diphtheria	ENSG00000101017	FALSE	Preclinical	1998-12-15	Unused	CD40
Disease	ENSG00000165646	FALSE	Phase I Clinical Trial	2007-10-24	Absent	SLC18A2
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000011677	FALSE	Preclinical	2009-07-16	Absent	GABRA3
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000022355	FALSE	Preclinical	2009-07-16	Absent	GABRA1
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000082556	FALSE	unknown	2001-01-22	Unused	OPRK1
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000112038	FALSE	unknown	2001-01-22	Unused	OPRM1
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000151834	FALSE	Preclinical	2009-07-16	Absent	GABRA2
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000166148	FALSE	Phase II Clinical Trial	2006-07-10	Absent	AVPR1A
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000169676	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DRD5
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000179142	FALSE	Preclinical	2009-07-16	Absent	CYP11B2
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000184845	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DRD1
Disruptive, Impulse Control, and Conduct Disorders	ENSG00000186297	FALSE	Preclinical	2009-07-16	Absent	GABRA5
Disseminated Intravascular Coagulation	ENSG00000057593	FALSE	Preclinical	1992-03-15	Unused	F7
Disseminated Intravascular Coagulation	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Disseminated Intravascular Coagulation	ENSG00000117525	FALSE	Preclinical	1992-03-15	Unused	F3
Disseminated Intravascular Coagulation	ENSG00000117601	TRUE	Approved	1993-08-15	Approved	SERPINC1
Disseminated Intravascular Coagulation	ENSG00000126218	TRUE	Approved	1992-03-15	Approved	F10
Disseminated Intravascular Coagulation	ENSG00000178726	FALSE	Approved	NA	Unused	THBD
Disseminated Intravascular Coagulation	ENSG00000180210	TRUE	Approved	2008-05-07	Approved	F2
Disseminated Intravascular Coagulation	ENSG00000197561	FALSE	Preclinical	1995-02-15	Unused	ELANE
Diverticulitis	ENSG00000070019	FALSE	Phase II Clinical Trial	2017-03-17	Absent	GUCY2C
Diverticulitis	ENSG00000073756	FALSE	Phase III Clinical Trial	2003-02-17	Phase III Clinical Trial	PTGS2
Diverticulitis	ENSG00000095303	FALSE	Phase III Clinical Trial	2003-02-17	Phase III Clinical Trial	PTGS1
Donohue Syndrome	ENSG00000140443	FALSE	Phase I Clinical Trial	NA	Absent	IGF1R
Down Syndrome	ENSG00000043591	FALSE	Preclinical	2014-11-20	Absent	ADRB1
Down Syndrome	ENSG00000087085	FALSE	Phase II Clinical Trial	1989-06-15	Phase II Clinical Trial	ACHE
Down Syndrome	ENSG00000109320	FALSE	Preclinical	2009-05-27	Absent	NFKB1
Down Syndrome	ENSG00000142192	FALSE	Phase II Clinical Trial	2000-03-01	Unused	APP
Down Syndrome	ENSG00000157540	FALSE	Preclinical	2008-07-17	Preclinical	DYRK1A
Down Syndrome	ENSG00000168539	FALSE	Preclinical	1997-10-15	Unused	CHRM1
Down Syndrome	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Down Syndrome	ENSG00000175344	FALSE	Preclinical	2013-06-19	Absent	CHRNA7
Down Syndrome	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Down Syndrome	ENSG00000186297	FALSE	Phase I Clinical Trial	2010-02-09	Phase I Clinical Trial	GABRA5
Down Syndrome	ENSG00000186868	FALSE	Preclinical	2017-12-21	Absent	MAPT
Down Syndrome	ENSG00000188906	FALSE	Preclinical	2012-08-22	Preclinical	LRRK2
Drug-Related Side Effects and Adverse Reactions	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Drug-Related Side Effects and Adverse Reactions	ENSG00000082556	TRUE	Approved	2016-09-27	Approved	OPRK1
Drug-Related Side Effects and Adverse Reactions	ENSG00000087085	FALSE	Preclinical	NA	Unused	ACHE
Drug-Related Side Effects and Adverse Reactions	ENSG00000104870	FALSE	Preclinical	2016-04-22	Absent	FCGRT
Drug-Related Side Effects and Adverse Reactions	ENSG00000112038	TRUE	Approved	2014-03-24	Approved	OPRM1
Drug-Related Side Effects and Adverse Reactions	ENSG00000112115	FALSE	Preclinical	2001-07-24	Absent	IL17A
Drug-Related Side Effects and Adverse Reactions	ENSG00000114200	FALSE	Preclinical	2001-09-07	Unused	BCHE
Drug-Related Side Effects and Adverse Reactions	ENSG00000116329	FALSE	Preclinical	1998-02-15	Unused	OPRD1
Drug-Related Side Effects and Adverse Reactions	ENSG00000125571	FALSE	Preclinical	2001-07-24	Absent	IL37
Drug-Related Side Effects and Adverse Reactions	ENSG00000163399	TRUE	Approved	1993-08-15	Approved	ATP1A1
Drug-Related Side Effects and Adverse Reactions	ENSG00000196218	FALSE	Preclinical	NA	Absent	RYR1
Drug-Related Side Effects and Adverse Reactions	ENSG00000282608	FALSE	Preclinical	2001-07-24	Absent	ADORA3
Ductus Arteriosus, Patent	ENSG00000073756	TRUE	Approved	2008-09-16	Approved	PTGS2
Ductus Arteriosus, Patent	ENSG00000095303	TRUE	Approved	2008-09-16	Approved	PTGS1
Duodenal Ulcer	ENSG00000050628	TRUE	Approved	NA	Approved	PTGER3
Duodenal Ulcer	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Duodenal Ulcer	ENSG00000093010	FALSE	Phase II Clinical Trial	NA	Unused	COMT
Duodenal Ulcer	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Duodenal Ulcer	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Duodenal Ulcer	ENSG00000110148	TRUE	Approved	2001-04-19	Approved	CCKBR
Duodenal Ulcer	ENSG00000113749	TRUE	Approved	1990-03-15	Approved	HRH2
Duodenal Ulcer	ENSG00000114859	FALSE	Phase I Clinical Trial	2002-09-25	Phase II Clinical Trial	CLCN2
Duodenal Ulcer	ENSG00000125384	TRUE	Approved	NA	Approved	PTGER2
Duodenal Ulcer	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Duodenal Ulcer	ENSG00000145545	TRUE	Approved	NA	Approved	SRD5A1
Duodenal Ulcer	ENSG00000160951	TRUE	Approved	NA	Approved	PTGER1
Duodenal Ulcer	ENSG00000164270	FALSE	unknown	NA	Unused	HTR4
Duodenal Ulcer	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Duodenal Ulcer	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Duodenal Ulcer	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Duodenal Ulcer	ENSG00000184502	TRUE	Approved	NA	Approved	GAST
Dwarfism	ENSG00000068078	FALSE	Preclinical	1998-10-15	Unused	FGFR3
Dwarfism	ENSG00000110680	FALSE	Preclinical	1993-01-15	Unused	CALCA
Dwarfism	ENSG00000112964	TRUE	Approved	1995-07-15	Approved	GHR
Dwarfism	ENSG00000121853	FALSE	Preclinical	1998-02-15	Unused	GHSR
Dwarfism	ENSG00000136960	FALSE	Preclinical	2014-10-09	Absent	ENPP2
Dwarfism	ENSG00000138685	FALSE	Preclinical	2014-10-09	Absent	FGF2
Dwarfism	ENSG00000140443	TRUE	Approved	NA	Approved	IGF1R
Dwarfism	ENSG00000169083	FALSE	unknown	NA	Absent	AR
Dwarfism	ENSG00000254647	FALSE	Preclinical	1993-01-15	Unused	INS
Dwarfism	ENSG00000259384	FALSE	Preclinical	1993-01-15	Unused	GH1
Dwarfism, Pituitary	ENSG00000106128	TRUE	Approved	1992-06-15	Approved	GHRHR
Dwarfism, Pituitary	ENSG00000110680	FALSE	Preclinical	1993-01-15	Unused	CALCA
Dwarfism, Pituitary	ENSG00000112964	TRUE	Approved	1992-08-15	Approved	GHR
Dwarfism, Pituitary	ENSG00000118702	FALSE	Preclinical	2011-11-18	Phase I Clinical Trial	GHRH
Dwarfism, Pituitary	ENSG00000121853	TRUE	Approved	1998-10-15	Phase III Clinical Trial	GHSR
Dwarfism, Pituitary	ENSG00000140443	FALSE	Phase II Clinical Trial	2007-08-07	Phase II Clinical Trial	IGF1R
Dwarfism, Pituitary	ENSG00000157017	FALSE	Preclinical	NA	Absent	GHRL
Dwarfism, Pituitary	ENSG00000197081	FALSE	Preclinical	1989-12-15	Unused	IGF2R
Dwarfism, Pituitary	ENSG00000254647	FALSE	Preclinical	1993-01-15	Unused	INS
Dwarfism, Pituitary	ENSG00000259384	FALSE	Preclinical	1993-01-15	Unused	GH1
Dysautonomia, Familial	ENSG00000070061	FALSE	Preclinical	2015-02-26	Absent	ELP1
Dyskinesias	ENSG00000004478	FALSE	Preclinical	2004-06-14	Unused	FKBP4
Dyskinesias	ENSG00000065989	FALSE	Preclinical	2009-02-09	Unused	PDE4A
Dyskinesias	ENSG00000069535	FALSE	Phase II Clinical Trial	1990-09-15	Approved	MAOB
Dyskinesias	ENSG00000069696	FALSE	unknown	1995-03-15	Unused	DRD4
Dyskinesias	ENSG00000082701	FALSE	Phase I Clinical Trial	2008-01-15	Phase II Clinical Trial	GSK3B
Dyskinesias	ENSG00000087085	FALSE	Preclinical	2001-09-14	Unused	ACHE
Dyskinesias	ENSG00000089250	FALSE	Preclinical	2006-05-22	Unused	NOS1
Dyskinesias	ENSG00000093010	FALSE	Phase I Clinical Trial	1990-05-15	Unused	COMT
Dyskinesias	ENSG00000102468	FALSE	Phase II Clinical Trial	1999-03-23	Phase II Clinical Trial	HTR2A
Dyskinesias	ENSG00000103546	FALSE	Preclinical	1997-10-15	Unused	SLC6A2
Dyskinesias	ENSG00000105650	FALSE	Preclinical	2009-02-09	Unused	PDE4C
Dyskinesias	ENSG00000108576	FALSE	Preclinical	1989-06-15	Unused	SLC6A4
Dyskinesias	ENSG00000109339	FALSE	Preclinical	2008-04-10	Unused	MAPK10
Dyskinesias	ENSG00000110148	FALSE	Preclinical	1994-11-15	Unused	CCKBR
Dyskinesias	ENSG00000112033	FALSE	Preclinical	2006-09-18	Unused	PPARD
Dyskinesias	ENSG00000112038	FALSE	Preclinical	2009-06-01	Unused	OPRM1
Dyskinesias	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Dyskinesias	ENSG00000112164	FALSE	Preclinical	2006-01-30	Unused	GLP1R
Dyskinesias	ENSG00000112541	FALSE	Preclinical	2009-02-09	Unused	PDE10A
Dyskinesias	ENSG00000113448	FALSE	Preclinical	2009-02-09	Unused	PDE4D
Dyskinesias	ENSG00000113749	FALSE	Preclinical	1994-06-15	Unused	HRH2
Dyskinesias	ENSG00000115138	FALSE	Phase I Clinical Trial	NA	Unused	POMC
Dyskinesias	ENSG00000119973	FALSE	unknown	NA	Unused	PRLHR
Dyskinesias	ENSG00000121691	FALSE	Preclinical	1995-06-15	Unused	CAT
Dyskinesias	ENSG00000123700	FALSE	Preclinical	2007-06-11	Unused	KCNJ2
Dyskinesias	ENSG00000125510	FALSE	Preclinical	2004-01-09	Unused	OPRL1
Dyskinesias	ENSG00000128271	FALSE	Preclinical	2008-07-04	Unused	ADORA2A
Dyskinesias	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Dyskinesias	ENSG00000132170	FALSE	Preclinical	2006-09-18	Unused	PPARG
Dyskinesias	ENSG00000132437	FALSE	Preclinical	NA	Unused	DDC
Dyskinesias	ENSG00000134259	FALSE	Preclinical	2001-12-11	Unused	NGF
Dyskinesias	ENSG00000135312	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	HTR1B
Dyskinesias	ENSG00000142319	FALSE	Phase II Clinical Trial	1990-09-15	Phase II Clinical Trial	SLC6A3
Dyskinesias	ENSG00000144285	FALSE	Preclinical	1997-06-15	Unused	SCN1A
Dyskinesias	ENSG00000146648	FALSE	Preclinical	1992-05-15	Unused	EGFR
Dyskinesias	ENSG00000147246	FALSE	unknown	NA	Unused	HTR2C
Dyskinesias	ENSG00000147955	FALSE	Phase II Clinical Trial	1999-01-15	Unused	SIGMAR1
Dyskinesias	ENSG00000148408	FALSE	Preclinical	1992-01-15	Unused	CACNA1B
Dyskinesias	ENSG00000149294	FALSE	Preclinical	1994-06-15	Unused	NCAM1
Dyskinesias	ENSG00000149295	TRUE	Approved	1990-06-15	Approved	DRD2
Dyskinesias	ENSG00000150594	FALSE	Phase III Clinical Trial	2001-07-25	Unused	ADRA2A
Dyskinesias	ENSG00000151577	FALSE	Phase II Clinical Trial	1993-11-15	Unused	DRD3
Dyskinesias	ENSG00000153234	FALSE	Preclinical	2004-01-15	Unused	NR4A2
Dyskinesias	ENSG00000153253	FALSE	Preclinical	1997-06-15	Unused	SCN3A
Dyskinesias	ENSG00000155511	FALSE	Phase II Clinical Trial	1996-08-15	Unused	GRIA1
Dyskinesias	ENSG00000158458	FALSE	Preclinical	2000-07-19	Unused	NRG2
Dyskinesias	ENSG00000159164	FALSE	Phase II Clinical Trial	NA	Unused	SV2A
Dyskinesias	ENSG00000163394	FALSE	unknown	NA	Unused	CCKAR
Dyskinesias	ENSG00000163485	FALSE	Preclinical	2008-07-04	Unused	ADORA1
Dyskinesias	ENSG00000164270	FALSE	unknown	1995-03-15	Unused	HTR4
Dyskinesias	ENSG00000164305	FALSE	Preclinical	2001-09-07	Unused	CASP3
Dyskinesias	ENSG00000165646	FALSE	unknown	2009-05-05	Unused	SLC18A2
Dyskinesias	ENSG00000168959	FALSE	Phase II Clinical Trial	2004-11-10	Phase II Clinical Trial	GRM5
Dyskinesias	ENSG00000169676	FALSE	Preclinical	1990-07-15	Unused	DRD5
Dyskinesias	ENSG00000169836	FALSE	Preclinical	1998-09-15	Unused	TACR3
Dyskinesias	ENSG00000175344	FALSE	Phase II Clinical Trial	1996-06-15	Phase II Clinical Trial	CHRNA7
Dyskinesias	ENSG00000176884	TRUE	Approved	1990-07-15	Phase III Clinical Trial	GRIN1
Dyskinesias	ENSG00000178394	FALSE	Phase II Clinical Trial	1991-10-15	Phase I Clinical Trial	HTR1A
Dyskinesias	ENSG00000179546	FALSE	Preclinical	1995-06-15	Unused	HTR1D
Dyskinesias	ENSG00000180176	FALSE	Preclinical	NA	Unused	TH
Dyskinesias	ENSG00000181072	FALSE	Preclinical	1992-12-15	Unused	CHRM2
Dyskinesias	ENSG00000184160	FALSE	Phase III Clinical Trial	2001-07-25	Unused	ADRA2C
Dyskinesias	ENSG00000184588	FALSE	Preclinical	2009-02-09	Unused	PDE4B
Dyskinesias	ENSG00000184845	FALSE	Phase I Clinical Trial	1990-06-15	Unused	DRD1
Dyskinesias	ENSG00000186951	FALSE	Preclinical	2006-09-18	Unused	PPARA
Dyskinesias	ENSG00000273079	FALSE	Preclinical	1996-09-15	Unused	GRIN2B
Dyskinesias	ENSG00000274286	FALSE	Phase III Clinical Trial	2001-07-25	Unused	ADRA2B
Dysmenorrhea	ENSG00000069764	FALSE	Preclinical	2005-09-16	Unused	PLA2G10
Dysmenorrhea	ENSG00000073756	TRUE	Approved	1996-10-15	Approved	PTGS2
Dysmenorrhea	ENSG00000075043	TRUE	Approved	NA	Approved	KCNQ2
Dysmenorrhea	ENSG00000082175	TRUE	Approved	1989-07-15	Approved	PGR
Dysmenorrhea	ENSG00000091831	TRUE	Approved	1995-06-15	Approved	ESR1
Dysmenorrhea	ENSG00000095303	TRUE	Approved	2001-12-06	Approved	PTGS1
Dysmenorrhea	ENSG00000108786	FALSE	Phase III Clinical Trial	2014-11-20	Absent	HSD17B1
Dysmenorrhea	ENSG00000122420	FALSE	Phase I Clinical Trial	2006-11-10	Phase I Clinical Trial	PTGFR
Dysmenorrhea	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Dysmenorrhea	ENSG00000135914	TRUE	Approved	NA	Approved	HTR2B
Dysmenorrhea	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Dysmenorrhea	ENSG00000166148	FALSE	Phase II Clinical Trial	1993-01-15	Phase II Clinical Trial	AVPR1A
Dysmenorrhea	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Dysmenorrhea	ENSG00000169252	FALSE	unknown	1998-08-15	Unused	ADRB2
Dysmenorrhea	ENSG00000169432	FALSE	Phase II Clinical Trial	2011-04-11	Phase II Clinical Trial	SCN9A
Dysmenorrhea	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Dysmenorrhea	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Dysmenorrhea	ENSG00000184156	TRUE	Approved	NA	Approved	KCNQ3
Dysmenorrhea	ENSG00000184381	FALSE	unknown	2005-08-02	Unused	PLA2G6
Dyspareunia	ENSG00000091831	TRUE	Approved	1995-06-15	Absent	ESR1
Dyspareunia	ENSG00000169083	TRUE	Approved	2008-07-22	Absent	AR
Dyspareunia	ENSG00000169432	FALSE	Phase I Clinical Trial	2005-10-04	Unused	SCN9A
Dyspepsia	ENSG00000070019	FALSE	unknown	2011-02-01	Phase II Clinical Trial	GUCY2C
Dyspepsia	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Dyspepsia	ENSG00000082556	FALSE	unknown	1990-02-15	Unused	OPRK1
Dyspepsia	ENSG00000087085	FALSE	Approved	2000-03-01	Unused	ACHE
Dyspepsia	ENSG00000102539	FALSE	Phase II Clinical Trial	1995-08-15	Unused	MLNR
Dyspepsia	ENSG00000105675	FALSE	Phase III Clinical Trial	1989-09-15	Phase II Clinical Trial	ATP4A
Dyspepsia	ENSG00000108576	FALSE	unknown	NA	Unused	SLC6A4
Dyspepsia	ENSG00000110148	FALSE	unknown	1997-06-15	Absent	CCKBR
Dyspepsia	ENSG00000112164	FALSE	unknown	2001-11-12	Unused	GLP1R
Dyspepsia	ENSG00000115353	FALSE	unknown	2001-03-07	Unused	TACR1
Dyspepsia	ENSG00000121853	FALSE	unknown	2004-03-08	Phase II Clinical Trial	GHSR
Dyspepsia	ENSG00000129167	FALSE	unknown	2006-02-15	Absent	TPH1
Dyspepsia	ENSG00000133019	FALSE	Preclinical	2010-11-20	Unused	CHRM3
Dyspepsia	ENSG00000149295	TRUE	Approved	1992-09-15	Approved	DRD2
Dyspepsia	ENSG00000151577	FALSE	Preclinical	2003-04-28	Unused	DRD3
Dyspepsia	ENSG00000163394	FALSE	Phase III Clinical Trial	1995-01-15	Unused	CCKAR
Dyspepsia	ENSG00000164270	TRUE	Approved	1992-09-15	Approved	HTR4
Dyspepsia	ENSG00000166736	FALSE	Approved	1993-10-15	Unused	HTR3A
Dyspepsia	ENSG00000168539	FALSE	Approved	2000-03-01	Unused	CHRM1
Dyspepsia	ENSG00000175535	TRUE	Approved	NA	Approved	PNLIP
Dyspepsia	ENSG00000178394	FALSE	Phase I Clinical Trial	2001-06-14	Unused	HTR1A
Dyspepsia	ENSG00000180720	FALSE	Preclinical	2010-11-20	Unused	CHRM4
Dyspepsia	ENSG00000181072	FALSE	Approved	2000-03-01	Unused	CHRM2
Dyspepsia	ENSG00000184502	TRUE	Approved	NA	Approved	GAST
Dystonia	ENSG00000136827	FALSE	Preclinical	2006-11-28	Unused	TOR1A
Dystonia	ENSG00000165646	FALSE	unknown	NA	Approved	SLC18A2
Dystonia	ENSG00000168959	FALSE	Phase I Clinical Trial	2005-10-04	Preclinical	GRM5
Dysuria	ENSG00000120907	TRUE	Approved	1996-05-15	Approved	ADRA1A
Dysuria	ENSG00000145545	FALSE	Preclinical	2000-03-01	Unused	SRD5A1
Dysuria	ENSG00000178394	TRUE	Approved	NA	Approved	HTR1A
Ear Diseases	ENSG00000101425	FALSE	Preclinical	1995-10-15	Unused	BPI
Ear Diseases	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Ear Diseases	ENSG00000140538	FALSE	Preclinical	1996-06-15	Unused	NTRK3
Ear Diseases	ENSG00000148053	FALSE	Preclinical	1996-06-15	Absent	NTRK2
Ear Diseases	ENSG00000149968	FALSE	Preclinical	2017-03-10	Absent	MMP3
Ear Diseases	ENSG00000197122	FALSE	Preclinical	2005-10-18	Unused	SRC
Ectodermal Dysplasia	ENSG00000112964	TRUE	Approved	NA	Approved	GHR
Ectodermal Dysplasia	ENSG00000158813	FALSE	Phase II Clinical Trial	2005-08-22	Phase I Clinical Trial	EDA
Eczema	ENSG00000005844	FALSE	Preclinical	2008-09-09	Unused	ITGAL
Eczema	ENSG00000012779	FALSE	Preclinical	1993-08-15	Unused	ALOX5
Eczema	ENSG00000026103	FALSE	Preclinical	2008-04-07	Unused	FAS
Eczema	ENSG00000027697	FALSE	unknown	NA	Absent	IFNGR1
Eczema	ENSG00000059377	TRUE	Approved	2011-12-15	Approved	TBXAS1
Eczema	ENSG00000067182	FALSE	Preclinical	2008-04-07	Unused	TNFRSF1A
Eczema	ENSG00000073756	TRUE	Approved	2000-03-29	Approved	PTGS2
Eczema	ENSG00000082556	FALSE	Preclinical	1992-06-15	Unused	OPRK1
Eczema	ENSG00000091181	FALSE	Preclinical	2003-06-26	Unused	IL5RA
Eczema	ENSG00000092009	FALSE	Preclinical	2007-05-02	Unused	CMA1
Eczema	ENSG00000095303	TRUE	Approved	2000-03-29	Approved	PTGS1
Eczema	ENSG00000104921	FALSE	Preclinical	1993-06-15	Unused	FCER2
Eczema	ENSG00000106348	FALSE	unknown	1989-12-15	Unused	IMPDH1
Eczema	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Eczema	ENSG00000112038	FALSE	Preclinical	1992-06-15	Unused	OPRM1
Eczema	ENSG00000112062	FALSE	Phase I Clinical Trial	2001-05-31	Unused	MAPK14
Eczema	ENSG00000113070	FALSE	Preclinical	2006-02-21	Unused	HBEGF
Eczema	ENSG00000113580	TRUE	Approved	1993-01-15	Approved	NR3C1
Eczema	ENSG00000115009	FALSE	unknown	2009-03-25	Absent	CCL20
Eczema	ENSG00000115232	FALSE	Preclinical	1992-01-15	Unused	ITGA4
Eczema	ENSG00000115415	FALSE	unknown	2004-03-10	Unused	STAT1
Eczema	ENSG00000117560	FALSE	Preclinical	2008-04-07	Unused	FASLG
Eczema	ENSG00000120659	FALSE	Preclinical	2008-04-07	Unused	TNFSF11
Eczema	ENSG00000125384	FALSE	Preclinical	1992-01-15	Unused	PTGER2
Eczema	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Eczema	ENSG00000131471	FALSE	Preclinical	2010-04-01	Absent	AOC3
Eczema	ENSG00000140287	FALSE	unknown	2001-10-15	Unused	HDC
Eczema	ENSG00000150093	FALSE	Preclinical	2001-09-11	Unused	ITGB1
Eczema	ENSG00000154229	FALSE	Preclinical	1992-03-15	Unused	PRKCA
Eczema	ENSG00000161905	FALSE	Preclinical	2006-07-31	Unused	ALOX15
Eczema	ENSG00000163106	FALSE	Preclinical	2008-04-14	Unused	HPGDS
Eczema	ENSG00000169083	FALSE	Preclinical	2009-11-10	Unused	AR
Eczema	ENSG00000169403	TRUE	Approved	1993-08-15	Approved	PTAFR
Eczema	ENSG00000180210	FALSE	unknown	1992-06-15	Unused	F2
Eczema	ENSG00000183625	FALSE	unknown	2004-09-17	Unused	CCR3
Eczema	ENSG00000183813	FALSE	Preclinical	2007-08-22	Unused	CCR4
Eczema	ENSG00000185386	FALSE	Preclinical	2001-09-25	Unused	MAPK11
Eczema	ENSG00000196639	TRUE	Approved	1993-08-15	Unused	HRH1
Eczema	ENSG00000196689	TRUE	Approved	NA	Approved	TRPV1
Eczema	ENSG00000213903	FALSE	Preclinical	1993-11-15	Unused	LTB4R
Edema	ENSG00000064651	TRUE	Approved	NA	Approved	SLC12A2
Edema	ENSG00000070915	TRUE	Approved	NA	Approved	SLC12A3
Edema	ENSG00000074803	TRUE	Approved	NA	Approved	SLC12A1
Edema	ENSG00000111319	TRUE	Approved	2017-08-17	Approved	SCNN1A
Edema	ENSG00000114378	FALSE	Phase I Clinical Trial	1999-04-28	Unused	HYAL1
Edema	ENSG00000126895	TRUE	Approved	1992-04-15	Approved	AVPR2
Edema	ENSG00000151623	TRUE	Approved	2017-08-17	Absent	NR3C2
Edema	ENSG00000154133	FALSE	Preclinical	2010-12-13	Unused	ROBO4
Edema	ENSG00000158859	FALSE	Phase II Clinical Trial	2015-09-03	Absent	ADAMTS4
Edema	ENSG00000163485	FALSE	Preclinical	1994-11-15	Unused	ADORA1
Edema	ENSG00000179776	FALSE	Preclinical	2013-11-07	Absent	CDH5
Edema, Cardiac	ENSG00000064651	FALSE	Phase II Clinical Trial	2002-11-22	Unused	SLC12A2
Edema, Cardiac	ENSG00000066230	FALSE	Preclinical	2011-05-02	Preclinical	SLC9A3
Edema, Cardiac	ENSG00000074803	FALSE	Phase II Clinical Trial	2002-11-22	Unused	SLC12A1
Edema, Cardiac	ENSG00000111319	TRUE	Approved	2017-08-17	Approved	SCNN1A
Edema, Cardiac	ENSG00000126895	TRUE	Approved	1992-04-15	Approved	AVPR2
Edema, Cardiac	ENSG00000151623	TRUE	Approved	2017-08-17	Approved	NR3C2
Edema, Cardiac	ENSG00000163485	FALSE	Phase II Clinical Trial	1997-12-15	Unused	ADORA1
Ehlers-Danlos Syndrome	ENSG00000043591	FALSE	Phase III Clinical Trial	NA	Absent	ADRB1
Ehlers-Danlos Syndrome	ENSG00000169252	FALSE	Phase III Clinical Trial	NA	Absent	ADRB2
Emotions	ENSG00000116329	FALSE	Phase I Clinical Trial	2008-01-16	Phase I Clinical Trial	OPRD1
Emotions	ENSG00000147955	TRUE	Approved	1999-01-15	Approved	SIGMAR1
Emotions	ENSG00000176884	TRUE	Approved	1999-01-15	Approved	GRIN1
Emphysema	ENSG00000100448	FALSE	Preclinical	1991-02-15	Unused	CTSG
Emphysema	ENSG00000115604	FALSE	Preclinical	2009-07-14	Unused	IL18R1
Emphysema	ENSG00000116044	FALSE	Preclinical	2009-02-23	Absent	NFE2L2
Emphysema	ENSG00000119535	FALSE	Preclinical	NA	Unused	CSF3R
Emphysema	ENSG00000124102	FALSE	Preclinical	NA	Unused	PI3
Emphysema	ENSG00000128271	TRUE	Approved	NA	Approved	ADORA2A
Emphysema	ENSG00000133019	TRUE	Approved	2000-03-08	Approved	CHRM3
Emphysema	ENSG00000139610	FALSE	unknown	NA	Unused	CELA1
Emphysema	ENSG00000163485	TRUE	Approved	1992-08-15	Approved	ADORA1
Emphysema	ENSG00000166311	FALSE	Preclinical	2009-10-20	Unused	SMPD1
Emphysema	ENSG00000168209	FALSE	Preclinical	2003-10-14	Absent	DDIT4
Emphysema	ENSG00000169252	TRUE	Approved	1990-06-15	Approved	ADRB2
Emphysema	ENSG00000172819	FALSE	Preclinical	2001-01-23	Phase II Clinical Trial	RARG
Emphysema	ENSG00000197249	FALSE	Preclinical	NA	Unused	SERPINA1
Emphysema	ENSG00000197561	FALSE	Preclinical	1989-12-15	Unused	ELANE
Emphysema	ENSG00000205542	FALSE	unknown	2010-01-14	Unused	TMSB4X
Encephalitis	ENSG00000069535	FALSE	Preclinical	2015-07-30	Absent	MAOB
Encephalitis	ENSG00000111537	FALSE	Preclinical	2003-10-06	Unused	IFNG
Encephalitis	ENSG00000131203	FALSE	Preclinical	2010-05-31	Unused	IDO1
Encephalitis	ENSG00000131471	FALSE	Preclinical	2015-07-30	Absent	AOC3
Encephalitis	ENSG00000134243	FALSE	Preclinical	2017-11-30	Absent	SORT1
Encephalitis	ENSG00000159110	TRUE	Approved	NA	Unused	IFNAR2
Encephalitis	ENSG00000197919	FALSE	Preclinical	2003-10-06	Unused	IFNA1
Encephalitis, Japanese	ENSG00000164342	FALSE	unknown	NA	Absent	TLR3
Encephalomyelitis, Venezuelan Equine	ENSG00000082898	FALSE	Preclinical	2013-09-05	Absent	XPO1
Endocarditis	ENSG00000213918	FALSE	Preclinical	2014-11-21	Absent	DNASE1
Endocrine System Diseases	ENSG00000004948	TRUE	Approved	1990-07-15	Absent	CALCR
Endocrine System Diseases	ENSG00000006638	FALSE	Preclinical	1993-06-15	Absent	TBXA2R
Endocrine System Diseases	ENSG00000012779	FALSE	Preclinical	NA	Absent	ALOX5
Endocrine System Diseases	ENSG00000059377	FALSE	Preclinical	NA	Absent	TBXAS1
Endocrine System Diseases	ENSG00000064989	FALSE	Preclinical	1991-02-15	Absent	CALCRL
Endocrine System Diseases	ENSG00000080293	TRUE	Approved	NA	Absent	SCTR
Endocrine System Diseases	ENSG00000106113	FALSE	Phase II Clinical Trial	1991-08-15	Absent	CRHR2
Endocrine System Diseases	ENSG00000106128	FALSE	Phase I Clinical Trial	1989-08-15	Absent	GHRHR
Endocrine System Diseases	ENSG00000109163	FALSE	Phase I Clinical Trial	1989-05-15	Absent	GNRHR
Endocrine System Diseases	ENSG00000110148	FALSE	Preclinical	NA	Absent	CCKBR
Endocrine System Diseases	ENSG00000111424	FALSE	Preclinical	1996-08-15	Absent	VDR
Endocrine System Diseases	ENSG00000112964	TRUE	Approved	NA	Absent	GHR
Endocrine System Diseases	ENSG00000113580	FALSE	Preclinical	1989-05-15	Absent	NR3C1
Endocrine System Diseases	ENSG00000114812	FALSE	Preclinical	NA	Absent	VIPR1
Endocrine System Diseases	ENSG00000115353	FALSE	unknown	2014-11-06	Absent	TACR1
Endocrine System Diseases	ENSG00000115705	TRUE	Approved	NA	Absent	TPO
Endocrine System Diseases	ENSG00000116014	FALSE	Preclinical	2015-08-05	Absent	KISS1R
Endocrine System Diseases	ENSG00000120088	FALSE	Phase II Clinical Trial	1991-08-15	Absent	CRHR1
Endocrine System Diseases	ENSG00000121853	FALSE	Preclinical	1996-08-15	Absent	GHSR
Endocrine System Diseases	ENSG00000122420	FALSE	Preclinical	1992-05-15	Absent	PTGFR
Endocrine System Diseases	ENSG00000125384	TRUE	Approved	1990-06-15	Absent	PTGER2
Endocrine System Diseases	ENSG00000126010	FALSE	Preclinical	1992-05-15	Absent	GRPR
Endocrine System Diseases	ENSG00000126895	FALSE	Preclinical	1992-06-15	Absent	AVPR2
Endocrine System Diseases	ENSG00000132329	FALSE	Preclinical	1991-02-15	Absent	RAMP1
Endocrine System Diseases	ENSG00000138039	FALSE	Preclinical	2015-08-05	Absent	LHCGR
Endocrine System Diseases	ENSG00000151090	FALSE	unknown	NA	Absent	THRB
Endocrine System Diseases	ENSG00000160013	FALSE	Preclinical	1990-05-15	Absent	PTGIR
Endocrine System Diseases	ENSG00000160801	FALSE	Preclinical	1990-04-15	Absent	PTH1R
Endocrine System Diseases	ENSG00000160951	FALSE	Preclinical	1990-02-15	Absent	PTGER1
Endocrine System Diseases	ENSG00000163106	FALSE	Preclinical	NA	Absent	HPGDS
Endocrine System Diseases	ENSG00000163399	FALSE	unknown	NA	Absent	ATP1A1
Endocrine System Diseases	ENSG00000166148	TRUE	Approved	1991-08-15	Absent	AVPR1A
Endocrine System Diseases	ENSG00000166573	FALSE	Phase II Clinical Trial	NA	Absent	GALR1
Endocrine System Diseases	ENSG00000168229	FALSE	Preclinical	1991-05-15	Absent	PTGDR
Endocrine System Diseases	ENSG00000169083	FALSE	Phase II Clinical Trial	1996-04-15	Absent	AR
Endocrine System Diseases	ENSG00000169836	FALSE	Preclinical	2013-06-21	Absent	TACR3
Endocrine System Diseases	ENSG00000171509	FALSE	Preclinical	NA	Absent	RXFP1
Endocrine System Diseases	ENSG00000174417	TRUE	Approved	1990-03-15	Absent	TRHR
Endocrine System Diseases	ENSG00000179142	FALSE	Preclinical	1990-10-15	Absent	CYP11B2
Endocrine System Diseases	ENSG00000180914	FALSE	Preclinical	1989-11-15	Absent	OXTR
Endocrine System Diseases	ENSG00000182687	FALSE	Phase II Clinical Trial	NA	Absent	GALR2
Endocrine System Diseases	ENSG00000183873	FALSE	unknown	NA	Absent	SCN5A
Endocrine System Diseases	ENSG00000184502	FALSE	Preclinical	NA	Absent	GAST
Endocrine System Diseases	ENSG00000185231	FALSE	Phase I Clinical Trial	2014-06-24	Absent	MC2R
Endocrine System Diseases	ENSG00000197406	FALSE	Preclinical	NA	Absent	DIO3
Endocrine System Diseases	ENSG00000198049	TRUE	Approved	1991-08-15	Absent	AVPR1B
Endocrine System Diseases	ENSG00000211452	FALSE	Preclinical	NA	Absent	DIO1
Endocrine System Diseases	ENSG00000258839	FALSE	Preclinical	NA	Absent	MC1R
Endometrial Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Endometrial Neoplasms	ENSG00000026103	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Endometrial Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FLT4
Endometrial Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Endometrial Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2009-06-29	Phase II Clinical Trial	PIK3CB
Endometrial Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Endometrial Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Endometrial Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Endometrial Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Endometrial Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Endometrial Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Endometrial Neoplasms	ENSG00000082175	TRUE	Approved	NA	Approved	PGR
Endometrial Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB5
Endometrial Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Endometrial Neoplasms	ENSG00000083312	FALSE	unknown	2005-06-27	Unused	TNPO1
Endometrial Neoplasms	ENSG00000091831	FALSE	Phase II Clinical Trial	1990-03-15	Phase II Clinical Trial	ESR1
Endometrial Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT2
Endometrial Neoplasms	ENSG00000097007	FALSE	unknown	2002-11-12	Unused	ABL1
Endometrial Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Endometrial Neoplasms	ENSG00000101846	FALSE	Phase II Clinical Trial	2000-03-15	Unused	STS
Endometrial Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FLT1
Endometrial Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Endometrial Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2014-07-14	Absent	CEACAM5
Endometrial Neoplasms	ENSG00000105851	FALSE	Phase II Clinical Trial	2003-09-05	Unused	PIK3CG
Endometrial Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	MET
Endometrial Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase I Clinical Trial	ENG
Endometrial Neoplasms	ENSG00000108424	FALSE	unknown	2005-06-27	Unused	KPNB1
Endometrial Neoplasms	ENSG00000108443	FALSE	unknown	2005-06-27	Unused	RPS6KB1
Endometrial Neoplasms	ENSG00000108786	FALSE	Preclinical	2004-01-20	Unused	HSD17B1
Endometrial Neoplasms	ENSG00000109163	FALSE	Phase I Clinical Trial	1998-06-15	Phase II Clinical Trial	GNRHR
Endometrial Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Unused	NFKB1
Endometrial Neoplasms	ENSG00000110195	FALSE	Phase III Clinical Trial	2003-02-24	Phase II Clinical Trial	FOLR1
Endometrial Neoplasms	ENSG00000112715	FALSE	unknown	2007-04-19	Phase I Clinical Trial	VEGFA
Endometrial Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Endometrial Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Endometrial Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB6
Endometrial Neoplasms	ENSG00000116478	FALSE	Phase I Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC1
Endometrial Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Endometrial Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG1
Endometrial Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	TEK
Endometrial Neoplasms	ENSG00000120217	FALSE	Preclinical	2017-04-14	Absent	CD274
Endometrial Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Endometrial Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Endometrial Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	FLT3
Endometrial Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2007-01-30	Phase II Clinical Trial	MAP2K2
Endometrial Neoplasms	ENSG00000128052	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	KDR
Endometrial Neoplasms	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Phase I Clinical Trial	PARP2
Endometrial Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Endometrial Neoplasms	ENSG00000131747	TRUE	Approved	1994-07-15	Phase II Clinical Trial	TOP2A
Endometrial Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Preclinical	CASP9
Endometrial Neoplasms	ENSG00000134258	FALSE	Preclinical	2016-12-17	Absent	VTCN1
Endometrial Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-04-03	Phase I Clinical Trial	PDGFRA
Endometrial Neoplasms	ENSG00000135409	FALSE	Phase I Clinical Trial	2014-09-15	Absent	AMHR2
Endometrial Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	2000-05-11	Unused	TXN
Endometrial Neoplasms	ENSG00000137869	FALSE	Phase II Clinical Trial	1995-10-15	Unused	CYP19A1
Endometrial Neoplasms	ENSG00000138039	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	LHCGR
Endometrial Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Endometrial Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGAV
Endometrial Neoplasms	ENSG00000139567	FALSE	Phase II Clinical Trial	2007-05-30	Phase II Clinical Trial	ACVRL1
Endometrial Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Endometrial Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	2006-12-08	Absent	TP53
Endometrial Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	2002-05-30	Phase II Clinical Trial	ERBB2
Endometrial Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Endometrial Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Endometrial Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Endometrial Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Endometrial Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Phase I Clinical Trial	PARP1
Endometrial Neoplasms	ENSG00000146648	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	EGFR
Endometrial Neoplasms	ENSG00000147437	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	GNRH1
Endometrial Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Endometrial Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT1
Endometrial Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	KIT
Endometrial Neoplasms	ENSG00000157764	FALSE	Phase I Clinical Trial	2001-04-03	Unused	BRAF
Endometrial Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2016-04-26	Absent	SLC34A2
Endometrial Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Endometrial Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Endometrial Neoplasms	ENSG00000161011	FALSE	Preclinical	2015-11-04	Absent	SQSTM1
Endometrial Neoplasms	ENSG00000163217	FALSE	Phase II Clinical Trial	2007-05-30	Absent	BMP10
Endometrial Neoplasms	ENSG00000163823	FALSE	Phase I Clinical Trial	2007-06-13	Unused	CCR1
Endometrial Neoplasms	ENSG00000164078	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	MST1R
Endometrial Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2008-07-04	Absent	CSF2
Endometrial Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	2002-03-21	Phase I Clinical Trial	RET
Endometrial Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Endometrial Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Endometrial Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Endometrial Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Unused	AXL
Endometrial Neoplasms	ENSG00000168610	FALSE	Phase I Clinical Trial	2010-05-18	Phase I Clinical Trial	STAT3
Endometrial Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2007-01-30	Phase II Clinical Trial	MAP2K1
Endometrial Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Endometrial Neoplasms	ENSG00000171608	FALSE	Phase II Clinical Trial	2003-09-05	Unused	PIK3CD
Endometrial Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Phase III Clinical Trial	TYMS
Endometrial Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Absent	ERBB4
Endometrial Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2010-08-09	Absent	CSF1R
Endometrial Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Endometrial Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Phase I Clinical Trial	CSF1
Endometrial Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Endometrial Neoplasms	ENSG00000196591	FALSE	Phase I Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC2
Endometrial Neoplasms	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Endometrial Neoplasms	ENSG00000197122	FALSE	unknown	2002-11-12	Unused	SRC
Endometrial Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	MTOR
Endometrial Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1999-07-06	Unused	TOP1
Endometrial Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Endometrial Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Endometrial Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB3
Endometrial Neoplasms	ENSG00000263761	FALSE	Phase II Clinical Trial	2007-05-30	Absent	GDF2
Endometriosis	ENSG00000050748	FALSE	Preclinical	2001-01-23	Phase II Clinical Trial	MAPK9
Endometriosis	ENSG00000082175	TRUE	Approved	1989-07-15	Approved	PGR
Endometriosis	ENSG00000091831	TRUE	Approved	1990-03-15	Unused	ESR1
Endometriosis	ENSG00000101846	FALSE	Phase II Clinical Trial	2007-07-16	Phase II Clinical Trial	STS
Endometriosis	ENSG00000107643	FALSE	Preclinical	2001-01-23	Phase II Clinical Trial	MAPK8
Endometriosis	ENSG00000108786	FALSE	Preclinical	2000-02-09	Unused	HSD17B1
Endometriosis	ENSG00000109163	TRUE	Approved	1990-10-15	Approved	GNRHR
Endometriosis	ENSG00000109339	FALSE	Preclinical	2001-01-23	Phase II Clinical Trial	MAPK10
Endometriosis	ENSG00000109991	FALSE	Phase I Clinical Trial	2016-07-05	Absent	P2RX3
Endometriosis	ENSG00000113494	FALSE	Phase I Clinical Trial	2014-08-25	Absent	PRLR
Endometriosis	ENSG00000116678	FALSE	Preclinical	2008-04-21	Unused	LEPR
Endometriosis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Endometriosis	ENSG00000136634	FALSE	Preclinical	2014-09-16	Absent	IL10
Endometriosis	ENSG00000137869	FALSE	Phase II Clinical Trial	1993-06-15	Phase II Clinical Trial	CYP19A1
Endometriosis	ENSG00000138039	FALSE	Preclinical	2009-02-19	Absent	LHCGR
Endometriosis	ENSG00000140009	FALSE	Phase II Clinical Trial	2003-08-20	Unused	ESR2
Endometriosis	ENSG00000147437	FALSE	Phase III Clinical Trial	2008-02-04	Absent	GNRH1
Endometriosis	ENSG00000148344	FALSE	Phase II Clinical Trial	2015-05-22	Absent	PTGES
Endometriosis	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Endometriosis	ENSG00000163823	FALSE	Phase II Clinical Trial	2000-04-05	Unused	CCR1
Endometriosis	ENSG00000169083	FALSE	Phase III Clinical Trial	1997-08-15	Phase III Clinical Trial	AR
Endometriosis	ENSG00000169252	FALSE	unknown	1998-08-15	Unused	ADRB2
Endometriosis	ENSG00000169432	FALSE	Preclinical	2011-04-11	Phase II Clinical Trial	SCN9A
Endometriosis	ENSG00000169836	FALSE	Phase I Clinical Trial	2007-09-12	Preclinical	TACR3
Endometriosis	ENSG00000170820	FALSE	Preclinical	2009-02-19	Absent	FSHR
Endometriosis	ENSG00000180914	FALSE	Phase II Clinical Trial	2010-02-26	Absent	OXTR
Endometriosis	ENSG00000196139	FALSE	Phase II Clinical Trial	2014-08-23	Absent	AKR1C3
Endometriosis	ENSG00000198001	FALSE	Phase I Clinical Trial	2017-05-09	Absent	IRAK4
Endomyocardial Fibrosis	ENSG00000100097	FALSE	Preclinical	NA	Preclinical	LGALS1
Endomyocardial Fibrosis	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Endomyocardial Fibrosis	ENSG00000105329	FALSE	Preclinical	2012-09-18	Preclinical	TGFB1
Endomyocardial Fibrosis	ENSG00000113083	FALSE	Preclinical	1996-02-15	Unused	LOX
Endomyocardial Fibrosis	ENSG00000115318	FALSE	Preclinical	2015-07-30	Absent	LOXL3
Endomyocardial Fibrosis	ENSG00000120915	FALSE	Preclinical	2014-07-04	Absent	EPHX2
Endomyocardial Fibrosis	ENSG00000131981	FALSE	Preclinical	NA	Preclinical	LGALS3
Endomyocardial Fibrosis	ENSG00000134013	FALSE	Preclinical	2015-07-30	Absent	LOXL2
Endomyocardial Fibrosis	ENSG00000138131	FALSE	Preclinical	2015-07-30	Absent	LOXL4
Endomyocardial Fibrosis	ENSG00000179142	FALSE	Preclinical	2010-05-17	Preclinical	CYP11B2
Enterocolitis, Necrotizing	ENSG00000065325	FALSE	Preclinical	1997-03-15	Preclinical	GLP2R
Enterocolitis, Necrotizing	ENSG00000073756	FALSE	Preclinical	2008-09-16	Preclinical	PTGS2
Enterocolitis, Necrotizing	ENSG00000095303	FALSE	Preclinical	2008-09-16	Preclinical	PTGS1
Enterocolitis, Necrotizing	ENSG00000113070	FALSE	unknown	NA	Preclinical	HBEGF
Enterocolitis, Necrotizing	ENSG00000134640	FALSE	Preclinical	NA	Absent	MTNR1B
Enterocolitis, Necrotizing	ENSG00000168412	FALSE	Preclinical	NA	Absent	MTNR1A
Enterocolitis, Necrotizing	ENSG00000178568	FALSE	Preclinical	2015-10-23	Absent	ERBB4
Enuresis	ENSG00000126895	TRUE	Approved	1991-05-15	Approved	AVPR2
Enuresis	ENSG00000133019	TRUE	Approved	1989-09-15	Approved	CHRM3
Enuresis	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Enuresis	ENSG00000168539	TRUE	Approved	1989-09-15	Approved	CHRM1
Enuresis	ENSG00000180720	TRUE	Approved	1989-09-15	Approved	CHRM4
Enuresis	ENSG00000181072	TRUE	Approved	1989-09-15	Approved	CHRM2
Eosinophilic Esophagitis	ENSG00000077238	FALSE	Phase II Clinical Trial	2009-11-19	Absent	IL4R
Eosinophilic Esophagitis	ENSG00000113525	FALSE	Phase III Clinical Trial	1993-03-15	Phase III Clinical Trial	IL5
Eosinophilic Esophagitis	ENSG00000113580	FALSE	Pre-registration	2004-07-24	Phase II Clinical Trial	NR3C1
Eosinophilic Esophagitis	ENSG00000169194	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	IL13
Eosinophilic Esophagitis	ENSG00000183134	FALSE	Phase II Clinical Trial	2005-06-01	Phase II Clinical Trial	PTGDR2
Epidermolysis Bullosa	ENSG00000100985	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP9
Epidermolysis Bullosa	ENSG00000111537	FALSE	Phase I Clinical Trial	1997-01-15	Unused	IFNG
Epidermolysis Bullosa	ENSG00000114270	FALSE	Preclinical	2016-05-27	Absent	COL7A1
Epidermolysis Bullosa	ENSG00000125538	FALSE	Preclinical	2017-01-02	Absent	IL1B
Epidermolysis Bullosa	ENSG00000162711	FALSE	Phase III Clinical Trial	2017-05-25	Absent	NLRP3
Epidermolysis Bullosa	ENSG00000178209	FALSE	Preclinical	2009-12-18	Unused	PLEC
Epidermolysis Bullosa	ENSG00000186847	FALSE	Preclinical	2015-11-03	Absent	KRT14
Epidermolysis Bullosa	ENSG00000196611	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP1
Epidermolysis Bullosa	ENSG00000196878	FALSE	Preclinical	2009-06-23	Unused	LAMB3
Epidermolysis Bullosa	ENSG00000197891	FALSE	Phase III Clinical Trial	2017-05-25	Absent	SLC22A12
Epidermolysis Bullosa	ENSG00000197919	FALSE	Phase I Clinical Trial	1997-01-15	Unused	IFNA1
Epidermolysis Bullosa	ENSG00000205542	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	TMSB4X
Epilepsies, Myoclonic	ENSG00000011677	FALSE	Phase III Clinical Trial	NA	Absent	GABRA3
Epilepsies, Myoclonic	ENSG00000022355	FALSE	Phase III Clinical Trial	2014-04-26	Absent	GABRA1
Epilepsies, Myoclonic	ENSG00000036530	FALSE	Phase II Clinical Trial	2014-07-28	Absent	CYP46A1
Epilepsies, Myoclonic	ENSG00000068078	TRUE	Approved	2014-11-22	Absent	FGFR3
Epilepsies, Myoclonic	ENSG00000087085	FALSE	Preclinical	2012-02-02	Absent	ACHE
Epilepsies, Myoclonic	ENSG00000108576	FALSE	Phase III Clinical Trial	NA	Absent	SLC6A4
Epilepsies, Myoclonic	ENSG00000144285	TRUE	Approved	2013-12-23	Unused	SCN1A
Epilepsies, Myoclonic	ENSG00000151834	FALSE	Phase III Clinical Trial	NA	Absent	GABRA2
Epilepsies, Myoclonic	ENSG00000153253	TRUE	Approved	NA	Absent	SCN3A
Epilepsies, Myoclonic	ENSG00000159164	TRUE	Approved	NA	Absent	SV2A
Epilepsies, Myoclonic	ENSG00000186297	FALSE	Phase III Clinical Trial	NA	Absent	GABRA5
Epilepsies, Myoclonic	ENSG00000196876	FALSE	Preclinical	2013-08-08	Absent	SCN8A
Epilepsies, Partial	ENSG00000011677	FALSE	Phase III Clinical Trial	2006-06-01	Phase III Clinical Trial	GABRA3
Epilepsies, Partial	ENSG00000022355	FALSE	Phase III Clinical Trial	2006-06-01	Phase III Clinical Trial	GABRA1
Epilepsies, Partial	ENSG00000068078	TRUE	Approved	2014-11-22	Absent	FGFR3
Epilepsies, Partial	ENSG00000075043	TRUE	Approved	1992-08-15	Approved	KCNQ2
Epilepsies, Partial	ENSG00000087085	FALSE	Phase I Clinical Trial	2012-02-02	Absent	ACHE
Epilepsies, Partial	ENSG00000092964	TRUE	Approved	2000-01-11	Approved	DPYSL2
Epilepsies, Partial	ENSG00000115232	FALSE	Phase II Clinical Trial	1991-12-15	Absent	ITGA4
Epilepsies, Partial	ENSG00000115604	FALSE	unknown	2000-01-11	Unused	IL18R1
Epilepsies, Partial	ENSG00000137752	FALSE	unknown	2000-01-11	Unused	CASP1
Epilepsies, Partial	ENSG00000139626	FALSE	Phase II Clinical Trial	1991-12-15	Absent	ITGB7
Epilepsies, Partial	ENSG00000144285	TRUE	Approved	1995-04-15	Approved	SCN1A
Epilepsies, Partial	ENSG00000150093	FALSE	Phase II Clinical Trial	1991-12-15	Absent	ITGB1
Epilepsies, Partial	ENSG00000151834	FALSE	Phase III Clinical Trial	2006-06-01	Phase III Clinical Trial	GABRA2
Epilepsies, Partial	ENSG00000153253	TRUE	Approved	1995-04-15	Approved	SCN3A
Epilepsies, Partial	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Epilepsies, Partial	ENSG00000155511	TRUE	Approved	1996-08-15	Approved	GRIA1
Epilepsies, Partial	ENSG00000159164	TRUE	Approved	2002-05-20	Approved	SV2A
Epilepsies, Partial	ENSG00000176884	FALSE	unknown	NA	Unused	GRIN1
Epilepsies, Partial	ENSG00000183023	TRUE	Approved	2002-05-20	Phase III Clinical Trial	SLC8A1
Epilepsies, Partial	ENSG00000183873	TRUE	Approved	2009-12-07	Approved	SCN5A
Epilepsies, Partial	ENSG00000184156	TRUE	Approved	1992-08-15	Approved	KCNQ3
Epilepsies, Partial	ENSG00000186297	FALSE	Phase III Clinical Trial	2006-06-01	Phase III Clinical Trial	GABRA5
Epilepsies, Partial	ENSG00000196876	FALSE	Preclinical	2013-08-08	Absent	SCN8A
Epilepsy	ENSG00000006283	FALSE	Preclinical	1999-04-28	Unused	CACNA1G
Epilepsy	ENSG00000007908	FALSE	unknown	2005-05-25	Unused	SELE
Epilepsy	ENSG00000011677	TRUE	Approved	1989-07-15	Approved	GABRA3
Epilepsy	ENSG00000022355	TRUE	Approved	1989-07-15	Approved	GABRA1
Epilepsy	ENSG00000036530	FALSE	Phase II Clinical Trial	2014-07-28	Absent	CYP46A1
Epilepsy	ENSG00000059377	FALSE	Preclinical	2017-12-05	Absent	TBXAS1
Epilepsy	ENSG00000064651	FALSE	Phase II Clinical Trial	2012-01-13	Phase II Clinical Trial	SLC12A2
Epilepsy	ENSG00000065989	FALSE	Preclinical	1997-10-15	Unused	PDE4A
Epilepsy	ENSG00000069431	FALSE	Preclinical	NA	Unused	ABCC9
Epilepsy	ENSG00000069535	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	MAOB
Epilepsy	ENSG00000069696	FALSE	Preclinical	1995-03-15	Unused	DRD4
Epilepsy	ENSG00000070748	FALSE	unknown	NA	Unused	CHAT
Epilepsy	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Epilepsy	ENSG00000074803	FALSE	Phase II Clinical Trial	2012-01-13	Phase II Clinical Trial	SLC12A1
Epilepsy	ENSG00000075043	TRUE	Approved	1992-08-15	Approved	KCNQ2
Epilepsy	ENSG00000082556	FALSE	Preclinical	NA	Unused	OPRK1
Epilepsy	ENSG00000085377	FALSE	Preclinical	NA	Unused	PREP
Epilepsy	ENSG00000087085	FALSE	Phase I Clinical Trial	2012-02-02	Phase I Clinical Trial	ACHE
Epilepsy	ENSG00000089041	FALSE	Preclinical	2015-09-02	Absent	P2RX7
Epilepsy	ENSG00000091831	FALSE	Preclinical	2007-08-22	Absent	ESR1
Epilepsy	ENSG00000092964	TRUE	Approved	2000-01-11	Approved	DPYSL2
Epilepsy	ENSG00000100300	FALSE	Preclinical	1997-07-15	Unused	TSPO
Epilepsy	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Epilepsy	ENSG00000101180	FALSE	Phase II Clinical Trial	1994-08-15	Unused	HRH3
Epilepsy	ENSG00000103546	FALSE	Preclinical	1990-09-15	Unused	SLC6A2
Epilepsy	ENSG00000104267	FALSE	Preclinical	NA	Unused	CA2
Epilepsy	ENSG00000105650	FALSE	Preclinical	1997-10-15	Unused	PDE4C
Epilepsy	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Epilepsy	ENSG00000108576	FALSE	Phase II Clinical Trial	1990-09-15	Unused	SLC6A4
Epilepsy	ENSG00000109158	FALSE	Preclinical	2014-11-27	Absent	GABRA4
Epilepsy	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Epilepsy	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Epilepsy	ENSG00000113161	FALSE	Preclinical	2009-11-13	Absent	HMGCR
Epilepsy	ENSG00000113327	FALSE	unknown	2004-11-03	Unused	GABRG2
Epilepsy	ENSG00000113448	FALSE	Preclinical	1997-10-15	Unused	PDE4D
Epilepsy	ENSG00000113580	FALSE	unknown	2012-04-20	Preclinical	NR3C1
Epilepsy	ENSG00000117013	FALSE	Preclinical	2001-06-19	Unused	KCNQ4
Epilepsy	ENSG00000117480	FALSE	Preclinical	2017-12-22	Absent	FAAH
Epilepsy	ENSG00000117594	FALSE	Preclinical	2015-03-06	Absent	HSD11B1
Epilepsy	ENSG00000118432	FALSE	Preclinical	2014-11-21	Unused	CNR1
Epilepsy	ENSG00000120088	FALSE	Preclinical	1999-03-23	Unused	CRHR1
Epilepsy	ENSG00000121361	FALSE	Preclinical	NA	Unused	KCNJ8
Epilepsy	ENSG00000122585	FALSE	Preclinical	2003-09-22	Unused	NPY
Epilepsy	ENSG00000123700	FALSE	Preclinical	2007-06-11	Unused	KCNJ2
Epilepsy	ENSG00000124140	FALSE	Preclinical	2009-01-19	Unused	SLC12A5
Epilepsy	ENSG00000125510	FALSE	Preclinical	1999-06-10	Unused	OPRL1
Epilepsy	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Epilepsy	ENSG00000133019	FALSE	Preclinical	2007-02-02	Preclinical	CHRM3
Epilepsy	ENSG00000142319	FALSE	Phase II Clinical Trial	1991-02-15	Phase II Clinical Trial	SLC6A3
Epilepsy	ENSG00000142408	FALSE	Preclinical	2016-01-31	Absent	CACNG8
Epilepsy	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Epilepsy	ENSG00000144285	TRUE	Approved	1989-05-15	Approved	SCN1A
Epilepsy	ENSG00000145050	FALSE	Preclinical	NA	Absent	MANF
Epilepsy	ENSG00000145864	FALSE	Phase II Clinical Trial	1990-07-15	Unused	GABRB2
Epilepsy	ENSG00000147955	FALSE	Preclinical	1994-08-15	Unused	SIGMAR1
Epilepsy	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Epilepsy	ENSG00000148408	FALSE	Preclinical	1992-01-15	Unused	CACNA1B
Epilepsy	ENSG00000151067	FALSE	Phase I Clinical Trial	1997-01-15	Unused	CACNA1C
Epilepsy	ENSG00000151834	TRUE	Approved	1989-07-15	Approved	GABRA2
Epilepsy	ENSG00000151892	FALSE	unknown	1993-07-15	Preclinical	GFRA1
Epilepsy	ENSG00000152822	FALSE	Preclinical	2001-06-06	Unused	GRM1
Epilepsy	ENSG00000153253	TRUE	Approved	1989-05-15	Approved	SCN3A
Epilepsy	ENSG00000153956	TRUE	Approved	1998-08-15	Approved	CACNA2D1
Epilepsy	ENSG00000154229	FALSE	Preclinical	1991-05-15	Unused	PRKCA
Epilepsy	ENSG00000155511	FALSE	Phase II Clinical Trial	1993-01-15	Unused	GRIA1
Epilepsy	ENSG00000156110	FALSE	Phase I Clinical Trial	1990-05-15	Unused	ADK
Epilepsy	ENSG00000157103	TRUE	Approved	1989-08-15	Approved	SLC6A1
Epilepsy	ENSG00000159164	TRUE	Approved	2002-05-20	Approved	SV2A
Epilepsy	ENSG00000163485	FALSE	Preclinical	1994-01-15	Unused	ADORA1
Epilepsy	ENSG00000164082	FALSE	Phase I Clinical Trial	2005-01-18	Absent	GRM2
Epilepsy	ENSG00000164128	FALSE	Preclinical	1996-05-15	Unused	NPY1R
Epilepsy	ENSG00000166206	FALSE	unknown	2004-11-03	Unused	GABRB3
Epilepsy	ENSG00000166573	FALSE	Preclinical	2008-02-08	Unused	GALR1
Epilepsy	ENSG00000169432	FALSE	Preclinical	2011-06-17	Absent	SCN9A
Epilepsy	ENSG00000171385	FALSE	Preclinical	2005-10-04	Unused	KCND3
Epilepsy	ENSG00000171497	FALSE	Preclinical	2009-07-28	Unused	PPID
Epilepsy	ENSG00000174175	FALSE	unknown	2005-05-25	Unused	SELP
Epilepsy	ENSG00000174417	FALSE	unknown	NA	Unused	TRHR
Epilepsy	ENSG00000175344	FALSE	Preclinical	2016-03-28	Absent	CHRNA7
Epilepsy	ENSG00000176884	FALSE	Phase I Clinical Trial	1989-08-15	Unused	GRIN1
Epilepsy	ENSG00000178394	FALSE	unknown	2003-05-06	Phase II Clinical Trial	HTR1A
Epilepsy	ENSG00000181072	FALSE	Preclinical	2007-02-02	Preclinical	CHRM2
Epilepsy	ENSG00000182687	FALSE	Preclinical	2017-02-24	Absent	GALR2
Epilepsy	ENSG00000183023	TRUE	Approved	2002-05-20	Phase III Clinical Trial	SLC8A1
Epilepsy	ENSG00000183873	FALSE	Preclinical	2006-04-10	Unused	SCN5A
Epilepsy	ENSG00000184156	TRUE	Approved	1992-08-15	Approved	KCNQ3
Epilepsy	ENSG00000184588	FALSE	Preclinical	1997-10-15	Unused	PDE4B
Epilepsy	ENSG00000185149	FALSE	Preclinical	2016-07-27	Absent	NPY2R
Epilepsy	ENSG00000185313	FALSE	Preclinical	2011-06-17	Absent	SCN10A
Epilepsy	ENSG00000185760	FALSE	Phase I Clinical Trial	2001-06-19	Absent	KCNQ5
Epilepsy	ENSG00000186297	TRUE	Approved	1989-07-15	Approved	GABRA5
Epilepsy	ENSG00000186868	FALSE	Preclinical	2008-09-08	Absent	MAPT
Epilepsy	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Epilepsy	ENSG00000188822	FALSE	Preclinical	2014-11-21	Absent	CNR2
Epilepsy	ENSG00000196639	FALSE	Preclinical	2009-07-01	Absent	HRH1
Epilepsy	ENSG00000196876	FALSE	Preclinical	2013-08-08	Absent	SCN8A
Epilepsy	ENSG00000273079	FALSE	Phase II Clinical Trial	1996-09-15	Unused	GRIN2B
Epilepsy	ENSG00000282608	FALSE	Preclinical	NA	Unused	ADORA3
Epilepsy, Absence	ENSG00000144285	TRUE	Approved	NA	Absent	SCN1A
Epilepsy, Absence	ENSG00000153253	TRUE	Approved	NA	Absent	SCN3A
Epilepsy, Absence	ENSG00000196557	FALSE	Phase II Clinical Trial	2015-12-23	Absent	CACNA1H
Epilepsy, Tonic-Clonic	ENSG00000068078	TRUE	Approved	2014-11-22	Absent	FGFR3
Epilepsy, Tonic-Clonic	ENSG00000092964	TRUE	Approved	2000-01-11	Approved	DPYSL2
Epilepsy, Tonic-Clonic	ENSG00000144285	TRUE	Approved	2000-01-11	Approved	SCN1A
Epilepsy, Tonic-Clonic	ENSG00000151067	FALSE	Preclinical	NA	Absent	CACNA1C
Epilepsy, Tonic-Clonic	ENSG00000153253	TRUE	Approved	2000-01-11	Approved	SCN3A
Epilepsy, Tonic-Clonic	ENSG00000153956	FALSE	Phase III Clinical Trial	1993-06-15	Phase III Clinical Trial	CACNA2D1
Epilepsy, Tonic-Clonic	ENSG00000155511	TRUE	Approved	2000-03-29	Approved	GRIA1
Epilepsy, Tonic-Clonic	ENSG00000159164	TRUE	Approved	NA	Approved	SV2A
Epilepsy, Tonic-Clonic	ENSG00000176884	FALSE	unknown	NA	Unused	GRIN1
Epilepsy, Tonic-Clonic	ENSG00000183873	TRUE	Approved	NA	Approved	SCN5A
Epstein-Barr Virus Infections	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Epstein-Barr Virus Infections	ENSG00000169508	FALSE	Preclinical	2016-06-16	Absent	GPR183
Erdheim-Chester Disease	ENSG00000157764	TRUE	Approved	2006-09-10	Absent	BRAF
Erectile Dysfunction	ENSG00000011677	FALSE	Preclinical	1994-05-15	Unused	GABRA3
Erectile Dysfunction	ENSG00000022355	FALSE	Preclinical	1994-05-15	Unused	GABRA1
Erectile Dysfunction	ENSG00000064989	FALSE	Preclinical	1993-02-15	Unused	CALCRL
Erectile Dysfunction	ENSG00000065989	FALSE	Preclinical	2000-10-10	Unused	PDE4A
Erectile Dysfunction	ENSG00000067900	FALSE	Phase II Clinical Trial	1998-10-15	Unused	ROCK1
Erectile Dysfunction	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Erectile Dysfunction	ENSG00000088832	FALSE	unknown	1993-12-15	Unused	FKBP1A
Erectile Dysfunction	ENSG00000091831	FALSE	Phase III Clinical Trial	2000-02-09	Phase II Clinical Trial	ESR1
Erectile Dysfunction	ENSG00000102468	FALSE	Preclinical	1990-07-15	Unused	HTR2A
Erectile Dysfunction	ENSG00000103546	FALSE	Phase III Clinical Trial	2000-05-02	Unused	SLC6A2
Erectile Dysfunction	ENSG00000105650	FALSE	Preclinical	2000-10-10	Unused	PDE4C
Erectile Dysfunction	ENSG00000108576	TRUE	Approved	1989-07-15	Approved	SLC6A4
Erectile Dysfunction	ENSG00000109163	FALSE	unknown	1997-08-15	Absent	GNRHR
Erectile Dysfunction	ENSG00000112038	FALSE	Pre-registration	2004-08-31	Phase III Clinical Trial	OPRM1
Erectile Dysfunction	ENSG00000113448	FALSE	Preclinical	2000-10-10	Unused	PDE4D
Erectile Dysfunction	ENSG00000114812	TRUE	Approved	1989-12-15	Approved	VIPR1
Erectile Dysfunction	ENSG00000116329	FALSE	Preclinical	2002-07-02	Unused	OPRD1
Erectile Dysfunction	ENSG00000120088	FALSE	Preclinical	1996-05-15	Unused	CRHR1
Erectile Dysfunction	ENSG00000120907	TRUE	Approved	2014-03-12	Approved	ADRA1A
Erectile Dysfunction	ENSG00000121361	FALSE	Phase II Clinical Trial	1999-04-13	Unused	KCNJ8
Erectile Dysfunction	ENSG00000132329	FALSE	Preclinical	1993-02-15	Unused	RAMP1
Erectile Dysfunction	ENSG00000134318	FALSE	Preclinical	2003-10-29	Unused	ROCK2
Erectile Dysfunction	ENSG00000135312	FALSE	Preclinical	1998-01-15	Unused	HTR1B
Erectile Dysfunction	ENSG00000138735	TRUE	Approved	1991-09-15	Approved	PDE5A
Erectile Dysfunction	ENSG00000140538	FALSE	Preclinical	2008-11-15	Unused	NTRK3
Erectile Dysfunction	ENSG00000142319	FALSE	unknown	2000-05-02	Unused	SLC6A3
Erectile Dysfunction	ENSG00000142515	FALSE	unknown	2005-01-01	Unused	KLK3
Erectile Dysfunction	ENSG00000143799	FALSE	Preclinical	2005-07-18	Unused	PARP1
Erectile Dysfunction	ENSG00000145545	FALSE	Preclinical	1993-06-15	Unused	SRD5A1
Erectile Dysfunction	ENSG00000147246	FALSE	Phase II Clinical Trial	1989-12-15	Unused	HTR2C
Erectile Dysfunction	ENSG00000149295	TRUE	Approved	1995-08-15	Unused	DRD2
Erectile Dysfunction	ENSG00000150594	FALSE	unknown	1990-11-15	Unused	ADRA2A
Erectile Dysfunction	ENSG00000151834	FALSE	Preclinical	1994-05-15	Unused	GABRA2
Erectile Dysfunction	ENSG00000151892	FALSE	Preclinical	2008-11-15	Unused	GFRA1
Erectile Dysfunction	ENSG00000155511	FALSE	Preclinical	1996-09-15	Unused	GRIA1
Erectile Dysfunction	ENSG00000156113	FALSE	Phase II Clinical Trial	2007-08-17	Phase I Clinical Trial	KCNMA1
Erectile Dysfunction	ENSG00000160951	TRUE	Approved	1996-10-15	Approved	PTGER1
Erectile Dysfunction	ENSG00000163485	FALSE	Phase II Clinical Trial	1996-12-15	Unused	ADORA1
Erectile Dysfunction	ENSG00000164270	FALSE	Preclinical	NA	Unused	HTR4
Erectile Dysfunction	ENSG00000166603	FALSE	Phase II Clinical Trial	2000-06-28	Phase II Clinical Trial	MC4R
Erectile Dysfunction	ENSG00000166736	FALSE	Phase II Clinical Trial	1999-09-08	Unused	HTR3A
Erectile Dysfunction	ENSG00000169083	TRUE	Approved	1997-08-15	Approved	AR
Erectile Dysfunction	ENSG00000169432	TRUE	Approved	2005-08-10	Approved	SCN9A
Erectile Dysfunction	ENSG00000170214	TRUE	Approved	NA	Approved	ADRA1B
Erectile Dysfunction	ENSG00000171119	FALSE	Preclinical	2008-11-15	Unused	NRTN
Erectile Dysfunction	ENSG00000171873	TRUE	Approved	NA	Approved	ADRA1D
Erectile Dysfunction	ENSG00000172572	FALSE	Preclinical	2000-12-12	Unused	PDE3A
Erectile Dysfunction	ENSG00000176884	FALSE	Preclinical	2011-07-18	Unused	GRIN1
Erectile Dysfunction	ENSG00000178394	FALSE	Phase II Clinical Trial	1991-11-15	Unused	HTR1A
Erectile Dysfunction	ENSG00000180914	FALSE	Phase II Clinical Trial	2003-09-11	Phase II Clinical Trial	OXTR
Erectile Dysfunction	ENSG00000184160	FALSE	unknown	1990-11-15	Unused	ADRA2C
Erectile Dysfunction	ENSG00000184588	FALSE	Preclinical	2000-10-10	Unused	PDE4B
Erectile Dysfunction	ENSG00000184845	FALSE	Preclinical	2005-07-04	Unused	DRD1
Erectile Dysfunction	ENSG00000186297	FALSE	Preclinical	1994-05-15	Unused	GABRA5
Erectile Dysfunction	ENSG00000196639	FALSE	Preclinical	NA	Unused	HRH1
Erectile Dysfunction	ENSG00000198400	FALSE	Preclinical	2015-07-18	Absent	NTRK1
Erectile Dysfunction	ENSG00000274286	FALSE	unknown	1990-11-15	Unused	ADRA2B
Erectile Dysfunction	ENSG00000282608	FALSE	Preclinical	2009-12-03	Preclinical	ADORA3
Erythema Multiforme	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Erythromelalgia	ENSG00000169432	FALSE	Phase II Clinical Trial	2007-08-17	Phase II Clinical Trial	SCN9A
Escherichia coli Infections	ENSG00000012223	FALSE	Phase I Clinical Trial	1994-08-15	Unused	LTF
Escherichia coli Infections	ENSG00000198223	FALSE	Phase I Clinical Trial	1994-08-15	Unused	CSF2RA
Esophageal Achalasia	ENSG00000070019	FALSE	Phase II Clinical Trial	2014-02-19	Absent	GUCY2C
Esophageal Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	NA	Absent	FYN
Esophageal Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Phase III Clinical Trial	HGF
Esophageal Neoplasms	ENSG00000026508	FALSE	unknown	2001-11-28	Absent	CD44
Esophageal Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2001-04-03	Phase I Clinical Trial	FLT4
Esophageal Neoplasms	ENSG00000051382	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CB
Esophageal Neoplasms	ENSG00000062038	FALSE	Phase I Clinical Trial	2014-07-16	Absent	CDH3
Esophageal Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Esophageal Neoplasms	ENSG00000066405	FALSE	Phase II Clinical Trial	2004-01-06	Absent	CLDN18
Esophageal Neoplasms	ENSG00000066468	FALSE	Phase III Clinical Trial	2006-05-05	Phase II Clinical Trial	FGFR2
Esophageal Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Esophageal Neoplasms	ENSG00000070019	FALSE	Phase II Clinical Trial	2012-02-17	Absent	GUCY2C
Esophageal Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Esophageal Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Esophageal Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Esophageal Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2004-02-03	Phase II Clinical Trial	HSP90AA1
Esophageal Neoplasms	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Esophageal Neoplasms	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Esophageal Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Esophageal Neoplasms	ENSG00000085563	FALSE	Phase I Clinical Trial	2005-04-13	Absent	ABCB1
Esophageal Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	FOLH1
Esophageal Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2006-11-20	Phase II Clinical Trial	AURKA
Esophageal Neoplasms	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Esophageal Neoplasms	ENSG00000091879	FALSE	unknown	2004-03-24	Phase II Clinical Trial	ANGPT2
Esophageal Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Esophageal Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2016-10-12	Absent	CDC7
Esophageal Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Esophageal Neoplasms	ENSG00000100644	FALSE	unknown	1997-04-15	Unused	HIF1A
Esophageal Neoplasms	ENSG00000100985	FALSE	Phase III Clinical Trial	2013-03-05	Preclinical	MMP9
Esophageal Neoplasms	ENSG00000101017	FALSE	Phase II Clinical Trial	2011-03-15	Absent	CD40
Esophageal Neoplasms	ENSG00000101868	FALSE	unknown	2003-02-19	Unused	POLA1
Esophageal Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	2001-04-03	Phase I Clinical Trial	FLT1
Esophageal Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	1999-04-21	Unused	MSLN
Esophageal Neoplasms	ENSG00000105146	FALSE	Phase I Clinical Trial	2007-02-06	Unused	AURKC
Esophageal Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2014-07-14	Absent	CEACAM5
Esophageal Neoplasms	ENSG00000105851	FALSE	unknown	2005-12-01	Absent	PIK3CG
Esophageal Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase III Clinical Trial	MET
Esophageal Neoplasms	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Absent	DKK1
Esophageal Neoplasms	ENSG00000109320	FALSE	unknown	1997-11-15	Unused	NFKB1
Esophageal Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Esophageal Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Esophageal Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Unused	PDGFRB
Esophageal Neoplasms	ENSG00000116157	FALSE	Preclinical	2016-07-06	Absent	GPX7
Esophageal Neoplasms	ENSG00000116478	FALSE	unknown	2003-12-09	Unused	HDAC1
Esophageal Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Esophageal Neoplasms	ENSG00000118520	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG1
Esophageal Neoplasms	ENSG00000119888	FALSE	Phase I Clinical Trial	2000-08-31	Unused	EPCAM
Esophageal Neoplasms	ENSG00000120156	FALSE	unknown	2004-03-24	Phase II Clinical Trial	TEK
Esophageal Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Esophageal Neoplasms	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Esophageal Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Esophageal Neoplasms	ENSG00000122025	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	FLT3
Esophageal Neoplasms	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Esophageal Neoplasms	ENSG00000124102	FALSE	Phase II Clinical Trial	2004-07-21	Phase I Clinical Trial	PI3
Esophageal Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K2
Esophageal Neoplasms	ENSG00000128052	TRUE	Approved	2001-04-03	Phase III Clinical Trial	KDR
Esophageal Neoplasms	ENSG00000128602	FALSE	Phase I Clinical Trial	2004-07-21	Phase I Clinical Trial	SMO
Esophageal Neoplasms	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Absent	PARP2
Esophageal Neoplasms	ENSG00000131747	FALSE	Phase I Clinical Trial	1991-06-15	Phase II Clinical Trial	TOP2A
Esophageal Neoplasms	ENSG00000131759	FALSE	Phase II Clinical Trial	2018-01-09	Absent	RARA
Esophageal Neoplasms	ENSG00000134853	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	PDGFRA
Esophageal Neoplasms	ENSG00000135446	FALSE	unknown	NA	Unused	CDK4
Esophageal Neoplasms	ENSG00000136807	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK9
Esophageal Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	2006-01-13	Phase II Clinical Trial	KIF11
Esophageal Neoplasms	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Esophageal Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Esophageal Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1995-01-15	Unused	TP53
Esophageal Neoplasms	ENSG00000141736	TRUE	Approved	1990-09-15	Approved	ERBB2
Esophageal Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Unused	AKT1
Esophageal Neoplasms	ENSG00000142627	FALSE	unknown	2006-09-11	Unused	EPHA2
Esophageal Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Esophageal Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Unused	MCL1
Esophageal Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Absent	PARP1
Esophageal Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1992-03-15	Phase III Clinical Trial	EGFR
Esophageal Neoplasms	ENSG00000147257	FALSE	Phase I Clinical Trial	2016-04-25	Absent	GPC3
Esophageal Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Esophageal Neoplasms	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Esophageal Neoplasms	ENSG00000154188	FALSE	unknown	2004-03-24	Phase II Clinical Trial	ANGPT1
Esophageal Neoplasms	ENSG00000154229	FALSE	Phase II Clinical Trial	2018-01-09	Unused	PRKCA
Esophageal Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	KIT
Esophageal Neoplasms	ENSG00000157764	FALSE	unknown	2001-04-03	Unused	BRAF
Esophageal Neoplasms	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Esophageal Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2006-05-05	Absent	FGFR4
Esophageal Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Esophageal Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase II Clinical Trial	CTLA4
Esophageal Neoplasms	ENSG00000164078	FALSE	Phase II Clinical Trial	2008-08-15	Phase I Clinical Trial	MST1R
Esophageal Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Esophageal Neoplasms	ENSG00000164305	FALSE	unknown	1997-04-15	Unused	CASP3
Esophageal Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2013-05-28	Absent	TERT
Esophageal Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Esophageal Neoplasms	ENSG00000165025	FALSE	Phase I Clinical Trial	2013-12-06	Absent	SYK
Esophageal Neoplasms	ENSG00000165731	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	RET
Esophageal Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Esophageal Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Unused	PLK1
Esophageal Neoplasms	ENSG00000167325	FALSE	unknown	1991-07-15	Unused	RRM1
Esophageal Neoplasms	ENSG00000167658	FALSE	unknown	1999-04-21	Unused	EEF2
Esophageal Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Unused	FNTA
Esophageal Neoplasms	ENSG00000168610	FALSE	Phase III Clinical Trial	2010-08-03	Absent	STAT3
Esophageal Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K1
Esophageal Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Esophageal Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2011-04-18	Absent	PTK2
Esophageal Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Esophageal Neoplasms	ENSG00000170558	FALSE	Phase I Clinical Trial	1999-06-30	Unused	CDH2
Esophageal Neoplasms	ENSG00000171552	FALSE	unknown	2005-11-21	Unused	BCL2L1
Esophageal Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CD
Esophageal Neoplasms	ENSG00000171791	FALSE	unknown	1992-03-15	Unused	BCL2
Esophageal Neoplasms	ENSG00000171848	FALSE	unknown	1991-07-15	Unused	RRM2
Esophageal Neoplasms	ENSG00000176890	FALSE	Approved	1991-09-15	Unused	TYMS
Esophageal Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2003-11-21	Phase II Clinical Trial	ERBB4
Esophageal Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2007-02-06	Unused	AURKB
Esophageal Neoplasms	ENSG00000182578	FALSE	Phase I Clinical Trial	2007-08-14	Absent	CSF1R
Esophageal Neoplasms	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Esophageal Neoplasms	ENSG00000184033	FALSE	Phase I Clinical Trial	2005-09-12	Phase I Clinical Trial	CTAG1B
Esophageal Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Esophageal Neoplasms	ENSG00000184502	FALSE	Phase II Clinical Trial	1994-08-15	Absent	GAST
Esophageal Neoplasms	ENSG00000185499	FALSE	Phase I Clinical Trial	2002-09-30	Unused	MUC1
Esophageal Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	PRAME
Esophageal Neoplasms	ENSG00000186716	FALSE	Phase I Clinical Trial	2007-02-06	Unused	BCR
Esophageal Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Absent	PDCD1
Esophageal Neoplasms	ENSG00000196591	FALSE	unknown	2003-12-09	Unused	HDAC2
Esophageal Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2006-12-07	Phase II Clinical Trial	MTOR
Esophageal Neoplasms	ENSG00000198851	FALSE	Phase I Clinical Trial	2016-04-25	Absent	CD3E
Esophageal Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	2000-10-26	Phase II Clinical Trial	TOP1
Esophageal Neoplasms	ENSG00000221867	FALSE	unknown	2003-02-19	Unused	MAGEA3
Esophageal Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	NA	Absent	LYN
Esophageal Neoplasms	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Esophagitis	ENSG00000078579	FALSE	unknown	2002-02-01	Unused	FGF20
Esophagitis	ENSG00000112096	FALSE	Preclinical	2000-10-26	Unused	SOD2
Esophagitis	ENSG00000124102	FALSE	Phase II Clinical Trial	2004-07-21	Absent	PI3
Esophagitis, Peptic	ENSG00000102539	FALSE	Phase II Clinical Trial	1995-08-15	Unused	MLNR
Esophagitis, Peptic	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Esophagitis, Peptic	ENSG00000110148	FALSE	unknown	2001-04-19	Unused	CCKBR
Esophagitis, Peptic	ENSG00000113749	TRUE	Approved	NA	Approved	HRH2
Esophagitis, Peptic	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Esophagitis, Peptic	ENSG00000163399	FALSE	Phase II Clinical Trial	NA	Unused	ATP1A1
Esophagitis, Peptic	ENSG00000164270	TRUE	Approved	2003-02-17	Approved	HTR4
Esophagitis, Peptic	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Esophagitis, Peptic	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Esophagitis, Peptic	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Essential Tremor	ENSG00000022355	FALSE	Phase II Clinical Trial	2013-04-19	Absent	GABRA1
Essential Tremor	ENSG00000070748	FALSE	Phase II Clinical Trial	2007-03-12	Phase II Clinical Trial	CHAT
Essential Tremor	ENSG00000155511	FALSE	unknown	NA	Unused	GRIA1
Essential Tremor	ENSG00000159164	FALSE	unknown	2002-05-20	Unused	SV2A
Essential Tremor	ENSG00000183023	FALSE	unknown	2002-05-20	Unused	SLC8A1
Essential Tremor	ENSG00000183873	FALSE	unknown	NA	Unused	SCN5A
Essential Tremor	ENSG00000196557	FALSE	Phase II Clinical Trial	2013-10-30	Absent	CACNA1H
Exocrine Pancreatic Insufficiency	ENSG00000175535	TRUE	Approved	1992-05-15	Approved	PNLIP
Exocrine Pancreatic Insufficiency	ENSG00000243480	TRUE	Approved	2000-02-23	Approved	AMY2A
Exophthalmos	ENSG00000113580	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	NR3C1
Exophthalmos	ENSG00000169252	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	ADRB2
Eye Diseases	ENSG00000016490	FALSE	Approved	NA	Unused	CLCA1
Eye Diseases	ENSG00000073756	TRUE	Approved	1990-06-15	Approved	PTGS2
Eye Diseases	ENSG00000090339	FALSE	Preclinical	2007-11-27	Unused	ICAM1
Eye Diseases	ENSG00000095303	TRUE	Approved	1990-06-15	Approved	PTGS1
Eye Diseases	ENSG00000106113	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CRHR2
Eye Diseases	ENSG00000106804	FALSE	Preclinical	2017-04-18	Absent	C5
Eye Diseases	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Eye Diseases	ENSG00000116044	FALSE	Phase II Clinical Trial	2014-01-07	Absent	NFE2L2
Eye Diseases	ENSG00000120088	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CRHR1
Eye Diseases	ENSG00000128271	FALSE	unknown	2005-07-05	Unused	ADORA2A
Eye Diseases	ENSG00000131747	FALSE	Preclinical	2014-12-02	Absent	TOP2A
Eye Diseases	ENSG00000134489	FALSE	unknown	2001-05-10	Unused	HRH4
Eye Diseases	ENSG00000168610	FALSE	Preclinical	2007-11-27	Preclinical	STAT3
Eye Diseases	ENSG00000168918	FALSE	Preclinical	2011-06-27	Unused	INPP5D
Eye Diseases	ENSG00000174175	FALSE	unknown	2006-10-09	Unused	SELP
Eye Diseases	ENSG00000176136	FALSE	Preclinical	NA	Absent	MC5R
Eye Diseases	ENSG00000185231	FALSE	Preclinical	NA	Absent	MC2R
Eye Diseases	ENSG00000196611	FALSE	unknown	1995-06-15	Unused	MMP1
Eye Diseases	ENSG00000196639	FALSE	unknown	2001-05-10	Unused	HRH1
Eye Diseases	ENSG00000197766	FALSE	unknown	2014-03-07	Absent	CFD
Eye Diseases	ENSG00000258839	FALSE	Preclinical	NA	Absent	MC1R
Eye Infections	ENSG00000012223	FALSE	unknown	1998-09-15	Unused	LTF
Eye Infections	ENSG00000065989	FALSE	Preclinical	2005-05-24	Absent	PDE4A
Eye Infections	ENSG00000073756	FALSE	unknown	NA	Absent	PTGS2
Eye Infections	ENSG00000095303	FALSE	unknown	NA	Absent	PTGS1
Eye Infections	ENSG00000101425	FALSE	Preclinical	NA	Unused	BPI
Eye Infections	ENSG00000102967	FALSE	Preclinical	2013-12-24	Absent	DHODH
Eye Infections	ENSG00000113580	TRUE	Approved	1994-06-15	Approved	NR3C1
Eye Infections	ENSG00000131747	FALSE	Preclinical	2014-12-02	Absent	TOP2A
Eye Infections	ENSG00000142166	FALSE	Approved	2016-11-26	Absent	IFNAR1
Eye Infections	ENSG00000159110	FALSE	Approved	2014-01-17	Absent	IFNAR2
Eye Infections	ENSG00000165025	FALSE	Preclinical	2015-05-06	Absent	SYK
Eye Neoplasms	ENSG00000105810	FALSE	Preclinical	2011-11-18	Unused	CDK6
Eye Neoplasms	ENSG00000109320	FALSE	Preclinical	2013-03-07	Absent	NFKB1
Eye Neoplasms	ENSG00000111424	FALSE	Preclinical	2013-12-28	Absent	VDR
Eye Neoplasms	ENSG00000112062	FALSE	Preclinical	2008-05-23	Absent	MAPK14
Eye Neoplasms	ENSG00000113721	FALSE	Preclinical	2004-02-09	Absent	PDGFRB
Eye Neoplasms	ENSG00000131747	TRUE	Approved	NA	Approved	TOP2A
Eye Neoplasms	ENSG00000135446	FALSE	Preclinical	2011-11-18	Unused	CDK4
Eye Neoplasms	ENSG00000135679	FALSE	Preclinical	2012-11-15	Absent	MDM2
Eye Neoplasms	ENSG00000141510	FALSE	Preclinical	2008-05-23	Absent	TP53
Eye Neoplasms	ENSG00000142208	FALSE	Preclinical	2008-05-23	Absent	AKT1
Eye Neoplasms	ENSG00000213903	FALSE	Preclinical	2008-05-23	Absent	LTB4R
Fabry Disease	ENSG00000102393	TRUE	Approved	1989-08-15	Approved	GLA
Fabry Disease	ENSG00000141867	FALSE	Preclinical	2005-03-04	Absent	BRD4
Fabry Disease	ENSG00000148154	FALSE	Phase II Clinical Trial	1989-06-15	Phase I Clinical Trial	UGCG
Factor VII Deficiency	ENSG00000057593	FALSE	Phase I Clinical Trial	2007-12-13	Absent	F7
Factor X Deficiency	ENSG00000101981	FALSE	Approved	NA	Absent	F9
Factor X Deficiency	ENSG00000126218	TRUE	Approved	NA	Absent	F10
Factor XI Deficiency	ENSG00000088926	TRUE	Approved	NA	Absent	F11
Factor XIII Deficiency	ENSG00000124491	TRUE	Approved	NA	Approved	F13A1
Fallopian Tube Neoplasms	ENSG00000003402	FALSE	unknown	1998-11-15	Phase III Clinical Trial	CFLAR
Fallopian Tube Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC3
Fallopian Tube Neoplasms	ENSG00000026103	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Fallopian Tube Neoplasms	ENSG00000026508	FALSE	Phase I Clinical Trial	1998-12-15	Unused	CD44
Fallopian Tube Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT4
Fallopian Tube Neoplasms	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Absent	LY75
Fallopian Tube Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2006-02-24	Phase II Clinical Trial	ERBB3
Fallopian Tube Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	FGFR2
Fallopian Tube Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Fallopian Tube Neoplasms	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Fallopian Tube Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Fallopian Tube Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Fallopian Tube Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Fallopian Tube Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	AURKA
Fallopian Tube Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2008-01-15	Phase II Clinical Trial	BIRC5
Fallopian Tube Neoplasms	ENSG00000091879	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT2
Fallopian Tube Neoplasms	ENSG00000100644	FALSE	Phase I Clinical Trial	2003-08-01	Absent	HIF1A
Fallopian Tube Neoplasms	ENSG00000101916	FALSE	Phase II Clinical Trial	2008-06-17	Phase II Clinical Trial	TLR8
Fallopian Tube Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	XIAP
Fallopian Tube Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT1
Fallopian Tube Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	2004-01-30	Absent	MSLN
Fallopian Tube Neoplasms	ENSG00000105976	FALSE	unknown	2004-08-09	Phase II Clinical Trial	MET
Fallopian Tube Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Fallopian Tube Neoplasms	ENSG00000110092	FALSE	unknown	2005-08-30	Phase I Clinical Trial	CCND1
Fallopian Tube Neoplasms	ENSG00000110195	FALSE	Phase III Clinical Trial	2003-02-24	Phase III Clinical Trial	FOLR1
Fallopian Tube Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC2
Fallopian Tube Neoplasms	ENSG00000112062	FALSE	Phase II Clinical Trial	2008-09-05	Phase II Clinical Trial	MAPK14
Fallopian Tube Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Approved	VEGFA
Fallopian Tube Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2011-01-21	Unused	HBEGF
Fallopian Tube Neoplasms	ENSG00000113302	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12B
Fallopian Tube Neoplasms	ENSG00000113494	FALSE	Phase I Clinical Trial	2010-01-28	Absent	PRLR
Fallopian Tube Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Fallopian Tube Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Fallopian Tube Neoplasms	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Fallopian Tube Neoplasms	ENSG00000116016	FALSE	Phase I Clinical Trial	2003-08-01	Absent	EPAS1
Fallopian Tube Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Absent	HDAC1
Fallopian Tube Neoplasms	ENSG00000120156	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	TEK
Fallopian Tube Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Fallopian Tube Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	2004-08-09	Phase II Clinical Trial	FLT3
Fallopian Tube Neoplasms	ENSG00000126934	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K2
Fallopian Tube Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	2000-03-16	Phase III Clinical Trial	KDR
Fallopian Tube Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2005-09-14	Absent	DLL4
Fallopian Tube Neoplasms	ENSG00000129484	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP2
Fallopian Tube Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Fallopian Tube Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	TOP2A
Fallopian Tube Neoplasms	ENSG00000132383	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RPA1
Fallopian Tube Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Absent	CASP9
Fallopian Tube Neoplasms	ENSG00000134853	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRA
Fallopian Tube Neoplasms	ENSG00000136869	FALSE	Phase I Clinical Trial	2013-11-01	Absent	TLR4
Fallopian Tube Neoplasms	ENSG00000137869	FALSE	Phase II Clinical Trial	1991-02-15	Unused	CYP19A1
Fallopian Tube Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Fallopian Tube Neoplasms	ENSG00000141096	FALSE	Preclinical	NA	Absent	DPEP3
Fallopian Tube Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	2003-12-10	Absent	TP53
Fallopian Tube Neoplasms	ENSG00000141736	FALSE	unknown	2000-11-16	Unused	ERBB2
Fallopian Tube Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Fallopian Tube Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Fallopian Tube Neoplasms	ENSG00000143799	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP1
Fallopian Tube Neoplasms	ENSG00000145545	FALSE	unknown	1998-11-15	Phase III Clinical Trial	SRD5A1
Fallopian Tube Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	EPHA1
Fallopian Tube Neoplasms	ENSG00000151617	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	EDNRA
Fallopian Tube Neoplasms	ENSG00000151694	FALSE	unknown	2005-08-30	Phase I Clinical Trial	ADAM17
Fallopian Tube Neoplasms	ENSG00000154188	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT1
Fallopian Tube Neoplasms	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KIT
Fallopian Tube Neoplasms	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	BRAF
Fallopian Tube Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2011-06-03	Absent	SLC34A2
Fallopian Tube Neoplasms	ENSG00000163599	FALSE	Phase I Clinical Trial	2004-07-07	Absent	CTLA4
Fallopian Tube Neoplasms	ENSG00000163785	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RYK
Fallopian Tube Neoplasms	ENSG00000164305	FALSE	Phase II Clinical Trial	2001-12-19	Phase II Clinical Trial	CASP3
Fallopian Tube Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2008-07-04	Absent	CSF2
Fallopian Tube Neoplasms	ENSG00000165675	FALSE	unknown	1998-11-15	Phase III Clinical Trial	ENOX2
Fallopian Tube Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	RET
Fallopian Tube Neoplasms	ENSG00000166483	FALSE	Phase II Clinical Trial	2008-04-09	Phase II Clinical Trial	WEE1
Fallopian Tube Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Fallopian Tube Neoplasms	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Fallopian Tube Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Fallopian Tube Neoplasms	ENSG00000168811	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12A
Fallopian Tube Neoplasms	ENSG00000169032	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K1
Fallopian Tube Neoplasms	ENSG00000170312	FALSE	unknown	2005-08-30	Phase I Clinical Trial	CDK1
Fallopian Tube Neoplasms	ENSG00000179776	FALSE	Phase III Clinical Trial	2000-12-11	Absent	CDH5
Fallopian Tube Neoplasms	ENSG00000181143	FALSE	Phase I Clinical Trial	2008-09-24	Unused	MUC16
Fallopian Tube Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	CSF1R
Fallopian Tube Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	2006-07-17	Absent	CTAG1B
Fallopian Tube Neoplasms	ENSG00000184697	FALSE	Phase II Clinical Trial	2011-02-25	Absent	CLDN6
Fallopian Tube Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2002-09-30	Phase III Clinical Trial	MUC1
Fallopian Tube Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Fallopian Tube Neoplasms	ENSG00000196591	FALSE	unknown	2002-06-10	Absent	HDAC2
Fallopian Tube Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	SRC
Fallopian Tube Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1999-07-06	Phase II Clinical Trial	TOP1
Fallopian Tube Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Familial Mediterranean Fever	ENSG00000125538	TRUE	Approved	2003-12-08	Phase II Clinical Trial	IL1B
Fasciitis, Plantar	ENSG00000026508	FALSE	Phase III Clinical Trial	1994-01-15	Phase III Clinical Trial	CD44
Fatigue	ENSG00000121853	FALSE	Phase II Clinical Trial	2004-11-09	Absent	GHSR
Fatigue	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Fatigue Syndrome, Chronic	ENSG00000064300	FALSE	Preclinical	1997-12-15	Unused	NGFR
Fatigue Syndrome, Chronic	ENSG00000101180	FALSE	Preclinical	2009-03-12	Unused	HRH3
Fatigue Syndrome, Chronic	ENSG00000159110	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	IFNAR2
Fatigue Syndrome, Chronic	ENSG00000164342	FALSE	Approved	NA	Approved	TLR3
Fatigue Syndrome, Chronic	ENSG00000169083	FALSE	unknown	2003-10-07	Unused	AR
Fatty Liver	ENSG00000004948	FALSE	Preclinical	2010-09-07	Absent	CALCR
Fatty Liver	ENSG00000005381	FALSE	Phase I Clinical Trial	2017-04-25	Absent	MPO
Fatty Liver	ENSG00000007952	FALSE	Preclinical	NA	Absent	NOX1
Fatty Liver	ENSG00000010310	FALSE	Preclinical	2017-05-11	Absent	GIPR
Fatty Liver	ENSG00000012504	FALSE	Phase III Clinical Trial	2004-08-13	Phase II Clinical Trial	NR1H4
Fatty Liver	ENSG00000043591	FALSE	Preclinical	2014-10-31	Absent	ADRB1
Fatty Liver	ENSG00000057252	FALSE	Preclinical	2013-09-05	Absent	SOAT1
Fatty Liver	ENSG00000062282	FALSE	Phase I Clinical Trial	2011-12-14	Preclinical	DGAT2
Fatty Liver	ENSG00000064012	FALSE	Phase II Clinical Trial	1999-01-15	Phase I Clinical Trial	CASP8
Fatty Liver	ENSG00000065559	FALSE	Preclinical	2017-01-05	Absent	MAP2K4
Fatty Liver	ENSG00000065989	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4A
Fatty Liver	ENSG00000072310	FALSE	unknown	2016-01-14	Absent	SREBF1
Fatty Liver	ENSG00000077782	FALSE	Preclinical	2015-12-04	Absent	FGFR1
Fatty Liver	ENSG00000079435	FALSE	Preclinical	2017-10-30	Absent	LIPE
Fatty Liver	ENSG00000086991	FALSE	Preclinical	NA	Absent	NOX4
Fatty Liver	ENSG00000096717	FALSE	Phase II Clinical Trial	2011-02-16	Absent	SIRT1
Fatty Liver	ENSG00000099194	FALSE	Phase III Clinical Trial	2007-08-21	Unused	SCD
Fatty Liver	ENSG00000100097	FALSE	Phase II Clinical Trial	NA	Preclinical	LGALS1
Fatty Liver	ENSG00000100170	FALSE	Phase II Clinical Trial	2011-08-04	Absent	SLC5A1
Fatty Liver	ENSG00000101986	FALSE	Phase II Clinical Trial	2015-02-09	Absent	ABCD1
Fatty Liver	ENSG00000103546	FALSE	Preclinical	2014-10-31	Absent	SLC6A2
Fatty Liver	ENSG00000105550	FALSE	Phase II Clinical Trial	2007-12-20	Unused	FGF21
Fatty Liver	ENSG00000105650	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4C
Fatty Liver	ENSG00000106144	FALSE	unknown	2005-10-05	Unused	CASP2
Fatty Liver	ENSG00000106178	FALSE	Phase I Clinical Trial	NA	Absent	CCL24
Fatty Liver	ENSG00000106991	FALSE	Preclinical	2015-01-02	Absent	ENG
Fatty Liver	ENSG00000108576	FALSE	Preclinical	2014-10-31	Absent	SLC6A4
Fatty Liver	ENSG00000111142	FALSE	Preclinical	2014-03-20	Absent	METAP2
Fatty Liver	ENSG00000112033	FALSE	Phase III Clinical Trial	2004-01-16	Unused	PPARD
Fatty Liver	ENSG00000112164	FALSE	Phase II Clinical Trial	2008-02-04	Preclinical	GLP1R
Fatty Liver	ENSG00000113448	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4D
Fatty Liver	ENSG00000113580	FALSE	Phase I Clinical Trial	2014-02-01	Absent	NR3C1
Fatty Liver	ENSG00000113749	FALSE	Preclinical	1996-05-15	Unused	HRH2
Fatty Liver	ENSG00000114650	FALSE	Preclinical	2009-02-20	Unused	SCAP
Fatty Liver	ENSG00000114859	FALSE	unknown	2002-09-25	Unused	CLCN2
Fatty Liver	ENSG00000115263	FALSE	Preclinical	2017-05-11	Absent	GCG
Fatty Liver	ENSG00000115318	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL3
Fatty Liver	ENSG00000117594	FALSE	Phase I Clinical Trial	2009-01-22	Phase I Clinical Trial	HSD11B1
Fatty Liver	ENSG00000118432	FALSE	Phase I Clinical Trial	2006-05-25	Phase I Clinical Trial	CNR1
Fatty Liver	ENSG00000121807	FALSE	Phase III Clinical Trial	2012-03-31	Absent	CCR2
Fatty Liver	ENSG00000121966	FALSE	Preclinical	2015-09-22	Absent	CXCR4
Fatty Liver	ENSG00000125255	FALSE	Phase I Clinical Trial	2012-07-25	Absent	SLC10A2
Fatty Liver	ENSG00000128285	FALSE	Phase I Clinical Trial	2008-05-27	Absent	MCHR1
Fatty Liver	ENSG00000130649	FALSE	Phase I Clinical Trial	2017-05-23	Absent	CYP2E1
Fatty Liver	ENSG00000131471	FALSE	Phase II Clinical Trial	2008-08-22	Absent	AOC3
Fatty Liver	ENSG00000131981	FALSE	Phase II Clinical Trial	2014-07-21	Preclinical	LGALS3
Fatty Liver	ENSG00000132170	FALSE	Phase III Clinical Trial	1989-09-15	Phase II Clinical Trial	PPARG
Fatty Liver	ENSG00000132855	FALSE	Phase II Clinical Trial	2015-03-18	Absent	ANGPTL3
Fatty Liver	ENSG00000132906	FALSE	unknown	2005-10-05	Unused	CASP9
Fatty Liver	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Absent	LOXL2
Fatty Liver	ENSG00000134318	FALSE	unknown	2005-05-24	Preclinical	ROCK2
Fatty Liver	ENSG00000134962	FALSE	Preclinical	2008-06-16	Unused	KLB
Fatty Liver	ENSG00000136634	FALSE	unknown	2013-11-28	Absent	IL10
Fatty Liver	ENSG00000136869	FALSE	Phase III Clinical Trial	2006-08-17	Absent	TLR4
Fatty Liver	ENSG00000136960	FALSE	Preclinical	2018-01-15	Absent	ENPP2
Fatty Liver	ENSG00000137462	FALSE	Preclinical	2006-08-17	Absent	TLR2
Fatty Liver	ENSG00000137752	FALSE	unknown	2005-10-05	Unused	CASP1
Fatty Liver	ENSG00000138030	FALSE	Phase I Clinical Trial	2016-11-29	Absent	KHK
Fatty Liver	ENSG00000138131	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL4
Fatty Liver	ENSG00000138735	FALSE	Phase II Clinical Trial	2014-08-26	Absent	PDE5A
Fatty Liver	ENSG00000140675	FALSE	Phase II Clinical Trial	2007-03-15	Absent	SLC5A2
Fatty Liver	ENSG00000141485	FALSE	Preclinical	2014-05-13	Absent	SLC13A5
Fatty Liver	ENSG00000142319	FALSE	Preclinical	2014-10-31	Absent	SLC6A3
Fatty Liver	ENSG00000142677	FALSE	Phase I Clinical Trial	2011-06-28	Phase I Clinical Trial	IL22RA1
Fatty Liver	ENSG00000144891	FALSE	Preclinical	2010-06-16	Absent	AGTR1
Fatty Liver	ENSG00000149257	FALSE	Phase I Clinical Trial	2010-09-27	Absent	SERPINH1
Fatty Liver	ENSG00000151090	FALSE	Phase II Clinical Trial	2008-03-20	Unused	THRB
Fatty Liver	ENSG00000151623	FALSE	Phase II Clinical Trial	2010-07-29	Absent	NR3C2
Fatty Liver	ENSG00000158125	FALSE	Preclinical	2002-07-03	Unused	XDH
Fatty Liver	ENSG00000160791	FALSE	Phase III Clinical Trial	NA	Absent	CCR5
Fatty Liver	ENSG00000160867	FALSE	Phase II Clinical Trial	2012-03-30	Absent	FGFR4
Fatty Liver	ENSG00000164305	FALSE	unknown	2005-10-05	Unused	CASP3
Fatty Liver	ENSG00000164733	FALSE	unknown	2007-11-30	Absent	CTSB
Fatty Liver	ENSG00000165029	FALSE	Phase III Clinical Trial	2007-08-21	Unused	ABCA1
Fatty Liver	ENSG00000167910	FALSE	Phase III Clinical Trial	2007-08-21	Unused	CYP7A1
Fatty Liver	ENSG00000171105	FALSE	Preclinical	2007-05-11	Absent	INSR
Fatty Liver	ENSG00000171298	FALSE	Preclinical	2016-08-26	Absent	GAA
Fatty Liver	ENSG00000171497	FALSE	Preclinical	2009-06-11	Absent	PPID
Fatty Liver	ENSG00000172016	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	REG3A
Fatty Liver	ENSG00000172156	FALSE	Phase II Clinical Trial	2000-08-02	Absent	CCL11
Fatty Liver	ENSG00000172572	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE3A
Fatty Liver	ENSG00000173198	FALSE	Phase II Clinical Trial	2002-07-12	Absent	CYSLTR1
Fatty Liver	ENSG00000173250	FALSE	Preclinical	2017-08-03	Absent	GPR151
Fatty Liver	ENSG00000175445	FALSE	unknown	2001-02-08	Unused	LPL
Fatty Liver	ENSG00000175535	FALSE	Preclinical	2016-08-26	Absent	PNLIP
Fatty Liver	ENSG00000179921	FALSE	Preclinical	2011-09-03	Absent	GPBAR1
Fatty Liver	ENSG00000181631	FALSE	Phase I Clinical Trial	2016-02-26	Absent	P2RY13
Fatty Liver	ENSG00000184588	FALSE	Phase II Clinical Trial	1999-01-08	Unused	PDE4B
Fatty Liver	ENSG00000185000	FALSE	Phase II Clinical Trial	2008-11-24	Absent	DGAT1
Fatty Liver	ENSG00000186951	FALSE	Phase III Clinical Trial	2004-08-02	Phase II Clinical Trial	PPARA
Fatty Liver	ENSG00000187871	FALSE	Preclinical	2015-10-15	Absent	GFRAL
Fatty Liver	ENSG00000197442	FALSE	Phase II Clinical Trial	2014-03-17	Absent	MAP3K5
Fatty Liver	ENSG00000197635	FALSE	Phase I Clinical Trial	2006-10-09	Preclinical	DPP4
Fatty Liver	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Fatty Liver	ENSG00000198851	FALSE	Phase I Clinical Trial	2004-02-24	Absent	CD3E
Fatty Liver	ENSG00000198911	FALSE	Preclinical	2013-08-22	Absent	SREBF2
Fatty Liver	ENSG00000215644	FALSE	Preclinical	2012-12-28	Absent	GCGR
Fatty Liver	ENSG00000249437	FALSE	Preclinical	2017-08-08	Absent	NAIP
Fatty Liver	ENSG00000260314	FALSE	Preclinical	2017-08-16	Absent	MRC1
Fatty Liver	ENSG00000278540	FALSE	Phase II Clinical Trial	2011-07-23	Absent	ACACA
Fatty Liver	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-08-07	Absent	ADORA3
Fecal Incontinence	ENSG00000115758	FALSE	unknown	1996-05-15	Unused	ODC1
Fecal Incontinence	ENSG00000134460	FALSE	Phase I Clinical Trial	NA	Absent	IL2RA
Feeding and Eating Disorders	ENSG00000011677	FALSE	Preclinical	2009-07-16	Absent	GABRA3
Feeding and Eating Disorders	ENSG00000022355	FALSE	Preclinical	2009-07-16	Absent	GABRA1
Feeding and Eating Disorders	ENSG00000101180	FALSE	Preclinical	2007-07-20	Absent	HRH3
Feeding and Eating Disorders	ENSG00000131096	FALSE	Preclinical	2005-12-30	Absent	PYY
Feeding and Eating Disorders	ENSG00000151834	FALSE	Preclinical	2009-07-16	Absent	GABRA2
Feeding and Eating Disorders	ENSG00000156097	FALSE	Preclinical	2017-07-20	Absent	GPR61
Feeding and Eating Disorders	ENSG00000164128	FALSE	unknown	1995-01-15	Absent	NPY1R
Feeding and Eating Disorders	ENSG00000164129	FALSE	Preclinical	2000-03-08	Absent	NPY5R
Feeding and Eating Disorders	ENSG00000165370	FALSE	Preclinical	2016-04-05	Absent	GPR101
Feeding and Eating Disorders	ENSG00000174946	FALSE	Preclinical	2016-11-02	Absent	GPR171
Feeding and Eating Disorders	ENSG00000179142	FALSE	Preclinical	2009-07-16	Absent	CYP11B2
Feeding and Eating Disorders	ENSG00000186297	FALSE	Preclinical	2009-07-16	Absent	GABRA5
Female Urogenital Diseases and Pregnancy Complications	ENSG00000170820	FALSE	unknown	2014-06-27	Absent	FSHR
Fetal Death	ENSG00000082175	TRUE	Approved	1989-05-15	Approved	PGR
Fetal Death	ENSG00000091831	FALSE	Preclinical	1990-03-15	Unused	ESR1
Fetal Death	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Fetal Death	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Fetal Death	ENSG00000122420	TRUE	Approved	NA	Approved	PTGFR
Fetal Death	ENSG00000125384	TRUE	Approved	NA	Approved	PTGER2
Fetal Death	ENSG00000160013	FALSE	Preclinical	NA	Unused	PTGIR
Fetal Death	ENSG00000160951	TRUE	Approved	NA	Approved	PTGER1
Fetal Death	ENSG00000169083	FALSE	Preclinical	1991-09-15	Unused	AR
Fever	ENSG00000050628	FALSE	Preclinical	2016-09-20	Absent	PTGER3
Fever	ENSG00000073756	TRUE	Approved	2003-10-07	Approved	PTGS2
Fever	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Fever	ENSG00000095303	TRUE	Approved	2003-10-07	Approved	PTGS1
Fever	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Fever	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Fever	ENSG00000115353	FALSE	unknown	2001-07-18	Preclinical	TACR1
Fever	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Fever	ENSG00000148344	FALSE	Preclinical	2012-01-09	Unused	PTGES
Fever	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Fibrocystic Breast Disease	ENSG00000109163	TRUE	Approved	2004-01-26	Approved	GNRHR
Fibromatosis, Aggressive	ENSG00000091831	FALSE	unknown	NA	Absent	ESR1
Fibromatosis, Aggressive	ENSG00000186088	FALSE	Phase II Clinical Trial	2007-01-08	Absent	GSAP
Fibromyalgia	ENSG00000073756	FALSE	Approved	2008-08-19	Unused	PTGS2
Fibromyalgia	ENSG00000075043	FALSE	Preclinical	NA	Phase II Clinical Trial	KCNQ2
Fibromyalgia	ENSG00000082556	FALSE	Preclinical	2011-08-11	Absent	OPRK1
Fibromyalgia	ENSG00000087085	FALSE	Phase II Clinical Trial	1994-11-15	Unused	ACHE
Fibromyalgia	ENSG00000092964	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	DPYSL2
Fibromyalgia	ENSG00000095303	FALSE	Approved	2008-08-19	Unused	PTGS1
Fibromyalgia	ENSG00000102468	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	HTR2A
Fibromyalgia	ENSG00000103546	TRUE	Approved	2002-03-28	Approved	SLC6A2
Fibromyalgia	ENSG00000108576	TRUE	Approved	2002-02-05	Approved	SLC6A4
Fibromyalgia	ENSG00000112038	FALSE	Preclinical	2011-07-18	Unused	OPRM1
Fibromyalgia	ENSG00000112964	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	GHR
Fibromyalgia	ENSG00000118432	FALSE	Preclinical	2013-01-02	Absent	CNR1
Fibromyalgia	ENSG00000134640	FALSE	unknown	2008-01-15	Preclinical	MTNR1B
Fibromyalgia	ENSG00000135914	FALSE	Phase II Clinical Trial	2008-01-15	Unused	HTR2B
Fibromyalgia	ENSG00000142319	FALSE	Phase I Clinical Trial	2002-03-28	Unused	SLC6A3
Fibromyalgia	ENSG00000144285	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	SCN1A
Fibromyalgia	ENSG00000147246	FALSE	Phase II Clinical Trial	1992-11-15	Unused	HTR2C
Fibromyalgia	ENSG00000149295	FALSE	Phase II Clinical Trial	1991-06-15	Phase II Clinical Trial	DRD2
Fibromyalgia	ENSG00000150594	FALSE	Phase II Clinical Trial	2011-08-11	Phase II Clinical Trial	ADRA2A
Fibromyalgia	ENSG00000151577	FALSE	Phase II Clinical Trial	1991-06-15	Phase II Clinical Trial	DRD3
Fibromyalgia	ENSG00000153253	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	SCN3A
Fibromyalgia	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Fibromyalgia	ENSG00000159110	FALSE	unknown	NA	Phase II Clinical Trial	IFNAR2
Fibromyalgia	ENSG00000166736	FALSE	Phase II Clinical Trial	2001-05-09	Phase II Clinical Trial	HTR3A
Fibromyalgia	ENSG00000168412	FALSE	unknown	2008-01-15	Preclinical	MTNR1A
Fibromyalgia	ENSG00000169083	FALSE	unknown	2003-10-07	Unused	AR
Fibromyalgia	ENSG00000176884	FALSE	Phase II Clinical Trial	2011-07-18	Unused	GRIN1
Fibromyalgia	ENSG00000178394	FALSE	unknown	2008-01-15	Preclinical	HTR1A
Fibromyalgia	ENSG00000179546	FALSE	unknown	2008-01-15	Preclinical	HTR1D
Fibromyalgia	ENSG00000184156	FALSE	Preclinical	NA	Phase II Clinical Trial	KCNQ3
Fibromyalgia	ENSG00000184160	FALSE	unknown	2011-08-11	Absent	ADRA2C
Fibromyalgia	ENSG00000185313	FALSE	Preclinical	2010-07-15	Preclinical	SCN10A
Fibromyalgia	ENSG00000188822	FALSE	Preclinical	2013-01-02	Absent	CNR2
Fibromyalgia	ENSG00000196689	FALSE	Preclinical	2013-01-02	Absent	TRPV1
Fibromyalgia	ENSG00000197249	FALSE	Phase II Clinical Trial	2009-05-15	Absent	SERPINA1
Fibromyalgia	ENSG00000213199	FALSE	Preclinical	2010-07-15	Preclinical	ASIC3
Fibromyalgia	ENSG00000274286	FALSE	Phase II Clinical Trial	2004-11-02	Phase II Clinical Trial	ADRA2B
Fibrosarcoma	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Unused	ABL1
Fibrosarcoma	ENSG00000179776	FALSE	unknown	2000-12-11	Phase I Clinical Trial	CDH5
Fibrosarcoma	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Unused	SRC
Fibrosarcoma	ENSG00000198400	FALSE	Phase II Clinical Trial	2013-07-11	Absent	NTRK1
Fibrosis	ENSG00000007952	FALSE	Preclinical	2015-03-25	Absent	NOX1
Fibrosis	ENSG00000067182	FALSE	Preclinical	2014-05-13	Unused	TNFRSF1A
Fibrosis	ENSG00000072571	FALSE	Preclinical	1998-07-15	Unused	HMMR
Fibrosis	ENSG00000078098	FALSE	Preclinical	2008-06-23	Preclinical	FAP
Fibrosis	ENSG00000081181	FALSE	Preclinical	2012-09-18	Preclinical	ARG2
Fibrosis	ENSG00000082781	FALSE	Preclinical	NA	Unused	ITGB5
Fibrosis	ENSG00000086991	FALSE	Preclinical	2015-03-25	Absent	NOX4
Fibrosis	ENSG00000092969	FALSE	Phase II Clinical Trial	1997-06-15	Unused	TGFB2
Fibrosis	ENSG00000100097	FALSE	Preclinical	NA	Absent	LGALS1
Fibrosis	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Fibrosis	ENSG00000100985	FALSE	Preclinical	2013-03-06	Absent	MMP9
Fibrosis	ENSG00000101017	FALSE	Phase II Clinical Trial	2004-10-05	Absent	CD40
Fibrosis	ENSG00000101144	FALSE	Preclinical	2014-03-15	Absent	BMP7
Fibrosis	ENSG00000102312	FALSE	Preclinical	2015-06-23	Absent	PORCN
Fibrosis	ENSG00000102468	FALSE	unknown	2008-05-23	Unused	HTR2A
Fibrosis	ENSG00000105329	FALSE	Phase II Clinical Trial	2000-05-24	Unused	TGFB1
Fibrosis	ENSG00000105366	FALSE	Preclinical	2016-06-24	Absent	SIGLEC8
Fibrosis	ENSG00000105550	FALSE	Phase II Clinical Trial	2007-12-20	Absent	FGF21
Fibrosis	ENSG00000106366	FALSE	Preclinical	2009-08-06	Unused	SERPINE1
Fibrosis	ENSG00000106799	FALSE	Preclinical	2004-11-09	Unused	TGFBR1
Fibrosis	ENSG00000106991	FALSE	Preclinical	2015-01-02	Absent	ENG
Fibrosis	ENSG00000108854	FALSE	Preclinical	2014-11-12	Absent	SMURF2
Fibrosis	ENSG00000110492	FALSE	Preclinical	2014-05-20	Absent	MDK
Fibrosis	ENSG00000111424	FALSE	Preclinical	NA	Absent	VDR
Fibrosis	ENSG00000112033	FALSE	Preclinical	2015-03-10	Absent	PPARD
Fibrosis	ENSG00000112062	FALSE	Preclinical	2006-05-19	Unused	MAPK14
Fibrosis	ENSG00000113083	FALSE	Preclinical	2013-06-24	Absent	LOX
Fibrosis	ENSG00000113163	FALSE	Preclinical	2006-09-06	Unused	COL4A3BP
Fibrosis	ENSG00000113273	FALSE	Preclinical	NA	Unused	ARSB
Fibrosis	ENSG00000113389	FALSE	Preclinical	2017-03-03	Absent	NPR3
Fibrosis	ENSG00000113594	FALSE	Preclinical	2014-12-16	Absent	LIFR
Fibrosis	ENSG00000115221	FALSE	Preclinical	2003-06-09	Phase I Clinical Trial	ITGB6
Fibrosis	ENSG00000115318	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL3
Fibrosis	ENSG00000116044	FALSE	Preclinical	2014-05-03	Absent	NFE2L2
Fibrosis	ENSG00000118432	FALSE	Preclinical	2009-02-13	Absent	CNR1
Fibrosis	ENSG00000118520	FALSE	Preclinical	2012-09-18	Preclinical	ARG1
Fibrosis	ENSG00000118523	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	CTGF
Fibrosis	ENSG00000119699	FALSE	Phase II Clinical Trial	2000-05-24	Absent	TGFB3
Fibrosis	ENSG00000121807	FALSE	Preclinical	2006-01-01	Absent	CCR2
Fibrosis	ENSG00000121966	FALSE	Preclinical	2015-09-22	Absent	CXCR4
Fibrosis	ENSG00000122884	FALSE	Preclinical	1998-02-15	Unused	P4HA1
Fibrosis	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Fibrosis	ENSG00000130368	FALSE	Preclinical	2008-03-25	Absent	MAS1
Fibrosis	ENSG00000131023	FALSE	Preclinical	2017-07-07	Absent	LATS1
Fibrosis	ENSG00000131981	FALSE	Preclinical	2014-02-05	Preclinical	LGALS3
Fibrosis	ENSG00000132170	FALSE	Preclinical	2017-06-15	Absent	PPARG
Fibrosis	ENSG00000132703	FALSE	unknown	2009-07-24	Absent	APCS
Fibrosis	ENSG00000134013	FALSE	Phase I Clinical Trial	2013-06-24	Absent	LOXL2
Fibrosis	ENSG00000134318	FALSE	Preclinical	2015-06-10	Absent	ROCK2
Fibrosis	ENSG00000134853	FALSE	Preclinical	1999-06-10	Unused	PDGFRA
Fibrosis	ENSG00000135914	FALSE	Preclinical	2008-05-23	Unused	HTR2B
Fibrosis	ENSG00000136869	FALSE	Preclinical	2006-08-17	Absent	TLR4
Fibrosis	ENSG00000136960	FALSE	Preclinical	2015-09-02	Absent	ENPP2
Fibrosis	ENSG00000137070	FALSE	Preclinical	2017-11-23	Absent	IL11RA
Fibrosis	ENSG00000137462	FALSE	Preclinical	2006-08-17	Absent	TLR2
Fibrosis	ENSG00000137672	FALSE	Preclinical	2015-05-27	Absent	TRPC6
Fibrosis	ENSG00000137801	FALSE	Preclinical	2017-11-16	Absent	THBS1
Fibrosis	ENSG00000138131	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL4
Fibrosis	ENSG00000138448	FALSE	Preclinical	2003-06-09	Phase I Clinical Trial	ITGAV
Fibrosis	ENSG00000143839	FALSE	Preclinical	NA	Absent	REN
Fibrosis	ENSG00000144891	FALSE	Phase II Clinical Trial	2003-04-01	Absent	AGTR1
Fibrosis	ENSG00000149021	FALSE	unknown	1997-08-15	Absent	SCGB1A1
Fibrosis	ENSG00000149257	FALSE	Phase I Clinical Trial	2010-09-27	Absent	SERPINH1
Fibrosis	ENSG00000149295	FALSE	unknown	NA	Preclinical	DRD2
Fibrosis	ENSG00000150093	FALSE	Preclinical	2016-02-22	Absent	ITGB1
Fibrosis	ENSG00000150457	FALSE	Preclinical	2017-07-07	Absent	LATS2
Fibrosis	ENSG00000151617	FALSE	Phase II Clinical Trial	2003-04-01	Absent	EDNRA
Fibrosis	ENSG00000152818	FALSE	Preclinical	NA	Absent	UTRN
Fibrosis	ENSG00000156738	FALSE	unknown	1993-09-15	Absent	MS4A1
Fibrosis	ENSG00000157404	FALSE	Preclinical	2014-06-07	Absent	KIT
Fibrosis	ENSG00000160013	FALSE	unknown	2005-11-25	Absent	PTGIR
Fibrosis	ENSG00000162733	FALSE	Preclinical	2001-05-09	Unused	DDR2
Fibrosis	ENSG00000163513	FALSE	Preclinical	2006-12-19	Unused	TGFBR2
Fibrosis	ENSG00000163823	FALSE	unknown	2000-04-05	Absent	CCR1
Fibrosis	ENSG00000165731	FALSE	Preclinical	2014-06-07	Absent	RET
Fibrosis	ENSG00000166090	FALSE	Preclinical	2015-06-19	Absent	IL25
Fibrosis	ENSG00000168487	FALSE	Preclinical	1999-02-05	Unused	BMP1
Fibrosis	ENSG00000169418	FALSE	Preclinical	2017-03-03	Absent	NPR1
Fibrosis	ENSG00000170027	FALSE	unknown	2006-08-09	Absent	YWHAG
Fibrosis	ENSG00000170820	FALSE	unknown	2012-09-18	Preclinical	FSHR
Fibrosis	ENSG00000171049	FALSE	Preclinical	2008-03-25	Absent	FPR2
Fibrosis	ENSG00000171517	FALSE	unknown	2010-10-28	Absent	LPAR3
Fibrosis	ENSG00000171791	FALSE	Preclinical	2008-04-02	Absent	BCL2
Fibrosis	ENSG00000172819	FALSE	Preclinical	2016-09-23	Absent	RARG
Fibrosis	ENSG00000173250	FALSE	Preclinical	2012-05-29	Absent	GPR151
Fibrosis	ENSG00000176170	FALSE	Preclinical	2013-01-22	Preclinical	SPHK1
Fibrosis	ENSG00000179142	FALSE	Preclinical	2016-01-14	Absent	CYP11B2
Fibrosis	ENSG00000180772	FALSE	Phase I Clinical Trial	2012-02-22	Preclinical	AGTR2
Fibrosis	ENSG00000182578	FALSE	Preclinical	2009-09-21	Absent	CSF1R
Fibrosis	ENSG00000188822	FALSE	Preclinical	2017-06-15	Absent	CNR2
Fibrosis	ENSG00000196664	FALSE	Preclinical	2009-12-23	Unused	TLR7
Fibrosis	ENSG00000198121	FALSE	Phase II Clinical Trial	2009-06-17	Preclinical	LPAR1
Fibrosis	ENSG00000213694	FALSE	Preclinical	2012-05-31	Preclinical	S1PR3
Fibrosis	ENSG00000267534	FALSE	Preclinical	2014-12-31	Absent	S1PR2
Fissure in Ano	ENSG00000151067	FALSE	Phase III Clinical Trial	2013-07-10	Phase III Clinical Trial	CACNA1C
Flatulence	ENSG00000175535	TRUE	Approved	NA	Approved	PNLIP
Food Hypersensitivity	ENSG00000077238	FALSE	Preclinical	2009-11-19	Absent	IL4R
Food Hypersensitivity	ENSG00000115602	FALSE	Phase II Clinical Trial	2014-01-16	Absent	IL1RL1
Food Hypersensitivity	ENSG00000136869	FALSE	Phase I Clinical Trial	2011-10-26	Absent	TLR4
Food Hypersensitivity	ENSG00000172156	FALSE	unknown	2000-08-02	Preclinical	CCL11
Food Hypersensitivity	ENSG00000239732	FALSE	Preclinical	2000-11-01	Unused	TLR9
Fractures, Bone	ENSG00000036828	FALSE	Phase II Clinical Trial	1994-02-15	Absent	CASR
Fractures, Bone	ENSG00000077782	FALSE	Phase II Clinical Trial	1997-04-15	Absent	FGFR1
Fractures, Bone	ENSG00000101144	TRUE	Approved	NA	Absent	BMP7
Fractures, Bone	ENSG00000106128	FALSE	unknown	1997-08-15	Absent	GHRHR
Fractures, Bone	ENSG00000107984	FALSE	Preclinical	2004-10-18	Absent	DKK1
Fractures, Bone	ENSG00000110492	FALSE	Preclinical	2016-08-10	Absent	MDK
Fractures, Bone	ENSG00000111424	FALSE	Preclinical	2013-12-28	Absent	VDR
Fractures, Bone	ENSG00000112964	FALSE	unknown	NA	Absent	GHR
Fractures, Bone	ENSG00000113721	FALSE	Phase II Clinical Trial	2005-02-22	Absent	PDGFRB
Fractures, Bone	ENSG00000124813	FALSE	Preclinical	2010-06-28	Absent	RUNX2
Fractures, Bone	ENSG00000125384	FALSE	Phase II Clinical Trial	2002-08-22	Absent	PTGER2
Fractures, Bone	ENSG00000125845	TRUE	Approved	2004-07-13	Absent	BMP2
Fractures, Bone	ENSG00000125965	FALSE	unknown	1994-12-15	Absent	GDF5
Fractures, Bone	ENSG00000152266	FALSE	Preclinical	2016-01-27	Absent	PTH
Fractures, Bone	ENSG00000160801	FALSE	Phase III Clinical Trial	1997-06-15	Absent	PTH1R
Fractures, Bone	ENSG00000167941	FALSE	unknown	1998-12-15	Absent	SOST
Fractures, Bone	ENSG00000169083	FALSE	Phase II Clinical Trial	2008-02-25	Absent	AR
Fractures, Bone	ENSG00000171522	FALSE	Phase II Clinical Trial	2001-10-26	Absent	PTGER4
Fragile X Syndrome	ENSG00000100300	FALSE	Phase I Clinical Trial	2003-09-12	Absent	TSPO
Fragile X Syndrome	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Fragile X Syndrome	ENSG00000147955	FALSE	Preclinical	2007-02-02	Absent	SIGMAR1
Fragile X Syndrome	ENSG00000155511	FALSE	Preclinical	1994-02-15	Unused	GRIA1
Fragile X Syndrome	ENSG00000168539	FALSE	Preclinical	2010-01-08	Preclinical	CHRM1
Fragile X Syndrome	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Phase III Clinical Trial	GRM5
Fragile X Syndrome	ENSG00000171132	FALSE	Preclinical	2009-05-01	Absent	PRKCE
Fragile X Syndrome	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Fragile X Syndrome	ENSG00000187730	FALSE	Phase I Clinical Trial	NA	Absent	GABRD
Fragile X Syndrome	ENSG00000189056	FALSE	Preclinical	2015-10-01	Absent	RELN
Friedreich Ataxia	ENSG00000027697	FALSE	Phase III Clinical Trial	NA	Absent	IFNGR1
Friedreich Ataxia	ENSG00000069535	FALSE	Preclinical	2011-08-20	Unused	MAOB
Friedreich Ataxia	ENSG00000107984	FALSE	Preclinical	2014-01-10	Absent	DKK1
Friedreich Ataxia	ENSG00000109320	FALSE	Preclinical	2010-04-24	Absent	NFKB1
Friedreich Ataxia	ENSG00000110887	FALSE	Phase II Clinical Trial	2015-10-05	Absent	DAO
Friedreich Ataxia	ENSG00000116044	FALSE	Phase II Clinical Trial	2010-04-24	Absent	NFE2L2
Friedreich Ataxia	ENSG00000165060	FALSE	Preclinical	2014-01-04	Absent	FXN
Friedreich Ataxia	ENSG00000171720	FALSE	Phase I Clinical Trial	2007-04-13	Phase I Clinical Trial	HDAC3
Friedreich Ataxia	ENSG00000187266	FALSE	unknown	2002-02-25	Unused	EPOR
Friedreich Ataxia	ENSG00000189221	FALSE	Preclinical	2011-08-20	Unused	MAOA
Frontotemporal Dementia	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Frontotemporal Dementia	ENSG00000120948	FALSE	Preclinical	2010-12-21	Absent	TARDBP
Frontotemporal Dementia	ENSG00000134243	FALSE	Preclinical	2017-11-30	Absent	SORT1
Frontotemporal Dementia	ENSG00000136634	FALSE	Preclinical	2017-03-17	Absent	IL10
Frontotemporal Dementia	ENSG00000142192	FALSE	unknown	2010-05-29	Absent	APP
Frontotemporal Dementia	ENSG00000147894	FALSE	Preclinical	2017-08-14	Absent	C9orf72
Frontotemporal Dementia	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Frontotemporal Dementia	ENSG00000164885	FALSE	Preclinical	NA	Absent	CDK5
Frontotemporal Dementia	ENSG00000168539	FALSE	Preclinical	NA	Absent	CHRM1
Frontotemporal Dementia	ENSG00000176884	FALSE	Phase II Clinical Trial	2008-01-16	Absent	GRIN1
Frontotemporal Dementia	ENSG00000186868	FALSE	Phase III Clinical Trial	2008-08-08	Absent	MAPT
Frontotemporal Dementia	ENSG00000198408	FALSE	Preclinical	2012-10-15	Absent	OGA
Galactorrhea	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Gangliosidosis, GM1	ENSG00000170266	FALSE	Preclinical	2015-02-11	Absent	GLB1
Gastritis	ENSG00000087085	FALSE	Approved	1989-12-15	Unused	ACHE
Gastritis	ENSG00000102539	FALSE	Phase II Clinical Trial	1996-10-15	Unused	MLNR
Gastritis	ENSG00000105675	FALSE	Approved	1998-05-15	Unused	ATP4A
Gastritis	ENSG00000110148	TRUE	Approved	NA	Approved	CCKBR
Gastritis	ENSG00000113749	TRUE	Approved	1989-05-15	Approved	HRH2
Gastritis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Gastritis	ENSG00000149295	FALSE	Approved	1989-12-15	Unused	DRD2
Gastritis	ENSG00000151067	TRUE	Approved	NA	Approved	CACNA1C
Gastritis	ENSG00000164270	FALSE	Approved	2014-08-01	Unused	HTR4
Gastritis	ENSG00000166736	FALSE	Approved	2006-10-30	Unused	HTR3A
Gastritis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Gastritis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Gastritis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Gastritis	ENSG00000184502	FALSE	unknown	2002-09-26	Unused	GAST
Gastroenteritis	ENSG00000113580	FALSE	Phase II Clinical Trial	2016-04-06	Phase II Clinical Trial	NR3C1
Gastroenteritis	ENSG00000166736	FALSE	Phase III Clinical Trial	2006-10-30	Absent	HTR3A
Gastroenteritis	ENSG00000183625	FALSE	Preclinical	2007-05-18	Unused	CCR3
Gastroesophageal Reflux	ENSG00000087085	FALSE	unknown	2000-03-01	Unused	ACHE
Gastroesophageal Reflux	ENSG00000102539	FALSE	Preclinical	1996-06-15	Unused	MLNR
Gastroesophageal Reflux	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Gastroesophageal Reflux	ENSG00000110148	FALSE	Phase I Clinical Trial	1997-06-15	Unused	CCKBR
Gastroesophageal Reflux	ENSG00000113749	TRUE	Approved	1989-05-15	Approved	HRH2
Gastroesophageal Reflux	ENSG00000114859	FALSE	Phase II Clinical Trial	2002-09-25	Absent	CLCN2
Gastroesophageal Reflux	ENSG00000121853	FALSE	Phase I Clinical Trial	1998-10-15	Phase II Clinical Trial	GHSR
Gastroesophageal Reflux	ENSG00000122194	FALSE	Approved	NA	Unused	PLG
Gastroesophageal Reflux	ENSG00000125384	FALSE	unknown	NA	Unused	PTGER2
Gastroesophageal Reflux	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Gastroesophageal Reflux	ENSG00000144481	FALSE	Preclinical	2016-02-01	Absent	TRPM8
Gastroesophageal Reflux	ENSG00000149295	TRUE	Approved	1992-09-15	Approved	DRD2
Gastroesophageal Reflux	ENSG00000151577	FALSE	Preclinical	2003-04-28	Unused	DRD3
Gastroesophageal Reflux	ENSG00000160951	FALSE	Phase I Clinical Trial	2007-03-30	Phase I Clinical Trial	PTGER1
Gastroesophageal Reflux	ENSG00000163394	FALSE	Phase III Clinical Trial	1995-01-15	Unused	CCKAR
Gastroesophageal Reflux	ENSG00000163399	FALSE	Phase III Clinical Trial	2012-10-18	Phase II Clinical Trial	ATP1A1
Gastroesophageal Reflux	ENSG00000164266	FALSE	Approved	NA	Absent	SPINK1
Gastroesophageal Reflux	ENSG00000164270	TRUE	Approved	1990-07-15	Approved	HTR4
Gastroesophageal Reflux	ENSG00000166736	FALSE	Phase II Clinical Trial	1990-07-15	Unused	HTR3A
Gastroesophageal Reflux	ENSG00000167748	FALSE	Approved	NA	Absent	KLK1
Gastroesophageal Reflux	ENSG00000168539	TRUE	Approved	2000-03-01	Approved	CHRM1
Gastroesophageal Reflux	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Unused	GRM5
Gastroesophageal Reflux	ENSG00000169403	FALSE	Phase II Clinical Trial	1995-01-15	Unused	PTAFR
Gastroesophageal Reflux	ENSG00000180210	FALSE	Approved	NA	Unused	F2
Gastroesophageal Reflux	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Gastroesophageal Reflux	ENSG00000181072	TRUE	Approved	2000-03-01	Approved	CHRM2
Gastroesophageal Reflux	ENSG00000184502	FALSE	Pre-registration	1994-08-15	Phase II Clinical Trial	GAST
Gastroesophageal Reflux	ENSG00000196689	FALSE	Phase II Clinical Trial	2007-08-06	Unused	TRPV1
Gastrointestinal Diseases	ENSG00000001626	FALSE	unknown	1992-11-15	Absent	CFTR
Gastrointestinal Diseases	ENSG00000007171	FALSE	Preclinical	1996-08-15	Absent	NOS2
Gastrointestinal Diseases	ENSG00000012223	FALSE	Phase I Clinical Trial	1996-06-15	Unused	LTF
Gastrointestinal Diseases	ENSG00000012504	FALSE	Preclinical	2017-10-07	Absent	NR1H4
Gastrointestinal Diseases	ENSG00000044012	FALSE	Preclinical	1997-05-15	Unused	GUCA2B
Gastrointestinal Diseases	ENSG00000066230	FALSE	Preclinical	2011-05-03	Unused	SLC9A3
Gastrointestinal Diseases	ENSG00000069431	FALSE	Preclinical	NA	Absent	ABCC9
Gastrointestinal Diseases	ENSG00000073756	TRUE	Approved	2017-12-05	Absent	PTGS2
Gastrointestinal Diseases	ENSG00000080293	TRUE	Approved	1999-03-23	Approved	SCTR
Gastrointestinal Diseases	ENSG00000081985	FALSE	Preclinical	2014-08-07	Absent	IL12RB2
Gastrointestinal Diseases	ENSG00000082556	FALSE	Preclinical	2005-03-07	Absent	OPRK1
Gastrointestinal Diseases	ENSG00000083457	FALSE	unknown	2014-03-07	Absent	ITGAE
Gastrointestinal Diseases	ENSG00000087085	FALSE	Phase I Clinical Trial	1993-08-15	Unused	ACHE
Gastrointestinal Diseases	ENSG00000089250	FALSE	Preclinical	1996-08-15	Absent	NOS1
Gastrointestinal Diseases	ENSG00000095303	TRUE	Approved	2017-12-05	Absent	PTGS1
Gastrointestinal Diseases	ENSG00000096996	FALSE	Preclinical	2014-08-07	Absent	IL12RB1
Gastrointestinal Diseases	ENSG00000101916	FALSE	Phase I Clinical Trial	2013-09-27	Absent	TLR8
Gastrointestinal Diseases	ENSG00000102539	FALSE	Phase II Clinical Trial	1990-08-15	Unused	MLNR
Gastrointestinal Diseases	ENSG00000104783	FALSE	Preclinical	1998-06-15	Unused	KCNN4
Gastrointestinal Diseases	ENSG00000105675	FALSE	Approved	2007-12-17	Absent	ATP4A
Gastrointestinal Diseases	ENSG00000110148	FALSE	Preclinical	1991-01-15	Absent	CCKBR
Gastrointestinal Diseases	ENSG00000112038	FALSE	Phase II Clinical Trial	1999-01-15	Phase III Clinical Trial	OPRM1
Gastrointestinal Diseases	ENSG00000113749	FALSE	Preclinical	1994-06-15	Absent	HRH2
Gastrointestinal Diseases	ENSG00000114859	FALSE	Phase III Clinical Trial	2002-05-28	Phase III Clinical Trial	CLCN2
Gastrointestinal Diseases	ENSG00000115232	FALSE	unknown	2014-03-07	Absent	ITGA4
Gastrointestinal Diseases	ENSG00000115263	FALSE	Preclinical	2014-06-07	Absent	GCG
Gastrointestinal Diseases	ENSG00000116329	FALSE	Preclinical	2002-11-05	Absent	OPRD1
Gastrointestinal Diseases	ENSG00000121361	FALSE	Preclinical	NA	Absent	KCNJ8
Gastrointestinal Diseases	ENSG00000121853	FALSE	Phase II Clinical Trial	2004-03-08	Phase II Clinical Trial	GHSR
Gastrointestinal Diseases	ENSG00000125510	FALSE	Preclinical	2008-04-02	Absent	OPRL1
Gastrointestinal Diseases	ENSG00000125571	FALSE	Preclinical	2014-08-07	Absent	IL37
Gastrointestinal Diseases	ENSG00000133019	TRUE	Approved	1992-05-15	Approved	CHRM3
Gastrointestinal Diseases	ENSG00000136160	FALSE	Preclinical	1990-02-15	Absent	EDNRB
Gastrointestinal Diseases	ENSG00000139626	FALSE	unknown	2014-03-07	Absent	ITGB7
Gastrointestinal Diseases	ENSG00000143125	FALSE	Preclinical	2006-12-06	Absent	PROK1
Gastrointestinal Diseases	ENSG00000149295	TRUE	Approved	1990-03-15	Approved	DRD2
Gastrointestinal Diseases	ENSG00000151067	FALSE	Pre-registration	NA	Absent	CACNA1C
Gastrointestinal Diseases	ENSG00000154646	FALSE	Preclinical	1997-09-15	Unused	TMPRSS15
Gastrointestinal Diseases	ENSG00000163394	TRUE	Approved	1999-06-15	Unused	CCKAR
Gastrointestinal Diseases	ENSG00000163421	FALSE	Preclinical	2004-09-16	Unused	PROK2
Gastrointestinal Diseases	ENSG00000164270	TRUE	Approved	1990-05-15	Phase II Clinical Trial	HTR4
Gastrointestinal Diseases	ENSG00000164867	FALSE	Preclinical	1996-08-15	Absent	NOS3
Gastrointestinal Diseases	ENSG00000166736	FALSE	Phase II Clinical Trial	1990-07-15	Unused	HTR3A
Gastrointestinal Diseases	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Gastrointestinal Diseases	ENSG00000169432	FALSE	Preclinical	2007-04-02	Unused	SCN9A
Gastrointestinal Diseases	ENSG00000169618	FALSE	Preclinical	2006-12-06	Absent	PROKR1
Gastrointestinal Diseases	ENSG00000169919	FALSE	Preclinical	2015-11-28	Absent	GUSB
Gastrointestinal Diseases	ENSG00000171105	FALSE	Phase III Clinical Trial	2015-04-11	Absent	INSR
Gastrointestinal Diseases	ENSG00000172236	FALSE	Phase I Clinical Trial	1996-06-15	Unused	TPSAB1
Gastrointestinal Diseases	ENSG00000173250	FALSE	Preclinical	2016-11-10	Absent	GPR151
Gastrointestinal Diseases	ENSG00000179921	FALSE	Preclinical	2015-08-14	Absent	GPBAR1
Gastrointestinal Diseases	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Gastrointestinal Diseases	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Gastrointestinal Diseases	ENSG00000182333	FALSE	unknown	1990-11-15	Absent	LIPF
Gastrointestinal Diseases	ENSG00000184502	FALSE	Preclinical	NA	Absent	GAST
Gastrointestinal Diseases	ENSG00000196664	FALSE	Phase I Clinical Trial	2013-09-27	Absent	TLR7
Gastrointestinal Diseases	ENSG00000198851	FALSE	Preclinical	2014-11-11	Absent	CD3E
Gastrointestinal Diseases	ENSG00000215644	TRUE	Approved	1991-09-15	Approved	GCGR
Gastrointestinal Diseases	ENSG00000239732	FALSE	Phase I Clinical Trial	2013-09-27	Absent	TLR9
Gastrointestinal Neoplasms	ENSG00000004487	FALSE	Preclinical	2008-07-31	Absent	KDM1A
Gastrointestinal Neoplasms	ENSG00000010810	FALSE	Pre-registration	2004-07-20	Absent	FYN
Gastrointestinal Neoplasms	ENSG00000025708	FALSE	Phase I Clinical Trial	1998-06-15	Absent	TYMP
Gastrointestinal Neoplasms	ENSG00000037280	TRUE	Approved	2001-04-03	Approved	FLT4
Gastrointestinal Neoplasms	ENSG00000039068	FALSE	Preclinical	2005-09-07	Unused	CDH1
Gastrointestinal Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2015-07-15	Absent	TNFRSF9
Gastrointestinal Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Gastrointestinal Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2004-03-31	Unused	FGFR2
Gastrointestinal Neoplasms	ENSG00000067182	FALSE	unknown	2003-05-23	Phase I Clinical Trial	TNFRSF1A
Gastrointestinal Neoplasms	ENSG00000068078	FALSE	Pre-registration	2001-04-03	Approved	FGFR3
Gastrointestinal Neoplasms	ENSG00000070019	FALSE	Phase I Clinical Trial	2012-02-17	Phase I Clinical Trial	GUCY2C
Gastrointestinal Neoplasms	ENSG00000077238	FALSE	unknown	NA	Unused	IL4R
Gastrointestinal Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Gastrointestinal Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-01-07	Phase II Clinical Trial	HSP90AA1
Gastrointestinal Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT2
Gastrointestinal Neoplasms	ENSG00000097007	TRUE	Approved	1999-03-17	Approved	ABL1
Gastrointestinal Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	NA	Absent	ST13
Gastrointestinal Neoplasms	ENSG00000101017	FALSE	Phase II Clinical Trial	2011-03-15	Absent	CD40
Gastrointestinal Neoplasms	ENSG00000101868	FALSE	unknown	1993-08-15	Phase I Clinical Trial	POLA1
Gastrointestinal Neoplasms	ENSG00000102755	TRUE	Approved	1991-02-15	Approved	FLT1
Gastrointestinal Neoplasms	ENSG00000105388	FALSE	Phase I Clinical Trial	2007-05-01	Phase I Clinical Trial	CEACAM5
Gastrointestinal Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CG
Gastrointestinal Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	2004-08-09	Phase I Clinical Trial	MET
Gastrointestinal Neoplasms	ENSG00000106128	TRUE	Approved	2011-05-31	Absent	GHRHR
Gastrointestinal Neoplasms	ENSG00000109320	FALSE	unknown	1997-11-15	Unused	NFKB1
Gastrointestinal Neoplasms	ENSG00000109471	FALSE	unknown	NA	Unused	IL2
Gastrointestinal Neoplasms	ENSG00000110148	FALSE	Phase II Clinical Trial	1997-06-15	Unused	CCKBR
Gastrointestinal Neoplasms	ENSG00000112715	FALSE	Phase I Clinical Trial	1991-02-15	Unused	VEGFA
Gastrointestinal Neoplasms	ENSG00000113721	FALSE	Pre-registration	1991-02-15	Approved	PDGFRB
Gastrointestinal Neoplasms	ENSG00000116478	FALSE	Preclinical	2008-07-31	Absent	HDAC1
Gastrointestinal Neoplasms	ENSG00000119888	FALSE	unknown	1991-12-15	Unused	EPCAM
Gastrointestinal Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-03-24	Phase I Clinical Trial	TEK
Gastrointestinal Neoplasms	ENSG00000120217	FALSE	Preclinical	2017-04-14	Absent	CD274
Gastrointestinal Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	PIK3CA
Gastrointestinal Neoplasms	ENSG00000122025	TRUE	Approved	1991-02-15	Approved	FLT3
Gastrointestinal Neoplasms	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Gastrointestinal Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL1
Gastrointestinal Neoplasms	ENSG00000126010	FALSE	Preclinical	2016-06-21	Absent	GRPR
Gastrointestinal Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2007-01-30	Absent	MAP2K2
Gastrointestinal Neoplasms	ENSG00000128052	TRUE	Approved	1991-02-15	Approved	KDR
Gastrointestinal Neoplasms	ENSG00000130816	FALSE	unknown	1996-06-15	Unused	DNMT1
Gastrointestinal Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1991-09-15	Unused	TOP2A
Gastrointestinal Neoplasms	ENSG00000134057	FALSE	Phase I Clinical Trial	1991-02-15	Unused	CCNB1
Gastrointestinal Neoplasms	ENSG00000134853	TRUE	Approved	1999-03-17	Approved	PDGFRA
Gastrointestinal Neoplasms	ENSG00000135446	FALSE	unknown	2012-01-04	Absent	CDK4
Gastrointestinal Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Gastrointestinal Neoplasms	ENSG00000136807	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK9
Gastrointestinal Neoplasms	ENSG00000136810	FALSE	unknown	2000-05-11	Unused	TXN
Gastrointestinal Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR1
Gastrointestinal Neoplasms	ENSG00000140443	FALSE	unknown	2005-05-13	Unused	IGF1R
Gastrointestinal Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	2002-05-30	Unused	ERBB2
Gastrointestinal Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Gastrointestinal Neoplasms	ENSG00000142208	FALSE	unknown	1992-08-15	Unused	AKT1
Gastrointestinal Neoplasms	ENSG00000143167	FALSE	unknown	2013-05-24	Absent	GPA33
Gastrointestinal Neoplasms	ENSG00000146648	FALSE	Phase II Clinical Trial	1992-03-15	Phase II Clinical Trial	EGFR
Gastrointestinal Neoplasms	ENSG00000147099	FALSE	Preclinical	2008-07-31	Absent	HDAC8
Gastrointestinal Neoplasms	ENSG00000149294	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NCAM1
Gastrointestinal Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT1
Gastrointestinal Neoplasms	ENSG00000154229	FALSE	Phase I Clinical Trial	1991-02-15	Unused	PRKCA
Gastrointestinal Neoplasms	ENSG00000157404	TRUE	Approved	1991-02-15	Approved	KIT
Gastrointestinal Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Unused	BRAF
Gastrointestinal Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Gastrointestinal Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2006-01-19	Preclinical	FGFR4
Gastrointestinal Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR5
Gastrointestinal Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Gastrointestinal Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	2014-07-15	Absent	CASP3
Gastrointestinal Neoplasms	ENSG00000164362	FALSE	unknown	NA	Unused	TERT
Gastrointestinal Neoplasms	ENSG00000164400	FALSE	Preclinical	2000-09-28	Phase I Clinical Trial	CSF2
Gastrointestinal Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Gastrointestinal Neoplasms	ENSG00000165731	TRUE	Approved	2002-03-21	Approved	RET
Gastrointestinal Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	2008-04-11	Unused	PLK1
Gastrointestinal Neoplasms	ENSG00000168610	FALSE	Phase I Clinical Trial	2010-05-18	Phase I Clinical Trial	STAT3
Gastrointestinal Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2007-01-30	Absent	MAP2K1
Gastrointestinal Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Gastrointestinal Neoplasms	ENSG00000170430	FALSE	unknown	2000-05-03	Unused	MGMT
Gastrointestinal Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CD
Gastrointestinal Neoplasms	ENSG00000171720	FALSE	Preclinical	2008-07-31	Absent	HDAC3
Gastrointestinal Neoplasms	ENSG00000171791	FALSE	unknown	1992-03-15	Unused	BCL2
Gastrointestinal Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Absent	CD248
Gastrointestinal Neoplasms	ENSG00000176105	FALSE	unknown	2004-07-20	Absent	YES1
Gastrointestinal Neoplasms	ENSG00000176890	FALSE	Approved	1991-10-15	Unused	TYMS
Gastrointestinal Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Unused	ERBB4
Gastrointestinal Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2013-01-21	Phase I Clinical Trial	AURKB
Gastrointestinal Neoplasms	ENSG00000179776	FALSE	Phase II Clinical Trial	2000-12-11	Absent	CDH5
Gastrointestinal Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR2
Gastrointestinal Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-08-14	Absent	CSF1R
Gastrointestinal Neoplasms	ENSG00000182866	FALSE	unknown	2004-07-20	Absent	LCK
Gastrointestinal Neoplasms	ENSG00000184502	FALSE	Phase I Clinical Trial	1994-08-15	Unused	GAST
Gastrointestinal Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Gastrointestinal Neoplasms	ENSG00000185338	FALSE	Preclinical	2013-03-15	Absent	SOCS1
Gastrointestinal Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	1993-08-15	Unused	MUC1
Gastrointestinal Neoplasms	ENSG00000186716	TRUE	Approved	1999-03-17	Approved	BCR
Gastrointestinal Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2014-02-21	Absent	PDCD1
Gastrointestinal Neoplasms	ENSG00000196591	FALSE	Preclinical	2008-07-31	Absent	HDAC2
Gastrointestinal Neoplasms	ENSG00000197122	FALSE	unknown	2002-11-12	Unused	SRC
Gastrointestinal Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Phase II Clinical Trial	MTOR
Gastrointestinal Neoplasms	ENSG00000198851	FALSE	unknown	2013-05-24	Absent	CD3E
Gastrointestinal Neoplasms	ENSG00000198900	FALSE	Phase I Clinical Trial	1996-05-15	Unused	TOP1
Gastrointestinal Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL3
Gastrointestinal Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Gastrointestinal Neoplasms	ENSG00000254087	FALSE	Pre-registration	2001-10-30	Phase II Clinical Trial	LYN
Gastrointestinal Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR3
Gastroparesis	ENSG00000070019	FALSE	Phase II Clinical Trial	2011-02-01	Phase II Clinical Trial	GUCY2C
Gastroparesis	ENSG00000080644	FALSE	Phase II Clinical Trial	2007-07-30	Absent	CHRNA3
Gastroparesis	ENSG00000087085	FALSE	unknown	2000-03-01	Unused	ACHE
Gastroparesis	ENSG00000101204	FALSE	Phase II Clinical Trial	2007-07-30	Absent	CHRNA4
Gastroparesis	ENSG00000102539	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	MLNR
Gastroparesis	ENSG00000115353	FALSE	Phase II Clinical Trial	NA	Absent	TACR1
Gastroparesis	ENSG00000117971	FALSE	Phase II Clinical Trial	2007-07-30	Absent	CHRNB4
Gastroparesis	ENSG00000121853	FALSE	Phase III Clinical Trial	1998-10-15	Phase II Clinical Trial	GHSR
Gastroparesis	ENSG00000138735	FALSE	Phase II Clinical Trial	1991-09-15	Unused	PDE5A
Gastroparesis	ENSG00000149295	TRUE	Approved	1992-09-15	Approved	DRD2
Gastroparesis	ENSG00000151577	FALSE	Phase II Clinical Trial	2003-04-28	Unused	DRD3
Gastroparesis	ENSG00000160716	FALSE	Phase II Clinical Trial	2007-07-30	Absent	CHRNB2
Gastroparesis	ENSG00000164270	TRUE	Approved	1991-07-15	Approved	HTR4
Gastroparesis	ENSG00000166736	FALSE	Preclinical	1991-07-15	Unused	HTR3A
Gastroparesis	ENSG00000168539	FALSE	unknown	2000-03-01	Unused	CHRM1
Gastroparesis	ENSG00000181072	FALSE	unknown	2000-03-01	Unused	CHRM2
Gaucher Disease	ENSG00000148154	TRUE	Approved	1989-06-15	Phase III Clinical Trial	UGCG
Gaucher Disease	ENSG00000177628	TRUE	Approved	1992-12-15	Approved	GBA
Giant Lymph Node Hyperplasia	ENSG00000101266	FALSE	Phase I Clinical Trial	2007-05-23	Phase I Clinical Trial	CSNK2A1
Giant Lymph Node Hyperplasia	ENSG00000115008	FALSE	unknown	2009-12-07	Phase II Clinical Trial	IL1A
Giant Lymph Node Hyperplasia	ENSG00000136244	TRUE	Approved	NA	Phase II Clinical Trial	IL6
Giant Lymph Node Hyperplasia	ENSG00000160712	TRUE	Approved	1993-07-15	Approved	IL6R
Glaucoma	ENSG00000004139	FALSE	Preclinical	2017-11-02	Absent	SARM1
Glaucoma	ENSG00000014216	FALSE	Preclinical	2016-04-28	Absent	CAPN1
Glaucoma	ENSG00000023445	FALSE	Preclinical	2002-07-03	Unused	BIRC3
Glaucoma	ENSG00000043591	TRUE	Approved	1994-05-15	Approved	ADRB1
Glaucoma	ENSG00000050628	FALSE	Phase II Clinical Trial	2012-01-17	Phase I Clinical Trial	PTGER3
Glaucoma	ENSG00000064300	FALSE	Phase I Clinical Trial	2011-07-05	Unused	NGFR
Glaucoma	ENSG00000064651	FALSE	Preclinical	2004-07-20	Unused	SLC12A2
Glaucoma	ENSG00000067900	FALSE	Approved	2001-01-10	Phase III Clinical Trial	ROCK1
Glaucoma	ENSG00000069535	FALSE	Preclinical	2002-04-23	Unused	MAOB
Glaucoma	ENSG00000073756	FALSE	Preclinical	1994-06-15	Unused	PTGS2
Glaucoma	ENSG00000074803	FALSE	Preclinical	2004-07-20	Unused	SLC12A1
Glaucoma	ENSG00000075043	FALSE	unknown	NA	Absent	KCNQ2
Glaucoma	ENSG00000089041	FALSE	Preclinical	2007-03-01	Unused	P2RX7
Glaucoma	ENSG00000091831	FALSE	Phase I Clinical Trial	2001-05-14	Unused	ESR1
Glaucoma	ENSG00000092439	FALSE	Preclinical	2011-09-28	Preclinical	TRPM7
Glaucoma	ENSG00000092969	FALSE	Phase I Clinical Trial	2013-03-06	Absent	TGFB2
Glaucoma	ENSG00000095303	FALSE	Preclinical	1994-06-15	Unused	PTGS1
Glaucoma	ENSG00000101966	FALSE	Preclinical	2002-07-03	Unused	XIAP
Glaucoma	ENSG00000102468	FALSE	Phase II Clinical Trial	2005-09-14	Unused	HTR2A
Glaucoma	ENSG00000103546	TRUE	Approved	2009-10-23	Absent	SLC6A2
Glaucoma	ENSG00000104267	TRUE	Approved	1990-01-15	Approved	CA2
Glaucoma	ENSG00000105329	FALSE	Preclinical	NA	Unused	TGFB1
Glaucoma	ENSG00000106144	FALSE	Phase II Clinical Trial	2008-09-30	Preclinical	CASP2
Glaucoma	ENSG00000106683	FALSE	Phase II Clinical Trial	2003-11-14	Absent	LIMK1
Glaucoma	ENSG00000109320	FALSE	Preclinical	1990-06-15	Unused	NFKB1
Glaucoma	ENSG00000110330	FALSE	Preclinical	2002-07-03	Unused	BIRC2
Glaucoma	ENSG00000112115	FALSE	Phase II Clinical Trial	2001-07-24	Absent	IL17A
Glaucoma	ENSG00000112715	FALSE	Phase III Clinical Trial	1993-05-15	Phase III Clinical Trial	VEGFA
Glaucoma	ENSG00000113580	TRUE	Approved	2013-11-21	Absent	NR3C1
Glaucoma	ENSG00000116478	FALSE	Preclinical	2009-01-23	Absent	HDAC1
Glaucoma	ENSG00000117594	FALSE	Phase II Clinical Trial	2008-01-22	Phase II Clinical Trial	HSD11B1
Glaucoma	ENSG00000118432	FALSE	Preclinical	1996-12-15	Unused	CNR1
Glaucoma	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Glaucoma	ENSG00000119630	FALSE	Phase III Clinical Trial	NA	Absent	PGF
Glaucoma	ENSG00000120907	TRUE	Approved	2001-01-04	Approved	ADRA1A
Glaucoma	ENSG00000122420	TRUE	Approved	1991-05-15	Approved	PTGFR
Glaucoma	ENSG00000122543	FALSE	Preclinical	2008-04-02	Unused	OCM
Glaucoma	ENSG00000122756	FALSE	Phase I Clinical Trial	2000-05-31	Unused	CNTFR
Glaucoma	ENSG00000123374	FALSE	Phase II Clinical Trial	2008-10-07	Unused	CDK2
Glaucoma	ENSG00000124762	FALSE	Preclinical	2001-10-04	Unused	CDKN1A
Glaucoma	ENSG00000125384	FALSE	Pre-registration	2007-12-19	Phase II Clinical Trial	PTGER2
Glaucoma	ENSG00000125571	FALSE	Phase II Clinical Trial	2001-07-24	Absent	IL37
Glaucoma	ENSG00000128271	FALSE	Phase II Clinical Trial	2009-07-13	Phase II Clinical Trial	ADORA2A
Glaucoma	ENSG00000130203	FALSE	Preclinical	1999-08-04	Unused	APOE
Glaucoma	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Glaucoma	ENSG00000132530	FALSE	Preclinical	2002-07-03	Unused	XAF1
Glaucoma	ENSG00000132646	FALSE	Preclinical	2004-08-04	Unused	PCNA
Glaucoma	ENSG00000132703	FALSE	Phase II Clinical Trial	2009-07-24	Phase II Clinical Trial	APCS
Glaucoma	ENSG00000133019	TRUE	Approved	1989-08-15	Approved	CHRM3
Glaucoma	ENSG00000134013	FALSE	Preclinical	2010-07-29	Unused	LOXL2
Glaucoma	ENSG00000134058	FALSE	Phase II Clinical Trial	2008-10-07	Unused	CDK7
Glaucoma	ENSG00000134318	TRUE	Approved	2002-06-17	Phase II Clinical Trial	ROCK2
Glaucoma	ENSG00000134640	FALSE	Phase II Clinical Trial	2008-01-15	Absent	MTNR1B
Glaucoma	ENSG00000135914	FALSE	Phase II Clinical Trial	2007-01-26	Unused	HTR2B
Glaucoma	ENSG00000136689	FALSE	Preclinical	1996-07-15	Unused	IL1RN
Glaucoma	ENSG00000136807	FALSE	Phase II Clinical Trial	2008-10-07	Unused	CDK9
Glaucoma	ENSG00000138685	FALSE	Preclinical	1993-05-15	Absent	FGF2
Glaucoma	ENSG00000139625	FALSE	Preclinical	NA	Absent	MAP3K12
Glaucoma	ENSG00000142192	FALSE	Preclinical	2003-06-17	Phase I Clinical Trial	APP
Glaucoma	ENSG00000143839	FALSE	unknown	1989-10-15	Unused	REN
Glaucoma	ENSG00000144891	FALSE	Phase II Clinical Trial	2000-03-29	Unused	AGTR1
Glaucoma	ENSG00000145050	FALSE	Preclinical	2010-01-11	Absent	MANF
Glaucoma	ENSG00000147246	FALSE	Preclinical	2007-01-26	Unused	HTR2C
Glaucoma	ENSG00000149295	FALSE	unknown	NA	Unused	DRD2
Glaucoma	ENSG00000150594	TRUE	Approved	1991-06-15	Approved	ADRA2A
Glaucoma	ENSG00000151067	FALSE	Phase III Clinical Trial	1989-12-15	Unused	CACNA1C
Glaucoma	ENSG00000156113	TRUE	Approved	1989-11-15	Approved	KCNMA1
Glaucoma	ENSG00000159640	FALSE	unknown	NA	Unused	ACE
Glaucoma	ENSG00000162909	FALSE	Preclinical	2016-04-28	Absent	CAPN2
Glaucoma	ENSG00000163485	FALSE	Phase II Clinical Trial	2003-10-08	Phase II Clinical Trial	ADORA1
Glaucoma	ENSG00000168209	FALSE	Preclinical	2003-10-14	Preclinical	DDIT4
Glaucoma	ENSG00000168412	FALSE	Phase II Clinical Trial	2008-01-15	Absent	MTNR1A
Glaucoma	ENSG00000168539	FALSE	Preclinical	1994-09-15	Preclinical	CHRM1
Glaucoma	ENSG00000169047	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IRS1
Glaucoma	ENSG00000169252	TRUE	Approved	1989-07-15	Approved	ADRB2
Glaucoma	ENSG00000169429	FALSE	unknown	2005-10-17	Unused	CXCL8
Glaucoma	ENSG00000170989	FALSE	Preclinical	2011-11-22	Preclinical	S1PR1
Glaucoma	ENSG00000171119	FALSE	Preclinical	NA	Unused	NRTN
Glaucoma	ENSG00000176884	FALSE	Phase III Clinical Trial	1990-06-15	Phase III Clinical Trial	GRIN1
Glaucoma	ENSG00000178394	FALSE	Phase II Clinical Trial	2008-01-15	Absent	HTR1A
Glaucoma	ENSG00000179546	FALSE	Phase II Clinical Trial	2008-01-15	Absent	HTR1D
Glaucoma	ENSG00000181072	FALSE	Preclinical	1997-10-15	Unused	CHRM2
Glaucoma	ENSG00000182541	FALSE	Phase II Clinical Trial	2003-11-14	Phase II Clinical Trial	LIMK2
Glaucoma	ENSG00000184156	FALSE	unknown	NA	Absent	KCNQ3
Glaucoma	ENSG00000186318	FALSE	Preclinical	2003-06-17	Absent	BACE1
Glaucoma	ENSG00000188778	FALSE	unknown	2002-05-21	Unused	ADRB3
Glaucoma	ENSG00000188822	FALSE	Preclinical	2014-11-11	Absent	CNR2
Glaucoma	ENSG00000188906	FALSE	Preclinical	2013-12-02	Absent	LRRK2
Glaucoma	ENSG00000196396	FALSE	Preclinical	2009-06-04	Absent	PTPN1
Glaucoma	ENSG00000197386	FALSE	Preclinical	2003-06-17	Absent	HTT
Glaucoma	ENSG00000197971	FALSE	Phase II Clinical Trial	NA	Unused	MBP
Glaucoma	ENSG00000198400	FALSE	Preclinical	2006-10-30	Preclinical	NTRK1
Glaucoma	ENSG00000249437	FALSE	Preclinical	2002-07-03	Unused	NAIP
Glaucoma	ENSG00000274286	FALSE	Preclinical	1991-03-15	Unused	ADRA2B
Glaucoma	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-07-24	Phase II Clinical Trial	ADORA3
Gliosarcoma	ENSG00000026103	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Gliosarcoma	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Gliosarcoma	ENSG00000092969	FALSE	Phase I Clinical Trial	NA	Unused	TGFB2
Gliosarcoma	ENSG00000105976	FALSE	unknown	2004-08-09	Phase I Clinical Trial	MET
Gliosarcoma	ENSG00000120156	FALSE	unknown	2004-08-09	Phase I Clinical Trial	TEK
Gliosarcoma	ENSG00000122025	FALSE	unknown	2004-08-09	Phase I Clinical Trial	FLT3
Gliosarcoma	ENSG00000128052	FALSE	unknown	2004-08-09	Phase I Clinical Trial	KDR
Gliosarcoma	ENSG00000131203	FALSE	Phase I Clinical Trial	2008-01-23	Absent	IDO1
Gliosarcoma	ENSG00000157404	FALSE	unknown	2004-08-09	Phase I Clinical Trial	KIT
Gliosarcoma	ENSG00000165731	FALSE	unknown	2004-08-09	Phase I Clinical Trial	RET
Gliosarcoma	ENSG00000166501	FALSE	Phase I Clinical Trial	2001-07-03	Phase I Clinical Trial	PRKCB
Glomerulonephritis	ENSG00000009724	FALSE	Preclinical	2008-01-15	Absent	MASP2
Glomerulonephritis	ENSG00000072694	FALSE	unknown	2006-07-31	Absent	FCGR2B
Glomerulonephritis	ENSG00000102524	FALSE	Phase III Clinical Trial	2000-05-03	Preclinical	TNFSF13B
Glomerulonephritis	ENSG00000106799	FALSE	Preclinical	2014-04-29	Absent	TGFBR1
Glomerulonephritis	ENSG00000106804	FALSE	Preclinical	2015-01-30	Absent	C5
Glomerulonephritis	ENSG00000109320	FALSE	Preclinical	2000-11-29	Unused	NFKB1
Glomerulonephritis	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Glomerulonephritis	ENSG00000111537	FALSE	Phase I Clinical Trial	2007-12-17	Phase I Clinical Trial	IFNG
Glomerulonephritis	ENSG00000116711	FALSE	Preclinical	2010-01-22	Unused	PLA2G4A
Glomerulonephritis	ENSG00000121807	FALSE	Phase I Clinical Trial	2007-05-16	Unused	CCR2
Glomerulonephritis	ENSG00000122025	FALSE	Phase II Clinical Trial	2003-10-31	Absent	FLT3
Glomerulonephritis	ENSG00000123374	FALSE	Preclinical	1997-05-15	Unused	CDK2
Glomerulonephritis	ENSG00000125730	FALSE	Phase I Clinical Trial	NA	Absent	C3
Glomerulonephritis	ENSG00000134058	FALSE	Preclinical	1997-05-15	Absent	CDK7
Glomerulonephritis	ENSG00000136807	FALSE	Preclinical	1997-05-15	Absent	CDK9
Glomerulonephritis	ENSG00000144891	FALSE	Phase II Clinical Trial	1992-11-15	Unused	AGTR1
Glomerulonephritis	ENSG00000151617	FALSE	Preclinical	2003-04-01	Preclinical	EDNRA
Glomerulonephritis	ENSG00000161955	FALSE	Phase II Clinical Trial	2000-05-03	Absent	TNFSF13
Glomerulonephritis	ENSG00000163485	FALSE	Preclinical	2015-05-27	Absent	ADORA1
Glomerulonephritis	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Absent	SYK
Glomerulonephritis	ENSG00000170962	FALSE	unknown	2001-05-14	Unused	PDGFD
Glomerulonephritis	ENSG00000188389	FALSE	Preclinical	2013-12-14	Absent	PDCD1
Glomerulonephritis	ENSG00000197405	FALSE	Phase II Clinical Trial	2006-07-25	Absent	C5AR1
Glomerulonephritis	ENSG00000197766	FALSE	Phase II Clinical Trial	2014-08-26	Absent	CFD
Glomerulonephritis	ENSG00000282608	FALSE	Phase I Clinical Trial	2015-05-27	Absent	ADORA3
Glomerulonephritis, Membranoproliferative	ENSG00000000971	FALSE	Preclinical	2009-07-23	Unused	CFH
Glomerulonephritis, Membranoproliferative	ENSG00000009724	FALSE	Phase II Clinical Trial	2008-01-15	Absent	MASP2
Glomerulonephritis, Membranoproliferative	ENSG00000106804	FALSE	Preclinical	1993-08-15	Phase I Clinical Trial	C5
Glomerulonephritis, Membranoproliferative	ENSG00000203710	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CR1
Glomerulonephritis, Membranous	ENSG00000106804	FALSE	Preclinical	2013-06-21	Absent	C5
Glucose Intolerance	ENSG00000004948	FALSE	unknown	NA	Unused	CALCR
Glucose Intolerance	ENSG00000006071	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	ABCC8
Glucose Intolerance	ENSG00000017797	FALSE	Preclinical	2018-01-10	Absent	RALBP1
Glucose Intolerance	ENSG00000085662	TRUE	Approved	NA	Unused	AKR1B1
Glucose Intolerance	ENSG00000112164	FALSE	Preclinical	2014-04-15	Absent	GLP1R
Glucose Intolerance	ENSG00000126266	FALSE	Preclinical	2009-07-28	Preclinical	FFAR1
Glucose Intolerance	ENSG00000132170	TRUE	Approved	1995-03-15	Unused	PPARG
Glucose Intolerance	ENSG00000140675	FALSE	unknown	2007-10-26	Preclinical	SLC5A2
Glucose Intolerance	ENSG00000144891	FALSE	Pre-registration	1992-05-15	Approved	AGTR1
Glucose Intolerance	ENSG00000147262	FALSE	unknown	2008-04-01	Unused	GPR119
Glucose Intolerance	ENSG00000171105	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	INSR
Glucose Intolerance	ENSG00000171298	TRUE	Approved	NA	Approved	GAA
Glucose Intolerance	ENSG00000187486	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	KCNJ11
Glycogen Storage Disease Type I	ENSG00000101986	FALSE	Preclinical	2015-02-09	Absent	ABCD1
Glycogen Storage Disease Type I	ENSG00000131482	FALSE	Preclinical	NA	Absent	G6PC
Glycogen Storage Disease Type I	ENSG00000151090	FALSE	Preclinical	2015-02-09	Absent	THRB
Glycogen Storage Disease Type II	ENSG00000134363	FALSE	Preclinical	2007-05-09	Unused	FST
Glycogen Storage Disease Type II	ENSG00000155511	FALSE	Preclinical	2002-11-15	Absent	GRIA1
Glycogen Storage Disease Type II	ENSG00000171298	TRUE	Approved	1997-04-15	Approved	GAA
Glycogen Storage Disease Type II	ENSG00000185010	FALSE	Preclinical	2013-04-25	Absent	F8
Glycogen Storage Disease Type II	ENSG00000197081	FALSE	Phase III Clinical Trial	2006-01-24	Phase II Clinical Trial	IGF2R
Goiter	ENSG00000165409	FALSE	Phase II Clinical Trial	1990-07-15	Unused	TSHR
Gonorrhea	ENSG00000010610	FALSE	Phase III Clinical Trial	1993-07-15	Unused	CD4
Gonorrhea	ENSG00000131747	FALSE	Phase II Clinical Trial	2012-06-15	Absent	TOP2A
Granulomatosis with Polyangiitis	ENSG00000102524	FALSE	Phase III Clinical Trial	1999-07-13	Preclinical	TNFSF13B
Granulomatosis with Polyangiitis	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Granulomatosis with Polyangiitis	ENSG00000156738	TRUE	Approved	1993-09-15	Approved	MS4A1
Granulomatosis with Polyangiitis	ENSG00000197405	FALSE	unknown	2006-07-25	Absent	C5AR1
Granulomatous Disease, Chronic	ENSG00000027697	TRUE	Approved	NA	Approved	IFNGR1
Granulomatous Disease, Chronic	ENSG00000051523	FALSE	Phase I Clinical Trial	1995-08-15	Unused	CYBA
Granulomatous Disease, Chronic	ENSG00000064300	FALSE	Preclinical	2000-10-25	Unused	NGFR
Granulomatous Disease, Chronic	ENSG00000127415	FALSE	unknown	2002-11-05	Unused	IDUA
Granulomatous Disease, Chronic	ENSG00000158517	FALSE	Phase I Clinical Trial	1995-08-15	Unused	NCF1
Granulomatous Disease, Chronic	ENSG00000165168	FALSE	Phase I Clinical Trial	1995-08-15	Unused	CYBB
Graves Ophthalmopathy	ENSG00000140443	FALSE	Phase III Clinical Trial	2005-08-05	Absent	IGF1R
Graves Ophthalmopathy	ENSG00000165409	FALSE	Preclinical	2015-08-10	Absent	TSHR
Guillain-Barre Syndrome	ENSG00000106804	FALSE	Preclinical	2005-01-31	Unused	C5
Guillain-Barre Syndrome	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Gynecomastia	ENSG00000091831	FALSE	Phase II Clinical Trial	NA	Unused	ESR1
Gynecomastia	ENSG00000109163	TRUE	Approved	NA	Approved	GNRHR
Gynecomastia	ENSG00000137869	FALSE	Phase II Clinical Trial	1991-02-15	Unused	CYP19A1
Haemophilus Infections	ENSG00000131747	FALSE	Preclinical	2017-06-19	Absent	TOP2A
Hamartoma Syndrome, Multiple	ENSG00000105221	FALSE	Preclinical	2008-11-12	Absent	AKT2
Hamartoma Syndrome, Multiple	ENSG00000121879	FALSE	Preclinical	2008-11-12	Phase II Clinical Trial	PIK3CA
Hand-Foot Syndrome	ENSG00000017797	FALSE	Preclinical	2009-03-02	Unused	RALBP1
Hand-Foot Syndrome	ENSG00000188641	FALSE	unknown	1993-07-15	Phase I Clinical Trial	DPYD
Hantavirus Infections	ENSG00000106348	FALSE	unknown	NA	Unused	IMPDH1
Head and Neck Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	2016-10-25	Absent	CFLAR
Head and Neck Neoplasms	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Head and Neck Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Head and Neck Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Head and Neck Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2014-01-01	Absent	BTK
Head and Neck Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Head and Neck Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2006-04-28	Absent	HGF
Head and Neck Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2005-11-21	Absent	BIRC3
Head and Neck Neoplasms	ENSG00000026103	FALSE	Preclinical	2008-06-03	Unused	FAS
Head and Neck Neoplasms	ENSG00000026508	FALSE	Phase I Clinical Trial	1992-11-15	Phase I Clinical Trial	CD44
Head and Neck Neoplasms	ENSG00000027697	FALSE	Phase II Clinical Trial	2005-11-15	Unused	IFNGR1
Head and Neck Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Head and Neck Neoplasms	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Head and Neck Neoplasms	ENSG00000047936	FALSE	unknown	2010-05-17	Absent	ROS1
Head and Neck Neoplasms	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Absent	TNFRSF9
Head and Neck Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Head and Neck Neoplasms	ENSG00000062038	FALSE	Phase I Clinical Trial	2014-07-16	Absent	CDH3
Head and Neck Neoplasms	ENSG00000063176	FALSE	Preclinical	2006-06-05	Absent	SPHK2
Head and Neck Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	ERBB3
Head and Neck Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Head and Neck Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2005-11-15	Unused	TNFRSF1A
Head and Neck Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR3
Head and Neck Neoplasms	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Head and Neck Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Head and Neck Neoplasms	ENSG00000075073	FALSE	Preclinical	2013-02-21	Preclinical	TACR2
Head and Neck Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Head and Neck Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase I Clinical Trial	FGFR1
Head and Neck Neoplasms	ENSG00000078098	FALSE	unknown	1998-07-15	Unused	FAP
Head and Neck Neoplasms	ENSG00000080824	FALSE	Phase I Clinical Trial	2005-12-05	Phase I Clinical Trial	HSP90AA1
Head and Neck Neoplasms	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Head and Neck Neoplasms	ENSG00000081985	FALSE	Phase II Clinical Trial	2011-06-06	Absent	IL12RB2
Head and Neck Neoplasms	ENSG00000082781	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGB5
Head and Neck Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Head and Neck Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Head and Neck Neoplasms	ENSG00000086205	FALSE	Phase II Clinical Trial	2008-03-04	Absent	FOLH1
Head and Neck Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2006-11-20	Phase II Clinical Trial	AURKA
Head and Neck Neoplasms	ENSG00000089685	FALSE	unknown	2005-07-13	Preclinical	BIRC5
Head and Neck Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2012-10-31	Absent	LAG3
Head and Neck Neoplasms	ENSG00000090339	FALSE	Phase I Clinical Trial	2004-07-19	Phase I Clinical Trial	ICAM1
Head and Neck Neoplasms	ENSG00000096968	FALSE	Preclinical	2006-03-06	Unused	JAK2
Head and Neck Neoplasms	ENSG00000096996	FALSE	Phase II Clinical Trial	2011-01-21	Preclinical	IL12RB1
Head and Neck Neoplasms	ENSG00000097007	FALSE	Preclinical	2006-03-06	Unused	ABL1
Head and Neck Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2016-10-12	Absent	CDC7
Head and Neck Neoplasms	ENSG00000100097	FALSE	Phase I Clinical Trial	NA	Absent	LGALS1
Head and Neck Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDGFB
Head and Neck Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	2015-06-16	Phase I Clinical Trial	HIF1A
Head and Neck Neoplasms	ENSG00000100823	FALSE	unknown	2007-02-13	Unused	APEX1
Head and Neck Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2010-07-20	Absent	CD40
Head and Neck Neoplasms	ENSG00000101266	FALSE	Preclinical	2014-10-28	Absent	CSNK2A1
Head and Neck Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Head and Neck Neoplasms	ENSG00000101868	FALSE	unknown	1996-08-15	Unused	POLA1
Head and Neck Neoplasms	ENSG00000101916	FALSE	Phase II Clinical Trial	2008-06-17	Phase I Clinical Trial	TLR8
Head and Neck Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	2015-07-15	Absent	XIAP
Head and Neck Neoplasms	ENSG00000102312	FALSE	Phase I Clinical Trial	2011-05-14	Absent	PORCN
Head and Neck Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Head and Neck Neoplasms	ENSG00000102854	FALSE	Phase I Clinical Trial	1999-04-21	Unused	MSLN
Head and Neck Neoplasms	ENSG00000103222	FALSE	Preclinical	2011-09-28	Preclinical	ABCC1
Head and Neck Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Head and Neck Neoplasms	ENSG00000104365	FALSE	Preclinical	NA	Preclinical	IKBKB
Head and Neck Neoplasms	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Absent	CCNE1
Head and Neck Neoplasms	ENSG00000105221	FALSE	Preclinical	2011-12-19	Absent	AKT2
Head and Neck Neoplasms	ENSG00000105388	FALSE	Phase I Clinical Trial	2010-06-10	Absent	CEACAM5
Head and Neck Neoplasms	ENSG00000105810	FALSE	Phase II Clinical Trial	1996-05-15	Unused	CDK6
Head and Neck Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2015-09-21	Absent	PIK3CG
Head and Neck Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2002-08-01	Phase II Clinical Trial	MET
Head and Neck Neoplasms	ENSG00000107018	FALSE	Phase I Clinical Trial	2007-06-25	Phase I Clinical Trial	RLN1
Head and Neck Neoplasms	ENSG00000107159	FALSE	Preclinical	2014-08-19	Absent	CA9
Head and Neck Neoplasms	ENSG00000109320	FALSE	unknown	1997-11-15	Phase I Clinical Trial	NFKB1
Head and Neck Neoplasms	ENSG00000109458	FALSE	Preclinical	2002-08-01	Unused	GAB1
Head and Neck Neoplasms	ENSG00000109471	FALSE	Phase II Clinical Trial	1997-05-15	Unused	IL2
Head and Neck Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Absent	BIRC2
Head and Neck Neoplasms	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Head and Neck Neoplasms	ENSG00000112062	FALSE	unknown	2008-05-23	Preclinical	MAPK14
Head and Neck Neoplasms	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase I Clinical Trial	VEGFA
Head and Neck Neoplasms	ENSG00000113302	FALSE	Preclinical	1995-09-15	Unused	IL12B
Head and Neck Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Head and Neck Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Unused	PDGFRB
Head and Neck Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Head and Neck Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Head and Neck Neoplasms	ENSG00000116478	FALSE	unknown	2003-12-09	Unused	HDAC1
Head and Neck Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Head and Neck Neoplasms	ENSG00000118520	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG1
Head and Neck Neoplasms	ENSG00000119888	FALSE	Preclinical	2017-09-25	Unused	EPCAM
Head and Neck Neoplasms	ENSG00000120156	FALSE	unknown	2004-06-18	Phase II Clinical Trial	TEK
Head and Neck Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Head and Neck Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Head and Neck Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Head and Neck Neoplasms	ENSG00000122861	FALSE	Phase I Clinical Trial	1999-03-10	Unused	PLAU
Head and Neck Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	2010-12-05	Unused	CDK2
Head and Neck Neoplasms	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Head and Neck Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL1
Head and Neck Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Head and Neck Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K2
Head and Neck Neoplasms	ENSG00000128052	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Head and Neck Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Head and Neck Neoplasms	ENSG00000129484	FALSE	Phase I Clinical Trial	2000-06-26	Phase I Clinical Trial	PARP2
Head and Neck Neoplasms	ENSG00000130037	FALSE	Preclinical	2015-08-14	Absent	KCNA5
Head and Neck Neoplasms	ENSG00000130816	FALSE	unknown	1996-06-15	Unused	DNMT1
Head and Neck Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Absent	IDO1
Head and Neck Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Head and Neck Neoplasms	ENSG00000131724	FALSE	Preclinical	2002-01-09	Unused	IL13RA1
Head and Neck Neoplasms	ENSG00000131747	FALSE	Approved	1991-06-15	Unused	TOP2A
Head and Neck Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	NA	Absent	LGALS3
Head and Neck Neoplasms	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Head and Neck Neoplasms	ENSG00000132646	FALSE	Preclinical	2011-03-30	Preclinical	PCNA
Head and Neck Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Absent	CASP9
Head and Neck Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	2010-12-05	Unused	CDK7
Head and Neck Neoplasms	ENSG00000134460	FALSE	Phase III Clinical Trial	2007-08-23	Phase III Clinical Trial	IL2RA
Head and Neck Neoplasms	ENSG00000134545	FALSE	Phase II Clinical Trial	2006-11-24	Absent	KLRC1
Head and Neck Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRA
Head and Neck Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CDK4
Head and Neck Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Head and Neck Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CDK9
Head and Neck Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Head and Neck Neoplasms	ENSG00000136997	FALSE	Preclinical	2006-03-06	Unused	MYC
Head and Neck Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Head and Neck Neoplasms	ENSG00000137462	FALSE	Phase II Clinical Trial	NA	Absent	TLR2
Head and Neck Neoplasms	ENSG00000137845	FALSE	unknown	2003-09-17	Unused	ADAM10
Head and Neck Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Head and Neck Neoplasms	ENSG00000138448	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGAV
Head and Neck Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Head and Neck Neoplasms	ENSG00000139567	FALSE	Phase I Clinical Trial	2007-05-30	Phase II Clinical Trial	ACVRL1
Head and Neck Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-09-24	Phase II Clinical Trial	IGF1R
Head and Neck Neoplasms	ENSG00000140538	FALSE	unknown	2010-05-17	Absent	NTRK3
Head and Neck Neoplasms	ENSG00000141510	FALSE	Approved	1993-10-15	Unused	TP53
Head and Neck Neoplasms	ENSG00000141736	TRUE	Approved	1997-09-15	Phase III Clinical Trial	ERBB2
Head and Neck Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Unused	AKT1
Head and Neck Neoplasms	ENSG00000142627	FALSE	unknown	2010-05-17	Absent	EPHA2
Head and Neck Neoplasms	ENSG00000143171	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRG
Head and Neck Neoplasms	ENSG00000143226	FALSE	unknown	2004-07-27	Absent	FCGR2A
Head and Neck Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Head and Neck Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Head and Neck Neoplasms	ENSG00000143799	FALSE	Phase I Clinical Trial	2000-06-26	Phase I Clinical Trial	PARP1
Head and Neck Neoplasms	ENSG00000144381	FALSE	Phase I Clinical Trial	2014-10-27	Absent	HSPD1
Head and Neck Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	2016-10-25	Absent	SRD5A1
Head and Neck Neoplasms	ENSG00000146242	FALSE	Preclinical	2016-11-24	Absent	TPBG
Head and Neck Neoplasms	ENSG00000146648	TRUE	Approved	1992-03-15	Approved	EGFR
Head and Neck Neoplasms	ENSG00000147889	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	CDKN2A
Head and Neck Neoplasms	ENSG00000148053	FALSE	unknown	2011-03-24	Absent	NTRK2
Head and Neck Neoplasms	ENSG00000149554	FALSE	Phase I Clinical Trial	2010-03-02	Absent	CHEK1
Head and Neck Neoplasms	ENSG00000150093	FALSE	unknown	2001-11-05	Preclinical	ITGB1
Head and Neck Neoplasms	ENSG00000150337	FALSE	unknown	1995-09-15	Unused	FCGR1A
Head and Neck Neoplasms	ENSG00000151694	FALSE	Preclinical	2003-09-17	Unused	ADAM17
Head and Neck Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Head and Neck Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	KIT
Head and Neck Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	BRAF
Head and Neck Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2016-04-26	Absent	SLC34A2
Head and Neck Neoplasms	ENSG00000159110	TRUE	Approved	2005-10-11	Approved	IFNAR2
Head and Neck Neoplasms	ENSG00000159131	FALSE	Phase III Clinical Trial	1990-07-15	Unused	GART
Head and Neck Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Absent	PKN3
Head and Neck Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Head and Neck Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Preclinical	ITGA5
Head and Neck Neoplasms	ENSG00000162747	FALSE	unknown	2004-07-27	Absent	FCGR3B
Head and Neck Neoplasms	ENSG00000162892	FALSE	Phase I Clinical Trial	1999-07-07	Unused	IL24
Head and Neck Neoplasms	ENSG00000163217	FALSE	Phase I Clinical Trial	2007-05-30	Absent	BMP10
Head and Neck Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Absent	CTLA4
Head and Neck Neoplasms	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Head and Neck Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Head and Neck Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	2014-07-15	Absent	CASP3
Head and Neck Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Absent	TLR3
Head and Neck Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2013-05-28	Absent	TERT
Head and Neck Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2000-09-28	Phase III Clinical Trial	CSF2
Head and Neck Neoplasms	ENSG00000165025	FALSE	Phase I Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Head and Neck Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	2016-10-25	Absent	ENOX2
Head and Neck Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Head and Neck Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Head and Neck Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Head and Neck Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Head and Neck Neoplasms	ENSG00000167325	FALSE	unknown	1997-03-15	Unused	RRM1
Head and Neck Neoplasms	ENSG00000167601	FALSE	Preclinical	2004-06-18	Phase II Clinical Trial	AXL
Head and Neck Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1999-04-21	Unused	EEF2
Head and Neck Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	1996-01-15	Phase II Clinical Trial	FNTA
Head and Neck Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-01-07	Absent	STAT3
Head and Neck Neoplasms	ENSG00000168685	FALSE	Preclinical	2015-10-09	Absent	IL7R
Head and Neck Neoplasms	ENSG00000168811	FALSE	Preclinical	1995-09-15	Unused	IL12A
Head and Neck Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K1
Head and Neck Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Head and Neck Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Unused	PTK2
Head and Neck Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Head and Neck Neoplasms	ENSG00000170312	FALSE	unknown	2004-08-16	Phase II Clinical Trial	CDK1
Head and Neck Neoplasms	ENSG00000171094	FALSE	unknown	2010-05-17	Absent	ALK
Head and Neck Neoplasms	ENSG00000171608	FALSE	Phase II Clinical Trial	2010-01-20	Absent	PIK3CD
Head and Neck Neoplasms	ENSG00000171791	FALSE	Preclinical	2009-04-29	Absent	BCL2
Head and Neck Neoplasms	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Head and Neck Neoplasms	ENSG00000171862	FALSE	unknown	2005-08-22	Phase II Clinical Trial	PTEN
Head and Neck Neoplasms	ENSG00000172270	FALSE	Preclinical	2013-02-21	Preclinical	BSG
Head and Neck Neoplasms	ENSG00000173546	FALSE	Preclinical	2010-05-21	Preclinical	CSPG4
Head and Neck Neoplasms	ENSG00000173638	FALSE	Preclinical	1996-12-15	Unused	SLC19A1
Head and Neck Neoplasms	ENSG00000174125	FALSE	Phase II Clinical Trial	NA	Absent	TLR1
Head and Neck Neoplasms	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-04-30	Absent	ATR
Head and Neck Neoplasms	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Absent	CCNE2
Head and Neck Neoplasms	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Head and Neck Neoplasms	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Head and Neck Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Head and Neck Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2003-11-21	Phase II Clinical Trial	ERBB4
Head and Neck Neoplasms	ENSG00000179295	FALSE	Phase I Clinical Trial	2005-08-19	Unused	PTPN11
Head and Neck Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Phase I Clinical Trial	CDH5
Head and Neck Neoplasms	ENSG00000180871	FALSE	Phase II Clinical Trial	2006-02-08	Absent	CXCR2
Head and Neck Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2008-08-14	Absent	CSF1R
Head and Neck Neoplasms	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Head and Neck Neoplasms	ENSG00000182871	FALSE	Phase III Clinical Trial	2012-01-06	Phase II Clinical Trial	COL18A1
Head and Neck Neoplasms	ENSG00000183765	FALSE	Phase I Clinical Trial	2010-03-02	Absent	CHEK2
Head and Neck Neoplasms	ENSG00000184033	FALSE	Preclinical	2017-01-17	Absent	CTAG1B
Head and Neck Neoplasms	ENSG00000184047	FALSE	Phase II Clinical Trial	2005-11-21	Absent	DIABLO
Head and Neck Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2002-10-02	Absent	TACSTD2
Head and Neck Neoplasms	ENSG00000184937	FALSE	Phase I Clinical Trial	2005-12-05	Phase I Clinical Trial	WT1
Head and Neck Neoplasms	ENSG00000185499	FALSE	Phase I Clinical Trial	2003-12-01	Phase I Clinical Trial	MUC1
Head and Neck Neoplasms	ENSG00000186350	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRA
Head and Neck Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	BCR
Head and Neck Neoplasms	ENSG00000186827	FALSE	Phase II Clinical Trial	2014-08-23	Absent	TNFRSF4
Head and Neck Neoplasms	ENSG00000187555	FALSE	Preclinical	2012-05-01	Absent	USP7
Head and Neck Neoplasms	ENSG00000187764	FALSE	Preclinical	2006-06-20	Absent	SEMA4D
Head and Neck Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Absent	PDCD1
Head and Neck Neoplasms	ENSG00000188641	FALSE	Approved	1993-07-15	Phase II Clinical Trial	DPYD
Head and Neck Neoplasms	ENSG00000196352	FALSE	Phase I Clinical Trial	2004-07-19	Phase I Clinical Trial	CD55
Head and Neck Neoplasms	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Head and Neck Neoplasms	ENSG00000196411	FALSE	Phase I Clinical Trial	2003-08-12	Unused	EPHB4
Head and Neck Neoplasms	ENSG00000196591	FALSE	unknown	2003-12-09	Unused	HDAC2
Head and Neck Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	SRC
Head and Neck Neoplasms	ENSG00000197919	FALSE	unknown	1998-09-15	Unused	IFNA1
Head and Neck Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Head and Neck Neoplasms	ENSG00000198625	FALSE	Preclinical	2015-07-15	Absent	MDM4
Head and Neck Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2006-12-07	Phase II Clinical Trial	MTOR
Head and Neck Neoplasms	ENSG00000198851	FALSE	Preclinical	2004-07-27	Absent	CD3E
Head and Neck Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1995-06-15	Unused	TOP1
Head and Neck Neoplasms	ENSG00000203747	FALSE	unknown	2004-07-27	Absent	FCGR3A
Head and Neck Neoplasms	ENSG00000213903	FALSE	unknown	2008-05-23	Preclinical	LTB4R
Head and Neck Neoplasms	ENSG00000221867	FALSE	Phase II Clinical Trial	2003-02-19	Phase II Clinical Trial	MAGEA3
Head and Neck Neoplasms	ENSG00000228716	FALSE	Phase III Clinical Trial	1991-03-15	Unused	DHFR
Head and Neck Neoplasms	ENSG00000239732	FALSE	Phase II Clinical Trial	2002-09-30	Phase II Clinical Trial	TLR9
Head and Neck Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL3
Head and Neck Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Head and Neck Neoplasms	ENSG00000259207	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGB3
Head and Neck Neoplasms	ENSG00000263761	FALSE	Phase I Clinical Trial	2007-05-30	Absent	GDF2
Headache	ENSG00000010322	FALSE	Phase II Clinical Trial	2012-07-03	Absent	NISCH
Headache	ENSG00000073756	TRUE	Approved	2010-01-04	Approved	PTGS2
Headache	ENSG00000075043	TRUE	Approved	NA	Approved	KCNQ2
Headache	ENSG00000089250	FALSE	unknown	2009-05-27	Phase I Clinical Trial	NOS1
Headache	ENSG00000095303	TRUE	Approved	2010-01-04	Approved	PTGS1
Headache	ENSG00000110680	FALSE	Phase II Clinical Trial	2004-11-12	Absent	CALCA
Headache	ENSG00000112038	TRUE	Approved	NA	Approved	OPRM1
Headache	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Headache	ENSG00000163485	FALSE	unknown	2003-08-19	Unused	ADORA1
Headache	ENSG00000169432	FALSE	unknown	1998-12-15	Unused	SCN9A
Headache	ENSG00000179546	FALSE	Phase II Clinical Trial	2004-11-03	Phase II Clinical Trial	HTR1D
Headache	ENSG00000180914	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	OXTR
Headache	ENSG00000184156	TRUE	Approved	NA	Approved	KCNQ3
Hearing Loss	ENSG00000077782	FALSE	unknown	2009-06-16	Preclinical	FGFR1
Hearing Loss	ENSG00000111276	FALSE	Preclinical	2003-08-26	Unused	CDKN1B
Hearing Loss	ENSG00000113580	FALSE	Phase II Clinical Trial	2002-06-12	Unused	NR3C1
Hearing Loss	ENSG00000121653	FALSE	Phase III Clinical Trial	2003-08-26	Phase II Clinical Trial	MAPK8IP1
Hearing Loss	ENSG00000132170	FALSE	Phase II Clinical Trial	2016-04-28	Absent	PPARG
Hearing Loss	ENSG00000136869	FALSE	Preclinical	2010-12-20	Absent	TLR4
Hearing Loss	ENSG00000137462	FALSE	Preclinical	2010-12-20	Absent	TLR2
Hearing Loss	ENSG00000139292	FALSE	Phase I Clinical Trial	2017-01-26	Absent	LGR5
Hearing Loss	ENSG00000139687	FALSE	Preclinical	2006-01-20	Unused	RB1
Hearing Loss	ENSG00000141510	FALSE	Preclinical	2007-01-31	Unused	TP53
Hearing Loss	ENSG00000151892	FALSE	Preclinical	1993-07-15	Preclinical	GFRA1
Hearing Loss	ENSG00000164342	FALSE	Preclinical	2010-12-21	Absent	TLR3
Hearing Loss	ENSG00000168621	FALSE	unknown	2008-09-26	Absent	GDNF
Hearing Loss	ENSG00000172238	FALSE	Phase II Clinical Trial	2003-06-10	Preclinical	ATOH1
Hearing Loss	ENSG00000196277	FALSE	Preclinical	2016-04-13	Absent	GRM7
Hearing Loss	ENSG00000239732	FALSE	Preclinical	2010-12-20	Absent	TLR9
Heart Failure	ENSG00000005381	FALSE	Preclinical	2016-03-21	Absent	MPO
Heart Failure	ENSG00000006283	TRUE	Approved	1989-09-15	Unused	CACNA1G
Heart Failure	ENSG00000006638	FALSE	unknown	NA	Unused	TBXA2R
Heart Failure	ENSG00000010322	FALSE	Preclinical	2006-11-03	Unused	NISCH
Heart Failure	ENSG00000019991	FALSE	Preclinical	2004-11-23	Absent	HGF
Heart Failure	ENSG00000043591	TRUE	Approved	1989-07-15	Approved	ADRB1
Heart Failure	ENSG00000059377	FALSE	Preclinical	1992-12-15	Unused	TBXAS1
Heart Failure	ENSG00000064012	FALSE	Preclinical	1999-01-15	Unused	CASP8
Heart Failure	ENSG00000064651	FALSE	Pre-registration	2013-04-16	Absent	SLC12A2
Heart Failure	ENSG00000064989	FALSE	Preclinical	2005-05-25	Unused	CALCRL
Heart Failure	ENSG00000065989	FALSE	Approved	1990-07-15	Unused	PDE4A
Heart Failure	ENSG00000066230	FALSE	Phase II Clinical Trial	2011-05-02	Phase II Clinical Trial	SLC9A3
Heart Failure	ENSG00000069431	TRUE	Approved	NA	Absent	ABCC9
Heart Failure	ENSG00000070019	FALSE	Phase II Clinical Trial	2013-12-16	Absent	GUCY2C
Heart Failure	ENSG00000070915	TRUE	Approved	1995-05-15	Approved	SLC12A3
Heart Failure	ENSG00000071242	FALSE	Preclinical	2011-11-16	Unused	RPS6KA2
Heart Failure	ENSG00000074603	FALSE	Phase III Clinical Trial	NA	Unused	DPP8
Heart Failure	ENSG00000074803	FALSE	Pre-registration	2013-04-16	Absent	SLC12A1
Heart Failure	ENSG00000077782	FALSE	unknown	2005-09-14	Unused	FGFR1
Heart Failure	ENSG00000080618	FALSE	Phase I Clinical Trial	2011-11-07	Absent	CPB2
Heart Failure	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Heart Failure	ENSG00000090020	FALSE	Phase I Clinical Trial	2001-08-08	Unused	SLC9A1
Heart Failure	ENSG00000092009	FALSE	Phase II Clinical Trial	2005-05-16	Unused	CMA1
Heart Failure	ENSG00000095303	FALSE	Approved	NA	Unused	PTGS1
Heart Failure	ENSG00000095321	TRUE	Approved	NA	Approved	CRAT
Heart Failure	ENSG00000099822	TRUE	Approved	1993-10-15	Approved	HCN2
Heart Failure	ENSG00000103546	FALSE	Preclinical	1990-08-15	Unused	SLC6A2
Heart Failure	ENSG00000105650	FALSE	Approved	1990-07-15	Unused	PDE4C
Heart Failure	ENSG00000106113	FALSE	unknown	2003-04-30	Phase II Clinical Trial	CRHR2
Heart Failure	ENSG00000107562	FALSE	Phase II Clinical Trial	2007-03-09	Phase II Clinical Trial	CXCL12
Heart Failure	ENSG00000110090	FALSE	Phase II Clinical Trial	2012-09-25	Unused	CPT1A
Heart Failure	ENSG00000111199	FALSE	Phase II Clinical Trial	2014-04-22	Absent	TRPV4
Heart Failure	ENSG00000111319	TRUE	Approved	2017-08-17	Approved	SCNN1A
Heart Failure	ENSG00000112164	FALSE	Phase II Clinical Trial	1997-01-15	Unused	GLP1R
Heart Failure	ENSG00000112715	FALSE	Preclinical	2000-05-24	Preclinical	VEGFA
Heart Failure	ENSG00000112964	FALSE	Phase II Clinical Trial	NA	Absent	GHR
Heart Failure	ENSG00000113083	FALSE	Preclinical	1996-02-15	Unused	LOX
Heart Failure	ENSG00000113161	FALSE	Approved	1997-02-15	Unused	HMGCR
Heart Failure	ENSG00000113448	FALSE	Approved	1990-07-15	Unused	PDE4D
Heart Failure	ENSG00000113749	FALSE	Preclinical	1990-01-15	Unused	HRH2
Heart Failure	ENSG00000114812	FALSE	Phase II Clinical Trial	2010-11-16	Preclinical	VIPR1
Heart Failure	ENSG00000114854	TRUE	Approved	1991-05-15	Approved	TNNC1
Heart Failure	ENSG00000115252	FALSE	Preclinical	2007-06-26	Absent	PDE1A
Heart Failure	ENSG00000115263	FALSE	Phase II Clinical Trial	2002-05-03	Phase II Clinical Trial	GCG
Heart Failure	ENSG00000116478	FALSE	Preclinical	2005-05-31	Unused	HDAC1
Heart Failure	ENSG00000116783	FALSE	Preclinical	NA	Absent	TNNI3K
Heart Failure	ENSG00000117298	FALSE	Phase II Clinical Trial	1995-10-15	Unused	ECE1
Heart Failure	ENSG00000119535	FALSE	Phase I Clinical Trial	2012-03-21	Phase II Clinical Trial	CSF3R
Heart Failure	ENSG00000120907	TRUE	Approved	2012-09-20	Approved	ADRA1A
Heart Failure	ENSG00000121361	TRUE	Approved	1997-12-15	Unused	KCNJ8
Heart Failure	ENSG00000122585	FALSE	unknown	NA	Unused	NPY
Heart Failure	ENSG00000123454	FALSE	Phase I Clinical Trial	1996-12-15	Unused	DBH
Heart Failure	ENSG00000125510	FALSE	Preclinical	2002-11-29	Unused	OPRL1
Heart Failure	ENSG00000125538	FALSE	unknown	2006-01-18	Preclinical	IL1B
Heart Failure	ENSG00000126218	FALSE	Phase III Clinical Trial	2001-01-09	Absent	F10
Heart Failure	ENSG00000126895	FALSE	Phase III Clinical Trial	1992-04-15	Phase III Clinical Trial	AVPR2
Heart Failure	ENSG00000128271	FALSE	Preclinical	1998-04-15	Unused	ADORA2A
Heart Failure	ENSG00000129151	FALSE	Approved	1995-07-15	Unused	BBOX1
Heart Failure	ENSG00000130234	FALSE	Preclinical	2000-09-14	Unused	ACE2
Heart Failure	ENSG00000130368	FALSE	Preclinical	2008-03-25	Preclinical	MAS1
Heart Failure	ENSG00000131196	FALSE	Preclinical	2000-08-16	Unused	NFATC1
Heart Failure	ENSG00000131981	FALSE	Preclinical	2012-04-28	Preclinical	LGALS3
Heart Failure	ENSG00000132170	FALSE	unknown	1989-09-15	Phase III Clinical Trial	PPARG
Heart Failure	ENSG00000132329	FALSE	Preclinical	2005-05-25	Unused	RAMP1
Heart Failure	ENSG00000134318	FALSE	Preclinical	2004-08-20	Unused	ROCK2
Heart Failure	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Heart Failure	ENSG00000135914	FALSE	Preclinical	2009-05-05	Unused	HTR2B
Heart Failure	ENSG00000136160	FALSE	Phase III Clinical Trial	1994-10-15	Unused	EDNRB
Heart Failure	ENSG00000136689	FALSE	Preclinical	2006-10-02	Preclinical	IL1RN
Heart Failure	ENSG00000137193	FALSE	Preclinical	2017-03-28	Absent	PIM1
Heart Failure	ENSG00000137752	FALSE	Preclinical	NA	Unused	CASP1
Heart Failure	ENSG00000138622	TRUE	Approved	1993-10-15	Approved	HCN4
Heart Failure	ENSG00000138735	FALSE	Phase I Clinical Trial	1991-09-15	Unused	PDE5A
Heart Failure	ENSG00000138792	FALSE	Phase II Clinical Trial	2007-12-11	Absent	ENPEP
Heart Failure	ENSG00000140675	FALSE	Phase III Clinical Trial	2004-11-22	Absent	SLC5A2
Heart Failure	ENSG00000142606	FALSE	Phase II Clinical Trial	1998-10-15	Unused	MMEL1
Heart Failure	ENSG00000143630	TRUE	Approved	1993-10-15	Approved	HCN3
Heart Failure	ENSG00000143839	FALSE	Phase III Clinical Trial	1998-03-15	Phase III Clinical Trial	REN
Heart Failure	ENSG00000144891	TRUE	Approved	1989-11-15	Approved	AGTR1
Heart Failure	ENSG00000147166	FALSE	Preclinical	2012-09-24	Preclinical	ITGB1BP2
Heart Failure	ENSG00000148926	FALSE	Preclinical	2013-01-04	Absent	ADM
Heart Failure	ENSG00000149295	FALSE	Phase III Clinical Trial	1990-06-15	Unused	DRD2
Heart Failure	ENSG00000150594	TRUE	Approved	NA	Approved	ADRA2A
Heart Failure	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Heart Failure	ENSG00000151617	FALSE	Phase III Clinical Trial	1991-04-15	Unused	EDNRA
Heart Failure	ENSG00000151623	TRUE	Approved	1994-05-15	Approved	NR3C2
Heart Failure	ENSG00000151704	FALSE	Phase I Clinical Trial	2011-06-13	Absent	KCNJ1
Heart Failure	ENSG00000151929	FALSE	Preclinical	2016-12-01	Absent	BAG3
Heart Failure	ENSG00000154229	FALSE	Preclinical	2005-06-01	Unused	PRKCA
Heart Failure	ENSG00000157168	FALSE	Pre-registration	1989-06-15	Phase III Clinical Trial	NRG1
Heart Failure	ENSG00000158125	FALSE	Phase II Clinical Trial	1997-06-15	Unused	XDH
Heart Failure	ENSG00000158458	FALSE	Preclinical	2000-07-19	Unused	NRG2
Heart Failure	ENSG00000158859	FALSE	Preclinical	2015-09-03	Absent	ADAMTS4
Heart Failure	ENSG00000159640	TRUE	Approved	1989-05-15	Approved	ACE
Heart Failure	ENSG00000159899	FALSE	Phase II Clinical Trial	2007-07-31	Phase II Clinical Trial	NPR2
Heart Failure	ENSG00000160013	FALSE	Phase II Clinical Trial	NA	Unused	PTGIR
Heart Failure	ENSG00000160712	FALSE	Approved	NA	Unused	IL6R
Heart Failure	ENSG00000160882	FALSE	Phase I Clinical Trial	2006-12-07	Absent	CYP11B1
Heart Failure	ENSG00000160951	FALSE	unknown	2010-11-12	Unused	PTGER1
Heart Failure	ENSG00000163399	TRUE	Approved	1992-10-15	Approved	ATP1A1
Heart Failure	ENSG00000163485	FALSE	Phase III Clinical Trial	1991-08-15	Phase I Clinical Trial	ADORA1
Heart Failure	ENSG00000164128	FALSE	Preclinical	1996-10-15	Unused	NPY1R
Heart Failure	ENSG00000164270	FALSE	Phase I Clinical Trial	1991-01-15	Phase I Clinical Trial	HTR4
Heart Failure	ENSG00000164305	FALSE	Preclinical	1998-05-15	Unused	CASP3
Heart Failure	ENSG00000164588	TRUE	Approved	1993-10-15	Approved	HCN1
Heart Failure	ENSG00000164867	FALSE	Phase I Clinical Trial	1998-05-15	Unused	NOS3
Heart Failure	ENSG00000166148	FALSE	Phase I Clinical Trial	1992-01-15	Unused	AVPR1A
Heart Failure	ENSG00000169083	FALSE	Phase II Clinical Trial	2014-01-29	Phase II Clinical Trial	AR
Heart Failure	ENSG00000169252	TRUE	Approved	1989-09-15	Approved	ADRB2
Heart Failure	ENSG00000169418	TRUE	Approved	1990-02-15	Approved	NPR1
Heart Failure	ENSG00000170214	TRUE	Approved	NA	Approved	ADRA1B
Heart Failure	ENSG00000171049	FALSE	Preclinical	2008-03-25	Absent	FPR2
Heart Failure	ENSG00000171388	FALSE	Phase I Clinical Trial	2013-09-18	Absent	APLN
Heart Failure	ENSG00000171509	FALSE	Approved	2007-10-23	Approved	RXFP1
Heart Failure	ENSG00000171522	FALSE	Preclinical	2012-01-17	Preclinical	PTGER4
Heart Failure	ENSG00000171608	FALSE	Preclinical	2010-05-26	Unused	PIK3CD
Heart Failure	ENSG00000171873	TRUE	Approved	NA	Approved	ADRA1D
Heart Failure	ENSG00000172572	TRUE	Approved	1989-05-15	Approved	PDE3A
Heart Failure	ENSG00000173020	FALSE	Preclinical	1997-05-15	Unused	GRK2
Heart Failure	ENSG00000173198	FALSE	Preclinical	NA	Unused	CYSLTR1
Heart Failure	ENSG00000173250	FALSE	Preclinical	2017-08-18	Absent	GPR151
Heart Failure	ENSG00000173327	FALSE	Phase I Clinical Trial	2015-10-26	Absent	MAP3K11
Heart Failure	ENSG00000174233	FALSE	Phase II Clinical Trial	2013-09-04	Absent	ADCY6
Heart Failure	ENSG00000174437	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	ATP2A2
Heart Failure	ENSG00000177272	FALSE	Approved	NA	Unused	KCNA3
Heart Failure	ENSG00000177606	FALSE	unknown	2008-08-26	Unused	JUN
Heart Failure	ENSG00000178473	FALSE	Phase II Clinical Trial	2010-05-11	Unused	UCN3
Heart Failure	ENSG00000179142	FALSE	Phase I Clinical Trial	2006-12-07	Unused	CYP11B2
Heart Failure	ENSG00000180772	FALSE	unknown	1993-06-15	Unused	AGTR2
Heart Failure	ENSG00000181104	FALSE	Preclinical	2000-09-06	Unused	F2R
Heart Failure	ENSG00000181408	FALSE	Preclinical	1999-09-22	Unused	UTS2R
Heart Failure	ENSG00000183023	FALSE	Phase II Clinical Trial	1998-12-15	Unused	SLC8A1
Heart Failure	ENSG00000183873	FALSE	Preclinical	2007-08-24	Unused	SCN5A
Heart Failure	ENSG00000184160	TRUE	Approved	NA	Approved	ADRA2C
Heart Failure	ENSG00000184381	FALSE	Preclinical	1998-12-15	Unused	PLA2G6
Heart Failure	ENSG00000184588	FALSE	Approved	1990-07-15	Unused	PDE4B
Heart Failure	ENSG00000184845	FALSE	Preclinical	1990-08-15	Unused	DRD1
Heart Failure	ENSG00000186951	FALSE	unknown	2004-02-06	Unused	PPARA
Heart Failure	ENSG00000187266	FALSE	Phase II Clinical Trial	1996-10-15	Phase III Clinical Trial	EPOR
Heart Failure	ENSG00000196218	FALSE	Preclinical	2004-12-03	Unused	RYR1
Heart Failure	ENSG00000196549	TRUE	Approved	1989-08-15	Phase III Clinical Trial	MME
Heart Failure	ENSG00000196591	FALSE	Preclinical	2005-05-31	Unused	HDAC2
Heart Failure	ENSG00000196639	FALSE	Preclinical	1990-01-15	Unused	HRH1
Heart Failure	ENSG00000196689	FALSE	Preclinical	NA	Absent	TRPV1
Heart Failure	ENSG00000197635	FALSE	Phase I Clinical Trial	2010-12-01	Phase II Clinical Trial	DPP4
Heart Failure	ENSG00000197747	FALSE	Preclinical	2014-08-13	Absent	S100A10
Heart Failure	ENSG00000198049	FALSE	Preclinical	1992-01-15	Unused	AVPR1B
Heart Failure	ENSG00000198523	FALSE	Preclinical	2002-11-22	Unused	PLN
Heart Failure	ENSG00000198626	FALSE	Phase II Clinical Trial	2004-12-03	Phase II Clinical Trial	RYR2
Heart Failure	ENSG00000198668	FALSE	Preclinical	NA	Unused	CALM1
Heart Failure	ENSG00000204174	FALSE	Preclinical	2006-11-03	Absent	NPY4R
Heart Failure	ENSG00000228716	FALSE	Preclinical	NA	Unused	DHFR
Heart Failure	ENSG00000269858	FALSE	Preclinical	2010-08-28	Absent	EGLN2
Heart Failure	ENSG00000274286	TRUE	Approved	NA	Approved	ADRA2B
Heat Stroke	ENSG00000196218	FALSE	Pre-registration	NA	Absent	RYR1
Helicobacter Infections	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Helicobacter Infections	ENSG00000110148	FALSE	Phase I Clinical Trial	2015-12-10	Absent	CCKBR
Helicobacter Infections	ENSG00000113749	TRUE	Approved	NA	Unused	HRH2
Hemangioma	ENSG00000043591	TRUE	Approved	NA	Absent	ADRB1
Hemangioma, Cavernous, Central Nervous System	ENSG00000134318	FALSE	Preclinical	2004-08-13	Absent	ROCK2
Hematologic Neoplasms	ENSG00000004487	FALSE	Preclinical	2010-08-17	Preclinical	KDM1A
Hematologic Neoplasms	ENSG00000005844	FALSE	Preclinical	2009-11-03	Unused	ITGAL
Hematologic Neoplasms	ENSG00000007908	FALSE	Phase I Clinical Trial	2005-05-25	Phase I Clinical Trial	SELE
Hematologic Neoplasms	ENSG00000010671	FALSE	Phase I Clinical Trial	2013-05-07	Preclinical	BTK
Hematologic Neoplasms	ENSG00000012124	FALSE	Preclinical	2017-01-09	Preclinical	CD22
Hematologic Neoplasms	ENSG00000019582	FALSE	Preclinical	2016-11-25	Absent	CD74
Hematologic Neoplasms	ENSG00000037280	FALSE	unknown	2003-07-23	Absent	FLT4
Hematologic Neoplasms	ENSG00000048462	FALSE	Preclinical	2015-01-24	Absent	TNFRSF17
Hematologic Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2015-01-05	Absent	TNFRSF9
Hematologic Neoplasms	ENSG00000051382	FALSE	Preclinical	2007-12-18	Absent	PIK3CB
Hematologic Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2006-01-19	Phase I Clinical Trial	FGFR2
Hematologic Neoplasms	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Hematologic Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-23	Phase I Clinical Trial	FGFR3
Hematologic Neoplasms	ENSG00000070501	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	POLB
Hematologic Neoplasms	ENSG00000072062	FALSE	Preclinical	2016-06-02	Absent	PRKACA
Hematologic Neoplasms	ENSG00000074590	FALSE	Preclinical	2007-05-16	Absent	NUAK1
Hematologic Neoplasms	ENSG00000077238	FALSE	Preclinical	2014-01-18	Absent	IL4R
Hematologic Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-23	Phase I Clinical Trial	FGFR1
Hematologic Neoplasms	ENSG00000080824	FALSE	Phase I Clinical Trial	2005-02-11	Unused	HSP90AA1
Hematologic Neoplasms	ENSG00000081051	FALSE	Preclinical	2014-11-13	Absent	AFP
Hematologic Neoplasms	ENSG00000082898	FALSE	Preclinical	2009-01-22	Absent	XPO1
Hematologic Neoplasms	ENSG00000086205	FALSE	Preclinical	2017-01-18	Absent	FOLH1
Hematologic Neoplasms	ENSG00000087586	FALSE	unknown	2004-12-14	Unused	AURKA
Hematologic Neoplasms	ENSG00000089692	FALSE	Phase I Clinical Trial	2015-10-14	Absent	LAG3
Hematologic Neoplasms	ENSG00000096968	FALSE	Preclinical	2007-03-05	Unused	JAK2
Hematologic Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Phase I Clinical Trial	ABL1
Hematologic Neoplasms	ENSG00000097046	FALSE	Preclinical	2008-10-16	Unused	CDC7
Hematologic Neoplasms	ENSG00000100823	FALSE	Preclinical	1993-03-15	Phase I Clinical Trial	APEX1
Hematologic Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2014-11-01	Absent	CD40
Hematologic Neoplasms	ENSG00000101868	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	POLA1
Hematologic Neoplasms	ENSG00000101916	FALSE	Preclinical	2006-07-28	Preclinical	TLR8
Hematologic Neoplasms	ENSG00000102755	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	FLT1
Hematologic Neoplasms	ENSG00000104365	FALSE	Phase I Clinical Trial	2001-01-23	Unused	IKBKB
Hematologic Neoplasms	ENSG00000104689	FALSE	unknown	2012-12-03	Phase II Clinical Trial	TNFRSF10A
Hematologic Neoplasms	ENSG00000105221	FALSE	Preclinical	2011-12-19	Preclinical	AKT2
Hematologic Neoplasms	ENSG00000105397	FALSE	Preclinical	2007-03-05	Unused	TYK2
Hematologic Neoplasms	ENSG00000105810	FALSE	Phase II Clinical Trial	2007-05-16	Absent	CDK6
Hematologic Neoplasms	ENSG00000105851	FALSE	Phase II Clinical Trial	2009-07-15	Phase I Clinical Trial	PIK3CG
Hematologic Neoplasms	ENSG00000105953	FALSE	Phase I Clinical Trial	2008-07-26	Absent	OGDH
Hematologic Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	2011-08-09	Absent	MET
Hematologic Neoplasms	ENSG00000107562	FALSE	Phase I Clinical Trial	2007-04-10	Phase I Clinical Trial	CXCL12
Hematologic Neoplasms	ENSG00000107738	FALSE	Preclinical	2016-12-20	Absent	VSIR
Hematologic Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	2008-10-02	Absent	NFKB1
Hematologic Neoplasms	ENSG00000110448	FALSE	Preclinical	2007-07-19	Unused	CD5
Hematologic Neoplasms	ENSG00000112486	FALSE	Preclinical	2015-10-27	Absent	CCR6
Hematologic Neoplasms	ENSG00000113575	FALSE	Preclinical	2008-02-29	Absent	PPP2CA
Hematologic Neoplasms	ENSG00000113580	FALSE	Preclinical	2015-09-14	Absent	NR3C1
Hematologic Neoplasms	ENSG00000113721	FALSE	unknown	2003-07-23	Absent	PDGFRB
Hematologic Neoplasms	ENSG00000114423	FALSE	Preclinical	2006-03-17	Absent	CBLB
Hematologic Neoplasms	ENSG00000115170	FALSE	Preclinical	2007-03-05	Unused	ACVR1
Hematologic Neoplasms	ENSG00000115232	FALSE	unknown	2006-05-17	Unused	ITGA4
Hematologic Neoplasms	ENSG00000115414	FALSE	Phase I Clinical Trial	2004-02-11	Unused	FN1
Hematologic Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Hematologic Neoplasms	ENSG00000118513	FALSE	Preclinical	2013-03-20	Absent	MYB
Hematologic Neoplasms	ENSG00000119535	FALSE	Preclinical	1999-04-21	Unused	CSF3R
Hematologic Neoplasms	ENSG00000120156	FALSE	Phase I Clinical Trial	2006-01-19	Phase I Clinical Trial	TEK
Hematologic Neoplasms	ENSG00000120217	FALSE	Phase I Clinical Trial	2011-04-27	Absent	CD274
Hematologic Neoplasms	ENSG00000120889	FALSE	unknown	2012-12-03	Phase II Clinical Trial	TNFRSF10B
Hematologic Neoplasms	ENSG00000120949	FALSE	Phase I Clinical Trial	2002-10-28	Absent	TNFRSF8
Hematologic Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	2008-11-24	Absent	PIK3CA
Hematologic Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	CXCR4
Hematologic Neoplasms	ENSG00000121989	FALSE	Preclinical	2000-01-19	Unused	ACVR2A
Hematologic Neoplasms	ENSG00000122025	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	FLT3
Hematologic Neoplasms	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK2
Hematologic Neoplasms	ENSG00000125498	FALSE	Phase I Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Hematologic Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Preclinical	CD70
Hematologic Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K2
Hematologic Neoplasms	ENSG00000128052	FALSE	unknown	2003-07-23	Unused	KDR
Hematologic Neoplasms	ENSG00000130816	FALSE	Preclinical	2010-08-16	Preclinical	DNMT1
Hematologic Neoplasms	ENSG00000131203	FALSE	Phase I Clinical Trial	2016-01-21	Absent	IDO1
Hematologic Neoplasms	ENSG00000131828	FALSE	Phase I Clinical Trial	2008-07-26	Phase I Clinical Trial	PDHA1
Hematologic Neoplasms	ENSG00000132964	FALSE	Preclinical	2010-07-12	Absent	CDK8
Hematologic Neoplasms	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK7
Hematologic Neoplasms	ENSG00000134545	FALSE	Phase I Clinical Trial	2006-11-24	Absent	KLRC1
Hematologic Neoplasms	ENSG00000134853	FALSE	Phase I Clinical Trial	2013-10-05	Absent	PDGFRA
Hematologic Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	2007-05-16	Phase I Clinical Trial	CDK4
Hematologic Neoplasms	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-09-07	Phase I Clinical Trial	MDM2
Hematologic Neoplasms	ENSG00000136244	FALSE	Preclinical	NA	Unused	IL6
Hematologic Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2015-06-01	Absent	IL10
Hematologic Neoplasms	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK9
Hematologic Neoplasms	ENSG00000136997	FALSE	Preclinical	2011-09-28	Preclinical	MYC
Hematologic Neoplasms	ENSG00000138039	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	LHCGR
Hematologic Neoplasms	ENSG00000138160	FALSE	Preclinical	2014-12-10	Absent	KIF11
Hematologic Neoplasms	ENSG00000138413	FALSE	Phase I Clinical Trial	2010-04-19	Absent	IDH1
Hematologic Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2004-10-04	Phase I Clinical Trial	IGF1R
Hematologic Neoplasms	ENSG00000140992	FALSE	Preclinical	NA	Absent	PDPK1
Hematologic Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	2008-08-11	Phase II Clinical Trial	TP53
Hematologic Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD4
Hematologic Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	2004-03-23	Phase II Clinical Trial	AKT1
Hematologic Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	MCL1
Hematologic Neoplasms	ENSG00000143799	FALSE	Preclinical	2011-12-19	Preclinical	PARP1
Hematologic Neoplasms	ENSG00000146648	FALSE	unknown	2003-07-23	Absent	EGFR
Hematologic Neoplasms	ENSG00000147437	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	GNRH1
Hematologic Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Hematologic Neoplasms	ENSG00000149554	FALSE	Preclinical	2007-09-24	Absent	CHEK1
Hematologic Neoplasms	ENSG00000156738	FALSE	Preclinical	2016-02-11	Preclinical	MS4A1
Hematologic Neoplasms	ENSG00000157404	FALSE	Phase I Clinical Trial	2003-07-23	Absent	KIT
Hematologic Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2011-09-22	Absent	BRAF
Hematologic Neoplasms	ENSG00000160255	FALSE	Preclinical	2009-11-03	Unused	ITGB2
Hematologic Neoplasms	ENSG00000160791	FALSE	Preclinical	2015-10-27	Absent	CCR5
Hematologic Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2006-01-19	Phase I Clinical Trial	FGFR4
Hematologic Neoplasms	ENSG00000162434	FALSE	Preclinical	2007-03-05	Unused	JAK1
Hematologic Neoplasms	ENSG00000163599	FALSE	Preclinical	2017-01-27	Absent	CTLA4
Hematologic Neoplasms	ENSG00000163600	FALSE	Phase II Clinical Trial	2015-11-05	Absent	ICOS
Hematologic Neoplasms	ENSG00000163823	FALSE	Preclinical	2015-12-08	Absent	CCR1
Hematologic Neoplasms	ENSG00000165025	FALSE	Phase II Clinical Trial	2010-06-25	Absent	SYK
Hematologic Neoplasms	ENSG00000165280	FALSE	Phase I Clinical Trial	2013-11-18	Absent	VCP
Hematologic Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	PLK1
Hematologic Neoplasms	ENSG00000167325	FALSE	unknown	1997-03-15	Unused	RRM1
Hematologic Neoplasms	ENSG00000167601	FALSE	Phase I Clinical Trial	2011-06-17	Absent	AXL
Hematologic Neoplasms	ENSG00000167658	FALSE	Preclinical	2008-03-26	Absent	EEF2
Hematologic Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	2006-07-12	Absent	FNTA
Hematologic Neoplasms	ENSG00000168918	FALSE	Preclinical	NA	Preclinical	INPP5D
Hematologic Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K1
Hematologic Neoplasms	ENSG00000169925	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD3
Hematologic Neoplasms	ENSG00000170425	FALSE	Preclinical	2016-07-28	Absent	ADORA2B
Hematologic Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-01-31	Absent	ALK
Hematologic Neoplasms	ENSG00000171552	FALSE	Phase I Clinical Trial	2006-12-15	Phase II Clinical Trial	BCL2L1
Hematologic Neoplasms	ENSG00000171608	FALSE	Phase II Clinical Trial	2007-12-18	Phase I Clinical Trial	PIK3CD
Hematologic Neoplasms	ENSG00000171791	FALSE	Phase I Clinical Trial	2006-12-15	Phase II Clinical Trial	BCL2
Hematologic Neoplasms	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Hematologic Neoplasms	ENSG00000173762	FALSE	Preclinical	2008-03-26	Absent	CD7
Hematologic Neoplasms	ENSG00000174175	FALSE	Phase I Clinical Trial	2005-05-25	Phase I Clinical Trial	SELP
Hematologic Neoplasms	ENSG00000177455	FALSE	Phase I Clinical Trial	2007-08-07	Phase I Clinical Trial	CD19
Hematologic Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Hematologic Neoplasms	ENSG00000178568	FALSE	Preclinical	2011-12-19	Preclinical	ERBB4
Hematologic Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2004-02-03	Unused	AURKB
Hematologic Neoplasms	ENSG00000180871	FALSE	Preclinical	2015-10-27	Absent	CXCR2
Hematologic Neoplasms	ENSG00000182054	FALSE	Phase I Clinical Trial	2011-11-14	Absent	IDH2
Hematologic Neoplasms	ENSG00000182578	FALSE	Phase I Clinical Trial	2009-09-21	Absent	CSF1R
Hematologic Neoplasms	ENSG00000183813	FALSE	Preclinical	2015-10-27	Absent	CCR4
Hematologic Neoplasms	ENSG00000184033	FALSE	Preclinical	2010-06-25	Absent	CTAG1B
Hematologic Neoplasms	ENSG00000184937	FALSE	Phase I Clinical Trial	2012-05-14	Preclinical	WT1
Hematologic Neoplasms	ENSG00000185291	FALSE	Phase I Clinical Trial	2007-03-13	Unused	IL3RA
Hematologic Neoplasms	ENSG00000185483	FALSE	Preclinical	2016-09-20	Absent	ROR1
Hematologic Neoplasms	ENSG00000185686	FALSE	Preclinical	2014-04-01	Absent	PRAME
Hematologic Neoplasms	ENSG00000186716	FALSE	Phase I Clinical Trial	2006-01-19	Phase I Clinical Trial	BCR
Hematologic Neoplasms	ENSG00000186827	FALSE	Phase II Clinical Trial	2015-08-19	Absent	TNFRSF4
Hematologic Neoplasms	ENSG00000186891	FALSE	Preclinical	2015-03-06	Absent	TNFRSF18
Hematologic Neoplasms	ENSG00000188211	FALSE	Preclinical	2015-10-15	Absent	NCR3LG1
Hematologic Neoplasms	ENSG00000188379	FALSE	Approved	2017-07-13	Absent	IFNA2
Hematologic Neoplasms	ENSG00000188389	FALSE	Phase I Clinical Trial	2015-10-14	Unused	PDCD1
Hematologic Neoplasms	ENSG00000188404	FALSE	Phase I Clinical Trial	2005-05-25	Phase I Clinical Trial	SELL
Hematologic Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Hematologic Neoplasms	ENSG00000196664	FALSE	Preclinical	2006-07-28	Preclinical	TLR7
Hematologic Neoplasms	ENSG00000196776	FALSE	Preclinical	2016-12-07	Absent	CD47
Hematologic Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Unused	SRC
Hematologic Neoplasms	ENSG00000198053	FALSE	Preclinical	2011-05-14	Preclinical	SIRPA
Hematologic Neoplasms	ENSG00000198625	FALSE	Phase I Clinical Trial	2012-09-07	Absent	MDM4
Hematologic Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2007-01-26	Phase I Clinical Trial	MTOR
Hematologic Neoplasms	ENSG00000198851	FALSE	Preclinical	2017-08-04	Absent	CD3E
Hematologic Neoplasms	ENSG00000198900	FALSE	Preclinical	2012-11-05	Preclinical	TOP1
Hematologic Neoplasms	ENSG00000240505	FALSE	Preclinical	2015-01-24	Absent	TNFRSF13B
Hematologic Neoplasms	ENSG00000243772	FALSE	Phase I Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Hemic and Lymphatic Diseases	ENSG00000005961	TRUE	Approved	1993-06-15	Absent	ITGA2B
Hemic and Lymphatic Diseases	ENSG00000132356	FALSE	Preclinical	NA	Absent	PRKAA1
Hemic and Lymphatic Diseases	ENSG00000160951	FALSE	Approved	NA	Absent	PTGER1
Hemic and Lymphatic Diseases	ENSG00000171557	FALSE	Phase III Clinical Trial	1999-11-18	Absent	FGG
Hemic and Lymphatic Diseases	ENSG00000171560	FALSE	Phase III Clinical Trial	1999-11-18	Absent	FGA
Hemic and Lymphatic Diseases	ENSG00000171564	FALSE	Phase III Clinical Trial	1999-11-18	Absent	FGB
Hemic and Lymphatic Diseases	ENSG00000259207	TRUE	Approved	1993-06-15	Absent	ITGB3
Hemiplegia	ENSG00000004948	FALSE	Phase II Clinical Trial	NA	Absent	CALCR
Hemiplegia	ENSG00000006283	TRUE	Approved	NA	Approved	CACNA1G
Hemochromatosis	ENSG00000110911	FALSE	Preclinical	2016-09-29	Absent	SLC11A2
Hemochromatosis	ENSG00000187045	FALSE	Preclinical	2011-12-23	Unused	TMPRSS6
Hemolytic-Uremic Syndrome	ENSG00000000971	FALSE	Preclinical	2009-07-23	Unused	CFH
Hemolytic-Uremic Syndrome	ENSG00000009724	FALSE	Phase III Clinical Trial	2008-01-15	Preclinical	MASP2
Hemolytic-Uremic Syndrome	ENSG00000106804	TRUE	Approved	1993-08-15	Approved	C5
Hemolytic-Uremic Syndrome	ENSG00000109320	FALSE	Preclinical	2006-10-23	Unused	NFKB1
Hemolytic-Uremic Syndrome	ENSG00000197405	FALSE	Phase II Clinical Trial	2006-07-25	Absent	C5AR1
Hemolytic-Uremic Syndrome	ENSG00000197766	FALSE	Phase I Clinical Trial	2014-08-26	Absent	CFD
Hemophilia A	ENSG00000003436	FALSE	Phase II Clinical Trial	2006-02-22	Phase I Clinical Trial	TFPI
Hemophilia A	ENSG00000010610	FALSE	Phase I Clinical Trial	2002-05-02	Unused	CD4
Hemophilia A	ENSG00000057593	TRUE	Approved	2004-12-07	Approved	F7
Hemophilia A	ENSG00000101981	TRUE	Approved	1993-04-15	Phase II Clinical Trial	F9
Hemophilia A	ENSG00000102245	FALSE	Phase II Clinical Trial	1994-06-15	Unused	CD40LG
Hemophilia A	ENSG00000110799	TRUE	Approved	1995-06-15	Approved	VWF
Hemophilia A	ENSG00000115718	FALSE	Preclinical	2014-01-24	Absent	PROC
Hemophilia A	ENSG00000117525	FALSE	Preclinical	1989-06-15	Phase I Clinical Trial	F3
Hemophilia A	ENSG00000117601	FALSE	Phase III Clinical Trial	2011-09-10	Preclinical	SERPINC1
Hemophilia A	ENSG00000122194	FALSE	Preclinical	2014-10-04	Absent	PLG
Hemophilia A	ENSG00000126218	TRUE	Approved	2008-01-21	Phase III Clinical Trial	F10
Hemophilia A	ENSG00000126895	FALSE	unknown	NA	Absent	AVPR2
Hemophilia A	ENSG00000158473	FALSE	Preclinical	2007-07-16	Absent	CD1D
Hemophilia A	ENSG00000174175	FALSE	Preclinical	2007-02-26	Unused	SELP
Hemophilia A	ENSG00000178726	FALSE	unknown	1992-06-15	Phase I Clinical Trial	THBD
Hemophilia A	ENSG00000180210	TRUE	Approved	2012-07-06	Absent	F2
Hemophilia A	ENSG00000185010	TRUE	Approved	1989-11-15	Approved	F8
Hemophilia A	ENSG00000187266	FALSE	Approved	NA	Absent	EPOR
Hemophilia A	ENSG00000198734	FALSE	Preclinical	2007-04-25	Unused	F5
Hemophilia B	ENSG00000003436	FALSE	Phase II Clinical Trial	2006-02-22	Phase I Clinical Trial	TFPI
Hemophilia B	ENSG00000057593	TRUE	Approved	2004-12-07	Approved	F7
Hemophilia B	ENSG00000101981	TRUE	Approved	1989-12-15	Approved	F9
Hemophilia B	ENSG00000102245	FALSE	Phase II Clinical Trial	1994-06-15	Absent	CD40LG
Hemophilia B	ENSG00000117601	FALSE	Phase III Clinical Trial	2011-09-10	Absent	SERPINC1
Hemophilia B	ENSG00000126218	TRUE	Approved	2015-12-31	Phase III Clinical Trial	F10
Hemophilia B	ENSG00000180210	TRUE	Approved	2015-12-31	Absent	F2
Hemophilia B	ENSG00000185010	FALSE	Preclinical	1993-04-15	Phase II Clinical Trial	F8
Hemorrhage	ENSG00000057593	TRUE	Approved	2011-11-11	Approved	F7
Hemorrhage	ENSG00000101981	TRUE	Approved	NA	Approved	F9
Hemorrhage	ENSG00000106804	FALSE	unknown	1993-08-15	Unused	C5
Hemorrhage	ENSG00000114378	TRUE	Approved	NA	Approved	HYAL1
Hemorrhage	ENSG00000117525	FALSE	Phase III Clinical Trial	2009-06-11	Phase I Clinical Trial	F3
Hemorrhage	ENSG00000122194	FALSE	Phase II Clinical Trial	2003-02-25	Unused	PLG
Hemorrhage	ENSG00000122420	FALSE	Preclinical	NA	Unused	PTGFR
Hemorrhage	ENSG00000124491	FALSE	unknown	2008-02-04	Phase I Clinical Trial	F13A1
Hemorrhage	ENSG00000126218	TRUE	Approved	2008-11-05	Phase II Clinical Trial	F10
Hemorrhage	ENSG00000160255	FALSE	unknown	1992-06-15	Unused	ITGB2
Hemorrhage	ENSG00000164344	FALSE	Phase II Clinical Trial	1999-01-15	Absent	KLKB1
Hemorrhage	ENSG00000171557	TRUE	Approved	1996-07-15	Approved	FGG
Hemorrhage	ENSG00000171560	TRUE	Approved	1996-07-15	Approved	FGA
Hemorrhage	ENSG00000171564	TRUE	Approved	1996-07-15	Approved	FGB
Hemorrhage	ENSG00000180210	TRUE	Approved	2003-02-25	Approved	F2
Hemorrhage	ENSG00000181104	TRUE	Approved	2006-10-20	Approved	F2R
Hemorrhage	ENSG00000197561	FALSE	Preclinical	NA	Unused	ELANE
Hemorrhage	ENSG00000197766	FALSE	unknown	NA	Unused	CFD
Hemorrhagic Fever, Ebola	ENSG00000057593	FALSE	Preclinical	2004-01-16	Absent	F7
Hemorrhagic Fever, Ebola	ENSG00000074319	FALSE	unknown	2003-02-04	Unused	TSG101
Hemorrhagic Fever, Ebola	ENSG00000097007	FALSE	Preclinical	2009-05-28	Absent	ABL1
Hemorrhagic Fever, Ebola	ENSG00000111319	FALSE	Preclinical	2014-12-20	Absent	SCNN1A
Hemorrhagic Fever, Ebola	ENSG00000126218	FALSE	Preclinical	2004-01-16	Absent	F10
Hemorrhagic Fever, Ebola	ENSG00000135047	FALSE	Preclinical	2014-03-10	Absent	CTSL
Hemorrhagic Fever, Ebola	ENSG00000142166	FALSE	Phase II Clinical Trial	2017-03-31	Absent	IFNAR1
Hemorrhagic Fever, Ebola	ENSG00000150093	FALSE	Preclinical	2013-12-31	Absent	ITGB1
Hemorrhagic Fever, Ebola	ENSG00000151623	FALSE	Preclinical	2014-12-20	Absent	NR3C2
Hemorrhagic Fever, Ebola	ENSG00000154133	FALSE	Preclinical	2010-12-13	Unused	ROBO4
Hemorrhagic Fever, Ebola	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Hemorrhagic Fever, Ebola	ENSG00000164342	FALSE	Preclinical	2015-12-22	Absent	TLR3
Hemorrhagic Fever, Ebola	ENSG00000186716	FALSE	Preclinical	2009-05-28	Absent	BCR
Hemorrhagic Fever, Ebola	ENSG00000188379	FALSE	Preclinical	NA	Absent	IFNA2
Hemorrhagic Fever, Ebola	ENSG00000197461	FALSE	Preclinical	2009-05-28	Absent	PDGFA
Hemorrhagic Fevers, Viral	ENSG00000106348	TRUE	Approved	NA	Approved	IMPDH1
Hemorrhagic Fevers, Viral	ENSG00000109320	FALSE	Preclinical	2002-08-29	Unused	NFKB1
Hemorrhagic Fevers, Viral	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Hepatitis	ENSG00000027697	FALSE	Preclinical	2006-03-20	Unused	IFNGR1
Hepatitis	ENSG00000064012	FALSE	unknown	1999-01-15	Unused	CASP8
Hepatitis	ENSG00000067182	FALSE	Preclinical	2006-03-20	Unused	TNFRSF1A
Hepatitis	ENSG00000088832	FALSE	Phase II Clinical Trial	2004-11-15	Unused	FKBP1A
Hepatitis	ENSG00000100823	FALSE	unknown	1993-03-15	Absent	APEX1
Hepatitis	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Hepatitis	ENSG00000116044	FALSE	unknown	2005-05-27	Unused	NFE2L2
Hepatitis	ENSG00000117560	FALSE	Preclinical	2000-03-29	Unused	FASLG
Hepatitis	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Hepatitis	ENSG00000131471	FALSE	Phase I Clinical Trial	2006-06-01	Phase I Clinical Trial	AOC3
Hepatitis	ENSG00000136869	FALSE	Phase II Clinical Trial	2007-01-03	Absent	TLR4
Hepatitis	ENSG00000142677	FALSE	unknown	2011-06-28	Phase I Clinical Trial	IL22RA1
Hepatitis	ENSG00000159110	FALSE	Approved	1995-07-15	Unused	IFNAR2
Hepatitis	ENSG00000159958	FALSE	Preclinical	2010-10-21	Absent	TNFRSF13C
Hepatitis	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Hepatitis	ENSG00000169083	FALSE	unknown	NA	Unused	AR
Hepatitis	ENSG00000172016	FALSE	unknown	NA	Phase II Clinical Trial	REG3A
Hepatitis	ENSG00000172215	FALSE	Preclinical	2011-09-21	Preclinical	CXCR6
Hepatitis	ENSG00000184502	FALSE	unknown	NA	Unused	GAST
Hepatitis A	ENSG00000121966	FALSE	unknown	1996-07-15	Unused	CXCR4
Hepatitis A	ENSG00000159110	FALSE	Approved	2004-07-27	Unused	IFNAR2
Hepatitis A	ENSG00000160791	FALSE	unknown	1996-07-15	Unused	CCR5
Hepatitis B	ENSG00000012504	FALSE	Phase I Clinical Trial	2009-12-04	Absent	NR1H4
Hepatitis B	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC3
Hepatitis B	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Hepatitis B	ENSG00000073614	FALSE	Phase I Clinical Trial	2016-10-04	Absent	KDM5A
Hepatitis B	ENSG00000074319	FALSE	Preclinical	2007-08-16	Unused	TSG101
Hepatitis B	ENSG00000077092	TRUE	Approved	NA	Absent	RARB
Hepatitis B	ENSG00000101017	FALSE	Preclinical	2010-07-20	Preclinical	CD40
Hepatitis B	ENSG00000101916	FALSE	Phase I Clinical Trial	2017-05-05	Absent	TLR8
Hepatitis B	ENSG00000101966	FALSE	Phase II Clinical Trial	2008-10-17	Absent	XIAP
Hepatitis B	ENSG00000107201	FALSE	Phase II Clinical Trial	2008-07-29	Absent	DDX58
Hepatitis B	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC2
Hepatitis B	ENSG00000112964	FALSE	Preclinical	2016-09-22	Absent	GHR
Hepatitis B	ENSG00000113302	FALSE	Phase II Clinical Trial	2008-06-18	Phase II Clinical Trial	IL12B
Hepatitis B	ENSG00000117400	FALSE	unknown	2002-01-08	Unused	MPL
Hepatitis B	ENSG00000121966	FALSE	unknown	1996-07-15	Unused	CXCR4
Hepatitis B	ENSG00000127951	FALSE	Preclinical	2002-07-08	Unused	FGL2
Hepatitis B	ENSG00000133321	FALSE	Preclinical	2009-07-23	Absent	RARRES3
Hepatitis B	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Hepatitis B	ENSG00000136634	FALSE	Preclinical	1998-09-15	Unused	IL10
Hepatitis B	ENSG00000136869	FALSE	Phase II Clinical Trial	2000-08-14	Phase II Clinical Trial	TLR4
Hepatitis B	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Hepatitis B	ENSG00000160211	FALSE	unknown	1999-01-15	Phase II Clinical Trial	G6PD
Hepatitis B	ENSG00000160791	FALSE	unknown	1996-07-15	Unused	CCR5
Hepatitis B	ENSG00000164342	FALSE	Phase II Clinical Trial	2013-12-14	Unused	TLR3
Hepatitis B	ENSG00000166794	FALSE	unknown	2007-06-06	Absent	PPIB
Hepatitis B	ENSG00000166851	FALSE	Phase II Clinical Trial	2008-04-11	Absent	PLK1
Hepatitis B	ENSG00000167207	FALSE	Phase II Clinical Trial	2008-07-29	Absent	NOD2
Hepatitis B	ENSG00000167325	FALSE	Preclinical	1992-08-15	Unused	RRM1
Hepatitis B	ENSG00000168811	FALSE	Phase II Clinical Trial	2008-06-18	Phase II Clinical Trial	IL12A
Hepatitis B	ENSG00000171497	FALSE	Preclinical	2009-06-11	Absent	PPID
Hepatitis B	ENSG00000171848	FALSE	Preclinical	1992-08-15	Unused	RRM2
Hepatitis B	ENSG00000184584	FALSE	Preclinical	2015-04-11	Absent	TMEM173
Hepatitis B	ENSG00000185436	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	IFNLR1
Hepatitis B	ENSG00000187514	TRUE	Approved	2004-06-09	Approved	PTMA
Hepatitis B	ENSG00000188379	FALSE	Approved	2012-04-12	Absent	IFNA2
Hepatitis B	ENSG00000188389	FALSE	Preclinical	2014-10-31	Absent	PDCD1
Hepatitis B	ENSG00000196262	FALSE	Preclinical	2014-11-07	Absent	PPIA
Hepatitis B	ENSG00000196664	FALSE	Phase II Clinical Trial	2004-02-17	Phase I Clinical Trial	TLR7
Hepatitis B	ENSG00000197919	FALSE	Preclinical	1998-09-15	Unused	IFNA1
Hepatitis B	ENSG00000239732	TRUE	Approved	1998-10-15	Approved	TLR9
Hepatitis B	ENSG00000282608	FALSE	unknown	2001-08-07	Preclinical	ADORA3
Hepatitis C	ENSG00000012504	FALSE	Phase II Clinical Trial	2006-12-07	Unused	NR1H4
Hepatitis C	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Hepatitis C	ENSG00000049768	FALSE	Preclinical	2011-06-29	Preclinical	FOXP3
Hepatitis C	ENSG00000055332	FALSE	Preclinical	1997-07-15	Unused	EIF2AK2
Hepatitis C	ENSG00000073060	FALSE	Preclinical	2009-02-09	Unused	SCARB1
Hepatitis C	ENSG00000074319	FALSE	Preclinical	2007-08-16	Unused	TSG101
Hepatitis C	ENSG00000081985	FALSE	unknown	NA	Unused	IL12RB2
Hepatitis C	ENSG00000082898	FALSE	Preclinical	2013-09-05	Absent	XPO1
Hepatitis C	ENSG00000087245	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP2
Hepatitis C	ENSG00000089692	FALSE	Phase I Clinical Trial	2004-06-08	Unused	LAG3
Hepatitis C	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Unused	IL12RB1
Hepatitis C	ENSG00000100985	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP9
Hepatitis C	ENSG00000101916	FALSE	unknown	NA	Unused	TLR8
Hepatitis C	ENSG00000104938	FALSE	Preclinical	2003-04-01	Unused	CLEC4M
Hepatitis C	ENSG00000106348	TRUE	Approved	1996-08-15	Unused	IMPDH1
Hepatitis C	ENSG00000107201	FALSE	unknown	2008-07-29	Absent	DDX58
Hepatitis C	ENSG00000110651	FALSE	Preclinical	2014-12-06	Absent	CD81
Hepatitis C	ENSG00000113749	FALSE	Phase II Clinical Trial	1996-05-15	Unused	HRH2
Hepatitis C	ENSG00000115904	FALSE	Preclinical	2017-03-22	Absent	SOS1
Hepatitis C	ENSG00000117400	FALSE	unknown	2002-01-08	Unused	MPL
Hepatitis C	ENSG00000118113	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP8
Hepatitis C	ENSG00000118137	FALSE	Preclinical	2011-06-29	Preclinical	APOA1
Hepatitis C	ENSG00000121966	FALSE	unknown	2004-08-03	Unused	CXCR4
Hepatitis C	ENSG00000132155	FALSE	Preclinical	2001-04-20	Preclinical	RAF1
Hepatitis C	ENSG00000133321	FALSE	Preclinical	2009-07-23	Preclinical	RARRES3
Hepatitis C	ENSG00000133703	FALSE	Preclinical	2017-03-22	Absent	KRAS
Hepatitis C	ENSG00000134460	FALSE	Approved	2002-03-11	Unused	IL2RA
Hepatitis C	ENSG00000135828	FALSE	Preclinical	2009-02-19	Unused	RNASEL
Hepatitis C	ENSG00000136634	FALSE	Preclinical	1998-09-15	Unused	IL10
Hepatitis C	ENSG00000136869	FALSE	Preclinical	NA	Unused	TLR4
Hepatitis C	ENSG00000137745	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP13
Hepatitis C	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Hepatitis C	ENSG00000142166	FALSE	Preclinical	2004-10-14	Unused	IFNAR1
Hepatitis C	ENSG00000143393	FALSE	Preclinical	2014-08-09	Absent	PI4KB
Hepatitis C	ENSG00000149968	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP3
Hepatitis C	ENSG00000157227	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP14
Hepatitis C	ENSG00000159110	TRUE	Approved	1992-03-15	Approved	IFNAR2
Hepatitis C	ENSG00000160712	FALSE	Preclinical	2011-06-29	Preclinical	IL6R
Hepatitis C	ENSG00000160791	FALSE	unknown	2004-08-03	Unused	CCR5
Hepatitis C	ENSG00000160868	FALSE	Phase II Clinical Trial	2012-05-09	Phase I Clinical Trial	CYP3A4
Hepatitis C	ENSG00000162434	FALSE	Preclinical	2014-06-23	Absent	JAK1
Hepatitis C	ENSG00000163599	FALSE	unknown	2004-07-07	Phase II Clinical Trial	CTLA4
Hepatitis C	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Unused	TLR3
Hepatitis C	ENSG00000164733	FALSE	unknown	2007-11-30	Unused	CTSB
Hepatitis C	ENSG00000166794	FALSE	Phase I Clinical Trial	2007-06-06	Phase II Clinical Trial	PPIB
Hepatitis C	ENSG00000167207	FALSE	unknown	2008-07-29	Absent	NOD2
Hepatitis C	ENSG00000169174	FALSE	Preclinical	2012-04-02	Preclinical	PCSK9
Hepatitis C	ENSG00000169710	FALSE	unknown	2009-09-18	Preclinical	FASN
Hepatitis C	ENSG00000171298	FALSE	Phase II Clinical Trial	1989-07-15	Unused	GAA
Hepatitis C	ENSG00000171497	FALSE	Preclinical	2009-06-11	Absent	PPID
Hepatitis C	ENSG00000175445	FALSE	Phase II Clinical Trial	2006-12-07	Unused	LPL
Hepatitis C	ENSG00000176890	FALSE	Preclinical	2008-09-15	Unused	TYMS
Hepatitis C	ENSG00000185000	FALSE	Phase II Clinical Trial	2008-11-24	Unused	DGAT1
Hepatitis C	ENSG00000185436	FALSE	Phase III Clinical Trial	2004-07-20	Phase III Clinical Trial	IFNLR1
Hepatitis C	ENSG00000187514	TRUE	Approved	2004-06-09	Approved	PTMA
Hepatitis C	ENSG00000188379	FALSE	Approved	2011-09-22	Phase II Clinical Trial	IFNA2
Hepatitis C	ENSG00000188389	FALSE	Phase I Clinical Trial	2005-05-12	Phase II Clinical Trial	PDCD1
Hepatitis C	ENSG00000196262	FALSE	Phase III Clinical Trial	1993-10-15	Unused	PPIA
Hepatitis C	ENSG00000196664	FALSE	Phase II Clinical Trial	2000-08-24	Phase I Clinical Trial	TLR7
Hepatitis C	ENSG00000197919	FALSE	Phase II Clinical Trial	1998-09-15	Unused	IFNA1
Hepatitis C	ENSG00000198851	FALSE	Phase II Clinical Trial	2013-05-11	Absent	CD3E
Hepatitis C	ENSG00000239732	FALSE	Preclinical	2002-10-31	Unused	TLR9
Hepatitis C	ENSG00000241973	FALSE	Preclinical	2013-08-24	Absent	PI4KA
Hepatitis C	ENSG00000262406	FALSE	Phase II Clinical Trial	2007-05-21	Phase II Clinical Trial	MMP12
Hepatitis C	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-08-07	Phase II Clinical Trial	ADORA3
Hepatitis D	ENSG00000107201	FALSE	Preclinical	2008-07-29	Absent	DDX58
Hepatitis D	ENSG00000159110	FALSE	Approved	1992-03-15	Phase III Clinical Trial	IFNAR2
Hepatitis D	ENSG00000167207	FALSE	Preclinical	2008-07-29	Absent	NOD2
Hepatitis D	ENSG00000168522	FALSE	Phase II Clinical Trial	1997-06-15	Absent	FNTA
Hepatitis D	ENSG00000185436	FALSE	Phase II Clinical Trial	2004-07-20	Absent	IFNLR1
Hepatitis D	ENSG00000188379	FALSE	Preclinical	2015-10-30	Absent	IFNA2
Hepatitis E	ENSG00000135047	FALSE	Preclinical	2014-03-10	Absent	CTSL
Hepatitis, Viral, Human	ENSG00000019991	FALSE	Approved	2016-10-19	Absent	HGF
Hepatitis, Viral, Human	ENSG00000026103	FALSE	Preclinical	2000-10-10	Unused	FAS
Hepatitis, Viral, Human	ENSG00000064012	FALSE	Preclinical	2000-08-21	Preclinical	CASP8
Hepatitis, Viral, Human	ENSG00000123384	FALSE	Preclinical	2007-09-14	Unused	LRP1
Hepatitis, Viral, Human	ENSG00000146648	FALSE	Preclinical	2017-01-06	Absent	EGFR
Hepatitis, Viral, Human	ENSG00000159110	FALSE	Approved	2001-01-31	Unused	IFNAR2
Hepatitis, Viral, Human	ENSG00000160951	FALSE	Phase II Clinical Trial	NA	Unused	PTGER1
Hepatitis, Viral, Human	ENSG00000187514	FALSE	Phase III Clinical Trial	2012-03-21	Unused	PTMA
Hepatolenticular Degeneration	ENSG00000123191	FALSE	Preclinical	1999-10-29	Unused	ATP7B
Hepatolenticular Degeneration	ENSG00000142168	FALSE	Phase II Clinical Trial	2002-07-01	Preclinical	SOD1
Hepatorenal Syndrome	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Phase II Clinical Trial	TBXA2R
Hepatorenal Syndrome	ENSG00000126895	TRUE	Approved	NA	Approved	AVPR2
Hepatorenal Syndrome	ENSG00000135744	FALSE	Phase II Clinical Trial	2013-03-05	Absent	AGT
Hepatorenal Syndrome	ENSG00000136160	FALSE	Phase II Clinical Trial	1998-03-01	Unused	EDNRB
Hepatorenal Syndrome	ENSG00000151617	FALSE	Phase II Clinical Trial	1998-03-01	Unused	EDNRA
Hepatorenal Syndrome	ENSG00000166148	TRUE	Approved	NA	Approved	AVPR1A
Hepatorenal Syndrome	ENSG00000198049	TRUE	Approved	NA	Approved	AVPR1B
Hereditary Autoinflammatory Diseases	ENSG00000125538	TRUE	Approved	2003-12-08	Absent	IL1B
Hereditary Sensory and Motor Neuropathy	ENSG00000106804	FALSE	unknown	1993-08-15	Phase I Clinical Trial	C5
Herpes Simplex	ENSG00000001626	FALSE	unknown	1992-11-15	Absent	CFTR
Herpes Simplex	ENSG00000010610	FALSE	Phase III Clinical Trial	1993-07-15	Unused	CD4
Herpes Simplex	ENSG00000070501	FALSE	Preclinical	1997-05-15	Unused	POLB
Herpes Simplex	ENSG00000073756	FALSE	Phase II Clinical Trial	2013-05-14	Absent	PTGS2
Herpes Simplex	ENSG00000101868	FALSE	Preclinical	1997-05-15	Unused	POLA1
Herpes Simplex	ENSG00000101916	FALSE	unknown	NA	Unused	TLR8
Herpes Simplex	ENSG00000106348	TRUE	Approved	NA	Approved	IMPDH1
Herpes Simplex	ENSG00000110400	FALSE	Preclinical	2009-01-26	Unused	NECTIN1
Herpes Simplex	ENSG00000111537	FALSE	unknown	1997-01-15	Unused	IFNG
Herpes Simplex	ENSG00000113580	TRUE	Approved	1998-06-15	Approved	NR3C1
Herpes Simplex	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Herpes Simplex	ENSG00000126218	TRUE	Approved	NA	Approved	F10
Herpes Simplex	ENSG00000128052	FALSE	Preclinical	2017-12-19	Absent	KDR
Herpes Simplex	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Herpes Simplex	ENSG00000136869	FALSE	Approved	NA	Unused	TLR4
Herpes Simplex	ENSG00000159110	FALSE	Approved	1997-12-15	Unused	IFNAR2
Herpes Simplex	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Herpes Simplex	ENSG00000175445	TRUE	Approved	1990-08-15	Approved	LPL
Herpes Simplex	ENSG00000180210	TRUE	Approved	NA	Approved	F2
Herpes Simplex	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Herpes Simplex	ENSG00000197272	FALSE	Phase II Clinical Trial	2004-08-03	Absent	IL27
Herpes Simplex	ENSG00000197919	FALSE	unknown	1997-01-15	Unused	IFNA1
Herpes Zoster	ENSG00000106348	TRUE	Approved	NA	Approved	IMPDH1
Herpes Zoster	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Herpes Zoster	ENSG00000128052	FALSE	Preclinical	2017-12-19	Absent	KDR
Herpes Zoster	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Herpes Zoster	ENSG00000159110	TRUE	Approved	2013-01-08	Unused	IFNAR2
Herpes Zoster	ENSG00000160868	FALSE	Phase III Clinical Trial	2006-06-12	Absent	CYP3A4
Herpes Zoster	ENSG00000164342	FALSE	Preclinical	2017-05-26	Absent	TLR3
Herpes Zoster	ENSG00000169432	TRUE	Approved	NA	Absent	SCN9A
Herpes Zoster	ENSG00000197272	FALSE	Phase II Clinical Trial	2004-08-03	Phase II Clinical Trial	IL27
Herpesviridae Infections	ENSG00000100312	FALSE	unknown	2002-03-20	Phase II Clinical Trial	ACR
Herpesviridae Infections	ENSG00000109320	FALSE	Preclinical	2009-01-23	Unused	NFKB1
Herpesviridae Infections	ENSG00000114378	FALSE	unknown	2002-03-20	Phase II Clinical Trial	HYAL1
Herpesviridae Infections	ENSG00000121966	FALSE	Phase II Clinical Trial	2004-08-03	Phase II Clinical Trial	CXCR4
Herpesviridae Infections	ENSG00000159110	TRUE	Approved	2000-02-24	Approved	IFNAR2
Herpesviridae Infections	ENSG00000160791	FALSE	Phase II Clinical Trial	2004-08-03	Phase II Clinical Trial	CCR5
Herpesviridae Infections	ENSG00000197249	FALSE	unknown	NA	Unused	SERPINA1
Hidradenitis Suppurativa	ENSG00000065989	FALSE	Preclinical	2005-05-24	Absent	PDE4A
Hidradenitis Suppurativa	ENSG00000106804	FALSE	Phase II Clinical Trial	2008-03-20	Absent	C5
Hidradenitis Suppurativa	ENSG00000112115	FALSE	Phase II Clinical Trial	2012-03-21	Absent	IL17A
Hidradenitis Suppurativa	ENSG00000112116	FALSE	Phase II Clinical Trial	2012-03-21	Absent	IL17F
Hidradenitis Suppurativa	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Absent	IL1A
Hidradenitis Suppurativa	ENSG00000115590	FALSE	unknown	2011-07-28	Absent	IL1R2
Hidradenitis Suppurativa	ENSG00000115594	FALSE	unknown	2011-07-28	Absent	IL1R1
Hidradenitis Suppurativa	ENSG00000125538	FALSE	Preclinical	2012-05-15	Absent	IL1B
Hidradenitis Suppurativa	ENSG00000139219	FALSE	Preclinical	2016-11-24	Absent	COL2A1
Hidradenitis Suppurativa	ENSG00000163464	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR1
Hidradenitis Suppurativa	ENSG00000180871	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR2
Hirsutism	ENSG00000091831	FALSE	Approved	NA	Unused	ESR1
Hirsutism	ENSG00000115758	TRUE	Approved	NA	Approved	ODC1
Hirsutism	ENSG00000145545	FALSE	Phase I Clinical Trial	1994-04-15	Unused	SRD5A1
Hirsutism	ENSG00000168453	FALSE	Preclinical	2005-02-01	Unused	HR
Hirsutism	ENSG00000169083	FALSE	Approved	1994-08-15	Unused	AR
Histiocytosis, Langerhans-Cell	ENSG00000142208	FALSE	unknown	2009-04-21	Absent	AKT1
Histiocytosis, Langerhans-Cell	ENSG00000159110	FALSE	Approved	2014-01-17	Absent	IFNAR2
HIV Infections	ENSG00000001626	FALSE	unknown	1992-11-15	Absent	CFTR
HIV Infections	ENSG00000005844	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	ITGAL
HIV Infections	ENSG00000007171	FALSE	Preclinical	1996-10-15	Unused	NOS2
HIV Infections	ENSG00000010610	FALSE	Pre-registration	1989-06-15	Phase II Clinical Trial	CD4
HIV Infections	ENSG00000019582	FALSE	Preclinical	2010-02-11	Absent	CD74
HIV Infections	ENSG00000023445	FALSE	unknown	2008-10-17	Absent	BIRC3
HIV Infections	ENSG00000026103	FALSE	Preclinical	1994-08-15	Unused	FAS
HIV Infections	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
HIV Infections	ENSG00000054219	FALSE	Phase I Clinical Trial	2006-07-17	Phase I Clinical Trial	LY75
HIV Infections	ENSG00000055332	FALSE	Preclinical	1998-07-15	Unused	EIF2AK2
HIV Infections	ENSG00000060491	FALSE	Phase II Clinical Trial	2012-09-01	Unused	OGFR
HIV Infections	ENSG00000065675	FALSE	Preclinical	NA	Absent	PRKCQ
HIV Infections	ENSG00000065989	FALSE	Preclinical	1998-09-15	Unused	PDE4A
HIV Infections	ENSG00000067182	FALSE	Preclinical	1999-04-28	Unused	TNFRSF1A
HIV Infections	ENSG00000074319	FALSE	Preclinical	2003-02-04	Unused	TSG101
HIV Infections	ENSG00000077238	FALSE	Preclinical	1991-04-15	Unused	IL4R
HIV Infections	ENSG00000077498	FALSE	unknown	2002-02-27	Unused	TYR
HIV Infections	ENSG00000081051	FALSE	Preclinical	2007-10-12	Unused	AFP
HIV Infections	ENSG00000081985	FALSE	Phase II Clinical Trial	2002-03-25	Unused	IL12RB2
HIV Infections	ENSG00000082175	FALSE	Phase I Clinical Trial	2016-08-05	Absent	PGR
HIV Infections	ENSG00000082556	FALSE	Approved	2012-09-01	Preclinical	OPRK1
HIV Infections	ENSG00000082898	FALSE	Preclinical	2013-09-05	Absent	XPO1
HIV Infections	ENSG00000089692	FALSE	Preclinical	2004-06-09	Unused	LAG3
HIV Infections	ENSG00000090659	FALSE	Preclinical	2001-11-06	Unused	CD209
HIV Infections	ENSG00000096996	FALSE	Phase II Clinical Trial	2002-03-25	Unused	IL12RB1
HIV Infections	ENSG00000099194	FALSE	unknown	NA	Unused	SCD
HIV Infections	ENSG00000100312	FALSE	Phase II Clinical Trial	2002-03-20	Phase II Clinical Trial	ACR
HIV Infections	ENSG00000100448	FALSE	Preclinical	1994-09-15	Unused	CTSG
HIV Infections	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
HIV Infections	ENSG00000101017	FALSE	Preclinical	2011-05-25	Unused	CD40
HIV Infections	ENSG00000101444	FALSE	Preclinical	NA	Unused	AHCY
HIV Infections	ENSG00000101966	FALSE	unknown	2008-10-17	Absent	XIAP
HIV Infections	ENSG00000102967	FALSE	Preclinical	2010-11-09	Unused	DHODH
HIV Infections	ENSG00000104938	FALSE	Preclinical	2001-11-06	Unused	CLEC4M
HIV Infections	ENSG00000105650	FALSE	Preclinical	1998-09-15	Unused	PDE4C
HIV Infections	ENSG00000105810	FALSE	Preclinical	2015-12-22	Absent	CDK6
HIV Infections	ENSG00000107201	FALSE	unknown	2008-07-29	Absent	DDX58
HIV Infections	ENSG00000107562	FALSE	Preclinical	1998-12-15	Unused	CXCL12
HIV Infections	ENSG00000108395	FALSE	Preclinical	2009-02-17	Unused	TRIM37
HIV Infections	ENSG00000108691	FALSE	unknown	1992-01-15	Unused	CCL2
HIV Infections	ENSG00000109163	FALSE	unknown	2002-05-14	Unused	GNRHR
HIV Infections	ENSG00000109320	FALSE	Preclinical	2008-06-19	Preclinical	NFKB1
HIV Infections	ENSG00000109471	FALSE	Preclinical	1994-08-15	Unused	IL2
HIV Infections	ENSG00000110330	FALSE	unknown	2008-10-17	Absent	BIRC2
HIV Infections	ENSG00000111537	FALSE	Preclinical	1997-01-15	Unused	IFNG
HIV Infections	ENSG00000112038	FALSE	Approved	2012-09-01	Preclinical	OPRM1
HIV Infections	ENSG00000112062	FALSE	unknown	1997-06-15	Unused	MAPK14
HIV Infections	ENSG00000112115	FALSE	unknown	NA	Phase II Clinical Trial	IL17A
HIV Infections	ENSG00000112164	FALSE	Preclinical	1990-03-15	Unused	GLP1R
HIV Infections	ENSG00000113448	FALSE	Preclinical	1998-09-15	Unused	PDE4D
HIV Infections	ENSG00000113749	FALSE	Preclinical	1996-10-15	Unused	HRH2
HIV Infections	ENSG00000114378	FALSE	Phase II Clinical Trial	2002-03-20	Phase II Clinical Trial	HYAL1
HIV Infections	ENSG00000115232	FALSE	unknown	NA	Phase II Clinical Trial	ITGA4
HIV Infections	ENSG00000115275	FALSE	Preclinical	1990-12-15	Unused	MOGS
HIV Infections	ENSG00000115353	FALSE	Preclinical	1991-04-15	Unused	TACR1
HIV Infections	ENSG00000118702	FALSE	unknown	2011-11-18	Preclinical	GHRH
HIV Infections	ENSG00000119535	FALSE	unknown	NA	Absent	CSF3R
HIV Infections	ENSG00000120217	FALSE	Phase I Clinical Trial	2008-01-16	Absent	CD274
HIV Infections	ENSG00000120948	FALSE	Preclinical	2015-02-26	Absent	TARDBP
HIV Infections	ENSG00000121807	FALSE	Phase II Clinical Trial	1998-07-15	Phase II Clinical Trial	CCR2
HIV Infections	ENSG00000121966	FALSE	Phase I Clinical Trial	1995-12-15	Phase I Clinical Trial	CXCR4
HIV Infections	ENSG00000122861	FALSE	unknown	1993-05-15	Unused	PLAU
HIV Infections	ENSG00000125384	FALSE	Phase II Clinical Trial	1993-07-15	Unused	PTGER2
HIV Infections	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
HIV Infections	ENSG00000132693	FALSE	unknown	1999-11-23	Unused	CRP
HIV Infections	ENSG00000133321	FALSE	Preclinical	2009-07-23	Preclinical	RARRES3
HIV Infections	ENSG00000134460	FALSE	Approved	2001-01-09	Unused	IL2RA
HIV Infections	ENSG00000134470	FALSE	Phase I Clinical Trial	2010-10-05	Absent	IL15RA
HIV Infections	ENSG00000135446	FALSE	Preclinical	2015-12-22	Absent	CDK4
HIV Infections	ENSG00000136807	FALSE	Preclinical	2007-05-16	Unused	CDK9
HIV Infections	ENSG00000136869	FALSE	Preclinical	2010-07-23	Unused	TLR4
HIV Infections	ENSG00000137462	FALSE	Preclinical	2010-07-23	Unused	TLR2
HIV Infections	ENSG00000137752	FALSE	unknown	NA	Phase II Clinical Trial	CASP1
HIV Infections	ENSG00000138039	FALSE	Phase I Clinical Trial	1996-10-15	Unused	LHCGR
HIV Infections	ENSG00000138448	FALSE	unknown	NA	Phase II Clinical Trial	ITGAV
HIV Infections	ENSG00000138685	FALSE	Preclinical	1989-07-15	Unused	FGF2
HIV Infections	ENSG00000138735	FALSE	Preclinical	1998-09-15	Unused	PDE5A
HIV Infections	ENSG00000140992	FALSE	unknown	2008-04-09	Absent	PDPK1
HIV Infections	ENSG00000141510	FALSE	Preclinical	2011-08-04	Absent	TP53
HIV Infections	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
HIV Infections	ENSG00000142166	FALSE	unknown	1991-08-15	Unused	IFNAR1
HIV Infections	ENSG00000142677	FALSE	Phase II Clinical Trial	2011-07-28	Absent	IL22RA1
HIV Infections	ENSG00000143799	FALSE	Preclinical	1993-09-15	Unused	PARP1
HIV Infections	ENSG00000143839	FALSE	Preclinical	1993-02-15	Unused	REN
HIV Infections	ENSG00000146648	FALSE	Preclinical	2001-04-25	Unused	EGFR
HIV Infections	ENSG00000147955	FALSE	unknown	1995-12-15	Unused	SIGMAR1
HIV Infections	ENSG00000149311	FALSE	Preclinical	2003-05-28	Unused	ATM
HIV Infections	ENSG00000150782	FALSE	unknown	NA	Phase II Clinical Trial	IL18
HIV Infections	ENSG00000151623	FALSE	Phase II Clinical Trial	2007-10-12	Unused	NR3C2
HIV Infections	ENSG00000153563	FALSE	Phase II Clinical Trial	NA	Unused	CD8A
HIV Infections	ENSG00000154229	FALSE	Preclinical	1991-04-15	Unused	PRKCA
HIV Infections	ENSG00000154447	FALSE	Preclinical	2009-01-29	Unused	SH3RF1
HIV Infections	ENSG00000159110	FALSE	Approved	1994-06-15	Unused	IFNAR2
HIV Infections	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
HIV Infections	ENSG00000160211	FALSE	unknown	1999-01-15	Phase II Clinical Trial	G6PD
HIV Infections	ENSG00000160712	FALSE	Preclinical	1990-03-15	Unused	IL6R
HIV Infections	ENSG00000160791	TRUE	Approved	1995-12-15	Approved	CCR5
HIV Infections	ENSG00000160868	TRUE	Approved	1994-05-15	Approved	CYP3A4
HIV Infections	ENSG00000163399	FALSE	unknown	2000-10-18	Unused	ATP1A1
HIV Infections	ENSG00000163599	FALSE	unknown	1998-09-15	Unused	CTLA4
HIV Infections	ENSG00000164305	FALSE	Preclinical	1997-03-15	Unused	CASP3
HIV Infections	ENSG00000164342	FALSE	Phase II Clinical Trial	2016-11-15	Unused	TLR3
HIV Infections	ENSG00000164362	FALSE	Preclinical	1999-12-01	Unused	TERT
HIV Infections	ENSG00000164400	FALSE	Phase I Clinical Trial	2011-04-13	Phase I Clinical Trial	CSF2
HIV Infections	ENSG00000164985	FALSE	Preclinical	1999-04-28	Unused	PSIP1
HIV Infections	ENSG00000166710	FALSE	Preclinical	1994-09-15	Unused	B2M
HIV Infections	ENSG00000166794	FALSE	unknown	2007-06-06	Preclinical	PPIB
HIV Infections	ENSG00000167207	FALSE	unknown	2008-07-29	Absent	NOD2
HIV Infections	ENSG00000167325	FALSE	Preclinical	1992-08-15	Unused	RRM1
HIV Infections	ENSG00000167658	FALSE	Phase II Clinical Trial	1989-10-15	Unused	EEF2
HIV Infections	ENSG00000169083	FALSE	Phase III Clinical Trial	NA	Unused	AR
HIV Infections	ENSG00000169174	FALSE	Preclinical	2009-12-10	Absent	PCSK9
HIV Infections	ENSG00000169403	FALSE	Preclinical	1989-06-15	Unused	PTAFR
HIV Infections	ENSG00000169855	FALSE	Preclinical	2011-03-03	Preclinical	ROBO1
HIV Infections	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
HIV Infections	ENSG00000170890	FALSE	unknown	2008-12-17	Unused	PLA2G1B
HIV Infections	ENSG00000171793	FALSE	Preclinical	1998-04-15	Unused	CTPS1
HIV Infections	ENSG00000171848	FALSE	Preclinical	1992-08-15	Unused	RRM2
HIV Infections	ENSG00000173391	FALSE	Preclinical	2016-12-08	Absent	OLR1
HIV Infections	ENSG00000173627	FALSE	Preclinical	NA	Unused	APOBEC4
HIV Infections	ENSG00000173762	FALSE	Phase I Clinical Trial	1998-09-15	Unused	CD7
HIV Infections	ENSG00000178562	FALSE	Phase I Clinical Trial	2008-02-13	Absent	CD28
HIV Infections	ENSG00000179934	FALSE	Preclinical	1998-07-15	Unused	CCR8
HIV Infections	ENSG00000183813	FALSE	Phase I Clinical Trial	1996-08-15	Unused	CCR4
HIV Infections	ENSG00000184588	FALSE	Preclinical	1998-09-15	Unused	PDE4B
HIV Infections	ENSG00000185664	FALSE	unknown	2002-02-27	Unused	PMEL
HIV Infections	ENSG00000187514	FALSE	unknown	NA	Unused	PTMA
HIV Infections	ENSG00000188379	FALSE	Preclinical	2015-10-30	Absent	IFNA2
HIV Infections	ENSG00000196262	FALSE	Phase I Clinical Trial	2004-08-31	Unused	PPIA
HIV Infections	ENSG00000196396	FALSE	unknown	2000-04-18	Unused	PTPN1
HIV Infections	ENSG00000196664	FALSE	Phase I Clinical Trial	2010-10-19	Absent	TLR7
HIV Infections	ENSG00000197249	FALSE	Preclinical	2009-06-04	Unused	SERPINA1
HIV Infections	ENSG00000197272	FALSE	Phase I Clinical Trial	2004-08-03	Unused	IL27
HIV Infections	ENSG00000197561	FALSE	Preclinical	1994-09-15	Unused	ELANE
HIV Infections	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
HIV Infections	ENSG00000198223	FALSE	Phase III Clinical Trial	NA	Unused	CSF2RA
HIV Infections	ENSG00000198793	FALSE	unknown	NA	Unused	MTOR
HIV Infections	ENSG00000198805	FALSE	Preclinical	1989-11-15	Unused	PNP
HIV Infections	ENSG00000198851	FALSE	Preclinical	2015-10-14	Absent	CD3E
HIV Infections	ENSG00000198900	FALSE	unknown	NA	Absent	TOP1
HIV Infections	ENSG00000203710	FALSE	Preclinical	2005-11-04	Unused	CR1
HIV Infections	ENSG00000213903	FALSE	unknown	2000-02-23	Unused	LTB4R
HIV Infections	ENSG00000213918	FALSE	Preclinical	1995-06-15	Unused	DNASE1
HIV Infections	ENSG00000239713	FALSE	Preclinical	2007-03-30	Unused	APOBEC3G
HIV Infections	ENSG00000239732	FALSE	Phase II Clinical Trial	2008-05-07	Absent	TLR9
HIV Infections	ENSG00000259207	FALSE	unknown	NA	Phase II Clinical Trial	ITGB3
HIV Infections	ENSG00000271503	FALSE	Phase II Clinical Trial	1996-10-15	Unused	CCL5
HIV Infections	ENSG00000275302	FALSE	Preclinical	1996-10-15	Unused	CCL4
HIV Infections	ENSG00000277632	FALSE	Preclinical	1996-10-15	Unused	CCL3
HIV Wasting Syndrome	ENSG00000082175	TRUE	Approved	NA	Absent	PGR
HIV Wasting Syndrome	ENSG00000118432	TRUE	Approved	2007-07-09	Absent	CNR1
Hodgkin Disease	ENSG00000010610	FALSE	Phase II Clinical Trial	NA	Absent	CD4
Hodgkin Disease	ENSG00000012124	FALSE	Preclinical	2014-07-03	Absent	CD22
Hodgkin Disease	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Hodgkin Disease	ENSG00000051382	FALSE	unknown	2009-05-05	Phase I Clinical Trial	PIK3CB
Hodgkin Disease	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Hodgkin Disease	ENSG00000072274	FALSE	unknown	1994-06-15	Unused	TFRC
Hodgkin Disease	ENSG00000089692	FALSE	Phase I Clinical Trial	2012-10-31	Absent	LAG3
Hodgkin Disease	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Hodgkin Disease	ENSG00000096968	FALSE	Phase II Clinical Trial	2007-06-15	Phase II Clinical Trial	JAK2
Hodgkin Disease	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Hodgkin Disease	ENSG00000100823	FALSE	Phase I Clinical Trial	2007-02-13	Absent	APEX1
Hodgkin Disease	ENSG00000101017	FALSE	unknown	1998-07-15	Phase II Clinical Trial	CD40
Hodgkin Disease	ENSG00000102755	FALSE	unknown	1994-03-15	Phase II Clinical Trial	FLT1
Hodgkin Disease	ENSG00000105953	FALSE	Phase I Clinical Trial	2008-07-26	Absent	OGDH
Hodgkin Disease	ENSG00000109320	FALSE	Phase I Clinical Trial	2008-10-02	Phase I Clinical Trial	NFKB1
Hodgkin Disease	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Hodgkin Disease	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-02-11	Phase II Clinical Trial	FN1
Hodgkin Disease	ENSG00000115590	FALSE	unknown	1997-05-15	Phase II Clinical Trial	IL1R2
Hodgkin Disease	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Hodgkin Disease	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Hodgkin Disease	ENSG00000116478	FALSE	Phase III Clinical Trial	2001-11-06	Phase III Clinical Trial	HDAC1
Hodgkin Disease	ENSG00000120217	FALSE	Phase I Clinical Trial	2008-01-16	Preclinical	CD274
Hodgkin Disease	ENSG00000120889	FALSE	Phase I Clinical Trial	2006-06-05	Absent	TNFRSF10B
Hodgkin Disease	ENSG00000120949	TRUE	Approved	2000-12-12	Approved	TNFRSF8
Hodgkin Disease	ENSG00000121594	FALSE	unknown	1994-06-15	Unused	CD80
Hodgkin Disease	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Hodgkin Disease	ENSG00000121966	FALSE	Phase I Clinical Trial	2004-06-22	Absent	CXCR4
Hodgkin Disease	ENSG00000122025	FALSE	Phase II Clinical Trial	2007-06-15	Phase II Clinical Trial	FLT3
Hodgkin Disease	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Absent	IDO1
Hodgkin Disease	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Hodgkin Disease	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Hodgkin Disease	ENSG00000131828	FALSE	Phase I Clinical Trial	2008-07-26	Absent	PDHA1
Hodgkin Disease	ENSG00000134460	FALSE	Phase I Clinical Trial	2013-06-18	Unused	IL2RA
Hodgkin Disease	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Hodgkin Disease	ENSG00000136826	FALSE	unknown	2004-05-21	Absent	KLF4
Hodgkin Disease	ENSG00000136997	FALSE	unknown	2004-05-21	Absent	MYC
Hodgkin Disease	ENSG00000137193	FALSE	Preclinical	2009-02-13	Absent	PIM1
Hodgkin Disease	ENSG00000138160	FALSE	unknown	2003-10-06	Phase II Clinical Trial	KIF11
Hodgkin Disease	ENSG00000139193	FALSE	Phase I Clinical Trial	2008-11-12	Absent	CD27
Hodgkin Disease	ENSG00000140443	FALSE	Phase I Clinical Trial	2005-08-05	Unused	IGF1R
Hodgkin Disease	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Hodgkin Disease	ENSG00000143384	FALSE	unknown	1999-10-20	Unused	MCL1
Hodgkin Disease	ENSG00000144744	FALSE	Phase I Clinical Trial	2007-04-27	Absent	UBA3
Hodgkin Disease	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	EGFR
Hodgkin Disease	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC8
Hodgkin Disease	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CHEK1
Hodgkin Disease	ENSG00000150337	FALSE	Phase I Clinical Trial	2002-01-16	Unused	FCGR1A
Hodgkin Disease	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Hodgkin Disease	ENSG00000156738	TRUE	Approved	1993-09-15	Phase II Clinical Trial	MS4A1
Hodgkin Disease	ENSG00000157404	FALSE	Phase II Clinical Trial	2007-06-15	Phase II Clinical Trial	KIT
Hodgkin Disease	ENSG00000160712	FALSE	unknown	1997-05-15	Phase II Clinical Trial	IL6R
Hodgkin Disease	ENSG00000162434	FALSE	Phase II Clinical Trial	2012-06-26	Absent	JAK1
Hodgkin Disease	ENSG00000162747	FALSE	Phase II Clinical Trial	2004-01-21	Phase I Clinical Trial	FCGR3B
Hodgkin Disease	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HDAC11
Hodgkin Disease	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Hodgkin Disease	ENSG00000166851	FALSE	unknown	2008-04-11	Phase I Clinical Trial	PLK1
Hodgkin Disease	ENSG00000169194	FALSE	unknown	2005-03-16	Unused	IL13
Hodgkin Disease	ENSG00000169442	FALSE	unknown	NA	Unused	CD52
Hodgkin Disease	ENSG00000170430	FALSE	Phase I Clinical Trial	2000-05-03	Unused	MGMT
Hodgkin Disease	ENSG00000171608	FALSE	Phase II Clinical Trial	2004-01-20	Phase II Clinical Trial	PIK3CD
Hodgkin Disease	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Hodgkin Disease	ENSG00000171791	FALSE	unknown	1999-10-20	Unused	BCL2
Hodgkin Disease	ENSG00000173638	FALSE	unknown	NA	Phase II Clinical Trial	SLC19A1
Hodgkin Disease	ENSG00000177455	FALSE	Phase II Clinical Trial	2012-09-12	Absent	CD19
Hodgkin Disease	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-15	Phase II Clinical Trial	CSF1R
Hodgkin Disease	ENSG00000185291	FALSE	Preclinical	2014-10-09	Absent	IL3RA
Hodgkin Disease	ENSG00000188389	TRUE	Approved	2005-05-12	Phase I Clinical Trial	PDCD1
Hodgkin Disease	ENSG00000196591	FALSE	Phase III Clinical Trial	2002-06-10	Phase III Clinical Trial	HDAC2
Hodgkin Disease	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Hodgkin Disease	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Hodgkin Disease	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Hodgkin Disease	ENSG00000198900	FALSE	unknown	2007-03-28	Unused	TOP1
Hodgkin Disease	ENSG00000203747	FALSE	Phase II Clinical Trial	2004-01-21	Phase I Clinical Trial	FCGR3A
Hodgkin Disease	ENSG00000228716	FALSE	unknown	NA	Phase II Clinical Trial	DHFR
Hodgkin Disease	ENSG00000275302	FALSE	Phase II Clinical Trial	2004-01-20	Phase II Clinical Trial	CCL4
Hodgkin Disease	ENSG00000277632	FALSE	Phase II Clinical Trial	2004-01-20	Phase II Clinical Trial	CCL3
Homocystinuria	ENSG00000160200	FALSE	Preclinical	2003-03-17	Unused	CBS
HTLV-I Infections	ENSG00000183813	FALSE	Phase III Clinical Trial	2003-05-20	Absent	CCR4
Huntington Disease	ENSG00000004487	FALSE	Phase I Clinical Trial	2010-07-08	Preclinical	KDM1A
Huntington Disease	ENSG00000064300	FALSE	Preclinical	1997-05-15	Absent	NGFR
Huntington Disease	ENSG00000065989	FALSE	Phase I Clinical Trial	2009-11-06	Phase I Clinical Trial	PDE4A
Huntington Disease	ENSG00000068024	FALSE	Preclinical	2011-09-02	Preclinical	HDAC4
Huntington Disease	ENSG00000068903	FALSE	Preclinical	2008-12-05	Unused	SIRT2
Huntington Disease	ENSG00000069535	FALSE	Phase I Clinical Trial	2010-07-08	Unused	MAOB
Huntington Disease	ENSG00000080824	FALSE	Preclinical	2008-01-19	Unused	HSP90AA1
Huntington Disease	ENSG00000082701	FALSE	Preclinical	2009-02-05	Unused	GSK3B
Huntington Disease	ENSG00000084093	FALSE	Preclinical	2009-09-16	Unused	REST
Huntington Disease	ENSG00000087085	FALSE	Phase I Clinical Trial	1989-06-15	Phase I Clinical Trial	ACHE
Huntington Disease	ENSG00000094631	FALSE	Preclinical	2016-10-04	Absent	HDAC6
Huntington Disease	ENSG00000096717	FALSE	Phase II Clinical Trial	2004-09-21	Phase II Clinical Trial	SIRT1
Huntington Disease	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Huntington Disease	ENSG00000101557	FALSE	Preclinical	2011-04-27	Unused	USP14
Huntington Disease	ENSG00000101966	FALSE	Preclinical	2007-01-15	Unused	XIAP
Huntington Disease	ENSG00000105650	FALSE	Phase I Clinical Trial	2009-11-06	Phase I Clinical Trial	PDE4C
Huntington Disease	ENSG00000112541	FALSE	Phase II Clinical Trial	2006-02-27	Unused	PDE10A
Huntington Disease	ENSG00000112715	FALSE	Preclinical	2008-12-05	Unused	VEGFA
Huntington Disease	ENSG00000113448	FALSE	Phase I Clinical Trial	2009-11-06	Phase I Clinical Trial	PDE4D
Huntington Disease	ENSG00000115457	FALSE	Preclinical	2010-10-19	Absent	IGFBP2
Huntington Disease	ENSG00000115828	FALSE	Preclinical	2008-07-01	Absent	QPCT
Huntington Disease	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Huntington Disease	ENSG00000116478	FALSE	Preclinical	2007-07-23	Unused	HDAC1
Huntington Disease	ENSG00000117009	FALSE	Preclinical	2011-09-05	Preclinical	KMO
Huntington Disease	ENSG00000118432	FALSE	Preclinical	2015-10-23	Absent	CNR1
Huntington Disease	ENSG00000122756	FALSE	Preclinical	1995-12-15	Unused	CNTFR
Huntington Disease	ENSG00000128271	FALSE	unknown	2011-06-25	Absent	ADORA2A
Huntington Disease	ENSG00000132170	FALSE	Preclinical	2013-06-13	Absent	PPARG
Huntington Disease	ENSG00000134318	FALSE	Preclinical	2014-08-11	Absent	ROCK2
Huntington Disease	ENSG00000138039	FALSE	unknown	2005-12-06	Unused	LHCGR
Huntington Disease	ENSG00000138685	FALSE	Preclinical	2008-03-03	Unused	FGF2
Huntington Disease	ENSG00000138794	FALSE	Preclinical	2011-05-26	Preclinical	CASP6
Huntington Disease	ENSG00000140443	FALSE	Preclinical	2010-10-19	Absent	IGF1R
Huntington Disease	ENSG00000142192	FALSE	Preclinical	2003-06-17	Absent	APP
Huntington Disease	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Huntington Disease	ENSG00000148053	FALSE	Preclinical	2016-10-24	Preclinical	NTRK2
Huntington Disease	ENSG00000149294	FALSE	Preclinical	2006-08-18	Unused	NCAM1
Huntington Disease	ENSG00000149295	FALSE	Phase III Clinical Trial	2002-04-22	Preclinical	DRD2
Huntington Disease	ENSG00000155511	FALSE	Preclinical	1995-07-15	Unused	GRIA1
Huntington Disease	ENSG00000158748	FALSE	Preclinical	NA	Preclinical	HTR6
Huntington Disease	ENSG00000160191	FALSE	Preclinical	2011-09-13	Unused	PDE9A
Huntington Disease	ENSG00000163485	FALSE	unknown	2011-06-25	Absent	ADORA1
Huntington Disease	ENSG00000165646	TRUE	Approved	2009-05-05	Approved	SLC18A2
Huntington Disease	ENSG00000166148	FALSE	Phase II Clinical Trial	2006-07-10	Absent	AVPR1A
Huntington Disease	ENSG00000168539	FALSE	unknown	1994-09-15	Preclinical	CHRM1
Huntington Disease	ENSG00000168621	FALSE	unknown	2008-09-26	Preclinical	GDNF
Huntington Disease	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Unused	GRM5
Huntington Disease	ENSG00000171119	FALSE	Preclinical	NA	Preclinical	NRTN
Huntington Disease	ENSG00000171720	FALSE	unknown	2007-04-13	Preclinical	HDAC3
Huntington Disease	ENSG00000172053	FALSE	Preclinical	2017-11-22	Absent	QARS
Huntington Disease	ENSG00000173250	FALSE	Preclinical	2009-06-27	Absent	GPR151
Huntington Disease	ENSG00000176884	FALSE	Phase III Clinical Trial	1995-07-15	Unused	GRIN1
Huntington Disease	ENSG00000184588	FALSE	Phase I Clinical Trial	2009-11-06	Phase I Clinical Trial	PDE4B
Huntington Disease	ENSG00000186318	FALSE	Preclinical	2003-06-17	Absent	BACE1
Huntington Disease	ENSG00000187266	FALSE	unknown	2005-12-06	Unused	EPOR
Huntington Disease	ENSG00000187764	FALSE	Phase II Clinical Trial	2006-06-20	Absent	SEMA4D
Huntington Disease	ENSG00000189221	FALSE	Preclinical	2011-08-20	Unused	MAOA
Huntington Disease	ENSG00000196218	FALSE	Preclinical	2012-09-07	Absent	RYR1
Huntington Disease	ENSG00000196591	FALSE	Preclinical	2007-07-23	Unused	HDAC2
Huntington Disease	ENSG00000197386	FALSE	Phase II Clinical Trial	2003-06-17	Unused	HTT
Huntington Disease	ENSG00000197971	FALSE	Phase II Clinical Trial	NA	Unused	MBP
Huntington Disease	ENSG00000198959	FALSE	Preclinical	2008-02-18	Preclinical	TGM2
Huntington Disease	ENSG00000205571	FALSE	Preclinical	2017-01-13	Absent	SMN2
Huntington Disease	ENSG00000273079	FALSE	Phase III Clinical Trial	2005-09-09	Unused	GRIN2B
Hyper-IgM Immunodeficiency Syndrome	ENSG00000102245	FALSE	Preclinical	2004-04-28	Unused	CD40LG
Hyperaldosteronism	ENSG00000160882	FALSE	Phase II Clinical Trial	2006-12-07	Absent	CYP11B1
Hyperaldosteronism	ENSG00000179142	FALSE	Phase II Clinical Trial	2006-12-07	Unused	CYP11B2
Hyperammonemia	ENSG00000021826	TRUE	Approved	NA	Approved	CPS1
Hyperammonemia	ENSG00000110887	FALSE	Preclinical	NA	Absent	DAO
Hyperammonemia	ENSG00000148672	FALSE	Preclinical	2016-09-23	Absent	GLUD1
Hyperargininemia	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Hyperargininemia	ENSG00000118520	FALSE	Preclinical	2016-12-14	Absent	ARG1
Hyperbilirubinemia	ENSG00000100292	FALSE	Phase III Clinical Trial	2002-04-23	Unused	HMOX1
Hypercalcemia	ENSG00000004948	TRUE	Approved	1992-12-15	Approved	CALCR
Hypercalcemia	ENSG00000036828	TRUE	Approved	1994-05-15	Approved	CASR
Hypercalcemia	ENSG00000087494	FALSE	Phase II Clinical Trial	2000-10-04	Unused	PTHLH
Hypercalcemia	ENSG00000110680	FALSE	Approved	NA	Unused	CALCA
Hypercalcemia	ENSG00000111012	FALSE	Preclinical	NA	Unused	CYP27B1
Hypercalcemia	ENSG00000120659	FALSE	Phase II Clinical Trial	1997-07-15	Phase II Clinical Trial	TNFSF11
Hypercalcemia	ENSG00000137869	FALSE	unknown	2002-12-17	Unused	CYP19A1
Hypercalcemia	ENSG00000160801	FALSE	Phase II Clinical Trial	2015-12-16	Unused	PTH1R
Hypercalcemia	ENSG00000166311	FALSE	unknown	2011-08-02	Preclinical	SMPD1
Hypercholesterolemia	ENSG00000001626	FALSE	unknown	1995-10-15	Unused	CFTR
Hypercholesterolemia	ENSG00000005421	FALSE	Preclinical	2015-01-12	Absent	PON1
Hypercholesterolemia	ENSG00000012504	FALSE	Phase II Clinical Trial	1996-06-15	Unused	NR1H4
Hypercholesterolemia	ENSG00000015520	TRUE	Approved	2000-06-06	Approved	NPC1L1
Hypercholesterolemia	ENSG00000025434	FALSE	Phase I Clinical Trial	2001-04-03	Unused	NR1H3
Hypercholesterolemia	ENSG00000057252	FALSE	Approved	1989-10-15	Unused	SOAT1
Hypercholesterolemia	ENSG00000065989	FALSE	Preclinical	2002-07-12	Absent	PDE4A
Hypercholesterolemia	ENSG00000070019	FALSE	Preclinical	2011-05-19	Unused	GUCY2C
Hypercholesterolemia	ENSG00000072274	FALSE	Preclinical	2005-02-09	Unused	TFRC
Hypercholesterolemia	ENSG00000073060	FALSE	Preclinical	2017-05-23	Absent	SCARB1
Hypercholesterolemia	ENSG00000073756	TRUE	Approved	2008-06-05	Absent	PTGS2
Hypercholesterolemia	ENSG00000079459	FALSE	Preclinical	1994-10-15	Unused	FDFT1
Hypercholesterolemia	ENSG00000084674	FALSE	Phase I Clinical Trial	2002-05-28	Approved	APOB
Hypercholesterolemia	ENSG00000087237	FALSE	Phase III Clinical Trial	2000-06-19	Phase III Clinical Trial	CETP
Hypercholesterolemia	ENSG00000095303	TRUE	Approved	2008-06-05	Absent	PTGS1
Hypercholesterolemia	ENSG00000100504	FALSE	Preclinical	2011-10-20	Preclinical	PYGL
Hypercholesterolemia	ENSG00000101986	FALSE	Phase II Clinical Trial	2015-02-09	Absent	ABCD1
Hypercholesterolemia	ENSG00000104549	FALSE	Preclinical	1997-10-15	Unused	SQLE
Hypercholesterolemia	ENSG00000105650	FALSE	Preclinical	2002-07-12	Absent	PDE4C
Hypercholesterolemia	ENSG00000109320	FALSE	Phase II Clinical Trial	2009-05-27	Absent	NFKB1
Hypercholesterolemia	ENSG00000112062	FALSE	Preclinical	2008-02-14	Unused	MAPK14
Hypercholesterolemia	ENSG00000113161	TRUE	Approved	1989-10-15	Approved	HMGCR
Hypercholesterolemia	ENSG00000113448	FALSE	Preclinical	2002-07-12	Absent	PDE4D
Hypercholesterolemia	ENSG00000116711	FALSE	Preclinical	1996-04-15	Unused	PLA2G4A
Hypercholesterolemia	ENSG00000117594	FALSE	Phase II Clinical Trial	2010-05-04	Absent	HSD11B1
Hypercholesterolemia	ENSG00000118137	FALSE	Preclinical	1997-11-15	Phase II Clinical Trial	APOA1
Hypercholesterolemia	ENSG00000125255	FALSE	Phase II Clinical Trial	1998-12-15	Phase II Clinical Trial	SLC10A2
Hypercholesterolemia	ENSG00000125538	FALSE	Preclinical	2015-06-29	Absent	IL1B
Hypercholesterolemia	ENSG00000130164	FALSE	Preclinical	1992-09-15	Unused	LDLR
Hypercholesterolemia	ENSG00000130203	FALSE	Preclinical	2002-09-11	Unused	APOE
Hypercholesterolemia	ENSG00000131408	FALSE	Phase I Clinical Trial	2001-04-03	Unused	NR1H2
Hypercholesterolemia	ENSG00000131473	FALSE	Phase III Clinical Trial	2015-03-20	Absent	ACLY
Hypercholesterolemia	ENSG00000132170	FALSE	Phase II Clinical Trial	1989-09-15	Phase III Clinical Trial	PPARG
Hypercholesterolemia	ENSG00000132855	FALSE	Phase II Clinical Trial	2013-11-19	Absent	ANGPTL3
Hypercholesterolemia	ENSG00000138115	TRUE	Approved	NA	Approved	CYP2C8
Hypercholesterolemia	ENSG00000138823	TRUE	Approved	1995-06-15	Approved	MTTP
Hypercholesterolemia	ENSG00000144891	FALSE	Approved	2011-08-08	Phase I Clinical Trial	AGTR1
Hypercholesterolemia	ENSG00000147852	FALSE	Preclinical	1997-09-15	Unused	VLDLR
Hypercholesterolemia	ENSG00000151067	TRUE	Approved	2003-07-01	Approved	CACNA1C
Hypercholesterolemia	ENSG00000151090	FALSE	Phase II Clinical Trial	2005-07-13	Phase I Clinical Trial	THRB
Hypercholesterolemia	ENSG00000159640	TRUE	Approved	2005-06-08	Unused	ACE
Hypercholesterolemia	ENSG00000160285	FALSE	unknown	NA	Absent	LSS
Hypercholesterolemia	ENSG00000163586	FALSE	Preclinical	2011-06-17	Unused	FABP1
Hypercholesterolemia	ENSG00000168229	TRUE	Approved	2005-12-15	Unused	PTGDR
Hypercholesterolemia	ENSG00000168522	FALSE	Preclinical	1996-06-15	Unused	FNTA
Hypercholesterolemia	ENSG00000169032	FALSE	Phase II Clinical Trial	2009-05-27	Absent	MAP2K1
Hypercholesterolemia	ENSG00000169083	FALSE	unknown	2000-09-29	Unused	AR
Hypercholesterolemia	ENSG00000169174	TRUE	Approved	2006-07-19	Phase III Clinical Trial	PCSK9
Hypercholesterolemia	ENSG00000172572	FALSE	Preclinical	2002-07-12	Absent	PDE3A
Hypercholesterolemia	ENSG00000173198	FALSE	Preclinical	2002-07-12	Absent	CYSLTR1
Hypercholesterolemia	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Hypercholesterolemia	ENSG00000177606	FALSE	Phase II Clinical Trial	2009-05-27	Absent	JUN
Hypercholesterolemia	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Hypercholesterolemia	ENSG00000182782	TRUE	Approved	2003-04-14	Approved	HCAR2
Hypercholesterolemia	ENSG00000184588	FALSE	Preclinical	2002-07-12	Absent	PDE4B
Hypercholesterolemia	ENSG00000186350	FALSE	Phase II Clinical Trial	2002-09-02	Unused	RXRA
Hypercholesterolemia	ENSG00000186951	TRUE	Approved	2002-09-02	Approved	PPARA
Hypercholesterolemia	ENSG00000188822	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CNR2
Hypercholesterolemia	ENSG00000197635	FALSE	unknown	2003-09-17	Preclinical	DPP4
Hypercholesterolemia	ENSG00000198911	FALSE	unknown	2013-08-22	Absent	SREBF2
Hypercholesterolemia	ENSG00000255398	FALSE	Phase II Clinical Trial	2009-07-22	Absent	HCAR3
Hypereosinophilic Syndrome	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Hypereosinophilic Syndrome	ENSG00000097007	TRUE	Approved	1999-03-17	Approved	ABL1
Hypereosinophilic Syndrome	ENSG00000113525	FALSE	Phase III Clinical Trial	1997-05-15	Unused	IL5
Hypereosinophilic Syndrome	ENSG00000134853	TRUE	Approved	1999-03-17	Approved	PDGFRA
Hypereosinophilic Syndrome	ENSG00000157404	TRUE	Approved	1999-03-17	Approved	KIT
Hypereosinophilic Syndrome	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Hypereosinophilic Syndrome	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Hypereosinophilic Syndrome	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Absent	IL3RA
Hypereosinophilic Syndrome	ENSG00000186716	TRUE	Approved	1999-03-17	Approved	BCR
Hypereosinophilic Syndrome	ENSG00000197122	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	SRC
Hypereosinophilic Syndrome	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Hyperglycinemia, Nonketotic	ENSG00000110887	FALSE	Preclinical	NA	Absent	DAO
Hyperhidrosis	ENSG00000133019	FALSE	Phase II Clinical Trial	2008-06-02	Absent	CHRM3
Hyperhidrosis	ENSG00000168539	FALSE	Phase II Clinical Trial	2008-06-02	Absent	CHRM1
Hyperhidrosis	ENSG00000180720	FALSE	Phase II Clinical Trial	2008-06-02	Absent	CHRM4
Hyperhidrosis	ENSG00000181072	FALSE	Phase II Clinical Trial	2008-06-02	Absent	CHRM2
Hyperlipidemias	ENSG00000005421	FALSE	Preclinical	2015-07-29	Absent	PON1
Hyperlipidemias	ENSG00000006071	FALSE	Preclinical	2013-08-29	Absent	ABCC8
Hyperlipidemias	ENSG00000006638	FALSE	unknown	1991-01-15	Unused	TBXA2R
Hyperlipidemias	ENSG00000007171	FALSE	unknown	1989-10-15	Unused	NOS2
Hyperlipidemias	ENSG00000007944	FALSE	Preclinical	2012-08-10	Preclinical	MYLIP
Hyperlipidemias	ENSG00000012504	FALSE	Phase III Clinical Trial	1991-01-15	Unused	NR1H4
Hyperlipidemias	ENSG00000015520	TRUE	Approved	1997-05-15	Approved	NPC1L1
Hyperlipidemias	ENSG00000025434	FALSE	Preclinical	2003-09-24	Unused	NR1H3
Hyperlipidemias	ENSG00000043591	FALSE	Phase I Clinical Trial	2017-08-10	Absent	ADRB1
Hyperlipidemias	ENSG00000057252	FALSE	Preclinical	1991-11-15	Unused	SOAT1
Hyperlipidemias	ENSG00000059377	FALSE	Preclinical	2010-11-02	Preclinical	TBXAS1
Hyperlipidemias	ENSG00000062282	FALSE	Phase I Clinical Trial	2014-08-06	Absent	DGAT2
Hyperlipidemias	ENSG00000065989	FALSE	Preclinical	2002-07-12	Absent	PDE4A
Hyperlipidemias	ENSG00000069431	FALSE	Preclinical	1995-10-15	Unused	ABCC9
Hyperlipidemias	ENSG00000072310	FALSE	unknown	2016-01-14	Absent	SREBF1
Hyperlipidemias	ENSG00000073756	FALSE	Preclinical	2008-10-17	Phase II Clinical Trial	PTGS2
Hyperlipidemias	ENSG00000079435	FALSE	Preclinical	2016-08-15	Absent	LIPE
Hyperlipidemias	ENSG00000079459	FALSE	Phase III Clinical Trial	1993-10-15	Unused	FDFT1
Hyperlipidemias	ENSG00000087237	FALSE	Phase III Clinical Trial	1997-04-15	Phase III Clinical Trial	CETP
Hyperlipidemias	ENSG00000091831	FALSE	Preclinical	1996-08-15	Unused	ESR1
Hyperlipidemias	ENSG00000095303	FALSE	Preclinical	2008-10-17	Phase II Clinical Trial	PTGS1
Hyperlipidemias	ENSG00000100504	FALSE	Preclinical	2012-06-25	Preclinical	PYGL
Hyperlipidemias	ENSG00000101180	FALSE	unknown	2007-02-07	Unused	HRH3
Hyperlipidemias	ENSG00000104549	FALSE	Preclinical	1995-10-15	Unused	SQLE
Hyperlipidemias	ENSG00000105650	FALSE	Preclinical	2002-07-12	Absent	PDE4C
Hyperlipidemias	ENSG00000109320	FALSE	Phase II Clinical Trial	2009-05-27	Absent	NFKB1
Hyperlipidemias	ENSG00000110245	FALSE	Preclinical	2009-05-01	Phase II Clinical Trial	APOC3
Hyperlipidemias	ENSG00000112033	FALSE	Phase II Clinical Trial	2001-02-28	Phase I Clinical Trial	PPARD
Hyperlipidemias	ENSG00000112062	FALSE	unknown	2005-08-15	Unused	MAPK14
Hyperlipidemias	ENSG00000113161	TRUE	Approved	1991-01-15	Approved	HMGCR
Hyperlipidemias	ENSG00000113448	FALSE	Preclinical	2002-07-12	Absent	PDE4D
Hyperlipidemias	ENSG00000113575	FALSE	Preclinical	2006-07-18	Unused	PPP2CA
Hyperlipidemias	ENSG00000116678	FALSE	unknown	1995-08-15	Unused	LEPR
Hyperlipidemias	ENSG00000117594	FALSE	Preclinical	2009-05-01	Unused	HSD11B1
Hyperlipidemias	ENSG00000118137	FALSE	Phase I Clinical Trial	2002-03-08	Unused	APOA1
Hyperlipidemias	ENSG00000118260	FALSE	Preclinical	2009-06-09	Unused	CREB1
Hyperlipidemias	ENSG00000118432	FALSE	unknown	1994-02-15	Unused	CNR1
Hyperlipidemias	ENSG00000121361	FALSE	Preclinical	1995-10-15	Unused	KCNJ8
Hyperlipidemias	ENSG00000122194	FALSE	Preclinical	2009-07-24	Unused	PLG
Hyperlipidemias	ENSG00000125255	FALSE	Phase I Clinical Trial	2002-11-11	Phase II Clinical Trial	SLC10A2
Hyperlipidemias	ENSG00000126262	FALSE	Preclinical	2009-06-29	Unused	FFAR2
Hyperlipidemias	ENSG00000130164	FALSE	Phase I Clinical Trial	1994-04-15	Unused	LDLR
Hyperlipidemias	ENSG00000130203	FALSE	Preclinical	2000-10-25	Unused	APOE
Hyperlipidemias	ENSG00000131408	FALSE	Preclinical	2003-09-24	Unused	NR1H2
Hyperlipidemias	ENSG00000131473	FALSE	Phase III Clinical Trial	2015-03-20	Phase II Clinical Trial	ACLY
Hyperlipidemias	ENSG00000132170	FALSE	Approved	1989-09-15	Unused	PPARG
Hyperlipidemias	ENSG00000132855	FALSE	Phase II Clinical Trial	2013-01-10	Absent	ANGPTL3
Hyperlipidemias	ENSG00000135744	FALSE	Phase III Clinical Trial	2015-02-04	Absent	AGT
Hyperlipidemias	ENSG00000138075	FALSE	Preclinical	2002-06-26	Unused	ABCG5
Hyperlipidemias	ENSG00000138115	TRUE	Approved	NA	Approved	CYP2C8
Hyperlipidemias	ENSG00000138823	FALSE	Phase II Clinical Trial	1997-07-15	Phase II Clinical Trial	MTTP
Hyperlipidemias	ENSG00000143171	FALSE	Preclinical	2008-07-10	Absent	RXRG
Hyperlipidemias	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Hyperlipidemias	ENSG00000143921	FALSE	Preclinical	2002-06-26	Unused	ABCG8
Hyperlipidemias	ENSG00000144891	FALSE	Approved	2004-04-20	Phase III Clinical Trial	AGTR1
Hyperlipidemias	ENSG00000147262	FALSE	Phase II Clinical Trial	2008-11-05	Phase II Clinical Trial	GPR119
Hyperlipidemias	ENSG00000151067	FALSE	Phase III Clinical Trial	2009-02-03	Phase II Clinical Trial	CACNA1C
Hyperlipidemias	ENSG00000151090	FALSE	Phase I Clinical Trial	2005-04-25	Unused	THRB
Hyperlipidemias	ENSG00000160285	FALSE	unknown	NA	Absent	LSS
Hyperlipidemias	ENSG00000163485	FALSE	unknown	2002-04-04	Unused	ADORA1
Hyperlipidemias	ENSG00000164687	FALSE	Preclinical	2011-02-17	Preclinical	FABP5
Hyperlipidemias	ENSG00000164849	FALSE	Preclinical	2016-11-03	Absent	GPR146
Hyperlipidemias	ENSG00000165029	FALSE	Phase I Clinical Trial	2002-06-26	Unused	ABCA1
Hyperlipidemias	ENSG00000168229	TRUE	Approved	2005-12-15	Unused	PTGDR
Hyperlipidemias	ENSG00000169032	FALSE	Phase II Clinical Trial	2009-05-27	Absent	MAP2K1
Hyperlipidemias	ENSG00000169083	FALSE	unknown	2006-07-07	Unused	AR
Hyperlipidemias	ENSG00000169174	TRUE	Approved	2009-10-13	Phase III Clinical Trial	PCSK9
Hyperlipidemias	ENSG00000170323	FALSE	Preclinical	2011-02-17	Preclinical	FABP4
Hyperlipidemias	ENSG00000172572	FALSE	Preclinical	2002-07-12	Absent	PDE3A
Hyperlipidemias	ENSG00000173198	FALSE	Preclinical	2002-07-12	Absent	CYSLTR1
Hyperlipidemias	ENSG00000175336	FALSE	Preclinical	2009-05-01	Unused	APOF
Hyperlipidemias	ENSG00000175445	TRUE	Approved	2005-07-04	Approved	LPL
Hyperlipidemias	ENSG00000175535	FALSE	unknown	NA	Unused	PNLIP
Hyperlipidemias	ENSG00000177606	FALSE	Phase II Clinical Trial	2009-05-27	Absent	JUN
Hyperlipidemias	ENSG00000179921	FALSE	Preclinical	2005-05-25	Unused	GPBAR1
Hyperlipidemias	ENSG00000182782	TRUE	Approved	2003-04-14	Approved	HCAR2
Hyperlipidemias	ENSG00000184588	FALSE	Preclinical	2002-07-12	Absent	PDE4B
Hyperlipidemias	ENSG00000185000	FALSE	Preclinical	2008-08-21	Unused	DGAT1
Hyperlipidemias	ENSG00000186350	FALSE	unknown	2002-09-02	Unused	RXRA
Hyperlipidemias	ENSG00000186951	TRUE	Approved	1995-05-15	Approved	PPARA
Hyperlipidemias	ENSG00000187486	FALSE	Preclinical	2013-08-29	Absent	KCNJ11
Hyperlipidemias	ENSG00000188822	FALSE	unknown	2007-04-23	Phase II Clinical Trial	CNR2
Hyperlipidemias	ENSG00000196639	FALSE	unknown	2007-02-07	Unused	HRH1
Hyperlipidemias	ENSG00000197635	TRUE	Approved	2008-12-15	Approved	DPP4
Hyperlipidemias	ENSG00000198670	FALSE	Phase II Clinical Trial	2015-03-10	Absent	LPA
Hyperlipidemias	ENSG00000198911	FALSE	Preclinical	2008-11-27	Preclinical	SREBF2
Hyperlipidemias	ENSG00000255398	FALSE	unknown	2005-10-31	Unused	HCAR3
Hyperlipoproteinemia Type I	ENSG00000110245	FALSE	Pre-registration	2009-05-01	Absent	APOC3
Hyperlipoproteinemia Type I	ENSG00000132855	FALSE	Phase II Clinical Trial	2015-03-18	Absent	ANGPTL3
Hyperlipoproteinemia Type I	ENSG00000175445	TRUE	Approved	2001-02-08	Absent	LPL
Hyperlipoproteinemia Type I	ENSG00000185000	FALSE	Phase III Clinical Trial	2008-11-24	Absent	DGAT1
Hyperlipoproteinemia Type II	ENSG00000005421	FALSE	Phase II Clinical Trial	2010-04-30	Absent	PON1
Hyperlipoproteinemia Type II	ENSG00000015520	TRUE	Approved	1997-05-15	Absent	NPC1L1
Hyperlipoproteinemia Type II	ENSG00000084674	TRUE	Approved	2003-05-12	Absent	APOB
Hyperlipoproteinemia Type II	ENSG00000087237	FALSE	Phase III Clinical Trial	2000-12-12	Absent	CETP
Hyperlipoproteinemia Type II	ENSG00000112033	FALSE	Phase II Clinical Trial	2007-05-01	Absent	PPARD
Hyperlipoproteinemia Type II	ENSG00000113161	TRUE	Approved	1991-07-15	Absent	HMGCR
Hyperlipoproteinemia Type II	ENSG00000118137	FALSE	unknown	2007-03-03	Absent	APOA1
Hyperlipoproteinemia Type II	ENSG00000130203	FALSE	Phase II Clinical Trial	2010-04-30	Absent	APOE
Hyperlipoproteinemia Type II	ENSG00000131473	FALSE	Phase III Clinical Trial	2015-03-20	Absent	ACLY
Hyperlipoproteinemia Type II	ENSG00000132855	FALSE	Phase II Clinical Trial	2013-01-10	Absent	ANGPTL3
Hyperlipoproteinemia Type II	ENSG00000136634	FALSE	unknown	2013-11-28	Absent	IL10
Hyperlipoproteinemia Type II	ENSG00000138823	TRUE	Approved	1995-06-15	Absent	MTTP
Hyperlipoproteinemia Type II	ENSG00000151090	FALSE	Phase II Clinical Trial	2009-01-06	Absent	THRB
Hyperlipoproteinemia Type II	ENSG00000168229	TRUE	Approved	2005-12-15	Absent	PTGDR
Hyperlipoproteinemia Type II	ENSG00000169174	TRUE	Approved	2009-10-13	Absent	PCSK9
Hyperlipoproteinemia Type II	ENSG00000182782	TRUE	Approved	2005-12-15	Absent	HCAR2
Hyperoxaluria	ENSG00000101323	FALSE	Phase II Clinical Trial	2014-10-15	Absent	HAO1
Hyperoxaluria	ENSG00000116882	FALSE	Phase I Clinical Trial	2014-01-03	Absent	HAO2
Hyperoxaluria	ENSG00000172482	FALSE	Preclinical	2005-12-03	Preclinical	AGXT
Hyperparathyroidism	ENSG00000019186	FALSE	Phase II Clinical Trial	2000-08-31	Unused	CYP24A1
Hyperparathyroidism	ENSG00000036828	TRUE	Approved	1994-05-15	Approved	CASR
Hyperparathyroidism	ENSG00000111424	TRUE	Approved	1991-09-15	Approved	VDR
Hyperparathyroidism	ENSG00000143839	FALSE	Preclinical	NA	Absent	REN
Hyperparathyroidism	ENSG00000152266	FALSE	Phase I Clinical Trial	2004-02-04	Unused	PTH
Hyperparathyroidism	ENSG00000160801	FALSE	Preclinical	2015-12-16	Absent	PTH1R
Hyperparathyroidism	ENSG00000171132	FALSE	Phase I Clinical Trial	2005-05-31	Unused	PRKCE
Hyperparathyroidism, Primary	ENSG00000036828	TRUE	Approved	1994-05-15	Absent	CASR
Hyperphagia	ENSG00000166603	FALSE	Phase III Clinical Trial	2009-01-09	Absent	MC4R
Hyperphosphatemia	ENSG00000066230	FALSE	Phase III Clinical Trial	2011-05-03	Absent	SLC9A3
Hyperphosphatemia	ENSG00000111424	FALSE	Preclinical	2001-10-18	Unused	VDR
Hyperphosphatemia	ENSG00000198569	FALSE	Preclinical	2007-01-15	Preclinical	SLC34A3
Hyperplasia	ENSG00000091831	FALSE	Preclinical	2003-05-13	Absent	ESR1
Hyperprolactinemia	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Hyperprolactinemia	ENSG00000108576	FALSE	unknown	NA	Unused	SLC6A4
Hyperprolactinemia	ENSG00000109163	FALSE	Preclinical	NA	Unused	GNRHR
Hyperprolactinemia	ENSG00000113494	FALSE	Phase II Clinical Trial	2009-12-10	Absent	PRLR
Hyperprolactinemia	ENSG00000119973	FALSE	Phase I Clinical Trial	NA	Unused	PRLHR
Hyperprolactinemia	ENSG00000135312	FALSE	Preclinical	1998-01-15	Unused	HTR1B
Hyperprolactinemia	ENSG00000147246	FALSE	unknown	NA	Unused	HTR2C
Hyperprolactinemia	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Hyperprolactinemia	ENSG00000169083	FALSE	Preclinical	1997-04-15	Unused	AR
Hyperprolactinemia	ENSG00000178394	FALSE	unknown	NA	Unused	HTR1A
Hypersensitivity	ENSG00000006638	FALSE	Preclinical	1990-09-15	Unused	TBXA2R
Hypersensitivity	ENSG00000010610	FALSE	Preclinical	1991-11-15	Unused	CD4
Hypersensitivity	ENSG00000012779	FALSE	Preclinical	1989-11-15	Unused	ALOX5
Hypersensitivity	ENSG00000027697	FALSE	Preclinical	1996-12-15	Unused	IFNGR1
Hypersensitivity	ENSG00000059377	FALSE	Preclinical	1993-06-15	Unused	TBXAS1
Hypersensitivity	ENSG00000064989	FALSE	Preclinical	1998-07-15	Unused	CALCRL
Hypersensitivity	ENSG00000065534	FALSE	Preclinical	NA	Unused	MYLK
Hypersensitivity	ENSG00000065989	FALSE	Preclinical	1993-08-15	Unused	PDE4A
Hypersensitivity	ENSG00000069764	FALSE	Preclinical	1998-07-15	Unused	PLA2G10
Hypersensitivity	ENSG00000072062	FALSE	Preclinical	NA	Unused	PRKACA
Hypersensitivity	ENSG00000072694	FALSE	Phase I Clinical Trial	2012-01-28	Absent	FCGR2B
Hypersensitivity	ENSG00000073756	FALSE	Preclinical	1996-08-15	Unused	PTGS2
Hypersensitivity	ENSG00000077238	FALSE	Preclinical	1991-04-15	Unused	IL4R
Hypersensitivity	ENSG00000095303	FALSE	unknown	NA	Absent	PTGS1
Hypersensitivity	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Hypersensitivity	ENSG00000100739	FALSE	Preclinical	1997-10-15	Unused	BDKRB1
Hypersensitivity	ENSG00000101017	FALSE	Preclinical	1997-01-15	Unused	CD40
Hypersensitivity	ENSG00000101180	FALSE	Preclinical	1990-01-15	Unused	HRH3
Hypersensitivity	ENSG00000102468	FALSE	Preclinical	1993-06-15	Unused	HTR2A
Hypersensitivity	ENSG00000104921	FALSE	Preclinical	1991-07-15	Unused	FCER2
Hypersensitivity	ENSG00000105650	FALSE	Preclinical	1993-08-15	Unused	PDE4C
Hypersensitivity	ENSG00000105851	FALSE	unknown	2009-07-15	Phase I Clinical Trial	PIK3CG
Hypersensitivity	ENSG00000107317	FALSE	Preclinical	2006-10-17	Unused	PTGDS
Hypersensitivity	ENSG00000108839	FALSE	Preclinical	NA	Unused	ALOX12
Hypersensitivity	ENSG00000109320	FALSE	unknown	2002-07-24	Unused	NFKB1
Hypersensitivity	ENSG00000113263	FALSE	Phase II Clinical Trial	2011-05-06	Phase I Clinical Trial	ITK
Hypersensitivity	ENSG00000113448	FALSE	Preclinical	1993-08-15	Unused	PDE4D
Hypersensitivity	ENSG00000113520	FALSE	Preclinical	2003-12-12	Unused	IL4
Hypersensitivity	ENSG00000113525	FALSE	Preclinical	1993-03-15	Unused	IL5
Hypersensitivity	ENSG00000113580	TRUE	Approved	1991-09-15	Approved	NR3C1
Hypersensitivity	ENSG00000113749	FALSE	Preclinical	1993-04-15	Unused	HRH2
Hypersensitivity	ENSG00000115008	FALSE	unknown	2012-05-09	Preclinical	IL1A
Hypersensitivity	ENSG00000115085	FALSE	Preclinical	1995-02-15	Unused	ZAP70
Hypersensitivity	ENSG00000115232	FALSE	unknown	1997-04-15	Unused	ITGA4
Hypersensitivity	ENSG00000115594	FALSE	Preclinical	1989-06-15	Unused	IL1R1
Hypersensitivity	ENSG00000116678	FALSE	Preclinical	1996-12-15	Unused	LEPR
Hypersensitivity	ENSG00000119535	FALSE	Preclinical	1996-12-15	Unused	CSF3R
Hypersensitivity	ENSG00000120907	FALSE	Phase III Clinical Trial	NA	Unused	ADRA1A
Hypersensitivity	ENSG00000122420	FALSE	Preclinical	NA	Unused	PTGFR
Hypersensitivity	ENSG00000125538	FALSE	unknown	2012-05-09	Preclinical	IL1B
Hypersensitivity	ENSG00000128052	FALSE	Preclinical	1998-12-15	Unused	KDR
Hypersensitivity	ENSG00000128271	FALSE	Preclinical	NA	Unused	ADORA2A
Hypersensitivity	ENSG00000131196	FALSE	Preclinical	1997-06-15	Unused	NFATC1
Hypersensitivity	ENSG00000132329	FALSE	Preclinical	1998-07-15	Unused	RAMP1
Hypersensitivity	ENSG00000133019	FALSE	unknown	NA	Unused	CHRM3
Hypersensitivity	ENSG00000134318	FALSE	Preclinical	2004-08-20	Unused	ROCK2
Hypersensitivity	ENSG00000134460	FALSE	Preclinical	1993-06-15	Unused	IL2RA
Hypersensitivity	ENSG00000134489	FALSE	Preclinical	2003-09-02	Unused	HRH4
Hypersensitivity	ENSG00000134853	FALSE	Preclinical	1998-12-15	Unused	PDGFRA
Hypersensitivity	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Hypersensitivity	ENSG00000140287	FALSE	Preclinical	NA	Unused	HDC
Hypersensitivity	ENSG00000140678	FALSE	Preclinical	1996-07-15	Unused	ITGAX
Hypersensitivity	ENSG00000143365	FALSE	Phase I Clinical Trial	2013-08-03	Absent	RORC
Hypersensitivity	ENSG00000146648	FALSE	Preclinical	1998-12-15	Unused	EGFR
Hypersensitivity	ENSG00000147246	FALSE	Preclinical	1993-06-15	Unused	HTR2C
Hypersensitivity	ENSG00000150093	FALSE	unknown	1997-04-15	Unused	ITGB1
Hypersensitivity	ENSG00000154229	FALSE	Preclinical	NA	Unused	PRKCA
Hypersensitivity	ENSG00000160013	FALSE	Preclinical	1998-09-15	Unused	PTGIR
Hypersensitivity	ENSG00000160712	FALSE	Preclinical	1996-12-15	Unused	IL6R
Hypersensitivity	ENSG00000163106	FALSE	Preclinical	2008-04-14	Unused	HPGDS
Hypersensitivity	ENSG00000163131	FALSE	Preclinical	1998-06-15	Unused	CTSS
Hypersensitivity	ENSG00000163485	TRUE	Approved	NA	Approved	ADORA1
Hypersensitivity	ENSG00000165025	FALSE	Preclinical	1994-07-15	Unused	SYK
Hypersensitivity	ENSG00000166888	FALSE	Preclinical	2009-09-25	Unused	STAT6
Hypersensitivity	ENSG00000167658	FALSE	Preclinical	1991-04-15	Unused	EEF2
Hypersensitivity	ENSG00000168229	FALSE	Preclinical	1999-11-02	Unused	PTGDR
Hypersensitivity	ENSG00000168539	FALSE	unknown	NA	Unused	CHRM1
Hypersensitivity	ENSG00000168918	FALSE	Preclinical	2007-10-29	Unused	INPP5D
Hypersensitivity	ENSG00000169083	FALSE	unknown	1996-11-15	Unused	AR
Hypersensitivity	ENSG00000169194	FALSE	unknown	NA	Unused	IL13
Hypersensitivity	ENSG00000169252	FALSE	Preclinical	NA	Unused	ADRB2
Hypersensitivity	ENSG00000169403	FALSE	Preclinical	1990-02-15	Unused	PTAFR
Hypersensitivity	ENSG00000169896	FALSE	Preclinical	1996-07-15	Unused	ITGAM
Hypersensitivity	ENSG00000170214	FALSE	Phase III Clinical Trial	NA	Unused	ADRA1B
Hypersensitivity	ENSG00000170989	FALSE	unknown	2005-05-17	Phase I Clinical Trial	S1PR1
Hypersensitivity	ENSG00000171049	FALSE	Preclinical	2015-12-10	Absent	FPR2
Hypersensitivity	ENSG00000171522	FALSE	Phase I Clinical Trial	2008-07-04	Phase I Clinical Trial	PTGER4
Hypersensitivity	ENSG00000171608	FALSE	unknown	2009-07-15	Phase I Clinical Trial	PIK3CD
Hypersensitivity	ENSG00000171873	FALSE	Phase I Clinical Trial	NA	Unused	ADRA1D
Hypersensitivity	ENSG00000172156	FALSE	Preclinical	1996-03-15	Unused	CCL11
Hypersensitivity	ENSG00000172236	FALSE	Preclinical	1997-02-15	Unused	TPSAB1
Hypersensitivity	ENSG00000172572	FALSE	Preclinical	1993-08-15	Unused	PDE3A
Hypersensitivity	ENSG00000172819	FALSE	Phase I Clinical Trial	2015-05-20	Absent	RARG
Hypersensitivity	ENSG00000173198	FALSE	Phase III Clinical Trial	1993-08-15	Phase III Clinical Trial	CYSLTR1
Hypersensitivity	ENSG00000178562	FALSE	Preclinical	1992-11-15	Unused	CD28
Hypersensitivity	ENSG00000178573	FALSE	Preclinical	1996-09-15	Unused	MAF
Hypersensitivity	ENSG00000183134	FALSE	Phase I Clinical Trial	2001-07-03	Unused	PTGDR2
Hypersensitivity	ENSG00000183625	FALSE	Preclinical	1996-03-15	Unused	CCR3
Hypersensitivity	ENSG00000183813	FALSE	Preclinical	1999-07-27	Unused	CCR4
Hypersensitivity	ENSG00000183873	FALSE	Preclinical	NA	Unused	SCN5A
Hypersensitivity	ENSG00000184451	FALSE	Preclinical	2016-11-09	Absent	CCR10
Hypersensitivity	ENSG00000184502	FALSE	unknown	NA	Unused	GAST
Hypersensitivity	ENSG00000184588	FALSE	Preclinical	1993-08-15	Unused	PDE4B
Hypersensitivity	ENSG00000184845	FALSE	Preclinical	NA	Unused	DRD1
Hypersensitivity	ENSG00000185532	FALSE	Preclinical	NA	Unused	PRKG1
Hypersensitivity	ENSG00000187266	FALSE	Preclinical	1996-12-15	Unused	EPOR
Hypersensitivity	ENSG00000188822	FALSE	Preclinical	1997-12-15	Unused	CNR2
Hypersensitivity	ENSG00000196639	TRUE	Approved	1989-06-15	Approved	HRH1
Hypersensitivity	ENSG00000196664	FALSE	Preclinical	2004-02-17	Unused	TLR7
Hypersensitivity	ENSG00000197122	FALSE	Preclinical	1996-06-15	Unused	SRC
Hypersensitivity	ENSG00000198668	FALSE	unknown	NA	Unused	CALM1
Hypersensitivity	ENSG00000213658	FALSE	Preclinical	1999-04-28	Unused	LAT
Hypersensitivity	ENSG00000213903	FALSE	Preclinical	NA	Unused	LTB4R
Hypersensitivity	ENSG00000239732	FALSE	Preclinical	1998-10-15	Phase I Clinical Trial	TLR9
Hypersensitivity	ENSG00000259207	FALSE	Preclinical	1997-02-15	Unused	ITGB3
Hypersomnolence, Idiopathic	ENSG00000101180	FALSE	unknown	2010-06-15	Absent	HRH3
Hypertension	ENSG00000004948	FALSE	Phase I Clinical Trial	1993-11-15	Unused	CALCR
Hypertension	ENSG00000006071	FALSE	Preclinical	2000-09-21	Unused	ABCC8
Hypertension	ENSG00000006283	TRUE	Approved	1989-09-15	Approved	CACNA1G
Hypertension	ENSG00000006638	FALSE	unknown	1991-04-15	Unused	TBXA2R
Hypertension	ENSG00000010322	TRUE	Approved	NA	Approved	NISCH
Hypertension	ENSG00000019582	FALSE	Preclinical	2010-02-11	Absent	CD74
Hypertension	ENSG00000043591	TRUE	Approved	1992-08-15	Approved	ADRB1
Hypertension	ENSG00000059377	FALSE	Preclinical	1992-06-15	Unused	TBXAS1
Hypertension	ENSG00000064651	TRUE	Approved	1989-11-15	Approved	SLC12A2
Hypertension	ENSG00000064989	FALSE	Preclinical	NA	Unused	CALCRL
Hypertension	ENSG00000065989	FALSE	Preclinical	1992-06-15	Unused	PDE4A
Hypertension	ENSG00000066230	FALSE	Preclinical	2011-05-02	Unused	SLC9A3
Hypertension	ENSG00000067900	FALSE	Preclinical	1998-10-15	Unused	ROCK1
Hypertension	ENSG00000069431	TRUE	Approved	1989-06-15	Approved	ABCC9
Hypertension	ENSG00000070019	FALSE	unknown	2013-12-16	Absent	GUCY2C
Hypertension	ENSG00000070915	TRUE	Approved	1989-06-15	Approved	SLC12A3
Hypertension	ENSG00000073756	TRUE	Approved	2008-06-05	Absent	PTGS2
Hypertension	ENSG00000074803	TRUE	Approved	1989-11-15	Approved	SLC12A1
Hypertension	ENSG00000075073	FALSE	Preclinical	2000-11-07	Unused	TACR2
Hypertension	ENSG00000079459	FALSE	Preclinical	1995-05-15	Unused	FDFT1
Hypertension	ENSG00000080644	FALSE	Phase I Clinical Trial	2005-12-06	Absent	CHRNA3
Hypertension	ENSG00000082175	FALSE	unknown	1996-12-15	Unused	PGR
Hypertension	ENSG00000082556	FALSE	Preclinical	1990-06-15	Unused	OPRK1
Hypertension	ENSG00000082701	FALSE	Preclinical	2011-04-28	Preclinical	GSK3B
Hypertension	ENSG00000087085	FALSE	unknown	1989-09-15	Unused	ACHE
Hypertension	ENSG00000091831	FALSE	unknown	1996-12-15	Unused	ESR1
Hypertension	ENSG00000093010	FALSE	unknown	1997-02-15	Unused	COMT
Hypertension	ENSG00000095303	TRUE	Approved	2008-06-05	Absent	PTGS1
Hypertension	ENSG00000100300	FALSE	unknown	NA	Unused	TSPO
Hypertension	ENSG00000100739	FALSE	Preclinical	1992-01-15	Unused	BDKRB1
Hypertension	ENSG00000101204	FALSE	Phase I Clinical Trial	2005-12-06	Unused	CHRNA4
Hypertension	ENSG00000102468	TRUE	Approved	1990-07-15	Approved	HTR2A
Hypertension	ENSG00000103546	TRUE	Approved	NA	Approved	SLC6A2
Hypertension	ENSG00000104267	TRUE	Approved	NA	Approved	CA2
Hypertension	ENSG00000105650	FALSE	Preclinical	1992-06-15	Unused	PDE4C
Hypertension	ENSG00000106018	FALSE	Preclinical	2007-03-13	Unused	VIPR2
Hypertension	ENSG00000106113	FALSE	Preclinical	NA	Unused	CRHR2
Hypertension	ENSG00000108576	FALSE	Approved	NA	Unused	SLC6A4
Hypertension	ENSG00000108839	FALSE	Preclinical	1995-03-15	Unused	ALOX12
Hypertension	ENSG00000109991	FALSE	Phase I Clinical Trial	2015-07-10	Absent	P2RX3
Hypertension	ENSG00000111319	TRUE	Approved	1989-08-15	Approved	SCNN1A
Hypertension	ENSG00000111424	FALSE	Phase I Clinical Trial	2006-10-23	Unused	VDR
Hypertension	ENSG00000112038	FALSE	Preclinical	NA	Unused	OPRM1
Hypertension	ENSG00000112062	FALSE	Preclinical	2003-12-01	Unused	MAPK14
Hypertension	ENSG00000113161	TRUE	Approved	2003-07-01	Approved	HMGCR
Hypertension	ENSG00000113448	FALSE	Preclinical	1992-06-15	Unused	PDE4D
Hypertension	ENSG00000113494	FALSE	Phase I Clinical Trial	NA	Unused	PRLR
Hypertension	ENSG00000113580	FALSE	Preclinical	NA	Unused	NR3C1
Hypertension	ENSG00000113749	FALSE	Preclinical	1990-05-15	Unused	HRH2
Hypertension	ENSG00000114812	FALSE	Phase I Clinical Trial	2010-11-16	Phase I Clinical Trial	VIPR1
Hypertension	ENSG00000115252	FALSE	Preclinical	1996-10-15	Unused	PDE1A
Hypertension	ENSG00000115353	FALSE	Preclinical	NA	Unused	TACR1
Hypertension	ENSG00000116882	FALSE	Preclinical	2012-06-13	Preclinical	HAO2
Hypertension	ENSG00000117298	FALSE	Preclinical	1992-07-15	Unused	ECE1
Hypertension	ENSG00000117594	FALSE	Phase II Clinical Trial	2006-01-23	Unused	HSD11B1
Hypertension	ENSG00000117971	FALSE	Phase I Clinical Trial	2005-12-06	Absent	CHRNB4
Hypertension	ENSG00000117984	FALSE	Preclinical	NA	Unused	CTSD
Hypertension	ENSG00000118523	FALSE	unknown	1999-09-14	Absent	CTGF
Hypertension	ENSG00000120088	FALSE	Preclinical	NA	Unused	CRHR1
Hypertension	ENSG00000120907	TRUE	Approved	1996-11-15	Approved	ADRA1A
Hypertension	ENSG00000120915	FALSE	Preclinical	2007-06-26	Unused	EPHX2
Hypertension	ENSG00000121361	TRUE	Approved	1989-06-15	Approved	KCNJ8
Hypertension	ENSG00000122420	FALSE	Preclinical	1994-08-15	Unused	PTGFR
Hypertension	ENSG00000122585	FALSE	unknown	NA	Unused	NPY
Hypertension	ENSG00000123454	FALSE	Pre-registration	1989-06-15	Unused	DBH
Hypertension	ENSG00000125384	FALSE	Preclinical	NA	Unused	PTGER2
Hypertension	ENSG00000125510	FALSE	Phase II Clinical Trial	2002-11-29	Phase I Clinical Trial	OPRL1
Hypertension	ENSG00000125910	FALSE	unknown	1997-12-15	Unused	S1PR4
Hypertension	ENSG00000126895	FALSE	Phase I Clinical Trial	1994-12-15	Unused	AVPR2
Hypertension	ENSG00000128271	FALSE	Preclinical	1992-06-15	Unused	ADORA2A
Hypertension	ENSG00000130234	FALSE	Preclinical	1992-10-15	Unused	ACE2
Hypertension	ENSG00000130368	FALSE	Preclinical	2003-10-30	Unused	MAS1
Hypertension	ENSG00000132170	FALSE	unknown	2006-07-21	Unused	PPARG
Hypertension	ENSG00000132329	FALSE	Preclinical	NA	Unused	RAMP1
Hypertension	ENSG00000132437	FALSE	Preclinical	NA	Unused	DDC
Hypertension	ENSG00000134318	FALSE	Preclinical	2009-08-25	Unused	ROCK2
Hypertension	ENSG00000134640	FALSE	unknown	NA	Unused	MTNR1B
Hypertension	ENSG00000135312	FALSE	Preclinical	1998-01-15	Unused	HTR1B
Hypertension	ENSG00000135744	TRUE	Approved	1997-02-15	Unused	AGT
Hypertension	ENSG00000136160	FALSE	Phase II Clinical Trial	1992-06-15	Unused	EDNRB
Hypertension	ENSG00000138735	FALSE	Phase I Clinical Trial	1992-12-15	Phase II Clinical Trial	PDE5A
Hypertension	ENSG00000138792	FALSE	Phase II Clinical Trial	2007-12-11	Phase I Clinical Trial	ENPEP
Hypertension	ENSG00000140675	FALSE	Phase III Clinical Trial	2007-11-21	Phase III Clinical Trial	SLC5A2
Hypertension	ENSG00000141744	FALSE	Preclinical	NA	Unused	PNMT
Hypertension	ENSG00000142606	FALSE	unknown	1998-10-15	Unused	MMEL1
Hypertension	ENSG00000143839	TRUE	Approved	1989-06-15	Approved	REN
Hypertension	ENSG00000144891	TRUE	Approved	1989-11-15	Approved	AGTR1
Hypertension	ENSG00000147246	TRUE	Approved	NA	Approved	HTR2C
Hypertension	ENSG00000148408	FALSE	Approved	2009-11-09	Unused	CACNA1B
Hypertension	ENSG00000149295	FALSE	Phase II Clinical Trial	1989-11-15	Unused	DRD2
Hypertension	ENSG00000150594	TRUE	Approved	1989-06-15	Approved	ADRA2A
Hypertension	ENSG00000151067	TRUE	Approved	1989-06-15	Approved	CACNA1C
Hypertension	ENSG00000151617	FALSE	Phase II Clinical Trial	1992-04-15	Phase II Clinical Trial	EDNRA
Hypertension	ENSG00000151623	TRUE	Approved	1990-10-15	Approved	NR3C2
Hypertension	ENSG00000151704	FALSE	Phase I Clinical Trial	2011-06-13	Unused	KCNJ1
Hypertension	ENSG00000154229	FALSE	Preclinical	1992-06-15	Unused	PRKCA
Hypertension	ENSG00000158769	FALSE	Preclinical	2009-09-30	Unused	F11R
Hypertension	ENSG00000159640	TRUE	Approved	1989-05-15	Approved	ACE
Hypertension	ENSG00000160013	FALSE	Preclinical	NA	Unused	PTGIR
Hypertension	ENSG00000160716	FALSE	Phase I Clinical Trial	2005-12-06	Unused	CHRNB2
Hypertension	ENSG00000160882	FALSE	Phase II Clinical Trial	2006-12-07	Absent	CYP11B1
Hypertension	ENSG00000160951	FALSE	Preclinical	NA	Unused	PTGER1
Hypertension	ENSG00000163399	FALSE	Phase II Clinical Trial	1992-10-15	Phase II Clinical Trial	ATP1A1
Hypertension	ENSG00000163485	FALSE	Phase II Clinical Trial	1991-11-15	Unused	ADORA1
Hypertension	ENSG00000164128	FALSE	Preclinical	1996-05-15	Unused	NPY1R
Hypertension	ENSG00000164867	TRUE	Approved	1998-05-15	Unused	NOS3
Hypertension	ENSG00000166148	FALSE	Preclinical	1992-01-15	Unused	AVPR1A
Hypertension	ENSG00000166736	FALSE	Preclinical	1990-06-15	Unused	HTR3A
Hypertension	ENSG00000168229	FALSE	Preclinical	NA	Unused	PTGDR
Hypertension	ENSG00000168398	FALSE	Preclinical	1992-01-15	Unused	BDKRB2
Hypertension	ENSG00000168412	FALSE	unknown	NA	Unused	MTNR1A
Hypertension	ENSG00000169252	TRUE	Approved	1989-09-15	Approved	ADRB2
Hypertension	ENSG00000169403	FALSE	Preclinical	1993-06-15	Unused	PTAFR
Hypertension	ENSG00000169418	FALSE	Phase II Clinical Trial	1990-06-15	Phase II Clinical Trial	NPR1
Hypertension	ENSG00000169432	FALSE	Preclinical	NA	Unused	SCN9A
Hypertension	ENSG00000169676	FALSE	Preclinical	1990-07-15	Unused	DRD5
Hypertension	ENSG00000170214	TRUE	Approved	NA	Approved	ADRA1B
Hypertension	ENSG00000170989	FALSE	unknown	1997-12-15	Unused	S1PR1
Hypertension	ENSG00000171049	FALSE	Preclinical	2008-03-25	Absent	FPR2
Hypertension	ENSG00000171759	FALSE	unknown	1989-06-15	Unused	PAH
Hypertension	ENSG00000171873	TRUE	Approved	NA	Approved	ADRA1D
Hypertension	ENSG00000172572	TRUE	Approved	1990-12-15	Unused	PDE3A
Hypertension	ENSG00000175445	FALSE	Preclinical	NA	Unused	LPL
Hypertension	ENSG00000175535	FALSE	unknown	NA	Unused	PNLIP
Hypertension	ENSG00000176884	FALSE	Phase II Clinical Trial	2014-02-05	Absent	GRIN1
Hypertension	ENSG00000178394	TRUE	Approved	1990-06-15	Approved	HTR1A
Hypertension	ENSG00000179142	FALSE	Phase II Clinical Trial	1990-10-15	Unused	CYP11B2
Hypertension	ENSG00000179546	FALSE	Preclinical	1995-06-15	Unused	HTR1D
Hypertension	ENSG00000180210	FALSE	unknown	NA	Unused	F2
Hypertension	ENSG00000180739	FALSE	unknown	1997-12-15	Unused	S1PR5
Hypertension	ENSG00000180772	FALSE	Preclinical	1992-03-15	Unused	AGTR2
Hypertension	ENSG00000180914	FALSE	Preclinical	1995-08-15	Unused	OXTR
Hypertension	ENSG00000183873	FALSE	Preclinical	NA	Unused	SCN5A
Hypertension	ENSG00000184160	TRUE	Approved	1989-06-15	Approved	ADRA2C
Hypertension	ENSG00000184502	FALSE	Preclinical	NA	Unused	GAST
Hypertension	ENSG00000184588	FALSE	Preclinical	1992-06-15	Unused	PDE4B
Hypertension	ENSG00000184845	TRUE	Approved	1990-06-15	Approved	DRD1
Hypertension	ENSG00000186350	FALSE	unknown	2002-09-02	Unused	RXRA
Hypertension	ENSG00000186951	FALSE	unknown	2002-09-02	Unused	PPARA
Hypertension	ENSG00000187486	FALSE	Preclinical	2000-09-21	Unused	KCNJ11
Hypertension	ENSG00000188778	TRUE	Approved	NA	Approved	ADRB3
Hypertension	ENSG00000196549	FALSE	Phase III Clinical Trial	1989-08-15	Phase III Clinical Trial	MME
Hypertension	ENSG00000196639	FALSE	Preclinical	1990-05-15	Unused	HRH1
Hypertension	ENSG00000197635	FALSE	Phase I Clinical Trial	2013-12-20	Absent	DPP4
Hypertension	ENSG00000197891	TRUE	Approved	NA	Unused	SLC22A12
Hypertension	ENSG00000198049	FALSE	Preclinical	1992-01-15	Unused	AVPR1B
Hypertension	ENSG00000198668	FALSE	Preclinical	1991-02-15	Unused	CALM1
Hypertension	ENSG00000198829	FALSE	Preclinical	NA	Absent	SUCNR1
Hypertension	ENSG00000213694	FALSE	unknown	1997-12-15	Unused	S1PR3
Hypertension	ENSG00000228716	FALSE	Preclinical	NA	Unused	DHFR
Hypertension	ENSG00000274286	TRUE	Approved	1989-06-15	Approved	ADRA2B
Hypertension, Portal	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Absent	TBXA2R
Hypertension, Portal	ENSG00000012504	FALSE	Phase II Clinical Trial	2004-08-13	Phase II Clinical Trial	NR1H4
Hypertension, Portal	ENSG00000064012	FALSE	Phase II Clinical Trial	1999-01-15	Absent	CASP8
Hypertension, Portal	ENSG00000114859	FALSE	unknown	2002-09-25	Unused	CLCN2
Hypertension, Portal	ENSG00000138735	FALSE	Phase II Clinical Trial	2001-05-31	Phase II Clinical Trial	PDE5A
Hypertension, Portal	ENSG00000164867	FALSE	unknown	NA	Absent	NOS3
Hypertension, Portal	ENSG00000166148	FALSE	Phase I Clinical Trial	2014-07-10	Absent	AVPR1A
Hypertension, Portal	ENSG00000171509	FALSE	Phase II Clinical Trial	2007-10-23	Absent	RXFP1
Hypertension, Portal	ENSG00000179921	FALSE	unknown	2005-05-26	Unused	GPBAR1
Hypertension, Pulmonary	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Unused	TBXA2R
Hypertension, Pulmonary	ENSG00000036828	FALSE	Preclinical	2010-11-17	Absent	CASR
Hypertension, Pulmonary	ENSG00000059377	FALSE	Phase II Clinical Trial	1993-08-15	Unused	TBXAS1
Hypertension, Pulmonary	ENSG00000067560	FALSE	Preclinical	2008-07-21	Unused	RHOA
Hypertension, Pulmonary	ENSG00000067900	FALSE	Phase I Clinical Trial	2007-03-13	Absent	ROCK1
Hypertension, Pulmonary	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Hypertension, Pulmonary	ENSG00000069696	FALSE	Phase II Clinical Trial	2008-07-22	Absent	DRD4
Hypertension, Pulmonary	ENSG00000070915	FALSE	Preclinical	2015-08-19	Absent	SLC12A3
Hypertension, Pulmonary	ENSG00000074181	FALSE	Preclinical	2009-04-28	Absent	NOTCH3
Hypertension, Pulmonary	ENSG00000080618	FALSE	unknown	2011-11-07	Absent	CPB2
Hypertension, Pulmonary	ENSG00000090020	FALSE	Preclinical	2001-08-08	Absent	SLC9A1
Hypertension, Pulmonary	ENSG00000096968	FALSE	Preclinical	2003-07-04	Unused	JAK2
Hypertension, Pulmonary	ENSG00000097007	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	ABL1
Hypertension, Pulmonary	ENSG00000100097	FALSE	Preclinical	NA	Absent	LGALS1
Hypertension, Pulmonary	ENSG00000102468	FALSE	Phase II Clinical Trial	2008-05-23	Unused	HTR2A
Hypertension, Pulmonary	ENSG00000104365	FALSE	unknown	2006-08-29	Unused	IKBKB
Hypertension, Pulmonary	ENSG00000106018	FALSE	Preclinical	2014-01-21	Absent	VIPR2
Hypertension, Pulmonary	ENSG00000106366	FALSE	unknown	2006-08-29	Unused	SERPINE1
Hypertension, Pulmonary	ENSG00000106804	FALSE	Phase I Clinical Trial	2017-04-12	Absent	C5
Hypertension, Pulmonary	ENSG00000109320	FALSE	Preclinical	1997-11-15	Unused	NFKB1
Hypertension, Pulmonary	ENSG00000111144	FALSE	Phase II Clinical Trial	2012-01-11	Absent	LTA4H
Hypertension, Pulmonary	ENSG00000112033	FALSE	Preclinical	2013-03-19	Absent	PPARD
Hypertension, Pulmonary	ENSG00000114812	FALSE	Phase II Clinical Trial	2003-12-09	Phase II Clinical Trial	VIPR1
Hypertension, Pulmonary	ENSG00000114854	FALSE	Preclinical	1991-05-15	Absent	TNNC1
Hypertension, Pulmonary	ENSG00000116016	FALSE	Preclinical	2016-11-29	Absent	EPAS1
Hypertension, Pulmonary	ENSG00000116044	FALSE	Phase III Clinical Trial	2005-05-27	Absent	NFE2L2
Hypertension, Pulmonary	ENSG00000117298	FALSE	Phase II Clinical Trial	1998-10-15	Unused	ECE1
Hypertension, Pulmonary	ENSG00000123454	FALSE	unknown	1989-06-15	Unused	DBH
Hypertension, Pulmonary	ENSG00000124102	FALSE	Preclinical	2004-07-21	Preclinical	PI3
Hypertension, Pulmonary	ENSG00000125510	FALSE	Phase I Clinical Trial	2002-11-29	Absent	OPRL1
Hypertension, Pulmonary	ENSG00000125845	FALSE	Phase II Clinical Trial	2015-03-24	Absent	BMP2
Hypertension, Pulmonary	ENSG00000129167	FALSE	Phase I Clinical Trial	2007-02-05	Preclinical	TPH1
Hypertension, Pulmonary	ENSG00000130234	FALSE	Phase I Clinical Trial	2007-07-13	Absent	ACE2
Hypertension, Pulmonary	ENSG00000131981	FALSE	Preclinical	NA	Absent	LGALS3
Hypertension, Pulmonary	ENSG00000132170	FALSE	Preclinical	2013-03-19	Absent	PPARG
Hypertension, Pulmonary	ENSG00000134318	FALSE	Preclinical	2014-10-07	Absent	ROCK2
Hypertension, Pulmonary	ENSG00000134853	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	PDGFRA
Hypertension, Pulmonary	ENSG00000135744	FALSE	Phase II Clinical Trial	2012-09-27	Absent	AGT
Hypertension, Pulmonary	ENSG00000135914	FALSE	Phase II Clinical Trial	2001-10-15	Phase II Clinical Trial	HTR2B
Hypertension, Pulmonary	ENSG00000136160	TRUE	Approved	1994-10-15	Approved	EDNRB
Hypertension, Pulmonary	ENSG00000137672	FALSE	Preclinical	2015-05-27	Absent	TRPC6
Hypertension, Pulmonary	ENSG00000138735	TRUE	Approved	1991-09-15	Approved	PDE5A
Hypertension, Pulmonary	ENSG00000142606	FALSE	Phase II Clinical Trial	1998-10-15	Unused	MMEL1
Hypertension, Pulmonary	ENSG00000144891	TRUE	Approved	1992-10-15	Approved	AGTR1
Hypertension, Pulmonary	ENSG00000147166	FALSE	Preclinical	2012-09-24	Preclinical	ITGB1BP2
Hypertension, Pulmonary	ENSG00000148680	FALSE	Phase II Clinical Trial	2008-07-22	Absent	HTR7
Hypertension, Pulmonary	ENSG00000149295	FALSE	Phase II Clinical Trial	2008-07-22	Phase II Clinical Trial	DRD2
Hypertension, Pulmonary	ENSG00000151577	FALSE	Phase II Clinical Trial	2008-07-22	Absent	DRD3
Hypertension, Pulmonary	ENSG00000151617	TRUE	Approved	1991-04-15	Approved	EDNRA
Hypertension, Pulmonary	ENSG00000151623	FALSE	Preclinical	2015-07-02	Absent	NR3C2
Hypertension, Pulmonary	ENSG00000157404	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	KIT
Hypertension, Pulmonary	ENSG00000158748	FALSE	Phase II Clinical Trial	2008-07-22	Absent	HTR6
Hypertension, Pulmonary	ENSG00000160013	TRUE	Approved	2005-01-17	Approved	PTGIR
Hypertension, Pulmonary	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Hypertension, Pulmonary	ENSG00000162434	FALSE	unknown	2006-11-24	Preclinical	JAK1
Hypertension, Pulmonary	ENSG00000163737	FALSE	Preclinical	2009-12-01	Preclinical	PF4
Hypertension, Pulmonary	ENSG00000164867	FALSE	Phase II Clinical Trial	2003-02-05	Phase II Clinical Trial	NOS3
Hypertension, Pulmonary	ENSG00000166736	FALSE	unknown	2004-05-24	Unused	HTR3A
Hypertension, Pulmonary	ENSG00000169398	FALSE	Phase I Clinical Trial	2009-10-16	Absent	PTK2
Hypertension, Pulmonary	ENSG00000169418	FALSE	Preclinical	2000-09-22	Unused	NPR1
Hypertension, Pulmonary	ENSG00000171759	FALSE	unknown	1989-06-15	Unused	PAH
Hypertension, Pulmonary	ENSG00000178394	FALSE	Phase II Clinical Trial	2008-07-22	Absent	HTR1A
Hypertension, Pulmonary	ENSG00000185532	FALSE	Preclinical	2010-01-06	Unused	PRKG1
Hypertension, Pulmonary	ENSG00000186716	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Hypertension, Pulmonary	ENSG00000186951	FALSE	Preclinical	2013-03-19	Absent	PPARA
Hypertension, Pulmonary	ENSG00000196218	FALSE	Preclinical	2016-04-15	Absent	RYR1
Hypertension, Pulmonary	ENSG00000196549	FALSE	Phase II Clinical Trial	1998-10-15	Unused	MME
Hypertension, Pulmonary	ENSG00000196776	FALSE	unknown	2014-05-27	Absent	CD47
Hypertension, Pulmonary	ENSG00000197249	FALSE	Preclinical	2009-12-01	Absent	SERPINA1
Hypertension, Pulmonary	ENSG00000197442	FALSE	Phase II Clinical Trial	2014-03-17	Absent	MAP3K5
Hypertension, Pulmonary	ENSG00000197561	FALSE	Preclinical	2008-06-19	Preclinical	ELANE
Hypertension, Pulmonary	ENSG00000198793	FALSE	Phase I Clinical Trial	2007-01-26	Absent	MTOR
Hypertension, Pulmonary	ENSG00000213903	FALSE	Phase II Clinical Trial	2017-04-12	Absent	LTB4R
Hypertension, Pulmonary	ENSG00000271503	FALSE	Preclinical	2009-12-01	Preclinical	CCL5
Hyperthyroidism	ENSG00000101017	FALSE	Phase II Clinical Trial	2014-03-18	Absent	CD40
Hyperthyroidism	ENSG00000111012	FALSE	Preclinical	2010-11-20	Unused	CYP27B1
Hyperthyroidism	ENSG00000113580	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	NR3C1
Hyperthyroidism	ENSG00000147138	FALSE	Preclinical	2016-06-16	Absent	GPR174
Hyperthyroidism	ENSG00000165409	FALSE	Phase I Clinical Trial	2011-11-04	Unused	TSHR
Hyperthyroidism	ENSG00000169252	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	ADRB2
Hyperthyroidism	ENSG00000198851	FALSE	Phase I Clinical Trial	2002-11-07	Phase I Clinical Trial	CD3E
Hypertriglyceridemia	ENSG00000005421	FALSE	Preclinical	2015-07-29	Absent	PON1
Hypertriglyceridemia	ENSG00000012504	FALSE	Phase II Clinical Trial	2004-01-15	Unused	NR1H4
Hypertriglyceridemia	ENSG00000057252	FALSE	Preclinical	1989-10-15	Unused	SOAT1
Hypertriglyceridemia	ENSG00000065989	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4A
Hypertriglyceridemia	ENSG00000100504	FALSE	Preclinical	1999-10-20	Unused	PYGL
Hypertriglyceridemia	ENSG00000105650	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4C
Hypertriglyceridemia	ENSG00000108691	FALSE	Phase II Clinical Trial	1992-01-15	Unused	CCL2
Hypertriglyceridemia	ENSG00000110245	FALSE	Pre-registration	2009-05-01	Phase II Clinical Trial	APOC3
Hypertriglyceridemia	ENSG00000112033	FALSE	Phase II Clinical Trial	2007-05-01	Unused	PPARD
Hypertriglyceridemia	ENSG00000112062	FALSE	Preclinical	2008-02-14	Unused	MAPK14
Hypertriglyceridemia	ENSG00000113161	TRUE	Approved	1989-10-15	Approved	HMGCR
Hypertriglyceridemia	ENSG00000113448	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4D
Hypertriglyceridemia	ENSG00000130203	FALSE	Preclinical	2015-07-29	Absent	APOE
Hypertriglyceridemia	ENSG00000132170	FALSE	Approved	2007-08-08	Phase III Clinical Trial	PPARG
Hypertriglyceridemia	ENSG00000132855	FALSE	Phase II Clinical Trial	2013-11-19	Absent	ANGPTL3
Hypertriglyceridemia	ENSG00000138823	FALSE	Phase II Clinical Trial	1995-06-15	Phase II Clinical Trial	MTTP
Hypertriglyceridemia	ENSG00000151067	TRUE	Approved	2003-07-01	Approved	CACNA1C
Hypertriglyceridemia	ENSG00000151090	FALSE	Phase II Clinical Trial	NA	Unused	THRB
Hypertriglyceridemia	ENSG00000163485	FALSE	Phase I Clinical Trial	2001-02-19	Unused	ADORA1
Hypertriglyceridemia	ENSG00000172572	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE3A
Hypertriglyceridemia	ENSG00000173198	FALSE	Phase II Clinical Trial	2002-07-12	Absent	CYSLTR1
Hypertriglyceridemia	ENSG00000175445	FALSE	unknown	1996-07-15	Unused	LPL
Hypertriglyceridemia	ENSG00000182782	TRUE	Approved	2003-04-14	Approved	HCAR2
Hypertriglyceridemia	ENSG00000184588	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4B
Hypertriglyceridemia	ENSG00000185000	FALSE	Phase II Clinical Trial	2008-11-24	Phase III Clinical Trial	DGAT1
Hypertriglyceridemia	ENSG00000186350	FALSE	unknown	2002-09-02	Unused	RXRA
Hypertriglyceridemia	ENSG00000186951	TRUE	Approved	2002-09-02	Approved	PPARA
Hypertriglyceridemia	ENSG00000278540	FALSE	Preclinical	2011-07-23	Absent	ACACA
Hyperuricemia	ENSG00000011677	FALSE	Phase II Clinical Trial	2004-02-20	Phase II Clinical Trial	GABRA3
Hyperuricemia	ENSG00000022355	FALSE	Phase II Clinical Trial	2004-02-20	Phase II Clinical Trial	GABRA1
Hyperuricemia	ENSG00000073756	TRUE	Approved	2008-08-19	Approved	PTGS2
Hyperuricemia	ENSG00000095303	TRUE	Approved	2008-08-19	Approved	PTGS1
Hyperuricemia	ENSG00000105329	FALSE	Phase II Clinical Trial	2010-04-21	Unused	TGFB1
Hyperuricemia	ENSG00000109667	FALSE	Preclinical	2015-02-23	Absent	SLC2A9
Hyperuricemia	ENSG00000111144	FALSE	unknown	2012-01-11	Absent	LTA4H
Hyperuricemia	ENSG00000115590	FALSE	Pre-registration	1995-08-15	Unused	IL1R2
Hyperuricemia	ENSG00000115594	FALSE	Pre-registration	1995-08-15	Unused	IL1R1
Hyperuricemia	ENSG00000125538	FALSE	Phase III Clinical Trial	2003-12-08	Phase III Clinical Trial	IL1B
Hyperuricemia	ENSG00000131747	FALSE	Preclinical	1989-10-15	Unused	TOP2A
Hyperuricemia	ENSG00000132170	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	PPARG
Hyperuricemia	ENSG00000136689	FALSE	Preclinical	2015-07-23	Absent	IL1RN
Hyperuricemia	ENSG00000137860	FALSE	Preclinical	2015-05-27	Absent	SLC28A2
Hyperuricemia	ENSG00000151834	FALSE	Phase II Clinical Trial	2004-02-20	Phase II Clinical Trial	GABRA2
Hyperuricemia	ENSG00000158125	TRUE	Approved	1992-06-15	Approved	XDH
Hyperuricemia	ENSG00000162711	FALSE	Phase II Clinical Trial	2010-01-19	Absent	NLRP3
Hyperuricemia	ENSG00000163464	FALSE	Preclinical	2009-06-12	Unused	CXCR1
Hyperuricemia	ENSG00000171132	FALSE	unknown	2002-11-15	Unused	PRKCE
Hyperuricemia	ENSG00000180871	FALSE	Preclinical	2009-06-12	Unused	CXCR2
Hyperuricemia	ENSG00000186297	FALSE	Phase II Clinical Trial	2004-02-20	Phase II Clinical Trial	GABRA5
Hyperuricemia	ENSG00000197891	TRUE	Approved	1989-06-15	Approved	SLC22A12
Hyperuricemia	ENSG00000198001	FALSE	Preclinical	2011-09-05	Preclinical	IRAK4
Hyperuricemia	ENSG00000198805	FALSE	Preclinical	1989-07-15	Phase II Clinical Trial	PNP
Hyperuricemia	ENSG00000249437	FALSE	Preclinical	2017-08-09	Absent	NAIP
Hypoalbuminemia	ENSG00000163631	FALSE	Phase I Clinical Trial	NA	Unused	ALB
Hypoalphalipoproteinemias	ENSG00000118137	FALSE	Phase III Clinical Trial	2007-03-03	Absent	APOA1
Hypocalcemia	ENSG00000036828	FALSE	unknown	2004-03-26	Preclinical	CASR
Hypocalcemia	ENSG00000160801	FALSE	Phase III Clinical Trial	1997-06-15	Unused	PTH1R
Hypoglycemia	ENSG00000112164	FALSE	Phase II Clinical Trial	2015-03-12	Absent	GLP1R
Hypoglycemia	ENSG00000115263	FALSE	Phase III Clinical Trial	2010-07-16	Preclinical	GCG
Hypoglycemia	ENSG00000140443	FALSE	Phase I Clinical Trial	2017-02-09	Absent	IGF1R
Hypoglycemia	ENSG00000169252	FALSE	Phase I Clinical Trial	2010-03-25	Absent	ADRB2
Hypoglycemia	ENSG00000171105	FALSE	Phase II Clinical Trial	2012-12-13	Absent	INSR
Hypoglycemia	ENSG00000176884	FALSE	Preclinical	1995-07-15	Unused	GRIN1
Hypoglycemia	ENSG00000180616	FALSE	Preclinical	2016-10-03	Absent	SSTR2
Hypoglycemia	ENSG00000215644	TRUE	Approved	1991-09-15	Approved	GCGR
Hypogonadism	ENSG00000091831	FALSE	Phase III Clinical Trial	2000-02-09	Phase II Clinical Trial	ESR1
Hypogonadism	ENSG00000116014	FALSE	unknown	2008-07-31	Absent	KISS1R
Hypogonadism	ENSG00000137869	FALSE	Phase II Clinical Trial	2009-07-17	Phase II Clinical Trial	CYP19A1
Hypogonadism	ENSG00000138039	TRUE	Approved	2017-01-06	Unused	LHCGR
Hypogonadism	ENSG00000145545	FALSE	Phase II Clinical Trial	2006-05-30	Unused	SRD5A1
Hypogonadism	ENSG00000147437	FALSE	Preclinical	2014-12-16	Absent	GNRH1
Hypogonadism	ENSG00000169083	TRUE	Approved	1991-07-15	Approved	AR
Hypogonadism	ENSG00000170820	TRUE	Approved	NA	Unused	FSHR
Hypogonadism	ENSG00000277893	FALSE	Phase II Clinical Trial	2006-05-30	Unused	SRD5A2
Hyponatremia	ENSG00000126895	TRUE	Approved	1992-04-15	Approved	AVPR2
Hyponatremia	ENSG00000166148	TRUE	Approved	1996-05-15	Approved	AVPR1A
Hypoparathyroidism	ENSG00000152266	FALSE	Phase II Clinical Trial	2003-10-01	Unused	PTH
Hypoparathyroidism	ENSG00000160801	TRUE	Approved	1992-04-15	Phase III Clinical Trial	PTH1R
Hypophosphatasia	ENSG00000162551	TRUE	Approved	2008-10-10	Phase III Clinical Trial	ALPL
Hypophosphatasia	ENSG00000167941	FALSE	Phase II Clinical Trial	2011-08-12	Phase II Clinical Trial	SOST
Hypophosphatemia	ENSG00000102174	FALSE	Preclinical	2005-08-17	Unused	PHEX
Hypophosphatemia	ENSG00000111424	FALSE	unknown	NA	Absent	VDR
Hypophosphatemia	ENSG00000118972	FALSE	Pre-registration	2009-01-30	Phase II Clinical Trial	FGF23
Hypoprothrombinemias	ENSG00000180210	FALSE	Approved	2010-11-26	Unused	F2
Hypotension	ENSG00000007171	FALSE	Preclinical	1992-09-15	Unused	NOS2
Hypotension	ENSG00000012779	FALSE	Preclinical	1996-06-15	Unused	ALOX5
Hypotension	ENSG00000043591	FALSE	Phase III Clinical Trial	2011-08-30	Absent	ADRB1
Hypotension	ENSG00000069696	FALSE	Preclinical	1999-06-10	Unused	DRD4
Hypotension	ENSG00000082175	FALSE	Phase I Clinical Trial	2002-03-22	Unused	PGR
Hypotension	ENSG00000120907	TRUE	Approved	2011-08-30	Approved	ADRA1A
Hypotension	ENSG00000126895	FALSE	Preclinical	NA	Unused	AVPR2
Hypotension	ENSG00000135744	TRUE	Approved	2013-03-05	Absent	AGT
Hypotension	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Hypotension	ENSG00000150594	FALSE	Phase III Clinical Trial	2001-07-25	Unused	ADRA2A
Hypotension	ENSG00000163485	FALSE	Phase II Clinical Trial	2002-03-12	Unused	ADORA1
Hypotension	ENSG00000166148	FALSE	Phase III Clinical Trial	2002-03-22	Phase II Clinical Trial	AVPR1A
Hypotension	ENSG00000169403	FALSE	Preclinical	1989-07-15	Unused	PTAFR
Hypotension	ENSG00000170214	TRUE	Approved	NA	Approved	ADRA1B
Hypotension	ENSG00000170989	FALSE	Preclinical	2010-09-28	Unused	S1PR1
Hypotension	ENSG00000171873	TRUE	Approved	NA	Approved	ADRA1D
Hypotension	ENSG00000184160	FALSE	Phase II Clinical Trial	2001-07-25	Unused	ADRA2C
Hypotension	ENSG00000185149	FALSE	Preclinical	NA	Unused	NPY2R
Hypotension	ENSG00000196549	FALSE	Preclinical	1992-12-15	Unused	MME
Hypotension	ENSG00000274286	FALSE	Phase II Clinical Trial	2001-07-25	Unused	ADRA2B
Hypothermia	ENSG00000123213	FALSE	Preclinical	2010-04-06	Preclinical	NLN
Hypothermia	ENSG00000135312	FALSE	Preclinical	1998-01-15	Unused	HTR1B
Hypotrichosis	ENSG00000122420	TRUE	Approved	1991-07-15	Approved	PTGFR
Ichthyosis	ENSG00000095596	FALSE	Phase III Clinical Trial	2002-09-06	Unused	CYP26A1
Ichthyosis	ENSG00000111424	TRUE	Approved	NA	Approved	VDR
Ichthyosis	ENSG00000172819	FALSE	Phase I Clinical Trial	2012-06-14	Absent	RARG
Ichthyosis	ENSG00000186395	FALSE	Preclinical	2016-04-06	Absent	KRT10
Idiopathic Pulmonary Fibrosis	ENSG00000007952	FALSE	Preclinical	NA	Preclinical	NOX1
Idiopathic Pulmonary Fibrosis	ENSG00000026103	FALSE	Preclinical	2015-09-21	Absent	FAS
Idiopathic Pulmonary Fibrosis	ENSG00000027697	FALSE	Phase II Clinical Trial	2001-09-06	Phase I Clinical Trial	IFNGR1
Idiopathic Pulmonary Fibrosis	ENSG00000037280	TRUE	Approved	2001-10-30	Phase III Clinical Trial	FLT4
Idiopathic Pulmonary Fibrosis	ENSG00000056736	FALSE	Preclinical	NA	Absent	IL17RB
Idiopathic Pulmonary Fibrosis	ENSG00000064012	FALSE	unknown	1999-01-15	Preclinical	CASP8
Idiopathic Pulmonary Fibrosis	ENSG00000065989	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4A
Idiopathic Pulmonary Fibrosis	ENSG00000067182	TRUE	Approved	2005-06-27	Approved	TNFRSF1A
Idiopathic Pulmonary Fibrosis	ENSG00000072571	FALSE	Preclinical	2014-10-14	Absent	HMMR
Idiopathic Pulmonary Fibrosis	ENSG00000080618	FALSE	unknown	2006-03-28	Unused	CPB2
Idiopathic Pulmonary Fibrosis	ENSG00000086991	FALSE	Preclinical	NA	Preclinical	NOX4
Idiopathic Pulmonary Fibrosis	ENSG00000091409	FALSE	Preclinical	2017-06-20	Absent	ITGA6
Idiopathic Pulmonary Fibrosis	ENSG00000092969	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB2
Idiopathic Pulmonary Fibrosis	ENSG00000100097	FALSE	Preclinical	NA	Absent	LGALS1
Idiopathic Pulmonary Fibrosis	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Idiopathic Pulmonary Fibrosis	ENSG00000100644	FALSE	unknown	2009-02-18	Preclinical	HIF1A
Idiopathic Pulmonary Fibrosis	ENSG00000102755	TRUE	Approved	2001-10-30	Phase III Clinical Trial	FLT1
Idiopathic Pulmonary Fibrosis	ENSG00000104415	FALSE	Preclinical	NA	Absent	WISP1
Idiopathic Pulmonary Fibrosis	ENSG00000104432	FALSE	Preclinical	2016-07-21	Absent	IL7
Idiopathic Pulmonary Fibrosis	ENSG00000105329	FALSE	Approved	2002-12-31	Unused	TGFB1
Idiopathic Pulmonary Fibrosis	ENSG00000105650	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4C
Idiopathic Pulmonary Fibrosis	ENSG00000105851	FALSE	Preclinical	2011-09-22	Absent	PIK3CG
Idiopathic Pulmonary Fibrosis	ENSG00000106178	FALSE	Phase I Clinical Trial	NA	Absent	CCL24
Idiopathic Pulmonary Fibrosis	ENSG00000106799	FALSE	Preclinical	2003-07-10	Unused	TGFBR1
Idiopathic Pulmonary Fibrosis	ENSG00000106991	FALSE	Preclinical	2015-01-02	Absent	ENG
Idiopathic Pulmonary Fibrosis	ENSG00000107643	FALSE	Phase II Clinical Trial	2013-01-15	Preclinical	MAPK8
Idiopathic Pulmonary Fibrosis	ENSG00000108691	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CCL2
Idiopathic Pulmonary Fibrosis	ENSG00000109991	FALSE	Phase II Clinical Trial	2006-02-13	Absent	P2RX3
Idiopathic Pulmonary Fibrosis	ENSG00000112033	FALSE	Preclinical	2013-03-19	Absent	PPARD
Idiopathic Pulmonary Fibrosis	ENSG00000112062	TRUE	Approved	2005-06-27	Approved	MAPK14
Idiopathic Pulmonary Fibrosis	ENSG00000113163	FALSE	Preclinical	2016-09-08	Absent	COL4A3BP
Idiopathic Pulmonary Fibrosis	ENSG00000113448	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4D
Idiopathic Pulmonary Fibrosis	ENSG00000113520	FALSE	Phase II Clinical Trial	2011-04-28	Phase II Clinical Trial	IL4
Idiopathic Pulmonary Fibrosis	ENSG00000113721	FALSE	Preclinical	2012-08-01	Preclinical	PDGFRB
Idiopathic Pulmonary Fibrosis	ENSG00000114812	FALSE	Phase II Clinical Trial	2003-12-09	Unused	VIPR1
Idiopathic Pulmonary Fibrosis	ENSG00000115221	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	ITGB6
Idiopathic Pulmonary Fibrosis	ENSG00000115318	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL3
Idiopathic Pulmonary Fibrosis	ENSG00000115353	FALSE	Preclinical	2003-08-19	Preclinical	TACR1
Idiopathic Pulmonary Fibrosis	ENSG00000118523	FALSE	Phase II Clinical Trial	1999-09-14	Phase II Clinical Trial	CTGF
Idiopathic Pulmonary Fibrosis	ENSG00000119699	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB3
Idiopathic Pulmonary Fibrosis	ENSG00000121879	FALSE	Phase I Clinical Trial	2009-09-04	Preclinical	PIK3CA
Idiopathic Pulmonary Fibrosis	ENSG00000121966	FALSE	Preclinical	2015-09-22	Absent	CXCR4
Idiopathic Pulmonary Fibrosis	ENSG00000122194	FALSE	Preclinical	NA	Absent	PLG
Idiopathic Pulmonary Fibrosis	ENSG00000128052	TRUE	Approved	2001-10-30	Phase III Clinical Trial	KDR
Idiopathic Pulmonary Fibrosis	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Absent	SMO
Idiopathic Pulmonary Fibrosis	ENSG00000131471	FALSE	Phase I Clinical Trial	2008-06-15	Phase I Clinical Trial	AOC3
Idiopathic Pulmonary Fibrosis	ENSG00000131724	FALSE	unknown	1996-10-15	Unused	IL13RA1
Idiopathic Pulmonary Fibrosis	ENSG00000131981	FALSE	Phase II Clinical Trial	2012-07-06	Absent	LGALS3
Idiopathic Pulmonary Fibrosis	ENSG00000132170	FALSE	Preclinical	2013-03-19	Absent	PPARG
Idiopathic Pulmonary Fibrosis	ENSG00000132703	FALSE	Phase II Clinical Trial	2009-07-24	Phase I Clinical Trial	APCS
Idiopathic Pulmonary Fibrosis	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Phase II Clinical Trial	LOXL2
Idiopathic Pulmonary Fibrosis	ENSG00000134216	FALSE	Phase I Clinical Trial	2014-12-23	Absent	CHIA
Idiopathic Pulmonary Fibrosis	ENSG00000134318	FALSE	Phase II Clinical Trial	2005-05-24	Absent	ROCK2
Idiopathic Pulmonary Fibrosis	ENSG00000134853	TRUE	Approved	2001-10-30	Phase III Clinical Trial	PDGFRA
Idiopathic Pulmonary Fibrosis	ENSG00000135218	FALSE	Preclinical	2007-02-12	Unused	CD36
Idiopathic Pulmonary Fibrosis	ENSG00000135744	FALSE	Phase I Clinical Trial	2012-09-27	Absent	AGT
Idiopathic Pulmonary Fibrosis	ENSG00000135914	FALSE	Preclinical	2015-01-29	Absent	HTR2B
Idiopathic Pulmonary Fibrosis	ENSG00000136160	FALSE	Phase III Clinical Trial	1994-10-15	Phase II Clinical Trial	EDNRB
Idiopathic Pulmonary Fibrosis	ENSG00000136634	FALSE	unknown	2013-11-28	Absent	IL10
Idiopathic Pulmonary Fibrosis	ENSG00000136869	FALSE	Preclinical	2011-11-27	Absent	TLR4
Idiopathic Pulmonary Fibrosis	ENSG00000136960	FALSE	Phase II Clinical Trial	2013-04-01	Absent	ENPP2
Idiopathic Pulmonary Fibrosis	ENSG00000138131	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL4
Idiopathic Pulmonary Fibrosis	ENSG00000138448	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	ITGAV
Idiopathic Pulmonary Fibrosis	ENSG00000138685	FALSE	Preclinical	2014-10-09	Absent	FGF2
Idiopathic Pulmonary Fibrosis	ENSG00000140937	FALSE	unknown	NA	Preclinical	CDH11
Idiopathic Pulmonary Fibrosis	ENSG00000143365	FALSE	Preclinical	2017-12-19	Absent	RORC
Idiopathic Pulmonary Fibrosis	ENSG00000149021	FALSE	unknown	NA	Unused	SCGB1A1
Idiopathic Pulmonary Fibrosis	ENSG00000150093	FALSE	Preclinical	2016-02-22	Absent	ITGB1
Idiopathic Pulmonary Fibrosis	ENSG00000151617	FALSE	Phase III Clinical Trial	1994-10-15	Phase II Clinical Trial	EDNRA
Idiopathic Pulmonary Fibrosis	ENSG00000154229	FALSE	Preclinical	1998-03-15	Unused	PRKCA
Idiopathic Pulmonary Fibrosis	ENSG00000157404	FALSE	Preclinical	2008-11-07	Unused	KIT
Idiopathic Pulmonary Fibrosis	ENSG00000159110	FALSE	Phase II Clinical Trial	2005-06-07	Phase II Clinical Trial	IFNAR2
Idiopathic Pulmonary Fibrosis	ENSG00000159958	FALSE	Preclinical	2010-10-21	Absent	TNFRSF13C
Idiopathic Pulmonary Fibrosis	ENSG00000160013	FALSE	Preclinical	2014-09-06	Absent	PTGIR
Idiopathic Pulmonary Fibrosis	ENSG00000162889	FALSE	Phase I Clinical Trial	2011-07-12	Preclinical	MAPKAPK2
Idiopathic Pulmonary Fibrosis	ENSG00000163106	FALSE	Phase I Clinical Trial	2014-08-23	Absent	HPGDS
Idiopathic Pulmonary Fibrosis	ENSG00000163235	FALSE	unknown	NA	Phase I Clinical Trial	TGFA
Idiopathic Pulmonary Fibrosis	ENSG00000163464	FALSE	Preclinical	1997-03-15	Unused	CXCR1
Idiopathic Pulmonary Fibrosis	ENSG00000164362	FALSE	Preclinical	2010-05-18	Preclinical	TERT
Idiopathic Pulmonary Fibrosis	ENSG00000165731	FALSE	Preclinical	2014-06-07	Absent	RET
Idiopathic Pulmonary Fibrosis	ENSG00000167658	FALSE	unknown	1996-10-15	Unused	EEF2
Idiopathic Pulmonary Fibrosis	ENSG00000168610	FALSE	unknown	2015-02-13	Absent	STAT3
Idiopathic Pulmonary Fibrosis	ENSG00000168918	FALSE	Phase I Clinical Trial	2009-10-12	Phase I Clinical Trial	INPP5D
Idiopathic Pulmonary Fibrosis	ENSG00000169194	FALSE	Phase II Clinical Trial	2003-05-20	Phase II Clinical Trial	IL13
Idiopathic Pulmonary Fibrosis	ENSG00000169429	FALSE	unknown	NA	Phase I Clinical Trial	CXCL8
Idiopathic Pulmonary Fibrosis	ENSG00000170027	FALSE	unknown	2006-08-09	Unused	YWHAG
Idiopathic Pulmonary Fibrosis	ENSG00000170425	FALSE	Phase I Clinical Trial	2015-05-27	Absent	ADORA2B
Idiopathic Pulmonary Fibrosis	ENSG00000170445	FALSE	unknown	NA	Absent	HARS
Idiopathic Pulmonary Fibrosis	ENSG00000171608	FALSE	Preclinical	2011-09-22	Absent	PIK3CD
Idiopathic Pulmonary Fibrosis	ENSG00000172572	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE3A
Idiopathic Pulmonary Fibrosis	ENSG00000173198	FALSE	Phase II Clinical Trial	2002-07-12	Absent	CYSLTR1
Idiopathic Pulmonary Fibrosis	ENSG00000173250	FALSE	Preclinical	2012-05-29	Absent	GPR151
Idiopathic Pulmonary Fibrosis	ENSG00000176601	FALSE	Preclinical	2017-05-04	Absent	MAP3K19
Idiopathic Pulmonary Fibrosis	ENSG00000178726	FALSE	Phase III Clinical Trial	NA	Absent	THBD
Idiopathic Pulmonary Fibrosis	ENSG00000180772	FALSE	Phase I Clinical Trial	2012-02-22	Absent	AGTR2
Idiopathic Pulmonary Fibrosis	ENSG00000180871	FALSE	Preclinical	1997-03-15	Unused	CXCR2
Idiopathic Pulmonary Fibrosis	ENSG00000184588	FALSE	Phase II Clinical Trial	2002-07-12	Absent	PDE4B
Idiopathic Pulmonary Fibrosis	ENSG00000186951	FALSE	Preclinical	2013-03-19	Absent	PPARA
Idiopathic Pulmonary Fibrosis	ENSG00000189403	FALSE	Preclinical	2014-10-08	Absent	HMGB1
Idiopathic Pulmonary Fibrosis	ENSG00000197081	FALSE	Phase I Clinical Trial	2008-06-15	Phase I Clinical Trial	IGF2R
Idiopathic Pulmonary Fibrosis	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Idiopathic Pulmonary Fibrosis	ENSG00000198121	FALSE	Phase II Clinical Trial	2009-06-17	Phase II Clinical Trial	LPAR1
Idiopathic Pulmonary Fibrosis	ENSG00000198793	FALSE	Phase I Clinical Trial	2009-09-04	Absent	MTOR
Idiopathic Pulmonary Fibrosis	ENSG00000254087	TRUE	Approved	2001-10-30	Phase III Clinical Trial	LYN
IgA Deficiency	ENSG00000102524	FALSE	unknown	1999-07-14	Unused	TNFSF13B
IgG Deficiency	ENSG00000081985	FALSE	unknown	2002-11-14	Unused	IL12RB2
IgG Deficiency	ENSG00000096996	FALSE	unknown	2002-11-14	Unused	IL12RB1
IgG Deficiency	ENSG00000102524	FALSE	unknown	1999-07-14	Unused	TNFSF13B
IgG Deficiency	ENSG00000110944	FALSE	unknown	2002-11-14	Unused	IL23A
Ileus	ENSG00000067182	FALSE	unknown	2007-11-12	Unused	TNFRSF1A
Ileus	ENSG00000073756	FALSE	Preclinical	2016-10-03	Absent	PTGS2
Ileus	ENSG00000075073	FALSE	Phase II Clinical Trial	1996-05-15	Unused	TACR2
Ileus	ENSG00000082556	FALSE	unknown	1994-05-15	Phase II Clinical Trial	OPRK1
Ileus	ENSG00000095303	FALSE	Preclinical	2016-10-03	Absent	PTGS1
Ileus	ENSG00000102539	FALSE	Preclinical	2009-02-19	Absent	MLNR
Ileus	ENSG00000104321	FALSE	Phase II Clinical Trial	2005-05-23	Absent	TRPA1
Ileus	ENSG00000110148	FALSE	Preclinical	2004-06-01	Unused	CCKBR
Ileus	ENSG00000112038	TRUE	Approved	1999-01-15	Approved	OPRM1
Ileus	ENSG00000112062	FALSE	unknown	2007-11-12	Unused	MAPK14
Ileus	ENSG00000114859	FALSE	Phase II Clinical Trial	2002-05-28	Unused	CLCN2
Ileus	ENSG00000121853	FALSE	Preclinical	1998-10-15	Phase II Clinical Trial	GHSR
Ileus	ENSG00000122585	FALSE	unknown	NA	Unused	NPY
Ileus	ENSG00000129167	FALSE	unknown	2006-02-15	Absent	TPH1
Ileus	ENSG00000164270	FALSE	Phase II Clinical Trial	1996-07-15	Phase II Clinical Trial	HTR4
Immune System Diseases	ENSG00000005844	FALSE	Phase I Clinical Trial	1993-06-15	Unused	ITGAL
Immune System Diseases	ENSG00000007171	FALSE	Preclinical	2005-06-01	Unused	NOS2
Immune System Diseases	ENSG00000007312	FALSE	Preclinical	2009-06-03	Unused	CD79B
Immune System Diseases	ENSG00000007908	FALSE	Preclinical	1999-08-26	Unused	SELE
Immune System Diseases	ENSG00000010610	FALSE	Preclinical	1991-11-15	Unused	CD4
Immune System Diseases	ENSG00000010671	FALSE	unknown	2011-04-07	Absent	BTK
Immune System Diseases	ENSG00000010810	FALSE	Preclinical	NA	Absent	FYN
Immune System Diseases	ENSG00000011677	FALSE	Preclinical	1990-09-15	Unused	GABRA3
Immune System Diseases	ENSG00000012779	FALSE	Preclinical	1989-09-15	Unused	ALOX5
Immune System Diseases	ENSG00000013725	FALSE	unknown	1991-08-15	Unused	CD6
Immune System Diseases	ENSG00000022355	FALSE	Preclinical	1990-09-15	Unused	GABRA1
Immune System Diseases	ENSG00000023445	FALSE	Preclinical	2002-07-03	Unused	BIRC3
Immune System Diseases	ENSG00000026103	FALSE	Preclinical	1999-10-05	Unused	FAS
Immune System Diseases	ENSG00000027697	FALSE	Preclinical	1990-07-15	Unused	IFNGR1
Immune System Diseases	ENSG00000030110	FALSE	Preclinical	1997-07-15	Absent	BAK1
Immune System Diseases	ENSG00000049249	FALSE	Preclinical	1999-09-16	Unused	TNFRSF9
Immune System Diseases	ENSG00000053918	FALSE	Preclinical	2001-05-10	Unused	KCNQ1
Immune System Diseases	ENSG00000055118	FALSE	Preclinical	2001-05-10	Unused	KCNH2
Immune System Diseases	ENSG00000065675	FALSE	Preclinical	2007-01-05	Unused	PRKCQ
Immune System Diseases	ENSG00000065989	FALSE	Phase I Clinical Trial	1994-10-15	Unused	PDE4A
Immune System Diseases	ENSG00000067182	FALSE	Preclinical	2008-07-31	Unused	TNFRSF1A
Immune System Diseases	ENSG00000068078	FALSE	Preclinical	NA	Absent	FGFR3
Immune System Diseases	ENSG00000073536	FALSE	Preclinical	2005-08-16	Unused	NLE1
Immune System Diseases	ENSG00000081237	FALSE	Preclinical	1990-06-15	Unused	PTPRC
Immune System Diseases	ENSG00000081985	FALSE	Preclinical	2004-01-05	Unused	IL12RB2
Immune System Diseases	ENSG00000083457	FALSE	Preclinical	2007-05-22	Unused	ITGAE
Immune System Diseases	ENSG00000087085	FALSE	unknown	1990-02-15	Unused	ACHE
Immune System Diseases	ENSG00000088832	FALSE	Preclinical	1996-03-15	Unused	FKBP1A
Immune System Diseases	ENSG00000090339	FALSE	Phase I Clinical Trial	1993-06-15	Unused	ICAM1
Immune System Diseases	ENSG00000090659	FALSE	Preclinical	2001-11-06	Unused	CD209
Immune System Diseases	ENSG00000091831	FALSE	Preclinical	2008-07-18	Unused	ESR1
Immune System Diseases	ENSG00000096968	FALSE	Preclinical	2013-09-23	Absent	JAK2
Immune System Diseases	ENSG00000096996	FALSE	Preclinical	2004-01-05	Unused	IL12RB1
Immune System Diseases	ENSG00000101017	FALSE	Preclinical	2002-09-12	Unused	CD40
Immune System Diseases	ENSG00000101444	FALSE	unknown	NA	Unused	AHCY
Immune System Diseases	ENSG00000101916	FALSE	Preclinical	2009-06-22	Unused	TLR8
Immune System Diseases	ENSG00000101966	FALSE	Preclinical	2002-07-03	Unused	XIAP
Immune System Diseases	ENSG00000102245	FALSE	Preclinical	2004-08-31	Unused	CD40LG
Immune System Diseases	ENSG00000102524	FALSE	Preclinical	2004-02-04	Unused	TNFSF13B
Immune System Diseases	ENSG00000102967	FALSE	Phase II Clinical Trial	1999-10-20	Unused	DHODH
Immune System Diseases	ENSG00000104365	FALSE	Preclinical	2004-04-20	Unused	IKBKB
Immune System Diseases	ENSG00000104938	FALSE	Preclinical	2001-11-06	Unused	CLEC4M
Immune System Diseases	ENSG00000105397	FALSE	Phase I Clinical Trial	2015-03-19	Absent	TYK2
Immune System Diseases	ENSG00000105639	FALSE	Preclinical	2008-12-12	Unused	JAK3
Immune System Diseases	ENSG00000105650	FALSE	Phase I Clinical Trial	1994-10-15	Unused	PDE4C
Immune System Diseases	ENSG00000105851	FALSE	Preclinical	2005-06-10	Unused	PIK3CG
Immune System Diseases	ENSG00000106348	FALSE	Approved	2009-11-25	Unused	IMPDH1
Immune System Diseases	ENSG00000106546	FALSE	Preclinical	2012-08-23	Preclinical	AHR
Immune System Diseases	ENSG00000106804	FALSE	Preclinical	2004-04-26	Unused	C5
Immune System Diseases	ENSG00000106952	FALSE	Preclinical	2001-05-30	Unused	TNFSF8
Immune System Diseases	ENSG00000108691	FALSE	Preclinical	2007-07-06	Unused	CCL2
Immune System Diseases	ENSG00000109320	FALSE	Preclinical	2008-02-12	Unused	NFKB1
Immune System Diseases	ENSG00000109471	FALSE	Preclinical	1993-04-15	Unused	IL2
Immune System Diseases	ENSG00000109610	FALSE	Preclinical	1999-01-15	Unused	SOD3
Immune System Diseases	ENSG00000110330	FALSE	Preclinical	2002-07-03	Unused	BIRC2
Immune System Diseases	ENSG00000110448	FALSE	unknown	NA	Unused	CD5
Immune System Diseases	ENSG00000110944	FALSE	Preclinical	2006-07-13	Unused	IL23A
Immune System Diseases	ENSG00000111424	FALSE	Preclinical	2002-03-27	Unused	VDR
Immune System Diseases	ENSG00000111537	FALSE	Preclinical	1991-12-15	Phase I Clinical Trial	IFNG
Immune System Diseases	ENSG00000112062	FALSE	Preclinical	2004-08-16	Unused	MAPK14
Immune System Diseases	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Immune System Diseases	ENSG00000112115	FALSE	Preclinical	2011-08-26	Preclinical	IL17A
Immune System Diseases	ENSG00000113263	FALSE	Preclinical	2014-07-22	Absent	ITK
Immune System Diseases	ENSG00000113302	FALSE	Preclinical	2001-05-03	Unused	IL12B
Immune System Diseases	ENSG00000113448	FALSE	Phase I Clinical Trial	1994-10-15	Unused	PDE4D
Immune System Diseases	ENSG00000113580	FALSE	Preclinical	1992-12-15	Unused	NR3C1
Immune System Diseases	ENSG00000113721	FALSE	Preclinical	NA	Absent	PDGFRB
Immune System Diseases	ENSG00000114013	FALSE	Preclinical	1992-09-15	Unused	CD86
Immune System Diseases	ENSG00000115009	FALSE	unknown	2009-03-25	Absent	CCL20
Immune System Diseases	ENSG00000115085	FALSE	Preclinical	1997-12-15	Unused	ZAP70
Immune System Diseases	ENSG00000115232	FALSE	Preclinical	1992-01-15	Unused	ITGA4
Immune System Diseases	ENSG00000115353	FALSE	Preclinical	1992-03-15	Unused	TACR1
Immune System Diseases	ENSG00000115594	FALSE	Preclinical	1990-12-15	Unused	IL1R1
Immune System Diseases	ENSG00000116329	FALSE	Preclinical	1998-02-15	Unused	OPRD1
Immune System Diseases	ENSG00000116824	FALSE	Preclinical	NA	Unused	CD2
Immune System Diseases	ENSG00000117560	FALSE	Preclinical	1999-10-05	Unused	FASLG
Immune System Diseases	ENSG00000117586	FALSE	Preclinical	NA	Unused	TNFSF4
Immune System Diseases	ENSG00000120833	FALSE	Preclinical	1998-11-15	Unused	SOCS2
Immune System Diseases	ENSG00000121594	FALSE	Preclinical	1992-09-15	Unused	CD80
Immune System Diseases	ENSG00000121653	FALSE	Preclinical	2003-08-26	Unused	MAPK8IP1
Immune System Diseases	ENSG00000121691	FALSE	Preclinical	1995-06-15	Unused	CAT
Immune System Diseases	ENSG00000121807	FALSE	Preclinical	2003-06-06	Unused	CCR2
Immune System Diseases	ENSG00000121966	FALSE	Preclinical	2009-08-24	Unused	CXCR4
Immune System Diseases	ENSG00000121989	FALSE	unknown	NA	Unused	ACVR2A
Immune System Diseases	ENSG00000128052	FALSE	Preclinical	1998-12-15	Unused	KDR
Immune System Diseases	ENSG00000130303	FALSE	Preclinical	2010-01-22	Preclinical	BST2
Immune System Diseases	ENSG00000130561	FALSE	unknown	1993-04-15	Unused	SAG
Immune System Diseases	ENSG00000131196	FALSE	Preclinical	1997-06-15	Unused	NFATC1
Immune System Diseases	ENSG00000131471	FALSE	Preclinical	2003-12-02	Unused	AOC3
Immune System Diseases	ENSG00000131747	FALSE	Preclinical	NA	Unused	TOP2A
Immune System Diseases	ENSG00000131759	FALSE	Preclinical	1999-03-23	Unused	RARA
Immune System Diseases	ENSG00000132170	FALSE	Preclinical	2002-06-28	Unused	PPARG
Immune System Diseases	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Immune System Diseases	ENSG00000132530	FALSE	Preclinical	2002-07-03	Unused	XAF1
Immune System Diseases	ENSG00000134460	FALSE	Phase II Clinical Trial	1990-07-15	Unused	IL2RA
Immune System Diseases	ENSG00000134470	FALSE	Preclinical	2001-04-12	Unused	IL15RA
Immune System Diseases	ENSG00000134489	FALSE	Preclinical	2003-09-02	Unused	HRH4
Immune System Diseases	ENSG00000134853	FALSE	Preclinical	1998-12-15	Unused	PDGFRA
Immune System Diseases	ENSG00000136244	FALSE	unknown	2009-10-12	Preclinical	IL6
Immune System Diseases	ENSG00000136689	FALSE	Preclinical	1990-06-15	Unused	IL1RN
Immune System Diseases	ENSG00000136807	FALSE	Preclinical	2008-08-28	Unused	CDK9
Immune System Diseases	ENSG00000136869	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	TLR4
Immune System Diseases	ENSG00000137462	FALSE	Preclinical	2017-07-07	Absent	TLR2
Immune System Diseases	ENSG00000137745	FALSE	Preclinical	2001-09-18	Unused	MMP13
Immune System Diseases	ENSG00000137752	FALSE	Preclinical	1993-12-15	Unused	CASP1
Immune System Diseases	ENSG00000138378	FALSE	Preclinical	1996-10-15	Unused	STAT4
Immune System Diseases	ENSG00000138684	FALSE	Preclinical	2011-11-23	Absent	IL21
Immune System Diseases	ENSG00000138685	FALSE	Preclinical	1994-12-15	Unused	FGF2
Immune System Diseases	ENSG00000138792	FALSE	Preclinical	1991-02-15	Unused	ENPEP
Immune System Diseases	ENSG00000139219	FALSE	Preclinical	1995-02-15	Unused	COL2A1
Immune System Diseases	ENSG00000139626	FALSE	Preclinical	2009-06-06	Unused	ITGB7
Immune System Diseases	ENSG00000141867	FALSE	Preclinical	2005-03-04	Preclinical	BRD4
Immune System Diseases	ENSG00000143171	FALSE	Preclinical	2010-10-26	Preclinical	RXRG
Immune System Diseases	ENSG00000143226	FALSE	Preclinical	2009-11-11	Unused	FCGR2A
Immune System Diseases	ENSG00000143365	FALSE	Preclinical	2015-05-26	Absent	RORC
Immune System Diseases	ENSG00000144285	FALSE	unknown	NA	Unused	SCN1A
Immune System Diseases	ENSG00000144668	FALSE	Preclinical	2007-07-23	Unused	ITGA9
Immune System Diseases	ENSG00000146070	FALSE	Preclinical	1997-08-15	Unused	PLA2G7
Immune System Diseases	ENSG00000146648	FALSE	Preclinical	1998-12-15	Unused	EGFR
Immune System Diseases	ENSG00000150093	FALSE	Preclinical	1992-01-15	Unused	ITGB1
Immune System Diseases	ENSG00000150782	FALSE	Phase I Clinical Trial	2000-05-18	Unused	IL18
Immune System Diseases	ENSG00000151834	FALSE	Preclinical	1990-09-15	Unused	GABRA2
Immune System Diseases	ENSG00000153253	FALSE	unknown	NA	Unused	SCN3A
Immune System Diseases	ENSG00000154229	FALSE	Preclinical	1994-10-15	Unused	PRKCA
Immune System Diseases	ENSG00000155380	FALSE	Preclinical	2012-11-20	Preclinical	SLC16A1
Immune System Diseases	ENSG00000156136	FALSE	Preclinical	2008-08-29	Unused	DCK
Immune System Diseases	ENSG00000156738	FALSE	Preclinical	1996-07-15	Unused	MS4A1
Immune System Diseases	ENSG00000157404	FALSE	Preclinical	2009-10-09	Unused	KIT
Immune System Diseases	ENSG00000158473	FALSE	Preclinical	2009-03-06	Unused	CD1D
Immune System Diseases	ENSG00000160255	FALSE	Preclinical	2001-04-07	Unused	ITGB2
Immune System Diseases	ENSG00000160712	FALSE	Preclinical	1993-06-15	Unused	IL6R
Immune System Diseases	ENSG00000160791	FALSE	Preclinical	2007-12-06	Unused	CCR5
Immune System Diseases	ENSG00000161955	FALSE	Preclinical	1999-11-24	Unused	TNFSF13
Immune System Diseases	ENSG00000162434	FALSE	Preclinical	2013-09-23	Absent	JAK1
Immune System Diseases	ENSG00000162692	FALSE	Preclinical	1989-06-15	Unused	VCAM1
Immune System Diseases	ENSG00000162747	FALSE	Preclinical	2005-11-09	Unused	FCGR3B
Immune System Diseases	ENSG00000163131	FALSE	Preclinical	2001-09-27	Unused	CTSS
Immune System Diseases	ENSG00000163220	FALSE	Preclinical	2010-03-11	Absent	S100A9
Immune System Diseases	ENSG00000163235	FALSE	Preclinical	NA	Unused	TGFA
Immune System Diseases	ENSG00000163464	FALSE	Preclinical	1990-01-15	Unused	CXCR1
Immune System Diseases	ENSG00000163599	FALSE	Preclinical	1997-01-15	Unused	CTLA4
Immune System Diseases	ENSG00000163823	FALSE	Preclinical	2005-04-27	Unused	CCR1
Immune System Diseases	ENSG00000164171	FALSE	Preclinical	2009-06-06	Unused	ITGA2
Immune System Diseases	ENSG00000164362	FALSE	Preclinical	1999-12-01	Unused	TERT
Immune System Diseases	ENSG00000164400	FALSE	Phase I Clinical Trial	1996-12-15	Unused	CSF2
Immune System Diseases	ENSG00000165025	FALSE	Preclinical	2009-06-10	Unused	SYK
Immune System Diseases	ENSG00000165471	FALSE	Phase II Clinical Trial	2001-01-26	Unused	MBL2
Immune System Diseases	ENSG00000166710	FALSE	Preclinical	2000-11-08	Unused	B2M
Immune System Diseases	ENSG00000166825	FALSE	Preclinical	2007-05-21	Unused	ANPEP
Immune System Diseases	ENSG00000166888	FALSE	Preclinical	1996-10-15	Unused	STAT6
Immune System Diseases	ENSG00000167658	FALSE	Preclinical	1991-08-15	Unused	EEF2
Immune System Diseases	ENSG00000168685	FALSE	Preclinical	1990-01-15	Unused	IL7R
Immune System Diseases	ENSG00000168811	FALSE	Preclinical	2001-05-03	Unused	IL12A
Immune System Diseases	ENSG00000168918	FALSE	Preclinical	2007-10-29	Unused	INPP5D
Immune System Diseases	ENSG00000169194	FALSE	Preclinical	2012-07-06	Absent	IL13
Immune System Diseases	ENSG00000169245	FALSE	Phase I Clinical Trial	2017-02-09	Absent	CXCL10
Immune System Diseases	ENSG00000169403	FALSE	Preclinical	1994-09-15	Unused	PTAFR
Immune System Diseases	ENSG00000169429	FALSE	Preclinical	1999-05-26	Unused	CXCL8
Immune System Diseases	ENSG00000169508	FALSE	Preclinical	2011-09-10	Unused	GPR183
Immune System Diseases	ENSG00000170445	FALSE	unknown	NA	Absent	HARS
Immune System Diseases	ENSG00000170677	FALSE	Preclinical	1998-11-15	Unused	SOCS6
Immune System Diseases	ENSG00000170989	FALSE	Phase I Clinical Trial	2005-03-14	Phase I Clinical Trial	S1PR1
Immune System Diseases	ENSG00000171150	FALSE	Preclinical	1998-11-15	Unused	SOCS5
Immune System Diseases	ENSG00000171608	FALSE	Preclinical	2010-07-10	Preclinical	PIK3CD
Immune System Diseases	ENSG00000173083	FALSE	Preclinical	1994-12-15	Unused	HPSE
Immune System Diseases	ENSG00000173762	FALSE	Phase I Clinical Trial	1990-06-15	Unused	CD7
Immune System Diseases	ENSG00000174059	FALSE	Phase I Clinical Trial	NA	Unused	CD34
Immune System Diseases	ENSG00000174175	FALSE	Preclinical	2000-06-07	Unused	SELP
Immune System Diseases	ENSG00000177272	FALSE	Preclinical	1990-02-15	Unused	KCNA3
Immune System Diseases	ENSG00000178562	FALSE	Phase I Clinical Trial	1992-09-15	Unused	CD28
Immune System Diseases	ENSG00000178573	FALSE	Preclinical	1996-09-15	Unused	MAF
Immune System Diseases	ENSG00000179295	FALSE	Preclinical	2016-08-03	Absent	PTPN11
Immune System Diseases	ENSG00000180644	FALSE	Preclinical	2009-06-06	Unused	PRF1
Immune System Diseases	ENSG00000180739	FALSE	Phase I Clinical Trial	2011-07-23	Phase I Clinical Trial	S1PR5
Immune System Diseases	ENSG00000180871	FALSE	Preclinical	1990-07-15	Unused	CXCR2
Immune System Diseases	ENSG00000182326	FALSE	Preclinical	1990-06-15	Unused	C1S
Immune System Diseases	ENSG00000182578	FALSE	Preclinical	2009-10-09	Unused	CSF1R
Immune System Diseases	ENSG00000182866	FALSE	Preclinical	1997-03-15	Unused	LCK
Immune System Diseases	ENSG00000184216	FALSE	Preclinical	2016-08-02	Absent	IRAK1
Immune System Diseases	ENSG00000184557	FALSE	Preclinical	1998-11-15	Unused	SOCS3
Immune System Diseases	ENSG00000184588	FALSE	Phase I Clinical Trial	1994-10-15	Unused	PDE4B
Immune System Diseases	ENSG00000185338	FALSE	Preclinical	1998-11-15	Unused	SOCS1
Immune System Diseases	ENSG00000186297	FALSE	Preclinical	1990-09-15	Unused	GABRA5
Immune System Diseases	ENSG00000186810	FALSE	Preclinical	2007-08-22	Unused	CXCR3
Immune System Diseases	ENSG00000188404	FALSE	Preclinical	2000-06-07	Unused	SELL
Immune System Diseases	ENSG00000196262	FALSE	Pre-registration	1994-08-15	Unused	PPIA
Immune System Diseases	ENSG00000196352	FALSE	Phase II Clinical Trial	1991-03-15	Unused	CD55
Immune System Diseases	ENSG00000196415	FALSE	Preclinical	1992-03-15	Unused	PRTN3
Immune System Diseases	ENSG00000196664	FALSE	Preclinical	2017-07-07	Absent	TLR7
Immune System Diseases	ENSG00000196839	FALSE	Preclinical	2013-01-11	Absent	ADA
Immune System Diseases	ENSG00000197122	FALSE	Preclinical	1997-10-15	Unused	SRC
Immune System Diseases	ENSG00000197405	FALSE	Preclinical	1994-05-15	Unused	C5AR1
Immune System Diseases	ENSG00000197635	FALSE	Preclinical	2007-05-21	Unused	DPP4
Immune System Diseases	ENSG00000197919	FALSE	Phase I Clinical Trial	NA	Unused	IFNA1
Immune System Diseases	ENSG00000198001	FALSE	Phase I Clinical Trial	2015-04-18	Absent	IRAK4
Immune System Diseases	ENSG00000198793	FALSE	Preclinical	2003-05-28	Unused	MTOR
Immune System Diseases	ENSG00000198805	FALSE	Phase I Clinical Trial	1989-07-15	Unused	PNP
Immune System Diseases	ENSG00000203710	FALSE	Preclinical	1992-11-15	Unused	CR1
Immune System Diseases	ENSG00000203747	FALSE	Preclinical	2005-11-09	Unused	FCGR3A
Immune System Diseases	ENSG00000204628	FALSE	Preclinical	1995-06-15	Unused	RACK1
Immune System Diseases	ENSG00000205268	FALSE	Preclinical	2005-03-13	Unused	PDE7A
Immune System Diseases	ENSG00000213694	FALSE	Preclinical	2013-01-22	Preclinical	S1PR3
Immune System Diseases	ENSG00000213903	FALSE	Preclinical	2010-07-28	Unused	LTB4R
Immune System Diseases	ENSG00000249437	FALSE	Preclinical	2002-07-03	Unused	NAIP
Immune System Diseases	ENSG00000254087	FALSE	Preclinical	2001-08-27	Unused	LYN
Immune System Diseases	ENSG00000271503	FALSE	Preclinical	2009-03-26	Unused	CCL5
Immune System Diseases	ENSG00000274211	FALSE	Preclinical	1998-11-15	Unused	SOCS7
Immune System Diseases	ENSG00000282608	FALSE	Preclinical	2006-10-30	Unused	ADORA3
Immunologic Deficiency Syndromes	ENSG00000007908	FALSE	Preclinical	1995-02-15	Unused	SELE
Immunologic Deficiency Syndromes	ENSG00000065989	FALSE	Preclinical	1995-03-15	Unused	PDE4A
Immunologic Deficiency Syndromes	ENSG00000088832	FALSE	Phase I Clinical Trial	2008-08-06	Unused	FKBP1A
Immunologic Deficiency Syndromes	ENSG00000090339	FALSE	Preclinical	1995-02-15	Unused	ICAM1
Immunologic Deficiency Syndromes	ENSG00000105650	FALSE	Preclinical	1995-03-15	Unused	PDE4C
Immunologic Deficiency Syndromes	ENSG00000111424	FALSE	Preclinical	1995-05-15	Unused	VDR
Immunologic Deficiency Syndromes	ENSG00000113448	FALSE	Preclinical	1995-03-15	Unused	PDE4D
Immunologic Deficiency Syndromes	ENSG00000113494	FALSE	Preclinical	1995-06-15	Unused	PRLR
Immunologic Deficiency Syndromes	ENSG00000116678	FALSE	Preclinical	2000-10-02	Unused	LEPR
Immunologic Deficiency Syndromes	ENSG00000121807	FALSE	Preclinical	1997-01-15	Unused	CCR2
Immunologic Deficiency Syndromes	ENSG00000121966	FALSE	Phase III Clinical Trial	2015-09-04	Absent	CXCR4
Immunologic Deficiency Syndromes	ENSG00000134460	FALSE	unknown	NA	Absent	IL2RA
Immunologic Deficiency Syndromes	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Immunologic Deficiency Syndromes	ENSG00000163599	FALSE	Preclinical	1997-07-15	Unused	CTLA4
Immunologic Deficiency Syndromes	ENSG00000168685	FALSE	Phase II Clinical Trial	1999-07-13	Phase II Clinical Trial	IL7R
Immunologic Deficiency Syndromes	ENSG00000171608	FALSE	Phase III Clinical Trial	2011-09-02	Absent	PIK3CD
Immunologic Deficiency Syndromes	ENSG00000174175	FALSE	Preclinical	1995-02-15	Unused	SELP
Immunologic Deficiency Syndromes	ENSG00000178562	FALSE	Preclinical	1997-07-15	Unused	CD28
Immunologic Deficiency Syndromes	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Immunologic Deficiency Syndromes	ENSG00000183813	FALSE	Phase III Clinical Trial	2017-01-31	Absent	CCR4
Immunologic Deficiency Syndromes	ENSG00000184588	FALSE	Preclinical	1995-03-15	Unused	PDE4B
Immunologic Deficiency Syndromes	ENSG00000185291	FALSE	unknown	NA	Unused	IL3RA
Immunologic Deficiency Syndromes	ENSG00000196262	FALSE	Preclinical	1993-11-15	Unused	PPIA
Immunologic Deficiency Syndromes	ENSG00000198223	FALSE	unknown	NA	Unused	CSF2RA
Immunologic Deficiency Syndromes	ENSG00000259207	FALSE	Preclinical	1997-02-15	Unused	ITGB3
Impetigo	ENSG00000101425	FALSE	unknown	2002-01-17	Unused	BPI
Impetigo	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Infection	ENSG00000005381	FALSE	Phase III Clinical Trial	2000-07-19	Phase I Clinical Trial	MPO
Infection	ENSG00000007171	FALSE	Preclinical	2015-07-01	Absent	NOS2
Infection	ENSG00000012223	FALSE	unknown	1994-08-15	Phase II Clinical Trial	LTF
Infection	ENSG00000027697	FALSE	Preclinical	1989-08-15	Unused	IFNGR1
Infection	ENSG00000044574	FALSE	Preclinical	2008-11-21	Unused	HSPA5
Infection	ENSG00000057252	FALSE	Preclinical	1995-09-15	Unused	SOAT1
Infection	ENSG00000059377	FALSE	unknown	2006-08-29	Preclinical	TBXAS1
Infection	ENSG00000067182	FALSE	Preclinical	2003-11-24	Unused	TNFRSF1A
Infection	ENSG00000070501	FALSE	Preclinical	NA	Unused	POLB
Infection	ENSG00000073614	FALSE	Phase I Clinical Trial	2016-10-04	Absent	KDM5A
Infection	ENSG00000082701	FALSE	Preclinical	2012-04-11	Preclinical	GSK3B
Infection	ENSG00000084207	FALSE	Preclinical	2002-04-29	Unused	GSTP1
Infection	ENSG00000085563	FALSE	Preclinical	2000-09-12	Unused	ABCB1
Infection	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Infection	ENSG00000088832	FALSE	Preclinical	1995-07-15	Unused	FKBP1A
Infection	ENSG00000089692	FALSE	unknown	2007-07-16	Preclinical	LAG3
Infection	ENSG00000090339	FALSE	Preclinical	1992-07-15	Unused	ICAM1
Infection	ENSG00000090659	FALSE	Preclinical	2001-11-06	Unused	CD209
Infection	ENSG00000092445	FALSE	Preclinical	2014-09-16	Absent	TYRO3
Infection	ENSG00000101017	FALSE	Preclinical	2004-09-30	Unused	CD40
Infection	ENSG00000101425	FALSE	Preclinical	2002-01-17	Unused	BPI
Infection	ENSG00000101444	FALSE	Preclinical	1996-12-15	Unused	AHCY
Infection	ENSG00000101868	FALSE	Preclinical	1994-03-15	Unused	POLA1
Infection	ENSG00000101916	FALSE	Preclinical	2006-07-28	Preclinical	TLR8
Infection	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Infection	ENSG00000104938	FALSE	Preclinical	2001-11-06	Unused	CLEC4M
Infection	ENSG00000106211	FALSE	Preclinical	2004-09-24	Absent	HSPB1
Infection	ENSG00000106348	FALSE	Preclinical	1997-04-15	Unused	IMPDH1
Infection	ENSG00000109163	FALSE	unknown	2002-05-14	Unused	GNRHR
Infection	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Infection	ENSG00000111319	FALSE	Preclinical	2014-12-20	Absent	SCNN1A
Infection	ENSG00000111321	FALSE	Preclinical	2011-02-14	Preclinical	LTBR
Infection	ENSG00000111796	FALSE	Preclinical	1995-01-15	Unused	KLRB1
Infection	ENSG00000113580	TRUE	Approved	1991-11-15	Approved	NR3C1
Infection	ENSG00000113749	FALSE	unknown	1993-06-15	Unused	HRH2
Infection	ENSG00000115353	FALSE	unknown	2001-07-18	Preclinical	TACR1
Infection	ENSG00000115590	FALSE	Pre-registration	NA	Unused	IL1R2
Infection	ENSG00000115758	FALSE	Preclinical	1995-06-15	Unused	ODC1
Infection	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Infection	ENSG00000117298	FALSE	Preclinical	1999-09-15	Unused	ECE1
Infection	ENSG00000117335	FALSE	Preclinical	1994-06-15	Unused	CD46
Infection	ENSG00000117601	TRUE	Approved	NA	Absent	SERPINC1
Infection	ENSG00000118432	FALSE	Preclinical	2017-11-14	Absent	CNR1
Infection	ENSG00000119535	FALSE	Phase II Clinical Trial	1991-08-15	Phase II Clinical Trial	CSF3R
Infection	ENSG00000121858	FALSE	Preclinical	2011-02-14	Preclinical	TNFSF10
Infection	ENSG00000121879	FALSE	Preclinical	2004-08-10	Absent	PIK3CA
Infection	ENSG00000122025	FALSE	unknown	1996-01-15	Unused	FLT3
Infection	ENSG00000123505	FALSE	Preclinical	1993-06-15	Unused	AMD1
Infection	ENSG00000124334	FALSE	Preclinical	1990-03-15	Unused	IL9R
Infection	ENSG00000126218	TRUE	Approved	NA	Absent	F10
Infection	ENSG00000131747	FALSE	Preclinical	1997-08-15	Unused	TOP2A
Infection	ENSG00000134318	FALSE	unknown	2005-05-24	Preclinical	ROCK2
Infection	ENSG00000134460	FALSE	Preclinical	1995-12-15	Unused	IL2RA
Infection	ENSG00000134470	FALSE	Preclinical	1995-07-15	Unused	IL15RA
Infection	ENSG00000134853	FALSE	Preclinical	1989-12-15	Unused	PDGFRA
Infection	ENSG00000135828	FALSE	Preclinical	1993-12-15	Unused	RNASEL
Infection	ENSG00000136244	FALSE	Phase II Clinical Trial	1996-09-15	Unused	IL6
Infection	ENSG00000136634	FALSE	Preclinical	2008-08-11	Unused	IL10
Infection	ENSG00000136810	FALSE	Preclinical	2003-11-19	Unused	TXN
Infection	ENSG00000136869	FALSE	Preclinical	2005-06-20	Unused	TLR4
Infection	ENSG00000140564	FALSE	Preclinical	1997-05-15	Unused	FURIN
Infection	ENSG00000141510	FALSE	Preclinical	2014-03-03	Absent	TP53
Infection	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Infection	ENSG00000142166	FALSE	Approved	2004-08-20	Unused	IFNAR1
Infection	ENSG00000146469	FALSE	Preclinical	NA	Unused	VIP
Infection	ENSG00000148926	FALSE	Preclinical	1996-09-15	Unused	ADM
Infection	ENSG00000149295	FALSE	unknown	NA	Unused	DRD2
Infection	ENSG00000149418	FALSE	Preclinical	2006-08-09	Absent	ST14
Infection	ENSG00000151623	FALSE	Preclinical	2014-12-20	Absent	NR3C2
Infection	ENSG00000153208	FALSE	Preclinical	2014-09-16	Absent	MERTK
Infection	ENSG00000158473	FALSE	Preclinical	2009-03-06	Unused	CD1D
Infection	ENSG00000159110	TRUE	Approved	1992-05-15	Unused	IFNAR2
Infection	ENSG00000160211	FALSE	unknown	1999-01-15	Phase II Clinical Trial	G6PD
Infection	ENSG00000160712	FALSE	unknown	1989-06-15	Unused	IL6R
Infection	ENSG00000160791	FALSE	Preclinical	2000-03-01	Unused	CCR5
Infection	ENSG00000167601	FALSE	Preclinical	2014-09-16	Absent	AXL
Infection	ENSG00000167658	FALSE	Preclinical	NA	Unused	EEF2
Infection	ENSG00000168522	FALSE	Preclinical	1997-06-15	Unused	FNTA
Infection	ENSG00000169403	FALSE	Preclinical	1996-10-15	Unused	PTAFR
Infection	ENSG00000169429	FALSE	Phase II Clinical Trial	2016-10-19	Absent	CXCL8
Infection	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Infection	ENSG00000171855	FALSE	Preclinical	2007-01-24	Unused	IFNB1
Infection	ENSG00000171867	FALSE	Preclinical	1996-11-15	Unused	PRNP
Infection	ENSG00000172236	FALSE	unknown	1996-06-15	Unused	TPSAB1
Infection	ENSG00000172243	FALSE	unknown	NA	Unused	CLEC7A
Infection	ENSG00000173327	FALSE	Preclinical	NA	Absent	MAP3K11
Infection	ENSG00000176393	FALSE	Preclinical	1992-06-15	Unused	RNPEP
Infection	ENSG00000180210	TRUE	Approved	NA	Absent	F2
Infection	ENSG00000182578	FALSE	Preclinical	1991-08-15	Unused	CSF1R
Infection	ENSG00000185291	FALSE	Preclinical	1991-01-15	Unused	IL3RA
Infection	ENSG00000185436	FALSE	Preclinical	2004-07-20	Unused	IFNLR1
Infection	ENSG00000187010	FALSE	Preclinical	1989-12-15	Unused	RHD
Infection	ENSG00000187514	FALSE	Preclinical	NA	Unused	PTMA
Infection	ENSG00000187554	FALSE	Preclinical	2017-01-09	Absent	TLR5
Infection	ENSG00000188389	FALSE	Preclinical	2013-01-21	Preclinical	PDCD1
Infection	ENSG00000196664	FALSE	Preclinical	2006-07-28	Preclinical	TLR7
Infection	ENSG00000197635	FALSE	Preclinical	1997-11-15	Unused	DPP4
Infection	ENSG00000197919	FALSE	Preclinical	1996-09-15	Unused	IFNA1
Infection	ENSG00000197992	FALSE	Preclinical	2008-08-05	Unused	CLEC9A
Infection	ENSG00000198223	FALSE	Phase III Clinical Trial	1991-01-15	Phase II Clinical Trial	CSF2RA
Infection	ENSG00000198793	FALSE	Preclinical	2004-08-10	Absent	MTOR
Infection	ENSG00000198900	FALSE	Preclinical	1997-08-15	Unused	TOP1
Infection	ENSG00000228716	FALSE	unknown	NA	Unused	DHFR
Infection	ENSG00000239732	FALSE	Preclinical	2014-10-15	Absent	TLR9
Infection	ENSG00000269858	FALSE	unknown	2010-12-10	Preclinical	EGLN2
Infertility, Female	ENSG00000082175	TRUE	Approved	1996-07-15	Approved	PGR
Infertility, Female	ENSG00000091831	FALSE	Approved	1992-10-15	Unused	ESR1
Infertility, Female	ENSG00000109163	TRUE	Approved	1990-03-15	Approved	GNRHR
Infertility, Female	ENSG00000112964	FALSE	unknown	NA	Unused	GHR
Infertility, Female	ENSG00000113594	FALSE	Phase II Clinical Trial	NA	Unused	LIFR
Infertility, Female	ENSG00000116014	FALSE	Phase I Clinical Trial	2008-07-31	Absent	KISS1R
Infertility, Female	ENSG00000119535	FALSE	unknown	NA	Absent	CSF3R
Infertility, Female	ENSG00000135914	TRUE	Approved	NA	Approved	HTR2B
Infertility, Female	ENSG00000137869	FALSE	Pre-registration	1989-05-15	Unused	CYP19A1
Infertility, Female	ENSG00000138039	TRUE	Approved	2002-11-28	Approved	LHCGR
Infertility, Female	ENSG00000147437	FALSE	Preclinical	2015-10-19	Absent	GNRH1
Infertility, Female	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Infertility, Female	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Infertility, Female	ENSG00000166148	TRUE	Approved	2002-03-22	Approved	AVPR1A
Infertility, Female	ENSG00000169252	FALSE	unknown	1998-08-15	Unused	ADRB2
Infertility, Female	ENSG00000169432	FALSE	Phase II Clinical Trial	2011-04-11	Unused	SCN9A
Infertility, Female	ENSG00000170820	TRUE	Approved	1992-07-15	Approved	FSHR
Infertility, Female	ENSG00000171509	FALSE	unknown	NA	Unused	RXFP1
Infertility, Female	ENSG00000180914	FALSE	Phase III Clinical Trial	2010-02-26	Phase I Clinical Trial	OXTR
Infertility, Male	ENSG00000091831	FALSE	Preclinical	2007-08-23	Preclinical	ESR1
Infertility, Male	ENSG00000111424	FALSE	unknown	2002-03-27	Unused	VDR
Infertility, Male	ENSG00000112964	FALSE	Phase II Clinical Trial	NA	Unused	GHR
Infertility, Male	ENSG00000138039	FALSE	Approved	2014-01-21	Unused	LHCGR
Infertility, Male	ENSG00000166148	FALSE	Preclinical	2009-02-09	Unused	AVPR1A
Infertility, Male	ENSG00000169418	FALSE	Preclinical	1995-06-15	Unused	NPR1
Infertility, Male	ENSG00000170820	TRUE	Approved	1992-07-15	Approved	FSHR
Infertility, Male	ENSG00000180914	FALSE	Preclinical	2007-08-23	Preclinical	OXTR
Inflammation	ENSG00000000971	FALSE	Preclinical	2014-11-05	Absent	CFH
Inflammation	ENSG00000001626	FALSE	Preclinical	1994-10-15	Unused	CFTR
Inflammation	ENSG00000003436	FALSE	Preclinical	2001-04-26	Unused	TFPI
Inflammation	ENSG00000004948	FALSE	Preclinical	1997-09-15	Unused	CALCR
Inflammation	ENSG00000005381	FALSE	Preclinical	2016-10-07	Absent	MPO
Inflammation	ENSG00000005844	FALSE	Preclinical	1994-08-15	Unused	ITGAL
Inflammation	ENSG00000005961	FALSE	Preclinical	1998-03-15	Unused	ITGA2B
Inflammation	ENSG00000006210	FALSE	Phase I Clinical Trial	2006-02-07	Absent	CX3CL1
Inflammation	ENSG00000006283	FALSE	Preclinical	1991-09-15	Unused	CACNA1G
Inflammation	ENSG00000006638	FALSE	Preclinical	1997-06-15	Unused	TBXA2R
Inflammation	ENSG00000007171	FALSE	Preclinical	1996-08-15	Unused	NOS2
Inflammation	ENSG00000007908	FALSE	Preclinical	1989-06-15	Unused	SELE
Inflammation	ENSG00000007952	FALSE	Preclinical	2015-03-25	Absent	NOX1
Inflammation	ENSG00000010327	FALSE	Preclinical	2009-11-12	Preclinical	STAB1
Inflammation	ENSG00000010610	FALSE	Preclinical	2001-11-12	Unused	CD4
Inflammation	ENSG00000010671	FALSE	Phase I Clinical Trial	2011-06-09	Unused	BTK
Inflammation	ENSG00000012124	FALSE	Preclinical	2006-05-16	Unused	CD22
Inflammation	ENSG00000012779	FALSE	Phase I Clinical Trial	1989-06-15	Unused	ALOX5
Inflammation	ENSG00000016490	FALSE	Approved	NA	Unused	CLCA1
Inflammation	ENSG00000019582	FALSE	Preclinical	2006-11-21	Unused	CD74
Inflammation	ENSG00000025434	FALSE	unknown	2001-07-09	Absent	NR1H3
Inflammation	ENSG00000026508	FALSE	Preclinical	2008-02-20	Unused	CD44
Inflammation	ENSG00000027697	FALSE	Preclinical	1990-07-15	Unused	IFNGR1
Inflammation	ENSG00000034152	FALSE	Preclinical	2004-02-05	Unused	MAP2K3
Inflammation	ENSG00000050628	FALSE	Preclinical	2016-09-20	Absent	PTGER3
Inflammation	ENSG00000051382	FALSE	Preclinical	2007-12-18	Unused	PIK3CB
Inflammation	ENSG00000057593	FALSE	Preclinical	1995-10-15	Unused	F7
Inflammation	ENSG00000059377	TRUE	Approved	1990-07-15	Approved	TBXAS1
Inflammation	ENSG00000063176	FALSE	Preclinical	2006-06-05	Preclinical	SPHK2
Inflammation	ENSG00000064989	FALSE	Preclinical	1997-09-15	Unused	CALCRL
Inflammation	ENSG00000065675	FALSE	Preclinical	2007-07-20	Unused	PRKCQ
Inflammation	ENSG00000065989	TRUE	Approved	1993-07-15	Approved	PDE4A
Inflammation	ENSG00000067182	FALSE	Preclinical	2003-08-27	Unused	TNFRSF1A
Inflammation	ENSG00000067900	FALSE	Preclinical	2006-02-14	Unused	ROCK1
Inflammation	ENSG00000069764	FALSE	Preclinical	2014-10-24	Absent	PLA2G10
Inflammation	ENSG00000071054	FALSE	Preclinical	2014-05-26	Absent	MAP4K4
Inflammation	ENSG00000072062	FALSE	Preclinical	1997-12-15	Unused	PRKACA
Inflammation	ENSG00000073756	TRUE	Approved	1989-05-15	Approved	PTGS2
Inflammation	ENSG00000074416	FALSE	Preclinical	2017-12-21	Absent	MGLL
Inflammation	ENSG00000074603	FALSE	Preclinical	2005-08-05	Unused	DPP8
Inflammation	ENSG00000074966	FALSE	Preclinical	2015-01-28	Absent	TXK
Inflammation	ENSG00000075073	FALSE	Preclinical	1995-02-15	Unused	TACR2
Inflammation	ENSG00000075213	FALSE	Preclinical	2011-09-26	Preclinical	SEMA3A
Inflammation	ENSG00000076706	FALSE	unknown	2013-01-11	Preclinical	MCAM
Inflammation	ENSG00000076984	FALSE	Preclinical	2004-02-02	Unused	MAP2K7
Inflammation	ENSG00000078098	FALSE	Preclinical	2008-06-23	Preclinical	FAP
Inflammation	ENSG00000078549	FALSE	Preclinical	2008-08-21	Unused	ADCYAP1R1
Inflammation	ENSG00000079277	FALSE	Preclinical	2013-09-17	Absent	MKNK1
Inflammation	ENSG00000079337	FALSE	Preclinical	2002-08-01	Unused	RAPGEF3
Inflammation	ENSG00000080824	FALSE	Preclinical	2011-06-09	Unused	HSP90AA1
Inflammation	ENSG00000082556	FALSE	Preclinical	1997-01-15	Unused	OPRK1
Inflammation	ENSG00000082701	FALSE	Preclinical	2000-08-04	Unused	GSK3B
Inflammation	ENSG00000084207	FALSE	Preclinical	2002-04-29	Unused	GSTP1
Inflammation	ENSG00000085662	FALSE	Preclinical	NA	Unused	AKR1B1
Inflammation	ENSG00000086991	FALSE	Preclinical	2015-03-25	Absent	NOX4
Inflammation	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Inflammation	ENSG00000088832	FALSE	Preclinical	2015-11-11	Absent	FKBP1A
Inflammation	ENSG00000089041	FALSE	Phase I Clinical Trial	2005-12-28	Phase I Clinical Trial	P2RX7
Inflammation	ENSG00000089250	FALSE	Preclinical	1996-08-15	Unused	NOS1
Inflammation	ENSG00000089692	FALSE	Preclinical	2015-04-10	Absent	LAG3
Inflammation	ENSG00000090339	FALSE	Preclinical	1990-07-15	Unused	ICAM1
Inflammation	ENSG00000090382	FALSE	Preclinical	NA	Unused	LYZ
Inflammation	ENSG00000090659	FALSE	Preclinical	2001-11-06	Unused	CD209
Inflammation	ENSG00000090863	FALSE	Preclinical	1997-06-15	Unused	GLG1
Inflammation	ENSG00000091831	FALSE	Preclinical	1991-02-15	Unused	ESR1
Inflammation	ENSG00000091879	FALSE	Preclinical	2014-03-01	Absent	ANGPT2
Inflammation	ENSG00000092009	FALSE	Preclinical	2002-04-10	Unused	CMA1
Inflammation	ENSG00000094631	FALSE	Preclinical	2009-10-10	Unused	HDAC6
Inflammation	ENSG00000095015	FALSE	Preclinical	2010-06-29	Unused	MAP3K1
Inflammation	ENSG00000095303	TRUE	Approved	1989-05-15	Approved	PTGS1
Inflammation	ENSG00000095970	FALSE	Preclinical	2008-07-04	Unused	TREM2
Inflammation	ENSG00000096717	FALSE	Preclinical	2008-10-21	Unused	SIRT1
Inflammation	ENSG00000096968	FALSE	Preclinical	2007-04-16	Phase I Clinical Trial	JAK2
Inflammation	ENSG00000099866	FALSE	Preclinical	1991-09-15	Unused	MADCAM1
Inflammation	ENSG00000100079	FALSE	Preclinical	2006-02-28	Unused	LGALS2
Inflammation	ENSG00000100385	FALSE	Preclinical	2016-09-02	Absent	IL2RB
Inflammation	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Inflammation	ENSG00000100739	FALSE	Preclinical	1993-03-15	Unused	BDKRB1
Inflammation	ENSG00000100985	FALSE	Preclinical	1995-12-15	Unused	MMP9
Inflammation	ENSG00000101017	FALSE	Preclinical	1997-01-15	Unused	CD40
Inflammation	ENSG00000101180	FALSE	Preclinical	1995-12-15	Unused	HRH3
Inflammation	ENSG00000101266	FALSE	Preclinical	2009-09-12	Preclinical	CSNK2A1
Inflammation	ENSG00000101327	FALSE	Preclinical	NA	Unused	PDYN
Inflammation	ENSG00000101425	FALSE	Preclinical	1995-02-15	Unused	BPI
Inflammation	ENSG00000101444	FALSE	unknown	NA	Unused	AHCY
Inflammation	ENSG00000101916	FALSE	Preclinical	2009-06-22	Unused	TLR8
Inflammation	ENSG00000101966	FALSE	Preclinical	2017-02-14	Absent	XIAP
Inflammation	ENSG00000102096	FALSE	Preclinical	2008-09-23	Unused	PIM2
Inflammation	ENSG00000102245	FALSE	Preclinical	2013-09-17	Absent	CD40LG
Inflammation	ENSG00000102854	FALSE	Phase I Clinical Trial	2010-04-30	Absent	MSLN
Inflammation	ENSG00000102967	FALSE	Preclinical	2013-01-18	Preclinical	DHODH
Inflammation	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Inflammation	ENSG00000103546	FALSE	Phase III Clinical Trial	2002-03-04	Phase III Clinical Trial	SLC6A2
Inflammation	ENSG00000104312	FALSE	Preclinical	2014-10-18	Absent	RIPK2
Inflammation	ENSG00000104321	FALSE	Preclinical	2009-01-28	Unused	TRPA1
Inflammation	ENSG00000104365	FALSE	Preclinical	2006-11-02	Unused	IKBKB
Inflammation	ENSG00000104368	FALSE	Preclinical	2000-09-21	Unused	PLAT
Inflammation	ENSG00000104763	FALSE	Preclinical	2011-09-02	Unused	ASAH1
Inflammation	ENSG00000104885	FALSE	Preclinical	2010-12-03	Preclinical	DOT1L
Inflammation	ENSG00000104921	FALSE	Preclinical	1996-07-15	Unused	FCER2
Inflammation	ENSG00000104938	FALSE	Preclinical	2001-11-06	Unused	CLEC4M
Inflammation	ENSG00000105397	FALSE	Preclinical	2007-10-02	Preclinical	TYK2
Inflammation	ENSG00000105639	FALSE	Preclinical	2008-11-05	Unused	JAK3
Inflammation	ENSG00000105650	TRUE	Approved	1993-07-15	Approved	PDE4C
Inflammation	ENSG00000105851	FALSE	Preclinical	2005-06-10	Unused	PIK3CG
Inflammation	ENSG00000105976	FALSE	Preclinical	2017-07-19	Absent	MET
Inflammation	ENSG00000106113	FALSE	Preclinical	2003-10-29	Unused	CRHR2
Inflammation	ENSG00000106366	FALSE	Preclinical	2000-09-21	Unused	SERPINE1
Inflammation	ENSG00000106538	FALSE	Preclinical	2005-06-20	Unused	RARRES2
Inflammation	ENSG00000106804	FALSE	Preclinical	2006-10-04	Unused	C5
Inflammation	ENSG00000106952	FALSE	Preclinical	2001-05-30	Unused	TNFSF8
Inflammation	ENSG00000107317	FALSE	Preclinical	2012-08-21	Preclinical	PTGDS
Inflammation	ENSG00000107562	FALSE	Preclinical	2013-07-12	Absent	CXCL12
Inflammation	ENSG00000107738	FALSE	Preclinical	2015-04-10	Absent	VSIR
Inflammation	ENSG00000107968	FALSE	Preclinical	2016-09-15	Absent	MAP3K8
Inflammation	ENSG00000108342	FALSE	Phase I Clinical Trial	2010-12-17	Preclinical	CSF3
Inflammation	ENSG00000108576	FALSE	Phase III Clinical Trial	2002-03-04	Phase III Clinical Trial	SLC6A4
Inflammation	ENSG00000108839	FALSE	Preclinical	1989-10-15	Unused	ALOX12
Inflammation	ENSG00000108984	FALSE	Preclinical	2004-02-05	Unused	MAP2K6
Inflammation	ENSG00000109320	FALSE	Preclinical	1994-06-15	Unused	NFKB1
Inflammation	ENSG00000109339	FALSE	Preclinical	2014-10-18	Absent	MAPK10
Inflammation	ENSG00000109471	FALSE	Phase II Clinical Trial	2017-08-24	Absent	IL2
Inflammation	ENSG00000109610	FALSE	Preclinical	NA	Unused	SOD3
Inflammation	ENSG00000109861	FALSE	Preclinical	2012-10-27	Preclinical	CTSC
Inflammation	ENSG00000109991	FALSE	Preclinical	2016-10-14	Absent	P2RX3
Inflammation	ENSG00000110195	FALSE	Phase III Clinical Trial	2007-05-30	Unused	FOLR1
Inflammation	ENSG00000110324	FALSE	Phase III Clinical Trial	1990-09-15	Unused	IL10RA
Inflammation	ENSG00000110429	FALSE	Preclinical	2017-09-27	Absent	FBXO3
Inflammation	ENSG00000110492	FALSE	Preclinical	2009-05-19	Preclinical	MDK
Inflammation	ENSG00000110680	FALSE	Preclinical	2013-12-31	Absent	CALCA
Inflammation	ENSG00000110719	FALSE	Preclinical	2007-07-03	Unused	TCIRG1
Inflammation	ENSG00000110876	FALSE	Preclinical	2007-02-26	Absent	SELPLG
Inflammation	ENSG00000110944	FALSE	Preclinical	2009-04-17	Unused	IL23A
Inflammation	ENSG00000111144	FALSE	Preclinical	1998-07-15	Unused	LTA4H
Inflammation	ENSG00000111319	FALSE	Preclinical	NA	Unused	SCNN1A
Inflammation	ENSG00000111424	FALSE	Preclinical	1996-06-15	Unused	VDR
Inflammation	ENSG00000111537	FALSE	unknown	2004-02-24	Preclinical	IFNG
Inflammation	ENSG00000112033	FALSE	Preclinical	2007-10-17	Unused	PPARD
Inflammation	ENSG00000112038	TRUE	Approved	1997-03-15	Approved	OPRM1
Inflammation	ENSG00000112062	FALSE	Phase I Clinical Trial	1999-06-30	Unused	MAPK14
Inflammation	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Inflammation	ENSG00000112115	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	IL17A
Inflammation	ENSG00000112116	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	IL17F
Inflammation	ENSG00000112486	FALSE	Preclinical	1999-09-01	Unused	CCR6
Inflammation	ENSG00000112679	FALSE	Preclinical	2000-09-04	Unused	DUSP22
Inflammation	ENSG00000112715	FALSE	Preclinical	2013-09-05	Absent	VEGFA
Inflammation	ENSG00000113070	FALSE	Preclinical	2006-02-21	Unused	HBEGF
Inflammation	ENSG00000113263	FALSE	Preclinical	2014-10-08	Absent	ITK
Inflammation	ENSG00000113302	FALSE	Preclinical	1998-11-15	Unused	IL12B
Inflammation	ENSG00000113448	TRUE	Approved	1993-07-15	Approved	PDE4D
Inflammation	ENSG00000113525	FALSE	Preclinical	1993-03-15	Unused	IL5
Inflammation	ENSG00000113580	TRUE	Approved	1989-12-15	Approved	NR3C1
Inflammation	ENSG00000113749	FALSE	Preclinical	1996-08-15	Unused	HRH2
Inflammation	ENSG00000114378	FALSE	Preclinical	2004-08-27	Unused	HYAL1
Inflammation	ENSG00000115085	FALSE	Preclinical	1999-01-15	Unused	ZAP70
Inflammation	ENSG00000115232	FALSE	Preclinical	1992-01-15	Unused	ITGA4
Inflammation	ENSG00000115263	FALSE	Preclinical	1997-10-15	Unused	GCG
Inflammation	ENSG00000115353	FALSE	Preclinical	1991-04-15	Unused	TACR1
Inflammation	ENSG00000115590	FALSE	Preclinical	1998-07-15	Unused	IL1R2
Inflammation	ENSG00000115594	FALSE	Preclinical	1999-08-17	Unused	IL1R1
Inflammation	ENSG00000115604	FALSE	Preclinical	2000-01-11	Unused	IL18R1
Inflammation	ENSG00000116044	FALSE	Phase III Clinical Trial	2004-11-18	Unused	NFE2L2
Inflammation	ENSG00000116096	FALSE	Preclinical	2014-01-11	Absent	SPR
Inflammation	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Inflammation	ENSG00000116478	FALSE	Preclinical	2006-12-20	Unused	HDAC1
Inflammation	ENSG00000116678	FALSE	Preclinical	1996-12-15	Unused	LEPR
Inflammation	ENSG00000116711	FALSE	Preclinical	1995-06-15	Unused	PLA2G4A
Inflammation	ENSG00000117480	FALSE	unknown	2009-01-16	Unused	FAAH
Inflammation	ENSG00000117560	FALSE	Preclinical	1998-07-15	Unused	FASLG
Inflammation	ENSG00000117586	FALSE	Preclinical	2014-01-31	Absent	TNFSF4
Inflammation	ENSG00000118137	FALSE	Preclinical	2003-10-13	Unused	APOA1
Inflammation	ENSG00000118432	FALSE	Preclinical	2006-09-10	Unused	CNR1
Inflammation	ENSG00000118702	FALSE	unknown	2011-11-18	Preclinical	GHRH
Inflammation	ENSG00000119535	FALSE	Preclinical	1996-12-15	Unused	CSF3R
Inflammation	ENSG00000119888	FALSE	Preclinical	2017-07-19	Absent	EPCAM
Inflammation	ENSG00000120217	FALSE	Preclinical	2013-12-30	Absent	CD274
Inflammation	ENSG00000120915	FALSE	Preclinical	2016-10-26	Absent	EPHX2
Inflammation	ENSG00000121653	FALSE	Phase III Clinical Trial	2003-08-26	Unused	MAPK8IP1
Inflammation	ENSG00000121691	FALSE	Preclinical	1989-12-15	Unused	CAT
Inflammation	ENSG00000121807	FALSE	Preclinical	1997-01-15	Unused	CCR2
Inflammation	ENSG00000121879	FALSE	Preclinical	2006-10-12	Unused	PIK3CA
Inflammation	ENSG00000121966	FALSE	Preclinical	1997-07-15	Unused	CXCR4
Inflammation	ENSG00000122025	FALSE	unknown	1996-01-15	Unused	FLT3
Inflammation	ENSG00000123146	FALSE	Preclinical	1998-03-15	Unused	ADGRE5
Inflammation	ENSG00000123610	FALSE	Preclinical	1997-05-15	Unused	TNFAIP6
Inflammation	ENSG00000124089	FALSE	Preclinical	2009-11-04	Unused	MC3R
Inflammation	ENSG00000125384	FALSE	Preclinical	1992-01-15	Unused	PTGER2
Inflammation	ENSG00000125450	FALSE	Preclinical	2008-08-18	Unused	NUP85
Inflammation	ENSG00000125538	FALSE	Phase II Clinical Trial	2012-07-12	Preclinical	IL1B
Inflammation	ENSG00000125726	FALSE	unknown	2011-05-17	Preclinical	CD70
Inflammation	ENSG00000125730	FALSE	Preclinical	NA	Absent	C3
Inflammation	ENSG00000126218	FALSE	Preclinical	1994-04-15	Unused	F10
Inflammation	ENSG00000126262	FALSE	Preclinical	2009-06-29	Absent	FFAR2
Inflammation	ENSG00000126353	FALSE	Preclinical	1999-09-01	Unused	CCR7
Inflammation	ENSG00000126934	FALSE	Preclinical	2007-01-30	Preclinical	MAP2K2
Inflammation	ENSG00000127533	FALSE	Preclinical	2004-03-15	Unused	F2RL3
Inflammation	ENSG00000127837	FALSE	Preclinical	1996-06-15	Unused	AAMP
Inflammation	ENSG00000128052	FALSE	Preclinical	1998-12-15	Unused	KDR
Inflammation	ENSG00000128271	FALSE	Preclinical	2016-07-29	Absent	ADORA2A
Inflammation	ENSG00000130234	FALSE	unknown	2007-07-13	Unused	ACE2
Inflammation	ENSG00000131196	FALSE	Preclinical	2001-11-13	Unused	NFATC1
Inflammation	ENSG00000131408	FALSE	unknown	2001-07-09	Absent	NR1H2
Inflammation	ENSG00000131471	FALSE	Preclinical	2000-08-17	Unused	AOC3
Inflammation	ENSG00000131981	FALSE	Preclinical	2004-11-22	Unused	LGALS3
Inflammation	ENSG00000132155	FALSE	Preclinical	2009-06-29	Unused	RAF1
Inflammation	ENSG00000132170	FALSE	Preclinical	2002-06-28	Unused	PPARG
Inflammation	ENSG00000132329	FALSE	Preclinical	1997-09-15	Unused	RAMP1
Inflammation	ENSG00000132693	FALSE	Preclinical	2003-02-12	Unused	CRP
Inflammation	ENSG00000132965	FALSE	Preclinical	2014-04-15	Absent	ALOX5AP
Inflammation	ENSG00000133105	FALSE	Preclinical	2008-05-20	Unused	RXFP2
Inflammation	ENSG00000134058	FALSE	Preclinical	2015-06-04	Absent	CDK7
Inflammation	ENSG00000134318	FALSE	Preclinical	2007-09-04	Unused	ROCK2
Inflammation	ENSG00000134460	FALSE	Preclinical	NA	Unused	IL2RA
Inflammation	ENSG00000134470	FALSE	Preclinical	2009-06-11	Unused	IL15RA
Inflammation	ENSG00000134489	FALSE	Preclinical	2009-01-22	Unused	HRH4
Inflammation	ENSG00000134853	FALSE	Preclinical	1998-12-15	Unused	PDGFRA
Inflammation	ENSG00000135077	FALSE	Preclinical	2005-07-01	Absent	HAVCR2
Inflammation	ENSG00000135218	FALSE	Preclinical	1995-03-15	Unused	CD36
Inflammation	ENSG00000135341	FALSE	Preclinical	2013-10-05	Absent	MAP3K7
Inflammation	ENSG00000135655	FALSE	Preclinical	2017-01-17	Absent	USP15
Inflammation	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Inflammation	ENSG00000135919	FALSE	Preclinical	NA	Unused	SERPINE2
Inflammation	ENSG00000136244	FALSE	Preclinical	2007-08-09	Unused	IL6
Inflammation	ENSG00000136689	FALSE	Preclinical	1991-11-15	Unused	IL1RN
Inflammation	ENSG00000136810	FALSE	Preclinical	2016-11-09	Absent	TXN
Inflammation	ENSG00000136869	FALSE	Phase I Clinical Trial	2009-06-04	Phase I Clinical Trial	TLR4
Inflammation	ENSG00000137275	FALSE	Preclinical	2015-06-03	Absent	RIPK1
Inflammation	ENSG00000137752	FALSE	Preclinical	1993-12-15	Unused	CASP1
Inflammation	ENSG00000137764	FALSE	Preclinical	2004-02-02	Unused	MAP2K5
Inflammation	ENSG00000138363	FALSE	Preclinical	NA	Unused	ATIC
Inflammation	ENSG00000138792	FALSE	Preclinical	1991-02-15	Unused	ENPEP
Inflammation	ENSG00000139626	FALSE	Preclinical	2008-08-08	Unused	ITGB7
Inflammation	ENSG00000140009	FALSE	Preclinical	2012-06-15	Unused	ESR2
Inflammation	ENSG00000140443	FALSE	Preclinical	2017-07-19	Absent	IGF1R
Inflammation	ENSG00000140678	FALSE	Preclinical	1996-07-15	Unused	ITGAX
Inflammation	ENSG00000140992	FALSE	Preclinical	NA	Absent	PDPK1
Inflammation	ENSG00000141510	FALSE	Preclinical	2001-03-12	Unused	TP53
Inflammation	ENSG00000141736	FALSE	Preclinical	2017-07-19	Absent	ERBB2
Inflammation	ENSG00000141867	FALSE	Preclinical	2013-10-01	Absent	BRD4
Inflammation	ENSG00000142002	FALSE	Preclinical	2005-08-05	Unused	DPP9
Inflammation	ENSG00000142168	FALSE	Phase I Clinical Trial	2005-08-18	Unused	SOD1
Inflammation	ENSG00000142677	FALSE	Preclinical	2012-12-07	Absent	IL22RA1
Inflammation	ENSG00000143171	FALSE	Phase I Clinical Trial	2008-07-10	Preclinical	RXRG
Inflammation	ENSG00000143226	FALSE	Preclinical	2009-11-11	Unused	FCGR2A
Inflammation	ENSG00000143365	FALSE	Phase I Clinical Trial	2013-05-30	Absent	RORC
Inflammation	ENSG00000143799	FALSE	Preclinical	2001-05-18	Unused	PARP1
Inflammation	ENSG00000144381	FALSE	Preclinical	2015-09-01	Absent	HSPD1
Inflammation	ENSG00000144481	FALSE	Preclinical	2009-10-29	Preclinical	TRPM8
Inflammation	ENSG00000146070	FALSE	Preclinical	1997-08-15	Unused	PLA2G7
Inflammation	ENSG00000146648	FALSE	Preclinical	1998-12-15	Unused	EGFR
Inflammation	ENSG00000147955	FALSE	Preclinical	1994-08-15	Unused	SIGMAR1
Inflammation	ENSG00000148344	FALSE	Phase II Clinical Trial	2005-01-24	Unused	PTGES
Inflammation	ENSG00000148408	FALSE	Preclinical	2004-08-16	Unused	CACNA1B
Inflammation	ENSG00000149021	FALSE	Preclinical	NA	Unused	SCGB1A1
Inflammation	ENSG00000149131	FALSE	Preclinical	2013-11-01	Absent	SERPING1
Inflammation	ENSG00000149295	FALSE	Preclinical	1991-09-15	Unused	DRD2
Inflammation	ENSG00000149418	FALSE	Preclinical	2006-08-09	Absent	ST14
Inflammation	ENSG00000149485	FALSE	Preclinical	2016-10-18	Absent	FADS1
Inflammation	ENSG00000149968	FALSE	Preclinical	1997-09-15	Unused	MMP3
Inflammation	ENSG00000150093	FALSE	Preclinical	1992-01-15	Unused	ITGB1
Inflammation	ENSG00000150782	FALSE	Preclinical	2016-09-02	Absent	IL18
Inflammation	ENSG00000151067	FALSE	Preclinical	2009-01-06	Unused	CACNA1C
Inflammation	ENSG00000151617	FALSE	Preclinical	1991-12-15	Unused	EDNRA
Inflammation	ENSG00000151694	FALSE	Preclinical	1997-09-15	Unused	ADAM17
Inflammation	ENSG00000153208	FALSE	Preclinical	2016-08-01	Absent	MERTK
Inflammation	ENSG00000153253	FALSE	Preclinical	2011-07-19	Preclinical	SCN3A
Inflammation	ENSG00000154188	FALSE	Preclinical	2014-03-01	Absent	ANGPT1
Inflammation	ENSG00000154229	FALSE	Preclinical	1991-04-15	Unused	PRKCA
Inflammation	ENSG00000156110	FALSE	Preclinical	2003-11-12	Unused	ADK
Inflammation	ENSG00000156234	FALSE	Preclinical	2006-06-20	Preclinical	CXCL13
Inflammation	ENSG00000156738	FALSE	Pre-registration	2005-05-16	Unused	MS4A1
Inflammation	ENSG00000156886	FALSE	Preclinical	1997-06-15	Unused	ITGAD
Inflammation	ENSG00000157404	FALSE	unknown	2008-11-07	Unused	KIT
Inflammation	ENSG00000158125	FALSE	Preclinical	2002-07-03	Absent	XDH
Inflammation	ENSG00000158473	FALSE	Preclinical	2015-05-20	Absent	CD1D
Inflammation	ENSG00000159110	FALSE	Preclinical	2000-09-20	Unused	IFNAR2
Inflammation	ENSG00000159339	FALSE	Preclinical	2015-10-07	Absent	PADI4
Inflammation	ENSG00000160113	FALSE	Preclinical	2016-06-16	Absent	NR2F6
Inflammation	ENSG00000160223	FALSE	Preclinical	2017-04-25	Absent	ICOSLG
Inflammation	ENSG00000160255	FALSE	Preclinical	1991-03-15	Unused	ITGB2
Inflammation	ENSG00000160683	FALSE	Preclinical	2014-04-10	Absent	CXCR5
Inflammation	ENSG00000160712	TRUE	Approved	1993-06-15	Unused	IL6R
Inflammation	ENSG00000160791	FALSE	Preclinical	1997-07-15	Phase I Clinical Trial	CCR5
Inflammation	ENSG00000161638	FALSE	Preclinical	2007-06-04	Unused	ITGA5
Inflammation	ENSG00000161649	FALSE	Preclinical	2008-07-04	Unused	CD300LG
Inflammation	ENSG00000161905	FALSE	Preclinical	2005-05-09	Unused	ALOX15
Inflammation	ENSG00000161921	FALSE	Preclinical	2009-02-16	Unused	CXCL16
Inflammation	ENSG00000162434	FALSE	Preclinical	2012-03-15	Absent	JAK1
Inflammation	ENSG00000162692	FALSE	Preclinical	1996-12-15	Unused	VCAM1
Inflammation	ENSG00000162711	FALSE	Preclinical	2013-03-28	Absent	NLRP3
Inflammation	ENSG00000162733	FALSE	Preclinical	2009-06-25	Unused	DDR2
Inflammation	ENSG00000162889	FALSE	Phase I Clinical Trial	2004-08-16	Unused	MAPKAPK2
Inflammation	ENSG00000162892	FALSE	Preclinical	2008-01-18	Preclinical	IL24
Inflammation	ENSG00000163106	FALSE	Preclinical	2011-04-02	Unused	HPGDS
Inflammation	ENSG00000163235	FALSE	Preclinical	2013-05-14	Absent	TGFA
Inflammation	ENSG00000163283	FALSE	Preclinical	2015-07-08	Absent	ALPP
Inflammation	ENSG00000163464	FALSE	Preclinical	2007-07-04	Unused	CXCR1
Inflammation	ENSG00000163823	FALSE	Preclinical	1997-04-15	Unused	CCR1
Inflammation	ENSG00000164111	FALSE	Phase II Clinical Trial	2010-05-11	Absent	ANXA5
Inflammation	ENSG00000164171	FALSE	Preclinical	2001-07-23	Unused	ITGA2
Inflammation	ENSG00000164251	FALSE	Preclinical	2002-06-17	Unused	F2RL1
Inflammation	ENSG00000164342	FALSE	Preclinical	2008-01-04	Unused	TLR3
Inflammation	ENSG00000164733	FALSE	Preclinical	NA	Unused	CTSB
Inflammation	ENSG00000164867	FALSE	Preclinical	1996-08-15	Unused	NOS3
Inflammation	ENSG00000165025	FALSE	Preclinical	1998-01-15	Unused	SYK
Inflammation	ENSG00000165168	FALSE	Preclinical	2012-11-13	Absent	CYBB
Inflammation	ENSG00000165471	FALSE	Preclinical	2004-01-06	Unused	MBL2
Inflammation	ENSG00000166311	FALSE	Preclinical	2004-03-15	Unused	SMPD1
Inflammation	ENSG00000166333	FALSE	Preclinical	2000-03-15	Unused	ILK
Inflammation	ENSG00000166598	FALSE	Preclinical	2008-04-03	Preclinical	HSP90B1
Inflammation	ENSG00000166825	FALSE	Preclinical	2007-05-21	Unused	ANPEP
Inflammation	ENSG00000166888	FALSE	Preclinical	2016-11-17	Absent	STAT6
Inflammation	ENSG00000167723	FALSE	Preclinical	2016-09-08	Absent	TRPV3
Inflammation	ENSG00000167748	FALSE	Preclinical	2009-07-22	Unused	KLK1
Inflammation	ENSG00000168398	FALSE	Preclinical	1993-03-15	Unused	BDKRB2
Inflammation	ENSG00000168522	FALSE	Preclinical	2010-12-23	Unused	FNTA
Inflammation	ENSG00000168610	FALSE	Preclinical	2003-02-11	Unused	STAT3
Inflammation	ENSG00000168811	FALSE	Preclinical	1998-11-15	Unused	IL12A
Inflammation	ENSG00000168918	FALSE	Preclinical	2008-10-28	Unused	INPP5D
Inflammation	ENSG00000169032	FALSE	Preclinical	2007-01-30	Unused	MAP2K1
Inflammation	ENSG00000169083	FALSE	Preclinical	NA	Unused	AR
Inflammation	ENSG00000169252	FALSE	Preclinical	NA	Unused	ADRB2
Inflammation	ENSG00000169403	TRUE	Approved	1990-03-15	Approved	PTAFR
Inflammation	ENSG00000169429	FALSE	Preclinical	2013-05-14	Absent	CXCL8
Inflammation	ENSG00000169432	FALSE	Preclinical	2011-07-19	Preclinical	SCN9A
Inflammation	ENSG00000169836	FALSE	Preclinical	1994-11-15	Unused	TACR3
Inflammation	ENSG00000169896	FALSE	Preclinical	1991-03-15	Unused	ITGAM
Inflammation	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Inflammation	ENSG00000170525	FALSE	Preclinical	2011-07-28	Unused	PFKFB3
Inflammation	ENSG00000170820	FALSE	unknown	2012-09-18	Preclinical	FSHR
Inflammation	ENSG00000170890	FALSE	Preclinical	NA	Unused	PLA2G1B
Inflammation	ENSG00000170989	FALSE	Preclinical	2011-04-01	Unused	S1PR1
Inflammation	ENSG00000171049	FALSE	Phase I Clinical Trial	2006-06-12	Unused	FPR2
Inflammation	ENSG00000171509	FALSE	Preclinical	2008-05-20	Unused	RXFP1
Inflammation	ENSG00000171522	FALSE	Phase I Clinical Trial	2001-12-03	Phase I Clinical Trial	PTGER4
Inflammation	ENSG00000171608	FALSE	Preclinical	2006-12-20	Unused	PIK3CD
Inflammation	ENSG00000171791	FALSE	Preclinical	2008-04-02	Absent	BCL2
Inflammation	ENSG00000172175	FALSE	Preclinical	NA	Absent	MALT1
Inflammation	ENSG00000172236	FALSE	Preclinical	2001-09-27	Unused	TPSAB1
Inflammation	ENSG00000172243	FALSE	Preclinical	NA	Unused	CLEC7A
Inflammation	ENSG00000172349	FALSE	Preclinical	2015-08-06	Absent	IL16
Inflammation	ENSG00000172482	FALSE	Preclinical	2006-11-13	Unused	AGXT
Inflammation	ENSG00000172572	FALSE	Preclinical	1990-10-15	Unused	PDE3A
Inflammation	ENSG00000172819	FALSE	Preclinical	2015-07-01	Absent	RARG
Inflammation	ENSG00000172936	FALSE	Preclinical	2001-07-18	Unused	MYD88
Inflammation	ENSG00000173083	FALSE	Preclinical	1999-09-02	Unused	HPSE
Inflammation	ENSG00000173198	FALSE	Preclinical	1993-10-15	Unused	CYSLTR1
Inflammation	ENSG00000173250	FALSE	Preclinical	2017-07-06	Absent	GPR151
Inflammation	ENSG00000173585	FALSE	Phase I Clinical Trial	2008-02-11	Unused	CCR9
Inflammation	ENSG00000174059	FALSE	Preclinical	2015-06-10	Absent	CD34
Inflammation	ENSG00000174080	FALSE	Preclinical	2001-03-05	Unused	CTSF
Inflammation	ENSG00000174175	FALSE	Preclinical	1994-08-15	Unused	SELP
Inflammation	ENSG00000175104	FALSE	Preclinical	2001-07-18	Unused	TRAF6
Inflammation	ENSG00000175344	FALSE	Preclinical	1997-10-15	Unused	CHRNA7
Inflammation	ENSG00000177272	FALSE	Preclinical	2005-06-17	Unused	KCNA3
Inflammation	ENSG00000177301	FALSE	Preclinical	2007-09-07	Unused	KCNA2
Inflammation	ENSG00000177464	FALSE	Preclinical	2017-06-07	Absent	GPR4
Inflammation	ENSG00000177606	FALSE	Preclinical	1994-06-15	Unused	JUN
Inflammation	ENSG00000177663	FALSE	Preclinical	2016-05-04	Absent	IL17RA
Inflammation	ENSG00000178562	FALSE	Preclinical	2017-04-25	Absent	CD28
Inflammation	ENSG00000178726	FALSE	Preclinical	1991-12-15	Unused	THBD
Inflammation	ENSG00000178789	FALSE	Preclinical	2008-07-04	Unused	CD300LB
Inflammation	ENSG00000179776	FALSE	Preclinical	2013-11-07	Absent	CDH5
Inflammation	ENSG00000179934	FALSE	Preclinical	2004-01-09	Unused	CCR8
Inflammation	ENSG00000180210	FALSE	Preclinical	1995-10-15	Unused	F2
Inflammation	ENSG00000180871	FALSE	Phase I Clinical Trial	1997-11-15	Unused	CXCR2
Inflammation	ENSG00000181847	FALSE	Preclinical	NA	Absent	TIGIT
Inflammation	ENSG00000181856	FALSE	Preclinical	2015-07-25	Absent	SLC2A4
Inflammation	ENSG00000182578	FALSE	Preclinical	2006-11-24	Unused	CSF1R
Inflammation	ENSG00000182866	FALSE	Preclinical	2004-02-02	Unused	LCK
Inflammation	ENSG00000183134	FALSE	Phase I Clinical Trial	2004-03-11	Unused	PTGDR2
Inflammation	ENSG00000183625	FALSE	Preclinical	1999-09-01	Unused	CCR3
Inflammation	ENSG00000183735	FALSE	Preclinical	2017-06-02	Absent	TBK1
Inflammation	ENSG00000183813	FALSE	Preclinical	2009-06-10	Absent	CCR4
Inflammation	ENSG00000183873	FALSE	Preclinical	2009-09-15	Unused	SCN5A
Inflammation	ENSG00000184216	FALSE	Preclinical	1997-07-15	Unused	IRAK1
Inflammation	ENSG00000184557	FALSE	Preclinical	2015-11-17	Absent	SOCS3
Inflammation	ENSG00000184584	FALSE	Preclinical	2016-02-11	Absent	TMEM173
Inflammation	ENSG00000184588	TRUE	Approved	1993-07-15	Approved	PDE4B
Inflammation	ENSG00000185313	FALSE	Preclinical	2012-11-19	Preclinical	SCN10A
Inflammation	ENSG00000185338	FALSE	Preclinical	2012-10-16	Preclinical	SOCS1
Inflammation	ENSG00000185386	FALSE	Preclinical	2004-02-02	Unused	MAPK11
Inflammation	ENSG00000186431	FALSE	Preclinical	2008-11-03	Preclinical	FCAR
Inflammation	ENSG00000186810	FALSE	Preclinical	2004-02-09	Unused	CXCR3
Inflammation	ENSG00000186827	FALSE	Preclinical	2015-04-10	Absent	TNFRSF4
Inflammation	ENSG00000186951	FALSE	Preclinical	2007-10-17	Unused	PPARA
Inflammation	ENSG00000187210	FALSE	Preclinical	2004-05-05	Unused	GCNT1
Inflammation	ENSG00000187266	FALSE	Preclinical	1996-12-15	Unused	EPOR
Inflammation	ENSG00000188257	FALSE	Preclinical	1991-02-15	Unused	PLA2G2A
Inflammation	ENSG00000188389	FALSE	Preclinical	2014-04-30	Absent	PDCD1
Inflammation	ENSG00000188404	FALSE	Preclinical	1994-08-15	Unused	SELL
Inflammation	ENSG00000188778	FALSE	Preclinical	1996-03-15	Unused	ADRB3
Inflammation	ENSG00000188822	FALSE	Preclinical	1997-12-15	Unused	CNR2
Inflammation	ENSG00000188906	FALSE	Preclinical	2016-11-10	Absent	LRRK2
Inflammation	ENSG00000189403	FALSE	Preclinical	2010-07-05	Unused	HMGB1
Inflammation	ENSG00000189430	FALSE	Preclinical	2013-01-21	Preclinical	NCR1
Inflammation	ENSG00000196083	FALSE	Preclinical	2016-09-02	Absent	IL1RAP
Inflammation	ENSG00000196154	FALSE	Preclinical	NA	Preclinical	S100A4
Inflammation	ENSG00000196262	FALSE	Preclinical	NA	Absent	PPIA
Inflammation	ENSG00000196549	FALSE	Preclinical	1993-07-15	Unused	MME
Inflammation	ENSG00000196591	FALSE	Preclinical	2006-12-20	Unused	HDAC2
Inflammation	ENSG00000196611	FALSE	Preclinical	1998-10-15	Unused	MMP1
Inflammation	ENSG00000196639	FALSE	Preclinical	1994-12-15	Unused	HRH1
Inflammation	ENSG00000196664	FALSE	Preclinical	2008-12-18	Unused	TLR7
Inflammation	ENSG00000196689	FALSE	Preclinical	2011-07-19	Unused	TRPV1
Inflammation	ENSG00000196839	FALSE	Preclinical	2005-07-26	Unused	ADA
Inflammation	ENSG00000197249	FALSE	Preclinical	2002-07-23	Unused	SERPINA1
Inflammation	ENSG00000197405	FALSE	Phase I Clinical Trial	1991-01-15	Unused	C5AR1
Inflammation	ENSG00000197561	FALSE	Preclinical	1995-02-15	Unused	ELANE
Inflammation	ENSG00000197635	FALSE	Preclinical	2007-05-21	Unused	DPP4
Inflammation	ENSG00000197766	FALSE	Preclinical	2000-06-01	Unused	CFD
Inflammation	ENSG00000197891	FALSE	unknown	NA	Unused	SLC22A12
Inflammation	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Inflammation	ENSG00000198001	FALSE	Preclinical	2015-11-13	Absent	IRAK4
Inflammation	ENSG00000198223	FALSE	Preclinical	1994-07-15	Unused	CSF2RA
Inflammation	ENSG00000198400	FALSE	Preclinical	2016-03-31	Preclinical	NTRK1
Inflammation	ENSG00000198668	FALSE	unknown	NA	Unused	CALM1
Inflammation	ENSG00000198793	FALSE	Preclinical	1992-12-15	Unused	MTOR
Inflammation	ENSG00000198805	FALSE	Preclinical	1994-04-15	Unused	PNP
Inflammation	ENSG00000198900	FALSE	Preclinical	2011-05-24	Preclinical	TOP1
Inflammation	ENSG00000203710	FALSE	Preclinical	1994-06-15	Unused	CR1
Inflammation	ENSG00000205268	FALSE	Preclinical	2005-03-13	Unused	PDE7A
Inflammation	ENSG00000213694	FALSE	Preclinical	2012-05-31	Preclinical	S1PR3
Inflammation	ENSG00000213903	FALSE	Phase I Clinical Trial	1989-08-15	Unused	LTB4R
Inflammation	ENSG00000213949	FALSE	Preclinical	2006-03-27	Unused	ITGA1
Inflammation	ENSG00000228716	FALSE	Preclinical	2009-08-11	Unused	DHFR
Inflammation	ENSG00000239732	FALSE	Preclinical	2008-08-28	Unused	TLR9
Inflammation	ENSG00000240972	FALSE	Preclinical	1997-11-15	Unused	MIF
Inflammation	ENSG00000242252	FALSE	Preclinical	2016-07-12	Absent	BGLAP
Inflammation	ENSG00000257008	FALSE	Preclinical	2017-01-03	Absent	GPR142
Inflammation	ENSG00000258839	FALSE	Preclinical	1997-08-15	Unused	MC1R
Inflammation	ENSG00000259207	FALSE	Preclinical	1998-03-15	Unused	ITGB3
Inflammation	ENSG00000260314	FALSE	Phase I Clinical Trial	2004-08-18	Absent	MRC1
Inflammation	ENSG00000261371	FALSE	Preclinical	1996-03-15	Absent	PECAM1
Inflammation	ENSG00000271503	FALSE	unknown	2009-06-04	Absent	CCL5
Inflammation	ENSG00000282608	FALSE	Preclinical	1995-06-15	Unused	ADORA3
Inflammatory Bowel Diseases	ENSG00000004948	FALSE	Preclinical	2008-03-20	Unused	CALCR
Inflammatory Bowel Diseases	ENSG00000006638	FALSE	unknown	NA	Unused	TBXA2R
Inflammatory Bowel Diseases	ENSG00000007171	FALSE	Preclinical	1993-06-15	Phase II Clinical Trial	NOS2
Inflammatory Bowel Diseases	ENSG00000007908	FALSE	Preclinical	1999-09-01	Unused	SELE
Inflammatory Bowel Diseases	ENSG00000012223	FALSE	Phase I Clinical Trial	2012-12-07	Preclinical	LTF
Inflammatory Bowel Diseases	ENSG00000012504	FALSE	Preclinical	2005-05-26	Unused	NR1H4
Inflammatory Bowel Diseases	ENSG00000012779	FALSE	Phase II Clinical Trial	1989-09-15	Unused	ALOX5
Inflammatory Bowel Diseases	ENSG00000017797	FALSE	Phase I Clinical Trial	2014-12-01	Absent	RALBP1
Inflammatory Bowel Diseases	ENSG00000025434	FALSE	Preclinical	2002-04-17	Unused	NR1H3
Inflammatory Bowel Diseases	ENSG00000026508	FALSE	unknown	2002-08-05	Unused	CD44
Inflammatory Bowel Diseases	ENSG00000050748	FALSE	unknown	2001-01-23	Absent	MAPK9
Inflammatory Bowel Diseases	ENSG00000059377	FALSE	unknown	1995-02-15	Unused	TBXAS1
Inflammatory Bowel Diseases	ENSG00000064012	FALSE	unknown	1999-01-15	Unused	CASP8
Inflammatory Bowel Diseases	ENSG00000065325	FALSE	Phase II Clinical Trial	2001-08-29	Phase I Clinical Trial	GLP2R
Inflammatory Bowel Diseases	ENSG00000065989	FALSE	Phase III Clinical Trial	1994-10-15	Unused	PDE4A
Inflammatory Bowel Diseases	ENSG00000067182	FALSE	Preclinical	2008-09-23	Unused	TNFRSF1A
Inflammatory Bowel Diseases	ENSG00000067900	FALSE	Preclinical	2007-11-26	Unused	ROCK1
Inflammatory Bowel Diseases	ENSG00000069431	FALSE	Preclinical	1995-08-15	Unused	ABCC9
Inflammatory Bowel Diseases	ENSG00000071054	FALSE	Preclinical	2008-10-17	Unused	MAP4K4
Inflammatory Bowel Diseases	ENSG00000073756	TRUE	Approved	1989-12-15	Approved	PTGS2
Inflammatory Bowel Diseases	ENSG00000075073	FALSE	Preclinical	1996-11-15	Unused	TACR2
Inflammatory Bowel Diseases	ENSG00000078098	FALSE	Preclinical	2009-02-09	Unused	FAP
Inflammatory Bowel Diseases	ENSG00000078579	FALSE	unknown	2002-02-01	Unused	FGF20
Inflammatory Bowel Diseases	ENSG00000079385	FALSE	Preclinical	2003-01-24	Unused	CEACAM1
Inflammatory Bowel Diseases	ENSG00000080824	FALSE	unknown	NA	Unused	HSP90AA1
Inflammatory Bowel Diseases	ENSG00000082556	FALSE	Preclinical	2005-03-07	Unused	OPRK1
Inflammatory Bowel Diseases	ENSG00000083457	FALSE	Preclinical	2007-05-22	Unused	ITGAE
Inflammatory Bowel Diseases	ENSG00000085563	FALSE	Preclinical	2002-02-18	Unused	ABCB1
Inflammatory Bowel Diseases	ENSG00000087085	FALSE	Phase I Clinical Trial	2001-09-14	Unused	ACHE
Inflammatory Bowel Diseases	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Inflammatory Bowel Diseases	ENSG00000088832	FALSE	Preclinical	2008-07-16	Unused	FKBP1A
Inflammatory Bowel Diseases	ENSG00000089041	FALSE	unknown	2001-12-04	Unused	P2RX7
Inflammatory Bowel Diseases	ENSG00000090339	FALSE	Preclinical	1990-07-15	Unused	ICAM1
Inflammatory Bowel Diseases	ENSG00000091831	FALSE	Phase I Clinical Trial	2004-12-09	Unused	ESR1
Inflammatory Bowel Diseases	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Inflammatory Bowel Diseases	ENSG00000095303	TRUE	Approved	1989-12-15	Approved	PTGS1
Inflammatory Bowel Diseases	ENSG00000099866	FALSE	Preclinical	1999-09-01	Unused	MADCAM1
Inflammatory Bowel Diseases	ENSG00000100079	FALSE	Preclinical	2006-02-28	Unused	LGALS2
Inflammatory Bowel Diseases	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Inflammatory Bowel Diseases	ENSG00000101017	FALSE	Preclinical	2007-05-01	Unused	CD40
Inflammatory Bowel Diseases	ENSG00000101665	FALSE	Preclinical	2015-11-03	Absent	SMAD7
Inflammatory Bowel Diseases	ENSG00000102245	FALSE	Preclinical	2013-02-04	Absent	CD40LG
Inflammatory Bowel Diseases	ENSG00000102468	FALSE	Preclinical	1993-06-15	Unused	HTR2A
Inflammatory Bowel Diseases	ENSG00000102539	FALSE	Preclinical	1999-07-28	Unused	MLNR
Inflammatory Bowel Diseases	ENSG00000102967	FALSE	Preclinical	2002-11-13	Unused	DHODH
Inflammatory Bowel Diseases	ENSG00000103222	FALSE	Preclinical	2001-07-18	Unused	ABCC1
Inflammatory Bowel Diseases	ENSG00000104312	FALSE	Preclinical	2012-09-20	Preclinical	RIPK2
Inflammatory Bowel Diseases	ENSG00000104365	FALSE	Preclinical	2004-04-20	Unused	IKBKB
Inflammatory Bowel Diseases	ENSG00000104783	FALSE	Preclinical	2014-05-08	Absent	KCNN4
Inflammatory Bowel Diseases	ENSG00000105329	FALSE	Preclinical	2013-10-03	Absent	TGFB1
Inflammatory Bowel Diseases	ENSG00000105397	FALSE	Phase I Clinical Trial	2014-12-09	Absent	TYK2
Inflammatory Bowel Diseases	ENSG00000105639	FALSE	Phase I Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK3
Inflammatory Bowel Diseases	ENSG00000105650	FALSE	Phase III Clinical Trial	1994-10-15	Unused	PDE4C
Inflammatory Bowel Diseases	ENSG00000105675	FALSE	Preclinical	1996-09-15	Unused	ATP4A
Inflammatory Bowel Diseases	ENSG00000106113	FALSE	Preclinical	1989-06-15	Unused	CRHR2
Inflammatory Bowel Diseases	ENSG00000107643	FALSE	unknown	2001-01-23	Absent	MAPK8
Inflammatory Bowel Diseases	ENSG00000108839	FALSE	Preclinical	1993-01-15	Unused	ALOX12
Inflammatory Bowel Diseases	ENSG00000109320	FALSE	Preclinical	1993-06-15	Unused	NFKB1
Inflammatory Bowel Diseases	ENSG00000109339	FALSE	unknown	2001-01-23	Absent	MAPK10
Inflammatory Bowel Diseases	ENSG00000109471	FALSE	Preclinical	2017-01-04	Absent	IL2
Inflammatory Bowel Diseases	ENSG00000110148	FALSE	Phase I Clinical Trial	1993-05-15	Unused	CCKBR
Inflammatory Bowel Diseases	ENSG00000110324	FALSE	Phase I Clinical Trial	2002-08-08	Unused	IL10RA
Inflammatory Bowel Diseases	ENSG00000110876	FALSE	Preclinical	NA	Absent	SELPLG
Inflammatory Bowel Diseases	ENSG00000110944	FALSE	Phase I Clinical Trial	2006-07-13	Unused	IL23A
Inflammatory Bowel Diseases	ENSG00000111321	FALSE	unknown	2007-07-20	Unused	LTBR
Inflammatory Bowel Diseases	ENSG00000111424	FALSE	Preclinical	2006-10-23	Unused	VDR
Inflammatory Bowel Diseases	ENSG00000112033	FALSE	Preclinical	2006-09-18	Unused	PPARD
Inflammatory Bowel Diseases	ENSG00000112038	FALSE	Preclinical	2013-05-20	Unused	OPRM1
Inflammatory Bowel Diseases	ENSG00000112062	FALSE	Phase I Clinical Trial	1999-01-15	Unused	MAPK14
Inflammatory Bowel Diseases	ENSG00000112096	FALSE	Preclinical	1992-11-15	Unused	SOD2
Inflammatory Bowel Diseases	ENSG00000113070	FALSE	Preclinical	1991-09-15	Unused	HBEGF
Inflammatory Bowel Diseases	ENSG00000113302	FALSE	Preclinical	2001-05-03	Unused	IL12B
Inflammatory Bowel Diseases	ENSG00000113448	FALSE	Phase III Clinical Trial	1994-10-15	Unused	PDE4D
Inflammatory Bowel Diseases	ENSG00000113580	TRUE	Approved	1993-08-15	Approved	NR3C1
Inflammatory Bowel Diseases	ENSG00000113749	FALSE	Preclinical	1996-08-15	Unused	HRH2
Inflammatory Bowel Diseases	ENSG00000114013	FALSE	Preclinical	2012-11-19	Absent	CD86
Inflammatory Bowel Diseases	ENSG00000114859	FALSE	unknown	2002-09-25	Unused	CLCN2
Inflammatory Bowel Diseases	ENSG00000115009	FALSE	Preclinical	2017-11-03	Absent	CCL20
Inflammatory Bowel Diseases	ENSG00000115020	FALSE	Preclinical	2012-09-20	Preclinical	PIKFYVE
Inflammatory Bowel Diseases	ENSG00000115138	FALSE	Preclinical	2000-12-07	Unused	POMC
Inflammatory Bowel Diseases	ENSG00000115232	FALSE	Preclinical	1999-09-01	Unused	ITGA4
Inflammatory Bowel Diseases	ENSG00000115353	FALSE	Preclinical	1992-06-15	Unused	TACR1
Inflammatory Bowel Diseases	ENSG00000115594	FALSE	Preclinical	1989-06-15	Unused	IL1R1
Inflammatory Bowel Diseases	ENSG00000116044	FALSE	Phase I Clinical Trial	2010-04-24	Absent	NFE2L2
Inflammatory Bowel Diseases	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Inflammatory Bowel Diseases	ENSG00000116678	FALSE	Preclinical	2008-11-13	Preclinical	LEPR
Inflammatory Bowel Diseases	ENSG00000117525	FALSE	Preclinical	2003-04-08	Unused	F3
Inflammatory Bowel Diseases	ENSG00000118432	FALSE	unknown	NA	Unused	CNR1
Inflammatory Bowel Diseases	ENSG00000120088	FALSE	Preclinical	1989-06-15	Unused	CRHR1
Inflammatory Bowel Diseases	ENSG00000120217	FALSE	Preclinical	2016-03-07	Absent	CD274
Inflammatory Bowel Diseases	ENSG00000121361	FALSE	Preclinical	1995-08-15	Unused	KCNJ8
Inflammatory Bowel Diseases	ENSG00000122025	FALSE	unknown	1993-05-15	Unused	FLT3
Inflammatory Bowel Diseases	ENSG00000124172	FALSE	Phase II Clinical Trial	2014-05-15	Absent	ATP5F1E
Inflammatory Bowel Diseases	ENSG00000124731	FALSE	Preclinical	2002-06-25	Unused	TREM1
Inflammatory Bowel Diseases	ENSG00000125510	FALSE	Preclinical	2008-04-02	Unused	OPRL1
Inflammatory Bowel Diseases	ENSG00000125735	FALSE	Preclinical	2009-05-14	Absent	TNFSF14
Inflammatory Bowel Diseases	ENSG00000125910	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR4
Inflammatory Bowel Diseases	ENSG00000126262	FALSE	Phase I Clinical Trial	2011-12-21	Phase I Clinical Trial	FFAR2
Inflammatory Bowel Diseases	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Inflammatory Bowel Diseases	ENSG00000128285	FALSE	Phase I Clinical Trial	2008-05-27	Absent	MCHR1
Inflammatory Bowel Diseases	ENSG00000129167	FALSE	unknown	2006-02-15	Absent	TPH1
Inflammatory Bowel Diseases	ENSG00000131408	FALSE	Preclinical	2002-04-17	Unused	NR1H2
Inflammatory Bowel Diseases	ENSG00000131471	FALSE	Phase II Clinical Trial	2006-06-01	Unused	AOC3
Inflammatory Bowel Diseases	ENSG00000131747	FALSE	unknown	1993-05-15	Unused	TOP2A
Inflammatory Bowel Diseases	ENSG00000132170	FALSE	Preclinical	2006-09-18	Unused	PPARG
Inflammatory Bowel Diseases	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Inflammatory Bowel Diseases	ENSG00000132965	FALSE	unknown	1989-07-15	Unused	ALOX5AP
Inflammatory Bowel Diseases	ENSG00000133019	FALSE	Phase III Clinical Trial	1992-10-15	Unused	CHRM3
Inflammatory Bowel Diseases	ENSG00000134216	FALSE	Phase I Clinical Trial	2014-12-23	Absent	CHIA
Inflammatory Bowel Diseases	ENSG00000134318	FALSE	Preclinical	2007-11-26	Unused	ROCK2
Inflammatory Bowel Diseases	ENSG00000134460	FALSE	Preclinical	NA	Absent	IL2RA
Inflammatory Bowel Diseases	ENSG00000135914	FALSE	unknown	2003-09-11	Unused	HTR2B
Inflammatory Bowel Diseases	ENSG00000136244	FALSE	Preclinical	2017-11-03	Absent	IL6
Inflammatory Bowel Diseases	ENSG00000136634	FALSE	Preclinical	2007-05-30	Preclinical	IL10
Inflammatory Bowel Diseases	ENSG00000136869	FALSE	Preclinical	2003-03-05	Unused	TLR4
Inflammatory Bowel Diseases	ENSG00000137752	FALSE	Preclinical	1993-11-15	Unused	CASP1
Inflammatory Bowel Diseases	ENSG00000138684	FALSE	Preclinical	2014-10-29	Absent	IL21
Inflammatory Bowel Diseases	ENSG00000138735	FALSE	unknown	1999-01-08	Unused	PDE5A
Inflammatory Bowel Diseases	ENSG00000139572	FALSE	Preclinical	2014-12-19	Absent	GPR84
Inflammatory Bowel Diseases	ENSG00000139626	FALSE	Preclinical	1999-09-01	Unused	ITGB7
Inflammatory Bowel Diseases	ENSG00000140009	FALSE	Preclinical	2006-08-09	Unused	ESR2
Inflammatory Bowel Diseases	ENSG00000141655	FALSE	Phase II Clinical Trial	2017-04-18	Absent	TNFRSF11A
Inflammatory Bowel Diseases	ENSG00000142677	FALSE	Preclinical	2004-09-14	Unused	IL22RA1
Inflammatory Bowel Diseases	ENSG00000143365	FALSE	Preclinical	2010-01-07	Preclinical	RORC
Inflammatory Bowel Diseases	ENSG00000144381	FALSE	Preclinical	2008-09-04	Unused	HSPD1
Inflammatory Bowel Diseases	ENSG00000146070	FALSE	Preclinical	1997-08-15	Unused	PLA2G7
Inflammatory Bowel Diseases	ENSG00000147246	FALSE	Preclinical	1993-06-15	Unused	HTR2C
Inflammatory Bowel Diseases	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Inflammatory Bowel Diseases	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Inflammatory Bowel Diseases	ENSG00000149968	FALSE	Preclinical	1998-10-15	Unused	MMP3
Inflammatory Bowel Diseases	ENSG00000150093	FALSE	Preclinical	2001-04-12	Unused	ITGB1
Inflammatory Bowel Diseases	ENSG00000150782	FALSE	Phase I Clinical Trial	2009-12-18	Phase I Clinical Trial	IL18
Inflammatory Bowel Diseases	ENSG00000151067	FALSE	Preclinical	1990-10-15	Unused	CACNA1C
Inflammatory Bowel Diseases	ENSG00000151623	FALSE	Phase III Clinical Trial	NA	Unused	NR3C2
Inflammatory Bowel Diseases	ENSG00000151694	FALSE	Preclinical	1995-05-15	Unused	ADAM17
Inflammatory Bowel Diseases	ENSG00000154229	FALSE	Preclinical	1992-03-15	Unused	PRKCA
Inflammatory Bowel Diseases	ENSG00000156273	FALSE	Phase I Clinical Trial	2015-08-20	Absent	BACH1
Inflammatory Bowel Diseases	ENSG00000160013	FALSE	Phase II Clinical Trial	NA	Unused	PTGIR
Inflammatory Bowel Diseases	ENSG00000160712	FALSE	Preclinical	1998-08-15	Unused	IL6R
Inflammatory Bowel Diseases	ENSG00000162434	FALSE	Phase I Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK1
Inflammatory Bowel Diseases	ENSG00000162594	FALSE	Preclinical	2010-12-15	Unused	IL23R
Inflammatory Bowel Diseases	ENSG00000162692	FALSE	Preclinical	2001-04-12	Unused	VCAM1
Inflammatory Bowel Diseases	ENSG00000163394	FALSE	Phase II Clinical Trial	1992-10-15	Unused	CCKAR
Inflammatory Bowel Diseases	ENSG00000163399	FALSE	Preclinical	NA	Unused	ATP1A1
Inflammatory Bowel Diseases	ENSG00000163702	FALSE	Preclinical	2007-08-10	Unused	IL17RC
Inflammatory Bowel Diseases	ENSG00000164120	FALSE	Preclinical	2017-08-02	Absent	HPGD
Inflammatory Bowel Diseases	ENSG00000164136	FALSE	Preclinical	2014-10-29	Absent	IL15
Inflammatory Bowel Diseases	ENSG00000164251	FALSE	Preclinical	2004-01-27	Unused	F2RL1
Inflammatory Bowel Diseases	ENSG00000164266	FALSE	Preclinical	NA	Unused	SPINK1
Inflammatory Bowel Diseases	ENSG00000164270	FALSE	Phase II Clinical Trial	1991-10-15	Unused	HTR4
Inflammatory Bowel Diseases	ENSG00000164342	FALSE	Preclinical	2012-03-07	Absent	TLR3
Inflammatory Bowel Diseases	ENSG00000165376	FALSE	Preclinical	2017-11-03	Absent	CLDN2
Inflammatory Bowel Diseases	ENSG00000166501	FALSE	Preclinical	1992-03-15	Unused	PRKCB
Inflammatory Bowel Diseases	ENSG00000166736	FALSE	Phase II Clinical Trial	1991-10-15	Unused	HTR3A
Inflammatory Bowel Diseases	ENSG00000168539	FALSE	Preclinical	NA	Unused	CHRM1
Inflammatory Bowel Diseases	ENSG00000168610	FALSE	Preclinical	2015-02-13	Absent	STAT3
Inflammatory Bowel Diseases	ENSG00000168811	FALSE	unknown	2001-05-03	Unused	IL12A
Inflammatory Bowel Diseases	ENSG00000168918	FALSE	Phase I Clinical Trial	2008-10-27	Phase I Clinical Trial	INPP5D
Inflammatory Bowel Diseases	ENSG00000169083	FALSE	Preclinical	NA	Unused	AR
Inflammatory Bowel Diseases	ENSG00000169218	FALSE	unknown	1998-12-15	Unused	RSPO1
Inflammatory Bowel Diseases	ENSG00000169403	FALSE	unknown	1990-09-15	Unused	PTAFR
Inflammatory Bowel Diseases	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Inflammatory Bowel Diseases	ENSG00000170425	FALSE	Preclinical	2012-08-02	Preclinical	ADORA2B
Inflammatory Bowel Diseases	ENSG00000170989	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR1
Inflammatory Bowel Diseases	ENSG00000171049	FALSE	Preclinical	NA	Preclinical	FPR2
Inflammatory Bowel Diseases	ENSG00000172156	FALSE	Preclinical	2000-08-02	Absent	CCL11
Inflammatory Bowel Diseases	ENSG00000172236	FALSE	Preclinical	1998-11-15	Unused	TPSAB1
Inflammatory Bowel Diseases	ENSG00000172819	FALSE	Phase I Clinical Trial	2015-05-20	Absent	RARG
Inflammatory Bowel Diseases	ENSG00000173039	FALSE	Phase II Clinical Trial	NA	Unused	RELA
Inflammatory Bowel Diseases	ENSG00000173083	FALSE	Preclinical	NA	Unused	HPSE
Inflammatory Bowel Diseases	ENSG00000173198	FALSE	unknown	NA	Unused	CYSLTR1
Inflammatory Bowel Diseases	ENSG00000173585	FALSE	Phase I Clinical Trial	2007-05-25	Phase I Clinical Trial	CCR9
Inflammatory Bowel Diseases	ENSG00000174175	FALSE	Preclinical	1995-11-15	Unused	SELP
Inflammatory Bowel Diseases	ENSG00000177272	FALSE	Preclinical	2008-04-16	Unused	KCNA3
Inflammatory Bowel Diseases	ENSG00000178394	FALSE	Preclinical	1994-06-15	Unused	HTR1A
Inflammatory Bowel Diseases	ENSG00000178726	FALSE	unknown	1992-06-15	Unused	THBD
Inflammatory Bowel Diseases	ENSG00000179921	FALSE	Preclinical	2011-09-03	Absent	GPBAR1
Inflammatory Bowel Diseases	ENSG00000180739	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR5
Inflammatory Bowel Diseases	ENSG00000180871	FALSE	Preclinical	2000-04-05	Unused	CXCR2
Inflammatory Bowel Diseases	ENSG00000181072	FALSE	Preclinical	NA	Unused	CHRM2
Inflammatory Bowel Diseases	ENSG00000181092	FALSE	Preclinical	2004-09-20	Unused	ADIPOQ
Inflammatory Bowel Diseases	ENSG00000182687	FALSE	Preclinical	2013-09-18	Absent	GALR2
Inflammatory Bowel Diseases	ENSG00000183735	FALSE	Preclinical	2010-07-30	Absent	TBK1
Inflammatory Bowel Diseases	ENSG00000184502	FALSE	Phase III Clinical Trial	NA	Unused	GAST
Inflammatory Bowel Diseases	ENSG00000184588	FALSE	Phase III Clinical Trial	1994-10-15	Unused	PDE4B
Inflammatory Bowel Diseases	ENSG00000185313	FALSE	Preclinical	2002-01-14	Unused	SCN10A
Inflammatory Bowel Diseases	ENSG00000186642	FALSE	unknown	1999-01-08	Unused	PDE2A
Inflammatory Bowel Diseases	ENSG00000186810	FALSE	Preclinical	1997-03-15	Unused	CXCR3
Inflammatory Bowel Diseases	ENSG00000186827	FALSE	Preclinical	1994-09-15	Unused	TNFRSF4
Inflammatory Bowel Diseases	ENSG00000186951	FALSE	Preclinical	2006-09-18	Unused	PPARA
Inflammatory Bowel Diseases	ENSG00000187210	FALSE	Preclinical	1999-01-15	Unused	GCNT1
Inflammatory Bowel Diseases	ENSG00000188257	FALSE	Preclinical	1994-08-15	Unused	PLA2G2A
Inflammatory Bowel Diseases	ENSG00000188404	FALSE	Preclinical	2005-01-24	Unused	SELL
Inflammatory Bowel Diseases	ENSG00000188822	FALSE	Preclinical	2004-09-09	Unused	CNR2
Inflammatory Bowel Diseases	ENSG00000196549	FALSE	Preclinical	NA	Unused	MME
Inflammatory Bowel Diseases	ENSG00000196689	FALSE	unknown	2009-06-30	Phase I Clinical Trial	TRPV1
Inflammatory Bowel Diseases	ENSG00000197561	FALSE	unknown	1998-10-15	Unused	ELANE
Inflammatory Bowel Diseases	ENSG00000198001	FALSE	Preclinical	NA	Absent	IRAK4
Inflammatory Bowel Diseases	ENSG00000198851	FALSE	unknown	2002-11-07	Unused	CD3E
Inflammatory Bowel Diseases	ENSG00000204671	FALSE	unknown	2004-07-20	Unused	IL31
Inflammatory Bowel Diseases	ENSG00000205542	FALSE	unknown	2007-07-16	Unused	TMSB4X
Inflammatory Bowel Diseases	ENSG00000213809	FALSE	Preclinical	2006-11-24	Absent	KLRK1
Inflammatory Bowel Diseases	ENSG00000213903	FALSE	Preclinical	2007-08-19	Unused	LTB4R
Inflammatory Bowel Diseases	ENSG00000228716	FALSE	unknown	2005-02-02	Unused	DHFR
Inflammatory Bowel Diseases	ENSG00000239732	FALSE	Phase II Clinical Trial	2001-09-14	Unused	TLR9
Inflammatory Bowel Diseases	ENSG00000240972	FALSE	Preclinical	2004-11-01	Unused	MIF
Inflammatory Bowel Diseases	ENSG00000249437	FALSE	Preclinical	2017-08-21	Absent	NAIP
Inflammatory Bowel Diseases	ENSG00000258839	FALSE	Preclinical	2004-08-23	Unused	MC1R
Inflammatory Bowel Diseases	ENSG00000261371	FALSE	Preclinical	1996-03-15	Absent	PECAM1
Inflammatory Bowel Diseases	ENSG00000263528	FALSE	Preclinical	2010-07-30	Absent	IKBKE
Inflammatory Bowel Diseases	ENSG00000269858	FALSE	Phase I Clinical Trial	2010-12-10	Preclinical	EGLN2
Inflammatory Bowel Diseases	ENSG00000282608	FALSE	Phase I Clinical Trial	2006-10-30	Unused	ADORA3
Influenza, Human	ENSG00000059377	FALSE	Preclinical	2006-08-29	Preclinical	TBXAS1
Influenza, Human	ENSG00000069869	FALSE	Preclinical	2011-03-03	Preclinical	NEDD4
Influenza, Human	ENSG00000070748	FALSE	Phase II Clinical Trial	2011-09-15	Absent	CHAT
Influenza, Human	ENSG00000074319	FALSE	Preclinical	2003-02-04	Unused	TSG101
Influenza, Human	ENSG00000082701	FALSE	Preclinical	2010-06-30	Unused	GSK3B
Influenza, Human	ENSG00000082898	FALSE	Phase I Clinical Trial	2013-09-05	Absent	XPO1
Influenza, Human	ENSG00000089692	FALSE	Phase I Clinical Trial	2004-06-08	Absent	LAG3
Influenza, Human	ENSG00000101017	FALSE	Preclinical	1998-12-15	Unused	CD40
Influenza, Human	ENSG00000111537	FALSE	Approved	2016-11-08	Absent	IFNG
Influenza, Human	ENSG00000113161	FALSE	Preclinical	2007-10-12	Unused	HMGCR
Influenza, Human	ENSG00000115353	FALSE	Preclinical	2003-08-19	Absent	TACR1
Influenza, Human	ENSG00000132434	FALSE	Preclinical	2017-02-28	Absent	LANCL2
Influenza, Human	ENSG00000133321	FALSE	Preclinical	2009-07-23	Preclinical	RARRES3
Influenza, Human	ENSG00000159110	FALSE	Approved	2004-11-16	Unused	IFNAR2
Influenza, Human	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
Influenza, Human	ENSG00000164342	FALSE	Phase II Clinical Trial	2015-03-30	Phase II Clinical Trial	TLR3
Influenza, Human	ENSG00000168398	FALSE	Preclinical	2011-04-28	Absent	BDKRB2
Influenza, Human	ENSG00000171298	FALSE	Phase I Clinical Trial	2013-12-31	Absent	GAA
Influenza, Human	ENSG00000173198	FALSE	Preclinical	2014-03-06	Absent	CYSLTR1
Influenza, Human	ENSG00000176884	FALSE	Phase II Clinical Trial	2009-05-29	Unused	GRIN1
Influenza, Human	ENSG00000178562	FALSE	unknown	2009-06-29	Preclinical	CD28
Influenza, Human	ENSG00000180871	FALSE	unknown	2010-02-25	Absent	CXCR2
Influenza, Human	ENSG00000184012	FALSE	Preclinical	2014-10-18	Absent	TMPRSS2
Influenza, Human	ENSG00000186827	FALSE	Preclinical	1994-09-15	Unused	TNFRSF4
Influenza, Human	ENSG00000196639	FALSE	Preclinical	2014-03-06	Absent	HRH1
Influenza, Human	ENSG00000197249	FALSE	unknown	2009-06-04	Preclinical	SERPINA1
Influenza, Human	ENSG00000198223	FALSE	unknown	NA	Unused	CSF2RA
Influenza, Human	ENSG00000239713	FALSE	unknown	2008-12-05	Unused	APOBEC3G
Influenza, Human	ENSG00000239732	FALSE	Phase I Clinical Trial	2003-10-09	Unused	TLR9
Intellectual Disability	ENSG00000011677	TRUE	Approved	2017-01-28	Approved	GABRA3
Intellectual Disability	ENSG00000022355	TRUE	Approved	2014-04-26	Approved	GABRA1
Intellectual Disability	ENSG00000036530	FALSE	Phase II Clinical Trial	2014-07-28	Absent	CYP46A1
Intellectual Disability	ENSG00000075043	TRUE	Approved	1992-08-15	Approved	KCNQ2
Intellectual Disability	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Intellectual Disability	ENSG00000108576	FALSE	Phase III Clinical Trial	NA	Absent	SLC6A4
Intellectual Disability	ENSG00000144285	TRUE	Approved	NA	Approved	SCN1A
Intellectual Disability	ENSG00000149295	FALSE	unknown	NA	Unused	DRD2
Intellectual Disability	ENSG00000151834	TRUE	Approved	2017-01-28	Approved	GABRA2
Intellectual Disability	ENSG00000153253	TRUE	Approved	NA	Approved	SCN3A
Intellectual Disability	ENSG00000155511	TRUE	Approved	2000-03-29	Approved	GRIA1
Intellectual Disability	ENSG00000183873	TRUE	Approved	NA	Approved	SCN5A
Intellectual Disability	ENSG00000184156	TRUE	Approved	1992-08-15	Approved	KCNQ3
Intellectual Disability	ENSG00000186297	TRUE	Approved	2017-01-28	Approved	GABRA5
Intermittent Claudication	ENSG00000050628	FALSE	Phase II Clinical Trial	2004-02-13	Absent	PTGER3
Intermittent Claudication	ENSG00000059377	FALSE	Phase II Clinical Trial	1994-06-15	Absent	TBXAS1
Intermittent Claudication	ENSG00000073756	FALSE	unknown	1996-04-15	Absent	PTGS2
Intermittent Claudication	ENSG00000077782	FALSE	Phase I Clinical Trial	2005-09-14	Absent	FGFR1
Intermittent Claudication	ENSG00000095303	FALSE	unknown	1996-04-15	Absent	PTGS1
Intermittent Claudication	ENSG00000095321	TRUE	Approved	NA	Absent	CRAT
Intermittent Claudication	ENSG00000100644	FALSE	Phase II Clinical Trial	1999-02-01	Absent	HIF1A
Intermittent Claudication	ENSG00000102468	FALSE	Phase II Clinical Trial	1989-11-15	Absent	HTR2A
Intermittent Claudication	ENSG00000104365	FALSE	unknown	1996-04-15	Absent	IKBKB
Intermittent Claudication	ENSG00000112715	FALSE	Phase I Clinical Trial	1994-02-15	Absent	VEGFA
Intermittent Claudication	ENSG00000113161	FALSE	unknown	2004-02-24	Absent	HMGCR
Intermittent Claudication	ENSG00000113578	FALSE	Phase II Clinical Trial	1999-05-04	Absent	FGF1
Intermittent Claudication	ENSG00000121966	FALSE	Phase I Clinical Trial	2004-06-22	Absent	CXCR4
Intermittent Claudication	ENSG00000123454	FALSE	unknown	1989-06-15	Absent	DBH
Intermittent Claudication	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Absent	IL1B
Intermittent Claudication	ENSG00000129151	FALSE	Phase II Clinical Trial	1995-07-15	Absent	BBOX1
Intermittent Claudication	ENSG00000135312	FALSE	Phase II Clinical Trial	2000-03-15	Absent	HTR1B
Intermittent Claudication	ENSG00000138735	FALSE	Phase II Clinical Trial	1994-06-15	Absent	PDE5A
Intermittent Claudication	ENSG00000151067	TRUE	Approved	NA	Absent	CACNA1C
Intermittent Claudication	ENSG00000154188	FALSE	unknown	2007-10-22	Absent	ANGPT1
Intermittent Claudication	ENSG00000160013	FALSE	unknown	NA	Absent	PTGIR
Intermittent Claudication	ENSG00000160951	FALSE	Approved	1999-05-11	Absent	PTGER1
Intermittent Claudication	ENSG00000164176	FALSE	unknown	1998-06-15	Absent	EDIL3
Intermittent Claudication	ENSG00000164867	FALSE	Phase II Clinical Trial	2000-02-24	Absent	NOS3
Intermittent Claudication	ENSG00000171759	FALSE	unknown	1989-06-15	Absent	PAH
Intermittent Claudication	ENSG00000172572	TRUE	Approved	1994-06-15	Absent	PDE3A
Intermittent Claudication	ENSG00000182782	FALSE	unknown	NA	Absent	HCAR2
Intervertebral Disc Degeneration	ENSG00000105329	FALSE	Phase II Clinical Trial	2010-07-19	Absent	TGFB1
Intervertebral Disc Degeneration	ENSG00000109320	FALSE	Preclinical	2001-07-18	Preclinical	NFKB1
Intervertebral Disc Degeneration	ENSG00000125965	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	GDF5
Intervertebral Disc Degeneration	ENSG00000152266	FALSE	Preclinical	2016-01-27	Absent	PTH
Intervertebral Disc Degeneration	ENSG00000171557	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGG
Intervertebral Disc Degeneration	ENSG00000171560	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGA
Intervertebral Disc Degeneration	ENSG00000171564	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGB
Intervertebral Disc Degeneration	ENSG00000181104	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	F2R
Intervertebral Disc Degeneration	ENSG00000261857	FALSE	Preclinical	2010-01-25	Preclinical	MIA
Intervertebral Disc Displacement	ENSG00000136689	FALSE	Preclinical	2010-12-15	Unused	IL1RN
Intervertebral Disc Displacement	ENSG00000169432	FALSE	Phase II Clinical Trial	2007-10-10	Absent	SCN9A
Intraabdominal Infections	ENSG00000101425	FALSE	unknown	1989-12-15	Unused	BPI
Intraabdominal Infections	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Intraabdominal Infections	ENSG00000178562	FALSE	unknown	2009-06-29	Preclinical	CD28
Intraabdominal Infections	ENSG00000198223	FALSE	Phase II Clinical Trial	2016-06-28	Absent	CSF2RA
Intracranial Thrombosis	ENSG00000059377	FALSE	Approved	NA	Unused	TBXAS1
Intracranial Thrombosis	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Intracranial Thrombosis	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Intracranial Thrombosis	ENSG00000101981	FALSE	Preclinical	NA	Absent	F9
Intracranial Thrombosis	ENSG00000105675	TRUE	Approved	NA	Approved	ATP4A
Intracranial Thrombosis	ENSG00000106366	FALSE	Preclinical	1991-11-15	Unused	SERPINE1
Intracranial Thrombosis	ENSG00000117601	FALSE	Phase II Clinical Trial	1989-11-15	Unused	SERPINC1
Intracranial Thrombosis	ENSG00000126218	FALSE	Preclinical	2003-06-23	Unused	F10
Intracranial Thrombosis	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Intracranial Thrombosis	ENSG00000169313	TRUE	Approved	NA	Approved	P2RY12
Intracranial Thrombosis	ENSG00000178726	FALSE	unknown	1992-06-15	Unused	THBD
Intracranial Thrombosis	ENSG00000180210	FALSE	Preclinical	2003-06-23	Unused	F2
Irritable Bowel Syndrome	ENSG00000001626	FALSE	unknown	1992-11-15	Phase II Clinical Trial	CFTR
Irritable Bowel Syndrome	ENSG00000011677	FALSE	unknown	2002-10-03	Unused	GABRA3
Irritable Bowel Syndrome	ENSG00000012779	FALSE	unknown	NA	Unused	ALOX5
Irritable Bowel Syndrome	ENSG00000022355	FALSE	unknown	2002-10-03	Unused	GABRA1
Irritable Bowel Syndrome	ENSG00000066230	FALSE	Phase III Clinical Trial	2011-05-03	Phase II Clinical Trial	SLC9A3
Irritable Bowel Syndrome	ENSG00000070019	TRUE	Approved	2003-07-23	Approved	GUCY2C
Irritable Bowel Syndrome	ENSG00000073756	FALSE	Phase II Clinical Trial	2003-02-17	Phase II Clinical Trial	PTGS2
Irritable Bowel Syndrome	ENSG00000075073	FALSE	Phase III Clinical Trial	1993-01-15	Phase II Clinical Trial	TACR2
Irritable Bowel Syndrome	ENSG00000080644	FALSE	Phase II Clinical Trial	2007-07-30	Phase II Clinical Trial	CHRNA3
Irritable Bowel Syndrome	ENSG00000082556	FALSE	Phase I Clinical Trial	1990-02-15	Phase III Clinical Trial	OPRK1
Irritable Bowel Syndrome	ENSG00000087085	FALSE	unknown	2000-03-01	Unused	ACHE
Irritable Bowel Syndrome	ENSG00000095303	FALSE	Phase II Clinical Trial	2003-02-17	Phase II Clinical Trial	PTGS1
Irritable Bowel Syndrome	ENSG00000100300	FALSE	Phase II Clinical Trial	2011-06-04	Phase I Clinical Trial	TSPO
Irritable Bowel Syndrome	ENSG00000101204	FALSE	Phase II Clinical Trial	2007-07-30	Phase II Clinical Trial	CHRNA4
Irritable Bowel Syndrome	ENSG00000102539	FALSE	unknown	1995-08-15	Unused	MLNR
Irritable Bowel Syndrome	ENSG00000103546	FALSE	unknown	1990-07-15	Unused	SLC6A2
Irritable Bowel Syndrome	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Irritable Bowel Syndrome	ENSG00000104321	FALSE	Phase II Clinical Trial	2005-05-23	Preclinical	TRPA1
Irritable Bowel Syndrome	ENSG00000108576	FALSE	unknown	NA	Unused	SLC6A4
Irritable Bowel Syndrome	ENSG00000110148	FALSE	Preclinical	1996-03-15	Unused	CCKBR
Irritable Bowel Syndrome	ENSG00000110881	FALSE	unknown	2006-08-10	Phase I Clinical Trial	ASIC1
Irritable Bowel Syndrome	ENSG00000112038	TRUE	Approved	1999-01-15	Phase III Clinical Trial	OPRM1
Irritable Bowel Syndrome	ENSG00000112164	FALSE	Phase II Clinical Trial	2001-11-12	Unused	GLP1R
Irritable Bowel Syndrome	ENSG00000113580	FALSE	unknown	1996-06-15	Unused	NR3C1
Irritable Bowel Syndrome	ENSG00000114859	TRUE	Approved	2002-05-28	Approved	CLCN2
Irritable Bowel Syndrome	ENSG00000115232	FALSE	unknown	1995-10-15	Unused	ITGA4
Irritable Bowel Syndrome	ENSG00000115353	FALSE	Phase I Clinical Trial	1998-10-15	Unused	TACR1
Irritable Bowel Syndrome	ENSG00000116329	TRUE	Approved	2001-04-03	Phase III Clinical Trial	OPRD1
Irritable Bowel Syndrome	ENSG00000117480	FALSE	Preclinical	2017-09-07	Absent	FAAH
Irritable Bowel Syndrome	ENSG00000117601	FALSE	unknown	2007-03-14	Unused	SERPINC1
Irritable Bowel Syndrome	ENSG00000117971	FALSE	Phase II Clinical Trial	2007-07-30	Phase II Clinical Trial	CHRNB4
Irritable Bowel Syndrome	ENSG00000120088	FALSE	unknown	2000-08-02	Unused	CRHR1
Irritable Bowel Syndrome	ENSG00000125255	FALSE	unknown	2008-04-18	Preclinical	SLC10A2
Irritable Bowel Syndrome	ENSG00000125510	FALSE	Preclinical	2009-02-09	Unused	OPRL1
Irritable Bowel Syndrome	ENSG00000126010	FALSE	Phase II Clinical Trial	2011-05-19	Phase I Clinical Trial	GRPR
Irritable Bowel Syndrome	ENSG00000126934	FALSE	unknown	2006-05-01	Preclinical	MAP2K2
Irritable Bowel Syndrome	ENSG00000129167	FALSE	Phase II Clinical Trial	2006-02-15	Phase II Clinical Trial	TPH1
Irritable Bowel Syndrome	ENSG00000133019	TRUE	Approved	1994-01-15	Approved	CHRM3
Irritable Bowel Syndrome	ENSG00000134640	FALSE	unknown	2008-01-15	Preclinical	MTNR1B
Irritable Bowel Syndrome	ENSG00000135914	FALSE	Phase I Clinical Trial	2001-10-15	Unused	HTR2B
Irritable Bowel Syndrome	ENSG00000136869	FALSE	Preclinical	2011-11-27	Absent	TLR4
Irritable Bowel Syndrome	ENSG00000139626	FALSE	unknown	1995-10-15	Unused	ITGB7
Irritable Bowel Syndrome	ENSG00000144285	FALSE	Preclinical	1997-09-15	Unused	SCN1A
Irritable Bowel Syndrome	ENSG00000148344	FALSE	unknown	2006-12-19	Unused	PTGES
Irritable Bowel Syndrome	ENSG00000148680	FALSE	Preclinical	2013-09-21	Absent	HTR7
Irritable Bowel Syndrome	ENSG00000150093	FALSE	unknown	1999-08-26	Unused	ITGB1
Irritable Bowel Syndrome	ENSG00000150782	FALSE	Preclinical	NA	Preclinical	IL18
Irritable Bowel Syndrome	ENSG00000151067	TRUE	Approved	2011-06-02	Approved	CACNA1C
Irritable Bowel Syndrome	ENSG00000151694	FALSE	unknown	2007-04-13	Unused	ADAM17
Irritable Bowel Syndrome	ENSG00000151834	FALSE	unknown	2002-10-03	Unused	GABRA2
Irritable Bowel Syndrome	ENSG00000153253	FALSE	Preclinical	1997-09-15	Unused	SCN3A
Irritable Bowel Syndrome	ENSG00000153956	FALSE	unknown	NA	Unused	CACNA2D1
Irritable Bowel Syndrome	ENSG00000160716	FALSE	Phase II Clinical Trial	2007-07-30	Phase II Clinical Trial	CHRNB2
Irritable Bowel Syndrome	ENSG00000163394	FALSE	Phase III Clinical Trial	1995-01-15	Unused	CCKAR
Irritable Bowel Syndrome	ENSG00000164270	TRUE	Approved	1991-07-15	Approved	HTR4
Irritable Bowel Syndrome	ENSG00000165731	FALSE	Phase I Clinical Trial	2016-04-04	Absent	RET
Irritable Bowel Syndrome	ENSG00000166736	TRUE	Approved	1990-07-15	Approved	HTR3A
Irritable Bowel Syndrome	ENSG00000168412	FALSE	unknown	2008-01-15	Preclinical	MTNR1A
Irritable Bowel Syndrome	ENSG00000168539	TRUE	Approved	2000-03-01	Approved	CHRM1
Irritable Bowel Syndrome	ENSG00000168685	FALSE	Preclinical	2011-07-13	Absent	IL7R
Irritable Bowel Syndrome	ENSG00000168918	FALSE	Preclinical	2007-10-29	Unused	INPP5D
Irritable Bowel Syndrome	ENSG00000169032	FALSE	unknown	2006-05-01	Preclinical	MAP2K1
Irritable Bowel Syndrome	ENSG00000169403	FALSE	unknown	1992-01-15	Unused	PTAFR
Irritable Bowel Syndrome	ENSG00000169836	FALSE	unknown	1996-03-15	Unused	TACR3
Irritable Bowel Syndrome	ENSG00000175591	FALSE	Preclinical	2008-04-18	Preclinical	P2RY2
Irritable Bowel Syndrome	ENSG00000176884	FALSE	Phase I Clinical Trial	NA	Unused	GRIN1
Irritable Bowel Syndrome	ENSG00000178394	FALSE	Phase I Clinical Trial	1994-03-15	Unused	HTR1A
Irritable Bowel Syndrome	ENSG00000179546	FALSE	unknown	2008-01-15	Preclinical	HTR1D
Irritable Bowel Syndrome	ENSG00000180720	TRUE	Approved	2000-08-30	Approved	CHRM4
Irritable Bowel Syndrome	ENSG00000181072	TRUE	Approved	2000-03-01	Approved	CHRM2
Irritable Bowel Syndrome	ENSG00000184502	FALSE	Preclinical	NA	Unused	GAST
Irritable Bowel Syndrome	ENSG00000186297	FALSE	unknown	2002-10-03	Unused	GABRA5
Irritable Bowel Syndrome	ENSG00000188404	FALSE	unknown	NA	Unused	SELL
Irritable Bowel Syndrome	ENSG00000188778	FALSE	Preclinical	1998-02-15	Phase II Clinical Trial	ADRB3
Irritable Bowel Syndrome	ENSG00000188822	FALSE	Preclinical	2009-02-19	Preclinical	CNR2
Irritable Bowel Syndrome	ENSG00000197405	FALSE	Preclinical	2010-06-04	Unused	C5AR1
Irritable Bowel Syndrome	ENSG00000274286	FALSE	Phase II Clinical Trial	2004-11-02	Phase II Clinical Trial	ADRA2B
Ischemia	ENSG00000005961	FALSE	unknown	1998-01-15	Unused	ITGA2B
Ischemia	ENSG00000006638	FALSE	unknown	1991-10-15	Unused	TBXA2R
Ischemia	ENSG00000019991	FALSE	Phase III Clinical Trial	2001-01-31	Phase I Clinical Trial	HGF
Ischemia	ENSG00000043591	FALSE	Approved	2010-01-04	Unused	ADRB1
Ischemia	ENSG00000050748	FALSE	unknown	2001-01-23	Absent	MAPK9
Ischemia	ENSG00000064989	FALSE	Preclinical	2005-05-25	Unused	CALCRL
Ischemia	ENSG00000069431	FALSE	unknown	1994-09-15	Unused	ABCC9
Ischemia	ENSG00000069535	FALSE	Preclinical	2011-03-03	Unused	MAOB
Ischemia	ENSG00000073756	FALSE	Approved	2010-01-04	Unused	PTGS2
Ischemia	ENSG00000075388	FALSE	Preclinical	NA	Absent	FGF4
Ischemia	ENSG00000077782	FALSE	Preclinical	2001-12-03	Unused	FGFR1
Ischemia	ENSG00000092439	FALSE	Preclinical	2011-09-28	Preclinical	TRPM7
Ischemia	ENSG00000095303	FALSE	Approved	2010-01-04	Unused	PTGS1
Ischemia	ENSG00000100311	FALSE	Preclinical	2002-06-26	Absent	PDGFB
Ischemia	ENSG00000100644	FALSE	Phase II Clinical Trial	1999-02-01	Absent	HIF1A
Ischemia	ENSG00000102755	FALSE	Preclinical	2001-04-19	Unused	FLT1
Ischemia	ENSG00000107562	FALSE	Phase II Clinical Trial	2009-03-25	Absent	CXCL12
Ischemia	ENSG00000107643	FALSE	unknown	2001-01-23	Absent	MAPK8
Ischemia	ENSG00000109339	FALSE	unknown	2001-01-23	Absent	MAPK10
Ischemia	ENSG00000110492	FALSE	Preclinical	2009-05-19	Unused	MDK
Ischemia	ENSG00000110876	FALSE	Preclinical	2007-02-27	Unused	SELPLG
Ischemia	ENSG00000112715	FALSE	Approved	1994-02-15	Phase I Clinical Trial	VEGFA
Ischemia	ENSG00000113070	FALSE	unknown	NA	Absent	HBEGF
Ischemia	ENSG00000113161	FALSE	Approved	2010-01-04	Unused	HMGCR
Ischemia	ENSG00000113575	FALSE	Preclinical	2008-02-29	Absent	PPP2CA
Ischemia	ENSG00000113578	FALSE	Phase III Clinical Trial	1999-05-04	Absent	FGF1
Ischemia	ENSG00000116748	FALSE	Preclinical	1997-11-15	Unused	AMPD1
Ischemia	ENSG00000117601	FALSE	Phase III Clinical Trial	NA	Unused	SERPINC1
Ischemia	ENSG00000118137	FALSE	unknown	NA	Unused	APOA1
Ischemia	ENSG00000120156	FALSE	Preclinical	2007-04-12	Unused	TEK
Ischemia	ENSG00000121361	FALSE	Preclinical	1994-06-15	Unused	KCNJ8
Ischemia	ENSG00000121853	FALSE	Preclinical	2012-06-05	Absent	GHSR
Ischemia	ENSG00000122194	FALSE	Phase II Clinical Trial	2000-10-30	Absent	PLG
Ischemia	ENSG00000126218	FALSE	Phase III Clinical Trial	NA	Unused	F10
Ischemia	ENSG00000128052	FALSE	Preclinical	1998-11-15	Unused	KDR
Ischemia	ENSG00000129151	FALSE	Approved	1995-07-15	Unused	BBOX1
Ischemia	ENSG00000129521	FALSE	Phase II Clinical Trial	2008-09-16	Absent	EGLN3
Ischemia	ENSG00000132329	FALSE	Preclinical	2005-05-25	Unused	RAMP1
Ischemia	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Ischemia	ENSG00000138448	FALSE	Preclinical	1999-08-26	Unused	ITGAV
Ischemia	ENSG00000138685	FALSE	Phase II Clinical Trial	2002-06-24	Absent	FGF2
Ischemia	ENSG00000143799	FALSE	Preclinical	2009-01-13	Unused	PARP1
Ischemia	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Ischemia	ENSG00000151617	FALSE	Preclinical	NA	Unused	EDNRA
Ischemia	ENSG00000152137	FALSE	Preclinical	2011-03-01	Unused	HSPB8
Ischemia	ENSG00000154188	FALSE	Preclinical	2007-10-22	Preclinical	ANGPT1
Ischemia	ENSG00000154229	FALSE	Preclinical	1998-03-15	Unused	PRKCA
Ischemia	ENSG00000155011	FALSE	Preclinical	2012-04-18	Absent	DKK2
Ischemia	ENSG00000155511	FALSE	Preclinical	1995-02-15	Unused	GRIA1
Ischemia	ENSG00000159640	FALSE	Approved	2010-01-04	Unused	ACE
Ischemia	ENSG00000160013	TRUE	Approved	NA	Absent	PTGIR
Ischemia	ENSG00000160951	TRUE	Approved	1999-05-11	Absent	PTGER1
Ischemia	ENSG00000163485	FALSE	unknown	1993-04-15	Unused	ADORA1
Ischemia	ENSG00000163932	FALSE	unknown	2004-09-29	Unused	PRKCD
Ischemia	ENSG00000164176	FALSE	Preclinical	1998-06-15	Unused	EDIL3
Ischemia	ENSG00000164867	FALSE	Preclinical	2002-10-14	Unused	NOS3
Ischemia	ENSG00000165197	FALSE	unknown	2009-08-26	Absent	VEGFD
Ischemia	ENSG00000168398	FALSE	Preclinical	1999-11-17	Unused	BDKRB2
Ischemia	ENSG00000171497	FALSE	Preclinical	2010-11-15	Unused	PPID
Ischemia	ENSG00000173511	FALSE	Preclinical	1997-07-15	Unused	VEGFB
Ischemia	ENSG00000175899	FALSE	unknown	2001-05-29	Absent	A2M
Ischemia	ENSG00000179776	FALSE	Preclinical	2013-11-07	Absent	CDH5
Ischemia	ENSG00000180210	FALSE	Phase III Clinical Trial	NA	Unused	F2
Ischemia	ENSG00000182492	FALSE	Preclinical	2009-07-24	Absent	BGN
Ischemia	ENSG00000183873	FALSE	Preclinical	2014-04-08	Absent	SCN5A
Ischemia	ENSG00000187266	FALSE	Preclinical	2003-07-02	Unused	EPOR
Ischemia	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Ischemia	ENSG00000196262	FALSE	Preclinical	NA	Absent	PPIA
Ischemia	ENSG00000196396	FALSE	unknown	2009-06-04	Absent	PTPN1
Ischemia	ENSG00000196549	FALSE	Approved	2010-01-04	Unused	MME
Ischemia	ENSG00000196839	FALSE	Preclinical	1993-08-15	Unused	ADA
Ischemia	ENSG00000259207	FALSE	Preclinical	1998-01-15	Unused	ITGB3
Ischemia	ENSG00000269858	FALSE	Phase II Clinical Trial	2003-07-02	Unused	EGLN2
Ischemia	ENSG00000273079	FALSE	Preclinical	2010-06-04	Absent	GRIN2B
Ischemia	ENSG00000282608	FALSE	Preclinical	2002-08-22	Unused	ADORA3
Jaundice	ENSG00000100292	FALSE	Phase III Clinical Trial	2002-04-23	Unused	HMOX1
Joint Diseases	ENSG00000073756	FALSE	Preclinical	NA	Absent	PTGS2
Joint Diseases	ENSG00000162711	FALSE	Phase II Clinical Trial	2010-01-19	Absent	NLRP3
Joint Diseases	ENSG00000197891	FALSE	Phase II Clinical Trial	2010-01-19	Absent	SLC22A12
Kartagener Syndrome	ENSG00000111319	FALSE	Phase II Clinical Trial	2013-02-18	Absent	SCNN1A
Kartagener Syndrome	ENSG00000197561	FALSE	Preclinical	2008-06-19	Absent	ELANE
Keratitis	ENSG00000064300	TRUE	Approved	2011-07-05	Absent	NGFR
Keratitis	ENSG00000100985	FALSE	Phase III Clinical Trial	1995-01-15	Absent	MMP9
Keratitis	ENSG00000196611	FALSE	Phase III Clinical Trial	1995-01-15	Absent	MMP1
Keratitis	ENSG00000205542	FALSE	Phase III Clinical Trial	1995-01-15	Absent	TMSB4X
Keratitis, Herpetic	ENSG00000102755	FALSE	Preclinical	2008-03-11	Absent	FLT1
Keratitis, Herpetic	ENSG00000112715	FALSE	Preclinical	2008-03-11	Absent	VEGFA
Keratitis, Herpetic	ENSG00000121966	FALSE	Phase II Clinical Trial	2004-08-03	Absent	CXCR4
Keratitis, Herpetic	ENSG00000128052	FALSE	Preclinical	2008-03-11	Absent	KDR
Keratitis, Herpetic	ENSG00000160791	FALSE	Phase II Clinical Trial	2004-08-03	Absent	CCR5
Keratoconjunctivitis	ENSG00000088832	TRUE	Approved	NA	Absent	FKBP1A
Keratoconjunctivitis	ENSG00000105366	FALSE	Phase I Clinical Trial	2016-06-24	Absent	SIGLEC8
Keratoconjunctivitis	ENSG00000106804	FALSE	Phase I Clinical Trial	2017-04-12	Absent	C5
Keratoconjunctivitis	ENSG00000113580	FALSE	Phase III Clinical Trial	2007-07-09	Phase III Clinical Trial	NR3C1
Keratoconjunctivitis	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Keratoconjunctivitis	ENSG00000159110	TRUE	Approved	2014-01-17	Unused	IFNAR2
Keratoconjunctivitis	ENSG00000172156	FALSE	Preclinical	2000-08-02	Preclinical	CCL11
Keratoconjunctivitis	ENSG00000183625	FALSE	unknown	2004-09-17	Unused	CCR3
Keratoconjunctivitis	ENSG00000196262	TRUE	Approved	1993-08-15	Unused	PPIA
Keratoconjunctivitis	ENSG00000196639	TRUE	Approved	NA	Absent	HRH1
Keratoconjunctivitis	ENSG00000213903	FALSE	Phase I Clinical Trial	2017-04-12	Absent	LTB4R
Keratoconus	ENSG00000114378	FALSE	unknown	2001-10-26	Unused	HYAL1
Keratosis	ENSG00000111424	TRUE	Approved	NA	Approved	VDR
Keratosis, Actinic	ENSG00000073756	TRUE	Approved	1992-08-15	Approved	PTGS2
Keratosis, Actinic	ENSG00000091831	FALSE	unknown	1999-05-19	Unused	ESR1
Keratosis, Actinic	ENSG00000095303	TRUE	Approved	1992-08-15	Approved	PTGS1
Keratosis, Actinic	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Keratosis, Actinic	ENSG00000101916	FALSE	unknown	NA	Phase II Clinical Trial	TLR8
Keratosis, Actinic	ENSG00000104783	FALSE	Phase II Clinical Trial	1995-09-15	Unused	KCNN4
Keratosis, Actinic	ENSG00000105329	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	TGFB1
Keratosis, Actinic	ENSG00000116478	FALSE	unknown	2007-07-24	Unused	HDAC1
Keratosis, Actinic	ENSG00000130037	FALSE	Phase II Clinical Trial	2015-08-14	Absent	KCNA5
Keratosis, Actinic	ENSG00000132906	FALSE	unknown	2007-03-05	Phase I Clinical Trial	CASP9
Keratosis, Actinic	ENSG00000163932	TRUE	Approved	2002-10-14	Approved	PRKCD
Keratosis, Actinic	ENSG00000164305	FALSE	Phase II Clinical Trial	2007-07-16	Unused	CASP3
Keratosis, Actinic	ENSG00000164342	FALSE	Preclinical	2008-11-03	Unused	TLR3
Keratosis, Actinic	ENSG00000170989	FALSE	Preclinical	2011-09-21	Absent	S1PR1
Keratosis, Actinic	ENSG00000176890	TRUE	Approved	1992-05-15	Approved	TYMS
Keratosis, Actinic	ENSG00000182782	FALSE	Preclinical	NA	Unused	HCAR2
Keratosis, Actinic	ENSG00000196591	FALSE	unknown	2007-07-24	Unused	HDAC2
Keratosis, Actinic	ENSG00000196664	FALSE	Phase II Clinical Trial	2007-08-16	Phase II Clinical Trial	TLR7
Keratosis, Actinic	ENSG00000197122	FALSE	Phase III Clinical Trial	2007-04-25	Absent	SRC
Keratosis, Actinic	ENSG00000258839	FALSE	unknown	2003-06-05	Phase II Clinical Trial	MC1R
Kernicterus	ENSG00000100292	FALSE	Phase II Clinical Trial	2002-04-23	Absent	HMOX1
Kidney Diseases	ENSG00000009724	FALSE	Phase III Clinical Trial	2008-01-15	Absent	MASP2
Kidney Diseases	ENSG00000072315	FALSE	Preclinical	2010-07-08	Absent	TRPC5
Kidney Diseases	ENSG00000081479	FALSE	Preclinical	2006-12-04	Unused	LRP2
Kidney Diseases	ENSG00000085662	FALSE	Approved	NA	Unused	AKR1B1
Kidney Diseases	ENSG00000097007	FALSE	Preclinical	2009-05-28	Absent	ABL1
Kidney Diseases	ENSG00000112715	FALSE	Preclinical	2003-07-02	Unused	VEGFA
Kidney Diseases	ENSG00000115221	FALSE	Phase I Clinical Trial	2003-06-09	Phase I Clinical Trial	ITGB6
Kidney Diseases	ENSG00000133107	FALSE	Preclinical	2010-07-08	Absent	TRPC4
Kidney Diseases	ENSG00000136810	FALSE	Preclinical	2016-10-17	Absent	TXN
Kidney Diseases	ENSG00000138448	FALSE	Phase I Clinical Trial	2003-06-09	Phase I Clinical Trial	ITGAV
Kidney Diseases	ENSG00000151623	FALSE	unknown	2010-10-25	Phase II Clinical Trial	NR3C2
Kidney Diseases	ENSG00000170962	FALSE	unknown	2001-05-14	Unused	PDGFD
Kidney Diseases	ENSG00000186716	FALSE	Preclinical	2009-05-28	Absent	BCR
Kidney Diseases	ENSG00000187266	FALSE	Preclinical	2003-07-02	Unused	EPOR
Kidney Diseases	ENSG00000197461	FALSE	Preclinical	2009-05-28	Absent	PDGFA
Kidney Diseases	ENSG00000269858	FALSE	Preclinical	2003-07-02	Unused	EGLN2
Kidney Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CFLAR
Kidney Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Kidney Neoplasms	ENSG00000010610	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CD4
Kidney Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Kidney Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Kidney Neoplasms	ENSG00000012223	FALSE	unknown	1994-08-15	Phase II Clinical Trial	LTF
Kidney Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Unused	HGF
Kidney Neoplasms	ENSG00000026103	FALSE	Phase I Clinical Trial	2002-06-26	Phase I Clinical Trial	FAS
Kidney Neoplasms	ENSG00000026508	FALSE	unknown	1992-09-15	Unused	CD44
Kidney Neoplasms	ENSG00000027697	TRUE	Approved	NA	Approved	IFNGR1
Kidney Neoplasms	ENSG00000037280	TRUE	Approved	1994-06-15	Approved	FLT4
Kidney Neoplasms	ENSG00000047936	FALSE	Preclinical	2006-12-05	Absent	ROS1
Kidney Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2009-07-15	Absent	PIK3CB
Kidney Neoplasms	ENSG00000060491	FALSE	Preclinical	2012-09-01	Absent	OGFR
Kidney Neoplasms	ENSG00000066468	TRUE	Approved	2003-07-22	Phase I Clinical Trial	FGFR2
Kidney Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2002-06-26	Phase I Clinical Trial	TNFRSF1A
Kidney Neoplasms	ENSG00000067225	FALSE	Phase II Clinical Trial	2006-06-29	Unused	PKM
Kidney Neoplasms	ENSG00000068078	TRUE	Approved	2001-04-03	Phase III Clinical Trial	FGFR3
Kidney Neoplasms	ENSG00000069667	FALSE	Preclinical	2016-01-11	Absent	RORA
Kidney Neoplasms	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Kidney Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Kidney Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Kidney Neoplasms	ENSG00000077238	FALSE	Phase I Clinical Trial	1996-06-15	Unused	IL4R
Kidney Neoplasms	ENSG00000077782	TRUE	Approved	2001-04-03	Phase III Clinical Trial	FGFR1
Kidney Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-02-11	Preclinical	HSP90AA1
Kidney Neoplasms	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Kidney Neoplasms	ENSG00000081985	FALSE	Phase I Clinical Trial	2001-06-07	Unused	IL12RB2
Kidney Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2001-11-05	Unused	ITGB5
Kidney Neoplasms	ENSG00000083312	FALSE	unknown	2005-06-27	Unused	TNPO1
Kidney Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Kidney Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	FOLH1
Kidney Neoplasms	ENSG00000087088	FALSE	Preclinical	2001-12-04	Unused	BAX
Kidney Neoplasms	ENSG00000087494	FALSE	Preclinical	2009-03-06	Unused	PTHLH
Kidney Neoplasms	ENSG00000087586	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	AURKA
Kidney Neoplasms	ENSG00000089685	FALSE	Preclinical	2014-02-12	Absent	BIRC5
Kidney Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2004-06-08	Phase II Clinical Trial	LAG3
Kidney Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Kidney Neoplasms	ENSG00000092969	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB2
Kidney Neoplasms	ENSG00000094631	FALSE	Preclinical	2003-03-06	Preclinical	HDAC6
Kidney Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2001-06-07	Unused	IL12RB1
Kidney Neoplasms	ENSG00000097007	FALSE	Phase I Clinical Trial	2003-01-13	Phase I Clinical Trial	ABL1
Kidney Neoplasms	ENSG00000100311	TRUE	Approved	1994-06-15	Approved	PDGFB
Kidney Neoplasms	ENSG00000100385	FALSE	Phase II Clinical Trial	2012-05-28	Absent	IL2RB
Kidney Neoplasms	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Preclinical	HDAC10
Kidney Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	HIF1A
Kidney Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	1998-07-15	Unused	CD40
Kidney Neoplasms	ENSG00000101868	FALSE	Preclinical	1993-08-15	Phase I Clinical Trial	POLA1
Kidney Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Unused	XIAP
Kidney Neoplasms	ENSG00000102245	FALSE	unknown	1996-01-15	Phase II Clinical Trial	CD40LG
Kidney Neoplasms	ENSG00000102755	TRUE	Approved	1994-03-15	Approved	FLT1
Kidney Neoplasms	ENSG00000103522	FALSE	unknown	2001-01-25	Phase I Clinical Trial	IL21R
Kidney Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Kidney Neoplasms	ENSG00000104415	FALSE	Preclinical	2015-01-07	Absent	WISP1
Kidney Neoplasms	ENSG00000104432	FALSE	unknown	2001-06-01	Phase II Clinical Trial	IL7
Kidney Neoplasms	ENSG00000105146	FALSE	Phase I Clinical Trial	2007-02-06	Unused	AURKC
Kidney Neoplasms	ENSG00000105329	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB1
Kidney Neoplasms	ENSG00000105810	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CDK6
Kidney Neoplasms	ENSG00000105835	FALSE	Preclinical	2014-01-22	Absent	NAMPT
Kidney Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CG
Kidney Neoplasms	ENSG00000105976	TRUE	Approved	2001-12-18	Phase II Clinical Trial	MET
Kidney Neoplasms	ENSG00000106128	FALSE	Phase II Clinical Trial	2006-06-29	Unused	GHRHR
Kidney Neoplasms	ENSG00000106211	FALSE	Phase II Clinical Trial	2005-04-26	Preclinical	HSPB1
Kidney Neoplasms	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Kidney Neoplasms	ENSG00000106546	FALSE	unknown	1999-04-13	Phase I Clinical Trial	AHR
Kidney Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase I Clinical Trial	ENG
Kidney Neoplasms	ENSG00000107159	FALSE	Phase III Clinical Trial	1999-09-08	Unused	CA9
Kidney Neoplasms	ENSG00000108424	FALSE	unknown	2005-06-27	Unused	KPNB1
Kidney Neoplasms	ENSG00000108443	FALSE	Phase I Clinical Trial	2005-06-27	Unused	RPS6KB1
Kidney Neoplasms	ENSG00000108654	FALSE	Preclinical	2006-08-30	Preclinical	DDX5
Kidney Neoplasms	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Kidney Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Phase II Clinical Trial	NFKB1
Kidney Neoplasms	ENSG00000109458	FALSE	Preclinical	2002-08-01	Unused	GAB1
Kidney Neoplasms	ENSG00000109471	FALSE	Phase I Clinical Trial	1993-10-15	Unused	IL2
Kidney Neoplasms	ENSG00000110195	FALSE	unknown	2007-05-30	Unused	FOLR1
Kidney Neoplasms	ENSG00000111537	FALSE	Phase I Clinical Trial	NA	Unused	IFNG
Kidney Neoplasms	ENSG00000111679	FALSE	Phase II Clinical Trial	2005-08-19	Unused	PTPN6
Kidney Neoplasms	ENSG00000112062	FALSE	Phase I Clinical Trial	2008-09-05	Phase I Clinical Trial	MAPK14
Kidney Neoplasms	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Kidney Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Approved	VEGFA
Kidney Neoplasms	ENSG00000113249	FALSE	Phase II Clinical Trial	2006-08-25	Preclinical	HAVCR1
Kidney Neoplasms	ENSG00000113302	FALSE	Phase I Clinical Trial	2001-10-02	Unused	IL12B
Kidney Neoplasms	ENSG00000113361	FALSE	Phase I Clinical Trial	2016-06-25	Absent	CDH6
Kidney Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Kidney Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Kidney Neoplasms	ENSG00000113721	TRUE	Approved	2001-04-03	Approved	PDGFRB
Kidney Neoplasms	ENSG00000113749	FALSE	Phase II Clinical Trial	1996-05-15	Unused	HRH2
Kidney Neoplasms	ENSG00000114423	FALSE	Phase I Clinical Trial	2011-06-24	Absent	CBLB
Kidney Neoplasms	ENSG00000115053	FALSE	Phase II Clinical Trial	2003-03-13	Unused	NCL
Kidney Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB6
Kidney Neoplasms	ENSG00000115414	FALSE	Phase I Clinical Trial	2001-06-07	Unused	FN1
Kidney Neoplasms	ENSG00000115419	FALSE	Phase II Clinical Trial	2013-05-02	Absent	GLS
Kidney Neoplasms	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Kidney Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Kidney Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Kidney Neoplasms	ENSG00000116044	FALSE	unknown	2005-05-27	Unused	NFE2L2
Kidney Neoplasms	ENSG00000116478	FALSE	Phase I Clinical Trial	1994-12-15	Phase I Clinical Trial	HDAC1
Kidney Neoplasms	ENSG00000118520	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG1
Kidney Neoplasms	ENSG00000119699	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB3
Kidney Neoplasms	ENSG00000119888	FALSE	Preclinical	2000-11-07	Unused	EPCAM
Kidney Neoplasms	ENSG00000120156	TRUE	Approved	2001-12-18	Phase II Clinical Trial	TEK
Kidney Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Kidney Neoplasms	ENSG00000120885	FALSE	unknown	2001-12-07	Unused	CLU
Kidney Neoplasms	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Kidney Neoplasms	ENSG00000121594	FALSE	unknown	2001-06-01	Phase II Clinical Trial	CD80
Kidney Neoplasms	ENSG00000121858	FALSE	unknown	2006-07-10	Unused	TNFSF10
Kidney Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Kidney Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	2009-04-07	Phase II Clinical Trial	CXCR4
Kidney Neoplasms	ENSG00000122025	TRUE	Approved	1994-06-15	Approved	FLT3
Kidney Neoplasms	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Kidney Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Kidney Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2004-03-29	Phase I Clinical Trial	CD70
Kidney Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K2
Kidney Neoplasms	ENSG00000128052	TRUE	Approved	1994-06-15	Approved	KDR
Kidney Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Kidney Neoplasms	ENSG00000130669	FALSE	Preclinical	2014-01-22	Absent	PAK4
Kidney Neoplasms	ENSG00000130816	FALSE	Phase I Clinical Trial	1996-06-15	Unused	DNMT1
Kidney Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Absent	IDO1
Kidney Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Kidney Neoplasms	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Kidney Neoplasms	ENSG00000131981	FALSE	unknown	1997-05-15	Unused	LGALS3
Kidney Neoplasms	ENSG00000132155	TRUE	Approved	1994-06-15	Approved	RAF1
Kidney Neoplasms	ENSG00000132906	FALSE	unknown	1997-05-15	Unused	CASP9
Kidney Neoplasms	ENSG00000134460	TRUE	Approved	2000-11-07	Approved	IL2RA
Kidney Neoplasms	ENSG00000134853	TRUE	Approved	2000-07-05	Approved	PDGFRA
Kidney Neoplasms	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Kidney Neoplasms	ENSG00000135446	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CDK4
Kidney Neoplasms	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-11-21	Absent	MDM2
Kidney Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Unused	IL6
Kidney Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Kidney Neoplasms	ENSG00000136807	FALSE	unknown	1996-05-15	Unused	CDK9
Kidney Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Kidney Neoplasms	ENSG00000136869	FALSE	Phase I Clinical Trial	2012-08-06	Absent	TLR4
Kidney Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Kidney Neoplasms	ENSG00000137193	FALSE	Preclinical	2009-02-13	Preclinical	PIM1
Kidney Neoplasms	ENSG00000138061	FALSE	unknown	NA	Unused	CYP1B1
Kidney Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Kidney Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2001-11-05	Unused	ITGAV
Kidney Neoplasms	ENSG00000138735	FALSE	unknown	1999-01-08	Unused	PDE5A
Kidney Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Phase I Clinical Trial	CD27
Kidney Neoplasms	ENSG00000139567	FALSE	unknown	2007-05-30	Phase II Clinical Trial	ACVRL1
Kidney Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Kidney Neoplasms	ENSG00000140465	FALSE	unknown	1999-04-13	Phase I Clinical Trial	CYP1A1
Kidney Neoplasms	ENSG00000140538	FALSE	Preclinical	2012-03-14	Absent	NTRK3
Kidney Neoplasms	ENSG00000141510	FALSE	unknown	1996-05-15	Phase II Clinical Trial	TP53
Kidney Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	1990-09-15	Phase I Clinical Trial	ERBB2
Kidney Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Kidney Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Kidney Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Kidney Neoplasms	ENSG00000143171	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRG
Kidney Neoplasms	ENSG00000143217	FALSE	Phase II Clinical Trial	2004-10-18	Absent	NECTIN4
Kidney Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Kidney Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Kidney Neoplasms	ENSG00000143437	FALSE	Preclinical	2015-07-29	Absent	ARNT
Kidney Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Unused	SRD5A1
Kidney Neoplasms	ENSG00000146049	FALSE	Preclinical	2015-02-24	Absent	KAAG1
Kidney Neoplasms	ENSG00000146242	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	TPBG
Kidney Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1995-03-15	Phase III Clinical Trial	EGFR
Kidney Neoplasms	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Kidney Neoplasms	ENSG00000147099	FALSE	Preclinical	2003-03-06	Preclinical	HDAC8
Kidney Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Kidney Neoplasms	ENSG00000150337	FALSE	unknown	1992-02-15	Unused	FCGR1A
Kidney Neoplasms	ENSG00000150630	FALSE	unknown	2003-12-09	Unused	VEGFC
Kidney Neoplasms	ENSG00000153563	FALSE	Phase III Clinical Trial	2007-07-23	Unused	CD8A
Kidney Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Kidney Neoplasms	ENSG00000154229	FALSE	unknown	NA	Unused	PRKCA
Kidney Neoplasms	ENSG00000154269	FALSE	Phase II Clinical Trial	2009-09-29	Absent	ENPP3
Kidney Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Kidney Neoplasms	ENSG00000157404	TRUE	Approved	2000-07-05	Approved	KIT
Kidney Neoplasms	ENSG00000157764	TRUE	Approved	2001-04-03	Approved	BRAF
Kidney Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2016-04-26	Absent	SLC34A2
Kidney Neoplasms	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Kidney Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Kidney Neoplasms	ENSG00000160712	FALSE	unknown	2005-01-11	Unused	IL6R
Kidney Neoplasms	ENSG00000160867	TRUE	Approved	2003-07-22	Absent	FGFR4
Kidney Neoplasms	ENSG00000161011	FALSE	Phase II Clinical Trial	2015-11-04	Absent	SQSTM1
Kidney Neoplasms	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Kidney Neoplasms	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Kidney Neoplasms	ENSG00000163220	FALSE	Phase II Clinical Trial	2001-05-18	Phase II Clinical Trial	S100A9
Kidney Neoplasms	ENSG00000163517	FALSE	Phase I Clinical Trial	2010-08-16	Phase I Clinical Trial	HDAC11
Kidney Neoplasms	ENSG00000163599	FALSE	Pre-registration	1998-09-15	Phase II Clinical Trial	CTLA4
Kidney Neoplasms	ENSG00000163737	FALSE	unknown	NA	Unused	PF4
Kidney Neoplasms	ENSG00000164078	FALSE	Phase I Clinical Trial	2001-12-18	Phase II Clinical Trial	MST1R
Kidney Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	1994-07-15	Unused	CASP3
Kidney Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Unused	TLR3
Kidney Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2000-07-26	Phase II Clinical Trial	TERT
Kidney Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Kidney Neoplasms	ENSG00000165025	FALSE	unknown	2003-10-31	Phase II Clinical Trial	SYK
Kidney Neoplasms	ENSG00000165197	FALSE	unknown	2003-12-09	Unused	VEGFD
Kidney Neoplasms	ENSG00000165304	FALSE	Preclinical	2013-07-03	Absent	MELK
Kidney Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Unused	ENOX2
Kidney Neoplasms	ENSG00000165731	TRUE	Approved	1994-06-15	Approved	RET
Kidney Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Kidney Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	PLK1
Kidney Neoplasms	ENSG00000167325	FALSE	unknown	1993-07-15	Unused	RRM1
Kidney Neoplasms	ENSG00000167601	FALSE	Phase I Clinical Trial	2004-06-18	Phase II Clinical Trial	AXL
Kidney Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1996-06-15	Unused	EEF2
Kidney Neoplasms	ENSG00000168078	FALSE	Preclinical	2016-03-07	Absent	PBK
Kidney Neoplasms	ENSG00000168811	FALSE	Phase I Clinical Trial	2001-10-02	Unused	IL12A
Kidney Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K1
Kidney Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Kidney Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2009-10-16	Phase I Clinical Trial	PTK2
Kidney Neoplasms	ENSG00000169403	FALSE	unknown	1991-07-15	Unused	PTAFR
Kidney Neoplasms	ENSG00000170430	FALSE	unknown	1998-06-15	Unused	MGMT
Kidney Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Kidney Neoplasms	ENSG00000171094	FALSE	Preclinical	2006-12-05	Preclinical	ALK
Kidney Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CD
Kidney Neoplasms	ENSG00000171720	FALSE	Phase I Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC3
Kidney Neoplasms	ENSG00000171791	FALSE	unknown	1992-03-15	Unused	BCL2
Kidney Neoplasms	ENSG00000171848	FALSE	Preclinical	1998-11-15	Unused	RRM2
Kidney Neoplasms	ENSG00000171862	TRUE	Approved	1999-02-15	Approved	PTEN
Kidney Neoplasms	ENSG00000172889	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	EGFL7
Kidney Neoplasms	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Kidney Neoplasms	ENSG00000173511	FALSE	unknown	2003-12-09	Unused	VEGFB
Kidney Neoplasms	ENSG00000174807	FALSE	unknown	2004-10-18	Unused	CD248
Kidney Neoplasms	ENSG00000175054	FALSE	Preclinical	2013-07-22	Absent	ATR
Kidney Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	TYMS
Kidney Neoplasms	ENSG00000178568	FALSE	unknown	2003-12-08	Unused	ERBB4
Kidney Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2007-02-06	Phase I Clinical Trial	AURKB
Kidney Neoplasms	ENSG00000179295	FALSE	Phase II Clinical Trial	2005-08-19	Unused	PTPN11
Kidney Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Phase II Clinical Trial	CDH5
Kidney Neoplasms	ENSG00000180616	FALSE	unknown	1999-09-02	Absent	SSTR2
Kidney Neoplasms	ENSG00000182578	FALSE	Phase III Clinical Trial	2005-04-26	Phase I Clinical Trial	CSF1R
Kidney Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Kidney Neoplasms	ENSG00000183813	FALSE	Preclinical	2004-02-03	Absent	CCR4
Kidney Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Kidney Neoplasms	ENSG00000184564	FALSE	Phase I Clinical Trial	2013-05-03	Absent	SLITRK6
Kidney Neoplasms	ENSG00000184937	FALSE	Phase I Clinical Trial	2008-10-09	Unused	WT1
Kidney Neoplasms	ENSG00000185499	FALSE	Phase I Clinical Trial	2002-09-30	Phase II Clinical Trial	MUC1
Kidney Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	PRAME
Kidney Neoplasms	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Kidney Neoplasms	ENSG00000186350	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRA
Kidney Neoplasms	ENSG00000186642	FALSE	unknown	1999-01-08	Unused	PDE2A
Kidney Neoplasms	ENSG00000186716	FALSE	Phase I Clinical Trial	2003-01-13	Phase I Clinical Trial	BCR
Kidney Neoplasms	ENSG00000186827	FALSE	Phase II Clinical Trial	2014-12-15	Absent	TNFRSF4
Kidney Neoplasms	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Kidney Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Phase III Clinical Trial	PDCD1
Kidney Neoplasms	ENSG00000196396	FALSE	Phase II Clinical Trial	2005-08-19	Unused	PTPN1
Kidney Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2004-08-23	Phase II Clinical Trial	EPHB4
Kidney Neoplasms	ENSG00000196591	FALSE	Phase I Clinical Trial	1994-12-15	Phase I Clinical Trial	HDAC2
Kidney Neoplasms	ENSG00000197122	FALSE	Phase I Clinical Trial	2003-01-13	Phase I Clinical Trial	SRC
Kidney Neoplasms	ENSG00000197635	FALSE	unknown	2004-02-24	Unused	DPP4
Kidney Neoplasms	ENSG00000198223	FALSE	unknown	1994-08-15	Phase II Clinical Trial	CSF2RA
Kidney Neoplasms	ENSG00000198400	FALSE	Preclinical	2012-03-14	Absent	NTRK1
Kidney Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Approved	MTOR
Kidney Neoplasms	ENSG00000198851	FALSE	Preclinical	2015-01-07	Absent	CD3E
Kidney Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	TOP1
Kidney Neoplasms	ENSG00000213903	FALSE	unknown	2000-02-23	Unused	LTB4R
Kidney Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Kidney Neoplasms	ENSG00000239732	FALSE	Phase I Clinical Trial	1998-10-15	Phase II Clinical Trial	TLR9
Kidney Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Kidney Neoplasms	ENSG00000243955	FALSE	Phase I Clinical Trial	1994-07-15	Unused	GSTA1
Kidney Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Kidney Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Kidney Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2001-11-05	Unused	ITGB3
Kidney Neoplasms	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Labyrinth Diseases	ENSG00000118515	FALSE	Preclinical	2017-04-07	Absent	SGK1
Lactation Disorders	ENSG00000180914	FALSE	Phase II Clinical Trial	2012-07-23	Absent	OXTR
Leber Congenital Amaurosis	ENSG00000081237	FALSE	Preclinical	2014-09-25	Absent	PTPRC
Leber Congenital Amaurosis	ENSG00000092200	FALSE	Preclinical	2005-12-03	Unused	RPGRIP1
Leber Congenital Amaurosis	ENSG00000116745	TRUE	Approved	2003-12-10	Phase II Clinical Trial	RPE65
Leber Congenital Amaurosis	ENSG00000198707	FALSE	Phase II Clinical Trial	2012-11-23	Absent	CEP290
Lecithin Cholesterol Acyltransferase Deficiency	ENSG00000213398	FALSE	Preclinical	2013-04-25	Absent	LCAT
Leiomyoma	ENSG00000067182	FALSE	Phase II Clinical Trial	NA	Unused	TNFRSF1A
Leiomyoma	ENSG00000082175	TRUE	Approved	1989-07-15	Approved	PGR
Leiomyoma	ENSG00000091831	FALSE	Preclinical	2003-08-20	Unused	ESR1
Leiomyoma	ENSG00000108786	FALSE	Preclinical	2000-02-09	Unused	HSD17B1
Leiomyoma	ENSG00000109163	TRUE	Approved	1989-08-15	Approved	GNRHR
Leiomyoma	ENSG00000112062	FALSE	Phase II Clinical Trial	NA	Unused	MAPK14
Leiomyoma	ENSG00000113580	FALSE	Phase II Clinical Trial	2010-04-23	Phase II Clinical Trial	NR3C1
Leiomyoma	ENSG00000137869	FALSE	unknown	1993-06-15	Unused	CYP19A1
Leiomyoma	ENSG00000138039	FALSE	Preclinical	2009-02-19	Absent	LHCGR
Leiomyoma	ENSG00000147437	FALSE	Phase III Clinical Trial	2008-02-04	Absent	GNRH1
Leiomyoma	ENSG00000169083	FALSE	unknown	2011-03-17	Unused	AR
Leiomyoma	ENSG00000169836	FALSE	Phase II Clinical Trial	2007-09-12	Absent	TACR3
Leiomyoma	ENSG00000170820	FALSE	Preclinical	2009-02-19	Absent	FSHR
Leiomyoma	ENSG00000180210	FALSE	unknown	2004-07-19	Unused	F2
Leiomyosarcoma	ENSG00000037280	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT4
Leiomyosarcoma	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Absent	FGFR3
Leiomyosarcoma	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Absent	FGFR1
Leiomyosarcoma	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Phase I Clinical Trial	BIRC5
Leiomyosarcoma	ENSG00000091879	FALSE	unknown	2010-10-29	Absent	ANGPT2
Leiomyosarcoma	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Unused	ABL1
Leiomyosarcoma	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Leiomyosarcoma	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT1
Leiomyosarcoma	ENSG00000105976	FALSE	unknown	2004-08-09	Phase I Clinical Trial	MET
Leiomyosarcoma	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Leiomyosarcoma	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Leiomyosarcoma	ENSG00000120156	FALSE	unknown	2004-08-09	Phase I Clinical Trial	TEK
Leiomyosarcoma	ENSG00000122025	FALSE	unknown	2004-08-09	Phase I Clinical Trial	FLT3
Leiomyosarcoma	ENSG00000126934	FALSE	Phase I Clinical Trial	2003-06-09	Unused	MAP2K2
Leiomyosarcoma	ENSG00000128052	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KDR
Leiomyosarcoma	ENSG00000131747	FALSE	Phase I Clinical Trial	2001-10-29	Unused	TOP2A
Leiomyosarcoma	ENSG00000134853	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRA
Leiomyosarcoma	ENSG00000138448	FALSE	unknown	1995-01-15	Unused	ITGAV
Leiomyosarcoma	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Leiomyosarcoma	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Leiomyosarcoma	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Leiomyosarcoma	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Leiomyosarcoma	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KIT
Leiomyosarcoma	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	BRAF
Leiomyosarcoma	ENSG00000165731	FALSE	unknown	2004-08-09	Phase I Clinical Trial	RET
Leiomyosarcoma	ENSG00000166851	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Leiomyosarcoma	ENSG00000169032	FALSE	Phase I Clinical Trial	2003-06-09	Unused	MAP2K1
Leiomyosarcoma	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Leiomyosarcoma	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Unused	SRC
Leiomyosarcoma	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Leiomyosarcoma	ENSG00000198793	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTOR
Leiomyosarcoma	ENSG00000198900	FALSE	unknown	1993-07-15	Unused	TOP1
Leiomyosarcoma	ENSG00000259207	FALSE	unknown	1995-01-15	Unused	ITGB3
Leishmaniasis	ENSG00000080644	FALSE	Phase I Clinical Trial	2012-11-02	Preclinical	CHRNA3
Leishmaniasis	ENSG00000111679	TRUE	Approved	2005-08-19	Approved	PTPN6
Leishmaniasis	ENSG00000117971	FALSE	Phase I Clinical Trial	2012-11-02	Preclinical	CHRNB4
Leishmaniasis	ENSG00000136869	FALSE	Preclinical	2010-07-24	Unused	TLR4
Leishmaniasis	ENSG00000137462	FALSE	Preclinical	2010-07-24	Unused	TLR2
Leishmaniasis	ENSG00000141510	FALSE	Preclinical	2011-08-04	Absent	TP53
Leishmaniasis	ENSG00000156508	FALSE	Preclinical	2013-03-02	Preclinical	EEF1A1
Leishmaniasis	ENSG00000179295	TRUE	Approved	2005-08-19	Approved	PTPN11
Leishmaniasis	ENSG00000196396	TRUE	Approved	2005-08-19	Approved	PTPN1
Leishmaniasis	ENSG00000260314	FALSE	Preclinical	2017-08-16	Absent	MRC1
Leprosy	ENSG00000086205	FALSE	Approved	NA	Absent	FOLH1
Leprosy	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Lesch-Nyhan Syndrome	ENSG00000169676	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	DRD5
Lesch-Nyhan Syndrome	ENSG00000184845	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	DRD1
Lesch-Nyhan Syndrome	ENSG00000196839	FALSE	Preclinical	NA	Unused	ADA
Lesch-Nyhan Syndrome	ENSG00000198805	FALSE	Preclinical	NA	Unused	PNP
Leukemia	ENSG00000004468	FALSE	Preclinical	2002-05-21	Unused	CD38
Leukemia	ENSG00000004487	FALSE	Preclinical	2016-10-26	Absent	KDM1A
Leukemia	ENSG00000010610	FALSE	Preclinical	NA	Absent	CD4
Leukemia	ENSG00000012124	FALSE	Phase II Clinical Trial	2006-09-05	Phase II Clinical Trial	CD22
Leukemia	ENSG00000026508	FALSE	Preclinical	2001-08-13	Unused	CD44
Leukemia	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Leukemia	ENSG00000037280	FALSE	unknown	2005-06-27	Absent	FLT4
Leukemia	ENSG00000066468	FALSE	unknown	2005-06-27	Absent	FGFR2
Leukemia	ENSG00000068078	FALSE	unknown	2005-06-27	Absent	FGFR3
Leukemia	ENSG00000070501	TRUE	Approved	2002-07-09	Approved	POLB
Leukemia	ENSG00000077238	FALSE	Preclinical	1991-04-15	Unused	IL4R
Leukemia	ENSG00000077782	FALSE	unknown	2005-06-27	Absent	FGFR1
Leukemia	ENSG00000080824	FALSE	Preclinical	2015-02-06	Absent	HSP90AA1
Leukemia	ENSG00000082701	FALSE	Preclinical	2010-06-30	Unused	GSK3B
Leukemia	ENSG00000085563	FALSE	unknown	1996-05-15	Unused	ABCB1
Leukemia	ENSG00000087586	FALSE	unknown	2005-06-27	Absent	AURKA
Leukemia	ENSG00000090534	FALSE	Preclinical	2004-09-14	Unused	THPO
Leukemia	ENSG00000091831	FALSE	Preclinical	2010-02-19	Unused	ESR1
Leukemia	ENSG00000094631	FALSE	Preclinical	2010-08-16	Preclinical	HDAC6
Leukemia	ENSG00000096968	FALSE	Preclinical	1994-12-15	Unused	JAK2
Leukemia	ENSG00000097007	FALSE	Phase II Clinical Trial	1996-06-15	Unused	ABL1
Leukemia	ENSG00000100385	FALSE	Preclinical	2008-07-24	Unused	IL2RB
Leukemia	ENSG00000100429	FALSE	Preclinical	2010-08-16	Preclinical	HDAC10
Leukemia	ENSG00000100644	FALSE	unknown	2003-05-16	Unused	HIF1A
Leukemia	ENSG00000101868	TRUE	Approved	1997-04-15	Approved	POLA1
Leukemia	ENSG00000102096	FALSE	unknown	2006-11-29	Unused	PIM2
Leukemia	ENSG00000102755	FALSE	unknown	1994-03-15	Phase II Clinical Trial	FLT1
Leukemia	ENSG00000104894	FALSE	Preclinical	2016-02-03	Absent	CD37
Leukemia	ENSG00000105329	FALSE	Preclinical	2015-06-16	Absent	TGFB1
Leukemia	ENSG00000105383	FALSE	unknown	2016-02-16	Absent	CD33
Leukemia	ENSG00000105639	FALSE	Preclinical	1999-07-20	Unused	JAK3
Leukemia	ENSG00000105810	FALSE	Preclinical	2015-12-22	Absent	CDK6
Leukemia	ENSG00000105851	FALSE	Phase I Clinical Trial	2013-06-13	Absent	PIK3CG
Leukemia	ENSG00000106348	FALSE	Preclinical	2000-11-09	Unused	IMPDH1
Leukemia	ENSG00000106683	FALSE	Preclinical	2014-04-03	Absent	LIMK1
Leukemia	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Leukemia	ENSG00000110448	FALSE	Phase III Clinical Trial	1993-10-15	Unused	CD5
Leukemia	ENSG00000111424	FALSE	Preclinical	1995-05-15	Unused	VDR
Leukemia	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Leukemia	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Leukemia	ENSG00000115008	FALSE	unknown	2009-12-07	Absent	IL1A
Leukemia	ENSG00000115053	FALSE	unknown	2004-03-31	Absent	NCL
Leukemia	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Leukemia	ENSG00000116478	FALSE	Phase I Clinical Trial	2001-11-05	Unused	HDAC1
Leukemia	ENSG00000118520	FALSE	Phase I Clinical Trial	2007-10-09	Phase I Clinical Trial	ARG1
Leukemia	ENSG00000120889	FALSE	unknown	2003-05-16	Unused	TNFRSF10B
Leukemia	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Phase II Clinical Trial	TNFRSF8
Leukemia	ENSG00000122025	FALSE	Preclinical	2004-11-15	Unused	FLT3
Leukemia	ENSG00000124762	FALSE	Phase I Clinical Trial	2001-11-05	Unused	CDKN1A
Leukemia	ENSG00000126934	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAP2K2
Leukemia	ENSG00000128052	FALSE	Preclinical	2005-06-27	Unused	KDR
Leukemia	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Leukemia	ENSG00000131747	TRUE	Approved	1992-04-15	Approved	TOP2A
Leukemia	ENSG00000133895	FALSE	Preclinical	2017-01-04	Absent	MEN1
Leukemia	ENSG00000134460	FALSE	Phase I Clinical Trial	1992-04-15	Unused	IL2RA
Leukemia	ENSG00000134853	FALSE	Phase II Clinical Trial	1996-06-15	Unused	PDGFRA
Leukemia	ENSG00000135446	FALSE	Preclinical	2015-12-22	Absent	CDK4
Leukemia	ENSG00000135679	FALSE	Preclinical	NA	Absent	MDM2
Leukemia	ENSG00000136807	FALSE	Preclinical	2015-12-22	Absent	CDK9
Leukemia	ENSG00000137101	FALSE	Preclinical	2001-04-26	Unused	CD72
Leukemia	ENSG00000137193	FALSE	unknown	2006-11-29	Unused	PIM1
Leukemia	ENSG00000137752	FALSE	Preclinical	1998-07-15	Unused	CASP1
Leukemia	ENSG00000139193	FALSE	Phase I Clinical Trial	2008-11-12	Phase I Clinical Trial	CD27
Leukemia	ENSG00000141867	FALSE	Preclinical	2014-06-10	Absent	BRD4
Leukemia	ENSG00000142168	FALSE	unknown	2002-07-01	Unused	SOD1
Leukemia	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	EGFR
Leukemia	ENSG00000146904	FALSE	unknown	2005-06-27	Absent	EPHA1
Leukemia	ENSG00000147099	FALSE	Preclinical	2010-08-16	Preclinical	HDAC8
Leukemia	ENSG00000148400	FALSE	unknown	2009-02-06	Phase I Clinical Trial	NOTCH1
Leukemia	ENSG00000153563	FALSE	Phase III Clinical Trial	1993-10-15	Unused	CD8A
Leukemia	ENSG00000156136	FALSE	Preclinical	2016-03-14	Absent	DCK
Leukemia	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Leukemia	ENSG00000156738	FALSE	Phase II Clinical Trial	2007-08-04	Phase I Clinical Trial	MS4A1
Leukemia	ENSG00000157404	FALSE	Phase II Clinical Trial	2004-11-15	Unused	KIT
Leukemia	ENSG00000157764	FALSE	Phase I Clinical Trial	2011-11-13	Absent	BRAF
Leukemia	ENSG00000159110	FALSE	Approved	2004-07-27	Unused	IFNAR2
Leukemia	ENSG00000162434	FALSE	Preclinical	2017-07-24	Absent	JAK1
Leukemia	ENSG00000162961	FALSE	Preclinical	2017-12-04	Absent	DPY30
Leukemia	ENSG00000163517	FALSE	Preclinical	2010-08-16	Preclinical	HDAC11
Leukemia	ENSG00000163599	FALSE	unknown	1998-09-15	Unused	CTLA4
Leukemia	ENSG00000163932	FALSE	Preclinical	2004-02-11	Unused	PRKCD
Leukemia	ENSG00000164305	FALSE	Preclinical	2001-10-31	Unused	CASP3
Leukemia	ENSG00000166851	FALSE	Phase I Clinical Trial	NA	Absent	PLK1
Leukemia	ENSG00000167325	FALSE	unknown	1997-03-15	Unused	RRM1
Leukemia	ENSG00000167658	FALSE	Phase I Clinical Trial	1991-04-15	Unused	EEF2
Leukemia	ENSG00000168522	FALSE	unknown	1997-06-15	Unused	FNTA
Leukemia	ENSG00000168610	FALSE	unknown	2007-08-28	Phase I Clinical Trial	STAT3
Leukemia	ENSG00000169032	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAP2K1
Leukemia	ENSG00000169136	FALSE	Preclinical	2016-07-14	Absent	ATF5
Leukemia	ENSG00000169403	FALSE	unknown	1991-07-15	Unused	PTAFR
Leukemia	ENSG00000170430	FALSE	unknown	2000-05-03	Unused	MGMT
Leukemia	ENSG00000171552	FALSE	unknown	NA	Absent	BCL2L1
Leukemia	ENSG00000171608	FALSE	Phase I Clinical Trial	2011-09-02	Unused	PIK3CD
Leukemia	ENSG00000171720	FALSE	Preclinical	2010-08-16	Preclinical	HDAC3
Leukemia	ENSG00000171791	FALSE	Preclinical	2009-04-29	Phase I Clinical Trial	BCL2
Leukemia	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Leukemia	ENSG00000177455	FALSE	Phase II Clinical Trial	2006-09-05	Unused	CD19
Leukemia	ENSG00000177606	FALSE	Preclinical	1994-06-15	Unused	JUN
Leukemia	ENSG00000178035	FALSE	unknown	2000-11-09	Unused	IMPDH2
Leukemia	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Leukemia	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Leukemia	ENSG00000182578	FALSE	unknown	2005-06-27	Absent	CSF1R
Leukemia	ENSG00000182866	FALSE	Preclinical	1998-10-15	Unused	LCK
Leukemia	ENSG00000184047	FALSE	Phase II Clinical Trial	2008-11-24	Absent	DIABLO
Leukemia	ENSG00000184937	FALSE	Preclinical	2005-08-10	Unused	WT1
Leukemia	ENSG00000185291	FALSE	Phase III Clinical Trial	1994-06-15	Unused	IL3RA
Leukemia	ENSG00000186431	FALSE	Preclinical	2008-11-03	Preclinical	FCAR
Leukemia	ENSG00000186716	FALSE	Phase II Clinical Trial	2001-10-17	Unused	BCR
Leukemia	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-11-15	Absent	PDCD1
Leukemia	ENSG00000196363	FALSE	Preclinical	2017-02-23	Absent	WDR5
Leukemia	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Leukemia	ENSG00000196591	FALSE	Phase I Clinical Trial	2001-11-05	Unused	HDAC2
Leukemia	ENSG00000196776	FALSE	Preclinical	2014-05-27	Absent	CD47
Leukemia	ENSG00000196839	FALSE	Approved	1991-06-15	Unused	ADA
Leukemia	ENSG00000197122	FALSE	unknown	2005-06-27	Absent	SRC
Leukemia	ENSG00000197635	FALSE	unknown	2004-02-24	Unused	DPP4
Leukemia	ENSG00000198223	FALSE	Approved	1991-09-15	Unused	CSF2RA
Leukemia	ENSG00000198355	FALSE	unknown	2006-11-29	Unused	PIM3
Leukemia	ENSG00000198625	FALSE	Preclinical	NA	Absent	MDM4
Leukemia	ENSG00000198793	FALSE	Preclinical	2013-07-09	Phase II Clinical Trial	MTOR
Leukemia	ENSG00000198900	FALSE	Phase I Clinical Trial	1993-07-15	Phase I Clinical Trial	TOP1
Leukemia, Hairy Cell	ENSG00000012124	FALSE	Phase III Clinical Trial	2001-03-27	Phase I Clinical Trial	CD22
Leukemia, Hairy Cell	ENSG00000070501	TRUE	Approved	1993-07-15	Unused	POLB
Leukemia, Hairy Cell	ENSG00000101868	TRUE	Approved	1993-07-15	Unused	POLA1
Leukemia, Hairy Cell	ENSG00000126934	FALSE	Phase II Clinical Trial	NA	Absent	MAP2K2
Leukemia, Hairy Cell	ENSG00000157764	FALSE	Phase II Clinical Trial	2009-04-21	Absent	BRAF
Leukemia, Hairy Cell	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Leukemia, Hairy Cell	ENSG00000167658	FALSE	Phase III Clinical Trial	2001-03-27	Phase I Clinical Trial	EEF2
Leukemia, Hairy Cell	ENSG00000169032	FALSE	Phase II Clinical Trial	NA	Absent	MAP2K1
Leukemia, Hairy Cell	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-04-30	Absent	ATR
Leukemia, Hairy Cell	ENSG00000185291	FALSE	Phase I Clinical Trial	2007-03-13	Absent	IL3RA
Leukemia, Hairy Cell	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Leukemia, Hairy Cell	ENSG00000196839	TRUE	Approved	1991-06-15	Approved	ADA
Leukemia, Lymphoid	ENSG00000000938	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	FGR
Leukemia, Lymphoid	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Phase I Clinical Trial	CD38
Leukemia, Lymphoid	ENSG00000004487	FALSE	Phase I Clinical Trial	2008-07-31	Absent	KDM1A
Leukemia, Lymphoid	ENSG00000007312	FALSE	unknown	2011-02-09	Phase I Clinical Trial	CD79B
Leukemia, Lymphoid	ENSG00000010671	TRUE	Approved	2007-12-12	Phase III Clinical Trial	BTK
Leukemia, Lymphoid	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Approved	FYN
Leukemia, Lymphoid	ENSG00000012124	TRUE	Approved	1993-08-15	Phase III Clinical Trial	CD22
Leukemia, Lymphoid	ENSG00000019582	FALSE	Phase II Clinical Trial	2003-04-08	Phase II Clinical Trial	CD74
Leukemia, Lymphoid	ENSG00000026103	FALSE	Preclinical	NA	Preclinical	FAS
Leukemia, Lymphoid	ENSG00000026508	FALSE	unknown	1998-12-15	Absent	CD44
Leukemia, Lymphoid	ENSG00000037280	FALSE	unknown	2005-06-27	Phase I Clinical Trial	FLT4
Leukemia, Lymphoid	ENSG00000044524	FALSE	Phase II Clinical Trial	2004-03-23	Phase I Clinical Trial	EPHA3
Leukemia, Lymphoid	ENSG00000048462	FALSE	Phase I Clinical Trial	2012-01-25	Absent	TNFRSF17
Leukemia, Lymphoid	ENSG00000049249	FALSE	Phase I Clinical Trial	2005-11-15	Preclinical	TNFRSF9
Leukemia, Lymphoid	ENSG00000051382	FALSE	unknown	2009-05-05	Phase I Clinical Trial	PIK3CB
Leukemia, Lymphoid	ENSG00000055118	FALSE	Preclinical	NA	Absent	KCNH2
Leukemia, Lymphoid	ENSG00000066468	TRUE	Approved	2005-06-27	Approved	FGFR2
Leukemia, Lymphoid	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Leukemia, Lymphoid	ENSG00000068078	TRUE	Approved	2005-06-27	Approved	FGFR3
Leukemia, Lymphoid	ENSG00000069667	FALSE	Preclinical	2011-01-18	Preclinical	RORA
Leukemia, Lymphoid	ENSG00000070501	FALSE	Phase II Clinical Trial	1996-08-15	Phase II Clinical Trial	POLB
Leukemia, Lymphoid	ENSG00000072694	FALSE	Phase II Clinical Trial	2005-08-09	Unused	FCGR2B
Leukemia, Lymphoid	ENSG00000073756	FALSE	unknown	2002-03-25	Unused	PTGS2
Leukemia, Lymphoid	ENSG00000077097	FALSE	unknown	1994-06-15	Unused	TOP2B
Leukemia, Lymphoid	ENSG00000077238	FALSE	unknown	2001-02-19	Unused	IL4R
Leukemia, Lymphoid	ENSG00000077782	TRUE	Approved	2005-06-27	Approved	FGFR1
Leukemia, Lymphoid	ENSG00000078098	FALSE	unknown	2001-06-11	Unused	FAP
Leukemia, Lymphoid	ENSG00000080824	FALSE	Phase I Clinical Trial	2001-05-21	Phase II Clinical Trial	HSP90AA1
Leukemia, Lymphoid	ENSG00000082898	FALSE	Phase II Clinical Trial	2010-09-14	Phase I Clinical Trial	XPO1
Leukemia, Lymphoid	ENSG00000083312	FALSE	Phase I Clinical Trial	2005-06-27	Unused	TNPO1
Leukemia, Lymphoid	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Leukemia, Lymphoid	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Unused	BIRC5
Leukemia, Lymphoid	ENSG00000089692	FALSE	Phase I Clinical Trial	2012-10-31	Absent	LAG3
Leukemia, Lymphoid	ENSG00000091972	FALSE	unknown	2006-06-13	Phase II Clinical Trial	CD200
Leukemia, Lymphoid	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Leukemia, Lymphoid	ENSG00000096968	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	JAK2
Leukemia, Lymphoid	ENSG00000097007	TRUE	Approved	1999-03-17	Approved	ABL1
Leukemia, Lymphoid	ENSG00000097046	FALSE	Preclinical	2017-03-15	Absent	CDC7
Leukemia, Lymphoid	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Leukemia, Lymphoid	ENSG00000100462	FALSE	Preclinical	NA	Preclinical	PRMT5
Leukemia, Lymphoid	ENSG00000100823	FALSE	unknown	2007-02-13	Absent	APEX1
Leukemia, Lymphoid	ENSG00000101017	FALSE	unknown	1998-07-15	Phase II Clinical Trial	CD40
Leukemia, Lymphoid	ENSG00000101336	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	HCK
Leukemia, Lymphoid	ENSG00000101868	TRUE	Approved	1993-08-15	Approved	POLA1
Leukemia, Lymphoid	ENSG00000101966	FALSE	unknown	1999-01-08	Phase II Clinical Trial	XIAP
Leukemia, Lymphoid	ENSG00000102096	FALSE	Preclinical	2006-11-29	Unused	PIM2
Leukemia, Lymphoid	ENSG00000102245	FALSE	Phase II Clinical Trial	2002-07-22	Unused	CD40LG
Leukemia, Lymphoid	ENSG00000102524	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13B
Leukemia, Lymphoid	ENSG00000102755	TRUE	Approved	1991-02-15	Approved	FLT1
Leukemia, Lymphoid	ENSG00000104365	FALSE	Phase I Clinical Trial	2003-04-22	Unused	IKBKB
Leukemia, Lymphoid	ENSG00000104885	FALSE	Phase I Clinical Trial	2010-12-03	Phase I Clinical Trial	DOT1L
Leukemia, Lymphoid	ENSG00000104894	FALSE	Phase II Clinical Trial	2003-12-17	Phase II Clinical Trial	CD37
Leukemia, Lymphoid	ENSG00000104921	FALSE	Phase II Clinical Trial	1995-08-15	Unused	FCER2
Leukemia, Lymphoid	ENSG00000105146	FALSE	Phase I Clinical Trial	2003-10-20	Phase I Clinical Trial	AURKC
Leukemia, Lymphoid	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Unused	CCNE1
Leukemia, Lymphoid	ENSG00000105397	FALSE	Preclinical	2015-03-19	Preclinical	TYK2
Leukemia, Lymphoid	ENSG00000105810	FALSE	unknown	1996-05-15	Unused	CDK6
Leukemia, Lymphoid	ENSG00000105835	FALSE	Phase I Clinical Trial	2003-04-22	Unused	NAMPT
Leukemia, Lymphoid	ENSG00000105851	FALSE	Phase III Clinical Trial	2003-09-05	Phase I Clinical Trial	PIK3CG
Leukemia, Lymphoid	ENSG00000106462	FALSE	Phase I Clinical Trial	2016-03-18	Absent	EZH2
Leukemia, Lymphoid	ENSG00000106633	FALSE	Preclinical	2008-06-02	Unused	GCK
Leukemia, Lymphoid	ENSG00000107562	FALSE	Phase II Clinical Trial	2007-04-10	Phase II Clinical Trial	CXCL12
Leukemia, Lymphoid	ENSG00000108424	FALSE	Phase I Clinical Trial	2005-06-27	Unused	KPNB1
Leukemia, Lymphoid	ENSG00000108443	FALSE	Phase I Clinical Trial	2005-06-27	Unused	RPS6KB1
Leukemia, Lymphoid	ENSG00000108799	FALSE	Phase I Clinical Trial	2016-03-18	Absent	EZH1
Leukemia, Lymphoid	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Unused	NFKB1
Leukemia, Lymphoid	ENSG00000110092	FALSE	Phase I Clinical Trial	2007-05-16	Unused	CCND1
Leukemia, Lymphoid	ENSG00000110448	FALSE	Preclinical	2005-08-09	Unused	CD5
Leukemia, Lymphoid	ENSG00000111424	FALSE	Phase II Clinical Trial	1995-06-15	Phase II Clinical Trial	VDR
Leukemia, Lymphoid	ENSG00000112715	FALSE	Phase III Clinical Trial	1991-02-15	Phase II Clinical Trial	VEGFA
Leukemia, Lymphoid	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Leukemia, Lymphoid	ENSG00000113575	FALSE	Preclinical	2014-08-21	Absent	PPP2CA
Leukemia, Lymphoid	ENSG00000113580	FALSE	Preclinical	2013-08-21	Absent	NR3C1
Leukemia, Lymphoid	ENSG00000113721	FALSE	Phase II Clinical Trial	1991-02-15	Absent	PDGFRB
Leukemia, Lymphoid	ENSG00000113851	FALSE	Phase II Clinical Trial	2011-08-26	Absent	CRBN
Leukemia, Lymphoid	ENSG00000115008	FALSE	Phase I Clinical Trial	2009-12-07	Phase I Clinical Trial	IL1A
Leukemia, Lymphoid	ENSG00000115053	FALSE	unknown	2004-03-31	Unused	NCL
Leukemia, Lymphoid	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Leukemia, Lymphoid	ENSG00000115524	FALSE	unknown	2015-11-18	Absent	SF3B1
Leukemia, Lymphoid	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Leukemia, Lymphoid	ENSG00000116044	FALSE	unknown	2004-11-18	Unused	NFE2L2
Leukemia, Lymphoid	ENSG00000116478	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC1
Leukemia, Lymphoid	ENSG00000118058	FALSE	Preclinical	2015-03-13	Absent	KMT2A
Leukemia, Lymphoid	ENSG00000120156	TRUE	Approved	2006-01-19	Approved	TEK
Leukemia, Lymphoid	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Leukemia, Lymphoid	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Leukemia, Lymphoid	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Leukemia, Lymphoid	ENSG00000121966	FALSE	Phase II Clinical Trial	1997-10-15	Phase I Clinical Trial	CXCR4
Leukemia, Lymphoid	ENSG00000122025	TRUE	Approved	1991-02-15	Approved	FLT3
Leukemia, Lymphoid	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase III Clinical Trial	CDK2
Leukemia, Lymphoid	ENSG00000125726	FALSE	Phase I Clinical Trial	2007-01-22	Unused	CD70
Leukemia, Lymphoid	ENSG00000128052	FALSE	Phase II Clinical Trial	1991-02-15	Phase I Clinical Trial	KDR
Leukemia, Lymphoid	ENSG00000128602	FALSE	Phase II Clinical Trial	2006-10-19	Phase II Clinical Trial	SMO
Leukemia, Lymphoid	ENSG00000129484	FALSE	Phase I Clinical Trial	2008-09-17	Phase I Clinical Trial	PARP2
Leukemia, Lymphoid	ENSG00000130816	FALSE	Phase I Clinical Trial	NA	Unused	DNMT1
Leukemia, Lymphoid	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Leukemia, Lymphoid	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Leukemia, Lymphoid	ENSG00000131981	FALSE	unknown	1997-05-15	Unused	LGALS3
Leukemia, Lymphoid	ENSG00000132510	FALSE	Preclinical	2014-10-27	Absent	KDM6B
Leukemia, Lymphoid	ENSG00000132906	FALSE	unknown	1997-05-15	Unused	CASP9
Leukemia, Lymphoid	ENSG00000133895	FALSE	Preclinical	2015-03-13	Absent	MEN1
Leukemia, Lymphoid	ENSG00000134057	FALSE	Phase II Clinical Trial	1991-02-15	Absent	CCNB1
Leukemia, Lymphoid	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-01-15	Unused	CDK7
Leukemia, Lymphoid	ENSG00000134250	FALSE	Phase II Clinical Trial	2012-09-29	Absent	NOTCH2
Leukemia, Lymphoid	ENSG00000134460	FALSE	Phase I Clinical Trial	2001-03-14	Unused	IL2RA
Leukemia, Lymphoid	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Leukemia, Lymphoid	ENSG00000134545	FALSE	Phase II Clinical Trial	2006-11-24	Absent	KLRC1
Leukemia, Lymphoid	ENSG00000134853	TRUE	Approved	1999-03-17	Approved	PDGFRA
Leukemia, Lymphoid	ENSG00000135446	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CDK4
Leukemia, Lymphoid	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Leukemia, Lymphoid	ENSG00000136244	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IL6
Leukemia, Lymphoid	ENSG00000136807	FALSE	Phase II Clinical Trial	1996-05-15	Phase III Clinical Trial	CDK9
Leukemia, Lymphoid	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Leukemia, Lymphoid	ENSG00000136997	FALSE	Phase I Clinical Trial	2012-09-20	Absent	MYC
Leukemia, Lymphoid	ENSG00000137193	FALSE	Preclinical	2006-11-29	Unused	PIM1
Leukemia, Lymphoid	ENSG00000138160	FALSE	Phase I Clinical Trial	2006-01-13	Phase I Clinical Trial	KIF11
Leukemia, Lymphoid	ENSG00000138735	FALSE	unknown	1999-01-08	Unused	PDE5A
Leukemia, Lymphoid	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Leukemia, Lymphoid	ENSG00000138795	FALSE	Preclinical	2010-02-15	Unused	LEF1
Leukemia, Lymphoid	ENSG00000140443	FALSE	unknown	2006-01-11	Unused	IGF1R
Leukemia, Lymphoid	ENSG00000141510	FALSE	Preclinical	1996-02-23	Unused	TP53
Leukemia, Lymphoid	ENSG00000141736	FALSE	unknown	2001-05-21	Unused	ERBB2
Leukemia, Lymphoid	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Phase I Clinical Trial	BRD4
Leukemia, Lymphoid	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Leukemia, Lymphoid	ENSG00000143384	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	MCL1
Leukemia, Lymphoid	ENSG00000143799	FALSE	Phase II Clinical Trial	2002-08-14	Phase I Clinical Trial	PARP1
Leukemia, Lymphoid	ENSG00000144744	FALSE	Phase I Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Leukemia, Lymphoid	ENSG00000145839	FALSE	Preclinical	2014-10-28	Absent	IL9
Leukemia, Lymphoid	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	EGFR
Leukemia, Lymphoid	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Leukemia, Lymphoid	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC8
Leukemia, Lymphoid	ENSG00000147168	FALSE	Preclinical	2014-10-28	Absent	IL2RG
Leukemia, Lymphoid	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Leukemia, Lymphoid	ENSG00000149554	FALSE	Phase I Clinical Trial	2004-02-10	Phase I Clinical Trial	CHEK1
Leukemia, Lymphoid	ENSG00000151247	FALSE	Phase I Clinical Trial	2007-05-16	Absent	EIF4E
Leukemia, Lymphoid	ENSG00000154229	FALSE	Phase II Clinical Trial	1991-02-15	Absent	PRKCA
Leukemia, Lymphoid	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Leukemia, Lymphoid	ENSG00000156738	TRUE	Approved	1993-09-15	Approved	MS4A1
Leukemia, Lymphoid	ENSG00000157404	TRUE	Approved	1991-02-15	Approved	KIT
Leukemia, Lymphoid	ENSG00000159110	FALSE	Preclinical	2008-12-12	Preclinical	IFNAR2
Leukemia, Lymphoid	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Leukemia, Lymphoid	ENSG00000159958	FALSE	Preclinical	2006-02-27	Phase I Clinical Trial	TNFRSF13C
Leukemia, Lymphoid	ENSG00000160712	FALSE	Phase I Clinical Trial	1996-05-15	Absent	IL6R
Leukemia, Lymphoid	ENSG00000160867	TRUE	Approved	2006-01-19	Approved	FGFR4
Leukemia, Lymphoid	ENSG00000161955	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13
Leukemia, Lymphoid	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Phase II Clinical Trial	JAK1
Leukemia, Lymphoid	ENSG00000162924	FALSE	Preclinical	2015-01-30	Absent	REL
Leukemia, Lymphoid	ENSG00000163517	FALSE	unknown	NA	Phase II Clinical Trial	HDAC11
Leukemia, Lymphoid	ENSG00000164136	FALSE	Preclinical	2014-10-28	Absent	IL15
Leukemia, Lymphoid	ENSG00000164305	FALSE	Phase I Clinical Trial	2001-12-19	Phase I Clinical Trial	CASP3
Leukemia, Lymphoid	ENSG00000164362	FALSE	Preclinical	2002-06-26	Preclinical	TERT
Leukemia, Lymphoid	ENSG00000164400	FALSE	Preclinical	2009-07-01	Unused	CSF2
Leukemia, Lymphoid	ENSG00000164885	FALSE	Phase II Clinical Trial	2003-03-06	Phase III Clinical Trial	CDK5
Leukemia, Lymphoid	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Leukemia, Lymphoid	ENSG00000165304	FALSE	Phase II Clinical Trial	2013-07-03	Absent	MELK
Leukemia, Lymphoid	ENSG00000166484	FALSE	Phase I Clinical Trial	2007-07-09	Absent	MAPK7
Leukemia, Lymphoid	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Leukemia, Lymphoid	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Leukemia, Lymphoid	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	PLK1
Leukemia, Lymphoid	ENSG00000167325	TRUE	Approved	1991-07-15	Approved	RRM1
Leukemia, Lymphoid	ENSG00000167601	FALSE	Preclinical	2012-05-03	Absent	AXL
Leukemia, Lymphoid	ENSG00000167658	FALSE	Phase II Clinical Trial	2001-03-27	Phase II Clinical Trial	EEF2
Leukemia, Lymphoid	ENSG00000168398	FALSE	Phase I Clinical Trial	2004-06-18	Unused	BDKRB2
Leukemia, Lymphoid	ENSG00000168522	FALSE	Phase II Clinical Trial	1997-06-15	Unused	FNTA
Leukemia, Lymphoid	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-05-18	Phase I Clinical Trial	STAT3
Leukemia, Lymphoid	ENSG00000168685	FALSE	Preclinical	2011-07-13	Absent	IL7R
Leukemia, Lymphoid	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Leukemia, Lymphoid	ENSG00000169398	FALSE	unknown	NA	Absent	PTK2
Leukemia, Lymphoid	ENSG00000169442	TRUE	Approved	2011-07-01	Unused	CD52
Leukemia, Lymphoid	ENSG00000169925	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD3
Leukemia, Lymphoid	ENSG00000170312	FALSE	Phase II Clinical Trial	2003-03-06	Phase III Clinical Trial	CDK1
Leukemia, Lymphoid	ENSG00000170430	FALSE	Phase II Clinical Trial	2000-05-03	Unused	MGMT
Leukemia, Lymphoid	ENSG00000171552	FALSE	Phase I Clinical Trial	2005-11-21	Phase II Clinical Trial	BCL2L1
Leukemia, Lymphoid	ENSG00000171608	TRUE	Approved	2003-09-05	Phase III Clinical Trial	PIK3CD
Leukemia, Lymphoid	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Leukemia, Lymphoid	ENSG00000171791	TRUE	Approved	1992-03-15	Phase II Clinical Trial	BCL2
Leukemia, Lymphoid	ENSG00000171848	TRUE	Approved	1991-07-15	Approved	RRM2
Leukemia, Lymphoid	ENSG00000173585	FALSE	Preclinical	2017-07-17	Absent	CCR9
Leukemia, Lymphoid	ENSG00000173638	FALSE	Preclinical	1996-12-15	Unused	SLC19A1
Leukemia, Lymphoid	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-04-30	Absent	ATR
Leukemia, Lymphoid	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Unused	CCNE2
Leukemia, Lymphoid	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Approved	YES1
Leukemia, Lymphoid	ENSG00000176890	TRUE	Approved	1992-06-15	Unused	TYMS
Leukemia, Lymphoid	ENSG00000177455	TRUE	Approved	1999-04-27	Phase II Clinical Trial	CD19
Leukemia, Lymphoid	ENSG00000177885	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	GRB2
Leukemia, Lymphoid	ENSG00000178562	FALSE	Preclinical	NA	Unused	CD28
Leukemia, Lymphoid	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Leukemia, Lymphoid	ENSG00000182578	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	CSF1R
Leukemia, Lymphoid	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Approved	LCK
Leukemia, Lymphoid	ENSG00000183765	FALSE	Phase I Clinical Trial	2004-02-10	Unused	CHEK2
Leukemia, Lymphoid	ENSG00000184937	FALSE	unknown	2005-12-05	Phase II Clinical Trial	WT1
Leukemia, Lymphoid	ENSG00000185291	FALSE	Phase I Clinical Trial	2014-04-03	Absent	IL3RA
Leukemia, Lymphoid	ENSG00000185483	FALSE	Phase I Clinical Trial	2015-01-02	Absent	ROR1
Leukemia, Lymphoid	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Leukemia, Lymphoid	ENSG00000186642	FALSE	unknown	1999-01-08	Unused	PDE2A
Leukemia, Lymphoid	ENSG00000186716	TRUE	Approved	1999-03-17	Approved	BCR
Leukemia, Lymphoid	ENSG00000187555	FALSE	Preclinical	2011-10-29	Unused	USP7
Leukemia, Lymphoid	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Unused	PDCD1
Leukemia, Lymphoid	ENSG00000196139	FALSE	Preclinical	2016-10-19	Absent	AKR1C3
Leukemia, Lymphoid	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Leukemia, Lymphoid	ENSG00000196664	FALSE	Preclinical	2004-12-15	Unused	TLR7
Leukemia, Lymphoid	ENSG00000196776	FALSE	Preclinical	2007-03-02	Unused	CD47
Leukemia, Lymphoid	ENSG00000196839	TRUE	Approved	1997-03-15	Approved	ADA
Leukemia, Lymphoid	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Approved	SRC
Leukemia, Lymphoid	ENSG00000197471	FALSE	unknown	2014-08-11	Absent	SPN
Leukemia, Lymphoid	ENSG00000198355	FALSE	Preclinical	2006-11-29	Unused	PIM3
Leukemia, Lymphoid	ENSG00000198793	FALSE	Phase I Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Leukemia, Lymphoid	ENSG00000198805	FALSE	unknown	2000-08-03	Phase II Clinical Trial	PNP
Leukemia, Lymphoid	ENSG00000198851	TRUE	Approved	1999-04-27	Phase II Clinical Trial	CD3E
Leukemia, Lymphoid	ENSG00000203710	FALSE	Preclinical	2004-10-01	Unused	CR1
Leukemia, Lymphoid	ENSG00000228716	TRUE	Approved	1992-06-15	Unused	DHFR
Leukemia, Lymphoid	ENSG00000239732	FALSE	Phase I Clinical Trial	2008-08-28	Phase I Clinical Trial	TLR9
Leukemia, Lymphoid	ENSG00000253729	FALSE	Phase I Clinical Trial	1999-03-31	Unused	PRKDC
Leukemia, Lymphoid	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Approved	LYN
Leukemia, Lymphoid	ENSG00000275302	TRUE	Approved	2004-01-20	Phase III Clinical Trial	CCL4
Leukemia, Lymphoid	ENSG00000277632	TRUE	Approved	2004-01-20	Phase III Clinical Trial	CCL3
Leukemia, Mast-Cell	ENSG00000102755	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	FLT1
Leukemia, Mast-Cell	ENSG00000112715	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	VEGFA
Leukemia, Mast-Cell	ENSG00000113721	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	PDGFRB
Leukemia, Mast-Cell	ENSG00000122025	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	FLT3
Leukemia, Mast-Cell	ENSG00000128052	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	KDR
Leukemia, Mast-Cell	ENSG00000134057	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	CCNB1
Leukemia, Mast-Cell	ENSG00000134853	FALSE	Phase I Clinical Trial	2013-10-05	Absent	PDGFRA
Leukemia, Mast-Cell	ENSG00000143384	FALSE	Phase I Clinical Trial	1999-10-20	Unused	MCL1
Leukemia, Mast-Cell	ENSG00000154229	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	PRKCA
Leukemia, Mast-Cell	ENSG00000157404	FALSE	Pre-registration	1991-02-15	Phase II Clinical Trial	KIT
Leukemia, Mast-Cell	ENSG00000171791	FALSE	Phase I Clinical Trial	1999-10-20	Unused	BCL2
Leukemia, Myeloid, Acute	ENSG00000000938	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	FGR
Leukemia, Myeloid, Acute	ENSG00000004468	FALSE	Phase II Clinical Trial	2002-05-21	Absent	CD38
Leukemia, Myeloid, Acute	ENSG00000004487	FALSE	Phase II Clinical Trial	2008-07-31	Preclinical	KDM1A
Leukemia, Myeloid, Acute	ENSG00000005339	FALSE	Preclinical	2016-09-28	Absent	CREBBP
Leukemia, Myeloid, Acute	ENSG00000007908	FALSE	Phase II Clinical Trial	2010-06-14	Preclinical	SELE
Leukemia, Myeloid, Acute	ENSG00000010610	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CD4
Leukemia, Myeloid, Acute	ENSG00000010671	FALSE	Preclinical	2007-12-12	Absent	BTK
Leukemia, Myeloid, Acute	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Leukemia, Myeloid, Acute	ENSG00000023445	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC3
Leukemia, Myeloid, Acute	ENSG00000026508	FALSE	Phase I Clinical Trial	2002-07-16	Phase I Clinical Trial	CD44
Leukemia, Myeloid, Acute	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Leukemia, Myeloid, Acute	ENSG00000041982	FALSE	Phase I Clinical Trial	2007-05-29	Absent	TNC
Leukemia, Myeloid, Acute	ENSG00000044524	FALSE	Phase II Clinical Trial	2004-03-23	Phase I Clinical Trial	EPHA3
Leukemia, Myeloid, Acute	ENSG00000065978	FALSE	Preclinical	2017-02-06	Absent	YBX1
Leukemia, Myeloid, Acute	ENSG00000066468	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	FGFR2
Leukemia, Myeloid, Acute	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Leukemia, Myeloid, Acute	ENSG00000068078	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	FGFR3
Leukemia, Myeloid, Acute	ENSG00000070501	TRUE	Approved	1996-08-15	Unused	POLB
Leukemia, Myeloid, Acute	ENSG00000072571	FALSE	unknown	2006-12-15	Unused	HMMR
Leukemia, Myeloid, Acute	ENSG00000073614	FALSE	Preclinical	2016-04-13	Absent	KDM5A
Leukemia, Myeloid, Acute	ENSG00000076662	FALSE	unknown	1992-11-15	Unused	ICAM3
Leukemia, Myeloid, Acute	ENSG00000077092	FALSE	Approved	NA	Unused	RARB
Leukemia, Myeloid, Acute	ENSG00000077097	FALSE	unknown	1994-06-15	Unused	TOP2B
Leukemia, Myeloid, Acute	ENSG00000077782	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	FGFR1
Leukemia, Myeloid, Acute	ENSG00000080824	FALSE	Phase III Clinical Trial	2003-11-25	Phase II Clinical Trial	HSP90AA1
Leukemia, Myeloid, Acute	ENSG00000081237	FALSE	Phase III Clinical Trial	2012-08-17	Absent	PTPRC
Leukemia, Myeloid, Acute	ENSG00000082701	FALSE	Phase II Clinical Trial	2008-08-15	Phase II Clinical Trial	GSK3B
Leukemia, Myeloid, Acute	ENSG00000082898	FALSE	Phase II Clinical Trial	2010-09-14	Phase I Clinical Trial	XPO1
Leukemia, Myeloid, Acute	ENSG00000083312	FALSE	Phase I Clinical Trial	2005-06-27	Unused	TNPO1
Leukemia, Myeloid, Acute	ENSG00000085563	FALSE	unknown	1996-05-15	Unused	ABCB1
Leukemia, Myeloid, Acute	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Leukemia, Myeloid, Acute	ENSG00000089685	FALSE	unknown	2002-04-29	Phase II Clinical Trial	BIRC5
Leukemia, Myeloid, Acute	ENSG00000091972	FALSE	Phase II Clinical Trial	2006-06-13	Absent	CD200
Leukemia, Myeloid, Acute	ENSG00000095015	FALSE	unknown	2007-08-10	Absent	MAP3K1
Leukemia, Myeloid, Acute	ENSG00000096968	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	JAK2
Leukemia, Myeloid, Acute	ENSG00000096996	FALSE	Phase I Clinical Trial	2016-02-22	Absent	IL12RB1
Leukemia, Myeloid, Acute	ENSG00000097007	FALSE	Phase II Clinical Trial	1999-03-17	Phase I Clinical Trial	ABL1
Leukemia, Myeloid, Acute	ENSG00000097046	FALSE	Preclinical	2017-03-15	Absent	CDC7
Leukemia, Myeloid, Acute	ENSG00000100030	FALSE	Phase II Clinical Trial	2013-01-18	Absent	MAPK1
Leukemia, Myeloid, Acute	ENSG00000100292	FALSE	Preclinical	2006-12-15	Unused	HMOX1
Leukemia, Myeloid, Acute	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Leukemia, Myeloid, Acute	ENSG00000100393	FALSE	Preclinical	2016-09-28	Absent	EP300
Leukemia, Myeloid, Acute	ENSG00000101336	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	HCK
Leukemia, Myeloid, Acute	ENSG00000101868	TRUE	Approved	1993-08-15	Unused	POLA1
Leukemia, Myeloid, Acute	ENSG00000101966	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	XIAP
Leukemia, Myeloid, Acute	ENSG00000102096	FALSE	Phase I Clinical Trial	2006-11-29	Phase I Clinical Trial	PIM2
Leukemia, Myeloid, Acute	ENSG00000102755	TRUE	Approved	1991-02-15	Phase III Clinical Trial	FLT1
Leukemia, Myeloid, Acute	ENSG00000102882	FALSE	Phase II Clinical Trial	2013-01-18	Absent	MAPK3
Leukemia, Myeloid, Acute	ENSG00000102967	FALSE	Phase II Clinical Trial	2007-06-11	Absent	DHODH
Leukemia, Myeloid, Acute	ENSG00000103257	FALSE	Phase I Clinical Trial	2011-05-18	Absent	SLC7A5
Leukemia, Myeloid, Acute	ENSG00000104365	FALSE	Preclinical	NA	Preclinical	IKBKB
Leukemia, Myeloid, Acute	ENSG00000104885	FALSE	Phase I Clinical Trial	2010-12-03	Phase I Clinical Trial	DOT1L
Leukemia, Myeloid, Acute	ENSG00000104894	FALSE	Phase I Clinical Trial	2014-04-19	Absent	CD37
Leukemia, Myeloid, Acute	ENSG00000105146	FALSE	Phase I Clinical Trial	2003-10-20	Phase I Clinical Trial	AURKC
Leukemia, Myeloid, Acute	ENSG00000105173	FALSE	Preclinical	2010-12-05	Absent	CCNE1
Leukemia, Myeloid, Acute	ENSG00000105383	TRUE	Approved	1991-02-15	Approved	CD33
Leukemia, Myeloid, Acute	ENSG00000105723	FALSE	Phase II Clinical Trial	2008-08-15	Absent	GSK3A
Leukemia, Myeloid, Acute	ENSG00000105810	FALSE	Phase II Clinical Trial	1996-05-15	Absent	CDK6
Leukemia, Myeloid, Acute	ENSG00000105835	FALSE	Preclinical	2014-08-02	Absent	NAMPT
Leukemia, Myeloid, Acute	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Leukemia, Myeloid, Acute	ENSG00000105976	FALSE	Preclinical	2012-12-21	Absent	MET
Leukemia, Myeloid, Acute	ENSG00000106348	FALSE	Phase I Clinical Trial	2000-11-09	Unused	IMPDH1
Leukemia, Myeloid, Acute	ENSG00000106462	FALSE	Phase I Clinical Trial	2016-03-18	Absent	EZH2
Leukemia, Myeloid, Acute	ENSG00000108424	FALSE	Phase I Clinical Trial	2005-06-27	Unused	KPNB1
Leukemia, Myeloid, Acute	ENSG00000108443	FALSE	Phase I Clinical Trial	2005-06-27	Unused	RPS6KB1
Leukemia, Myeloid, Acute	ENSG00000108799	FALSE	Phase I Clinical Trial	2016-03-18	Absent	EZH1
Leukemia, Myeloid, Acute	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Unused	NFKB1
Leukemia, Myeloid, Acute	ENSG00000109743	FALSE	Phase I Clinical Trial	2012-11-06	Absent	BST1
Leukemia, Myeloid, Acute	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC2
Leukemia, Myeloid, Acute	ENSG00000111424	FALSE	Phase II Clinical Trial	1993-07-15	Unused	VDR
Leukemia, Myeloid, Acute	ENSG00000111679	FALSE	Preclinical	NA	Absent	PTPN6
Leukemia, Myeloid, Acute	ENSG00000112062	FALSE	Preclinical	2008-05-23	Preclinical	MAPK14
Leukemia, Myeloid, Acute	ENSG00000112115	FALSE	unknown	NA	Absent	IL17A
Leukemia, Myeloid, Acute	ENSG00000112715	TRUE	Approved	1991-02-15	Phase III Clinical Trial	VEGFA
Leukemia, Myeloid, Acute	ENSG00000112742	FALSE	Preclinical	2011-11-19	Absent	TTK
Leukemia, Myeloid, Acute	ENSG00000113712	FALSE	Preclinical	2016-05-05	Absent	CSNK1A1
Leukemia, Myeloid, Acute	ENSG00000113721	TRUE	Approved	1991-02-15	Phase III Clinical Trial	PDGFRB
Leukemia, Myeloid, Acute	ENSG00000113749	TRUE	Approved	1996-05-15	Approved	HRH2
Leukemia, Myeloid, Acute	ENSG00000113851	FALSE	Preclinical	2011-08-26	Absent	CRBN
Leukemia, Myeloid, Acute	ENSG00000115008	FALSE	Phase I Clinical Trial	2009-12-07	Phase I Clinical Trial	IL1A
Leukemia, Myeloid, Acute	ENSG00000115053	FALSE	Preclinical	2003-03-13	Phase II Clinical Trial	NCL
Leukemia, Myeloid, Acute	ENSG00000115232	FALSE	unknown	NA	Absent	ITGA4
Leukemia, Myeloid, Acute	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Leukemia, Myeloid, Acute	ENSG00000115524	FALSE	Phase I Clinical Trial	2014-04-08	Absent	SF3B1
Leukemia, Myeloid, Acute	ENSG00000115590	FALSE	unknown	1997-05-15	Phase II Clinical Trial	IL1R2
Leukemia, Myeloid, Acute	ENSG00000116044	FALSE	Phase I Clinical Trial	2004-11-18	Unused	NFE2L2
Leukemia, Myeloid, Acute	ENSG00000116478	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Leukemia, Myeloid, Acute	ENSG00000118058	FALSE	Preclinical	2015-03-13	Absent	KMT2A
Leukemia, Myeloid, Acute	ENSG00000118513	FALSE	unknown	1994-02-15	Unused	MYB
Leukemia, Myeloid, Acute	ENSG00000118520	FALSE	Phase II Clinical Trial	2007-10-09	Absent	ARG1
Leukemia, Myeloid, Acute	ENSG00000119535	FALSE	Approved	2014-10-01	Absent	CSF3R
Leukemia, Myeloid, Acute	ENSG00000120156	FALSE	Phase I Clinical Trial	2006-01-19	Phase I Clinical Trial	TEK
Leukemia, Myeloid, Acute	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Leukemia, Myeloid, Acute	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Leukemia, Myeloid, Acute	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Unused	PIK3CA
Leukemia, Myeloid, Acute	ENSG00000121966	FALSE	Phase II Clinical Trial	1997-10-15	Phase II Clinical Trial	CXCR4
Leukemia, Myeloid, Acute	ENSG00000122025	TRUE	Approved	1991-02-15	Phase III Clinical Trial	FLT3
Leukemia, Myeloid, Acute	ENSG00000123374	FALSE	Phase II Clinical Trial	2005-03-14	Phase I Clinical Trial	CDK2
Leukemia, Myeloid, Acute	ENSG00000125498	FALSE	Phase II Clinical Trial	2001-12-19	Phase II Clinical Trial	KIR2DL1
Leukemia, Myeloid, Acute	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Leukemia, Myeloid, Acute	ENSG00000126934	FALSE	Phase II Clinical Trial	2006-10-23	Phase II Clinical Trial	MAP2K2
Leukemia, Myeloid, Acute	ENSG00000128052	TRUE	Approved	1991-02-15	Phase III Clinical Trial	KDR
Leukemia, Myeloid, Acute	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Absent	SMO
Leukemia, Myeloid, Acute	ENSG00000129484	FALSE	Phase I Clinical Trial	2009-04-11	Phase I Clinical Trial	PARP2
Leukemia, Myeloid, Acute	ENSG00000130816	TRUE	Approved	1996-06-15	Approved	DNMT1
Leukemia, Myeloid, Acute	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Absent	IDO1
Leukemia, Myeloid, Acute	ENSG00000131747	TRUE	Approved	1993-07-15	Approved	TOP2A
Leukemia, Myeloid, Acute	ENSG00000131759	FALSE	Approved	2011-11-25	Unused	RARA
Leukemia, Myeloid, Acute	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Phase I Clinical Trial	PDHA1
Leukemia, Myeloid, Acute	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Leukemia, Myeloid, Acute	ENSG00000132646	FALSE	Preclinical	2011-03-30	Preclinical	PCNA
Leukemia, Myeloid, Acute	ENSG00000132906	FALSE	Preclinical	2006-12-08	Absent	CASP9
Leukemia, Myeloid, Acute	ENSG00000132964	FALSE	Preclinical	2010-07-12	Absent	CDK8
Leukemia, Myeloid, Acute	ENSG00000133895	FALSE	Preclinical	2015-03-13	Absent	MEN1
Leukemia, Myeloid, Acute	ENSG00000134057	TRUE	Approved	1991-02-15	Phase III Clinical Trial	CCNB1
Leukemia, Myeloid, Acute	ENSG00000134058	FALSE	Preclinical	2010-12-05	Absent	CDK7
Leukemia, Myeloid, Acute	ENSG00000134323	FALSE	Preclinical	2017-02-07	Absent	MYCN
Leukemia, Myeloid, Acute	ENSG00000134460	FALSE	Phase II Clinical Trial	2001-03-14	Phase II Clinical Trial	IL2RA
Leukemia, Myeloid, Acute	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Leukemia, Myeloid, Acute	ENSG00000134853	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	PDGFRA
Leukemia, Myeloid, Acute	ENSG00000135077	FALSE	Preclinical	2005-07-01	Absent	HAVCR2
Leukemia, Myeloid, Acute	ENSG00000135446	FALSE	Phase II Clinical Trial	1996-05-15	Absent	CDK4
Leukemia, Myeloid, Acute	ENSG00000135679	FALSE	Phase III Clinical Trial	2004-03-09	Phase I Clinical Trial	MDM2
Leukemia, Myeloid, Acute	ENSG00000136807	FALSE	Phase II Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK9
Leukemia, Myeloid, Acute	ENSG00000136826	FALSE	unknown	2004-05-21	Absent	KLF4
Leukemia, Myeloid, Acute	ENSG00000136997	FALSE	Phase I Clinical Trial	2004-05-21	Absent	MYC
Leukemia, Myeloid, Acute	ENSG00000137193	FALSE	Phase II Clinical Trial	2006-11-29	Phase I Clinical Trial	PIM1
Leukemia, Myeloid, Acute	ENSG00000137752	FALSE	unknown	NA	Absent	CASP1
Leukemia, Myeloid, Acute	ENSG00000138160	FALSE	Phase II Clinical Trial	2006-01-13	Phase II Clinical Trial	KIF11
Leukemia, Myeloid, Acute	ENSG00000138413	FALSE	Pre-registration	2010-04-19	Absent	IDH1
Leukemia, Myeloid, Acute	ENSG00000138448	FALSE	unknown	NA	Absent	ITGAV
Leukemia, Myeloid, Acute	ENSG00000138735	FALSE	unknown	1999-01-08	Preclinical	PDE5A
Leukemia, Myeloid, Acute	ENSG00000141510	FALSE	Phase III Clinical Trial	1992-09-15	Unused	TP53
Leukemia, Myeloid, Acute	ENSG00000141867	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD4
Leukemia, Myeloid, Acute	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Leukemia, Myeloid, Acute	ENSG00000143171	FALSE	Phase I Clinical Trial	1992-09-15	Unused	RXRG
Leukemia, Myeloid, Acute	ENSG00000143384	FALSE	Phase II Clinical Trial	1999-10-20	Phase II Clinical Trial	MCL1
Leukemia, Myeloid, Acute	ENSG00000143799	FALSE	Phase I Clinical Trial	2009-04-11	Phase I Clinical Trial	PARP1
Leukemia, Myeloid, Acute	ENSG00000144744	FALSE	Phase III Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Leukemia, Myeloid, Acute	ENSG00000146648	FALSE	Phase I Clinical Trial	2003-07-23	Unused	EGFR
Leukemia, Myeloid, Acute	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Leukemia, Myeloid, Acute	ENSG00000147099	FALSE	Phase I Clinical Trial	2008-07-31	Phase I Clinical Trial	HDAC8
Leukemia, Myeloid, Acute	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Leukemia, Myeloid, Acute	ENSG00000149554	FALSE	Phase II Clinical Trial	2011-04-21	Phase I Clinical Trial	CHEK1
Leukemia, Myeloid, Acute	ENSG00000150782	FALSE	unknown	NA	Absent	IL18
Leukemia, Myeloid, Acute	ENSG00000151702	FALSE	Preclinical	2016-01-22	Absent	FLI1
Leukemia, Myeloid, Acute	ENSG00000153208	FALSE	Phase I Clinical Trial	2012-12-21	Absent	MERTK
Leukemia, Myeloid, Acute	ENSG00000154229	TRUE	Approved	1991-02-15	Phase III Clinical Trial	PRKCA
Leukemia, Myeloid, Acute	ENSG00000157404	TRUE	Approved	1991-02-15	Phase III Clinical Trial	KIT
Leukemia, Myeloid, Acute	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Leukemia, Myeloid, Acute	ENSG00000160712	FALSE	unknown	1997-05-15	Phase II Clinical Trial	IL6R
Leukemia, Myeloid, Acute	ENSG00000160867	FALSE	Phase I Clinical Trial	2006-01-19	Phase I Clinical Trial	FGFR4
Leukemia, Myeloid, Acute	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Phase II Clinical Trial	JAK1
Leukemia, Myeloid, Acute	ENSG00000163517	FALSE	unknown	NA	Phase II Clinical Trial	HDAC11
Leukemia, Myeloid, Acute	ENSG00000164078	FALSE	Preclinical	2012-12-21	Absent	MST1R
Leukemia, Myeloid, Acute	ENSG00000164305	FALSE	unknown	2001-12-19	Preclinical	CASP3
Leukemia, Myeloid, Acute	ENSG00000164362	FALSE	Preclinical	2000-07-26	Unused	TERT
Leukemia, Myeloid, Acute	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Leukemia, Myeloid, Acute	ENSG00000164885	FALSE	Phase II Clinical Trial	2005-03-14	Unused	CDK5
Leukemia, Myeloid, Acute	ENSG00000165025	FALSE	Phase II Clinical Trial	2010-06-25	Absent	SYK
Leukemia, Myeloid, Acute	ENSG00000165280	FALSE	Preclinical	2013-11-18	Absent	VCP
Leukemia, Myeloid, Acute	ENSG00000165304	FALSE	Phase II Clinical Trial	2013-07-03	Absent	MELK
Leukemia, Myeloid, Acute	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Leukemia, Myeloid, Acute	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Leukemia, Myeloid, Acute	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Leukemia, Myeloid, Acute	ENSG00000166851	FALSE	Phase III Clinical Trial	2002-05-27	Phase III Clinical Trial	PLK1
Leukemia, Myeloid, Acute	ENSG00000167325	FALSE	Pre-registration	1991-07-15	Unused	RRM1
Leukemia, Myeloid, Acute	ENSG00000167601	FALSE	Phase III Clinical Trial	2011-06-17	Absent	AXL
Leukemia, Myeloid, Acute	ENSG00000168036	FALSE	Phase II Clinical Trial	2011-03-05	Phase II Clinical Trial	CTNNB1
Leukemia, Myeloid, Acute	ENSG00000168522	FALSE	Phase II Clinical Trial	1997-06-15	Unused	FNTA
Leukemia, Myeloid, Acute	ENSG00000168610	FALSE	Phase I Clinical Trial	2005-04-25	Phase I Clinical Trial	STAT3
Leukemia, Myeloid, Acute	ENSG00000169032	FALSE	Phase II Clinical Trial	2006-10-23	Phase II Clinical Trial	MAP2K1
Leukemia, Myeloid, Acute	ENSG00000169398	FALSE	Preclinical	2012-04-05	Absent	PTK2
Leukemia, Myeloid, Acute	ENSG00000169925	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD3
Leukemia, Myeloid, Acute	ENSG00000170312	FALSE	Phase II Clinical Trial	2004-08-16	Phase I Clinical Trial	CDK1
Leukemia, Myeloid, Acute	ENSG00000170430	FALSE	Phase II Clinical Trial	2000-05-03	Preclinical	MGMT
Leukemia, Myeloid, Acute	ENSG00000171608	FALSE	unknown	2004-01-20	Phase I Clinical Trial	PIK3CD
Leukemia, Myeloid, Acute	ENSG00000171720	FALSE	Phase I Clinical Trial	2008-07-31	Phase II Clinical Trial	HDAC3
Leukemia, Myeloid, Acute	ENSG00000171791	FALSE	Phase III Clinical Trial	1992-03-15	Unused	BCL2
Leukemia, Myeloid, Acute	ENSG00000171848	FALSE	Pre-registration	1991-07-15	Phase II Clinical Trial	RRM2
Leukemia, Myeloid, Acute	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Leukemia, Myeloid, Acute	ENSG00000172322	FALSE	Phase I Clinical Trial	2013-01-16	Preclinical	CLEC12A
Leukemia, Myeloid, Acute	ENSG00000173762	FALSE	Phase II Clinical Trial	2016-04-21	Absent	CD7
Leukemia, Myeloid, Acute	ENSG00000175305	FALSE	Preclinical	2010-12-05	Absent	CCNE2
Leukemia, Myeloid, Acute	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Leukemia, Myeloid, Acute	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Leukemia, Myeloid, Acute	ENSG00000177455	FALSE	Preclinical	2016-09-15	Absent	CD19
Leukemia, Myeloid, Acute	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Leukemia, Myeloid, Acute	ENSG00000177885	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	GRB2
Leukemia, Myeloid, Acute	ENSG00000178035	FALSE	Phase I Clinical Trial	2000-11-09	Unused	IMPDH2
Leukemia, Myeloid, Acute	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Leukemia, Myeloid, Acute	ENSG00000179295	FALSE	Preclinical	NA	Absent	PTPN11
Leukemia, Myeloid, Acute	ENSG00000181163	FALSE	Phase II Clinical Trial	2016-08-23	Absent	NPM1
Leukemia, Myeloid, Acute	ENSG00000182054	TRUE	Approved	2011-11-14	Absent	IDH2
Leukemia, Myeloid, Acute	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	CSF1R
Leukemia, Myeloid, Acute	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Leukemia, Myeloid, Acute	ENSG00000183087	FALSE	Preclinical	2016-02-16	Absent	GAS6
Leukemia, Myeloid, Acute	ENSG00000183484	FALSE	Preclinical	2015-08-13	Absent	GPR132
Leukemia, Myeloid, Acute	ENSG00000184047	FALSE	Phase I Clinical Trial	2005-11-21	Phase I Clinical Trial	DIABLO
Leukemia, Myeloid, Acute	ENSG00000184937	FALSE	Phase III Clinical Trial	1999-06-15	Phase II Clinical Trial	WT1
Leukemia, Myeloid, Acute	ENSG00000185291	FALSE	Phase III Clinical Trial	2000-11-28	Phase II Clinical Trial	IL3RA
Leukemia, Myeloid, Acute	ENSG00000185499	FALSE	Phase II Clinical Trial	2011-01-22	Absent	MUC1
Leukemia, Myeloid, Acute	ENSG00000185686	FALSE	Phase I Clinical Trial	2014-04-01	Absent	PRAME
Leukemia, Myeloid, Acute	ENSG00000186074	FALSE	Preclinical	2009-05-22	Unused	CD300LF
Leukemia, Myeloid, Acute	ENSG00000186350	FALSE	Phase I Clinical Trial	1992-09-15	Unused	RXRA
Leukemia, Myeloid, Acute	ENSG00000186642	FALSE	unknown	1999-01-08	Preclinical	PDE2A
Leukemia, Myeloid, Acute	ENSG00000186716	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Leukemia, Myeloid, Acute	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-02-21	Unused	PDCD1
Leukemia, Myeloid, Acute	ENSG00000196083	FALSE	Preclinical	2015-11-26	Absent	IL1RAP
Leukemia, Myeloid, Acute	ENSG00000196396	FALSE	Preclinical	NA	Absent	PTPN1
Leukemia, Myeloid, Acute	ENSG00000196411	FALSE	Preclinical	2014-04-19	Absent	EPHB4
Leukemia, Myeloid, Acute	ENSG00000196415	FALSE	Phase II Clinical Trial	NA	Phase III Clinical Trial	PRTN3
Leukemia, Myeloid, Acute	ENSG00000196591	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Leukemia, Myeloid, Acute	ENSG00000196628	FALSE	Preclinical	2007-10-03	Unused	TCF4
Leukemia, Myeloid, Acute	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Leukemia, Myeloid, Acute	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Preclinical	CD47
Leukemia, Myeloid, Acute	ENSG00000196839	FALSE	Preclinical	2013-10-08	Absent	ADA
Leukemia, Myeloid, Acute	ENSG00000197122	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	SRC
Leukemia, Myeloid, Acute	ENSG00000197471	FALSE	Preclinical	2013-09-02	Absent	SPN
Leukemia, Myeloid, Acute	ENSG00000198223	FALSE	Preclinical	1998-12-15	Unused	CSF2RA
Leukemia, Myeloid, Acute	ENSG00000198355	FALSE	Phase I Clinical Trial	2006-11-29	Phase I Clinical Trial	PIM3
Leukemia, Myeloid, Acute	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Unused	NTRK1
Leukemia, Myeloid, Acute	ENSG00000198625	FALSE	Phase I Clinical Trial	2012-09-07	Absent	MDM4
Leukemia, Myeloid, Acute	ENSG00000198793	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	MTOR
Leukemia, Myeloid, Acute	ENSG00000198851	FALSE	Phase I Clinical Trial	2012-09-21	Preclinical	CD3E
Leukemia, Myeloid, Acute	ENSG00000213903	FALSE	Preclinical	2008-05-23	Preclinical	LTB4R
Leukemia, Myeloid, Acute	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Leukemia, Myeloid, Acute	ENSG00000243772	FALSE	Phase II Clinical Trial	2001-12-19	Phase II Clinical Trial	KIR2DL3
Leukemia, Myeloid, Acute	ENSG00000253729	FALSE	Phase III Clinical Trial	1999-03-31	Phase III Clinical Trial	PRKDC
Leukemia, Myeloid, Acute	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Leukemia, Myeloid, Acute	ENSG00000259207	FALSE	unknown	NA	Absent	ITGB3
Leukemia, Myeloid, Acute	ENSG00000275302	FALSE	unknown	2004-01-20	Phase I Clinical Trial	CCL4
Leukemia, Myeloid, Acute	ENSG00000277632	FALSE	unknown	2004-01-20	Phase I Clinical Trial	CCL3
Leukemia, Myelomonocytic, Chronic	ENSG00000000938	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	FGR
Leukemia, Myelomonocytic, Chronic	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CFLAR
Leukemia, Myelomonocytic, Chronic	ENSG00000010810	TRUE	Approved	2004-07-20	Approved	FYN
Leukemia, Myelomonocytic, Chronic	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC3
Leukemia, Myelomonocytic, Chronic	ENSG00000027697	FALSE	Approved	1991-09-15	Unused	IFNGR1
Leukemia, Myelomonocytic, Chronic	ENSG00000037280	FALSE	unknown	1994-06-15	Phase II Clinical Trial	FLT4
Leukemia, Myelomonocytic, Chronic	ENSG00000044524	FALSE	Phase II Clinical Trial	2004-03-23	Phase I Clinical Trial	EPHA3
Leukemia, Myelomonocytic, Chronic	ENSG00000066468	TRUE	Approved	2005-06-27	Approved	FGFR2
Leukemia, Myelomonocytic, Chronic	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Leukemia, Myelomonocytic, Chronic	ENSG00000068078	TRUE	Approved	2005-06-27	Approved	FGFR3
Leukemia, Myelomonocytic, Chronic	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Leukemia, Myelomonocytic, Chronic	ENSG00000077097	FALSE	unknown	1994-06-15	Unused	TOP2B
Leukemia, Myelomonocytic, Chronic	ENSG00000077782	TRUE	Approved	2005-06-27	Approved	FGFR1
Leukemia, Myelomonocytic, Chronic	ENSG00000080824	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	HSP90AA1
Leukemia, Myelomonocytic, Chronic	ENSG00000083312	FALSE	Phase I Clinical Trial	2005-06-27	Unused	TNPO1
Leukemia, Myelomonocytic, Chronic	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Leukemia, Myelomonocytic, Chronic	ENSG00000089685	FALSE	unknown	2002-04-29	Phase II Clinical Trial	BIRC5
Leukemia, Myelomonocytic, Chronic	ENSG00000095015	FALSE	unknown	2007-08-10	Absent	MAP3K1
Leukemia, Myelomonocytic, Chronic	ENSG00000096968	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	JAK2
Leukemia, Myelomonocytic, Chronic	ENSG00000097007	TRUE	Approved	1995-03-15	Approved	ABL1
Leukemia, Myelomonocytic, Chronic	ENSG00000097046	FALSE	Preclinical	2017-03-15	Absent	CDC7
Leukemia, Myelomonocytic, Chronic	ENSG00000100292	FALSE	Preclinical	NA	Preclinical	HMOX1
Leukemia, Myelomonocytic, Chronic	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Leukemia, Myelomonocytic, Chronic	ENSG00000100644	FALSE	Preclinical	2015-06-10	Absent	HIF1A
Leukemia, Myelomonocytic, Chronic	ENSG00000100823	FALSE	unknown	2007-02-13	Absent	APEX1
Leukemia, Myelomonocytic, Chronic	ENSG00000101336	FALSE	Phase I Clinical Trial	2007-10-29	Phase I Clinical Trial	HCK
Leukemia, Myelomonocytic, Chronic	ENSG00000101868	FALSE	unknown	1996-08-15	Unused	POLA1
Leukemia, Myelomonocytic, Chronic	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Unused	XIAP
Leukemia, Myelomonocytic, Chronic	ENSG00000102755	TRUE	Approved	2006-01-19	Approved	FLT1
Leukemia, Myelomonocytic, Chronic	ENSG00000102967	FALSE	Preclinical	2017-04-20	Absent	DHODH
Leukemia, Myelomonocytic, Chronic	ENSG00000104885	FALSE	Phase I Clinical Trial	2010-12-03	Phase I Clinical Trial	DOT1L
Leukemia, Myelomonocytic, Chronic	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKC
Leukemia, Myelomonocytic, Chronic	ENSG00000105383	FALSE	Phase II Clinical Trial	1992-04-15	Unused	CD33
Leukemia, Myelomonocytic, Chronic	ENSG00000105810	FALSE	unknown	1996-05-15	Unused	CDK6
Leukemia, Myelomonocytic, Chronic	ENSG00000106348	FALSE	unknown	NA	Unused	IMPDH1
Leukemia, Myelomonocytic, Chronic	ENSG00000108424	FALSE	Phase I Clinical Trial	2005-06-27	Unused	KPNB1
Leukemia, Myelomonocytic, Chronic	ENSG00000108443	FALSE	Phase I Clinical Trial	2005-06-27	Unused	RPS6KB1
Leukemia, Myelomonocytic, Chronic	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC2
Leukemia, Myelomonocytic, Chronic	ENSG00000111424	FALSE	Phase II Clinical Trial	1995-06-15	Absent	VDR
Leukemia, Myelomonocytic, Chronic	ENSG00000115008	FALSE	Phase I Clinical Trial	2009-12-07	Phase I Clinical Trial	IL1A
Leukemia, Myelomonocytic, Chronic	ENSG00000115524	FALSE	Phase I Clinical Trial	2014-04-08	Absent	SF3B1
Leukemia, Myelomonocytic, Chronic	ENSG00000116044	FALSE	unknown	2004-11-18	Unused	NFE2L2
Leukemia, Myelomonocytic, Chronic	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Phase II Clinical Trial	HDAC1
Leukemia, Myelomonocytic, Chronic	ENSG00000118513	FALSE	unknown	1994-02-15	Unused	MYB
Leukemia, Myelomonocytic, Chronic	ENSG00000120156	TRUE	Approved	2006-01-19	Approved	TEK
Leukemia, Myelomonocytic, Chronic	ENSG00000120217	FALSE	Preclinical	2008-01-16	Preclinical	CD274
Leukemia, Myelomonocytic, Chronic	ENSG00000121879	FALSE	unknown	1992-08-15	Unused	PIK3CA
Leukemia, Myelomonocytic, Chronic	ENSG00000121966	FALSE	Phase II Clinical Trial	2008-06-19	Absent	CXCR4
Leukemia, Myelomonocytic, Chronic	ENSG00000122025	TRUE	Approved	1994-06-15	Approved	FLT3
Leukemia, Myelomonocytic, Chronic	ENSG00000123374	FALSE	unknown	2007-07-09	Phase I Clinical Trial	CDK2
Leukemia, Myelomonocytic, Chronic	ENSG00000125726	FALSE	unknown	2011-05-17	Absent	CD70
Leukemia, Myelomonocytic, Chronic	ENSG00000126934	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAP2K2
Leukemia, Myelomonocytic, Chronic	ENSG00000128052	FALSE	Phase I Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Leukemia, Myelomonocytic, Chronic	ENSG00000128602	FALSE	Phase II Clinical Trial	2006-10-19	Phase II Clinical Trial	SMO
Leukemia, Myelomonocytic, Chronic	ENSG00000130816	TRUE	Approved	2006-12-06	Approved	DNMT1
Leukemia, Myelomonocytic, Chronic	ENSG00000131747	FALSE	Phase II Clinical Trial	1998-11-15	Unused	TOP2A
Leukemia, Myelomonocytic, Chronic	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Leukemia, Myelomonocytic, Chronic	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Leukemia, Myelomonocytic, Chronic	ENSG00000134853	TRUE	Approved	1999-03-17	Approved	PDGFRA
Leukemia, Myelomonocytic, Chronic	ENSG00000135446	FALSE	unknown	1996-05-15	Unused	CDK4
Leukemia, Myelomonocytic, Chronic	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Leukemia, Myelomonocytic, Chronic	ENSG00000136807	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK9
Leukemia, Myelomonocytic, Chronic	ENSG00000136997	FALSE	Phase I Clinical Trial	2012-09-20	Absent	MYC
Leukemia, Myelomonocytic, Chronic	ENSG00000138160	FALSE	Phase II Clinical Trial	2006-04-03	Phase II Clinical Trial	KIF11
Leukemia, Myelomonocytic, Chronic	ENSG00000140443	FALSE	unknown	2006-01-11	Unused	IGF1R
Leukemia, Myelomonocytic, Chronic	ENSG00000141736	FALSE	unknown	2001-05-21	Unused	ERBB2
Leukemia, Myelomonocytic, Chronic	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	AKT1
Leukemia, Myelomonocytic, Chronic	ENSG00000143384	FALSE	Phase III Clinical Trial	1999-10-20	Phase III Clinical Trial	MCL1
Leukemia, Myelomonocytic, Chronic	ENSG00000144744	FALSE	Phase III Clinical Trial	2007-04-27	Absent	UBA3
Leukemia, Myelomonocytic, Chronic	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Unused	SRD5A1
Leukemia, Myelomonocytic, Chronic	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Leukemia, Myelomonocytic, Chronic	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CHEK1
Leukemia, Myelomonocytic, Chronic	ENSG00000157404	TRUE	Approved	1999-03-17	Approved	KIT
Leukemia, Myelomonocytic, Chronic	ENSG00000158825	FALSE	Phase III Clinical Trial	2013-07-10	Absent	CDA
Leukemia, Myelomonocytic, Chronic	ENSG00000159110	TRUE	Approved	1992-03-15	Approved	IFNAR2
Leukemia, Myelomonocytic, Chronic	ENSG00000159131	FALSE	Phase I Clinical Trial	1992-06-15	Unused	GART
Leukemia, Myelomonocytic, Chronic	ENSG00000160867	TRUE	Approved	2006-01-19	Approved	FGFR4
Leukemia, Myelomonocytic, Chronic	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Phase II Clinical Trial	JAK1
Leukemia, Myelomonocytic, Chronic	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Leukemia, Myelomonocytic, Chronic	ENSG00000165025	FALSE	Preclinical	2004-06-24	Unused	SYK
Leukemia, Myelomonocytic, Chronic	ENSG00000165304	FALSE	Phase II Clinical Trial	2013-07-03	Absent	MELK
Leukemia, Myelomonocytic, Chronic	ENSG00000165392	FALSE	Preclinical	2015-06-10	Absent	WRN
Leukemia, Myelomonocytic, Chronic	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Unused	ENOX2
Leukemia, Myelomonocytic, Chronic	ENSG00000165731	FALSE	Preclinical	1994-06-15	Phase II Clinical Trial	RET
Leukemia, Myelomonocytic, Chronic	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Leukemia, Myelomonocytic, Chronic	ENSG00000166851	FALSE	Phase III Clinical Trial	2002-05-27	Phase III Clinical Trial	PLK1
Leukemia, Myelomonocytic, Chronic	ENSG00000167325	FALSE	unknown	1997-03-15	Unused	RRM1
Leukemia, Myelomonocytic, Chronic	ENSG00000168036	FALSE	Phase II Clinical Trial	2011-03-05	Phase II Clinical Trial	CTNNB1
Leukemia, Myelomonocytic, Chronic	ENSG00000168522	FALSE	Phase II Clinical Trial	1997-06-15	Unused	FNTA
Leukemia, Myelomonocytic, Chronic	ENSG00000168610	FALSE	Phase I Clinical Trial	2010-05-18	Phase I Clinical Trial	STAT3
Leukemia, Myelomonocytic, Chronic	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Leukemia, Myelomonocytic, Chronic	ENSG00000169032	FALSE	Phase II Clinical Trial	2007-08-10	Phase II Clinical Trial	MAP2K1
Leukemia, Myelomonocytic, Chronic	ENSG00000169442	FALSE	Phase II Clinical Trial	NA	Unused	CD52
Leukemia, Myelomonocytic, Chronic	ENSG00000170312	FALSE	unknown	2007-07-09	Phase I Clinical Trial	CDK1
Leukemia, Myelomonocytic, Chronic	ENSG00000171791	FALSE	Phase I Clinical Trial	1992-03-15	Unused	BCL2
Leukemia, Myelomonocytic, Chronic	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Leukemia, Myelomonocytic, Chronic	ENSG00000176105	TRUE	Approved	2004-07-20	Approved	YES1
Leukemia, Myelomonocytic, Chronic	ENSG00000176890	FALSE	Phase I Clinical Trial	1992-06-15	Unused	TYMS
Leukemia, Myelomonocytic, Chronic	ENSG00000177885	FALSE	Phase II Clinical Trial	NA	Absent	GRB2
Leukemia, Myelomonocytic, Chronic	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Leukemia, Myelomonocytic, Chronic	ENSG00000182054	FALSE	Phase I Clinical Trial	NA	Absent	IDH2
Leukemia, Myelomonocytic, Chronic	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase I Clinical Trial	CSF1R
Leukemia, Myelomonocytic, Chronic	ENSG00000182866	TRUE	Approved	2004-07-20	Approved	LCK
Leukemia, Myelomonocytic, Chronic	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Leukemia, Myelomonocytic, Chronic	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Preclinical	IL3RA
Leukemia, Myelomonocytic, Chronic	ENSG00000186716	TRUE	Approved	1995-03-15	Approved	BCR
Leukemia, Myelomonocytic, Chronic	ENSG00000188389	FALSE	Phase I Clinical Trial	2005-05-12	Phase I Clinical Trial	PDCD1
Leukemia, Myelomonocytic, Chronic	ENSG00000196083	FALSE	Preclinical	NA	Preclinical	IL1RAP
Leukemia, Myelomonocytic, Chronic	ENSG00000196415	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PRTN3
Leukemia, Myelomonocytic, Chronic	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Leukemia, Myelomonocytic, Chronic	ENSG00000197122	TRUE	Approved	2003-01-13	Approved	SRC
Leukemia, Myelomonocytic, Chronic	ENSG00000197461	FALSE	Preclinical	2009-05-28	Absent	PDGFA
Leukemia, Myelomonocytic, Chronic	ENSG00000198223	FALSE	Phase I Clinical Trial	1990-04-15	Absent	CSF2RA
Leukemia, Myelomonocytic, Chronic	ENSG00000198793	FALSE	Phase I Clinical Trial	2005-06-27	Unused	MTOR
Leukemia, Myelomonocytic, Chronic	ENSG00000198900	FALSE	Preclinical	2015-06-10	Phase II Clinical Trial	TOP1
Leukemia, Myelomonocytic, Chronic	ENSG00000228716	FALSE	Phase I Clinical Trial	1992-06-15	Unused	DHFR
Leukemia, Myelomonocytic, Chronic	ENSG00000253729	FALSE	Phase I Clinical Trial	1999-03-31	Unused	PRKDC
Leukemia, Myelomonocytic, Chronic	ENSG00000254087	TRUE	Approved	2004-07-20	Approved	LYN
Leukemia, Myelomonocytic, Juvenile	ENSG00000143384	FALSE	Preclinical	2002-05-27	Absent	MCL1
Leukemia, Myelomonocytic, Juvenile	ENSG00000164400	FALSE	unknown	1999-09-02	Absent	CSF2
Leukemia, Myelomonocytic, Juvenile	ENSG00000166851	FALSE	Preclinical	2002-05-27	Absent	PLK1
Leukemia, Myelomonocytic, Juvenile	ENSG00000198223	FALSE	Preclinical	2006-11-27	Absent	CSF2RA
Leukodystrophy, Globoid Cell	ENSG00000054983	FALSE	Preclinical	2007-09-10	Unused	GALC
Leukodystrophy, Globoid Cell	ENSG00000065989	FALSE	Preclinical	NA	Absent	PDE4A
Leukodystrophy, Globoid Cell	ENSG00000105650	FALSE	Preclinical	NA	Absent	PDE4C
Leukodystrophy, Globoid Cell	ENSG00000112541	FALSE	Preclinical	NA	Absent	PDE10A
Leukodystrophy, Globoid Cell	ENSG00000113448	FALSE	Preclinical	NA	Absent	PDE4D
Leukodystrophy, Globoid Cell	ENSG00000128655	FALSE	Preclinical	NA	Absent	PDE11A
Leukodystrophy, Globoid Cell	ENSG00000136869	FALSE	Preclinical	NA	Absent	TLR4
Leukodystrophy, Globoid Cell	ENSG00000184588	FALSE	Preclinical	NA	Absent	PDE4B
Leukodystrophy, Globoid Cell	ENSG00000240972	FALSE	Preclinical	NA	Absent	MIF
Leukodystrophy, Metachromatic	ENSG00000100299	FALSE	Phase III Clinical Trial	2001-12-14	Phase II Clinical Trial	ARSA
Leukoencephalopathy, Progressive Multifocal	ENSG00000097007	FALSE	Preclinical	2009-05-28	Absent	ABL1
Leukoencephalopathy, Progressive Multifocal	ENSG00000168685	FALSE	Preclinical	2004-01-19	Preclinical	IL7R
Leukoencephalopathy, Progressive Multifocal	ENSG00000186716	FALSE	Preclinical	2009-05-28	Absent	BCR
Leukoencephalopathy, Progressive Multifocal	ENSG00000197461	FALSE	Preclinical	2009-05-28	Absent	PDGFA
Leukopenia	ENSG00000119535	TRUE	Approved	2006-05-09	Approved	CSF3R
Leukopenia	ENSG00000198223	FALSE	unknown	NA	Unused	CSF2RA
Leukoplakia	ENSG00000141510	FALSE	unknown	2005-11-04	Unused	TP53
Lewy Body Disease	ENSG00000068078	FALSE	Phase I Clinical Trial	2016-08-25	Absent	FGFR3
Lewy Body Disease	ENSG00000087085	TRUE	Approved	1989-06-15	Phase III Clinical Trial	ACHE
Lewy Body Disease	ENSG00000102468	FALSE	Phase II Clinical Trial	2003-08-13	Absent	HTR2A
Lewy Body Disease	ENSG00000114200	FALSE	Phase I Clinical Trial	2016-08-25	Absent	BCHE
Lewy Body Disease	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Lewy Body Disease	ENSG00000133019	FALSE	Phase I Clinical Trial	2016-08-25	Absent	CHRM3
Lewy Body Disease	ENSG00000145335	FALSE	Preclinical	2008-08-09	Preclinical	SNCA
Lewy Body Disease	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Lewy Body Disease	ENSG00000158748	FALSE	Phase III Clinical Trial	2004-02-18	Absent	HTR6
Lewy Body Disease	ENSG00000160191	FALSE	Phase I Clinical Trial	2015-04-16	Absent	PDE9A
Lewy Body Disease	ENSG00000168539	FALSE	Phase I Clinical Trial	2003-11-20	Preclinical	CHRM1
Lewy Body Disease	ENSG00000176884	FALSE	Phase II Clinical Trial	2008-01-16	Absent	GRIN1
Lewy Body Disease	ENSG00000186642	FALSE	unknown	2015-07-20	Absent	PDE2A
Lichen Planus, Oral	ENSG00000113580	FALSE	Phase I Clinical Trial	2017-12-01	Absent	NR3C1
Lipid Metabolism Disorders	ENSG00000112033	FALSE	Preclinical	2013-10-08	Absent	PPARD
Lipodystrophy	ENSG00000099194	FALSE	Phase II Clinical Trial	2007-08-21	Absent	SCD
Lipodystrophy	ENSG00000106128	TRUE	Approved	1997-08-15	Approved	GHRHR
Lipodystrophy	ENSG00000110245	FALSE	Phase III Clinical Trial	2009-05-01	Absent	APOC3
Lipodystrophy	ENSG00000112964	FALSE	Phase II Clinical Trial	2008-11-11	Unused	GHR
Lipodystrophy	ENSG00000116678	TRUE	Approved	1999-04-28	Approved	LEPR
Lipodystrophy	ENSG00000118702	FALSE	unknown	2011-11-18	Preclinical	GHRH
Lipodystrophy	ENSG00000121853	FALSE	unknown	NA	Unused	GHSR
Lipodystrophy	ENSG00000132170	FALSE	Phase III Clinical Trial	2007-08-08	Absent	PPARG
Lipodystrophy	ENSG00000132855	FALSE	Preclinical	2015-03-18	Absent	ANGPTL3
Lipodystrophy	ENSG00000140443	FALSE	unknown	NA	Phase II Clinical Trial	IGF1R
Lipodystrophy	ENSG00000159640	FALSE	Phase II Clinical Trial	1998-12-15	Unused	ACE
Lipodystrophy	ENSG00000165029	FALSE	Phase II Clinical Trial	2007-08-21	Absent	ABCA1
Lipodystrophy	ENSG00000167910	FALSE	Phase II Clinical Trial	2007-08-21	Absent	CYP7A1
Lipodystrophy	ENSG00000168000	FALSE	Preclinical	2008-08-26	Unused	BSCL2
Lipodystrophy	ENSG00000186951	FALSE	Phase III Clinical Trial	2007-08-08	Absent	PPARA
Lipoma	ENSG00000169252	FALSE	unknown	2013-01-04	Absent	ADRB2
Liposarcoma	ENSG00000037280	FALSE	Phase I Clinical Trial	2007-08-14	Absent	FLT4
Liposarcoma	ENSG00000074181	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH3
Liposarcoma	ENSG00000077782	FALSE	Phase I Clinical Trial	2007-08-14	Absent	FGFR1
Liposarcoma	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Liposarcoma	ENSG00000082898	FALSE	Phase III Clinical Trial	2012-06-02	Absent	XPO1
Liposarcoma	ENSG00000087586	FALSE	unknown	2006-11-20	Phase I Clinical Trial	AURKA
Liposarcoma	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Unused	ABL1
Liposarcoma	ENSG00000102755	FALSE	Phase I Clinical Trial	2007-08-14	Absent	FLT1
Liposarcoma	ENSG00000105810	FALSE	Phase II Clinical Trial	2009-12-10	Absent	CDK6
Liposarcoma	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Liposarcoma	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-06-20	Absent	CD274
Liposarcoma	ENSG00000128052	FALSE	Phase I Clinical Trial	2007-08-14	Absent	KDR
Liposarcoma	ENSG00000134250	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH2
Liposarcoma	ENSG00000135446	FALSE	Phase II Clinical Trial	2009-12-10	Absent	CDK4
Liposarcoma	ENSG00000135679	FALSE	Phase II Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Liposarcoma	ENSG00000136869	FALSE	Phase II Clinical Trial	2013-11-01	Absent	TLR4
Liposarcoma	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Liposarcoma	ENSG00000140443	FALSE	Phase I Clinical Trial	2009-01-13	Phase I Clinical Trial	IGF1R
Liposarcoma	ENSG00000141510	FALSE	Phase II Clinical Trial	2014-05-22	Absent	TP53
Liposarcoma	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Liposarcoma	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Liposarcoma	ENSG00000169398	FALSE	Phase I Clinical Trial	2011-04-18	Phase I Clinical Trial	PTK2
Liposarcoma	ENSG00000182578	FALSE	Phase I Clinical Trial	2007-08-14	Absent	CSF1R
Liposarcoma	ENSG00000184033	FALSE	Phase II Clinical Trial	2009-04-09	Absent	CTAG1B
Liposarcoma	ENSG00000197081	FALSE	Phase I Clinical Trial	2009-01-13	Phase I Clinical Trial	IGF2R
Liposarcoma	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Unused	SRC
Liposarcoma	ENSG00000198793	FALSE	unknown	NA	Phase II Clinical Trial	MTOR
Liposarcoma	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Liver Cirrhosis	ENSG00000007952	FALSE	Preclinical	NA	Preclinical	NOX1
Liver Cirrhosis	ENSG00000012504	FALSE	Phase II Clinical Trial	2005-05-26	Absent	NR1H4
Liver Cirrhosis	ENSG00000017427	FALSE	Preclinical	2007-12-29	Unused	IGF1
Liver Cirrhosis	ENSG00000019991	FALSE	Phase I Clinical Trial	1998-11-15	Unused	HGF
Liver Cirrhosis	ENSG00000027697	FALSE	Approved	2006-03-20	Unused	IFNGR1
Liver Cirrhosis	ENSG00000064012	FALSE	Phase III Clinical Trial	1999-01-15	Phase II Clinical Trial	CASP8
Liver Cirrhosis	ENSG00000067182	FALSE	Approved	2006-03-20	Unused	TNFRSF1A
Liver Cirrhosis	ENSG00000086991	FALSE	Preclinical	NA	Preclinical	NOX4
Liver Cirrhosis	ENSG00000092969	FALSE	unknown	2002-12-31	Unused	TGFB2
Liver Cirrhosis	ENSG00000099194	FALSE	Preclinical	2007-08-21	Absent	SCD
Liver Cirrhosis	ENSG00000100097	FALSE	Phase II Clinical Trial	NA	Preclinical	LGALS1
Liver Cirrhosis	ENSG00000105329	FALSE	Approved	2002-12-31	Unused	TGFB1
Liver Cirrhosis	ENSG00000106144	FALSE	unknown	2005-10-05	Unused	CASP2
Liver Cirrhosis	ENSG00000106991	FALSE	Preclinical	2006-05-01	Absent	ENG
Liver Cirrhosis	ENSG00000107643	FALSE	Phase I Clinical Trial	2013-01-15	Preclinical	MAPK8
Liver Cirrhosis	ENSG00000110492	FALSE	Preclinical	2014-05-20	Absent	MDK
Liver Cirrhosis	ENSG00000112033	FALSE	Phase III Clinical Trial	2004-08-02	Absent	PPARD
Liver Cirrhosis	ENSG00000112062	FALSE	Approved	NA	Unused	MAPK14
Liver Cirrhosis	ENSG00000113721	FALSE	Preclinical	2012-08-01	Preclinical	PDGFRB
Liver Cirrhosis	ENSG00000113749	FALSE	Preclinical	2004-03-03	Unused	HRH2
Liver Cirrhosis	ENSG00000115232	FALSE	Preclinical	1995-10-15	Absent	ITGA4
Liver Cirrhosis	ENSG00000115318	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL3
Liver Cirrhosis	ENSG00000116044	FALSE	Preclinical	2015-10-05	Absent	NFE2L2
Liver Cirrhosis	ENSG00000118432	FALSE	Phase I Clinical Trial	2006-05-25	Phase I Clinical Trial	CNR1
Liver Cirrhosis	ENSG00000118523	FALSE	Phase II Clinical Trial	1999-09-14	Phase II Clinical Trial	CTGF
Liver Cirrhosis	ENSG00000119699	FALSE	unknown	2002-12-31	Unused	TGFB3
Liver Cirrhosis	ENSG00000121807	FALSE	Phase III Clinical Trial	2007-08-07	Unused	CCR2
Liver Cirrhosis	ENSG00000121966	FALSE	Preclinical	2015-09-22	Absent	CXCR4
Liver Cirrhosis	ENSG00000126895	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	AVPR2
Liver Cirrhosis	ENSG00000131981	FALSE	Phase II Clinical Trial	2012-04-28	Preclinical	LGALS3
Liver Cirrhosis	ENSG00000132170	FALSE	unknown	1997-02-15	Unused	PPARG
Liver Cirrhosis	ENSG00000132703	FALSE	Preclinical	2009-07-24	Preclinical	APCS
Liver Cirrhosis	ENSG00000132906	FALSE	unknown	2005-10-05	Unused	CASP9
Liver Cirrhosis	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Phase II Clinical Trial	LOXL2
Liver Cirrhosis	ENSG00000134318	FALSE	unknown	2005-05-24	Preclinical	ROCK2
Liver Cirrhosis	ENSG00000134853	FALSE	Preclinical	2010-08-09	Unused	PDGFRA
Liver Cirrhosis	ENSG00000136869	FALSE	Phase II Clinical Trial	2005-08-03	Absent	TLR4
Liver Cirrhosis	ENSG00000136943	FALSE	Preclinical	2009-01-21	Absent	CTSV
Liver Cirrhosis	ENSG00000136960	FALSE	Preclinical	2014-10-09	Absent	ENPP2
Liver Cirrhosis	ENSG00000137462	FALSE	Preclinical	2006-08-17	Absent	TLR2
Liver Cirrhosis	ENSG00000137752	FALSE	unknown	2005-10-05	Unused	CASP1
Liver Cirrhosis	ENSG00000138131	FALSE	Phase I Clinical Trial	2015-07-30	Absent	LOXL4
Liver Cirrhosis	ENSG00000138448	FALSE	Preclinical	2003-08-12	Unused	ITGAV
Liver Cirrhosis	ENSG00000139626	FALSE	Preclinical	1995-10-15	Absent	ITGB7
Liver Cirrhosis	ENSG00000143387	FALSE	Preclinical	2009-01-21	Absent	CTSK
Liver Cirrhosis	ENSG00000149257	FALSE	Phase I Clinical Trial	2010-09-27	Absent	SERPINH1
Liver Cirrhosis	ENSG00000150093	FALSE	Preclinical	2016-02-22	Absent	ITGB1
Liver Cirrhosis	ENSG00000159110	FALSE	Approved	1992-03-15	Unused	IFNAR2
Liver Cirrhosis	ENSG00000160791	FALSE	Phase III Clinical Trial	2010-09-28	Unused	CCR5
Liver Cirrhosis	ENSG00000163131	FALSE	Preclinical	2009-01-21	Absent	CTSS
Liver Cirrhosis	ENSG00000163235	FALSE	unknown	NA	Phase I Clinical Trial	TGFA
Liver Cirrhosis	ENSG00000164305	FALSE	unknown	2005-10-05	Unused	CASP3
Liver Cirrhosis	ENSG00000164362	FALSE	Preclinical	2010-05-18	Unused	TERT
Liver Cirrhosis	ENSG00000164733	FALSE	Preclinical	2007-11-30	Phase I Clinical Trial	CTSB
Liver Cirrhosis	ENSG00000165029	FALSE	Preclinical	2007-08-21	Absent	ABCA1
Liver Cirrhosis	ENSG00000166148	FALSE	Phase II Clinical Trial	2016-08-22	Absent	AVPR1A
Liver Cirrhosis	ENSG00000167910	FALSE	Preclinical	2007-08-21	Absent	CYP7A1
Liver Cirrhosis	ENSG00000168398	FALSE	Phase II Clinical Trial	1989-08-15	Unused	BDKRB2
Liver Cirrhosis	ENSG00000169429	FALSE	unknown	NA	Phase I Clinical Trial	CXCL8
Liver Cirrhosis	ENSG00000171509	FALSE	Phase II Clinical Trial	2007-10-23	Preclinical	RXFP1
Liver Cirrhosis	ENSG00000172016	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	REG3A
Liver Cirrhosis	ENSG00000173250	FALSE	Preclinical	NA	Absent	GPR151
Liver Cirrhosis	ENSG00000179921	FALSE	Phase I Clinical Trial	2005-05-26	Absent	GPBAR1
Liver Cirrhosis	ENSG00000186951	FALSE	Phase III Clinical Trial	2004-08-02	Phase II Clinical Trial	PPARA
Liver Cirrhosis	ENSG00000188379	FALSE	Approved	2014-06-05	Absent	IFNA2
Liver Cirrhosis	ENSG00000189403	FALSE	Preclinical	2009-05-18	Unused	HMGB1
Liver Cirrhosis	ENSG00000197442	FALSE	Phase III Clinical Trial	2014-03-17	Absent	MAP3K5
Liver Cirrhosis	ENSG00000197635	FALSE	Preclinical	2006-10-09	Absent	DPP4
Liver Cirrhosis	ENSG00000198049	FALSE	Phase II Clinical Trial	2016-08-22	Absent	AVPR1B
Liver Cirrhosis	ENSG00000198121	FALSE	Preclinical	2012-03-29	Preclinical	LPAR1
Liver Cirrhosis	ENSG00000249437	FALSE	Preclinical	2017-08-08	Absent	NAIP
Liver Cirrhosis	ENSG00000259207	FALSE	Preclinical	2003-08-12	Unused	ITGB3
Liver Cirrhosis	ENSG00000260314	FALSE	Preclinical	2017-08-16	Absent	MRC1
Liver Cirrhosis	ENSG00000262406	FALSE	unknown	2000-10-19	Absent	MMP12
Liver Cirrhosis, Biliary	ENSG00000001626	FALSE	Preclinical	2017-03-29	Absent	CFTR
Liver Cirrhosis, Biliary	ENSG00000006210	FALSE	Phase II Clinical Trial	2010-02-25	Absent	CX3CL1
Liver Cirrhosis, Biliary	ENSG00000007952	FALSE	Phase II Clinical Trial	NA	Absent	NOX1
Liver Cirrhosis, Biliary	ENSG00000012504	TRUE	Approved	1999-03-17	Phase III Clinical Trial	NR1H4
Liver Cirrhosis, Biliary	ENSG00000086991	FALSE	Phase II Clinical Trial	NA	Absent	NOX4
Liver Cirrhosis, Biliary	ENSG00000101017	FALSE	Phase II Clinical Trial	2006-12-06	Absent	CD40
Liver Cirrhosis, Biliary	ENSG00000112033	FALSE	Phase III Clinical Trial	2004-08-02	Absent	PPARD
Liver Cirrhosis, Biliary	ENSG00000113302	FALSE	Phase II Clinical Trial	2003-04-30	Phase II Clinical Trial	IL12B
Liver Cirrhosis, Biliary	ENSG00000113580	FALSE	unknown	2004-07-24	Phase III Clinical Trial	NR3C1
Liver Cirrhosis, Biliary	ENSG00000121594	FALSE	unknown	1998-09-15	Preclinical	CD80
Liver Cirrhosis, Biliary	ENSG00000125255	FALSE	Phase II Clinical Trial	2008-04-18	Preclinical	SLC10A2
Liver Cirrhosis, Biliary	ENSG00000125910	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR4
Liver Cirrhosis, Biliary	ENSG00000132170	FALSE	Phase II Clinical Trial	2007-08-08	Absent	PPARG
Liver Cirrhosis, Biliary	ENSG00000136943	FALSE	Preclinical	2009-01-21	Absent	CTSV
Liver Cirrhosis, Biliary	ENSG00000143387	FALSE	Preclinical	2009-01-21	Absent	CTSK
Liver Cirrhosis, Biliary	ENSG00000160867	FALSE	Phase II Clinical Trial	2012-03-30	Absent	FGFR4
Liver Cirrhosis, Biliary	ENSG00000163131	FALSE	Preclinical	2009-01-21	Absent	CTSS
Liver Cirrhosis, Biliary	ENSG00000164733	FALSE	Preclinical	2009-01-21	Absent	CTSB
Liver Cirrhosis, Biliary	ENSG00000169245	FALSE	unknown	2008-01-14	Phase II Clinical Trial	CXCL10
Liver Cirrhosis, Biliary	ENSG00000170989	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR1
Liver Cirrhosis, Biliary	ENSG00000180739	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR5
Liver Cirrhosis, Biliary	ENSG00000186951	FALSE	Phase II Clinical Trial	2004-08-02	Absent	PPARA
Liver Cirrhosis, Biliary	ENSG00000198851	FALSE	Phase I Clinical Trial	2004-02-24	Absent	CD3E
Liver Diseases	ENSG00000011465	FALSE	Preclinical	1991-06-15	Unused	DCN
Liver Diseases	ENSG00000011677	FALSE	Preclinical	1990-09-15	Unused	GABRA3
Liver Diseases	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Liver Diseases	ENSG00000012504	FALSE	Phase II Clinical Trial	2005-05-26	Phase I Clinical Trial	NR1H4
Liver Diseases	ENSG00000022355	FALSE	Preclinical	1990-09-15	Unused	GABRA1
Liver Diseases	ENSG00000025434	FALSE	Preclinical	NA	Absent	NR1H3
Liver Diseases	ENSG00000026103	FALSE	Preclinical	2000-10-10	Unused	FAS
Liver Diseases	ENSG00000064012	FALSE	Phase II Clinical Trial	1999-01-15	Phase II Clinical Trial	CASP8
Liver Diseases	ENSG00000065559	FALSE	Preclinical	2017-01-05	Absent	MAP2K4
Liver Diseases	ENSG00000073756	FALSE	Preclinical	NA	Preclinical	PTGS2
Liver Diseases	ENSG00000083444	FALSE	Preclinical	1993-12-15	Unused	PLOD1
Liver Diseases	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Liver Diseases	ENSG00000095303	FALSE	Preclinical	NA	Preclinical	PTGS1
Liver Diseases	ENSG00000100311	FALSE	Preclinical	2012-08-01	Absent	PDGFB
Liver Diseases	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Liver Diseases	ENSG00000104870	FALSE	Preclinical	2016-04-22	Absent	FCGRT
Liver Diseases	ENSG00000105976	FALSE	Preclinical	1990-02-15	Unused	MET
Liver Diseases	ENSG00000106799	FALSE	Preclinical	1991-06-15	Unused	TGFBR1
Liver Diseases	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Liver Diseases	ENSG00000110245	FALSE	Preclinical	2017-08-14	Absent	APOC3
Liver Diseases	ENSG00000110492	FALSE	Preclinical	2009-05-19	Unused	MDK
Liver Diseases	ENSG00000115353	FALSE	unknown	2001-07-18	Preclinical	TACR1
Liver Diseases	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Liver Diseases	ENSG00000117400	FALSE	unknown	2003-01-22	Unused	MPL
Liver Diseases	ENSG00000118432	FALSE	Preclinical	2006-05-25	Phase I Clinical Trial	CNR1
Liver Diseases	ENSG00000121807	FALSE	unknown	2007-08-07	Unused	CCR2
Liver Diseases	ENSG00000122420	FALSE	unknown	NA	Unused	PTGFR
Liver Diseases	ENSG00000122884	FALSE	Phase II Clinical Trial	1989-12-15	Unused	P4HA1
Liver Diseases	ENSG00000126895	FALSE	Phase II Clinical Trial	1998-10-15	Unused	AVPR2
Liver Diseases	ENSG00000130234	FALSE	unknown	2007-07-13	Unused	ACE2
Liver Diseases	ENSG00000131408	FALSE	Preclinical	NA	Absent	NR1H2
Liver Diseases	ENSG00000131981	FALSE	unknown	1997-05-15	Preclinical	LGALS3
Liver Diseases	ENSG00000132906	FALSE	unknown	1997-05-15	Preclinical	CASP9
Liver Diseases	ENSG00000136160	FALSE	Preclinical	1994-08-15	Unused	EDNRB
Liver Diseases	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Absent	TXN
Liver Diseases	ENSG00000136869	FALSE	Phase III Clinical Trial	2017-12-27	Absent	TLR4
Liver Diseases	ENSG00000142208	FALSE	unknown	1997-05-15	Preclinical	AKT1
Liver Diseases	ENSG00000143799	FALSE	Preclinical	2009-01-13	Unused	PARP1
Liver Diseases	ENSG00000146648	FALSE	Preclinical	2006-10-16	Unused	EGFR
Liver Diseases	ENSG00000150281	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CTF1
Liver Diseases	ENSG00000151617	FALSE	unknown	1994-08-15	Unused	EDNRA
Liver Diseases	ENSG00000151834	FALSE	Preclinical	1990-09-15	Unused	GABRA2
Liver Diseases	ENSG00000159339	FALSE	Preclinical	2017-10-06	Absent	PADI4
Liver Diseases	ENSG00000160013	FALSE	Phase III Clinical Trial	2016-12-02	Absent	PTGIR
Liver Diseases	ENSG00000160255	FALSE	Preclinical	1997-06-15	Unused	ITGB2
Liver Diseases	ENSG00000160712	FALSE	Preclinical	2000-09-12	Unused	IL6R
Liver Diseases	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Liver Diseases	ENSG00000164305	FALSE	Preclinical	2001-09-07	Unused	CASP3
Liver Diseases	ENSG00000166148	FALSE	Phase I Clinical Trial	2014-07-10	Preclinical	AVPR1A
Liver Diseases	ENSG00000167910	FALSE	unknown	NA	Unused	CYP7A1
Liver Diseases	ENSG00000168522	FALSE	Preclinical	2010-12-23	Unused	FNTA
Liver Diseases	ENSG00000169418	FALSE	unknown	1997-05-15	Unused	NPR1
Liver Diseases	ENSG00000169896	FALSE	Preclinical	1997-06-15	Unused	ITGAM
Liver Diseases	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Liver Diseases	ENSG00000170820	FALSE	Preclinical	2000-01-19	Unused	FSHR
Liver Diseases	ENSG00000172016	FALSE	unknown	NA	Phase II Clinical Trial	REG3A
Liver Diseases	ENSG00000179921	FALSE	unknown	2005-05-26	Preclinical	GPBAR1
Liver Diseases	ENSG00000181092	FALSE	Preclinical	2004-09-20	Unused	ADIPOQ
Liver Diseases	ENSG00000183134	FALSE	Preclinical	2010-12-07	Absent	PTGDR2
Liver Diseases	ENSG00000184502	FALSE	unknown	NA	Unused	GAST
Liver Diseases	ENSG00000186297	FALSE	Preclinical	1990-09-15	Unused	GABRA5
Liver Diseases	ENSG00000188822	FALSE	Preclinical	2011-05-06	Unused	CNR2
Liver Diseases	ENSG00000197442	FALSE	Preclinical	2017-04-04	Absent	MAP3K5
Liver Diseases	ENSG00000198049	FALSE	Preclinical	NA	Preclinical	AVPR1B
Liver Diseases	ENSG00000198793	FALSE	Phase I Clinical Trial	1997-08-15	Unused	MTOR
Liver Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Liver Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Liver Neoplasms	ENSG00000010327	FALSE	Preclinical	2009-11-12	Absent	STAB1
Liver Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	NA	Absent	FYN
Liver Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Liver Neoplasms	ENSG00000037280	TRUE	Approved	1994-06-15	Approved	FLT4
Liver Neoplasms	ENSG00000043591	FALSE	unknown	2007-01-23	Absent	ADRB1
Liver Neoplasms	ENSG00000044574	FALSE	Preclinical	2009-07-23	Preclinical	HSPA5
Liver Neoplasms	ENSG00000047936	FALSE	Preclinical	2006-12-05	Absent	ROS1
Liver Neoplasms	ENSG00000050165	FALSE	Phase I Clinical Trial	2010-07-26	Absent	DKK3
Liver Neoplasms	ENSG00000060491	FALSE	Phase II Clinical Trial	2012-09-01	Absent	OGFR
Liver Neoplasms	ENSG00000063176	FALSE	Phase II Clinical Trial	2006-06-05	Absent	SPHK2
Liver Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	1994-09-15	Phase I Clinical Trial	ERBB3
Liver Neoplasms	ENSG00000066468	TRUE	Approved	2003-07-22	Absent	FGFR2
Liver Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase I Clinical Trial	TNFRSF1A
Liver Neoplasms	ENSG00000068024	FALSE	Phase II Clinical Trial	2002-06-10	Absent	HDAC4
Liver Neoplasms	ENSG00000068078	TRUE	Approved	2001-04-03	Phase II Clinical Trial	FGFR3
Liver Neoplasms	ENSG00000070501	FALSE	Phase II Clinical Trial	2002-06-25	Phase II Clinical Trial	POLB
Liver Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Liver Neoplasms	ENSG00000073756	FALSE	unknown	2007-01-23	Absent	PTGS2
Liver Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Liver Neoplasms	ENSG00000077092	FALSE	unknown	NA	Phase II Clinical Trial	RARB
Liver Neoplasms	ENSG00000077782	TRUE	Approved	2001-04-03	Phase III Clinical Trial	FGFR1
Liver Neoplasms	ENSG00000079277	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK1
Liver Neoplasms	ENSG00000080824	FALSE	unknown	2005-12-05	Phase II Clinical Trial	HSP90AA1
Liver Neoplasms	ENSG00000081051	FALSE	Phase II Clinical Trial	1999-05-19	Unused	AFP
Liver Neoplasms	ENSG00000082701	FALSE	Preclinical	NA	Absent	GSK3B
Liver Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGB5
Liver Neoplasms	ENSG00000085563	FALSE	unknown	1994-04-15	Unused	ABCB1
Liver Neoplasms	ENSG00000087245	FALSE	unknown	2001-07-18	Phase II Clinical Trial	MMP2
Liver Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2005-06-27	Absent	AURKA
Liver Neoplasms	ENSG00000089685	FALSE	unknown	2002-04-29	Unused	BIRC5
Liver Neoplasms	ENSG00000091831	FALSE	Pre-registration	2010-02-19	Absent	ESR1
Liver Neoplasms	ENSG00000091879	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Liver Neoplasms	ENSG00000094631	FALSE	Preclinical	2010-08-16	Preclinical	HDAC6
Liver Neoplasms	ENSG00000096717	FALSE	unknown	2006-01-16	Unused	SIRT1
Liver Neoplasms	ENSG00000096968	FALSE	Phase I Clinical Trial	2007-07-09	Unused	JAK2
Liver Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Liver Neoplasms	ENSG00000099875	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK2
Liver Neoplasms	ENSG00000100311	TRUE	Approved	1994-06-15	Approved	PDGFB
Liver Neoplasms	ENSG00000100429	FALSE	Preclinical	2010-08-16	Preclinical	HDAC10
Liver Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	HIF1A
Liver Neoplasms	ENSG00000100823	FALSE	unknown	2007-02-13	Unused	APEX1
Liver Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2016-11-14	Absent	CD40
Liver Neoplasms	ENSG00000101843	FALSE	Preclinical	2005-09-12	Unused	PSMD10
Liver Neoplasms	ENSG00000101868	FALSE	Phase II Clinical Trial	2002-06-25	Phase II Clinical Trial	POLA1
Liver Neoplasms	ENSG00000101966	FALSE	unknown	1999-01-08	Phase II Clinical Trial	XIAP
Liver Neoplasms	ENSG00000102755	TRUE	Approved	1994-03-15	Phase III Clinical Trial	FLT1
Liver Neoplasms	ENSG00000103222	FALSE	unknown	1994-04-15	Phase II Clinical Trial	ABCC1
Liver Neoplasms	ENSG00000104689	FALSE	Phase II Clinical Trial	2001-02-22	Phase II Clinical Trial	TNFRSF10A
Liver Neoplasms	ENSG00000105221	FALSE	Preclinical	2017-02-17	Absent	AKT2
Liver Neoplasms	ENSG00000105388	FALSE	Preclinical	1997-04-15	Unused	CEACAM5
Liver Neoplasms	ENSG00000105675	FALSE	Phase I Clinical Trial	2010-03-29	Phase I Clinical Trial	ATP4A
Liver Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CG
Liver Neoplasms	ENSG00000105976	FALSE	Phase III Clinical Trial	2003-07-18	Phase III Clinical Trial	MET
Liver Neoplasms	ENSG00000106799	FALSE	Phase II Clinical Trial	2003-09-17	Phase II Clinical Trial	TGFBR1
Liver Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Liver Neoplasms	ENSG00000107562	FALSE	unknown	2003-04-10	Unused	CXCL12
Liver Neoplasms	ENSG00000107738	FALSE	Preclinical	2016-04-25	Absent	VSIR
Liver Neoplasms	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Absent	DKK1
Liver Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Liver Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1990-06-15	Phase II Clinical Trial	NFKB1
Liver Neoplasms	ENSG00000109471	FALSE	Phase I Clinical Trial	2011-07-21	Phase I Clinical Trial	IL2
Liver Neoplasms	ENSG00000110195	FALSE	Phase I Clinical Trial	2013-05-06	Absent	FOLR1
Liver Neoplasms	ENSG00000111142	FALSE	Preclinical	2009-01-26	Unused	METAP2
Liver Neoplasms	ENSG00000111424	FALSE	Phase III Clinical Trial	1993-07-15	Unused	VDR
Liver Neoplasms	ENSG00000111537	FALSE	unknown	NA	Unused	IFNG
Liver Neoplasms	ENSG00000111640	FALSE	Preclinical	2013-07-26	Absent	GAPDH
Liver Neoplasms	ENSG00000111679	FALSE	Preclinical	2016-11-08	Absent	PTPN6
Liver Neoplasms	ENSG00000112062	FALSE	Preclinical	NA	Absent	MAPK14
Liver Neoplasms	ENSG00000112115	FALSE	Preclinical	2001-07-24	Absent	IL17A
Liver Neoplasms	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Liver Neoplasms	ENSG00000113070	FALSE	unknown	2004-02-04	Unused	HBEGF
Liver Neoplasms	ENSG00000113328	FALSE	Phase II Clinical Trial	2003-08-05	Unused	CCNG1
Liver Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Liver Neoplasms	ENSG00000113575	FALSE	Preclinical	2008-02-29	Absent	PPP2CA
Liver Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Liver Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Liver Neoplasms	ENSG00000113749	FALSE	Phase II Clinical Trial	1996-05-15	Unused	HRH2
Liver Neoplasms	ENSG00000113851	FALSE	Phase II Clinical Trial	2011-08-26	Absent	CRBN
Liver Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Liver Neoplasms	ENSG00000114378	FALSE	Preclinical	NA	Absent	HYAL1
Liver Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2008-01-15	Phase I Clinical Trial	ITGB6
Liver Neoplasms	ENSG00000115353	FALSE	unknown	2001-07-18	Phase II Clinical Trial	TACR1
Liver Neoplasms	ENSG00000115414	FALSE	unknown	2004-06-14	Unused	FN1
Liver Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase I Clinical Trial	ODC1
Liver Neoplasms	ENSG00000116044	FALSE	Preclinical	2009-02-23	Unused	NFE2L2
Liver Neoplasms	ENSG00000116329	FALSE	unknown	2001-07-18	Phase II Clinical Trial	OPRD1
Liver Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC1
Liver Neoplasms	ENSG00000118137	FALSE	unknown	2005-07-04	Unused	APOA1
Liver Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2007-10-09	Phase II Clinical Trial	ARG1
Liver Neoplasms	ENSG00000119630	FALSE	unknown	2003-07-24	Preclinical	PGF
Liver Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1999-04-28	Unused	EPCAM
Liver Neoplasms	ENSG00000120156	FALSE	Phase III Clinical Trial	2004-03-24	Phase II Clinical Trial	TEK
Liver Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Liver Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	2001-08-23	Phase II Clinical Trial	TNFRSF10B
Liver Neoplasms	ENSG00000121022	FALSE	Preclinical	2011-04-22	Unused	COPS5
Liver Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Unused	PIK3CA
Liver Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	2003-04-10	Unused	CXCR4
Liver Neoplasms	ENSG00000122025	TRUE	Approved	1994-06-15	Approved	FLT3
Liver Neoplasms	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK2
Liver Neoplasms	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Preclinical	LRP1
Liver Neoplasms	ENSG00000124102	FALSE	Preclinical	2017-02-17	Phase I Clinical Trial	PI3
Liver Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL1
Liver Neoplasms	ENSG00000125571	FALSE	Preclinical	2001-07-24	Absent	IL37
Liver Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K2
Liver Neoplasms	ENSG00000128052	TRUE	Approved	1994-06-15	Approved	KDR
Liver Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Phase II Clinical Trial	SMO
Liver Neoplasms	ENSG00000129484	FALSE	Phase II Clinical Trial	2006-08-16	Phase I Clinical Trial	PARP2
Liver Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	2006-12-06	Phase II Clinical Trial	DNMT1
Liver Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase I Clinical Trial	PPT1
Liver Neoplasms	ENSG00000131747	TRUE	Approved	1989-07-15	Approved	TOP2A
Liver Neoplasms	ENSG00000131759	FALSE	unknown	NA	Phase II Clinical Trial	RARA
Liver Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	2002-08-05	Unused	LGALS3
Liver Neoplasms	ENSG00000132155	TRUE	Approved	1994-06-15	Approved	RAF1
Liver Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Liver Neoplasms	ENSG00000134318	FALSE	Preclinical	2005-05-24	Phase I Clinical Trial	ROCK2
Liver Neoplasms	ENSG00000134460	FALSE	Approved	2004-06-14	Unused	IL2RA
Liver Neoplasms	ENSG00000134853	TRUE	Approved	1996-12-15	Phase III Clinical Trial	PDGFRA
Liver Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	2007-02-06	Absent	CDK4
Liver Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK9
Liver Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	2000-05-11	Unused	TXN
Liver Neoplasms	ENSG00000136856	FALSE	Preclinical	2004-11-24	Absent	SLC2A8
Liver Neoplasms	ENSG00000136997	FALSE	Phase II Clinical Trial	2013-03-27	Absent	MYC
Liver Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Liver Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGAV
Liver Neoplasms	ENSG00000138685	FALSE	Preclinical	2011-02-18	Preclinical	FGF2
Liver Neoplasms	ENSG00000138735	FALSE	unknown	1999-01-08	Unused	PDE5A
Liver Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Liver Neoplasms	ENSG00000139567	FALSE	Phase II Clinical Trial	2007-05-30	Phase I Clinical Trial	ACVRL1
Liver Neoplasms	ENSG00000139625	FALSE	Preclinical	2016-07-15	Absent	MAP3K12
Liver Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-02-11	Phase II Clinical Trial	IGF1R
Liver Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	1993-10-15	Phase I Clinical Trial	TP53
Liver Neoplasms	ENSG00000141736	FALSE	Phase I Clinical Trial	2000-11-16	Phase I Clinical Trial	ERBB2
Liver Neoplasms	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Liver Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	AKT1
Liver Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	1999-10-20	Phase I Clinical Trial	MCL1
Liver Neoplasms	ENSG00000143799	FALSE	Phase II Clinical Trial	2006-08-16	Phase I Clinical Trial	PARP1
Liver Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1993-07-15	Phase II Clinical Trial	EGFR
Liver Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Absent	EPHA1
Liver Neoplasms	ENSG00000147099	FALSE	Preclinical	2010-08-16	Preclinical	HDAC8
Liver Neoplasms	ENSG00000147257	FALSE	Phase II Clinical Trial	2008-09-10	Phase II Clinical Trial	GPC3
Liver Neoplasms	ENSG00000147889	FALSE	Preclinical	1999-10-29	Unused	CDKN2A
Liver Neoplasms	ENSG00000148795	FALSE	Preclinical	2008-10-27	Absent	CYP17A1
Liver Neoplasms	ENSG00000150093	FALSE	Phase I Clinical Trial	2000-02-02	Phase I Clinical Trial	ITGB1
Liver Neoplasms	ENSG00000154188	FALSE	Phase II Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Liver Neoplasms	ENSG00000154269	FALSE	Phase I Clinical Trial	2009-09-29	Absent	ENPP3
Liver Neoplasms	ENSG00000155760	FALSE	Preclinical	2016-12-27	Absent	FZD7
Liver Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase I Clinical Trial	EEF1A1
Liver Neoplasms	ENSG00000157404	TRUE	Approved	2001-04-03	Phase III Clinical Trial	KIT
Liver Neoplasms	ENSG00000157764	FALSE	Phase I Clinical Trial	2001-04-03	Unused	BRAF
Liver Neoplasms	ENSG00000159110	FALSE	Phase II Clinical Trial	2003-07-30	Phase II Clinical Trial	IFNAR2
Liver Neoplasms	ENSG00000159131	FALSE	Phase I Clinical Trial	1992-06-15	Unused	GART
Liver Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Liver Neoplasms	ENSG00000160867	TRUE	Approved	2002-06-10	Absent	FGFR4
Liver Neoplasms	ENSG00000161638	FALSE	unknown	2000-02-02	Phase I Clinical Trial	ITGA5
Liver Neoplasms	ENSG00000163217	FALSE	Phase II Clinical Trial	2007-05-30	Absent	BMP10
Liver Neoplasms	ENSG00000163220	FALSE	unknown	2001-05-18	Phase II Clinical Trial	S100A9
Liver Neoplasms	ENSG00000163517	FALSE	Preclinical	2010-08-16	Preclinical	HDAC11
Liver Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	2004-07-07	Phase II Clinical Trial	CTLA4
Liver Neoplasms	ENSG00000164078	FALSE	Phase I Clinical Trial	2008-08-15	Phase II Clinical Trial	MST1R
Liver Neoplasms	ENSG00000164342	FALSE	Phase I Clinical Trial	NA	Absent	TLR3
Liver Neoplasms	ENSG00000164362	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TERT
Liver Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2000-09-28	Phase II Clinical Trial	CSF2
Liver Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Liver Neoplasms	ENSG00000165025	FALSE	unknown	2003-10-31	Phase II Clinical Trial	SYK
Liver Neoplasms	ENSG00000165731	TRUE	Approved	1994-06-15	Approved	RET
Liver Neoplasms	ENSG00000166483	FALSE	Preclinical	2011-05-02	Preclinical	WEE1
Liver Neoplasms	ENSG00000166484	FALSE	Preclinical	2007-07-09	Absent	MAPK7
Liver Neoplasms	ENSG00000166825	FALSE	unknown	2003-02-20	Unused	ANPEP
Liver Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Liver Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Phase II Clinical Trial	AXL
Liver Neoplasms	ENSG00000167658	FALSE	Preclinical	1997-12-15	Unused	EEF2
Liver Neoplasms	ENSG00000168036	FALSE	Preclinical	2013-07-26	Absent	CTNNB1
Liver Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Unused	FNTA
Liver Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2007-08-28	Phase II Clinical Trial	STAT3
Liver Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K1
Liver Neoplasms	ENSG00000169083	FALSE	Phase II Clinical Trial	2005-09-27	Absent	AR
Liver Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Liver Neoplasms	ENSG00000169252	FALSE	unknown	2007-01-23	Absent	ADRB2
Liver Neoplasms	ENSG00000169855	FALSE	Preclinical	2014-07-30	Absent	ROBO1
Liver Neoplasms	ENSG00000169919	FALSE	unknown	2001-07-18	Phase II Clinical Trial	GUSB
Liver Neoplasms	ENSG00000170312	FALSE	Phase II Clinical Trial	2005-03-14	Phase I Clinical Trial	CDK1
Liver Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Liver Neoplasms	ENSG00000171094	FALSE	Preclinical	2006-12-05	Preclinical	ALK
Liver Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CD
Liver Neoplasms	ENSG00000171720	FALSE	Preclinical	2010-08-16	Preclinical	HDAC3
Liver Neoplasms	ENSG00000171791	FALSE	Phase I Clinical Trial	1992-03-15	Unused	BCL2
Liver Neoplasms	ENSG00000171855	FALSE	unknown	2000-08-17	Unused	IFNB1
Liver Neoplasms	ENSG00000173083	FALSE	unknown	1997-09-15	Phase III Clinical Trial	HPSE
Liver Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Phase I Clinical Trial	CD248
Liver Neoplasms	ENSG00000175189	FALSE	Preclinical	1996-12-15	Unused	INHBC
Liver Neoplasms	ENSG00000176884	FALSE	Phase I Clinical Trial	1990-06-15	Absent	GRIN1
Liver Neoplasms	ENSG00000176890	TRUE	Approved	1992-04-15	Approved	TYMS
Liver Neoplasms	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Liver Neoplasms	ENSG00000178562	FALSE	Phase I Clinical Trial	2008-02-13	Absent	CD28
Liver Neoplasms	ENSG00000178568	FALSE	Phase I Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB4
Liver Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2013-01-21	Phase I Clinical Trial	AURKB
Liver Neoplasms	ENSG00000180210	FALSE	unknown	2004-07-19	Unused	F2
Liver Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase III Clinical Trial	CSF1R
Liver Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Liver Neoplasms	ENSG00000184033	FALSE	Preclinical	2009-04-09	Absent	CTAG1B
Liver Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Liver Neoplasms	ENSG00000184489	FALSE	Preclinical	2002-04-09	Unused	PTP4A3
Liver Neoplasms	ENSG00000184584	FALSE	Preclinical	2016-10-24	Absent	TMEM173
Liver Neoplasms	ENSG00000184937	FALSE	unknown	2005-12-05	Phase II Clinical Trial	WT1
Liver Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2005-05-23	Unused	MUC1
Liver Neoplasms	ENSG00000185559	FALSE	Preclinical	2009-05-15	Absent	DLK1
Liver Neoplasms	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Liver Neoplasms	ENSG00000186642	FALSE	unknown	1999-01-08	Unused	PDE2A
Liver Neoplasms	ENSG00000186652	FALSE	Preclinical	2015-03-31	Absent	PRG2
Liver Neoplasms	ENSG00000186827	FALSE	Phase II Clinical Trial	2014-12-15	Absent	TNFRSF4
Liver Neoplasms	ENSG00000187514	TRUE	Approved	NA	Approved	PTMA
Liver Neoplasms	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Liver Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Phase I Clinical Trial	PDCD1
Liver Neoplasms	ENSG00000188641	FALSE	unknown	1993-07-15	Phase II Clinical Trial	DPYD
Liver Neoplasms	ENSG00000196139	FALSE	Preclinical	2016-10-19	Absent	AKR1C3
Liver Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Liver Neoplasms	ENSG00000196664	FALSE	Preclinical	2016-12-27	Absent	TLR7
Liver Neoplasms	ENSG00000197081	FALSE	unknown	2009-01-13	Phase II Clinical Trial	IGF2R
Liver Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2005-06-27	Absent	SRC
Liver Neoplasms	ENSG00000197635	FALSE	unknown	2004-02-24	Unused	DPP4
Liver Neoplasms	ENSG00000198363	FALSE	Preclinical	2007-12-07	Unused	ASPH
Liver Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Absent	NTRK1
Liver Neoplasms	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Phase III Clinical Trial	MTOR
Liver Neoplasms	ENSG00000198805	FALSE	Preclinical	1997-04-15	Unused	PNP
Liver Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1990-07-15	Phase II Clinical Trial	TOP1
Liver Neoplasms	ENSG00000204397	FALSE	Preclinical	2010-10-21	Unused	CARD16
Liver Neoplasms	ENSG00000228716	FALSE	Phase I Clinical Trial	1992-06-15	Unused	DHFR
Liver Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Absent	KIR2DL3
Liver Neoplasms	ENSG00000245848	FALSE	Phase II Clinical Trial	2014-11-21	Absent	CEBPA
Liver Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Preclinical	PRKDC
Liver Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Liver Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGB3
Liver Neoplasms	ENSG00000263761	FALSE	Phase II Clinical Trial	2007-05-30	Absent	GDF2
Liver Neoplasms	ENSG00000278540	FALSE	Preclinical	2011-07-23	Absent	ACACA
Liver Neoplasms	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-07-24	Phase II Clinical Trial	ADORA3
Long QT Syndrome	ENSG00000055118	FALSE	Preclinical	2004-01-20	Unused	KCNH2
Long QT Syndrome	ENSG00000131747	FALSE	Approved	2007-03-05	Absent	TOP2A
Long QT Syndrome	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Lung Diseases, Interstitial	ENSG00000067182	FALSE	Phase II Clinical Trial	2005-06-27	Absent	TNFRSF1A
Lung Diseases, Interstitial	ENSG00000105329	FALSE	Phase II Clinical Trial	2005-06-27	Absent	TGFB1
Lung Diseases, Interstitial	ENSG00000112062	FALSE	Phase II Clinical Trial	2005-06-27	Absent	MAPK14
Lung Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Lung Neoplasms	ENSG00000026025	FALSE	Preclinical	2012-02-29	Absent	VIM
Lung Neoplasms	ENSG00000026508	FALSE	Preclinical	1992-09-15	Unused	CD44
Lung Neoplasms	ENSG00000030582	FALSE	Preclinical	NA	Unused	GRN
Lung Neoplasms	ENSG00000037280	FALSE	Preclinical	2009-06-30	Phase I Clinical Trial	FLT4
Lung Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-08-27	Absent	CDH1
Lung Neoplasms	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-06-05	Unused	TNC
Lung Neoplasms	ENSG00000047936	FALSE	Preclinical	2014-11-03	Absent	ROS1
Lung Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2011-01-31	Absent	TNFRSF9
Lung Neoplasms	ENSG00000060491	FALSE	Preclinical	2012-09-01	Absent	OGFR
Lung Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Lung Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2002-06-10	Absent	ERBB3
Lung Neoplasms	ENSG00000066468	FALSE	Phase I Clinical Trial	2006-05-05	Absent	FGFR2
Lung Neoplasms	ENSG00000068078	FALSE	Phase I Clinical Trial	2006-05-05	Absent	FGFR3
Lung Neoplasms	ENSG00000069667	FALSE	Preclinical	2011-01-18	Absent	RORA
Lung Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Lung Neoplasms	ENSG00000073756	FALSE	Preclinical	2014-12-04	Absent	PTGS2
Lung Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Lung Neoplasms	ENSG00000077782	FALSE	Phase I Clinical Trial	2006-05-05	Absent	FGFR1
Lung Neoplasms	ENSG00000078401	FALSE	Preclinical	2005-05-18	Unused	EDN1
Lung Neoplasms	ENSG00000080824	FALSE	Phase I Clinical Trial	2004-12-07	Unused	HSP90AA1
Lung Neoplasms	ENSG00000082701	FALSE	Preclinical	NA	Absent	GSK3B
Lung Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Lung Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Lung Neoplasms	ENSG00000085563	FALSE	unknown	1992-05-15	Unused	ABCB1
Lung Neoplasms	ENSG00000087586	FALSE	Preclinical	2003-01-31	Unused	AURKA
Lung Neoplasms	ENSG00000091831	FALSE	Preclinical	2014-04-25	Absent	ESR1
Lung Neoplasms	ENSG00000096968	FALSE	Preclinical	2017-07-24	Absent	JAK2
Lung Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Lung Neoplasms	ENSG00000100644	FALSE	Preclinical	2009-02-18	Absent	HIF1A
Lung Neoplasms	ENSG00000100823	FALSE	Phase I Clinical Trial	2007-02-13	Unused	APEX1
Lung Neoplasms	ENSG00000101868	FALSE	Preclinical	2003-02-19	Unused	POLA1
Lung Neoplasms	ENSG00000102239	FALSE	Preclinical	NA	Unused	BRS3
Lung Neoplasms	ENSG00000102245	FALSE	unknown	2001-06-01	Preclinical	CD40LG
Lung Neoplasms	ENSG00000102755	FALSE	unknown	NA	Phase I Clinical Trial	FLT1
Lung Neoplasms	ENSG00000102854	FALSE	Preclinical	2016-03-02	Absent	MSLN
Lung Neoplasms	ENSG00000103222	FALSE	unknown	1992-05-15	Unused	ABCC1
Lung Neoplasms	ENSG00000104432	FALSE	Preclinical	2001-06-01	Preclinical	IL7
Lung Neoplasms	ENSG00000105146	FALSE	Preclinical	2003-01-31	Unused	AURKC
Lung Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1992-09-15	Phase II Clinical Trial	CEACAM5
Lung Neoplasms	ENSG00000105639	FALSE	Preclinical	2017-07-24	Absent	JAK3
Lung Neoplasms	ENSG00000105835	FALSE	Phase II Clinical Trial	1998-05-15	Unused	NAMPT
Lung Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	1996-01-15	Phase I Clinical Trial	MET
Lung Neoplasms	ENSG00000106128	FALSE	Phase I Clinical Trial	2011-05-31	Absent	GHRHR
Lung Neoplasms	ENSG00000107562	FALSE	unknown	2003-04-10	Unused	CXCL12
Lung Neoplasms	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Lung Neoplasms	ENSG00000108443	FALSE	Phase I Clinical Trial	2013-11-01	Absent	RPS6KB1
Lung Neoplasms	ENSG00000108679	FALSE	Preclinical	2014-07-22	Absent	LGALS3BP
Lung Neoplasms	ENSG00000109471	FALSE	Phase I Clinical Trial	1998-03-15	Unused	IL2
Lung Neoplasms	ENSG00000111142	FALSE	Preclinical	2009-01-26	Unused	METAP2
Lung Neoplasms	ENSG00000111144	FALSE	Approved	NA	Absent	LTA4H
Lung Neoplasms	ENSG00000111640	FALSE	Preclinical	2013-07-26	Absent	GAPDH
Lung Neoplasms	ENSG00000112062	FALSE	Preclinical	2008-05-23	Preclinical	MAPK14
Lung Neoplasms	ENSG00000112541	FALSE	Preclinical	2015-06-16	Absent	PDE10A
Lung Neoplasms	ENSG00000112715	FALSE	Phase I Clinical Trial	2008-10-30	Unused	VEGFA
Lung Neoplasms	ENSG00000113302	FALSE	unknown	2001-10-02	Unused	IL12B
Lung Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Lung Neoplasms	ENSG00000113575	FALSE	Preclinical	2014-08-21	Absent	PPP2CA
Lung Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Lung Neoplasms	ENSG00000115053	FALSE	Phase II Clinical Trial	2008-07-31	Phase II Clinical Trial	NCL
Lung Neoplasms	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-02-11	Unused	FN1
Lung Neoplasms	ENSG00000116016	FALSE	Preclinical	2011-08-02	Absent	EPAS1
Lung Neoplasms	ENSG00000116478	FALSE	Preclinical	2005-07-20	Phase I Clinical Trial	HDAC1
Lung Neoplasms	ENSG00000117020	FALSE	Phase I Clinical Trial	2013-11-01	Absent	AKT3
Lung Neoplasms	ENSG00000117525	FALSE	Preclinical	2015-01-22	Absent	F3
Lung Neoplasms	ENSG00000119630	FALSE	Preclinical	2014-07-12	Absent	PGF
Lung Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1991-12-15	Phase I Clinical Trial	EPCAM
Lung Neoplasms	ENSG00000120156	FALSE	Preclinical	2004-05-24	Absent	TEK
Lung Neoplasms	ENSG00000120217	FALSE	Preclinical	2016-02-08	Absent	CD274
Lung Neoplasms	ENSG00000120885	FALSE	unknown	2007-10-05	Preclinical	CLU
Lung Neoplasms	ENSG00000121594	FALSE	unknown	2001-06-01	Preclinical	CD80
Lung Neoplasms	ENSG00000121879	FALSE	Preclinical	2012-08-01	Preclinical	PIK3CA
Lung Neoplasms	ENSG00000121966	FALSE	unknown	2003-04-10	Unused	CXCR4
Lung Neoplasms	ENSG00000122861	FALSE	unknown	1993-05-15	Unused	PLAU
Lung Neoplasms	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Lung Neoplasms	ENSG00000124151	FALSE	Preclinical	2014-07-04	Absent	NCOA3
Lung Neoplasms	ENSG00000124762	FALSE	unknown	2002-06-26	Unused	CDKN1A
Lung Neoplasms	ENSG00000128052	FALSE	Preclinical	2012-03-14	Phase I Clinical Trial	KDR
Lung Neoplasms	ENSG00000128271	FALSE	Preclinical	2015-05-27	Absent	ADORA2A
Lung Neoplasms	ENSG00000129484	FALSE	Phase II Clinical Trial	2012-04-23	Absent	PARP2
Lung Neoplasms	ENSG00000130037	FALSE	Preclinical	2015-08-14	Absent	KCNA5
Lung Neoplasms	ENSG00000130669	FALSE	Phase I Clinical Trial	2014-01-22	Absent	PAK4
Lung Neoplasms	ENSG00000130816	FALSE	unknown	NA	Unused	DNMT1
Lung Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1992-04-15	Phase II Clinical Trial	TOP2A
Lung Neoplasms	ENSG00000131981	FALSE	Preclinical	2002-08-05	Unused	LGALS3
Lung Neoplasms	ENSG00000132155	FALSE	unknown	2000-07-03	Unused	RAF1
Lung Neoplasms	ENSG00000132383	FALSE	Preclinical	1998-06-15	Unused	RPA1
Lung Neoplasms	ENSG00000132906	FALSE	unknown	2004-01-30	Unused	CASP9
Lung Neoplasms	ENSG00000133083	FALSE	Preclinical	2014-07-24	Absent	DCLK1
Lung Neoplasms	ENSG00000133703	FALSE	Preclinical	2013-06-04	Absent	KRAS
Lung Neoplasms	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Lung Neoplasms	ENSG00000134853	FALSE	Phase I Clinical Trial	2006-06-15	Phase I Clinical Trial	PDGFRA
Lung Neoplasms	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Lung Neoplasms	ENSG00000135446	FALSE	unknown	NA	Unused	CDK4
Lung Neoplasms	ENSG00000136810	FALSE	unknown	2000-05-11	Unused	TXN
Lung Neoplasms	ENSG00000136997	FALSE	unknown	NA	Unused	MYC
Lung Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Lung Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	2017-03-02	Absent	KIF11
Lung Neoplasms	ENSG00000138448	FALSE	unknown	2005-01-11	Unused	ITGAV
Lung Neoplasms	ENSG00000138592	FALSE	Preclinical	NA	Absent	USP8
Lung Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Lung Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR1
Lung Neoplasms	ENSG00000140443	FALSE	Preclinical	1997-10-15	Unused	IGF1R
Lung Neoplasms	ENSG00000140538	FALSE	Preclinical	2012-03-14	Absent	NTRK3
Lung Neoplasms	ENSG00000141510	FALSE	Preclinical	2008-05-23	Absent	TP53
Lung Neoplasms	ENSG00000141736	FALSE	Phase I Clinical Trial	1993-05-15	Phase I Clinical Trial	ERBB2
Lung Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	2004-03-23	Unused	AKT1
Lung Neoplasms	ENSG00000143226	FALSE	Phase II Clinical Trial	NA	Absent	FCGR2A
Lung Neoplasms	ENSG00000143799	FALSE	Phase II Clinical Trial	2012-04-23	Absent	PARP1
Lung Neoplasms	ENSG00000146648	FALSE	Phase I Clinical Trial	1993-02-15	Phase I Clinical Trial	EGFR
Lung Neoplasms	ENSG00000147257	FALSE	Phase I Clinical Trial	2014-12-01	Absent	GPC3
Lung Neoplasms	ENSG00000148053	FALSE	unknown	2014-11-03	Absent	NTRK2
Lung Neoplasms	ENSG00000148795	FALSE	Preclinical	2008-10-27	Absent	CYP17A1
Lung Neoplasms	ENSG00000149554	FALSE	Phase I Clinical Trial	2006-02-07	Unused	CHEK1
Lung Neoplasms	ENSG00000150337	FALSE	Phase II Clinical Trial	1995-09-15	Unused	FCGR1A
Lung Neoplasms	ENSG00000150630	FALSE	Preclinical	2008-11-25	Preclinical	VEGFC
Lung Neoplasms	ENSG00000150656	FALSE	Phase II Clinical Trial	2005-06-06	Absent	CNDP1
Lung Neoplasms	ENSG00000154229	FALSE	unknown	NA	Unused	PRKCA
Lung Neoplasms	ENSG00000159110	FALSE	Preclinical	2005-10-11	Unused	IFNAR2
Lung Neoplasms	ENSG00000159131	FALSE	unknown	1992-02-15	Unused	GART
Lung Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Lung Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2006-05-05	Absent	FGFR4
Lung Neoplasms	ENSG00000161011	FALSE	Phase II Clinical Trial	2015-11-04	Absent	SQSTM1
Lung Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR5
Lung Neoplasms	ENSG00000162434	FALSE	Preclinical	2017-07-24	Absent	JAK1
Lung Neoplasms	ENSG00000162747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3B
Lung Neoplasms	ENSG00000163517	FALSE	unknown	NA	Phase I Clinical Trial	HDAC11
Lung Neoplasms	ENSG00000164305	FALSE	unknown	2004-01-30	Unused	CASP3
Lung Neoplasms	ENSG00000164342	FALSE	Preclinical	NA	Absent	TLR3
Lung Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2002-06-26	Unused	TERT
Lung Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Lung Neoplasms	ENSG00000165197	FALSE	Preclinical	2008-11-25	Preclinical	VEGFD
Lung Neoplasms	ENSG00000165392	FALSE	unknown	2015-06-10	Absent	WRN
Lung Neoplasms	ENSG00000165731	FALSE	Preclinical	2012-11-19	Preclinical	RET
Lung Neoplasms	ENSG00000166148	FALSE	unknown	1993-01-15	Unused	AVPR1A
Lung Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Lung Neoplasms	ENSG00000166851	FALSE	Preclinical	2007-07-09	Unused	PLK1
Lung Neoplasms	ENSG00000167601	FALSE	Preclinical	2012-05-03	Preclinical	AXL
Lung Neoplasms	ENSG00000167658	FALSE	Preclinical	1993-05-15	Unused	EEF2
Lung Neoplasms	ENSG00000168398	FALSE	Preclinical	2008-06-03	Unused	BDKRB2
Lung Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	1995-06-15	Unused	FNTA
Lung Neoplasms	ENSG00000168615	FALSE	Preclinical	2007-02-27	Unused	ADAM9
Lung Neoplasms	ENSG00000168811	FALSE	unknown	2001-10-02	Unused	IL12A
Lung Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Lung Neoplasms	ENSG00000169398	FALSE	unknown	2007-01-08	Unused	PTK2
Lung Neoplasms	ENSG00000169429	FALSE	Preclinical	2003-02-21	Unused	CXCL8
Lung Neoplasms	ENSG00000170145	FALSE	Preclinical	2012-08-17	Preclinical	SIK2
Lung Neoplasms	ENSG00000170425	FALSE	Phase I Clinical Trial	2015-05-27	Absent	ADORA2B
Lung Neoplasms	ENSG00000170525	FALSE	unknown	2014-01-27	Absent	PFKFB3
Lung Neoplasms	ENSG00000170558	FALSE	Phase I Clinical Trial	1999-06-30	Unused	CDH2
Lung Neoplasms	ENSG00000170965	FALSE	Preclinical	2007-06-08	Unused	PLAC1
Lung Neoplasms	ENSG00000171094	FALSE	Preclinical	2013-05-22	Absent	ALK
Lung Neoplasms	ENSG00000171720	FALSE	unknown	NA	Phase I Clinical Trial	HDAC3
Lung Neoplasms	ENSG00000171791	FALSE	Preclinical	2017-04-12	Absent	BCL2
Lung Neoplasms	ENSG00000172062	FALSE	Preclinical	2014-06-26	Absent	SMN1
Lung Neoplasms	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Lung Neoplasms	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Lung Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Absent	CD248
Lung Neoplasms	ENSG00000176890	TRUE	Approved	1999-01-15	Approved	TYMS
Lung Neoplasms	ENSG00000178568	FALSE	Phase I Clinical Trial	2013-10-11	Unused	ERBB4
Lung Neoplasms	ENSG00000178999	FALSE	Preclinical	2003-01-31	Unused	AURKB
Lung Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR2
Lung Neoplasms	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Lung Neoplasms	ENSG00000184033	FALSE	Preclinical	2002-10-10	Unused	CTAG1B
Lung Neoplasms	ENSG00000184292	FALSE	Preclinical	2007-04-30	Preclinical	TACSTD2
Lung Neoplasms	ENSG00000184937	FALSE	Preclinical	2005-12-05	Preclinical	WT1
Lung Neoplasms	ENSG00000185499	FALSE	Phase I Clinical Trial	1997-06-15	Phase I Clinical Trial	MUC1
Lung Neoplasms	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-03-17	Absent	PDCD1
Lung Neoplasms	ENSG00000196591	FALSE	Preclinical	2005-07-20	Phase I Clinical Trial	HDAC2
Lung Neoplasms	ENSG00000198223	FALSE	Preclinical	2011-09-23	Preclinical	CSF2RA
Lung Neoplasms	ENSG00000198400	FALSE	Preclinical	2012-03-14	Absent	NTRK1
Lung Neoplasms	ENSG00000198759	FALSE	Preclinical	2000-01-26	Unused	EGFL6
Lung Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Phase I Clinical Trial	MTOR
Lung Neoplasms	ENSG00000198851	FALSE	Phase II Clinical Trial	NA	Absent	CD3E
Lung Neoplasms	ENSG00000198900	TRUE	Approved	1995-03-15	Approved	TOP1
Lung Neoplasms	ENSG00000203747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3A
Lung Neoplasms	ENSG00000213903	FALSE	Approved	2008-05-23	Preclinical	LTB4R
Lung Neoplasms	ENSG00000221867	FALSE	unknown	2003-02-19	Unused	MAGEA3
Lung Neoplasms	ENSG00000228716	FALSE	unknown	NA	Unused	DHFR
Lung Neoplasms	ENSG00000239732	FALSE	Preclinical	2001-06-01	Unused	TLR9
Lung Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR3
Lupus Erythematosus, Cutaneous	ENSG00000010610	FALSE	Phase I Clinical Trial	2002-05-02	Unused	CD4
Lupus Erythematosus, Cutaneous	ENSG00000065989	FALSE	Phase II Clinical Trial	2004-01-28	Phase II Clinical Trial	PDE4A
Lupus Erythematosus, Cutaneous	ENSG00000067182	FALSE	Phase II Clinical Trial	2004-01-28	Unused	TNFRSF1A
Lupus Erythematosus, Cutaneous	ENSG00000100453	FALSE	Preclinical	2016-08-02	Absent	GZMB
Lupus Erythematosus, Cutaneous	ENSG00000105639	FALSE	Phase II Clinical Trial	2011-02-23	Phase II Clinical Trial	JAK3
Lupus Erythematosus, Cutaneous	ENSG00000105650	FALSE	Phase II Clinical Trial	2004-01-28	Phase II Clinical Trial	PDE4C
Lupus Erythematosus, Cutaneous	ENSG00000111424	FALSE	unknown	1991-04-15	Unused	VDR
Lupus Erythematosus, Cutaneous	ENSG00000111537	FALSE	Phase I Clinical Trial	2007-12-17	Phase I Clinical Trial	IFNG
Lupus Erythematosus, Cutaneous	ENSG00000113448	FALSE	Phase II Clinical Trial	2004-01-28	Phase II Clinical Trial	PDE4D
Lupus Erythematosus, Cutaneous	ENSG00000136244	FALSE	Phase I Clinical Trial	2007-08-23	Unused	IL6
Lupus Erythematosus, Cutaneous	ENSG00000160223	FALSE	Phase I Clinical Trial	2007-03-13	Phase I Clinical Trial	ICOSLG
Lupus Erythematosus, Cutaneous	ENSG00000162434	FALSE	Phase II Clinical Trial	2009-12-11	Absent	JAK1
Lupus Erythematosus, Cutaneous	ENSG00000165025	FALSE	Phase II Clinical Trial	2011-02-23	Phase II Clinical Trial	SYK
Lupus Erythematosus, Cutaneous	ENSG00000177272	FALSE	Preclinical	2016-03-01	Absent	KCNA3
Lupus Erythematosus, Cutaneous	ENSG00000184371	FALSE	Phase I Clinical Trial	2006-12-21	Phase I Clinical Trial	CSF1
Lupus Erythematosus, Cutaneous	ENSG00000184588	FALSE	Phase II Clinical Trial	2004-01-28	Phase II Clinical Trial	PDE4B
Lupus Erythematosus, Cutaneous	ENSG00000198178	FALSE	Phase II Clinical Trial	2014-04-09	Absent	CLEC4C
Lupus Erythematosus, Systemic	ENSG00000004468	FALSE	Phase I Clinical Trial	2014-08-20	Absent	CD38
Lupus Erythematosus, Systemic	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-10-17	Absent	TNFRSF12A
Lupus Erythematosus, Systemic	ENSG00000007312	FALSE	Phase I Clinical Trial	2014-03-26	Absent	CD79B
Lupus Erythematosus, Systemic	ENSG00000010610	FALSE	unknown	2002-05-02	Unused	CD4
Lupus Erythematosus, Systemic	ENSG00000010671	FALSE	Phase II Clinical Trial	2004-08-23	Unused	BTK
Lupus Erythematosus, Systemic	ENSG00000012124	FALSE	Phase II Clinical Trial	1993-08-15	Phase III Clinical Trial	CD22
Lupus Erythematosus, Systemic	ENSG00000019582	FALSE	Phase II Clinical Trial	2005-02-25	Absent	CD74
Lupus Erythematosus, Systemic	ENSG00000072694	FALSE	Phase II Clinical Trial	2006-07-31	Phase II Clinical Trial	FCGR2B
Lupus Erythematosus, Systemic	ENSG00000088832	TRUE	Approved	NA	Absent	FKBP1A
Lupus Erythematosus, Systemic	ENSG00000091831	FALSE	Phase I Clinical Trial	1990-03-15	Unused	ESR1
Lupus Erythematosus, Systemic	ENSG00000096968	FALSE	Phase II Clinical Trial	2007-10-10	Unused	JAK2
Lupus Erythematosus, Systemic	ENSG00000100385	FALSE	Phase I Clinical Trial	NA	Absent	IL2RB
Lupus Erythematosus, Systemic	ENSG00000100425	FALSE	Preclinical	2016-04-11	Absent	BRD1
Lupus Erythematosus, Systemic	ENSG00000101017	FALSE	Preclinical	2016-08-08	Absent	CD40
Lupus Erythematosus, Systemic	ENSG00000101144	FALSE	unknown	NA	Absent	BMP7
Lupus Erythematosus, Systemic	ENSG00000101868	FALSE	unknown	1999-06-02	Unused	POLA1
Lupus Erythematosus, Systemic	ENSG00000101916	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR8
Lupus Erythematosus, Systemic	ENSG00000102245	FALSE	Phase II Clinical Trial	1994-06-15	Phase I Clinical Trial	CD40LG
Lupus Erythematosus, Systemic	ENSG00000102524	TRUE	Approved	1999-07-13	Approved	TNFSF13B
Lupus Erythematosus, Systemic	ENSG00000102967	FALSE	Preclinical	2003-05-15	Unused	DHODH
Lupus Erythematosus, Systemic	ENSG00000103522	FALSE	Preclinical	2008-04-24	Phase I Clinical Trial	IL21R
Lupus Erythematosus, Systemic	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Lupus Erythematosus, Systemic	ENSG00000104852	FALSE	Phase III Clinical Trial	2005-08-17	Phase III Clinical Trial	SNRNP70
Lupus Erythematosus, Systemic	ENSG00000104870	FALSE	Phase I Clinical Trial	2013-04-25	Absent	FCGRT
Lupus Erythematosus, Systemic	ENSG00000105397	FALSE	Phase II Clinical Trial	2013-04-19	Absent	TYK2
Lupus Erythematosus, Systemic	ENSG00000105639	FALSE	Phase II Clinical Trial	2011-02-23	Phase II Clinical Trial	JAK3
Lupus Erythematosus, Systemic	ENSG00000105851	FALSE	unknown	2009-07-15	Phase I Clinical Trial	PIK3CG
Lupus Erythematosus, Systemic	ENSG00000106348	FALSE	Phase III Clinical Trial	NA	Absent	IMPDH1
Lupus Erythematosus, Systemic	ENSG00000106804	FALSE	Preclinical	1993-08-15	Phase I Clinical Trial	C5
Lupus Erythematosus, Systemic	ENSG00000107738	FALSE	Preclinical	2011-10-03	Absent	VSIR
Lupus Erythematosus, Systemic	ENSG00000109320	FALSE	Phase I Clinical Trial	2008-10-02	Absent	NFKB1
Lupus Erythematosus, Systemic	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Lupus Erythematosus, Systemic	ENSG00000110876	FALSE	unknown	2002-08-22	Absent	SELPLG
Lupus Erythematosus, Systemic	ENSG00000111537	FALSE	Phase I Clinical Trial	2004-02-24	Phase I Clinical Trial	IFNG
Lupus Erythematosus, Systemic	ENSG00000112033	FALSE	Phase I Clinical Trial	2004-01-16	Absent	PPARD
Lupus Erythematosus, Systemic	ENSG00000113302	FALSE	Phase II Clinical Trial	2003-04-30	Absent	IL12B
Lupus Erythematosus, Systemic	ENSG00000113520	FALSE	Preclinical	2014-10-29	Absent	IL4
Lupus Erythematosus, Systemic	ENSG00000113580	TRUE	Approved	2012-11-05	Approved	NR3C1
Lupus Erythematosus, Systemic	ENSG00000114013	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD86
Lupus Erythematosus, Systemic	ENSG00000115085	FALSE	Preclinical	1995-02-15	Unused	ZAP70
Lupus Erythematosus, Systemic	ENSG00000115541	FALSE	Phase II Clinical Trial	2002-09-04	Phase I Clinical Trial	HSPE1
Lupus Erythematosus, Systemic	ENSG00000116478	FALSE	Preclinical	2006-12-20	Unused	HDAC1
Lupus Erythematosus, Systemic	ENSG00000116824	FALSE	Preclinical	1989-08-15	Unused	CD2
Lupus Erythematosus, Systemic	ENSG00000117281	FALSE	Preclinical	2004-10-20	Unused	CD160
Lupus Erythematosus, Systemic	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Absent	TNFRSF8
Lupus Erythematosus, Systemic	ENSG00000121594	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD80
Lupus Erythematosus, Systemic	ENSG00000121807	FALSE	unknown	2007-04-10	Absent	CCR2
Lupus Erythematosus, Systemic	ENSG00000122025	FALSE	unknown	2003-10-31	Unused	FLT3
Lupus Erythematosus, Systemic	ENSG00000127418	FALSE	Preclinical	2003-05-16	Unused	FGFRL1
Lupus Erythematosus, Systemic	ENSG00000134258	FALSE	unknown	2008-07-10	Absent	VTCN1
Lupus Erythematosus, Systemic	ENSG00000134318	FALSE	unknown	2005-05-24	Absent	ROCK2
Lupus Erythematosus, Systemic	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Lupus Erythematosus, Systemic	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-08-23	Phase I Clinical Trial	IL6
Lupus Erythematosus, Systemic	ENSG00000136634	FALSE	Phase II Clinical Trial	2007-03-06	Unused	IL10
Lupus Erythematosus, Systemic	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Lupus Erythematosus, Systemic	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Lupus Erythematosus, Systemic	ENSG00000138684	FALSE	Phase I Clinical Trial	2010-06-21	Absent	IL21
Lupus Erythematosus, Systemic	ENSG00000139219	FALSE	Preclinical	2016-11-24	Absent	COL2A1
Lupus Erythematosus, Systemic	ENSG00000142166	FALSE	Phase III Clinical Trial	2004-02-23	Phase II Clinical Trial	IFNAR1
Lupus Erythematosus, Systemic	ENSG00000143365	FALSE	Preclinical	2012-06-15	Preclinical	RORC
Lupus Erythematosus, Systemic	ENSG00000145839	FALSE	Preclinical	2014-10-29	Absent	IL9
Lupus Erythematosus, Systemic	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Lupus Erythematosus, Systemic	ENSG00000156738	FALSE	Phase III Clinical Trial	1993-09-15	Unused	MS4A1
Lupus Erythematosus, Systemic	ENSG00000158473	FALSE	unknown	2007-07-16	Absent	CD1D
Lupus Erythematosus, Systemic	ENSG00000159110	FALSE	Phase II Clinical Trial	2007-03-23	Phase II Clinical Trial	IFNAR2
Lupus Erythematosus, Systemic	ENSG00000159339	FALSE	Preclinical	2015-10-07	Absent	PADI4
Lupus Erythematosus, Systemic	ENSG00000160223	FALSE	Phase I Clinical Trial	2007-03-13	Phase I Clinical Trial	ICOSLG
Lupus Erythematosus, Systemic	ENSG00000160683	FALSE	Phase I Clinical Trial	2012-10-26	Phase I Clinical Trial	CXCR5
Lupus Erythematosus, Systemic	ENSG00000160712	FALSE	Phase II Clinical Trial	1996-05-15	Unused	IL6R
Lupus Erythematosus, Systemic	ENSG00000161955	FALSE	Phase III Clinical Trial	2000-05-03	Phase III Clinical Trial	TNFSF13
Lupus Erythematosus, Systemic	ENSG00000162434	FALSE	Phase II Clinical Trial	2007-10-10	Phase II Clinical Trial	JAK1
Lupus Erythematosus, Systemic	ENSG00000162747	FALSE	Preclinical	2006-07-31	Unused	FCGR3B
Lupus Erythematosus, Systemic	ENSG00000163220	FALSE	Phase II Clinical Trial	2002-06-05	Unused	S100A9
Lupus Erythematosus, Systemic	ENSG00000163485	FALSE	Preclinical	2016-06-03	Absent	ADORA1
Lupus Erythematosus, Systemic	ENSG00000163599	FALSE	unknown	2008-01-30	Absent	CTLA4
Lupus Erythematosus, Systemic	ENSG00000163600	FALSE	Phase I Clinical Trial	2007-04-05	Phase I Clinical Trial	ICOS
Lupus Erythematosus, Systemic	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Lupus Erythematosus, Systemic	ENSG00000167325	FALSE	unknown	1999-06-02	Unused	RRM1
Lupus Erythematosus, Systemic	ENSG00000168610	FALSE	Preclinical	2016-06-23	Absent	STAT3
Lupus Erythematosus, Systemic	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Lupus Erythematosus, Systemic	ENSG00000170989	FALSE	Phase II Clinical Trial	2011-02-24	Absent	S1PR1
Lupus Erythematosus, Systemic	ENSG00000171608	FALSE	Preclinical	2009-07-15	Phase I Clinical Trial	PIK3CD
Lupus Erythematosus, Systemic	ENSG00000171791	FALSE	Phase I Clinical Trial	2010-11-27	Phase I Clinical Trial	BCL2
Lupus Erythematosus, Systemic	ENSG00000171848	FALSE	unknown	1999-06-02	Unused	RRM2
Lupus Erythematosus, Systemic	ENSG00000177047	FALSE	Phase I Clinical Trial	2015-01-19	Absent	IFNW1
Lupus Erythematosus, Systemic	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Lupus Erythematosus, Systemic	ENSG00000177455	FALSE	Phase II Clinical Trial	2007-12-11	Phase I Clinical Trial	CD19
Lupus Erythematosus, Systemic	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Lupus Erythematosus, Systemic	ENSG00000177885	FALSE	Preclinical	NA	Absent	GRB2
Lupus Erythematosus, Systemic	ENSG00000178562	FALSE	Phase II Clinical Trial	2010-02-16	Absent	CD28
Lupus Erythematosus, Systemic	ENSG00000180739	FALSE	Phase I Clinical Trial	2011-05-10	Absent	S1PR5
Lupus Erythematosus, Systemic	ENSG00000182578	FALSE	Preclinical	2009-09-21	Preclinical	CSF1R
Lupus Erythematosus, Systemic	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Lupus Erythematosus, Systemic	ENSG00000185291	FALSE	Preclinical	2009-12-10	Absent	IL3RA
Lupus Erythematosus, Systemic	ENSG00000186818	FALSE	Preclinical	2004-10-20	Unused	LILRB4
Lupus Erythematosus, Systemic	ENSG00000186827	FALSE	Preclinical	2015-09-23	Absent	TNFRSF4
Lupus Erythematosus, Systemic	ENSG00000188822	FALSE	Phase II Clinical Trial	2011-05-13	Absent	CNR2
Lupus Erythematosus, Systemic	ENSG00000189403	FALSE	Preclinical	2009-06-26	Unused	HMGB1
Lupus Erythematosus, Systemic	ENSG00000196591	FALSE	Preclinical	2006-12-20	Unused	HDAC2
Lupus Erythematosus, Systemic	ENSG00000196664	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR7
Lupus Erythematosus, Systemic	ENSG00000197122	FALSE	Preclinical	1996-06-15	Unused	SRC
Lupus Erythematosus, Systemic	ENSG00000197405	FALSE	Phase I Clinical Trial	2005-07-22	Phase I Clinical Trial	C5AR1
Lupus Erythematosus, Systemic	ENSG00000197919	FALSE	Phase II Clinical Trial	2000-03-30	Phase II Clinical Trial	IFNA1
Lupus Erythematosus, Systemic	ENSG00000198001	FALSE	Phase I Clinical Trial	2011-03-28	Unused	IRAK4
Lupus Erythematosus, Systemic	ENSG00000198178	FALSE	Phase II Clinical Trial	2014-04-09	Absent	CLEC4C
Lupus Erythematosus, Systemic	ENSG00000198793	FALSE	Preclinical	2004-06-14	Preclinical	MTOR
Lupus Erythematosus, Systemic	ENSG00000198851	FALSE	unknown	2002-11-07	Unused	CD3E
Lupus Erythematosus, Systemic	ENSG00000203710	FALSE	unknown	2002-01-29	Unused	CR1
Lupus Erythematosus, Systemic	ENSG00000203747	FALSE	Preclinical	2006-07-31	Unused	FCGR3A
Lupus Erythematosus, Systemic	ENSG00000239732	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR9
Lupus Erythematosus, Systemic	ENSG00000239961	FALSE	Phase I Clinical Trial	2010-01-21	Preclinical	LILRA4
Lupus Erythematosus, Systemic	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Lupus Erythematosus, Systemic	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Lupus Erythematosus, Systemic	ENSG00000271503	FALSE	unknown	2009-06-04	Absent	CCL5
Lupus Erythematosus, Systemic	ENSG00000276409	FALSE	Preclinical	1996-12-15	Unused	CCL14
Lupus Erythematosus, Systemic	ENSG00000282608	FALSE	Preclinical	2016-06-03	Absent	ADORA3
Lupus Nephritis	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-10-17	Phase II Clinical Trial	TNFRSF12A
Lupus Nephritis	ENSG00000010671	FALSE	Preclinical	2013-01-11	Absent	BTK
Lupus Nephritis	ENSG00000088832	TRUE	Approved	NA	Approved	FKBP1A
Lupus Nephritis	ENSG00000101017	FALSE	Phase II Clinical Trial	2012-01-18	Absent	CD40
Lupus Nephritis	ENSG00000102524	FALSE	Phase III Clinical Trial	1999-07-13	Phase III Clinical Trial	TNFSF13B
Lupus Nephritis	ENSG00000106348	TRUE	Approved	1989-12-15	Approved	IMPDH1
Lupus Nephritis	ENSG00000106804	FALSE	Phase I Clinical Trial	1993-08-15	Unused	C5
Lupus Nephritis	ENSG00000108691	FALSE	unknown	1992-01-15	Unused	CCL2
Lupus Nephritis	ENSG00000109320	FALSE	Phase I Clinical Trial	2008-10-02	Absent	NFKB1
Lupus Nephritis	ENSG00000110448	FALSE	unknown	NA	Unused	CD5
Lupus Nephritis	ENSG00000111537	FALSE	unknown	2004-02-24	Phase I Clinical Trial	IFNG
Lupus Nephritis	ENSG00000114013	FALSE	Phase III Clinical Trial	1992-11-15	Phase III Clinical Trial	CD86
Lupus Nephritis	ENSG00000121594	FALSE	Phase III Clinical Trial	1992-11-15	Phase III Clinical Trial	CD80
Lupus Nephritis	ENSG00000121807	FALSE	unknown	1998-03-15	Phase I Clinical Trial	CCR2
Lupus Nephritis	ENSG00000132693	FALSE	Preclinical	2010-01-27	Unused	CRP
Lupus Nephritis	ENSG00000134318	FALSE	unknown	2005-05-24	Absent	ROCK2
Lupus Nephritis	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-08-23	Phase II Clinical Trial	IL6
Lupus Nephritis	ENSG00000142166	FALSE	Phase II Clinical Trial	2004-11-23	Absent	IFNAR1
Lupus Nephritis	ENSG00000156738	FALSE	Phase II Clinical Trial	1993-09-15	Unused	MS4A1
Lupus Nephritis	ENSG00000161955	FALSE	unknown	2000-05-03	Phase III Clinical Trial	TNFSF13
Lupus Nephritis	ENSG00000163823	FALSE	unknown	1998-03-15	Unused	CCR1
Lupus Nephritis	ENSG00000169031	FALSE	Preclinical	1997-04-15	Unused	COL4A3
Lupus Nephritis	ENSG00000169032	FALSE	Preclinical	2009-05-27	Preclinical	MAP2K1
Lupus Nephritis	ENSG00000171608	FALSE	Preclinical	2014-07-23	Absent	PIK3CD
Lupus Nephritis	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Lupus Nephritis	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Lupus Nephritis	ENSG00000196776	FALSE	Preclinical	2008-06-26	Unused	CD47
Lupus Nephritis	ENSG00000198793	FALSE	unknown	NA	Unused	MTOR
Lupus Nephritis	ENSG00000203710	FALSE	unknown	2002-01-29	Unused	CR1
Lupus Nephritis	ENSG00000240972	FALSE	Phase I Clinical Trial	2004-01-13	Phase I Clinical Trial	MIF
Lyme Disease	ENSG00000019582	FALSE	Preclinical	2010-02-11	Absent	CD74
Lymphangioleiomyomatosis	ENSG00000198793	TRUE	Approved	1997-08-15	Phase II Clinical Trial	MTOR
Lymphedema	ENSG00000019991	FALSE	Phase II Clinical Trial	2001-01-31	Preclinical	HGF
Lymphedema	ENSG00000111144	FALSE	Phase II Clinical Trial	NA	Absent	LTA4H
Lymphedema	ENSG00000150630	FALSE	Phase II Clinical Trial	2007-07-02	Preclinical	VEGFC
Lymphedema	ENSG00000213903	FALSE	Phase II Clinical Trial	NA	Absent	LTB4R
Lymphohistiocytosis, Hemophagocytic	ENSG00000111537	FALSE	Phase II Clinical Trial	2004-02-24	Absent	IFNG
Lymphohistiocytosis, Hemophagocytic	ENSG00000150782	FALSE	Preclinical	2015-04-01	Absent	IL18
Lymphoma	ENSG00000004468	FALSE	Preclinical	2014-06-19	Absent	CD38
Lymphoma	ENSG00000004487	FALSE	Phase I Clinical Trial	2008-07-31	Absent	KDM1A
Lymphoma	ENSG00000010671	FALSE	Phase I Clinical Trial	2014-08-27	Absent	BTK
Lymphoma	ENSG00000023445	FALSE	Phase II Clinical Trial	2002-07-03	Phase II Clinical Trial	BIRC3
Lymphoma	ENSG00000025434	FALSE	Phase I Clinical Trial	2014-11-13	Absent	NR1H3
Lymphoma	ENSG00000037280	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FLT4
Lymphoma	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-06-05	Unused	TNC
Lymphoma	ENSG00000047936	FALSE	Phase I Clinical Trial	2006-12-05	Absent	ROS1
Lymphoma	ENSG00000051382	FALSE	Phase II Clinical Trial	2009-05-05	Phase I Clinical Trial	PIK3CB
Lymphoma	ENSG00000066468	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Lymphoma	ENSG00000068078	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR3
Lymphoma	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Lymphoma	ENSG00000072694	FALSE	Preclinical	2006-07-31	Unused	FCGR2B
Lymphoma	ENSG00000077238	FALSE	Preclinical	1991-04-15	Unused	IL4R
Lymphoma	ENSG00000077782	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR1
Lymphoma	ENSG00000079277	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK1
Lymphoma	ENSG00000080824	FALSE	Phase I Clinical Trial	2005-02-11	Phase I Clinical Trial	HSP90AA1
Lymphoma	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Lymphoma	ENSG00000085563	FALSE	Preclinical	1998-04-15	Unused	ABCB1
Lymphoma	ENSG00000087586	FALSE	unknown	2005-06-27	Phase I Clinical Trial	AURKA
Lymphoma	ENSG00000089685	FALSE	unknown	2003-11-19	Phase I Clinical Trial	BIRC5
Lymphoma	ENSG00000094631	FALSE	Preclinical	2014-03-11	Absent	HDAC6
Lymphoma	ENSG00000096968	FALSE	unknown	2006-12-01	Phase I Clinical Trial	JAK2
Lymphoma	ENSG00000099875	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK2
Lymphoma	ENSG00000100311	FALSE	Phase I Clinical Trial	2003-07-22	Absent	PDGFB
Lymphoma	ENSG00000100644	FALSE	Phase I Clinical Trial	2002-08-07	Phase I Clinical Trial	HIF1A
Lymphoma	ENSG00000101868	FALSE	unknown	1996-08-15	Unused	POLA1
Lymphoma	ENSG00000101916	FALSE	unknown	2008-06-17	Unused	TLR8
Lymphoma	ENSG00000101966	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	XIAP
Lymphoma	ENSG00000102096	FALSE	Phase I Clinical Trial	2011-12-14	Phase I Clinical Trial	PIM2
Lymphoma	ENSG00000102755	FALSE	Phase I Clinical Trial	1994-03-15	Phase I Clinical Trial	FLT1
Lymphoma	ENSG00000104365	FALSE	Phase I Clinical Trial	2003-04-22	Unused	IKBKB
Lymphoma	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Absent	CCNE1
Lymphoma	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Lymphoma	ENSG00000105639	FALSE	Preclinical	2011-04-22	Preclinical	JAK3
Lymphoma	ENSG00000105810	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK6
Lymphoma	ENSG00000105835	FALSE	Phase I Clinical Trial	2003-04-22	Unused	NAMPT
Lymphoma	ENSG00000105851	FALSE	Phase I Clinical Trial	2009-07-15	Absent	PIK3CG
Lymphoma	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Lymphoma	ENSG00000105976	FALSE	Phase I Clinical Trial	2004-08-09	Phase I Clinical Trial	MET
Lymphoma	ENSG00000106348	FALSE	unknown	2000-11-09	Unused	IMPDH1
Lymphoma	ENSG00000107611	FALSE	Preclinical	1993-06-15	Unused	CUBN
Lymphoma	ENSG00000107738	FALSE	Phase I Clinical Trial	2015-01-22	Absent	VSIR
Lymphoma	ENSG00000108443	FALSE	Phase I Clinical Trial	2013-11-01	Absent	RPS6KB1
Lymphoma	ENSG00000109320	FALSE	Phase II Clinical Trial	2003-04-22	Phase I Clinical Trial	NFKB1
Lymphoma	ENSG00000110092	FALSE	Phase I Clinical Trial	2007-05-16	Unused	CCND1
Lymphoma	ENSG00000110195	FALSE	unknown	2001-12-07	Unused	FOLR1
Lymphoma	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC2
Lymphoma	ENSG00000110448	FALSE	unknown	NA	Unused	CD5
Lymphoma	ENSG00000110719	FALSE	Preclinical	2007-07-03	Unused	TCIRG1
Lymphoma	ENSG00000112062	FALSE	Phase I Clinical Trial	2008-09-05	Phase I Clinical Trial	MAPK14
Lymphoma	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Lymphoma	ENSG00000113721	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	PDGFRB
Lymphoma	ENSG00000114013	FALSE	Preclinical	2008-11-20	Absent	CD86
Lymphoma	ENSG00000115008	FALSE	unknown	2009-12-07	Preclinical	IL1A
Lymphoma	ENSG00000115053	FALSE	Phase I Clinical Trial	2004-03-31	Unused	NCL
Lymphoma	ENSG00000115414	FALSE	Phase I Clinical Trial	2004-06-14	Unused	FN1
Lymphoma	ENSG00000115758	FALSE	unknown	1994-03-15	Phase I Clinical Trial	ODC1
Lymphoma	ENSG00000116044	FALSE	unknown	2005-05-27	Unused	NFE2L2
Lymphoma	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Lymphoma	ENSG00000117020	FALSE	Phase I Clinical Trial	2013-11-01	Absent	AKT3
Lymphoma	ENSG00000117560	FALSE	Preclinical	2008-11-20	Absent	FASLG
Lymphoma	ENSG00000117586	FALSE	Phase I Clinical Trial	2017-01-25	Absent	TNFSF4
Lymphoma	ENSG00000118520	FALSE	Phase I Clinical Trial	2007-10-09	Phase I Clinical Trial	ARG1
Lymphoma	ENSG00000119535	FALSE	Phase I Clinical Trial	2007-12-17	Absent	CSF3R
Lymphoma	ENSG00000120156	FALSE	unknown	2004-08-09	Phase I Clinical Trial	TEK
Lymphoma	ENSG00000120217	FALSE	Phase II Clinical Trial	2013-01-23	Absent	CD274
Lymphoma	ENSG00000120889	FALSE	Phase I Clinical Trial	2001-08-23	Unused	TNFRSF10B
Lymphoma	ENSG00000120949	FALSE	unknown	2002-05-30	Unused	TNFRSF8
Lymphoma	ENSG00000121594	FALSE	Preclinical	2008-11-20	Absent	CD80
Lymphoma	ENSG00000121879	FALSE	Phase II Clinical Trial	2006-10-23	Phase I Clinical Trial	PIK3CA
Lymphoma	ENSG00000121966	FALSE	Phase I Clinical Trial	2009-04-07	Unused	CXCR4
Lymphoma	ENSG00000122025	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	FLT3
Lymphoma	ENSG00000123374	FALSE	Phase I Clinical Trial	2007-07-09	Phase I Clinical Trial	CDK2
Lymphoma	ENSG00000126934	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	MAP2K2
Lymphoma	ENSG00000128052	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	KDR
Lymphoma	ENSG00000128602	FALSE	Phase I Clinical Trial	2004-07-21	Phase I Clinical Trial	SMO
Lymphoma	ENSG00000129484	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PARP2
Lymphoma	ENSG00000130669	FALSE	Phase I Clinical Trial	2014-01-22	Absent	PAK4
Lymphoma	ENSG00000131238	FALSE	unknown	1994-03-15	Phase I Clinical Trial	PPT1
Lymphoma	ENSG00000131747	TRUE	Approved	2014-01-27	Approved	TOP2A
Lymphoma	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Phase II Clinical Trial	PDHA1
Lymphoma	ENSG00000133321	FALSE	Phase II Clinical Trial	2014-10-18	Absent	RARRES3
Lymphoma	ENSG00000134058	FALSE	Phase I Clinical Trial	2010-12-05	Unused	CDK7
Lymphoma	ENSG00000134323	FALSE	Preclinical	2017-02-07	Absent	MYCN
Lymphoma	ENSG00000134460	FALSE	Approved	1997-08-15	Unused	IL2RA
Lymphoma	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Unused	IL15RA
Lymphoma	ENSG00000134853	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	PDGFRA
Lymphoma	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Lymphoma	ENSG00000135446	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK4
Lymphoma	ENSG00000135679	FALSE	Phase II Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Lymphoma	ENSG00000136807	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK9
Lymphoma	ENSG00000136810	FALSE	unknown	2000-05-11	Unused	TXN
Lymphoma	ENSG00000136997	FALSE	Phase I Clinical Trial	1994-09-15	Unused	MYC
Lymphoma	ENSG00000137193	FALSE	Phase I Clinical Trial	2011-12-14	Phase I Clinical Trial	PIM1
Lymphoma	ENSG00000138160	FALSE	Phase I Clinical Trial	2007-11-16	Phase I Clinical Trial	KIF11
Lymphoma	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Lymphoma	ENSG00000140538	FALSE	Phase II Clinical Trial	2010-05-17	Absent	NTRK3
Lymphoma	ENSG00000140992	FALSE	unknown	2008-04-09	Phase I Clinical Trial	PDPK1
Lymphoma	ENSG00000141510	FALSE	Phase I Clinical Trial	2010-06-04	Phase I Clinical Trial	TP53
Lymphoma	ENSG00000141736	FALSE	Preclinical	NA	Absent	ERBB2
Lymphoma	ENSG00000141867	FALSE	Phase I Clinical Trial	2016-02-18	Absent	BRD4
Lymphoma	ENSG00000142168	FALSE	unknown	2002-07-01	Unused	SOD1
Lymphoma	ENSG00000142208	FALSE	Phase I Clinical Trial	2007-03-13	Phase II Clinical Trial	AKT1
Lymphoma	ENSG00000142627	FALSE	unknown	2010-05-17	Absent	EPHA2
Lymphoma	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Lymphoma	ENSG00000143799	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PARP1
Lymphoma	ENSG00000146648	FALSE	Phase I Clinical Trial	2003-07-23	Phase I Clinical Trial	EGFR
Lymphoma	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Lymphoma	ENSG00000147099	FALSE	Phase I Clinical Trial	2008-07-31	Phase I Clinical Trial	HDAC8
Lymphoma	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Lymphoma	ENSG00000148400	FALSE	unknown	2009-02-06	Phase I Clinical Trial	NOTCH1
Lymphoma	ENSG00000149554	FALSE	Phase I Clinical Trial	2004-02-10	Phase I Clinical Trial	CHEK1
Lymphoma	ENSG00000151247	FALSE	Phase I Clinical Trial	2007-05-16	Absent	EIF4E
Lymphoma	ENSG00000154229	FALSE	unknown	NA	Unused	PRKCA
Lymphoma	ENSG00000156508	FALSE	unknown	1994-03-15	Phase I Clinical Trial	EEF1A1
Lymphoma	ENSG00000156738	FALSE	Preclinical	2010-03-03	Unused	MS4A1
Lymphoma	ENSG00000157404	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	KIT
Lymphoma	ENSG00000159110	FALSE	Approved	2010-08-28	Absent	IFNAR2
Lymphoma	ENSG00000160867	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR4
Lymphoma	ENSG00000162434	FALSE	Preclinical	2006-12-01	Preclinical	JAK1
Lymphoma	ENSG00000163430	FALSE	Preclinical	2015-10-08	Absent	FSTL1
Lymphoma	ENSG00000163599	FALSE	Preclinical	2008-11-20	Absent	CTLA4
Lymphoma	ENSG00000164136	FALSE	Preclinical	2014-01-23	Absent	IL15
Lymphoma	ENSG00000164305	FALSE	Phase I Clinical Trial	2014-07-15	Absent	CASP3
Lymphoma	ENSG00000164362	FALSE	Preclinical	1999-12-08	Unused	TERT
Lymphoma	ENSG00000164400	FALSE	unknown	1996-02-15	Unused	CSF2
Lymphoma	ENSG00000165025	FALSE	Phase I Clinical Trial	2011-10-18	Absent	SYK
Lymphoma	ENSG00000165731	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	RET
Lymphoma	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Lymphoma	ENSG00000166501	FALSE	Phase I Clinical Trial	2001-07-03	Phase I Clinical Trial	PRKCB
Lymphoma	ENSG00000166851	FALSE	Phase I Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Lymphoma	ENSG00000167325	FALSE	unknown	1997-03-15	Unused	RRM1
Lymphoma	ENSG00000167658	FALSE	Preclinical	1991-04-15	Unused	EEF2
Lymphoma	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-01-07	Phase I Clinical Trial	STAT3
Lymphoma	ENSG00000169032	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	MAP2K1
Lymphoma	ENSG00000169136	FALSE	Preclinical	2016-07-14	Absent	ATF5
Lymphoma	ENSG00000169403	FALSE	unknown	1991-07-15	Unused	PTAFR
Lymphoma	ENSG00000169429	FALSE	unknown	1992-01-15	Unused	CXCL8
Lymphoma	ENSG00000170312	FALSE	unknown	2007-07-09	Phase I Clinical Trial	CDK1
Lymphoma	ENSG00000170430	FALSE	unknown	2000-05-03	Unused	MGMT
Lymphoma	ENSG00000171094	FALSE	Phase II Clinical Trial	2006-12-05	Phase I Clinical Trial	ALK
Lymphoma	ENSG00000171552	FALSE	Phase I Clinical Trial	2006-12-15	Phase II Clinical Trial	BCL2L1
Lymphoma	ENSG00000171608	FALSE	Phase II Clinical Trial	2009-05-05	Absent	PIK3CD
Lymphoma	ENSG00000171720	FALSE	Phase I Clinical Trial	2008-07-31	Phase I Clinical Trial	HDAC3
Lymphoma	ENSG00000171791	FALSE	Phase I Clinical Trial	2006-12-15	Phase II Clinical Trial	BCL2
Lymphoma	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Lymphoma	ENSG00000171862	FALSE	unknown	1999-02-15	Phase II Clinical Trial	PTEN
Lymphoma	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Absent	CD248
Lymphoma	ENSG00000175054	FALSE	Phase I Clinical Trial	2014-10-31	Absent	ATR
Lymphoma	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Absent	CCNE2
Lymphoma	ENSG00000176890	FALSE	Preclinical	2001-12-07	Unused	TYMS
Lymphoma	ENSG00000177030	FALSE	Preclinical	1997-04-15	Unused	DEAF1
Lymphoma	ENSG00000177455	FALSE	Phase II Clinical Trial	2011-04-01	Unused	CD19
Lymphoma	ENSG00000178035	FALSE	unknown	2000-11-09	Unused	IMPDH2
Lymphoma	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Lymphoma	ENSG00000178999	FALSE	Phase I Clinical Trial	2008-12-15	Unused	AURKB
Lymphoma	ENSG00000181163	FALSE	Preclinical	2016-08-23	Absent	NPM1
Lymphoma	ENSG00000182578	FALSE	unknown	2005-06-27	Phase I Clinical Trial	CSF1R
Lymphoma	ENSG00000183765	FALSE	unknown	2004-02-10	Unused	CHEK2
Lymphoma	ENSG00000184047	FALSE	Phase I Clinical Trial	2005-11-21	Phase I Clinical Trial	DIABLO
Lymphoma	ENSG00000184584	FALSE	Phase I Clinical Trial	2014-04-02	Absent	TMEM173
Lymphoma	ENSG00000184937	FALSE	Preclinical	2005-08-10	Unused	WT1
Lymphoma	ENSG00000185499	FALSE	Phase I Clinical Trial	2011-01-22	Phase I Clinical Trial	MUC1
Lymphoma	ENSG00000186891	FALSE	Phase I Clinical Trial	2016-04-18	Absent	TNFRSF18
Lymphoma	ENSG00000188389	FALSE	Phase II Clinical Trial	2011-02-17	Absent	PDCD1
Lymphoma	ENSG00000196591	FALSE	Phase I Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Lymphoma	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Lymphoma	ENSG00000197122	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	SRC
Lymphoma	ENSG00000198355	FALSE	Phase I Clinical Trial	2011-12-14	Phase I Clinical Trial	PIM3
Lymphoma	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Lymphoma	ENSG00000198625	FALSE	Phase II Clinical Trial	2012-09-07	Absent	MDM4
Lymphoma	ENSG00000198793	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	MTOR
Lymphoma	ENSG00000198900	TRUE	Approved	1995-06-15	Approved	TOP1
Lymphoma	ENSG00000213809	FALSE	Preclinical	NA	Absent	KLRK1
Lymphoma	ENSG00000228716	FALSE	Preclinical	2007-05-02	Preclinical	DHFR
Lymphoma	ENSG00000244734	FALSE	Phase II Clinical Trial	2009-10-05	Unused	HBB
Lymphoma	ENSG00000253729	FALSE	Phase I Clinical Trial	NA	Absent	PRKDC
Lymphoma, B-Cell	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Phase I Clinical Trial	CD38
Lymphoma, B-Cell	ENSG00000005844	FALSE	Preclinical	2009-11-03	Absent	ITGAL
Lymphoma, B-Cell	ENSG00000007312	FALSE	Phase III Clinical Trial	2011-02-09	Phase II Clinical Trial	CD79B
Lymphoma, B-Cell	ENSG00000010671	TRUE	Approved	2005-11-07	Phase III Clinical Trial	BTK
Lymphoma, B-Cell	ENSG00000012124	FALSE	Phase III Clinical Trial	1993-08-15	Phase III Clinical Trial	CD22
Lymphoma, B-Cell	ENSG00000014257	FALSE	Phase I Clinical Trial	1997-10-15	Unused	ACPP
Lymphoma, B-Cell	ENSG00000019582	FALSE	Preclinical	2012-06-07	Absent	CD74
Lymphoma, B-Cell	ENSG00000026103	FALSE	Preclinical	NA	Preclinical	FAS
Lymphoma, B-Cell	ENSG00000026751	FALSE	Preclinical	2015-01-16	Absent	SLAMF7
Lymphoma, B-Cell	ENSG00000027075	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCH
Lymphoma, B-Cell	ENSG00000048462	FALSE	Preclinical	2016-09-19	Absent	TNFRSF17
Lymphoma, B-Cell	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Phase I Clinical Trial	TNFRSF9
Lymphoma, B-Cell	ENSG00000051382	FALSE	Phase I Clinical Trial	2014-11-01	Absent	PIK3CB
Lymphoma, B-Cell	ENSG00000054219	FALSE	Preclinical	2007-12-20	Absent	LY75
Lymphoma, B-Cell	ENSG00000063176	FALSE	Preclinical	2006-06-05	Absent	SPHK2
Lymphoma, B-Cell	ENSG00000065675	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCQ
Lymphoma, B-Cell	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Lymphoma, B-Cell	ENSG00000072694	FALSE	Preclinical	2005-07-06	Unused	FCGR2B
Lymphoma, B-Cell	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Lymphoma, B-Cell	ENSG00000079277	FALSE	Preclinical	2013-11-21	Absent	MKNK1
Lymphoma, B-Cell	ENSG00000080824	FALSE	Phase I Clinical Trial	2007-08-22	Phase I Clinical Trial	HSP90AA1
Lymphoma, B-Cell	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Lymphoma, B-Cell	ENSG00000087586	FALSE	Phase II Clinical Trial	2006-11-20	Phase II Clinical Trial	AURKA
Lymphoma, B-Cell	ENSG00000089685	FALSE	Phase II Clinical Trial	2005-07-13	Unused	BIRC5
Lymphoma, B-Cell	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Lymphoma, B-Cell	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC6
Lymphoma, B-Cell	ENSG00000096968	FALSE	Phase I Clinical Trial	2007-06-15	Phase I Clinical Trial	JAK2
Lymphoma, B-Cell	ENSG00000099875	FALSE	Preclinical	2013-11-21	Absent	MKNK2
Lymphoma, B-Cell	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Lymphoma, B-Cell	ENSG00000101017	FALSE	Preclinical	1998-07-15	Unused	CD40
Lymphoma, B-Cell	ENSG00000101916	FALSE	unknown	2008-06-17	Unused	TLR8
Lymphoma, B-Cell	ENSG00000101966	FALSE	unknown	1999-01-08	Phase II Clinical Trial	XIAP
Lymphoma, B-Cell	ENSG00000102524	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13B
Lymphoma, B-Cell	ENSG00000103522	FALSE	unknown	2001-01-25	Unused	IL21R
Lymphoma, B-Cell	ENSG00000104365	FALSE	Preclinical	2014-11-08	Absent	IKBKB
Lymphoma, B-Cell	ENSG00000104689	FALSE	Phase II Clinical Trial	1998-08-15	Unused	TNFRSF10A
Lymphoma, B-Cell	ENSG00000104894	FALSE	Phase II Clinical Trial	2010-02-25	Absent	CD37
Lymphoma, B-Cell	ENSG00000104921	FALSE	Preclinical	2015-08-06	Absent	FCER2
Lymphoma, B-Cell	ENSG00000105639	FALSE	Preclinical	2017-06-16	Absent	JAK3
Lymphoma, B-Cell	ENSG00000105851	FALSE	Phase III Clinical Trial	2003-09-05	Unused	PIK3CG
Lymphoma, B-Cell	ENSG00000106462	FALSE	Phase I Clinical Trial	2010-12-03	Absent	EZH2
Lymphoma, B-Cell	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Lymphoma, B-Cell	ENSG00000109320	FALSE	unknown	1997-11-15	Phase II Clinical Trial	NFKB1
Lymphoma, B-Cell	ENSG00000111537	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IFNG
Lymphoma, B-Cell	ENSG00000112715	FALSE	unknown	1995-04-15	Unused	VEGFA
Lymphoma, B-Cell	ENSG00000113302	FALSE	Preclinical	2008-10-20	Absent	IL12B
Lymphoma, B-Cell	ENSG00000113851	FALSE	Phase II Clinical Trial	2011-08-26	Absent	CRBN
Lymphoma, B-Cell	ENSG00000113916	FALSE	Preclinical	2010-03-17	Unused	BCL6
Lymphoma, B-Cell	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-06-14	Absent	FN1
Lymphoma, B-Cell	ENSG00000115604	FALSE	unknown	2000-04-04	Unused	IL18R1
Lymphoma, B-Cell	ENSG00000116030	FALSE	Preclinical	2017-09-12	Absent	SUMO1
Lymphoma, B-Cell	ENSG00000116478	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC1
Lymphoma, B-Cell	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Lymphoma, B-Cell	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Approved	TNFRSF8
Lymphoma, B-Cell	ENSG00000121879	FALSE	Phase II Clinical Trial	2003-09-05	Unused	PIK3CA
Lymphoma, B-Cell	ENSG00000122025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	FLT3
Lymphoma, B-Cell	ENSG00000123374	FALSE	Preclinical	1997-01-15	Unused	CDK2
Lymphoma, B-Cell	ENSG00000125726	FALSE	Phase I Clinical Trial	2012-04-06	Absent	CD70
Lymphoma, B-Cell	ENSG00000128271	FALSE	Phase II Clinical Trial	1996-07-15	Absent	ADORA2A
Lymphoma, B-Cell	ENSG00000129484	FALSE	Phase II Clinical Trial	2012-04-23	Phase II Clinical Trial	PARP2
Lymphoma, B-Cell	ENSG00000131747	FALSE	Phase III Clinical Trial	1991-06-15	Phase III Clinical Trial	TOP2A
Lymphoma, B-Cell	ENSG00000132507	FALSE	unknown	2009-02-05	Phase II Clinical Trial	EIF5A
Lymphoma, B-Cell	ENSG00000134058	FALSE	unknown	1997-01-15	Unused	CDK7
Lymphoma, B-Cell	ENSG00000134460	FALSE	Phase II Clinical Trial	2004-06-14	Absent	IL2RA
Lymphoma, B-Cell	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Lymphoma, B-Cell	ENSG00000135446	FALSE	Preclinical	2007-08-14	Absent	CDK4
Lymphoma, B-Cell	ENSG00000135679	FALSE	Phase II Clinical Trial	2004-03-09	Absent	MDM2
Lymphoma, B-Cell	ENSG00000136807	FALSE	Preclinical	1997-01-15	Unused	CDK9
Lymphoma, B-Cell	ENSG00000138160	FALSE	unknown	2003-10-06	Phase II Clinical Trial	KIF11
Lymphoma, B-Cell	ENSG00000141510	FALSE	Phase II Clinical Trial	2004-03-09	Absent	TP53
Lymphoma, B-Cell	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Phase I Clinical Trial	BRD4
Lymphoma, B-Cell	ENSG00000143384	FALSE	Phase I Clinical Trial	1997-01-15	Unused	MCL1
Lymphoma, B-Cell	ENSG00000143799	FALSE	Phase II Clinical Trial	2012-04-23	Phase II Clinical Trial	PARP1
Lymphoma, B-Cell	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC8
Lymphoma, B-Cell	ENSG00000151247	FALSE	Preclinical	2016-02-02	Absent	EIF4E
Lymphoma, B-Cell	ENSG00000154229	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCA
Lymphoma, B-Cell	ENSG00000155380	FALSE	Phase I Clinical Trial	2010-09-13	Absent	SLC16A1
Lymphoma, B-Cell	ENSG00000156738	TRUE	Approved	1992-06-15	Approved	MS4A1
Lymphoma, B-Cell	ENSG00000157404	FALSE	Phase I Clinical Trial	2007-06-15	Absent	KIT
Lymphoma, B-Cell	ENSG00000159110	FALSE	Preclinical	2008-12-12	Preclinical	IFNAR2
Lymphoma, B-Cell	ENSG00000159958	FALSE	Preclinical	2011-10-01	Unused	TNFRSF13C
Lymphoma, B-Cell	ENSG00000160255	FALSE	Preclinical	2009-11-03	Absent	ITGB2
Lymphoma, B-Cell	ENSG00000161955	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13
Lymphoma, B-Cell	ENSG00000162434	FALSE	Phase II Clinical Trial	2012-06-26	Absent	JAK1
Lymphoma, B-Cell	ENSG00000162924	FALSE	Preclinical	2015-01-30	Absent	REL
Lymphoma, B-Cell	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HDAC11
Lymphoma, B-Cell	ENSG00000163599	FALSE	Phase I Clinical Trial	1998-09-15	Unused	CTLA4
Lymphoma, B-Cell	ENSG00000163932	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCD
Lymphoma, B-Cell	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Unused	CASP3
Lymphoma, B-Cell	ENSG00000164885	FALSE	Preclinical	2005-03-14	Absent	CDK5
Lymphoma, B-Cell	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Lymphoma, B-Cell	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase III Clinical Trial	PRKCB
Lymphoma, B-Cell	ENSG00000167325	TRUE	Approved	NA	Absent	RRM1
Lymphoma, B-Cell	ENSG00000167658	FALSE	Phase II Clinical Trial	2004-12-16	Phase II Clinical Trial	EEF2
Lymphoma, B-Cell	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-01-07	Absent	STAT3
Lymphoma, B-Cell	ENSG00000168811	FALSE	Preclinical	2008-10-20	Absent	IL12A
Lymphoma, B-Cell	ENSG00000169442	FALSE	Preclinical	2011-07-01	Preclinical	CD52
Lymphoma, B-Cell	ENSG00000169925	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD3
Lymphoma, B-Cell	ENSG00000170145	FALSE	Preclinical	2012-08-17	Preclinical	SIK2
Lymphoma, B-Cell	ENSG00000170312	FALSE	Preclinical	2005-03-14	Absent	CDK1
Lymphoma, B-Cell	ENSG00000171094	FALSE	Phase I Clinical Trial	2011-01-28	Phase I Clinical Trial	ALK
Lymphoma, B-Cell	ENSG00000171132	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCE
Lymphoma, B-Cell	ENSG00000171552	FALSE	Preclinical	2006-12-15	Preclinical	BCL2L1
Lymphoma, B-Cell	ENSG00000171608	FALSE	Phase III Clinical Trial	2003-09-05	Phase I Clinical Trial	PIK3CD
Lymphoma, B-Cell	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Lymphoma, B-Cell	ENSG00000171791	FALSE	Phase II Clinical Trial	1992-03-15	Unused	BCL2
Lymphoma, B-Cell	ENSG00000171848	TRUE	Approved	NA	Absent	RRM2
Lymphoma, B-Cell	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Lymphoma, B-Cell	ENSG00000172175	FALSE	Preclinical	2016-02-29	Absent	MALT1
Lymphoma, B-Cell	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Lymphoma, B-Cell	ENSG00000173638	FALSE	unknown	NA	Phase II Clinical Trial	SLC19A1
Lymphoma, B-Cell	ENSG00000177455	TRUE	Approved	1999-04-27	Phase II Clinical Trial	CD19
Lymphoma, B-Cell	ENSG00000177885	FALSE	Preclinical	NA	Absent	GRB2
Lymphoma, B-Cell	ENSG00000182578	FALSE	Phase I Clinical Trial	2007-06-15	Absent	CSF1R
Lymphoma, B-Cell	ENSG00000185291	FALSE	Phase I Clinical Trial	2016-06-28	Absent	IL3RA
Lymphoma, B-Cell	ENSG00000186827	FALSE	unknown	2011-11-05	Absent	TNFRSF4
Lymphoma, B-Cell	ENSG00000188389	FALSE	Pre-registration	2005-05-12	Phase II Clinical Trial	PDCD1
Lymphoma, B-Cell	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Lymphoma, B-Cell	ENSG00000196664	FALSE	unknown	2012-03-16	Absent	TLR7
Lymphoma, B-Cell	ENSG00000196776	FALSE	Phase II Clinical Trial	2011-05-14	Absent	CD47
Lymphoma, B-Cell	ENSG00000198001	FALSE	Preclinical	2011-07-23	Preclinical	IRAK4
Lymphoma, B-Cell	ENSG00000198223	FALSE	Phase II Clinical Trial	NA	Unused	CSF2RA
Lymphoma, B-Cell	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase III Clinical Trial	MTOR
Lymphoma, B-Cell	ENSG00000198851	FALSE	Phase II Clinical Trial	1999-04-27	Absent	CD3E
Lymphoma, B-Cell	ENSG00000203747	FALSE	Phase I Clinical Trial	2016-05-19	Absent	FCGR3A
Lymphoma, B-Cell	ENSG00000228716	FALSE	unknown	NA	Phase II Clinical Trial	DHFR
Lymphoma, B-Cell	ENSG00000239732	FALSE	Phase II Clinical Trial	2006-09-01	Absent	TLR9
Lymphoma, B-Cell	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Lymphoma, B-Cell	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Lymphoma, B-Cell, Marginal Zone	ENSG00000010671	TRUE	Approved	2007-12-12	Absent	BTK
Lymphoma, B-Cell, Marginal Zone	ENSG00000012124	FALSE	unknown	NA	Absent	CD22
Lymphoma, B-Cell, Marginal Zone	ENSG00000019582	FALSE	Phase II Clinical Trial	2005-02-25	Absent	CD74
Lymphoma, B-Cell, Marginal Zone	ENSG00000096968	FALSE	Preclinical	2007-06-15	Absent	JAK2
Lymphoma, B-Cell, Marginal Zone	ENSG00000101017	FALSE	unknown	1998-07-15	Absent	CD40
Lymphoma, B-Cell, Marginal Zone	ENSG00000102524	FALSE	unknown	2001-06-21	Absent	TNFSF13B
Lymphoma, B-Cell, Marginal Zone	ENSG00000104894	FALSE	Phase II Clinical Trial	2003-12-17	Absent	CD37
Lymphoma, B-Cell, Marginal Zone	ENSG00000105851	FALSE	Phase III Clinical Trial	2009-07-15	Absent	PIK3CG
Lymphoma, B-Cell, Marginal Zone	ENSG00000106462	FALSE	Phase I Clinical Trial	2010-12-03	Absent	EZH2
Lymphoma, B-Cell, Marginal Zone	ENSG00000109320	FALSE	unknown	1997-11-15	Absent	NFKB1
Lymphoma, B-Cell, Marginal Zone	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Absent	HBEGF
Lymphoma, B-Cell, Marginal Zone	ENSG00000120217	FALSE	Preclinical	2011-06-20	Absent	CD274
Lymphoma, B-Cell, Marginal Zone	ENSG00000121879	FALSE	Phase III Clinical Trial	2009-09-01	Absent	PIK3CA
Lymphoma, B-Cell, Marginal Zone	ENSG00000122025	FALSE	Preclinical	2003-10-31	Absent	FLT3
Lymphoma, B-Cell, Marginal Zone	ENSG00000136244	FALSE	Phase I Clinical Trial	NA	Absent	IL6
Lymphoma, B-Cell, Marginal Zone	ENSG00000141867	FALSE	Preclinical	2012-06-18	Absent	BRD4
Lymphoma, B-Cell, Marginal Zone	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Absent	EGFR
Lymphoma, B-Cell, Marginal Zone	ENSG00000156738	TRUE	Approved	1992-06-15	Absent	MS4A1
Lymphoma, B-Cell, Marginal Zone	ENSG00000157404	FALSE	Preclinical	2007-06-15	Absent	KIT
Lymphoma, B-Cell, Marginal Zone	ENSG00000165025	FALSE	unknown	2003-10-31	Absent	SYK
Lymphoma, B-Cell, Marginal Zone	ENSG00000169925	FALSE	Preclinical	2012-06-18	Absent	BRD3
Lymphoma, B-Cell, Marginal Zone	ENSG00000171608	FALSE	Phase III Clinical Trial	2004-01-20	Absent	PIK3CD
Lymphoma, B-Cell, Marginal Zone	ENSG00000177455	FALSE	Phase I Clinical Trial	2005-09-22	Absent	CD19
Lymphoma, B-Cell, Marginal Zone	ENSG00000182578	FALSE	Preclinical	2007-06-15	Absent	CSF1R
Lymphoma, B-Cell, Marginal Zone	ENSG00000275302	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL4
Lymphoma, B-Cell, Marginal Zone	ENSG00000277632	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL3
Lymphoma, Follicular	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Lymphoma, Follicular	ENSG00000007312	FALSE	Phase II Clinical Trial	2011-02-09	Absent	CD79B
Lymphoma, Follicular	ENSG00000010671	FALSE	Phase III Clinical Trial	2007-12-12	Absent	BTK
Lymphoma, Follicular	ENSG00000012124	FALSE	Phase II Clinical Trial	1993-08-15	Absent	CD22
Lymphoma, Follicular	ENSG00000019582	FALSE	Phase II Clinical Trial	2005-02-25	Absent	CD74
Lymphoma, Follicular	ENSG00000049249	FALSE	Phase I Clinical Trial	2011-01-31	Absent	TNFRSF9
Lymphoma, Follicular	ENSG00000072694	FALSE	Preclinical	2013-04-18	Absent	FCGR2B
Lymphoma, Follicular	ENSG00000089692	FALSE	Phase I Clinical Trial	2016-10-05	Absent	LAG3
Lymphoma, Follicular	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC6
Lymphoma, Follicular	ENSG00000096968	FALSE	Phase II Clinical Trial	2007-06-15	Absent	JAK2
Lymphoma, Follicular	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC10
Lymphoma, Follicular	ENSG00000101017	FALSE	unknown	2008-12-08	Absent	CD40
Lymphoma, Follicular	ENSG00000104894	FALSE	Phase II Clinical Trial	2003-12-17	Absent	CD37
Lymphoma, Follicular	ENSG00000105810	FALSE	Phase I Clinical Trial	2004-03-28	Absent	CDK6
Lymphoma, Follicular	ENSG00000105851	FALSE	Phase II Clinical Trial	2009-07-15	Absent	PIK3CG
Lymphoma, Follicular	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Lymphoma, Follicular	ENSG00000109320	FALSE	Phase II Clinical Trial	1997-11-15	Absent	NFKB1
Lymphoma, Follicular	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Absent	HBEGF
Lymphoma, Follicular	ENSG00000116478	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC1
Lymphoma, Follicular	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Lymphoma, Follicular	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Absent	TNFRSF8
Lymphoma, Follicular	ENSG00000121879	TRUE	Approved	2006-10-23	Absent	PIK3CA
Lymphoma, Follicular	ENSG00000122025	FALSE	Phase II Clinical Trial	2007-06-15	Absent	FLT3
Lymphoma, Follicular	ENSG00000134460	FALSE	unknown	NA	Absent	IL2RA
Lymphoma, Follicular	ENSG00000135446	FALSE	Phase I Clinical Trial	2004-03-28	Absent	CDK4
Lymphoma, Follicular	ENSG00000135679	FALSE	Phase II Clinical Trial	2004-03-09	Absent	MDM2
Lymphoma, Follicular	ENSG00000136244	FALSE	Phase I Clinical Trial	NA	Absent	IL6
Lymphoma, Follicular	ENSG00000136869	FALSE	Phase II Clinical Trial	2014-02-19	Absent	TLR4
Lymphoma, Follicular	ENSG00000141510	FALSE	Phase II Clinical Trial	2004-03-09	Absent	TP53
Lymphoma, Follicular	ENSG00000141867	FALSE	Phase II Clinical Trial	2017-10-04	Absent	BRD4
Lymphoma, Follicular	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Absent	EGFR
Lymphoma, Follicular	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC8
Lymphoma, Follicular	ENSG00000156738	TRUE	Approved	1992-06-15	Absent	MS4A1
Lymphoma, Follicular	ENSG00000157404	FALSE	Phase II Clinical Trial	2007-06-15	Absent	KIT
Lymphoma, Follicular	ENSG00000159110	TRUE	Approved	2010-06-07	Absent	IFNAR2
Lymphoma, Follicular	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Absent	HDAC11
Lymphoma, Follicular	ENSG00000165025	FALSE	Phase II Clinical Trial	2010-06-25	Absent	SYK
Lymphoma, Follicular	ENSG00000166501	FALSE	unknown	2001-07-03	Absent	PRKCB
Lymphoma, Follicular	ENSG00000167325	TRUE	Approved	NA	Absent	RRM1
Lymphoma, Follicular	ENSG00000167658	FALSE	unknown	NA	Absent	EEF2
Lymphoma, Follicular	ENSG00000171552	FALSE	Phase II Clinical Trial	2006-12-15	Absent	BCL2L1
Lymphoma, Follicular	ENSG00000171608	TRUE	Approved	2004-01-20	Absent	PIK3CD
Lymphoma, Follicular	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC3
Lymphoma, Follicular	ENSG00000171791	FALSE	Phase II Clinical Trial	2006-12-15	Absent	BCL2
Lymphoma, Follicular	ENSG00000171848	TRUE	Approved	NA	Absent	RRM2
Lymphoma, Follicular	ENSG00000171862	FALSE	unknown	1999-02-15	Absent	PTEN
Lymphoma, Follicular	ENSG00000173638	FALSE	unknown	NA	Absent	SLC19A1
Lymphoma, Follicular	ENSG00000177455	TRUE	Approved	1999-04-27	Absent	CD19
Lymphoma, Follicular	ENSG00000177885	FALSE	Preclinical	NA	Absent	GRB2
Lymphoma, Follicular	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-15	Absent	CSF1R
Lymphoma, Follicular	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Lymphoma, Follicular	ENSG00000196591	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC2
Lymphoma, Follicular	ENSG00000198223	FALSE	unknown	NA	Absent	CSF2RA
Lymphoma, Follicular	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Absent	MTOR
Lymphoma, Follicular	ENSG00000198851	FALSE	Phase I Clinical Trial	1999-04-27	Absent	CD3E
Lymphoma, Follicular	ENSG00000228716	FALSE	unknown	NA	Absent	DHFR
Lymphoma, Follicular	ENSG00000239732	FALSE	Preclinical	2014-04-08	Absent	TLR9
Lymphoma, Follicular	ENSG00000275302	TRUE	Approved	2004-01-20	Absent	CCL4
Lymphoma, Follicular	ENSG00000277632	TRUE	Approved	2004-01-20	Absent	CCL3
Lymphoma, Large-Cell, Anaplastic	ENSG00000047936	FALSE	Phase I Clinical Trial	2006-12-05	Absent	ROS1
Lymphoma, Large-Cell, Anaplastic	ENSG00000105397	FALSE	Preclinical	NA	Absent	TYK2
Lymphoma, Large-Cell, Anaplastic	ENSG00000105976	FALSE	Phase I Clinical Trial	2006-12-05	Absent	MET
Lymphoma, Large-Cell, Anaplastic	ENSG00000120949	TRUE	Approved	2000-12-12	Absent	TNFRSF8
Lymphoma, Large-Cell, Anaplastic	ENSG00000140538	FALSE	Preclinical	2009-05-20	Absent	NTRK3
Lymphoma, Large-Cell, Anaplastic	ENSG00000148053	FALSE	Preclinical	2009-05-20	Absent	NTRK2
Lymphoma, Large-Cell, Anaplastic	ENSG00000162434	FALSE	Preclinical	NA	Absent	JAK1
Lymphoma, Large-Cell, Anaplastic	ENSG00000171094	FALSE	Phase I Clinical Trial	2006-02-22	Absent	ALK
Lymphoma, Large-Cell, Anaplastic	ENSG00000198400	FALSE	Preclinical	2009-05-20	Absent	NTRK1
Lymphoma, Non-Hodgkin	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Phase I Clinical Trial	CD38
Lymphoma, Non-Hodgkin	ENSG00000004487	FALSE	Phase I Clinical Trial	2016-02-02	Absent	KDM1A
Lymphoma, Non-Hodgkin	ENSG00000007312	FALSE	Phase II Clinical Trial	2011-02-09	Absent	CD79B
Lymphoma, Non-Hodgkin	ENSG00000010671	TRUE	Approved	2007-12-12	Phase III Clinical Trial	BTK
Lymphoma, Non-Hodgkin	ENSG00000012124	FALSE	Phase III Clinical Trial	1993-08-15	Phase III Clinical Trial	CD22
Lymphoma, Non-Hodgkin	ENSG00000013725	FALSE	unknown	2007-09-10	Unused	CD6
Lymphoma, Non-Hodgkin	ENSG00000019582	FALSE	Phase II Clinical Trial	2003-04-08	Phase II Clinical Trial	CD74
Lymphoma, Non-Hodgkin	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Lymphoma, Non-Hodgkin	ENSG00000041982	FALSE	Phase I Clinical Trial	2006-04-19	Unused	TNC
Lymphoma, Non-Hodgkin	ENSG00000047936	FALSE	Phase II Clinical Trial	2016-06-09	Absent	ROS1
Lymphoma, Non-Hodgkin	ENSG00000048462	FALSE	Phase I Clinical Trial	2012-01-25	Absent	TNFRSF17
Lymphoma, Non-Hodgkin	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Phase I Clinical Trial	TNFRSF9
Lymphoma, Non-Hodgkin	ENSG00000051382	FALSE	unknown	2005-12-01	Phase I Clinical Trial	PIK3CB
Lymphoma, Non-Hodgkin	ENSG00000054219	FALSE	Phase I Clinical Trial	2007-12-20	Absent	LY75
Lymphoma, Non-Hodgkin	ENSG00000070501	FALSE	unknown	2015-09-11	Absent	POLB
Lymphoma, Non-Hodgkin	ENSG00000072694	FALSE	Phase II Clinical Trial	2013-04-18	Absent	FCGR2B
Lymphoma, Non-Hodgkin	ENSG00000078098	FALSE	unknown	2001-06-11	Unused	FAP
Lymphoma, Non-Hodgkin	ENSG00000080824	FALSE	Phase I Clinical Trial	2005-02-11	Phase I Clinical Trial	HSP90AA1
Lymphoma, Non-Hodgkin	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-01-02	Phase I Clinical Trial	XPO1
Lymphoma, Non-Hodgkin	ENSG00000085563	FALSE	unknown	1994-12-15	Unused	ABCB1
Lymphoma, Non-Hodgkin	ENSG00000087586	FALSE	unknown	2003-10-20	Phase II Clinical Trial	AURKA
Lymphoma, Non-Hodgkin	ENSG00000089685	FALSE	Phase II Clinical Trial	2005-07-13	Phase II Clinical Trial	BIRC5
Lymphoma, Non-Hodgkin	ENSG00000089692	FALSE	Phase I Clinical Trial	2012-10-31	Absent	LAG3
Lymphoma, Non-Hodgkin	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Lymphoma, Non-Hodgkin	ENSG00000096968	FALSE	Phase II Clinical Trial	2007-06-15	Phase II Clinical Trial	JAK2
Lymphoma, Non-Hodgkin	ENSG00000100385	FALSE	Phase I Clinical Trial	2007-03-01	Phase I Clinical Trial	IL2RB
Lymphoma, Non-Hodgkin	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Lymphoma, Non-Hodgkin	ENSG00000100462	FALSE	Phase I Clinical Trial	2011-01-11	Preclinical	PRMT5
Lymphoma, Non-Hodgkin	ENSG00000100823	FALSE	Phase I Clinical Trial	2007-02-13	Absent	APEX1
Lymphoma, Non-Hodgkin	ENSG00000101017	FALSE	Phase I Clinical Trial	1998-07-15	Phase II Clinical Trial	CD40
Lymphoma, Non-Hodgkin	ENSG00000101868	FALSE	unknown	1999-06-02	Unused	POLA1
Lymphoma, Non-Hodgkin	ENSG00000102096	FALSE	Preclinical	2006-11-29	Unused	PIM2
Lymphoma, Non-Hodgkin	ENSG00000102245	FALSE	unknown	1996-01-15	Unused	CD40LG
Lymphoma, Non-Hodgkin	ENSG00000102524	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13B
Lymphoma, Non-Hodgkin	ENSG00000102755	FALSE	unknown	1994-03-15	Phase II Clinical Trial	FLT1
Lymphoma, Non-Hodgkin	ENSG00000103522	FALSE	unknown	2001-01-25	Unused	IL21R
Lymphoma, Non-Hodgkin	ENSG00000104689	FALSE	Phase II Clinical Trial	1998-08-15	Unused	TNFRSF10A
Lymphoma, Non-Hodgkin	ENSG00000104894	FALSE	Phase II Clinical Trial	2003-12-17	Phase II Clinical Trial	CD37
Lymphoma, Non-Hodgkin	ENSG00000105146	FALSE	unknown	2003-10-20	Phase I Clinical Trial	AURKC
Lymphoma, Non-Hodgkin	ENSG00000105329	FALSE	Preclinical	2009-12-02	Unused	TGFB1
Lymphoma, Non-Hodgkin	ENSG00000105810	FALSE	Phase II Clinical Trial	2004-03-28	Phase I Clinical Trial	CDK6
Lymphoma, Non-Hodgkin	ENSG00000105835	FALSE	Phase I Clinical Trial	2014-01-22	Absent	NAMPT
Lymphoma, Non-Hodgkin	ENSG00000105851	FALSE	Phase III Clinical Trial	2005-12-01	Phase I Clinical Trial	PIK3CG
Lymphoma, Non-Hodgkin	ENSG00000105953	FALSE	Phase I Clinical Trial	2008-07-26	Absent	OGDH
Lymphoma, Non-Hodgkin	ENSG00000105976	FALSE	Phase I Clinical Trial	2009-11-09	Phase I Clinical Trial	MET
Lymphoma, Non-Hodgkin	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Lymphoma, Non-Hodgkin	ENSG00000108443	FALSE	Phase I Clinical Trial	2009-04-27	Unused	RPS6KB1
Lymphoma, Non-Hodgkin	ENSG00000108799	FALSE	Phase I Clinical Trial	2016-03-18	Absent	EZH1
Lymphoma, Non-Hodgkin	ENSG00000109320	TRUE	Approved	1997-11-15	Approved	NFKB1
Lymphoma, Non-Hodgkin	ENSG00000110092	FALSE	Preclinical	2015-07-18	Absent	CCND1
Lymphoma, Non-Hodgkin	ENSG00000111142	FALSE	unknown	2003-02-04	Unused	METAP2
Lymphoma, Non-Hodgkin	ENSG00000112715	FALSE	unknown	1995-04-15	Phase I Clinical Trial	VEGFA
Lymphoma, Non-Hodgkin	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Lymphoma, Non-Hodgkin	ENSG00000113851	FALSE	Phase II Clinical Trial	2011-08-26	Absent	CRBN
Lymphoma, Non-Hodgkin	ENSG00000115020	FALSE	Phase II Clinical Trial	NA	Absent	PIKFYVE
Lymphoma, Non-Hodgkin	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Lymphoma, Non-Hodgkin	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Lymphoma, Non-Hodgkin	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Lymphoma, Non-Hodgkin	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Lymphoma, Non-Hodgkin	ENSG00000120217	FALSE	Phase II Clinical Trial	2008-01-16	Preclinical	CD274
Lymphoma, Non-Hodgkin	ENSG00000120889	FALSE	Phase II Clinical Trial	2006-06-05	Unused	TNFRSF10B
Lymphoma, Non-Hodgkin	ENSG00000120949	TRUE	Approved	2000-12-12	Approved	TNFRSF8
Lymphoma, Non-Hodgkin	ENSG00000121594	FALSE	Phase III Clinical Trial	1994-06-15	Unused	CD80
Lymphoma, Non-Hodgkin	ENSG00000121858	FALSE	Phase II Clinical Trial	2006-07-10	Unused	TNFSF10
Lymphoma, Non-Hodgkin	ENSG00000121879	TRUE	Approved	1992-08-15	Phase II Clinical Trial	PIK3CA
Lymphoma, Non-Hodgkin	ENSG00000121966	FALSE	Phase II Clinical Trial	1997-10-15	Phase II Clinical Trial	CXCR4
Lymphoma, Non-Hodgkin	ENSG00000122025	FALSE	Phase II Clinical Trial	1996-01-15	Phase II Clinical Trial	FLT3
Lymphoma, Non-Hodgkin	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK2
Lymphoma, Non-Hodgkin	ENSG00000125726	FALSE	Phase I Clinical Trial	2004-03-29	Phase I Clinical Trial	CD70
Lymphoma, Non-Hodgkin	ENSG00000128052	FALSE	Phase I Clinical Trial	2003-10-02	Unused	KDR
Lymphoma, Non-Hodgkin	ENSG00000128271	FALSE	Phase II Clinical Trial	2011-06-23	Absent	ADORA2A
Lymphoma, Non-Hodgkin	ENSG00000129484	FALSE	Phase I Clinical Trial	2007-02-26	Phase I Clinical Trial	PARP2
Lymphoma, Non-Hodgkin	ENSG00000130669	FALSE	Phase I Clinical Trial	2014-01-22	Absent	PAK4
Lymphoma, Non-Hodgkin	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Absent	IDO1
Lymphoma, Non-Hodgkin	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Lymphoma, Non-Hodgkin	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Lymphoma, Non-Hodgkin	ENSG00000131828	FALSE	Phase I Clinical Trial	2008-07-26	Absent	PDHA1
Lymphoma, Non-Hodgkin	ENSG00000131981	FALSE	unknown	1997-05-15	Absent	LGALS3
Lymphoma, Non-Hodgkin	ENSG00000132507	FALSE	unknown	2009-02-05	Phase II Clinical Trial	EIF5A
Lymphoma, Non-Hodgkin	ENSG00000132906	FALSE	unknown	1997-05-15	Absent	CASP9
Lymphoma, Non-Hodgkin	ENSG00000134058	FALSE	unknown	1997-01-15	Unused	CDK7
Lymphoma, Non-Hodgkin	ENSG00000134460	FALSE	Phase II Clinical Trial	2003-08-18	Phase I Clinical Trial	IL2RA
Lymphoma, Non-Hodgkin	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Lymphoma, Non-Hodgkin	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Lymphoma, Non-Hodgkin	ENSG00000135446	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK4
Lymphoma, Non-Hodgkin	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Lymphoma, Non-Hodgkin	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Lymphoma, Non-Hodgkin	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK9
Lymphoma, Non-Hodgkin	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Lymphoma, Non-Hodgkin	ENSG00000136826	FALSE	unknown	2004-05-21	Absent	KLF4
Lymphoma, Non-Hodgkin	ENSG00000136869	FALSE	Preclinical	2013-11-01	Absent	TLR4
Lymphoma, Non-Hodgkin	ENSG00000136997	FALSE	unknown	2004-05-21	Absent	MYC
Lymphoma, Non-Hodgkin	ENSG00000137193	FALSE	Preclinical	2006-11-29	Unused	PIM1
Lymphoma, Non-Hodgkin	ENSG00000138039	FALSE	unknown	2008-10-31	Absent	LHCGR
Lymphoma, Non-Hodgkin	ENSG00000138160	FALSE	Phase I Clinical Trial	2003-10-06	Phase II Clinical Trial	KIF11
Lymphoma, Non-Hodgkin	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Lymphoma, Non-Hodgkin	ENSG00000139193	FALSE	Phase I Clinical Trial	2008-11-12	Absent	CD27
Lymphoma, Non-Hodgkin	ENSG00000140443	FALSE	Phase I Clinical Trial	2005-08-05	Unused	IGF1R
Lymphoma, Non-Hodgkin	ENSG00000140538	FALSE	Phase II Clinical Trial	2016-06-09	Absent	NTRK3
Lymphoma, Non-Hodgkin	ENSG00000141510	FALSE	unknown	1996-02-23	Unused	TP53
Lymphoma, Non-Hodgkin	ENSG00000141867	FALSE	Phase II Clinical Trial	2017-10-04	Absent	BRD4
Lymphoma, Non-Hodgkin	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	AKT1
Lymphoma, Non-Hodgkin	ENSG00000143384	FALSE	unknown	1997-01-15	Phase II Clinical Trial	MCL1
Lymphoma, Non-Hodgkin	ENSG00000143799	FALSE	Phase I Clinical Trial	2007-02-26	Phase I Clinical Trial	PARP1
Lymphoma, Non-Hodgkin	ENSG00000144744	FALSE	Phase II Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Lymphoma, Non-Hodgkin	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	EGFR
Lymphoma, Non-Hodgkin	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC8
Lymphoma, Non-Hodgkin	ENSG00000147437	FALSE	unknown	2008-10-31	Absent	GNRH1
Lymphoma, Non-Hodgkin	ENSG00000148053	FALSE	Phase II Clinical Trial	2016-06-09	Absent	NTRK2
Lymphoma, Non-Hodgkin	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Lymphoma, Non-Hodgkin	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CHEK1
Lymphoma, Non-Hodgkin	ENSG00000154229	FALSE	unknown	1991-01-15	Unused	PRKCA
Lymphoma, Non-Hodgkin	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Lymphoma, Non-Hodgkin	ENSG00000156738	TRUE	Approved	1992-06-15	Approved	MS4A1
Lymphoma, Non-Hodgkin	ENSG00000157404	FALSE	Phase II Clinical Trial	2007-06-15	Absent	KIT
Lymphoma, Non-Hodgkin	ENSG00000159110	TRUE	Approved	2008-12-12	Approved	IFNAR2
Lymphoma, Non-Hodgkin	ENSG00000159131	FALSE	unknown	1992-02-15	Unused	GART
Lymphoma, Non-Hodgkin	ENSG00000159958	FALSE	Preclinical	2011-10-01	Unused	TNFRSF13C
Lymphoma, Non-Hodgkin	ENSG00000161955	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13
Lymphoma, Non-Hodgkin	ENSG00000162434	FALSE	Phase I Clinical Trial	2013-05-03	Absent	JAK1
Lymphoma, Non-Hodgkin	ENSG00000162747	FALSE	Preclinical	2007-04-10	Preclinical	FCGR3B
Lymphoma, Non-Hodgkin	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HDAC11
Lymphoma, Non-Hodgkin	ENSG00000163599	FALSE	unknown	1998-09-15	Unused	CTLA4
Lymphoma, Non-Hodgkin	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Unused	CASP3
Lymphoma, Non-Hodgkin	ENSG00000164885	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK5
Lymphoma, Non-Hodgkin	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Lymphoma, Non-Hodgkin	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase III Clinical Trial	PRKCB
Lymphoma, Non-Hodgkin	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Lymphoma, Non-Hodgkin	ENSG00000166851	FALSE	Phase I Clinical Trial	2006-10-19	Phase I Clinical Trial	PLK1
Lymphoma, Non-Hodgkin	ENSG00000167325	TRUE	Approved	1999-06-02	Unused	RRM1
Lymphoma, Non-Hodgkin	ENSG00000167658	FALSE	Phase II Clinical Trial	2001-03-27	Phase I Clinical Trial	EEF2
Lymphoma, Non-Hodgkin	ENSG00000168398	FALSE	Phase I Clinical Trial	2004-06-18	Unused	BDKRB2
Lymphoma, Non-Hodgkin	ENSG00000168610	FALSE	Phase I Clinical Trial	2007-08-28	Phase I Clinical Trial	STAT3
Lymphoma, Non-Hodgkin	ENSG00000169398	FALSE	unknown	2011-02-23	Unused	PTK2
Lymphoma, Non-Hodgkin	ENSG00000169403	FALSE	unknown	1996-01-15	Unused	PTAFR
Lymphoma, Non-Hodgkin	ENSG00000169442	FALSE	Phase II Clinical Trial	NA	Unused	CD52
Lymphoma, Non-Hodgkin	ENSG00000170312	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK1
Lymphoma, Non-Hodgkin	ENSG00000171094	FALSE	Phase II Clinical Trial	2004-06-22	Phase I Clinical Trial	ALK
Lymphoma, Non-Hodgkin	ENSG00000171552	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BCL2L1
Lymphoma, Non-Hodgkin	ENSG00000171608	TRUE	Approved	2004-01-20	Phase III Clinical Trial	PIK3CD
Lymphoma, Non-Hodgkin	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Lymphoma, Non-Hodgkin	ENSG00000171791	FALSE	Phase III Clinical Trial	1992-03-15	Phase II Clinical Trial	BCL2
Lymphoma, Non-Hodgkin	ENSG00000171848	TRUE	Approved	1999-06-02	Unused	RRM2
Lymphoma, Non-Hodgkin	ENSG00000171862	TRUE	Approved	1999-02-15	Approved	PTEN
Lymphoma, Non-Hodgkin	ENSG00000173638	FALSE	Preclinical	1996-12-15	Phase II Clinical Trial	SLC19A1
Lymphoma, Non-Hodgkin	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-04-30	Absent	ATR
Lymphoma, Non-Hodgkin	ENSG00000176890	FALSE	unknown	2009-05-22	Unused	TYMS
Lymphoma, Non-Hodgkin	ENSG00000177455	TRUE	Approved	1999-04-27	Phase II Clinical Trial	CD19
Lymphoma, Non-Hodgkin	ENSG00000177885	FALSE	Preclinical	NA	Absent	GRB2
Lymphoma, Non-Hodgkin	ENSG00000178999	FALSE	Phase I Clinical Trial	2003-10-20	Phase I Clinical Trial	AURKB
Lymphoma, Non-Hodgkin	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-15	Absent	CSF1R
Lymphoma, Non-Hodgkin	ENSG00000184033	FALSE	Preclinical	2013-11-01	Absent	CTAG1B
Lymphoma, Non-Hodgkin	ENSG00000185483	FALSE	Preclinical	2015-09-18	Absent	ROR1
Lymphoma, Non-Hodgkin	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Phase II Clinical Trial	PDCD1
Lymphoma, Non-Hodgkin	ENSG00000196591	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Lymphoma, Non-Hodgkin	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Lymphoma, Non-Hodgkin	ENSG00000196776	FALSE	Phase II Clinical Trial	2013-03-01	Absent	CD47
Lymphoma, Non-Hodgkin	ENSG00000196839	TRUE	Approved	NA	Approved	ADA
Lymphoma, Non-Hodgkin	ENSG00000197122	FALSE	Phase II Clinical Trial	2016-06-09	Absent	SRC
Lymphoma, Non-Hodgkin	ENSG00000198001	FALSE	Phase I Clinical Trial	2013-08-27	Absent	IRAK4
Lymphoma, Non-Hodgkin	ENSG00000198223	FALSE	Phase II Clinical Trial	NA	Unused	CSF2RA
Lymphoma, Non-Hodgkin	ENSG00000198355	FALSE	Preclinical	2006-11-29	Unused	PIM3
Lymphoma, Non-Hodgkin	ENSG00000198400	FALSE	Phase II Clinical Trial	2016-06-09	Absent	NTRK1
Lymphoma, Non-Hodgkin	ENSG00000198793	TRUE	Approved	1997-08-15	Approved	MTOR
Lymphoma, Non-Hodgkin	ENSG00000198805	FALSE	unknown	2000-08-03	Absent	PNP
Lymphoma, Non-Hodgkin	ENSG00000198851	FALSE	Phase III Clinical Trial	1999-04-27	Absent	CD3E
Lymphoma, Non-Hodgkin	ENSG00000198900	FALSE	unknown	NA	Unused	TOP1
Lymphoma, Non-Hodgkin	ENSG00000203710	FALSE	Preclinical	2004-10-01	Unused	CR1
Lymphoma, Non-Hodgkin	ENSG00000203747	FALSE	Preclinical	2007-04-10	Preclinical	FCGR3A
Lymphoma, Non-Hodgkin	ENSG00000228716	FALSE	unknown	2009-05-22	Phase II Clinical Trial	DHFR
Lymphoma, Non-Hodgkin	ENSG00000239732	FALSE	Phase II Clinical Trial	1998-10-15	Unused	TLR9
Lymphoma, Non-Hodgkin	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Lymphoma, Non-Hodgkin	ENSG00000253729	FALSE	Phase I Clinical Trial	2011-01-24	Phase I Clinical Trial	PRKDC
Lymphoma, Non-Hodgkin	ENSG00000275302	TRUE	Approved	2004-01-20	Phase III Clinical Trial	CCL4
Lymphoma, Non-Hodgkin	ENSG00000277632	TRUE	Approved	2004-01-20	Phase III Clinical Trial	CCL3
Lymphoma, T-Cell	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Lymphoma, T-Cell	ENSG00000010610	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	CD4
Lymphoma, T-Cell	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Lymphoma, T-Cell	ENSG00000013725	FALSE	unknown	1996-05-15	Unused	CD6
Lymphoma, T-Cell	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Lymphoma, T-Cell	ENSG00000068024	TRUE	Approved	2002-06-10	Absent	HDAC4
Lymphoma, T-Cell	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Absent	FGFR3
Lymphoma, T-Cell	ENSG00000072274	FALSE	Preclinical	1994-06-15	Unused	TFRC
Lymphoma, T-Cell	ENSG00000080824	FALSE	Phase III Clinical Trial	NA	Unused	HSP90AA1
Lymphoma, T-Cell	ENSG00000081985	FALSE	Phase II Clinical Trial	2011-06-06	Phase II Clinical Trial	IL12RB2
Lymphoma, T-Cell	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Lymphoma, T-Cell	ENSG00000087586	FALSE	unknown	2006-11-20	Phase III Clinical Trial	AURKA
Lymphoma, T-Cell	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC6
Lymphoma, T-Cell	ENSG00000096996	FALSE	Phase II Clinical Trial	2011-06-06	Phase II Clinical Trial	IL12RB1
Lymphoma, T-Cell	ENSG00000100385	FALSE	Preclinical	2008-07-24	Unused	IL2RB
Lymphoma, T-Cell	ENSG00000100429	FALSE	Approved	2003-03-06	Phase II Clinical Trial	HDAC10
Lymphoma, T-Cell	ENSG00000101868	FALSE	unknown	1993-08-15	Unused	POLA1
Lymphoma, T-Cell	ENSG00000101916	FALSE	Preclinical	NA	Absent	TLR8
Lymphoma, T-Cell	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Lymphoma, T-Cell	ENSG00000104365	FALSE	Preclinical	2014-11-08	Absent	IKBKB
Lymphoma, T-Cell	ENSG00000104894	FALSE	Phase II Clinical Trial	2003-12-17	Absent	CD37
Lymphoma, T-Cell	ENSG00000105851	FALSE	Phase I Clinical Trial	2009-07-15	Absent	PIK3CG
Lymphoma, T-Cell	ENSG00000110448	FALSE	Preclinical	2016-08-09	Absent	CD5
Lymphoma, T-Cell	ENSG00000111537	FALSE	unknown	NA	Unused	IFNG
Lymphoma, T-Cell	ENSG00000113263	FALSE	Preclinical	2016-02-17	Absent	ITK
Lymphoma, T-Cell	ENSG00000113302	FALSE	Phase II Clinical Trial	1995-09-15	Unused	IL12B
Lymphoma, T-Cell	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Absent	PDGFRB
Lymphoma, T-Cell	ENSG00000115138	FALSE	Phase II Clinical Trial	2004-01-26	Unused	POMC
Lymphoma, T-Cell	ENSG00000115758	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	ODC1
Lymphoma, T-Cell	ENSG00000116478	TRUE	Approved	1994-12-15	Approved	HDAC1
Lymphoma, T-Cell	ENSG00000116824	FALSE	unknown	1997-07-15	Unused	CD2
Lymphoma, T-Cell	ENSG00000120949	TRUE	Approved	2002-10-28	Approved	TNFRSF8
Lymphoma, T-Cell	ENSG00000121879	FALSE	Phase II Clinical Trial	2009-09-01	Absent	PIK3CA
Lymphoma, T-Cell	ENSG00000122025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	FLT3
Lymphoma, T-Cell	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Lymphoma, T-Cell	ENSG00000130037	FALSE	Preclinical	2015-08-14	Absent	KCNA5
Lymphoma, T-Cell	ENSG00000131238	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	PPT1
Lymphoma, T-Cell	ENSG00000131747	FALSE	Approved	2014-01-27	Unused	TOP2A
Lymphoma, T-Cell	ENSG00000131759	FALSE	Phase II Clinical Trial	2018-01-09	Absent	RARA
Lymphoma, T-Cell	ENSG00000134250	FALSE	Phase II Clinical Trial	2012-09-29	Absent	NOTCH2
Lymphoma, T-Cell	ENSG00000134460	TRUE	Approved	2008-07-24	Approved	IL2RA
Lymphoma, T-Cell	ENSG00000135446	FALSE	unknown	NA	Unused	CDK4
Lymphoma, T-Cell	ENSG00000135679	FALSE	Phase II Clinical Trial	2012-09-07	Absent	MDM2
Lymphoma, T-Cell	ENSG00000138160	FALSE	unknown	2003-10-06	Phase II Clinical Trial	KIF11
Lymphoma, T-Cell	ENSG00000142208	FALSE	unknown	NA	Unused	AKT1
Lymphoma, T-Cell	ENSG00000143171	TRUE	Approved	1992-09-15	Approved	RXRG
Lymphoma, T-Cell	ENSG00000143799	FALSE	Phase II Clinical Trial	2002-08-14	Unused	PARP1
Lymphoma, T-Cell	ENSG00000144285	FALSE	unknown	NA	Preclinical	SCN1A
Lymphoma, T-Cell	ENSG00000145839	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL9
Lymphoma, T-Cell	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC8
Lymphoma, T-Cell	ENSG00000147168	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL2RG
Lymphoma, T-Cell	ENSG00000151067	FALSE	unknown	NA	Preclinical	CACNA1C
Lymphoma, T-Cell	ENSG00000153253	FALSE	unknown	NA	Preclinical	SCN3A
Lymphoma, T-Cell	ENSG00000154229	FALSE	Phase II Clinical Trial	2018-01-09	Unused	PRKCA
Lymphoma, T-Cell	ENSG00000156508	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	EEF1A1
Lymphoma, T-Cell	ENSG00000157404	FALSE	Phase III Clinical Trial	NA	Absent	KIT
Lymphoma, T-Cell	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Lymphoma, T-Cell	ENSG00000162747	FALSE	Preclinical	2004-01-21	Absent	FCGR3B
Lymphoma, T-Cell	ENSG00000164136	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL15
Lymphoma, T-Cell	ENSG00000165025	FALSE	Phase II Clinical Trial	2003-10-31	Phase II Clinical Trial	SYK
Lymphoma, T-Cell	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Lymphoma, T-Cell	ENSG00000167658	TRUE	Approved	NA	Approved	EEF2
Lymphoma, T-Cell	ENSG00000168522	FALSE	Phase II Clinical Trial	NA	Absent	FNTA
Lymphoma, T-Cell	ENSG00000168610	FALSE	Preclinical	2013-04-09	Absent	STAT3
Lymphoma, T-Cell	ENSG00000168811	FALSE	Phase II Clinical Trial	1995-09-15	Unused	IL12A
Lymphoma, T-Cell	ENSG00000169442	FALSE	Phase III Clinical Trial	NA	Unused	CD52
Lymphoma, T-Cell	ENSG00000170430	FALSE	unknown	1998-06-15	Unused	MGMT
Lymphoma, T-Cell	ENSG00000171552	FALSE	Phase II Clinical Trial	2006-12-15	Absent	BCL2L1
Lymphoma, T-Cell	ENSG00000171608	FALSE	Phase I Clinical Trial	2009-07-15	Phase I Clinical Trial	PIK3CD
Lymphoma, T-Cell	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Absent	HDAC3
Lymphoma, T-Cell	ENSG00000171791	FALSE	Phase II Clinical Trial	2006-12-15	Absent	BCL2
Lymphoma, T-Cell	ENSG00000172819	FALSE	Preclinical	2012-06-14	Absent	RARG
Lymphoma, T-Cell	ENSG00000173638	TRUE	Approved	NA	Approved	SLC19A1
Lymphoma, T-Cell	ENSG00000173762	FALSE	Phase II Clinical Trial	2016-04-21	Absent	CD7
Lymphoma, T-Cell	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-09-15	Unused	TYMS
Lymphoma, T-Cell	ENSG00000177455	FALSE	Phase I Clinical Trial	2017-10-24	Absent	CD19
Lymphoma, T-Cell	ENSG00000182054	FALSE	Phase II Clinical Trial	NA	Absent	IDH2
Lymphoma, T-Cell	ENSG00000182866	FALSE	Preclinical	1998-10-15	Unused	LCK
Lymphoma, T-Cell	ENSG00000183813	FALSE	Approved	2003-05-20	Unused	CCR4
Lymphoma, T-Cell	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Lymphoma, T-Cell	ENSG00000186350	TRUE	Approved	1992-09-15	Approved	RXRA
Lymphoma, T-Cell	ENSG00000188389	FALSE	Phase I Clinical Trial	2008-07-10	Phase I Clinical Trial	PDCD1
Lymphoma, T-Cell	ENSG00000196591	TRUE	Approved	1994-12-15	Approved	HDAC2
Lymphoma, T-Cell	ENSG00000196664	FALSE	Preclinical	NA	Absent	TLR7
Lymphoma, T-Cell	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Lymphoma, T-Cell	ENSG00000196839	FALSE	unknown	1991-06-15	Unused	ADA
Lymphoma, T-Cell	ENSG00000197635	FALSE	unknown	2004-02-24	Unused	DPP4
Lymphoma, T-Cell	ENSG00000198625	FALSE	Phase II Clinical Trial	2012-09-07	Absent	MDM4
Lymphoma, T-Cell	ENSG00000198805	FALSE	Approved	1992-12-15	Phase II Clinical Trial	PNP
Lymphoma, T-Cell	ENSG00000198851	FALSE	Phase II Clinical Trial	2013-01-07	Phase II Clinical Trial	CD3E
Lymphoma, T-Cell	ENSG00000203747	FALSE	Preclinical	2004-01-21	Absent	FCGR3A
Lymphoma, T-Cell	ENSG00000228716	TRUE	Approved	1992-09-15	Approved	DHFR
Lymphoma, T-Cell	ENSG00000239732	FALSE	unknown	1998-10-15	Unused	TLR9
Lymphoma, T-Cell	ENSG00000240403	FALSE	Phase I Clinical Trial	2006-11-24	Preclinical	KIR3DL2
Lymphoma, T-Cell	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Lymphopenia	ENSG00000168685	FALSE	Phase I Clinical Trial	2015-10-09	Absent	IL7R
Macrophage Activation Syndrome	ENSG00000150782	FALSE	Preclinical	2015-04-01	Absent	IL18
Macular Degeneration	ENSG00000000971	FALSE	Preclinical	2009-07-23	Unused	CFH
Macular Degeneration	ENSG00000009724	FALSE	Phase I Clinical Trial	2008-01-15	Preclinical	MASP2
Macular Degeneration	ENSG00000011422	FALSE	Preclinical	1998-12-15	Unused	PLAUR
Macular Degeneration	ENSG00000026103	FALSE	Preclinical	NA	Absent	FAS
Macular Degeneration	ENSG00000067560	FALSE	Preclinical	2004-08-11	Unused	RHOA
Macular Degeneration	ENSG00000067900	FALSE	Phase II Clinical Trial	2006-08-14	Unused	ROCK1
Macular Degeneration	ENSG00000068903	FALSE	Preclinical	2008-12-05	Unused	SIRT2
Macular Degeneration	ENSG00000073756	FALSE	Preclinical	2007-03-19	Unused	PTGS2
Macular Degeneration	ENSG00000076706	FALSE	Preclinical	2015-01-30	Absent	MCAM
Macular Degeneration	ENSG00000077782	FALSE	Preclinical	NA	Unused	FGFR1
Macular Degeneration	ENSG00000085563	FALSE	Preclinical	2002-02-18	Unused	ABCB1
Macular Degeneration	ENSG00000087085	FALSE	Preclinical	2014-01-17	Absent	ACHE
Macular Degeneration	ENSG00000090339	FALSE	Preclinical	2005-06-29	Unused	ICAM1
Macular Degeneration	ENSG00000091831	FALSE	Preclinical	2010-08-05	Unused	ESR1
Macular Degeneration	ENSG00000095303	FALSE	Preclinical	2008-07-07	Unused	PTGS1
Macular Degeneration	ENSG00000096063	FALSE	Preclinical	NA	Absent	SRPK1
Macular Degeneration	ENSG00000096717	FALSE	Phase I Clinical Trial	2011-02-16	Absent	SIRT1
Macular Degeneration	ENSG00000100311	FALSE	Preclinical	2016-04-07	Absent	PDGFB
Macular Degeneration	ENSG00000100644	FALSE	Preclinical	2007-11-27	Phase I Clinical Trial	HIF1A
Macular Degeneration	ENSG00000100823	FALSE	Preclinical	1993-03-15	Unused	APEX1
Macular Degeneration	ENSG00000102755	FALSE	Preclinical	2007-04-30	Unused	FLT1
Macular Degeneration	ENSG00000103222	FALSE	Preclinical	2002-02-18	Unused	ABCC1
Macular Degeneration	ENSG00000105675	FALSE	Preclinical	NA	Absent	ATP4A
Macular Degeneration	ENSG00000106804	FALSE	Phase III Clinical Trial	1993-08-15	Phase II Clinical Trial	C5
Macular Degeneration	ENSG00000107562	FALSE	unknown	2007-04-10	Unused	CXCL12
Macular Degeneration	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Macular Degeneration	ENSG00000109320	FALSE	Preclinical	2006-10-23	Unused	NFKB1
Macular Degeneration	ENSG00000111276	FALSE	Preclinical	2003-08-26	Absent	CDKN1B
Macular Degeneration	ENSG00000112096	FALSE	Preclinical	2009-02-18	Unused	SOD2
Macular Degeneration	ENSG00000112715	FALSE	Phase II Clinical Trial	1993-05-15	Phase I Clinical Trial	VEGFA
Macular Degeneration	ENSG00000113580	FALSE	Preclinical	2005-02-28	Phase II Clinical Trial	NR3C1
Macular Degeneration	ENSG00000113721	FALSE	Phase II Clinical Trial	2005-08-01	Unused	PDGFRB
Macular Degeneration	ENSG00000115053	FALSE	Preclinical	2008-07-31	Absent	NCL
Macular Degeneration	ENSG00000115414	FALSE	Preclinical	2007-05-29	Unused	FN1
Macular Degeneration	ENSG00000116044	FALSE	Preclinical	2015-06-09	Absent	NFE2L2
Macular Degeneration	ENSG00000116745	FALSE	Phase II Clinical Trial	2008-06-17	Absent	RPE65
Macular Degeneration	ENSG00000117411	FALSE	Preclinical	2009-07-09	Unused	B4GALT2
Macular Degeneration	ENSG00000118432	FALSE	Preclinical	2016-12-30	Absent	CNR1
Macular Degeneration	ENSG00000119630	FALSE	Preclinical	2014-07-12	Absent	PGF
Macular Degeneration	ENSG00000121879	FALSE	Preclinical	2006-10-10	Unused	PIK3CA
Macular Degeneration	ENSG00000121966	FALSE	unknown	2004-06-22	Phase I Clinical Trial	CXCR4
Macular Degeneration	ENSG00000122756	FALSE	Phase II Clinical Trial	2000-05-31	Phase II Clinical Trial	CNTFR
Macular Degeneration	ENSG00000123384	FALSE	Preclinical	2008-07-07	Unused	LRP1
Macular Degeneration	ENSG00000125730	FALSE	Phase II Clinical Trial	2007-03-26	Phase II Clinical Trial	C3
Macular Degeneration	ENSG00000128052	FALSE	Preclinical	1992-03-15	Unused	KDR
Macular Degeneration	ENSG00000131981	FALSE	Preclinical	2004-11-22	Unused	LGALS3
Macular Degeneration	ENSG00000132386	FALSE	Preclinical	1996-11-15	Unused	SERPINF1
Macular Degeneration	ENSG00000132703	FALSE	Preclinical	2012-03-16	Preclinical	APCS
Macular Degeneration	ENSG00000134318	FALSE	Preclinical	2002-06-17	Unused	ROCK2
Macular Degeneration	ENSG00000135218	FALSE	Preclinical	2012-04-02	Preclinical	CD36
Macular Degeneration	ENSG00000136960	FALSE	Preclinical	2014-10-09	Absent	ENPP2
Macular Degeneration	ENSG00000138207	FALSE	Preclinical	2014-09-22	Absent	RBP4
Macular Degeneration	ENSG00000138448	FALSE	Phase I Clinical Trial	2006-05-30	Unused	ITGAV
Macular Degeneration	ENSG00000138685	FALSE	Preclinical	1993-05-15	Absent	FGF2
Macular Degeneration	ENSG00000139567	FALSE	unknown	2007-05-30	Preclinical	ACVRL1
Macular Degeneration	ENSG00000141867	FALSE	Preclinical	2005-03-04	Absent	BRD4
Macular Degeneration	ENSG00000142192	FALSE	Phase II Clinical Trial	2007-08-06	Phase II Clinical Trial	APP
Macular Degeneration	ENSG00000143799	FALSE	Preclinical	2009-02-18	Unused	PARP1
Macular Degeneration	ENSG00000150093	FALSE	Preclinical	2003-01-24	Unused	ITGB1
Macular Degeneration	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Macular Degeneration	ENSG00000156113	FALSE	Phase I Clinical Trial	1989-11-15	Phase II Clinical Trial	KCNMA1
Macular Degeneration	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Macular Degeneration	ENSG00000160951	FALSE	Phase III Clinical Trial	NA	Unused	PTGER1
Macular Degeneration	ENSG00000161638	FALSE	Preclinical	2003-01-24	Unused	ITGA5
Macular Degeneration	ENSG00000163217	FALSE	unknown	2007-05-30	Absent	BMP10
Macular Degeneration	ENSG00000164690	FALSE	Preclinical	2008-07-07	Unused	SHH
Macular Degeneration	ENSG00000165025	FALSE	unknown	2006-12-19	Unused	SYK
Macular Degeneration	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Macular Degeneration	ENSG00000167995	FALSE	Preclinical	1999-06-02	Unused	BEST1
Macular Degeneration	ENSG00000168610	FALSE	Preclinical	2007-11-27	Preclinical	STAT3
Macular Degeneration	ENSG00000169047	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IRS1
Macular Degeneration	ENSG00000171119	FALSE	unknown	NA	Unused	NRTN
Macular Degeneration	ENSG00000171236	FALSE	Preclinical	NA	Absent	LRG1
Macular Degeneration	ENSG00000171773	FALSE	Preclinical	2004-12-13	Unused	NXNL1
Macular Degeneration	ENSG00000174807	FALSE	Preclinical	2004-10-18	Preclinical	CD248
Macular Degeneration	ENSG00000176105	FALSE	Phase II Clinical Trial	2005-08-01	Unused	YES1
Macular Degeneration	ENSG00000176884	FALSE	unknown	2002-05-03	Unused	GRIN1
Macular Degeneration	ENSG00000177606	FALSE	Preclinical	2006-07-25	Unused	JUN
Macular Degeneration	ENSG00000178394	FALSE	Phase III Clinical Trial	2003-05-06	Phase III Clinical Trial	HTR1A
Macular Degeneration	ENSG00000181634	FALSE	Preclinical	NA	Unused	TNFSF15
Macular Degeneration	ENSG00000182866	FALSE	Phase II Clinical Trial	2005-08-01	Unused	LCK
Macular Degeneration	ENSG00000183625	FALSE	Phase I Clinical Trial	2014-10-30	Absent	CCR3
Macular Degeneration	ENSG00000185149	FALSE	Preclinical	2003-09-15	Unused	NPY2R
Macular Degeneration	ENSG00000186951	FALSE	Phase II Clinical Trial	2016-02-10	Absent	PPARA
Macular Degeneration	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Macular Degeneration	ENSG00000188822	FALSE	Preclinical	2016-12-30	Absent	CNR2
Macular Degeneration	ENSG00000196411	FALSE	Preclinical	2003-12-15	Unused	EPHB4
Macular Degeneration	ENSG00000196611	FALSE	unknown	NA	Unused	MMP1
Macular Degeneration	ENSG00000197122	FALSE	Phase II Clinical Trial	2005-08-01	Unused	SRC
Macular Degeneration	ENSG00000197329	FALSE	Preclinical	2017-04-04	Absent	PELI1
Macular Degeneration	ENSG00000197405	FALSE	Preclinical	2003-06-24	Phase I Clinical Trial	C5AR1
Macular Degeneration	ENSG00000197766	FALSE	Phase III Clinical Trial	2006-05-03	Phase II Clinical Trial	CFD
Macular Degeneration	ENSG00000198625	FALSE	Preclinical	2016-10-20	Absent	MDM4
Macular Degeneration	ENSG00000198691	FALSE	Phase II Clinical Trial	2002-01-04	Phase II Clinical Trial	ABCA4
Macular Degeneration	ENSG00000198793	FALSE	unknown	1997-08-15	Unused	MTOR
Macular Degeneration	ENSG00000203710	FALSE	unknown	NA	Unused	CR1
Macular Degeneration	ENSG00000240972	FALSE	Preclinical	2008-03-07	Unused	MIF
Macular Degeneration	ENSG00000258839	FALSE	Preclinical	1995-06-15	Unused	MC1R
Macular Degeneration	ENSG00000263761	FALSE	unknown	2007-05-30	Absent	GDF2
Macular Edema	ENSG00000037280	FALSE	Preclinical	2013-03-05	Absent	FLT4
Macular Edema	ENSG00000067900	FALSE	Phase II Clinical Trial	2006-08-14	Absent	ROCK1
Macular Edema	ENSG00000073756	TRUE	Approved	2010-08-24	Approved	PTGS2
Macular Edema	ENSG00000075213	FALSE	Preclinical	2014-06-19	Absent	SEMA3A
Macular Edema	ENSG00000082781	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGB5
Macular Edema	ENSG00000085662	FALSE	Phase II Clinical Trial	NA	Absent	AKR1B1
Macular Edema	ENSG00000091879	FALSE	Phase II Clinical Trial	2010-10-29	Unused	ANGPT2
Macular Edema	ENSG00000092969	FALSE	Preclinical	2013-03-06	Absent	TGFB2
Macular Edema	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Macular Edema	ENSG00000096717	FALSE	Preclinical	2015-10-13	Absent	SIRT1
Macular Edema	ENSG00000100644	FALSE	Preclinical	2006-12-19	Unused	HIF1A
Macular Edema	ENSG00000100739	FALSE	Phase II Clinical Trial	2009-02-12	Unused	BDKRB1
Macular Edema	ENSG00000102755	FALSE	Preclinical	1991-02-15	Unused	FLT1
Macular Edema	ENSG00000112715	TRUE	Approved	1991-02-15	Approved	VEGFA
Macular Edema	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Macular Edema	ENSG00000113721	FALSE	Preclinical	1991-02-15	Unused	PDGFRB
Macular Edema	ENSG00000116745	FALSE	Preclinical	2008-06-17	Absent	RPE65
Macular Edema	ENSG00000119630	TRUE	Approved	NA	Phase III Clinical Trial	PGF
Macular Edema	ENSG00000121807	FALSE	Phase II Clinical Trial	2010-09-28	Absent	CCR2
Macular Edema	ENSG00000122025	FALSE	unknown	1991-02-15	Unused	FLT3
Macular Edema	ENSG00000122194	FALSE	unknown	2000-10-30	Phase II Clinical Trial	PLG
Macular Edema	ENSG00000128052	FALSE	Preclinical	1991-02-15	Unused	KDR
Macular Edema	ENSG00000130427	FALSE	Phase I Clinical Trial	2014-11-04	Absent	EPO
Macular Edema	ENSG00000131471	FALSE	Phase II Clinical Trial	2011-11-11	Absent	AOC3
Macular Edema	ENSG00000132155	FALSE	Phase I Clinical Trial	2001-04-20	Phase II Clinical Trial	RAF1
Macular Edema	ENSG00000132703	FALSE	Preclinical	2012-03-16	Preclinical	APCS
Macular Edema	ENSG00000134057	FALSE	unknown	1991-02-15	Unused	CCNB1
Macular Edema	ENSG00000136244	FALSE	Preclinical	2013-05-29	Absent	IL6
Macular Edema	ENSG00000138448	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGAV
Macular Edema	ENSG00000138685	FALSE	Phase II Clinical Trial	1993-05-15	Absent	FGF2
Macular Edema	ENSG00000140443	FALSE	Phase I Clinical Trial	2005-08-05	Absent	IGF1R
Macular Edema	ENSG00000143799	FALSE	Preclinical	2009-02-18	Unused	PARP1
Macular Edema	ENSG00000143839	FALSE	Phase II Clinical Trial	2000-11-23	Phase II Clinical Trial	REN
Macular Edema	ENSG00000146070	FALSE	Phase II Clinical Trial	2000-11-07	Phase II Clinical Trial	PLA2G7
Macular Edema	ENSG00000150093	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGB1
Macular Edema	ENSG00000150630	FALSE	Phase II Clinical Trial	2008-11-25	Absent	VEGFC
Macular Edema	ENSG00000154229	FALSE	Preclinical	1991-02-15	Unused	PRKCA
Macular Edema	ENSG00000156113	FALSE	Phase I Clinical Trial	1989-11-15	Unused	KCNMA1
Macular Edema	ENSG00000157404	FALSE	Phase II Clinical Trial	1991-02-15	Unused	KIT
Macular Edema	ENSG00000160712	FALSE	Preclinical	2013-03-19	Absent	IL6R
Macular Edema	ENSG00000160791	FALSE	Phase II Clinical Trial	2010-09-28	Absent	CCR5
Macular Edema	ENSG00000161638	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGA5
Macular Edema	ENSG00000164171	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGA2
Macular Edema	ENSG00000164344	FALSE	Phase II Clinical Trial	2007-05-24	Absent	KLKB1
Macular Edema	ENSG00000165197	FALSE	Phase II Clinical Trial	2008-11-25	Absent	VEGFD
Macular Edema	ENSG00000166501	FALSE	Phase III Clinical Trial	1996-06-15	Unused	PRKCB
Macular Edema	ENSG00000168209	FALSE	Phase II Clinical Trial	2003-10-14	Phase II Clinical Trial	DDIT4
Macular Edema	ENSG00000175591	FALSE	unknown	NA	Unused	P2RY2
Macular Edema	ENSG00000182871	FALSE	unknown	2002-08-29	Absent	COL18A1
Macular Edema	ENSG00000185338	FALSE	Preclinical	2015-02-19	Absent	SOCS1
Macular Edema	ENSG00000186951	FALSE	Phase II Clinical Trial	2006-09-22	Phase II Clinical Trial	PPARA
Macular Edema	ENSG00000196396	FALSE	Phase II Clinical Trial	2009-06-04	Phase II Clinical Trial	PTPN1
Macular Edema	ENSG00000198793	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTOR
Macular Edema	ENSG00000259207	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGB3
Malabsorption Syndromes	ENSG00000077943	FALSE	Preclinical	2017-11-17	Absent	ITGA8
Malabsorption Syndromes	ENSG00000150093	FALSE	Preclinical	2017-11-17	Absent	ITGB1
Malabsorption Syndromes	ENSG00000170835	FALSE	Phase III Clinical Trial	2003-07-10	Phase III Clinical Trial	CEL
Malaria	ENSG00000068903	FALSE	Preclinical	2015-08-26	Absent	SIRT2
Malaria	ENSG00000073060	FALSE	Preclinical	2008-09-16	Unused	SCARB1
Malaria	ENSG00000099624	FALSE	Preclinical	2015-01-23	Absent	ATP5F1D
Malaria	ENSG00000100292	FALSE	Preclinical	2008-05-22	Unused	HMOX1
Malaria	ENSG00000128951	FALSE	Preclinical	2013-02-28	Preclinical	DUT
Malaria	ENSG00000135218	FALSE	Preclinical	1989-11-15	Unused	CD36
Malaria	ENSG00000136869	FALSE	Preclinical	2010-07-23	Unused	TLR4
Malaria	ENSG00000137462	FALSE	Preclinical	2010-07-23	Unused	TLR2
Malaria	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Malaria	ENSG00000156508	FALSE	Preclinical	2013-03-02	Preclinical	EEF1A1
Malaria	ENSG00000160211	FALSE	unknown	1999-01-15	Phase II Clinical Trial	G6PD
Malaria	ENSG00000167658	FALSE	Phase I Clinical Trial	2012-07-21	Absent	EEF2
Malaria	ENSG00000198805	FALSE	Preclinical	1989-07-15	Unused	PNP
Malaria	ENSG00000213614	FALSE	Approved	2013-11-20	Absent	HEXA
Malaria	ENSG00000228716	FALSE	Preclinical	2015-02-06	Absent	DHFR
Malaria	ENSG00000239732	FALSE	Preclinical	2012-10-30	Preclinical	TLR9
Malaria	ENSG00000241973	FALSE	Phase II Clinical Trial	2011-07-22	Absent	PI4KA
Malignant Carcinoid Syndrome	ENSG00000129167	TRUE	Approved	2006-02-15	Phase III Clinical Trial	TPH1
Malignant Carcinoid Syndrome	ENSG00000139874	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR1
Malignant Carcinoid Syndrome	ENSG00000162009	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR5
Malignant Carcinoid Syndrome	ENSG00000180616	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR2
Malignant Carcinoid Syndrome	ENSG00000278195	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR3
Malignant Hyperthermia	ENSG00000196218	TRUE	Approved	2016-04-15	Absent	RYR1
Maple Syrup Urine Disease	ENSG00000103507	FALSE	Phase II Clinical Trial	NA	Absent	BCKDK
Maple Syrup Urine Disease	ENSG00000178394	FALSE	Preclinical	2001-01-12	Absent	HTR1A
Marburg Virus Disease	ENSG00000154133	FALSE	Preclinical	2010-12-13	Unused	ROBO4
Marfan Syndrome	ENSG00000100985	FALSE	Preclinical	2011-09-29	Absent	MMP9
Mastocytosis	ENSG00000010671	FALSE	Preclinical	NA	Unused	BTK
Mastocytosis	ENSG00000010810	FALSE	Pre-registration	NA	Absent	FYN
Mastocytosis	ENSG00000012779	FALSE	unknown	NA	Unused	ALOX5
Mastocytosis	ENSG00000068078	FALSE	Pre-registration	NA	Phase III Clinical Trial	FGFR3
Mastocytosis	ENSG00000080824	FALSE	Preclinical	2008-06-19	Absent	HSP90AA1
Mastocytosis	ENSG00000097007	TRUE	Approved	1999-03-17	Approved	ABL1
Mastocytosis	ENSG00000102755	TRUE	Approved	1991-02-15	Phase II Clinical Trial	FLT1
Mastocytosis	ENSG00000105366	FALSE	Phase I Clinical Trial	2016-06-24	Absent	SIGLEC8
Mastocytosis	ENSG00000112715	TRUE	Approved	1991-02-15	Phase II Clinical Trial	VEGFA
Mastocytosis	ENSG00000113721	TRUE	Approved	1991-02-15	Phase III Clinical Trial	PDGFRB
Mastocytosis	ENSG00000122025	TRUE	Approved	1991-02-15	Phase II Clinical Trial	FLT3
Mastocytosis	ENSG00000128052	TRUE	Approved	1991-02-15	Phase II Clinical Trial	KDR
Mastocytosis	ENSG00000134057	TRUE	Approved	1991-02-15	Phase II Clinical Trial	CCNB1
Mastocytosis	ENSG00000134853	TRUE	Approved	1999-03-17	Approved	PDGFRA
Mastocytosis	ENSG00000140287	FALSE	Phase II Clinical Trial	NA	Unused	HDC
Mastocytosis	ENSG00000154229	TRUE	Approved	1991-02-15	Phase II Clinical Trial	PRKCA
Mastocytosis	ENSG00000157404	TRUE	Approved	1991-02-15	Approved	KIT
Mastocytosis	ENSG00000178623	FALSE	Phase II Clinical Trial	2015-01-09	Absent	GPR35
Mastocytosis	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Absent	IL3RA
Mastocytosis	ENSG00000186716	TRUE	Approved	1999-03-17	Approved	BCR
Mastocytosis	ENSG00000196639	FALSE	Preclinical	NA	Absent	HRH1
Mastocytosis	ENSG00000254087	FALSE	Pre-registration	NA	Absent	LYN
Mastodynia	ENSG00000059377	TRUE	Approved	NA	Approved	TBXAS1
Mastodynia	ENSG00000082175	TRUE	Approved	NA	Approved	PGR
Mastodynia	ENSG00000091831	FALSE	unknown	2003-05-13	Phase II Clinical Trial	ESR1
Mastodynia	ENSG00000109163	FALSE	Phase II Clinical Trial	2004-01-26	Phase II Clinical Trial	GNRHR
Measles	ENSG00000159110	FALSE	Phase II Clinical Trial	NA	Unused	IFNAR2
Meconium Aspiration Syndrome	ENSG00000149021	FALSE	unknown	2011-02-22	Phase II Clinical Trial	SCGB1A1
Melanoma	ENSG00000004487	FALSE	Phase II Clinical Trial	2008-07-31	Absent	KDM1A
Melanoma	ENSG00000006283	FALSE	Preclinical	2010-01-12	Unused	CACNA1G
Melanoma	ENSG00000010278	FALSE	Preclinical	2012-05-05	Absent	CD9
Melanoma	ENSG00000010327	FALSE	Preclinical	2009-11-12	Absent	STAB1
Melanoma	ENSG00000010610	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CD4
Melanoma	ENSG00000010810	FALSE	Phase III Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Melanoma	ENSG00000012779	FALSE	unknown	1993-10-15	Unused	ALOX5
Melanoma	ENSG00000023445	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC3
Melanoma	ENSG00000025434	FALSE	Phase I Clinical Trial	2014-11-13	Absent	NR1H3
Melanoma	ENSG00000026103	FALSE	Preclinical	2002-06-26	Unused	FAS
Melanoma	ENSG00000026508	FALSE	Preclinical	1997-03-15	Unused	CD44
Melanoma	ENSG00000027075	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCH
Melanoma	ENSG00000027697	FALSE	unknown	NA	Unused	IFNGR1
Melanoma	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Melanoma	ENSG00000044574	FALSE	Preclinical	2007-11-19	Phase I Clinical Trial	HSPA5
Melanoma	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Unused	TNFRSF9
Melanoma	ENSG00000051382	FALSE	Phase I Clinical Trial	2005-12-01	Phase I Clinical Trial	PIK3CB
Melanoma	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Melanoma	ENSG00000060491	FALSE	Preclinical	2012-09-01	Absent	OGFR
Melanoma	ENSG00000065361	FALSE	Phase II Clinical Trial	1994-09-15	Phase I Clinical Trial	ERBB3
Melanoma	ENSG00000065675	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCQ
Melanoma	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Melanoma	ENSG00000067182	FALSE	Phase I Clinical Trial	2002-06-26	Phase III Clinical Trial	TNFRSF1A
Melanoma	ENSG00000067225	FALSE	Phase II Clinical Trial	2006-06-29	Unused	PKM
Melanoma	ENSG00000068078	FALSE	Phase III Clinical Trial	2003-07-22	Phase III Clinical Trial	FGFR3
Melanoma	ENSG00000070501	FALSE	Phase II Clinical Trial	1996-08-15	Unused	POLB
Melanoma	ENSG00000073756	FALSE	Preclinical	2007-05-30	Absent	PTGS2
Melanoma	ENSG00000076706	FALSE	Phase I Clinical Trial	2003-02-27	Unused	MCAM
Melanoma	ENSG00000077498	FALSE	Phase III Clinical Trial	1998-08-15	Phase II Clinical Trial	TYR
Melanoma	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FGFR1
Melanoma	ENSG00000078098	FALSE	Phase I Clinical Trial	2001-06-11	Unused	FAP
Melanoma	ENSG00000079385	FALSE	Phase I Clinical Trial	2012-09-18	Preclinical	CEACAM1
Melanoma	ENSG00000080166	FALSE	Phase II Clinical Trial	1999-05-19	Phase II Clinical Trial	DCT
Melanoma	ENSG00000080824	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	HSP90AA1
Melanoma	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Melanoma	ENSG00000081985	FALSE	Phase II Clinical Trial	2001-06-07	Phase II Clinical Trial	IL12RB2
Melanoma	ENSG00000082781	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	ITGB5
Melanoma	ENSG00000082898	FALSE	Phase I Clinical Trial	2012-06-02	Absent	XPO1
Melanoma	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Melanoma	ENSG00000085563	FALSE	Phase I Clinical Trial	1994-01-15	Unused	ABCB1
Melanoma	ENSG00000086205	FALSE	Phase II Clinical Trial	2003-11-27	Phase I Clinical Trial	FOLH1
Melanoma	ENSG00000087586	FALSE	unknown	2005-06-27	Phase I Clinical Trial	AURKA
Melanoma	ENSG00000089041	FALSE	unknown	2008-08-11	Unused	P2RX7
Melanoma	ENSG00000089327	FALSE	Preclinical	2011-01-25	Absent	FXYD5
Melanoma	ENSG00000089685	FALSE	Phase II Clinical Trial	2005-07-13	Unused	BIRC5
Melanoma	ENSG00000089692	FALSE	Phase II Clinical Trial	2004-06-08	Phase II Clinical Trial	LAG3
Melanoma	ENSG00000090339	FALSE	Phase II Clinical Trial	2004-01-26	Phase II Clinical Trial	ICAM1
Melanoma	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Melanoma	ENSG00000092969	FALSE	Phase III Clinical Trial	2001-06-12	Phase II Clinical Trial	TGFB2
Melanoma	ENSG00000094631	FALSE	Phase I Clinical Trial	2015-03-31	Absent	HDAC6
Melanoma	ENSG00000095015	FALSE	Phase I Clinical Trial	2007-08-10	Phase I Clinical Trial	MAP3K1
Melanoma	ENSG00000095303	FALSE	Preclinical	2007-05-30	Absent	PTGS1
Melanoma	ENSG00000096996	FALSE	Phase II Clinical Trial	2001-06-07	Phase II Clinical Trial	IL12RB1
Melanoma	ENSG00000097007	FALSE	Phase I Clinical Trial	2003-01-13	Phase II Clinical Trial	ABL1
Melanoma	ENSG00000100030	FALSE	Phase II Clinical Trial	2013-01-18	Absent	MAPK1
Melanoma	ENSG00000100097	FALSE	Phase I Clinical Trial	NA	Absent	LGALS1
Melanoma	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Unused	PDGFB
Melanoma	ENSG00000100385	FALSE	Phase II Clinical Trial	2007-03-01	Absent	IL2RB
Melanoma	ENSG00000100429	FALSE	Phase II Clinical Trial	2006-05-08	Absent	HDAC10
Melanoma	ENSG00000100462	FALSE	Preclinical	NA	Preclinical	PRMT5
Melanoma	ENSG00000101017	FALSE	Phase II Clinical Trial	2008-12-08	Unused	CD40
Melanoma	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Melanoma	ENSG00000101868	FALSE	Phase II Clinical Trial	1996-08-15	Unused	POLA1
Melanoma	ENSG00000101916	FALSE	unknown	2008-06-17	Unused	TLR8
Melanoma	ENSG00000101966	FALSE	Phase II Clinical Trial	2006-05-17	Phase II Clinical Trial	XIAP
Melanoma	ENSG00000102245	FALSE	unknown	2001-06-01	Phase II Clinical Trial	CD40LG
Melanoma	ENSG00000102312	FALSE	Phase I Clinical Trial	2011-05-14	Phase I Clinical Trial	PORCN
Melanoma	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Melanoma	ENSG00000102882	FALSE	Phase II Clinical Trial	2011-05-26	Absent	MAPK3
Melanoma	ENSG00000103222	FALSE	Preclinical	2011-09-28	Preclinical	ABCC1
Melanoma	ENSG00000103522	FALSE	unknown	2001-01-25	Phase II Clinical Trial	IL21R
Melanoma	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Melanoma	ENSG00000104365	FALSE	unknown	2003-04-22	Unused	IKBKB
Melanoma	ENSG00000104432	FALSE	unknown	2001-06-01	Phase II Clinical Trial	IL7
Melanoma	ENSG00000105146	FALSE	unknown	2011-04-07	Phase I Clinical Trial	AURKC
Melanoma	ENSG00000105329	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB1
Melanoma	ENSG00000105388	FALSE	unknown	1993-08-15	Unused	CEACAM5
Melanoma	ENSG00000105810	FALSE	Phase II Clinical Trial	1996-05-15	Unused	CDK6
Melanoma	ENSG00000105835	FALSE	unknown	2003-04-22	Unused	NAMPT
Melanoma	ENSG00000105851	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CG
Melanoma	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Melanoma	ENSG00000106128	FALSE	Phase II Clinical Trial	2006-06-29	Unused	GHRHR
Melanoma	ENSG00000106462	FALSE	Phase I Clinical Trial	2015-04-01	Absent	EZH2
Melanoma	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	TGFBR1
Melanoma	ENSG00000107018	FALSE	Phase I Clinical Trial	2007-06-25	Phase I Clinical Trial	RLN1
Melanoma	ENSG00000107165	FALSE	Phase I Clinical Trial	1992-02-15	Unused	TYRP1
Melanoma	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Melanoma	ENSG00000108654	FALSE	Preclinical	2006-08-30	Preclinical	DDX5
Melanoma	ENSG00000108679	FALSE	Preclinical	2014-07-22	Absent	LGALS3BP
Melanoma	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Melanoma	ENSG00000109163	FALSE	unknown	2002-05-14	Unused	GNRHR
Melanoma	ENSG00000109320	FALSE	Phase I Clinical Trial	1990-06-15	Phase I Clinical Trial	NFKB1
Melanoma	ENSG00000109471	FALSE	Phase II Clinical Trial	1992-12-15	Unused	IL2
Melanoma	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC2
Melanoma	ENSG00000111087	FALSE	Preclinical	2014-05-06	Absent	GLI1
Melanoma	ENSG00000111537	FALSE	Phase I Clinical Trial	1993-01-15	Unused	IFNG
Melanoma	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Melanoma	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Melanoma	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Melanoma	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Melanoma	ENSG00000113302	FALSE	Phase I Clinical Trial	1995-09-15	Phase I Clinical Trial	IL12B
Melanoma	ENSG00000113721	FALSE	Phase III Clinical Trial	2003-07-16	Phase III Clinical Trial	PDGFRB
Melanoma	ENSG00000113749	FALSE	Phase II Clinical Trial	1996-05-15	Unused	HRH2
Melanoma	ENSG00000114013	FALSE	unknown	1997-07-15	Unused	CD86
Melanoma	ENSG00000114251	FALSE	Preclinical	2016-01-05	Absent	WNT5A
Melanoma	ENSG00000114423	FALSE	Phase I Clinical Trial	2011-06-24	Absent	CBLB
Melanoma	ENSG00000115053	FALSE	unknown	2008-07-31	Unused	NCL
Melanoma	ENSG00000115221	FALSE	Phase II Clinical Trial	2002-11-26	Phase II Clinical Trial	ITGB6
Melanoma	ENSG00000115232	FALSE	Phase I Clinical Trial	1995-10-15	Absent	ITGA4
Melanoma	ENSG00000115414	FALSE	Phase II Clinical Trial	2001-06-07	Phase II Clinical Trial	FN1
Melanoma	ENSG00000115419	FALSE	Phase II Clinical Trial	2013-05-02	Absent	GLS
Melanoma	ENSG00000115594	FALSE	unknown	NA	Absent	IL1R1
Melanoma	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Melanoma	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Melanoma	ENSG00000116016	FALSE	Preclinical	2011-08-02	Absent	EPAS1
Melanoma	ENSG00000116044	FALSE	Phase II Clinical Trial	2005-05-27	Unused	NFE2L2
Melanoma	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Phase II Clinical Trial	HDAC1
Melanoma	ENSG00000116745	FALSE	Preclinical	2005-05-24	Unused	RPE65
Melanoma	ENSG00000117020	FALSE	Preclinical	2014-06-25	Absent	AKT3
Melanoma	ENSG00000117525	FALSE	Phase I Clinical Trial	2007-09-05	Unused	F3
Melanoma	ENSG00000117632	FALSE	unknown	2008-07-04	Phase I Clinical Trial	STMN1
Melanoma	ENSG00000118520	FALSE	Phase I Clinical Trial	2007-10-09	Preclinical	ARG1
Melanoma	ENSG00000119535	FALSE	Phase I Clinical Trial	2011-10-19	Phase I Clinical Trial	CSF3R
Melanoma	ENSG00000119699	FALSE	Phase II Clinical Trial	2002-12-31	Phase II Clinical Trial	TGFB3
Melanoma	ENSG00000120156	FALSE	Phase I Clinical Trial	2004-06-18	Phase II Clinical Trial	TEK
Melanoma	ENSG00000120215	FALSE	Phase II Clinical Trial	1995-03-15	Phase II Clinical Trial	MLANA
Melanoma	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Melanoma	ENSG00000120889	FALSE	unknown	2006-12-15	Unused	TNFRSF10B
Melanoma	ENSG00000121594	FALSE	unknown	2001-06-01	Phase II Clinical Trial	CD80
Melanoma	ENSG00000121807	FALSE	Phase I Clinical Trial	2003-02-24	Absent	CCR2
Melanoma	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Melanoma	ENSG00000121966	FALSE	Phase I Clinical Trial	2001-04-09	Preclinical	CXCR4
Melanoma	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Melanoma	ENSG00000122861	FALSE	unknown	1993-05-15	Unused	PLAU
Melanoma	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK2
Melanoma	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Melanoma	ENSG00000124486	FALSE	Preclinical	2015-10-20	Absent	USP9X
Melanoma	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Melanoma	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Melanoma	ENSG00000126934	TRUE	Approved	2003-06-09	Approved	MAP2K2
Melanoma	ENSG00000128052	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Melanoma	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Melanoma	ENSG00000129484	FALSE	Phase II Clinical Trial	2006-08-16	Phase II Clinical Trial	PARP2
Melanoma	ENSG00000130164	FALSE	unknown	2007-11-19	Absent	LDLR
Melanoma	ENSG00000130816	FALSE	Phase I Clinical Trial	2006-12-06	Unused	DNMT1
Melanoma	ENSG00000131203	FALSE	Phase III Clinical Trial	2008-01-23	Phase II Clinical Trial	IDO1
Melanoma	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Melanoma	ENSG00000131724	FALSE	Preclinical	2002-01-09	Unused	IL13RA1
Melanoma	ENSG00000131747	TRUE	Approved	1994-09-15	Approved	TOP2A
Melanoma	ENSG00000131981	FALSE	Phase I Clinical Trial	1997-05-15	Phase II Clinical Trial	LGALS3
Melanoma	ENSG00000132155	FALSE	Phase I Clinical Trial	1992-11-15	Phase I Clinical Trial	RAF1
Melanoma	ENSG00000132170	FALSE	unknown	1993-10-15	Unused	PPARG
Melanoma	ENSG00000132906	FALSE	unknown	1997-05-15	Preclinical	CASP9
Melanoma	ENSG00000133321	FALSE	unknown	2014-10-18	Absent	RARRES3
Melanoma	ENSG00000133703	FALSE	Preclinical	1992-11-15	Unused	KRAS
Melanoma	ENSG00000134058	FALSE	unknown	1997-01-15	Unused	CDK7
Melanoma	ENSG00000134460	TRUE	Approved	1998-06-15	Approved	IL2RA
Melanoma	ENSG00000134470	FALSE	Phase I Clinical Trial	2010-10-05	Absent	IL15RA
Melanoma	ENSG00000134853	FALSE	Phase II Clinical Trial	2002-03-21	Phase II Clinical Trial	PDGFRA
Melanoma	ENSG00000135218	FALSE	Phase I Clinical Trial	2001-03-14	Unused	CD36
Melanoma	ENSG00000135404	FALSE	Preclinical	2003-04-15	Unused	CD63
Melanoma	ENSG00000135446	FALSE	Phase II Clinical Trial	1996-02-15	Phase II Clinical Trial	CDK4
Melanoma	ENSG00000135679	FALSE	Phase II Clinical Trial	2012-11-09	Absent	MDM2
Melanoma	ENSG00000136160	FALSE	Phase II Clinical Trial	1994-10-15	Unused	EDNRB
Melanoma	ENSG00000136235	FALSE	Phase II Clinical Trial	1999-12-10	Phase II Clinical Trial	GPNMB
Melanoma	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Melanoma	ENSG00000136807	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	CDK9
Melanoma	ENSG00000136810	FALSE	Phase I Clinical Trial	2000-05-11	Unused	TXN
Melanoma	ENSG00000136869	FALSE	Phase I Clinical Trial	2012-08-06	Absent	TLR4
Melanoma	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Melanoma	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Melanoma	ENSG00000138160	FALSE	Phase I Clinical Trial	2008-02-19	Absent	KIF11
Melanoma	ENSG00000138448	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGAV
Melanoma	ENSG00000138755	FALSE	Preclinical	2005-01-27	Unused	CXCL9
Melanoma	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Melanoma	ENSG00000139626	FALSE	Phase I Clinical Trial	1995-10-15	Absent	ITGB7
Melanoma	ENSG00000139874	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR1
Melanoma	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Melanoma	ENSG00000141510	FALSE	Phase II Clinical Trial	1993-10-15	Phase I Clinical Trial	TP53
Melanoma	ENSG00000141736	FALSE	Phase I Clinical Trial	2000-04-04	Phase I Clinical Trial	ERBB2
Melanoma	ENSG00000141867	FALSE	Phase II Clinical Trial	2017-10-04	Absent	BRD4
Melanoma	ENSG00000142168	FALSE	Phase II Clinical Trial	2002-07-01	Unused	SOD1
Melanoma	ENSG00000142208	FALSE	unknown	1992-08-15	Unused	AKT1
Melanoma	ENSG00000143384	FALSE	Preclinical	1997-01-15	Unused	MCL1
Melanoma	ENSG00000143537	FALSE	Phase II Clinical Trial	2004-02-04	Phase II Clinical Trial	ADAM15
Melanoma	ENSG00000143549	FALSE	Preclinical	2013-10-15	Absent	TPM3
Melanoma	ENSG00000143799	FALSE	Phase II Clinical Trial	2002-07-04	Phase II Clinical Trial	PARP1
Melanoma	ENSG00000144744	FALSE	Phase I Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Melanoma	ENSG00000146648	FALSE	Phase II Clinical Trial	1995-03-15	Phase II Clinical Trial	EGFR
Melanoma	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Melanoma	ENSG00000147099	FALSE	Phase II Clinical Trial	2008-07-31	Absent	HDAC8
Melanoma	ENSG00000147138	FALSE	Preclinical	2016-06-16	Absent	GPR174
Melanoma	ENSG00000147955	FALSE	Preclinical	2011-02-05	Absent	SIGMAR1
Melanoma	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Melanoma	ENSG00000151617	FALSE	Phase II Clinical Trial	1994-10-15	Unused	EDNRA
Melanoma	ENSG00000154229	FALSE	Phase II Clinical Trial	1991-01-15	Phase I Clinical Trial	PRKCA
Melanoma	ENSG00000156052	FALSE	Preclinical	2008-12-18	Unused	GNAQ
Melanoma	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Melanoma	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-05-15	Phase III Clinical Trial	KIT
Melanoma	ENSG00000157764	TRUE	Approved	2005-05-25	Approved	BRAF
Melanoma	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Melanoma	ENSG00000159131	FALSE	Phase I Clinical Trial	1990-07-15	Unused	GART
Melanoma	ENSG00000160712	FALSE	unknown	2005-01-11	Phase III Clinical Trial	IL6R
Melanoma	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Melanoma	ENSG00000161011	FALSE	Phase II Clinical Trial	2015-11-04	Absent	SQSTM1
Melanoma	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Melanoma	ENSG00000162009	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR5
Melanoma	ENSG00000162892	FALSE	unknown	1999-07-07	Unused	IL24
Melanoma	ENSG00000163399	FALSE	Preclinical	2011-01-25	Absent	ATP1A1
Melanoma	ENSG00000163430	FALSE	Preclinical	2015-10-08	Absent	FSTL1
Melanoma	ENSG00000163464	FALSE	Preclinical	2005-01-27	Unused	CXCR1
Melanoma	ENSG00000163599	TRUE	Approved	1998-09-15	Approved	CTLA4
Melanoma	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Melanoma	ENSG00000163737	FALSE	unknown	NA	Unused	PF4
Melanoma	ENSG00000163932	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCD
Melanoma	ENSG00000163975	FALSE	Preclinical	1998-07-15	Unused	MELTF
Melanoma	ENSG00000164305	FALSE	Phase I Clinical Trial	2001-12-19	Phase I Clinical Trial	CASP3
Melanoma	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Unused	TLR3
Melanoma	ENSG00000164362	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TERT
Melanoma	ENSG00000164400	TRUE	Approved	1991-12-15	Phase III Clinical Trial	CSF2
Melanoma	ENSG00000164885	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK5
Melanoma	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Melanoma	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Melanoma	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Melanoma	ENSG00000166501	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCB
Melanoma	ENSG00000166851	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	PLK1
Melanoma	ENSG00000167325	FALSE	unknown	1993-07-15	Unused	RRM1
Melanoma	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Unused	AXL
Melanoma	ENSG00000167658	FALSE	Preclinical	2002-01-09	Phase II Clinical Trial	EEF2
Melanoma	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Unused	FNTA
Melanoma	ENSG00000168610	FALSE	Phase II Clinical Trial	2005-04-25	Phase I Clinical Trial	STAT3
Melanoma	ENSG00000168811	FALSE	Phase I Clinical Trial	1995-09-15	Phase I Clinical Trial	IL12A
Melanoma	ENSG00000169032	TRUE	Approved	2003-06-09	Approved	MAP2K1
Melanoma	ENSG00000169398	FALSE	Phase I Clinical Trial	2009-10-16	Phase I Clinical Trial	PTK2
Melanoma	ENSG00000170312	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK1
Melanoma	ENSG00000170430	FALSE	unknown	2002-05-15	Unused	MGMT
Melanoma	ENSG00000170525	FALSE	unknown	2014-01-27	Absent	PFKFB3
Melanoma	ENSG00000170558	FALSE	Phase III Clinical Trial	1999-06-30	Unused	CDH2
Melanoma	ENSG00000171132	FALSE	Phase II Clinical Trial	2005-01-26	Phase I Clinical Trial	PRKCE
Melanoma	ENSG00000171608	FALSE	unknown	2005-12-01	Absent	PIK3CD
Melanoma	ENSG00000171720	FALSE	Phase II Clinical Trial	2008-07-31	Absent	HDAC3
Melanoma	ENSG00000171791	FALSE	Preclinical	1992-03-15	Unused	BCL2
Melanoma	ENSG00000171848	FALSE	unknown	NA	Absent	RRM2
Melanoma	ENSG00000171855	FALSE	Preclinical	2007-06-08	Unused	IFNB1
Melanoma	ENSG00000171862	FALSE	Preclinical	2005-08-22	Phase II Clinical Trial	PTEN
Melanoma	ENSG00000173083	FALSE	unknown	1997-09-15	Unused	HPSE
Melanoma	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Melanoma	ENSG00000173546	FALSE	Preclinical	2004-01-13	Unused	CSPG4
Melanoma	ENSG00000174807	FALSE	Phase II Clinical Trial	2004-10-18	Phase II Clinical Trial	CD248
Melanoma	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Melanoma	ENSG00000176884	FALSE	Preclinical	1990-06-15	Preclinical	GRIN1
Melanoma	ENSG00000176890	FALSE	Phase I Clinical Trial	1992-06-15	Unused	TYMS
Melanoma	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Melanoma	ENSG00000178568	FALSE	Phase I Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB4
Melanoma	ENSG00000178999	FALSE	Phase I Clinical Trial	2004-02-03	Phase I Clinical Trial	AURKB
Melanoma	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Melanoma	ENSG00000180616	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR2
Melanoma	ENSG00000180871	FALSE	Preclinical	1995-06-15	Unused	CXCR2
Melanoma	ENSG00000181408	FALSE	unknown	2002-06-07	Unused	UTS2R
Melanoma	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase I Clinical Trial	CSF1R
Melanoma	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Melanoma	ENSG00000182871	FALSE	unknown	1997-02-15	Phase II Clinical Trial	COL18A1
Melanoma	ENSG00000184033	FALSE	Phase II Clinical Trial	2005-08-10	Phase II Clinical Trial	CTAG1B
Melanoma	ENSG00000184047	FALSE	Phase I Clinical Trial	2005-11-21	Absent	DIABLO
Melanoma	ENSG00000184371	FALSE	Phase II Clinical Trial	1994-01-15	Unused	CSF1
Melanoma	ENSG00000184584	FALSE	Preclinical	2014-04-02	Absent	TMEM173
Melanoma	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Melanoma	ENSG00000185338	FALSE	Preclinical	2013-03-15	Absent	SOCS1
Melanoma	ENSG00000185664	FALSE	Phase III Clinical Trial	1995-03-15	Phase I Clinical Trial	PMEL
Melanoma	ENSG00000185686	FALSE	Phase II Clinical Trial	2003-11-27	Phase II Clinical Trial	PRAME
Melanoma	ENSG00000186716	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	BCR
Melanoma	ENSG00000186827	FALSE	Phase II Clinical Trial	2014-12-15	Absent	TNFRSF4
Melanoma	ENSG00000186891	FALSE	Phase I Clinical Trial	2004-10-20	Phase I Clinical Trial	TNFRSF18
Melanoma	ENSG00000187098	FALSE	Preclinical	2017-06-22	Absent	MITF
Melanoma	ENSG00000187514	FALSE	unknown	NA	Unused	PTMA
Melanoma	ENSG00000187764	FALSE	Preclinical	2006-06-20	Absent	SEMA4D
Melanoma	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Melanoma	ENSG00000188389	TRUE	Approved	2005-05-12	Phase III Clinical Trial	PDCD1
Melanoma	ENSG00000196154	FALSE	Preclinical	2011-09-15	Absent	S100A4
Melanoma	ENSG00000196352	FALSE	Phase II Clinical Trial	2004-07-19	Phase II Clinical Trial	CD55
Melanoma	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Melanoma	ENSG00000196411	FALSE	Preclinical	2005-07-04	Unused	EPHB4
Melanoma	ENSG00000196591	FALSE	Phase II Clinical Trial	2008-07-31	Absent	HDAC2
Melanoma	ENSG00000196664	FALSE	unknown	2005-12-09	Unused	TLR7
Melanoma	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Melanoma	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Melanoma	ENSG00000197408	FALSE	unknown	NA	Phase II Clinical Trial	CYP2B6
Melanoma	ENSG00000197919	FALSE	Preclinical	1998-09-15	Unused	IFNA1
Melanoma	ENSG00000198223	FALSE	Phase III Clinical Trial	NA	Unused	CSF2RA
Melanoma	ENSG00000198400	FALSE	Phase II Clinical Trial	2013-07-11	Absent	NTRK1
Melanoma	ENSG00000198681	FALSE	Phase II Clinical Trial	2001-05-21	Unused	MAGEA1
Melanoma	ENSG00000198793	FALSE	Phase II Clinical Trial	2006-10-23	Phase I Clinical Trial	MTOR
Melanoma	ENSG00000198805	FALSE	Preclinical	1997-04-15	Unused	PNP
Melanoma	ENSG00000198851	FALSE	Phase II Clinical Trial	2013-01-07	Absent	CD3E
Melanoma	ENSG00000198900	FALSE	Phase II Clinical Trial	1994-10-15	Phase II Clinical Trial	TOP1
Melanoma	ENSG00000213903	FALSE	unknown	1993-10-15	Unused	LTB4R
Melanoma	ENSG00000221867	FALSE	Phase III Clinical Trial	1998-07-15	Phase III Clinical Trial	MAGEA3
Melanoma	ENSG00000228716	FALSE	Phase I Clinical Trial	1992-06-15	Unused	DHFR
Melanoma	ENSG00000239732	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	TLR9
Melanoma	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Melanoma	ENSG00000253729	FALSE	Phase II Clinical Trial	2006-11-29	Phase I Clinical Trial	PRKDC
Melanoma	ENSG00000254087	FALSE	Phase III Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Melanoma	ENSG00000258839	FALSE	Preclinical	2015-02-05	Unused	MC1R
Melanoma	ENSG00000259207	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGB3
Melanoma	ENSG00000261857	FALSE	Preclinical	2014-01-29	Absent	MIA
Melanoma	ENSG00000278195	FALSE	Phase I Clinical Trial	2002-11-27	Preclinical	SSTR3
Melanosis	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Memory Disorders	ENSG00000007171	FALSE	Preclinical	1998-10-15	Unused	NOS2
Memory Disorders	ENSG00000011677	FALSE	Phase I Clinical Trial	1991-07-15	Unused	GABRA3
Memory Disorders	ENSG00000022355	FALSE	Phase I Clinical Trial	1991-07-15	Unused	GABRA1
Memory Disorders	ENSG00000025434	FALSE	Preclinical	2002-12-03	Unused	NR1H3
Memory Disorders	ENSG00000064300	FALSE	Preclinical	1989-06-15	Unused	NGFR
Memory Disorders	ENSG00000065989	FALSE	Phase II Clinical Trial	2001-02-06	Unused	PDE4A
Memory Disorders	ENSG00000069535	FALSE	Preclinical	1990-09-15	Unused	MAOB
Memory Disorders	ENSG00000069696	FALSE	Preclinical	2006-10-16	Unused	DRD4
Memory Disorders	ENSG00000073756	FALSE	Preclinical	2002-05-27	Unused	PTGS2
Memory Disorders	ENSG00000075043	FALSE	Preclinical	2001-06-19	Unused	KCNQ2
Memory Disorders	ENSG00000077782	FALSE	unknown	2004-06-16	Unused	FGFR1
Memory Disorders	ENSG00000080824	FALSE	Preclinical	2007-09-04	Unused	HSP90AA1
Memory Disorders	ENSG00000082175	FALSE	Preclinical	2009-03-10	Unused	PGR
Memory Disorders	ENSG00000082556	FALSE	Preclinical	NA	Unused	OPRK1
Memory Disorders	ENSG00000082701	FALSE	Preclinical	2004-07-05	Unused	GSK3B
Memory Disorders	ENSG00000085377	FALSE	Phase II Clinical Trial	1990-12-15	Unused	PREP
Memory Disorders	ENSG00000087085	FALSE	Pre-registration	1989-06-15	Phase III Clinical Trial	ACHE
Memory Disorders	ENSG00000089250	FALSE	Preclinical	1998-10-15	Unused	NOS1
Memory Disorders	ENSG00000091831	FALSE	Phase II Clinical Trial	1999-09-16	Phase III Clinical Trial	ESR1
Memory Disorders	ENSG00000095303	FALSE	unknown	NA	Unused	PTGS1
Memory Disorders	ENSG00000101126	FALSE	Phase II Clinical Trial	2005-01-26	Unused	ADNP
Memory Disorders	ENSG00000101180	FALSE	Phase I Clinical Trial	1992-03-15	Unused	HRH3
Memory Disorders	ENSG00000101204	FALSE	Preclinical	2003-01-15	Unused	CHRNA4
Memory Disorders	ENSG00000101846	FALSE	Preclinical	1995-06-15	Unused	STS
Memory Disorders	ENSG00000102468	FALSE	unknown	1991-06-15	Unused	HTR2A
Memory Disorders	ENSG00000103546	FALSE	Phase II Clinical Trial	1989-09-15	Unused	SLC6A2
Memory Disorders	ENSG00000105650	FALSE	Phase II Clinical Trial	2001-02-06	Unused	PDE4C
Memory Disorders	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Memory Disorders	ENSG00000108576	FALSE	Phase II Clinical Trial	1989-09-15	Unused	SLC6A4
Memory Disorders	ENSG00000109320	FALSE	unknown	1990-06-15	Unused	NFKB1
Memory Disorders	ENSG00000109339	FALSE	Preclinical	2008-04-10	Unused	MAPK10
Memory Disorders	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Memory Disorders	ENSG00000110887	FALSE	Phase I Clinical Trial	2007-06-15	Unused	DAO
Memory Disorders	ENSG00000112033	FALSE	Preclinical	2006-09-18	Unused	PPARD
Memory Disorders	ENSG00000112038	FALSE	Preclinical	NA	Unused	OPRM1
Memory Disorders	ENSG00000112164	FALSE	Preclinical	2006-01-30	Unused	GLP1R
Memory Disorders	ENSG00000112541	FALSE	Preclinical	2009-02-09	Unused	PDE10A
Memory Disorders	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Memory Disorders	ENSG00000113448	FALSE	Phase II Clinical Trial	2001-02-06	Unused	PDE4D
Memory Disorders	ENSG00000113494	FALSE	Preclinical	NA	Unused	PRLR
Memory Disorders	ENSG00000114200	FALSE	Preclinical	1999-05-19	Unused	BCHE
Memory Disorders	ENSG00000115252	TRUE	Approved	1991-04-15	Approved	PDE1A
Memory Disorders	ENSG00000115310	FALSE	Preclinical	2003-05-06	Unused	RTN4
Memory Disorders	ENSG00000115590	FALSE	Preclinical	NA	Unused	IL1R2
Memory Disorders	ENSG00000115828	FALSE	unknown	2008-07-01	Absent	QPCT
Memory Disorders	ENSG00000116478	FALSE	Preclinical	2004-10-19	Unused	HDAC1
Memory Disorders	ENSG00000117013	FALSE	Preclinical	2001-06-19	Unused	KCNQ4
Memory Disorders	ENSG00000117362	FALSE	Preclinical	1999-04-28	Unused	APH1A
Memory Disorders	ENSG00000117594	FALSE	Phase I Clinical Trial	2015-03-06	Absent	HSD11B1
Memory Disorders	ENSG00000117984	FALSE	Preclinical	1994-06-15	Unused	CTSD
Memory Disorders	ENSG00000118432	FALSE	Phase I Clinical Trial	2011-03-01	Unused	CNR1
Memory Disorders	ENSG00000125510	FALSE	Preclinical	1999-04-28	Unused	OPRL1
Memory Disorders	ENSG00000126895	FALSE	Preclinical	1995-08-15	Unused	AVPR2
Memory Disorders	ENSG00000128271	FALSE	Preclinical	2008-07-04	Unused	ADORA2A
Memory Disorders	ENSG00000128272	FALSE	unknown	1991-05-15	Unused	ATF4
Memory Disorders	ENSG00000128310	FALSE	Preclinical	2005-11-15	Unused	GALR3
Memory Disorders	ENSG00000130203	FALSE	Preclinical	1999-01-15	Unused	APOE
Memory Disorders	ENSG00000131408	FALSE	Preclinical	2002-12-03	Unused	NR1H2
Memory Disorders	ENSG00000131747	FALSE	unknown	NA	Unused	TOP2A
Memory Disorders	ENSG00000132170	FALSE	Preclinical	1995-03-15	Unused	PPARG
Memory Disorders	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Memory Disorders	ENSG00000133019	FALSE	Phase I Clinical Trial	1990-12-15	Unused	CHRM3
Memory Disorders	ENSG00000134259	FALSE	Preclinical	2001-12-11	Unused	NGF
Memory Disorders	ENSG00000135312	FALSE	Preclinical	1992-12-15	Unused	HTR1B
Memory Disorders	ENSG00000135519	FALSE	unknown	2008-05-13	Absent	KCNH3
Memory Disorders	ENSG00000135914	FALSE	Pre-registration	NA	Unused	HTR2B
Memory Disorders	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Memory Disorders	ENSG00000141736	FALSE	Preclinical	1999-05-11	Unused	ERBB2
Memory Disorders	ENSG00000142192	FALSE	Preclinical	1992-03-15	Unused	APP
Memory Disorders	ENSG00000142319	FALSE	Preclinical	1994-02-15	Unused	SLC6A3
Memory Disorders	ENSG00000143171	FALSE	Preclinical	2008-07-10	Absent	RXRG
Memory Disorders	ENSG00000143799	FALSE	Phase II Clinical Trial	2004-01-12	Unused	PARP1
Memory Disorders	ENSG00000147246	FALSE	Preclinical	2006-10-30	Unused	HTR2C
Memory Disorders	ENSG00000147955	FALSE	Preclinical	1993-09-15	Unused	SIGMAR1
Memory Disorders	ENSG00000148408	FALSE	Preclinical	1992-01-15	Unused	CACNA1B
Memory Disorders	ENSG00000149177	FALSE	Preclinical	1996-10-15	Unused	PTPRJ
Memory Disorders	ENSG00000149294	FALSE	Preclinical	1994-06-15	Unused	NCAM1
Memory Disorders	ENSG00000149295	FALSE	Preclinical	2006-10-16	Unused	DRD2
Memory Disorders	ENSG00000150594	FALSE	Phase II Clinical Trial	1989-09-15	Unused	ADRA2A
Memory Disorders	ENSG00000151577	FALSE	Preclinical	2006-02-13	Unused	DRD3
Memory Disorders	ENSG00000151834	FALSE	Phase I Clinical Trial	1991-07-15	Unused	GABRA2
Memory Disorders	ENSG00000155511	TRUE	Approved	1990-08-15	Approved	GRIA1
Memory Disorders	ENSG00000158748	FALSE	Preclinical	2002-11-07	Unused	HTR6
Memory Disorders	ENSG00000159164	FALSE	Preclinical	2014-12-15	Absent	SV2A
Memory Disorders	ENSG00000159640	FALSE	Phase I Clinical Trial	1989-12-15	Unused	ACE
Memory Disorders	ENSG00000160191	FALSE	Preclinical	2014-03-27	Absent	PDE9A
Memory Disorders	ENSG00000160716	FALSE	Preclinical	2003-01-15	Unused	CHRNB2
Memory Disorders	ENSG00000162882	FALSE	Preclinical	1994-12-15	Unused	HAAO
Memory Disorders	ENSG00000163394	FALSE	Preclinical	1993-06-15	Unused	CCKAR
Memory Disorders	ENSG00000163485	FALSE	Preclinical	1990-05-15	Unused	ADORA1
Memory Disorders	ENSG00000164082	FALSE	Preclinical	1996-10-15	Unused	GRM2
Memory Disorders	ENSG00000164129	FALSE	unknown	2007-04-15	Unused	NPY5R
Memory Disorders	ENSG00000164270	FALSE	Phase I Clinical Trial	1992-09-15	Unused	HTR4
Memory Disorders	ENSG00000164305	FALSE	Preclinical	2001-09-07	Unused	CASP3
Memory Disorders	ENSG00000164867	FALSE	Preclinical	1998-10-15	Unused	NOS3
Memory Disorders	ENSG00000165646	FALSE	Phase II Clinical Trial	2005-01-28	Absent	SLC18A2
Memory Disorders	ENSG00000166148	FALSE	unknown	NA	Unused	AVPR1A
Memory Disorders	ENSG00000166501	FALSE	Preclinical	1995-09-15	Unused	PRKCB
Memory Disorders	ENSG00000166573	FALSE	Preclinical	1994-11-15	Unused	GALR1
Memory Disorders	ENSG00000166736	FALSE	Phase I Clinical Trial	1992-09-15	Unused	HTR3A
Memory Disorders	ENSG00000167186	FALSE	Preclinical	2006-05-03	Unused	COQ7
Memory Disorders	ENSG00000168539	FALSE	Phase I Clinical Trial	1990-12-15	Unused	CHRM1
Memory Disorders	ENSG00000168959	FALSE	Preclinical	2004-11-10	Unused	GRM5
Memory Disorders	ENSG00000169083	FALSE	unknown	1991-02-15	Phase II Clinical Trial	AR
Memory Disorders	ENSG00000169403	FALSE	unknown	NA	Unused	PTAFR
Memory Disorders	ENSG00000169836	FALSE	Preclinical	1998-09-15	Unused	TACR3
Memory Disorders	ENSG00000170425	FALSE	Preclinical	2004-03-31	Unused	ADORA2B
Memory Disorders	ENSG00000171720	FALSE	unknown	2007-04-13	Preclinical	HDAC3
Memory Disorders	ENSG00000172817	FALSE	Preclinical	2001-08-07	Unused	CYP7B1
Memory Disorders	ENSG00000173198	FALSE	Phase I Clinical Trial	NA	Absent	CYSLTR1
Memory Disorders	ENSG00000173250	FALSE	Preclinical	2015-03-18	Absent	GPR151
Memory Disorders	ENSG00000173327	FALSE	Phase I Clinical Trial	2015-10-26	Absent	MAP3K11
Memory Disorders	ENSG00000174417	FALSE	Phase III Clinical Trial	1991-07-15	Unused	TRHR
Memory Disorders	ENSG00000175344	FALSE	Preclinical	1996-06-15	Unused	CHRNA7
Memory Disorders	ENSG00000176884	FALSE	Phase II Clinical Trial	1989-08-15	Phase II Clinical Trial	GRIN1
Memory Disorders	ENSG00000177272	FALSE	unknown	1990-02-15	Unused	KCNA3
Memory Disorders	ENSG00000178394	FALSE	Phase II Clinical Trial	1991-06-15	Unused	HTR1A
Memory Disorders	ENSG00000180720	FALSE	Preclinical	1994-08-15	Unused	CHRM4
Memory Disorders	ENSG00000180914	FALSE	Preclinical	1995-08-15	Unused	OXTR
Memory Disorders	ENSG00000181072	FALSE	Phase I Clinical Trial	1990-12-15	Unused	CHRM2
Memory Disorders	ENSG00000182687	FALSE	Preclinical	1994-11-15	Unused	GALR2
Memory Disorders	ENSG00000184156	FALSE	Preclinical	2001-06-19	Unused	KCNQ3
Memory Disorders	ENSG00000184588	FALSE	Phase II Clinical Trial	2001-02-06	Unused	PDE4B
Memory Disorders	ENSG00000184845	FALSE	Phase I Clinical Trial	1995-06-15	Unused	DRD1
Memory Disorders	ENSG00000185291	FALSE	Preclinical	1992-03-15	Unused	IL3RA
Memory Disorders	ENSG00000186297	FALSE	Phase I Clinical Trial	1991-07-15	Unused	GABRA5
Memory Disorders	ENSG00000186642	FALSE	Preclinical	2009-09-18	Unused	PDE2A
Memory Disorders	ENSG00000186951	FALSE	Preclinical	2006-09-18	Unused	PPARA
Memory Disorders	ENSG00000196218	FALSE	Preclinical	2012-09-07	Preclinical	RYR1
Memory Disorders	ENSG00000196517	FALSE	Preclinical	2015-06-04	Absent	SLC6A9
Memory Disorders	ENSG00000196549	FALSE	Preclinical	1992-10-15	Unused	MME
Memory Disorders	ENSG00000196591	FALSE	Preclinical	2004-10-19	Unused	HDAC2
Memory Disorders	ENSG00000198049	FALSE	unknown	NA	Unused	AVPR1B
Memory Disorders	ENSG00000198822	FALSE	Preclinical	1996-10-15	Unused	GRM3
Memory Disorders	ENSG00000205155	FALSE	Preclinical	1999-04-28	Unused	PSENEN
Meniere Disease	ENSG00000101180	FALSE	Preclinical	2013-02-23	Absent	HRH3
Meniere Disease	ENSG00000113580	FALSE	Phase III Clinical Trial	2009-11-26	Unused	NR3C1
Meniere Disease	ENSG00000196639	FALSE	Preclinical	2013-02-23	Absent	HRH1
Meningioma	ENSG00000116478	FALSE	Preclinical	2007-03-13	Absent	HDAC1
Meningioma	ENSG00000142208	FALSE	Preclinical	2007-03-13	Absent	AKT1
Meningioma	ENSG00000196591	FALSE	Preclinical	2007-03-13	Absent	HDAC2
Meningitis, Aseptic	ENSG00000070501	TRUE	Approved	2015-10-19	Approved	POLB
Meningitis, Aseptic	ENSG00000101868	TRUE	Approved	2015-10-19	Approved	POLA1
Meningitis, Viral	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Meningococcal Infections	ENSG00000101425	FALSE	unknown	1989-12-15	Unused	BPI
Menorrhagia	ENSG00000073756	FALSE	unknown	2001-12-06	Unused	PTGS2
Menorrhagia	ENSG00000082175	TRUE	Approved	1996-07-15	Approved	PGR
Menorrhagia	ENSG00000091831	TRUE	Approved	2001-06-26	Approved	ESR1
Menorrhagia	ENSG00000095303	FALSE	unknown	2001-12-06	Unused	PTGS1
Menorrhagia	ENSG00000171557	TRUE	Approved	2004-11-17	Approved	FGG
Menorrhagia	ENSG00000171560	TRUE	Approved	2004-11-17	Approved	FGA
Menorrhagia	ENSG00000171564	TRUE	Approved	2004-11-17	Approved	FGB
Menstruation Disturbances	ENSG00000011677	FALSE	Phase I Clinical Trial	2004-02-20	Unused	GABRA3
Menstruation Disturbances	ENSG00000022355	FALSE	Phase I Clinical Trial	2004-02-20	Unused	GABRA1
Menstruation Disturbances	ENSG00000059377	TRUE	Approved	1993-11-15	Approved	TBXAS1
Menstruation Disturbances	ENSG00000064989	FALSE	Phase I Clinical Trial	2012-09-22	Absent	CALCRL
Menstruation Disturbances	ENSG00000082175	TRUE	Approved	1989-10-15	Approved	PGR
Menstruation Disturbances	ENSG00000082556	FALSE	Preclinical	2005-03-07	Unused	OPRK1
Menstruation Disturbances	ENSG00000091831	TRUE	Approved	1990-03-15	Approved	ESR1
Menstruation Disturbances	ENSG00000103546	FALSE	Preclinical	NA	Unused	SLC6A2
Menstruation Disturbances	ENSG00000108342	FALSE	Phase I Clinical Trial	2014-12-05	Absent	CSF3
Menstruation Disturbances	ENSG00000108576	TRUE	Approved	2002-02-05	Approved	SLC6A4
Menstruation Disturbances	ENSG00000108786	FALSE	Preclinical	2006-03-03	Unused	HSD17B1
Menstruation Disturbances	ENSG00000109163	TRUE	Approved	1995-05-15	Approved	GNRHR
Menstruation Disturbances	ENSG00000110680	FALSE	unknown	2004-11-12	Unused	CALCA
Menstruation Disturbances	ENSG00000111424	FALSE	Preclinical	2006-10-23	Unused	VDR
Menstruation Disturbances	ENSG00000115353	FALSE	Phase II Clinical Trial	2014-11-06	Absent	TACR1
Menstruation Disturbances	ENSG00000116678	FALSE	Phase II Clinical Trial	1999-04-28	Unused	LEPR
Menstruation Disturbances	ENSG00000126895	FALSE	Preclinical	1995-08-15	Unused	AVPR2
Menstruation Disturbances	ENSG00000140009	FALSE	Phase III Clinical Trial	2001-12-06	Phase II Clinical Trial	ESR2
Menstruation Disturbances	ENSG00000147246	FALSE	Preclinical	2003-09-02	Unused	HTR2C
Menstruation Disturbances	ENSG00000147437	FALSE	Approved	NA	Absent	GNRH1
Menstruation Disturbances	ENSG00000150594	FALSE	Preclinical	2008-07-01	Unused	ADRA2A
Menstruation Disturbances	ENSG00000151834	FALSE	Phase I Clinical Trial	2004-02-20	Unused	GABRA2
Menstruation Disturbances	ENSG00000153956	FALSE	Phase III Clinical Trial	2003-09-23	Unused	CACNA2D1
Menstruation Disturbances	ENSG00000164128	FALSE	Preclinical	1996-05-15	Unused	NPY1R
Menstruation Disturbances	ENSG00000166148	FALSE	Preclinical	2006-07-10	Unused	AVPR1A
Menstruation Disturbances	ENSG00000169083	TRUE	Approved	1993-04-15	Approved	AR
Menstruation Disturbances	ENSG00000169836	FALSE	Phase II Clinical Trial	2007-09-12	Absent	TACR3
Menstruation Disturbances	ENSG00000171557	TRUE	Approved	NA	Approved	FGG
Menstruation Disturbances	ENSG00000171560	TRUE	Approved	NA	Approved	FGA
Menstruation Disturbances	ENSG00000171564	TRUE	Approved	NA	Approved	FGB
Menstruation Disturbances	ENSG00000180914	FALSE	Phase II Clinical Trial	1995-08-15	Unused	OXTR
Menstruation Disturbances	ENSG00000186297	FALSE	Phase I Clinical Trial	2004-02-20	Unused	GABRA5
Menstruation Disturbances	ENSG00000198049	FALSE	Preclinical	2006-07-10	Unused	AVPR1B
Menstruation Disturbances	ENSG00000274286	FALSE	Preclinical	2008-07-01	Unused	ADRA2B
Mesothelioma	ENSG00000023445	FALSE	Preclinical	2015-07-15	Absent	BIRC3
Mesothelioma	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Mesothelioma	ENSG00000049249	FALSE	Preclinical	2016-06-28	Absent	TNFRSF9
Mesothelioma	ENSG00000050165	FALSE	Phase II Clinical Trial	2010-07-26	Absent	DKK3
Mesothelioma	ENSG00000051382	FALSE	unknown	2005-12-01	Phase I Clinical Trial	PIK3CB
Mesothelioma	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Mesothelioma	ENSG00000068078	FALSE	unknown	2001-04-03	Absent	FGFR3
Mesothelioma	ENSG00000077782	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	FGFR1
Mesothelioma	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	FOLH1
Mesothelioma	ENSG00000087586	FALSE	unknown	2004-12-14	Unused	AURKA
Mesothelioma	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Phase I Clinical Trial	BIRC5
Mesothelioma	ENSG00000090339	FALSE	Preclinical	2004-07-19	Preclinical	ICAM1
Mesothelioma	ENSG00000091879	FALSE	unknown	2010-10-29	Absent	ANGPT2
Mesothelioma	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Mesothelioma	ENSG00000100823	FALSE	Phase II Clinical Trial	2007-02-13	Absent	APEX1
Mesothelioma	ENSG00000101966	FALSE	Preclinical	2015-07-15	Absent	XIAP
Mesothelioma	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-04-03	Phase I Clinical Trial	FLT1
Mesothelioma	ENSG00000102854	FALSE	Phase II Clinical Trial	1999-04-21	Phase II Clinical Trial	MSLN
Mesothelioma	ENSG00000104415	FALSE	Preclinical	2015-01-07	Absent	WISP1
Mesothelioma	ENSG00000105810	FALSE	unknown	1996-05-15	Unused	CDK6
Mesothelioma	ENSG00000105851	FALSE	Phase I Clinical Trial	2005-12-01	Phase I Clinical Trial	PIK3CG
Mesothelioma	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Mesothelioma	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Mesothelioma	ENSG00000106546	FALSE	unknown	1999-04-13	Phase I Clinical Trial	AHR
Mesothelioma	ENSG00000108443	FALSE	Phase I Clinical Trial	2010-05-10	Absent	RPS6KB1
Mesothelioma	ENSG00000109471	FALSE	unknown	NA	Unused	IL2
Mesothelioma	ENSG00000110195	FALSE	unknown	NA	Phase I Clinical Trial	FOLR1
Mesothelioma	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Mesothelioma	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Unused	VEGFA
Mesothelioma	ENSG00000113721	FALSE	unknown	2001-04-03	Unused	PDGFRB
Mesothelioma	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Mesothelioma	ENSG00000116478	FALSE	unknown	2002-06-10	Unused	HDAC1
Mesothelioma	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-06-20	Absent	CD274
Mesothelioma	ENSG00000121879	FALSE	Phase I Clinical Trial	2005-12-01	Phase I Clinical Trial	PIK3CA
Mesothelioma	ENSG00000122025	FALSE	Phase I Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Mesothelioma	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Mesothelioma	ENSG00000126934	FALSE	unknown	2003-06-09	Unused	MAP2K2
Mesothelioma	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Mesothelioma	ENSG00000131747	FALSE	unknown	1999-03-31	Unused	TOP2A
Mesothelioma	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Mesothelioma	ENSG00000134853	FALSE	Phase III Clinical Trial	2001-04-03	Phase I Clinical Trial	PDGFRA
Mesothelioma	ENSG00000135446	FALSE	unknown	1996-05-15	Unused	CDK4
Mesothelioma	ENSG00000136807	FALSE	unknown	1996-05-15	Unused	CDK9
Mesothelioma	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Mesothelioma	ENSG00000140009	FALSE	Preclinical	2007-06-04	Absent	ESR2
Mesothelioma	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Mesothelioma	ENSG00000140465	FALSE	unknown	1999-04-13	Phase I Clinical Trial	CYP1A1
Mesothelioma	ENSG00000141736	FALSE	Phase I Clinical Trial	2000-04-04	Unused	ERBB2
Mesothelioma	ENSG00000142208	FALSE	Phase I Clinical Trial	2010-05-10	Phase I Clinical Trial	AKT1
Mesothelioma	ENSG00000143384	FALSE	Preclinical	2015-07-15	Absent	MCL1
Mesothelioma	ENSG00000143799	FALSE	Phase I Clinical Trial	2002-08-14	Unused	PARP1
Mesothelioma	ENSG00000146242	FALSE	Phase II Clinical Trial	1999-06-10	Preclinical	TPBG
Mesothelioma	ENSG00000146648	FALSE	Phase II Clinical Trial	1999-12-09	Unused	EGFR
Mesothelioma	ENSG00000146674	FALSE	unknown	2008-01-04	Unused	IGFBP3
Mesothelioma	ENSG00000149418	FALSE	Preclinical	2007-04-17	Unused	ST14
Mesothelioma	ENSG00000149554	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	CHEK1
Mesothelioma	ENSG00000150630	FALSE	unknown	2003-12-09	Unused	VEGFC
Mesothelioma	ENSG00000157404	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	KIT
Mesothelioma	ENSG00000157764	FALSE	unknown	2001-04-03	Unused	BRAF
Mesothelioma	ENSG00000159131	TRUE	Approved	1992-06-15	Approved	GART
Mesothelioma	ENSG00000160712	FALSE	unknown	2005-01-11	Unused	IL6R
Mesothelioma	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Absent	CTLA4
Mesothelioma	ENSG00000164400	FALSE	Phase II Clinical Trial	2009-12-15	Absent	CSF2
Mesothelioma	ENSG00000165197	FALSE	unknown	2003-12-09	Unused	VEGFD
Mesothelioma	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Mesothelioma	ENSG00000166825	FALSE	Phase III Clinical Trial	2003-02-20	Phase III Clinical Trial	ANPEP
Mesothelioma	ENSG00000167658	FALSE	Phase I Clinical Trial	1999-04-21	Unused	EEF2
Mesothelioma	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Unused	FNTA
Mesothelioma	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Mesothelioma	ENSG00000169032	FALSE	unknown	2003-06-09	Unused	MAP2K1
Mesothelioma	ENSG00000169398	FALSE	Phase II Clinical Trial	2008-11-11	Phase I Clinical Trial	PTK2
Mesothelioma	ENSG00000171608	FALSE	unknown	2005-12-01	Phase I Clinical Trial	PIK3CD
Mesothelioma	ENSG00000171855	FALSE	unknown	2000-08-17	Unused	IFNB1
Mesothelioma	ENSG00000173511	FALSE	unknown	2003-12-09	Unused	VEGFB
Mesothelioma	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Mesothelioma	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Mesothelioma	ENSG00000178999	FALSE	unknown	2004-12-14	Unused	AURKB
Mesothelioma	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Mesothelioma	ENSG00000184937	FALSE	Phase II Clinical Trial	2006-01-10	Phase II Clinical Trial	WT1
Mesothelioma	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	PRAME
Mesothelioma	ENSG00000187079	FALSE	Preclinical	2014-11-05	Absent	TEAD1
Mesothelioma	ENSG00000188389	FALSE	Pre-registration	2005-05-12	Absent	PDCD1
Mesothelioma	ENSG00000196352	FALSE	Preclinical	2004-07-19	Preclinical	CD55
Mesothelioma	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Mesothelioma	ENSG00000196411	FALSE	Phase I Clinical Trial	2003-08-12	Unused	EPHB4
Mesothelioma	ENSG00000196591	FALSE	unknown	2002-06-10	Unused	HDAC2
Mesothelioma	ENSG00000197122	FALSE	Phase I Clinical Trial	2003-08-12	Unused	SRC
Mesothelioma	ENSG00000197635	FALSE	Phase II Clinical Trial	2004-02-24	Phase II Clinical Trial	DPP4
Mesothelioma	ENSG00000198625	FALSE	Preclinical	2015-07-15	Absent	MDM4
Mesothelioma	ENSG00000198668	FALSE	Phase II Clinical Trial	2003-12-09	Absent	CALM1
Mesothelioma	ENSG00000198793	FALSE	Phase I Clinical Trial	2006-10-23	Unused	MTOR
Mesothelioma	ENSG00000198851	FALSE	Preclinical	2015-01-07	Absent	CD3E
Mesothelioma	ENSG00000198900	FALSE	Phase I Clinical Trial	2015-07-15	Unused	TOP1
Mesothelioma	ENSG00000198964	FALSE	Phase II Clinical Trial	2008-11-07	Absent	SGMS1
Mesothelioma	ENSG00000228716	TRUE	Approved	1992-06-15	Approved	DHFR
Mesothelioma	ENSG00000239732	FALSE	Phase I Clinical Trial	1998-10-15	Unused	TLR9
Mesothelioma	ENSG00000253729	FALSE	unknown	1999-03-31	Unused	PRKDC
Mesothelioma	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Absent	LYN
Metabolic Diseases	ENSG00000005421	FALSE	Preclinical	2015-01-12	Absent	PON1
Metabolic Diseases	ENSG00000007952	FALSE	Preclinical	2015-03-26	Absent	NOX1
Metabolic Diseases	ENSG00000012779	FALSE	Preclinical	1993-01-15	Unused	ALOX5
Metabolic Diseases	ENSG00000017427	FALSE	Preclinical	2016-10-18	Absent	IGF1
Metabolic Diseases	ENSG00000025434	FALSE	Phase I Clinical Trial	2005-12-08	Phase I Clinical Trial	NR1H3
Metabolic Diseases	ENSG00000030110	FALSE	Preclinical	1997-07-15	Absent	BAK1
Metabolic Diseases	ENSG00000062282	FALSE	Preclinical	2014-07-26	Absent	DGAT2
Metabolic Diseases	ENSG00000065325	FALSE	Preclinical	2009-01-26	Unused	GLP2R
Metabolic Diseases	ENSG00000067182	FALSE	Preclinical	2008-04-07	Unused	TNFRSF1A
Metabolic Diseases	ENSG00000073756	FALSE	Phase II Clinical Trial	NA	Unused	PTGS2
Metabolic Diseases	ENSG00000076555	FALSE	Preclinical	2006-08-09	Unused	ACACB
Metabolic Diseases	ENSG00000077943	FALSE	Preclinical	2017-11-17	Absent	ITGA8
Metabolic Diseases	ENSG00000080293	TRUE	Approved	NA	Approved	SCTR
Metabolic Diseases	ENSG00000082701	FALSE	Preclinical	2004-08-16	Unused	GSK3B
Metabolic Diseases	ENSG00000087245	FALSE	Preclinical	1999-09-01	Unused	MMP2
Metabolic Diseases	ENSG00000091831	FALSE	Preclinical	2012-07-05	Preclinical	ESR1
Metabolic Diseases	ENSG00000095303	FALSE	Phase II Clinical Trial	NA	Unused	PTGS1
Metabolic Diseases	ENSG00000095970	FALSE	Preclinical	2008-07-04	Unused	TREM2
Metabolic Diseases	ENSG00000096717	FALSE	Preclinical	2014-07-31	Absent	SIRT1
Metabolic Diseases	ENSG00000099194	FALSE	Preclinical	2010-09-01	Absent	SCD
Metabolic Diseases	ENSG00000099953	FALSE	Preclinical	1999-09-01	Unused	MMP11
Metabolic Diseases	ENSG00000100380	FALSE	Preclinical	2015-07-06	Absent	ST13
Metabolic Diseases	ENSG00000100985	FALSE	Preclinical	1999-09-01	Unused	MMP9
Metabolic Diseases	ENSG00000101144	FALSE	unknown	1994-04-15	Unused	BMP7
Metabolic Diseases	ENSG00000101557	FALSE	Preclinical	2011-04-27	Absent	USP14
Metabolic Diseases	ENSG00000102393	FALSE	Preclinical	1989-08-15	Unused	GLA
Metabolic Diseases	ENSG00000102468	FALSE	Preclinical	1995-08-15	Unused	HTR2A
Metabolic Diseases	ENSG00000105550	FALSE	Preclinical	2011-03-01	Preclinical	FGF21
Metabolic Diseases	ENSG00000106113	FALSE	unknown	2003-04-30	Preclinical	CRHR2
Metabolic Diseases	ENSG00000106633	FALSE	Preclinical	2011-09-06	Preclinical	GCK
Metabolic Diseases	ENSG00000109339	FALSE	Preclinical	2014-10-18	Absent	MAPK10
Metabolic Diseases	ENSG00000110148	FALSE	Phase II Clinical Trial	1991-07-15	Unused	CCKBR
Metabolic Diseases	ENSG00000110245	FALSE	Preclinical	2016-05-05	Absent	APOC3
Metabolic Diseases	ENSG00000110887	FALSE	Preclinical	NA	Absent	DAO
Metabolic Diseases	ENSG00000111142	FALSE	unknown	2011-07-21	Absent	METAP2
Metabolic Diseases	ENSG00000111199	FALSE	Preclinical	2010-07-08	Absent	TRPV4
Metabolic Diseases	ENSG00000112033	FALSE	Preclinical	2007-04-17	Unused	PPARD
Metabolic Diseases	ENSG00000112164	FALSE	Preclinical	2003-03-17	Unused	GLP1R
Metabolic Diseases	ENSG00000112964	TRUE	Approved	2007-08-03	Approved	GHR
Metabolic Diseases	ENSG00000113580	TRUE	Approved	1990-05-15	Approved	NR3C1
Metabolic Diseases	ENSG00000114378	FALSE	Preclinical	2004-08-27	Unused	HYAL1
Metabolic Diseases	ENSG00000116044	FALSE	Preclinical	2013-08-22	Absent	NFE2L2
Metabolic Diseases	ENSG00000116678	FALSE	Preclinical	2011-07-20	Unused	LEPR
Metabolic Diseases	ENSG00000117594	FALSE	Preclinical	2006-09-13	Unused	HSD11B1
Metabolic Diseases	ENSG00000118432	FALSE	Preclinical	2009-02-13	Preclinical	CNR1
Metabolic Diseases	ENSG00000121807	FALSE	unknown	2012-03-31	Phase I Clinical Trial	CCR2
Metabolic Diseases	ENSG00000121853	FALSE	Preclinical	2004-03-03	Unused	GHSR
Metabolic Diseases	ENSG00000121966	FALSE	Preclinical	2017-12-20	Absent	CXCR4
Metabolic Diseases	ENSG00000125384	FALSE	Preclinical	NA	Unused	PTGER2
Metabolic Diseases	ENSG00000125845	FALSE	unknown	1994-04-15	Unused	BMP2
Metabolic Diseases	ENSG00000130203	FALSE	Preclinical	2015-01-12	Absent	APOE
Metabolic Diseases	ENSG00000130707	FALSE	Preclinical	2015-07-02	Absent	ASS1
Metabolic Diseases	ENSG00000131408	FALSE	Phase I Clinical Trial	2005-12-08	Phase I Clinical Trial	NR1H2
Metabolic Diseases	ENSG00000132170	FALSE	Preclinical	2007-04-17	Unused	PPARG
Metabolic Diseases	ENSG00000135744	FALSE	Phase I Clinical Trial	2012-09-27	Absent	AGT
Metabolic Diseases	ENSG00000136244	FALSE	unknown	2009-10-12	Absent	IL6
Metabolic Diseases	ENSG00000140443	FALSE	Preclinical	NA	Unused	IGF1R
Metabolic Diseases	ENSG00000141485	FALSE	Preclinical	2016-04-13	Absent	SLC13A5
Metabolic Diseases	ENSG00000142677	FALSE	unknown	2011-06-28	Phase I Clinical Trial	IL22RA1
Metabolic Diseases	ENSG00000143387	FALSE	Preclinical	1997-10-15	Unused	CTSK
Metabolic Diseases	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Metabolic Diseases	ENSG00000144891	FALSE	Preclinical	2012-08-28	Preclinical	AGTR1
Metabolic Diseases	ENSG00000146399	FALSE	Phase I Clinical Trial	2013-07-25	Absent	TAAR1
Metabolic Diseases	ENSG00000147246	FALSE	Preclinical	1995-08-15	Unused	HTR2C
Metabolic Diseases	ENSG00000147437	FALSE	Preclinical	2012-04-21	Absent	GNRH1
Metabolic Diseases	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Metabolic Diseases	ENSG00000150093	FALSE	Preclinical	2017-11-17	Absent	ITGB1
Metabolic Diseases	ENSG00000152207	FALSE	Preclinical	2018-01-04	Absent	CYSLTR2
Metabolic Diseases	ENSG00000158473	FALSE	Preclinical	2007-07-16	Absent	CD1D
Metabolic Diseases	ENSG00000160791	FALSE	Preclinical	2000-03-01	Unused	CCR5
Metabolic Diseases	ENSG00000161649	FALSE	Preclinical	2008-07-04	Unused	CD300LG
Metabolic Diseases	ENSG00000161905	FALSE	Preclinical	2005-05-09	Unused	ALOX15
Metabolic Diseases	ENSG00000163394	FALSE	Preclinical	1989-07-15	Unused	CCKAR
Metabolic Diseases	ENSG00000164251	FALSE	Preclinical	2011-06-02	Absent	F2RL1
Metabolic Diseases	ENSG00000164266	FALSE	Preclinical	1990-03-15	Unused	SPINK1
Metabolic Diseases	ENSG00000164270	FALSE	Preclinical	1995-03-15	Unused	HTR4
Metabolic Diseases	ENSG00000165092	FALSE	Preclinical	2012-10-08	Preclinical	ALDH1A1
Metabolic Diseases	ENSG00000166391	FALSE	Phase I Clinical Trial	2013-09-17	Absent	MOGAT2
Metabolic Diseases	ENSG00000166603	FALSE	Preclinical	NA	Unused	MC4R
Metabolic Diseases	ENSG00000166825	FALSE	Preclinical	2007-05-21	Unused	ANPEP
Metabolic Diseases	ENSG00000167910	FALSE	Preclinical	NA	Unused	CYP7A1
Metabolic Diseases	ENSG00000169083	FALSE	Preclinical	2008-09-22	Unused	AR
Metabolic Diseases	ENSG00000169174	FALSE	Preclinical	2016-05-10	Absent	PCSK9
Metabolic Diseases	ENSG00000169313	FALSE	Preclinical	2008-12-04	Unused	P2RY12
Metabolic Diseases	ENSG00000169403	FALSE	Preclinical	1996-06-15	Unused	PTAFR
Metabolic Diseases	ENSG00000169710	FALSE	Preclinical	2003-11-26	Unused	FASN
Metabolic Diseases	ENSG00000170323	FALSE	Preclinical	NA	Unused	FABP4
Metabolic Diseases	ENSG00000170522	FALSE	Preclinical	2009-06-23	Unused	ELOVL6
Metabolic Diseases	ENSG00000171497	FALSE	Preclinical	2009-07-28	Unused	PPID
Metabolic Diseases	ENSG00000171791	FALSE	Preclinical	2001-02-28	Unused	BCL2
Metabolic Diseases	ENSG00000173153	FALSE	Preclinical	2012-05-23	Absent	ESRRA
Metabolic Diseases	ENSG00000173250	FALSE	Preclinical	2014-01-17	Absent	GPR151
Metabolic Diseases	ENSG00000174437	FALSE	Preclinical	2014-02-26	Absent	ATP2A2
Metabolic Diseases	ENSG00000175445	FALSE	Preclinical	2012-11-23	Absent	LPL
Metabolic Diseases	ENSG00000177628	FALSE	Preclinical	1992-12-15	Unused	GBA
Metabolic Diseases	ENSG00000177669	FALSE	Preclinical	2011-08-16	Unused	MBOAT4
Metabolic Diseases	ENSG00000178394	FALSE	Preclinical	1995-08-15	Unused	HTR1A
Metabolic Diseases	ENSG00000178789	FALSE	Preclinical	2008-07-04	Unused	CD300LB
Metabolic Diseases	ENSG00000179921	FALSE	Preclinical	2012-12-21	Preclinical	GPBAR1
Metabolic Diseases	ENSG00000180871	FALSE	Preclinical	2017-12-20	Absent	CXCR2
Metabolic Diseases	ENSG00000181104	FALSE	Preclinical	2008-12-04	Unused	F2R
Metabolic Diseases	ENSG00000181856	FALSE	Phase II Clinical Trial	2010-02-26	Absent	SLC2A4
Metabolic Diseases	ENSG00000182333	FALSE	Preclinical	NA	Unused	LIPF
Metabolic Diseases	ENSG00000184502	FALSE	Preclinical	1994-11-15	Unused	GAST
Metabolic Diseases	ENSG00000185000	FALSE	Preclinical	2012-04-03	Preclinical	DGAT1
Metabolic Diseases	ENSG00000186188	FALSE	Preclinical	2011-08-16	Preclinical	FFAR4
Metabolic Diseases	ENSG00000186951	FALSE	Preclinical	2007-04-17	Unused	PPARA
Metabolic Diseases	ENSG00000188778	FALSE	Preclinical	1995-06-15	Unused	ADRB3
Metabolic Diseases	ENSG00000196396	FALSE	Preclinical	2006-08-09	Unused	PTPN1
Metabolic Diseases	ENSG00000196549	FALSE	Pre-registration	1993-03-15	Unused	MME
Metabolic Diseases	ENSG00000196611	FALSE	Preclinical	1990-05-15	Unused	MMP1
Metabolic Diseases	ENSG00000196664	FALSE	Preclinical	2017-04-05	Absent	TLR7
Metabolic Diseases	ENSG00000197635	FALSE	Preclinical	2007-05-21	Unused	DPP4
Metabolic Diseases	ENSG00000198793	FALSE	Preclinical	2014-07-04	Absent	MTOR
Metabolic Diseases	ENSG00000213903	FALSE	Preclinical	1998-07-15	Unused	LTB4R
Metabolic Diseases	ENSG00000215644	FALSE	unknown	2008-03-04	Absent	GCGR
Metabolic Diseases	ENSG00000228716	FALSE	unknown	NA	Unused	DHFR
Metabolic Diseases	ENSG00000243480	FALSE	Preclinical	NA	Unused	AMY2A
Metabolic Diseases	ENSG00000278540	FALSE	Preclinical	2006-08-09	Unused	ACACA
Metabolic Syndrome X	ENSG00000012504	FALSE	unknown	2010-09-21	Preclinical	NR1H4
Metabolic Syndrome X	ENSG00000017427	FALSE	unknown	2011-10-05	Absent	IGF1
Metabolic Syndrome X	ENSG00000072310	FALSE	unknown	2016-01-14	Absent	SREBF1
Metabolic Syndrome X	ENSG00000073756	FALSE	unknown	1996-04-15	Unused	PTGS2
Metabolic Syndrome X	ENSG00000091831	FALSE	Preclinical	2010-03-17	Unused	ESR1
Metabolic Syndrome X	ENSG00000095303	FALSE	unknown	1996-04-15	Unused	PTGS1
Metabolic Syndrome X	ENSG00000096717	FALSE	Phase I Clinical Trial	2011-02-16	Phase I Clinical Trial	SIRT1
Metabolic Syndrome X	ENSG00000104365	FALSE	unknown	1996-04-15	Unused	IKBKB
Metabolic Syndrome X	ENSG00000112033	FALSE	Preclinical	2003-11-20	Unused	PPARD
Metabolic Syndrome X	ENSG00000112541	FALSE	Preclinical	2008-09-26	Unused	PDE10A
Metabolic Syndrome X	ENSG00000113580	FALSE	Preclinical	2005-04-20	Unused	NR3C1
Metabolic Syndrome X	ENSG00000117594	FALSE	Phase II Clinical Trial	2005-03-13	Phase I Clinical Trial	HSD11B1
Metabolic Syndrome X	ENSG00000118432	FALSE	Preclinical	2007-04-23	Unused	CNR1
Metabolic Syndrome X	ENSG00000120915	FALSE	unknown	2007-06-26	Unused	EPHX2
Metabolic Syndrome X	ENSG00000121853	FALSE	Preclinical	2006-08-29	Preclinical	GHSR
Metabolic Syndrome X	ENSG00000126266	FALSE	Preclinical	2006-08-09	Unused	FFAR1
Metabolic Syndrome X	ENSG00000128285	FALSE	unknown	1996-12-15	Unused	MCHR1
Metabolic Syndrome X	ENSG00000132170	FALSE	Preclinical	1999-12-09	Unused	PPARG
Metabolic Syndrome X	ENSG00000134318	FALSE	unknown	2005-05-24	Phase I Clinical Trial	ROCK2
Metabolic Syndrome X	ENSG00000140443	FALSE	unknown	2004-10-21	Unused	IGF1R
Metabolic Syndrome X	ENSG00000141736	FALSE	unknown	2004-10-21	Unused	ERBB2
Metabolic Syndrome X	ENSG00000142949	FALSE	Preclinical	2005-05-24	Unused	PTPRF
Metabolic Syndrome X	ENSG00000151090	FALSE	unknown	NA	Unused	THRB
Metabolic Syndrome X	ENSG00000159640	FALSE	Preclinical	2005-08-08	Unused	ACE
Metabolic Syndrome X	ENSG00000166603	FALSE	Preclinical	2005-12-18	Unused	MC4R
Metabolic Syndrome X	ENSG00000167772	FALSE	Preclinical	2004-01-26	Unused	ANGPTL4
Metabolic Syndrome X	ENSG00000168000	FALSE	Preclinical	2008-08-26	Unused	BSCL2
Metabolic Syndrome X	ENSG00000171105	FALSE	Preclinical	2000-11-07	Unused	INSR
Metabolic Syndrome X	ENSG00000185000	FALSE	Phase II Clinical Trial	2008-11-24	Phase II Clinical Trial	DGAT1
Metabolic Syndrome X	ENSG00000186951	FALSE	Preclinical	1999-12-09	Unused	PPARA
Metabolic Syndrome X	ENSG00000188822	FALSE	Phase II Clinical Trial	2007-04-23	Phase II Clinical Trial	CNR2
Metabolic Syndrome X	ENSG00000198911	FALSE	unknown	2016-01-14	Absent	SREBF2
Metabolic Syndrome X	ENSG00000258839	FALSE	unknown	2005-12-18	Unused	MC1R
Mevalonate Kinase Deficiency	ENSG00000125538	TRUE	Approved	2003-12-08	Absent	IL1B
Microscopic Polyangiitis	ENSG00000102524	FALSE	Phase III Clinical Trial	1999-07-13	Absent	TNFSF13B
Microscopic Polyangiitis	ENSG00000156738	TRUE	Approved	1993-09-15	Absent	MS4A1
Microscopic Polyangiitis	ENSG00000197405	FALSE	unknown	2006-07-25	Absent	C5AR1
Migraine Disorders	ENSG00000006283	TRUE	Approved	2016-07-20	Approved	CACNA1G
Migraine Disorders	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-04-15	Phase II Clinical Trial	TBXA2R
Migraine Disorders	ENSG00000007171	FALSE	Phase III Clinical Trial	1992-09-15	Unused	NOS2
Migraine Disorders	ENSG00000043591	TRUE	Approved	1997-04-15	Approved	ADRB1
Migraine Disorders	ENSG00000050628	FALSE	Preclinical	2014-10-30	Absent	PTGER3
Migraine Disorders	ENSG00000059377	FALSE	Phase II Clinical Trial	2012-08-04	Phase II Clinical Trial	TBXAS1
Migraine Disorders	ENSG00000064989	FALSE	Pre-registration	1998-07-15	Phase II Clinical Trial	CALCRL
Migraine Disorders	ENSG00000069696	FALSE	unknown	1990-09-15	Unused	DRD4
Migraine Disorders	ENSG00000073756	TRUE	Approved	1997-01-15	Approved	PTGS2
Migraine Disorders	ENSG00000075043	TRUE	Approved	2003-09-05	Approved	KCNQ2
Migraine Disorders	ENSG00000078549	FALSE	Phase II Clinical Trial	2015-09-04	Absent	ADCYAP1R1
Migraine Disorders	ENSG00000082175	FALSE	Phase II Clinical Trial	1999-10-20	Phase II Clinical Trial	PGR
Migraine Disorders	ENSG00000082556	TRUE	Approved	2002-03-11	Approved	OPRK1
Migraine Disorders	ENSG00000087085	FALSE	Phase II Clinical Trial	1989-06-15	Unused	ACHE
Migraine Disorders	ENSG00000089250	FALSE	Preclinical	1996-03-15	Phase II Clinical Trial	NOS1
Migraine Disorders	ENSG00000091831	FALSE	Phase II Clinical Trial	1999-07-28	Phase II Clinical Trial	ESR1
Migraine Disorders	ENSG00000092964	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	DPYSL2
Migraine Disorders	ENSG00000095303	TRUE	Approved	1997-04-15	Approved	PTGS1
Migraine Disorders	ENSG00000101180	FALSE	Phase II Clinical Trial	2005-01-31	Phase II Clinical Trial	HRH3
Migraine Disorders	ENSG00000102468	TRUE	Approved	1990-09-15	Approved	HTR2A
Migraine Disorders	ENSG00000103546	FALSE	Preclinical	2009-05-27	Unused	SLC6A2
Migraine Disorders	ENSG00000108576	FALSE	Phase II Clinical Trial	2005-01-31	Phase II Clinical Trial	SLC6A4
Migraine Disorders	ENSG00000109991	FALSE	Preclinical	2012-11-23	Absent	P2RX3
Migraine Disorders	ENSG00000110680	FALSE	Pre-registration	2002-11-04	Phase I Clinical Trial	CALCA
Migraine Disorders	ENSG00000112038	TRUE	Approved	1993-09-15	Approved	OPRM1
Migraine Disorders	ENSG00000113749	FALSE	Phase II Clinical Trial	2005-01-31	Phase II Clinical Trial	HRH2
Migraine Disorders	ENSG00000115353	FALSE	Phase I Clinical Trial	1993-01-15	Unused	TACR1
Migraine Disorders	ENSG00000116329	FALSE	Phase III Clinical Trial	2002-03-11	Phase III Clinical Trial	OPRD1
Migraine Disorders	ENSG00000118432	FALSE	Phase II Clinical Trial	2003-08-19	Unused	CNR1
Migraine Disorders	ENSG00000121764	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR1
Migraine Disorders	ENSG00000129167	FALSE	unknown	NA	Unused	TPH1
Migraine Disorders	ENSG00000132329	FALSE	Phase III Clinical Trial	1998-07-15	Phase I Clinical Trial	RAMP1
Migraine Disorders	ENSG00000134640	FALSE	Phase II Clinical Trial	2000-07-11	Phase II Clinical Trial	MTNR1B
Migraine Disorders	ENSG00000135312	TRUE	Approved	1989-09-15	Approved	HTR1B
Migraine Disorders	ENSG00000135914	TRUE	Approved	1998-03-15	Approved	HTR2B
Migraine Disorders	ENSG00000136160	FALSE	Preclinical	1997-10-15	Unused	EDNRB
Migraine Disorders	ENSG00000137252	FALSE	Phase II Clinical Trial	2008-12-15	Phase II Clinical Trial	HCRTR2
Migraine Disorders	ENSG00000141433	FALSE	Preclinical	2016-08-17	Absent	ADCYAP1
Migraine Disorders	ENSG00000142319	FALSE	Phase II Clinical Trial	2005-01-31	Phase II Clinical Trial	SLC6A3
Migraine Disorders	ENSG00000144285	TRUE	Approved	1995-04-15	Approved	SCN1A
Migraine Disorders	ENSG00000144481	FALSE	Phase I Clinical Trial	2013-10-03	Absent	TRPM8
Migraine Disorders	ENSG00000144891	FALSE	Phase II Clinical Trial	1993-09-15	Unused	AGTR1
Migraine Disorders	ENSG00000147155	FALSE	unknown	NA	Unused	EBP
Migraine Disorders	ENSG00000147246	FALSE	Phase II Clinical Trial	1994-06-15	Unused	HTR2C
Migraine Disorders	ENSG00000147955	FALSE	Preclinical	1998-11-15	Unused	SIGMAR1
Migraine Disorders	ENSG00000148680	FALSE	Preclinical	2003-02-10	Unused	HTR7
Migraine Disorders	ENSG00000149295	TRUE	Approved	1994-08-15	Approved	DRD2
Migraine Disorders	ENSG00000150594	FALSE	unknown	2011-08-11	Absent	ADRA2A
Migraine Disorders	ENSG00000151067	FALSE	unknown	NA	Unused	CACNA1C
Migraine Disorders	ENSG00000151617	FALSE	Preclinical	1997-10-15	Unused	EDNRA
Migraine Disorders	ENSG00000153253	TRUE	Approved	1995-04-15	Approved	SCN3A
Migraine Disorders	ENSG00000153956	FALSE	Phase II Clinical Trial	2002-11-25	Phase II Clinical Trial	CACNA2D1
Migraine Disorders	ENSG00000155511	TRUE	Approved	1993-09-15	Approved	GRIA1
Migraine Disorders	ENSG00000157219	FALSE	Preclinical	2006-11-24	Unused	HTR5A
Migraine Disorders	ENSG00000159164	FALSE	Phase II Clinical Trial	NA	Unused	SV2A
Migraine Disorders	ENSG00000163485	FALSE	Phase I Clinical Trial	2002-04-04	Unused	ADORA1
Migraine Disorders	ENSG00000164082	FALSE	Phase II Clinical Trial	2009-04-21	Unused	GRM2
Migraine Disorders	ENSG00000164270	TRUE	Approved	NA	Approved	HTR4
Migraine Disorders	ENSG00000164867	FALSE	Preclinical	2009-06-26	Unused	NOS3
Migraine Disorders	ENSG00000166736	FALSE	Phase II Clinical Trial	1990-12-15	Phase I Clinical Trial	HTR3A
Migraine Disorders	ENSG00000168398	FALSE	Preclinical	1993-09-15	Unused	BDKRB2
Migraine Disorders	ENSG00000168412	FALSE	Phase II Clinical Trial	2000-07-11	Phase II Clinical Trial	MTNR1A
Migraine Disorders	ENSG00000168959	FALSE	Phase I Clinical Trial	2005-12-05	Unused	GRM5
Migraine Disorders	ENSG00000169252	TRUE	Approved	1999-10-20	Approved	ADRB2
Migraine Disorders	ENSG00000169432	FALSE	Preclinical	1997-01-15	Unused	SCN9A
Migraine Disorders	ENSG00000169836	FALSE	Preclinical	1994-11-15	Unused	TACR3
Migraine Disorders	ENSG00000171189	FALSE	Phase I Clinical Trial	2007-08-21	Unused	GRIK1
Migraine Disorders	ENSG00000171522	FALSE	Preclinical	2001-12-03	Phase I Clinical Trial	PTGER4
Migraine Disorders	ENSG00000173198	FALSE	Phase II Clinical Trial	2009-04-21	Unused	CYSLTR1
Migraine Disorders	ENSG00000176884	FALSE	Preclinical	1997-01-15	Unused	GRIN1
Migraine Disorders	ENSG00000178394	FALSE	Preclinical	1989-09-15	Unused	HTR1A
Migraine Disorders	ENSG00000179097	TRUE	Approved	1994-06-15	Approved	HTR1F
Migraine Disorders	ENSG00000179546	TRUE	Approved	1989-09-15	Approved	HTR1D
Migraine Disorders	ENSG00000180914	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	OXTR
Migraine Disorders	ENSG00000183873	TRUE	Approved	2009-12-07	Approved	SCN5A
Migraine Disorders	ENSG00000184156	TRUE	Approved	NA	Approved	KCNQ3
Migraine Disorders	ENSG00000184160	FALSE	unknown	2011-08-11	Absent	ADRA2C
Migraine Disorders	ENSG00000184845	FALSE	unknown	2004-03-30	Unused	DRD1
Migraine Disorders	ENSG00000186642	FALSE	unknown	2011-09-08	Absent	PDE2A
Migraine Disorders	ENSG00000186795	FALSE	Preclinical	2013-11-15	Absent	KCNK18
Migraine Disorders	ENSG00000196549	FALSE	Preclinical	1990-11-15	Unused	MME
Migraine Disorders	ENSG00000196639	FALSE	Phase II Clinical Trial	2005-01-31	Phase III Clinical Trial	HRH1
Migraine Disorders	ENSG00000196689	FALSE	Phase III Clinical Trial	2004-08-16	Unused	TRPV1
Migraine Disorders	ENSG00000198822	FALSE	Phase II Clinical Trial	2006-12-13	Unused	GRM3
Migraine Disorders	ENSG00000274286	FALSE	unknown	2011-08-11	Absent	ADRA2B
Mitochondrial Diseases	ENSG00000112033	FALSE	Preclinical	2013-10-08	Absent	PPARD
Mitochondrial Diseases	ENSG00000116044	FALSE	Phase II Clinical Trial	2014-01-07	Absent	NFE2L2
Mitochondrial Diseases	ENSG00000132170	FALSE	Preclinical	2017-08-04	Absent	PPARG
Mitochondrial Diseases	ENSG00000187266	FALSE	unknown	2008-06-12	Unused	EPOR
Mitochondrial Diseases	ENSG00000198793	FALSE	Preclinical	2007-01-26	Absent	MTOR
Mitochondrial Encephalomyopathies	ENSG00000025708	FALSE	Preclinical	2013-02-07	Absent	TYMP
Mitochondrial Encephalomyopathies	ENSG00000096717	FALSE	unknown	2006-01-16	Unused	SIRT1
Mitochondrial Encephalomyopathies	ENSG00000171497	FALSE	Preclinical	2009-06-11	Absent	PPID
Mitochondrial Myopathies	ENSG00000171497	FALSE	Preclinical	2009-06-11	Absent	PPID
Morphine Dependence	ENSG00000011677	FALSE	Preclinical	2009-07-16	Absent	GABRA3
Morphine Dependence	ENSG00000022355	FALSE	Preclinical	2009-07-16	Absent	GABRA1
Morphine Dependence	ENSG00000065989	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4A
Morphine Dependence	ENSG00000082556	FALSE	unknown	2009-12-04	Absent	OPRK1
Morphine Dependence	ENSG00000105650	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4C
Morphine Dependence	ENSG00000112038	FALSE	unknown	2009-12-04	Absent	OPRM1
Morphine Dependence	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE10A
Morphine Dependence	ENSG00000113448	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4D
Morphine Dependence	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE11A
Morphine Dependence	ENSG00000132170	FALSE	Preclinical	2009-09-28	Preclinical	PPARG
Morphine Dependence	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Morphine Dependence	ENSG00000151577	FALSE	Preclinical	1999-09-08	Unused	DRD3
Morphine Dependence	ENSG00000151834	FALSE	Preclinical	2009-07-16	Absent	GABRA2
Morphine Dependence	ENSG00000155511	FALSE	Preclinical	2002-11-15	Absent	GRIA1
Morphine Dependence	ENSG00000179142	FALSE	Preclinical	2009-07-16	Absent	CYP11B2
Morphine Dependence	ENSG00000184588	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4B
Morphine Dependence	ENSG00000186297	FALSE	Preclinical	2009-07-16	Absent	GABRA5
Morphine Dependence	ENSG00000187554	FALSE	Preclinical	2017-01-09	Absent	TLR5
Morphine Dependence	ENSG00000240972	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MIF
Motor Neuron Disease	ENSG00000064300	FALSE	Preclinical	1997-12-15	Unused	NGFR
Motor Neuron Disease	ENSG00000205542	FALSE	unknown	2010-01-14	Unused	TMSB4X
Mouth Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Mouth Neoplasms	ENSG00000027697	FALSE	Phase II Clinical Trial	2005-11-15	Absent	IFNGR1
Mouth Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2005-11-15	Absent	TNFRSF1A
Mouth Neoplasms	ENSG00000080824	FALSE	unknown	2003-11-25	Unused	HSP90AA1
Mouth Neoplasms	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Mouth Neoplasms	ENSG00000134545	FALSE	unknown	2006-11-24	Absent	KLRC1
Mouth Neoplasms	ENSG00000141510	FALSE	unknown	1995-01-15	Unused	TP53
Mouth Neoplasms	ENSG00000141736	FALSE	unknown	2012-07-10	Phase I Clinical Trial	ERBB2
Mouth Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2011-02-17	Absent	PDCD1
Mouth Neoplasms	ENSG00000198668	FALSE	unknown	2003-12-09	Absent	CALM1
Mouth Neoplasms	ENSG00000198900	FALSE	Preclinical	2007-02-28	Absent	TOP1
Movement Disorders	ENSG00000016391	FALSE	Preclinical	NA	Unused	CHDH
Movement Disorders	ENSG00000134640	FALSE	unknown	1995-12-15	Unused	MTNR1B
Movement Disorders	ENSG00000147246	FALSE	unknown	1995-12-15	Unused	HTR2C
Movement Disorders	ENSG00000165646	TRUE	Approved	2009-05-05	Approved	SLC18A2
Movement Disorders	ENSG00000168412	FALSE	unknown	1995-12-15	Unused	MTNR1A
Movement Disorders	ENSG00000168959	FALSE	unknown	2005-10-04	Preclinical	GRM5
Movement Disorders	ENSG00000176884	FALSE	Preclinical	NA	Absent	GRIN1
Mucocutaneous Lymph Node Syndrome	ENSG00000100453	FALSE	Preclinical	2013-03-12	Absent	GZMB
Mucocutaneous Lymph Node Syndrome	ENSG00000113580	FALSE	Pre-registration	2005-08-05	Approved	NR3C1
Mucocutaneous Lymph Node Syndrome	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Absent	IL1B
Mucopolysaccharidoses	ENSG00000010404	FALSE	Preclinical	2017-05-11	Absent	IDS
Mucopolysaccharidosis I	ENSG00000127415	TRUE	Approved	1996-09-15	Approved	IDUA
Mucopolysaccharidosis I	ENSG00000144285	FALSE	Preclinical	2013-12-23	Absent	SCN1A
Mucopolysaccharidosis I	ENSG00000171105	FALSE	Phase II Clinical Trial	2007-07-03	Preclinical	INSR
Mucopolysaccharidosis II	ENSG00000010404	TRUE	Approved	2000-09-28	Approved	IDS
Mucopolysaccharidosis III	ENSG00000108784	FALSE	Phase II Clinical Trial	2011-03-02	Preclinical	NAGLU
Mucopolysaccharidosis III	ENSG00000144455	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	SUMF1
Mucopolysaccharidosis III	ENSG00000181523	FALSE	Phase II Clinical Trial	2006-11-27	Phase II Clinical Trial	SGSH
Mucopolysaccharidosis IV	ENSG00000141012	TRUE	Approved	2002-03-01	Phase III Clinical Trial	GALNS
Mucopolysaccharidosis VI	ENSG00000113273	TRUE	Approved	1999-01-29	Approved	ARSB
Mucopolysaccharidosis VII	ENSG00000169919	TRUE	Approved	1999-12-07	Unused	GUSB
Mucositis	ENSG00000007171	FALSE	Phase II Clinical Trial	2001-05-09	Phase II Clinical Trial	NOS2
Mucositis	ENSG00000059377	FALSE	Preclinical	2017-12-06	Absent	TBXAS1
Mucositis	ENSG00000065325	FALSE	unknown	1997-03-15	Preclinical	GLP2R
Mucositis	ENSG00000065989	FALSE	Phase II Clinical Trial	2005-05-24	Absent	PDE4A
Mucositis	ENSG00000066468	TRUE	Approved	1996-06-15	Approved	FGFR2
Mucositis	ENSG00000067182	FALSE	Phase II Clinical Trial	2005-06-22	Unused	TNFRSF1A
Mucositis	ENSG00000073756	FALSE	Phase II Clinical Trial	2005-06-22	Unused	PTGS2
Mucositis	ENSG00000078579	FALSE	unknown	2002-02-01	Unused	FGF20
Mucositis	ENSG00000105976	FALSE	Preclinical	2007-07-04	Unused	MET
Mucositis	ENSG00000112096	FALSE	Preclinical	1999-10-20	Unused	SOD2
Mucositis	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Mucositis	ENSG00000114859	FALSE	Phase II Clinical Trial	2002-09-25	Phase I Clinical Trial	CLCN2
Mucositis	ENSG00000115590	FALSE	Phase II Clinical Trial	2005-06-22	Unused	IL1R2
Mucositis	ENSG00000116044	FALSE	unknown	2004-11-18	Unused	NFE2L2
Mucositis	ENSG00000118432	FALSE	Phase I Clinical Trial	1998-08-15	Absent	CNR1
Mucositis	ENSG00000134470	FALSE	Preclinical	1995-07-15	Unused	IL15RA
Mucositis	ENSG00000134640	FALSE	Phase II Clinical Trial	2014-12-11	Absent	MTNR1B
Mucositis	ENSG00000135446	FALSE	unknown	2005-08-02	Phase III Clinical Trial	CDK4
Mucositis	ENSG00000136244	FALSE	Phase II Clinical Trial	2007-01-15	Phase II Clinical Trial	IL6
Mucositis	ENSG00000146648	FALSE	Phase III Clinical Trial	1997-11-15	Phase III Clinical Trial	EGFR
Mucositis	ENSG00000150594	FALSE	Phase II Clinical Trial	2009-03-09	Phase II Clinical Trial	ADRA2A
Mucositis	ENSG00000164078	FALSE	Preclinical	2007-07-04	Unused	MST1R
Mucositis	ENSG00000168412	FALSE	Phase II Clinical Trial	2014-12-11	Absent	MTNR1A
Mucositis	ENSG00000169218	FALSE	unknown	1998-12-15	Unused	RSPO1
Mucositis	ENSG00000169432	FALSE	Preclinical	2017-12-06	Absent	SCN9A
Mucositis	ENSG00000170312	FALSE	unknown	2005-08-02	Phase III Clinical Trial	CDK1
Mucositis	ENSG00000184160	FALSE	Phase II Clinical Trial	2009-03-09	Phase II Clinical Trial	ADRA2C
Mucositis	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Mucositis	ENSG00000204174	FALSE	unknown	2006-07-31	Absent	NPY4R
Mucositis	ENSG00000274286	FALSE	Phase II Clinical Trial	2009-03-09	Phase II Clinical Trial	ADRA2B
Multiple Myeloma	ENSG00000004468	TRUE	Approved	2001-04-26	Phase II Clinical Trial	CD38
Multiple Myeloma	ENSG00000004487	FALSE	Phase I Clinical Trial	2008-07-31	Absent	KDM1A
Multiple Myeloma	ENSG00000005884	FALSE	Preclinical	2016-05-25	Absent	ITGA3
Multiple Myeloma	ENSG00000007908	FALSE	Phase I Clinical Trial	NA	Absent	SELE
Multiple Myeloma	ENSG00000010278	FALSE	Preclinical	2012-05-05	Absent	CD9
Multiple Myeloma	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Phase II Clinical Trial	BTK
Multiple Myeloma	ENSG00000010810	FALSE	Phase III Clinical Trial	2004-07-20	Phase I Clinical Trial	FYN
Multiple Myeloma	ENSG00000019582	FALSE	Phase I Clinical Trial	2003-04-08	Phase II Clinical Trial	CD74
Multiple Myeloma	ENSG00000019991	FALSE	Phase II Clinical Trial	2006-04-28	Absent	HGF
Multiple Myeloma	ENSG00000023445	FALSE	Preclinical	2008-10-17	Absent	BIRC3
Multiple Myeloma	ENSG00000026103	FALSE	Phase II Clinical Trial	2004-04-28	Absent	FAS
Multiple Myeloma	ENSG00000026508	FALSE	Preclinical	2012-06-12	Preclinical	CD44
Multiple Myeloma	ENSG00000026751	TRUE	Approved	2006-11-01	Phase III Clinical Trial	SLAMF7
Multiple Myeloma	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Multiple Myeloma	ENSG00000044574	FALSE	Phase II Clinical Trial	2007-11-19	Phase II Clinical Trial	HSPA5
Multiple Myeloma	ENSG00000048462	FALSE	Phase II Clinical Trial	2012-01-25	Absent	TNFRSF17
Multiple Myeloma	ENSG00000049249	FALSE	Phase I Clinical Trial	2005-11-15	Absent	TNFRSF9
Multiple Myeloma	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Multiple Myeloma	ENSG00000063176	FALSE	Phase II Clinical Trial	2006-06-05	Absent	SPHK2
Multiple Myeloma	ENSG00000066468	FALSE	Phase II Clinical Trial	2005-06-27	Phase I Clinical Trial	FGFR2
Multiple Myeloma	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Multiple Myeloma	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FGFR3
Multiple Myeloma	ENSG00000072571	FALSE	unknown	2006-12-15	Unused	HMMR
Multiple Myeloma	ENSG00000073756	FALSE	unknown	2002-03-25	Unused	PTGS2
Multiple Myeloma	ENSG00000076984	FALSE	Preclinical	2014-10-17	Absent	MAP2K7
Multiple Myeloma	ENSG00000077092	FALSE	unknown	NA	Preclinical	RARB
Multiple Myeloma	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Multiple Myeloma	ENSG00000078668	FALSE	unknown	2004-10-15	Phase II Clinical Trial	VDAC3
Multiple Myeloma	ENSG00000080824	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	HSP90AA1
Multiple Myeloma	ENSG00000082781	FALSE	Preclinical	2016-05-25	Absent	ITGB5
Multiple Myeloma	ENSG00000082898	FALSE	Phase III Clinical Trial	2012-01-06	Phase I Clinical Trial	XPO1
Multiple Myeloma	ENSG00000085563	FALSE	unknown	NA	Unused	ABCB1
Multiple Myeloma	ENSG00000087586	FALSE	Phase II Clinical Trial	2005-06-27	Phase I Clinical Trial	AURKA
Multiple Myeloma	ENSG00000089685	FALSE	Phase I Clinical Trial	2015-10-07	Absent	BIRC5
Multiple Myeloma	ENSG00000090339	FALSE	Phase II Clinical Trial	2004-01-26	Phase I Clinical Trial	ICAM1
Multiple Myeloma	ENSG00000091831	FALSE	Preclinical	2004-01-19	Unused	ESR1
Multiple Myeloma	ENSG00000091972	FALSE	Preclinical	2006-06-13	Phase II Clinical Trial	CD200
Multiple Myeloma	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Multiple Myeloma	ENSG00000096717	FALSE	unknown	2006-01-16	Unused	SIRT1
Multiple Myeloma	ENSG00000096968	FALSE	Phase II Clinical Trial	1999-03-17	Phase I Clinical Trial	JAK2
Multiple Myeloma	ENSG00000099860	FALSE	Preclinical	2014-10-17	Absent	GADD45B
Multiple Myeloma	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Multiple Myeloma	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC10
Multiple Myeloma	ENSG00000100644	FALSE	Phase I Clinical Trial	1997-04-15	Unused	HIF1A
Multiple Myeloma	ENSG00000100823	FALSE	Phase I Clinical Trial	2007-02-13	Unused	APEX1
Multiple Myeloma	ENSG00000101017	FALSE	unknown	1998-07-15	Unused	CD40
Multiple Myeloma	ENSG00000101266	FALSE	Phase I Clinical Trial	2007-05-23	Phase I Clinical Trial	CSNK2A1
Multiple Myeloma	ENSG00000101557	FALSE	Phase II Clinical Trial	2014-10-08	Absent	USP14
Multiple Myeloma	ENSG00000101966	FALSE	Preclinical	2008-10-17	Absent	XIAP
Multiple Myeloma	ENSG00000102096	FALSE	Preclinical	2011-03-15	Absent	PIM2
Multiple Myeloma	ENSG00000102524	FALSE	Phase II Clinical Trial	2000-05-03	Phase III Clinical Trial	TNFSF13B
Multiple Myeloma	ENSG00000102755	FALSE	Pre-registration	1994-03-15	Phase III Clinical Trial	FLT1
Multiple Myeloma	ENSG00000104365	FALSE	Phase I Clinical Trial	2003-04-22	Unused	IKBKB
Multiple Myeloma	ENSG00000104689	FALSE	Phase III Clinical Trial	2001-02-22	Phase II Clinical Trial	TNFRSF10A
Multiple Myeloma	ENSG00000105146	FALSE	Phase II Clinical Trial	2007-02-06	Unused	AURKC
Multiple Myeloma	ENSG00000105173	FALSE	Preclinical	2010-12-05	Unused	CCNE1
Multiple Myeloma	ENSG00000105383	FALSE	Phase I Clinical Trial	2017-02-07	Absent	CD33
Multiple Myeloma	ENSG00000105810	FALSE	unknown	2004-03-28	Phase II Clinical Trial	CDK6
Multiple Myeloma	ENSG00000105835	FALSE	Phase I Clinical Trial	2003-04-22	Unused	NAMPT
Multiple Myeloma	ENSG00000105851	FALSE	unknown	2003-09-05	Unused	PIK3CG
Multiple Myeloma	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase I Clinical Trial	MET
Multiple Myeloma	ENSG00000106348	FALSE	Phase I Clinical Trial	2000-11-09	Unused	IMPDH1
Multiple Myeloma	ENSG00000106462	FALSE	Preclinical	2016-03-18	Absent	EZH2
Multiple Myeloma	ENSG00000107562	FALSE	Phase II Clinical Trial	2007-04-10	Phase II Clinical Trial	CXCL12
Multiple Myeloma	ENSG00000107984	FALSE	Phase II Clinical Trial	2011-11-01	Phase II Clinical Trial	DKK1
Multiple Myeloma	ENSG00000108799	FALSE	Preclinical	2016-03-18	Absent	EZH1
Multiple Myeloma	ENSG00000109320	TRUE	Approved	1997-11-15	Approved	NFKB1
Multiple Myeloma	ENSG00000109685	FALSE	Preclinical	2015-07-27	Absent	NSD2
Multiple Myeloma	ENSG00000110330	FALSE	Preclinical	2008-10-17	Absent	BIRC2
Multiple Myeloma	ENSG00000110876	FALSE	Preclinical	2007-02-26	Absent	SELPLG
Multiple Myeloma	ENSG00000112062	FALSE	unknown	1998-07-15	Unused	MAPK14
Multiple Myeloma	ENSG00000112115	FALSE	Phase I Clinical Trial	2013-04-16	Absent	IL17A
Multiple Myeloma	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Multiple Myeloma	ENSG00000113070	FALSE	Phase II Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Multiple Myeloma	ENSG00000113580	TRUE	Approved	2011-05-20	Unused	NR3C1
Multiple Myeloma	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Multiple Myeloma	ENSG00000113749	FALSE	unknown	1996-05-15	Unused	HRH2
Multiple Myeloma	ENSG00000113851	FALSE	Phase I Clinical Trial	2011-08-26	Absent	CRBN
Multiple Myeloma	ENSG00000115232	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	ITGA4
Multiple Myeloma	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Multiple Myeloma	ENSG00000115590	FALSE	unknown	1997-05-15	Phase II Clinical Trial	IL1R2
Multiple Myeloma	ENSG00000115758	FALSE	Pre-registration	1994-03-15	Phase III Clinical Trial	ODC1
Multiple Myeloma	ENSG00000115884	FALSE	Phase II Clinical Trial	2004-04-05	Phase II Clinical Trial	SDC1
Multiple Myeloma	ENSG00000116044	FALSE	unknown	2005-05-27	Unused	NFE2L2
Multiple Myeloma	ENSG00000116478	TRUE	Approved	1994-12-15	Phase III Clinical Trial	HDAC1
Multiple Myeloma	ENSG00000116750	FALSE	Phase II Clinical Trial	2014-10-08	Absent	UCHL5
Multiple Myeloma	ENSG00000117091	FALSE	Preclinical	2016-10-27	Absent	CD48
Multiple Myeloma	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-08-09	Absent	TEK
Multiple Myeloma	ENSG00000120217	FALSE	Phase II Clinical Trial	2008-01-16	Preclinical	CD274
Multiple Myeloma	ENSG00000120659	FALSE	Phase II Clinical Trial	1997-07-15	Absent	TNFSF11
Multiple Myeloma	ENSG00000120889	FALSE	Phase III Clinical Trial	1997-04-15	Phase II Clinical Trial	TNFRSF10B
Multiple Myeloma	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Phase II Clinical Trial	TNFRSF8
Multiple Myeloma	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Multiple Myeloma	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase III Clinical Trial	PIK3CA
Multiple Myeloma	ENSG00000121966	FALSE	Phase III Clinical Trial	1997-10-15	Phase II Clinical Trial	CXCR4
Multiple Myeloma	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Multiple Myeloma	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK2
Multiple Myeloma	ENSG00000125498	FALSE	Phase I Clinical Trial	2001-12-19	Phase II Clinical Trial	KIR2DL1
Multiple Myeloma	ENSG00000125538	FALSE	unknown	2006-01-18	Preclinical	IL1B
Multiple Myeloma	ENSG00000126934	FALSE	Phase II Clinical Trial	2006-10-23	Phase II Clinical Trial	MAP2K2
Multiple Myeloma	ENSG00000128052	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Multiple Myeloma	ENSG00000128602	FALSE	Phase I Clinical Trial	2006-10-19	Phase I Clinical Trial	SMO
Multiple Myeloma	ENSG00000130164	FALSE	Phase II Clinical Trial	2007-11-19	Absent	LDLR
Multiple Myeloma	ENSG00000130303	FALSE	Preclinical	2007-07-19	Unused	BST2
Multiple Myeloma	ENSG00000131238	FALSE	Pre-registration	1994-03-15	Phase III Clinical Trial	PPT1
Multiple Myeloma	ENSG00000131747	TRUE	Approved	2003-04-08	Approved	TOP2A
Multiple Myeloma	ENSG00000131759	FALSE	unknown	NA	Preclinical	RARA
Multiple Myeloma	ENSG00000131981	FALSE	unknown	1997-05-15	Absent	LGALS3
Multiple Myeloma	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Multiple Myeloma	ENSG00000132507	FALSE	unknown	2009-02-05	Phase II Clinical Trial	EIF5A
Multiple Myeloma	ENSG00000132646	FALSE	Preclinical	2011-03-30	Preclinical	PCNA
Multiple Myeloma	ENSG00000132693	FALSE	unknown	2006-05-02	Phase I Clinical Trial	CRP
Multiple Myeloma	ENSG00000132906	FALSE	unknown	1997-05-15	Absent	CASP9
Multiple Myeloma	ENSG00000134058	FALSE	Preclinical	1997-01-15	Unused	CDK7
Multiple Myeloma	ENSG00000134250	FALSE	Phase II Clinical Trial	2012-09-29	Absent	NOTCH2
Multiple Myeloma	ENSG00000134460	FALSE	Phase II Clinical Trial	2007-08-23	Phase II Clinical Trial	IL2RA
Multiple Myeloma	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Multiple Myeloma	ENSG00000134853	FALSE	Phase I Clinical Trial	2001-04-03	Phase I Clinical Trial	PDGFRA
Multiple Myeloma	ENSG00000135077	FALSE	Preclinical	2005-07-01	Absent	HAVCR2
Multiple Myeloma	ENSG00000135446	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK4
Multiple Myeloma	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-11-09	Absent	MDM2
Multiple Myeloma	ENSG00000136244	FALSE	Phase II Clinical Trial	2010-07-09	Phase II Clinical Trial	IL6
Multiple Myeloma	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-01-15	Phase II Clinical Trial	CDK9
Multiple Myeloma	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Multiple Myeloma	ENSG00000136826	FALSE	unknown	2004-05-21	Absent	KLF4
Multiple Myeloma	ENSG00000136997	FALSE	Phase I Clinical Trial	2004-05-21	Absent	MYC
Multiple Myeloma	ENSG00000137193	FALSE	Preclinical	2009-02-13	Absent	PIM1
Multiple Myeloma	ENSG00000137801	FALSE	Preclinical	2017-11-16	Absent	THBS1
Multiple Myeloma	ENSG00000138160	FALSE	Phase III Clinical Trial	2006-04-03	Phase II Clinical Trial	KIF11
Multiple Myeloma	ENSG00000138448	FALSE	Preclinical	2016-05-25	Absent	ITGAV
Multiple Myeloma	ENSG00000139567	FALSE	Phase I Clinical Trial	2007-05-30	Phase I Clinical Trial	ACVRL1
Multiple Myeloma	ENSG00000139626	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	ITGB7
Multiple Myeloma	ENSG00000140009	FALSE	Preclinical	2004-01-19	Unused	ESR2
Multiple Myeloma	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-02-11	Phase I Clinical Trial	IGF1R
Multiple Myeloma	ENSG00000141655	FALSE	Preclinical	1999-09-15	Unused	TNFRSF11A
Multiple Myeloma	ENSG00000141736	FALSE	Preclinical	NA	Absent	ERBB2
Multiple Myeloma	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Phase I Clinical Trial	BRD4
Multiple Myeloma	ENSG00000142168	FALSE	unknown	2002-07-01	Unused	SOD1
Multiple Myeloma	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase III Clinical Trial	AKT1
Multiple Myeloma	ENSG00000143297	FALSE	Preclinical	2012-08-03	Preclinical	FCRL5
Multiple Myeloma	ENSG00000143384	FALSE	Phase I Clinical Trial	1997-01-15	Unused	MCL1
Multiple Myeloma	ENSG00000144744	FALSE	Phase II Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Multiple Myeloma	ENSG00000146648	FALSE	Phase II Clinical Trial	1999-12-09	Phase II Clinical Trial	EGFR
Multiple Myeloma	ENSG00000146904	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	EPHA1
Multiple Myeloma	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC8
Multiple Myeloma	ENSG00000147155	FALSE	unknown	1993-01-15	Unused	EBP
Multiple Myeloma	ENSG00000147955	FALSE	unknown	1993-01-15	Unused	SIGMAR1
Multiple Myeloma	ENSG00000149294	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NCAM1
Multiple Myeloma	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Multiple Myeloma	ENSG00000150093	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	ITGB1
Multiple Myeloma	ENSG00000156508	FALSE	Pre-registration	1994-03-15	Phase III Clinical Trial	EEF1A1
Multiple Myeloma	ENSG00000156738	FALSE	Preclinical	NA	Absent	MS4A1
Multiple Myeloma	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KIT
Multiple Myeloma	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	BRAF
Multiple Myeloma	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Multiple Myeloma	ENSG00000160712	FALSE	Phase II Clinical Trial	1991-04-15	Phase II Clinical Trial	IL6R
Multiple Myeloma	ENSG00000160801	FALSE	unknown	2003-04-08	Unused	PTH1R
Multiple Myeloma	ENSG00000161011	FALSE	Preclinical	2015-01-19	Absent	SQSTM1
Multiple Myeloma	ENSG00000161955	FALSE	Phase II Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13
Multiple Myeloma	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Unused	JAK1
Multiple Myeloma	ENSG00000162739	FALSE	Phase I Clinical Trial	2016-04-28	Absent	SLAMF6
Multiple Myeloma	ENSG00000162924	FALSE	Preclinical	2015-01-30	Absent	REL
Multiple Myeloma	ENSG00000163217	FALSE	Phase I Clinical Trial	2007-05-30	Absent	BMP10
Multiple Myeloma	ENSG00000163220	FALSE	Preclinical	2001-05-18	Absent	S100A9
Multiple Myeloma	ENSG00000163823	FALSE	Phase II Clinical Trial	1997-04-15	Unused	CCR1
Multiple Myeloma	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Unused	CASP3
Multiple Myeloma	ENSG00000164400	FALSE	Phase I Clinical Trial	1991-12-15	Unused	CSF2
Multiple Myeloma	ENSG00000164885	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK5
Multiple Myeloma	ENSG00000165280	FALSE	Phase I Clinical Trial	2013-11-18	Absent	VCP
Multiple Myeloma	ENSG00000165637	FALSE	unknown	2004-10-15	Phase II Clinical Trial	VDAC2
Multiple Myeloma	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Multiple Myeloma	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Multiple Myeloma	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Multiple Myeloma	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Multiple Myeloma	ENSG00000167325	TRUE	Approved	2000-07-26	Unused	RRM1
Multiple Myeloma	ENSG00000167658	FALSE	Preclinical	1991-04-15	Unused	EEF2
Multiple Myeloma	ENSG00000168398	FALSE	Phase II Clinical Trial	2004-06-18	Unused	BDKRB2
Multiple Myeloma	ENSG00000168522	FALSE	Phase I Clinical Trial	2006-07-12	Unused	FNTA
Multiple Myeloma	ENSG00000168610	FALSE	Phase I Clinical Trial	2007-08-28	Phase I Clinical Trial	STAT3
Multiple Myeloma	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Multiple Myeloma	ENSG00000169032	FALSE	Phase II Clinical Trial	2006-10-23	Phase II Clinical Trial	MAP2K1
Multiple Myeloma	ENSG00000169398	FALSE	Preclinical	2008-11-11	Absent	PTK2
Multiple Myeloma	ENSG00000169925	FALSE	Phase I Clinical Trial	2012-06-18	Phase I Clinical Trial	BRD3
Multiple Myeloma	ENSG00000170242	FALSE	Preclinical	2010-01-08	Preclinical	USP47
Multiple Myeloma	ENSG00000170312	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	CDK1
Multiple Myeloma	ENSG00000170430	FALSE	Phase I Clinical Trial	1998-06-15	Unused	MGMT
Multiple Myeloma	ENSG00000170820	FALSE	Preclinical	2010-08-25	Absent	FSHR
Multiple Myeloma	ENSG00000171608	FALSE	Phase II Clinical Trial	2003-09-05	Phase I Clinical Trial	PIK3CD
Multiple Myeloma	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC3
Multiple Myeloma	ENSG00000171791	FALSE	Phase III Clinical Trial	1992-03-15	Phase I Clinical Trial	BCL2
Multiple Myeloma	ENSG00000171848	TRUE	Approved	NA	Absent	RRM2
Multiple Myeloma	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Multiple Myeloma	ENSG00000172071	FALSE	Preclinical	2017-05-12	Absent	EIF2AK3
Multiple Myeloma	ENSG00000173083	FALSE	Phase I Clinical Trial	1997-09-15	Phase I Clinical Trial	HPSE
Multiple Myeloma	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Multiple Myeloma	ENSG00000175305	FALSE	Preclinical	2010-12-05	Unused	CCNE2
Multiple Myeloma	ENSG00000176105	FALSE	Phase I Clinical Trial	2004-07-20	Phase I Clinical Trial	YES1
Multiple Myeloma	ENSG00000177455	FALSE	Phase II Clinical Trial	2007-08-07	Phase II Clinical Trial	CD19
Multiple Myeloma	ENSG00000178035	FALSE	Phase I Clinical Trial	2000-11-09	Unused	IMPDH2
Multiple Myeloma	ENSG00000178562	FALSE	Phase I Clinical Trial	2008-02-13	Phase II Clinical Trial	CD28
Multiple Myeloma	ENSG00000178607	FALSE	Preclinical	2010-03-31	Preclinical	ERN1
Multiple Myeloma	ENSG00000178999	FALSE	Phase II Clinical Trial	2007-02-06	Unused	AURKB
Multiple Myeloma	ENSG00000181163	FALSE	Preclinical	2017-09-26	Absent	NPM1
Multiple Myeloma	ENSG00000182578	FALSE	Phase I Clinical Trial	2005-06-27	Phase I Clinical Trial	CSF1R
Multiple Myeloma	ENSG00000182866	FALSE	Phase I Clinical Trial	2004-07-20	Phase I Clinical Trial	LCK
Multiple Myeloma	ENSG00000184033	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	CTAG1B
Multiple Myeloma	ENSG00000184047	FALSE	Phase II Clinical Trial	2008-11-24	Absent	DIABLO
Multiple Myeloma	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Multiple Myeloma	ENSG00000185122	FALSE	Preclinical	2018-01-17	Absent	HSF1
Multiple Myeloma	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Absent	IL3RA
Multiple Myeloma	ENSG00000185499	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	MUC1
Multiple Myeloma	ENSG00000185686	FALSE	Preclinical	2014-04-01	Absent	PRAME
Multiple Myeloma	ENSG00000186716	FALSE	Phase II Clinical Trial	2004-07-20	Phase I Clinical Trial	BCR
Multiple Myeloma	ENSG00000187266	FALSE	Phase I Clinical Trial	2009-04-15	Preclinical	EPOR
Multiple Myeloma	ENSG00000187555	FALSE	Preclinical	2010-01-08	Preclinical	USP7
Multiple Myeloma	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Phase I Clinical Trial	PDCD1
Multiple Myeloma	ENSG00000196352	FALSE	Preclinical	2004-07-19	Preclinical	CD55
Multiple Myeloma	ENSG00000196591	TRUE	Approved	1994-12-15	Phase III Clinical Trial	HDAC2
Multiple Myeloma	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Multiple Myeloma	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Multiple Myeloma	ENSG00000197122	FALSE	Phase I Clinical Trial	2004-07-20	Phase I Clinical Trial	SRC
Multiple Myeloma	ENSG00000198355	FALSE	Preclinical	2011-03-15	Absent	PIM3
Multiple Myeloma	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Unused	NTRK1
Multiple Myeloma	ENSG00000198793	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	MTOR
Multiple Myeloma	ENSG00000198851	FALSE	Phase I Clinical Trial	2014-04-03	Absent	CD3E
Multiple Myeloma	ENSG00000198900	FALSE	Phase II Clinical Trial	2007-02-13	Phase II Clinical Trial	TOP1
Multiple Myeloma	ENSG00000203747	FALSE	Phase I Clinical Trial	2015-01-12	Absent	FCGR3A
Multiple Myeloma	ENSG00000213809	FALSE	Preclinical	NA	Absent	KLRK1
Multiple Myeloma	ENSG00000221867	FALSE	Phase II Clinical Trial	1998-07-15	Phase II Clinical Trial	MAGEA3
Multiple Myeloma	ENSG00000240505	FALSE	Phase II Clinical Trial	2015-01-24	Absent	TNFRSF13B
Multiple Myeloma	ENSG00000243772	FALSE	Phase I Clinical Trial	2001-12-19	Phase II Clinical Trial	KIR2DL3
Multiple Myeloma	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Multiple Myeloma	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Phase I Clinical Trial	PRKDC
Multiple Myeloma	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Phase I Clinical Trial	LYN
Multiple Myeloma	ENSG00000263761	FALSE	Phase I Clinical Trial	2007-05-30	Absent	GDF2
Multiple Myeloma	ENSG00000275302	FALSE	unknown	2004-01-20	Phase I Clinical Trial	CCL4
Multiple Myeloma	ENSG00000277632	FALSE	unknown	2004-01-20	Phase I Clinical Trial	CCL3
Multiple Sclerosis	ENSG00000004139	FALSE	Preclinical	2017-11-02	Absent	SARM1
Multiple Sclerosis	ENSG00000004487	FALSE	Phase I Clinical Trial	NA	Absent	KDM1A
Multiple Sclerosis	ENSG00000005381	FALSE	unknown	2005-01-28	Unused	MPO
Multiple Sclerosis	ENSG00000006210	FALSE	unknown	2006-02-07	Absent	CX3CL1
Multiple Sclerosis	ENSG00000006283	FALSE	Preclinical	1991-09-15	Unused	CACNA1G
Multiple Sclerosis	ENSG00000007171	FALSE	Preclinical	2003-09-17	Unused	NOS2
Multiple Sclerosis	ENSG00000007312	FALSE	Preclinical	2009-06-03	Unused	CD79B
Multiple Sclerosis	ENSG00000010610	FALSE	Phase I Clinical Trial	1990-06-15	Unused	CD4
Multiple Sclerosis	ENSG00000010671	FALSE	Phase I Clinical Trial	2013-01-11	Absent	BTK
Multiple Sclerosis	ENSG00000011677	FALSE	unknown	1999-12-13	Absent	GABRA3
Multiple Sclerosis	ENSG00000013725	FALSE	Phase I Clinical Trial	2007-09-10	Unused	CD6
Multiple Sclerosis	ENSG00000022355	FALSE	unknown	1999-12-13	Absent	GABRA1
Multiple Sclerosis	ENSG00000039537	FALSE	Preclinical	NA	Absent	C6
Multiple Sclerosis	ENSG00000050748	FALSE	unknown	2001-01-23	Absent	MAPK9
Multiple Sclerosis	ENSG00000064012	FALSE	unknown	1999-01-15	Unused	CASP8
Multiple Sclerosis	ENSG00000064300	FALSE	Preclinical	1997-12-15	Unused	NGFR
Multiple Sclerosis	ENSG00000065675	FALSE	Preclinical	2008-04-26	Unused	PRKCQ
Multiple Sclerosis	ENSG00000065989	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	PDE4A
Multiple Sclerosis	ENSG00000067182	FALSE	Preclinical	1992-05-15	Unused	TNFRSF1A
Multiple Sclerosis	ENSG00000067560	FALSE	Preclinical	2016-01-13	Absent	RHOA
Multiple Sclerosis	ENSG00000069535	FALSE	Phase I Clinical Trial	2011-08-20	Unused	MAOB
Multiple Sclerosis	ENSG00000072274	FALSE	Preclinical	2016-11-16	Absent	TFRC
Multiple Sclerosis	ENSG00000072571	FALSE	Preclinical	2000-10-26	Unused	HMMR
Multiple Sclerosis	ENSG00000072694	FALSE	Preclinical	2006-07-31	Preclinical	FCGR2B
Multiple Sclerosis	ENSG00000076706	FALSE	Preclinical	2015-01-30	Absent	MCAM
Multiple Sclerosis	ENSG00000077092	FALSE	Phase I Clinical Trial	1990-06-15	Unused	RARB
Multiple Sclerosis	ENSG00000077238	FALSE	Phase I Clinical Trial	1999-01-15	Unused	IL4R
Multiple Sclerosis	ENSG00000081051	FALSE	unknown	2001-02-27	Unused	AFP
Multiple Sclerosis	ENSG00000081237	FALSE	Preclinical	1997-11-15	Unused	PTPRC
Multiple Sclerosis	ENSG00000081985	FALSE	Preclinical	2002-11-14	Unused	IL12RB2
Multiple Sclerosis	ENSG00000082556	FALSE	Approved	2012-09-01	Absent	OPRK1
Multiple Sclerosis	ENSG00000082898	FALSE	unknown	2014-01-11	Absent	XPO1
Multiple Sclerosis	ENSG00000087085	FALSE	unknown	1990-02-15	Unused	ACHE
Multiple Sclerosis	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Multiple Sclerosis	ENSG00000088832	FALSE	Preclinical	1989-10-15	Unused	FKBP1A
Multiple Sclerosis	ENSG00000089041	FALSE	Preclinical	2005-12-28	Unused	P2RX7
Multiple Sclerosis	ENSG00000089692	FALSE	Preclinical	1998-06-15	Unused	LAG3
Multiple Sclerosis	ENSG00000090339	FALSE	Preclinical	2014-08-18	Absent	ICAM1
Multiple Sclerosis	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Multiple Sclerosis	ENSG00000094631	FALSE	Preclinical	2016-09-28	Absent	HDAC6
Multiple Sclerosis	ENSG00000096996	FALSE	Preclinical	2002-11-14	Unused	IL12RB1
Multiple Sclerosis	ENSG00000100292	FALSE	Preclinical	2015-02-12	Absent	HMOX1
Multiple Sclerosis	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Multiple Sclerosis	ENSG00000100644	FALSE	unknown	1997-04-15	Preclinical	HIF1A
Multiple Sclerosis	ENSG00000100985	FALSE	unknown	1995-01-15	Preclinical	MMP9
Multiple Sclerosis	ENSG00000101017	FALSE	Preclinical	2006-12-06	Unused	CD40
Multiple Sclerosis	ENSG00000101916	FALSE	unknown	2006-07-28	Phase I Clinical Trial	TLR8
Multiple Sclerosis	ENSG00000102245	FALSE	Phase II Clinical Trial	1994-06-15	Unused	CD40LG
Multiple Sclerosis	ENSG00000102524	FALSE	Preclinical	1999-07-13	Preclinical	TNFSF13B
Multiple Sclerosis	ENSG00000102967	FALSE	Phase I Clinical Trial	2002-11-13	Phase I Clinical Trial	DHODH
Multiple Sclerosis	ENSG00000103546	FALSE	Preclinical	2015-09-03	Absent	SLC6A2
Multiple Sclerosis	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Multiple Sclerosis	ENSG00000104321	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPA1
Multiple Sclerosis	ENSG00000104365	FALSE	unknown	2006-01-18	Unused	IKBKB
Multiple Sclerosis	ENSG00000105329	FALSE	Phase I Clinical Trial	NA	Unused	TGFB1
Multiple Sclerosis	ENSG00000105397	FALSE	Preclinical	NA	Preclinical	TYK2
Multiple Sclerosis	ENSG00000105639	FALSE	Phase I Clinical Trial	2009-06-10	Unused	JAK3
Multiple Sclerosis	ENSG00000105650	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	PDE4C
Multiple Sclerosis	ENSG00000105851	FALSE	unknown	2009-07-15	Phase I Clinical Trial	PIK3CG
Multiple Sclerosis	ENSG00000106018	FALSE	Preclinical	2014-09-09	Absent	VIPR2
Multiple Sclerosis	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Multiple Sclerosis	ENSG00000107643	FALSE	unknown	2001-01-23	Absent	MAPK8
Multiple Sclerosis	ENSG00000108576	FALSE	Preclinical	2015-09-03	Absent	SLC6A4
Multiple Sclerosis	ENSG00000108691	FALSE	Preclinical	2000-11-07	Phase I Clinical Trial	CCL2
Multiple Sclerosis	ENSG00000109320	FALSE	Preclinical	2009-05-27	Absent	NFKB1
Multiple Sclerosis	ENSG00000109339	FALSE	unknown	2001-01-23	Absent	MAPK10
Multiple Sclerosis	ENSG00000109471	FALSE	Phase I Clinical Trial	2013-11-26	Absent	IL2
Multiple Sclerosis	ENSG00000110324	FALSE	Preclinical	2010-08-16	Preclinical	IL10RA
Multiple Sclerosis	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Multiple Sclerosis	ENSG00000110492	FALSE	Preclinical	2009-05-19	Preclinical	MDK
Multiple Sclerosis	ENSG00000110719	FALSE	Preclinical	2002-11-21	Unused	TCIRG1
Multiple Sclerosis	ENSG00000110876	FALSE	Preclinical	2002-08-22	Absent	SELPLG
Multiple Sclerosis	ENSG00000110944	FALSE	Preclinical	2002-11-14	Unused	IL23A
Multiple Sclerosis	ENSG00000111144	FALSE	Preclinical	2012-01-11	Preclinical	LTA4H
Multiple Sclerosis	ENSG00000111262	FALSE	Preclinical	1994-12-15	Unused	KCNA1
Multiple Sclerosis	ENSG00000111319	FALSE	Preclinical	2007-07-13	Absent	SCNN1A
Multiple Sclerosis	ENSG00000111321	FALSE	unknown	2007-07-20	Unused	LTBR
Multiple Sclerosis	ENSG00000111424	FALSE	Preclinical	2011-05-07	Unused	VDR
Multiple Sclerosis	ENSG00000111537	FALSE	Preclinical	1990-11-15	Unused	IFNG
Multiple Sclerosis	ENSG00000112033	FALSE	Preclinical	2006-09-22	Unused	PPARD
Multiple Sclerosis	ENSG00000112038	FALSE	Approved	2012-09-01	Absent	OPRM1
Multiple Sclerosis	ENSG00000112062	FALSE	unknown	2001-09-11	Unused	MAPK14
Multiple Sclerosis	ENSG00000112115	FALSE	Preclinical	2007-03-28	Unused	IL17A
Multiple Sclerosis	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE10A
Multiple Sclerosis	ENSG00000113302	FALSE	Phase II Clinical Trial	1997-06-15	Unused	IL12B
Multiple Sclerosis	ENSG00000113448	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	PDE4D
Multiple Sclerosis	ENSG00000113494	FALSE	Phase II Clinical Trial	2007-12-13	Phase II Clinical Trial	PRLR
Multiple Sclerosis	ENSG00000113580	TRUE	Approved	1992-12-15	Approved	NR3C1
Multiple Sclerosis	ENSG00000113594	FALSE	Preclinical	2017-06-14	Absent	LIFR
Multiple Sclerosis	ENSG00000113721	FALSE	Preclinical	2006-12-08	Unused	PDGFRB
Multiple Sclerosis	ENSG00000114013	FALSE	Preclinical	1992-09-15	Unused	CD86
Multiple Sclerosis	ENSG00000115085	FALSE	Preclinical	2007-09-18	Unused	ZAP70
Multiple Sclerosis	ENSG00000115138	FALSE	Preclinical	2000-12-07	Unused	POMC
Multiple Sclerosis	ENSG00000115232	FALSE	Phase II Clinical Trial	1992-01-15	Phase II Clinical Trial	ITGA4
Multiple Sclerosis	ENSG00000115275	FALSE	Preclinical	NA	Unused	MOGS
Multiple Sclerosis	ENSG00000115310	FALSE	Phase I Clinical Trial	2003-05-06	Phase I Clinical Trial	RTN4
Multiple Sclerosis	ENSG00000115353	FALSE	Preclinical	1996-03-15	Unused	TACR1
Multiple Sclerosis	ENSG00000115414	FALSE	Preclinical	1997-04-15	Unused	FN1
Multiple Sclerosis	ENSG00000115457	FALSE	Phase I Clinical Trial	2010-10-19	Absent	IGFBP2
Multiple Sclerosis	ENSG00000115541	FALSE	Phase I Clinical Trial	2002-09-04	Unused	HSPE1
Multiple Sclerosis	ENSG00000115594	FALSE	Preclinical	2009-06-09	Preclinical	IL1R1
Multiple Sclerosis	ENSG00000116044	FALSE	Phase I Clinical Trial	2007-04-27	Unused	NFE2L2
Multiple Sclerosis	ENSG00000116478	FALSE	Preclinical	2007-12-18	Unused	HDAC1
Multiple Sclerosis	ENSG00000116824	FALSE	Preclinical	1989-08-15	Unused	CD2
Multiple Sclerosis	ENSG00000117480	FALSE	Preclinical	2012-03-17	Preclinical	FAAH
Multiple Sclerosis	ENSG00000118432	FALSE	Preclinical	2002-06-14	Approved	CNR1
Multiple Sclerosis	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Multiple Sclerosis	ENSG00000120889	FALSE	unknown	1997-04-15	Preclinical	TNFRSF10B
Multiple Sclerosis	ENSG00000121594	FALSE	Preclinical	1992-09-15	Unused	CD80
Multiple Sclerosis	ENSG00000121807	FALSE	Phase I Clinical Trial	1999-06-30	Unused	CCR2
Multiple Sclerosis	ENSG00000121966	FALSE	unknown	1996-07-15	Unused	CXCR4
Multiple Sclerosis	ENSG00000122025	FALSE	Preclinical	1993-05-15	Unused	FLT3
Multiple Sclerosis	ENSG00000124493	FALSE	Preclinical	2004-05-24	Preclinical	GRM4
Multiple Sclerosis	ENSG00000125538	FALSE	unknown	2009-06-09	Unused	IL1B
Multiple Sclerosis	ENSG00000125910	FALSE	unknown	2009-01-15	Absent	S1PR4
Multiple Sclerosis	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE11A
Multiple Sclerosis	ENSG00000130203	FALSE	Preclinical	1999-01-15	Unused	APOE
Multiple Sclerosis	ENSG00000131471	FALSE	Preclinical	2015-07-30	Preclinical	AOC3
Multiple Sclerosis	ENSG00000131747	FALSE	unknown	1993-05-15	Unused	TOP2A
Multiple Sclerosis	ENSG00000131981	FALSE	Preclinical	1998-04-15	Unused	LGALS3
Multiple Sclerosis	ENSG00000132170	FALSE	Preclinical	2006-09-22	Preclinical	PPARG
Multiple Sclerosis	ENSG00000132437	FALSE	unknown	2011-12-07	Absent	DDC
Multiple Sclerosis	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Multiple Sclerosis	ENSG00000134258	FALSE	unknown	2008-07-10	Unused	VTCN1
Multiple Sclerosis	ENSG00000134318	FALSE	Preclinical	2014-08-11	Absent	ROCK2
Multiple Sclerosis	ENSG00000134460	FALSE	Preclinical	NA	Unused	IL2RA
Multiple Sclerosis	ENSG00000134640	FALSE	unknown	2012-08-22	Absent	MTNR1B
Multiple Sclerosis	ENSG00000135655	FALSE	Preclinical	2017-01-17	Absent	USP15
Multiple Sclerosis	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Multiple Sclerosis	ENSG00000135898	FALSE	Phase II Clinical Trial	2009-11-14	Preclinical	GPR55
Multiple Sclerosis	ENSG00000136244	FALSE	unknown	2008-06-30	Phase I Clinical Trial	IL6
Multiple Sclerosis	ENSG00000136634	FALSE	Preclinical	2008-06-30	Phase I Clinical Trial	IL10
Multiple Sclerosis	ENSG00000136807	FALSE	Preclinical	2008-08-28	Unused	CDK9
Multiple Sclerosis	ENSG00000136869	FALSE	Phase II Clinical Trial	2006-08-17	Absent	TLR4
Multiple Sclerosis	ENSG00000137462	FALSE	unknown	2006-08-17	Absent	TLR2
Multiple Sclerosis	ENSG00000137752	FALSE	Preclinical	2013-01-03	Preclinical	CASP1
Multiple Sclerosis	ENSG00000138039	FALSE	unknown	2005-12-06	Unused	LHCGR
Multiple Sclerosis	ENSG00000139626	FALSE	Phase II Clinical Trial	1999-08-26	Phase II Clinical Trial	ITGB7
Multiple Sclerosis	ENSG00000140009	FALSE	Preclinical	2011-05-26	Preclinical	ESR2
Multiple Sclerosis	ENSG00000140443	FALSE	Phase I Clinical Trial	1999-04-28	Unused	IGF1R
Multiple Sclerosis	ENSG00000141505	FALSE	Preclinical	2017-05-30	Absent	ASGR1
Multiple Sclerosis	ENSG00000142166	FALSE	Phase I Clinical Trial	2007-06-15	Phase I Clinical Trial	IFNAR1
Multiple Sclerosis	ENSG00000143365	FALSE	Phase I Clinical Trial	2010-01-07	Preclinical	RORC
Multiple Sclerosis	ENSG00000146072	FALSE	Preclinical	2011-07-05	Unused	TNFRSF21
Multiple Sclerosis	ENSG00000146674	FALSE	Preclinical	2008-01-04	Absent	IGFBP3
Multiple Sclerosis	ENSG00000147246	FALSE	unknown	2012-08-22	Absent	HTR2C
Multiple Sclerosis	ENSG00000147955	FALSE	Preclinical	1996-05-15	Unused	SIGMAR1
Multiple Sclerosis	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Multiple Sclerosis	ENSG00000148180	FALSE	Preclinical	NA	Absent	GSN
Multiple Sclerosis	ENSG00000148408	FALSE	Preclinical	2000-03-22	Unused	CACNA1B
Multiple Sclerosis	ENSG00000150093	FALSE	Phase II Clinical Trial	1992-01-15	Phase II Clinical Trial	ITGB1
Multiple Sclerosis	ENSG00000150782	FALSE	unknown	1999-05-04	Unused	IL18
Multiple Sclerosis	ENSG00000151694	FALSE	Preclinical	1995-05-15	Unused	ADAM17
Multiple Sclerosis	ENSG00000151834	FALSE	unknown	1999-12-13	Absent	GABRA2
Multiple Sclerosis	ENSG00000152207	FALSE	Preclinical	2016-08-10	Absent	CYSLTR2
Multiple Sclerosis	ENSG00000153234	FALSE	Preclinical	2014-10-14	Absent	NR4A2
Multiple Sclerosis	ENSG00000154229	FALSE	Preclinical	1995-06-15	Unused	PRKCA
Multiple Sclerosis	ENSG00000155511	FALSE	Preclinical	1996-08-15	Unused	GRIA1
Multiple Sclerosis	ENSG00000156234	FALSE	Preclinical	2006-06-20	Preclinical	CXCL13
Multiple Sclerosis	ENSG00000156273	FALSE	Phase I Clinical Trial	2015-08-20	Absent	BACH1
Multiple Sclerosis	ENSG00000156738	FALSE	Preclinical	2013-05-24	Absent	MS4A1
Multiple Sclerosis	ENSG00000157168	FALSE	unknown	1989-06-15	Unused	NRG1
Multiple Sclerosis	ENSG00000157404	FALSE	Preclinical	2003-11-21	Unused	KIT
Multiple Sclerosis	ENSG00000158458	FALSE	Preclinical	2000-07-19	Unused	NRG2
Multiple Sclerosis	ENSG00000158473	FALSE	unknown	2007-07-16	Absent	CD1D
Multiple Sclerosis	ENSG00000159110	TRUE	Approved	1997-12-15	Approved	IFNAR2
Multiple Sclerosis	ENSG00000159164	FALSE	Phase II Clinical Trial	NA	Unused	SV2A
Multiple Sclerosis	ENSG00000159339	FALSE	Preclinical	2015-10-07	Absent	PADI4
Multiple Sclerosis	ENSG00000160712	FALSE	Preclinical	2007-11-16	Unused	IL6R
Multiple Sclerosis	ENSG00000160791	FALSE	Preclinical	1996-07-15	Unused	CCR5
Multiple Sclerosis	ENSG00000162434	FALSE	Preclinical	NA	Absent	JAK1
Multiple Sclerosis	ENSG00000162594	FALSE	Preclinical	2010-12-15	Unused	IL23R
Multiple Sclerosis	ENSG00000162692	FALSE	Preclinical	1997-04-15	Unused	VCAM1
Multiple Sclerosis	ENSG00000162924	FALSE	Preclinical	2015-01-30	Absent	REL
Multiple Sclerosis	ENSG00000163131	FALSE	Preclinical	1998-06-15	Unused	CTSS
Multiple Sclerosis	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Multiple Sclerosis	ENSG00000163599	FALSE	unknown	1999-06-30	Unused	CTLA4
Multiple Sclerosis	ENSG00000163702	FALSE	Preclinical	2007-08-10	Unused	IL17RC
Multiple Sclerosis	ENSG00000163823	FALSE	Preclinical	1997-04-15	Unused	CCR1
Multiple Sclerosis	ENSG00000164251	FALSE	Preclinical	2011-08-30	Unused	F2RL1
Multiple Sclerosis	ENSG00000164305	FALSE	Preclinical	1997-04-15	Preclinical	CASP3
Multiple Sclerosis	ENSG00000164400	FALSE	unknown	2002-04-15	Phase I Clinical Trial	CSF2
Multiple Sclerosis	ENSG00000165025	FALSE	Phase I Clinical Trial	2009-06-10	Unused	SYK
Multiple Sclerosis	ENSG00000165168	FALSE	Preclinical	2012-11-13	Preclinical	CYBB
Multiple Sclerosis	ENSG00000166224	FALSE	unknown	2006-11-03	Unused	SGPL1
Multiple Sclerosis	ENSG00000166598	FALSE	Preclinical	2001-05-22	Unused	HSP90B1
Multiple Sclerosis	ENSG00000166825	FALSE	Preclinical	2000-07-11	Unused	ANPEP
Multiple Sclerosis	ENSG00000167658	FALSE	Preclinical	1997-12-15	Unused	EEF2
Multiple Sclerosis	ENSG00000168412	FALSE	unknown	2012-08-22	Absent	MTNR1A
Multiple Sclerosis	ENSG00000168685	FALSE	Phase I Clinical Trial	2013-03-01	Absent	IL7R
Multiple Sclerosis	ENSG00000168811	FALSE	Phase II Clinical Trial	1997-06-15	Unused	IL12A
Multiple Sclerosis	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Multiple Sclerosis	ENSG00000169245	FALSE	Preclinical	2002-12-04	Unused	CXCL10
Multiple Sclerosis	ENSG00000169442	FALSE	Preclinical	2015-08-06	Absent	CD52
Multiple Sclerosis	ENSG00000169783	FALSE	Phase II Clinical Trial	2009-02-06	Phase II Clinical Trial	LINGO1
Multiple Sclerosis	ENSG00000170989	FALSE	Phase II Clinical Trial	2005-05-17	Phase I Clinical Trial	S1PR1
Multiple Sclerosis	ENSG00000171608	FALSE	Preclinical	2009-07-15	Phase I Clinical Trial	PIK3CD
Multiple Sclerosis	ENSG00000171855	FALSE	Phase I Clinical Trial	2000-03-29	Unused	IFNB1
Multiple Sclerosis	ENSG00000171862	FALSE	unknown	1999-02-15	Unused	PTEN
Multiple Sclerosis	ENSG00000172819	FALSE	Phase I Clinical Trial	2015-05-20	Absent	RARG
Multiple Sclerosis	ENSG00000172936	FALSE	unknown	2000-03-01	Unused	MYD88
Multiple Sclerosis	ENSG00000173083	FALSE	Preclinical	2000-08-04	Unused	HPSE
Multiple Sclerosis	ENSG00000173327	FALSE	Phase I Clinical Trial	2015-10-26	Absent	MAP3K11
Multiple Sclerosis	ENSG00000174080	FALSE	Preclinical	2001-03-05	Unused	CTSF
Multiple Sclerosis	ENSG00000174417	FALSE	Preclinical	NA	Unused	TRHR
Multiple Sclerosis	ENSG00000174600	FALSE	Preclinical	2014-12-15	Absent	CMKLR1
Multiple Sclerosis	ENSG00000175104	FALSE	unknown	2000-03-01	Unused	TRAF6
Multiple Sclerosis	ENSG00000175344	FALSE	unknown	NA	Preclinical	CHRNA7
Multiple Sclerosis	ENSG00000176884	FALSE	Phase II Clinical Trial	NA	Phase III Clinical Trial	GRIN1
Multiple Sclerosis	ENSG00000177272	FALSE	Preclinical	1990-02-15	Unused	KCNA3
Multiple Sclerosis	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Multiple Sclerosis	ENSG00000177663	FALSE	Preclinical	2016-03-18	Absent	IL17RA
Multiple Sclerosis	ENSG00000178394	FALSE	unknown	2011-12-07	Absent	HTR1A
Multiple Sclerosis	ENSG00000178562	FALSE	Preclinical	1992-09-15	Unused	CD28
Multiple Sclerosis	ENSG00000180739	FALSE	Phase II Clinical Trial	2006-02-13	Unused	S1PR5
Multiple Sclerosis	ENSG00000180871	FALSE	Preclinical	2003-09-09	Unused	CXCR2
Multiple Sclerosis	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Multiple Sclerosis	ENSG00000181092	FALSE	Preclinical	2004-09-20	Unused	ADIPOQ
Multiple Sclerosis	ENSG00000182578	FALSE	Preclinical	2003-11-21	Unused	CSF1R
Multiple Sclerosis	ENSG00000182687	FALSE	Preclinical	2013-09-18	Absent	GALR2
Multiple Sclerosis	ENSG00000183023	FALSE	Preclinical	2011-08-29	Unused	SLC8A1
Multiple Sclerosis	ENSG00000184216	FALSE	unknown	2000-03-01	Unused	IRAK1
Multiple Sclerosis	ENSG00000184588	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	PDE4B
Multiple Sclerosis	ENSG00000186297	FALSE	unknown	1999-12-13	Absent	GABRA5
Multiple Sclerosis	ENSG00000186810	FALSE	Preclinical	1997-03-15	Unused	CXCR3
Multiple Sclerosis	ENSG00000186951	FALSE	Preclinical	2006-09-22	Preclinical	PPARA
Multiple Sclerosis	ENSG00000187210	FALSE	Preclinical	NA	Unused	GCNT1
Multiple Sclerosis	ENSG00000187266	FALSE	Phase II Clinical Trial	2005-12-06	Phase II Clinical Trial	EPOR
Multiple Sclerosis	ENSG00000187764	FALSE	Phase I Clinical Trial	2006-06-20	Phase I Clinical Trial	SEMA4D
Multiple Sclerosis	ENSG00000188404	FALSE	Preclinical	2005-01-24	Unused	SELL
Multiple Sclerosis	ENSG00000188822	FALSE	Phase I Clinical Trial	2002-02-26	Approved	CNR2
Multiple Sclerosis	ENSG00000189221	FALSE	Preclinical	2011-08-20	Unused	MAOA
Multiple Sclerosis	ENSG00000196591	FALSE	Preclinical	2007-12-18	Unused	HDAC2
Multiple Sclerosis	ENSG00000196611	FALSE	unknown	1995-01-15	Preclinical	MMP1
Multiple Sclerosis	ENSG00000196664	FALSE	unknown	2006-07-28	Phase I Clinical Trial	TLR7
Multiple Sclerosis	ENSG00000196689	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPV1
Multiple Sclerosis	ENSG00000197272	FALSE	Phase I Clinical Trial	2004-08-03	Phase I Clinical Trial	IL27
Multiple Sclerosis	ENSG00000197329	FALSE	Preclinical	2017-04-04	Absent	PELI1
Multiple Sclerosis	ENSG00000197919	FALSE	unknown	1997-01-15	Unused	IFNA1
Multiple Sclerosis	ENSG00000197971	FALSE	Phase II Clinical Trial	1994-08-15	Unused	MBP
Multiple Sclerosis	ENSG00000198223	FALSE	Preclinical	1998-04-15	Unused	CSF2RA
Multiple Sclerosis	ENSG00000198793	FALSE	Preclinical	1999-02-15	Unused	MTOR
Multiple Sclerosis	ENSG00000198851	FALSE	Preclinical	2002-11-07	Unused	CD3E
Multiple Sclerosis	ENSG00000204628	FALSE	Preclinical	1995-06-15	Unused	RACK1
Multiple Sclerosis	ENSG00000205542	FALSE	unknown	1995-01-15	Preclinical	TMSB4X
Multiple Sclerosis	ENSG00000239732	FALSE	Preclinical	2006-07-28	Phase I Clinical Trial	TLR9
Multiple Sclerosis	ENSG00000240972	FALSE	Phase II Clinical Trial	2004-11-01	Phase II Clinical Trial	MIF
Multiple Sclerosis	ENSG00000261371	FALSE	Preclinical	1996-03-15	Absent	PECAM1
Multiple Sclerosis	ENSG00000262406	FALSE	Phase I Clinical Trial	2000-10-19	Phase I Clinical Trial	MMP12
Multiple Sclerosis	ENSG00000269858	FALSE	Preclinical	2010-07-08	Unused	EGLN2
Multiple Sclerosis	ENSG00000271503	FALSE	Preclinical	2000-11-07	Unused	CCL5
Multiple Sclerosis	ENSG00000272398	FALSE	Phase I Clinical Trial	NA	Absent	CD24
Multiple Sclerosis	ENSG00000275302	FALSE	Preclinical	2000-11-07	Unused	CCL4
Multiple Sclerosis	ENSG00000277632	FALSE	Preclinical	2000-11-07	Unused	CCL3
Multiple Sclerosis	ENSG00000282608	FALSE	Preclinical	2006-10-30	Unused	ADORA3
Multiple Sclerosis, Chronic Progressive	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Multiple Sclerosis, Chronic Progressive	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Multiple Sclerosis, Chronic Progressive	ENSG00000065989	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4A
Multiple Sclerosis, Chronic Progressive	ENSG00000067182	FALSE	unknown	NA	Unused	TNFRSF1A
Multiple Sclerosis, Chronic Progressive	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	FGFR3
Multiple Sclerosis, Chronic Progressive	ENSG00000069535	FALSE	Preclinical	NA	Absent	MAOB
Multiple Sclerosis, Chronic Progressive	ENSG00000100030	FALSE	Phase II Clinical Trial	2014-10-30	Absent	MAPK1
Multiple Sclerosis, Chronic Progressive	ENSG00000102882	FALSE	Phase II Clinical Trial	2014-10-30	Absent	MAPK3
Multiple Sclerosis, Chronic Progressive	ENSG00000103546	FALSE	Phase II Clinical Trial	2006-01-04	Phase II Clinical Trial	SLC6A2
Multiple Sclerosis, Chronic Progressive	ENSG00000105650	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4C
Multiple Sclerosis, Chronic Progressive	ENSG00000106018	FALSE	Preclinical	2014-09-09	Absent	VIPR2
Multiple Sclerosis, Chronic Progressive	ENSG00000108576	FALSE	Phase II Clinical Trial	2006-01-04	Phase II Clinical Trial	SLC6A4
Multiple Sclerosis, Chronic Progressive	ENSG00000110090	FALSE	Phase I Clinical Trial	2013-01-15	Phase I Clinical Trial	CPT1A
Multiple Sclerosis, Chronic Progressive	ENSG00000111144	FALSE	Preclinical	2012-01-11	Preclinical	LTA4H
Multiple Sclerosis, Chronic Progressive	ENSG00000111321	FALSE	Phase II Clinical Trial	2007-07-20	Unused	LTBR
Multiple Sclerosis, Chronic Progressive	ENSG00000112062	FALSE	unknown	NA	Unused	MAPK14
Multiple Sclerosis, Chronic Progressive	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE10A
Multiple Sclerosis, Chronic Progressive	ENSG00000113448	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4D
Multiple Sclerosis, Chronic Progressive	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	PDGFRB
Multiple Sclerosis, Chronic Progressive	ENSG00000115232	TRUE	Approved	1991-12-15	Phase III Clinical Trial	ITGA4
Multiple Sclerosis, Chronic Progressive	ENSG00000115310	FALSE	Phase I Clinical Trial	2009-04-08	Phase I Clinical Trial	RTN4
Multiple Sclerosis, Chronic Progressive	ENSG00000116044	FALSE	Phase III Clinical Trial	2003-10-13	Absent	NFE2L2
Multiple Sclerosis, Chronic Progressive	ENSG00000118432	TRUE	Approved	1998-08-15	Phase III Clinical Trial	CNR1
Multiple Sclerosis, Chronic Progressive	ENSG00000125910	FALSE	unknown	1997-12-15	Phase III Clinical Trial	S1PR4
Multiple Sclerosis, Chronic Progressive	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE11A
Multiple Sclerosis, Chronic Progressive	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Multiple Sclerosis, Chronic Progressive	ENSG00000131747	TRUE	Approved	1993-07-15	Approved	TOP2A
Multiple Sclerosis, Chronic Progressive	ENSG00000134460	FALSE	unknown	1992-04-15	Unused	IL2RA
Multiple Sclerosis, Chronic Progressive	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Multiple Sclerosis, Chronic Progressive	ENSG00000139626	TRUE	Approved	1991-12-15	Phase III Clinical Trial	ITGB7
Multiple Sclerosis, Chronic Progressive	ENSG00000142166	FALSE	Approved	2011-09-22	Absent	IFNAR1
Multiple Sclerosis, Chronic Progressive	ENSG00000150093	TRUE	Approved	1991-12-15	Phase III Clinical Trial	ITGB1
Multiple Sclerosis, Chronic Progressive	ENSG00000156738	TRUE	Approved	1993-09-15	Phase III Clinical Trial	MS4A1
Multiple Sclerosis, Chronic Progressive	ENSG00000157404	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	KIT
Multiple Sclerosis, Chronic Progressive	ENSG00000159110	TRUE	Approved	2010-04-26	Unused	IFNAR2
Multiple Sclerosis, Chronic Progressive	ENSG00000164400	FALSE	unknown	2005-06-06	Phase II Clinical Trial	CSF2
Multiple Sclerosis, Chronic Progressive	ENSG00000169442	TRUE	Approved	2014-09-09	Unused	CD52
Multiple Sclerosis, Chronic Progressive	ENSG00000169783	FALSE	Phase II Clinical Trial	2009-02-06	Phase I Clinical Trial	LINGO1
Multiple Sclerosis, Chronic Progressive	ENSG00000170989	FALSE	Phase III Clinical Trial	1997-12-15	Phase III Clinical Trial	S1PR1
Multiple Sclerosis, Chronic Progressive	ENSG00000171855	FALSE	Preclinical	2017-04-25	Absent	IFNB1
Multiple Sclerosis, Chronic Progressive	ENSG00000176890	FALSE	Preclinical	NA	Absent	TYMS
Multiple Sclerosis, Chronic Progressive	ENSG00000180739	FALSE	Phase III Clinical Trial	1997-12-15	Phase III Clinical Trial	S1PR5
Multiple Sclerosis, Chronic Progressive	ENSG00000184588	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4B
Multiple Sclerosis, Chronic Progressive	ENSG00000187266	FALSE	Preclinical	2006-10-18	Unused	EPOR
Multiple Sclerosis, Chronic Progressive	ENSG00000196839	FALSE	Phase III Clinical Trial	NA	Unused	ADA
Multiple Sclerosis, Chronic Progressive	ENSG00000197971	FALSE	Phase II Clinical Trial	2001-09-07	Phase I Clinical Trial	MBP
Multiple Sclerosis, Chronic Progressive	ENSG00000213694	FALSE	unknown	1997-12-15	Phase III Clinical Trial	S1PR3
Multiple Sclerosis, Chronic Progressive	ENSG00000228716	FALSE	Preclinical	NA	Absent	DHFR
Multiple Sclerosis, Chronic Progressive	ENSG00000240972	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MIF
Multiple Sclerosis, Chronic Progressive	ENSG00000242950	FALSE	Preclinical	2007-07-20	Absent	ERVW-1
Multiple Sclerosis, Chronic Progressive	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Multiple Sclerosis, Relapsing-Remitting	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000005844	FALSE	Phase II Clinical Trial	2006-12-04	Absent	ITGAL
Multiple Sclerosis, Relapsing-Remitting	ENSG00000010671	FALSE	Phase II Clinical Trial	2014-12-29	Absent	BTK
Multiple Sclerosis, Relapsing-Remitting	ENSG00000065989	FALSE	Phase II Clinical Trial	2001-06-27	Phase II Clinical Trial	PDE4A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000069535	FALSE	Preclinical	NA	Absent	MAOB
Multiple Sclerosis, Relapsing-Remitting	ENSG00000091831	FALSE	Phase II Clinical Trial	NA	Phase III Clinical Trial	ESR1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000101180	FALSE	Phase II Clinical Trial	2007-03-15	Phase II Clinical Trial	HRH3
Multiple Sclerosis, Relapsing-Remitting	ENSG00000102524	FALSE	Phase II Clinical Trial	2000-05-03	Phase II Clinical Trial	TNFSF13B
Multiple Sclerosis, Relapsing-Remitting	ENSG00000102967	TRUE	Approved	2001-02-20	Approved	DHODH
Multiple Sclerosis, Relapsing-Remitting	ENSG00000103546	FALSE	Phase II Clinical Trial	2006-01-04	Phase II Clinical Trial	SLC6A2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000105650	FALSE	Phase II Clinical Trial	2001-06-27	Phase II Clinical Trial	PDE4C
Multiple Sclerosis, Relapsing-Remitting	ENSG00000107738	FALSE	Preclinical	2011-10-03	Absent	VSIR
Multiple Sclerosis, Relapsing-Remitting	ENSG00000108576	FALSE	Phase II Clinical Trial	2006-01-04	Phase II Clinical Trial	SLC6A4
Multiple Sclerosis, Relapsing-Remitting	ENSG00000112115	FALSE	Phase II Clinical Trial	2006-02-01	Phase II Clinical Trial	IL17A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE10A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000113448	FALSE	Phase II Clinical Trial	2001-06-27	Phase II Clinical Trial	PDE4D
Multiple Sclerosis, Relapsing-Remitting	ENSG00000113580	FALSE	Phase II Clinical Trial	2008-04-21	Phase II Clinical Trial	NR3C1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000115232	TRUE	Approved	1991-12-15	Approved	ITGA4
Multiple Sclerosis, Relapsing-Remitting	ENSG00000115310	FALSE	Phase I Clinical Trial	2009-04-08	Phase I Clinical Trial	RTN4
Multiple Sclerosis, Relapsing-Remitting	ENSG00000116044	TRUE	Approved	2003-10-13	Approved	NFE2L2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000118432	TRUE	Approved	1998-08-15	Absent	CNR1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000121807	FALSE	unknown	2003-02-24	Unused	CCR2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000125910	TRUE	Approved	1997-12-15	Approved	S1PR4
Multiple Sclerosis, Relapsing-Remitting	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE11A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Multiple Sclerosis, Relapsing-Remitting	ENSG00000131747	TRUE	Approved	1993-07-15	Approved	TOP2A
Multiple Sclerosis, Relapsing-Remitting	ENSG00000132170	FALSE	Phase II Clinical Trial	2000-05-11	Absent	PPARG
Multiple Sclerosis, Relapsing-Remitting	ENSG00000134460	TRUE	Approved	1992-04-15	Unused	IL2RA
Multiple Sclerosis, Relapsing-Remitting	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Multiple Sclerosis, Relapsing-Remitting	ENSG00000139626	TRUE	Approved	1991-12-15	Approved	ITGB7
Multiple Sclerosis, Relapsing-Remitting	ENSG00000142166	FALSE	Approved	2005-05-27	Unused	IFNAR1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000150093	TRUE	Approved	1991-12-15	Approved	ITGB1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000156738	TRUE	Approved	1993-09-15	Phase III Clinical Trial	MS4A1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000159110	TRUE	Approved	2005-05-27	Unused	IFNAR2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
Multiple Sclerosis, Relapsing-Remitting	ENSG00000159958	FALSE	unknown	2010-10-21	Absent	TNFRSF13C
Multiple Sclerosis, Relapsing-Remitting	ENSG00000161955	FALSE	unknown	2000-05-03	Unused	TNFSF13
Multiple Sclerosis, Relapsing-Remitting	ENSG00000163823	FALSE	unknown	2000-04-05	Unused	CCR1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000164171	FALSE	Phase II Clinical Trial	2006-02-13	Phase I Clinical Trial	ITGA2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000164400	FALSE	Phase II Clinical Trial	2005-06-06	Phase II Clinical Trial	CSF2
Multiple Sclerosis, Relapsing-Remitting	ENSG00000168685	FALSE	Phase I Clinical Trial	2013-03-09	Absent	IL7R
Multiple Sclerosis, Relapsing-Remitting	ENSG00000169442	TRUE	Approved	2011-07-01	Approved	CD52
Multiple Sclerosis, Relapsing-Remitting	ENSG00000169783	FALSE	Phase II Clinical Trial	2009-02-06	Phase I Clinical Trial	LINGO1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000170989	TRUE	Approved	1997-12-15	Approved	S1PR1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000171855	FALSE	Preclinical	2015-01-05	Absent	IFNB1
Multiple Sclerosis, Relapsing-Remitting	ENSG00000177455	FALSE	Phase II Clinical Trial	2007-08-07	Phase I Clinical Trial	CD19
Multiple Sclerosis, Relapsing-Remitting	ENSG00000180739	TRUE	Approved	1997-12-15	Approved	S1PR5
Multiple Sclerosis, Relapsing-Remitting	ENSG00000182175	FALSE	Phase I Clinical Trial	2015-11-13	Absent	RGMA
Multiple Sclerosis, Relapsing-Remitting	ENSG00000184588	FALSE	Phase II Clinical Trial	2001-06-27	Phase II Clinical Trial	PDE4B
Multiple Sclerosis, Relapsing-Remitting	ENSG00000196839	FALSE	unknown	NA	Unused	ADA
Multiple Sclerosis, Relapsing-Remitting	ENSG00000197971	TRUE	Approved	1994-12-15	Approved	MBP
Multiple Sclerosis, Relapsing-Remitting	ENSG00000213694	TRUE	Approved	1997-12-15	Approved	S1PR3
Multiple Sclerosis, Relapsing-Remitting	ENSG00000240972	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MIF
Multiple Sclerosis, Relapsing-Remitting	ENSG00000242950	FALSE	Phase II Clinical Trial	2007-07-20	Absent	ERVW-1
Multiple System Atrophy	ENSG00000005381	FALSE	unknown	2006-02-07	Absent	MPO
Multiple System Atrophy	ENSG00000069535	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAOB
Multiple System Atrophy	ENSG00000138379	FALSE	Preclinical	2016-12-20	Absent	MSTN
Multiple System Atrophy	ENSG00000145335	FALSE	Phase I Clinical Trial	2009-06-01	Absent	SNCA
Multiple System Atrophy	ENSG00000168621	FALSE	unknown	2008-09-26	Preclinical	GDNF
Muscle Spasticity	ENSG00000011677	FALSE	unknown	2000-05-24	Unused	GABRA3
Muscle Spasticity	ENSG00000022355	FALSE	Preclinical	2000-05-24	Unused	GABRA1
Muscle Spasticity	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Muscle Spasticity	ENSG00000104321	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPA1
Muscle Spasticity	ENSG00000118432	TRUE	Approved	1998-08-15	Approved	CNR1
Muscle Spasticity	ENSG00000135898	FALSE	Phase II Clinical Trial	2009-11-14	Absent	GPR55
Muscle Spasticity	ENSG00000145839	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL9
Muscle Spasticity	ENSG00000147168	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL2RG
Muscle Spasticity	ENSG00000151834	FALSE	unknown	2000-05-24	Unused	GABRA2
Muscle Spasticity	ENSG00000155511	FALSE	Preclinical	2005-03-30	Unused	GRIA1
Muscle Spasticity	ENSG00000164136	FALSE	Phase I Clinical Trial	2014-10-28	Absent	IL15
Muscle Spasticity	ENSG00000186297	FALSE	unknown	2000-05-24	Unused	GABRA5
Muscle Spasticity	ENSG00000188822	FALSE	Phase I Clinical Trial	2014-11-21	Absent	CNR2
Muscle Spasticity	ENSG00000196689	FALSE	Phase II Clinical Trial	2014-09-11	Absent	TRPV1
Muscular Atrophy	ENSG00000096717	FALSE	unknown	2008-10-21	Preclinical	SIRT1
Muscular Atrophy	ENSG00000114739	FALSE	Phase II Clinical Trial	2010-07-02	Preclinical	ACVR2B
Muscular Atrophy	ENSG00000138379	FALSE	Phase II Clinical Trial	2009-06-02	Phase II Clinical Trial	MSTN
Muscular Atrophy	ENSG00000169083	FALSE	Phase II Clinical Trial	2008-07-22	Unused	AR
Muscular Atrophy	ENSG00000259384	FALSE	Preclinical	1999-09-09	Unused	GH1
Muscular Atrophy, Spinal	ENSG00000105329	FALSE	Preclinical	2014-03-15	Absent	TGFB1
Muscular Atrophy, Spinal	ENSG00000106018	FALSE	Preclinical	2014-09-09	Absent	VIPR2
Muscular Atrophy, Spinal	ENSG00000110063	FALSE	Phase I Clinical Trial	2010-06-10	Phase I Clinical Trial	DCPS
Muscular Atrophy, Spinal	ENSG00000116478	FALSE	Preclinical	2008-08-11	Unused	HDAC1
Muscular Atrophy, Spinal	ENSG00000122756	FALSE	unknown	NA	Absent	CNTFR
Muscular Atrophy, Spinal	ENSG00000134569	FALSE	Preclinical	2016-07-28	Absent	LRP4
Muscular Atrophy, Spinal	ENSG00000144285	FALSE	Phase III Clinical Trial	NA	Absent	SCN1A
Muscular Atrophy, Spinal	ENSG00000153253	FALSE	Phase III Clinical Trial	NA	Absent	SCN3A
Muscular Atrophy, Spinal	ENSG00000171720	FALSE	unknown	2007-04-13	Preclinical	HDAC3
Muscular Atrophy, Spinal	ENSG00000172062	FALSE	Phase III Clinical Trial	2003-01-02	Unused	SMN1
Muscular Atrophy, Spinal	ENSG00000205571	TRUE	Approved	2003-02-13	Phase II Clinical Trial	SMN2
Muscular Disorders, Atrophic	ENSG00000017427	FALSE	Phase II Clinical Trial	2011-10-05	Absent	IGF1
Muscular Disorders, Atrophic	ENSG00000080824	FALSE	Phase I Clinical Trial	2009-10-27	Absent	HSP90AA1
Muscular Disorders, Atrophic	ENSG00000196218	FALSE	Preclinical	2008-07-04	Absent	RYR1
Muscular Dystrophies	ENSG00000109320	FALSE	Preclinical	2008-02-11	Unused	NFKB1
Muscular Dystrophies	ENSG00000111640	FALSE	Phase I Clinical Trial	1998-10-15	Phase I Clinical Trial	GAPDH
Muscular Dystrophies	ENSG00000130368	FALSE	Preclinical	2016-02-10	Absent	MAS1
Muscular Dystrophies	ENSG00000135047	FALSE	Preclinical	1997-01-15	Unused	CTSL
Muscular Dystrophies	ENSG00000135424	FALSE	Preclinical	2015-11-16	Preclinical	ITGA7
Muscular Dystrophies	ENSG00000150093	FALSE	Preclinical	2015-11-16	Absent	ITGB1
Muscular Dystrophies	ENSG00000152818	FALSE	Preclinical	NA	Preclinical	UTRN
Muscular Dystrophies	ENSG00000164733	FALSE	Preclinical	1997-01-15	Unused	CTSB
Muscular Dystrophies	ENSG00000173402	FALSE	Preclinical	2014-10-28	Preclinical	DAG1
Muscular Dystrophies	ENSG00000178209	FALSE	Preclinical	2009-12-18	Unused	PLEC
Muscular Dystrophies	ENSG00000198947	FALSE	Preclinical	1993-11-15	Unused	DMD
Muscular Dystrophies, Limb-Girdle	ENSG00000135424	FALSE	Preclinical	NA	Preclinical	ITGA7
Muscular Dystrophies, Limb-Girdle	ENSG00000135636	FALSE	Preclinical	2011-05-10	Preclinical	DYSF
Muscular Dystrophies, Limb-Girdle	ENSG00000138379	FALSE	unknown	1997-04-15	Unused	MSTN
Muscular Dystrophies, Limb-Girdle	ENSG00000152818	FALSE	Preclinical	NA	Preclinical	UTRN
Muscular Dystrophies, Limb-Girdle	ENSG00000170445	FALSE	Phase II Clinical Trial	NA	Absent	HARS
Muscular Dystrophies, Limb-Girdle	ENSG00000173402	FALSE	Preclinical	NA	Preclinical	DAG1
Muscular Dystrophies, Limb-Girdle	ENSG00000196218	FALSE	Preclinical	2008-07-04	Absent	RYR1
Muscular Dystrophies, Limb-Girdle	ENSG00000198947	FALSE	Preclinical	NA	Preclinical	DMD
Muscular Dystrophy, Duchenne	ENSG00000006638	FALSE	Preclinical	1991-10-15	Absent	TBXA2R
Muscular Dystrophy, Duchenne	ENSG00000017427	FALSE	Preclinical	NA	Unused	IGF1
Muscular Dystrophy, Duchenne	ENSG00000073756	FALSE	Phase II Clinical Trial	1996-08-15	Absent	PTGS2
Muscular Dystrophy, Duchenne	ENSG00000090006	FALSE	Preclinical	2016-10-21	Absent	LTBP4
Muscular Dystrophy, Duchenne	ENSG00000090020	FALSE	Phase I Clinical Trial	2001-08-08	Absent	SLC9A1
Muscular Dystrophy, Duchenne	ENSG00000095303	FALSE	Phase II Clinical Trial	1996-08-15	Absent	PTGS1
Muscular Dystrophy, Duchenne	ENSG00000101916	FALSE	unknown	2012-03-16	Absent	TLR8
Muscular Dystrophy, Duchenne	ENSG00000103811	FALSE	Phase III Clinical Trial	NA	Unused	CTSH
Muscular Dystrophy, Duchenne	ENSG00000108576	FALSE	Preclinical	2008-09-18	Unused	SLC6A4
Muscular Dystrophy, Duchenne	ENSG00000109320	FALSE	Preclinical	2011-08-20	Absent	NFKB1
Muscular Dystrophy, Duchenne	ENSG00000112033	FALSE	Phase I Clinical Trial	2013-10-08	Absent	PPARD
Muscular Dystrophy, Duchenne	ENSG00000113580	TRUE	Approved	2005-08-05	Preclinical	NR3C1
Muscular Dystrophy, Duchenne	ENSG00000114812	FALSE	Phase I Clinical Trial	2010-11-16	Absent	VIPR1
Muscular Dystrophy, Duchenne	ENSG00000115232	FALSE	Preclinical	2000-01-26	Absent	ITGA4
Muscular Dystrophy, Duchenne	ENSG00000115590	FALSE	Phase III Clinical Trial	1997-05-15	Preclinical	IL1R2
Muscular Dystrophy, Duchenne	ENSG00000118523	FALSE	Phase II Clinical Trial	1999-09-14	Absent	CTGF
Muscular Dystrophy, Duchenne	ENSG00000123374	FALSE	Preclinical	1999-06-10	Absent	CDK2
Muscular Dystrophy, Duchenne	ENSG00000130368	FALSE	Preclinical	NA	Absent	MAS1
Muscular Dystrophy, Duchenne	ENSG00000135047	FALSE	Phase III Clinical Trial	NA	Unused	CTSL
Muscular Dystrophy, Duchenne	ENSG00000135424	FALSE	Preclinical	2015-11-11	Unused	ITGA7
Muscular Dystrophy, Duchenne	ENSG00000138379	FALSE	Phase III Clinical Trial	1997-04-15	Phase II Clinical Trial	MSTN
Muscular Dystrophy, Duchenne	ENSG00000138735	FALSE	Phase III Clinical Trial	1991-09-15	Absent	PDE5A
Muscular Dystrophy, Duchenne	ENSG00000143799	FALSE	unknown	2002-03-12	Preclinical	PARP1
Muscular Dystrophy, Duchenne	ENSG00000150093	FALSE	Preclinical	2015-11-11	Absent	ITGB1
Muscular Dystrophy, Duchenne	ENSG00000152818	FALSE	Phase II Clinical Trial	1995-05-15	Phase I Clinical Trial	UTRN
Muscular Dystrophy, Duchenne	ENSG00000160712	FALSE	Phase III Clinical Trial	1997-05-15	Preclinical	IL6R
Muscular Dystrophy, Duchenne	ENSG00000163106	FALSE	Preclinical	2013-12-10	Absent	HPGDS
Muscular Dystrophy, Duchenne	ENSG00000164733	FALSE	Phase III Clinical Trial	NA	Unused	CTSB
Muscular Dystrophy, Duchenne	ENSG00000166224	FALSE	Preclinical	2006-11-03	Absent	SGPL1
Muscular Dystrophy, Duchenne	ENSG00000168229	FALSE	Phase II Clinical Trial	2014-09-24	Absent	PTGDR
Muscular Dystrophy, Duchenne	ENSG00000169083	FALSE	Phase I Clinical Trial	2004-01-19	Unused	AR
Muscular Dystrophy, Duchenne	ENSG00000173402	FALSE	Preclinical	NA	Preclinical	DAG1
Muscular Dystrophy, Duchenne	ENSG00000174437	FALSE	Preclinical	2012-09-04	Preclinical	ATP2A2
Muscular Dystrophy, Duchenne	ENSG00000185231	FALSE	Phase II Clinical Trial	2013-09-03	Absent	MC2R
Muscular Dystrophy, Duchenne	ENSG00000196218	FALSE	Phase I Clinical Trial	2008-07-04	Preclinical	RYR1
Muscular Dystrophy, Duchenne	ENSG00000196262	FALSE	Preclinical	2004-08-31	Absent	PPIA
Muscular Dystrophy, Duchenne	ENSG00000196664	FALSE	unknown	2012-03-16	Absent	TLR7
Muscular Dystrophy, Duchenne	ENSG00000198947	TRUE	Approved	1997-05-15	Approved	DMD
Muscular Dystrophy, Duchenne	ENSG00000205542	FALSE	unknown	2010-01-14	Unused	TMSB4X
Muscular Dystrophy, Duchenne	ENSG00000239732	FALSE	unknown	2012-03-16	Absent	TLR9
Muscular Dystrophy, Facioscapulohumeral	ENSG00000138379	FALSE	Preclinical	1997-04-15	Unused	MSTN
Muscular Dystrophy, Facioscapulohumeral	ENSG00000141867	FALSE	Preclinical	2005-03-04	Absent	BRD4
Muscular Dystrophy, Facioscapulohumeral	ENSG00000162711	FALSE	Preclinical	2014-09-02	Absent	NLRP3
Muscular Dystrophy, Facioscapulohumeral	ENSG00000170445	FALSE	Phase II Clinical Trial	NA	Absent	HARS
Muscular Dystrophy, Oculopharyngeal	ENSG00000100836	FALSE	Preclinical	2011-11-17	Preclinical	PABPN1
Musculoskeletal Diseases	ENSG00000017427	FALSE	Preclinical	1993-11-15	Unused	IGF1
Musculoskeletal Diseases	ENSG00000030304	FALSE	Preclinical	1997-05-15	Unused	MUSK
Musculoskeletal Diseases	ENSG00000073756	FALSE	Preclinical	NA	Unused	PTGS2
Musculoskeletal Diseases	ENSG00000087085	FALSE	unknown	1989-05-15	Unused	ACHE
Musculoskeletal Diseases	ENSG00000095303	FALSE	Preclinical	NA	Unused	PTGS1
Musculoskeletal Diseases	ENSG00000105329	FALSE	Phase II Clinical Trial	2007-10-09	Absent	TGFB1
Musculoskeletal Diseases	ENSG00000106113	FALSE	Preclinical	2011-02-04	Unused	CRHR2
Musculoskeletal Diseases	ENSG00000108576	FALSE	Preclinical	NA	Unused	SLC6A4
Musculoskeletal Diseases	ENSG00000111424	FALSE	Preclinical	NA	Unused	VDR
Musculoskeletal Diseases	ENSG00000113721	FALSE	Preclinical	2006-07-10	Absent	PDGFRB
Musculoskeletal Diseases	ENSG00000115457	FALSE	Preclinical	2010-10-19	Absent	IGFBP2
Musculoskeletal Diseases	ENSG00000118113	FALSE	Preclinical	1997-10-15	Unused	MMP8
Musculoskeletal Diseases	ENSG00000118523	FALSE	Preclinical	1997-08-15	Absent	CTGF
Musculoskeletal Diseases	ENSG00000118785	FALSE	Preclinical	NA	Unused	SPP1
Musculoskeletal Diseases	ENSG00000120659	FALSE	Preclinical	2003-09-09	Unused	TNFSF11
Musculoskeletal Diseases	ENSG00000125845	TRUE	Approved	2011-12-07	Preclinical	BMP2
Musculoskeletal Diseases	ENSG00000133895	FALSE	Preclinical	1997-08-15	Unused	MEN1
Musculoskeletal Diseases	ENSG00000134318	FALSE	Preclinical	2007-09-04	Unused	ROCK2
Musculoskeletal Diseases	ENSG00000137752	FALSE	Preclinical	1995-01-15	Unused	CASP1
Musculoskeletal Diseases	ENSG00000138379	FALSE	Preclinical	2002-06-17	Unused	MSTN
Musculoskeletal Diseases	ENSG00000140443	FALSE	Preclinical	2010-10-19	Absent	IGF1R
Musculoskeletal Diseases	ENSG00000143387	FALSE	Preclinical	1998-07-15	Unused	CTSK
Musculoskeletal Diseases	ENSG00000154229	FALSE	Preclinical	1995-01-15	Unused	PRKCA
Musculoskeletal Diseases	ENSG00000156427	FALSE	Phase II Clinical Trial	2002-05-08	Absent	FGF18
Musculoskeletal Diseases	ENSG00000158859	FALSE	Preclinical	2000-08-21	Unused	ADAMTS4
Musculoskeletal Diseases	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Musculoskeletal Diseases	ENSG00000160801	FALSE	Preclinical	NA	Unused	PTH1R
Musculoskeletal Diseases	ENSG00000163131	FALSE	Preclinical	1998-06-15	Unused	CTSS
Musculoskeletal Diseases	ENSG00000163736	FALSE	Preclinical	NA	Unused	PPBP
Musculoskeletal Diseases	ENSG00000164342	FALSE	Preclinical	2008-01-04	Unused	TLR3
Musculoskeletal Diseases	ENSG00000165197	FALSE	Preclinical	2008-08-30	Preclinical	VEGFD
Musculoskeletal Diseases	ENSG00000183691	FALSE	Preclinical	1994-01-15	Unused	NOG
Musculoskeletal Diseases	ENSG00000188157	FALSE	Preclinical	1997-05-15	Unused	AGRN
Musculoskeletal Diseases	ENSG00000196262	FALSE	unknown	NA	Unused	PPIA
Musculoskeletal Diseases	ENSG00000198793	FALSE	Preclinical	2014-07-04	Absent	MTOR
Musculoskeletal Diseases	ENSG00000228716	FALSE	Preclinical	1990-05-15	Unused	DHFR
Musculoskeletal Diseases	ENSG00000261857	FALSE	Preclinical	2004-07-13	Absent	MIA
Musculoskeletal Pain	ENSG00000004948	TRUE	Approved	2004-08-20	Approved	CALCR
Musculoskeletal Pain	ENSG00000007171	FALSE	Preclinical	2004-08-23	Unused	NOS2
Musculoskeletal Pain	ENSG00000012779	FALSE	Phase II Clinical Trial	2008-02-28	Unused	ALOX5
Musculoskeletal Pain	ENSG00000026508	TRUE	Approved	2008-05-01	Unused	CD44
Musculoskeletal Pain	ENSG00000050628	FALSE	Preclinical	2014-10-30	Absent	PTGER3
Musculoskeletal Pain	ENSG00000056291	FALSE	Preclinical	2004-11-10	Unused	NPFFR2
Musculoskeletal Pain	ENSG00000064300	FALSE	Preclinical	1997-12-15	Unused	NGFR
Musculoskeletal Pain	ENSG00000065989	TRUE	Approved	NA	Approved	PDE4A
Musculoskeletal Pain	ENSG00000073756	TRUE	Approved	1992-09-15	Approved	PTGS2
Musculoskeletal Pain	ENSG00000075043	TRUE	Approved	NA	Approved	KCNQ2
Musculoskeletal Pain	ENSG00000082556	TRUE	Approved	1996-04-15	Approved	OPRK1
Musculoskeletal Pain	ENSG00000089041	FALSE	unknown	2006-12-21	Unused	P2RX7
Musculoskeletal Pain	ENSG00000089250	FALSE	Preclinical	2009-05-27	Unused	NOS1
Musculoskeletal Pain	ENSG00000091831	FALSE	Preclinical	2007-07-16	Unused	ESR1
Musculoskeletal Pain	ENSG00000095303	TRUE	Approved	1992-09-15	Approved	PTGS1
Musculoskeletal Pain	ENSG00000100739	FALSE	Phase II Clinical Trial	2007-07-20	Preclinical	BDKRB1
Musculoskeletal Pain	ENSG00000101180	FALSE	Phase II Clinical Trial	2010-06-15	Phase II Clinical Trial	HRH3
Musculoskeletal Pain	ENSG00000101327	FALSE	unknown	1994-04-15	Unused	PDYN
Musculoskeletal Pain	ENSG00000102468	FALSE	Preclinical	2007-06-21	Unused	HTR2A
Musculoskeletal Pain	ENSG00000103546	TRUE	Approved	1998-08-15	Approved	SLC6A2
Musculoskeletal Pain	ENSG00000104267	FALSE	Approved	2006-08-11	Phase II Clinical Trial	CA2
Musculoskeletal Pain	ENSG00000104365	FALSE	Phase II Clinical Trial	2008-02-12	Phase II Clinical Trial	IKBKB
Musculoskeletal Pain	ENSG00000105650	TRUE	Approved	NA	Approved	PDE4C
Musculoskeletal Pain	ENSG00000105675	TRUE	Approved	2007-08-10	Approved	ATP4A
Musculoskeletal Pain	ENSG00000108576	TRUE	Approved	1998-08-15	Approved	SLC6A4
Musculoskeletal Pain	ENSG00000109320	FALSE	Preclinical	2001-07-18	Absent	NFKB1
Musculoskeletal Pain	ENSG00000109991	FALSE	Phase II Clinical Trial	2006-02-13	Phase II Clinical Trial	P2RX3
Musculoskeletal Pain	ENSG00000110680	FALSE	Phase II Clinical Trial	2011-10-25	Absent	CALCA
Musculoskeletal Pain	ENSG00000112038	TRUE	Approved	1993-07-15	Approved	OPRM1
Musculoskeletal Pain	ENSG00000112062	FALSE	Phase II Clinical Trial	2003-11-21	Phase II Clinical Trial	MAPK14
Musculoskeletal Pain	ENSG00000113448	TRUE	Approved	NA	Approved	PDE4D
Musculoskeletal Pain	ENSG00000113580	FALSE	Preclinical	2017-08-18	Unused	NR3C1
Musculoskeletal Pain	ENSG00000113749	TRUE	Approved	2007-01-05	Approved	HRH2
Musculoskeletal Pain	ENSG00000115353	FALSE	Preclinical	1995-07-15	Unused	TACR1
Musculoskeletal Pain	ENSG00000116329	TRUE	Approved	1996-04-15	Approved	OPRD1
Musculoskeletal Pain	ENSG00000117480	FALSE	unknown	2008-09-30	Unused	FAAH
Musculoskeletal Pain	ENSG00000121807	FALSE	unknown	2007-08-07	Unused	CCR2
Musculoskeletal Pain	ENSG00000125510	FALSE	Phase II Clinical Trial	2009-03-15	Phase II Clinical Trial	OPRL1
Musculoskeletal Pain	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Absent	IL1B
Musculoskeletal Pain	ENSG00000131471	FALSE	Phase II Clinical Trial	NA	Absent	AOC3
Musculoskeletal Pain	ENSG00000134259	FALSE	Phase III Clinical Trial	2003-03-26	Phase II Clinical Trial	NGF
Musculoskeletal Pain	ENSG00000136244	FALSE	unknown	2006-08-21	Phase I Clinical Trial	IL6
Musculoskeletal Pain	ENSG00000136634	FALSE	Preclinical	2016-04-01	Absent	IL10
Musculoskeletal Pain	ENSG00000142319	FALSE	Preclinical	2005-03-01	Unused	SLC6A3
Musculoskeletal Pain	ENSG00000143387	FALSE	Phase II Clinical Trial	2001-11-05	Unused	CTSK
Musculoskeletal Pain	ENSG00000144285	FALSE	Preclinical	2017-05-08	Absent	SCN1A
Musculoskeletal Pain	ENSG00000144891	FALSE	Preclinical	2016-12-29	Absent	AGTR1
Musculoskeletal Pain	ENSG00000148344	FALSE	Phase II Clinical Trial	2012-01-09	Absent	PTGES
Musculoskeletal Pain	ENSG00000148408	FALSE	Phase I Clinical Trial	2010-10-04	Phase I Clinical Trial	CACNA1B
Musculoskeletal Pain	ENSG00000151067	FALSE	Phase II Clinical Trial	2012-07-27	Absent	CACNA1C
Musculoskeletal Pain	ENSG00000151577	FALSE	Phase II Clinical Trial	2007-01-08	Absent	DRD3
Musculoskeletal Pain	ENSG00000153956	FALSE	unknown	2007-09-12	Unused	CACNA2D1
Musculoskeletal Pain	ENSG00000157766	FALSE	Preclinical	2015-01-07	Absent	ACAN
Musculoskeletal Pain	ENSG00000159640	FALSE	Preclinical	2016-12-28	Absent	ACE
Musculoskeletal Pain	ENSG00000160712	FALSE	Preclinical	2014-11-21	Absent	IL6R
Musculoskeletal Pain	ENSG00000162711	FALSE	Phase II Clinical Trial	2013-04-09	Absent	NLRP3
Musculoskeletal Pain	ENSG00000163131	FALSE	Phase I Clinical Trial	2010-10-28	Unused	CTSS
Musculoskeletal Pain	ENSG00000164270	FALSE	Preclinical	1994-12-15	Unused	HTR4
Musculoskeletal Pain	ENSG00000165970	FALSE	unknown	2010-08-18	Absent	SLC6A5
Musculoskeletal Pain	ENSG00000167723	FALSE	Phase II Clinical Trial	2008-10-28	Phase II Clinical Trial	TRPV3
Musculoskeletal Pain	ENSG00000168398	FALSE	Phase II Clinical Trial	1989-08-15	Phase II Clinical Trial	BDKRB2
Musculoskeletal Pain	ENSG00000169432	FALSE	Phase III Clinical Trial	2001-01-15	Unused	SCN9A
Musculoskeletal Pain	ENSG00000170989	FALSE	Phase I Clinical Trial	2011-09-21	Absent	S1PR1
Musculoskeletal Pain	ENSG00000171189	FALSE	Phase II Clinical Trial	2006-12-13	Unused	GRIK1
Musculoskeletal Pain	ENSG00000171522	FALSE	Phase II Clinical Trial	2007-01-09	Phase II Clinical Trial	PTGER4
Musculoskeletal Pain	ENSG00000171557	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGG
Musculoskeletal Pain	ENSG00000171560	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGA
Musculoskeletal Pain	ENSG00000171564	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	FGB
Musculoskeletal Pain	ENSG00000176884	FALSE	unknown	1994-07-15	Phase I Clinical Trial	GRIN1
Musculoskeletal Pain	ENSG00000180772	FALSE	unknown	2008-09-09	Absent	AGTR2
Musculoskeletal Pain	ENSG00000181104	FALSE	Phase III Clinical Trial	2011-08-31	Phase III Clinical Trial	F2R
Musculoskeletal Pain	ENSG00000184156	TRUE	Approved	NA	Approved	KCNQ3
Musculoskeletal Pain	ENSG00000184588	TRUE	Approved	NA	Approved	PDE4B
Musculoskeletal Pain	ENSG00000185313	FALSE	Phase II Clinical Trial	2010-07-15	Preclinical	SCN10A
Musculoskeletal Pain	ENSG00000188822	FALSE	Phase II Clinical Trial	2005-03-13	Unused	CNR2
Musculoskeletal Pain	ENSG00000196639	FALSE	Pre-registration	2009-01-15	Absent	HRH1
Musculoskeletal Pain	ENSG00000196689	FALSE	Approved	1995-07-15	Approved	TRPV1
Musculoskeletal Pain	ENSG00000198400	FALSE	Phase II Clinical Trial	2003-01-06	Preclinical	NTRK1
Musculoskeletal Pain	ENSG00000213199	FALSE	Preclinical	2010-07-15	Preclinical	ASIC3
Myasthenia Gravis	ENSG00000039537	FALSE	Preclinical	NA	Absent	C6
Myasthenia Gravis	ENSG00000081051	FALSE	Preclinical	2001-02-27	Unused	AFP
Myasthenia Gravis	ENSG00000087085	FALSE	Phase II Clinical Trial	2001-09-14	Unused	ACHE
Myasthenia Gravis	ENSG00000088832	TRUE	Approved	NA	Approved	FKBP1A
Myasthenia Gravis	ENSG00000101017	FALSE	Phase II Clinical Trial	2014-03-18	Absent	CD40
Myasthenia Gravis	ENSG00000102524	FALSE	Phase II Clinical Trial	1999-07-13	Absent	TNFSF13B
Myasthenia Gravis	ENSG00000104870	FALSE	Phase II Clinical Trial	2011-11-19	Absent	FCGRT
Myasthenia Gravis	ENSG00000106348	FALSE	unknown	1989-12-15	Unused	IMPDH1
Myasthenia Gravis	ENSG00000106804	TRUE	Approved	1993-08-15	Phase II Clinical Trial	C5
Myasthenia Gravis	ENSG00000134569	FALSE	Preclinical	2016-07-28	Absent	LRP4
Myasthenia Gravis	ENSG00000196262	TRUE	Approved	NA	Approved	PPIA
Myasthenia Gravis	ENSG00000197272	FALSE	Preclinical	2004-08-03	Unused	IL27
Myasthenia Gravis	ENSG00000197766	FALSE	unknown	2014-08-26	Absent	CFD
Myasthenia Gravis	ENSG00000198851	FALSE	Phase II Clinical Trial	2002-11-07	Phase II Clinical Trial	CD3E
Myasthenia Gravis	ENSG00000239732	FALSE	Phase II Clinical Trial	2001-09-14	Unused	TLR9
Mycobacterium avium-intracellulare Infection	ENSG00000111537	FALSE	unknown	2012-11-19	Absent	IFNG
Mycobacterium Infections, Nontuberculous	ENSG00000198223	FALSE	Preclinical	NA	Absent	CSF2RA
Mycoses	ENSG00000001630	FALSE	Preclinical	2012-06-20	Preclinical	CYP51A1
Mycoses	ENSG00000079459	FALSE	Preclinical	1992-08-15	Unused	FDFT1
Mycoses	ENSG00000080824	FALSE	Preclinical	2011-06-09	Unused	HSP90AA1
Mycoses	ENSG00000088832	FALSE	Preclinical	1996-03-15	Unused	FKBP1A
Mycoses	ENSG00000101425	FALSE	Preclinical	NA	Unused	BPI
Mycoses	ENSG00000113580	TRUE	Approved	2008-03-31	Approved	NR3C1
Mycoses	ENSG00000121879	FALSE	Preclinical	2004-08-10	Preclinical	PIK3CA
Mycoses	ENSG00000131747	FALSE	Preclinical	NA	Unused	TOP2A
Mycoses	ENSG00000159110	TRUE	Approved	NA	Approved	IFNAR2
Mycoses	ENSG00000160285	FALSE	Preclinical	1994-07-15	Unused	LSS
Mycoses	ENSG00000168522	FALSE	Preclinical	1994-11-15	Unused	FNTA
Mycoses	ENSG00000169083	FALSE	unknown	NA	Unused	AR
Mycoses	ENSG00000182578	FALSE	unknown	NA	Unused	CSF1R
Mycoses	ENSG00000198793	FALSE	Preclinical	2004-08-10	Preclinical	MTOR
Mycoses	ENSG00000205649	FALSE	Preclinical	2016-08-30	Absent	HTN3
Mycoses	ENSG00000213903	FALSE	Preclinical	1991-09-15	Unused	LTB4R
Mycoses	ENSG00000228716	FALSE	unknown	NA	Unused	DHFR
Myelinolysis, Central Pontine	ENSG00000140009	FALSE	Preclinical	2011-05-26	Absent	ESR2
Myelodysplastic Syndromes	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Myelodysplastic Syndromes	ENSG00000004487	FALSE	Phase II Clinical Trial	2008-07-31	Absent	KDM1A
Myelodysplastic Syndromes	ENSG00000010610	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CD4
Myelodysplastic Syndromes	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Myelodysplastic Syndromes	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC3
Myelodysplastic Syndromes	ENSG00000037280	FALSE	Phase I Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Myelodysplastic Syndromes	ENSG00000044524	FALSE	Phase II Clinical Trial	2004-03-23	Phase I Clinical Trial	EPHA3
Myelodysplastic Syndromes	ENSG00000065989	FALSE	Phase II Clinical Trial	1994-10-15	Unused	PDE4A
Myelodysplastic Syndromes	ENSG00000066468	FALSE	unknown	2005-06-27	Phase I Clinical Trial	FGFR2
Myelodysplastic Syndromes	ENSG00000068024	FALSE	Phase I Clinical Trial	2002-06-10	Absent	HDAC4
Myelodysplastic Syndromes	ENSG00000068078	FALSE	unknown	2005-06-27	Phase I Clinical Trial	FGFR3
Myelodysplastic Syndromes	ENSG00000070501	FALSE	Approved	NA	Unused	POLB
Myelodysplastic Syndromes	ENSG00000072571	FALSE	unknown	2006-12-15	Unused	HMMR
Myelodysplastic Syndromes	ENSG00000077092	FALSE	Phase II Clinical Trial	NA	Preclinical	RARB
Myelodysplastic Syndromes	ENSG00000077782	FALSE	unknown	2005-06-27	Phase I Clinical Trial	FGFR1
Myelodysplastic Syndromes	ENSG00000080824	FALSE	Phase III Clinical Trial	2005-12-05	Phase II Clinical Trial	HSP90AA1
Myelodysplastic Syndromes	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Myelodysplastic Syndromes	ENSG00000083312	FALSE	Phase I Clinical Trial	2005-06-27	Unused	TNPO1
Myelodysplastic Syndromes	ENSG00000084207	FALSE	unknown	1994-06-15	Phase II Clinical Trial	GSTP1
Myelodysplastic Syndromes	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKA
Myelodysplastic Syndromes	ENSG00000095015	FALSE	unknown	2007-08-10	Absent	MAP3K1
Myelodysplastic Syndromes	ENSG00000096968	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	JAK2
Myelodysplastic Syndromes	ENSG00000097007	TRUE	Approved	1999-03-17	Unused	ABL1
Myelodysplastic Syndromes	ENSG00000097046	FALSE	Preclinical	2017-03-15	Absent	CDC7
Myelodysplastic Syndromes	ENSG00000100030	FALSE	Phase II Clinical Trial	2013-01-18	Absent	MAPK1
Myelodysplastic Syndromes	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Myelodysplastic Syndromes	ENSG00000101868	FALSE	Approved	1993-08-15	Unused	POLA1
Myelodysplastic Syndromes	ENSG00000101966	FALSE	Phase II Clinical Trial	2008-10-17	Absent	XIAP
Myelodysplastic Syndromes	ENSG00000102755	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	FLT1
Myelodysplastic Syndromes	ENSG00000102882	FALSE	Phase II Clinical Trial	2013-01-18	Absent	MAPK3
Myelodysplastic Syndromes	ENSG00000102967	FALSE	Preclinical	2017-04-20	Absent	DHODH
Myelodysplastic Syndromes	ENSG00000104885	FALSE	Phase I Clinical Trial	2010-12-03	Phase I Clinical Trial	DOT1L
Myelodysplastic Syndromes	ENSG00000105146	FALSE	Phase I Clinical Trial	2003-10-20	Phase I Clinical Trial	AURKC
Myelodysplastic Syndromes	ENSG00000105383	FALSE	Phase III Clinical Trial	1992-04-15	Unused	CD33
Myelodysplastic Syndromes	ENSG00000105650	FALSE	Phase II Clinical Trial	1994-10-15	Unused	PDE4C
Myelodysplastic Syndromes	ENSG00000105810	FALSE	Preclinical	1996-05-15	Absent	CDK6
Myelodysplastic Syndromes	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Myelodysplastic Syndromes	ENSG00000106348	FALSE	Phase II Clinical Trial	1989-12-15	Absent	IMPDH1
Myelodysplastic Syndromes	ENSG00000106799	FALSE	Phase III Clinical Trial	2003-09-17	Absent	TGFBR1
Myelodysplastic Syndromes	ENSG00000108424	FALSE	Phase I Clinical Trial	2005-06-27	Unused	KPNB1
Myelodysplastic Syndromes	ENSG00000108443	FALSE	Phase I Clinical Trial	2005-06-27	Unused	RPS6KB1
Myelodysplastic Syndromes	ENSG00000110092	FALSE	unknown	2007-05-16	Unused	CCND1
Myelodysplastic Syndromes	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC2
Myelodysplastic Syndromes	ENSG00000111424	FALSE	Phase II Clinical Trial	1993-07-15	Unused	VDR
Myelodysplastic Syndromes	ENSG00000112062	FALSE	Phase II Clinical Trial	1998-01-15	Phase I Clinical Trial	MAPK14
Myelodysplastic Syndromes	ENSG00000112115	FALSE	unknown	NA	Absent	IL17A
Myelodysplastic Syndromes	ENSG00000112715	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	VEGFA
Myelodysplastic Syndromes	ENSG00000113448	FALSE	Phase II Clinical Trial	1994-10-15	Unused	PDE4D
Myelodysplastic Syndromes	ENSG00000113575	FALSE	Preclinical	2008-02-29	Absent	PPP2CA
Myelodysplastic Syndromes	ENSG00000113712	FALSE	Preclinical	2016-05-05	Absent	CSNK1A1
Myelodysplastic Syndromes	ENSG00000113721	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	PDGFRB
Myelodysplastic Syndromes	ENSG00000113749	FALSE	Preclinical	1996-05-15	Unused	HRH2
Myelodysplastic Syndromes	ENSG00000115008	FALSE	Phase I Clinical Trial	2009-12-07	Phase I Clinical Trial	IL1A
Myelodysplastic Syndromes	ENSG00000115232	FALSE	unknown	NA	Absent	ITGA4
Myelodysplastic Syndromes	ENSG00000115524	FALSE	Phase I Clinical Trial	2014-04-08	Absent	SF3B1
Myelodysplastic Syndromes	ENSG00000115594	FALSE	unknown	1991-03-15	Unused	IL1R1
Myelodysplastic Syndromes	ENSG00000116044	FALSE	Phase I Clinical Trial	2004-11-18	Unused	NFE2L2
Myelodysplastic Syndromes	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Phase II Clinical Trial	HDAC1
Myelodysplastic Syndromes	ENSG00000117400	FALSE	Phase III Clinical Trial	2002-07-31	Unused	MPL
Myelodysplastic Syndromes	ENSG00000117560	FALSE	Phase I Clinical Trial	2004-01-19	Phase I Clinical Trial	FASLG
Myelodysplastic Syndromes	ENSG00000119535	FALSE	unknown	NA	Absent	CSF3R
Myelodysplastic Syndromes	ENSG00000120156	FALSE	Phase I Clinical Trial	2007-04-24	Phase I Clinical Trial	TEK
Myelodysplastic Syndromes	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Myelodysplastic Syndromes	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Myelodysplastic Syndromes	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Unused	PIK3CA
Myelodysplastic Syndromes	ENSG00000121966	FALSE	Phase II Clinical Trial	2008-06-19	Absent	CXCR4
Myelodysplastic Syndromes	ENSG00000122025	FALSE	Phase II Clinical Trial	1991-02-15	Phase II Clinical Trial	FLT3
Myelodysplastic Syndromes	ENSG00000123374	FALSE	unknown	2007-07-09	Phase I Clinical Trial	CDK2
Myelodysplastic Syndromes	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Myelodysplastic Syndromes	ENSG00000126934	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAP2K2
Myelodysplastic Syndromes	ENSG00000128052	FALSE	Phase I Clinical Trial	1991-02-15	Phase II Clinical Trial	KDR
Myelodysplastic Syndromes	ENSG00000128602	FALSE	unknown	2004-07-21	Absent	SMO
Myelodysplastic Syndromes	ENSG00000129484	FALSE	Phase I Clinical Trial	2009-04-11	Phase I Clinical Trial	PARP2
Myelodysplastic Syndromes	ENSG00000130816	TRUE	Approved	1996-06-15	Approved	DNMT1
Myelodysplastic Syndromes	ENSG00000131747	FALSE	Phase II Clinical Trial	1999-03-31	Unused	TOP2A
Myelodysplastic Syndromes	ENSG00000131759	FALSE	Phase II Clinical Trial	NA	Preclinical	RARA
Myelodysplastic Syndromes	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Preclinical	PDHA1
Myelodysplastic Syndromes	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Myelodysplastic Syndromes	ENSG00000134057	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	CCNB1
Myelodysplastic Syndromes	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Myelodysplastic Syndromes	ENSG00000134853	TRUE	Approved	1999-03-17	Phase II Clinical Trial	PDGFRA
Myelodysplastic Syndromes	ENSG00000135077	FALSE	Preclinical	2005-07-01	Absent	HAVCR2
Myelodysplastic Syndromes	ENSG00000135446	FALSE	Preclinical	1996-05-15	Absent	CDK4
Myelodysplastic Syndromes	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-09-07	Absent	MDM2
Myelodysplastic Syndromes	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Myelodysplastic Syndromes	ENSG00000136807	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	CDK9
Myelodysplastic Syndromes	ENSG00000136826	FALSE	unknown	2004-05-21	Absent	KLF4
Myelodysplastic Syndromes	ENSG00000136997	FALSE	Phase I Clinical Trial	2004-05-21	Absent	MYC
Myelodysplastic Syndromes	ENSG00000137462	FALSE	Phase II Clinical Trial	2006-02-15	Absent	TLR2
Myelodysplastic Syndromes	ENSG00000137752	FALSE	unknown	NA	Absent	CASP1
Myelodysplastic Syndromes	ENSG00000138039	FALSE	unknown	1996-02-15	Unused	LHCGR
Myelodysplastic Syndromes	ENSG00000138160	FALSE	Phase II Clinical Trial	2006-04-03	Phase II Clinical Trial	KIF11
Myelodysplastic Syndromes	ENSG00000138413	FALSE	Phase III Clinical Trial	2010-04-19	Absent	IDH1
Myelodysplastic Syndromes	ENSG00000138448	FALSE	unknown	NA	Absent	ITGAV
Myelodysplastic Syndromes	ENSG00000139567	FALSE	Phase III Clinical Trial	2009-01-15	Absent	ACVRL1
Myelodysplastic Syndromes	ENSG00000141510	FALSE	Phase II Clinical Trial	1992-09-15	Unused	TP53
Myelodysplastic Syndromes	ENSG00000141867	FALSE	Phase I Clinical Trial	2016-02-18	Absent	BRD4
Myelodysplastic Syndromes	ENSG00000142168	FALSE	unknown	2002-07-01	Unused	SOD1
Myelodysplastic Syndromes	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Myelodysplastic Syndromes	ENSG00000143384	FALSE	Phase III Clinical Trial	1999-10-20	Phase III Clinical Trial	MCL1
Myelodysplastic Syndromes	ENSG00000143799	FALSE	Phase I Clinical Trial	2009-04-11	Phase I Clinical Trial	PARP1
Myelodysplastic Syndromes	ENSG00000144285	FALSE	unknown	NA	Preclinical	SCN1A
Myelodysplastic Syndromes	ENSG00000144744	FALSE	Phase III Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Myelodysplastic Syndromes	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Myelodysplastic Syndromes	ENSG00000147099	FALSE	Phase I Clinical Trial	2008-07-31	Phase I Clinical Trial	HDAC8
Myelodysplastic Syndromes	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Myelodysplastic Syndromes	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CHEK1
Myelodysplastic Syndromes	ENSG00000150782	FALSE	unknown	NA	Absent	IL18
Myelodysplastic Syndromes	ENSG00000151067	FALSE	unknown	NA	Preclinical	CACNA1C
Myelodysplastic Syndromes	ENSG00000151247	FALSE	unknown	2007-05-16	Absent	EIF4E
Myelodysplastic Syndromes	ENSG00000153253	FALSE	unknown	NA	Preclinical	SCN3A
Myelodysplastic Syndromes	ENSG00000154229	FALSE	Phase I Clinical Trial	1991-02-15	Phase I Clinical Trial	PRKCA
Myelodysplastic Syndromes	ENSG00000157404	TRUE	Approved	1991-02-15	Phase II Clinical Trial	KIT
Myelodysplastic Syndromes	ENSG00000158825	FALSE	Phase III Clinical Trial	2013-07-10	Absent	CDA
Myelodysplastic Syndromes	ENSG00000160712	FALSE	Phase II Clinical Trial	NA	Unused	IL6R
Myelodysplastic Syndromes	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Phase II Clinical Trial	JAK1
Myelodysplastic Syndromes	ENSG00000163517	FALSE	unknown	NA	Phase II Clinical Trial	HDAC11
Myelodysplastic Syndromes	ENSG00000163599	FALSE	unknown	1998-09-15	Unused	CTLA4
Myelodysplastic Syndromes	ENSG00000164362	FALSE	Preclinical	2010-05-18	Unused	TERT
Myelodysplastic Syndromes	ENSG00000164400	FALSE	Phase I Clinical Trial	1991-12-15	Unused	CSF2
Myelodysplastic Syndromes	ENSG00000165304	FALSE	Phase II Clinical Trial	2013-07-03	Absent	MELK
Myelodysplastic Syndromes	ENSG00000165731	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RET
Myelodysplastic Syndromes	ENSG00000166484	FALSE	unknown	2007-07-09	Absent	MAPK7
Myelodysplastic Syndromes	ENSG00000166851	FALSE	Phase III Clinical Trial	2002-05-27	Phase III Clinical Trial	PLK1
Myelodysplastic Syndromes	ENSG00000167325	TRUE	Approved	1999-06-02	Phase II Clinical Trial	RRM1
Myelodysplastic Syndromes	ENSG00000167601	FALSE	Phase II Clinical Trial	2011-06-17	Absent	AXL
Myelodysplastic Syndromes	ENSG00000168036	FALSE	Phase II Clinical Trial	2011-03-05	Phase II Clinical Trial	CTNNB1
Myelodysplastic Syndromes	ENSG00000168522	FALSE	Phase II Clinical Trial	1997-06-15	Unused	FNTA
Myelodysplastic Syndromes	ENSG00000168610	FALSE	Phase I Clinical Trial	2007-08-28	Phase I Clinical Trial	STAT3
Myelodysplastic Syndromes	ENSG00000169032	FALSE	Phase II Clinical Trial	2007-08-10	Phase II Clinical Trial	MAP2K1
Myelodysplastic Syndromes	ENSG00000170312	FALSE	unknown	2004-08-16	Phase I Clinical Trial	CDK1
Myelodysplastic Syndromes	ENSG00000170430	FALSE	unknown	2000-05-03	Unused	MGMT
Myelodysplastic Syndromes	ENSG00000171720	FALSE	Phase I Clinical Trial	2008-07-31	Phase II Clinical Trial	HDAC3
Myelodysplastic Syndromes	ENSG00000171791	FALSE	Phase II Clinical Trial	1999-10-20	Phase II Clinical Trial	BCL2
Myelodysplastic Syndromes	ENSG00000171848	TRUE	Approved	1998-11-15	Phase II Clinical Trial	RRM2
Myelodysplastic Syndromes	ENSG00000172322	FALSE	Preclinical	2013-01-16	Absent	CLEC12A
Myelodysplastic Syndromes	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Myelodysplastic Syndromes	ENSG00000176890	FALSE	Preclinical	2009-05-22	Absent	TYMS
Myelodysplastic Syndromes	ENSG00000177885	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	GRB2
Myelodysplastic Syndromes	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-24	Phase II Clinical Trial	AURKB
Myelodysplastic Syndromes	ENSG00000182054	FALSE	Phase I Clinical Trial	2011-11-14	Absent	IDH2
Myelodysplastic Syndromes	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-04-26	Phase I Clinical Trial	CSF1R
Myelodysplastic Syndromes	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Myelodysplastic Syndromes	ENSG00000184588	FALSE	Phase II Clinical Trial	1994-10-15	Unused	PDE4B
Myelodysplastic Syndromes	ENSG00000184937	FALSE	Phase III Clinical Trial	1999-06-15	Phase II Clinical Trial	WT1
Myelodysplastic Syndromes	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Phase II Clinical Trial	IL3RA
Myelodysplastic Syndromes	ENSG00000185686	FALSE	Phase I Clinical Trial	2014-04-01	Absent	PRAME
Myelodysplastic Syndromes	ENSG00000186716	TRUE	Approved	1999-03-17	Phase II Clinical Trial	BCR
Myelodysplastic Syndromes	ENSG00000187266	FALSE	Phase III Clinical Trial	NA	Unused	EPOR
Myelodysplastic Syndromes	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-02-21	Absent	PDCD1
Myelodysplastic Syndromes	ENSG00000196083	FALSE	Preclinical	2015-11-26	Absent	IL1RAP
Myelodysplastic Syndromes	ENSG00000196415	FALSE	unknown	NA	Unused	PRTN3
Myelodysplastic Syndromes	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Myelodysplastic Syndromes	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Myelodysplastic Syndromes	ENSG00000197122	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	SRC
Myelodysplastic Syndromes	ENSG00000198223	FALSE	unknown	NA	Absent	CSF2RA
Myelodysplastic Syndromes	ENSG00000198625	FALSE	Phase I Clinical Trial	2012-09-07	Absent	MDM4
Myelodysplastic Syndromes	ENSG00000198793	FALSE	Phase I Clinical Trial	1997-08-15	Unused	MTOR
Myelodysplastic Syndromes	ENSG00000198851	FALSE	Phase I Clinical Trial	2012-09-21	Absent	CD3E
Myelodysplastic Syndromes	ENSG00000198900	FALSE	Phase III Clinical Trial	2008-04-09	Unused	TOP1
Myelodysplastic Syndromes	ENSG00000228716	FALSE	Preclinical	1993-05-15	Unused	DHFR
Myelodysplastic Syndromes	ENSG00000253729	FALSE	Phase I Clinical Trial	1999-03-31	Unused	PRKDC
Myelodysplastic Syndromes	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Myelodysplastic Syndromes	ENSG00000259207	FALSE	unknown	NA	Absent	ITGB3
Myelodysplastic Syndromes	ENSG00000269858	FALSE	Phase II Clinical Trial	2003-07-02	Unused	EGLN2
Myocardial Infarction	ENSG00000005381	FALSE	Preclinical	2010-05-22	Preclinical	MPO
Myocardial Infarction	ENSG00000005961	TRUE	Approved	1991-01-15	Approved	ITGA2B
Myocardial Infarction	ENSG00000006071	FALSE	unknown	2010-06-10	Preclinical	ABCC8
Myocardial Infarction	ENSG00000007908	FALSE	unknown	2005-05-25	Unused	SELE
Myocardial Infarction	ENSG00000012779	FALSE	unknown	1994-10-15	Unused	ALOX5
Myocardial Infarction	ENSG00000019582	FALSE	Preclinical	2015-07-30	Absent	CD74
Myocardial Infarction	ENSG00000019991	FALSE	Phase II Clinical Trial	2004-11-23	Unused	HGF
Myocardial Infarction	ENSG00000026103	FALSE	Preclinical	2008-03-06	Unused	FAS
Myocardial Infarction	ENSG00000043591	TRUE	Approved	1997-05-15	Approved	ADRB1
Myocardial Infarction	ENSG00000057593	FALSE	unknown	1992-03-15	Unused	F7
Myocardial Infarction	ENSG00000060491	FALSE	Preclinical	2008-07-14	Unused	OGFR
Myocardial Infarction	ENSG00000064989	FALSE	Preclinical	2005-05-25	Unused	CALCRL
Myocardial Infarction	ENSG00000065989	TRUE	Approved	NA	Approved	PDE4A
Myocardial Infarction	ENSG00000069431	FALSE	Preclinical	2000-04-18	Unused	ABCC9
Myocardial Infarction	ENSG00000069535	FALSE	Preclinical	2011-03-03	Unused	MAOB
Myocardial Infarction	ENSG00000071054	FALSE	Preclinical	2015-10-22	Absent	MAP4K4
Myocardial Infarction	ENSG00000073756	TRUE	Approved	1996-04-15	Approved	PTGS2
Myocardial Infarction	ENSG00000077238	FALSE	Preclinical	2013-07-09	Absent	IL4R
Myocardial Infarction	ENSG00000077782	FALSE	Preclinical	NA	Unused	FGFR1
Myocardial Infarction	ENSG00000080824	FALSE	Preclinical	2015-06-24	Absent	HSP90AA1
Myocardial Infarction	ENSG00000085662	TRUE	Approved	NA	Unused	AKR1B1
Myocardial Infarction	ENSG00000087245	FALSE	Preclinical	2009-07-24	Unused	MMP2
Myocardial Infarction	ENSG00000090020	FALSE	Phase III Clinical Trial	2001-08-08	Absent	SLC9A1
Myocardial Infarction	ENSG00000090339	FALSE	unknown	1990-06-15	Unused	ICAM1
Myocardial Infarction	ENSG00000091831	FALSE	Phase III Clinical Trial	1997-12-15	Unused	ESR1
Myocardial Infarction	ENSG00000092009	FALSE	Phase II Clinical Trial	2014-03-18	Absent	CMA1
Myocardial Infarction	ENSG00000092439	FALSE	Preclinical	2011-09-28	Preclinical	TRPM7
Myocardial Infarction	ENSG00000095303	TRUE	Approved	1995-05-15	Approved	PTGS1
Myocardial Infarction	ENSG00000096717	FALSE	Preclinical	2015-10-13	Absent	SIRT1
Myocardial Infarction	ENSG00000100504	FALSE	Preclinical	1999-11-30	Unused	PYGL
Myocardial Infarction	ENSG00000100906	FALSE	Preclinical	2000-06-06	Unused	NFKBIA
Myocardial Infarction	ENSG00000100985	FALSE	Phase I Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP9
Myocardial Infarction	ENSG00000101981	FALSE	Preclinical	2012-05-18	Preclinical	F9
Myocardial Infarction	ENSG00000104365	FALSE	unknown	1996-04-15	Unused	IKBKB
Myocardial Infarction	ENSG00000104368	TRUE	Approved	1989-07-15	Approved	PLAT
Myocardial Infarction	ENSG00000105650	TRUE	Approved	NA	Approved	PDE4C
Myocardial Infarction	ENSG00000105675	TRUE	Approved	2005-10-28	Approved	ATP4A
Myocardial Infarction	ENSG00000106128	FALSE	Preclinical	2013-01-22	Preclinical	GHRHR
Myocardial Infarction	ENSG00000106366	FALSE	Preclinical	2007-03-09	Unused	SERPINE1
Myocardial Infarction	ENSG00000106804	FALSE	unknown	1993-08-15	Unused	C5
Myocardial Infarction	ENSG00000107562	FALSE	Preclinical	2007-03-09	Phase I Clinical Trial	CXCL12
Myocardial Infarction	ENSG00000109320	FALSE	unknown	1990-06-15	Unused	NFKB1
Myocardial Infarction	ENSG00000110492	FALSE	Preclinical	2009-05-19	Preclinical	MDK
Myocardial Infarction	ENSG00000111144	FALSE	Phase II Clinical Trial	2006-05-01	Unused	LTA4H
Myocardial Infarction	ENSG00000112038	FALSE	Preclinical	2008-07-14	Unused	OPRM1
Myocardial Infarction	ENSG00000112062	FALSE	Phase II Clinical Trial	2000-10-25	Phase II Clinical Trial	MAPK14
Myocardial Infarction	ENSG00000112715	FALSE	Preclinical	2002-06-24	Unused	VEGFA
Myocardial Infarction	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Myocardial Infarction	ENSG00000113448	TRUE	Approved	NA	Approved	PDE4D
Myocardial Infarction	ENSG00000115263	FALSE	Phase I Clinical Trial	2004-03-05	Phase I Clinical Trial	GCG
Myocardial Infarction	ENSG00000115718	FALSE	Preclinical	1996-07-15	Unused	PROC
Myocardial Infarction	ENSG00000116329	FALSE	Preclinical	2008-07-14	Unused	OPRD1
Myocardial Infarction	ENSG00000117525	FALSE	unknown	1992-03-15	Unused	F3
Myocardial Infarction	ENSG00000117560	FALSE	unknown	2004-01-19	Unused	FASLG
Myocardial Infarction	ENSG00000117594	FALSE	Preclinical	2015-03-06	Absent	HSD11B1
Myocardial Infarction	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Myocardial Infarction	ENSG00000118137	FALSE	Phase II Clinical Trial	2009-12-10	Absent	APOA1
Myocardial Infarction	ENSG00000118702	FALSE	Phase II Clinical Trial	NA	Absent	GHRH
Myocardial Infarction	ENSG00000120907	TRUE	Approved	2012-09-20	Approved	ADRA1A
Myocardial Infarction	ENSG00000121361	FALSE	Preclinical	2000-04-18	Unused	KCNJ8
Myocardial Infarction	ENSG00000121653	FALSE	Phase I Clinical Trial	2003-08-26	Unused	MAPK8IP1
Myocardial Infarction	ENSG00000121807	FALSE	Preclinical	2006-01-01	Preclinical	CCR2
Myocardial Infarction	ENSG00000121966	FALSE	Phase II Clinical Trial	2004-06-22	Phase II Clinical Trial	CXCR4
Myocardial Infarction	ENSG00000122194	FALSE	Approved	1991-05-15	Unused	PLG
Myocardial Infarction	ENSG00000122861	FALSE	Approved	2002-05-09	Unused	PLAU
Myocardial Infarction	ENSG00000122884	FALSE	Preclinical	2001-02-06	Unused	P4HA1
Myocardial Infarction	ENSG00000124731	FALSE	Phase I Clinical Trial	2014-03-18	Absent	TREM1
Myocardial Infarction	ENSG00000125538	FALSE	unknown	2006-01-18	Preclinical	IL1B
Myocardial Infarction	ENSG00000126218	TRUE	Approved	1992-03-15	Approved	F10
Myocardial Infarction	ENSG00000128271	FALSE	Phase I Clinical Trial	2000-04-03	Unused	ADORA2A
Myocardial Infarction	ENSG00000130234	FALSE	unknown	2007-07-13	Unused	ACE2
Myocardial Infarction	ENSG00000130368	FALSE	Preclinical	2008-03-25	Preclinical	MAS1
Myocardial Infarction	ENSG00000132170	TRUE	Approved	NA	Unused	PPARG
Myocardial Infarction	ENSG00000132329	FALSE	Preclinical	2005-05-25	Unused	RAMP1
Myocardial Infarction	ENSG00000132693	FALSE	Preclinical	1993-04-15	Unused	CRP
Myocardial Infarction	ENSG00000132965	FALSE	Phase III Clinical Trial	2003-11-17	Unused	ALOX5AP
Myocardial Infarction	ENSG00000135047	FALSE	Preclinical	1997-09-15	Unused	CTSL
Myocardial Infarction	ENSG00000135218	FALSE	Preclinical	2012-04-02	Preclinical	CD36
Myocardial Infarction	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Myocardial Infarction	ENSG00000136160	FALSE	Preclinical	1993-09-15	Unused	EDNRB
Myocardial Infarction	ENSG00000137193	FALSE	Preclinical	2017-03-28	Absent	PIM1
Myocardial Infarction	ENSG00000137745	FALSE	Preclinical	NA	Unused	MMP13
Myocardial Infarction	ENSG00000138448	FALSE	unknown	NA	Unused	ITGAV
Myocardial Infarction	ENSG00000140443	FALSE	Preclinical	2006-11-15	Unused	IGF1R
Myocardial Infarction	ENSG00000141510	FALSE	Preclinical	2000-10-04	Unused	TP53
Myocardial Infarction	ENSG00000142166	FALSE	unknown	NA	Unused	IFNAR1
Myocardial Infarction	ENSG00000143799	FALSE	unknown	2002-07-04	Unused	PARP1
Myocardial Infarction	ENSG00000144891	TRUE	Approved	1992-05-15	Approved	AGTR1
Myocardial Infarction	ENSG00000145050	FALSE	Preclinical	2010-01-11	Preclinical	MANF
Myocardial Infarction	ENSG00000149131	FALSE	unknown	2012-09-27	Phase I Clinical Trial	SERPING1
Myocardial Infarction	ENSG00000150093	FALSE	Preclinical	2001-07-23	Unused	ITGB1
Myocardial Infarction	ENSG00000151617	FALSE	Preclinical	1994-08-15	Unused	EDNRA
Myocardial Infarction	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Myocardial Infarction	ENSG00000159640	TRUE	Approved	1989-06-15	Approved	ACE
Myocardial Infarction	ENSG00000160255	FALSE	unknown	1992-06-15	Unused	ITGB2
Myocardial Infarction	ENSG00000163464	FALSE	Preclinical	NA	Unused	CXCR1
Myocardial Infarction	ENSG00000163932	FALSE	Phase II Clinical Trial	2004-09-29	Unused	PRKCD
Myocardial Infarction	ENSG00000164171	FALSE	Preclinical	2001-07-23	Unused	ITGA2
Myocardial Infarction	ENSG00000164305	FALSE	Preclinical	2013-01-03	Preclinical	CASP3
Myocardial Infarction	ENSG00000164867	FALSE	Preclinical	2000-02-23	Unused	NOS3
Myocardial Infarction	ENSG00000165029	FALSE	Preclinical	2014-09-10	Absent	ABCA1
Myocardial Infarction	ENSG00000165973	FALSE	Preclinical	2008-10-09	Unused	NELL1
Myocardial Infarction	ENSG00000167711	FALSE	Phase I Clinical Trial	2013-11-28	Absent	SERPINF2
Myocardial Infarction	ENSG00000169252	FALSE	Phase III Clinical Trial	2012-09-20	Preclinical	ADRB2
Myocardial Infarction	ENSG00000169313	TRUE	Approved	2005-03-09	Approved	P2RY12
Myocardial Infarction	ENSG00000169403	FALSE	Preclinical	1996-01-15	Unused	PTAFR
Myocardial Infarction	ENSG00000169418	FALSE	unknown	NA	Unused	NPR1
Myocardial Infarction	ENSG00000171049	FALSE	Preclinical	2008-03-25	Preclinical	FPR2
Myocardial Infarction	ENSG00000171105	FALSE	unknown	2001-02-21	Unused	INSR
Myocardial Infarction	ENSG00000171497	FALSE	Preclinical	2015-10-20	Absent	PPID
Myocardial Infarction	ENSG00000171509	FALSE	Preclinical	2012-03-13	Preclinical	RXFP1
Myocardial Infarction	ENSG00000171557	TRUE	Approved	NA	Approved	FGG
Myocardial Infarction	ENSG00000171560	TRUE	Approved	NA	Approved	FGA
Myocardial Infarction	ENSG00000171564	TRUE	Approved	NA	Approved	FGB
Myocardial Infarction	ENSG00000174175	FALSE	Phase II Clinical Trial	2005-05-25	Unused	SELP
Myocardial Infarction	ENSG00000175445	FALSE	unknown	2001-02-08	Unused	LPL
Myocardial Infarction	ENSG00000175899	FALSE	Preclinical	NA	Absent	A2M
Myocardial Infarction	ENSG00000176884	FALSE	Preclinical	1990-06-15	Unused	GRIN1
Myocardial Infarction	ENSG00000180210	TRUE	Approved	1991-02-15	Approved	F2
Myocardial Infarction	ENSG00000180871	FALSE	Preclinical	NA	Unused	CXCR2
Myocardial Infarction	ENSG00000181104	FALSE	Preclinical	1991-11-15	Unused	F2R
Myocardial Infarction	ENSG00000182492	FALSE	Preclinical	2009-07-24	Preclinical	BGN
Myocardial Infarction	ENSG00000182782	TRUE	Approved	NA	Approved	HCAR2
Myocardial Infarction	ENSG00000183023	FALSE	unknown	1998-12-15	Unused	SLC8A1
Myocardial Infarction	ENSG00000183873	FALSE	unknown	2003-07-29	Unused	SCN5A
Myocardial Infarction	ENSG00000184381	FALSE	Preclinical	1998-12-15	Unused	PLA2G6
Myocardial Infarction	ENSG00000184588	TRUE	Approved	NA	Approved	PDE4B
Myocardial Infarction	ENSG00000185245	FALSE	Phase II Clinical Trial	2009-10-08	Absent	GP1BA
Myocardial Infarction	ENSG00000186951	FALSE	Preclinical	2015-10-13	Absent	PPARA
Myocardial Infarction	ENSG00000187266	FALSE	Preclinical	2016-11-21	Absent	EPOR
Myocardial Infarction	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Myocardial Infarction	ENSG00000196262	FALSE	unknown	2004-04-27	Phase III Clinical Trial	PPIA
Myocardial Infarction	ENSG00000196549	FALSE	Phase III Clinical Trial	2007-09-14	Absent	MME
Myocardial Infarction	ENSG00000196611	FALSE	Phase I Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP1
Myocardial Infarction	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-04-17	Unused	SRC
Myocardial Infarction	ENSG00000197249	FALSE	Phase II Clinical Trial	2009-06-04	Absent	SERPINA1
Myocardial Infarction	ENSG00000197442	FALSE	Preclinical	2017-10-05	Absent	MAP3K5
Myocardial Infarction	ENSG00000197635	FALSE	Phase I Clinical Trial	2010-12-01	Phase II Clinical Trial	DPP4
Myocardial Infarction	ENSG00000198626	FALSE	Phase II Clinical Trial	1997-05-15	Unused	RYR2
Myocardial Infarction	ENSG00000205542	FALSE	Phase I Clinical Trial	1995-01-15	Phase II Clinical Trial	TMSB4X
Myocardial Infarction	ENSG00000259207	TRUE	Approved	1991-01-15	Approved	ITGB3
Myocardial Infarction	ENSG00000269858	FALSE	Preclinical	2010-08-28	Absent	EGLN2
Myopathies, Structural, Congenital	ENSG00000079805	FALSE	Preclinical	2017-10-17	Absent	DNM2
Myopathies, Structural, Congenital	ENSG00000171100	FALSE	Phase II Clinical Trial	2012-02-23	Absent	MTM1
Myopia	ENSG00000112715	TRUE	Approved	1999-11-02	Approved	VEGFA
Myopia	ENSG00000119630	TRUE	Approved	NA	Phase III Clinical Trial	PGF
Myopia	ENSG00000168539	FALSE	Phase II Clinical Trial	2003-01-28	Unused	CHRM1
Myopia	ENSG00000179776	FALSE	unknown	2000-12-11	Phase II Clinical Trial	CDH5
Myositis	ENSG00000073756	FALSE	Approved	1997-05-15	Unused	PTGS2
Myositis	ENSG00000088832	TRUE	Approved	NA	Absent	FKBP1A
Myositis	ENSG00000095303	FALSE	Approved	1997-05-15	Unused	PTGS1
Myositis	ENSG00000101916	FALSE	unknown	2012-03-16	Absent	TLR8
Myositis	ENSG00000102524	FALSE	Preclinical	2016-08-12	Absent	TNFSF13B
Myositis	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Myositis	ENSG00000114013	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD86
Myositis	ENSG00000121594	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD80
Myositis	ENSG00000125538	FALSE	Phase II Clinical Trial	2006-01-18	Absent	IL1B
Myositis	ENSG00000138379	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MSTN
Myositis	ENSG00000170989	FALSE	unknown	2006-12-07	Phase II Clinical Trial	S1PR1
Myositis	ENSG00000180739	FALSE	unknown	2006-12-07	Phase II Clinical Trial	S1PR5
Myositis	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Myositis	ENSG00000196664	FALSE	unknown	2012-03-16	Absent	TLR7
Myositis	ENSG00000239732	FALSE	unknown	2012-03-16	Absent	TLR9
Myositis	ENSG00000239961	FALSE	Phase I Clinical Trial	2010-01-21	Absent	LILRA4
Myositis	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Myositis Ossificans	ENSG00000112715	FALSE	Phase I Clinical Trial	1993-05-15	Absent	VEGFA
Myositis Ossificans	ENSG00000115170	FALSE	Phase II Clinical Trial	2015-03-04	Absent	ACVR1
Myositis Ossificans	ENSG00000122641	FALSE	Phase II Clinical Trial	2015-09-14	Absent	INHBA
Myositis Ossificans	ENSG00000138685	FALSE	Phase I Clinical Trial	1993-05-15	Absent	FGF2
Myositis Ossificans	ENSG00000168487	FALSE	Preclinical	NA	Absent	BMP1
Myositis Ossificans	ENSG00000172819	FALSE	Phase III Clinical Trial	2001-01-23	Absent	RARG
Myositis Ossificans	ENSG00000183691	FALSE	Preclinical	2002-08-21	Unused	NOG
Myositis, Inclusion Body	ENSG00000114739	FALSE	unknown	2010-07-02	Absent	ACVR2B
Myositis, Inclusion Body	ENSG00000159921	FALSE	Phase I Clinical Trial	NA	Unused	GNE
Myotonic Dystrophy	ENSG00000082701	FALSE	Phase II Clinical Trial	2015-10-01	Absent	GSK3B
Myotonic Dystrophy	ENSG00000104783	FALSE	Preclinical	1998-06-15	Unused	KCNN4
Myotonic Dystrophy	ENSG00000104936	FALSE	Phase II Clinical Trial	2012-06-29	Preclinical	DMPK
Myotonic Dystrophy	ENSG00000140443	FALSE	unknown	NA	Unused	IGF1R
Narcolepsy	ENSG00000011677	FALSE	Phase II Clinical Trial	2012-05-15	Absent	GABRA3
Narcolepsy	ENSG00000022355	FALSE	Phase II Clinical Trial	2012-05-15	Absent	GABRA1
Narcolepsy	ENSG00000101180	TRUE	Approved	2004-08-24	Phase III Clinical Trial	HRH3
Narcolepsy	ENSG00000103546	FALSE	unknown	NA	Absent	SLC6A2
Narcolepsy	ENSG00000104783	FALSE	Preclinical	1998-06-15	Unused	KCNN4
Narcolepsy	ENSG00000108576	FALSE	Preclinical	2007-09-05	Unused	SLC6A4
Narcolepsy	ENSG00000121764	FALSE	Preclinical	2000-07-04	Unused	HCRTR1
Narcolepsy	ENSG00000137252	FALSE	Phase III Clinical Trial	2000-07-04	Unused	HCRTR2
Narcolepsy	ENSG00000146399	FALSE	Preclinical	2016-10-18	Absent	TAAR1
Narcolepsy	ENSG00000151834	FALSE	Phase II Clinical Trial	2012-05-15	Absent	GABRA2
Narcolepsy	ENSG00000186297	FALSE	Phase II Clinical Trial	2012-05-15	Absent	GABRA5
Nasal Polyps	ENSG00000012779	FALSE	Phase II Clinical Trial	NA	Unused	ALOX5
Nasal Polyps	ENSG00000077238	FALSE	Phase III Clinical Trial	2009-11-19	Absent	IL4R
Nasal Polyps	ENSG00000091181	FALSE	Phase III Clinical Trial	2003-08-27	Absent	IL5RA
Nasal Polyps	ENSG00000113525	FALSE	Phase III Clinical Trial	1997-05-15	Phase II Clinical Trial	IL5
Nasal Polyps	ENSG00000113580	TRUE	Approved	2008-08-21	Approved	NR3C1
Nasal Polyps	ENSG00000115602	FALSE	Phase I Clinical Trial	2013-08-26	Absent	IL1RL1
Nasal Polyps	ENSG00000149021	FALSE	Phase II Clinical Trial	1997-08-15	Unused	SCGB1A1
Nasopharyngeal Neoplasms	ENSG00000037280	FALSE	Preclinical	2001-04-03	Absent	FLT4
Nasopharyngeal Neoplasms	ENSG00000066468	FALSE	Preclinical	2008-09-16	Absent	FGFR2
Nasopharyngeal Neoplasms	ENSG00000068078	FALSE	Preclinical	2001-04-03	Absent	FGFR3
Nasopharyngeal Neoplasms	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Nasopharyngeal Neoplasms	ENSG00000077782	FALSE	Preclinical	2001-04-03	Absent	FGFR1
Nasopharyngeal Neoplasms	ENSG00000102755	FALSE	Preclinical	2001-04-03	Absent	FLT1
Nasopharyngeal Neoplasms	ENSG00000113721	FALSE	Preclinical	2001-04-03	Absent	PDGFRB
Nasopharyngeal Neoplasms	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	CDK2
Nasopharyngeal Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Nasopharyngeal Neoplasms	ENSG00000128052	FALSE	Preclinical	2001-04-03	Absent	KDR
Nasopharyngeal Neoplasms	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK7
Nasopharyngeal Neoplasms	ENSG00000134460	FALSE	Phase III Clinical Trial	NA	Preclinical	IL2RA
Nasopharyngeal Neoplasms	ENSG00000134853	FALSE	Preclinical	2001-04-03	Absent	PDGFRA
Nasopharyngeal Neoplasms	ENSG00000135446	FALSE	unknown	2007-08-14	Phase I Clinical Trial	CDK4
Nasopharyngeal Neoplasms	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK9
Nasopharyngeal Neoplasms	ENSG00000141736	FALSE	Phase I Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB2
Nasopharyngeal Neoplasms	ENSG00000146648	FALSE	Approved	2003-11-21	Approved	EGFR
Nasopharyngeal Neoplasms	ENSG00000156738	FALSE	unknown	1993-09-15	Absent	MS4A1
Nasopharyngeal Neoplasms	ENSG00000157404	FALSE	Preclinical	2001-04-03	Absent	KIT
Nasopharyngeal Neoplasms	ENSG00000157764	FALSE	Preclinical	2001-04-03	Absent	BRAF
Nasopharyngeal Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2017-01-18	Absent	FGFR4
Nasopharyngeal Neoplasms	ENSG00000168522	FALSE	Preclinical	2011-04-18	Absent	FNTA
Nasopharyngeal Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2009-10-16	Phase I Clinical Trial	PTK2
Nasopharyngeal Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1993-12-15	Absent	TYMS
Nasopharyngeal Neoplasms	ENSG00000178568	FALSE	Phase I Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB4
Nasopharyngeal Neoplasms	ENSG00000182871	FALSE	Phase II Clinical Trial	NA	Absent	COL18A1
Nasopharyngeal Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2011-02-17	Absent	PDCD1
Nasopharyngeal Neoplasms	ENSG00000198900	FALSE	Phase I Clinical Trial	2007-10-08	Phase I Clinical Trial	TOP1
Nausea	ENSG00000069696	FALSE	Phase III Clinical Trial	1989-12-15	Absent	DRD4
Nausea	ENSG00000073756	TRUE	Approved	NA	Absent	PTGS2
Nausea	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Nausea	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Nausea	ENSG00000102468	FALSE	Phase III Clinical Trial	1989-12-15	Absent	HTR2A
Nausea	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Nausea	ENSG00000103546	FALSE	unknown	1990-07-15	Unused	SLC6A2
Nausea	ENSG00000108576	FALSE	Preclinical	1992-12-15	Unused	SLC6A4
Nausea	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Nausea	ENSG00000115353	TRUE	Approved	1991-04-15	Approved	TACR1
Nausea	ENSG00000116329	FALSE	unknown	2001-07-18	Preclinical	OPRD1
Nausea	ENSG00000117480	FALSE	Preclinical	2017-09-08	Absent	FAAH
Nausea	ENSG00000118432	TRUE	Approved	1989-06-15	Approved	CNR1
Nausea	ENSG00000133019	TRUE	Approved	1992-09-15	Approved	CHRM3
Nausea	ENSG00000135312	FALSE	Preclinical	1992-12-15	Phase I Clinical Trial	HTR1B
Nausea	ENSG00000147246	FALSE	Phase III Clinical Trial	1989-12-15	Unused	HTR2C
Nausea	ENSG00000149295	TRUE	Approved	1989-12-15	Approved	DRD2
Nausea	ENSG00000151577	FALSE	Phase III Clinical Trial	1989-12-15	Unused	DRD3
Nausea	ENSG00000151617	FALSE	Preclinical	1994-10-15	Unused	EDNRA
Nausea	ENSG00000155511	FALSE	Preclinical	1998-10-15	Unused	GRIA1
Nausea	ENSG00000163394	FALSE	unknown	1993-01-15	Unused	CCKAR
Nausea	ENSG00000164270	TRUE	Approved	1990-10-15	Approved	HTR4
Nausea	ENSG00000166148	FALSE	unknown	1993-01-15	Unused	AVPR1A
Nausea	ENSG00000166736	TRUE	Approved	1989-06-15	Approved	HTR3A
Nausea	ENSG00000168539	TRUE	Approved	1997-03-15	Approved	CHRM1
Nausea	ENSG00000169836	FALSE	Preclinical	1994-11-15	Unused	TACR3
Nausea	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Nausea	ENSG00000178394	FALSE	Phase I Clinical Trial	1992-03-15	Unused	HTR1A
Nausea	ENSG00000179546	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	HTR1D
Nausea	ENSG00000180720	TRUE	Approved	1997-03-15	Approved	CHRM4
Nausea	ENSG00000181072	TRUE	Approved	1997-03-15	Approved	CHRM2
Nausea	ENSG00000184845	FALSE	Phase III Clinical Trial	1989-12-15	Absent	DRD1
Nausea	ENSG00000185149	FALSE	Preclinical	2018-01-23	Absent	NPY2R
Nausea	ENSG00000188822	FALSE	Preclinical	2016-12-21	Absent	CNR2
Nausea	ENSG00000196639	TRUE	Approved	1992-09-15	Unused	HRH1
Neoplasms	ENSG00000000938	FALSE	Phase I Clinical Trial	2007-10-29	Absent	FGR
Neoplasms	ENSG00000000971	FALSE	Preclinical	2017-09-01	Absent	CFH
Neoplasms	ENSG00000001626	FALSE	Preclinical	2009-09-30	Absent	CFTR
Neoplasms	ENSG00000002549	FALSE	Preclinical	NA	Unused	LAP3
Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	2016-10-25	Absent	CFLAR
Neoplasms	ENSG00000003436	FALSE	Preclinical	2001-04-26	Unused	TFPI
Neoplasms	ENSG00000004468	FALSE	Preclinical	2010-06-25	Preclinical	CD38
Neoplasms	ENSG00000004487	FALSE	Phase I Clinical Trial	2008-06-10	Unused	KDM1A
Neoplasms	ENSG00000005339	FALSE	Preclinical	2016-01-21	Absent	CREBBP
Neoplasms	ENSG00000005884	FALSE	Preclinical	1999-11-24	Unused	ITGA3
Neoplasms	ENSG00000005961	FALSE	Preclinical	1998-03-15	Unused	ITGA2B
Neoplasms	ENSG00000006210	FALSE	Preclinical	2006-02-07	Absent	CX3CL1
Neoplasms	ENSG00000006283	FALSE	Preclinical	1991-09-15	Unused	CACNA1G
Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2001-01-30	Phase I Clinical Trial	TNFRSF12A
Neoplasms	ENSG00000006744	FALSE	Preclinical	1997-07-15	Unused	ELAC2
Neoplasms	ENSG00000007062	FALSE	Preclinical	2012-05-18	Preclinical	PROM1
Neoplasms	ENSG00000007171	FALSE	Preclinical	1997-12-15	Unused	NOS2
Neoplasms	ENSG00000007312	FALSE	Preclinical	2009-06-03	Unused	CD79B
Neoplasms	ENSG00000007908	FALSE	Phase I Clinical Trial	1989-06-15	Unused	SELE
Neoplasms	ENSG00000007952	FALSE	Preclinical	2011-06-01	Unused	NOX1
Neoplasms	ENSG00000009694	FALSE	Preclinical	2004-03-30	Unused	TENM1
Neoplasms	ENSG00000010278	FALSE	Preclinical	2008-03-19	Unused	CD9
Neoplasms	ENSG00000010610	FALSE	Phase I Clinical Trial	1992-05-15	Unused	CD4
Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Unused	BTK
Neoplasms	ENSG00000010810	FALSE	Phase I Clinical Trial	NA	Unused	FYN
Neoplasms	ENSG00000011422	FALSE	Preclinical	1994-09-15	Unused	PLAUR
Neoplasms	ENSG00000011485	FALSE	Preclinical	2016-11-08	Absent	PPP5C
Neoplasms	ENSG00000012048	TRUE	Approved	2013-09-04	Absent	BRCA1
Neoplasms	ENSG00000012061	FALSE	Preclinical	1999-04-21	Unused	ERCC1
Neoplasms	ENSG00000012124	FALSE	Phase II Clinical Trial	1992-07-15	Unused	CD22
Neoplasms	ENSG00000012779	FALSE	Preclinical	1991-09-15	Unused	ALOX5
Neoplasms	ENSG00000013725	FALSE	unknown	1991-08-15	Unused	CD6
Neoplasms	ENSG00000013810	FALSE	Preclinical	2017-03-06	Absent	TACC3
Neoplasms	ENSG00000017427	FALSE	Phase I Clinical Trial	2004-08-17	Phase I Clinical Trial	IGF1
Neoplasms	ENSG00000018408	FALSE	Preclinical	2016-07-26	Absent	WWTR1
Neoplasms	ENSG00000019186	FALSE	Preclinical	2005-07-11	Unused	CYP24A1
Neoplasms	ENSG00000019582	FALSE	Preclinical	1994-10-15	Unused	CD74
Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	1993-06-15	Phase I Clinical Trial	HGF
Neoplasms	ENSG00000020633	FALSE	Preclinical	2010-06-28	Unused	RUNX3
Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2002-07-03	Phase II Clinical Trial	BIRC3
Neoplasms	ENSG00000025434	FALSE	Phase I Clinical Trial	2005-12-01	Unused	NR1H3
Neoplasms	ENSG00000025708	FALSE	Phase I Clinical Trial	1998-06-15	Unused	TYMP
Neoplasms	ENSG00000026103	FALSE	Phase II Clinical Trial	1989-09-15	Phase II Clinical Trial	FAS
Neoplasms	ENSG00000026508	FALSE	Phase II Clinical Trial	1992-09-15	Phase I Clinical Trial	CD44
Neoplasms	ENSG00000026751	FALSE	unknown	2008-07-03	Unused	SLAMF7
Neoplasms	ENSG00000027697	FALSE	Phase I Clinical Trial	1989-08-15	Unused	IFNGR1
Neoplasms	ENSG00000030110	FALSE	Preclinical	1997-07-15	Absent	BAK1
Neoplasms	ENSG00000033178	FALSE	Phase I Clinical Trial	2011-11-23	Preclinical	UBA6
Neoplasms	ENSG00000034152	FALSE	Preclinical	2004-02-05	Unused	MAP2K3
Neoplasms	ENSG00000035862	FALSE	Preclinical	1991-02-15	Unused	TIMP2
Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Neoplasms	ENSG00000037474	FALSE	Preclinical	NA	Unused	NSUN2
Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-06-17	Absent	CDH1
Neoplasms	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-05-29	Phase II Clinical Trial	TNC
Neoplasms	ENSG00000042088	FALSE	Preclinical	2009-04-02	Preclinical	TDP1
Neoplasms	ENSG00000044524	FALSE	Preclinical	2004-03-23	Preclinical	EPHA3
Neoplasms	ENSG00000044574	FALSE	Preclinical	2007-11-19	Phase I Clinical Trial	HSPA5
Neoplasms	ENSG00000047936	FALSE	Phase III Clinical Trial	2006-12-05	Absent	ROS1
Neoplasms	ENSG00000048028	FALSE	Preclinical	2016-06-17	Absent	USP28
Neoplasms	ENSG00000048462	FALSE	Preclinical	2014-06-19	Absent	TNFRSF17
Neoplasms	ENSG00000049249	FALSE	Phase II Clinical Trial	1999-09-16	Phase II Clinical Trial	TNFRSF9
Neoplasms	ENSG00000049768	FALSE	Preclinical	2015-09-29	Absent	FOXP3
Neoplasms	ENSG00000051180	FALSE	Preclinical	2003-06-18	Unused	RAD51
Neoplasms	ENSG00000051341	FALSE	Preclinical	2017-06-29	Absent	POLQ
Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CB
Neoplasms	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Neoplasms	ENSG00000055332	FALSE	Preclinical	1995-05-15	Unused	EIF2AK2
Neoplasms	ENSG00000056736	FALSE	Preclinical	2007-09-21	Preclinical	IL17RB
Neoplasms	ENSG00000057252	FALSE	Preclinical	2013-12-06	Absent	SOAT1
Neoplasms	ENSG00000058085	FALSE	Preclinical	1997-04-15	Unused	LAMC2
Neoplasms	ENSG00000059728	FALSE	Preclinical	1995-08-15	Unused	MXD1
Neoplasms	ENSG00000060491	FALSE	unknown	NA	Unused	OGFR
Neoplasms	ENSG00000061938	FALSE	Phase I Clinical Trial	2011-04-04	Unused	TNK2
Neoplasms	ENSG00000062038	FALSE	Phase I Clinical Trial	2007-01-10	Unused	CDH3
Neoplasms	ENSG00000063176	FALSE	Phase I Clinical Trial	2006-06-05	Phase I Clinical Trial	SPHK2
Neoplasms	ENSG00000063660	FALSE	Phase I Clinical Trial	2014-09-02	Absent	GPC1
Neoplasms	ENSG00000064547	FALSE	Preclinical	NA	Unused	LPAR2
Neoplasms	ENSG00000064651	FALSE	unknown	NA	Unused	SLC12A2
Neoplasms	ENSG00000065057	FALSE	Preclinical	2000-01-26	Unused	NTHL1
Neoplasms	ENSG00000065320	FALSE	Phase I Clinical Trial	2010-07-07	Preclinical	NTN1
Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	1996-09-15	Phase II Clinical Trial	ERBB3
Neoplasms	ENSG00000065427	FALSE	Preclinical	2015-06-22	Absent	KARS
Neoplasms	ENSG00000065675	FALSE	Preclinical	2008-07-21	Unused	PRKCQ
Neoplasms	ENSG00000065883	FALSE	Preclinical	2016-09-06	Absent	CDK13
Neoplasms	ENSG00000065978	FALSE	Preclinical	2002-07-19	Unused	YBX1
Neoplasms	ENSG00000065989	FALSE	Preclinical	1994-10-15	Unused	PDE4A
Neoplasms	ENSG00000066056	FALSE	Preclinical	2005-08-15	Unused	TIE1
Neoplasms	ENSG00000066405	TRUE	Approved	2016-06-01	Absent	CLDN18
Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	1996-09-15	Phase II Clinical Trial	FGFR2
Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Neoplasms	ENSG00000067225	FALSE	Preclinical	2011-11-17	Preclinical	PKM
Neoplasms	ENSG00000067560	FALSE	Preclinical	2004-08-11	Unused	RHOA
Neoplasms	ENSG00000067606	FALSE	Preclinical	2014-04-10	Absent	PRKCZ
Neoplasms	ENSG00000067900	FALSE	Preclinical	1998-10-15	Unused	ROCK1
Neoplasms	ENSG00000068024	FALSE	Phase II Clinical Trial	2002-06-10	Absent	HDAC4
Neoplasms	ENSG00000068028	FALSE	Preclinical	2012-10-22	Preclinical	RASSF1
Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Neoplasms	ENSG00000068903	FALSE	Preclinical	2009-07-07	Unused	SIRT2
Neoplasms	ENSG00000069667	FALSE	Preclinical	2011-01-24	Absent	RORA
Neoplasms	ENSG00000070018	FALSE	Preclinical	2010-09-03	Unused	LRP6
Neoplasms	ENSG00000070501	FALSE	Pre-registration	1990-10-15	Phase II Clinical Trial	POLB
Neoplasms	ENSG00000071054	FALSE	Preclinical	2014-04-22	Absent	MAP4K4
Neoplasms	ENSG00000072062	FALSE	Preclinical	1990-11-15	Unused	PRKACA
Neoplasms	ENSG00000072274	FALSE	Phase I Clinical Trial	2000-10-16	Unused	TFRC
Neoplasms	ENSG00000072571	FALSE	Preclinical	2000-11-14	Unused	HMMR
Neoplasms	ENSG00000073008	FALSE	Preclinical	2006-07-31	Unused	PVR
Neoplasms	ENSG00000073060	FALSE	Preclinical	NA	Absent	SCARB1
Neoplasms	ENSG00000073614	FALSE	Preclinical	2016-09-27	Absent	KDM5A
Neoplasms	ENSG00000073756	TRUE	Approved	1997-01-15	Unused	PTGS2
Neoplasms	ENSG00000074047	FALSE	Preclinical	2009-11-19	Unused	GLI2
Neoplasms	ENSG00000074181	FALSE	Phase I Clinical Trial	2009-04-28	Phase I Clinical Trial	NOTCH3
Neoplasms	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Neoplasms	ENSG00000074410	FALSE	Preclinical	2011-06-18	Unused	CA12
Neoplasms	ENSG00000074416	FALSE	Preclinical	2015-09-02	Absent	MGLL
Neoplasms	ENSG00000074590	FALSE	Preclinical	2007-05-16	Preclinical	NUAK1
Neoplasms	ENSG00000074803	FALSE	unknown	NA	Unused	SLC12A1
Neoplasms	ENSG00000074966	FALSE	Preclinical	2015-01-28	Absent	TXK
Neoplasms	ENSG00000075073	FALSE	Preclinical	2000-11-07	Unused	TACR2
Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-09-26	Preclinical	SEMA3A
Neoplasms	ENSG00000076706	FALSE	Preclinical	2013-01-11	Preclinical	MCAM
Neoplasms	ENSG00000076984	FALSE	Preclinical	2004-02-02	Unused	MAP2K7
Neoplasms	ENSG00000077092	FALSE	Phase II Clinical Trial	1998-04-15	Unused	RARB
Neoplasms	ENSG00000077238	FALSE	Phase II Clinical Trial	1991-04-15	Unused	IL4R
Neoplasms	ENSG00000077254	FALSE	Preclinical	2004-10-20	Unused	USP33
Neoplasms	ENSG00000077463	FALSE	Preclinical	NA	Absent	SIRT6
Neoplasms	ENSG00000077498	FALSE	Preclinical	1993-06-15	Unused	TYR
Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	1993-07-15	Phase II Clinical Trial	FGFR1
Neoplasms	ENSG00000078098	FALSE	Phase I Clinical Trial	2001-12-20	Unused	FAP
Neoplasms	ENSG00000078142	FALSE	Preclinical	2014-10-29	Preclinical	PIK3C3
Neoplasms	ENSG00000078401	FALSE	Preclinical	2009-07-25	Unused	EDN1
Neoplasms	ENSG00000078668	FALSE	Phase I Clinical Trial	2004-10-15	Phase I Clinical Trial	VDAC3
Neoplasms	ENSG00000079277	FALSE	Phase II Clinical Trial	2010-02-04	Unused	MKNK1
Neoplasms	ENSG00000079337	FALSE	Preclinical	2002-08-01	Unused	RAPGEF3
Neoplasms	ENSG00000079385	FALSE	Preclinical	2015-07-22	Absent	CEACAM1
Neoplasms	ENSG00000079435	FALSE	Preclinical	2014-07-17	Absent	LIPE
Neoplasms	ENSG00000079459	FALSE	Preclinical	1993-10-15	Unused	FDFT1
Neoplasms	ENSG00000080166	FALSE	Preclinical	2008-10-29	Unused	DCT
Neoplasms	ENSG00000080293	TRUE	Approved	1999-03-23	Approved	SCTR
Neoplasms	ENSG00000080503	FALSE	Preclinical	2015-07-24	Absent	SMARCA2
Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2002-03-27	Phase II Clinical Trial	HSP90AA1
Neoplasms	ENSG00000081051	FALSE	Phase II Clinical Trial	2014-11-13	Unused	AFP
Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Neoplasms	ENSG00000081237	FALSE	unknown	2012-01-23	Absent	PTPRC
Neoplasms	ENSG00000081479	FALSE	Preclinical	2006-12-04	Unused	LRP2
Neoplasms	ENSG00000081985	FALSE	Phase I Clinical Trial	1998-08-15	Phase I Clinical Trial	IL12RB2
Neoplasms	ENSG00000082175	FALSE	Phase I Clinical Trial	1990-04-15	Unused	PGR
Neoplasms	ENSG00000082556	FALSE	Approved	2012-09-01	Preclinical	OPRK1
Neoplasms	ENSG00000082701	FALSE	Phase I Clinical Trial	2000-08-04	Phase I Clinical Trial	GSK3B
Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2001-01-30	Phase I Clinical Trial	ITGB5
Neoplasms	ENSG00000082898	FALSE	Phase I Clinical Trial	2009-01-22	Phase I Clinical Trial	XPO1
Neoplasms	ENSG00000083312	FALSE	Phase I Clinical Trial	2005-06-27	Unused	TNPO1
Neoplasms	ENSG00000084207	FALSE	Preclinical	1995-06-15	Unused	GSTP1
Neoplasms	ENSG00000084774	FALSE	Phase II Clinical Trial	1989-07-15	Unused	CAD
Neoplasms	ENSG00000085063	FALSE	Preclinical	NA	Unused	CD59
Neoplasms	ENSG00000085563	FALSE	Phase II Clinical Trial	1989-08-15	Phase II Clinical Trial	ABCB1
Neoplasms	ENSG00000085662	FALSE	Preclinical	2010-06-01	Unused	AKR1B1
Neoplasms	ENSG00000086205	TRUE	Approved	1991-03-15	Approved	FOLH1
Neoplasms	ENSG00000086548	FALSE	Preclinical	2003-05-14	Unused	CEACAM6
Neoplasms	ENSG00000087088	FALSE	Preclinical	2007-02-14	Unused	BAX
Neoplasms	ENSG00000087245	FALSE	Phase I Clinical Trial	1989-06-15	Unused	MMP2
Neoplasms	ENSG00000087586	FALSE	Phase I Clinical Trial	1998-09-15	Phase I Clinical Trial	AURKA
Neoplasms	ENSG00000089041	FALSE	Preclinical	2014-07-30	Absent	P2RX7
Neoplasms	ENSG00000089050	FALSE	Preclinical	1999-01-15	Unused	RBBP9
Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Phase I Clinical Trial	BIRC5
Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2007-07-16	Preclinical	LAG3
Neoplasms	ENSG00000090339	FALSE	Preclinical	1992-07-15	Unused	ICAM1
Neoplasms	ENSG00000090659	FALSE	Preclinical	2001-11-06	Unused	CD209
Neoplasms	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Neoplasms	ENSG00000091181	FALSE	Preclinical	NA	Unused	IL5RA
Neoplasms	ENSG00000091831	FALSE	Phase II Clinical Trial	1989-08-15	Unused	ESR1
Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Neoplasms	ENSG00000091972	FALSE	Phase I Clinical Trial	2002-07-08	Preclinical	CD200
Neoplasms	ENSG00000092439	FALSE	Preclinical	2011-09-28	Preclinical	TRPM7
Neoplasms	ENSG00000092445	FALSE	Preclinical	2014-05-23	Absent	TYRO3
Neoplasms	ENSG00000092969	FALSE	Phase I Clinical Trial	2000-05-24	Phase I Clinical Trial	TGFB2
Neoplasms	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC6
Neoplasms	ENSG00000095015	FALSE	Preclinical	2007-08-10	Phase I Clinical Trial	MAP3K1
Neoplasms	ENSG00000095059	FALSE	Preclinical	1996-12-15	Unused	DHPS
Neoplasms	ENSG00000095303	FALSE	Preclinical	2001-04-11	Phase II Clinical Trial	PTGS1
Neoplasms	ENSG00000095380	FALSE	Preclinical	1993-07-15	Unused	NANS
Neoplasms	ENSG00000095596	FALSE	Preclinical	2000-09-04	Unused	CYP26A1
Neoplasms	ENSG00000096717	FALSE	Preclinical	2004-09-21	Preclinical	SIRT1
Neoplasms	ENSG00000096968	FALSE	Phase I Clinical Trial	2000-04-04	Phase I Clinical Trial	JAK2
Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	1998-08-15	Phase I Clinical Trial	IL12RB1
Neoplasms	ENSG00000097007	TRUE	Approved	1989-06-15	Phase I Clinical Trial	ABL1
Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2003-11-28	Unused	CDC7
Neoplasms	ENSG00000099194	FALSE	Preclinical	2013-08-27	Unused	SCD
Neoplasms	ENSG00000099250	FALSE	Phase I Clinical Trial	2002-08-20	Phase I Clinical Trial	NRP1
Neoplasms	ENSG00000099810	FALSE	Preclinical	NA	Absent	MTAP
Neoplasms	ENSG00000099875	FALSE	Phase II Clinical Trial	2013-11-21	Absent	MKNK2
Neoplasms	ENSG00000099953	FALSE	Preclinical	1999-09-01	Unused	MMP11
Neoplasms	ENSG00000100030	FALSE	Phase II Clinical Trial	2005-01-21	Preclinical	MAPK1
Neoplasms	ENSG00000100097	FALSE	Phase I Clinical Trial	2006-12-14	Phase I Clinical Trial	LGALS1
Neoplasms	ENSG00000100292	FALSE	Preclinical	2014-02-18	Absent	HMOX1
Neoplasms	ENSG00000100300	FALSE	unknown	2002-05-14	Unused	TSPO
Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDGFB
Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	2004-03-30	Unused	ST13
Neoplasms	ENSG00000100385	FALSE	Phase II Clinical Trial	1998-12-15	Phase I Clinical Trial	IL2RB
Neoplasms	ENSG00000100393	FALSE	Preclinical	2017-11-23	Absent	EP300
Neoplasms	ENSG00000100422	FALSE	Preclinical	2009-11-25	Unused	CERK
Neoplasms	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC10
Neoplasms	ENSG00000100462	FALSE	Phase I Clinical Trial	2011-01-11	Absent	PRMT5
Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	2000-04-27	Phase II Clinical Trial	HIF1A
Neoplasms	ENSG00000100739	FALSE	Preclinical	2012-07-12	Preclinical	BDKRB1
Neoplasms	ENSG00000100784	FALSE	Preclinical	2014-08-25	Absent	RPS6KA5
Neoplasms	ENSG00000100823	FALSE	Phase I Clinical Trial	1993-03-15	Phase I Clinical Trial	APEX1
Neoplasms	ENSG00000100906	FALSE	Preclinical	2012-03-12	Preclinical	NFKBIA
Neoplasms	ENSG00000100985	FALSE	Phase I Clinical Trial	1995-11-15	Unused	MMP9
Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2000-12-14	Unused	CD40
Neoplasms	ENSG00000101188	FALSE	Preclinical	2016-02-23	Absent	NTSR1
Neoplasms	ENSG00000101213	FALSE	Preclinical	2011-09-06	Unused	PTK6
Neoplasms	ENSG00000101224	FALSE	Preclinical	2002-04-08	Unused	CDC25B
Neoplasms	ENSG00000101266	FALSE	Preclinical	2009-09-12	Unused	CSNK2A1
Neoplasms	ENSG00000101336	FALSE	Phase I Clinical Trial	2007-10-29	Absent	HCK
Neoplasms	ENSG00000101384	FALSE	Preclinical	2010-11-19	Preclinical	JAG1
Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2004-01-23	Phase I Clinical Trial	E2F1
Neoplasms	ENSG00000101425	FALSE	Preclinical	1995-02-15	Unused	BPI
Neoplasms	ENSG00000101842	FALSE	Preclinical	2008-01-04	Unused	VSIG1
Neoplasms	ENSG00000101846	FALSE	Preclinical	1995-12-15	Unused	STS
Neoplasms	ENSG00000101868	FALSE	Pre-registration	1990-10-15	Phase II Clinical Trial	POLA1
Neoplasms	ENSG00000101916	FALSE	Phase I Clinical Trial	2007-03-14	Unused	TLR8
Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	2002-07-03	Phase II Clinical Trial	XIAP
Neoplasms	ENSG00000102010	FALSE	Preclinical	2006-02-14	Unused	BMX
Neoplasms	ENSG00000102096	FALSE	Phase I Clinical Trial	2011-10-07	Phase I Clinical Trial	PIM2
Neoplasms	ENSG00000102245	FALSE	Preclinical	1996-01-15	Unused	CD40LG
Neoplasms	ENSG00000102312	FALSE	Preclinical	2015-06-23	Absent	PORCN
Neoplasms	ENSG00000102554	FALSE	Preclinical	2009-08-13	Unused	KLF5
Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	1999-10-27	Phase II Clinical Trial	FLT1
Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	2008-07-14	Phase I Clinical Trial	MSLN
Neoplasms	ENSG00000102882	FALSE	Phase II Clinical Trial	2005-01-21	Preclinical	MAPK3
Neoplasms	ENSG00000102962	FALSE	Preclinical	2010-03-18	Unused	CCL22
Neoplasms	ENSG00000102967	FALSE	Phase II Clinical Trial	1994-08-15	Unused	DHODH
Neoplasms	ENSG00000102970	FALSE	Preclinical	2010-03-18	Unused	CCL17
Neoplasms	ENSG00000103222	FALSE	Preclinical	1993-08-15	Unused	ABCC1
Neoplasms	ENSG00000103257	FALSE	Phase II Clinical Trial	2009-11-24	Phase I Clinical Trial	SLC7A5
Neoplasms	ENSG00000103522	FALSE	unknown	2001-01-25	Phase I Clinical Trial	IL21R
Neoplasms	ENSG00000103855	FALSE	Phase II Clinical Trial	2012-01-20	Absent	CD276
Neoplasms	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Neoplasms	ENSG00000104365	FALSE	Phase I Clinical Trial	2003-04-22	Unused	IKBKB
Neoplasms	ENSG00000104368	FALSE	Phase II Clinical Trial	2000-09-21	Unused	PLAT
Neoplasms	ENSG00000104415	FALSE	Preclinical	2015-01-07	Absent	WISP1
Neoplasms	ENSG00000104689	FALSE	Phase II Clinical Trial	2001-02-22	Unused	TNFRSF10A
Neoplasms	ENSG00000104763	FALSE	Preclinical	2009-07-27	Unused	ASAH1
Neoplasms	ENSG00000104827	FALSE	Preclinical	1998-12-15	Unused	CGB3
Neoplasms	ENSG00000104885	FALSE	Preclinical	2013-05-23	Absent	DOT1L
Neoplasms	ENSG00000104894	FALSE	Phase I Clinical Trial	2014-04-19	Absent	CD37
Neoplasms	ENSG00000104936	FALSE	Preclinical	2018-01-23	Absent	DMPK
Neoplasms	ENSG00000104938	FALSE	Preclinical	2001-11-06	Unused	CLEC4M
Neoplasms	ENSG00000105146	FALSE	Phase I Clinical Trial	2003-10-20	Phase I Clinical Trial	AURKC
Neoplasms	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE1
Neoplasms	ENSG00000105204	FALSE	Preclinical	2016-04-12	Absent	DYRK1B
Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2004-10-06	Phase I Clinical Trial	AKT2
Neoplasms	ENSG00000105246	FALSE	Preclinical	2016-03-17	Absent	EBI3
Neoplasms	ENSG00000105281	FALSE	Preclinical	2016-12-12	Absent	SLC1A5
Neoplasms	ENSG00000105287	FALSE	Preclinical	2014-05-23	Absent	PRKD2
Neoplasms	ENSG00000105329	FALSE	Phase I Clinical Trial	2000-05-24	Phase I Clinical Trial	TGFB1
Neoplasms	ENSG00000105355	FALSE	Preclinical	2002-10-22	Unused	PLIN3
Neoplasms	ENSG00000105383	FALSE	Phase II Clinical Trial	NA	Unused	CD33
Neoplasms	ENSG00000105388	TRUE	Approved	1991-03-15	Approved	CEACAM5
Neoplasms	ENSG00000105397	FALSE	Preclinical	2007-03-05	Unused	TYK2
Neoplasms	ENSG00000105641	FALSE	Preclinical	2000-11-29	Unused	SLC5A5
Neoplasms	ENSG00000105650	FALSE	Preclinical	1994-10-15	Unused	PDE4C
Neoplasms	ENSG00000105675	FALSE	Preclinical	2010-04-01	Unused	ATP4A
Neoplasms	ENSG00000105723	FALSE	Phase I Clinical Trial	2008-08-15	Absent	GSK3A
Neoplasms	ENSG00000105810	FALSE	Phase II Clinical Trial	2004-03-28	Phase II Clinical Trial	CDK6
Neoplasms	ENSG00000105835	FALSE	Phase I Clinical Trial	2003-04-22	Unused	NAMPT
Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2005-02-11	Phase II Clinical Trial	PIK3CG
Neoplasms	ENSG00000105894	FALSE	Preclinical	1997-12-15	Unused	PTN
Neoplasms	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2001-07-04	Phase II Clinical Trial	MET
Neoplasms	ENSG00000106105	FALSE	Preclinical	2015-06-22	Absent	GARS
Neoplasms	ENSG00000106128	FALSE	Preclinical	1994-05-15	Unused	GHRHR
Neoplasms	ENSG00000106144	FALSE	Preclinical	2001-09-12	Absent	CASP2
Neoplasms	ENSG00000106211	FALSE	Phase I Clinical Trial	2004-09-24	Unused	HSPB1
Neoplasms	ENSG00000106268	FALSE	Preclinical	2015-08-10	Absent	NUDT1
Neoplasms	ENSG00000106305	FALSE	Preclinical	2015-06-22	Absent	AIMP2
Neoplasms	ENSG00000106348	FALSE	Phase II Clinical Trial	1989-06-15	Unused	IMPDH1
Neoplasms	ENSG00000106366	FALSE	Preclinical	1996-12-15	Unused	SERPINE1
Neoplasms	ENSG00000106462	FALSE	Phase II Clinical Trial	2004-06-28	Unused	EZH2
Neoplasms	ENSG00000106546	FALSE	Preclinical	1992-09-15	Phase I Clinical Trial	AHR
Neoplasms	ENSG00000106633	FALSE	Preclinical	2008-06-02	Unused	GCK
Neoplasms	ENSG00000106683	FALSE	Preclinical	2005-08-17	Unused	LIMK1
Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	1998-06-15	Phase I Clinical Trial	TGFBR1
Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Neoplasms	ENSG00000107159	FALSE	Phase III Clinical Trial	1999-09-08	Phase III Clinical Trial	CA9
Neoplasms	ENSG00000107165	FALSE	Preclinical	2006-06-15	Unused	TYRP1
Neoplasms	ENSG00000107562	FALSE	Phase I Clinical Trial	2006-04-04	Phase I Clinical Trial	CXCL12
Neoplasms	ENSG00000107611	FALSE	Preclinical	2001-02-02	Preclinical	CUBN
Neoplasms	ENSG00000107643	FALSE	Preclinical	2014-03-24	Absent	MAPK8
Neoplasms	ENSG00000107738	FALSE	Phase I Clinical Trial	2011-10-03	Absent	VSIR
Neoplasms	ENSG00000107831	FALSE	Preclinical	2003-05-20	Unused	FGF8
Neoplasms	ENSG00000107854	FALSE	Phase II Clinical Trial	2009-10-28	Unused	TNKS2
Neoplasms	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Phase I Clinical Trial	DKK1
Neoplasms	ENSG00000108342	FALSE	Approved	2004-07-13	Unused	CSF3
Neoplasms	ENSG00000108424	FALSE	Phase I Clinical Trial	2005-06-27	Unused	KPNB1
Neoplasms	ENSG00000108443	FALSE	Phase I Clinical Trial	2003-03-20	Phase I Clinical Trial	RPS6KB1
Neoplasms	ENSG00000108654	FALSE	Phase I Clinical Trial	2006-08-30	Absent	DDX5
Neoplasms	ENSG00000108679	FALSE	Preclinical	2015-07-20	Absent	LGALS3BP
Neoplasms	ENSG00000108691	FALSE	Phase II Clinical Trial	2009-03-26	Unused	CCL2
Neoplasms	ENSG00000108786	FALSE	Preclinical	2006-03-03	Unused	HSD17B1
Neoplasms	ENSG00000108821	FALSE	Preclinical	2001-07-09	Unused	COL1A1
Neoplasms	ENSG00000108946	FALSE	Phase II Clinical Trial	1996-06-15	Unused	PRKAR1A
Neoplasms	ENSG00000108984	FALSE	Preclinical	2004-02-05	Unused	MAP2K6
Neoplasms	ENSG00000109072	FALSE	Preclinical	2000-07-19	Absent	VTN
Neoplasms	ENSG00000109163	FALSE	Approved	1989-05-15	Unused	GNRHR
Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1990-06-15	Phase I Clinical Trial	NFKB1
Neoplasms	ENSG00000109321	FALSE	Preclinical	1989-05-15	Unused	AREG
Neoplasms	ENSG00000109339	FALSE	Preclinical	2008-04-10	Unused	MAPK10
Neoplasms	ENSG00000109471	FALSE	Phase I Clinical Trial	1993-04-15	Unused	IL2
Neoplasms	ENSG00000109685	FALSE	Preclinical	2014-04-28	Absent	NSD2
Neoplasms	ENSG00000109971	FALSE	Preclinical	2009-11-24	Unused	HSPA8
Neoplasms	ENSG00000110092	FALSE	Phase I Clinical Trial	1995-02-15	Unused	CCND1
Neoplasms	ENSG00000110148	FALSE	Phase II Clinical Trial	1991-06-15	Unused	CCKBR
Neoplasms	ENSG00000110195	FALSE	Phase III Clinical Trial	2001-12-07	Phase I Clinical Trial	FOLR1
Neoplasms	ENSG00000110324	FALSE	Preclinical	NA	Unused	IL10RA
Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Phase II Clinical Trial	BIRC2
Neoplasms	ENSG00000110448	FALSE	Preclinical	1993-12-15	Unused	CD5
Neoplasms	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Neoplasms	ENSG00000110721	FALSE	Phase I Clinical Trial	2009-06-05	Phase I Clinical Trial	CHKA
Neoplasms	ENSG00000110876	FALSE	unknown	2002-08-22	Absent	SELPLG
Neoplasms	ENSG00000111087	FALSE	Preclinical	1998-11-15	Unused	GLI1
Neoplasms	ENSG00000111142	FALSE	Phase I Clinical Trial	1998-07-15	Phase I Clinical Trial	METAP2
Neoplasms	ENSG00000111276	FALSE	Preclinical	1995-02-15	Unused	CDKN1B
Neoplasms	ENSG00000111319	FALSE	Preclinical	2009-09-30	Unused	SCNN1A
Neoplasms	ENSG00000111321	FALSE	Phase I Clinical Trial	2001-11-16	Unused	LTBR
Neoplasms	ENSG00000111424	FALSE	Phase I Clinical Trial	1990-04-15	Unused	VDR
Neoplasms	ENSG00000111481	FALSE	Preclinical	2015-03-06	Absent	COPZ1
Neoplasms	ENSG00000111537	FALSE	Phase I Clinical Trial	1996-04-15	Unused	IFNG
Neoplasms	ENSG00000111640	FALSE	Preclinical	2009-07-24	Unused	GAPDH
Neoplasms	ENSG00000111641	FALSE	Preclinical	1992-11-15	Unused	NOP2
Neoplasms	ENSG00000111679	FALSE	Preclinical	2005-08-19	Unused	PTPN6
Neoplasms	ENSG00000111796	FALSE	Preclinical	1995-01-15	Unused	KLRB1
Neoplasms	ENSG00000112033	FALSE	Preclinical	2009-08-04	Unused	PPARD
Neoplasms	ENSG00000112038	FALSE	Approved	2012-09-01	Unused	OPRM1
Neoplasms	ENSG00000112062	FALSE	Phase I Clinical Trial	1997-06-15	Phase I Clinical Trial	MAPK14
Neoplasms	ENSG00000112115	FALSE	Preclinical	1998-06-15	Unused	IL17A
Neoplasms	ENSG00000112486	FALSE	Preclinical	2014-01-06	Absent	CCR6
Neoplasms	ENSG00000112655	FALSE	Phase I Clinical Trial	2007-01-22	Unused	PTK7
Neoplasms	ENSG00000112715	FALSE	Phase II Clinical Trial	1994-12-15	Phase I Clinical Trial	VEGFA
Neoplasms	ENSG00000112742	FALSE	Phase I Clinical Trial	2009-05-05	Unused	TTK
Neoplasms	ENSG00000112964	FALSE	Preclinical	2004-11-29	Unused	GHR
Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2002-06-13	Unused	HBEGF
Neoplasms	ENSG00000113083	FALSE	Preclinical	1998-12-15	Unused	LOX
Neoplasms	ENSG00000113163	FALSE	unknown	2016-09-08	Absent	COL4A3BP
Neoplasms	ENSG00000113263	FALSE	Preclinical	2014-10-08	Absent	ITK
Neoplasms	ENSG00000113273	FALSE	Preclinical	2000-04-26	Unused	ARSB
Neoplasms	ENSG00000113302	FALSE	Preclinical	1998-06-15	Unused	IL12B
Neoplasms	ENSG00000113328	FALSE	Approved	2003-08-05	Unused	CCNG1
Neoplasms	ENSG00000113441	FALSE	Preclinical	NA	Unused	LNPEP
Neoplasms	ENSG00000113448	FALSE	Preclinical	1994-10-15	Unused	PDE4D
Neoplasms	ENSG00000113494	FALSE	Preclinical	1995-06-15	Unused	PRLR
Neoplasms	ENSG00000113520	FALSE	Phase I Clinical Trial	1993-06-15	Unused	IL4
Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	1999-10-20	Unused	PPP2CA
Neoplasms	ENSG00000113578	FALSE	Preclinical	2013-04-20	Absent	FGF1
Neoplasms	ENSG00000113580	FALSE	Phase II Clinical Trial	1990-12-15	Unused	NR3C1
Neoplasms	ENSG00000113594	FALSE	Preclinical	2014-12-16	Absent	LIFR
Neoplasms	ENSG00000113712	FALSE	Preclinical	2011-03-15	Preclinical	CSNK1A1
Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Neoplasms	ENSG00000113749	FALSE	unknown	2008-06-03	Phase II Clinical Trial	HRH2
Neoplasms	ENSG00000113851	FALSE	Phase I Clinical Trial	2011-08-26	Absent	CRBN
Neoplasms	ENSG00000113889	FALSE	Preclinical	2005-05-27	Unused	KNG1
Neoplasms	ENSG00000114013	FALSE	unknown	1997-07-15	Unused	CD86
Neoplasms	ENSG00000114062	FALSE	Preclinical	NA	Preclinical	UBE3A
Neoplasms	ENSG00000114378	FALSE	Phase I Clinical Trial	2004-08-26	Phase I Clinical Trial	HYAL1
Neoplasms	ENSG00000114388	FALSE	Preclinical	2006-11-21	Unused	NPRL2
Neoplasms	ENSG00000114423	FALSE	Phase I Clinical Trial	2006-03-17	Preclinical	CBLB
Neoplasms	ENSG00000114491	FALSE	Phase II Clinical Trial	NA	Unused	UMPS
Neoplasms	ENSG00000114739	FALSE	Phase I Clinical Trial	2012-10-31	Absent	ACVR2B
Neoplasms	ENSG00000114812	FALSE	Preclinical	1999-04-21	Unused	VIPR1
Neoplasms	ENSG00000114867	FALSE	Preclinical	2015-07-30	Absent	EIF4G1
Neoplasms	ENSG00000115008	FALSE	unknown	2009-12-07	Preclinical	IL1A
Neoplasms	ENSG00000115009	FALSE	Preclinical	2001-06-06	Unused	CCL20
Neoplasms	ENSG00000115053	FALSE	Phase II Clinical Trial	2004-03-31	Phase II Clinical Trial	NCL
Neoplasms	ENSG00000115085	FALSE	Preclinical	1998-09-15	Unused	ZAP70
Neoplasms	ENSG00000115170	FALSE	Preclinical	2007-03-05	Unused	ACVR1
Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Phase I Clinical Trial	ITGB6
Neoplasms	ENSG00000115232	FALSE	Preclinical	1994-06-15	Unused	ITGA4
Neoplasms	ENSG00000115267	FALSE	Phase I Clinical Trial	2016-07-13	Absent	IFIH1
Neoplasms	ENSG00000115318	FALSE	Preclinical	2015-07-30	Absent	LOXL3
Neoplasms	ENSG00000115353	FALSE	Preclinical	NA	Unused	TACR1
Neoplasms	ENSG00000115414	FALSE	Phase I Clinical Trial	2004-02-11	Unused	FN1
Neoplasms	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Neoplasms	ENSG00000115457	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP2
Neoplasms	ENSG00000115461	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP5
Neoplasms	ENSG00000115464	FALSE	Preclinical	2012-08-08	Preclinical	USP34
Neoplasms	ENSG00000115524	FALSE	Preclinical	2015-10-30	Absent	SF3B1
Neoplasms	ENSG00000115590	FALSE	Preclinical	NA	Phase II Clinical Trial	IL1R2
Neoplasms	ENSG00000115758	FALSE	Phase I Clinical Trial	1992-09-15	Phase I Clinical Trial	ODC1
Neoplasms	ENSG00000115904	FALSE	Preclinical	2017-03-06	Absent	SOS1
Neoplasms	ENSG00000115919	FALSE	Preclinical	2018-01-15	Absent	KYNU
Neoplasms	ENSG00000116014	FALSE	Preclinical	2004-05-20	Unused	KISS1R
Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Unused	EPAS1
Neoplasms	ENSG00000116030	FALSE	Preclinical	2017-05-02	Absent	SUMO1
Neoplasms	ENSG00000116044	FALSE	Preclinical	2015-08-14	Absent	NFE2L2
Neoplasms	ENSG00000116106	FALSE	Phase I Clinical Trial	2006-05-16	Unused	EPHA4
Neoplasms	ENSG00000116237	FALSE	Preclinical	1998-11-15	Unused	ICMT
Neoplasms	ENSG00000116329	FALSE	Preclinical	NA	Unused	OPRD1
Neoplasms	ENSG00000116478	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Neoplasms	ENSG00000116678	FALSE	Preclinical	1996-12-15	Unused	LEPR
Neoplasms	ENSG00000116711	FALSE	Preclinical	2017-03-14	Absent	PLA2G4A
Neoplasms	ENSG00000116717	FALSE	Preclinical	1999-11-23	Unused	GADD45A
Neoplasms	ENSG00000116809	FALSE	Preclinical	2000-07-07	Unused	ZBTB17
Neoplasms	ENSG00000116824	FALSE	unknown	1989-08-15	Unused	CD2
Neoplasms	ENSG00000117020	FALSE	Phase I Clinical Trial	2007-04-16	Unused	AKT3
Neoplasms	ENSG00000117139	FALSE	Preclinical	2016-09-27	Absent	KDM5B
Neoplasms	ENSG00000117228	FALSE	Preclinical	2007-01-03	Unused	GBP1
Neoplasms	ENSG00000117281	FALSE	Preclinical	2007-05-01	Unused	CD160
Neoplasms	ENSG00000117318	FALSE	Preclinical	1999-11-23	Preclinical	ID3
Neoplasms	ENSG00000117335	FALSE	Preclinical	2001-01-09	Unused	CD46
Neoplasms	ENSG00000117394	FALSE	Preclinical	2011-06-23	Absent	SLC2A1
Neoplasms	ENSG00000117400	FALSE	Preclinical	2003-07-08	Unused	MPL
Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	F3
Neoplasms	ENSG00000117560	FALSE	Phase I Clinical Trial	2004-01-19	Preclinical	FASLG
Neoplasms	ENSG00000117586	FALSE	Phase I Clinical Trial	2012-12-08	Preclinical	TNFSF4
Neoplasms	ENSG00000117601	FALSE	Preclinical	1999-09-22	Unused	SERPINC1
Neoplasms	ENSG00000117632	FALSE	Phase I Clinical Trial	2008-07-04	Phase I Clinical Trial	STMN1
Neoplasms	ENSG00000118113	FALSE	Phase I Clinical Trial	1995-11-15	Unused	MMP8
Neoplasms	ENSG00000118137	FALSE	unknown	2005-07-04	Phase I Clinical Trial	APOA1
Neoplasms	ENSG00000118181	FALSE	Preclinical	2017-12-04	Absent	RPS25
Neoplasms	ENSG00000118513	FALSE	Preclinical	2009-07-17	Unused	MYB
Neoplasms	ENSG00000118515	FALSE	Preclinical	2014-01-11	Absent	SGK1
Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	1992-03-15	Unused	ARG1
Neoplasms	ENSG00000118702	FALSE	unknown	2011-11-18	Preclinical	GHRH
Neoplasms	ENSG00000118777	FALSE	Preclinical	2003-06-20	Unused	ABCG2
Neoplasms	ENSG00000118785	FALSE	Preclinical	2016-09-12	Absent	SPP1
Neoplasms	ENSG00000119535	FALSE	Phase I Clinical Trial	1993-11-15	Unused	CSF3R
Neoplasms	ENSG00000119630	FALSE	Preclinical	2003-07-24	Phase II Clinical Trial	PGF
Neoplasms	ENSG00000119699	FALSE	Preclinical	2000-05-24	Phase I Clinical Trial	TGFB3
Neoplasms	ENSG00000119715	FALSE	Preclinical	1999-12-20	Unused	ESRRB
Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1999-04-27	Phase II Clinical Trial	EPCAM
Neoplasms	ENSG00000120129	FALSE	Preclinical	2001-11-16	Unused	DUSP1
Neoplasms	ENSG00000120156	FALSE	Phase I Clinical Trial	1995-08-15	Phase II Clinical Trial	TEK
Neoplasms	ENSG00000120217	TRUE	Approved	2011-04-27	Phase I Clinical Trial	CD274
Neoplasms	ENSG00000120885	FALSE	Phase I Clinical Trial	2001-12-07	Phase I Clinical Trial	CLU
Neoplasms	ENSG00000120889	FALSE	Phase I Clinical Trial	2000-11-29	Phase I Clinical Trial	TNFRSF10B
Neoplasms	ENSG00000120915	FALSE	Preclinical	2016-10-27	Absent	EPHX2
Neoplasms	ENSG00000120949	FALSE	Phase II Clinical Trial	2002-10-28	Phase II Clinical Trial	TNFRSF8
Neoplasms	ENSG00000121022	FALSE	Preclinical	2011-06-03	Preclinical	COPS5
Neoplasms	ENSG00000121807	FALSE	Phase I Clinical Trial	1993-03-15	Unused	CCR2
Neoplasms	ENSG00000121858	FALSE	Phase I Clinical Trial	2007-06-25	Unused	TNFSF10
Neoplasms	ENSG00000121879	FALSE	Phase III Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Neoplasms	ENSG00000121966	FALSE	Phase I Clinical Trial	1996-07-15	Unused	CXCR4
Neoplasms	ENSG00000121989	FALSE	Preclinical	NA	Unused	ACVR2A
Neoplasms	ENSG00000122025	FALSE	Phase III Clinical Trial	1993-01-15	Phase II Clinical Trial	FLT3
Neoplasms	ENSG00000122194	FALSE	Preclinical	1998-06-15	Unused	PLG
Neoplasms	ENSG00000122641	FALSE	Phase I Clinical Trial	2012-10-31	Absent	INHBA
Neoplasms	ENSG00000122779	FALSE	Preclinical	2015-06-23	Absent	TRIM24
Neoplasms	ENSG00000122861	FALSE	Preclinical	1991-01-15	Unused	PLAU
Neoplasms	ENSG00000123080	FALSE	Preclinical	2008-10-20	Unused	CDKN2C
Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	1995-02-15	Phase I Clinical Trial	CDK2
Neoplasms	ENSG00000123384	FALSE	Preclinical	2013-05-06	Absent	LRP1
Neoplasms	ENSG00000123496	FALSE	Preclinical	2016-04-28	Absent	IL13RA2
Neoplasms	ENSG00000123505	FALSE	Phase II Clinical Trial	1991-06-15	Unused	AMD1
Neoplasms	ENSG00000124102	FALSE	Preclinical	2013-07-04	Phase I Clinical Trial	PI3
Neoplasms	ENSG00000124334	FALSE	Preclinical	1990-03-15	Unused	IL9R
Neoplasms	ENSG00000124466	FALSE	Phase I Clinical Trial	NA	Absent	LYPD3
Neoplasms	ENSG00000124762	FALSE	Preclinical	1990-10-15	Unused	CDKN1A
Neoplasms	ENSG00000124767	FALSE	Preclinical	2004-06-28	Unused	GLO1
Neoplasms	ENSG00000125257	FALSE	Preclinical	2014-08-01	Absent	ABCC4
Neoplasms	ENSG00000125266	FALSE	Preclinical	2007-04-05	Unused	EFNB2
Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Neoplasms	ENSG00000125538	FALSE	Preclinical	NA	Unused	IL1B
Neoplasms	ENSG00000125571	FALSE	Preclinical	2003-07-09	Unused	IL37
Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Phase I Clinical Trial	CD70
Neoplasms	ENSG00000125952	FALSE	Preclinical	1992-11-15	Unused	MAX
Neoplasms	ENSG00000125968	FALSE	Preclinical	1999-11-23	Preclinical	ID1
Neoplasms	ENSG00000126010	FALSE	Phase II Clinical Trial	1990-05-15	Unused	GRPR
Neoplasms	ENSG00000126016	FALSE	Preclinical	2004-09-22	Unused	AMOT
Neoplasms	ENSG00000126218	FALSE	Preclinical	1989-10-15	Unused	F10
Neoplasms	ENSG00000126233	FALSE	Preclinical	2000-09-25	Unused	SLURP1
Neoplasms	ENSG00000126353	FALSE	Preclinical	2009-05-26	Unused	CCR7
Neoplasms	ENSG00000126457	FALSE	Preclinical	2014-09-22	Absent	PRMT1
Neoplasms	ENSG00000126583	FALSE	Preclinical	2014-12-17	Absent	PRKCG
Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K2
Neoplasms	ENSG00000127418	FALSE	Preclinical	2002-07-19	Unused	FGFRL1
Neoplasms	ENSG00000127445	FALSE	Preclinical	2003-05-02	Unused	PIN1
Neoplasms	ENSG00000127837	FALSE	Preclinical	1996-06-15	Unused	AAMP
Neoplasms	ENSG00000128050	FALSE	Preclinical	2017-06-02	Absent	PAICS
Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1992-03-15	Phase III Clinical Trial	KDR
Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	1995-06-15	Absent	ADORA2A
Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Phase II Clinical Trial	SMO
Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2005-09-14	Phase I Clinical Trial	DLL4
Neoplasms	ENSG00000128951	FALSE	Phase I Clinical Trial	2012-06-07	Phase I Clinical Trial	DUT
Neoplasms	ENSG00000129465	FALSE	Preclinical	1998-12-15	Unused	RIPK3
Neoplasms	ENSG00000129484	FALSE	Phase II Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Neoplasms	ENSG00000129514	FALSE	Preclinical	2012-12-04	Preclinical	FOXA1
Neoplasms	ENSG00000130037	FALSE	Preclinical	2014-11-19	Absent	KCNA5
Neoplasms	ENSG00000130066	FALSE	Preclinical	NA	Unused	SAT1
Neoplasms	ENSG00000130150	FALSE	Preclinical	2016-03-29	Absent	MOSPD2
Neoplasms	ENSG00000130164	FALSE	Preclinical	2006-02-20	Unused	LDLR
Neoplasms	ENSG00000130203	FALSE	Preclinical	1995-03-15	Unused	APOE
Neoplasms	ENSG00000130234	FALSE	unknown	2007-07-13	Unused	ACE2
Neoplasms	ENSG00000130303	FALSE	Preclinical	2010-01-22	Preclinical	BST2
Neoplasms	ENSG00000130427	FALSE	Preclinical	2004-08-05	Unused	EPO
Neoplasms	ENSG00000130522	FALSE	Preclinical	1997-06-15	Unused	JUND
Neoplasms	ENSG00000130635	FALSE	Preclinical	2001-07-09	Unused	COL5A1
Neoplasms	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Preclinical	PAK4
Neoplasms	ENSG00000130779	FALSE	Preclinical	1999-08-11	Unused	CLIP1
Neoplasms	ENSG00000130810	FALSE	Preclinical	2001-04-11	Unused	PPAN
Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	1990-12-15	Phase I Clinical Trial	DNMT1
Neoplasms	ENSG00000130985	FALSE	Phase I Clinical Trial	2011-11-23	Preclinical	UBA1
Neoplasms	ENSG00000131023	FALSE	Preclinical	2017-07-07	Absent	LATS1
Neoplasms	ENSG00000131069	FALSE	Preclinical	2017-12-08	Absent	ACSS2
Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Phase II Clinical Trial	IDO1
Neoplasms	ENSG00000131408	FALSE	Preclinical	2005-12-01	Unused	NR1H2
Neoplasms	ENSG00000131471	FALSE	unknown	2011-11-11	Preclinical	AOC3
Neoplasms	ENSG00000131724	FALSE	Preclinical	2014-05-21	Absent	IL13RA1
Neoplasms	ENSG00000131747	TRUE	Approved	1989-06-15	Approved	TOP2A
Neoplasms	ENSG00000131759	FALSE	Phase II Clinical Trial	1997-07-15	Unused	RARA
Neoplasms	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Phase II Clinical Trial	PDHA1
Neoplasms	ENSG00000131981	FALSE	Preclinical	1997-05-15	Unused	LGALS3
Neoplasms	ENSG00000132155	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RAF1
Neoplasms	ENSG00000132383	FALSE	Preclinical	2009-07-17	Unused	RPA1
Neoplasms	ENSG00000132386	FALSE	Preclinical	2001-08-22	Unused	SERPINF1
Neoplasms	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Neoplasms	ENSG00000132646	FALSE	Preclinical	1998-05-15	Unused	PCNA
Neoplasms	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Neoplasms	ENSG00000132693	FALSE	unknown	1999-11-23	Unused	CRP
Neoplasms	ENSG00000132906	FALSE	Preclinical	1997-05-15	Unused	CASP9
Neoplasms	ENSG00000132964	FALSE	Preclinical	2010-07-12	Absent	CDK8
Neoplasms	ENSG00000133019	FALSE	Preclinical	2007-02-13	Unused	CHRM3
Neoplasms	ENSG00000133275	FALSE	Preclinical	2011-03-15	Preclinical	CSNK1G2
Neoplasms	ENSG00000133321	FALSE	Phase II Clinical Trial	2008-11-03	Unused	RARRES3
Neoplasms	ENSG00000133703	TRUE	Approved	1992-03-15	Approved	KRAS
Neoplasms	ENSG00000133895	FALSE	Preclinical	1997-08-15	Unused	MEN1
Neoplasms	ENSG00000134001	FALSE	Preclinical	2009-05-14	Unused	EIF2S1
Neoplasms	ENSG00000134013	FALSE	Preclinical	2010-07-29	Phase I Clinical Trial	LOXL2
Neoplasms	ENSG00000134046	FALSE	Preclinical	2003-02-12	Unused	MBD2
Neoplasms	ENSG00000134057	FALSE	Preclinical	2001-10-17	Unused	CCNB1
Neoplasms	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-01-15	Unused	CDK7
Neoplasms	ENSG00000134250	FALSE	Phase I Clinical Trial	2009-12-30	Phase I Clinical Trial	NOTCH2
Neoplasms	ENSG00000134258	FALSE	Preclinical	2016-12-17	Absent	VTCN1
Neoplasms	ENSG00000134318	FALSE	Preclinical	2003-10-29	Unused	ROCK2
Neoplasms	ENSG00000134333	FALSE	Preclinical	2014-08-19	Absent	LDHA
Neoplasms	ENSG00000134443	FALSE	Phase I Clinical Trial	NA	Unused	GRP
Neoplasms	ENSG00000134460	FALSE	Pre-registration	1989-08-15	Phase I Clinical Trial	IL2RA
Neoplasms	ENSG00000134470	FALSE	Preclinical	2010-10-05	Preclinical	IL15RA
Neoplasms	ENSG00000134545	FALSE	Phase I Clinical Trial	2006-11-24	Absent	KLRC1
Neoplasms	ENSG00000134640	FALSE	Phase II Clinical Trial	1989-08-15	Unused	MTNR1B
Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	1989-12-15	Phase II Clinical Trial	PDGFRA
Neoplasms	ENSG00000134917	FALSE	Preclinical	1997-06-15	Unused	ADAMTS8
Neoplasms	ENSG00000135047	FALSE	Preclinical	1997-09-15	Unused	CTSL
Neoplasms	ENSG00000135077	FALSE	Phase II Clinical Trial	2014-01-22	Absent	HAVCR2
Neoplasms	ENSG00000135093	FALSE	Preclinical	2016-03-22	Absent	USP30
Neoplasms	ENSG00000135218	FALSE	Phase I Clinical Trial	1992-03-15	Unused	CD36
Neoplasms	ENSG00000135318	FALSE	Phase II Clinical Trial	2015-07-23	Absent	NT5E
Neoplasms	ENSG00000135341	FALSE	Preclinical	2013-10-05	Absent	MAP3K7
Neoplasms	ENSG00000135409	FALSE	Phase I Clinical Trial	2014-09-15	Unused	AMHR2
Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	1995-02-15	Phase II Clinical Trial	CDK4
Neoplasms	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Neoplasms	ENSG00000135679	FALSE	Phase II Clinical Trial	1995-02-15	Phase I Clinical Trial	MDM2
Neoplasms	ENSG00000135919	FALSE	Preclinical	NA	Unused	SERPINE2
Neoplasms	ENSG00000136098	FALSE	Preclinical	2009-06-29	Unused	NEK3
Neoplasms	ENSG00000136160	FALSE	Preclinical	2011-11-19	Unused	EDNRB
Neoplasms	ENSG00000136238	FALSE	Preclinical	2017-08-28	Absent	RAC1
Neoplasms	ENSG00000136244	FALSE	Preclinical	1996-09-15	Unused	IL6
Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2004-08-11	Unused	IL10
Neoplasms	ENSG00000136758	FALSE	Preclinical	NA	Unused	YME1L1
Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-01-15	Phase I Clinical Trial	CDK9
Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Neoplasms	ENSG00000136826	FALSE	Phase I Clinical Trial	2014-06-10	Absent	KLF4
Neoplasms	ENSG00000136856	FALSE	Preclinical	NA	Unused	SLC2A8
Neoplasms	ENSG00000136869	FALSE	Phase I Clinical Trial	2010-07-24	Unused	TLR4
Neoplasms	ENSG00000136936	FALSE	Preclinical	2004-08-06	Unused	XPA
Neoplasms	ENSG00000136943	FALSE	Preclinical	2011-04-04	Unused	CTSV
Neoplasms	ENSG00000136960	FALSE	Preclinical	2010-05-17	Absent	ENPP2
Neoplasms	ENSG00000136997	FALSE	Preclinical	1991-09-15	Unused	MYC
Neoplasms	ENSG00000137193	FALSE	Phase I Clinical Trial	2008-04-23	Phase I Clinical Trial	PIM1
Neoplasms	ENSG00000137265	FALSE	Preclinical	2017-05-04	Absent	IRF4
Neoplasms	ENSG00000137309	FALSE	Preclinical	2005-05-16	Unused	HMGA1
Neoplasms	ENSG00000137462	FALSE	Preclinical	2007-04-18	Unused	TLR2
Neoplasms	ENSG00000137507	FALSE	Preclinical	2015-03-09	Absent	LRRC32
Neoplasms	ENSG00000137673	FALSE	Preclinical	1992-03-15	Unused	MMP7
Neoplasms	ENSG00000137693	FALSE	Preclinical	2016-07-26	Absent	YAP1
Neoplasms	ENSG00000137745	FALSE	Preclinical	1999-03-09	Unused	MMP13
Neoplasms	ENSG00000137752	FALSE	Preclinical	1994-04-15	Unused	CASP1
Neoplasms	ENSG00000137764	FALSE	Preclinical	2004-02-02	Unused	MAP2K5
Neoplasms	ENSG00000137801	FALSE	Preclinical	2000-02-24	Unused	THBS1
Neoplasms	ENSG00000137817	FALSE	Preclinical	2013-11-14	Absent	PARP6
Neoplasms	ENSG00000137845	FALSE	unknown	2002-12-06	Unused	ADAM10
Neoplasms	ENSG00000137869	FALSE	Phase I Clinical Trial	1990-07-15	Unused	CYP19A1
Neoplasms	ENSG00000137948	FALSE	Phase I Clinical Trial	2015-08-07	Absent	BRDT
Neoplasms	ENSG00000138039	FALSE	Preclinical	2001-12-10	Unused	LHCGR
Neoplasms	ENSG00000138061	FALSE	Preclinical	2004-08-23	Unused	CYP1B1
Neoplasms	ENSG00000138131	FALSE	Preclinical	2015-07-30	Absent	LOXL4
Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Neoplasms	ENSG00000138185	FALSE	Preclinical	2012-11-23	Absent	ENTPD1
Neoplasms	ENSG00000138363	FALSE	Preclinical	NA	Unused	ATIC
Neoplasms	ENSG00000138413	FALSE	Phase I Clinical Trial	2010-04-19	Absent	IDH1
Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	1993-06-15	Phase I Clinical Trial	ITGAV
Neoplasms	ENSG00000138685	FALSE	Phase I Clinical Trial	1994-06-15	Unused	FGF2
Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2002-11-05	Phase I Clinical Trial	CENPE
Neoplasms	ENSG00000138798	FALSE	Phase I Clinical Trial	1989-05-15	Unused	EGF
Neoplasms	ENSG00000138823	FALSE	Preclinical	2009-03-06	Unused	MTTP
Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Phase I Clinical Trial	CD27
Neoplasms	ENSG00000139219	FALSE	Preclinical	2001-07-09	Unused	COL2A1
Neoplasms	ENSG00000139292	FALSE	Preclinical	2016-06-10	Absent	LGR5
Neoplasms	ENSG00000139567	FALSE	Phase I Clinical Trial	2007-05-30	Phase I Clinical Trial	ACVRL1
Neoplasms	ENSG00000139618	TRUE	Approved	2013-09-04	Absent	BRCA2
Neoplasms	ENSG00000139625	FALSE	Preclinical	2016-07-15	Absent	MAP3K12
Neoplasms	ENSG00000139626	FALSE	Preclinical	2002-08-05	Unused	ITGB7
Neoplasms	ENSG00000139687	FALSE	Phase I Clinical Trial	2007-03-23	Phase I Clinical Trial	RB1
Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2001-07-26	Phase I Clinical Trial	SSTR1
Neoplasms	ENSG00000140009	FALSE	Preclinical	2004-09-14	Unused	ESR2
Neoplasms	ENSG00000140287	FALSE	Preclinical	NA	Unused	HDC
Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-02-11	Phase II Clinical Trial	IGF1R
Neoplasms	ENSG00000140465	FALSE	Preclinical	1999-04-13	Phase I Clinical Trial	CYP1A1
Neoplasms	ENSG00000140479	FALSE	Preclinical	2013-01-02	Preclinical	PCSK6
Neoplasms	ENSG00000140505	FALSE	Preclinical	2002-10-14	Unused	CYP1A2
Neoplasms	ENSG00000140538	FALSE	Phase III Clinical Trial	2009-05-20	Absent	NTRK3
Neoplasms	ENSG00000140545	FALSE	Phase I Clinical Trial	1991-01-15	Unused	MFGE8
Neoplasms	ENSG00000140937	FALSE	Preclinical	2000-09-25	Unused	CDH11
Neoplasms	ENSG00000140992	FALSE	Preclinical	2007-05-02	Phase I Clinical Trial	PDPK1
Neoplasms	ENSG00000141068	FALSE	Preclinical	2012-05-04	Preclinical	KSR1
Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	1990-08-15	Phase I Clinical Trial	TP53
Neoplasms	ENSG00000141543	FALSE	Preclinical	2017-11-30	Absent	EIF4A3
Neoplasms	ENSG00000141736	TRUE	Approved	1990-09-15	Approved	ERBB2
Neoplasms	ENSG00000141837	FALSE	Preclinical	1998-11-15	Unused	CACNA1A
Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2008-09-09	Absent	BRD4
Neoplasms	ENSG00000142166	FALSE	Preclinical	2012-11-17	Preclinical	IFNAR1
Neoplasms	ENSG00000142168	FALSE	Preclinical	2016-07-12	Absent	SOD1
Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Neoplasms	ENSG00000142515	FALSE	Preclinical	2001-02-23	Unused	KLK3
Neoplasms	ENSG00000142627	FALSE	Phase II Clinical Trial	2001-10-29	Unused	EPHA2
Neoplasms	ENSG00000142731	FALSE	Preclinical	2018-01-23	Absent	PLK4
Neoplasms	ENSG00000143184	FALSE	Preclinical	1998-06-15	Unused	XCL1
Neoplasms	ENSG00000143217	FALSE	Phase I Clinical Trial	2004-10-18	Phase I Clinical Trial	NECTIN4
Neoplasms	ENSG00000143226	FALSE	Phase I Clinical Trial	NA	Absent	FCGR2A
Neoplasms	ENSG00000143258	FALSE	Preclinical	2000-10-04	Unused	USP21
Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	1997-01-15	Phase I Clinical Trial	MCL1
Neoplasms	ENSG00000143387	FALSE	Preclinical	2016-03-24	Absent	CTSK
Neoplasms	ENSG00000143499	FALSE	Preclinical	2015-07-23	Absent	SMYD2
Neoplasms	ENSG00000143556	FALSE	Preclinical	2012-09-06	Absent	S100A7
Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	1990-07-15	Phase II Clinical Trial	PARP1
Neoplasms	ENSG00000143839	FALSE	Preclinical	2012-11-23	Absent	REN
Neoplasms	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Neoplasms	ENSG00000144285	FALSE	Preclinical	2017-12-05	Absent	SCN1A
Neoplasms	ENSG00000144381	FALSE	Preclinical	1996-10-15	Unused	HSPD1
Neoplasms	ENSG00000144476	FALSE	Preclinical	2009-05-26	Unused	ACKR3
Neoplasms	ENSG00000144481	FALSE	Phase I Clinical Trial	2001-05-01	Phase I Clinical Trial	TRPM8
Neoplasms	ENSG00000144668	FALSE	Preclinical	2007-07-23	Unused	ITGA9
Neoplasms	ENSG00000144744	FALSE	Phase I Clinical Trial	2007-04-27	Phase I Clinical Trial	UBA3
Neoplasms	ENSG00000144891	FALSE	Preclinical	2005-06-08	Unused	AGTR1
Neoplasms	ENSG00000144959	FALSE	Preclinical	2011-04-04	Unused	NCEH1
Neoplasms	ENSG00000145088	FALSE	Preclinical	2005-05-27	Unused	EAF2
Neoplasms	ENSG00000145386	FALSE	Preclinical	2001-10-17	Unused	CCNA2
Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	1992-01-15	Unused	SRD5A1
Neoplasms	ENSG00000145632	FALSE	Preclinical	2009-11-21	Preclinical	PLK2
Neoplasms	ENSG00000145779	FALSE	Preclinical	2001-07-20	Unused	TNFAIP8
Neoplasms	ENSG00000146242	FALSE	Phase I Clinical Trial	2000-06-01	Unused	TPBG
Neoplasms	ENSG00000146374	FALSE	Phase I Clinical Trial	2012-10-11	Absent	RSPO3
Neoplasms	ENSG00000146469	FALSE	Preclinical	NA	Unused	VIP
Neoplasms	ENSG00000146648	TRUE	Approved	1989-12-15	Approved	EGFR
Neoplasms	ENSG00000146674	FALSE	unknown	2008-01-04	Unused	IGFBP3
Neoplasms	ENSG00000146904	FALSE	Preclinical	2012-03-15	Unused	EPHA1
Neoplasms	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC8
Neoplasms	ENSG00000147138	FALSE	Preclinical	2016-06-16	Absent	GPR174
Neoplasms	ENSG00000147168	FALSE	Preclinical	2017-05-15	Absent	IL2RG
Neoplasms	ENSG00000147257	FALSE	Phase I Clinical Trial	2012-05-17	Preclinical	GPC3
Neoplasms	ENSG00000147437	FALSE	Preclinical	2012-04-09	Unused	GNRH1
Neoplasms	ENSG00000147601	FALSE	Preclinical	2000-01-11	Unused	TERF1
Neoplasms	ENSG00000147883	FALSE	Preclinical	1997-01-15	Unused	CDKN2B
Neoplasms	ENSG00000147889	FALSE	Preclinical	1995-02-15	Unused	CDKN2A
Neoplasms	ENSG00000147955	FALSE	Phase II Clinical Trial	1993-01-15	Unused	SIGMAR1
Neoplasms	ENSG00000148053	FALSE	Phase III Clinical Trial	2006-02-14	Unused	NTRK2
Neoplasms	ENSG00000148154	FALSE	Preclinical	2010-01-18	Preclinical	UGCG
Neoplasms	ENSG00000148400	FALSE	Phase I Clinical Trial	2000-10-23	Unused	NOTCH1
Neoplasms	ENSG00000148795	FALSE	Phase I Clinical Trial	1991-07-15	Unused	CYP17A1
Neoplasms	ENSG00000148926	FALSE	Preclinical	1996-09-15	Unused	ADM
Neoplasms	ENSG00000148985	FALSE	Preclinical	1999-11-24	Unused	PGAP2
Neoplasms	ENSG00000149177	FALSE	Preclinical	2002-01-30	Unused	PTPRJ
Neoplasms	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-13	Preclinical	PAK1
Neoplasms	ENSG00000149294	FALSE	Phase II Clinical Trial	1991-02-15	Phase II Clinical Trial	NCAM1
Neoplasms	ENSG00000149295	FALSE	Phase I Clinical Trial	1996-01-15	Unused	DRD2
Neoplasms	ENSG00000149311	FALSE	Phase I Clinical Trial	2003-05-28	Unused	ATM
Neoplasms	ENSG00000149418	FALSE	Preclinical	2002-03-18	Unused	ST14
Neoplasms	ENSG00000149451	FALSE	Preclinical	2002-07-19	Unused	ADAM33
Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	CHEK1
Neoplasms	ENSG00000149968	FALSE	Preclinical	1994-07-15	Unused	MMP3
Neoplasms	ENSG00000150093	FALSE	Phase I Clinical Trial	1994-06-15	Phase I Clinical Trial	ITGB1
Neoplasms	ENSG00000150337	FALSE	Phase I Clinical Trial	NA	Absent	FCGR1A
Neoplasms	ENSG00000150457	FALSE	Preclinical	2017-07-07	Absent	LATS2
Neoplasms	ENSG00000150630	FALSE	Phase I Clinical Trial	2007-07-02	Phase I Clinical Trial	VEGFC
Neoplasms	ENSG00000150782	FALSE	Preclinical	1998-06-15	Unused	IL18
Neoplasms	ENSG00000150867	FALSE	Preclinical	2016-07-07	Absent	PIP4K2A
Neoplasms	ENSG00000151067	FALSE	Preclinical	1998-08-15	Unused	CACNA1C
Neoplasms	ENSG00000151247	FALSE	Phase I Clinical Trial	2004-09-22	Phase I Clinical Trial	EIF4E
Neoplasms	ENSG00000151292	FALSE	Preclinical	2011-03-15	Preclinical	CSNK1G3
Neoplasms	ENSG00000151474	FALSE	Preclinical	NA	Preclinical	FRMD4A
Neoplasms	ENSG00000151617	FALSE	Phase I Clinical Trial	2000-04-05	Phase I Clinical Trial	EDNRA
Neoplasms	ENSG00000151651	FALSE	Preclinical	2013-02-14	Preclinical	ADAM8
Neoplasms	ENSG00000151694	FALSE	Preclinical	1995-05-15	Unused	ADAM17
Neoplasms	ENSG00000151790	FALSE	Phase I Clinical Trial	2014-04-03	Absent	TDO2
Neoplasms	ENSG00000152256	FALSE	Preclinical	2008-01-23	Unused	PDK1
Neoplasms	ENSG00000153208	FALSE	Preclinical	2012-12-21	Absent	MERTK
Neoplasms	ENSG00000153253	FALSE	Preclinical	2017-12-05	Absent	SCN3A
Neoplasms	ENSG00000153563	FALSE	Phase I Clinical Trial	2012-08-17	Absent	CD8A
Neoplasms	ENSG00000153956	FALSE	Preclinical	2016-11-23	Absent	CACNA2D1
Neoplasms	ENSG00000154016	FALSE	Preclinical	1995-10-15	Unused	GRAP
Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT1
Neoplasms	ENSG00000154229	FALSE	Phase II Clinical Trial	1989-05-15	Unused	PRKCA
Neoplasms	ENSG00000154277	FALSE	Preclinical	2015-04-30	Absent	UCHL1
Neoplasms	ENSG00000154310	FALSE	Preclinical	2013-11-14	Absent	TNIK
Neoplasms	ENSG00000154380	FALSE	Preclinical	2014-01-04	Absent	ENAH
Neoplasms	ENSG00000154734	FALSE	Preclinical	1997-06-15	Unused	ADAMTS1
Neoplasms	ENSG00000155111	FALSE	Preclinical	2017-05-04	Absent	CDK19
Neoplasms	ENSG00000155366	FALSE	Preclinical	2008-07-21	Unused	RHOC
Neoplasms	ENSG00000155380	FALSE	Phase I Clinical Trial	2010-09-13	Unused	SLC16A1
Neoplasms	ENSG00000155760	FALSE	unknown	2010-06-19	Phase I Clinical Trial	FZD7
Neoplasms	ENSG00000156136	FALSE	Preclinical	2008-08-29	Unused	DCK
Neoplasms	ENSG00000156738	FALSE	Phase III Clinical Trial	1992-06-15	Unused	MS4A1
Neoplasms	ENSG00000156802	FALSE	Preclinical	2017-12-22	Absent	ATAD2
Neoplasms	ENSG00000156983	FALSE	Preclinical	2015-06-23	Absent	BRPF1
Neoplasms	ENSG00000157168	FALSE	unknown	2012-04-10	Absent	NRG1
Neoplasms	ENSG00000157227	FALSE	Preclinical	2001-02-02	Unused	MMP14
Neoplasms	ENSG00000157404	TRUE	Approved	1992-01-15	Approved	KIT
Neoplasms	ENSG00000157540	FALSE	Preclinical	2012-10-11	Absent	DYRK1A
Neoplasms	ENSG00000157764	TRUE	Approved	2001-04-03	Approved	BRAF
Neoplasms	ENSG00000157873	FALSE	Preclinical	2016-09-08	Absent	TNFRSF14
Neoplasms	ENSG00000158125	FALSE	Phase I Clinical Trial	NA	Unused	XDH
Neoplasms	ENSG00000158402	FALSE	Preclinical	1995-02-15	Phase II Clinical Trial	CDC25C
Neoplasms	ENSG00000158458	FALSE	Preclinical	2000-07-19	Unused	NRG2
Neoplasms	ENSG00000158473	FALSE	Preclinical	2009-03-06	Unused	CD1D
Neoplasms	ENSG00000158769	FALSE	Preclinical	2008-10-31	Unused	F11R
Neoplasms	ENSG00000158825	FALSE	Phase II Clinical Trial	1990-12-15	Unused	CDA
Neoplasms	ENSG00000158859	FALSE	Preclinical	1995-09-15	Unused	ADAMTS4
Neoplasms	ENSG00000159110	TRUE	Approved	1990-10-15	Approved	IFNAR2
Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1989-07-15	Unused	GART
Neoplasms	ENSG00000159263	FALSE	Preclinical	2003-06-06	Unused	SIM2
Neoplasms	ENSG00000159399	FALSE	Preclinical	2015-12-17	Absent	HK2
Neoplasms	ENSG00000159840	FALSE	Preclinical	2004-02-04	Preclinical	ZYX
Neoplasms	ENSG00000160013	FALSE	unknown	NA	Unused	PTGIR
Neoplasms	ENSG00000160113	FALSE	Preclinical	2014-12-08	Absent	NR2F6
Neoplasms	ENSG00000160447	FALSE	unknown	2004-07-13	Phase I Clinical Trial	PKN3
Neoplasms	ENSG00000160683	FALSE	Preclinical	2014-04-10	Absent	CXCR5
Neoplasms	ENSG00000160712	FALSE	Preclinical	1989-06-15	Phase II Clinical Trial	IL6R
Neoplasms	ENSG00000160791	FALSE	Phase II Clinical Trial	1996-07-15	Unused	CCR5
Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2002-06-10	Phase I Clinical Trial	FGFR4
Neoplasms	ENSG00000160882	FALSE	Phase II Clinical Trial	2006-12-07	Absent	CYP11B1
Neoplasms	ENSG00000160932	FALSE	Phase I Clinical Trial	2014-03-18	Absent	LY6E
Neoplasms	ENSG00000160951	FALSE	Preclinical	NA	Unused	PTGER1
Neoplasms	ENSG00000161381	FALSE	Preclinical	2001-11-21	Unused	PLXDC1
Neoplasms	ENSG00000161638	FALSE	Phase I Clinical Trial	2001-04-01	Phase I Clinical Trial	ITGA5
Neoplasms	ENSG00000161905	FALSE	Preclinical	2005-10-19	Unused	ALOX15
Neoplasms	ENSG00000161955	FALSE	unknown	2012-02-27	Preclinical	TNFSF13
Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	SSTR5
Neoplasms	ENSG00000162302	FALSE	Preclinical	2014-08-25	Absent	RPS6KA4
Neoplasms	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Unused	JAK1
Neoplasms	ENSG00000162692	FALSE	Preclinical	1994-06-15	Unused	VCAM1
Neoplasms	ENSG00000162711	FALSE	Preclinical	2013-03-28	Absent	NLRP3
Neoplasms	ENSG00000162739	FALSE	Preclinical	2007-06-20	Unused	SLAMF6
Neoplasms	ENSG00000162747	FALSE	Phase II Clinical Trial	1993-06-15	Phase II Clinical Trial	FCGR3B
Neoplasms	ENSG00000162892	FALSE	Preclinical	2006-11-27	Unused	IL24
Neoplasms	ENSG00000163131	FALSE	Preclinical	2009-01-23	Preclinical	CTSS
Neoplasms	ENSG00000163217	FALSE	Phase I Clinical Trial	2007-05-30	Absent	BMP10
Neoplasms	ENSG00000163220	FALSE	Preclinical	2010-03-11	Absent	S100A9
Neoplasms	ENSG00000163235	FALSE	Preclinical	2004-08-31	Unused	TGFA
Neoplasms	ENSG00000163394	FALSE	Phase II Clinical Trial	NA	Unused	CCKAR
Neoplasms	ENSG00000163399	FALSE	Phase I Clinical Trial	2000-10-18	Unused	ATP1A1
Neoplasms	ENSG00000163464	FALSE	Preclinical	1992-09-15	Unused	CXCR1
Neoplasms	ENSG00000163485	FALSE	Preclinical	1997-07-15	Unused	ADORA1
Neoplasms	ENSG00000163513	FALSE	Phase I Clinical Trial	1998-06-15	Phase I Clinical Trial	TGFBR2
Neoplasms	ENSG00000163558	FALSE	Preclinical	2007-10-23	Unused	PRKCI
Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	2002-09-20	Unused	CTLA4
Neoplasms	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Neoplasms	ENSG00000163823	FALSE	Preclinical	2015-12-08	Absent	CCR1
Neoplasms	ENSG00000163931	FALSE	Preclinical	2003-09-29	Unused	TKT
Neoplasms	ENSG00000163975	FALSE	Preclinical	2013-05-15	Unused	MELTF
Neoplasms	ENSG00000163993	FALSE	Preclinical	2011-09-15	Absent	S100P
Neoplasms	ENSG00000164024	FALSE	Phase I Clinical Trial	2000-04-04	Unused	METAP1
Neoplasms	ENSG00000164045	FALSE	Preclinical	2002-04-08	Unused	CDC25A
Neoplasms	ENSG00000164078	FALSE	Phase II Clinical Trial	2001-12-18	Phase I Clinical Trial	MST1R
Neoplasms	ENSG00000164111	FALSE	Phase II Clinical Trial	1999-11-11	Unused	ANXA5
Neoplasms	ENSG00000164136	FALSE	Phase I Clinical Trial	2015-05-26	Absent	IL15
Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Neoplasms	ENSG00000164176	FALSE	Phase II Clinical Trial	2002-02-11	Unused	EDIL3
Neoplasms	ENSG00000164251	FALSE	Preclinical	2003-04-08	Unused	F2RL1
Neoplasms	ENSG00000164266	FALSE	Preclinical	1999-06-02	Unused	SPINK1
Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	2000-05-10	Phase I Clinical Trial	CASP3
Neoplasms	ENSG00000164342	FALSE	Phase I Clinical Trial	2012-03-07	Absent	TLR3
Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	1994-10-15	Phase I Clinical Trial	TERT
Neoplasms	ENSG00000164400	FALSE	Phase I Clinical Trial	1998-08-15	Phase I Clinical Trial	CSF2
Neoplasms	ENSG00000164690	FALSE	Preclinical	1998-11-15	Unused	SHH
Neoplasms	ENSG00000164733	FALSE	Preclinical	1996-10-15	Unused	CTSB
Neoplasms	ENSG00000164741	FALSE	Preclinical	1999-04-21	Unused	DLC1
Neoplasms	ENSG00000164825	FALSE	Preclinical	2000-09-25	Unused	DEFB1
Neoplasms	ENSG00000164867	FALSE	Preclinical	2008-08-29	Unused	NOS3
Neoplasms	ENSG00000164885	FALSE	Phase I Clinical Trial	2003-03-06	Phase I Clinical Trial	CDK5
Neoplasms	ENSG00000164985	FALSE	Preclinical	1999-04-28	Unused	PSIP1
Neoplasms	ENSG00000165025	FALSE	Phase II Clinical Trial	2009-11-02	Unused	SYK
Neoplasms	ENSG00000165092	FALSE	Preclinical	2016-02-27	Absent	ALDH1A1
Neoplasms	ENSG00000165125	FALSE	Phase I Clinical Trial	2011-08-04	Phase I Clinical Trial	TRPV6
Neoplasms	ENSG00000165168	FALSE	Preclinical	2011-06-01	Unused	CYBB
Neoplasms	ENSG00000165197	FALSE	Preclinical	2010-04-12	Preclinical	VEGFD
Neoplasms	ENSG00000165280	FALSE	Phase I Clinical Trial	2013-11-18	Absent	VCP
Neoplasms	ENSG00000165304	FALSE	Phase I Clinical Trial	2010-01-25	Preclinical	MELK
Neoplasms	ENSG00000165392	FALSE	Phase I Clinical Trial	2015-06-10	Absent	WRN
Neoplasms	ENSG00000165409	TRUE	Approved	1990-07-15	Approved	TSHR
Neoplasms	ENSG00000165637	FALSE	Phase I Clinical Trial	2004-10-15	Phase I Clinical Trial	VDAC2
Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	2016-10-25	Absent	ENOX2
Neoplasms	ENSG00000165704	FALSE	Approved	1989-11-15	Unused	HPRT1
Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Neoplasms	ENSG00000166049	FALSE	Preclinical	2009-02-10	Preclinical	PASD1
Neoplasms	ENSG00000166145	FALSE	Preclinical	2008-08-19	Unused	SPINT1
Neoplasms	ENSG00000166333	FALSE	Preclinical	2000-03-15	Unused	ILK
Neoplasms	ENSG00000166478	FALSE	Preclinical	2017-03-01	Absent	ZNF143
Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	1995-07-15	Phase I Clinical Trial	WEE1
Neoplasms	ENSG00000166484	FALSE	Preclinical	2014-01-06	Absent	MAPK7
Neoplasms	ENSG00000166501	FALSE	Phase I Clinical Trial	1995-09-15	Phase I Clinical Trial	PRKCB
Neoplasms	ENSG00000166598	FALSE	Preclinical	2008-04-03	Preclinical	HSP90B1
Neoplasms	ENSG00000166710	FALSE	Preclinical	1999-04-21	Unused	B2M
Neoplasms	ENSG00000166736	FALSE	Phase II Clinical Trial	2015-12-23	Absent	HTR3A
Neoplasms	ENSG00000166825	FALSE	Phase I Clinical Trial	1998-07-15	Phase I Clinical Trial	ANPEP
Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	1997-12-15	Phase I Clinical Trial	PLK1
Neoplasms	ENSG00000167244	FALSE	Preclinical	2002-08-20	Unused	IGF2
Neoplasms	ENSG00000167258	FALSE	Preclinical	2016-09-06	Absent	CDK12
Neoplasms	ENSG00000167325	FALSE	Phase II Clinical Trial	1992-06-15	Unused	RRM1
Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2006-12-05	Phase I Clinical Trial	AXL
Neoplasms	ENSG00000167642	FALSE	Preclinical	2008-08-19	Unused	SPINT2
Neoplasms	ENSG00000167653	FALSE	Phase I Clinical Trial	2012-08-13	Preclinical	PSCA
Neoplasms	ENSG00000167658	FALSE	Phase III Clinical Trial	1989-08-15	Unused	EEF2
Neoplasms	ENSG00000167775	FALSE	Preclinical	2010-03-04	Unused	CD320
Neoplasms	ENSG00000168036	FALSE	Phase I Clinical Trial	2011-03-05	Phase I Clinical Trial	CTNNB1
Neoplasms	ENSG00000168078	FALSE	Preclinical	2013-08-07	Absent	PBK
Neoplasms	ENSG00000168229	FALSE	Preclinical	NA	Unused	PTGDR
Neoplasms	ENSG00000168283	FALSE	Phase I Clinical Trial	2010-06-08	Absent	BMI1
Neoplasms	ENSG00000168398	FALSE	Preclinical	2008-07-11	Unused	BDKRB2
Neoplasms	ENSG00000168412	FALSE	Phase II Clinical Trial	1989-08-15	Unused	MTNR1A
Neoplasms	ENSG00000168522	FALSE	Approved	1991-07-15	Unused	FNTA
Neoplasms	ENSG00000168542	FALSE	Preclinical	2001-07-09	Unused	COL3A1
Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2003-02-11	Phase II Clinical Trial	STAT3
Neoplasms	ENSG00000168615	FALSE	Preclinical	2017-04-12	Absent	ADAM9
Neoplasms	ENSG00000168685	FALSE	Phase I Clinical Trial	2015-10-09	Unused	IL7R
Neoplasms	ENSG00000168811	FALSE	Preclinical	1998-06-15	Unused	IL12A
Neoplasms	ENSG00000168906	FALSE	Preclinical	2017-07-11	Absent	MAT2A
Neoplasms	ENSG00000168918	FALSE	Preclinical	2008-10-27	Unused	INPP5D
Neoplasms	ENSG00000168961	FALSE	Preclinical	2015-03-27	Absent	LGALS9
Neoplasms	ENSG00000169031	FALSE	Preclinical	2000-10-25	Unused	COL4A3
Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K1
Neoplasms	ENSG00000169047	FALSE	Preclinical	2013-12-06	Absent	IRS1
Neoplasms	ENSG00000169083	FALSE	Approved	1991-09-15	Unused	AR
Neoplasms	ENSG00000169118	FALSE	Preclinical	2011-03-15	Preclinical	CSNK1G1
Neoplasms	ENSG00000169194	FALSE	Phase III Clinical Trial	1993-06-15	Unused	IL13
Neoplasms	ENSG00000169245	FALSE	Preclinical	1998-04-15	Unused	CXCL10
Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	1996-05-15	Phase I Clinical Trial	PTK2
Neoplasms	ENSG00000169403	FALSE	Preclinical	1989-07-15	Unused	PTAFR
Neoplasms	ENSG00000169427	FALSE	Preclinical	2003-08-12	Unused	KCNK9
Neoplasms	ENSG00000169429	FALSE	Phase II Clinical Trial	2001-08-28	Preclinical	CXCL8
Neoplasms	ENSG00000169604	FALSE	Preclinical	2011-04-09	Unused	ANTXR1
Neoplasms	ENSG00000169679	FALSE	Preclinical	2017-05-22	Absent	BUB1
Neoplasms	ENSG00000169692	FALSE	Preclinical	2001-01-09	Unused	AGPAT2
Neoplasms	ENSG00000169710	FALSE	Phase I Clinical Trial	2003-11-26	Unused	FASN
Neoplasms	ENSG00000169908	FALSE	Preclinical	2015-07-15	Absent	TM4SF1
Neoplasms	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2009-06-10	Unused	ALCAM
Neoplasms	ENSG00000170145	FALSE	Preclinical	2016-02-11	Absent	SIK2
Neoplasms	ENSG00000170312	FALSE	Phase I Clinical Trial	1996-10-15	Phase I Clinical Trial	CDK1
Neoplasms	ENSG00000170381	FALSE	Preclinical	2017-08-29	Absent	SEMA3E
Neoplasms	ENSG00000170421	FALSE	Preclinical	2016-12-28	Absent	KRT8
Neoplasms	ENSG00000170425	FALSE	Phase I Clinical Trial	2004-03-31	Unused	ADORA2B
Neoplasms	ENSG00000170430	FALSE	Preclinical	1999-04-21	Unused	MGMT
Neoplasms	ENSG00000170445	FALSE	Preclinical	NA	Absent	HARS
Neoplasms	ENSG00000170458	FALSE	Preclinical	1999-05-19	Unused	CD14
Neoplasms	ENSG00000170525	FALSE	Phase I Clinical Trial	2005-07-22	Unused	PFKFB3
Neoplasms	ENSG00000170558	FALSE	Phase I Clinical Trial	1999-06-30	Unused	CDH2
Neoplasms	ENSG00000170820	FALSE	Preclinical	2001-12-10	Unused	FSHR
Neoplasms	ENSG00000170836	FALSE	Preclinical	2003-08-12	Unused	PPM1D
Neoplasms	ENSG00000170890	FALSE	Phase I Clinical Trial	2008-12-17	Unused	PLA2G1B
Neoplasms	ENSG00000170989	FALSE	Preclinical	2009-05-26	Phase I Clinical Trial	S1PR1
Neoplasms	ENSG00000171094	TRUE	Approved	2006-05-16	Approved	ALK
Neoplasms	ENSG00000171105	FALSE	Preclinical	2009-04-28	Unused	INSR
Neoplasms	ENSG00000171132	FALSE	Preclinical	2008-04-28	Unused	PRKCE
Neoplasms	ENSG00000171316	FALSE	Approved	2012-11-22	Absent	CHD7
Neoplasms	ENSG00000171444	FALSE	Preclinical	1995-03-15	Unused	MCC
Neoplasms	ENSG00000171517	FALSE	Preclinical	2007-02-02	Unused	LPAR3
Neoplasms	ENSG00000171522	FALSE	Phase I Clinical Trial	2008-07-04	Preclinical	PTGER4
Neoplasms	ENSG00000171552	FALSE	Phase I Clinical Trial	1996-01-15	Phase II Clinical Trial	BCL2L1
Neoplasms	ENSG00000171557	FALSE	Preclinical	2001-10-19	Unused	FGG
Neoplasms	ENSG00000171560	FALSE	Preclinical	2001-10-19	Unused	FGA
Neoplasms	ENSG00000171564	FALSE	Preclinical	2001-10-19	Unused	FGB
Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CD
Neoplasms	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase I Clinical Trial	HDAC3
Neoplasms	ENSG00000171791	FALSE	Phase I Clinical Trial	1992-03-15	Phase II Clinical Trial	BCL2
Neoplasms	ENSG00000171793	FALSE	Preclinical	1996-06-15	Unused	CTPS1
Neoplasms	ENSG00000171848	FALSE	Phase I Clinical Trial	1999-06-02	Phase I Clinical Trial	RRM2
Neoplasms	ENSG00000171855	FALSE	Preclinical	2000-07-29	Unused	IFNB1
Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1997-07-15	Phase II Clinical Trial	PTEN
Neoplasms	ENSG00000171867	FALSE	Preclinical	2013-02-22	Preclinical	PRNP
Neoplasms	ENSG00000172053	FALSE	Preclinical	2002-08-13	Unused	QARS
Neoplasms	ENSG00000172061	FALSE	Phase I Clinical Trial	2015-10-05	Absent	LRRC15
Neoplasms	ENSG00000172071	FALSE	Preclinical	2013-10-10	Absent	EIF2AK3
Neoplasms	ENSG00000172175	FALSE	Preclinical	NA	Absent	MALT1
Neoplasms	ENSG00000172243	FALSE	unknown	NA	Unused	CLEC7A
Neoplasms	ENSG00000172724	FALSE	Preclinical	2016-07-21	Absent	CCL19
Neoplasms	ENSG00000172819	FALSE	Phase II Clinical Trial	1998-10-15	Unused	RARG
Neoplasms	ENSG00000172889	FALSE	Phase I Clinical Trial	NA	Phase II Clinical Trial	EGFL7
Neoplasms	ENSG00000172938	FALSE	Preclinical	2012-11-01	Preclinical	MRGPRD
Neoplasms	ENSG00000173083	FALSE	Phase II Clinical Trial	1994-12-15	Unused	HPSE
Neoplasms	ENSG00000173153	FALSE	Preclinical	1999-12-20	Unused	ESRRA
Neoplasms	ENSG00000173250	FALSE	Preclinical	2008-09-11	Absent	GPR151
Neoplasms	ENSG00000173273	FALSE	Phase II Clinical Trial	2009-10-28	Unused	TNKS
Neoplasms	ENSG00000173402	FALSE	Preclinical	2014-10-28	Absent	DAG1
Neoplasms	ENSG00000173511	FALSE	Preclinical	1997-07-15	Unused	VEGFB
Neoplasms	ENSG00000173546	FALSE	Preclinical	1991-03-15	Unused	CSPG4
Neoplasms	ENSG00000173846	FALSE	Preclinical	2005-09-14	Unused	PLK3
Neoplasms	ENSG00000174059	FALSE	Preclinical	2015-03-14	Absent	CD34
Neoplasms	ENSG00000174437	FALSE	Preclinical	NA	Preclinical	ATP2A2
Neoplasms	ENSG00000174775	FALSE	Preclinical	1994-09-15	Unused	HRAS
Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Phase I Clinical Trial	CD248
Neoplasms	ENSG00000175054	FALSE	Phase II Clinical Trial	2011-04-15	Preclinical	ATR
Neoplasms	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE2
Neoplasms	ENSG00000175344	FALSE	Preclinical	2017-09-06	Absent	CHRNA7
Neoplasms	ENSG00000176105	FALSE	Phase I Clinical Trial	NA	Unused	YES1
Neoplasms	ENSG00000176170	FALSE	Preclinical	2013-01-22	Preclinical	SPHK1
Neoplasms	ENSG00000176393	FALSE	Preclinical	NA	Unused	RNPEP
Neoplasms	ENSG00000176435	FALSE	Preclinical	2016-01-11	Absent	CLEC14A
Neoplasms	ENSG00000176444	FALSE	Preclinical	2017-12-08	Absent	CLK2
Neoplasms	ENSG00000176884	FALSE	Phase I Clinical Trial	1990-06-15	Phase I Clinical Trial	GRIN1
Neoplasms	ENSG00000176890	TRUE	Approved	1989-07-15	Approved	TYMS
Neoplasms	ENSG00000177169	FALSE	Preclinical	2015-08-18	Absent	ULK1
Neoplasms	ENSG00000177455	FALSE	Phase I Clinical Trial	2010-05-31	Unused	CD19
Neoplasms	ENSG00000177464	FALSE	Preclinical	2014-08-21	Absent	GPR4
Neoplasms	ENSG00000177602	FALSE	Preclinical	2007-03-05	Unused	HASPIN
Neoplasms	ENSG00000177606	FALSE	Preclinical	1998-04-15	Unused	JUN
Neoplasms	ENSG00000177697	FALSE	Preclinical	2014-01-29	Absent	CD151
Neoplasms	ENSG00000177885	FALSE	Preclinical	1998-10-15	Unused	GRB2
Neoplasms	ENSG00000178035	FALSE	Preclinical	1995-07-15	Unused	IMPDH2
Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2002-09-20	Unused	CD28
Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Phase II Clinical Trial	ERBB4
Neoplasms	ENSG00000178573	FALSE	Preclinical	1996-09-15	Unused	MAF
Neoplasms	ENSG00000178607	FALSE	Preclinical	2014-04-16	Absent	ERN1
Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2002-11-19	Phase I Clinical Trial	AURKB
Neoplasms	ENSG00000179142	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	CYP11B2
Neoplasms	ENSG00000179218	FALSE	Preclinical	1999-04-21	Unused	CALR
Neoplasms	ENSG00000179295	FALSE	Phase I Clinical Trial	2002-01-17	Unused	PTPN11
Neoplasms	ENSG00000179750	FALSE	Preclinical	2016-11-25	Absent	APOBEC3B
Neoplasms	ENSG00000179776	FALSE	Preclinical	2000-04-26	Unused	CDH5
Neoplasms	ENSG00000180210	FALSE	Preclinical	1993-05-15	Unused	F2
Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2005-05-20	Phase I Clinical Trial	SSTR2
Neoplasms	ENSG00000180739	FALSE	unknown	2011-07-23	Phase I Clinical Trial	S1PR5
Neoplasms	ENSG00000180871	FALSE	Preclinical	1992-09-15	Unused	CXCR2
Neoplasms	ENSG00000181019	FALSE	Phase I Clinical Trial	2007-11-12	Absent	NQO1
Neoplasms	ENSG00000181104	FALSE	Preclinical	2005-06-01	Unused	F2R
Neoplasms	ENSG00000181143	FALSE	Preclinical	2016-08-30	Absent	MUC16
Neoplasms	ENSG00000181634	FALSE	Preclinical	NA	Unused	TNFSF15
Neoplasms	ENSG00000181847	FALSE	Phase II Clinical Trial	2016-06-10	Absent	TIGIT
Neoplasms	ENSG00000182054	FALSE	Phase II Clinical Trial	2011-11-14	Preclinical	IDH2
Neoplasms	ENSG00000182199	FALSE	Preclinical	2017-07-26	Absent	SHMT2
Neoplasms	ENSG00000182541	FALSE	Preclinical	2009-12-24	Preclinical	LIMK2
Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	1989-10-15	Phase I Clinical Trial	CSF1R
Neoplasms	ENSG00000182866	FALSE	Phase I Clinical Trial	1998-09-15	Unused	LCK
Neoplasms	ENSG00000182871	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	COL18A1
Neoplasms	ENSG00000183087	FALSE	unknown	2016-02-16	Absent	GAS6
Neoplasms	ENSG00000183484	FALSE	Preclinical	2015-08-13	Absent	GPR132
Neoplasms	ENSG00000183625	FALSE	Preclinical	2006-01-01	Unused	CCR3
Neoplasms	ENSG00000183696	FALSE	Phase I Clinical Trial	1989-10-15	Unused	UPP1
Neoplasms	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Neoplasms	ENSG00000183765	FALSE	Phase II Clinical Trial	2004-02-10	Phase II Clinical Trial	CHEK2
Neoplasms	ENSG00000183813	FALSE	Approved	2002-11-06	Unused	CCR4
Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	1999-04-21	Phase II Clinical Trial	CTAG1B
Neoplasms	ENSG00000184047	FALSE	Phase I Clinical Trial	2005-05-16	Phase I Clinical Trial	DIABLO
Neoplasms	ENSG00000184216	FALSE	Preclinical	2016-08-02	Absent	IRAK1
Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Unused	TACSTD2
Neoplasms	ENSG00000184304	FALSE	Preclinical	2007-10-23	Unused	PRKD1
Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Absent	CSF1
Neoplasms	ENSG00000184502	FALSE	Phase II Clinical Trial	1991-09-15	Unused	GAST
Neoplasms	ENSG00000184557	FALSE	Preclinical	2013-10-19	Absent	SOCS3
Neoplasms	ENSG00000184584	FALSE	Phase I Clinical Trial	2014-04-02	Absent	TMEM173
Neoplasms	ENSG00000184588	FALSE	Preclinical	1994-10-15	Unused	PDE4B
Neoplasms	ENSG00000184697	FALSE	Preclinical	2013-11-20	Absent	CLDN6
Neoplasms	ENSG00000184845	FALSE	Preclinical	1996-01-15	Unused	DRD1
Neoplasms	ENSG00000184916	FALSE	Preclinical	2010-11-19	Absent	JAG2
Neoplasms	ENSG00000184937	FALSE	Phase I Clinical Trial	2010-06-11	Phase I Clinical Trial	WT1
Neoplasms	ENSG00000185231	FALSE	Preclinical	1992-06-15	Unused	MC2R
Neoplasms	ENSG00000185291	FALSE	Preclinical	1991-07-15	Unused	IL3RA
Neoplasms	ENSG00000185339	FALSE	Preclinical	2001-02-02	Preclinical	TCN2
Neoplasms	ENSG00000185386	FALSE	Preclinical	2004-02-02	Unused	MAPK11
Neoplasms	ENSG00000185420	FALSE	Preclinical	2016-10-24	Absent	SMYD3
Neoplasms	ENSG00000185436	FALSE	Preclinical	2013-05-16	Absent	IFNLR1
Neoplasms	ENSG00000185483	FALSE	Phase I Clinical Trial	2015-01-02	Absent	ROR1
Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	1993-07-15	Phase I Clinical Trial	MUC1
Neoplasms	ENSG00000185559	FALSE	Preclinical	2009-05-15	Absent	DLK1
Neoplasms	ENSG00000185686	FALSE	Preclinical	2009-07-21	Unused	PRAME
Neoplasms	ENSG00000185896	FALSE	Phase I Clinical Trial	2015-10-19	Absent	LAMP1
Neoplasms	ENSG00000185920	FALSE	Preclinical	2012-05-18	Preclinical	PTCH1
Neoplasms	ENSG00000185950	FALSE	Preclinical	2013-12-06	Absent	IRS2
Neoplasms	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Neoplasms	ENSG00000186265	FALSE	Preclinical	2016-07-21	Absent	BTLA
Neoplasms	ENSG00000186350	FALSE	Preclinical	2015-11-18	Absent	RXRA
Neoplasms	ENSG00000186431	FALSE	Phase II Clinical Trial	NA	Unused	FCAR
Neoplasms	ENSG00000186652	FALSE	Preclinical	2014-01-11	Absent	PRG2
Neoplasms	ENSG00000186716	TRUE	Approved	1989-06-15	Phase I Clinical Trial	BCR
Neoplasms	ENSG00000186818	FALSE	Preclinical	2004-10-20	Unused	LILRB4
Neoplasms	ENSG00000186827	FALSE	Phase II Clinical Trial	2000-02-17	Phase II Clinical Trial	TNFRSF4
Neoplasms	ENSG00000186868	FALSE	Preclinical	2007-11-23	Unused	MAPT
Neoplasms	ENSG00000186891	FALSE	Phase II Clinical Trial	2004-10-20	Absent	TNFRSF18
Neoplasms	ENSG00000187079	FALSE	Preclinical	2014-09-25	Absent	TEAD1
Neoplasms	ENSG00000187210	FALSE	Preclinical	1999-01-15	Unused	GCNT1
Neoplasms	ENSG00000187266	FALSE	Preclinical	1996-12-15	Unused	EPOR
Neoplasms	ENSG00000187323	FALSE	Preclinical	1995-03-15	Unused	DCC
Neoplasms	ENSG00000187498	FALSE	Preclinical	2001-07-04	Unused	COL4A1
Neoplasms	ENSG00000187514	FALSE	Preclinical	2004-06-09	Unused	PTMA
Neoplasms	ENSG00000187554	FALSE	Preclinical	2017-01-09	Absent	TLR5
Neoplasms	ENSG00000187555	FALSE	Preclinical	2009-09-09	Unused	USP7
Neoplasms	ENSG00000187764	FALSE	Phase I Clinical Trial	2006-06-20	Phase I Clinical Trial	SEMA4D
Neoplasms	ENSG00000188211	FALSE	Preclinical	2015-10-15	Absent	NCR3LG1
Neoplasms	ENSG00000188372	FALSE	Preclinical	2006-12-13	Unused	ZP3
Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Phase I Clinical Trial	PDCD1
Neoplasms	ENSG00000188641	FALSE	Phase I Clinical Trial	2002-04-11	Phase I Clinical Trial	DPYD
Neoplasms	ENSG00000188786	FALSE	Preclinical	2008-02-06	Preclinical	MTF1
Neoplasms	ENSG00000188906	FALSE	Preclinical	2009-03-23	Unused	LRRK2
Neoplasms	ENSG00000189403	FALSE	Preclinical	2004-09-13	Unused	HMGB1
Neoplasms	ENSG00000189430	FALSE	Preclinical	2013-01-21	Preclinical	NCR1
Neoplasms	ENSG00000196139	FALSE	Preclinical	2016-10-19	Absent	AKR1C3
Neoplasms	ENSG00000196154	FALSE	Preclinical	1996-11-15	Unused	S100A4
Neoplasms	ENSG00000196262	FALSE	Preclinical	1993-01-15	Unused	PPIA
Neoplasms	ENSG00000196313	FALSE	Preclinical	NA	Unused	POM121
Neoplasms	ENSG00000196352	FALSE	Preclinical	2000-08-03	Unused	CD55
Neoplasms	ENSG00000196363	FALSE	Preclinical	2016-12-28	Absent	WDR5
Neoplasms	ENSG00000196396	FALSE	Preclinical	2005-08-19	Unused	PTPN1
Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	EPHB4
Neoplasms	ENSG00000196482	FALSE	Preclinical	1999-12-20	Unused	ESRRG
Neoplasms	ENSG00000196591	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Neoplasms	ENSG00000196611	FALSE	Preclinical	1995-09-15	Unused	MMP1
Neoplasms	ENSG00000196664	FALSE	Phase I Clinical Trial	2004-02-17	Unused	TLR7
Neoplasms	ENSG00000196776	FALSE	Phase II Clinical Trial	2011-05-14	Absent	CD47
Neoplasms	ENSG00000196839	FALSE	Preclinical	1990-02-15	Unused	ADA
Neoplasms	ENSG00000197081	FALSE	Phase I Clinical Trial	1999-01-15	Phase I Clinical Trial	IGF2R
Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	1995-06-15	Phase II Clinical Trial	SRC
Neoplasms	ENSG00000197405	FALSE	Preclinical	2012-06-06	Absent	C5AR1
Neoplasms	ENSG00000197408	FALSE	Preclinical	2000-01-26	Unused	CYP2B6
Neoplasms	ENSG00000197442	FALSE	Preclinical	2010-12-23	Unused	MAP3K5
Neoplasms	ENSG00000197461	FALSE	Preclinical	2015-06-17	Absent	PDGFA
Neoplasms	ENSG00000197632	FALSE	Preclinical	1989-10-15	Unused	SERPINB2
Neoplasms	ENSG00000197646	FALSE	Preclinical	2016-09-05	Absent	PDCD1LG2
Neoplasms	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Neoplasms	ENSG00000197912	FALSE	Preclinical	1992-11-15	Unused	SPG7
Neoplasms	ENSG00000197919	FALSE	Preclinical	1996-09-15	Unused	IFNA1
Neoplasms	ENSG00000197992	FALSE	Preclinical	2008-08-05	Unused	CLEC9A
Neoplasms	ENSG00000198001	FALSE	Preclinical	2014-05-26	Absent	IRAK4
Neoplasms	ENSG00000198053	FALSE	Preclinical	2013-10-18	Absent	SIRPA
Neoplasms	ENSG00000198121	FALSE	Preclinical	2007-02-02	Unused	LPAR1
Neoplasms	ENSG00000198223	FALSE	Preclinical	1992-12-15	Unused	CSF2RA
Neoplasms	ENSG00000198355	FALSE	Phase I Clinical Trial	2011-10-07	Phase I Clinical Trial	PIM3
Neoplasms	ENSG00000198400	FALSE	Pre-registration	2007-01-08	Phase I Clinical Trial	NTRK1
Neoplasms	ENSG00000198625	FALSE	Phase II Clinical Trial	2012-07-25	Preclinical	MDM4
Neoplasms	ENSG00000198668	FALSE	Phase II Clinical Trial	1990-06-15	Unused	CALM1
Neoplasms	ENSG00000198681	FALSE	Phase II Clinical Trial	1993-11-15	Unused	MAGEA1
Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Neoplasms	ENSG00000198805	FALSE	Preclinical	1989-07-15	Unused	PNP
Neoplasms	ENSG00000198822	FALSE	Preclinical	2013-09-26	Absent	GRM3
Neoplasms	ENSG00000198851	FALSE	Phase I Clinical Trial	2012-11-19	Preclinical	CD3E
Neoplasms	ENSG00000198890	FALSE	Preclinical	2015-05-07	Absent	PRMT6
Neoplasms	ENSG00000198900	TRUE	Approved	1989-07-15	Phase II Clinical Trial	TOP1
Neoplasms	ENSG00000198964	FALSE	Phase II Clinical Trial	2008-11-07	Absent	SGMS1
Neoplasms	ENSG00000203747	FALSE	Phase II Clinical Trial	1993-06-15	Phase II Clinical Trial	FCGR3A
Neoplasms	ENSG00000203859	FALSE	Preclinical	2004-09-14	Unused	HSD3B2
Neoplasms	ENSG00000204577	FALSE	Preclinical	2010-02-15	Unused	LILRB3
Neoplasms	ENSG00000213281	FALSE	unknown	2012-11-18	Absent	NRAS
Neoplasms	ENSG00000213413	FALSE	Preclinical	2014-06-23	Absent	PVRIG
Neoplasms	ENSG00000213658	FALSE	Preclinical	2016-06-17	Absent	LAT
Neoplasms	ENSG00000213694	FALSE	Preclinical	2010-07-02	Unused	S1PR3
Neoplasms	ENSG00000213809	FALSE	Preclinical	2017-03-17	Absent	KLRK1
Neoplasms	ENSG00000213853	FALSE	Preclinical	2017-11-13	Absent	EMP2
Neoplasms	ENSG00000213903	FALSE	Phase I Clinical Trial	2004-01-28	Phase I Clinical Trial	LTB4R
Neoplasms	ENSG00000213918	FALSE	Preclinical	1997-05-15	Unused	DNASE1
Neoplasms	ENSG00000213949	FALSE	Preclinical	1998-03-15	Unused	ITGA1
Neoplasms	ENSG00000214274	FALSE	Preclinical	1998-07-15	Unused	ANG
Neoplasms	ENSG00000215788	FALSE	Preclinical	2017-12-18	Absent	TNFRSF25
Neoplasms	ENSG00000221867	FALSE	Phase II Clinical Trial	2012-01-16	Absent	MAGEA3
Neoplasms	ENSG00000227345	FALSE	Preclinical	2001-01-11	Unused	PARG
Neoplasms	ENSG00000228716	TRUE	Approved	1989-07-15	Approved	DHFR
Neoplasms	ENSG00000239672	FALSE	Preclinical	1991-02-15	Unused	NME1
Neoplasms	ENSG00000239732	FALSE	Phase I Clinical Trial	2004-07-23	Unused	TLR9
Neoplasms	ENSG00000240505	FALSE	Preclinical	2015-01-24	Absent	TNFRSF13B
Neoplasms	ENSG00000240972	FALSE	Phase I Clinical Trial	1993-07-15	Phase I Clinical Trial	MIF
Neoplasms	ENSG00000241186	FALSE	Phase I Clinical Trial	2002-09-06	Unused	TDGF1
Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	1999-05-19	Phase I Clinical Trial	PRKDC
Neoplasms	ENSG00000254087	FALSE	Phase I Clinical Trial	2001-10-30	Phase I Clinical Trial	LYN
Neoplasms	ENSG00000258839	FALSE	Preclinical	1994-11-15	Unused	MC1R
Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	1993-06-15	Phase I Clinical Trial	ITGB3
Neoplasms	ENSG00000260314	TRUE	Approved	2004-08-18	Absent	MRC1
Neoplasms	ENSG00000261371	FALSE	Preclinical	1996-03-15	Absent	PECAM1
Neoplasms	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Neoplasms	ENSG00000263761	FALSE	Phase I Clinical Trial	2007-05-30	Absent	GDF2
Neoplasms	ENSG00000269858	FALSE	Preclinical	2014-02-25	Absent	EGLN2
Neoplasms	ENSG00000271503	FALSE	Preclinical	2009-03-26	Unused	CCL5
Neoplasms	ENSG00000272398	FALSE	Preclinical	2011-11-21	Absent	CD24
Neoplasms	ENSG00000275152	FALSE	Preclinical	2004-03-01	Unused	CCL16
Neoplasms	ENSG00000276043	FALSE	Preclinical	1998-12-15	Unused	UHRF1
Neoplasms	ENSG00000276409	FALSE	Preclinical	1997-05-15	Unused	CCL14
Neoplasms	ENSG00000277893	FALSE	Preclinical	1994-01-15	Unused	SRD5A2
Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	NA	Phase I Clinical Trial	SSTR3
Neoplasms	ENSG00000282608	FALSE	Preclinical	1997-07-15	Unused	ADORA3
Neoplasms, Basal Cell	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CFLAR
Neoplasms, Basal Cell	ENSG00000089041	FALSE	Phase I Clinical Trial	2008-08-11	Unused	P2RX7
Neoplasms, Basal Cell	ENSG00000101916	FALSE	unknown	NA	Absent	TLR8
Neoplasms, Basal Cell	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Unused	XIAP
Neoplasms, Basal Cell	ENSG00000111537	FALSE	Phase II Clinical Trial	NA	Preclinical	IFNG
Neoplasms, Basal Cell	ENSG00000112715	FALSE	Phase I Clinical Trial	2003-11-26	Phase I Clinical Trial	VEGFA
Neoplasms, Basal Cell	ENSG00000115758	FALSE	unknown	1996-05-15	Unused	ODC1
Neoplasms, Basal Cell	ENSG00000116478	FALSE	Phase II Clinical Trial	2005-03-02	Phase II Clinical Trial	HDAC1
Neoplasms, Basal Cell	ENSG00000116824	FALSE	unknown	1997-07-15	Unused	CD2
Neoplasms, Basal Cell	ENSG00000121879	FALSE	unknown	2006-12-07	Phase II Clinical Trial	PIK3CA
Neoplasms, Basal Cell	ENSG00000128052	FALSE	unknown	1997-11-15	Unused	KDR
Neoplasms, Basal Cell	ENSG00000128602	TRUE	Approved	2004-07-21	Approved	SMO
Neoplasms, Basal Cell	ENSG00000131747	FALSE	Phase II Clinical Trial	1998-11-15	Unused	TOP2A
Neoplasms, Basal Cell	ENSG00000132906	FALSE	unknown	2007-03-05	Preclinical	CASP9
Neoplasms, Basal Cell	ENSG00000135828	FALSE	unknown	1997-01-15	Unused	RNASEL
Neoplasms, Basal Cell	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Unused	SRD5A1
Neoplasms, Basal Cell	ENSG00000159110	FALSE	Approved	2013-01-08	Unused	IFNAR2
Neoplasms, Basal Cell	ENSG00000163932	FALSE	Phase II Clinical Trial	2002-10-14	Phase II Clinical Trial	PRKCD
Neoplasms, Basal Cell	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Absent	TLR3
Neoplasms, Basal Cell	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Unused	ENOX2
Neoplasms, Basal Cell	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Neoplasms, Basal Cell	ENSG00000176890	FALSE	unknown	NA	Unused	TYMS
Neoplasms, Basal Cell	ENSG00000177606	FALSE	Phase I Clinical Trial	2006-07-25	Phase I Clinical Trial	JUN
Neoplasms, Basal Cell	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Neoplasms, Basal Cell	ENSG00000185920	FALSE	Phase I Clinical Trial	1996-08-15	Unused	PTCH1
Neoplasms, Basal Cell	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Neoplasms, Basal Cell	ENSG00000188389	FALSE	Phase II Clinical Trial	2015-02-11	Absent	PDCD1
Neoplasms, Basal Cell	ENSG00000196591	FALSE	Phase II Clinical Trial	2005-03-02	Phase II Clinical Trial	HDAC2
Neoplasms, Basal Cell	ENSG00000196664	FALSE	Preclinical	2009-12-23	Preclinical	TLR7
Neoplasms, Basal Cell	ENSG00000198793	FALSE	unknown	2006-12-07	Phase II Clinical Trial	MTOR
Neoplasms, Basal Cell	ENSG00000198900	FALSE	Phase I Clinical Trial	2007-10-08	Phase I Clinical Trial	TOP1
Neoplasms, Basal Cell	ENSG00000239732	FALSE	unknown	1998-10-15	Unused	TLR9
Neoplasms, Squamous Cell	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Unused	CFLAR
Neoplasms, Squamous Cell	ENSG00000037280	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	FLT4
Neoplasms, Squamous Cell	ENSG00000049249	FALSE	Phase II Clinical Trial	2005-11-15	Absent	TNFRSF9
Neoplasms, Squamous Cell	ENSG00000065361	FALSE	Preclinical	2008-07-24	Absent	ERBB3
Neoplasms, Squamous Cell	ENSG00000077782	FALSE	Preclinical	2012-01-25	Absent	FGFR1
Neoplasms, Squamous Cell	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Neoplasms, Squamous Cell	ENSG00000086205	FALSE	unknown	2008-03-04	Absent	FOLH1
Neoplasms, Squamous Cell	ENSG00000089041	FALSE	unknown	2008-08-11	Unused	P2RX7
Neoplasms, Squamous Cell	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Unused	XIAP
Neoplasms, Squamous Cell	ENSG00000102755	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	FLT1
Neoplasms, Squamous Cell	ENSG00000105810	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK6
Neoplasms, Squamous Cell	ENSG00000105976	FALSE	unknown	2003-07-18	Phase II Clinical Trial	MET
Neoplasms, Squamous Cell	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Neoplasms, Squamous Cell	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Neoplasms, Squamous Cell	ENSG00000115758	FALSE	unknown	1996-05-15	Unused	ODC1
Neoplasms, Squamous Cell	ENSG00000116478	FALSE	unknown	2007-07-24	Phase II Clinical Trial	HDAC1
Neoplasms, Squamous Cell	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Neoplasms, Squamous Cell	ENSG00000124466	FALSE	Phase I Clinical Trial	NA	Absent	LYPD3
Neoplasms, Squamous Cell	ENSG00000128052	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	KDR
Neoplasms, Squamous Cell	ENSG00000130037	FALSE	Phase I Clinical Trial	2015-08-14	Absent	KCNA5
Neoplasms, Squamous Cell	ENSG00000130816	FALSE	unknown	1996-06-15	Unused	DNMT1
Neoplasms, Squamous Cell	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Absent	IDO1
Neoplasms, Squamous Cell	ENSG00000131747	FALSE	Phase II Clinical Trial	1998-11-15	Unused	TOP2A
Neoplasms, Squamous Cell	ENSG00000134460	FALSE	Phase III Clinical Trial	2015-09-15	Phase III Clinical Trial	IL2RA
Neoplasms, Squamous Cell	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	PDGFRA
Neoplasms, Squamous Cell	ENSG00000135446	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK4
Neoplasms, Squamous Cell	ENSG00000136235	FALSE	Phase II Clinical Trial	1999-12-10	Absent	GPNMB
Neoplasms, Squamous Cell	ENSG00000140443	FALSE	unknown	2004-10-04	Absent	IGF1R
Neoplasms, Squamous Cell	ENSG00000141736	FALSE	Phase I Clinical Trial	1997-09-15	Phase III Clinical Trial	ERBB2
Neoplasms, Squamous Cell	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Unused	SRD5A1
Neoplasms, Squamous Cell	ENSG00000146242	FALSE	Preclinical	2016-11-24	Absent	TPBG
Neoplasms, Squamous Cell	ENSG00000146648	FALSE	Approved	1995-03-15	Approved	EGFR
Neoplasms, Squamous Cell	ENSG00000151694	FALSE	Preclinical	2014-08-01	Absent	ADAM17
Neoplasms, Squamous Cell	ENSG00000157764	FALSE	Phase II Clinical Trial	2006-11-27	Absent	BRAF
Neoplasms, Squamous Cell	ENSG00000162892	FALSE	unknown	1999-07-07	Unused	IL24
Neoplasms, Squamous Cell	ENSG00000163599	FALSE	Phase III Clinical Trial	2004-07-07	Absent	CTLA4
Neoplasms, Squamous Cell	ENSG00000163932	FALSE	Phase II Clinical Trial	2002-10-14	Phase II Clinical Trial	PRKCD
Neoplasms, Squamous Cell	ENSG00000164400	FALSE	Phase III Clinical Trial	2000-09-28	Phase III Clinical Trial	CSF2
Neoplasms, Squamous Cell	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Unused	ENOX2
Neoplasms, Squamous Cell	ENSG00000165731	FALSE	Phase II Clinical Trial	2006-11-27	Absent	RET
Neoplasms, Squamous Cell	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Neoplasms, Squamous Cell	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Unused	PTK2
Neoplasms, Squamous Cell	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Neoplasms, Squamous Cell	ENSG00000176890	TRUE	Approved	1992-03-15	Unused	TYMS
Neoplasms, Squamous Cell	ENSG00000178568	FALSE	Phase I Clinical Trial	2003-11-21	Phase I Clinical Trial	ERBB4
Neoplasms, Squamous Cell	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Neoplasms, Squamous Cell	ENSG00000188389	FALSE	Pre-registration	2005-05-12	Absent	PDCD1
Neoplasms, Squamous Cell	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Neoplasms, Squamous Cell	ENSG00000196591	FALSE	unknown	2007-07-24	Phase II Clinical Trial	HDAC2
Neoplasms, Squamous Cell	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Neoplasms, Squamous Cell	ENSG00000198900	TRUE	Approved	NA	Approved	TOP1
Neoplasms, Squamous Cell	ENSG00000254087	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Neoplasms, Squamous Cell	ENSG00000258839	FALSE	unknown	2003-06-05	Phase II Clinical Trial	MC1R
Nephritis	ENSG00000059377	FALSE	Preclinical	1992-12-15	Unused	TBXAS1
Nephritis	ENSG00000101266	FALSE	Preclinical	2012-06-06	Preclinical	CSNK2A1
Nephritis	ENSG00000106804	FALSE	unknown	1993-08-15	Unused	C5
Nephritis	ENSG00000121807	FALSE	Phase II Clinical Trial	2011-12-05	Unused	CCR2
Nephritis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Nephritis	ENSG00000136689	FALSE	Approved	1992-03-15	Unused	IL1RN
Nephritis	ENSG00000136869	FALSE	Preclinical	2011-11-27	Absent	TLR4
Nephritis	ENSG00000138735	FALSE	Preclinical	1992-12-15	Unused	PDE5A
Nephritis	ENSG00000160791	FALSE	Phase II Clinical Trial	2013-10-17	Absent	CCR5
Nephritis	ENSG00000169031	FALSE	Preclinical	1997-04-15	Unused	COL4A3
Nephritis	ENSG00000182578	FALSE	Preclinical	2012-05-11	Preclinical	CSF1R
Nephritis	ENSG00000187266	FALSE	Preclinical	1991-06-15	Unused	EPOR
Nephritis	ENSG00000188389	FALSE	Preclinical	2013-12-14	Absent	PDCD1
Nephritis	ENSG00000188822	FALSE	Preclinical	1997-12-15	Unused	CNR2
Nephritis	ENSG00000240972	FALSE	unknown	2004-01-13	Unused	MIF
Nephritis	ENSG00000258839	FALSE	Preclinical	2013-03-20	Absent	MC1R
Nephritis, Hereditary	ENSG00000082701	FALSE	Preclinical	2009-02-05	Absent	GSK3B
Nephritis, Hereditary	ENSG00000101144	FALSE	Preclinical	NA	Absent	BMP7
Nephritis, Hereditary	ENSG00000116044	FALSE	Phase III Clinical Trial	2005-05-27	Absent	NFE2L2
Nephritis, Hereditary	ENSG00000188153	FALSE	Preclinical	1997-04-15	Absent	COL4A5
Nephritis, Hereditary	ENSG00000262406	FALSE	Preclinical	2016-10-11	Absent	MMP12
Nephrotic Syndrome	ENSG00000073756	FALSE	Preclinical	2011-09-29	Absent	PTGS2
Nephrotic Syndrome	ENSG00000088832	FALSE	Preclinical	NA	Absent	FKBP1A
Nephrotic Syndrome	ENSG00000095303	FALSE	Preclinical	2011-09-29	Absent	PTGS1
Nephrotic Syndrome	ENSG00000102524	FALSE	Phase II Clinical Trial	1999-07-13	Absent	TNFSF13B
Nephrotic Syndrome	ENSG00000106348	FALSE	Phase III Clinical Trial	NA	Absent	IMPDH1
Nephrotic Syndrome	ENSG00000113580	TRUE	Approved	2014-09-19	Approved	NR3C1
Nephrotic Syndrome	ENSG00000114013	FALSE	Phase II Clinical Trial	1992-11-15	Absent	CD86
Nephrotic Syndrome	ENSG00000121594	FALSE	Phase II Clinical Trial	1992-11-15	Absent	CD80
Nephrotic Syndrome	ENSG00000126895	FALSE	Preclinical	1998-10-15	Unused	AVPR2
Nephrotic Syndrome	ENSG00000144891	FALSE	Preclinical	2010-06-16	Absent	AGTR1
Nephrotic Syndrome	ENSG00000151617	FALSE	Preclinical	1995-10-15	Absent	EDNRA
Nephrotic Syndrome	ENSG00000156738	FALSE	unknown	1993-09-15	Absent	MS4A1
Nephrotic Syndrome	ENSG00000182782	FALSE	Preclinical	2011-09-29	Preclinical	HCAR2
Nephrotic Syndrome	ENSG00000185231	FALSE	Phase I Clinical Trial	2013-09-03	Absent	MC2R
Nephrotic Syndrome	ENSG00000196262	TRUE	Approved	NA	Approved	PPIA
Nervous System Diseases	ENSG00000004139	FALSE	Preclinical	2017-11-02	Absent	SARM1
Nervous System Diseases	ENSG00000004478	FALSE	Preclinical	2004-06-14	Unused	FKBP4
Nervous System Diseases	ENSG00000005961	FALSE	Preclinical	1991-11-15	Unused	ITGA2B
Nervous System Diseases	ENSG00000006283	FALSE	Phase I Clinical Trial	1993-06-15	Unused	CACNA1G
Nervous System Diseases	ENSG00000006638	FALSE	unknown	1991-04-15	Unused	TBXA2R
Nervous System Diseases	ENSG00000007171	FALSE	Preclinical	1996-08-15	Unused	NOS2
Nervous System Diseases	ENSG00000007402	FALSE	Preclinical	2015-02-12	Absent	CACNA2D2
Nervous System Diseases	ENSG00000007908	FALSE	Preclinical	2000-06-07	Unused	SELE
Nervous System Diseases	ENSG00000007952	FALSE	Preclinical	2011-06-01	Unused	NOX1
Nervous System Diseases	ENSG00000010671	FALSE	Preclinical	2017-08-14	Absent	BTK
Nervous System Diseases	ENSG00000011677	TRUE	Approved	1991-10-15	Approved	GABRA3
Nervous System Diseases	ENSG00000012779	FALSE	Preclinical	2005-05-09	Unused	ALOX5
Nervous System Diseases	ENSG00000017427	FALSE	Preclinical	1993-11-15	Unused	IGF1
Nervous System Diseases	ENSG00000022355	TRUE	Approved	1991-10-15	Approved	GABRA1
Nervous System Diseases	ENSG00000023445	FALSE	Preclinical	1997-02-15	Unused	BIRC3
Nervous System Diseases	ENSG00000030110	FALSE	Preclinical	1997-07-15	Absent	BAK1
Nervous System Diseases	ENSG00000044524	FALSE	Preclinical	1996-05-15	Unused	EPHA3
Nervous System Diseases	ENSG00000057252	FALSE	Preclinical	2013-12-06	Absent	SOAT1
Nervous System Diseases	ENSG00000059377	FALSE	Preclinical	NA	Unused	TBXAS1
Nervous System Diseases	ENSG00000064300	FALSE	Phase I Clinical Trial	1993-04-15	Unused	NGFR
Nervous System Diseases	ENSG00000064651	FALSE	Preclinical	2008-01-19	Unused	SLC12A2
Nervous System Diseases	ENSG00000064989	FALSE	Preclinical	1991-06-15	Unused	CALCRL
Nervous System Diseases	ENSG00000065320	FALSE	Preclinical	1998-01-15	Absent	NTN1
Nervous System Diseases	ENSG00000065989	FALSE	Preclinical	1990-06-15	Unused	PDE4A
Nervous System Diseases	ENSG00000067900	FALSE	Preclinical	2003-05-12	Unused	ROCK1
Nervous System Diseases	ENSG00000068903	FALSE	Preclinical	2010-08-17	Unused	SIRT2
Nervous System Diseases	ENSG00000069431	FALSE	Preclinical	1996-07-15	Unused	ABCC9
Nervous System Diseases	ENSG00000069535	FALSE	Preclinical	1992-08-15	Unused	MAOB
Nervous System Diseases	ENSG00000069696	FALSE	Preclinical	1995-03-15	Preclinical	DRD4
Nervous System Diseases	ENSG00000070748	FALSE	Preclinical	1991-06-15	Unused	CHAT
Nervous System Diseases	ENSG00000073756	FALSE	Preclinical	2007-05-16	Unused	PTGS2
Nervous System Diseases	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Nervous System Diseases	ENSG00000075043	FALSE	Preclinical	2012-06-28	Preclinical	KCNQ2
Nervous System Diseases	ENSG00000076984	FALSE	Preclinical	2003-08-26	Unused	MAP2K7
Nervous System Diseases	ENSG00000077782	FALSE	Preclinical	NA	Unused	FGFR1
Nervous System Diseases	ENSG00000080824	FALSE	Preclinical	2011-09-06	Absent	HSP90AA1
Nervous System Diseases	ENSG00000082175	FALSE	Preclinical	2011-04-08	Unused	PGR
Nervous System Diseases	ENSG00000082556	FALSE	Preclinical	1991-11-15	Unused	OPRK1
Nervous System Diseases	ENSG00000082701	FALSE	Preclinical	2004-07-05	Unused	GSK3B
Nervous System Diseases	ENSG00000085662	TRUE	Approved	1990-05-15	Unused	AKR1B1
Nervous System Diseases	ENSG00000087074	FALSE	Preclinical	2014-04-30	Absent	PPP1R15A
Nervous System Diseases	ENSG00000087085	FALSE	Preclinical	1990-02-15	Unused	ACHE
Nervous System Diseases	ENSG00000087088	FALSE	Preclinical	1995-11-15	Unused	BAX
Nervous System Diseases	ENSG00000088832	FALSE	Preclinical	1989-10-15	Unused	FKBP1A
Nervous System Diseases	ENSG00000089041	FALSE	Preclinical	2008-09-30	Unused	P2RX7
Nervous System Diseases	ENSG00000089250	FALSE	Preclinical	1996-08-15	Unused	NOS1
Nervous System Diseases	ENSG00000091831	FALSE	Preclinical	1999-09-16	Unused	ESR1
Nervous System Diseases	ENSG00000093010	FALSE	Preclinical	2013-03-21	Absent	COMT
Nervous System Diseases	ENSG00000095970	FALSE	Preclinical	2008-07-04	Unused	TREM2
Nervous System Diseases	ENSG00000100300	FALSE	Phase I Clinical Trial	2002-11-05	Unused	TSPO
Nervous System Diseases	ENSG00000100739	FALSE	Preclinical	2003-05-06	Unused	BDKRB1
Nervous System Diseases	ENSG00000101144	FALSE	unknown	NA	Unused	BMP7
Nervous System Diseases	ENSG00000101180	FALSE	Preclinical	1990-01-15	Unused	HRH3
Nervous System Diseases	ENSG00000101255	FALSE	Preclinical	2015-10-13	Absent	TRIB3
Nervous System Diseases	ENSG00000101916	FALSE	Preclinical	2008-08-18	Unused	TLR8
Nervous System Diseases	ENSG00000101966	FALSE	Preclinical	2002-07-03	Unused	XIAP
Nervous System Diseases	ENSG00000102468	FALSE	Preclinical	1998-03-15	Unused	HTR2A
Nervous System Diseases	ENSG00000103546	FALSE	Phase II Clinical Trial	1998-06-15	Unused	SLC6A2
Nervous System Diseases	ENSG00000104267	FALSE	Preclinical	NA	Unused	CA2
Nervous System Diseases	ENSG00000105376	FALSE	Preclinical	NA	Unused	ICAM5
Nervous System Diseases	ENSG00000105650	FALSE	Preclinical	1990-06-15	Unused	PDE4C
Nervous System Diseases	ENSG00000105835	FALSE	Preclinical	2014-09-12	Absent	NAMPT
Nervous System Diseases	ENSG00000105894	FALSE	Preclinical	1993-03-15	Unused	PTN
Nervous System Diseases	ENSG00000106683	FALSE	Preclinical	2016-04-22	Absent	LIMK1
Nervous System Diseases	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Nervous System Diseases	ENSG00000106804	FALSE	Preclinical	2016-06-28	Absent	C5
Nervous System Diseases	ENSG00000107611	FALSE	Approved	NA	Unused	CUBN
Nervous System Diseases	ENSG00000108342	FALSE	Preclinical	2012-12-01	Absent	CSF3
Nervous System Diseases	ENSG00000108443	FALSE	Preclinical	2011-12-13	Preclinical	RPS6KB1
Nervous System Diseases	ENSG00000108576	FALSE	Preclinical	1993-05-15	Unused	SLC6A4
Nervous System Diseases	ENSG00000109320	FALSE	Preclinical	1990-06-15	Unused	NFKB1
Nervous System Diseases	ENSG00000109339	FALSE	Preclinical	2008-04-10	Unused	MAPK10
Nervous System Diseases	ENSG00000110090	FALSE	Preclinical	1999-04-13	Unused	CPT1A
Nervous System Diseases	ENSG00000110148	FALSE	Preclinical	NA	Unused	CCKBR
Nervous System Diseases	ENSG00000110330	FALSE	Preclinical	2002-07-03	Unused	BIRC2
Nervous System Diseases	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Nervous System Diseases	ENSG00000111262	FALSE	Preclinical	1994-12-15	Unused	KCNA1
Nervous System Diseases	ENSG00000112033	FALSE	Preclinical	2007-10-17	Absent	PPARD
Nervous System Diseases	ENSG00000112038	FALSE	Preclinical	2009-06-15	Absent	OPRM1
Nervous System Diseases	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Nervous System Diseases	ENSG00000112115	FALSE	unknown	2012-03-21	Absent	IL17A
Nervous System Diseases	ENSG00000112116	FALSE	unknown	2012-03-21	Absent	IL17F
Nervous System Diseases	ENSG00000112541	FALSE	Preclinical	2011-03-30	Absent	PDE10A
Nervous System Diseases	ENSG00000112715	FALSE	Preclinical	2010-08-26	Unused	VEGFA
Nervous System Diseases	ENSG00000113161	FALSE	Preclinical	2001-05-09	Unused	HMGCR
Nervous System Diseases	ENSG00000113448	FALSE	Preclinical	1990-06-15	Unused	PDE4D
Nervous System Diseases	ENSG00000113580	FALSE	Preclinical	1996-06-15	Unused	NR3C1
Nervous System Diseases	ENSG00000114200	FALSE	Preclinical	1999-04-21	Absent	BCHE
Nervous System Diseases	ENSG00000114378	FALSE	Preclinical	2004-08-27	Unused	HYAL1
Nervous System Diseases	ENSG00000115310	FALSE	Preclinical	2003-05-06	Unused	RTN4
Nervous System Diseases	ENSG00000115353	FALSE	Preclinical	1991-05-15	Unused	TACR1
Nervous System Diseases	ENSG00000115828	FALSE	Preclinical	2012-05-31	Preclinical	QPCT
Nervous System Diseases	ENSG00000116044	FALSE	Preclinical	2013-08-22	Absent	NFE2L2
Nervous System Diseases	ENSG00000116329	FALSE	Preclinical	2010-09-09	Unused	OPRD1
Nervous System Diseases	ENSG00000116478	FALSE	Preclinical	2004-08-23	Unused	HDAC1
Nervous System Diseases	ENSG00000117009	FALSE	Preclinical	1998-07-15	Unused	KMO
Nervous System Diseases	ENSG00000117298	FALSE	Preclinical	1989-07-15	Unused	ECE1
Nervous System Diseases	ENSG00000117480	FALSE	Preclinical	2012-05-24	Absent	FAAH
Nervous System Diseases	ENSG00000118113	FALSE	Preclinical	2001-10-16	Unused	MMP8
Nervous System Diseases	ENSG00000118271	FALSE	Preclinical	2015-08-25	Absent	TTR
Nervous System Diseases	ENSG00000118432	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	CNR1
Nervous System Diseases	ENSG00000118702	FALSE	unknown	2011-11-18	Preclinical	GHRH
Nervous System Diseases	ENSG00000118785	FALSE	Phase I Clinical Trial	2007-03-05	Unused	SPP1
Nervous System Diseases	ENSG00000120907	FALSE	unknown	NA	Unused	ADRA1A
Nervous System Diseases	ENSG00000120948	FALSE	Preclinical	2016-04-18	Unused	TARDBP
Nervous System Diseases	ENSG00000121361	FALSE	Preclinical	1996-07-15	Unused	KCNJ8
Nervous System Diseases	ENSG00000121653	FALSE	Preclinical	2003-08-26	Unused	MAPK8IP1
Nervous System Diseases	ENSG00000121691	FALSE	Preclinical	1995-06-15	Unused	CAT
Nervous System Diseases	ENSG00000121879	FALSE	Preclinical	2014-09-04	Absent	PIK3CA
Nervous System Diseases	ENSG00000121966	FALSE	Preclinical	2010-09-18	Preclinical	CXCR4
Nervous System Diseases	ENSG00000121989	FALSE	Preclinical	1995-07-15	Unused	ACVR2A
Nervous System Diseases	ENSG00000122025	FALSE	Preclinical	2010-01-14	Unused	FLT3
Nervous System Diseases	ENSG00000122585	FALSE	Preclinical	1999-04-13	Unused	NPY
Nervous System Diseases	ENSG00000122756	FALSE	Preclinical	1991-09-15	Unused	CNTFR
Nervous System Diseases	ENSG00000123213	FALSE	Preclinical	2003-09-10	Unused	NLN
Nervous System Diseases	ENSG00000123454	FALSE	Preclinical	NA	Unused	DBH
Nervous System Diseases	ENSG00000125730	FALSE	Preclinical	2016-06-28	Absent	C3
Nervous System Diseases	ENSG00000126218	FALSE	Preclinical	1994-06-15	Unused	F10
Nervous System Diseases	ENSG00000128271	FALSE	Preclinical	2008-07-04	Unused	ADORA2A
Nervous System Diseases	ENSG00000128285	FALSE	Preclinical	2004-03-03	Unused	MCHR1
Nervous System Diseases	ENSG00000128310	FALSE	Preclinical	2004-08-31	Unused	GALR3
Nervous System Diseases	ENSG00000130203	FALSE	Preclinical	1999-01-15	Unused	APOE
Nervous System Diseases	ENSG00000130427	FALSE	Preclinical	2011-06-20	Absent	EPO
Nervous System Diseases	ENSG00000130816	FALSE	Preclinical	2010-08-16	Preclinical	DNMT1
Nervous System Diseases	ENSG00000131203	FALSE	Preclinical	2008-04-16	Unused	IDO1
Nervous System Diseases	ENSG00000132170	FALSE	Preclinical	2007-10-17	Unused	PPARG
Nervous System Diseases	ENSG00000132329	FALSE	Preclinical	1991-06-15	Unused	RAMP1
Nervous System Diseases	ENSG00000132530	FALSE	Preclinical	2002-07-03	Unused	XAF1
Nervous System Diseases	ENSG00000132703	FALSE	Preclinical	1995-06-15	Unused	APCS
Nervous System Diseases	ENSG00000132906	FALSE	Preclinical	1999-04-14	Unused	CASP9
Nervous System Diseases	ENSG00000134243	FALSE	Preclinical	2014-01-03	Absent	SORT1
Nervous System Diseases	ENSG00000134259	FALSE	Preclinical	1995-11-15	Unused	NGF
Nervous System Diseases	ENSG00000134318	FALSE	Preclinical	2003-07-07	Unused	ROCK2
Nervous System Diseases	ENSG00000134363	FALSE	Preclinical	1995-07-15	Unused	FST
Nervous System Diseases	ENSG00000134640	FALSE	Phase III Clinical Trial	1996-03-15	Unused	MTNR1B
Nervous System Diseases	ENSG00000135312	FALSE	Preclinical	NA	Unused	HTR1B
Nervous System Diseases	ENSG00000135919	FALSE	Preclinical	1991-11-15	Unused	SERPINE2
Nervous System Diseases	ENSG00000136160	FALSE	Preclinical	1989-07-15	Unused	EDNRB
Nervous System Diseases	ENSG00000136869	FALSE	Preclinical	2008-08-18	Unused	TLR4
Nervous System Diseases	ENSG00000137252	FALSE	Preclinical	2014-08-21	Absent	HCRTR2
Nervous System Diseases	ENSG00000137462	FALSE	Preclinical	2014-09-10	Absent	TLR2
Nervous System Diseases	ENSG00000137752	FALSE	Preclinical	1998-09-15	Unused	CASP1
Nervous System Diseases	ENSG00000138379	FALSE	Preclinical	2016-08-17	Preclinical	MSTN
Nervous System Diseases	ENSG00000139625	FALSE	Preclinical	2014-11-03	Absent	MAP3K12
Nervous System Diseases	ENSG00000139874	FALSE	Preclinical	2003-02-06	Unused	SSTR1
Nervous System Diseases	ENSG00000140443	FALSE	Preclinical	1999-04-28	Unused	IGF1R
Nervous System Diseases	ENSG00000141736	FALSE	Preclinical	1999-05-11	Unused	ERBB2
Nervous System Diseases	ENSG00000141837	FALSE	Preclinical	1998-07-15	Unused	CACNA1A
Nervous System Diseases	ENSG00000142166	FALSE	Approved	2016-12-27	Absent	IFNAR1
Nervous System Diseases	ENSG00000142192	TRUE	Approved	1991-11-15	Unused	APP
Nervous System Diseases	ENSG00000142319	TRUE	Approved	1993-12-15	Unused	SLC6A3
Nervous System Diseases	ENSG00000143799	FALSE	Preclinical	2001-05-18	Unused	PARP1
Nervous System Diseases	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Nervous System Diseases	ENSG00000144285	FALSE	Preclinical	1993-06-15	Unused	SCN1A
Nervous System Diseases	ENSG00000145335	FALSE	Preclinical	2010-12-21	Unused	SNCA
Nervous System Diseases	ENSG00000145632	FALSE	Preclinical	2010-01-14	Unused	PLK2
Nervous System Diseases	ENSG00000145936	FALSE	Preclinical	1995-08-15	Unused	KCNMB1
Nervous System Diseases	ENSG00000146469	FALSE	Preclinical	1994-04-15	Absent	VIP
Nervous System Diseases	ENSG00000147099	FALSE	Preclinical	2004-08-23	Unused	HDAC8
Nervous System Diseases	ENSG00000147155	FALSE	unknown	NA	Unused	EBP
Nervous System Diseases	ENSG00000147246	FALSE	Preclinical	1995-01-15	Unused	HTR2C
Nervous System Diseases	ENSG00000147955	FALSE	Preclinical	1992-11-15	Unused	SIGMAR1
Nervous System Diseases	ENSG00000148053	FALSE	Preclinical	2006-10-25	Unused	NTRK2
Nervous System Diseases	ENSG00000148408	FALSE	Preclinical	1990-07-15	Unused	CACNA1B
Nervous System Diseases	ENSG00000148680	FALSE	Preclinical	1994-05-15	Unused	HTR7
Nervous System Diseases	ENSG00000149177	FALSE	Preclinical	2002-03-13	Absent	PTPRJ
Nervous System Diseases	ENSG00000149294	FALSE	Preclinical	1994-06-15	Unused	NCAM1
Nervous System Diseases	ENSG00000149295	TRUE	Approved	1995-03-15	Approved	DRD2
Nervous System Diseases	ENSG00000150594	FALSE	Phase I Clinical Trial	1995-10-15	Unused	ADRA2A
Nervous System Diseases	ENSG00000151012	FALSE	Phase I Clinical Trial	2009-11-04	Absent	SLC7A11
Nervous System Diseases	ENSG00000151067	FALSE	Phase III Clinical Trial	1990-12-15	Unused	CACNA1C
Nervous System Diseases	ENSG00000151090	FALSE	unknown	NA	Unused	THRB
Nervous System Diseases	ENSG00000151092	FALSE	Preclinical	NA	Absent	NGLY1
Nervous System Diseases	ENSG00000151577	FALSE	Phase II Clinical Trial	1995-03-15	Phase I Clinical Trial	DRD3
Nervous System Diseases	ENSG00000151617	FALSE	Preclinical	1989-07-15	Unused	EDNRA
Nervous System Diseases	ENSG00000151834	TRUE	Approved	1991-10-15	Approved	GABRA2
Nervous System Diseases	ENSG00000152822	FALSE	Preclinical	2005-10-03	Unused	GRM1
Nervous System Diseases	ENSG00000153253	FALSE	Preclinical	1993-06-15	Unused	SCN3A
Nervous System Diseases	ENSG00000153956	FALSE	Phase I Clinical Trial	2007-08-28	Unused	CACNA2D1
Nervous System Diseases	ENSG00000154229	FALSE	Preclinical	1991-04-15	Unused	PRKCA
Nervous System Diseases	ENSG00000155511	FALSE	Preclinical	1989-06-15	Unused	GRIA1
Nervous System Diseases	ENSG00000156110	FALSE	Preclinical	1997-06-15	Unused	ADK
Nervous System Diseases	ENSG00000156738	FALSE	Preclinical	2005-05-16	Absent	MS4A1
Nervous System Diseases	ENSG00000157219	FALSE	Preclinical	2006-11-24	Unused	HTR5A
Nervous System Diseases	ENSG00000158022	FALSE	Preclinical	2017-01-12	Absent	TRIM63
Nervous System Diseases	ENSG00000158748	FALSE	Preclinical	2006-03-27	Unused	HTR6
Nervous System Diseases	ENSG00000158769	FALSE	Preclinical	2009-09-30	Unused	F11R
Nervous System Diseases	ENSG00000159110	FALSE	Preclinical	2000-09-20	Unused	IFNAR2
Nervous System Diseases	ENSG00000159164	FALSE	Phase I Clinical Trial	2014-05-01	Absent	SV2A
Nervous System Diseases	ENSG00000160013	FALSE	Preclinical	1998-09-15	Unused	PTGIR
Nervous System Diseases	ENSG00000160691	FALSE	Preclinical	2007-07-23	Unused	SHC1
Nervous System Diseases	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Nervous System Diseases	ENSG00000161649	FALSE	Preclinical	2008-07-04	Unused	CD300LG
Nervous System Diseases	ENSG00000162909	FALSE	Preclinical	2016-05-09	Absent	CAPN2
Nervous System Diseases	ENSG00000163283	FALSE	Preclinical	2015-07-08	Absent	ALPP
Nervous System Diseases	ENSG00000163485	FALSE	Preclinical	1990-05-15	Unused	ADORA1
Nervous System Diseases	ENSG00000164082	FALSE	Phase I Clinical Trial	2006-12-13	Phase I Clinical Trial	GRM2
Nervous System Diseases	ENSG00000164251	FALSE	Preclinical	2011-06-02	Absent	F2RL1
Nervous System Diseases	ENSG00000164270	FALSE	Preclinical	1995-10-15	Unused	HTR4
Nervous System Diseases	ENSG00000164305	FALSE	Preclinical	2000-05-10	Unused	CASP3
Nervous System Diseases	ENSG00000164342	FALSE	Preclinical	2008-01-04	Unused	TLR3
Nervous System Diseases	ENSG00000164400	FALSE	Preclinical	2013-09-18	Absent	CSF2
Nervous System Diseases	ENSG00000164733	FALSE	Preclinical	2017-08-24	Absent	CTSB
Nervous System Diseases	ENSG00000164867	FALSE	Preclinical	1996-08-15	Unused	NOS3
Nervous System Diseases	ENSG00000164885	FALSE	Preclinical	2006-02-14	Unused	CDK5
Nervous System Diseases	ENSG00000165168	FALSE	Preclinical	2011-06-01	Unused	CYBB
Nervous System Diseases	ENSG00000165471	FALSE	Preclinical	2000-03-29	Unused	MBL2
Nervous System Diseases	ENSG00000165646	FALSE	Phase III Clinical Trial	2007-10-24	Absent	SLC18A2
Nervous System Diseases	ENSG00000166340	FALSE	Preclinical	2013-10-29	Absent	TPP1
Nervous System Diseases	ENSG00000166736	FALSE	Preclinical	1990-07-15	Unused	HTR3A
Nervous System Diseases	ENSG00000166825	FALSE	Preclinical	2007-05-21	Unused	ANPEP
Nervous System Diseases	ENSG00000168398	FALSE	Preclinical	2003-05-06	Unused	BDKRB2
Nervous System Diseases	ENSG00000168412	FALSE	Phase III Clinical Trial	1996-03-15	Unused	MTNR1A
Nervous System Diseases	ENSG00000168539	FALSE	Preclinical	2008-09-11	Absent	CHRM1
Nervous System Diseases	ENSG00000168621	FALSE	Preclinical	2009-08-03	Absent	GDNF
Nervous System Diseases	ENSG00000168959	FALSE	Preclinical	2002-09-10	Unused	GRM5
Nervous System Diseases	ENSG00000169047	FALSE	Preclinical	2013-12-06	Absent	IRS1
Nervous System Diseases	ENSG00000169313	FALSE	Preclinical	2001-12-04	Unused	P2RY12
Nervous System Diseases	ENSG00000169403	FALSE	Preclinical	1990-01-15	Unused	PTAFR
Nervous System Diseases	ENSG00000169432	FALSE	Phase II Clinical Trial	2007-10-10	Preclinical	SCN9A
Nervous System Diseases	ENSG00000169836	FALSE	Preclinical	1995-02-15	Unused	TACR3
Nervous System Diseases	ENSG00000170017	FALSE	Preclinical	2009-06-10	Unused	ALCAM
Nervous System Diseases	ENSG00000170989	FALSE	Preclinical	2015-07-02	Absent	S1PR1
Nervous System Diseases	ENSG00000171189	FALSE	Preclinical	1999-07-08	Unused	GRIK1
Nervous System Diseases	ENSG00000171385	FALSE	Preclinical	2005-10-04	Unused	KCND3
Nervous System Diseases	ENSG00000171497	FALSE	Preclinical	2015-11-04	Absent	PPID
Nervous System Diseases	ENSG00000171720	FALSE	Preclinical	2004-08-23	Unused	HDAC3
Nervous System Diseases	ENSG00000171791	FALSE	Preclinical	2001-02-28	Unused	BCL2
Nervous System Diseases	ENSG00000172016	FALSE	unknown	NA	Preclinical	REG3A
Nervous System Diseases	ENSG00000172817	FALSE	Preclinical	2001-08-07	Unused	CYP7B1
Nervous System Diseases	ENSG00000173250	FALSE	Preclinical	2015-03-18	Absent	GPR151
Nervous System Diseases	ENSG00000174175	FALSE	Preclinical	2000-06-07	Unused	SELP
Nervous System Diseases	ENSG00000174417	FALSE	unknown	1991-03-15	Unused	TRHR
Nervous System Diseases	ENSG00000175344	FALSE	Preclinical	2005-04-29	Unused	CHRNA7
Nervous System Diseases	ENSG00000175591	FALSE	Preclinical	1997-12-15	Unused	P2RY2
Nervous System Diseases	ENSG00000176884	TRUE	Approved	1990-06-15	Approved	GRIN1
Nervous System Diseases	ENSG00000177272	FALSE	unknown	1990-02-15	Unused	KCNA3
Nervous System Diseases	ENSG00000178394	FALSE	Phase II Clinical Trial	1991-07-15	Unused	HTR1A
Nervous System Diseases	ENSG00000178789	FALSE	Preclinical	2008-07-04	Unused	CD300LB
Nervous System Diseases	ENSG00000179546	FALSE	Preclinical	1992-11-15	Unused	HTR1D
Nervous System Diseases	ENSG00000180210	FALSE	Preclinical	2002-07-23	Unused	F2
Nervous System Diseases	ENSG00000180720	FALSE	Preclinical	2013-04-23	Absent	CHRM4
Nervous System Diseases	ENSG00000180739	FALSE	Preclinical	2015-07-02	Absent	S1PR5
Nervous System Diseases	ENSG00000180772	FALSE	Preclinical	2015-11-12	Absent	AGTR2
Nervous System Diseases	ENSG00000181072	FALSE	Preclinical	1992-12-15	Unused	CHRM2
Nervous System Diseases	ENSG00000181104	FALSE	Preclinical	1991-11-15	Unused	F2R
Nervous System Diseases	ENSG00000181408	FALSE	Preclinical	1999-09-22	Unused	UTS2R
Nervous System Diseases	ENSG00000182326	FALSE	Preclinical	2016-06-27	Absent	C1S
Nervous System Diseases	ENSG00000182687	FALSE	Preclinical	2005-01-05	Unused	GALR2
Nervous System Diseases	ENSG00000183454	FALSE	Preclinical	2015-09-09	Absent	GRIN2A
Nervous System Diseases	ENSG00000183873	FALSE	Preclinical	2005-01-05	Unused	SCN5A
Nervous System Diseases	ENSG00000184156	FALSE	Preclinical	2012-06-28	Preclinical	KCNQ3
Nervous System Diseases	ENSG00000184160	FALSE	Phase I Clinical Trial	2010-08-18	Unused	ADRA2C
Nervous System Diseases	ENSG00000184588	FALSE	Preclinical	1990-06-15	Unused	PDE4B
Nervous System Diseases	ENSG00000184845	FALSE	Preclinical	2004-09-07	Unused	DRD1
Nervous System Diseases	ENSG00000185149	FALSE	Preclinical	2004-11-15	Unused	NPY2R
Nervous System Diseases	ENSG00000185231	FALSE	Preclinical	NA	Unused	MC2R
Nervous System Diseases	ENSG00000185313	FALSE	Preclinical	2005-01-05	Unused	SCN10A
Nervous System Diseases	ENSG00000185345	FALSE	Preclinical	2009-01-30	Preclinical	PRKN
Nervous System Diseases	ENSG00000185803	FALSE	Preclinical	2017-03-02	Absent	SLC52A2
Nervous System Diseases	ENSG00000185950	FALSE	Preclinical	2013-12-06	Absent	IRS2
Nervous System Diseases	ENSG00000186297	TRUE	Approved	1991-10-15	Approved	GABRA5
Nervous System Diseases	ENSG00000186318	FALSE	Preclinical	2005-08-30	Unused	BACE1
Nervous System Diseases	ENSG00000186642	FALSE	Preclinical	2014-03-27	Absent	PDE2A
Nervous System Diseases	ENSG00000186868	FALSE	Phase III Clinical Trial	2009-09-08	Unused	MAPT
Nervous System Diseases	ENSG00000187258	FALSE	Preclinical	2009-08-26	Unused	NPSR1
Nervous System Diseases	ENSG00000187266	FALSE	Preclinical	2007-08-21	Unused	EPOR
Nervous System Diseases	ENSG00000188157	FALSE	Preclinical	1994-09-15	Unused	AGRN
Nervous System Diseases	ENSG00000188404	FALSE	Preclinical	2000-06-07	Unused	SELL
Nervous System Diseases	ENSG00000188906	FALSE	Preclinical	2016-11-10	Absent	LRRK2
Nervous System Diseases	ENSG00000189221	FALSE	Preclinical	2017-09-21	Absent	MAOA
Nervous System Diseases	ENSG00000196262	FALSE	Preclinical	2002-09-10	Unused	PPIA
Nervous System Diseases	ENSG00000196517	FALSE	Preclinical	2015-04-28	Absent	SLC6A9
Nervous System Diseases	ENSG00000196549	FALSE	unknown	2005-11-29	Unused	MME
Nervous System Diseases	ENSG00000196557	FALSE	Preclinical	NA	Absent	CACNA1H
Nervous System Diseases	ENSG00000196591	FALSE	Preclinical	2004-08-23	Unused	HDAC2
Nervous System Diseases	ENSG00000196664	FALSE	Preclinical	2008-08-18	Unused	TLR7
Nervous System Diseases	ENSG00000196689	TRUE	Approved	2001-06-08	Approved	TRPV1
Nervous System Diseases	ENSG00000197442	FALSE	Preclinical	2010-12-23	Unused	MAP3K5
Nervous System Diseases	ENSG00000197635	FALSE	Preclinical	2003-04-30	Unused	DPP4
Nervous System Diseases	ENSG00000198216	FALSE	Preclinical	1997-12-15	Unused	CACNA1E
Nervous System Diseases	ENSG00000198408	FALSE	Preclinical	2011-07-23	Preclinical	OGA
Nervous System Diseases	ENSG00000198668	FALSE	Preclinical	1989-05-15	Unused	CALM1
Nervous System Diseases	ENSG00000198793	FALSE	Preclinical	2015-02-18	Absent	MTOR
Nervous System Diseases	ENSG00000198822	FALSE	Phase I Clinical Trial	2006-12-13	Phase I Clinical Trial	GRM3
Nervous System Diseases	ENSG00000203710	FALSE	Preclinical	1992-11-15	Unused	CR1
Nervous System Diseases	ENSG00000213694	FALSE	Preclinical	2012-05-31	Preclinical	S1PR3
Nervous System Diseases	ENSG00000213903	FALSE	Preclinical	1998-07-15	Unused	LTB4R
Nervous System Diseases	ENSG00000239732	FALSE	Preclinical	2008-08-18	Unused	TLR9
Nervous System Diseases	ENSG00000240184	FALSE	Preclinical	NA	Unused	NA
Nervous System Diseases	ENSG00000240972	FALSE	Preclinical	1999-01-15	Unused	MIF
Nervous System Diseases	ENSG00000249437	FALSE	Preclinical	2002-07-03	Unused	NAIP
Nervous System Diseases	ENSG00000256618	FALSE	Preclinical	2005-05-23	Unused	MTRNR2L1
Nervous System Diseases	ENSG00000258839	FALSE	Preclinical	NA	Unused	MC1R
Nervous System Diseases	ENSG00000259207	FALSE	Preclinical	1991-11-15	Unused	ITGB3
Nervous System Diseases	ENSG00000273079	FALSE	Phase II Clinical Trial	1996-09-15	Unused	GRIN2B
Nervous System Diseases	ENSG00000274286	FALSE	Phase I Clinical Trial	2010-08-18	Unused	ADRA2B
Nervous System Diseases	ENSG00000282608	FALSE	Preclinical	1995-06-15	Unused	ADORA3
Netherton Syndrome	ENSG00000129437	FALSE	Preclinical	2017-12-04	Absent	KLK14
Netherton Syndrome	ENSG00000133710	FALSE	Preclinical	2011-04-02	Unused	SPINK5
Netherton Syndrome	ENSG00000167751	FALSE	Preclinical	2009-06-30	Absent	KLK2
Netherton Syndrome	ENSG00000167754	FALSE	Preclinical	2017-12-04	Absent	KLK5
Netherton Syndrome	ENSG00000169035	FALSE	Preclinical	2003-03-05	Unused	KLK7
Neuralgia	ENSG00000006283	FALSE	Phase I Clinical Trial	2001-10-23	Absent	CACNA1G
Neuralgia	ENSG00000007171	FALSE	Preclinical	2004-08-23	Unused	NOS2
Neuralgia	ENSG00000011677	FALSE	Preclinical	2007-10-31	Absent	GABRA3
Neuralgia	ENSG00000022355	FALSE	Preclinical	2009-10-12	Preclinical	GABRA1
Neuralgia	ENSG00000034152	FALSE	Preclinical	2011-10-06	Absent	MAP2K3
Neuralgia	ENSG00000056291	FALSE	Preclinical	2004-11-10	Unused	NPFFR2
Neuralgia	ENSG00000064989	FALSE	unknown	1990-05-15	Unused	CALCRL
Neuralgia	ENSG00000065989	FALSE	unknown	NA	Unused	PDE4A
Neuralgia	ENSG00000067182	FALSE	unknown	2009-06-09	Absent	TNFRSF1A
Neuralgia	ENSG00000067900	FALSE	Phase II Clinical Trial	2007-03-13	Unused	ROCK1
Neuralgia	ENSG00000069535	FALSE	unknown	1999-08-17	Unused	MAOB
Neuralgia	ENSG00000072062	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	PRKACA
Neuralgia	ENSG00000073756	FALSE	Phase II Clinical Trial	2000-06-16	Phase I Clinical Trial	PTGS2
Neuralgia	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Neuralgia	ENSG00000075043	FALSE	Preclinical	2005-11-01	Phase II Clinical Trial	KCNQ2
Neuralgia	ENSG00000078549	FALSE	Preclinical	2008-08-21	Unused	ADCYAP1R1
Neuralgia	ENSG00000080644	FALSE	unknown	2007-07-30	Unused	CHRNA3
Neuralgia	ENSG00000082556	TRUE	Approved	2001-08-09	Approved	OPRK1
Neuralgia	ENSG00000086205	FALSE	Phase I Clinical Trial	1997-03-15	Unused	FOLH1
Neuralgia	ENSG00000087085	FALSE	unknown	2005-12-14	Unused	ACHE
Neuralgia	ENSG00000087245	FALSE	Phase I Clinical Trial	2015-04-21	Absent	MMP2
Neuralgia	ENSG00000089041	FALSE	Preclinical	2007-02-12	Unused	P2RX7
Neuralgia	ENSG00000089250	FALSE	Preclinical	2006-05-22	Phase II Clinical Trial	NOS1
Neuralgia	ENSG00000092964	FALSE	unknown	2000-01-11	Phase III Clinical Trial	DPYSL2
Neuralgia	ENSG00000095303	FALSE	unknown	2000-06-16	Unused	PTGS1
Neuralgia	ENSG00000100300	FALSE	Preclinical	2013-02-26	Absent	TSPO
Neuralgia	ENSG00000100504	FALSE	unknown	2004-04-28	Preclinical	PYGL
Neuralgia	ENSG00000100739	FALSE	Preclinical	2001-10-15	Unused	BDKRB1
Neuralgia	ENSG00000100985	FALSE	Phase I Clinical Trial	2015-04-21	Absent	MMP9
Neuralgia	ENSG00000101180	FALSE	unknown	2010-06-15	Phase II Clinical Trial	HRH3
Neuralgia	ENSG00000101204	FALSE	Phase I Clinical Trial	1998-03-15	Unused	CHRNA4
Neuralgia	ENSG00000102468	FALSE	Preclinical	2007-06-21	Unused	HTR2A
Neuralgia	ENSG00000102967	FALSE	Phase II Clinical Trial	NA	Absent	DHODH
Neuralgia	ENSG00000103546	TRUE	Approved	2000-01-19	Approved	SLC6A2
Neuralgia	ENSG00000104267	FALSE	unknown	2006-08-11	Phase I Clinical Trial	CA2
Neuralgia	ENSG00000104321	FALSE	Phase II Clinical Trial	2008-10-29	Phase II Clinical Trial	TRPA1
Neuralgia	ENSG00000104365	FALSE	Preclinical	2003-11-13	Unused	IKBKB
Neuralgia	ENSG00000105639	FALSE	Preclinical	2011-10-06	Absent	JAK3
Neuralgia	ENSG00000105650	FALSE	unknown	NA	Unused	PDE4C
Neuralgia	ENSG00000108576	TRUE	Approved	1996-08-15	Approved	SLC6A4
Neuralgia	ENSG00000109320	FALSE	unknown	2007-11-07	Unused	NFKB1
Neuralgia	ENSG00000109991	FALSE	Preclinical	2013-03-20	Absent	P2RX3
Neuralgia	ENSG00000110324	FALSE	Preclinical	2003-12-12	Unused	IL10RA
Neuralgia	ENSG00000110429	FALSE	Preclinical	2017-09-27	Absent	FBXO3
Neuralgia	ENSG00000110881	FALSE	Preclinical	2011-03-15	Preclinical	ASIC1
Neuralgia	ENSG00000110887	FALSE	Preclinical	2007-08-22	Unused	DAO
Neuralgia	ENSG00000112038	TRUE	Approved	2001-08-09	Approved	OPRM1
Neuralgia	ENSG00000112062	FALSE	unknown	2001-09-11	Phase II Clinical Trial	MAPK14
Neuralgia	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Neuralgia	ENSG00000112115	FALSE	Preclinical	2001-07-24	Absent	IL17A
Neuralgia	ENSG00000112541	FALSE	unknown	NA	Unused	PDE10A
Neuralgia	ENSG00000113070	FALSE	unknown	NA	Absent	HBEGF
Neuralgia	ENSG00000113161	FALSE	Preclinical	2010-06-02	Preclinical	HMGCR
Neuralgia	ENSG00000113448	FALSE	unknown	NA	Unused	PDE4D
Neuralgia	ENSG00000113580	FALSE	unknown	2012-04-20	Preclinical	NR3C1
Neuralgia	ENSG00000113889	FALSE	Preclinical	2015-04-13	Absent	KNG1
Neuralgia	ENSG00000115353	FALSE	Preclinical	1990-05-15	Unused	TACR1
Neuralgia	ENSG00000115977	FALSE	Phase I Clinical Trial	2015-04-20	Absent	AAK1
Neuralgia	ENSG00000116096	FALSE	Preclinical	2014-01-11	Absent	SPR
Neuralgia	ENSG00000116329	TRUE	Approved	1996-03-15	Approved	OPRD1
Neuralgia	ENSG00000117480	FALSE	Phase II Clinical Trial	2009-01-16	Phase I Clinical Trial	FAAH
Neuralgia	ENSG00000117594	FALSE	Phase II Clinical Trial	2013-05-14	Absent	HSD11B1
Neuralgia	ENSG00000117971	FALSE	unknown	2007-07-30	Unused	CHRNB4
Neuralgia	ENSG00000118432	TRUE	Approved	1998-08-15	Approved	CNR1
Neuralgia	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Neuralgia	ENSG00000119535	FALSE	Phase II Clinical Trial	2010-05-26	Absent	CSF3R
Neuralgia	ENSG00000120915	FALSE	Preclinical	2016-01-22	Absent	EPHX2
Neuralgia	ENSG00000121764	FALSE	unknown	2008-12-15	Phase II Clinical Trial	HCRTR1
Neuralgia	ENSG00000121807	FALSE	Preclinical	2004-11-01	Unused	CCR2
Neuralgia	ENSG00000124140	FALSE	Preclinical	2009-01-19	Unused	SLC12A5
Neuralgia	ENSG00000124493	FALSE	Preclinical	NA	Absent	GRM4
Neuralgia	ENSG00000125510	FALSE	Phase II Clinical Trial	2001-12-17	Phase II Clinical Trial	OPRL1
Neuralgia	ENSG00000125538	FALSE	unknown	2009-06-09	Absent	IL1B
Neuralgia	ENSG00000125571	FALSE	Preclinical	2001-07-24	Absent	IL37
Neuralgia	ENSG00000126583	FALSE	Preclinical	2008-08-27	Unused	PRKCG
Neuralgia	ENSG00000128271	FALSE	unknown	2003-05-23	Unused	ADORA2A
Neuralgia	ENSG00000128655	FALSE	unknown	NA	Unused	PDE11A
Neuralgia	ENSG00000128683	FALSE	Preclinical	2007-06-04	Preclinical	GAD1
Neuralgia	ENSG00000131979	FALSE	Preclinical	2006-11-22	Unused	GCH1
Neuralgia	ENSG00000132155	FALSE	unknown	2008-02-21	Unused	RAF1
Neuralgia	ENSG00000132170	FALSE	unknown	1999-11-18	Unused	PPARG
Neuralgia	ENSG00000132329	FALSE	unknown	1990-05-15	Unused	RAMP1
Neuralgia	ENSG00000133019	FALSE	Preclinical	2007-02-13	Preclinical	CHRM3
Neuralgia	ENSG00000134259	FALSE	Phase II Clinical Trial	2003-03-26	Phase I Clinical Trial	NGF
Neuralgia	ENSG00000134640	FALSE	unknown	NA	Absent	MTNR1B
Neuralgia	ENSG00000135047	FALSE	Preclinical	2009-01-20	Preclinical	CTSL
Neuralgia	ENSG00000135124	FALSE	Phase I Clinical Trial	2014-11-27	Absent	P2RX4
Neuralgia	ENSG00000136634	FALSE	Preclinical	2002-10-02	Unused	IL10
Neuralgia	ENSG00000136689	FALSE	Preclinical	2005-06-10	Unused	IL1RN
Neuralgia	ENSG00000136869	FALSE	Preclinical	2013-01-02	Preclinical	TLR4
Neuralgia	ENSG00000137252	FALSE	unknown	2008-12-15	Phase II Clinical Trial	HCRTR2
Neuralgia	ENSG00000138735	FALSE	unknown	2007-01-08	Unused	PDE5A
Neuralgia	ENSG00000140009	FALSE	Preclinical	2008-07-04	Preclinical	ESR2
Neuralgia	ENSG00000140538	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	NTRK3
Neuralgia	ENSG00000142166	FALSE	Phase I Clinical Trial	NA	Unused	IFNAR1
Neuralgia	ENSG00000142319	FALSE	unknown	2002-03-28	Phase I Clinical Trial	SLC6A3
Neuralgia	ENSG00000143387	FALSE	Preclinical	2009-01-20	Unused	CTSK
Neuralgia	ENSG00000144285	TRUE	Approved	1995-12-15	Approved	SCN1A
Neuralgia	ENSG00000144481	FALSE	Preclinical	2009-10-29	Preclinical	TRPM8
Neuralgia	ENSG00000145864	FALSE	Preclinical	2013-02-26	Preclinical	GABRB2
Neuralgia	ENSG00000146013	FALSE	Phase I Clinical Trial	2000-06-16	Phase I Clinical Trial	GFRA3
Neuralgia	ENSG00000147955	FALSE	Phase II Clinical Trial	1996-08-15	Phase III Clinical Trial	SIGMAR1
Neuralgia	ENSG00000148053	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	NTRK2
Neuralgia	ENSG00000148408	TRUE	Approved	1992-05-15	Approved	CACNA1B
Neuralgia	ENSG00000150594	FALSE	Phase II Clinical Trial	1999-07-08	Phase II Clinical Trial	ADRA2A
Neuralgia	ENSG00000151834	FALSE	Preclinical	2007-10-31	Absent	GABRA2
Neuralgia	ENSG00000152822	FALSE	Phase I Clinical Trial	2004-10-13	Unused	GRM1
Neuralgia	ENSG00000153253	TRUE	Approved	1995-12-15	Approved	SCN3A
Neuralgia	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Neuralgia	ENSG00000154229	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	PRKCA
Neuralgia	ENSG00000155511	FALSE	unknown	1993-09-15	Unused	GRIA1
Neuralgia	ENSG00000156113	FALSE	Preclinical	2010-03-15	Absent	KCNMA1
Neuralgia	ENSG00000159164	FALSE	unknown	2002-05-20	Unused	SV2A
Neuralgia	ENSG00000160716	FALSE	Phase I Clinical Trial	1998-03-15	Unused	CHRNB2
Neuralgia	ENSG00000160791	FALSE	Preclinical	2009-08-07	Preclinical	CCR5
Neuralgia	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Neuralgia	ENSG00000163131	FALSE	Preclinical	2003-05-22	Unused	CTSS
Neuralgia	ENSG00000163485	FALSE	Preclinical	2002-04-04	Unused	ADORA1
Neuralgia	ENSG00000164270	FALSE	Preclinical	2007-06-21	Unused	HTR4
Neuralgia	ENSG00000164733	FALSE	Preclinical	2009-01-20	Preclinical	CTSB
Neuralgia	ENSG00000165970	FALSE	Preclinical	1997-10-15	Unused	SLC6A5
Neuralgia	ENSG00000166206	FALSE	Preclinical	2013-02-26	Preclinical	GABRB3
Neuralgia	ENSG00000166573	FALSE	Preclinical	2004-07-26	Unused	GALR1
Neuralgia	ENSG00000166825	FALSE	Phase II Clinical Trial	2008-10-06	Phase I Clinical Trial	ANPEP
Neuralgia	ENSG00000167723	FALSE	Preclinical	2008-06-02	Phase II Clinical Trial	TRPV3
Neuralgia	ENSG00000168398	FALSE	Preclinical	2001-10-15	Unused	BDKRB2
Neuralgia	ENSG00000168412	FALSE	unknown	NA	Absent	MTNR1A
Neuralgia	ENSG00000168539	FALSE	Phase II Clinical Trial	2009-07-31	Unused	CHRM1
Neuralgia	ENSG00000168918	FALSE	Phase III Clinical Trial	2009-10-12	Absent	INPP5D
Neuralgia	ENSG00000168959	FALSE	Preclinical	2004-09-03	Unused	GRM5
Neuralgia	ENSG00000169432	FALSE	Pre-registration	2001-03-06	Phase III Clinical Trial	SCN9A
Neuralgia	ENSG00000171132	FALSE	unknown	2005-05-31	Unused	PRKCE
Neuralgia	ENSG00000171189	FALSE	unknown	2006-12-13	Unused	GRIK1
Neuralgia	ENSG00000173250	FALSE	Preclinical	2003-05-23	Absent	GPR151
Neuralgia	ENSG00000174080	FALSE	Preclinical	2009-01-20	Preclinical	CTSF
Neuralgia	ENSG00000176884	FALSE	Phase II Clinical Trial	1994-07-15	Phase III Clinical Trial	GRIN1
Neuralgia	ENSG00000177606	FALSE	unknown	2007-11-07	Unused	JUN
Neuralgia	ENSG00000178394	FALSE	Phase II Clinical Trial	1996-08-15	Phase II Clinical Trial	HTR1A
Neuralgia	ENSG00000180772	FALSE	Phase II Clinical Trial	2008-09-09	Phase II Clinical Trial	AGTR2
Neuralgia	ENSG00000183023	FALSE	unknown	2002-05-20	Unused	SLC8A1
Neuralgia	ENSG00000183873	FALSE	Preclinical	2005-01-05	Unused	SCN5A
Neuralgia	ENSG00000184156	FALSE	Preclinical	2005-11-01	Phase II Clinical Trial	KCNQ3
Neuralgia	ENSG00000184160	FALSE	Phase II Clinical Trial	1999-07-08	Phase II Clinical Trial	ADRA2C
Neuralgia	ENSG00000184574	FALSE	Preclinical	2004-05-20	Unused	LPAR5
Neuralgia	ENSG00000184588	FALSE	unknown	NA	Unused	PDE4B
Neuralgia	ENSG00000185313	FALSE	Phase II Clinical Trial	2004-02-12	Unused	SCN10A
Neuralgia	ENSG00000185532	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	PRKG1
Neuralgia	ENSG00000185760	FALSE	unknown	2005-11-01	Absent	KCNQ5
Neuralgia	ENSG00000188822	FALSE	Phase II Clinical Trial	2004-02-17	Phase II Clinical Trial	CNR2
Neuralgia	ENSG00000189221	FALSE	unknown	1999-08-17	Unused	MAOA
Neuralgia	ENSG00000189403	FALSE	Phase II Clinical Trial	2006-09-06	Phase II Clinical Trial	HMGB1
Neuralgia	ENSG00000196277	FALSE	Preclinical	NA	Absent	GRM7
Neuralgia	ENSG00000196517	FALSE	Preclinical	2016-09-07	Absent	SLC6A9
Neuralgia	ENSG00000196549	FALSE	Phase II Clinical Trial	2008-10-06	Phase I Clinical Trial	MME
Neuralgia	ENSG00000196557	FALSE	Phase III Clinical Trial	2010-11-11	Absent	CACNA1H
Neuralgia	ENSG00000196689	TRUE	Approved	1996-12-15	Approved	TRPV1
Neuralgia	ENSG00000197405	FALSE	Preclinical	2014-12-31	Absent	C5AR1
Neuralgia	ENSG00000197442	FALSE	Preclinical	2011-12-02	Absent	MAP3K5
Neuralgia	ENSG00000198400	FALSE	Phase II Clinical Trial	2003-01-23	Phase II Clinical Trial	NTRK1
Neuralgia	ENSG00000198763	FALSE	Preclinical	2012-09-14	Absent	MT-ND2
Neuralgia	ENSG00000205268	FALSE	unknown	2007-08-07	Unused	PDE7A
Neuralgia	ENSG00000240972	FALSE	Preclinical	2009-02-13	Unused	MIF
Neuralgia	ENSG00000273079	FALSE	Preclinical	2002-08-21	Phase I Clinical Trial	GRIN2B
Neuralgia	ENSG00000274286	FALSE	Phase II Clinical Trial	1999-07-08	Phase II Clinical Trial	ADRA2B
Neuralgia	ENSG00000282608	FALSE	Preclinical	2001-07-24	Absent	ADORA3
Neuralgia, Postherpetic	ENSG00000007171	FALSE	unknown	2004-08-23	Unused	NOS2
Neuralgia, Postherpetic	ENSG00000073756	FALSE	unknown	2001-02-28	Unused	PTGS2
Neuralgia, Postherpetic	ENSG00000075043	TRUE	Approved	1992-08-15	Phase II Clinical Trial	KCNQ2
Neuralgia, Postherpetic	ENSG00000082556	FALSE	Pre-registration	2000-11-01	Phase III Clinical Trial	OPRK1
Neuralgia, Postherpetic	ENSG00000089250	FALSE	unknown	2009-05-27	Phase II Clinical Trial	NOS1
Neuralgia, Postherpetic	ENSG00000100504	FALSE	unknown	2004-04-28	Preclinical	PYGL
Neuralgia, Postherpetic	ENSG00000100739	FALSE	unknown	2006-01-23	Unused	BDKRB1
Neuralgia, Postherpetic	ENSG00000101204	FALSE	Phase II Clinical Trial	2000-12-12	Phase II Clinical Trial	CHRNA4
Neuralgia, Postherpetic	ENSG00000101327	FALSE	unknown	2000-11-01	Unused	PDYN
Neuralgia, Postherpetic	ENSG00000103546	FALSE	Phase II Clinical Trial	2000-01-19	Phase II Clinical Trial	SLC6A2
Neuralgia, Postherpetic	ENSG00000108576	FALSE	Phase II Clinical Trial	2000-01-19	Phase II Clinical Trial	SLC6A4
Neuralgia, Postherpetic	ENSG00000112038	FALSE	Pre-registration	2003-02-06	Phase III Clinical Trial	OPRM1
Neuralgia, Postherpetic	ENSG00000112062	FALSE	Phase II Clinical Trial	2006-12-21	Unused	MAPK14
Neuralgia, Postherpetic	ENSG00000115353	FALSE	unknown	1995-07-15	Unused	TACR1
Neuralgia, Postherpetic	ENSG00000116329	FALSE	Phase III Clinical Trial	2003-02-18	Phase III Clinical Trial	OPRD1
Neuralgia, Postherpetic	ENSG00000117480	FALSE	unknown	2009-01-16	Absent	FAAH
Neuralgia, Postherpetic	ENSG00000132170	FALSE	Phase II Clinical Trial	1999-11-18	Unused	PPARG
Neuralgia, Postherpetic	ENSG00000134259	FALSE	Phase II Clinical Trial	2003-03-26	Phase II Clinical Trial	NGF
Neuralgia, Postherpetic	ENSG00000138735	FALSE	unknown	2006-12-21	Unused	PDE5A
Neuralgia, Postherpetic	ENSG00000144285	FALSE	Phase III Clinical Trial	2002-02-25	Phase III Clinical Trial	SCN1A
Neuralgia, Postherpetic	ENSG00000145864	FALSE	Preclinical	2013-02-26	Preclinical	GABRB2
Neuralgia, Postherpetic	ENSG00000146013	FALSE	unknown	2000-06-16	Preclinical	GFRA3
Neuralgia, Postherpetic	ENSG00000148408	FALSE	Phase II Clinical Trial	2000-10-31	Phase II Clinical Trial	CACNA1B
Neuralgia, Postherpetic	ENSG00000150594	FALSE	unknown	2011-08-11	Absent	ADRA2A
Neuralgia, Postherpetic	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Neuralgia, Postherpetic	ENSG00000155511	FALSE	Phase III Clinical Trial	2000-03-29	Phase III Clinical Trial	GRIA1
Neuralgia, Postherpetic	ENSG00000159164	FALSE	Phase II Clinical Trial	2002-05-20	Unused	SV2A
Neuralgia, Postherpetic	ENSG00000160716	FALSE	Phase II Clinical Trial	2000-12-12	Phase II Clinical Trial	CHRNB2
Neuralgia, Postherpetic	ENSG00000160868	FALSE	Phase III Clinical Trial	2006-06-12	Absent	CYP3A4
Neuralgia, Postherpetic	ENSG00000166206	FALSE	Preclinical	2013-02-26	Preclinical	GABRB3
Neuralgia, Postherpetic	ENSG00000167723	FALSE	Phase II Clinical Trial	2008-10-28	Phase II Clinical Trial	TRPV3
Neuralgia, Postherpetic	ENSG00000169432	TRUE	Approved	2003-05-02	Approved	SCN9A
Neuralgia, Postherpetic	ENSG00000171132	FALSE	unknown	2005-05-31	Unused	PRKCE
Neuralgia, Postherpetic	ENSG00000176884	FALSE	Phase II Clinical Trial	2000-01-19	Phase II Clinical Trial	GRIN1
Neuralgia, Postherpetic	ENSG00000180772	FALSE	Phase II Clinical Trial	2008-09-09	Phase II Clinical Trial	AGTR2
Neuralgia, Postherpetic	ENSG00000183023	FALSE	Phase II Clinical Trial	2002-05-20	Unused	SLC8A1
Neuralgia, Postherpetic	ENSG00000184156	TRUE	Approved	1992-08-15	Phase II Clinical Trial	KCNQ3
Neuralgia, Postherpetic	ENSG00000184160	FALSE	unknown	2011-08-11	Absent	ADRA2C
Neuralgia, Postherpetic	ENSG00000188822	FALSE	Phase II Clinical Trial	2004-02-17	Phase II Clinical Trial	CNR2
Neuralgia, Postherpetic	ENSG00000196689	TRUE	Approved	1992-06-15	Approved	TRPV1
Neuralgia, Postherpetic	ENSG00000274286	FALSE	unknown	2011-08-11	Unused	ADRA2B
Neurilemmoma	ENSG00000116478	FALSE	Preclinical	2007-03-13	Absent	HDAC1
Neurilemmoma	ENSG00000142208	FALSE	Preclinical	2007-03-13	Absent	AKT1
Neurilemmoma	ENSG00000196591	FALSE	Preclinical	2007-03-13	Absent	HDAC2
Neuroblastoma	ENSG00000047936	FALSE	Phase II Clinical Trial	2009-02-24	Absent	ROS1
Neuroblastoma	ENSG00000087586	FALSE	unknown	2004-05-20	Phase II Clinical Trial	AURKA
Neuroblastoma	ENSG00000096968	FALSE	unknown	1999-03-17	Phase I Clinical Trial	JAK2
Neuroblastoma	ENSG00000103855	FALSE	Phase III Clinical Trial	2010-11-22	Absent	CD276
Neuroblastoma	ENSG00000105173	FALSE	Preclinical	2010-12-05	Absent	CCNE1
Neuroblastoma	ENSG00000105810	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK6
Neuroblastoma	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CG
Neuroblastoma	ENSG00000105976	FALSE	unknown	2010-05-17	Absent	MET
Neuroblastoma	ENSG00000109471	FALSE	Phase I Clinical Trial	1992-12-15	Unused	IL2
Neuroblastoma	ENSG00000115758	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ODC1
Neuroblastoma	ENSG00000116478	FALSE	Preclinical	2017-01-13	Absent	HDAC1
Neuroblastoma	ENSG00000119630	FALSE	Phase II Clinical Trial	2003-07-24	Absent	PGF
Neuroblastoma	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Absent	PIK3CA
Neuroblastoma	ENSG00000122025	FALSE	unknown	1999-03-17	Unused	FLT3
Neuroblastoma	ENSG00000123374	FALSE	Preclinical	2010-12-05	Absent	CDK2
Neuroblastoma	ENSG00000128602	FALSE	Phase II Clinical Trial	2008-11-24	Phase II Clinical Trial	SMO
Neuroblastoma	ENSG00000131747	TRUE	Approved	2007-03-05	Unused	TOP2A
Neuroblastoma	ENSG00000131759	FALSE	unknown	NA	Unused	RARA
Neuroblastoma	ENSG00000134058	FALSE	Preclinical	2010-12-05	Absent	CDK7
Neuroblastoma	ENSG00000134323	FALSE	Preclinical	1998-06-15	Unused	MYCN
Neuroblastoma	ENSG00000134460	FALSE	unknown	1998-06-15	Phase II Clinical Trial	IL2RA
Neuroblastoma	ENSG00000135446	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK4
Neuroblastoma	ENSG00000136807	FALSE	Preclinical	2010-12-05	Absent	CDK9
Neuroblastoma	ENSG00000136997	FALSE	Preclinical	NA	Absent	MYC
Neuroblastoma	ENSG00000140538	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK3
Neuroblastoma	ENSG00000141736	FALSE	Phase I Clinical Trial	2006-06-05	Absent	ERBB2
Neuroblastoma	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Neuroblastoma	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Absent	AKT1
Neuroblastoma	ENSG00000142627	FALSE	unknown	2010-05-17	Absent	EPHA2
Neuroblastoma	ENSG00000143384	FALSE	Preclinical	2010-12-05	Absent	MCL1
Neuroblastoma	ENSG00000143549	FALSE	Preclinical	2013-10-15	Absent	TPM3
Neuroblastoma	ENSG00000146648	FALSE	Phase I Clinical Trial	2006-06-05	Preclinical	EGFR
Neuroblastoma	ENSG00000148053	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK2
Neuroblastoma	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Preclinical	CHEK1
Neuroblastoma	ENSG00000154229	FALSE	Preclinical	2003-02-26	Preclinical	PRKCA
Neuroblastoma	ENSG00000165197	FALSE	Preclinical	2012-09-12	Preclinical	VEGFD
Neuroblastoma	ENSG00000166503	FALSE	Preclinical	2011-04-28	Preclinical	HDGFL3
Neuroblastoma	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Neuroblastoma	ENSG00000169136	FALSE	Preclinical	2016-07-14	Absent	ATF5
Neuroblastoma	ENSG00000169398	FALSE	Preclinical	2011-01-18	Unused	PTK2
Neuroblastoma	ENSG00000171094	FALSE	Phase II Clinical Trial	2009-02-24	Unused	ALK
Neuroblastoma	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CD
Neuroblastoma	ENSG00000171855	FALSE	Preclinical	2007-06-08	Preclinical	IFNB1
Neuroblastoma	ENSG00000171862	FALSE	unknown	1999-02-15	Phase II Clinical Trial	PTEN
Neuroblastoma	ENSG00000174807	FALSE	Preclinical	2017-03-14	Absent	CD248
Neuroblastoma	ENSG00000175305	FALSE	Preclinical	2010-12-05	Absent	CCNE2
Neuroblastoma	ENSG00000177455	FALSE	Preclinical	2016-11-01	Absent	CD19
Neuroblastoma	ENSG00000178999	FALSE	unknown	2004-05-20	Phase I Clinical Trial	AURKB
Neuroblastoma	ENSG00000185686	FALSE	Preclinical	NA	Absent	PRAME
Neuroblastoma	ENSG00000196591	FALSE	Preclinical	2017-01-13	Absent	HDAC2
Neuroblastoma	ENSG00000198400	FALSE	Phase II Clinical Trial	1998-06-15	Unused	NTRK1
Neuroblastoma	ENSG00000198793	FALSE	Phase I Clinical Trial	1999-02-15	Phase II Clinical Trial	MTOR
Neuroblastoma	ENSG00000198851	FALSE	Preclinical	2014-01-10	Absent	CD3E
Neuroblastoma	ENSG00000198900	FALSE	Phase I Clinical Trial	2005-01-28	Absent	TOP1
Neuroblastoma	ENSG00000198910	FALSE	Phase I Clinical Trial	2014-12-30	Absent	L1CAM
Neuroblastoma	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PRKDC
Neuroblastoma	ENSG00000263761	FALSE	Phase III Clinical Trial	2017-02-10	Absent	GDF2
Neuroblastoma	ENSG00000267534	FALSE	Preclinical	2015-07-21	Absent	S1PR2
Neurodegenerative Diseases	ENSG00000101126	FALSE	unknown	2003-06-17	Absent	ADNP
Neurodegenerative Diseases	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Neurodegenerative Diseases	ENSG00000143799	FALSE	unknown	2003-06-17	Absent	PARP1
Neurodegenerative Diseases	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Neurodegenerative Diseases	ENSG00000176884	FALSE	Phase II Clinical Trial	2008-01-16	Absent	GRIN1
Neurodegenerative Diseases	ENSG00000186868	FALSE	unknown	2014-04-09	Absent	MAPT
Neuroectodermal Tumors, Primitive	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT4
Neuroectodermal Tumors, Primitive	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Neuroectodermal Tumors, Primitive	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR3
Neuroectodermal Tumors, Primitive	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR1
Neuroectodermal Tumors, Primitive	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Neuroectodermal Tumors, Primitive	ENSG00000102755	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT1
Neuroectodermal Tumors, Primitive	ENSG00000128052	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KDR
Neuroectodermal Tumors, Primitive	ENSG00000140443	FALSE	unknown	2003-09-24	Phase II Clinical Trial	IGF1R
Neuroectodermal Tumors, Primitive	ENSG00000141736	FALSE	Phase I Clinical Trial	2006-06-05	Absent	ERBB2
Neuroectodermal Tumors, Primitive	ENSG00000146648	FALSE	Phase I Clinical Trial	2004-07-12	Phase I Clinical Trial	EGFR
Neuroectodermal Tumors, Primitive	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KIT
Neuroectodermal Tumors, Primitive	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Neuroectodermal Tumors, Primitive	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Neuroectodermal Tumors, Primitive	ENSG00000165731	FALSE	Phase II Clinical Trial	2003-07-22	Absent	RET
Neuroectodermal Tumors, Primitive	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Neuroectodermal Tumors, Primitive	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Unused	TOP1
Neuroectodermal Tumors, Primitive	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Neurofibromatoses	ENSG00000080824	FALSE	Preclinical	2008-01-14	Unused	HSP90AA1
Neurofibromatoses	ENSG00000106991	FALSE	Preclinical	2006-05-01	Absent	ENG
Neurofibromatoses	ENSG00000112715	FALSE	Phase II Clinical Trial	2003-11-26	Phase II Clinical Trial	VEGFA
Neurofibromatoses	ENSG00000126602	FALSE	Preclinical	2013-09-14	Absent	TRAP1
Neurofibromatoses	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Absent	MAP2K2
Neurofibromatoses	ENSG00000157404	FALSE	unknown	2013-12-07	Absent	KIT
Neurofibromatoses	ENSG00000162551	FALSE	Preclinical	2008-10-10	Absent	ALPL
Neurofibromatoses	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Absent	MAP2K1
Neurofibromatoses	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Neurofibromatosis 1	ENSG00000126934	FALSE	Phase II Clinical Trial	2005-11-28	Absent	MAP2K2
Neurofibromatosis 1	ENSG00000169032	FALSE	Phase II Clinical Trial	2005-11-28	Absent	MAP2K1
Neurofibromatosis 2	ENSG00000109320	FALSE	Phase I Clinical Trial	NA	Absent	NFKB1
Neuroma	ENSG00000196689	FALSE	Phase II Clinical Trial	2002-08-30	Unused	TRPV1
Neuronal Ceroid-Lipofuscinoses	ENSG00000082701	FALSE	unknown	2007-07-23	Absent	GSK3B
Neuronal Ceroid-Lipofuscinoses	ENSG00000136750	FALSE	Preclinical	NA	Unused	GAD2
Neuronal Ceroid-Lipofuscinoses	ENSG00000166340	TRUE	Approved	2011-12-08	Preclinical	TPP1
Neurotic Disorders	ENSG00000011677	FALSE	unknown	NA	Unused	GABRA3
Neurotic Disorders	ENSG00000022355	FALSE	unknown	NA	Unused	GABRA1
Neurotic Disorders	ENSG00000102468	FALSE	Preclinical	1995-08-15	Unused	HTR2A
Neurotic Disorders	ENSG00000108576	FALSE	Preclinical	1989-10-15	Unused	SLC6A4
Neurotic Disorders	ENSG00000142319	FALSE	unknown	NA	Unused	SLC6A3
Neurotic Disorders	ENSG00000147246	FALSE	Preclinical	1995-08-15	Unused	HTR2C
Neurotic Disorders	ENSG00000151834	FALSE	unknown	NA	Unused	GABRA2
Neurotic Disorders	ENSG00000164270	FALSE	unknown	1995-03-15	Unused	HTR4
Neurotic Disorders	ENSG00000178394	FALSE	Preclinical	1991-11-15	Unused	HTR1A
Neurotic Disorders	ENSG00000179546	FALSE	Preclinical	1995-06-15	Unused	HTR1D
Neurotic Disorders	ENSG00000186297	FALSE	unknown	NA	Unused	GABRA5
Neurotic Disorders	ENSG00000189221	FALSE	unknown	NA	Unused	MAOA
Neutropenia	ENSG00000065989	FALSE	Preclinical	2013-07-16	Absent	PDE4A
Neutropenia	ENSG00000078098	FALSE	unknown	2001-06-11	Unused	FAP
Neutropenia	ENSG00000084207	FALSE	unknown	1994-06-15	Phase II Clinical Trial	GSTP1
Neutropenia	ENSG00000106178	FALSE	Phase II Clinical Trial	1997-07-15	Unused	CCL24
Neutropenia	ENSG00000108342	TRUE	Approved	2009-03-17	Unused	CSF3
Neutropenia	ENSG00000112115	FALSE	Phase I Clinical Trial	2001-07-24	Absent	IL17A
Neutropenia	ENSG00000112164	FALSE	Preclinical	1990-03-15	Unused	GLP1R
Neutropenia	ENSG00000115594	FALSE	Phase II Clinical Trial	NA	Absent	IL1R1
Neutropenia	ENSG00000119535	TRUE	Approved	1990-03-15	Approved	CSF3R
Neutropenia	ENSG00000121966	FALSE	unknown	2009-03-27	Phase II Clinical Trial	CXCR4
Neutropenia	ENSG00000125571	FALSE	Phase I Clinical Trial	2001-07-24	Absent	IL37
Neutropenia	ENSG00000130368	FALSE	Preclinical	2010-09-20	Preclinical	MAS1
Neutropenia	ENSG00000131759	FALSE	Phase II Clinical Trial	2005-08-08	Unused	RARA
Neutropenia	ENSG00000143171	FALSE	Preclinical	2011-11-11	Preclinical	RXRG
Neutropenia	ENSG00000160712	FALSE	Preclinical	1990-03-15	Unused	IL6R
Neutropenia	ENSG00000167751	FALSE	Preclinical	NA	Absent	KLK2
Neutropenia	ENSG00000168918	FALSE	Preclinical	2007-10-29	Unused	INPP5D
Neutropenia	ENSG00000185291	FALSE	unknown	1990-03-15	Unused	IL3RA
Neutropenia	ENSG00000186350	FALSE	Preclinical	2011-11-11	Preclinical	RXRA
Neutropenia	ENSG00000197045	FALSE	Preclinical	1992-04-15	Unused	GMFB
Neutropenia	ENSG00000198223	TRUE	Approved	1990-03-15	Approved	CSF2RA
Neutropenia	ENSG00000274736	FALSE	Phase II Clinical Trial	1997-07-15	Unused	CCL23
Neutropenia	ENSG00000282608	FALSE	Phase I Clinical Trial	2001-07-24	Phase I Clinical Trial	ADORA3
Niemann-Pick Diseases	ENSG00000090674	FALSE	Preclinical	2015-06-17	Absent	MCOLN1
Niemann-Pick Diseases	ENSG00000148154	TRUE	Approved	1989-06-15	Absent	UGCG
Niemann-Pick Diseases	ENSG00000166311	FALSE	Phase III Clinical Trial	1999-05-11	Phase II Clinical Trial	SMPD1
Niemann-Pick Diseases	ENSG00000171132	FALSE	Preclinical	2009-05-01	Absent	PRKCE
Noonan Syndrome	ENSG00000112964	TRUE	Approved	NA	Approved	GHR
Noonan Syndrome	ENSG00000126934	FALSE	unknown	2006-05-01	Phase II Clinical Trial	MAP2K2
Noonan Syndrome	ENSG00000169032	FALSE	unknown	2006-05-01	Phase II Clinical Trial	MAP2K1
Nystagmus, Pathologic	ENSG00000176884	FALSE	Phase II Clinical Trial	1998-12-15	Unused	GRIN1
Obesity	ENSG00000004948	FALSE	Phase II Clinical Trial	1992-02-15	Unused	CALCR
Obesity	ENSG00000010310	FALSE	Preclinical	2009-07-02	Unused	GIPR
Obesity	ENSG00000010810	FALSE	Preclinical	2016-10-05	Absent	FYN
Obesity	ENSG00000011677	FALSE	Preclinical	2009-07-16	Unused	GABRA3
Obesity	ENSG00000017797	FALSE	Preclinical	2018-01-10	Absent	RALBP1
Obesity	ENSG00000022355	FALSE	Preclinical	2009-07-16	Unused	GABRA1
Obesity	ENSG00000043591	FALSE	Phase I Clinical Trial	2014-10-31	Absent	ADRB1
Obesity	ENSG00000065325	FALSE	Preclinical	2014-01-22	Absent	GLP2R
Obesity	ENSG00000065989	FALSE	unknown	1994-10-15	Unused	PDE4A
Obesity	ENSG00000068903	FALSE	Preclinical	2010-01-08	Unused	SIRT2
Obesity	ENSG00000069535	FALSE	Preclinical	NA	Unused	MAOB
Obesity	ENSG00000072062	FALSE	Preclinical	1990-02-15	Unused	PRKACA
Obesity	ENSG00000072310	FALSE	unknown	2016-01-14	Absent	SREBF1
Obesity	ENSG00000072571	FALSE	Preclinical	2000-10-26	Unused	HMMR
Obesity	ENSG00000074590	FALSE	Preclinical	2014-11-18	Absent	NUAK1
Obesity	ENSG00000076555	FALSE	Preclinical	2004-06-06	Unused	ACACB
Obesity	ENSG00000077782	FALSE	Phase I Clinical Trial	2013-04-26	Absent	FGFR1
Obesity	ENSG00000080644	FALSE	Phase I Clinical Trial	2012-11-02	Absent	CHRNA3
Obesity	ENSG00000082556	TRUE	Approved	1990-10-15	Phase III Clinical Trial	OPRK1
Obesity	ENSG00000084674	FALSE	Preclinical	2009-11-27	Unused	APOB
Obesity	ENSG00000085662	FALSE	Preclinical	1993-09-15	Unused	AKR1B1
Obesity	ENSG00000087237	FALSE	Preclinical	2000-06-19	Unused	CETP
Obesity	ENSG00000091831	FALSE	Preclinical	2010-03-17	Unused	ESR1
Obesity	ENSG00000096717	FALSE	Preclinical	2009-03-30	Phase I Clinical Trial	SIRT1
Obesity	ENSG00000099194	FALSE	Preclinical	2002-03-06	Unused	SCD
Obesity	ENSG00000100170	FALSE	Phase II Clinical Trial	2011-08-04	Absent	SLC5A1
Obesity	ENSG00000100504	FALSE	Preclinical	2001-12-04	Unused	PYGL
Obesity	ENSG00000101144	FALSE	Preclinical	NA	Preclinical	BMP7
Obesity	ENSG00000101180	FALSE	Phase II Clinical Trial	1993-05-15	Phase II Clinical Trial	HRH3
Obesity	ENSG00000101204	FALSE	Preclinical	2007-09-20	Unused	CHRNA4
Obesity	ENSG00000101266	FALSE	Preclinical	2015-12-01	Absent	CSNK2A1
Obesity	ENSG00000102239	FALSE	Preclinical	2010-03-24	Unused	BRS3
Obesity	ENSG00000102468	FALSE	Preclinical	2001-11-13	Unused	HTR2A
Obesity	ENSG00000103150	FALSE	Preclinical	2010-09-30	Unused	MLYCD
Obesity	ENSG00000103546	TRUE	Approved	1997-07-15	Approved	SLC6A2
Obesity	ENSG00000105550	FALSE	Phase I Clinical Trial	2007-12-20	Unused	FGF21
Obesity	ENSG00000105552	FALSE	Preclinical	2015-09-04	Absent	BCAT2
Obesity	ENSG00000105650	FALSE	unknown	1994-10-15	Unused	PDE4C
Obesity	ENSG00000105851	FALSE	Preclinical	2012-08-28	Preclinical	PIK3CG
Obesity	ENSG00000106113	FALSE	Preclinical	2000-11-13	Unused	CRHR2
Obesity	ENSG00000106348	FALSE	Preclinical	2008-10-10	Unused	IMPDH1
Obesity	ENSG00000106546	FALSE	Preclinical	2012-08-23	Preclinical	AHR
Obesity	ENSG00000106633	FALSE	Phase I Clinical Trial	2007-08-06	Unused	GCK
Obesity	ENSG00000107643	FALSE	Preclinical	2007-07-24	Unused	MAPK8
Obesity	ENSG00000108576	TRUE	Approved	1997-10-15	Unused	SLC6A4
Obesity	ENSG00000109320	FALSE	unknown	2006-09-27	Absent	NFKB1
Obesity	ENSG00000110090	FALSE	Preclinical	1999-04-13	Unused	CPT1A
Obesity	ENSG00000110148	FALSE	Phase II Clinical Trial	1990-07-15	Unused	CCKBR
Obesity	ENSG00000110395	FALSE	Preclinical	2003-09-24	Unused	CBL
Obesity	ENSG00000110680	FALSE	Preclinical	2015-07-15	Absent	CALCA
Obesity	ENSG00000111142	FALSE	Phase II Clinical Trial	1998-07-15	Phase II Clinical Trial	METAP2
Obesity	ENSG00000111199	FALSE	Preclinical	2012-09-29	Preclinical	TRPV4
Obesity	ENSG00000112033	FALSE	Phase I Clinical Trial	1997-12-15	Phase I Clinical Trial	PPARD
Obesity	ENSG00000112038	TRUE	Approved	1990-10-15	Phase III Clinical Trial	OPRM1
Obesity	ENSG00000112164	TRUE	Approved	1996-12-15	Phase III Clinical Trial	GLP1R
Obesity	ENSG00000112541	FALSE	Preclinical	2011-08-10	Unused	PDE10A
Obesity	ENSG00000112964	FALSE	Preclinical	2001-12-11	Unused	GHR
Obesity	ENSG00000113448	FALSE	unknown	1994-10-15	Unused	PDE4D
Obesity	ENSG00000113578	FALSE	Phase I Clinical Trial	2015-11-03	Absent	FGF1
Obesity	ENSG00000113580	FALSE	Phase II Clinical Trial	2001-08-28	Phase II Clinical Trial	NR3C1
Obesity	ENSG00000115263	FALSE	Phase I Clinical Trial	1996-09-15	Unused	GCG
Obesity	ENSG00000116329	FALSE	Preclinical	1990-10-15	Unused	OPRD1
Obesity	ENSG00000116678	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	LEPR
Obesity	ENSG00000117362	FALSE	Preclinical	1999-04-28	Unused	APH1A
Obesity	ENSG00000117594	FALSE	Preclinical	2005-03-13	Unused	HSD11B1
Obesity	ENSG00000117971	FALSE	Phase I Clinical Trial	2012-11-02	Absent	CHRNB4
Obesity	ENSG00000118432	TRUE	Approved	1994-02-15	Unused	CNR1
Obesity	ENSG00000118473	FALSE	Preclinical	1998-03-15	Unused	SGIP1
Obesity	ENSG00000119715	FALSE	Preclinical	1999-12-20	Unused	ESRRB
Obesity	ENSG00000119927	FALSE	Preclinical	2004-12-08	Unused	GPAM
Obesity	ENSG00000121351	FALSE	Preclinical	2009-12-17	Preclinical	IAPP
Obesity	ENSG00000121764	FALSE	Preclinical	1999-07-27	Unused	HCRTR1
Obesity	ENSG00000121853	FALSE	Phase I Clinical Trial	2003-07-07	Unused	GHSR
Obesity	ENSG00000122194	FALSE	Preclinical	2009-07-24	Unused	PLG
Obesity	ENSG00000122585	FALSE	Phase II Clinical Trial	1999-04-13	Unused	NPY
Obesity	ENSG00000122756	FALSE	Phase III Clinical Trial	1994-08-15	Unused	CNTFR
Obesity	ENSG00000125255	FALSE	Preclinical	2011-02-04	Unused	SLC10A2
Obesity	ENSG00000126010	FALSE	Preclinical	1992-05-15	Unused	GRPR
Obesity	ENSG00000126266	FALSE	Preclinical	2017-08-30	Absent	FFAR1
Obesity	ENSG00000128285	FALSE	Phase II Clinical Trial	1996-12-15	Unused	MCHR1
Obesity	ENSG00000129167	FALSE	unknown	NA	Unused	TPH1
Obesity	ENSG00000130234	FALSE	Preclinical	2007-07-31	Unused	ACE2
Obesity	ENSG00000130368	FALSE	Phase II Clinical Trial	2016-02-10	Absent	MAS1
Obesity	ENSG00000131096	FALSE	Phase I Clinical Trial	2005-12-30	Unused	PYY
Obesity	ENSG00000131871	FALSE	Preclinical	2005-08-08	Unused	SELENOS
Obesity	ENSG00000132170	FALSE	Preclinical	1996-07-15	Unused	PPARG
Obesity	ENSG00000132693	FALSE	Preclinical	2006-09-11	Unused	CRP
Obesity	ENSG00000132911	FALSE	Preclinical	2017-03-30	Absent	NMUR2
Obesity	ENSG00000134318	FALSE	Preclinical	2005-05-24	Phase I Clinical Trial	ROCK2
Obesity	ENSG00000134640	FALSE	Preclinical	1993-10-15	Unused	MTNR1B
Obesity	ENSG00000134900	FALSE	Preclinical	1996-06-15	Unused	TPP2
Obesity	ENSG00000134962	FALSE	Phase I Clinical Trial	2008-06-16	Unused	KLB
Obesity	ENSG00000135312	FALSE	Preclinical	2004-10-26	Unused	HTR1B
Obesity	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Obesity	ENSG00000135914	FALSE	Preclinical	2001-11-13	Unused	HTR2B
Obesity	ENSG00000137509	FALSE	Preclinical	2011-03-15	Unused	PRCP
Obesity	ENSG00000138030	FALSE	Preclinical	2011-08-27	Preclinical	KHK
Obesity	ENSG00000138379	FALSE	Preclinical	2006-08-07	Unused	MSTN
Obesity	ENSG00000138735	FALSE	Preclinical	2014-08-26	Absent	PDE5A
Obesity	ENSG00000138823	FALSE	Phase II Clinical Trial	2005-05-24	Phase II Clinical Trial	MTTP
Obesity	ENSG00000140675	FALSE	Phase II Clinical Trial	2000-10-05	Phase II Clinical Trial	SLC5A2
Obesity	ENSG00000141485	FALSE	Preclinical	2014-05-13	Absent	SLC13A5
Obesity	ENSG00000142319	FALSE	Phase III Clinical Trial	1997-07-15	Phase II Clinical Trial	SLC6A3
Obesity	ENSG00000143171	FALSE	Preclinical	2008-07-10	Absent	RXRG
Obesity	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Obesity	ENSG00000145708	FALSE	unknown	1993-06-15	Unused	CRHBP
Obesity	ENSG00000147246	TRUE	Approved	1996-07-15	Approved	HTR2C
Obesity	ENSG00000147262	FALSE	Preclinical	2005-07-27	Unused	GPR119
Obesity	ENSG00000149295	FALSE	Phase II Clinical Trial	1995-07-15	Unused	DRD2
Obesity	ENSG00000150281	FALSE	Preclinical	NA	Preclinical	CTF1
Obesity	ENSG00000151090	FALSE	Phase I Clinical Trial	2005-04-25	Unused	THRB
Obesity	ENSG00000151623	FALSE	unknown	2014-02-01	Absent	NR3C2
Obesity	ENSG00000151834	FALSE	Preclinical	2009-07-16	Unused	GABRA2
Obesity	ENSG00000152207	FALSE	Preclinical	2018-01-04	Absent	CYSLTR2
Obesity	ENSG00000154229	FALSE	Preclinical	1990-02-15	Unused	PRKCA
Obesity	ENSG00000154646	FALSE	Phase I Clinical Trial	2013-01-09	Preclinical	TMPRSS15
Obesity	ENSG00000155511	FALSE	Phase III Clinical Trial	NA	Unused	GRIA1
Obesity	ENSG00000157017	FALSE	Phase II Clinical Trial	2002-06-17	Unused	GHRL
Obesity	ENSG00000158748	FALSE	Phase I Clinical Trial	2001-10-19	Unused	HTR6
Obesity	ENSG00000159224	FALSE	Phase I Clinical Trial	2007-03-28	Unused	GIP
Obesity	ENSG00000159640	FALSE	Preclinical	2005-08-08	Unused	ACE
Obesity	ENSG00000159723	FALSE	Phase II Clinical Trial	1998-04-15	Unused	AGRP
Obesity	ENSG00000160691	FALSE	Preclinical	2016-11-25	Absent	SHC1
Obesity	ENSG00000160716	FALSE	Preclinical	2007-09-20	Unused	CHRNB2
Obesity	ENSG00000160867	FALSE	Phase II Clinical Trial	2008-10-10	Phase I Clinical Trial	FGFR4
Obesity	ENSG00000163394	FALSE	Phase III Clinical Trial	1991-06-15	Unused	CCKAR
Obesity	ENSG00000163586	FALSE	Preclinical	2011-06-17	Unused	FABP1
Obesity	ENSG00000163631	FALSE	Phase I Clinical Trial	2012-03-09	Phase I Clinical Trial	ALB
Obesity	ENSG00000164128	FALSE	Preclinical	1994-10-15	Unused	NPY1R
Obesity	ENSG00000164129	FALSE	Phase II Clinical Trial	1994-10-15	Phase II Clinical Trial	NPY5R
Obesity	ENSG00000164687	FALSE	Preclinical	2011-12-26	Unused	FABP5
Obesity	ENSG00000166391	FALSE	Preclinical	2015-05-21	Absent	MOGAT2
Obesity	ENSG00000166573	FALSE	Preclinical	1996-07-15	Unused	GALR1
Obesity	ENSG00000166603	FALSE	Phase III Clinical Trial	1994-08-15	Phase II Clinical Trial	MC4R
Obesity	ENSG00000166736	FALSE	Preclinical	2011-05-26	Phase I Clinical Trial	HTR3A
Obesity	ENSG00000167085	FALSE	Phase I Clinical Trial	2010-12-22	Phase I Clinical Trial	PHB
Obesity	ENSG00000167114	FALSE	Preclinical	1999-10-13	Unused	SLC27A4
Obesity	ENSG00000168412	FALSE	Preclinical	1993-10-15	Unused	MTNR1A
Obesity	ENSG00000168539	FALSE	Preclinical	1995-08-15	Unused	CHRM1
Obesity	ENSG00000169083	FALSE	Preclinical	NA	Unused	AR
Obesity	ENSG00000169252	FALSE	Phase II Clinical Trial	2010-02-17	Phase II Clinical Trial	ADRB2
Obesity	ENSG00000169676	FALSE	Phase III Clinical Trial	NA	Unused	DRD5
Obesity	ENSG00000170323	FALSE	Preclinical	2011-12-26	Unused	FABP4
Obesity	ENSG00000171105	FALSE	Phase I Clinical Trial	2000-11-07	Phase I Clinical Trial	INSR
Obesity	ENSG00000171132	FALSE	Preclinical	2002-11-15	Unused	PRKCE
Obesity	ENSG00000171298	FALSE	Phase II Clinical Trial	2007-03-27	Unused	GAA
Obesity	ENSG00000171596	FALSE	Preclinical	2017-03-30	Absent	NMUR1
Obesity	ENSG00000171657	FALSE	Preclinical	2016-10-25	Absent	GPR82
Obesity	ENSG00000173153	FALSE	Preclinical	1999-12-20	Unused	ESRRA
Obesity	ENSG00000173250	FALSE	Preclinical	2016-08-12	Absent	GPR151
Obesity	ENSG00000174697	FALSE	Preclinical	2006-09-11	Unused	LEP
Obesity	ENSG00000175193	FALSE	Preclinical	1999-08-25	Unused	PARL
Obesity	ENSG00000175445	FALSE	Phase II Clinical Trial	1996-07-15	Unused	LPL
Obesity	ENSG00000175535	TRUE	Approved	1995-10-15	Approved	PNLIP
Obesity	ENSG00000175567	FALSE	Preclinical	1994-08-15	Unused	UCP2
Obesity	ENSG00000178394	FALSE	Phase I Clinical Trial	1999-06-10	Unused	HTR1A
Obesity	ENSG00000179097	FALSE	Preclinical	NA	Absent	HTR1F
Obesity	ENSG00000179142	FALSE	Preclinical	2009-07-16	Preclinical	CYP11B2
Obesity	ENSG00000179921	FALSE	Preclinical	2005-05-25	Unused	GPBAR1
Obesity	ENSG00000180530	FALSE	Preclinical	2003-05-06	Unused	NRIP1
Obesity	ENSG00000181092	FALSE	Preclinical	2000-11-10	Unused	ADIPOQ
Obesity	ENSG00000182687	FALSE	Preclinical	1996-07-15	Unused	GALR2
Obesity	ENSG00000183048	FALSE	Preclinical	2007-07-24	Unused	SLC25A10
Obesity	ENSG00000183729	FALSE	Preclinical	2012-01-05	Unused	NPBWR1
Obesity	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Obesity	ENSG00000183840	FALSE	Preclinical	2010-06-04	Unused	GPR39
Obesity	ENSG00000183873	FALSE	Phase III Clinical Trial	NA	Unused	SCN5A
Obesity	ENSG00000184502	FALSE	Preclinical	2011-06-30	Absent	GAST
Obesity	ENSG00000184557	FALSE	Preclinical	2013-11-13	Absent	SOCS3
Obesity	ENSG00000184588	FALSE	unknown	1994-10-15	Unused	PDE4B
Obesity	ENSG00000184845	FALSE	Phase III Clinical Trial	1995-07-15	Unused	DRD1
Obesity	ENSG00000185000	FALSE	Phase I Clinical Trial	2006-06-20	Phase I Clinical Trial	DGAT1
Obesity	ENSG00000185149	FALSE	Phase II Clinical Trial	1994-10-15	Phase I Clinical Trial	NPY2R
Obesity	ENSG00000185532	FALSE	Preclinical	1990-02-15	Unused	PRKG1
Obesity	ENSG00000186188	FALSE	Preclinical	2016-07-27	Absent	FFAR4
Obesity	ENSG00000186297	FALSE	Preclinical	2009-07-16	Unused	GABRA5
Obesity	ENSG00000186951	FALSE	Phase I Clinical Trial	1996-07-15	Unused	PPARA
Obesity	ENSG00000187486	FALSE	Preclinical	2002-09-05	Unused	KCNJ11
Obesity	ENSG00000187871	FALSE	Preclinical	2015-10-15	Absent	GFRAL
Obesity	ENSG00000188778	FALSE	Phase II Clinical Trial	1990-03-15	Unused	ADRB3
Obesity	ENSG00000188822	FALSE	Preclinical	2007-04-23	Phase I Clinical Trial	CNR2
Obesity	ENSG00000196396	FALSE	Preclinical	2000-04-18	Unused	PTPN1
Obesity	ENSG00000196482	FALSE	Preclinical	1999-12-20	Unused	ESRRG
Obesity	ENSG00000196549	FALSE	Preclinical	NA	Unused	MME
Obesity	ENSG00000196639	FALSE	Phase II Clinical Trial	2007-02-07	Unused	HRH1
Obesity	ENSG00000197635	FALSE	Phase I Clinical Trial	2002-11-04	Phase I Clinical Trial	DPP4
Obesity	ENSG00000198911	FALSE	unknown	2016-01-14	Absent	SREBF2
Obesity	ENSG00000204174	FALSE	Phase II Clinical Trial	1994-10-15	Absent	NPY4R
Obesity	ENSG00000205155	FALSE	Preclinical	1999-04-28	Unused	PSENEN
Obesity	ENSG00000215644	FALSE	Phase I Clinical Trial	2008-03-10	Phase I Clinical Trial	GCGR
Obesity	ENSG00000240972	FALSE	Preclinical	2012-06-15	Preclinical	MIF
Obesity	ENSG00000242252	FALSE	Preclinical	2008-09-04	Unused	BGLAP
Obesity	ENSG00000254647	FALSE	Preclinical	2014-05-15	Absent	INS
Obesity	ENSG00000258839	FALSE	Preclinical	1997-08-15	Unused	MC1R
Obesity	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Obesity	ENSG00000278540	FALSE	Preclinical	2004-06-06	Unused	ACACA
Obsessive-Compulsive Disorder	ENSG00000022355	FALSE	Preclinical	2013-11-21	Absent	GABRA1
Obsessive-Compulsive Disorder	ENSG00000080293	FALSE	Phase I Clinical Trial	1999-03-23	Unused	SCTR
Obsessive-Compulsive Disorder	ENSG00000082556	FALSE	Phase II Clinical Trial	2008-04-30	Unused	OPRK1
Obsessive-Compulsive Disorder	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Obsessive-Compulsive Disorder	ENSG00000103546	FALSE	unknown	NA	Unused	SLC6A2
Obsessive-Compulsive Disorder	ENSG00000108576	TRUE	Approved	1998-10-15	Approved	SLC6A4
Obsessive-Compulsive Disorder	ENSG00000112038	FALSE	Phase II Clinical Trial	2008-04-30	Unused	OPRM1
Obsessive-Compulsive Disorder	ENSG00000112541	FALSE	Preclinical	2011-08-10	Unused	PDE10A
Obsessive-Compulsive Disorder	ENSG00000134640	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTNR1B
Obsessive-Compulsive Disorder	ENSG00000135312	FALSE	Preclinical	1998-05-15	Unused	HTR1B
Obsessive-Compulsive Disorder	ENSG00000147246	FALSE	Phase II Clinical Trial	2002-10-08	Phase II Clinical Trial	HTR2C
Obsessive-Compulsive Disorder	ENSG00000149295	FALSE	Phase III Clinical Trial	NA	Unused	DRD2
Obsessive-Compulsive Disorder	ENSG00000150594	FALSE	Phase II Clinical Trial	2006-10-23	Unused	ADRA2A
Obsessive-Compulsive Disorder	ENSG00000151577	FALSE	Preclinical	1995-12-15	Unused	DRD3
Obsessive-Compulsive Disorder	ENSG00000166736	FALSE	Phase II Clinical Trial	2008-12-08	Phase II Clinical Trial	HTR3A
Obsessive-Compulsive Disorder	ENSG00000168412	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTNR1A
Obsessive-Compulsive Disorder	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Absent	GRM5
Obsessive-Compulsive Disorder	ENSG00000176884	FALSE	unknown	2007-09-03	Unused	GRIN1
Obsessive-Compulsive Disorder	ENSG00000178394	FALSE	Phase III Clinical Trial	NA	Absent	HTR1A
Obsessive-Compulsive Disorder	ENSG00000179546	FALSE	Preclinical	1998-05-15	Unused	HTR1D
Obsessive-Compulsive Disorder	ENSG00000184845	FALSE	Phase III Clinical Trial	NA	Absent	DRD1
Obsessive-Compulsive Disorder	ENSG00000196517	FALSE	Phase II Clinical Trial	2005-02-07	Phase II Clinical Trial	SLC6A9
Obstetric Labor Complications	ENSG00000050628	TRUE	Approved	2014-12-05	Absent	PTGER3
Obstetric Labor Complications	ENSG00000082175	TRUE	Approved	1996-07-15	Approved	PGR
Obstetric Labor Complications	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Obstetric Labor Complications	ENSG00000122420	FALSE	Approved	2005-07-11	Unused	PTGFR
Obstetric Labor Complications	ENSG00000125384	TRUE	Approved	1989-10-15	Approved	PTGER2
Obstetric Labor Complications	ENSG00000126895	FALSE	Preclinical	1995-05-15	Unused	AVPR2
Obstetric Labor Complications	ENSG00000133105	FALSE	Preclinical	2008-05-20	Unused	RXFP2
Obstetric Labor Complications	ENSG00000160801	FALSE	Preclinical	1996-05-15	Unused	PTH1R
Obstetric Labor Complications	ENSG00000160951	TRUE	Approved	2003-04-22	Approved	PTGER1
Obstetric Labor Complications	ENSG00000166148	FALSE	unknown	1993-01-15	Unused	AVPR1A
Obstetric Labor Complications	ENSG00000169083	FALSE	Approved	1991-01-15	Unused	AR
Obstetric Labor Complications	ENSG00000169252	TRUE	Approved	1993-12-15	Approved	ADRB2
Obstetric Labor Complications	ENSG00000171509	FALSE	Phase II Clinical Trial	2007-10-23	Unused	RXFP1
Obstetric Labor Complications	ENSG00000180914	TRUE	Approved	1989-11-15	Approved	OXTR
Obstetric Labor Complications	ENSG00000188778	FALSE	Preclinical	2007-03-05	Unused	ADRB3
Ocular Motility Disorders	ENSG00000007952	FALSE	Preclinical	NA	Preclinical	NOX1
Ocular Motility Disorders	ENSG00000012779	FALSE	Preclinical	NA	Unused	ALOX5
Ocular Motility Disorders	ENSG00000023445	FALSE	Preclinical	2002-07-03	Unused	BIRC3
Ocular Motility Disorders	ENSG00000026508	FALSE	Preclinical	2008-02-20	Unused	CD44
Ocular Motility Disorders	ENSG00000043591	FALSE	unknown	1993-02-15	Unused	ADRB1
Ocular Motility Disorders	ENSG00000059377	FALSE	unknown	NA	Unused	TBXAS1
Ocular Motility Disorders	ENSG00000064651	FALSE	Phase III Clinical Trial	1992-07-15	Unused	SLC12A2
Ocular Motility Disorders	ENSG00000065154	FALSE	Preclinical	1995-06-15	Unused	OAT
Ocular Motility Disorders	ENSG00000065675	FALSE	Preclinical	2008-07-21	Unused	PRKCQ
Ocular Motility Disorders	ENSG00000069535	FALSE	Preclinical	2002-04-23	Unused	MAOB
Ocular Motility Disorders	ENSG00000069702	FALSE	Preclinical	1992-03-15	Unused	TGFBR3
Ocular Motility Disorders	ENSG00000073756	TRUE	Approved	1991-05-15	Approved	PTGS2
Ocular Motility Disorders	ENSG00000074803	FALSE	Phase III Clinical Trial	1992-07-15	Unused	SLC12A1
Ocular Motility Disorders	ENSG00000077782	FALSE	unknown	1990-06-15	Unused	FGFR1
Ocular Motility Disorders	ENSG00000080824	FALSE	unknown	NA	Unused	HSP90AA1
Ocular Motility Disorders	ENSG00000081985	FALSE	Preclinical	2014-08-07	Absent	IL12RB2
Ocular Motility Disorders	ENSG00000082781	FALSE	Preclinical	2001-01-30	Unused	ITGB5
Ocular Motility Disorders	ENSG00000085662	TRUE	Approved	1989-10-15	Unused	AKR1B1
Ocular Motility Disorders	ENSG00000086991	FALSE	Preclinical	NA	Preclinical	NOX4
Ocular Motility Disorders	ENSG00000087085	FALSE	Preclinical	1995-05-15	Unused	ACHE
Ocular Motility Disorders	ENSG00000088832	FALSE	Preclinical	2017-11-13	Absent	FKBP1A
Ocular Motility Disorders	ENSG00000090339	FALSE	Preclinical	2008-07-31	Unused	ICAM1
Ocular Motility Disorders	ENSG00000092969	FALSE	Preclinical	2011-09-28	Absent	TGFB2
Ocular Motility Disorders	ENSG00000095303	TRUE	Approved	1991-05-15	Approved	PTGS1
Ocular Motility Disorders	ENSG00000096996	FALSE	Preclinical	2014-08-07	Absent	IL12RB1
Ocular Motility Disorders	ENSG00000097007	FALSE	Preclinical	2007-05-16	Unused	ABL1
Ocular Motility Disorders	ENSG00000100644	FALSE	Preclinical	2010-10-01	Unused	HIF1A
Ocular Motility Disorders	ENSG00000100739	FALSE	Preclinical	2011-08-16	Absent	BDKRB1
Ocular Motility Disorders	ENSG00000101966	FALSE	Preclinical	2002-07-03	Unused	XIAP
Ocular Motility Disorders	ENSG00000102755	FALSE	Preclinical	2000-03-01	Unused	FLT1
Ocular Motility Disorders	ENSG00000104267	TRUE	Approved	NA	Approved	CA2
Ocular Motility Disorders	ENSG00000104804	FALSE	Preclinical	1996-06-15	Unused	TULP2
Ocular Motility Disorders	ENSG00000105329	FALSE	Preclinical	2011-09-28	Absent	TGFB1
Ocular Motility Disorders	ENSG00000106144	FALSE	Preclinical	2011-07-04	Unused	CASP2
Ocular Motility Disorders	ENSG00000106683	FALSE	Preclinical	2016-04-22	Absent	LIMK1
Ocular Motility Disorders	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Ocular Motility Disorders	ENSG00000106799	FALSE	Preclinical	1992-03-15	Unused	TGFBR1
Ocular Motility Disorders	ENSG00000106804	FALSE	Preclinical	2008-12-02	Unused	C5
Ocular Motility Disorders	ENSG00000110330	FALSE	Preclinical	2002-07-03	Unused	BIRC2
Ocular Motility Disorders	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Ocular Motility Disorders	ENSG00000111424	FALSE	Preclinical	2006-10-23	Unused	VDR
Ocular Motility Disorders	ENSG00000112041	FALSE	Preclinical	1996-06-15	Unused	TULP1
Ocular Motility Disorders	ENSG00000112062	FALSE	Preclinical	2005-07-13	Unused	MAPK14
Ocular Motility Disorders	ENSG00000112715	FALSE	Phase I Clinical Trial	1996-09-15	Unused	VEGFA
Ocular Motility Disorders	ENSG00000113070	FALSE	Preclinical	1991-09-15	Unused	HBEGF
Ocular Motility Disorders	ENSG00000113580	FALSE	Phase I Clinical Trial	1989-12-15	Unused	NR3C1
Ocular Motility Disorders	ENSG00000113721	FALSE	Preclinical	2011-09-12	Preclinical	PDGFRB
Ocular Motility Disorders	ENSG00000114378	FALSE	Preclinical	NA	Unused	HYAL1
Ocular Motility Disorders	ENSG00000115353	FALSE	Preclinical	1997-02-15	Unused	TACR1
Ocular Motility Disorders	ENSG00000115414	FALSE	unknown	NA	Unused	FN1
Ocular Motility Disorders	ENSG00000116044	FALSE	Preclinical	2014-11-18	Absent	NFE2L2
Ocular Motility Disorders	ENSG00000117318	FALSE	Preclinical	2015-01-06	Absent	ID3
Ocular Motility Disorders	ENSG00000118513	FALSE	Preclinical	1992-06-15	Unused	MYB
Ocular Motility Disorders	ENSG00000120156	FALSE	Preclinical	1995-08-15	Unused	TEK
Ocular Motility Disorders	ENSG00000121879	FALSE	Preclinical	2014-07-10	Absent	PIK3CA
Ocular Motility Disorders	ENSG00000122420	FALSE	Preclinical	2008-10-16	Unused	PTGFR
Ocular Motility Disorders	ENSG00000122543	FALSE	Preclinical	2008-04-02	Unused	OCM
Ocular Motility Disorders	ENSG00000122861	FALSE	unknown	NA	Unused	PLAU
Ocular Motility Disorders	ENSG00000125571	FALSE	Preclinical	2014-08-07	Absent	IL37
Ocular Motility Disorders	ENSG00000125968	FALSE	Preclinical	2015-01-06	Absent	ID1
Ocular Motility Disorders	ENSG00000126016	FALSE	Preclinical	2004-09-22	Unused	AMOT
Ocular Motility Disorders	ENSG00000128052	FALSE	Preclinical	2000-05-10	Unused	KDR
Ocular Motility Disorders	ENSG00000130561	FALSE	unknown	1993-04-15	Unused	SAG
Ocular Motility Disorders	ENSG00000131471	FALSE	Preclinical	2015-06-09	Absent	AOC3
Ocular Motility Disorders	ENSG00000132530	FALSE	Preclinical	2002-07-03	Unused	XAF1
Ocular Motility Disorders	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Ocular Motility Disorders	ENSG00000132965	FALSE	Preclinical	2008-08-20	Unused	ALOX5AP
Ocular Motility Disorders	ENSG00000133019	FALSE	Preclinical	NA	Unused	CHRM3
Ocular Motility Disorders	ENSG00000138448	FALSE	Preclinical	1998-10-15	Unused	ITGAV
Ocular Motility Disorders	ENSG00000138685	FALSE	Preclinical	1994-06-15	Unused	FGF2
Ocular Motility Disorders	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Ocular Motility Disorders	ENSG00000140009	FALSE	Preclinical	2012-06-29	Preclinical	ESR2
Ocular Motility Disorders	ENSG00000140443	FALSE	Preclinical	1999-04-28	Unused	IGF1R
Ocular Motility Disorders	ENSG00000142208	FALSE	Preclinical	2004-10-19	Unused	AKT1
Ocular Motility Disorders	ENSG00000143799	FALSE	Preclinical	2004-01-12	Unused	PARP1
Ocular Motility Disorders	ENSG00000146648	FALSE	Preclinical	1992-05-15	Unused	EGFR
Ocular Motility Disorders	ENSG00000150093	FALSE	Preclinical	2012-01-09	Absent	ITGB1
Ocular Motility Disorders	ENSG00000150594	FALSE	Preclinical	2011-08-02	Unused	ADRA2A
Ocular Motility Disorders	ENSG00000150630	FALSE	unknown	2007-07-02	Preclinical	VEGFC
Ocular Motility Disorders	ENSG00000155511	FALSE	Preclinical	1999-02-15	Unused	GRIA1
Ocular Motility Disorders	ENSG00000161638	FALSE	Preclinical	2012-01-09	Absent	ITGA5
Ocular Motility Disorders	ENSG00000163485	FALSE	unknown	2003-10-08	Absent	ADORA1
Ocular Motility Disorders	ENSG00000163513	FALSE	Preclinical	1992-03-15	Unused	TGFBR2
Ocular Motility Disorders	ENSG00000164362	FALSE	Preclinical	1999-12-01	Unused	TERT
Ocular Motility Disorders	ENSG00000165025	FALSE	unknown	2010-07-10	Preclinical	SYK
Ocular Motility Disorders	ENSG00000166402	FALSE	Preclinical	1996-06-15	Unused	TUB
Ocular Motility Disorders	ENSG00000166501	FALSE	Preclinical	2005-10-31	Unused	PRKCB
Ocular Motility Disorders	ENSG00000168522	FALSE	Preclinical	2010-12-23	Unused	FNTA
Ocular Motility Disorders	ENSG00000168539	FALSE	Preclinical	NA	Unused	CHRM1
Ocular Motility Disorders	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Ocular Motility Disorders	ENSG00000169398	FALSE	Preclinical	2010-02-01	Unused	PTK2
Ocular Motility Disorders	ENSG00000170989	FALSE	Preclinical	2010-07-02	Unused	S1PR1
Ocular Motility Disorders	ENSG00000171557	FALSE	Preclinical	1995-06-15	Unused	FGG
Ocular Motility Disorders	ENSG00000171560	FALSE	Preclinical	1995-06-15	Unused	FGA
Ocular Motility Disorders	ENSG00000171564	FALSE	Preclinical	1995-06-15	Unused	FGB
Ocular Motility Disorders	ENSG00000172236	FALSE	Preclinical	2001-04-02	Unused	TPSAB1
Ocular Motility Disorders	ENSG00000176884	FALSE	Preclinical	1999-02-15	Unused	GRIN1
Ocular Motility Disorders	ENSG00000177272	FALSE	unknown	2008-04-16	Absent	KCNA3
Ocular Motility Disorders	ENSG00000180720	FALSE	Phase III Clinical Trial	2014-04-07	Absent	CHRM4
Ocular Motility Disorders	ENSG00000182326	FALSE	Preclinical	2016-06-27	Absent	C1S
Ocular Motility Disorders	ENSG00000186868	FALSE	Preclinical	2013-04-22	Absent	MAPT
Ocular Motility Disorders	ENSG00000196262	FALSE	Phase III Clinical Trial	1993-08-15	Phase III Clinical Trial	PPIA
Ocular Motility Disorders	ENSG00000196411	FALSE	Preclinical	2006-08-15	Unused	EPHB4
Ocular Motility Disorders	ENSG00000196549	FALSE	Preclinical	1990-12-15	Unused	MME
Ocular Motility Disorders	ENSG00000196639	TRUE	Approved	1992-01-15	Phase I Clinical Trial	HRH1
Ocular Motility Disorders	ENSG00000197081	FALSE	Preclinical	1992-08-15	Unused	IGF2R
Ocular Motility Disorders	ENSG00000197122	FALSE	Preclinical	2005-10-18	Unused	SRC
Ocular Motility Disorders	ENSG00000198793	FALSE	Preclinical	2014-07-10	Absent	MTOR
Ocular Motility Disorders	ENSG00000198959	FALSE	Preclinical	2003-12-01	Unused	TGM2
Ocular Motility Disorders	ENSG00000213694	FALSE	Preclinical	2010-07-02	Unused	S1PR3
Ocular Motility Disorders	ENSG00000249437	FALSE	Preclinical	2002-07-03	Unused	NAIP
Ocular Motility Disorders	ENSG00000259207	FALSE	Preclinical	1998-10-15	Unused	ITGB3
Ocular Motility Disorders	ENSG00000269858	FALSE	Preclinical	2014-02-25	Absent	EGLN2
Opioid-Related Disorders	ENSG00000065989	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4A
Opioid-Related Disorders	ENSG00000073756	FALSE	Pre-registration	2008-06-19	Absent	PTGS2
Opioid-Related Disorders	ENSG00000082556	TRUE	Approved	1999-12-01	Approved	OPRK1
Opioid-Related Disorders	ENSG00000095303	FALSE	Pre-registration	2008-06-19	Phase III Clinical Trial	PTGS1
Opioid-Related Disorders	ENSG00000101327	FALSE	unknown	1994-04-15	Unused	PDYN
Opioid-Related Disorders	ENSG00000105650	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4C
Opioid-Related Disorders	ENSG00000109163	FALSE	unknown	1999-01-25	Unused	GNRHR
Opioid-Related Disorders	ENSG00000112038	TRUE	Approved	1999-12-01	Approved	OPRM1
Opioid-Related Disorders	ENSG00000112541	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE10A
Opioid-Related Disorders	ENSG00000113448	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4D
Opioid-Related Disorders	ENSG00000116329	FALSE	Pre-registration	1998-02-15	Phase III Clinical Trial	OPRD1
Opioid-Related Disorders	ENSG00000125510	FALSE	Preclinical	2004-10-26	Unused	OPRL1
Opioid-Related Disorders	ENSG00000128655	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE11A
Opioid-Related Disorders	ENSG00000132170	FALSE	Phase II Clinical Trial	2009-09-28	Phase II Clinical Trial	PPARG
Opioid-Related Disorders	ENSG00000136869	FALSE	Phase II Clinical Trial	NA	Absent	TLR4
Opioid-Related Disorders	ENSG00000147955	FALSE	unknown	1999-01-15	Preclinical	SIGMAR1
Opioid-Related Disorders	ENSG00000149295	TRUE	Approved	NA	Approved	DRD2
Opioid-Related Disorders	ENSG00000150594	TRUE	Approved	NA	Approved	ADRA2A
Opioid-Related Disorders	ENSG00000164270	FALSE	unknown	1990-10-15	Unused	HTR4
Opioid-Related Disorders	ENSG00000166736	FALSE	Phase I Clinical Trial	1990-10-15	Phase I Clinical Trial	HTR3A
Opioid-Related Disorders	ENSG00000176884	FALSE	Phase I Clinical Trial	1999-01-15	Phase I Clinical Trial	GRIN1
Opioid-Related Disorders	ENSG00000184588	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PDE4B
Opioid-Related Disorders	ENSG00000196639	FALSE	Pre-registration	2009-01-15	Phase III Clinical Trial	HRH1
Opioid-Related Disorders	ENSG00000240972	FALSE	Phase II Clinical Trial	2009-02-13	Phase II Clinical Trial	MIF
Opsoclonus-Myoclonus Syndrome	ENSG00000156738	FALSE	unknown	1993-09-15	Unused	MS4A1
Optic Atrophy, Hereditary, Leber	ENSG00000198886	FALSE	Phase III Clinical Trial	2011-05-10	Absent	MT-ND4
Optic Neuritis	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Optic Neuritis	ENSG00000102524	FALSE	Phase III Clinical Trial	2014-10-13	Absent	TNFSF13B
Optic Neuritis	ENSG00000104870	FALSE	Preclinical	2011-11-19	Absent	FCGRT
Optic Neuritis	ENSG00000106804	FALSE	Phase III Clinical Trial	1993-08-15	Phase II Clinical Trial	C5
Optic Neuritis	ENSG00000110090	FALSE	Phase I Clinical Trial	2013-01-15	Preclinical	CPT1A
Optic Neuritis	ENSG00000113580	TRUE	Approved	2012-04-20	Approved	NR3C1
Optic Neuritis	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Optic Neuritis	ENSG00000125910	FALSE	Phase II Clinical Trial	1997-12-15	Preclinical	S1PR4
Optic Neuritis	ENSG00000143365	FALSE	Phase I Clinical Trial	2013-08-28	Absent	RORC
Optic Neuritis	ENSG00000149131	FALSE	Phase I Clinical Trial	2016-01-28	Absent	SERPING1
Optic Neuritis	ENSG00000156738	FALSE	Preclinical	2002-10-28	Unused	MS4A1
Optic Neuritis	ENSG00000160712	FALSE	Phase III Clinical Trial	2011-02-02	Absent	IL6R
Optic Neuritis	ENSG00000161955	FALSE	Phase III Clinical Trial	2014-10-13	Absent	TNFSF13
Optic Neuritis	ENSG00000169783	FALSE	Phase II Clinical Trial	2009-02-06	Phase II Clinical Trial	LINGO1
Optic Neuritis	ENSG00000170989	FALSE	Phase II Clinical Trial	1997-12-15	Preclinical	S1PR1
Optic Neuritis	ENSG00000177455	FALSE	Phase III Clinical Trial	2007-08-07	Absent	CD19
Optic Neuritis	ENSG00000180739	FALSE	Phase II Clinical Trial	1997-12-15	Preclinical	S1PR5
Optic Neuritis	ENSG00000197971	FALSE	unknown	NA	Phase III Clinical Trial	MBP
Optic Neuritis	ENSG00000213694	FALSE	Phase II Clinical Trial	1997-12-15	Preclinical	S1PR3
Optic Neuropathy, Ischemic	ENSG00000064300	FALSE	Phase I Clinical Trial	2011-07-05	Absent	NGFR
Optic Neuropathy, Ischemic	ENSG00000067900	FALSE	Preclinical	2013-10-08	Absent	ROCK1
Optic Neuropathy, Ischemic	ENSG00000075213	FALSE	Preclinical	NA	Absent	SEMA3A
Optic Neuropathy, Ischemic	ENSG00000106144	FALSE	Phase III Clinical Trial	2008-09-30	Phase I Clinical Trial	CASP2
Optic Neuropathy, Ischemic	ENSG00000110492	FALSE	Preclinical	2009-05-19	Unused	MDK
Optic Neuropathy, Ischemic	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Optic Neuropathy, Ischemic	ENSG00000150594	FALSE	unknown	1991-06-15	Absent	ADRA2A
Ornithine Carbamoyltransferase Deficiency Disease	ENSG00000036473	FALSE	Preclinical	2014-03-11	Absent	OTC
Ornithine Carbamoyltransferase Deficiency Disease	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Ornithine Carbamoyltransferase Deficiency Disease	ENSG00000198793	FALSE	Preclinical	2016-07-22	Absent	MTOR
Ossification, Heterotopic	ENSG00000183691	FALSE	Preclinical	2002-08-21	Unused	NOG
Osteitis Deformans	ENSG00000004948	TRUE	Approved	1992-12-15	Approved	CALCR
Osteitis Deformans	ENSG00000110680	FALSE	Approved	NA	Unused	CALCA
Osteitis Deformans	ENSG00000167325	FALSE	Phase I Clinical Trial	2000-07-26	Unused	RRM1
Osteitis Deformans	ENSG00000196689	FALSE	Preclinical	2015-12-02	Absent	TRPV1
Osteoarthritis	ENSG00000004948	FALSE	Phase II Clinical Trial	2000-01-26	Phase III Clinical Trial	CALCR
Osteoarthritis	ENSG00000007171	FALSE	Phase III Clinical Trial	2004-01-02	Unused	NOS2
Osteoarthritis	ENSG00000012779	FALSE	unknown	1994-07-15	Unused	ALOX5
Osteoarthritis	ENSG00000026103	FALSE	unknown	2003-03-04	Unused	FAS
Osteoarthritis	ENSG00000026508	TRUE	Approved	1994-01-15	Approved	CD44
Osteoarthritis	ENSG00000059377	FALSE	unknown	1995-07-15	Unused	TBXAS1
Osteoarthritis	ENSG00000064300	FALSE	Phase I Clinical Trial	2014-10-10	Absent	NGFR
Osteoarthritis	ENSG00000064989	FALSE	Preclinical	2016-11-14	Absent	CALCRL
Osteoarthritis	ENSG00000065989	FALSE	Phase II Clinical Trial	2004-01-28	Absent	PDE4A
Osteoarthritis	ENSG00000067182	FALSE	Phase II Clinical Trial	2004-01-28	Unused	TNFRSF1A
Osteoarthritis	ENSG00000073756	TRUE	Approved	1991-08-15	Approved	PTGS2
Osteoarthritis	ENSG00000080824	FALSE	Preclinical	2009-07-17	Unused	HSP90AA1
Osteoarthritis	ENSG00000087085	FALSE	Phase I Clinical Trial	1994-11-15	Unused	ACHE
Osteoarthritis	ENSG00000087245	FALSE	Phase I Clinical Trial	1997-01-15	Unused	MMP2
Osteoarthritis	ENSG00000089041	FALSE	unknown	2001-12-04	Unused	P2RX7
Osteoarthritis	ENSG00000089250	FALSE	Preclinical	2009-05-27	Unused	NOS1
Osteoarthritis	ENSG00000092964	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	DPYSL2
Osteoarthritis	ENSG00000095303	TRUE	Approved	1991-08-15	Approved	PTGS1
Osteoarthritis	ENSG00000100234	FALSE	Preclinical	2008-08-13	Unused	TIMP3
Osteoarthritis	ENSG00000100739	FALSE	Phase I Clinical Trial	2006-01-23	Phase I Clinical Trial	BDKRB1
Osteoarthritis	ENSG00000100985	FALSE	Preclinical	1997-01-15	Unused	MMP9
Osteoarthritis	ENSG00000101144	FALSE	Phase II Clinical Trial	NA	Unused	BMP7
Osteoarthritis	ENSG00000104267	FALSE	Approved	2006-08-11	Phase II Clinical Trial	CA2
Osteoarthritis	ENSG00000104321	FALSE	unknown	2010-09-01	Preclinical	TRPA1
Osteoarthritis	ENSG00000104365	FALSE	Phase II Clinical Trial	2008-02-12	Phase II Clinical Trial	IKBKB
Osteoarthritis	ENSG00000105329	FALSE	Approved	2007-10-09	Phase II Clinical Trial	TGFB1
Osteoarthritis	ENSG00000105650	FALSE	Phase II Clinical Trial	2004-01-28	Absent	PDE4C
Osteoarthritis	ENSG00000105675	TRUE	Approved	2005-10-28	Approved	ATP4A
Osteoarthritis	ENSG00000106128	FALSE	Preclinical	1997-02-15	Unused	GHRHR
Osteoarthritis	ENSG00000109320	FALSE	Phase I Clinical Trial	2001-07-18	Unused	NFKB1
Osteoarthritis	ENSG00000109991	FALSE	unknown	2006-02-13	Unused	P2RX3
Osteoarthritis	ENSG00000112038	FALSE	unknown	2013-02-25	Phase I Clinical Trial	OPRM1
Osteoarthritis	ENSG00000112062	FALSE	Preclinical	2010-01-29	Phase II Clinical Trial	MAPK14
Osteoarthritis	ENSG00000113448	FALSE	Phase II Clinical Trial	2004-01-28	Absent	PDE4D
Osteoarthritis	ENSG00000113580	TRUE	Approved	2013-10-03	Approved	NR3C1
Osteoarthritis	ENSG00000115008	FALSE	Phase II Clinical Trial	2007-11-13	Phase I Clinical Trial	IL1A
Osteoarthritis	ENSG00000115590	FALSE	Phase II Clinical Trial	1995-08-15	Unused	IL1R2
Osteoarthritis	ENSG00000115594	FALSE	Phase II Clinical Trial	1995-08-15	Unused	IL1R1
Osteoarthritis	ENSG00000117984	FALSE	Preclinical	2014-08-13	Absent	CTSD
Osteoarthritis	ENSG00000118113	TRUE	Approved	1998-10-15	Approved	MMP8
Osteoarthritis	ENSG00000118432	FALSE	Phase II Clinical Trial	2013-01-02	Unused	CNR1
Osteoarthritis	ENSG00000124391	FALSE	unknown	2008-11-28	Absent	IL17C
Osteoarthritis	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Osteoarthritis	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Osteoarthritis	ENSG00000128271	FALSE	Preclinical	2009-07-29	Unused	ADORA2A
Osteoarthritis	ENSG00000134259	FALSE	Phase III Clinical Trial	2003-03-26	Unused	NGF
Osteoarthritis	ENSG00000135047	FALSE	Preclinical	1997-01-15	Unused	CTSL
Osteoarthritis	ENSG00000136634	FALSE	Preclinical	2008-04-28	Unused	IL10
Osteoarthritis	ENSG00000136689	FALSE	Preclinical	2002-11-04	Unused	IL1RN
Osteoarthritis	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Osteoarthritis	ENSG00000136943	FALSE	unknown	2002-07-17	Unused	CTSV
Osteoarthritis	ENSG00000136960	FALSE	Preclinical	2015-09-03	Absent	ENPP2
Osteoarthritis	ENSG00000137745	FALSE	Phase I Clinical Trial	2003-08-12	Unused	MMP13
Osteoarthritis	ENSG00000137752	FALSE	unknown	1993-10-15	Unused	CASP1
Osteoarthritis	ENSG00000137809	FALSE	Preclinical	2003-10-20	Unused	ITGA11
Osteoarthritis	ENSG00000138448	FALSE	Preclinical	1996-06-15	Unused	ITGAV
Osteoarthritis	ENSG00000143127	FALSE	Preclinical	2003-10-20	Unused	ITGA10
Osteoarthritis	ENSG00000143387	FALSE	Phase II Clinical Trial	1995-08-15	Unused	CTSK
Osteoarthritis	ENSG00000144230	FALSE	Preclinical	2010-07-01	Absent	GPR17
Osteoarthritis	ENSG00000144285	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	SCN1A
Osteoarthritis	ENSG00000148344	FALSE	Phase I Clinical Trial	2012-07-04	Absent	PTGES
Osteoarthritis	ENSG00000149418	FALSE	Preclinical	2018-01-09	Absent	ST14
Osteoarthritis	ENSG00000149968	FALSE	Preclinical	1997-01-15	Unused	MMP3
Osteoarthritis	ENSG00000150093	FALSE	Preclinical	2003-10-20	Unused	ITGB1
Osteoarthritis	ENSG00000153253	FALSE	Phase II Clinical Trial	2000-01-11	Phase II Clinical Trial	SCN3A
Osteoarthritis	ENSG00000154736	FALSE	Phase I Clinical Trial	2009-12-08	Unused	ADAMTS5
Osteoarthritis	ENSG00000156427	FALSE	Phase II Clinical Trial	2002-05-08	Phase I Clinical Trial	FGF18
Osteoarthritis	ENSG00000157766	FALSE	Phase II Clinical Trial	2015-01-07	Absent	ACAN
Osteoarthritis	ENSG00000158859	FALSE	Phase II Clinical Trial	1997-03-15	Unused	ADAMTS4
Osteoarthritis	ENSG00000160951	TRUE	Approved	NA	Approved	PTGER1
Osteoarthritis	ENSG00000162434	FALSE	unknown	2009-12-08	Unused	JAK1
Osteoarthritis	ENSG00000162711	FALSE	Phase II Clinical Trial	2010-01-19	Absent	NLRP3
Osteoarthritis	ENSG00000164400	FALSE	Phase II Clinical Trial	2005-06-06	Absent	CSF2
Osteoarthritis	ENSG00000164733	FALSE	Preclinical	1997-01-15	Unused	CTSB
Osteoarthritis	ENSG00000166888	FALSE	Preclinical	2016-11-17	Absent	STAT6
Osteoarthritis	ENSG00000167723	FALSE	Preclinical	2008-06-02	Unused	TRPV3
Osteoarthritis	ENSG00000168398	FALSE	Phase II Clinical Trial	2006-12-14	Phase II Clinical Trial	BDKRB2
Osteoarthritis	ENSG00000169432	FALSE	Phase II Clinical Trial	2008-06-18	Absent	SCN9A
Osteoarthritis	ENSG00000171522	FALSE	Phase I Clinical Trial	2001-12-03	Unused	PTGER4
Osteoarthritis	ENSG00000176884	FALSE	Phase II Clinical Trial	1998-12-15	Unused	GRIN1
Osteoarthritis	ENSG00000176890	FALSE	Preclinical	2008-04-14	Unused	TYMS
Osteoarthritis	ENSG00000177606	FALSE	Phase I Clinical Trial	1994-06-15	Unused	JUN
Osteoarthritis	ENSG00000180720	FALSE	unknown	1995-12-15	Unused	CHRM4
Osteoarthritis	ENSG00000184381	FALSE	unknown	2005-08-02	Unused	PLA2G6
Osteoarthritis	ENSG00000184588	FALSE	Phase II Clinical Trial	2004-01-28	Absent	PDE4B
Osteoarthritis	ENSG00000188822	FALSE	Phase II Clinical Trial	2007-03-12	Unused	CNR2
Osteoarthritis	ENSG00000196689	FALSE	Phase II Clinical Trial	2007-08-06	Unused	TRPV1
Osteoarthritis	ENSG00000197405	FALSE	unknown	2003-06-24	Unused	C5AR1
Osteoarthritis	ENSG00000197891	FALSE	Phase II Clinical Trial	2010-01-19	Absent	SLC22A12
Osteoarthritis	ENSG00000198400	FALSE	Phase II Clinical Trial	2012-01-09	Preclinical	NTRK1
Osteoarthritis	ENSG00000213614	FALSE	Preclinical	2002-10-11	Unused	HEXA
Osteoarthritis	ENSG00000228716	FALSE	Preclinical	2008-04-14	Unused	DHFR
Osteoarthritis	ENSG00000259207	FALSE	Preclinical	1996-06-15	Unused	ITGB3
Osteoarthritis	ENSG00000261857	FALSE	Preclinical	2010-01-25	Preclinical	MIA
Osteoarthritis	ENSG00000282608	FALSE	Preclinical	2009-12-03	Preclinical	ADORA3
Osteochondroma	ENSG00000172819	FALSE	Preclinical	2001-01-23	Absent	RARG
Osteogenesis Imperfecta	ENSG00000120659	FALSE	Phase III Clinical Trial	1997-07-15	Absent	TNFSF11
Osteogenesis Imperfecta	ENSG00000167941	FALSE	Phase II Clinical Trial	2011-08-12	Phase II Clinical Trial	SOST
Osteomalacia	ENSG00000118972	FALSE	Phase III Clinical Trial	2009-01-30	Absent	FGF23
Osteomyelitis	ENSG00000065989	FALSE	Phase I Clinical Trial	2005-05-24	Absent	PDE4A
Osteomyelitis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Osteomyelitis	ENSG00000196689	FALSE	Preclinical	2015-12-02	Absent	TRPV1
Osteonecrosis	ENSG00000113721	FALSE	unknown	2001-10-16	Unused	PDGFRB
Osteonecrosis	ENSG00000125845	FALSE	Phase II Clinical Trial	NA	Unused	BMP2
Osteonecrosis	ENSG00000160013	FALSE	unknown	NA	Unused	PTGIR
Osteonecrosis	ENSG00000196689	FALSE	Preclinical	2015-12-02	Absent	TRPV1
Osteopetrosis	ENSG00000027697	TRUE	Approved	NA	Approved	IFNGR1
Osteopetrosis	ENSG00000160801	FALSE	Phase I Clinical Trial	2013-02-19	Phase I Clinical Trial	PTH1R
Osteoporosis	ENSG00000004948	TRUE	Approved	1990-01-15	Approved	CALCR
Osteoporosis	ENSG00000005961	FALSE	Preclinical	1998-03-15	Unused	ITGA2B
Osteoporosis	ENSG00000007952	FALSE	Preclinical	NA	Absent	NOX1
Osteoporosis	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Osteoporosis	ENSG00000012504	FALSE	Phase II Clinical Trial	1996-05-15	Unused	NR1H4
Osteoporosis	ENSG00000012779	FALSE	Phase II Clinical Trial	1994-08-15	Unused	ALOX5
Osteoporosis	ENSG00000017427	FALSE	Preclinical	1993-11-15	Unused	IGF1
Osteoporosis	ENSG00000019186	FALSE	unknown	2000-08-31	Absent	CYP24A1
Osteoporosis	ENSG00000036828	FALSE	Phase II Clinical Trial	1994-02-15	Phase II Clinical Trial	CASR
Osteoporosis	ENSG00000064989	FALSE	Preclinical	NA	Unused	CALCRL
Osteoporosis	ENSG00000065989	FALSE	Preclinical	NA	Unused	PDE4A
Osteoporosis	ENSG00000067182	FALSE	Preclinical	2008-04-07	Unused	TNFRSF1A
Osteoporosis	ENSG00000070018	FALSE	Preclinical	2006-11-13	Preclinical	LRP6
Osteoporosis	ENSG00000077782	FALSE	Preclinical	2007-10-12	Unused	FGFR1
Osteoporosis	ENSG00000082175	TRUE	Approved	1991-04-15	Approved	PGR
Osteoporosis	ENSG00000082701	FALSE	Preclinical	2006-10-10	Unused	GSK3B
Osteoporosis	ENSG00000082781	FALSE	Preclinical	2001-01-30	Unused	ITGB5
Osteoporosis	ENSG00000086696	FALSE	Preclinical	2001-03-19	Unused	HSD17B2
Osteoporosis	ENSG00000086991	FALSE	Preclinical	NA	Absent	NOX4
Osteoporosis	ENSG00000089041	FALSE	Preclinical	2011-12-09	Preclinical	P2RX7
Osteoporosis	ENSG00000091831	TRUE	Approved	1991-04-15	Approved	ESR1
Osteoporosis	ENSG00000101144	FALSE	unknown	1994-04-15	Unused	BMP7
Osteoporosis	ENSG00000104332	FALSE	Preclinical	2007-08-22	Unused	SFRP1
Osteoporosis	ENSG00000105397	FALSE	Preclinical	2011-05-04	Unused	TYK2
Osteoporosis	ENSG00000105650	FALSE	Preclinical	NA	Unused	PDE4C
Osteoporosis	ENSG00000106128	FALSE	Phase I Clinical Trial	1992-09-15	Unused	GHRHR
Osteoporosis	ENSG00000107831	FALSE	Preclinical	2008-08-08	Unused	FGF8
Osteoporosis	ENSG00000107984	FALSE	Preclinical	2004-10-18	Unused	DKK1
Osteoporosis	ENSG00000109320	FALSE	Preclinical	2002-11-08	Unused	NFKB1
Osteoporosis	ENSG00000110680	FALSE	Approved	NA	Unused	CALCA
Osteoporosis	ENSG00000111199	FALSE	Preclinical	2010-07-08	Preclinical	TRPV4
Osteoporosis	ENSG00000111424	TRUE	Approved	1989-07-15	Approved	VDR
Osteoporosis	ENSG00000112033	FALSE	unknown	2004-08-26	Unused	PPARD
Osteoporosis	ENSG00000112964	FALSE	Preclinical	2001-12-11	Unused	GHR
Osteoporosis	ENSG00000113161	TRUE	Approved	1992-08-15	Unused	HMGCR
Osteoporosis	ENSG00000113448	FALSE	Preclinical	NA	Unused	PDE4D
Osteoporosis	ENSG00000113580	FALSE	Preclinical	NA	Unused	NR3C1
Osteoporosis	ENSG00000114378	FALSE	Phase I Clinical Trial	2004-08-26	Unused	HYAL1
Osteoporosis	ENSG00000115085	FALSE	Preclinical	1995-02-15	Unused	ZAP70
Osteoporosis	ENSG00000115263	FALSE	Phase II Clinical Trial	NA	Unused	GCG
Osteoporosis	ENSG00000115457	FALSE	Preclinical	2014-12-04	Absent	IGFBP2
Osteoporosis	ENSG00000119715	FALSE	Preclinical	1999-12-20	Unused	ESRRB
Osteoporosis	ENSG00000120659	TRUE	Approved	1997-07-15	Approved	TNFSF11
Osteoporosis	ENSG00000121853	FALSE	Preclinical	2008-08-28	Unused	GHSR
Osteoporosis	ENSG00000121989	FALSE	Preclinical	NA	Unused	ACVR2A
Osteoporosis	ENSG00000122420	FALSE	Preclinical	2001-08-29	Unused	PTGFR
Osteoporosis	ENSG00000124391	FALSE	unknown	2008-11-28	Absent	IL17C
Osteoporosis	ENSG00000124813	FALSE	Preclinical	2010-06-28	Unused	RUNX2
Osteoporosis	ENSG00000125845	FALSE	Phase II Clinical Trial	1994-04-15	Phase II Clinical Trial	BMP2
Osteoporosis	ENSG00000127418	FALSE	Preclinical	2003-05-16	Unused	FGFRL1
Osteoporosis	ENSG00000132170	FALSE	Preclinical	2001-03-19	Unused	PPARG
Osteoporosis	ENSG00000132329	FALSE	Preclinical	NA	Unused	RAMP1
Osteoporosis	ENSG00000134318	FALSE	Preclinical	2003-10-29	Unused	ROCK2
Osteoporosis	ENSG00000135047	FALSE	Phase I Clinical Trial	1994-11-15	Unused	CTSL
Osteoporosis	ENSG00000136943	FALSE	Phase I Clinical Trial	2002-07-17	Unused	CTSV
Osteoporosis	ENSG00000137752	FALSE	Preclinical	NA	Unused	CASP1
Osteoporosis	ENSG00000137869	FALSE	unknown	2002-12-17	Unused	CYP19A1
Osteoporosis	ENSG00000138039	FALSE	Preclinical	2009-02-19	Absent	LHCGR
Osteoporosis	ENSG00000138448	FALSE	Phase I Clinical Trial	1993-06-15	Unused	ITGAV
Osteoporosis	ENSG00000140009	FALSE	Phase I Clinical Trial	2001-12-06	Phase I Clinical Trial	ESR2
Osteoporosis	ENSG00000140443	FALSE	Phase II Clinical Trial	NA	Unused	IGF1R
Osteoporosis	ENSG00000140937	FALSE	Preclinical	2003-12-03	Unused	CDH11
Osteoporosis	ENSG00000141655	FALSE	Preclinical	1999-09-15	Unused	TNFRSF11A
Osteoporosis	ENSG00000143387	FALSE	Phase II Clinical Trial	1995-08-15	Phase III Clinical Trial	CTSK
Osteoporosis	ENSG00000149295	FALSE	Preclinical	1996-01-15	Unused	DRD2
Osteoporosis	ENSG00000152266	FALSE	Approved	1998-07-15	Unused	PTH
Osteoporosis	ENSG00000160801	TRUE	Approved	1990-04-15	Approved	PTH1R
Osteoporosis	ENSG00000162337	FALSE	Preclinical	1997-06-15	Unused	LRP5
Osteoporosis	ENSG00000162891	FALSE	Preclinical	2012-05-16	Preclinical	IL20
Osteoporosis	ENSG00000164733	FALSE	Preclinical	1994-12-15	Unused	CTSB
Osteoporosis	ENSG00000164761	FALSE	Preclinical	1998-06-15	Unused	TNFRSF11B
Osteoporosis	ENSG00000166311	FALSE	Phase I Clinical Trial	2011-08-02	Preclinical	SMPD1
Osteoporosis	ENSG00000167941	FALSE	Pre-registration	1998-12-15	Phase III Clinical Trial	SOST
Osteoporosis	ENSG00000169083	TRUE	Approved	1995-09-15	Approved	AR
Osteoporosis	ENSG00000169252	FALSE	Preclinical	2004-01-19	Unused	ADRB2
Osteoporosis	ENSG00000169432	FALSE	Phase III Clinical Trial	2011-05-09	Phase III Clinical Trial	SCN9A
Osteoporosis	ENSG00000169508	FALSE	Preclinical	2016-06-16	Absent	GPR183
Osteoporosis	ENSG00000170820	FALSE	Preclinical	2009-02-19	Unused	FSHR
Osteoporosis	ENSG00000172216	FALSE	Preclinical	1994-11-15	Unused	CEBPB
Osteoporosis	ENSG00000173153	FALSE	Preclinical	1999-12-20	Unused	ESRRA
Osteoporosis	ENSG00000174697	FALSE	Preclinical	2001-07-19	Unused	LEP
Osteoporosis	ENSG00000175104	FALSE	Preclinical	2012-06-26	Preclinical	TRAF6
Osteoporosis	ENSG00000184588	FALSE	Preclinical	NA	Unused	PDE4B
Osteoporosis	ENSG00000184845	FALSE	Preclinical	1996-01-15	Unused	DRD1
Osteoporosis	ENSG00000185269	FALSE	Preclinical	2016-05-27	Absent	NOTUM
Osteoporosis	ENSG00000186951	FALSE	unknown	2004-08-26	Unused	PPARA
Osteoporosis	ENSG00000188729	FALSE	Preclinical	2005-08-17	Unused	OSTN
Osteoporosis	ENSG00000188822	FALSE	Preclinical	2009-06-11	Unused	CNR2
Osteoporosis	ENSG00000196482	FALSE	Preclinical	1999-12-20	Unused	ESRRG
Osteoporosis	ENSG00000196611	FALSE	Preclinical	1990-05-15	Unused	MMP1
Osteoporosis	ENSG00000196689	FALSE	unknown	1994-05-15	Unused	TRPV1
Osteoporosis	ENSG00000197046	FALSE	Phase I Clinical Trial	2011-02-11	Absent	SIGLEC15
Osteoporosis	ENSG00000197081	FALSE	Preclinical	1989-12-15	Unused	IGF2R
Osteoporosis	ENSG00000197122	FALSE	Preclinical	1996-01-15	Unused	SRC
Osteoporosis	ENSG00000198668	FALSE	Preclinical	NA	Unused	CALM1
Osteoporosis	ENSG00000213903	FALSE	Phase I Clinical Trial	2001-03-08	Unused	LTB4R
Osteoporosis	ENSG00000259207	FALSE	Phase I Clinical Trial	1993-06-15	Unused	ITGB3
Osteoporosis	ENSG00000261857	FALSE	Preclinical	2004-07-13	Unused	MIA
Osteosarcoma	ENSG00000026025	FALSE	Preclinical	2014-10-14	Absent	VIM
Osteosarcoma	ENSG00000026103	FALSE	Preclinical	2008-06-03	Unused	FAS
Osteosarcoma	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT4
Osteosarcoma	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Osteosarcoma	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Osteosarcoma	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR3
Osteosarcoma	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR1
Osteosarcoma	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Osteosarcoma	ENSG00000082898	FALSE	Phase I Clinical Trial	2012-06-02	Absent	XPO1
Osteosarcoma	ENSG00000085563	FALSE	unknown	1997-01-15	Unused	ABCB1
Osteosarcoma	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Osteosarcoma	ENSG00000102755	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT1
Osteosarcoma	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Osteosarcoma	ENSG00000105976	FALSE	Phase II Clinical Trial	2004-08-09	Absent	MET
Osteosarcoma	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Unused	NFKB1
Osteosarcoma	ENSG00000113328	FALSE	Phase III Clinical Trial	2003-08-05	Phase II Clinical Trial	CCNG1
Osteosarcoma	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-08-09	Absent	TEK
Osteosarcoma	ENSG00000122025	FALSE	Phase II Clinical Trial	2004-08-09	Absent	FLT3
Osteosarcoma	ENSG00000128052	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KDR
Osteosarcoma	ENSG00000128602	FALSE	Phase II Clinical Trial	2008-11-24	Phase II Clinical Trial	SMO
Osteosarcoma	ENSG00000130368	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAS1
Osteosarcoma	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK4
Osteosarcoma	ENSG00000131747	TRUE	Approved	2006-12-05	Approved	TOP2A
Osteosarcoma	ENSG00000135679	FALSE	Phase I Clinical Trial	2012-11-21	Absent	MDM2
Osteosarcoma	ENSG00000136235	FALSE	Phase II Clinical Trial	1999-12-10	Absent	GPNMB
Osteosarcoma	ENSG00000138448	FALSE	Preclinical	2001-11-05	Unused	ITGAV
Osteosarcoma	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-09-24	Phase II Clinical Trial	IGF1R
Osteosarcoma	ENSG00000141736	FALSE	Phase II Clinical Trial	2005-08-10	Preclinical	ERBB2
Osteosarcoma	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK1
Osteosarcoma	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Osteosarcoma	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KIT
Osteosarcoma	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Osteosarcoma	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Osteosarcoma	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Osteosarcoma	ENSG00000165731	FALSE	Phase II Clinical Trial	2003-07-22	Absent	RET
Osteosarcoma	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Osteosarcoma	ENSG00000173638	FALSE	Preclinical	1996-12-15	Absent	SLC19A1
Osteosarcoma	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Osteosarcoma	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Osteosarcoma	ENSG00000184033	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	CTAG1B
Osteosarcoma	ENSG00000196352	FALSE	unknown	1994-06-15	Unused	CD55
Osteosarcoma	ENSG00000196689	FALSE	Preclinical	2015-12-02	Absent	TRPV1
Osteosarcoma	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Approved	MTOR
Osteosarcoma	ENSG00000198900	FALSE	Phase I Clinical Trial	1998-11-15	Absent	TOP1
Osteosarcoma	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Osteosarcoma	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Osteosarcoma	ENSG00000263761	FALSE	Preclinical	NA	Absent	GDF2
Otitis	ENSG00000065989	FALSE	Preclinical	2005-05-24	Absent	PDE4A
Otitis	ENSG00000113580	TRUE	Approved	1998-12-15	Approved	NR3C1
Otitis	ENSG00000159110	TRUE	Approved	NA	Unused	IFNAR2
Otitis Externa	ENSG00000113580	TRUE	Approved	2002-06-12	Approved	NR3C1
Otitis Media	ENSG00000101180	FALSE	unknown	2013-02-23	Preclinical	HRH3
Otitis Media	ENSG00000113580	TRUE	Approved	2002-06-12	Phase III Clinical Trial	NR3C1
Otitis Media	ENSG00000136869	FALSE	Preclinical	2010-12-20	Absent	TLR4
Otitis Media	ENSG00000137462	FALSE	Preclinical	2010-12-20	Absent	TLR2
Otitis Media	ENSG00000169432	FALSE	Phase III Clinical Trial	2014-01-08	Absent	SCN9A
Otitis Media	ENSG00000196639	FALSE	unknown	2013-02-23	Preclinical	HRH1
Otitis Media	ENSG00000239732	FALSE	Preclinical	2010-12-20	Absent	TLR9
Ovarian Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	CFLAR
Ovarian Neoplasms	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Ovarian Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Ovarian Neoplasms	ENSG00000010327	FALSE	Preclinical	2009-11-12	Absent	STAB1
Ovarian Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2014-01-01	Absent	BTK
Ovarian Neoplasms	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Ovarian Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Ovarian Neoplasms	ENSG00000012048	FALSE	Phase I Clinical Trial	1993-07-15	Unused	BRCA1
Ovarian Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Ovarian Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2005-11-21	Absent	BIRC3
Ovarian Neoplasms	ENSG00000025434	FALSE	Phase I Clinical Trial	2014-11-13	Absent	NR1H3
Ovarian Neoplasms	ENSG00000026025	FALSE	Preclinical	2014-10-14	Absent	VIM
Ovarian Neoplasms	ENSG00000026103	FALSE	Phase III Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Ovarian Neoplasms	ENSG00000026508	FALSE	Phase I Clinical Trial	1997-03-15	Unused	CD44
Ovarian Neoplasms	ENSG00000027697	FALSE	unknown	NA	Unused	IFNGR1
Ovarian Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT4
Ovarian Neoplasms	ENSG00000041982	FALSE	unknown	2007-05-29	Unused	TNC
Ovarian Neoplasms	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Ovarian Neoplasms	ENSG00000049249	FALSE	unknown	2005-11-15	Unused	TNFRSF9
Ovarian Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Ovarian Neoplasms	ENSG00000051341	FALSE	Preclinical	2017-03-02	Absent	POLQ
Ovarian Neoplasms	ENSG00000051382	FALSE	unknown	2005-12-01	Absent	PIK3CB
Ovarian Neoplasms	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Phase II Clinical Trial	LY75
Ovarian Neoplasms	ENSG00000058085	FALSE	Preclinical	2009-02-12	Unused	LAMC2
Ovarian Neoplasms	ENSG00000060491	FALSE	Phase II Clinical Trial	2012-09-01	Absent	OGFR
Ovarian Neoplasms	ENSG00000063176	FALSE	Phase I Clinical Trial	2006-06-05	Absent	SPHK2
Ovarian Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	ERBB3
Ovarian Neoplasms	ENSG00000066044	FALSE	Preclinical	2016-09-21	Absent	ELAVL1
Ovarian Neoplasms	ENSG00000066405	FALSE	unknown	2004-01-06	Absent	CLDN18
Ovarian Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FGFR2
Ovarian Neoplasms	ENSG00000067182	FALSE	Phase III Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Ovarian Neoplasms	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Ovarian Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Ovarian Neoplasms	ENSG00000070501	FALSE	Phase II Clinical Trial	1995-06-15	Unused	POLB
Ovarian Neoplasms	ENSG00000071242	FALSE	Preclinical	1999-07-06	Unused	RPS6KA2
Ovarian Neoplasms	ENSG00000073756	FALSE	Phase II Clinical Trial	2001-04-11	Unused	PTGS2
Ovarian Neoplasms	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Ovarian Neoplasms	ENSG00000076706	FALSE	Preclinical	2003-02-27	Unused	MCAM
Ovarian Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Ovarian Neoplasms	ENSG00000079385	FALSE	Phase I Clinical Trial	2015-01-09	Absent	CEACAM1
Ovarian Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2003-11-25	Unused	HSP90AA1
Ovarian Neoplasms	ENSG00000081051	FALSE	Preclinical	2014-11-13	Absent	AFP
Ovarian Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Ovarian Neoplasms	ENSG00000082175	FALSE	Phase II Clinical Trial	NA	Absent	PGR
Ovarian Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGB5
Ovarian Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Ovarian Neoplasms	ENSG00000083312	FALSE	Phase II Clinical Trial	2005-06-27	Unused	TNPO1
Ovarian Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Ovarian Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Ovarian Neoplasms	ENSG00000085563	FALSE	unknown	1994-04-15	Unused	ABCB1
Ovarian Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Absent	FOLH1
Ovarian Neoplasms	ENSG00000087245	FALSE	unknown	1997-01-15	Unused	MMP2
Ovarian Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKA
Ovarian Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2002-04-29	Phase II Clinical Trial	BIRC5
Ovarian Neoplasms	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Ovarian Neoplasms	ENSG00000090339	FALSE	Preclinical	2004-07-19	Preclinical	ICAM1
Ovarian Neoplasms	ENSG00000091831	FALSE	Pre-registration	1989-06-15	Unused	ESR1
Ovarian Neoplasms	ENSG00000091879	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT2
Ovarian Neoplasms	ENSG00000095303	FALSE	Phase II Clinical Trial	2001-04-11	Unused	PTGS1
Ovarian Neoplasms	ENSG00000096968	FALSE	unknown	2007-08-07	Unused	JAK2
Ovarian Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Ovarian Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Phase I Clinical Trial	ABL1
Ovarian Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2016-10-12	Absent	CDC7
Ovarian Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Ovarian Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Ovarian Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDGFB
Ovarian Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	1997-04-15	Phase I Clinical Trial	HIF1A
Ovarian Neoplasms	ENSG00000100823	FALSE	Preclinical	2003-06-18	Unused	APEX1
Ovarian Neoplasms	ENSG00000100985	FALSE	unknown	1997-01-15	Unused	MMP9
Ovarian Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2010-07-20	Absent	CD40
Ovarian Neoplasms	ENSG00000101266	FALSE	unknown	2007-05-23	Preclinical	CSNK2A1
Ovarian Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Ovarian Neoplasms	ENSG00000101846	FALSE	unknown	2000-03-15	Unused	STS
Ovarian Neoplasms	ENSG00000101868	FALSE	Phase II Clinical Trial	1993-08-15	Phase I Clinical Trial	POLA1
Ovarian Neoplasms	ENSG00000101916	FALSE	Phase II Clinical Trial	2008-06-17	Phase II Clinical Trial	TLR8
Ovarian Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	XIAP
Ovarian Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	1994-03-15	Phase III Clinical Trial	FLT1
Ovarian Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	1999-04-21	Phase I Clinical Trial	MSLN
Ovarian Neoplasms	ENSG00000102967	FALSE	unknown	1994-12-15	Unused	DHODH
Ovarian Neoplasms	ENSG00000103222	FALSE	unknown	1994-04-15	Unused	ABCC1
Ovarian Neoplasms	ENSG00000103522	FALSE	unknown	2001-01-25	Unused	IL21R
Ovarian Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Ovarian Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	2004-10-06	Phase I Clinical Trial	CGB3
Ovarian Neoplasms	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKC
Ovarian Neoplasms	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE1
Ovarian Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Ovarian Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1999-05-19	Phase II Clinical Trial	CEACAM5
Ovarian Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CG
Ovarian Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Ovarian Neoplasms	ENSG00000106128	FALSE	Preclinical	2013-01-22	Absent	GHRHR
Ovarian Neoplasms	ENSG00000106211	FALSE	Phase I Clinical Trial	2004-09-24	Phase I Clinical Trial	HSPB1
Ovarian Neoplasms	ENSG00000106268	FALSE	Preclinical	2015-03-23	Absent	NUDT1
Ovarian Neoplasms	ENSG00000106348	FALSE	unknown	NA	Unused	IMPDH1
Ovarian Neoplasms	ENSG00000106546	FALSE	unknown	1999-04-13	Unused	AHR
Ovarian Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Ovarian Neoplasms	ENSG00000107562	FALSE	unknown	2003-04-10	Unused	CXCL12
Ovarian Neoplasms	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Ovarian Neoplasms	ENSG00000108424	FALSE	Phase II Clinical Trial	2005-06-27	Unused	KPNB1
Ovarian Neoplasms	ENSG00000108443	FALSE	Phase II Clinical Trial	2003-03-20	Unused	RPS6KB1
Ovarian Neoplasms	ENSG00000108654	FALSE	Preclinical	2006-08-30	Preclinical	DDX5
Ovarian Neoplasms	ENSG00000108679	FALSE	Preclinical	2014-07-22	Absent	LGALS3BP
Ovarian Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Ovarian Neoplasms	ENSG00000109163	FALSE	Phase I Clinical Trial	1998-06-15	Phase II Clinical Trial	GNRHR
Ovarian Neoplasms	ENSG00000109193	FALSE	Preclinical	2004-01-20	Unused	SULT1E1
Ovarian Neoplasms	ENSG00000109320	FALSE	Preclinical	1997-11-15	Unused	NFKB1
Ovarian Neoplasms	ENSG00000109471	FALSE	unknown	2003-08-05	Unused	IL2
Ovarian Neoplasms	ENSG00000110092	FALSE	unknown	2005-08-30	Phase I Clinical Trial	CCND1
Ovarian Neoplasms	ENSG00000110195	FALSE	Pre-registration	1993-07-15	Approved	FOLR1
Ovarian Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2005-11-21	Absent	BIRC2
Ovarian Neoplasms	ENSG00000111640	FALSE	Preclinical	2013-07-26	Absent	GAPDH
Ovarian Neoplasms	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Ovarian Neoplasms	ENSG00000112062	FALSE	Phase II Clinical Trial	2008-05-23	Phase II Clinical Trial	MAPK14
Ovarian Neoplasms	ENSG00000112541	FALSE	Preclinical	2017-05-12	Absent	PDE10A
Ovarian Neoplasms	ENSG00000112655	FALSE	Phase I Clinical Trial	2014-08-25	Absent	PTK7
Ovarian Neoplasms	ENSG00000112715	TRUE	Approved	1993-05-15	Approved	VEGFA
Ovarian Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2002-06-13	Unused	HBEGF
Ovarian Neoplasms	ENSG00000113249	FALSE	Preclinical	2006-08-25	Preclinical	HAVCR1
Ovarian Neoplasms	ENSG00000113302	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12B
Ovarian Neoplasms	ENSG00000113328	FALSE	unknown	2003-08-05	Unused	CCNG1
Ovarian Neoplasms	ENSG00000113361	FALSE	Phase I Clinical Trial	2016-06-25	Absent	CDH6
Ovarian Neoplasms	ENSG00000113494	FALSE	Phase I Clinical Trial	2010-01-28	Unused	PRLR
Ovarian Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Ovarian Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Ovarian Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	1998-02-15	Phase III Clinical Trial	PDGFRB
Ovarian Neoplasms	ENSG00000114739	FALSE	Phase I Clinical Trial	2012-10-31	Absent	ACVR2B
Ovarian Neoplasms	ENSG00000115008	FALSE	unknown	2009-12-07	Preclinical	IL1A
Ovarian Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Phase I Clinical Trial	ITGB6
Ovarian Neoplasms	ENSG00000115457	FALSE	Phase II Clinical Trial	2017-06-13	Absent	IGFBP2
Ovarian Neoplasms	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Ovarian Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase I Clinical Trial	ODC1
Ovarian Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Ovarian Neoplasms	ENSG00000116106	FALSE	Phase I Clinical Trial	2014-03-06	Absent	EPHA4
Ovarian Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Unused	HDAC1
Ovarian Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Ovarian Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG1
Ovarian Neoplasms	ENSG00000119630	FALSE	unknown	2003-07-24	Phase II Clinical Trial	PGF
Ovarian Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1991-12-15	Phase III Clinical Trial	EPCAM
Ovarian Neoplasms	ENSG00000120156	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	TEK
Ovarian Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Ovarian Neoplasms	ENSG00000120885	FALSE	unknown	2001-12-07	Unused	CLU
Ovarian Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	TNFRSF10B
Ovarian Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Ovarian Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Ovarian Neoplasms	ENSG00000121966	FALSE	Phase I Clinical Trial	2003-04-10	Unused	CXCR4
Ovarian Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Ovarian Neoplasms	ENSG00000122194	FALSE	unknown	1995-05-15	Unused	PLG
Ovarian Neoplasms	ENSG00000122641	FALSE	Phase I Clinical Trial	2012-10-31	Absent	INHBA
Ovarian Neoplasms	ENSG00000122861	FALSE	Preclinical	1999-03-10	Unused	PLAU
Ovarian Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK2
Ovarian Neoplasms	ENSG00000123384	FALSE	Phase II Clinical Trial	2006-01-09	Absent	LRP1
Ovarian Neoplasms	ENSG00000123496	FALSE	Preclinical	2006-12-01	Unused	IL13RA2
Ovarian Neoplasms	ENSG00000124762	FALSE	Preclinical	1996-05-15	Unused	CDKN1A
Ovarian Neoplasms	ENSG00000125498	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL1
Ovarian Neoplasms	ENSG00000125726	FALSE	Phase II Clinical Trial	2011-05-17	Absent	CD70
Ovarian Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K2
Ovarian Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	KDR
Ovarian Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Unused	SMO
Ovarian Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2005-09-14	Preclinical	DLL4
Ovarian Neoplasms	ENSG00000129484	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP2
Ovarian Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	2006-12-06	Phase II Clinical Trial	DNMT1
Ovarian Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Ovarian Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase I Clinical Trial	PPT1
Ovarian Neoplasms	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Ovarian Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	2002-08-05	Unused	LGALS3
Ovarian Neoplasms	ENSG00000132155	FALSE	Phase I Clinical Trial	1994-06-15	Phase II Clinical Trial	RAF1
Ovarian Neoplasms	ENSG00000132383	FALSE	Preclinical	1998-06-15	Phase I Clinical Trial	RPA1
Ovarian Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Preclinical	CASP9
Ovarian Neoplasms	ENSG00000133703	FALSE	Preclinical	2015-07-24	Absent	KRAS
Ovarian Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Ovarian Neoplasms	ENSG00000134258	FALSE	Preclinical	2007-01-22	Unused	VTCN1
Ovarian Neoplasms	ENSG00000134460	FALSE	Phase I Clinical Trial	2000-11-07	Unused	IL2RA
Ovarian Neoplasms	ENSG00000134470	FALSE	Preclinical	2010-10-05	Absent	IL15RA
Ovarian Neoplasms	ENSG00000134545	FALSE	Phase II Clinical Trial	2006-11-24	Absent	KLRC1
Ovarian Neoplasms	ENSG00000134853	FALSE	Phase III Clinical Trial	1994-12-15	Phase III Clinical Trial	PDGFRA
Ovarian Neoplasms	ENSG00000135409	FALSE	Phase I Clinical Trial	2004-09-17	Unused	AMHR2
Ovarian Neoplasms	ENSG00000135446	FALSE	unknown	NA	Unused	CDK4
Ovarian Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Ovarian Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL6
Ovarian Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Ovarian Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK9
Ovarian Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Ovarian Neoplasms	ENSG00000136869	FALSE	Phase I Clinical Trial	2012-08-06	Absent	TLR4
Ovarian Neoplasms	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Ovarian Neoplasms	ENSG00000137869	FALSE	Phase II Clinical Trial	1991-02-15	Unused	CYP19A1
Ovarian Neoplasms	ENSG00000138039	FALSE	Phase II Clinical Trial	2008-10-31	Phase II Clinical Trial	LHCGR
Ovarian Neoplasms	ENSG00000138061	FALSE	unknown	NA	Unused	CYP1B1
Ovarian Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Ovarian Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGAV
Ovarian Neoplasms	ENSG00000138685	FALSE	Phase II Clinical Trial	1993-05-15	Absent	FGF2
Ovarian Neoplasms	ENSG00000139193	FALSE	Phase II Clinical Trial	2008-11-12	Absent	CD27
Ovarian Neoplasms	ENSG00000139567	FALSE	Phase II Clinical Trial	2007-05-30	Phase II Clinical Trial	ACVRL1
Ovarian Neoplasms	ENSG00000139618	FALSE	Preclinical	1996-02-15	Unused	BRCA2
Ovarian Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Ovarian Neoplasms	ENSG00000140465	FALSE	unknown	1999-04-13	Unused	CYP1A1
Ovarian Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Ovarian Neoplasms	ENSG00000141096	FALSE	Preclinical	NA	Absent	DPEP3
Ovarian Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1993-10-15	Phase II Clinical Trial	TP53
Ovarian Neoplasms	ENSG00000141736	FALSE	Phase III Clinical Trial	1992-02-15	Phase III Clinical Trial	ERBB2
Ovarian Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Absent	BRD4
Ovarian Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase I Clinical Trial	AKT1
Ovarian Neoplasms	ENSG00000142627	FALSE	Preclinical	2006-09-11	Unused	EPHA2
Ovarian Neoplasms	ENSG00000143171	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRG
Ovarian Neoplasms	ENSG00000143226	FALSE	Phase II Clinical Trial	NA	Absent	FCGR2A
Ovarian Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	MCL1
Ovarian Neoplasms	ENSG00000143799	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP1
Ovarian Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	SRD5A1
Ovarian Neoplasms	ENSG00000146049	FALSE	Preclinical	2015-02-24	Absent	KAAG1
Ovarian Neoplasms	ENSG00000146242	FALSE	Phase II Clinical Trial	1999-06-10	Preclinical	TPBG
Ovarian Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1992-03-15	Phase III Clinical Trial	EGFR
Ovarian Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	EPHA1
Ovarian Neoplasms	ENSG00000147437	FALSE	Phase II Clinical Trial	2008-10-31	Phase II Clinical Trial	GNRH1
Ovarian Neoplasms	ENSG00000147955	FALSE	Preclinical	2011-02-04	Absent	SIGMAR1
Ovarian Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Ovarian Neoplasms	ENSG00000148795	FALSE	Preclinical	2008-10-27	Absent	CYP17A1
Ovarian Neoplasms	ENSG00000149294	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	NCAM1
Ovarian Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Ovarian Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	2007-04-23	Phase I Clinical Trial	CHEK1
Ovarian Neoplasms	ENSG00000149968	FALSE	unknown	1997-01-15	Unused	MMP3
Ovarian Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Ovarian Neoplasms	ENSG00000150337	FALSE	Phase II Clinical Trial	1992-02-15	Unused	FCGR1A
Ovarian Neoplasms	ENSG00000151617	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	EDNRA
Ovarian Neoplasms	ENSG00000151694	FALSE	unknown	2005-08-30	Phase I Clinical Trial	ADAM17
Ovarian Neoplasms	ENSG00000154188	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT1
Ovarian Neoplasms	ENSG00000154229	FALSE	Preclinical	1991-01-15	Unused	PRKCA
Ovarian Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase I Clinical Trial	EEF1A1
Ovarian Neoplasms	ENSG00000157036	FALSE	unknown	2009-12-08	Unused	EXOG
Ovarian Neoplasms	ENSG00000157404	FALSE	Phase III Clinical Trial	2000-07-05	Phase III Clinical Trial	KIT
Ovarian Neoplasms	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	BRAF
Ovarian Neoplasms	ENSG00000157765	FALSE	Phase II Clinical Trial	2011-06-03	Absent	SLC34A2
Ovarian Neoplasms	ENSG00000159110	FALSE	Approved	2013-01-08	Unused	IFNAR2
Ovarian Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Ovarian Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Ovarian Neoplasms	ENSG00000161011	FALSE	Phase II Clinical Trial	2015-11-04	Absent	SQSTM1
Ovarian Neoplasms	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Ovarian Neoplasms	ENSG00000162747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3B
Ovarian Neoplasms	ENSG00000163217	FALSE	Phase II Clinical Trial	2007-05-30	Absent	BMP10
Ovarian Neoplasms	ENSG00000163220	FALSE	Phase II Clinical Trial	2001-05-18	Phase II Clinical Trial	S100A9
Ovarian Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	1998-09-15	Phase II Clinical Trial	CTLA4
Ovarian Neoplasms	ENSG00000163785	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RYK
Ovarian Neoplasms	ENSG00000164171	FALSE	Preclinical	2008-08-19	Preclinical	ITGA2
Ovarian Neoplasms	ENSG00000164305	FALSE	Phase II Clinical Trial	1994-07-15	Phase II Clinical Trial	CASP3
Ovarian Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	TLR3
Ovarian Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2013-05-28	Absent	TERT
Ovarian Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Ovarian Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Ovarian Neoplasms	ENSG00000165125	FALSE	Phase I Clinical Trial	2011-08-04	Phase I Clinical Trial	TRPV6
Ovarian Neoplasms	ENSG00000165215	FALSE	Preclinical	2009-02-12	Unused	CLDN3
Ovarian Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	ENOX2
Ovarian Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Ovarian Neoplasms	ENSG00000166483	FALSE	Phase II Clinical Trial	2008-04-09	Phase II Clinical Trial	WEE1
Ovarian Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Ovarian Neoplasms	ENSG00000166825	FALSE	Approved	2003-02-20	Phase II Clinical Trial	ANPEP
Ovarian Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase II Clinical Trial	PLK1
Ovarian Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1993-07-15	Unused	RRM1
Ovarian Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2014-09-11	Absent	AXL
Ovarian Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1993-05-15	Unused	EEF2
Ovarian Neoplasms	ENSG00000168078	FALSE	Preclinical	2013-08-07	Absent	PBK
Ovarian Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	NA	Phase II Clinical Trial	FNTA
Ovarian Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Unused	STAT3
Ovarian Neoplasms	ENSG00000168811	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12A
Ovarian Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2003-06-09	Phase II Clinical Trial	MAP2K1
Ovarian Neoplasms	ENSG00000169035	FALSE	unknown	2006-06-27	Unused	KLK7
Ovarian Neoplasms	ENSG00000169083	FALSE	Preclinical	2008-07-15	Preclinical	AR
Ovarian Neoplasms	ENSG00000169398	FALSE	Phase II Clinical Trial	2007-01-08	Phase II Clinical Trial	PTK2
Ovarian Neoplasms	ENSG00000169403	FALSE	Preclinical	2008-01-22	Unused	PTAFR
Ovarian Neoplasms	ENSG00000169429	FALSE	unknown	1992-01-15	Unused	CXCL8
Ovarian Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Ovarian Neoplasms	ENSG00000170145	FALSE	Preclinical	2012-08-17	Preclinical	SIK2
Ovarian Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Ovarian Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Ovarian Neoplasms	ENSG00000170965	FALSE	Preclinical	2007-06-08	Unused	PLAC1
Ovarian Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Ovarian Neoplasms	ENSG00000171509	FALSE	Preclinical	2011-10-20	Preclinical	RXFP1
Ovarian Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CD
Ovarian Neoplasms	ENSG00000171848	FALSE	Preclinical	1997-03-15	Unused	RRM2
Ovarian Neoplasms	ENSG00000171862	FALSE	unknown	2005-08-22	Phase II Clinical Trial	PTEN
Ovarian Neoplasms	ENSG00000172201	FALSE	Preclinical	2001-01-05	Unused	ID4
Ovarian Neoplasms	ENSG00000172819	FALSE	Phase I Clinical Trial	2003-11-28	Unused	RARG
Ovarian Neoplasms	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Ovarian Neoplasms	ENSG00000173546	FALSE	Preclinical	2004-01-13	Unused	CSPG4
Ovarian Neoplasms	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Ovarian Neoplasms	ENSG00000175054	FALSE	Phase II Clinical Trial	2013-07-22	Absent	ATR
Ovarian Neoplasms	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE2
Ovarian Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Ovarian Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Ovarian Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Phase I Clinical Trial	ERBB4
Ovarian Neoplasms	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-10-20	Phase II Clinical Trial	AURKB
Ovarian Neoplasms	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Ovarian Neoplasms	ENSG00000179776	FALSE	Phase III Clinical Trial	2000-12-11	Phase II Clinical Trial	CDH5
Ovarian Neoplasms	ENSG00000181143	FALSE	Phase III Clinical Trial	2001-03-23	Phase III Clinical Trial	MUC16
Ovarian Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	CSF1R
Ovarian Neoplasms	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Ovarian Neoplasms	ENSG00000183087	FALSE	Preclinical	2016-02-16	Absent	GAS6
Ovarian Neoplasms	ENSG00000183735	FALSE	Preclinical	2010-07-30	Preclinical	TBK1
Ovarian Neoplasms	ENSG00000183765	FALSE	Phase II Clinical Trial	2010-03-02	Phase I Clinical Trial	CHEK2
Ovarian Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	2005-08-10	Phase II Clinical Trial	CTAG1B
Ovarian Neoplasms	ENSG00000184047	FALSE	Phase II Clinical Trial	2005-11-21	Phase I Clinical Trial	DIABLO
Ovarian Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Ovarian Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2010-08-09	Phase I Clinical Trial	CSF1
Ovarian Neoplasms	ENSG00000184697	FALSE	Phase II Clinical Trial	2011-02-25	Absent	CLDN6
Ovarian Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Unused	WT1
Ovarian Neoplasms	ENSG00000185483	FALSE	Preclinical	2016-03-03	Absent	ROR1
Ovarian Neoplasms	ENSG00000185499	FALSE	Phase III Clinical Trial	1992-07-15	Unused	MUC1
Ovarian Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Absent	PRAME
Ovarian Neoplasms	ENSG00000186350	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRA
Ovarian Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	BCR
Ovarian Neoplasms	ENSG00000187079	FALSE	Preclinical	2014-11-05	Absent	TEAD1
Ovarian Neoplasms	ENSG00000188372	FALSE	Preclinical	2007-08-23	Preclinical	ZP3
Ovarian Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Phase II Clinical Trial	PDCD1
Ovarian Neoplasms	ENSG00000189143	FALSE	Preclinical	2009-07-14	Unused	CLDN4
Ovarian Neoplasms	ENSG00000196352	FALSE	Preclinical	2004-07-19	Preclinical	CD55
Ovarian Neoplasms	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Ovarian Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	EPHB4
Ovarian Neoplasms	ENSG00000196557	FALSE	Phase I Clinical Trial	NA	Absent	CACNA1H
Ovarian Neoplasms	ENSG00000196591	FALSE	unknown	1994-12-15	Unused	HDAC2
Ovarian Neoplasms	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Ovarian Neoplasms	ENSG00000196776	FALSE	Preclinical	2016-02-25	Absent	CD47
Ovarian Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	SRC
Ovarian Neoplasms	ENSG00000197408	FALSE	unknown	NA	Unused	CYP2B6
Ovarian Neoplasms	ENSG00000198223	FALSE	Preclinical	2011-09-23	Preclinical	CSF2RA
Ovarian Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Ovarian Neoplasms	ENSG00000198625	FALSE	Preclinical	2015-07-15	Absent	MDM4
Ovarian Neoplasms	ENSG00000198668	FALSE	unknown	2003-12-09	Absent	CALM1
Ovarian Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	MTOR
Ovarian Neoplasms	ENSG00000198851	FALSE	Phase II Clinical Trial	NA	Absent	CD3E
Ovarian Neoplasms	ENSG00000198900	TRUE	Approved	1993-07-15	Approved	TOP1
Ovarian Neoplasms	ENSG00000203747	FALSE	Phase II Clinical Trial	2007-04-11	Absent	FCGR3A
Ovarian Neoplasms	ENSG00000213903	FALSE	Phase II Clinical Trial	2008-05-23	Absent	LTB4R
Ovarian Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Ovarian Neoplasms	ENSG00000240972	FALSE	Phase II Clinical Trial	2004-01-13	Absent	MIF
Ovarian Neoplasms	ENSG00000243772	FALSE	Phase II Clinical Trial	2011-03-02	Phase I Clinical Trial	KIR2DL3
Ovarian Neoplasms	ENSG00000243955	FALSE	Phase II Clinical Trial	1994-07-15	Unused	GSTA1
Ovarian Neoplasms	ENSG00000253729	FALSE	Phase II Clinical Trial	1999-03-31	Phase II Clinical Trial	PRKDC
Ovarian Neoplasms	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Phase III Clinical Trial	LYN
Ovarian Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2001-11-05	Phase I Clinical Trial	ITGB3
Ovarian Neoplasms	ENSG00000263528	FALSE	Preclinical	2010-07-30	Preclinical	IKBKE
Ovarian Neoplasms	ENSG00000263761	FALSE	Phase II Clinical Trial	2007-05-30	Absent	GDF2
Pachyonychia Congenita	ENSG00000198793	FALSE	Phase II Clinical Trial	NA	Absent	MTOR
Pachyonychia Congenita	ENSG00000205420	FALSE	Phase I Clinical Trial	2008-06-05	Unused	KRT6A
Pain	ENSG00000003402	FALSE	unknown	1998-11-15	Unused	CFLAR
Pain	ENSG00000004948	FALSE	Preclinical	1993-06-15	Unused	CALCR
Pain	ENSG00000006210	FALSE	Phase I Clinical Trial	2006-02-07	Absent	CX3CL1
Pain	ENSG00000006283	FALSE	Phase I Clinical Trial	1999-04-28	Phase I Clinical Trial	CACNA1G
Pain	ENSG00000006638	FALSE	Preclinical	1995-07-15	Unused	TBXA2R
Pain	ENSG00000007171	FALSE	Preclinical	2004-11-03	Unused	NOS2
Pain	ENSG00000007952	FALSE	Preclinical	2015-03-26	Absent	NOX1
Pain	ENSG00000011677	FALSE	Preclinical	2014-02-13	Unused	GABRA3
Pain	ENSG00000012779	FALSE	Preclinical	1989-06-15	Unused	ALOX5
Pain	ENSG00000034152	FALSE	Preclinical	2011-10-06	Absent	MAP2K3
Pain	ENSG00000043591	FALSE	unknown	NA	Unused	ADRB1
Pain	ENSG00000050628	FALSE	Preclinical	1995-07-15	Unused	PTGER3
Pain	ENSG00000056291	FALSE	Preclinical	2001-07-26	Unused	NPFFR2
Pain	ENSG00000059377	TRUE	Approved	2017-12-06	Approved	TBXAS1
Pain	ENSG00000060491	FALSE	Preclinical	2005-07-18	Unused	OGFR
Pain	ENSG00000064300	FALSE	Preclinical	1997-05-15	Unused	NGFR
Pain	ENSG00000064989	FALSE	Preclinical	1997-09-15	Unused	CALCRL
Pain	ENSG00000065989	TRUE	Approved	1995-03-15	Approved	PDE4A
Pain	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Pain	ENSG00000073756	TRUE	Approved	1989-05-15	Approved	PTGS2
Pain	ENSG00000074416	FALSE	Preclinical	2010-01-18	Unused	MGLL
Pain	ENSG00000075043	TRUE	Approved	2003-09-05	Approved	KCNQ2
Pain	ENSG00000075073	FALSE	Preclinical	1991-04-15	Unused	TACR2
Pain	ENSG00000080293	FALSE	unknown	NA	Unused	SCTR
Pain	ENSG00000082482	FALSE	Preclinical	2014-11-25	Absent	KCNK2
Pain	ENSG00000082556	TRUE	Approved	1989-10-15	Approved	OPRK1
Pain	ENSG00000086205	FALSE	Preclinical	2007-04-27	Unused	FOLH1
Pain	ENSG00000087085	FALSE	Preclinical	NA	Unused	ACHE
Pain	ENSG00000087245	FALSE	unknown	2001-07-18	Preclinical	MMP2
Pain	ENSG00000089041	FALSE	Preclinical	2005-12-28	Unused	P2RX7
Pain	ENSG00000089250	FALSE	Preclinical	1996-07-15	Phase I Clinical Trial	NOS1
Pain	ENSG00000091831	FALSE	unknown	2003-05-13	Preclinical	ESR1
Pain	ENSG00000095303	TRUE	Approved	1989-05-15	Approved	PTGS1
Pain	ENSG00000099822	FALSE	Preclinical	2008-11-03	Unused	HCN2
Pain	ENSG00000100739	FALSE	Phase II Clinical Trial	1997-10-15	Unused	BDKRB1
Pain	ENSG00000100823	FALSE	Preclinical	1993-03-15	Absent	APEX1
Pain	ENSG00000101180	FALSE	Preclinical	2007-07-20	Preclinical	HRH3
Pain	ENSG00000101204	FALSE	Preclinical	1998-03-15	Unused	CHRNA4
Pain	ENSG00000101266	FALSE	Preclinical	2009-09-12	Preclinical	CSNK2A1
Pain	ENSG00000101327	FALSE	Phase II Clinical Trial	1989-10-15	Phase II Clinical Trial	PDYN
Pain	ENSG00000101966	FALSE	unknown	1998-11-15	Unused	XIAP
Pain	ENSG00000102468	TRUE	Approved	1989-11-15	Unused	HTR2A
Pain	ENSG00000103222	FALSE	unknown	2001-07-18	Preclinical	ABCC1
Pain	ENSG00000103546	TRUE	Approved	1998-06-15	Approved	SLC6A2
Pain	ENSG00000104321	FALSE	Preclinical	2007-09-10	Phase I Clinical Trial	TRPA1
Pain	ENSG00000104365	FALSE	unknown	1996-04-15	Unused	IKBKB
Pain	ENSG00000105639	FALSE	Preclinical	2011-10-06	Absent	JAK3
Pain	ENSG00000105650	TRUE	Approved	1995-03-15	Approved	PDE4C
Pain	ENSG00000105675	FALSE	Preclinical	2015-04-21	Phase I Clinical Trial	ATP4A
Pain	ENSG00000108576	TRUE	Approved	1989-10-15	Approved	SLC6A4
Pain	ENSG00000108691	FALSE	unknown	2002-02-27	Unused	CCL2
Pain	ENSG00000109320	FALSE	unknown	2001-07-18	Unused	NFKB1
Pain	ENSG00000109991	FALSE	Phase II Clinical Trial	2003-09-07	Phase II Clinical Trial	P2RX3
Pain	ENSG00000110148	FALSE	Preclinical	1993-04-15	Unused	CCKBR
Pain	ENSG00000110881	FALSE	Preclinical	2006-08-10	Phase I Clinical Trial	ASIC1
Pain	ENSG00000110887	FALSE	Preclinical	2007-06-15	Unused	DAO
Pain	ENSG00000111199	FALSE	Preclinical	2007-03-19	Unused	TRPV4
Pain	ENSG00000111262	FALSE	Preclinical	2004-06-29	Unused	KCNA1
Pain	ENSG00000112038	TRUE	Approved	1989-10-15	Approved	OPRM1
Pain	ENSG00000112062	FALSE	Preclinical	2004-08-16	Unused	MAPK14
Pain	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Pain	ENSG00000112541	FALSE	Preclinical	2009-02-09	Unused	PDE10A
Pain	ENSG00000113161	FALSE	Preclinical	2010-06-02	Preclinical	HMGCR
Pain	ENSG00000113448	TRUE	Approved	1995-03-15	Approved	PDE4D
Pain	ENSG00000113580	FALSE	Phase III Clinical Trial	2010-02-12	Phase III Clinical Trial	NR3C1
Pain	ENSG00000113749	TRUE	Approved	2007-01-05	Approved	HRH2
Pain	ENSG00000115041	FALSE	Preclinical	2006-03-17	Unused	KCNIP3
Pain	ENSG00000115138	FALSE	Preclinical	1999-09-01	Unused	POMC
Pain	ENSG00000115353	FALSE	Phase I Clinical Trial	1990-12-15	Unused	TACR1
Pain	ENSG00000115594	FALSE	Preclinical	1991-01-15	Unused	IL1R1
Pain	ENSG00000116096	FALSE	Preclinical	2010-01-23	Unused	SPR
Pain	ENSG00000116329	TRUE	Approved	1989-10-15	Approved	OPRD1
Pain	ENSG00000117480	FALSE	Phase II Clinical Trial	2003-04-16	Phase I Clinical Trial	FAAH
Pain	ENSG00000118113	FALSE	Preclinical	2005-05-31	Unused	MMP8
Pain	ENSG00000118432	TRUE	Approved	1998-08-15	Approved	CNR1
Pain	ENSG00000119973	FALSE	Preclinical	2003-07-08	Unused	PRLHR
Pain	ENSG00000120915	FALSE	Preclinical	2016-10-26	Absent	EPHX2
Pain	ENSG00000121807	FALSE	Phase I Clinical Trial	2007-08-07	Unused	CCR2
Pain	ENSG00000121853	FALSE	Phase I Clinical Trial	2014-06-11	Absent	GHSR
Pain	ENSG00000121966	FALSE	unknown	NA	Unused	CXCR4
Pain	ENSG00000123213	FALSE	Preclinical	2010-04-06	Preclinical	NLN
Pain	ENSG00000125384	FALSE	Preclinical	1993-06-15	Unused	PTGER2
Pain	ENSG00000125510	FALSE	Phase III Clinical Trial	1995-12-15	Phase I Clinical Trial	OPRL1
Pain	ENSG00000126583	FALSE	Preclinical	2012-09-04	Absent	PRKCG
Pain	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Pain	ENSG00000128271	FALSE	Preclinical	1998-08-15	Unused	ADORA2A
Pain	ENSG00000128655	FALSE	unknown	NA	Unused	PDE11A
Pain	ENSG00000131471	FALSE	unknown	NA	Preclinical	AOC3
Pain	ENSG00000131747	TRUE	Approved	1998-11-15	Approved	TOP2A
Pain	ENSG00000132155	FALSE	unknown	2008-02-21	Unused	RAF1
Pain	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Pain	ENSG00000132329	FALSE	Preclinical	1997-09-15	Unused	RAMP1
Pain	ENSG00000132671	FALSE	Phase I Clinical Trial	2016-03-30	Absent	SSTR4
Pain	ENSG00000132911	FALSE	Preclinical	2012-02-22	Unused	NMUR2
Pain	ENSG00000133019	TRUE	Approved	1991-11-15	Approved	CHRM3
Pain	ENSG00000134243	FALSE	Preclinical	2016-12-27	Absent	SORT1
Pain	ENSG00000134259	FALSE	Phase III Clinical Trial	2003-03-26	Phase II Clinical Trial	NGF
Pain	ENSG00000134489	FALSE	Preclinical	2008-02-28	Unused	HRH4
Pain	ENSG00000134640	FALSE	unknown	2012-08-22	Phase I Clinical Trial	MTNR1B
Pain	ENSG00000135312	FALSE	Preclinical	2007-05-29	Unused	HTR1B
Pain	ENSG00000136807	FALSE	Preclinical	2008-08-28	Unused	CDK9
Pain	ENSG00000136869	FALSE	unknown	NA	Absent	TLR4
Pain	ENSG00000136960	FALSE	Preclinical	2014-10-09	Absent	ENPP2
Pain	ENSG00000138622	FALSE	Preclinical	2008-11-03	Unused	HCN4
Pain	ENSG00000138685	FALSE	Preclinical	2014-10-09	Absent	FGF2
Pain	ENSG00000139572	FALSE	Preclinical	2011-12-02	Absent	GPR84
Pain	ENSG00000140009	FALSE	Preclinical	2004-11-08	Unused	ESR2
Pain	ENSG00000140538	FALSE	Preclinical	1989-06-15	Unused	NTRK3
Pain	ENSG00000141837	FALSE	Preclinical	2012-10-19	Preclinical	CACNA1A
Pain	ENSG00000142319	FALSE	Phase II Clinical Trial	2008-06-10	Unused	SLC6A3
Pain	ENSG00000143171	FALSE	unknown	2000-02-09	Unused	RXRG
Pain	ENSG00000143630	FALSE	Preclinical	2008-11-03	Unused	HCN3
Pain	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Pain	ENSG00000144285	TRUE	Approved	1993-06-15	Approved	SCN1A
Pain	ENSG00000144481	FALSE	Preclinical	2010-07-08	Unused	TRPM8
Pain	ENSG00000145545	FALSE	unknown	1998-11-15	Unused	SRD5A1
Pain	ENSG00000147246	TRUE	Approved	2012-08-22	Unused	HTR2C
Pain	ENSG00000147262	FALSE	Preclinical	2011-12-02	Preclinical	GPR119
Pain	ENSG00000147955	FALSE	Phase II Clinical Trial	2000-03-29	Phase II Clinical Trial	SIGMAR1
Pain	ENSG00000148053	FALSE	Preclinical	1989-06-15	Unused	NTRK2
Pain	ENSG00000148344	FALSE	Phase II Clinical Trial	2005-01-24	Unused	PTGES
Pain	ENSG00000148408	TRUE	Approved	1992-05-15	Approved	CACNA1B
Pain	ENSG00000148680	FALSE	Preclinical	2011-10-03	Preclinical	HTR7
Pain	ENSG00000149294	FALSE	Preclinical	1994-06-15	Unused	NCAM1
Pain	ENSG00000149295	TRUE	Approved	1996-01-15	Approved	DRD2
Pain	ENSG00000150594	TRUE	Approved	1995-10-15	Approved	ADRA2A
Pain	ENSG00000151067	FALSE	Phase III Clinical Trial	1999-04-21	Absent	CACNA1C
Pain	ENSG00000151617	FALSE	Preclinical	1998-10-15	Unused	EDNRA
Pain	ENSG00000151834	FALSE	Preclinical	2014-02-13	Unused	GABRA2
Pain	ENSG00000152822	FALSE	Preclinical	2005-10-03	Unused	GRM1
Pain	ENSG00000153253	TRUE	Approved	1993-06-15	Approved	SCN3A
Pain	ENSG00000153956	FALSE	Phase III Clinical Trial	1998-10-15	Phase II Clinical Trial	CACNA2D1
Pain	ENSG00000155511	FALSE	Preclinical	1995-07-15	Unused	GRIA1
Pain	ENSG00000156110	FALSE	Preclinical	1998-07-15	Unused	ADK
Pain	ENSG00000157103	FALSE	Preclinical	1996-11-15	Unused	SLC6A1
Pain	ENSG00000157219	FALSE	Preclinical	2006-11-24	Unused	HTR5A
Pain	ENSG00000158748	FALSE	Preclinical	2010-10-14	Preclinical	HTR6
Pain	ENSG00000159640	FALSE	Preclinical	1995-10-15	Unused	ACE
Pain	ENSG00000160013	FALSE	Phase I Clinical Trial	2007-01-15	Unused	PTGIR
Pain	ENSG00000160712	FALSE	unknown	2015-09-22	Absent	IL6R
Pain	ENSG00000160716	FALSE	Preclinical	1998-03-15	Unused	CHRNB2
Pain	ENSG00000160951	FALSE	Phase II Clinical Trial	1995-07-15	Unused	PTGER1
Pain	ENSG00000162711	FALSE	Phase II Clinical Trial	2013-04-09	Absent	NLRP3
Pain	ENSG00000163106	FALSE	Preclinical	NA	Unused	HPGDS
Pain	ENSG00000163394	TRUE	Approved	NA	Approved	CCKAR
Pain	ENSG00000163485	FALSE	Phase II Clinical Trial	1990-05-15	Unused	ADORA1
Pain	ENSG00000164082	FALSE	Phase I Clinical Trial	2014-01-31	Absent	GRM2
Pain	ENSG00000164128	FALSE	Preclinical	1994-10-15	Unused	NPY1R
Pain	ENSG00000164129	FALSE	Preclinical	1994-10-15	Unused	NPY5R
Pain	ENSG00000164251	FALSE	Preclinical	2002-06-17	Unused	F2RL1
Pain	ENSG00000164270	FALSE	Preclinical	1994-06-15	Unused	HTR4
Pain	ENSG00000164588	FALSE	Preclinical	2008-11-03	Unused	HCN1
Pain	ENSG00000165125	FALSE	Preclinical	2011-08-04	Preclinical	TRPV6
Pain	ENSG00000165675	FALSE	unknown	1998-11-15	Unused	ENOX2
Pain	ENSG00000165970	FALSE	Preclinical	2018-01-10	Absent	SLC6A5
Pain	ENSG00000166573	FALSE	Preclinical	1997-05-15	Unused	GALR1
Pain	ENSG00000166736	TRUE	Approved	1990-12-15	Unused	HTR3A
Pain	ENSG00000166825	FALSE	Preclinical	2011-12-02	Unused	ANPEP
Pain	ENSG00000167325	FALSE	unknown	2005-05-18	Unused	RRM1
Pain	ENSG00000167720	FALSE	Preclinical	2008-09-26	Unused	SRR
Pain	ENSG00000167723	FALSE	Preclinical	2007-09-11	Preclinical	TRPV3
Pain	ENSG00000168398	FALSE	Preclinical	1993-09-15	Unused	BDKRB2
Pain	ENSG00000168412	FALSE	unknown	2012-08-22	Phase I Clinical Trial	MTNR1A
Pain	ENSG00000168539	TRUE	Approved	1991-11-15	Approved	CHRM1
Pain	ENSG00000168959	FALSE	Preclinical	2002-09-10	Unused	GRM5
Pain	ENSG00000169432	TRUE	Approved	1994-04-15	Approved	SCN9A
Pain	ENSG00000169836	FALSE	Preclinical	1994-11-15	Unused	TACR3
Pain	ENSG00000169919	FALSE	unknown	2001-07-18	Preclinical	GUSB
Pain	ENSG00000170255	FALSE	Preclinical	2006-03-06	Unused	MRGPRX1
Pain	ENSG00000170890	FALSE	Phase I Clinical Trial	2008-12-17	Unused	PLA2G1B
Pain	ENSG00000171132	FALSE	Preclinical	2008-04-02	Unused	PRKCE
Pain	ENSG00000171189	FALSE	Preclinical	2002-04-30	Unused	GRIK1
Pain	ENSG00000171385	FALSE	Preclinical	2005-10-04	Unused	KCND3
Pain	ENSG00000171522	FALSE	Preclinical	2001-12-03	Phase I Clinical Trial	PTGER4
Pain	ENSG00000173250	FALSE	Preclinical	2016-08-12	Absent	GPR151
Pain	ENSG00000174944	FALSE	Preclinical	2013-10-10	Absent	P2RY14
Pain	ENSG00000175344	FALSE	Preclinical	1996-06-15	Unused	CHRNA7
Pain	ENSG00000176884	TRUE	Approved	1995-03-15	Phase I Clinical Trial	GRIN1
Pain	ENSG00000177464	FALSE	Preclinical	2017-06-07	Absent	GPR4
Pain	ENSG00000177606	FALSE	unknown	2007-11-07	Unused	JUN
Pain	ENSG00000178394	FALSE	Phase II Clinical Trial	1991-07-15	Phase II Clinical Trial	HTR1A
Pain	ENSG00000178726	FALSE	Phase II Clinical Trial	NA	Absent	THBD
Pain	ENSG00000179546	FALSE	Preclinical	1995-06-15	Unused	HTR1D
Pain	ENSG00000180210	FALSE	Preclinical	1992-06-15	Unused	F2
Pain	ENSG00000180720	TRUE	Approved	1995-12-15	Approved	CHRM4
Pain	ENSG00000180772	FALSE	unknown	2008-09-09	Phase II Clinical Trial	AGTR2
Pain	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Pain	ENSG00000182578	FALSE	Preclinical	2008-11-13	Unused	CSF1R
Pain	ENSG00000182687	FALSE	Preclinical	1997-05-15	Unused	GALR2
Pain	ENSG00000183625	FALSE	Preclinical	2003-10-07	Unused	CCR3
Pain	ENSG00000183873	FALSE	Preclinical	2009-09-15	Unused	SCN5A
Pain	ENSG00000184156	TRUE	Approved	2007-12-13	Approved	KCNQ3
Pain	ENSG00000184160	TRUE	Approved	1996-06-15	Approved	ADRA2C
Pain	ENSG00000184350	FALSE	Preclinical	2016-11-03	Absent	MRGPRE
Pain	ENSG00000184588	TRUE	Approved	1995-03-15	Approved	PDE4B
Pain	ENSG00000184845	FALSE	Preclinical	1996-01-15	Unused	DRD1
Pain	ENSG00000185149	FALSE	Preclinical	1994-10-15	Unused	NPY2R
Pain	ENSG00000185313	FALSE	Phase II Clinical Trial	2001-02-06	Phase I Clinical Trial	SCN10A
Pain	ENSG00000186350	FALSE	unknown	2000-02-09	Unused	RXRA
Pain	ENSG00000186795	FALSE	Preclinical	2010-01-18	Unused	KCNK18
Pain	ENSG00000187094	FALSE	Preclinical	2003-07-07	Unused	CCK
Pain	ENSG00000187848	FALSE	Preclinical	2003-09-07	Unused	P2RX2
Pain	ENSG00000188822	FALSE	Phase II Clinical Trial	2001-12-14	Approved	CNR2
Pain	ENSG00000196549	FALSE	Phase II Clinical Trial	1989-08-15	Unused	MME
Pain	ENSG00000196557	FALSE	Preclinical	2013-10-30	Absent	CACNA1H
Pain	ENSG00000196639	FALSE	Phase III Clinical Trial	2004-02-04	Phase III Clinical Trial	HRH1
Pain	ENSG00000196689	TRUE	Approved	1991-04-15	Approved	TRPV1
Pain	ENSG00000197405	FALSE	Preclinical	2014-12-31	Absent	C5AR1
Pain	ENSG00000197442	FALSE	Preclinical	2011-12-02	Absent	MAP3K5
Pain	ENSG00000198400	FALSE	Phase I Clinical Trial	2003-01-06	Unused	NTRK1
Pain	ENSG00000198763	FALSE	Preclinical	2012-09-14	Absent	MT-ND2
Pain	ENSG00000198822	FALSE	Phase I Clinical Trial	2014-01-31	Absent	GRM3
Pain	ENSG00000204174	FALSE	Preclinical	1994-10-15	Absent	NPY4R
Pain	ENSG00000205268	FALSE	unknown	2007-08-07	Unused	PDE7A
Pain	ENSG00000213199	FALSE	Preclinical	2006-08-11	Unused	ASIC3
Pain	ENSG00000213903	FALSE	Preclinical	NA	Absent	LTB4R
Pain	ENSG00000240972	FALSE	unknown	NA	Unused	MIF
Pain	ENSG00000258839	FALSE	Preclinical	1997-08-15	Unused	MC1R
Pain	ENSG00000273079	FALSE	Preclinical	1995-12-15	Unused	GRIN2B
Pain	ENSG00000274286	TRUE	Approved	1996-06-15	Approved	ADRA2B
Pain	ENSG00000282608	FALSE	Preclinical	1997-07-15	Unused	ADORA3
Pain, Postoperative	ENSG00000060491	FALSE	Preclinical	2005-07-18	Preclinical	OGFR
Pain, Postoperative	ENSG00000069535	FALSE	unknown	1999-08-17	Unused	MAOB
Pain, Postoperative	ENSG00000073756	TRUE	Approved	1994-04-15	Approved	PTGS2
Pain, Postoperative	ENSG00000075043	TRUE	Approved	NA	Approved	KCNQ2
Pain, Postoperative	ENSG00000082556	TRUE	Approved	1989-10-15	Approved	OPRK1
Pain, Postoperative	ENSG00000089250	FALSE	Preclinical	2009-05-27	Unused	NOS1
Pain, Postoperative	ENSG00000095303	TRUE	Approved	1994-04-15	Approved	PTGS1
Pain, Postoperative	ENSG00000100739	FALSE	unknown	2006-01-23	Unused	BDKRB1
Pain, Postoperative	ENSG00000101204	FALSE	Phase II Clinical Trial	2002-04-15	Unused	CHRNA4
Pain, Postoperative	ENSG00000101327	FALSE	unknown	1994-04-15	Unused	PDYN
Pain, Postoperative	ENSG00000102468	FALSE	Phase II Clinical Trial	2010-08-18	Absent	HTR2A
Pain, Postoperative	ENSG00000103546	TRUE	Approved	2002-03-04	Approved	SLC6A2
Pain, Postoperative	ENSG00000108576	FALSE	Approved	2002-03-04	Unused	SLC6A4
Pain, Postoperative	ENSG00000112038	TRUE	Approved	1989-10-15	Approved	OPRM1
Pain, Postoperative	ENSG00000112062	FALSE	unknown	1998-07-15	Phase II Clinical Trial	MAPK14
Pain, Postoperative	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Pain, Postoperative	ENSG00000113580	TRUE	Approved	2004-03-30	Approved	NR3C1
Pain, Postoperative	ENSG00000115353	FALSE	Phase II Clinical Trial	1998-06-15	Unused	TACR1
Pain, Postoperative	ENSG00000116044	FALSE	Phase II Clinical Trial	2014-01-07	Absent	NFE2L2
Pain, Postoperative	ENSG00000116329	TRUE	Approved	1989-10-15	Approved	OPRD1
Pain, Postoperative	ENSG00000118432	FALSE	Phase II Clinical Trial	2002-09-18	Phase II Clinical Trial	CNR1
Pain, Postoperative	ENSG00000120738	FALSE	Phase II Clinical Trial	2012-08-10	Phase II Clinical Trial	EGR1
Pain, Postoperative	ENSG00000120907	TRUE	Approved	2008-01-15	Absent	ADRA1A
Pain, Postoperative	ENSG00000121653	FALSE	Phase III Clinical Trial	2003-08-26	Absent	MAPK8IP1
Pain, Postoperative	ENSG00000122585	FALSE	unknown	NA	Unused	NPY
Pain, Postoperative	ENSG00000125510	FALSE	Phase II Clinical Trial	2005-01-18	Phase II Clinical Trial	OPRL1
Pain, Postoperative	ENSG00000134259	FALSE	Phase I Clinical Trial	2003-03-26	Phase I Clinical Trial	NGF
Pain, Postoperative	ENSG00000143171	FALSE	unknown	2000-02-09	Unused	RXRG
Pain, Postoperative	ENSG00000145864	FALSE	Preclinical	2013-02-26	Preclinical	GABRB2
Pain, Postoperative	ENSG00000147955	FALSE	Phase II Clinical Trial	2003-07-07	Phase II Clinical Trial	SIGMAR1
Pain, Postoperative	ENSG00000148344	FALSE	Phase II Clinical Trial	2012-07-04	Absent	PTGES
Pain, Postoperative	ENSG00000148408	TRUE	Approved	1992-05-15	Approved	CACNA1B
Pain, Postoperative	ENSG00000150594	FALSE	Phase II Clinical Trial	1999-07-08	Absent	ADRA2A
Pain, Postoperative	ENSG00000152822	FALSE	Preclinical	NA	Unused	GRM1
Pain, Postoperative	ENSG00000153956	FALSE	unknown	1993-06-15	Phase III Clinical Trial	CACNA2D1
Pain, Postoperative	ENSG00000155511	FALSE	unknown	2003-05-07	Unused	GRIA1
Pain, Postoperative	ENSG00000160716	FALSE	Phase II Clinical Trial	2002-04-15	Unused	CHRNB2
Pain, Postoperative	ENSG00000165970	FALSE	Phase II Clinical Trial	2010-08-18	Absent	SLC6A5
Pain, Postoperative	ENSG00000166206	FALSE	Preclinical	2013-02-26	Preclinical	GABRB3
Pain, Postoperative	ENSG00000166603	FALSE	Phase II Clinical Trial	1994-08-15	Unused	MC4R
Pain, Postoperative	ENSG00000166736	FALSE	Phase II Clinical Trial	2016-10-24	Absent	HTR3A
Pain, Postoperative	ENSG00000166825	FALSE	Phase I Clinical Trial	2011-12-01	Preclinical	ANPEP
Pain, Postoperative	ENSG00000168398	FALSE	Preclinical	1997-03-15	Unused	BDKRB2
Pain, Postoperative	ENSG00000169432	TRUE	Approved	1994-04-15	Approved	SCN9A
Pain, Postoperative	ENSG00000170214	TRUE	Approved	2008-01-15	Absent	ADRA1B
Pain, Postoperative	ENSG00000171132	FALSE	unknown	2005-05-31	Unused	PRKCE
Pain, Postoperative	ENSG00000171873	TRUE	Approved	2008-01-15	Absent	ADRA1D
Pain, Postoperative	ENSG00000176884	FALSE	Phase III Clinical Trial	1997-01-15	Unused	GRIN1
Pain, Postoperative	ENSG00000184156	TRUE	Approved	NA	Approved	KCNQ3
Pain, Postoperative	ENSG00000184160	FALSE	Phase II Clinical Trial	1999-07-08	Absent	ADRA2C
Pain, Postoperative	ENSG00000185313	FALSE	Preclinical	2010-07-15	Preclinical	SCN10A
Pain, Postoperative	ENSG00000186350	FALSE	unknown	2000-02-09	Unused	RXRA
Pain, Postoperative	ENSG00000188822	FALSE	unknown	2006-02-07	Absent	CNR2
Pain, Postoperative	ENSG00000189221	FALSE	unknown	1999-08-17	Unused	MAOA
Pain, Postoperative	ENSG00000196549	FALSE	Phase I Clinical Trial	2011-12-01	Preclinical	MME
Pain, Postoperative	ENSG00000196639	FALSE	Pre-registration	2009-01-15	Absent	HRH1
Pain, Postoperative	ENSG00000196689	FALSE	Phase III Clinical Trial	2000-05-17	Unused	TRPV1
Pain, Postoperative	ENSG00000198400	FALSE	Preclinical	2012-01-09	Absent	NTRK1
Pain, Postoperative	ENSG00000213199	FALSE	Preclinical	2010-07-15	Preclinical	ASIC3
Pain, Postoperative	ENSG00000258839	FALSE	Phase II Clinical Trial	1994-08-15	Unused	MC1R
Pain, Postoperative	ENSG00000273079	FALSE	Preclinical	2004-11-05	Phase I Clinical Trial	GRIN2B
Pain, Postoperative	ENSG00000274286	FALSE	Phase II Clinical Trial	1999-07-08	Absent	ADRA2B
Pancreatic Neoplasms	ENSG00000003402	FALSE	Preclinical	2015-05-11	Absent	CFLAR
Pancreatic Neoplasms	ENSG00000004468	FALSE	Phase II Clinical Trial	2005-05-13	Absent	CD38
Pancreatic Neoplasms	ENSG00000006210	FALSE	unknown	2006-02-07	Absent	CX3CL1
Pancreatic Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Pancreatic Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Pancreatic Neoplasms	ENSG00000010327	FALSE	Preclinical	2009-11-12	Absent	STAB1
Pancreatic Neoplasms	ENSG00000010671	FALSE	Phase III Clinical Trial	2007-12-12	Absent	BTK
Pancreatic Neoplasms	ENSG00000010810	FALSE	Pre-registration	2004-07-20	Phase II Clinical Trial	FYN
Pancreatic Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Pancreatic Neoplasms	ENSG00000012779	FALSE	unknown	1993-10-15	Unused	ALOX5
Pancreatic Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Pancreatic Neoplasms	ENSG00000023445	FALSE	Preclinical	2015-07-15	Absent	BIRC3
Pancreatic Neoplasms	ENSG00000026025	FALSE	Preclinical	2012-02-29	Absent	VIM
Pancreatic Neoplasms	ENSG00000026508	FALSE	Preclinical	2007-04-09	Unused	CD44
Pancreatic Neoplasms	ENSG00000037280	TRUE	Approved	1994-06-15	Unused	FLT4
Pancreatic Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-08-27	Absent	CDH1
Pancreatic Neoplasms	ENSG00000043591	FALSE	unknown	2007-01-23	Absent	ADRB1
Pancreatic Neoplasms	ENSG00000044574	FALSE	Phase I Clinical Trial	2006-08-07	Phase I Clinical Trial	HSPA5
Pancreatic Neoplasms	ENSG00000047936	FALSE	Phase II Clinical Trial	2006-12-05	Absent	ROS1
Pancreatic Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2011-01-31	Absent	TNFRSF9
Pancreatic Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Pancreatic Neoplasms	ENSG00000051382	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CB
Pancreatic Neoplasms	ENSG00000057252	FALSE	Preclinical	2017-03-31	Absent	SOAT1
Pancreatic Neoplasms	ENSG00000057593	FALSE	unknown	1995-11-15	Phase II Clinical Trial	F7
Pancreatic Neoplasms	ENSG00000058085	FALSE	Preclinical	2009-02-12	Unused	LAMC2
Pancreatic Neoplasms	ENSG00000060491	FALSE	Phase II Clinical Trial	2005-04-04	Unused	OGFR
Pancreatic Neoplasms	ENSG00000062038	FALSE	Phase I Clinical Trial	2012-11-23	Absent	CDH3
Pancreatic Neoplasms	ENSG00000063176	FALSE	Phase I Clinical Trial	2003-09-19	Unused	SPHK2
Pancreatic Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Pancreatic Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Pancreatic Neoplasms	ENSG00000065559	FALSE	Preclinical	1998-01-15	Unused	MAP2K4
Pancreatic Neoplasms	ENSG00000066044	FALSE	Preclinical	2016-09-22	Absent	ELAVL1
Pancreatic Neoplasms	ENSG00000066405	FALSE	Phase II Clinical Trial	2004-01-06	Absent	CLDN18
Pancreatic Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Pancreatic Neoplasms	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase II Clinical Trial	TNFRSF1A
Pancreatic Neoplasms	ENSG00000067225	FALSE	Phase II Clinical Trial	2006-06-29	Unused	PKM
Pancreatic Neoplasms	ENSG00000067560	FALSE	Phase II Clinical Trial	1999-03-17	Unused	RHOA
Pancreatic Neoplasms	ENSG00000068078	FALSE	Pre-registration	2001-04-03	Approved	FGFR3
Pancreatic Neoplasms	ENSG00000069667	FALSE	Preclinical	2011-01-18	Absent	RORA
Pancreatic Neoplasms	ENSG00000070019	FALSE	Phase II Clinical Trial	2012-02-17	Absent	GUCY2C
Pancreatic Neoplasms	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Pancreatic Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Pancreatic Neoplasms	ENSG00000073756	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	PTGS2
Pancreatic Neoplasms	ENSG00000074181	FALSE	unknown	NA	Phase II Clinical Trial	NOTCH3
Pancreatic Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Pancreatic Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Unused	FGFR1
Pancreatic Neoplasms	ENSG00000078098	FALSE	Phase I Clinical Trial	2001-06-11	Unused	FAP
Pancreatic Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	HSP90AA1
Pancreatic Neoplasms	ENSG00000082701	FALSE	Phase II Clinical Trial	2008-08-15	Preclinical	GSK3B
Pancreatic Neoplasms	ENSG00000082781	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGB5
Pancreatic Neoplasms	ENSG00000083312	FALSE	unknown	2005-06-27	Unused	TNPO1
Pancreatic Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Pancreatic Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Pancreatic Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Absent	FOLH1
Pancreatic Neoplasms	ENSG00000086548	FALSE	Preclinical	2008-05-30	Preclinical	CEACAM6
Pancreatic Neoplasms	ENSG00000087245	FALSE	unknown	1997-01-15	Unused	MMP2
Pancreatic Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2003-01-31	Phase II Clinical Trial	AURKA
Pancreatic Neoplasms	ENSG00000089327	FALSE	Preclinical	2011-01-25	Absent	FXYD5
Pancreatic Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-14	Phase I Clinical Trial	BIRC5
Pancreatic Neoplasms	ENSG00000089692	FALSE	unknown	2004-06-08	Phase II Clinical Trial	LAG3
Pancreatic Neoplasms	ENSG00000090339	FALSE	Preclinical	2004-07-19	Preclinical	ICAM1
Pancreatic Neoplasms	ENSG00000090863	FALSE	Preclinical	2003-10-17	Unused	GLG1
Pancreatic Neoplasms	ENSG00000091409	FALSE	Preclinical	2016-07-29	Absent	ITGA6
Pancreatic Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT2
Pancreatic Neoplasms	ENSG00000092969	FALSE	Phase III Clinical Trial	2001-06-12	Phase II Clinical Trial	TGFB2
Pancreatic Neoplasms	ENSG00000094631	FALSE	Preclinical	2011-08-04	Absent	HDAC6
Pancreatic Neoplasms	ENSG00000095303	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	PTGS1
Pancreatic Neoplasms	ENSG00000096968	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	JAK2
Pancreatic Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Pancreatic Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	ABL1
Pancreatic Neoplasms	ENSG00000097046	FALSE	Phase II Clinical Trial	2016-03-08	Absent	CDC7
Pancreatic Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Pancreatic Neoplasms	ENSG00000100030	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MAPK1
Pancreatic Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Pancreatic Neoplasms	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Pancreatic Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	NA	Absent	ST13
Pancreatic Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	HIF1A
Pancreatic Neoplasms	ENSG00000100823	FALSE	Preclinical	1993-03-15	Phase II Clinical Trial	APEX1
Pancreatic Neoplasms	ENSG00000100985	FALSE	Phase I Clinical Trial	1997-01-15	Unused	MMP9
Pancreatic Neoplasms	ENSG00000101017	FALSE	Phase II Clinical Trial	2011-03-15	Unused	CD40
Pancreatic Neoplasms	ENSG00000101188	FALSE	Preclinical	2016-02-23	Absent	NTSR1
Pancreatic Neoplasms	ENSG00000101266	FALSE	Phase I Clinical Trial	2007-05-23	Phase I Clinical Trial	CSNK2A1
Pancreatic Neoplasms	ENSG00000101384	FALSE	Preclinical	2010-11-19	Absent	JAG1
Pancreatic Neoplasms	ENSG00000101412	FALSE	Phase II Clinical Trial	2001-02-02	Unused	E2F1
Pancreatic Neoplasms	ENSG00000101868	FALSE	Phase II Clinical Trial	1993-08-15	Phase II Clinical Trial	POLA1
Pancreatic Neoplasms	ENSG00000101916	FALSE	unknown	2008-06-17	Preclinical	TLR8
Pancreatic Neoplasms	ENSG00000101966	FALSE	Phase I Clinical Trial	1999-01-08	Phase II Clinical Trial	XIAP
Pancreatic Neoplasms	ENSG00000102096	FALSE	Preclinical	2011-03-15	Unused	PIM2
Pancreatic Neoplasms	ENSG00000102312	FALSE	Phase I Clinical Trial	2011-05-14	Phase I Clinical Trial	PORCN
Pancreatic Neoplasms	ENSG00000102755	TRUE	Approved	1994-03-15	Unused	FLT1
Pancreatic Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	2004-01-30	Phase II Clinical Trial	MSLN
Pancreatic Neoplasms	ENSG00000102882	FALSE	Phase I Clinical Trial	2016-06-16	Absent	MAPK3
Pancreatic Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Pancreatic Neoplasms	ENSG00000104415	FALSE	Preclinical	2016-03-03	Absent	WISP1
Pancreatic Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	1996-02-15	Phase I Clinical Trial	CGB3
Pancreatic Neoplasms	ENSG00000105146	FALSE	Phase II Clinical Trial	2003-01-31	Phase II Clinical Trial	AURKC
Pancreatic Neoplasms	ENSG00000105173	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE1
Pancreatic Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1999-10-05	Phase II Clinical Trial	CEACAM5
Pancreatic Neoplasms	ENSG00000105639	FALSE	Preclinical	2006-07-10	Unused	JAK3
Pancreatic Neoplasms	ENSG00000105641	FALSE	Preclinical	2011-05-25	Preclinical	SLC5A5
Pancreatic Neoplasms	ENSG00000105723	FALSE	Phase II Clinical Trial	2008-08-15	Absent	GSK3A
Pancreatic Neoplasms	ENSG00000105810	FALSE	Phase II Clinical Trial	2004-03-28	Preclinical	CDK6
Pancreatic Neoplasms	ENSG00000105835	FALSE	Phase I Clinical Trial	2014-01-22	Absent	NAMPT
Pancreatic Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CG
Pancreatic Neoplasms	ENSG00000105953	FALSE	Phase II Clinical Trial	2008-07-26	Absent	OGDH
Pancreatic Neoplasms	ENSG00000105976	FALSE	Phase I Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Pancreatic Neoplasms	ENSG00000106128	TRUE	Approved	2006-06-29	Phase II Clinical Trial	GHRHR
Pancreatic Neoplasms	ENSG00000106211	FALSE	Phase II Clinical Trial	2004-09-24	Preclinical	HSPB1
Pancreatic Neoplasms	ENSG00000106268	FALSE	Preclinical	2015-03-23	Absent	NUDT1
Pancreatic Neoplasms	ENSG00000106348	FALSE	unknown	2000-11-09	Unused	IMPDH1
Pancreatic Neoplasms	ENSG00000106799	FALSE	Phase II Clinical Trial	2003-09-17	Phase II Clinical Trial	TGFBR1
Pancreatic Neoplasms	ENSG00000106991	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	ENG
Pancreatic Neoplasms	ENSG00000107562	FALSE	Phase II Clinical Trial	2007-04-10	Absent	CXCL12
Pancreatic Neoplasms	ENSG00000107854	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS2
Pancreatic Neoplasms	ENSG00000108424	FALSE	unknown	2005-06-27	Unused	KPNB1
Pancreatic Neoplasms	ENSG00000108443	FALSE	Phase II Clinical Trial	2005-06-27	Unused	RPS6KB1
Pancreatic Neoplasms	ENSG00000108654	FALSE	Preclinical	2006-08-30	Preclinical	DDX5
Pancreatic Neoplasms	ENSG00000108691	FALSE	Phase II Clinical Trial	2010-01-15	Unused	CCL2
Pancreatic Neoplasms	ENSG00000109163	FALSE	Preclinical	2013-09-30	Unused	GNRHR
Pancreatic Neoplasms	ENSG00000109320	FALSE	Phase II Clinical Trial	1990-06-15	Phase I Clinical Trial	NFKB1
Pancreatic Neoplasms	ENSG00000109471	FALSE	unknown	2003-08-05	Unused	IL2
Pancreatic Neoplasms	ENSG00000110092	FALSE	Preclinical	2015-04-13	Absent	CCND1
Pancreatic Neoplasms	ENSG00000110148	FALSE	Phase II Clinical Trial	2001-04-19	Phase II Clinical Trial	CCKBR
Pancreatic Neoplasms	ENSG00000111424	FALSE	Phase II Clinical Trial	1993-07-15	Unused	VDR
Pancreatic Neoplasms	ENSG00000111640	FALSE	Preclinical	2013-07-26	Absent	GAPDH
Pancreatic Neoplasms	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Pancreatic Neoplasms	ENSG00000112062	FALSE	Preclinical	2008-05-23	Absent	MAPK14
Pancreatic Neoplasms	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase III Clinical Trial	VEGFA
Pancreatic Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Pancreatic Neoplasms	ENSG00000113302	FALSE	Preclinical	2001-10-02	Unused	IL12B
Pancreatic Neoplasms	ENSG00000113328	FALSE	Phase III Clinical Trial	2003-08-05	Phase II Clinical Trial	CCNG1
Pancreatic Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Pancreatic Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Pancreatic Neoplasms	ENSG00000113580	FALSE	Preclinical	2014-08-06	Absent	NR3C1
Pancreatic Neoplasms	ENSG00000113594	FALSE	Preclinical	2017-12-22	Absent	LIFR
Pancreatic Neoplasms	ENSG00000113721	FALSE	Pre-registration	2001-04-03	Approved	PDGFRB
Pancreatic Neoplasms	ENSG00000113749	FALSE	Phase II Clinical Trial	2008-06-03	Phase II Clinical Trial	HRH2
Pancreatic Neoplasms	ENSG00000114378	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	HYAL1
Pancreatic Neoplasms	ENSG00000114423	FALSE	Phase I Clinical Trial	2011-06-24	Absent	CBLB
Pancreatic Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Pancreatic Neoplasms	ENSG00000115008	FALSE	Phase I Clinical Trial	2009-12-07	Absent	IL1A
Pancreatic Neoplasms	ENSG00000115053	FALSE	Preclinical	2008-07-31	Unused	NCL
Pancreatic Neoplasms	ENSG00000115221	FALSE	Preclinical	2013-07-17	Preclinical	ITGB6
Pancreatic Neoplasms	ENSG00000115353	FALSE	unknown	NA	Unused	TACR1
Pancreatic Neoplasms	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-06-14	Phase II Clinical Trial	FN1
Pancreatic Neoplasms	ENSG00000115758	FALSE	Preclinical	1994-03-15	Phase II Clinical Trial	ODC1
Pancreatic Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Pancreatic Neoplasms	ENSG00000116044	FALSE	unknown	2004-11-18	Unused	NFE2L2
Pancreatic Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Pancreatic Neoplasms	ENSG00000117525	FALSE	Phase I Clinical Trial	1995-11-15	Phase II Clinical Trial	F3
Pancreatic Neoplasms	ENSG00000117601	FALSE	Phase III Clinical Trial	NA	Unused	SERPINC1
Pancreatic Neoplasms	ENSG00000118523	FALSE	Phase II Clinical Trial	1999-09-14	Phase II Clinical Trial	CTGF
Pancreatic Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	2000-11-07	Phase I Clinical Trial	EPCAM
Pancreatic Neoplasms	ENSG00000120156	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	TEK
Pancreatic Neoplasms	ENSG00000120217	FALSE	Phase II Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Pancreatic Neoplasms	ENSG00000120885	FALSE	unknown	2007-10-05	Absent	CLU
Pancreatic Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	1997-04-15	Phase II Clinical Trial	TNFRSF10B
Pancreatic Neoplasms	ENSG00000121807	FALSE	Phase II Clinical Trial	2007-08-07	Absent	CCR2
Pancreatic Neoplasms	ENSG00000121858	FALSE	unknown	2006-07-10	Unused	TNFSF10
Pancreatic Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Pancreatic Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	2008-07-14	Absent	CXCR4
Pancreatic Neoplasms	ENSG00000122025	TRUE	Approved	1994-06-15	Unused	FLT3
Pancreatic Neoplasms	ENSG00000122861	FALSE	Phase II Clinical Trial	1993-05-15	Phase II Clinical Trial	PLAU
Pancreatic Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK2
Pancreatic Neoplasms	ENSG00000124486	FALSE	Preclinical	2015-10-20	Absent	USP9X
Pancreatic Neoplasms	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Pancreatic Neoplasms	ENSG00000126218	FALSE	Phase III Clinical Trial	NA	Unused	F10
Pancreatic Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K2
Pancreatic Neoplasms	ENSG00000128052	TRUE	Approved	1994-06-15	Unused	KDR
Pancreatic Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2011-06-23	Absent	ADORA2A
Pancreatic Neoplasms	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Phase II Clinical Trial	SMO
Pancreatic Neoplasms	ENSG00000128917	FALSE	unknown	2005-09-14	Phase I Clinical Trial	DLL4
Pancreatic Neoplasms	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Pancreatic Neoplasms	ENSG00000130164	FALSE	unknown	2007-11-19	Absent	LDLR
Pancreatic Neoplasms	ENSG00000130669	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK4
Pancreatic Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	2005-12-02	Preclinical	DNMT1
Pancreatic Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Phase I Clinical Trial	IDO1
Pancreatic Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Pancreatic Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	TOP2A
Pancreatic Neoplasms	ENSG00000131828	FALSE	Phase II Clinical Trial	2008-07-26	Phase II Clinical Trial	PDHA1
Pancreatic Neoplasms	ENSG00000131981	FALSE	Phase I Clinical Trial	1997-05-15	Unused	LGALS3
Pancreatic Neoplasms	ENSG00000132155	FALSE	Phase I Clinical Trial	1992-11-15	Phase II Clinical Trial	RAF1
Pancreatic Neoplasms	ENSG00000132170	FALSE	unknown	1993-10-15	Unused	PPARG
Pancreatic Neoplasms	ENSG00000132470	FALSE	Preclinical	2016-07-29	Absent	ITGB4
Pancreatic Neoplasms	ENSG00000132507	FALSE	Preclinical	2016-03-03	Absent	EIF5A
Pancreatic Neoplasms	ENSG00000132671	FALSE	Preclinical	1998-09-15	Preclinical	SSTR4
Pancreatic Neoplasms	ENSG00000132906	FALSE	Preclinical	1997-05-15	Unused	CASP9
Pancreatic Neoplasms	ENSG00000133083	FALSE	Preclinical	2014-07-24	Absent	DCLK1
Pancreatic Neoplasms	ENSG00000133703	FALSE	Phase II Clinical Trial	1992-11-15	Unused	KRAS
Pancreatic Neoplasms	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Phase II Clinical Trial	LOXL2
Pancreatic Neoplasms	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Pancreatic Neoplasms	ENSG00000134250	FALSE	unknown	NA	Phase II Clinical Trial	NOTCH2
Pancreatic Neoplasms	ENSG00000134460	FALSE	Phase II Clinical Trial	2000-11-07	Phase II Clinical Trial	IL2RA
Pancreatic Neoplasms	ENSG00000134470	FALSE	Phase II Clinical Trial	2010-10-05	Absent	IL15RA
Pancreatic Neoplasms	ENSG00000134853	TRUE	Approved	2000-07-05	Unused	PDGFRA
Pancreatic Neoplasms	ENSG00000135404	FALSE	Preclinical	2003-04-15	Unused	CD63
Pancreatic Neoplasms	ENSG00000135446	FALSE	Phase II Clinical Trial	2004-03-28	Phase II Clinical Trial	CDK4
Pancreatic Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Pancreatic Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	2014-08-27	Phase II Clinical Trial	IL6
Pancreatic Neoplasms	ENSG00000136634	FALSE	Phase III Clinical Trial	2013-11-28	Absent	IL10
Pancreatic Neoplasms	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Phase I Clinical Trial	CDK9
Pancreatic Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Pancreatic Neoplasms	ENSG00000136997	FALSE	Preclinical	2013-03-27	Absent	MYC
Pancreatic Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Pancreatic Neoplasms	ENSG00000137193	FALSE	Preclinical	2011-03-15	Unused	PIM1
Pancreatic Neoplasms	ENSG00000137462	FALSE	Preclinical	2006-02-15	Unused	TLR2
Pancreatic Neoplasms	ENSG00000138039	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	LHCGR
Pancreatic Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Pancreatic Neoplasms	ENSG00000138448	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGAV
Pancreatic Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Pancreatic Neoplasms	ENSG00000139292	FALSE	Preclinical	2011-11-01	Absent	LGR5
Pancreatic Neoplasms	ENSG00000139515	FALSE	Preclinical	2011-07-05	Preclinical	PDX1
Pancreatic Neoplasms	ENSG00000139874	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR1
Pancreatic Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Pancreatic Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK3
Pancreatic Neoplasms	ENSG00000141068	FALSE	Preclinical	2007-12-21	Unused	KSR1
Pancreatic Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1996-05-15	Phase I Clinical Trial	TP53
Pancreatic Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	1990-09-15	Phase II Clinical Trial	ERBB2
Pancreatic Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Absent	BRD4
Pancreatic Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Pancreatic Neoplasms	ENSG00000143217	FALSE	unknown	2004-10-18	Unused	NECTIN4
Pancreatic Neoplasms	ENSG00000143226	FALSE	unknown	NA	Absent	FCGR2A
Pancreatic Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	2002-05-27	Phase III Clinical Trial	MCL1
Pancreatic Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Pancreatic Neoplasms	ENSG00000146242	FALSE	Phase I Clinical Trial	1998-09-15	Unused	TPBG
Pancreatic Neoplasms	ENSG00000146648	TRUE	Approved	1992-03-15	Approved	EGFR
Pancreatic Neoplasms	ENSG00000146674	FALSE	Phase I Clinical Trial	2008-01-04	Absent	IGFBP3
Pancreatic Neoplasms	ENSG00000147437	FALSE	Phase I Clinical Trial	2008-10-31	Phase I Clinical Trial	GNRH1
Pancreatic Neoplasms	ENSG00000147955	FALSE	Preclinical	2011-02-04	Absent	SIGMAR1
Pancreatic Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2009-05-20	Absent	NTRK2
Pancreatic Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Pancreatic Neoplasms	ENSG00000149269	FALSE	Phase I Clinical Trial	2009-07-13	Absent	PAK1
Pancreatic Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	CHEK1
Pancreatic Neoplasms	ENSG00000149968	FALSE	unknown	1997-01-15	Unused	MMP3
Pancreatic Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Pancreatic Neoplasms	ENSG00000150337	FALSE	unknown	NA	Absent	FCGR1A
Pancreatic Neoplasms	ENSG00000151651	FALSE	Preclinical	2015-04-14	Absent	ADAM8
Pancreatic Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT1
Pancreatic Neoplasms	ENSG00000155760	FALSE	Phase I Clinical Trial	2010-06-19	Absent	FZD7
Pancreatic Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Pancreatic Neoplasms	ENSG00000156709	FALSE	unknown	2005-07-19	Preclinical	AIFM1
Pancreatic Neoplasms	ENSG00000157036	FALSE	unknown	2009-12-08	Phase II Clinical Trial	EXOG
Pancreatic Neoplasms	ENSG00000157404	TRUE	Approved	2000-07-05	Approved	KIT
Pancreatic Neoplasms	ENSG00000157540	FALSE	Preclinical	2015-06-05	Absent	DYRK1A
Pancreatic Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Unused	BRAF
Pancreatic Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Pancreatic Neoplasms	ENSG00000160447	FALSE	Phase II Clinical Trial	2004-07-13	Preclinical	PKN3
Pancreatic Neoplasms	ENSG00000160712	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	IL6R
Pancreatic Neoplasms	ENSG00000160791	FALSE	Phase II Clinical Trial	2010-01-15	Absent	CCR5
Pancreatic Neoplasms	ENSG00000160867	FALSE	unknown	2003-07-22	Absent	FGFR4
Pancreatic Neoplasms	ENSG00000161011	FALSE	Preclinical	2015-11-04	Absent	SQSTM1
Pancreatic Neoplasms	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Pancreatic Neoplasms	ENSG00000162009	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	SSTR5
Pancreatic Neoplasms	ENSG00000162434	FALSE	Phase III Clinical Trial	2006-11-24	Phase II Clinical Trial	JAK1
Pancreatic Neoplasms	ENSG00000162747	FALSE	unknown	NA	Absent	FCGR3B
Pancreatic Neoplasms	ENSG00000162892	FALSE	unknown	1999-07-07	Unused	IL24
Pancreatic Neoplasms	ENSG00000163394	FALSE	unknown	1993-01-15	Unused	CCKAR
Pancreatic Neoplasms	ENSG00000163399	FALSE	Phase II Clinical Trial	2008-10-22	Absent	ATP1A1
Pancreatic Neoplasms	ENSG00000163513	FALSE	Preclinical	2016-02-11	Absent	TGFBR2
Pancreatic Neoplasms	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HDAC11
Pancreatic Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	1998-09-15	Phase I Clinical Trial	CTLA4
Pancreatic Neoplasms	ENSG00000163932	FALSE	Preclinical	2009-07-01	Unused	PRKCD
Pancreatic Neoplasms	ENSG00000164171	FALSE	Phase II Clinical Trial	2000-04-26	Phase II Clinical Trial	ITGA2
Pancreatic Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	1997-04-15	Unused	CASP3
Pancreatic Neoplasms	ENSG00000164342	FALSE	Phase III Clinical Trial	NA	Absent	TLR3
Pancreatic Neoplasms	ENSG00000164362	FALSE	Approved	2002-06-26	Phase III Clinical Trial	TERT
Pancreatic Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Pancreatic Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Pancreatic Neoplasms	ENSG00000165125	FALSE	Preclinical	2011-08-04	Absent	TRPV6
Pancreatic Neoplasms	ENSG00000165215	FALSE	Preclinical	2014-04-29	Absent	CLDN3
Pancreatic Neoplasms	ENSG00000165280	FALSE	Preclinical	2013-11-18	Absent	VCP
Pancreatic Neoplasms	ENSG00000165731	TRUE	Approved	1994-06-15	Unused	RET
Pancreatic Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Pancreatic Neoplasms	ENSG00000166501	FALSE	unknown	2001-07-03	Phase II Clinical Trial	PRKCB
Pancreatic Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	1997-12-15	Phase III Clinical Trial	PLK1
Pancreatic Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1997-03-15	Unused	RRM1
Pancreatic Neoplasms	ENSG00000167601	FALSE	Preclinical	2011-06-17	Preclinical	AXL
Pancreatic Neoplasms	ENSG00000167653	FALSE	Phase II Clinical Trial	2000-07-26	Unused	PSCA
Pancreatic Neoplasms	ENSG00000167658	FALSE	unknown	2004-03-03	Unused	EEF2
Pancreatic Neoplasms	ENSG00000168036	FALSE	Phase I Clinical Trial	2011-03-05	Phase I Clinical Trial	CTNNB1
Pancreatic Neoplasms	ENSG00000168522	FALSE	Preclinical	1995-04-15	Unused	FNTA
Pancreatic Neoplasms	ENSG00000168610	FALSE	Phase III Clinical Trial	2005-04-25	Phase II Clinical Trial	STAT3
Pancreatic Neoplasms	ENSG00000168811	FALSE	Preclinical	2001-10-02	Unused	IL12A
Pancreatic Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	1999-04-14	Phase II Clinical Trial	MAP2K1
Pancreatic Neoplasms	ENSG00000169035	FALSE	unknown	2006-06-27	Unused	KLK7
Pancreatic Neoplasms	ENSG00000169136	FALSE	Preclinical	2016-07-14	Absent	ATF5
Pancreatic Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Pancreatic Neoplasms	ENSG00000169252	FALSE	unknown	2007-01-23	Absent	ADRB2
Pancreatic Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Phase I Clinical Trial	PTK2
Pancreatic Neoplasms	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Pancreatic Neoplasms	ENSG00000170312	FALSE	Phase II Clinical Trial	2005-03-14	Phase II Clinical Trial	CDK1
Pancreatic Neoplasms	ENSG00000170525	FALSE	unknown	2014-01-27	Absent	PFKFB3
Pancreatic Neoplasms	ENSG00000170835	FALSE	Preclinical	2009-02-13	Unused	CEL
Pancreatic Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2006-12-05	Phase I Clinical Trial	ALK
Pancreatic Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CD
Pancreatic Neoplasms	ENSG00000171720	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HDAC3
Pancreatic Neoplasms	ENSG00000171791	FALSE	unknown	1992-03-15	Phase I Clinical Trial	BCL2
Pancreatic Neoplasms	ENSG00000171848	FALSE	Preclinical	1997-03-15	Unused	RRM2
Pancreatic Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Pancreatic Neoplasms	ENSG00000172062	FALSE	Preclinical	2014-06-26	Absent	SMN1
Pancreatic Neoplasms	ENSG00000173273	FALSE	Phase II Clinical Trial	2012-04-23	Absent	TNKS
Pancreatic Neoplasms	ENSG00000174130	FALSE	Preclinical	2009-02-23	Unused	TLR6
Pancreatic Neoplasms	ENSG00000174775	FALSE	Preclinical	2007-07-24	Unused	HRAS
Pancreatic Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Phase I Clinical Trial	CD248
Pancreatic Neoplasms	ENSG00000175305	FALSE	Phase I Clinical Trial	2010-12-05	Phase I Clinical Trial	CCNE2
Pancreatic Neoplasms	ENSG00000176105	FALSE	unknown	2004-07-20	Phase II Clinical Trial	YES1
Pancreatic Neoplasms	ENSG00000176170	FALSE	Preclinical	2003-09-19	Unused	SPHK1
Pancreatic Neoplasms	ENSG00000176884	FALSE	Phase I Clinical Trial	1990-06-15	Absent	GRIN1
Pancreatic Neoplasms	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Pancreatic Neoplasms	ENSG00000177034	FALSE	Preclinical	2016-10-24	Absent	MTX3
Pancreatic Neoplasms	ENSG00000177606	FALSE	Phase II Clinical Trial	2009-05-27	Absent	JUN
Pancreatic Neoplasms	ENSG00000177885	FALSE	Preclinical	NA	Absent	GRB2
Pancreatic Neoplasms	ENSG00000178035	FALSE	unknown	2000-11-09	Unused	IMPDH2
Pancreatic Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Pancreatic Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2003-11-21	Phase II Clinical Trial	ERBB4
Pancreatic Neoplasms	ENSG00000178999	FALSE	Phase II Clinical Trial	2003-01-31	Phase II Clinical Trial	AURKB
Pancreatic Neoplasms	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Pancreatic Neoplasms	ENSG00000179776	FALSE	Phase II Clinical Trial	2000-12-11	Phase I Clinical Trial	CDH5
Pancreatic Neoplasms	ENSG00000180210	FALSE	Phase III Clinical Trial	NA	Unused	F2
Pancreatic Neoplasms	ENSG00000180616	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	SSTR2
Pancreatic Neoplasms	ENSG00000181019	FALSE	Phase II Clinical Trial	2007-11-12	Absent	NQO1
Pancreatic Neoplasms	ENSG00000181143	FALSE	Phase I Clinical Trial	2008-09-24	Preclinical	MUC16
Pancreatic Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-08	Absent	CSF1R
Pancreatic Neoplasms	ENSG00000182866	FALSE	unknown	2004-07-20	Phase II Clinical Trial	LCK
Pancreatic Neoplasms	ENSG00000182871	FALSE	Phase I Clinical Trial	1997-02-15	Phase I Clinical Trial	COL18A1
Pancreatic Neoplasms	ENSG00000183087	FALSE	Preclinical	2016-02-16	Absent	GAS6
Pancreatic Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-03-06	Unused	TACSTD2
Pancreatic Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Phase I Clinical Trial	CSF1
Pancreatic Neoplasms	ENSG00000184502	FALSE	Phase III Clinical Trial	1994-08-15	Phase III Clinical Trial	GAST
Pancreatic Neoplasms	ENSG00000184916	FALSE	Preclinical	2010-11-19	Absent	JAG2
Pancreatic Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Pancreatic Neoplasms	ENSG00000185483	FALSE	Preclinical	2015-09-18	Absent	ROR1
Pancreatic Neoplasms	ENSG00000185499	FALSE	Phase III Clinical Trial	1992-07-15	Phase II Clinical Trial	MUC1
Pancreatic Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Absent	PRAME
Pancreatic Neoplasms	ENSG00000186088	FALSE	Phase II Clinical Trial	2007-01-08	Absent	GSAP
Pancreatic Neoplasms	ENSG00000186716	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	BCR
Pancreatic Neoplasms	ENSG00000187079	FALSE	Preclinical	2014-11-05	Absent	TEAD1
Pancreatic Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Pancreatic Neoplasms	ENSG00000188641	FALSE	Approved	1993-07-15	Phase II Clinical Trial	DPYD
Pancreatic Neoplasms	ENSG00000189143	FALSE	Preclinical	2009-07-14	Unused	CLDN4
Pancreatic Neoplasms	ENSG00000196083	FALSE	Phase II Clinical Trial	NA	Absent	IL1RAP
Pancreatic Neoplasms	ENSG00000196154	FALSE	Preclinical	2011-09-15	Absent	S100A4
Pancreatic Neoplasms	ENSG00000196352	FALSE	Preclinical	2004-07-19	Preclinical	CD55
Pancreatic Neoplasms	ENSG00000196396	FALSE	Preclinical	2005-08-19	Unused	PTPN1
Pancreatic Neoplasms	ENSG00000196557	FALSE	Phase I Clinical Trial	NA	Absent	CACNA1H
Pancreatic Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Pancreatic Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	SRC
Pancreatic Neoplasms	ENSG00000197408	FALSE	unknown	NA	Phase II Clinical Trial	CYP2B6
Pancreatic Neoplasms	ENSG00000198355	FALSE	Preclinical	2011-03-15	Unused	PIM3
Pancreatic Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Unused	NTRK1
Pancreatic Neoplasms	ENSG00000198625	FALSE	Preclinical	2015-07-15	Absent	MDM4
Pancreatic Neoplasms	ENSG00000198793	TRUE	Approved	1997-08-15	Unused	MTOR
Pancreatic Neoplasms	ENSG00000198851	FALSE	Preclinical	2013-06-28	Absent	CD3E
Pancreatic Neoplasms	ENSG00000198900	TRUE	Approved	1993-07-15	Phase III Clinical Trial	TOP1
Pancreatic Neoplasms	ENSG00000203747	FALSE	unknown	NA	Absent	FCGR3A
Pancreatic Neoplasms	ENSG00000213281	FALSE	Preclinical	2007-07-24	Preclinical	NRAS
Pancreatic Neoplasms	ENSG00000213903	FALSE	Preclinical	1993-10-15	Unused	LTB4R
Pancreatic Neoplasms	ENSG00000213949	FALSE	Preclinical	2013-07-17	Absent	ITGA1
Pancreatic Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Phase II Clinical Trial	DHFR
Pancreatic Neoplasms	ENSG00000239732	FALSE	Preclinical	2005-06-03	Absent	TLR9
Pancreatic Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PRKDC
Pancreatic Neoplasms	ENSG00000254087	FALSE	Pre-registration	2004-07-20	Phase II Clinical Trial	LYN
Pancreatic Neoplasms	ENSG00000259207	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ITGB3
Pancreatic Neoplasms	ENSG00000275302	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL4
Pancreatic Neoplasms	ENSG00000277632	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL3
Pancreatic Neoplasms	ENSG00000278195	FALSE	Phase III Clinical Trial	2002-11-27	Phase III Clinical Trial	SSTR3
Pancreatitis	ENSG00000005421	FALSE	Preclinical	2015-07-29	Absent	PON1
Pancreatitis	ENSG00000044012	FALSE	Preclinical	1997-05-15	Unused	GUCA2B
Pancreatitis	ENSG00000069764	FALSE	Preclinical	1998-04-15	Unused	PLA2G10
Pancreatitis	ENSG00000080293	FALSE	Phase III Clinical Trial	1999-03-23	Unused	SCTR
Pancreatitis	ENSG00000080824	FALSE	Preclinical	2001-12-11	Unused	HSP90AA1
Pancreatitis	ENSG00000088832	FALSE	Preclinical	2017-10-24	Absent	FKBP1A
Pancreatitis	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Pancreatitis	ENSG00000102468	FALSE	Preclinical	2006-08-07	Unused	HTR2A
Pancreatitis	ENSG00000110148	FALSE	Preclinical	1996-03-15	Unused	CCKBR
Pancreatitis	ENSG00000112062	FALSE	Preclinical	1997-06-15	Unused	MAPK14
Pancreatitis	ENSG00000117009	FALSE	Preclinical	2017-04-27	Absent	KMO
Pancreatitis	ENSG00000122194	FALSE	Approved	NA	Unused	PLG
Pancreatitis	ENSG00000130203	FALSE	Preclinical	2015-07-29	Absent	APOE
Pancreatitis	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Pancreatitis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Pancreatitis	ENSG00000139610	FALSE	Preclinical	1995-02-15	Unused	CELA1
Pancreatitis	ENSG00000142677	FALSE	Preclinical	2011-06-28	Absent	IL22RA1
Pancreatitis	ENSG00000143799	FALSE	Preclinical	2011-04-30	Unused	PARP1
Pancreatitis	ENSG00000146070	FALSE	Preclinical	1998-04-15	Unused	PLA2G7
Pancreatitis	ENSG00000149131	FALSE	Preclinical	NA	Absent	SERPING1
Pancreatitis	ENSG00000163394	FALSE	Phase III Clinical Trial	1995-11-15	Unused	CCKAR
Pancreatitis	ENSG00000164266	FALSE	Approved	NA	Absent	SPINK1
Pancreatitis	ENSG00000164305	FALSE	Preclinical	2014-04-08	Absent	CASP3
Pancreatitis	ENSG00000167748	FALSE	Approved	NA	Absent	KLK1
Pancreatitis	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Pancreatitis	ENSG00000169403	FALSE	Phase III Clinical Trial	1995-11-15	Unused	PTAFR
Pancreatitis	ENSG00000170835	FALSE	unknown	1998-06-15	Unused	CEL
Pancreatitis	ENSG00000171497	FALSE	Preclinical	2015-11-04	Absent	PPID
Pancreatitis	ENSG00000175445	TRUE	Approved	2014-05-20	Approved	LPL
Pancreatitis	ENSG00000175535	TRUE	Approved	2003-05-19	Approved	PNLIP
Pancreatitis	ENSG00000178562	FALSE	unknown	2009-06-29	Absent	CD28
Pancreatitis	ENSG00000180210	FALSE	Approved	NA	Unused	F2
Pancreatitis	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Pancreatitis	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Pancreatitis	ENSG00000184381	FALSE	Preclinical	1998-04-15	Unused	PLA2G6
Pancreatitis	ENSG00000184502	FALSE	Preclinical	NA	Unused	GAST
Pancreatitis	ENSG00000188257	FALSE	Preclinical	1998-04-15	Unused	PLA2G2A
Pancreatitis	ENSG00000197249	FALSE	Preclinical	2007-03-06	Unused	SERPINA1
Pancreatitis	ENSG00000197561	FALSE	Preclinical	1995-02-15	Unused	ELANE
Pancreatitis	ENSG00000243480	TRUE	Approved	2014-05-20	Approved	AMY2A
Pancreatitis	ENSG00000276045	FALSE	Phase I Clinical Trial	2016-11-21	Absent	ORAI1
Panic Disorder	ENSG00000011677	TRUE	Approved	1993-02-15	Approved	GABRA3
Panic Disorder	ENSG00000022355	TRUE	Approved	1993-02-15	Approved	GABRA1
Panic Disorder	ENSG00000043591	FALSE	unknown	1997-04-15	Unused	ADRB1
Panic Disorder	ENSG00000069696	FALSE	Phase I Clinical Trial	1999-06-15	Unused	DRD4
Panic Disorder	ENSG00000100300	FALSE	Phase II Clinical Trial	2000-03-29	Unused	TSPO
Panic Disorder	ENSG00000102468	TRUE	Approved	NA	Unused	HTR2A
Panic Disorder	ENSG00000103546	TRUE	Approved	NA	Approved	SLC6A2
Panic Disorder	ENSG00000108576	TRUE	Approved	1998-10-15	Approved	SLC6A4
Panic Disorder	ENSG00000109158	FALSE	Phase II Clinical Trial	2007-04-27	Unused	GABRA4
Panic Disorder	ENSG00000110148	FALSE	Phase II Clinical Trial	1991-06-15	Unused	CCKBR
Panic Disorder	ENSG00000142319	TRUE	Approved	NA	Approved	SLC6A3
Panic Disorder	ENSG00000147246	TRUE	Approved	NA	Unused	HTR2C
Panic Disorder	ENSG00000147955	FALSE	Preclinical	1992-11-15	Unused	SIGMAR1
Panic Disorder	ENSG00000149295	FALSE	Phase I Clinical Trial	1999-06-15	Unused	DRD2
Panic Disorder	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Unused	ADRA2A
Panic Disorder	ENSG00000151577	FALSE	Phase I Clinical Trial	1999-06-15	Unused	DRD3
Panic Disorder	ENSG00000151834	TRUE	Approved	1993-02-15	Approved	GABRA2
Panic Disorder	ENSG00000164270	FALSE	unknown	1990-10-15	Unused	HTR4
Panic Disorder	ENSG00000166736	FALSE	Phase II Clinical Trial	1990-10-15	Unused	HTR3A
Panic Disorder	ENSG00000176884	FALSE	unknown	2007-09-03	Unused	GRIN1
Panic Disorder	ENSG00000178394	FALSE	Phase I Clinical Trial	1999-06-15	Unused	HTR1A
Panic Disorder	ENSG00000186297	TRUE	Approved	1993-02-15	Approved	GABRA5
Panic Disorder	ENSG00000196517	FALSE	Phase II Clinical Trial	2006-03-27	Unused	SLC6A9
Papilloma	ENSG00000100312	FALSE	unknown	2002-03-20	Preclinical	ACR
Papilloma	ENSG00000114378	FALSE	unknown	2002-03-20	Preclinical	HYAL1
Papilloma	ENSG00000159110	TRUE	Approved	NA	Absent	IFNAR2
Papilloma	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Papillomavirus Infections	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Unused	IFNGR1
Papillomavirus Infections	ENSG00000064651	FALSE	Phase II Clinical Trial	2008-01-21	Unused	SLC12A2
Papillomavirus Infections	ENSG00000070501	FALSE	Phase I Clinical Trial	NA	Unused	POLB
Papillomavirus Infections	ENSG00000074803	FALSE	Phase II Clinical Trial	2008-01-21	Unused	SLC12A1
Papillomavirus Infections	ENSG00000077498	FALSE	unknown	2002-02-27	Unused	TYR
Papillomavirus Infections	ENSG00000101017	FALSE	Preclinical	2003-06-25	Unused	CD40
Papillomavirus Infections	ENSG00000101868	FALSE	Phase I Clinical Trial	NA	Unused	POLA1
Papillomavirus Infections	ENSG00000101916	FALSE	unknown	NA	Absent	TLR8
Papillomavirus Infections	ENSG00000109471	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL2
Papillomavirus Infections	ENSG00000112115	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL17A
Papillomavirus Infections	ENSG00000115232	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ITGA4
Papillomavirus Infections	ENSG00000121966	FALSE	unknown	1996-07-15	Unused	CXCR4
Papillomavirus Infections	ENSG00000128052	FALSE	Phase II Clinical Trial	2017-12-19	Absent	KDR
Papillomavirus Infections	ENSG00000135828	FALSE	unknown	1997-01-15	Unused	RNASEL
Papillomavirus Infections	ENSG00000137752	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	CASP1
Papillomavirus Infections	ENSG00000138448	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ITGAV
Papillomavirus Infections	ENSG00000150782	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL18
Papillomavirus Infections	ENSG00000159110	TRUE	Approved	1999-06-02	Approved	IFNAR2
Papillomavirus Infections	ENSG00000160791	FALSE	unknown	1996-07-15	Unused	CCR5
Papillomavirus Infections	ENSG00000163399	FALSE	Phase II Clinical Trial	2008-01-21	Unused	ATP1A1
Papillomavirus Infections	ENSG00000163932	FALSE	Phase II Clinical Trial	2002-10-14	Absent	PRKCD
Papillomavirus Infections	ENSG00000164342	FALSE	Preclinical	2008-11-03	Unused	TLR3
Papillomavirus Infections	ENSG00000168685	FALSE	Phase I Clinical Trial	2015-10-09	Absent	IL7R
Papillomavirus Infections	ENSG00000169432	TRUE	Approved	NA	Approved	SCN9A
Papillomavirus Infections	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Papillomavirus Infections	ENSG00000176890	TRUE	Approved	1992-03-15	Unused	TYMS
Papillomavirus Infections	ENSG00000185664	FALSE	unknown	2002-02-27	Unused	PMEL
Papillomavirus Infections	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Papillomavirus Infections	ENSG00000196664	FALSE	Preclinical	2009-12-23	Preclinical	TLR7
Papillomavirus Infections	ENSG00000239732	FALSE	unknown	2002-10-31	Unused	TLR9
Papillomavirus Infections	ENSG00000259207	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ITGB3
Paramyxoviridae Infections	ENSG00000169385	FALSE	Preclinical	1999-09-01	Unused	RNASE2
Paraphilic Disorders	ENSG00000109163	TRUE	Approved	2006-06-20	Approved	GNRHR
Parasitic Diseases	ENSG00000027697	FALSE	unknown	NA	Absent	IFNGR1
Parasitic Diseases	ENSG00000123505	FALSE	Preclinical	1992-06-15	Absent	AMD1
Parasitic Diseases	ENSG00000135047	FALSE	Preclinical	1994-12-15	Absent	CTSL
Parasitic Diseases	ENSG00000164733	FALSE	Preclinical	1994-12-15	Absent	CTSB
Parasitic Diseases	ENSG00000184502	FALSE	Preclinical	NA	Absent	GAST
Parkinson Disease	ENSG00000004478	FALSE	Preclinical	2016-07-15	Absent	FKBP4
Parkinson Disease	ENSG00000004487	FALSE	Phase I Clinical Trial	2010-07-08	Preclinical	KDM1A
Parkinson Disease	ENSG00000004948	FALSE	Preclinical	2010-09-07	Absent	CALCR
Parkinson Disease	ENSG00000005381	FALSE	Phase I Clinical Trial	2006-02-07	Phase II Clinical Trial	MPO
Parkinson Disease	ENSG00000007952	FALSE	Preclinical	2015-03-26	Absent	NOX1
Parkinson Disease	ENSG00000010810	FALSE	Phase II Clinical Trial	NA	Absent	FYN
Parkinson Disease	ENSG00000019991	FALSE	Preclinical	2001-01-31	Preclinical	HGF
Parkinson Disease	ENSG00000022355	FALSE	Phase II Clinical Trial	2006-05-31	Unused	GABRA1
Parkinson Disease	ENSG00000026103	FALSE	Phase I Clinical Trial	2016-12-13	Absent	FAS
Parkinson Disease	ENSG00000065989	FALSE	Phase I Clinical Trial	2005-03-21	Preclinical	PDE4A
Parkinson Disease	ENSG00000068078	FALSE	Phase II Clinical Trial	NA	Absent	FGFR3
Parkinson Disease	ENSG00000068903	FALSE	Preclinical	2008-12-05	Unused	SIRT2
Parkinson Disease	ENSG00000069535	TRUE	Approved	1992-01-15	Approved	MAOB
Parkinson Disease	ENSG00000069696	FALSE	Phase III Clinical Trial	1995-03-15	Unused	DRD4
Parkinson Disease	ENSG00000070748	FALSE	unknown	NA	Preclinical	CHAT
Parkinson Disease	ENSG00000080824	FALSE	Preclinical	2008-09-09	Unused	HSP90AA1
Parkinson Disease	ENSG00000082701	FALSE	Phase I Clinical Trial	2008-01-15	Phase II Clinical Trial	GSK3B
Parkinson Disease	ENSG00000087085	FALSE	Phase I Clinical Trial	1997-10-15	Unused	ACHE
Parkinson Disease	ENSG00000088832	FALSE	Preclinical	1993-12-15	Unused	FKBP1A
Parkinson Disease	ENSG00000089250	FALSE	Preclinical	2003-08-01	Unused	NOS1
Parkinson Disease	ENSG00000091831	FALSE	unknown	1995-05-15	Unused	ESR1
Parkinson Disease	ENSG00000093010	TRUE	Approved	1992-10-15	Approved	COMT
Parkinson Disease	ENSG00000095596	FALSE	Preclinical	2014-12-31	Absent	CYP26A1
Parkinson Disease	ENSG00000097007	FALSE	Preclinical	2011-06-17	Absent	ABL1
Parkinson Disease	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Parkinson Disease	ENSG00000101126	FALSE	Phase I Clinical Trial	2003-06-17	Unused	ADNP
Parkinson Disease	ENSG00000101180	FALSE	Preclinical	2012-11-23	Preclinical	HRH3
Parkinson Disease	ENSG00000101204	FALSE	Preclinical	2012-08-29	Preclinical	CHRNA4
Parkinson Disease	ENSG00000101557	FALSE	Preclinical	2011-04-27	Preclinical	USP14
Parkinson Disease	ENSG00000102468	TRUE	Approved	1999-03-23	Phase III Clinical Trial	HTR2A
Parkinson Disease	ENSG00000103546	FALSE	Preclinical	1997-10-15	Unused	SLC6A2
Parkinson Disease	ENSG00000105464	FALSE	Preclinical	2011-07-28	Absent	GRIN2D
Parkinson Disease	ENSG00000105650	FALSE	Phase I Clinical Trial	2005-03-21	Preclinical	PDE4C
Parkinson Disease	ENSG00000105701	FALSE	Preclinical	2007-05-21	Unused	FKBP8
Parkinson Disease	ENSG00000106018	FALSE	Preclinical	2014-09-09	Absent	VIPR2
Parkinson Disease	ENSG00000106144	FALSE	Preclinical	2001-09-12	Absent	CASP2
Parkinson Disease	ENSG00000108576	FALSE	Preclinical	1997-10-15	Unused	SLC6A4
Parkinson Disease	ENSG00000109320	FALSE	Preclinical	2006-09-27	Unused	NFKB1
Parkinson Disease	ENSG00000111276	FALSE	Preclinical	2003-08-26	Absent	CDKN1B
Parkinson Disease	ENSG00000111640	FALSE	Phase II Clinical Trial	1998-10-15	Unused	GAPDH
Parkinson Disease	ENSG00000112033	FALSE	Preclinical	2004-08-26	Absent	PPARD
Parkinson Disease	ENSG00000112038	FALSE	Preclinical	2002-07-02	Phase III Clinical Trial	OPRM1
Parkinson Disease	ENSG00000112715	FALSE	Preclinical	2008-12-05	Unused	VEGFA
Parkinson Disease	ENSG00000113448	FALSE	Phase I Clinical Trial	2005-03-21	Preclinical	PDE4D
Parkinson Disease	ENSG00000113575	FALSE	Preclinical	2009-02-13	Unused	PPP2CA
Parkinson Disease	ENSG00000113580	FALSE	Preclinical	2012-04-20	Preclinical	NR3C1
Parkinson Disease	ENSG00000113721	FALSE	Phase II Clinical Trial	2003-09-23	Phase II Clinical Trial	PDGFRB
Parkinson Disease	ENSG00000115252	FALSE	Phase II Clinical Trial	2007-06-26	Unused	PDE1A
Parkinson Disease	ENSG00000115263	FALSE	Phase I Clinical Trial	2015-10-05	Absent	GCG
Parkinson Disease	ENSG00000115457	FALSE	Phase II Clinical Trial	2010-10-19	Absent	IGFBP2
Parkinson Disease	ENSG00000116288	FALSE	Preclinical	2013-12-17	Absent	PARK7
Parkinson Disease	ENSG00000116329	FALSE	Preclinical	2002-07-02	Phase III Clinical Trial	OPRD1
Parkinson Disease	ENSG00000117594	FALSE	Preclinical	2015-03-06	Absent	HSD11B1
Parkinson Disease	ENSG00000118432	FALSE	Phase I Clinical Trial	2004-02-06	Unused	CNR1
Parkinson Disease	ENSG00000118515	FALSE	Preclinical	2012-02-21	Absent	SGK1
Parkinson Disease	ENSG00000118762	FALSE	Preclinical	2008-12-05	Unused	PKD2
Parkinson Disease	ENSG00000118785	FALSE	Preclinical	2007-10-29	Unused	SPP1
Parkinson Disease	ENSG00000119535	FALSE	Preclinical	2003-04-24	Phase I Clinical Trial	CSF3R
Parkinson Disease	ENSG00000120948	FALSE	Preclinical	2017-11-22	Absent	TARDBP
Parkinson Disease	ENSG00000121653	FALSE	unknown	2003-08-26	Unused	MAPK8IP1
Parkinson Disease	ENSG00000123454	FALSE	Preclinical	1997-12-15	Unused	DBH
Parkinson Disease	ENSG00000124493	FALSE	Phase II Clinical Trial	2004-05-24	Preclinical	GRM4
Parkinson Disease	ENSG00000125510	FALSE	Preclinical	2009-10-01	Preclinical	OPRL1
Parkinson Disease	ENSG00000128245	FALSE	Preclinical	2017-11-22	Absent	YWHAH
Parkinson Disease	ENSG00000128271	FALSE	Approved	1995-06-15	Approved	ADORA2A
Parkinson Disease	ENSG00000128683	FALSE	Phase II Clinical Trial	2002-11-04	Unused	GAD1
Parkinson Disease	ENSG00000129484	FALSE	Preclinical	2004-09-02	Unused	PARP2
Parkinson Disease	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Parkinson Disease	ENSG00000131979	FALSE	Phase II Clinical Trial	1998-12-15	Phase II Clinical Trial	GCH1
Parkinson Disease	ENSG00000132170	FALSE	Preclinical	2004-08-26	Unused	PPARG
Parkinson Disease	ENSG00000132437	TRUE	Approved	1992-11-15	Approved	DDC
Parkinson Disease	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Parkinson Disease	ENSG00000135093	FALSE	Preclinical	2016-03-22	Absent	USP30
Parkinson Disease	ENSG00000135312	FALSE	Phase II Clinical Trial	1998-01-15	Phase I Clinical Trial	HTR1B
Parkinson Disease	ENSG00000135914	TRUE	Approved	NA	Approved	HTR2B
Parkinson Disease	ENSG00000136750	FALSE	Preclinical	NA	Unused	GAD2
Parkinson Disease	ENSG00000136827	FALSE	Preclinical	2008-11-04	Preclinical	TOR1A
Parkinson Disease	ENSG00000137462	FALSE	Preclinical	2014-09-10	Absent	TLR2
Parkinson Disease	ENSG00000140009	FALSE	Preclinical	2009-01-08	Unused	ESR2
Parkinson Disease	ENSG00000140443	FALSE	Phase II Clinical Trial	2010-10-19	Absent	IGF1R
Parkinson Disease	ENSG00000140538	FALSE	Preclinical	2016-10-25	Absent	NTRK3
Parkinson Disease	ENSG00000141510	FALSE	Preclinical	2002-10-01	Unused	TP53
Parkinson Disease	ENSG00000142192	FALSE	Preclinical	2003-06-17	Unused	APP
Parkinson Disease	ENSG00000142319	TRUE	Approved	1993-04-15	Phase III Clinical Trial	SLC6A3
Parkinson Disease	ENSG00000143799	FALSE	Phase I Clinical Trial	2003-06-17	Unused	PARP1
Parkinson Disease	ENSG00000145050	FALSE	Preclinical	2010-01-11	Preclinical	MANF
Parkinson Disease	ENSG00000145335	FALSE	Phase II Clinical Trial	2000-06-23	Phase I Clinical Trial	SNCA
Parkinson Disease	ENSG00000145632	FALSE	Preclinical	2013-03-16	Absent	PLK2
Parkinson Disease	ENSG00000146674	FALSE	Phase I Clinical Trial	2008-01-04	Preclinical	IGFBP3
Parkinson Disease	ENSG00000147246	FALSE	Phase I Clinical Trial	2017-01-31	Absent	HTR2C
Parkinson Disease	ENSG00000147434	FALSE	Preclinical	2014-11-27	Absent	CHRNA6
Parkinson Disease	ENSG00000147955	FALSE	Phase II Clinical Trial	1999-01-15	Preclinical	SIGMAR1
Parkinson Disease	ENSG00000148053	FALSE	Preclinical	2016-10-25	Preclinical	NTRK2
Parkinson Disease	ENSG00000148154	FALSE	Phase II Clinical Trial	2012-08-31	Absent	UGCG
Parkinson Disease	ENSG00000148344	FALSE	Phase I Clinical Trial	2006-12-19	Phase I Clinical Trial	PTGES
Parkinson Disease	ENSG00000148680	FALSE	Phase II Clinical Trial	2008-07-22	Absent	HTR7
Parkinson Disease	ENSG00000149295	TRUE	Approved	1989-10-15	Approved	DRD2
Parkinson Disease	ENSG00000150594	FALSE	Phase III Clinical Trial	1999-03-24	Unused	ADRA2A
Parkinson Disease	ENSG00000151577	TRUE	Approved	1991-06-15	Approved	DRD3
Parkinson Disease	ENSG00000151790	FALSE	Preclinical	2012-12-05	Absent	TDO2
Parkinson Disease	ENSG00000151892	FALSE	Phase II Clinical Trial	1993-07-15	Unused	GFRA1
Parkinson Disease	ENSG00000152207	FALSE	Preclinical	2015-11-12	Absent	CYSLTR2
Parkinson Disease	ENSG00000153234	FALSE	Preclinical	2010-11-17	Preclinical	NR4A2
Parkinson Disease	ENSG00000155511	FALSE	Phase II Clinical Trial	1995-07-15	Unused	GRIA1
Parkinson Disease	ENSG00000157404	FALSE	Phase II Clinical Trial	NA	Absent	KIT
Parkinson Disease	ENSG00000157540	FALSE	Preclinical	2012-08-22	Preclinical	DYRK1A
Parkinson Disease	ENSG00000158104	FALSE	Phase II Clinical Trial	1992-11-15	Unused	HPD
Parkinson Disease	ENSG00000158748	FALSE	Phase II Clinical Trial	2008-07-22	Preclinical	HTR6
Parkinson Disease	ENSG00000158828	FALSE	Preclinical	2015-03-18	Absent	PINK1
Parkinson Disease	ENSG00000159164	FALSE	Phase II Clinical Trial	NA	Unused	SV2A
Parkinson Disease	ENSG00000159267	FALSE	Preclinical	2007-05-21	Unused	HLCS
Parkinson Disease	ENSG00000160712	FALSE	Preclinical	2004-04-05	Unused	IL6R
Parkinson Disease	ENSG00000160716	FALSE	Preclinical	2012-08-29	Preclinical	CHRNB2
Parkinson Disease	ENSG00000161509	FALSE	Preclinical	2011-07-28	Absent	GRIN2C
Parkinson Disease	ENSG00000163485	FALSE	Preclinical	2008-07-24	Unused	ADORA1
Parkinson Disease	ENSG00000164082	FALSE	Preclinical	2011-01-27	Absent	GRM2
Parkinson Disease	ENSG00000164270	FALSE	unknown	NA	Absent	HTR4
Parkinson Disease	ENSG00000164305	FALSE	Preclinical	1997-03-15	Unused	CASP3
Parkinson Disease	ENSG00000166736	FALSE	Phase II Clinical Trial	NA	Unused	HTR3A
Parkinson Disease	ENSG00000167720	FALSE	Preclinical	2000-03-01	Unused	SRR
Parkinson Disease	ENSG00000168539	FALSE	Phase II Clinical Trial	1994-09-15	Phase II Clinical Trial	CHRM1
Parkinson Disease	ENSG00000168621	FALSE	Preclinical	1997-10-15	Unused	GDNF
Parkinson Disease	ENSG00000168959	FALSE	Phase II Clinical Trial	2005-10-04	Phase II Clinical Trial	GRM5
Parkinson Disease	ENSG00000169032	FALSE	Preclinical	2009-05-27	Absent	MAP2K1
Parkinson Disease	ENSG00000169083	FALSE	Preclinical	1997-04-15	Unused	AR
Parkinson Disease	ENSG00000169676	FALSE	Phase I Clinical Trial	1993-10-15	Unused	DRD5
Parkinson Disease	ENSG00000171105	FALSE	Preclinical	2009-07-31	Absent	INSR
Parkinson Disease	ENSG00000171119	FALSE	Phase II Clinical Trial	1993-12-15	Phase II Clinical Trial	NRTN
Parkinson Disease	ENSG00000171408	FALSE	Preclinical	2009-01-09	Preclinical	PDE7B
Parkinson Disease	ENSG00000171497	FALSE	Preclinical	2015-10-20	Absent	PPID
Parkinson Disease	ENSG00000174417	FALSE	unknown	2003-08-15	Unused	TRHR
Parkinson Disease	ENSG00000175344	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	CHRNA7
Parkinson Disease	ENSG00000176884	TRUE	Approved	1990-12-15	Approved	GRIN1
Parkinson Disease	ENSG00000177606	FALSE	Preclinical	2009-05-27	Absent	JUN
Parkinson Disease	ENSG00000177628	FALSE	Phase I Clinical Trial	2007-01-24	Preclinical	GBA
Parkinson Disease	ENSG00000178394	FALSE	Phase III Clinical Trial	1995-03-15	Phase I Clinical Trial	HTR1A
Parkinson Disease	ENSG00000178568	FALSE	Preclinical	2010-10-27	Absent	ERBB4
Parkinson Disease	ENSG00000179546	FALSE	Preclinical	1995-06-15	Unused	HTR1D
Parkinson Disease	ENSG00000180176	FALSE	Phase II Clinical Trial	1991-06-15	Phase II Clinical Trial	TH
Parkinson Disease	ENSG00000180720	FALSE	Preclinical	2000-08-22	Unused	CHRM4
Parkinson Disease	ENSG00000181072	FALSE	Preclinical	2002-06-25	Unused	CHRM2
Parkinson Disease	ENSG00000184160	FALSE	Phase III Clinical Trial	1999-03-24	Unused	ADRA2C
Parkinson Disease	ENSG00000184588	FALSE	Phase I Clinical Trial	2001-12-03	Unused	PDE4B
Parkinson Disease	ENSG00000184845	TRUE	Approved	1989-10-15	Approved	DRD1
Parkinson Disease	ENSG00000185267	FALSE	Phase II Clinical Trial	2012-10-23	Preclinical	CDNF
Parkinson Disease	ENSG00000185345	FALSE	Preclinical	2005-07-20	Unused	PRKN
Parkinson Disease	ENSG00000186318	FALSE	Preclinical	2003-06-17	Preclinical	BACE1
Parkinson Disease	ENSG00000186716	FALSE	Preclinical	2011-06-17	Absent	BCR
Parkinson Disease	ENSG00000186868	FALSE	Phase I Clinical Trial	2008-08-08	Unused	MAPT
Parkinson Disease	ENSG00000186951	FALSE	Preclinical	2004-08-26	Absent	PPARA
Parkinson Disease	ENSG00000187266	FALSE	Preclinical	2010-05-17	Absent	EPOR
Parkinson Disease	ENSG00000188822	FALSE	Preclinical	2004-09-09	Unused	CNR2
Parkinson Disease	ENSG00000188906	FALSE	Phase I Clinical Trial	2007-01-24	Unused	LRRK2
Parkinson Disease	ENSG00000189221	FALSE	Phase I Clinical Trial	1999-08-11	Unused	MAOA
Parkinson Disease	ENSG00000196591	FALSE	Preclinical	2014-01-10	Absent	HDAC2
Parkinson Disease	ENSG00000197386	FALSE	Preclinical	2003-06-17	Absent	HTT
Parkinson Disease	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Parkinson Disease	ENSG00000198793	FALSE	Preclinical	2017-08-01	Absent	MTOR
Parkinson Disease	ENSG00000198822	FALSE	Preclinical	2012-01-31	Preclinical	GRM3
Parkinson Disease	ENSG00000198959	FALSE	Preclinical	2012-04-03	Preclinical	TGM2
Parkinson Disease	ENSG00000205268	FALSE	Preclinical	2009-01-09	Preclinical	PDE7A
Parkinson Disease	ENSG00000254087	FALSE	Phase II Clinical Trial	NA	Absent	LYN
Parkinson Disease	ENSG00000273079	FALSE	Phase I Clinical Trial	1995-12-15	Unused	GRIN2B
Parkinson Disease	ENSG00000274286	FALSE	Phase III Clinical Trial	1999-03-24	Unused	ADRA2B
Pemphigoid, Bullous	ENSG00000100453	FALSE	Preclinical	2013-03-12	Absent	GZMB
Pemphigoid, Bullous	ENSG00000106804	FALSE	Phase I Clinical Trial	2005-01-31	Absent	C5
Pemphigoid, Bullous	ENSG00000116044	FALSE	Phase I Clinical Trial	NA	Absent	NFE2L2
Pemphigoid, Bullous	ENSG00000156738	FALSE	unknown	1993-09-15	Phase II Clinical Trial	MS4A1
Pemphigoid, Bullous	ENSG00000162711	FALSE	Phase II Clinical Trial	2017-05-25	Absent	NLRP3
Pemphigoid, Bullous	ENSG00000163464	FALSE	Phase II Clinical Trial	2007-07-04	Phase II Clinical Trial	CXCR1
Pemphigoid, Bullous	ENSG00000172156	FALSE	Phase II Clinical Trial	2000-08-02	Absent	CCL11
Pemphigoid, Bullous	ENSG00000180871	FALSE	Phase II Clinical Trial	2007-07-04	Phase II Clinical Trial	CXCR2
Pemphigoid, Bullous	ENSG00000182326	FALSE	Phase I Clinical Trial	2012-05-21	Absent	C1S
Pemphigoid, Bullous	ENSG00000197891	FALSE	Phase II Clinical Trial	2017-05-25	Absent	SLC22A12
Pemphigoid, Bullous	ENSG00000213903	FALSE	Phase I Clinical Trial	2017-04-12	Absent	LTB4R
Pemphigus	ENSG00000010671	FALSE	Phase II Clinical Trial	2012-11-06	Absent	BTK
Pemphigus	ENSG00000092009	FALSE	Preclinical	1995-02-15	Unused	CMA1
Pemphigus	ENSG00000104870	FALSE	Phase II Clinical Trial	2011-11-19	Preclinical	FCGRT
Pemphigus	ENSG00000106348	FALSE	unknown	1989-12-15	Unused	IMPDH1
Pemphigus	ENSG00000111537	FALSE	Preclinical	1997-01-15	Unused	IFNG
Pemphigus	ENSG00000117560	FALSE	Preclinical	NA	Absent	FASLG
Pemphigus	ENSG00000134757	FALSE	Phase II Clinical Trial	1998-11-15	Unused	DSG3
Pemphigus	ENSG00000134760	FALSE	Preclinical	2014-10-30	Absent	DSG1
Pemphigus	ENSG00000156738	FALSE	Phase III Clinical Trial	1993-09-15	Absent	MS4A1
Pemphigus	ENSG00000159958	FALSE	Phase II Clinical Trial	2010-10-21	Absent	TNFRSF13C
Pemphigus	ENSG00000162711	FALSE	Phase I Clinical Trial	2017-05-25	Absent	NLRP3
Pemphigus	ENSG00000166224	FALSE	Phase II Clinical Trial	2017-12-04	Absent	SGPL1
Pemphigus	ENSG00000196262	FALSE	Preclinical	2015-06-11	Absent	PPIA
Pemphigus	ENSG00000197891	FALSE	Phase I Clinical Trial	2017-05-25	Absent	SLC22A12
Pemphigus	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
Pemphigus	ENSG00000258839	FALSE	unknown	2003-06-05	Absent	MC1R
Penile Induration	ENSG00000142168	FALSE	Phase III Clinical Trial	2005-08-18	Phase III Clinical Trial	SOD1
Penile Induration	ENSG00000159110	FALSE	Approved	NA	Unused	IFNAR2
Peptic Ulcer	ENSG00000006638	FALSE	Phase III Clinical Trial	NA	Unused	TBXA2R
Peptic Ulcer	ENSG00000012779	FALSE	Preclinical	1989-06-15	Unused	ALOX5
Peptic Ulcer	ENSG00000059377	FALSE	Phase III Clinical Trial	NA	Unused	TBXAS1
Peptic Ulcer	ENSG00000065989	FALSE	Preclinical	NA	Unused	PDE4A
Peptic Ulcer	ENSG00000073756	TRUE	Approved	2013-03-28	Approved	PTGS2
Peptic Ulcer	ENSG00000077782	FALSE	Phase II Clinical Trial	1992-11-15	Unused	FGFR1
Peptic Ulcer	ENSG00000095303	TRUE	Approved	2013-03-28	Approved	PTGS1
Peptic Ulcer	ENSG00000101180	FALSE	unknown	1990-01-15	Unused	HRH3
Peptic Ulcer	ENSG00000102468	FALSE	unknown	NA	Unused	HTR2A
Peptic Ulcer	ENSG00000105650	FALSE	Preclinical	NA	Unused	PDE4C
Peptic Ulcer	ENSG00000105675	TRUE	Approved	1989-08-15	Approved	ATP4A
Peptic Ulcer	ENSG00000110148	FALSE	Phase II Clinical Trial	1991-06-15	Unused	CCKBR
Peptic Ulcer	ENSG00000111319	FALSE	Preclinical	NA	Unused	SCNN1A
Peptic Ulcer	ENSG00000112096	FALSE	Preclinical	NA	Unused	SOD2
Peptic Ulcer	ENSG00000113448	FALSE	Preclinical	NA	Unused	PDE4D
Peptic Ulcer	ENSG00000113749	TRUE	Approved	1989-10-15	Approved	HRH2
Peptic Ulcer	ENSG00000122420	FALSE	Preclinical	NA	Unused	PTGFR
Peptic Ulcer	ENSG00000125384	TRUE	Approved	1990-06-15	Unused	PTGER2
Peptic Ulcer	ENSG00000131747	FALSE	unknown	NA	Unused	TOP2A
Peptic Ulcer	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Peptic Ulcer	ENSG00000133895	FALSE	Preclinical	1997-08-15	Unused	MEN1
Peptic Ulcer	ENSG00000134460	FALSE	Preclinical	NA	Unused	IL2RA
Peptic Ulcer	ENSG00000146648	FALSE	Phase I Clinical Trial	NA	Unused	EGFR
Peptic Ulcer	ENSG00000147246	FALSE	unknown	NA	Unused	HTR2C
Peptic Ulcer	ENSG00000147955	FALSE	Phase II Clinical Trial	NA	Unused	SIGMAR1
Peptic Ulcer	ENSG00000159640	FALSE	Preclinical	NA	Unused	ACE
Peptic Ulcer	ENSG00000160013	FALSE	Preclinical	1990-05-15	Unused	PTGIR
Peptic Ulcer	ENSG00000160951	FALSE	Preclinical	1990-07-15	Unused	PTGER1
Peptic Ulcer	ENSG00000163394	FALSE	Preclinical	1996-03-15	Unused	CCKAR
Peptic Ulcer	ENSG00000163399	FALSE	Phase III Clinical Trial	2012-10-18	Phase II Clinical Trial	ATP1A1
Peptic Ulcer	ENSG00000168539	TRUE	Approved	1989-05-15	Approved	CHRM1
Peptic Ulcer	ENSG00000169403	FALSE	Preclinical	1990-09-15	Unused	PTAFR
Peptic Ulcer	ENSG00000169432	FALSE	unknown	NA	Unused	SCN9A
Peptic Ulcer	ENSG00000173198	FALSE	Preclinical	1994-07-15	Unused	CYSLTR1
Peptic Ulcer	ENSG00000178394	FALSE	Preclinical	1995-10-15	Unused	HTR1A
Peptic Ulcer	ENSG00000180720	TRUE	Approved	1989-05-15	Approved	CHRM4
Peptic Ulcer	ENSG00000181072	TRUE	Approved	1989-05-15	Approved	CHRM2
Peptic Ulcer	ENSG00000184502	TRUE	Approved	1989-05-15	Approved	GAST
Peptic Ulcer	ENSG00000184588	FALSE	Preclinical	NA	Unused	PDE4B
Peptic Ulcer	ENSG00000196639	FALSE	Phase III Clinical Trial	NA	Unused	HRH1
Peptic Ulcer	ENSG00000215644	FALSE	Preclinical	NA	Unused	GCGR
Periodontitis	ENSG00000007171	FALSE	unknown	2002-07-03	Unused	NOS2
Periodontitis	ENSG00000073756	FALSE	Approved	1995-05-15	Unused	PTGS2
Periodontitis	ENSG00000077782	FALSE	Pre-registration	NA	Phase III Clinical Trial	FGFR1
Periodontitis	ENSG00000087245	FALSE	Preclinical	1997-06-15	Unused	MMP2
Periodontitis	ENSG00000095303	FALSE	Approved	1995-05-15	Unused	PTGS1
Periodontitis	ENSG00000110719	FALSE	Preclinical	2006-07-18	Unused	TCIRG1
Periodontitis	ENSG00000117594	FALSE	Preclinical	2006-07-25	Unused	HSD11B1
Periodontitis	ENSG00000121807	FALSE	Preclinical	2011-02-16	Unused	CCR2
Periodontitis	ENSG00000125730	FALSE	Preclinical	NA	Absent	C3
Periodontitis	ENSG00000149968	FALSE	Preclinical	1998-10-15	Unused	MMP3
Periodontitis	ENSG00000176387	FALSE	Preclinical	2006-07-25	Unused	HSD11B2
Periodontitis	ENSG00000196611	TRUE	Approved	1995-06-15	Approved	MMP1
Periodontitis	ENSG00000205649	FALSE	Phase II Clinical Trial	1998-03-15	Unused	HTN3
Periodontitis	ENSG00000213949	FALSE	Preclinical	1998-12-15	Unused	ITGA1
Peripheral Vascular Diseases	ENSG00000005421	FALSE	Preclinical	2010-04-30	Absent	PON1
Peripheral Vascular Diseases	ENSG00000005961	FALSE	Phase II Clinical Trial	1993-06-15	Unused	ITGA2B
Peripheral Vascular Diseases	ENSG00000006638	FALSE	Phase II Clinical Trial	1993-08-15	Unused	TBXA2R
Peripheral Vascular Diseases	ENSG00000019991	FALSE	Phase III Clinical Trial	2001-01-31	Phase III Clinical Trial	HGF
Peripheral Vascular Diseases	ENSG00000026508	FALSE	unknown	1996-11-15	Unused	CD44
Peripheral Vascular Diseases	ENSG00000050628	FALSE	unknown	2004-02-13	Unused	PTGER3
Peripheral Vascular Diseases	ENSG00000059377	FALSE	Phase II Clinical Trial	1993-08-15	Phase II Clinical Trial	TBXAS1
Peripheral Vascular Diseases	ENSG00000069535	FALSE	Preclinical	2011-09-13	Preclinical	MAOB
Peripheral Vascular Diseases	ENSG00000073756	TRUE	Approved	1996-04-15	Approved	PTGS2
Peripheral Vascular Diseases	ENSG00000075388	FALSE	Preclinical	NA	Unused	FGF4
Peripheral Vascular Diseases	ENSG00000077782	FALSE	Phase I Clinical Trial	2005-09-14	Unused	FGFR1
Peripheral Vascular Diseases	ENSG00000095303	TRUE	Approved	1996-04-15	Approved	PTGS1
Peripheral Vascular Diseases	ENSG00000095321	TRUE	Approved	NA	Approved	CRAT
Peripheral Vascular Diseases	ENSG00000100311	FALSE	Preclinical	2002-06-26	Unused	PDGFB
Peripheral Vascular Diseases	ENSG00000100644	FALSE	Phase II Clinical Trial	1999-02-01	Unused	HIF1A
Peripheral Vascular Diseases	ENSG00000102468	FALSE	unknown	1989-11-15	Unused	HTR2A
Peripheral Vascular Diseases	ENSG00000104365	FALSE	unknown	1996-04-15	Unused	IKBKB
Peripheral Vascular Diseases	ENSG00000104368	FALSE	Preclinical	2008-12-03	Unused	PLAT
Peripheral Vascular Diseases	ENSG00000106366	FALSE	Preclinical	2007-03-09	Unused	SERPINE1
Peripheral Vascular Diseases	ENSG00000107562	FALSE	Phase II Clinical Trial	2009-03-25	Phase II Clinical Trial	CXCL12
Peripheral Vascular Diseases	ENSG00000108691	FALSE	Phase I Clinical Trial	2001-07-04	Unused	CCL2
Peripheral Vascular Diseases	ENSG00000111275	FALSE	Preclinical	2017-10-06	Absent	ALDH2
Peripheral Vascular Diseases	ENSG00000112715	FALSE	Approved	1994-02-15	Unused	VEGFA
Peripheral Vascular Diseases	ENSG00000113161	FALSE	Phase I Clinical Trial	2004-02-24	Unused	HMGCR
Peripheral Vascular Diseases	ENSG00000113578	FALSE	Phase III Clinical Trial	1999-05-04	Unused	FGF1
Peripheral Vascular Diseases	ENSG00000114859	FALSE	unknown	2005-12-31	Unused	CLCN2
Peripheral Vascular Diseases	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Absent	IL1A
Peripheral Vascular Diseases	ENSG00000119535	FALSE	unknown	2003-04-24	Phase I Clinical Trial	CSF3R
Peripheral Vascular Diseases	ENSG00000121966	FALSE	Phase I Clinical Trial	2004-06-22	Unused	CXCR4
Peripheral Vascular Diseases	ENSG00000122194	FALSE	Phase II Clinical Trial	2000-10-30	Phase II Clinical Trial	PLG
Peripheral Vascular Diseases	ENSG00000122861	FALSE	Preclinical	1992-06-15	Unused	PLAU
Peripheral Vascular Diseases	ENSG00000123454	FALSE	unknown	1989-06-15	Phase II Clinical Trial	DBH
Peripheral Vascular Diseases	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Peripheral Vascular Diseases	ENSG00000126218	FALSE	Pre-registration	1993-08-15	Phase II Clinical Trial	F10
Peripheral Vascular Diseases	ENSG00000128052	FALSE	Phase II Clinical Trial	1997-06-15	Unused	KDR
Peripheral Vascular Diseases	ENSG00000129151	FALSE	Phase II Clinical Trial	1995-07-15	Unused	BBOX1
Peripheral Vascular Diseases	ENSG00000129521	FALSE	Phase II Clinical Trial	2008-09-16	Absent	EGLN3
Peripheral Vascular Diseases	ENSG00000130203	FALSE	Preclinical	2010-04-30	Absent	APOE
Peripheral Vascular Diseases	ENSG00000130368	FALSE	Preclinical	2010-09-20	Absent	MAS1
Peripheral Vascular Diseases	ENSG00000135312	FALSE	unknown	2000-03-15	Unused	HTR1B
Peripheral Vascular Diseases	ENSG00000138685	FALSE	Phase II Clinical Trial	2002-06-24	Phase II Clinical Trial	FGF2
Peripheral Vascular Diseases	ENSG00000138735	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	PDE5A
Peripheral Vascular Diseases	ENSG00000139610	FALSE	Phase I Clinical Trial	2004-08-20	Phase I Clinical Trial	CELA1
Peripheral Vascular Diseases	ENSG00000140443	FALSE	unknown	2004-10-21	Unused	IGF1R
Peripheral Vascular Diseases	ENSG00000141510	FALSE	Preclinical	2003-12-10	Absent	TP53
Peripheral Vascular Diseases	ENSG00000141736	FALSE	unknown	2004-10-21	Unused	ERBB2
Peripheral Vascular Diseases	ENSG00000141867	FALSE	Preclinical	2005-03-04	Absent	BRD4
Peripheral Vascular Diseases	ENSG00000142871	FALSE	Preclinical	2000-07-19	Unused	CYR61
Peripheral Vascular Diseases	ENSG00000149295	FALSE	Phase II Clinical Trial	1995-07-15	Unused	DRD2
Peripheral Vascular Diseases	ENSG00000151067	TRUE	Approved	NA	Approved	CACNA1C
Peripheral Vascular Diseases	ENSG00000151617	FALSE	Preclinical	1998-07-15	Unused	EDNRA
Peripheral Vascular Diseases	ENSG00000151623	FALSE	Preclinical	2006-01-11	Preclinical	NR3C2
Peripheral Vascular Diseases	ENSG00000154188	FALSE	unknown	2007-10-22	Phase II Clinical Trial	ANGPT1
Peripheral Vascular Diseases	ENSG00000155011	FALSE	Preclinical	2012-04-18	Preclinical	DKK2
Peripheral Vascular Diseases	ENSG00000160013	TRUE	Approved	2005-01-17	Approved	PTGIR
Peripheral Vascular Diseases	ENSG00000160951	TRUE	Approved	1999-05-11	Approved	PTGER1
Peripheral Vascular Diseases	ENSG00000164176	FALSE	Phase I Clinical Trial	1998-06-15	Unused	EDIL3
Peripheral Vascular Diseases	ENSG00000164867	FALSE	Preclinical	2000-02-24	Unused	NOS3
Peripheral Vascular Diseases	ENSG00000165197	FALSE	Phase II Clinical Trial	1998-06-15	Phase II Clinical Trial	VEGFD
Peripheral Vascular Diseases	ENSG00000167748	FALSE	Preclinical	2007-03-06	Unused	KLK1
Peripheral Vascular Diseases	ENSG00000169313	TRUE	Approved	2001-04-07	Approved	P2RY12
Peripheral Vascular Diseases	ENSG00000169403	TRUE	Approved	NA	Approved	PTAFR
Peripheral Vascular Diseases	ENSG00000169418	FALSE	Preclinical	1995-06-15	Unused	NPR1
Peripheral Vascular Diseases	ENSG00000171509	FALSE	unknown	NA	Unused	RXFP1
Peripheral Vascular Diseases	ENSG00000171759	FALSE	unknown	1989-06-15	Phase II Clinical Trial	PAH
Peripheral Vascular Diseases	ENSG00000172572	TRUE	Approved	1994-06-15	Approved	PDE3A
Peripheral Vascular Diseases	ENSG00000174175	FALSE	Phase I Clinical Trial	2006-11-27	Phase II Clinical Trial	SELP
Peripheral Vascular Diseases	ENSG00000175899	FALSE	unknown	2001-05-29	Unused	A2M
Peripheral Vascular Diseases	ENSG00000180210	TRUE	Approved	1994-01-15	Approved	F2
Peripheral Vascular Diseases	ENSG00000181104	TRUE	Approved	2001-04-10	Absent	F2R
Peripheral Vascular Diseases	ENSG00000182782	FALSE	Phase I Clinical Trial	NA	Unused	HCAR2
Peripheral Vascular Diseases	ENSG00000184160	FALSE	Phase II Clinical Trial	2015-09-04	Absent	ADRA2C
Peripheral Vascular Diseases	ENSG00000184845	FALSE	Phase II Clinical Trial	1995-07-15	Unused	DRD1
Peripheral Vascular Diseases	ENSG00000185149	FALSE	Preclinical	2005-05-31	Unused	NPY2R
Peripheral Vascular Diseases	ENSG00000186951	FALSE	Preclinical	2007-08-19	Unused	PPARA
Peripheral Vascular Diseases	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Peripheral Vascular Diseases	ENSG00000196396	FALSE	unknown	2009-06-04	Unused	PTPN1
Peripheral Vascular Diseases	ENSG00000197561	FALSE	unknown	1994-06-15	Unused	ELANE
Peripheral Vascular Diseases	ENSG00000197635	FALSE	unknown	2012-03-21	Phase I Clinical Trial	DPP4
Peripheral Vascular Diseases	ENSG00000198911	FALSE	Preclinical	2008-11-27	Preclinical	SREBF2
Peripheral Vascular Diseases	ENSG00000204174	FALSE	Preclinical	2005-09-13	Absent	NPY4R
Peripheral Vascular Diseases	ENSG00000259207	FALSE	Phase II Clinical Trial	1993-06-15	Unused	ITGB3
Peripheral Vascular Diseases	ENSG00000269858	FALSE	Phase II Clinical Trial	2008-09-16	Absent	EGLN2
Peritoneal Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	CFLAR
Peritoneal Neoplasms	ENSG00000023445	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC3
Peritoneal Neoplasms	ENSG00000026103	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Peritoneal Neoplasms	ENSG00000026508	FALSE	Phase I Clinical Trial	1998-12-15	Unused	CD44
Peritoneal Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT4
Peritoneal Neoplasms	ENSG00000054219	FALSE	Phase II Clinical Trial	2006-07-17	Absent	LY75
Peritoneal Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2006-02-24	Phase II Clinical Trial	ERBB3
Peritoneal Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	FGFR2
Peritoneal Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Peritoneal Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Peritoneal Neoplasms	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Peritoneal Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB5
Peritoneal Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Peritoneal Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	AURKA
Peritoneal Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2008-01-15	Phase II Clinical Trial	BIRC5
Peritoneal Neoplasms	ENSG00000091831	FALSE	Phase II Clinical Trial	1997-06-15	Unused	ESR1
Peritoneal Neoplasms	ENSG00000091879	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT2
Peritoneal Neoplasms	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Peritoneal Neoplasms	ENSG00000100644	FALSE	Phase I Clinical Trial	2003-08-01	Absent	HIF1A
Peritoneal Neoplasms	ENSG00000101916	FALSE	Phase II Clinical Trial	2008-06-17	Phase II Clinical Trial	TLR8
Peritoneal Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	XIAP
Peritoneal Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT1
Peritoneal Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	1999-04-21	Absent	MSLN
Peritoneal Neoplasms	ENSG00000105976	FALSE	unknown	2004-08-09	Phase II Clinical Trial	MET
Peritoneal Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Peritoneal Neoplasms	ENSG00000110092	FALSE	unknown	2005-08-30	Phase I Clinical Trial	CCND1
Peritoneal Neoplasms	ENSG00000110195	FALSE	Phase III Clinical Trial	2003-02-24	Phase III Clinical Trial	FOLR1
Peritoneal Neoplasms	ENSG00000110330	FALSE	Phase II Clinical Trial	2008-10-17	Absent	BIRC2
Peritoneal Neoplasms	ENSG00000112062	FALSE	Phase II Clinical Trial	2008-09-05	Phase II Clinical Trial	MAPK14
Peritoneal Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Approved	VEGFA
Peritoneal Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2011-01-21	Unused	HBEGF
Peritoneal Neoplasms	ENSG00000113302	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12B
Peritoneal Neoplasms	ENSG00000113494	FALSE	Phase I Clinical Trial	2010-01-28	Absent	PRLR
Peritoneal Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Peritoneal Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Peritoneal Neoplasms	ENSG00000114739	FALSE	Phase I Clinical Trial	2012-10-31	Absent	ACVR2B
Peritoneal Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB6
Peritoneal Neoplasms	ENSG00000115604	FALSE	Phase I Clinical Trial	2000-04-04	Unused	IL18R1
Peritoneal Neoplasms	ENSG00000116016	FALSE	Phase I Clinical Trial	2003-08-01	Absent	EPAS1
Peritoneal Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2001-11-06	Absent	HDAC1
Peritoneal Neoplasms	ENSG00000120156	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	TEK
Peritoneal Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Peritoneal Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	2001-08-23	Phase II Clinical Trial	TNFRSF10B
Peritoneal Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	2006-10-23	Absent	PIK3CA
Peritoneal Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Peritoneal Neoplasms	ENSG00000122641	FALSE	Phase I Clinical Trial	2012-10-31	Absent	INHBA
Peritoneal Neoplasms	ENSG00000126934	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K2
Peritoneal Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	KDR
Peritoneal Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2005-09-14	Absent	DLL4
Peritoneal Neoplasms	ENSG00000129484	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP2
Peritoneal Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Peritoneal Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	TOP2A
Peritoneal Neoplasms	ENSG00000132155	FALSE	unknown	1994-06-15	Phase II Clinical Trial	RAF1
Peritoneal Neoplasms	ENSG00000132383	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RPA1
Peritoneal Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Absent	CASP9
Peritoneal Neoplasms	ENSG00000134853	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRA
Peritoneal Neoplasms	ENSG00000137869	FALSE	Phase II Clinical Trial	1991-02-15	Unused	CYP19A1
Peritoneal Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGAV
Peritoneal Neoplasms	ENSG00000140443	FALSE	unknown	2006-04-25	Phase II Clinical Trial	IGF1R
Peritoneal Neoplasms	ENSG00000141096	FALSE	Preclinical	NA	Absent	DPEP3
Peritoneal Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	1993-10-15	Absent	TP53
Peritoneal Neoplasms	ENSG00000141736	FALSE	unknown	2000-11-16	Unused	ERBB2
Peritoneal Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Peritoneal Neoplasms	ENSG00000143226	FALSE	unknown	2004-07-27	Absent	FCGR2A
Peritoneal Neoplasms	ENSG00000143799	TRUE	Approved	2000-06-26	Phase II Clinical Trial	PARP1
Peritoneal Neoplasms	ENSG00000145545	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	SRD5A1
Peritoneal Neoplasms	ENSG00000146648	FALSE	Phase I Clinical Trial	2001-02-28	Phase I Clinical Trial	EGFR
Peritoneal Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	EPHA1
Peritoneal Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Peritoneal Neoplasms	ENSG00000150337	FALSE	unknown	2004-07-27	Absent	FCGR1A
Peritoneal Neoplasms	ENSG00000151617	FALSE	Phase II Clinical Trial	2002-11-12	Phase II Clinical Trial	EDNRA
Peritoneal Neoplasms	ENSG00000151694	FALSE	unknown	2005-08-30	Phase I Clinical Trial	ADAM17
Peritoneal Neoplasms	ENSG00000154188	FALSE	Phase III Clinical Trial	2004-03-24	Phase III Clinical Trial	ANGPT1
Peritoneal Neoplasms	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KIT
Peritoneal Neoplasms	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	BRAF
Peritoneal Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2011-06-03	Absent	SLC34A2
Peritoneal Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Peritoneal Neoplasms	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Peritoneal Neoplasms	ENSG00000162747	FALSE	unknown	2004-07-27	Absent	FCGR3B
Peritoneal Neoplasms	ENSG00000163599	FALSE	Phase I Clinical Trial	2004-07-07	Absent	CTLA4
Peritoneal Neoplasms	ENSG00000163785	FALSE	unknown	2005-08-30	Phase I Clinical Trial	RYK
Peritoneal Neoplasms	ENSG00000164305	FALSE	Phase II Clinical Trial	2001-12-19	Phase II Clinical Trial	CASP3
Peritoneal Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2008-07-04	Absent	CSF2
Peritoneal Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Phase III Clinical Trial	ENOX2
Peritoneal Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Peritoneal Neoplasms	ENSG00000166483	FALSE	Phase II Clinical Trial	2008-04-09	Phase II Clinical Trial	WEE1
Peritoneal Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Peritoneal Neoplasms	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Peritoneal Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1999-04-21	Absent	EEF2
Peritoneal Neoplasms	ENSG00000168811	FALSE	Phase II Clinical Trial	2005-10-25	Phase II Clinical Trial	IL12A
Peritoneal Neoplasms	ENSG00000169032	FALSE	Phase I Clinical Trial	2006-05-01	Phase I Clinical Trial	MAP2K1
Peritoneal Neoplasms	ENSG00000170312	FALSE	unknown	2005-08-30	Phase I Clinical Trial	CDK1
Peritoneal Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Peritoneal Neoplasms	ENSG00000179776	FALSE	Phase III Clinical Trial	2000-12-11	Absent	CDH5
Peritoneal Neoplasms	ENSG00000181143	FALSE	Phase II Clinical Trial	2008-09-24	Phase II Clinical Trial	MUC16
Peritoneal Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	CSF1R
Peritoneal Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	2006-07-17	Absent	CTAG1B
Peritoneal Neoplasms	ENSG00000184697	FALSE	Phase II Clinical Trial	2011-02-25	Absent	CLDN6
Peritoneal Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2002-09-30	Phase III Clinical Trial	MUC1
Peritoneal Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Peritoneal Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	SRC
Peritoneal Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	2006-10-23	Absent	MTOR
Peritoneal Neoplasms	ENSG00000198851	FALSE	unknown	2004-07-27	Absent	CD3E
Peritoneal Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1999-07-06	Phase II Clinical Trial	TOP1
Peritoneal Neoplasms	ENSG00000203747	FALSE	unknown	2004-07-27	Absent	FCGR3A
Peritoneal Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Peritoneal Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Peritoneal Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB3
Phenylketonurias	ENSG00000123454	TRUE	Approved	1989-06-15	Approved	DBH
Phenylketonurias	ENSG00000131979	FALSE	Preclinical	2000-11-08	Unused	GCH1
Phenylketonurias	ENSG00000171759	TRUE	Approved	1989-06-15	Approved	PAH
Phobic Disorders	ENSG00000011677	FALSE	Phase I Clinical Trial	1993-02-15	Phase I Clinical Trial	GABRA3
Phobic Disorders	ENSG00000022355	FALSE	Preclinical	1993-02-15	Unused	GABRA1
Phobic Disorders	ENSG00000103546	TRUE	Approved	NA	Approved	SLC6A2
Phobic Disorders	ENSG00000108576	TRUE	Approved	1998-10-15	Approved	SLC6A4
Phobic Disorders	ENSG00000115353	FALSE	Phase II Clinical Trial	NA	Unused	TACR1
Phobic Disorders	ENSG00000117480	FALSE	Phase II Clinical Trial	2012-08-08	Absent	FAAH
Phobic Disorders	ENSG00000120088	FALSE	Phase II Clinical Trial	2000-08-02	Unused	CRHR1
Phobic Disorders	ENSG00000142319	TRUE	Approved	NA	Approved	SLC6A3
Phobic Disorders	ENSG00000149295	FALSE	Phase III Clinical Trial	NA	Absent	DRD2
Phobic Disorders	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Phobic Disorders	ENSG00000151834	FALSE	Phase I Clinical Trial	1993-02-15	Phase I Clinical Trial	GABRA2
Phobic Disorders	ENSG00000153956	FALSE	Phase III Clinical Trial	1993-06-15	Phase III Clinical Trial	CACNA2D1
Phobic Disorders	ENSG00000175344	FALSE	Preclinical	2007-05-30	Absent	CHRNA7
Phobic Disorders	ENSG00000176884	FALSE	unknown	2007-09-03	Unused	GRIN1
Phobic Disorders	ENSG00000178394	FALSE	Phase III Clinical Trial	2005-07-05	Unused	HTR1A
Phobic Disorders	ENSG00000184845	FALSE	Phase III Clinical Trial	NA	Absent	DRD1
Phobic Disorders	ENSG00000186297	FALSE	Preclinical	1993-02-15	Unused	GABRA5
Phobic Disorders	ENSG00000189221	TRUE	Approved	NA	Approved	MAOA
Photosensitivity Disorders	ENSG00000258839	FALSE	unknown	2003-06-05	Absent	MC1R
Picornaviridae Infections	ENSG00000090339	FALSE	Phase II Clinical Trial	2003-01-13	Unused	ICAM1
Picornaviridae Infections	ENSG00000112038	TRUE	Approved	2010-03-05	Absent	OPRM1
Picornaviridae Infections	ENSG00000116329	FALSE	unknown	2010-03-05	Absent	OPRD1
Picornaviridae Infections	ENSG00000143393	FALSE	Preclinical	2013-06-13	Absent	PI4KB
Picornaviridae Infections	ENSG00000159110	FALSE	Phase II Clinical Trial	2004-11-16	Phase II Clinical Trial	IFNAR2
Picornaviridae Infections	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
Picornaviridae Infections	ENSG00000185436	FALSE	Preclinical	2004-11-16	Unused	IFNLR1
Picornaviridae Infections	ENSG00000196639	TRUE	Approved	2010-03-05	Absent	HRH1
Pituitary ACTH Hypersecretion	ENSG00000057252	FALSE	Preclinical	NA	Absent	SOAT1
Pituitary ACTH Hypersecretion	ENSG00000091831	TRUE	Approved	NA	Approved	ESR1
Pituitary ACTH Hypersecretion	ENSG00000113580	TRUE	Approved	2002-02-05	Approved	NR3C1
Pituitary ACTH Hypersecretion	ENSG00000121966	FALSE	unknown	1995-12-15	Unused	CXCR4
Pituitary ACTH Hypersecretion	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK2
Pituitary ACTH Hypersecretion	ENSG00000132671	FALSE	Preclinical	1998-09-15	Preclinical	SSTR4
Pituitary ACTH Hypersecretion	ENSG00000134058	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK7
Pituitary ACTH Hypersecretion	ENSG00000136244	FALSE	unknown	2007-01-15	Absent	IL6
Pituitary ACTH Hypersecretion	ENSG00000136807	FALSE	Phase II Clinical Trial	1997-05-15	Absent	CDK9
Pituitary ACTH Hypersecretion	ENSG00000136931	FALSE	Preclinical	2010-09-02	Preclinical	NR5A1
Pituitary ACTH Hypersecretion	ENSG00000138592	FALSE	Preclinical	NA	Absent	USP8
Pituitary ACTH Hypersecretion	ENSG00000139874	TRUE	Approved	2002-11-27	Approved	SSTR1
Pituitary ACTH Hypersecretion	ENSG00000140009	TRUE	Approved	NA	Approved	ESR2
Pituitary ACTH Hypersecretion	ENSG00000147955	FALSE	unknown	1995-12-15	Unused	SIGMAR1
Pituitary ACTH Hypersecretion	ENSG00000149295	FALSE	Preclinical	2016-01-28	Absent	DRD2
Pituitary ACTH Hypersecretion	ENSG00000160791	FALSE	unknown	1995-12-15	Unused	CCR5
Pituitary ACTH Hypersecretion	ENSG00000160882	FALSE	Phase III Clinical Trial	2006-12-07	Unused	CYP11B1
Pituitary ACTH Hypersecretion	ENSG00000162009	TRUE	Approved	1998-09-15	Approved	SSTR5
Pituitary ACTH Hypersecretion	ENSG00000173250	FALSE	Preclinical	2016-11-09	Absent	GPR151
Pituitary ACTH Hypersecretion	ENSG00000177606	TRUE	Approved	NA	Approved	JUN
Pituitary ACTH Hypersecretion	ENSG00000179142	FALSE	Phase III Clinical Trial	2006-12-07	Phase II Clinical Trial	CYP11B2
Pituitary ACTH Hypersecretion	ENSG00000180616	TRUE	Approved	1998-09-15	Approved	SSTR2
Pituitary ACTH Hypersecretion	ENSG00000185231	FALSE	Preclinical	2015-01-17	Absent	MC2R
Pituitary ACTH Hypersecretion	ENSG00000203859	TRUE	Approved	NA	Approved	HSD3B2
Pituitary ACTH Hypersecretion	ENSG00000278195	TRUE	Approved	2002-11-27	Approved	SSTR3
Pituitary Neoplasms	ENSG00000110195	FALSE	unknown	2003-10-15	Unused	FOLR1
Pituitary Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR1
Pituitary Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR5
Pituitary Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR2
Pituitary Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Phase II Clinical Trial	SSTR3
Placental Insufficiency	ENSG00000165197	FALSE	Preclinical	2014-10-14	Absent	VEGFD
Plant Poisoning	ENSG00000163399	TRUE	Approved	NA	Approved	ATP1A1
Pleural Effusion, Malignant	ENSG00000101868	FALSE	Phase I Clinical Trial	2007-06-20	Absent	POLA1
Pleural Effusion, Malignant	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Pneumococcal Infections	ENSG00000003436	FALSE	unknown	1994-11-15	Unused	TFPI
Pneumococcal Infections	ENSG00000117525	FALSE	unknown	1994-11-15	Unused	F3
Pneumococcal Infections	ENSG00000131747	FALSE	Preclinical	2017-06-19	Absent	TOP2A
Pneumococcal Infections	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Pneumococcal Infections	ENSG00000197405	FALSE	Preclinical	2015-04-29	Absent	C5AR1
Pneumococcal Infections	ENSG00000228716	FALSE	Preclinical	NA	Unused	DHFR
Pneumonia	ENSG00000003436	FALSE	unknown	1994-11-15	Unused	TFPI
Pneumonia	ENSG00000005381	FALSE	Preclinical	2011-06-07	Absent	MPO
Pneumonia	ENSG00000007908	FALSE	unknown	2005-05-25	Unused	SELE
Pneumonia	ENSG00000016490	FALSE	Approved	NA	Unused	CLCA1
Pneumonia	ENSG00000073756	TRUE	Approved	NA	Absent	PTGS2
Pneumonia	ENSG00000089250	FALSE	Phase I Clinical Trial	2015-08-19	Absent	NOS1
Pneumonia	ENSG00000091972	FALSE	Preclinical	2002-07-08	Preclinical	CD200
Pneumonia	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Pneumonia	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Pneumonia	ENSG00000112062	FALSE	Preclinical	2008-12-02	Unused	MAPK14
Pneumonia	ENSG00000112115	FALSE	Preclinical	2012-07-06	Absent	IL17A
Pneumonia	ENSG00000113580	FALSE	Preclinical	2011-02-23	Unused	NR3C1
Pneumonia	ENSG00000115718	FALSE	Preclinical	2013-08-17	Absent	PROC
Pneumonia	ENSG00000117525	FALSE	unknown	1994-11-15	Unused	F3
Pneumonia	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Pneumonia	ENSG00000136869	FALSE	Preclinical	2011-11-27	Absent	TLR4
Pneumonia	ENSG00000148180	FALSE	Phase I Clinical Trial	NA	Absent	GSN
Pneumonia	ENSG00000160255	FALSE	unknown	1991-03-15	Unused	ITGB2
Pneumonia	ENSG00000163464	FALSE	Preclinical	2011-02-14	Unused	CXCR1
Pneumonia	ENSG00000169194	FALSE	Preclinical	2012-07-06	Absent	IL13
Pneumonia	ENSG00000169252	FALSE	Preclinical	2011-02-23	Unused	ADRB2
Pneumonia	ENSG00000169896	FALSE	unknown	1991-03-15	Unused	ITGAM
Pneumonia	ENSG00000170458	FALSE	unknown	1999-01-25	Unused	CD14
Pneumonia	ENSG00000171855	FALSE	Preclinical	2008-08-28	Absent	IFNB1
Pneumonia	ENSG00000174175	FALSE	unknown	2005-05-25	Unused	SELP
Pneumonia	ENSG00000176884	TRUE	Approved	NA	Approved	GRIN1
Pneumonia	ENSG00000180871	FALSE	Preclinical	2011-02-14	Unused	CXCR2
Pneumonia	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Pneumonia	ENSG00000197919	FALSE	Phase II Clinical Trial	2017-06-01	Absent	IFNA1
Pneumonia	ENSG00000239732	FALSE	Preclinical	2008-08-28	Absent	TLR9
Poisoning	ENSG00000087085	FALSE	Phase I Clinical Trial	1989-05-15	Phase I Clinical Trial	ACHE
Poisoning	ENSG00000110911	FALSE	Preclinical	2002-01-09	Unused	SLC11A2
Poisoning	ENSG00000114200	FALSE	Phase I Clinical Trial	2004-04-29	Phase I Clinical Trial	BCHE
Poisoning	ENSG00000115138	FALSE	Phase I Clinical Trial	2009-10-10	Unused	POMC
Poisoning	ENSG00000133019	TRUE	Approved	2006-10-05	Approved	CHRM3
Poisoning	ENSG00000136810	FALSE	Preclinical	2016-10-17	Absent	TXN
Poisoning	ENSG00000142192	FALSE	unknown	1999-05-19	Unused	APP
Poisoning	ENSG00000143799	FALSE	Preclinical	2016-10-17	Absent	PARP1
Poisoning	ENSG00000147955	FALSE	Preclinical	2004-10-21	Unused	SIGMAR1
Poisoning	ENSG00000168539	TRUE	Approved	2006-10-05	Approved	CHRM1
Poisoning	ENSG00000180210	FALSE	Preclinical	2003-12-09	Unused	F2
Poisoning	ENSG00000180720	TRUE	Approved	2006-10-05	Approved	CHRM4
Poisoning	ENSG00000181072	TRUE	Approved	2006-10-05	Approved	CHRM2
Poisoning	ENSG00000186318	FALSE	unknown	2003-06-17	Unused	BACE1
Poisoning	ENSG00000196262	FALSE	Preclinical	2002-01-07	Unused	PPIA
Poisoning	ENSG00000197386	FALSE	unknown	2003-06-17	Absent	HTT
Polycystic Kidney Diseases	ENSG00000001626	FALSE	Preclinical	2009-09-30	Unused	CFTR
Polycystic Kidney Diseases	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	FLT4
Polycystic Kidney Diseases	ENSG00000065989	FALSE	Preclinical	2016-06-23	Absent	PDE4A
Polycystic Kidney Diseases	ENSG00000094631	FALSE	Phase I Clinical Trial	2009-08-13	Absent	HDAC6
Polycystic Kidney Diseases	ENSG00000097007	FALSE	unknown	2003-01-13	Phase II Clinical Trial	ABL1
Polycystic Kidney Diseases	ENSG00000111319	FALSE	Preclinical	2009-09-30	Absent	SCNN1A
Polycystic Kidney Diseases	ENSG00000112715	FALSE	Phase II Clinical Trial	2003-08-12	Phase I Clinical Trial	VEGFA
Polycystic Kidney Diseases	ENSG00000117411	FALSE	Preclinical	2009-07-09	Unused	B4GALT2
Polycystic Kidney Diseases	ENSG00000126895	TRUE	Approved	1992-04-15	Phase III Clinical Trial	AVPR2
Polycystic Kidney Diseases	ENSG00000128052	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	KDR
Polycystic Kidney Diseases	ENSG00000132155	FALSE	Phase I Clinical Trial	2008-02-21	Unused	RAF1
Polycystic Kidney Diseases	ENSG00000132170	FALSE	Preclinical	2013-11-04	Absent	PPARG
Polycystic Kidney Diseases	ENSG00000136997	FALSE	unknown	2000-02-10	Unused	MYC
Polycystic Kidney Diseases	ENSG00000141736	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	ERBB2
Polycystic Kidney Diseases	ENSG00000146648	FALSE	Phase II Clinical Trial	2003-08-12	Phase II Clinical Trial	EGFR
Polycystic Kidney Diseases	ENSG00000148154	FALSE	Preclinical	2012-08-31	Absent	UGCG
Polycystic Kidney Diseases	ENSG00000158125	FALSE	Phase I Clinical Trial	2016-03-31	Absent	XDH
Polycystic Kidney Diseases	ENSG00000168610	FALSE	Preclinical	2015-09-21	Absent	STAT3
Polycystic Kidney Diseases	ENSG00000186716	FALSE	unknown	2003-01-13	Phase II Clinical Trial	BCR
Polycystic Kidney Diseases	ENSG00000196411	FALSE	Phase II Clinical Trial	2003-08-12	Phase I Clinical Trial	EPHB4
Polycystic Kidney Diseases	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Polycystic Kidney Diseases	ENSG00000198793	FALSE	Preclinical	1997-08-15	Unused	MTOR
Polycystic Ovary Syndrome	ENSG00000085662	TRUE	Approved	NA	Unused	AKR1B1
Polycystic Ovary Syndrome	ENSG00000091831	TRUE	Approved	NA	Approved	ESR1
Polycystic Ovary Syndrome	ENSG00000116014	FALSE	Preclinical	2013-09-14	Absent	KISS1R
Polycystic Ovary Syndrome	ENSG00000132170	TRUE	Approved	1995-03-15	Unused	PPARG
Polycystic Ovary Syndrome	ENSG00000135218	FALSE	Preclinical	2010-11-18	Unused	CD36
Polycystic Ovary Syndrome	ENSG00000138039	FALSE	Phase III Clinical Trial	2009-02-19	Absent	LHCGR
Polycystic Ovary Syndrome	ENSG00000147437	FALSE	Preclinical	2012-04-21	Absent	GNRH1
Polycystic Ovary Syndrome	ENSG00000169083	TRUE	Approved	NA	Approved	AR
Polycystic Ovary Syndrome	ENSG00000169836	FALSE	Phase II Clinical Trial	2007-09-12	Absent	TACR3
Polycystic Ovary Syndrome	ENSG00000170820	TRUE	Approved	1992-07-15	Approved	FSHR
Polycythemia Vera	ENSG00000004487	FALSE	Preclinical	2015-12-10	Absent	KDM1A
Polycythemia Vera	ENSG00000010810	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	FYN
Polycythemia Vera	ENSG00000027697	FALSE	unknown	2003-11-24	Unused	IFNGR1
Polycythemia Vera	ENSG00000044524	FALSE	Phase II Clinical Trial	2004-03-23	Absent	EPHA3
Polycythemia Vera	ENSG00000073756	FALSE	unknown	NA	Absent	PTGS2
Polycythemia Vera	ENSG00000080824	FALSE	Phase I Clinical Trial	2017-04-27	Absent	HSP90AA1
Polycythemia Vera	ENSG00000095303	FALSE	unknown	NA	Absent	PTGS1
Polycythemia Vera	ENSG00000096968	TRUE	Approved	1999-03-17	Phase III Clinical Trial	JAK2
Polycythemia Vera	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Preclinical	FLT1
Polycythemia Vera	ENSG00000105639	FALSE	Preclinical	2017-07-24	Absent	JAK3
Polycythemia Vera	ENSG00000105810	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK6
Polycythemia Vera	ENSG00000113083	FALSE	Preclinical	2018-01-23	Absent	LOX
Polycythemia Vera	ENSG00000115008	FALSE	unknown	2009-12-07	Absent	IL1A
Polycythemia Vera	ENSG00000115590	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	IL1R2
Polycythemia Vera	ENSG00000115758	FALSE	Phase II Clinical Trial	1994-03-15	Preclinical	ODC1
Polycythemia Vera	ENSG00000116478	FALSE	Phase II Clinical Trial	2003-12-09	Absent	HDAC1
Polycythemia Vera	ENSG00000121879	FALSE	Phase I Clinical Trial	2008-11-24	Phase I Clinical Trial	PIK3CA
Polycythemia Vera	ENSG00000122025	FALSE	Pre-registration	1999-03-17	Phase III Clinical Trial	FLT3
Polycythemia Vera	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Absent	SMO
Polycythemia Vera	ENSG00000131238	FALSE	Phase II Clinical Trial	1994-03-15	Preclinical	PPT1
Polycythemia Vera	ENSG00000132703	FALSE	Phase II Clinical Trial	2009-07-24	Absent	APCS
Polycythemia Vera	ENSG00000134013	FALSE	Phase II Clinical Trial	2010-07-29	Absent	LOXL2
Polycythemia Vera	ENSG00000134853	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	PDGFRA
Polycythemia Vera	ENSG00000135446	FALSE	Phase I Clinical Trial	2009-12-10	Absent	CDK4
Polycythemia Vera	ENSG00000135679	FALSE	Phase II Clinical Trial	2004-03-09	Absent	MDM2
Polycythemia Vera	ENSG00000136997	FALSE	Phase II Clinical Trial	2012-09-20	Absent	MYC
Polycythemia Vera	ENSG00000139567	FALSE	Phase II Clinical Trial	2009-01-15	Absent	ACVRL1
Polycythemia Vera	ENSG00000141510	FALSE	Phase II Clinical Trial	2004-03-09	Absent	TP53
Polycythemia Vera	ENSG00000143384	FALSE	Phase I Clinical Trial	1999-10-20	Absent	MCL1
Polycythemia Vera	ENSG00000156508	FALSE	Phase II Clinical Trial	1994-03-15	Preclinical	EEF1A1
Polycythemia Vera	ENSG00000157404	FALSE	Pre-registration	2004-07-20	Phase II Clinical Trial	KIT
Polycythemia Vera	ENSG00000159110	FALSE	Pre-registration	2007-07-31	Phase II Clinical Trial	IFNAR2
Polycythemia Vera	ENSG00000160712	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	IL6R
Polycythemia Vera	ENSG00000162434	TRUE	Approved	2006-11-24	Phase III Clinical Trial	JAK1
Polycythemia Vera	ENSG00000165025	FALSE	Phase II Clinical Trial	2014-08-20	Absent	SYK
Polycythemia Vera	ENSG00000165731	FALSE	Preclinical	2007-01-10	Phase III Clinical Trial	RET
Polycythemia Vera	ENSG00000168036	FALSE	Phase II Clinical Trial	2011-03-05	Absent	CTNNB1
Polycythemia Vera	ENSG00000171552	FALSE	Phase II Clinical Trial	2006-12-15	Absent	BCL2L1
Polycythemia Vera	ENSG00000171608	FALSE	Phase II Clinical Trial	2004-01-20	Absent	PIK3CD
Polycythemia Vera	ENSG00000171791	FALSE	Phase II Clinical Trial	1999-10-20	Absent	BCL2
Polycythemia Vera	ENSG00000172572	TRUE	Approved	NA	Approved	PDE3A
Polycythemia Vera	ENSG00000176105	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	YES1
Polycythemia Vera	ENSG00000182578	FALSE	Pre-registration	2007-06-15	Absent	CSF1R
Polycythemia Vera	ENSG00000182866	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LCK
Polycythemia Vera	ENSG00000185291	FALSE	Phase II Clinical Trial	2007-03-13	Absent	IL3RA
Polycythemia Vera	ENSG00000186716	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	BCR
Polycythemia Vera	ENSG00000196591	FALSE	Phase II Clinical Trial	2003-12-09	Absent	HDAC2
Polycythemia Vera	ENSG00000197122	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	SRC
Polycythemia Vera	ENSG00000198400	FALSE	unknown	1999-03-17	Unused	NTRK1
Polycythemia Vera	ENSG00000254087	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	LYN
Polycythemia Vera	ENSG00000275302	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL4
Polycythemia Vera	ENSG00000277632	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL3
Polymyalgia Rheumatica	ENSG00000112115	FALSE	Phase II Clinical Trial	2006-02-01	Phase II Clinical Trial	IL17A
Polymyalgia Rheumatica	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Polymyalgia Rheumatica	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Polymyalgia Rheumatica	ENSG00000136244	FALSE	unknown	2007-08-23	Absent	IL6
Polymyalgia Rheumatica	ENSG00000160712	FALSE	Preclinical	2007-11-29	Absent	IL6R
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000125910	FALSE	Phase III Clinical Trial	1997-12-15	Phase II Clinical Trial	S1PR4
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000170989	FALSE	Phase III Clinical Trial	1997-12-15	Phase II Clinical Trial	S1PR1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000180739	FALSE	Phase III Clinical Trial	1997-12-15	Phase II Clinical Trial	S1PR5
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000213694	FALSE	Phase III Clinical Trial	1997-12-15	Phase II Clinical Trial	S1PR3
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	ENSG00000242950	FALSE	Preclinical	2007-07-20	Absent	ERVW-1
Polyuria	ENSG00000073756	FALSE	Phase II Clinical Trial	2016-01-08	Absent	PTGS2
Polyuria	ENSG00000095303	FALSE	Phase II Clinical Trial	2016-01-08	Absent	PTGS1
Polyuria	ENSG00000120907	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	ADRA1A
Polyuria	ENSG00000126895	TRUE	Approved	1998-10-15	Approved	AVPR2
Polyuria	ENSG00000169432	FALSE	unknown	2007-04-02	Unused	SCN9A
Porphyrias	ENSG00000023330	FALSE	Phase III Clinical Trial	2013-01-09	Preclinical	ALAS1
Porphyrias	ENSG00000122861	FALSE	unknown	1995-02-15	Unused	PLAU
Porphyrias	ENSG00000256269	FALSE	Phase III Clinical Trial	2000-11-07	Phase I Clinical Trial	HMBS
Porphyrias	ENSG00000258839	TRUE	Approved	2003-06-05	Absent	MC1R
Postcholecystectomy Syndrome	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Postcholecystectomy Syndrome	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Postcholecystectomy Syndrome	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Postcholecystectomy Syndrome	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Postgastrectomy Syndromes	ENSG00000164270	FALSE	Phase II Clinical Trial	NA	Unused	HTR4
Postgastrectomy Syndromes	ENSG00000166736	FALSE	Phase II Clinical Trial	NA	Unused	HTR3A
Postoperative Complications	ENSG00000173327	FALSE	Phase II Clinical Trial	2015-10-26	Absent	MAP3K11
Postoperative Complications	ENSG00000269858	FALSE	Preclinical	2010-08-28	Absent	EGLN2
Postoperative Nausea and Vomiting	ENSG00000082556	FALSE	Phase II Clinical Trial	2016-10-24	Absent	OPRK1
Postoperative Nausea and Vomiting	ENSG00000112038	FALSE	Phase II Clinical Trial	2016-10-24	Absent	OPRM1
Postoperative Nausea and Vomiting	ENSG00000115353	TRUE	Approved	1995-12-15	Approved	TACR1
Postoperative Nausea and Vomiting	ENSG00000149295	TRUE	Approved	1992-09-15	Approved	DRD2
Postoperative Nausea and Vomiting	ENSG00000151577	FALSE	Pre-registration	2010-07-15	Absent	DRD3
Postoperative Nausea and Vomiting	ENSG00000164270	TRUE	Approved	1990-10-15	Approved	HTR4
Postoperative Nausea and Vomiting	ENSG00000166736	TRUE	Approved	1990-07-15	Approved	HTR3A
Postpartum Hemorrhage	ENSG00000115474	FALSE	Preclinical	2014-07-25	Absent	KCNJ13
Postpartum Hemorrhage	ENSG00000180914	TRUE	Approved	2014-09-26	Approved	OXTR
Postpoliomyelitis Syndrome	ENSG00000140443	FALSE	Preclinical	NA	Absent	IGF1R
Postthrombotic Syndrome	ENSG00000012223	FALSE	Phase I Clinical Trial	1994-08-15	Phase II Clinical Trial	LTF
Postthrombotic Syndrome	ENSG00000100311	FALSE	unknown	2006-11-15	Unused	PDGFB
Postthrombotic Syndrome	ENSG00000100985	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP9
Postthrombotic Syndrome	ENSG00000113721	FALSE	Phase II Clinical Trial	2007-03-20	Unused	PDGFRB
Postthrombotic Syndrome	ENSG00000134853	FALSE	Phase II Clinical Trial	2007-03-20	Unused	PDGFRA
Postthrombotic Syndrome	ENSG00000146648	FALSE	unknown	NA	Unused	EGFR
Postthrombotic Syndrome	ENSG00000160951	FALSE	Phase II Clinical Trial	1999-05-11	Absent	PTGER1
Postthrombotic Syndrome	ENSG00000196611	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP1
Postthrombotic Syndrome	ENSG00000198223	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	CSF2RA
Postthrombotic Syndrome	ENSG00000205542	FALSE	unknown	1995-01-15	Phase II Clinical Trial	TMSB4X
Pouchitis	ENSG00000090339	FALSE	Pre-registration	1993-07-15	Phase III Clinical Trial	ICAM1
Pouchitis	ENSG00000239732	FALSE	Pre-registration	1993-07-15	Absent	TLR9
Prader-Willi Syndrome	ENSG00000010810	FALSE	Preclinical	2016-10-05	Absent	FYN
Prader-Willi Syndrome	ENSG00000043591	FALSE	Phase II Clinical Trial	2014-10-31	Absent	ADRB1
Prader-Willi Syndrome	ENSG00000101180	FALSE	Phase I Clinical Trial	2012-06-05	Absent	HRH3
Prader-Willi Syndrome	ENSG00000103546	FALSE	Phase II Clinical Trial	2014-10-31	Absent	SLC6A2
Prader-Willi Syndrome	ENSG00000108576	FALSE	Phase II Clinical Trial	2014-10-31	Absent	SLC6A4
Prader-Willi Syndrome	ENSG00000111142	FALSE	Phase II Clinical Trial	1998-07-15	Preclinical	METAP2
Prader-Willi Syndrome	ENSG00000112964	TRUE	Approved	2014-01-21	Approved	GHR
Prader-Willi Syndrome	ENSG00000121853	FALSE	Phase II Clinical Trial	2005-05-16	Preclinical	GHSR
Prader-Willi Syndrome	ENSG00000142319	FALSE	Phase II Clinical Trial	2014-10-31	Absent	SLC6A3
Prader-Willi Syndrome	ENSG00000166603	FALSE	Phase II Clinical Trial	2009-01-09	Absent	MC4R
Prader-Willi Syndrome	ENSG00000180914	FALSE	Phase II Clinical Trial	2013-12-02	Absent	OXTR
Pre-Eclampsia	ENSG00000019582	FALSE	Preclinical	2010-02-11	Absent	CD74
Pre-Eclampsia	ENSG00000117298	FALSE	Preclinical	1995-10-15	Unused	ECE1
Pre-Eclampsia	ENSG00000117601	FALSE	Phase III Clinical Trial	1993-08-15	Absent	SERPINC1
Pre-Eclampsia	ENSG00000119630	FALSE	Preclinical	2017-03-16	Absent	PGF
Pre-Eclampsia	ENSG00000136160	FALSE	Preclinical	1995-12-15	Unused	EDNRB
Pre-Eclampsia	ENSG00000151617	FALSE	Preclinical	1995-12-15	Unused	EDNRA
Pre-Eclampsia	ENSG00000163399	FALSE	Phase III Clinical Trial	1993-08-15	Phase II Clinical Trial	ATP1A1
Pre-Eclampsia	ENSG00000171509	FALSE	Phase II Clinical Trial	2007-10-23	Unused	RXFP1
Pre-Eclampsia	ENSG00000196549	FALSE	Preclinical	1995-10-15	Unused	MME
Premenstrual Syndrome	ENSG00000082175	TRUE	Approved	1996-07-15	Approved	PGR
Premenstrual Syndrome	ENSG00000091831	TRUE	Approved	2009-01-12	Approved	ESR1
Premenstrual Syndrome	ENSG00000108576	TRUE	Approved	2001-10-16	Approved	SLC6A4
Premenstrual Syndrome	ENSG00000142319	FALSE	Preclinical	2008-08-28	Unused	SLC6A3
Premenstrual Syndrome	ENSG00000147246	FALSE	unknown	2001-10-16	Unused	HTR2C
Premenstrual Syndrome	ENSG00000166148	FALSE	unknown	2006-07-10	Unused	AVPR1A
Presbyopia	ENSG00000133019	FALSE	Phase II Clinical Trial	2017-05-19	Absent	CHRM3
Presbyopia	ENSG00000180720	FALSE	Phase II Clinical Trial	2017-05-19	Absent	CHRM4
Pressure Ulcer	ENSG00000026508	FALSE	Approved	NA	Unused	CD44
Pressure Ulcer	ENSG00000077782	FALSE	Approved	NA	Unused	FGFR1
Pressure Ulcer	ENSG00000100311	FALSE	unknown	2006-11-15	Unused	PDGFB
Pressure Ulcer	ENSG00000100453	FALSE	Preclinical	2013-03-08	Absent	GZMB
Pressure Ulcer	ENSG00000113721	FALSE	unknown	2010-04-09	Preclinical	PDGFRB
Pressure Ulcer	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Pressure Ulcer	ENSG00000117601	FALSE	Preclinical	2012-04-28	Preclinical	SERPINC1
Pressure Ulcer	ENSG00000126218	FALSE	Preclinical	2012-04-28	Preclinical	F10
Pressure Ulcer	ENSG00000160013	FALSE	unknown	NA	Unused	PTGIR
Pressure Ulcer	ENSG00000180210	FALSE	Preclinical	2012-04-28	Preclinical	F2
Pressure Ulcer	ENSG00000197632	FALSE	unknown	NA	Unused	SERPINB2
Proctitis	ENSG00000065989	FALSE	Phase II Clinical Trial	2005-05-24	Absent	PDE4A
Proctitis	ENSG00000073756	FALSE	Phase III Clinical Trial	1993-05-15	Phase III Clinical Trial	PTGS2
Proctitis	ENSG00000095303	FALSE	Phase III Clinical Trial	1993-05-15	Phase III Clinical Trial	PTGS1
Proctitis	ENSG00000113580	TRUE	Approved	2004-07-24	Phase III Clinical Trial	NR3C1
Progeria	ENSG00000168522	FALSE	unknown	1997-06-15	Phase II Clinical Trial	FNTA
Prostatic Diseases	ENSG00000111424	FALSE	unknown	2002-03-27	Unused	VDR
Prostatic Diseases	ENSG00000159110	FALSE	Approved	NA	Unused	IFNAR2
Prostatic Hyperplasia	ENSG00000067182	FALSE	unknown	NA	Unused	TNFRSF1A
Prostatic Hyperplasia	ENSG00000073756	FALSE	Preclinical	2001-09-24	Unused	PTGS2
Prostatic Hyperplasia	ENSG00000091831	FALSE	unknown	2000-02-09	Absent	ESR1
Prostatic Hyperplasia	ENSG00000095303	FALSE	Preclinical	2001-09-24	Unused	PTGS1
Prostatic Hyperplasia	ENSG00000102468	FALSE	Preclinical	NA	Unused	HTR2A
Prostatic Hyperplasia	ENSG00000103175	FALSE	Preclinical	1993-11-15	Unused	WFDC1
Prostatic Hyperplasia	ENSG00000106633	FALSE	Phase III Clinical Trial	2004-08-17	Unused	GCK
Prostatic Hyperplasia	ENSG00000108828	FALSE	Preclinical	2011-04-30	Unused	VAT1
Prostatic Hyperplasia	ENSG00000109163	FALSE	Phase III Clinical Trial	1993-05-15	Unused	GNRHR
Prostatic Hyperplasia	ENSG00000111424	FALSE	Preclinical	2002-03-27	Unused	VDR
Prostatic Hyperplasia	ENSG00000112062	FALSE	unknown	NA	Unused	MAPK14
Prostatic Hyperplasia	ENSG00000120907	TRUE	Approved	1992-06-15	Approved	ADRA1A
Prostatic Hyperplasia	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Prostatic Hyperplasia	ENSG00000133019	TRUE	Approved	2005-08-10	Approved	CHRM3
Prostatic Hyperplasia	ENSG00000136160	FALSE	Preclinical	1999-09-22	Unused	EDNRB
Prostatic Hyperplasia	ENSG00000137869	FALSE	Preclinical	1993-08-15	Unused	CYP19A1
Prostatic Hyperplasia	ENSG00000138039	FALSE	unknown	1996-02-15	Unused	LHCGR
Prostatic Hyperplasia	ENSG00000138735	TRUE	Approved	1991-09-15	Approved	PDE5A
Prostatic Hyperplasia	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Prostatic Hyperplasia	ENSG00000140009	FALSE	Phase II Clinical Trial	2004-07-20	Phase II Clinical Trial	ESR2
Prostatic Hyperplasia	ENSG00000142515	FALSE	Phase III Clinical Trial	2005-01-01	Phase III Clinical Trial	KLK3
Prostatic Hyperplasia	ENSG00000144481	FALSE	unknown	2001-05-01	Absent	TRPM8
Prostatic Hyperplasia	ENSG00000145545	TRUE	Approved	1989-08-15	Approved	SRD5A1
Prostatic Hyperplasia	ENSG00000147246	FALSE	Preclinical	NA	Unused	HTR2C
Prostatic Hyperplasia	ENSG00000148795	FALSE	Preclinical	1992-10-15	Unused	CYP17A1
Prostatic Hyperplasia	ENSG00000150594	FALSE	Preclinical	1992-06-15	Unused	ADRA2A
Prostatic Hyperplasia	ENSG00000151617	FALSE	Preclinical	1999-09-22	Unused	EDNRA
Prostatic Hyperplasia	ENSG00000153956	FALSE	unknown	2011-07-13	Unused	CACNA2D1
Prostatic Hyperplasia	ENSG00000160191	FALSE	Phase II Clinical Trial	2010-10-19	Absent	PDE9A
Prostatic Hyperplasia	ENSG00000164270	FALSE	unknown	1998-08-15	Unused	HTR4
Prostatic Hyperplasia	ENSG00000164362	FALSE	Phase II Clinical Trial	2002-06-26	Absent	TERT
Prostatic Hyperplasia	ENSG00000169083	TRUE	Approved	1990-02-15	Approved	AR
Prostatic Hyperplasia	ENSG00000170214	FALSE	Preclinical	1992-06-15	Unused	ADRA1B
Prostatic Hyperplasia	ENSG00000171873	FALSE	Phase II Clinical Trial	1992-06-15	Unused	ADRA1D
Prostatic Hyperplasia	ENSG00000181072	FALSE	Phase I Clinical Trial	2005-08-10	Unused	CHRM2
Prostatic Hyperplasia	ENSG00000184160	FALSE	Preclinical	1992-06-15	Unused	ADRA2C
Prostatic Hyperplasia	ENSG00000198121	FALSE	Preclinical	2016-11-17	Absent	LPAR1
Prostatic Hyperplasia	ENSG00000198400	FALSE	unknown	NA	Unused	NTRK1
Prostatic Hyperplasia	ENSG00000274286	FALSE	Preclinical	1992-06-15	Unused	ADRA2B
Prostatic Hyperplasia	ENSG00000277893	TRUE	Approved	1994-01-15	Approved	SRD5A2
Prostatic Neoplasms	ENSG00000003402	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	CFLAR
Prostatic Neoplasms	ENSG00000004468	FALSE	Phase II Clinical Trial	2008-02-12	Absent	CD38
Prostatic Neoplasms	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Prostatic Neoplasms	ENSG00000005339	FALSE	Preclinical	2015-11-06	Absent	CREBBP
Prostatic Neoplasms	ENSG00000006283	FALSE	Preclinical	2008-04-02	Unused	CACNA1G
Prostatic Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Prostatic Neoplasms	ENSG00000007062	FALSE	Preclinical	2017-09-25	Absent	PROM1
Prostatic Neoplasms	ENSG00000010810	FALSE	Phase III Clinical Trial	2004-07-20	Unused	FYN
Prostatic Neoplasms	ENSG00000011422	FALSE	Preclinical	2005-04-26	Preclinical	PLAUR
Prostatic Neoplasms	ENSG00000014257	TRUE	Approved	1997-10-15	Approved	ACPP
Prostatic Neoplasms	ENSG00000019186	FALSE	Phase I Clinical Trial	2005-07-22	Unused	CYP24A1
Prostatic Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Unused	HGF
Prostatic Neoplasms	ENSG00000023445	FALSE	Preclinical	2002-07-03	Preclinical	BIRC3
Prostatic Neoplasms	ENSG00000026508	FALSE	Preclinical	1992-09-15	Unused	CD44
Prostatic Neoplasms	ENSG00000030582	FALSE	Preclinical	2004-02-24	Unused	GRN
Prostatic Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Prostatic Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-08-27	Absent	CDH1
Prostatic Neoplasms	ENSG00000041982	FALSE	Phase II Clinical Trial	2007-06-05	Unused	TNC
Prostatic Neoplasms	ENSG00000043591	FALSE	Phase II Clinical Trial	2007-01-23	Absent	ADRB1
Prostatic Neoplasms	ENSG00000050165	FALSE	Phase II Clinical Trial	2010-07-26	Absent	DKK3
Prostatic Neoplasms	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Prostatic Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CB
Prostatic Neoplasms	ENSG00000057252	FALSE	Preclinical	2017-03-31	Absent	SOAT1
Prostatic Neoplasms	ENSG00000063176	FALSE	Preclinical	2006-06-05	Absent	SPHK2
Prostatic Neoplasms	ENSG00000063660	FALSE	Preclinical	2014-09-02	Absent	GPC1
Prostatic Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	1994-09-15	Phase I Clinical Trial	ERBB3
Prostatic Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Prostatic Neoplasms	ENSG00000068028	FALSE	Preclinical	2012-10-22	Preclinical	RASSF1
Prostatic Neoplasms	ENSG00000068078	FALSE	Phase III Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR3
Prostatic Neoplasms	ENSG00000070018	FALSE	Preclinical	2012-01-13	Unused	LRP6
Prostatic Neoplasms	ENSG00000070501	FALSE	unknown	1996-08-15	Unused	POLB
Prostatic Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Prostatic Neoplasms	ENSG00000073008	FALSE	Preclinical	2004-12-07	Unused	PVR
Prostatic Neoplasms	ENSG00000073756	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	PTGS2
Prostatic Neoplasms	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Prostatic Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Prostatic Neoplasms	ENSG00000075891	FALSE	Preclinical	2011-09-22	Preclinical	PAX2
Prostatic Neoplasms	ENSG00000076706	FALSE	Preclinical	2003-02-27	Unused	MCAM
Prostatic Neoplasms	ENSG00000077238	FALSE	Phase I Clinical Trial	1996-06-15	Unused	IL4R
Prostatic Neoplasms	ENSG00000077498	FALSE	unknown	2002-02-27	Unused	TYR
Prostatic Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR1
Prostatic Neoplasms	ENSG00000078098	FALSE	Phase I Clinical Trial	NA	Absent	FAP
Prostatic Neoplasms	ENSG00000079385	FALSE	Preclinical	1997-06-15	Unused	CEACAM1
Prostatic Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-01-07	Phase II Clinical Trial	HSP90AA1
Prostatic Neoplasms	ENSG00000082175	FALSE	Phase II Clinical Trial	NA	Absent	PGR
Prostatic Neoplasms	ENSG00000082781	FALSE	Phase II Clinical Trial	2001-11-05	Phase II Clinical Trial	ITGB5
Prostatic Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Prostatic Neoplasms	ENSG00000085063	FALSE	Preclinical	2007-03-06	Unused	CD59
Prostatic Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Prostatic Neoplasms	ENSG00000085563	FALSE	Preclinical	1994-04-15	Unused	ABCB1
Prostatic Neoplasms	ENSG00000086205	FALSE	Phase III Clinical Trial	1996-07-15	Phase II Clinical Trial	FOLH1
Prostatic Neoplasms	ENSG00000087245	FALSE	unknown	1997-06-15	Unused	MMP2
Prostatic Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2004-11-19	Phase I Clinical Trial	AURKA
Prostatic Neoplasms	ENSG00000089685	FALSE	Phase II Clinical Trial	2002-04-29	Phase II Clinical Trial	BIRC5
Prostatic Neoplasms	ENSG00000089692	FALSE	Preclinical	2004-06-08	Absent	LAG3
Prostatic Neoplasms	ENSG00000090339	FALSE	Phase III Clinical Trial	2004-07-19	Phase III Clinical Trial	ICAM1
Prostatic Neoplasms	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Prostatic Neoplasms	ENSG00000091409	FALSE	Preclinical	2002-07-12	Unused	ITGA6
Prostatic Neoplasms	ENSG00000091831	TRUE	Approved	1993-04-15	Approved	ESR1
Prostatic Neoplasms	ENSG00000094631	FALSE	Preclinical	2016-10-27	Absent	HDAC6
Prostatic Neoplasms	ENSG00000095303	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	PTGS1
Prostatic Neoplasms	ENSG00000095596	FALSE	Preclinical	2004-03-29	Unused	CYP26A1
Prostatic Neoplasms	ENSG00000096968	FALSE	Phase II Clinical Trial	1999-03-17	Unused	JAK2
Prostatic Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Prostatic Neoplasms	ENSG00000097007	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	ABL1
Prostatic Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Prostatic Neoplasms	ENSG00000100300	FALSE	unknown	2003-09-12	Unused	TSPO
Prostatic Neoplasms	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Prostatic Neoplasms	ENSG00000100380	FALSE	Phase I Clinical Trial	NA	Absent	ST13
Prostatic Neoplasms	ENSG00000100393	FALSE	Preclinical	2015-11-06	Absent	EP300
Prostatic Neoplasms	ENSG00000100429	FALSE	Phase II Clinical Trial	2006-05-08	Phase II Clinical Trial	HDAC10
Prostatic Neoplasms	ENSG00000100644	FALSE	Preclinical	1997-04-15	Phase I Clinical Trial	HIF1A
Prostatic Neoplasms	ENSG00000100823	FALSE	unknown	2007-02-13	Unused	APEX1
Prostatic Neoplasms	ENSG00000100985	FALSE	Phase II Clinical Trial	1997-06-15	Unused	MMP9
Prostatic Neoplasms	ENSG00000101017	FALSE	Phase II Clinical Trial	2006-11-10	Phase II Clinical Trial	CD40
Prostatic Neoplasms	ENSG00000101266	FALSE	Phase I Clinical Trial	2007-05-23	Phase I Clinical Trial	CSNK2A1
Prostatic Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2007-11-12	Absent	E2F1
Prostatic Neoplasms	ENSG00000101846	FALSE	Phase II Clinical Trial	2000-03-15	Unused	STS
Prostatic Neoplasms	ENSG00000101868	FALSE	Phase III Clinical Trial	1996-03-15	Phase III Clinical Trial	POLA1
Prostatic Neoplasms	ENSG00000101951	FALSE	Preclinical	1999-01-15	Unused	PAGE4
Prostatic Neoplasms	ENSG00000101966	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	XIAP
Prostatic Neoplasms	ENSG00000102096	FALSE	Preclinical	2006-11-29	Unused	PIM2
Prostatic Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Prostatic Neoplasms	ENSG00000102967	FALSE	unknown	1994-12-15	Unused	DHODH
Prostatic Neoplasms	ENSG00000103175	FALSE	Preclinical	1993-11-15	Unused	WFDC1
Prostatic Neoplasms	ENSG00000103222	FALSE	Preclinical	1994-04-15	Unused	ABCC1
Prostatic Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Prostatic Neoplasms	ENSG00000104365	FALSE	Preclinical	NA	Preclinical	IKBKB
Prostatic Neoplasms	ENSG00000104763	FALSE	Preclinical	NA	Absent	ASAH1
Prostatic Neoplasms	ENSG00000104827	FALSE	unknown	1996-02-15	Unused	CGB3
Prostatic Neoplasms	ENSG00000105146	FALSE	Phase II Clinical Trial	2004-11-19	Unused	AURKC
Prostatic Neoplasms	ENSG00000105329	FALSE	Preclinical	2003-04-10	Unused	TGFB1
Prostatic Neoplasms	ENSG00000105388	FALSE	Phase I Clinical Trial	2007-02-28	Phase I Clinical Trial	CEACAM5
Prostatic Neoplasms	ENSG00000105707	FALSE	Preclinical	2001-12-19	Unused	HPN
Prostatic Neoplasms	ENSG00000105810	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CDK6
Prostatic Neoplasms	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CG
Prostatic Neoplasms	ENSG00000105976	FALSE	Phase III Clinical Trial	2001-12-18	Phase III Clinical Trial	MET
Prostatic Neoplasms	ENSG00000106128	FALSE	Preclinical	2013-01-22	Preclinical	GHRHR
Prostatic Neoplasms	ENSG00000106211	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	HSPB1
Prostatic Neoplasms	ENSG00000106462	FALSE	Phase I Clinical Trial	2015-04-01	Absent	EZH2
Prostatic Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	TGFBR1
Prostatic Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Prostatic Neoplasms	ENSG00000107562	FALSE	unknown	2003-04-10	Unused	CXCL12
Prostatic Neoplasms	ENSG00000107854	FALSE	Preclinical	2012-04-23	Absent	TNKS2
Prostatic Neoplasms	ENSG00000108443	FALSE	Phase I Clinical Trial	2003-03-20	Phase I Clinical Trial	RPS6KB1
Prostatic Neoplasms	ENSG00000108679	FALSE	Preclinical	2014-07-22	Absent	LGALS3BP
Prostatic Neoplasms	ENSG00000108691	FALSE	Phase II Clinical Trial	NA	Unused	CCL2
Prostatic Neoplasms	ENSG00000108786	FALSE	Preclinical	2004-09-16	Unused	HSD17B1
Prostatic Neoplasms	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Prostatic Neoplasms	ENSG00000109163	TRUE	Approved	1989-08-15	Approved	GNRHR
Prostatic Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Phase II Clinical Trial	NFKB1
Prostatic Neoplasms	ENSG00000109471	FALSE	unknown	1995-05-15	Unused	IL2
Prostatic Neoplasms	ENSG00000110195	FALSE	Preclinical	2008-08-29	Phase I Clinical Trial	FOLR1
Prostatic Neoplasms	ENSG00000111142	FALSE	Preclinical	2011-07-21	Absent	METAP2
Prostatic Neoplasms	ENSG00000111424	FALSE	Phase II Clinical Trial	1991-09-15	Phase II Clinical Trial	VDR
Prostatic Neoplasms	ENSG00000111679	FALSE	unknown	2005-08-19	Unused	PTPN6
Prostatic Neoplasms	ENSG00000112062	FALSE	Preclinical	2008-05-23	Phase I Clinical Trial	MAPK14
Prostatic Neoplasms	ENSG00000112096	FALSE	Preclinical	2007-06-08	Unused	SOD2
Prostatic Neoplasms	ENSG00000112715	FALSE	Phase III Clinical Trial	1993-05-15	Phase III Clinical Trial	VEGFA
Prostatic Neoplasms	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Prostatic Neoplasms	ENSG00000113302	FALSE	unknown	2001-10-02	Unused	IL12B
Prostatic Neoplasms	ENSG00000113328	FALSE	unknown	2003-08-05	Unused	CCNG1
Prostatic Neoplasms	ENSG00000113494	FALSE	Phase I Clinical Trial	2009-12-10	Phase I Clinical Trial	PRLR
Prostatic Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Prostatic Neoplasms	ENSG00000113575	FALSE	Preclinical	2007-08-17	Absent	PPP2CA
Prostatic Neoplasms	ENSG00000113580	FALSE	Preclinical	2013-12-19	Absent	NR3C1
Prostatic Neoplasms	ENSG00000113721	FALSE	Phase III Clinical Trial	2008-09-16	Unused	PDGFRB
Prostatic Neoplasms	ENSG00000113749	FALSE	unknown	2008-06-03	Phase II Clinical Trial	HRH2
Prostatic Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Prostatic Neoplasms	ENSG00000114378	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	HYAL1
Prostatic Neoplasms	ENSG00000115053	FALSE	Phase I Clinical Trial	2003-03-13	Unused	NCL
Prostatic Neoplasms	ENSG00000115107	FALSE	Preclinical	2000-11-07	Unused	STEAP3
Prostatic Neoplasms	ENSG00000115221	FALSE	Phase II Clinical Trial	2002-11-26	Phase II Clinical Trial	ITGB6
Prostatic Neoplasms	ENSG00000115414	FALSE	Phase II Clinical Trial	2004-02-11	Unused	FN1
Prostatic Neoplasms	ENSG00000115457	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP2
Prostatic Neoplasms	ENSG00000115461	FALSE	Preclinical	2003-03-19	Preclinical	IGFBP5
Prostatic Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Prostatic Neoplasms	ENSG00000116014	FALSE	Phase I Clinical Trial	2008-02-04	Unused	KISS1R
Prostatic Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC1
Prostatic Neoplasms	ENSG00000116815	FALSE	Phase III Clinical Trial	NA	Absent	CD58
Prostatic Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Prostatic Neoplasms	ENSG00000117560	FALSE	Preclinical	1999-09-16	Unused	FASLG
Prostatic Neoplasms	ENSG00000117601	FALSE	Phase III Clinical Trial	NA	Unused	SERPINC1
Prostatic Neoplasms	ENSG00000117632	FALSE	unknown	2008-07-04	Phase I Clinical Trial	STMN1
Prostatic Neoplasms	ENSG00000118137	FALSE	unknown	2005-07-04	Unused	APOA1
Prostatic Neoplasms	ENSG00000118181	FALSE	Preclinical	2017-12-04	Absent	RPS25
Prostatic Neoplasms	ENSG00000118520	FALSE	Preclinical	2007-10-09	Preclinical	ARG1
Prostatic Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	EPCAM
Prostatic Neoplasms	ENSG00000120156	FALSE	Phase III Clinical Trial	2001-12-18	Phase III Clinical Trial	TEK
Prostatic Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-06-20	Absent	CD274
Prostatic Neoplasms	ENSG00000120659	FALSE	Preclinical	2009-11-02	Unused	TNFSF11
Prostatic Neoplasms	ENSG00000120885	FALSE	Phase II Clinical Trial	2001-12-07	Phase III Clinical Trial	CLU
Prostatic Neoplasms	ENSG00000120889	FALSE	Preclinical	1997-04-15	Unused	TNFRSF10B
Prostatic Neoplasms	ENSG00000121594	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	CD80
Prostatic Neoplasms	ENSG00000121807	FALSE	Preclinical	2005-08-08	Unused	CCR2
Prostatic Neoplasms	ENSG00000121858	FALSE	Phase II Clinical Trial	2009-06-03	Absent	TNFSF10
Prostatic Neoplasms	ENSG00000121879	FALSE	Phase II Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Prostatic Neoplasms	ENSG00000121966	FALSE	Phase I Clinical Trial	2000-06-06	Unused	CXCR4
Prostatic Neoplasms	ENSG00000122025	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	FLT3
Prostatic Neoplasms	ENSG00000122194	FALSE	Preclinical	2001-07-24	Unused	PLG
Prostatic Neoplasms	ENSG00000122861	FALSE	unknown	1999-03-10	Unused	PLAU
Prostatic Neoplasms	ENSG00000123143	FALSE	Preclinical	2007-10-23	Unused	PKN1
Prostatic Neoplasms	ENSG00000123374	FALSE	Phase I Clinical Trial	2005-03-14	Phase I Clinical Trial	CDK2
Prostatic Neoplasms	ENSG00000125498	FALSE	Phase I Clinical Trial	2011-03-02	Absent	KIR2DL1
Prostatic Neoplasms	ENSG00000126010	FALSE	Preclinical	1994-07-15	Unused	GRPR
Prostatic Neoplasms	ENSG00000126218	FALSE	Phase III Clinical Trial	NA	Unused	F10
Prostatic Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2007-01-30	Phase II Clinical Trial	MAP2K2
Prostatic Neoplasms	ENSG00000127418	FALSE	Preclinical	2003-05-16	Unused	FGFRL1
Prostatic Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	KDR
Prostatic Neoplasms	ENSG00000128271	FALSE	Phase I Clinical Trial	2008-10-21	Absent	ADORA2A
Prostatic Neoplasms	ENSG00000128602	FALSE	Phase I Clinical Trial	2004-07-21	Phase I Clinical Trial	SMO
Prostatic Neoplasms	ENSG00000128917	FALSE	unknown	2012-04-23	Phase I Clinical Trial	DLL4
Prostatic Neoplasms	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Prostatic Neoplasms	ENSG00000130037	FALSE	Preclinical	2014-11-19	Absent	KCNA5
Prostatic Neoplasms	ENSG00000130948	FALSE	Preclinical	2005-05-04	Unused	HSD17B3
Prostatic Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2008-01-23	Phase II Clinical Trial	IDO1
Prostatic Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Prostatic Neoplasms	ENSG00000131747	FALSE	Approved	1992-09-15	Phase II Clinical Trial	TOP2A
Prostatic Neoplasms	ENSG00000131759	FALSE	unknown	NA	Unused	RARA
Prostatic Neoplasms	ENSG00000131981	FALSE	unknown	1997-05-15	Preclinical	LGALS3
Prostatic Neoplasms	ENSG00000132155	FALSE	Phase I Clinical Trial	1994-06-15	Phase II Clinical Trial	RAF1
Prostatic Neoplasms	ENSG00000132646	FALSE	Preclinical	2011-03-30	Preclinical	PCNA
Prostatic Neoplasms	ENSG00000132906	FALSE	Preclinical	1997-05-15	Unused	CASP9
Prostatic Neoplasms	ENSG00000132964	FALSE	Preclinical	2015-03-06	Absent	CDK8
Prostatic Neoplasms	ENSG00000133019	FALSE	Preclinical	2007-02-13	Unused	CHRM3
Prostatic Neoplasms	ENSG00000133321	FALSE	unknown	2014-10-18	Absent	RARRES3
Prostatic Neoplasms	ENSG00000134250	FALSE	Phase I Clinical Trial	2012-09-29	Absent	NOTCH2
Prostatic Neoplasms	ENSG00000134460	FALSE	Phase II Clinical Trial	2000-11-07	Phase II Clinical Trial	IL2RA
Prostatic Neoplasms	ENSG00000134853	FALSE	Phase III Clinical Trial	1994-12-15	Phase II Clinical Trial	PDGFRA
Prostatic Neoplasms	ENSG00000135404	FALSE	Preclinical	2003-04-15	Unused	CD63
Prostatic Neoplasms	ENSG00000135446	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CDK4
Prostatic Neoplasms	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-14	Unused	MDM2
Prostatic Neoplasms	ENSG00000135914	FALSE	Preclinical	2004-07-12	Unused	HTR2B
Prostatic Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2016-04-28	Phase I Clinical Trial	EDNRB
Prostatic Neoplasms	ENSG00000136244	FALSE	Phase II Clinical Trial	2014-08-27	Phase II Clinical Trial	IL6
Prostatic Neoplasms	ENSG00000136634	FALSE	Phase I Clinical Trial	2013-11-28	Absent	IL10
Prostatic Neoplasms	ENSG00000136807	FALSE	unknown	1996-05-15	Phase I Clinical Trial	CDK9
Prostatic Neoplasms	ENSG00000136810	FALSE	Phase I Clinical Trial	1995-01-15	Unused	TXN
Prostatic Neoplasms	ENSG00000136856	FALSE	Preclinical	2004-11-24	Absent	SLC2A8
Prostatic Neoplasms	ENSG00000136931	FALSE	Preclinical	2010-09-02	Preclinical	NR5A1
Prostatic Neoplasms	ENSG00000136997	FALSE	unknown	2000-02-10	Unused	MYC
Prostatic Neoplasms	ENSG00000137070	FALSE	Phase I Clinical Trial	2013-03-05	Phase I Clinical Trial	IL11RA
Prostatic Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Prostatic Neoplasms	ENSG00000137193	FALSE	Preclinical	2006-11-29	Unused	PIM1
Prostatic Neoplasms	ENSG00000137845	FALSE	unknown	2003-09-17	Unused	ADAM10
Prostatic Neoplasms	ENSG00000138039	FALSE	Phase II Clinical Trial	2008-02-19	Phase II Clinical Trial	LHCGR
Prostatic Neoplasms	ENSG00000138061	FALSE	unknown	NA	Unused	CYP1B1
Prostatic Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase II Clinical Trial	KIF11
Prostatic Neoplasms	ENSG00000138448	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGAV
Prostatic Neoplasms	ENSG00000138685	FALSE	unknown	1993-05-15	Absent	FGF2
Prostatic Neoplasms	ENSG00000138735	FALSE	unknown	1994-12-15	Unused	PDE5A
Prostatic Neoplasms	ENSG00000138798	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	EGF
Prostatic Neoplasms	ENSG00000139193	FALSE	Phase I Clinical Trial	2008-11-12	Absent	CD27
Prostatic Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2010-07-30	Preclinical	SSTR1
Prostatic Neoplasms	ENSG00000140009	FALSE	Phase II Clinical Trial	1999-09-02	Unused	ESR2
Prostatic Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	1997-10-15	Phase II Clinical Trial	IGF1R
Prostatic Neoplasms	ENSG00000141510	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	TP53
Prostatic Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	1992-02-15	Phase II Clinical Trial	ERBB2
Prostatic Neoplasms	ENSG00000141867	FALSE	Phase II Clinical Trial	2003-09-05	Absent	BRD4
Prostatic Neoplasms	ENSG00000142168	FALSE	Phase II Clinical Trial	2002-07-01	Unused	SOD1
Prostatic Neoplasms	ENSG00000142208	FALSE	Phase III Clinical Trial	1992-08-15	Phase II Clinical Trial	AKT1
Prostatic Neoplasms	ENSG00000142515	FALSE	Phase III Clinical Trial	1996-02-15	Phase III Clinical Trial	KLK3
Prostatic Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Prostatic Neoplasms	ENSG00000143384	FALSE	Phase I Clinical Trial	1999-10-20	Phase II Clinical Trial	MCL1
Prostatic Neoplasms	ENSG00000143537	FALSE	Preclinical	2015-06-24	Absent	ADAM15
Prostatic Neoplasms	ENSG00000143549	FALSE	Preclinical	2013-10-15	Absent	TPM3
Prostatic Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Prostatic Neoplasms	ENSG00000145545	FALSE	Pre-registration	1994-02-15	Phase II Clinical Trial	SRD5A1
Prostatic Neoplasms	ENSG00000146242	FALSE	Phase II Clinical Trial	1999-06-10	Phase II Clinical Trial	TPBG
Prostatic Neoplasms	ENSG00000146648	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	EGFR
Prostatic Neoplasms	ENSG00000146674	FALSE	Phase II Clinical Trial	2008-01-04	Phase II Clinical Trial	IGFBP3
Prostatic Neoplasms	ENSG00000147099	FALSE	Preclinical	2017-02-23	Absent	HDAC8
Prostatic Neoplasms	ENSG00000147155	FALSE	unknown	1993-01-15	Unused	EBP
Prostatic Neoplasms	ENSG00000147437	FALSE	Phase III Clinical Trial	1990-08-15	Phase I Clinical Trial	GNRH1
Prostatic Neoplasms	ENSG00000147889	FALSE	Phase II Clinical Trial	2000-11-07	Unused	CDKN2A
Prostatic Neoplasms	ENSG00000147955	FALSE	Preclinical	1993-01-15	Unused	SIGMAR1
Prostatic Neoplasms	ENSG00000148795	TRUE	Approved	1994-06-15	Approved	CYP17A1
Prostatic Neoplasms	ENSG00000148832	FALSE	Preclinical	2007-06-08	Absent	PAOX
Prostatic Neoplasms	ENSG00000149295	FALSE	Phase II Clinical Trial	2009-06-03	Absent	DRD2
Prostatic Neoplasms	ENSG00000149418	FALSE	Preclinical	2002-02-13	Unused	ST14
Prostatic Neoplasms	ENSG00000149554	FALSE	Phase II Clinical Trial	2010-03-02	Phase I Clinical Trial	CHEK1
Prostatic Neoplasms	ENSG00000150093	FALSE	Phase II Clinical Trial	2001-11-05	Phase II Clinical Trial	ITGB1
Prostatic Neoplasms	ENSG00000150337	FALSE	unknown	1992-02-15	Unused	FCGR1A
Prostatic Neoplasms	ENSG00000150630	FALSE	unknown	2007-07-02	Preclinical	VEGFC
Prostatic Neoplasms	ENSG00000151247	FALSE	Phase II Clinical Trial	2004-09-22	Phase II Clinical Trial	EIF4E
Prostatic Neoplasms	ENSG00000151617	FALSE	Phase II Clinical Trial	1995-10-15	Unused	EDNRA
Prostatic Neoplasms	ENSG00000151694	FALSE	unknown	2003-09-17	Unused	ADAM17
Prostatic Neoplasms	ENSG00000151702	FALSE	Preclinical	2016-01-22	Absent	FLI1
Prostatic Neoplasms	ENSG00000154229	FALSE	Preclinical	1991-01-15	Unused	PRKCA
Prostatic Neoplasms	ENSG00000155380	FALSE	Phase I Clinical Trial	2010-09-13	Absent	SLC16A1
Prostatic Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Prostatic Neoplasms	ENSG00000157404	FALSE	Phase III Clinical Trial	1999-03-17	Phase III Clinical Trial	KIT
Prostatic Neoplasms	ENSG00000157764	FALSE	Phase I Clinical Trial	2006-01-11	Phase I Clinical Trial	BRAF
Prostatic Neoplasms	ENSG00000160180	FALSE	Preclinical	2012-07-17	Preclinical	TFF3
Prostatic Neoplasms	ENSG00000160182	FALSE	Preclinical	2012-07-17	Preclinical	TFF1
Prostatic Neoplasms	ENSG00000160285	FALSE	Preclinical	2016-09-06	Absent	LSS
Prostatic Neoplasms	ENSG00000160791	FALSE	unknown	2000-06-06	Unused	CCR5
Prostatic Neoplasms	ENSG00000160867	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR4
Prostatic Neoplasms	ENSG00000161011	FALSE	Preclinical	2015-11-04	Absent	SQSTM1
Prostatic Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Prostatic Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2010-07-30	Preclinical	SSTR5
Prostatic Neoplasms	ENSG00000162434	FALSE	unknown	2006-12-01	Unused	JAK1
Prostatic Neoplasms	ENSG00000163220	FALSE	Phase III Clinical Trial	2001-05-18	Phase III Clinical Trial	S100A9
Prostatic Neoplasms	ENSG00000163399	FALSE	Preclinical	2013-12-17	Absent	ATP1A1
Prostatic Neoplasms	ENSG00000163517	FALSE	unknown	NA	Phase I Clinical Trial	HDAC11
Prostatic Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	CTLA4
Prostatic Neoplasms	ENSG00000163814	FALSE	Preclinical	2007-05-04	Unused	CDCP1
Prostatic Neoplasms	ENSG00000163823	FALSE	Phase I Clinical Trial	2007-06-13	Unused	CCR1
Prostatic Neoplasms	ENSG00000164078	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	MST1R
Prostatic Neoplasms	ENSG00000164171	FALSE	Preclinical	2008-08-19	Preclinical	ITGA2
Prostatic Neoplasms	ENSG00000164305	FALSE	Preclinical	1997-04-15	Unused	CASP3
Prostatic Neoplasms	ENSG00000164342	FALSE	Phase I Clinical Trial	NA	Unused	TLR3
Prostatic Neoplasms	ENSG00000164362	FALSE	Phase II Clinical Trial	2000-07-26	Phase II Clinical Trial	TERT
Prostatic Neoplasms	ENSG00000164399	FALSE	Preclinical	NA	Unused	IL3
Prostatic Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1991-12-15	Phase II Clinical Trial	CSF2
Prostatic Neoplasms	ENSG00000164647	FALSE	Phase II Clinical Trial	1999-12-14	Phase I Clinical Trial	STEAP1
Prostatic Neoplasms	ENSG00000164778	FALSE	Preclinical	2011-09-22	Absent	EN2
Prostatic Neoplasms	ENSG00000164825	FALSE	Preclinical	2011-09-22	Unused	DEFB1
Prostatic Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Prostatic Neoplasms	ENSG00000165125	FALSE	Preclinical	2011-08-04	Preclinical	TRPV6
Prostatic Neoplasms	ENSG00000165215	FALSE	Preclinical	2014-04-29	Absent	CLDN3
Prostatic Neoplasms	ENSG00000165675	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	ENOX2
Prostatic Neoplasms	ENSG00000165731	FALSE	Phase III Clinical Trial	1994-06-15	Phase III Clinical Trial	RET
Prostatic Neoplasms	ENSG00000166199	FALSE	Preclinical	2015-04-09	Absent	ALKBH3
Prostatic Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Prostatic Neoplasms	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Prostatic Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Prostatic Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	1997-12-15	Phase I Clinical Trial	PLK1
Prostatic Neoplasms	ENSG00000167034	FALSE	Phase I Clinical Trial	2010-07-01	Absent	NKX3-1
Prostatic Neoplasms	ENSG00000167085	FALSE	Phase I Clinical Trial	2010-12-22	Phase I Clinical Trial	PHB
Prostatic Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1997-03-15	Unused	RRM1
Prostatic Neoplasms	ENSG00000167653	FALSE	Phase II Clinical Trial	2000-07-26	Unused	PSCA
Prostatic Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1996-06-15	Unused	EEF2
Prostatic Neoplasms	ENSG00000167751	FALSE	Preclinical	NA	Unused	KLK2
Prostatic Neoplasms	ENSG00000168398	FALSE	Preclinical	2008-06-03	Unused	BDKRB2
Prostatic Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	1995-04-15	Unused	FNTA
Prostatic Neoplasms	ENSG00000168610	FALSE	Preclinical	2015-02-25	Absent	STAT3
Prostatic Neoplasms	ENSG00000168811	FALSE	unknown	2001-10-02	Unused	IL12A
Prostatic Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2007-01-30	Phase II Clinical Trial	MAP2K1
Prostatic Neoplasms	ENSG00000169047	FALSE	Preclinical	2014-10-14	Absent	IRS1
Prostatic Neoplasms	ENSG00000169083	TRUE	Approved	1997-08-15	Approved	AR
Prostatic Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Prostatic Neoplasms	ENSG00000169252	FALSE	Phase II Clinical Trial	2007-01-23	Absent	ADRB2
Prostatic Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Unused	PTK2
Prostatic Neoplasms	ENSG00000169403	FALSE	unknown	1996-01-15	Unused	PTAFR
Prostatic Neoplasms	ENSG00000169925	FALSE	Phase II Clinical Trial	2012-06-18	Absent	BRD3
Prostatic Neoplasms	ENSG00000170017	FALSE	Phase II Clinical Trial	2013-09-10	Absent	ALCAM
Prostatic Neoplasms	ENSG00000170145	FALSE	Preclinical	2012-08-17	Preclinical	SIK2
Prostatic Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Prostatic Neoplasms	ENSG00000170430	FALSE	unknown	2000-05-03	Unused	MGMT
Prostatic Neoplasms	ENSG00000171094	FALSE	unknown	2011-02-23	Unused	ALK
Prostatic Neoplasms	ENSG00000171509	FALSE	Preclinical	2011-10-20	Preclinical	RXFP1
Prostatic Neoplasms	ENSG00000171552	FALSE	Preclinical	2005-11-21	Phase II Clinical Trial	BCL2L1
Prostatic Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PIK3CD
Prostatic Neoplasms	ENSG00000171720	FALSE	Preclinical	2017-02-23	Phase I Clinical Trial	HDAC3
Prostatic Neoplasms	ENSG00000171791	FALSE	Phase I Clinical Trial	1992-03-15	Phase II Clinical Trial	BCL2
Prostatic Neoplasms	ENSG00000171848	FALSE	unknown	1997-03-15	Unused	RRM2
Prostatic Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Prostatic Neoplasms	ENSG00000172016	FALSE	Phase I Clinical Trial	2010-07-01	Absent	REG3A
Prostatic Neoplasms	ENSG00000173083	FALSE	unknown	1997-09-15	Unused	HPSE
Prostatic Neoplasms	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Prostatic Neoplasms	ENSG00000173273	FALSE	Preclinical	2012-04-23	Absent	TNKS
Prostatic Neoplasms	ENSG00000173638	FALSE	unknown	NA	Unused	SLC19A1
Prostatic Neoplasms	ENSG00000174807	FALSE	unknown	2004-10-18	Unused	CD248
Prostatic Neoplasms	ENSG00000176105	FALSE	Phase III Clinical Trial	2004-07-20	Unused	YES1
Prostatic Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-04-15	Phase II Clinical Trial	TYMS
Prostatic Neoplasms	ENSG00000177606	FALSE	Preclinical	2009-05-27	Unused	JUN
Prostatic Neoplasms	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Prostatic Neoplasms	ENSG00000178568	FALSE	Phase I Clinical Trial	2003-11-21	Phase II Clinical Trial	ERBB4
Prostatic Neoplasms	ENSG00000178999	FALSE	Phase II Clinical Trial	2004-11-19	Unused	AURKB
Prostatic Neoplasms	ENSG00000179295	FALSE	unknown	2005-08-19	Unused	PTPN11
Prostatic Neoplasms	ENSG00000180210	FALSE	Phase III Clinical Trial	NA	Unused	F2
Prostatic Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2010-07-30	Preclinical	SSTR2
Prostatic Neoplasms	ENSG00000181019	FALSE	Phase I Clinical Trial	2007-11-12	Absent	NQO1
Prostatic Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2008-08-14	Phase II Clinical Trial	CSF1R
Prostatic Neoplasms	ENSG00000182866	FALSE	Phase III Clinical Trial	2004-07-20	Unused	LCK
Prostatic Neoplasms	ENSG00000183765	FALSE	Phase II Clinical Trial	2010-03-02	Absent	CHEK2
Prostatic Neoplasms	ENSG00000184033	FALSE	Phase I Clinical Trial	2008-10-09	Preclinical	CTAG1B
Prostatic Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-04-30	Preclinical	TACSTD2
Prostatic Neoplasms	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Phase I Clinical Trial	CSF1
Prostatic Neoplasms	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Prostatic Neoplasms	ENSG00000185483	FALSE	Preclinical	2015-09-18	Absent	ROR1
Prostatic Neoplasms	ENSG00000185499	FALSE	Phase I Clinical Trial	1994-08-15	Phase II Clinical Trial	MUC1
Prostatic Neoplasms	ENSG00000185664	FALSE	unknown	2002-02-27	Unused	PMEL
Prostatic Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Phase I Clinical Trial	PRAME
Prostatic Neoplasms	ENSG00000185950	FALSE	Preclinical	2014-10-14	Absent	IRS2
Prostatic Neoplasms	ENSG00000186318	FALSE	unknown	1999-07-20	Unused	BACE1
Prostatic Neoplasms	ENSG00000186642	FALSE	unknown	1994-12-15	Unused	PDE2A
Prostatic Neoplasms	ENSG00000186716	FALSE	Phase III Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Prostatic Neoplasms	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Prostatic Neoplasms	ENSG00000187554	FALSE	Phase I Clinical Trial	2006-08-01	Preclinical	TLR5
Prostatic Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Phase II Clinical Trial	PDCD1
Prostatic Neoplasms	ENSG00000189143	FALSE	Preclinical	2014-04-29	Absent	CLDN4
Prostatic Neoplasms	ENSG00000196139	FALSE	Preclinical	2013-02-19	Preclinical	AKR1C3
Prostatic Neoplasms	ENSG00000196352	FALSE	Phase II Clinical Trial	1994-06-15	Phase I Clinical Trial	CD55
Prostatic Neoplasms	ENSG00000196396	FALSE	unknown	2005-08-19	Unused	PTPN1
Prostatic Neoplasms	ENSG00000196411	FALSE	Phase II Clinical Trial	2004-08-23	Phase II Clinical Trial	EPHB4
Prostatic Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	HDAC2
Prostatic Neoplasms	ENSG00000197122	FALSE	Phase III Clinical Trial	2000-11-07	Phase I Clinical Trial	SRC
Prostatic Neoplasms	ENSG00000198223	FALSE	Preclinical	2011-09-23	Preclinical	CSF2RA
Prostatic Neoplasms	ENSG00000198355	FALSE	Preclinical	2006-11-29	Unused	PIM3
Prostatic Neoplasms	ENSG00000198363	FALSE	Phase I Clinical Trial	2014-11-17	Absent	ASPH
Prostatic Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Unused	NTRK1
Prostatic Neoplasms	ENSG00000198625	FALSE	Preclinical	2015-07-15	Absent	MDM4
Prostatic Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	1997-08-15	Phase II Clinical Trial	MTOR
Prostatic Neoplasms	ENSG00000198851	FALSE	Phase I Clinical Trial	2012-11-19	Absent	CD3E
Prostatic Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Phase I Clinical Trial	TOP1
Prostatic Neoplasms	ENSG00000203859	FALSE	unknown	NA	Unused	HSD3B2
Prostatic Neoplasms	ENSG00000213903	FALSE	Preclinical	2008-05-23	Preclinical	LTB4R
Prostatic Neoplasms	ENSG00000213918	FALSE	Preclinical	1995-06-15	Unused	DNASE1
Prostatic Neoplasms	ENSG00000221867	FALSE	unknown	NA	Unused	MAGEA3
Prostatic Neoplasms	ENSG00000228716	FALSE	unknown	1991-03-15	Unused	DHFR
Prostatic Neoplasms	ENSG00000239732	FALSE	Phase I Clinical Trial	1998-10-15	Unused	TLR9
Prostatic Neoplasms	ENSG00000243772	FALSE	Phase I Clinical Trial	2011-03-02	Absent	KIR2DL3
Prostatic Neoplasms	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Unused	PRKDC
Prostatic Neoplasms	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Phase II Clinical Trial	LYN
Prostatic Neoplasms	ENSG00000259207	FALSE	Phase II Clinical Trial	1995-01-15	Phase II Clinical Trial	ITGB3
Prostatic Neoplasms	ENSG00000277893	FALSE	Pre-registration	1994-02-15	Unused	SRD5A2
Prostatic Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2010-07-30	Preclinical	SSTR3
Prostatitis	ENSG00000073756	FALSE	Preclinical	2014-02-24	Absent	PTGS2
Prostatitis	ENSG00000091831	FALSE	unknown	2000-02-09	Absent	ESR1
Prostatitis	ENSG00000095303	FALSE	Preclinical	2014-02-24	Absent	PTGS1
Prostatitis	ENSG00000120907	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	ADRA1A
Prostatitis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Prostatitis	ENSG00000138039	FALSE	unknown	1996-02-15	Unused	LHCGR
Prostatitis	ENSG00000140009	FALSE	Preclinical	2007-08-02	Unused	ESR2
Prostatitis	ENSG00000142515	FALSE	Phase II Clinical Trial	2005-02-21	Preclinical	KLK3
Prostatitis	ENSG00000169083	FALSE	unknown	NA	Unused	AR
Prostatitis	ENSG00000196639	FALSE	Preclinical	2015-02-26	Absent	HRH1
Proteinuria	ENSG00000059377	FALSE	unknown	2006-08-29	Phase I Clinical Trial	TBXAS1
Proteinuria	ENSG00000111424	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	VDR
Proteinuria	ENSG00000118523	FALSE	Phase I Clinical Trial	1999-09-14	Phase I Clinical Trial	CTGF
Proteinuria	ENSG00000131471	FALSE	Phase II Clinical Trial	2013-02-04	Absent	AOC3
Proteinuria	ENSG00000143839	FALSE	Phase II Clinical Trial	2011-02-03	Absent	REN
Proteinuria	ENSG00000159640	FALSE	Phase II Clinical Trial	2008-11-27	Unused	ACE
Proteinuria	ENSG00000197891	FALSE	Phase II Clinical Trial	NA	Absent	SLC22A12
Protoporphyria, Erythropoietic	ENSG00000258839	TRUE	Approved	2003-06-05	Absent	MC1R
Pruritus	ENSG00000011677	FALSE	Phase I Clinical Trial	2016-05-14	Absent	GABRA3
Pruritus	ENSG00000034152	FALSE	Preclinical	2011-10-06	Absent	MAP2K3
Pruritus	ENSG00000065989	FALSE	Phase I Clinical Trial	2004-01-28	Unused	PDE4A
Pruritus	ENSG00000067182	FALSE	Phase I Clinical Trial	2004-01-28	Unused	TNFRSF1A
Pruritus	ENSG00000072062	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	PRKACA
Pruritus	ENSG00000073756	FALSE	Approved	NA	Unused	PTGS2
Pruritus	ENSG00000082556	FALSE	Approved	1994-05-15	Approved	OPRK1
Pruritus	ENSG00000095303	FALSE	Approved	NA	Unused	PTGS1
Pruritus	ENSG00000105639	FALSE	Preclinical	2011-10-06	Absent	JAK3
Pruritus	ENSG00000105650	FALSE	Phase I Clinical Trial	2004-01-28	Unused	PDE4C
Pruritus	ENSG00000112038	FALSE	Phase III Clinical Trial	2008-07-03	Phase II Clinical Trial	OPRM1
Pruritus	ENSG00000113448	FALSE	Phase I Clinical Trial	2004-01-28	Unused	PDE4D
Pruritus	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Pruritus	ENSG00000113749	TRUE	Approved	1992-06-15	Approved	HRH2
Pruritus	ENSG00000115353	FALSE	Phase II Clinical Trial	1999-06-01	Preclinical	TACR1
Pruritus	ENSG00000118432	FALSE	Preclinical	2012-04-17	Preclinical	CNR1
Pruritus	ENSG00000134489	FALSE	Preclinical	2011-12-27	Unused	HRH4
Pruritus	ENSG00000140538	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	NTRK3
Pruritus	ENSG00000142319	TRUE	Approved	1992-06-15	Approved	SLC6A3
Pruritus	ENSG00000148053	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	NTRK2
Pruritus	ENSG00000151834	FALSE	Phase I Clinical Trial	2016-05-14	Absent	GABRA2
Pruritus	ENSG00000154229	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	PRKCA
Pruritus	ENSG00000168229	FALSE	Phase II Clinical Trial	2003-07-07	Unused	PTGDR
Pruritus	ENSG00000169403	FALSE	Phase III Clinical Trial	1993-08-15	Absent	PTAFR
Pruritus	ENSG00000178623	FALSE	Phase II Clinical Trial	2015-01-09	Absent	GPR35
Pruritus	ENSG00000184588	FALSE	Phase I Clinical Trial	2004-01-28	Unused	PDE4B
Pruritus	ENSG00000185532	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	PRKG1
Pruritus	ENSG00000188822	FALSE	Preclinical	2006-08-08	Unused	CNR2
Pruritus	ENSG00000189403	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	HMGB1
Pruritus	ENSG00000196639	TRUE	Approved	1992-06-15	Approved	HRH1
Pruritus	ENSG00000196689	FALSE	Phase II Clinical Trial	2004-08-16	Phase I Clinical Trial	TRPV1
Pruritus	ENSG00000198400	FALSE	Phase II Clinical Trial	2006-09-06	Preclinical	NTRK1
Pruritus	ENSG00000204671	FALSE	Phase II Clinical Trial	2012-10-17	Absent	IL31
Pruritus	ENSG00000228716	FALSE	unknown	1999-03-08	Unused	DHFR
Pruritus	ENSG00000282608	FALSE	Preclinical	1998-07-15	Unused	ADORA3
Pseudohypoaldosteronism	ENSG00000067182	FALSE	Preclinical	2009-11-16	Absent	TNFRSF1A
Pseudomonas Infections	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Pseudomonas Infections	ENSG00000131747	FALSE	Preclinical	2014-03-11	Absent	TOP2A
Pseudomonas Infections	ENSG00000167325	FALSE	unknown	2000-07-26	Unused	RRM1
Pseudomonas Infections	ENSG00000187554	FALSE	Preclinical	2009-01-22	Unused	TLR5
Pseudomonas Infections	ENSG00000205649	FALSE	unknown	1998-03-15	Unused	HTN3
Psoriasis	ENSG00000005844	TRUE	Approved	1996-06-15	Unused	ITGAL
Psoriasis	ENSG00000007908	FALSE	Phase I Clinical Trial	1994-02-15	Phase II Clinical Trial	SELE
Psoriasis	ENSG00000010610	FALSE	Phase II Clinical Trial	1998-11-15	Phase II Clinical Trial	CD4
Psoriasis	ENSG00000012779	FALSE	Phase III Clinical Trial	1989-07-15	Unused	ALOX5
Psoriasis	ENSG00000013725	FALSE	Approved	1996-05-15	Unused	CD6
Psoriasis	ENSG00000017797	FALSE	Phase II Clinical Trial	2014-12-01	Absent	RALBP1
Psoriasis	ENSG00000019186	FALSE	Phase II Clinical Trial	2000-08-31	Unused	CYP24A1
Psoriasis	ENSG00000026508	FALSE	Preclinical	1992-09-15	Unused	CD44
Psoriasis	ENSG00000027075	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCH
Psoriasis	ENSG00000034152	FALSE	Preclinical	2011-10-06	Absent	MAP2K3
Psoriasis	ENSG00000037280	FALSE	unknown	2001-04-03	Unused	FLT4
Psoriasis	ENSG00000059377	TRUE	Approved	2011-12-15	Approved	TBXAS1
Psoriasis	ENSG00000065361	FALSE	Phase II Clinical Trial	1994-09-15	Unused	ERBB3
Psoriasis	ENSG00000065675	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCQ
Psoriasis	ENSG00000065989	TRUE	Approved	1999-01-08	Phase III Clinical Trial	PDE4A
Psoriasis	ENSG00000067182	TRUE	Approved	2003-11-24	Phase III Clinical Trial	TNFRSF1A
Psoriasis	ENSG00000068078	FALSE	Phase I Clinical Trial	2001-04-03	Absent	FGFR3
Psoriasis	ENSG00000071054	FALSE	Preclinical	2008-10-17	Unused	MAP4K4
Psoriasis	ENSG00000072062	FALSE	Phase II Clinical Trial	2005-12-13	Phase II Clinical Trial	PRKACA
Psoriasis	ENSG00000072694	FALSE	Preclinical	2006-07-31	Preclinical	FCGR2B
Psoriasis	ENSG00000073756	TRUE	Approved	2000-03-29	Approved	PTGS2
Psoriasis	ENSG00000075073	FALSE	Preclinical	2013-04-19	Absent	TACR2
Psoriasis	ENSG00000076706	FALSE	Preclinical	2013-01-11	Absent	MCAM
Psoriasis	ENSG00000077092	TRUE	Approved	1990-06-15	Approved	RARB
Psoriasis	ENSG00000077782	FALSE	unknown	2001-04-03	Absent	FGFR1
Psoriasis	ENSG00000080824	FALSE	Phase II Clinical Trial	NA	Unused	HSP90AA1
Psoriasis	ENSG00000081051	FALSE	unknown	2001-02-27	Unused	AFP
Psoriasis	ENSG00000081985	FALSE	Phase I Clinical Trial	2002-11-14	Unused	IL12RB2
Psoriasis	ENSG00000082898	FALSE	Preclinical	2011-08-20	Absent	XPO1
Psoriasis	ENSG00000088832	FALSE	Phase II Clinical Trial	1995-02-15	Phase II Clinical Trial	FKBP1A
Psoriasis	ENSG00000089692	FALSE	Phase I Clinical Trial	NA	Absent	LAG3
Psoriasis	ENSG00000090339	FALSE	Phase II Clinical Trial	1993-07-15	Unused	ICAM1
Psoriasis	ENSG00000092009	FALSE	Preclinical	1995-02-15	Unused	CMA1
Psoriasis	ENSG00000095015	FALSE	unknown	2007-08-10	Phase II Clinical Trial	MAP3K1
Psoriasis	ENSG00000095303	TRUE	Approved	2000-03-29	Approved	PTGS1
Psoriasis	ENSG00000095596	FALSE	Phase III Clinical Trial	2000-09-04	Unused	CYP26A1
Psoriasis	ENSG00000096717	FALSE	Phase II Clinical Trial	2008-10-21	Phase II Clinical Trial	SIRT1
Psoriasis	ENSG00000096968	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	JAK2
Psoriasis	ENSG00000096996	FALSE	Phase I Clinical Trial	2002-11-14	Unused	IL12RB1
Psoriasis	ENSG00000100030	FALSE	unknown	NA	Unused	MAPK1
Psoriasis	ENSG00000100097	FALSE	Phase II Clinical Trial	NA	Absent	LGALS1
Psoriasis	ENSG00000100385	FALSE	Preclinical	NA	Absent	IL2RB
Psoriasis	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Psoriasis	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Psoriasis	ENSG00000100644	FALSE	Preclinical	2009-02-18	Preclinical	HIF1A
Psoriasis	ENSG00000100784	FALSE	Preclinical	2014-08-25	Absent	RPS6KA5
Psoriasis	ENSG00000101017	FALSE	Phase II Clinical Trial	2000-06-01	Phase II Clinical Trial	CD40
Psoriasis	ENSG00000101204	FALSE	Preclinical	2010-10-07	Absent	CHRNA4
Psoriasis	ENSG00000101868	FALSE	Phase I Clinical Trial	1999-06-02	Unused	POLA1
Psoriasis	ENSG00000101916	FALSE	Phase II Clinical Trial	2006-07-28	Phase II Clinical Trial	TLR8
Psoriasis	ENSG00000102096	FALSE	Preclinical	NA	Absent	PIM2
Psoriasis	ENSG00000102245	FALSE	Phase II Clinical Trial	1995-10-15	Phase II Clinical Trial	CD40LG
Psoriasis	ENSG00000102755	FALSE	unknown	2001-04-03	Unused	FLT1
Psoriasis	ENSG00000102882	FALSE	unknown	NA	Unused	MAPK3
Psoriasis	ENSG00000102967	FALSE	unknown	2002-11-13	Unused	DHODH
Psoriasis	ENSG00000104312	FALSE	Preclinical	2016-02-09	Absent	RIPK2
Psoriasis	ENSG00000105329	FALSE	Phase I Clinical Trial	NA	Unused	TGFB1
Psoriasis	ENSG00000105397	FALSE	Phase II Clinical Trial	2013-04-19	Preclinical	TYK2
Psoriasis	ENSG00000105639	FALSE	Phase III Clinical Trial	2003-06-25	Phase III Clinical Trial	JAK3
Psoriasis	ENSG00000105650	TRUE	Approved	1999-01-08	Phase III Clinical Trial	PDE4C
Psoriasis	ENSG00000105851	FALSE	unknown	2009-07-15	Phase I Clinical Trial	PIK3CG
Psoriasis	ENSG00000106348	FALSE	Phase II Clinical Trial	1996-08-15	Unused	IMPDH1
Psoriasis	ENSG00000106546	FALSE	Phase II Clinical Trial	2004-01-28	Absent	AHR
Psoriasis	ENSG00000106804	FALSE	unknown	1993-08-15	Unused	C5
Psoriasis	ENSG00000108691	FALSE	Preclinical	1992-01-15	Phase I Clinical Trial	CCL2
Psoriasis	ENSG00000108839	FALSE	Preclinical	1993-01-15	Unused	ALOX12
Psoriasis	ENSG00000109163	FALSE	Preclinical	2012-03-21	Preclinical	GNRHR
Psoriasis	ENSG00000109320	FALSE	Phase II Clinical Trial	1994-09-15	Unused	NFKB1
Psoriasis	ENSG00000109471	FALSE	Phase II Clinical Trial	2000-07-26	Absent	IL2
Psoriasis	ENSG00000109610	FALSE	Preclinical	1992-12-15	Unused	SOD3
Psoriasis	ENSG00000110448	FALSE	Phase II Clinical Trial	NA	Unused	CD5
Psoriasis	ENSG00000110876	FALSE	Phase II Clinical Trial	2002-08-22	Phase I Clinical Trial	SELPLG
Psoriasis	ENSG00000110944	TRUE	Approved	2002-11-14	Phase III Clinical Trial	IL23A
Psoriasis	ENSG00000111012	FALSE	Pre-registration	1996-03-15	Unused	CYP27B1
Psoriasis	ENSG00000111424	TRUE	Approved	1990-04-15	Approved	VDR
Psoriasis	ENSG00000111537	FALSE	Phase II Clinical Trial	1992-04-15	Phase I Clinical Trial	IFNG
Psoriasis	ENSG00000112062	FALSE	Phase II Clinical Trial	1997-06-15	Phase I Clinical Trial	MAPK14
Psoriasis	ENSG00000112096	FALSE	Preclinical	2003-06-25	Unused	SOD2
Psoriasis	ENSG00000112115	TRUE	Approved	2001-07-24	Phase III Clinical Trial	IL17A
Psoriasis	ENSG00000112116	FALSE	Phase III Clinical Trial	2011-12-12	Absent	IL17F
Psoriasis	ENSG00000112149	FALSE	Preclinical	2007-03-23	Preclinical	CD83
Psoriasis	ENSG00000112486	FALSE	Preclinical	2012-02-10	Absent	CCR6
Psoriasis	ENSG00000112715	FALSE	Phase II Clinical Trial	1996-09-15	Phase II Clinical Trial	VEGFA
Psoriasis	ENSG00000113070	FALSE	Preclinical	2002-02-25	Unused	HBEGF
Psoriasis	ENSG00000113263	FALSE	Phase II Clinical Trial	2012-02-22	Absent	ITK
Psoriasis	ENSG00000113302	TRUE	Approved	1997-06-15	Approved	IL12B
Psoriasis	ENSG00000113448	TRUE	Approved	1999-01-08	Phase III Clinical Trial	PDE4D
Psoriasis	ENSG00000113520	FALSE	Phase I Clinical Trial	2017-01-31	Absent	IL4
Psoriasis	ENSG00000113580	TRUE	Approved	1993-09-15	Approved	NR3C1
Psoriasis	ENSG00000113721	FALSE	unknown	2001-04-03	Unused	PDGFRB
Psoriasis	ENSG00000114013	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	CD86
Psoriasis	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Phase II Clinical Trial	IL1A
Psoriasis	ENSG00000115138	FALSE	Preclinical	2004-01-26	Unused	POMC
Psoriasis	ENSG00000115232	FALSE	unknown	NA	Phase II Clinical Trial	ITGA4
Psoriasis	ENSG00000115353	FALSE	Preclinical	2013-04-19	Absent	TACR1
Psoriasis	ENSG00000115415	FALSE	Phase I Clinical Trial	2003-09-01	Unused	STAT1
Psoriasis	ENSG00000115541	FALSE	unknown	2002-09-04	Unused	HSPE1
Psoriasis	ENSG00000115594	FALSE	Phase I Clinical Trial	2017-01-31	Absent	IL1R1
Psoriasis	ENSG00000115598	FALSE	Phase I Clinical Trial	2015-04-20	Absent	IL1RL2
Psoriasis	ENSG00000115604	FALSE	unknown	2000-01-11	Unused	IL18R1
Psoriasis	ENSG00000116044	TRUE	Approved	2003-10-01	Approved	NFE2L2
Psoriasis	ENSG00000116478	FALSE	Preclinical	2007-12-18	Unused	HDAC1
Psoriasis	ENSG00000116711	FALSE	Phase II Clinical Trial	2009-05-06	Preclinical	PLA2G4A
Psoriasis	ENSG00000116824	TRUE	Approved	1989-08-15	Unused	CD2
Psoriasis	ENSG00000117281	FALSE	Preclinical	2004-10-20	Unused	CD160
Psoriasis	ENSG00000117560	FALSE	Preclinical	2000-03-29	Unused	FASLG
Psoriasis	ENSG00000117586	FALSE	Phase I Clinical Trial	2014-01-31	Absent	TNFSF4
Psoriasis	ENSG00000117594	FALSE	Phase II Clinical Trial	2004-11-17	Unused	HSD11B1
Psoriasis	ENSG00000120217	FALSE	Preclinical	2016-03-07	Absent	CD274
Psoriasis	ENSG00000121594	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	CD80
Psoriasis	ENSG00000121807	FALSE	Preclinical	2001-08-11	Unused	CCR2
Psoriasis	ENSG00000121989	FALSE	unknown	NA	Unused	ACVR2A
Psoriasis	ENSG00000122025	FALSE	Phase II Clinical Trial	1999-03-17	Unused	FLT3
Psoriasis	ENSG00000124089	FALSE	Preclinical	2004-11-02	Preclinical	MC3R
Psoriasis	ENSG00000124172	FALSE	Phase II Clinical Trial	2014-05-15	Absent	ATP5F1E
Psoriasis	ENSG00000124762	FALSE	Preclinical	1994-01-15	Unused	CDKN1A
Psoriasis	ENSG00000125384	FALSE	Preclinical	1992-01-15	Unused	PTGER2
Psoriasis	ENSG00000125538	FALSE	Preclinical	2011-03-15	Preclinical	IL1B
Psoriasis	ENSG00000125571	FALSE	Phase III Clinical Trial	2001-07-24	Absent	IL37
Psoriasis	ENSG00000125726	FALSE	Phase I Clinical Trial	NA	Unused	CD70
Psoriasis	ENSG00000125910	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR4
Psoriasis	ENSG00000126934	FALSE	Preclinical	2011-07-26	Absent	MAP2K2
Psoriasis	ENSG00000128052	FALSE	unknown	2001-04-03	Unused	KDR
Psoriasis	ENSG00000128271	FALSE	Preclinical	2004-12-13	Unused	ADORA2A
Psoriasis	ENSG00000131196	FALSE	Preclinical	1997-06-15	Unused	NFATC1
Psoriasis	ENSG00000131471	FALSE	Phase I Clinical Trial	2000-08-17	Phase I Clinical Trial	AOC3
Psoriasis	ENSG00000131747	FALSE	Preclinical	2000-07-26	Absent	TOP2A
Psoriasis	ENSG00000131759	TRUE	Approved	1991-02-15	Approved	RARA
Psoriasis	ENSG00000131981	FALSE	Phase II Clinical Trial	NA	Absent	LGALS3
Psoriasis	ENSG00000132170	FALSE	Phase III Clinical Trial	1995-03-15	Unused	PPARG
Psoriasis	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Psoriasis	ENSG00000132646	FALSE	Preclinical	NA	Unused	PCNA
Psoriasis	ENSG00000132906	FALSE	unknown	2007-03-05	Preclinical	CASP9
Psoriasis	ENSG00000132965	FALSE	unknown	1989-07-15	Unused	ALOX5AP
Psoriasis	ENSG00000134318	FALSE	Phase II Clinical Trial	2005-05-24	Absent	ROCK2
Psoriasis	ENSG00000134460	FALSE	Phase II Clinical Trial	1992-04-15	Unused	IL2RA
Psoriasis	ENSG00000134489	FALSE	Phase II Clinical Trial	2008-02-28	Absent	HRH4
Psoriasis	ENSG00000134853	FALSE	unknown	2001-04-03	Unused	PDGFRA
Psoriasis	ENSG00000135047	FALSE	Preclinical	2009-01-20	Preclinical	CTSL
Psoriasis	ENSG00000135828	FALSE	Phase II Clinical Trial	1997-01-15	Unused	RNASEL
Psoriasis	ENSG00000136244	FALSE	unknown	2008-06-30	Phase I Clinical Trial	IL6
Psoriasis	ENSG00000136634	FALSE	unknown	2008-06-30	Phase I Clinical Trial	IL10
Psoriasis	ENSG00000136807	FALSE	Preclinical	2008-08-28	Unused	CDK9
Psoriasis	ENSG00000136869	FALSE	Preclinical	2006-08-17	Absent	TLR4
Psoriasis	ENSG00000137193	FALSE	Preclinical	NA	Absent	PIM1
Psoriasis	ENSG00000137462	FALSE	Preclinical	2006-08-17	Absent	TLR2
Psoriasis	ENSG00000137752	FALSE	Preclinical	1993-10-15	Phase II Clinical Trial	CASP1
Psoriasis	ENSG00000138448	FALSE	unknown	NA	Phase II Clinical Trial	ITGAV
Psoriasis	ENSG00000138684	FALSE	Preclinical	2010-06-21	Absent	IL21
Psoriasis	ENSG00000139219	FALSE	Preclinical	2016-11-24	Absent	COL2A1
Psoriasis	ENSG00000140443	FALSE	Preclinical	2001-07-23	Unused	IGF1R
Psoriasis	ENSG00000140538	FALSE	Phase II Clinical Trial	2005-12-13	Phase II Clinical Trial	NTRK3
Psoriasis	ENSG00000141510	FALSE	Preclinical	1996-09-15	Unused	TP53
Psoriasis	ENSG00000141655	FALSE	Preclinical	2017-04-18	Absent	TNFRSF11A
Psoriasis	ENSG00000142677	FALSE	Phase I Clinical Trial	2004-09-14	Unused	IL22RA1
Psoriasis	ENSG00000143171	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRG
Psoriasis	ENSG00000143365	FALSE	Phase II Clinical Trial	2010-01-07	Preclinical	RORC
Psoriasis	ENSG00000143387	FALSE	Preclinical	2009-01-20	Preclinical	CTSK
Psoriasis	ENSG00000146648	FALSE	Phase II Clinical Trial	1992-03-15	Unused	EGFR
Psoriasis	ENSG00000148053	FALSE	Phase II Clinical Trial	2005-12-13	Phase II Clinical Trial	NTRK2
Psoriasis	ENSG00000149021	FALSE	Preclinical	2009-07-17	Unused	SCGB1A1
Psoriasis	ENSG00000150782	FALSE	Phase II Clinical Trial	1999-05-04	Phase II Clinical Trial	IL18
Psoriasis	ENSG00000151694	FALSE	Preclinical	2012-02-03	Preclinical	ADAM17
Psoriasis	ENSG00000153563	FALSE	Preclinical	2000-11-15	Unused	CD8A
Psoriasis	ENSG00000154229	FALSE	Phase II Clinical Trial	1992-03-15	Phase II Clinical Trial	PRKCA
Psoriasis	ENSG00000157404	FALSE	unknown	2001-04-03	Unused	KIT
Psoriasis	ENSG00000157764	FALSE	unknown	2001-04-03	Unused	BRAF
Psoriasis	ENSG00000160223	FALSE	unknown	2007-03-13	Phase I Clinical Trial	ICOSLG
Psoriasis	ENSG00000160255	FALSE	Preclinical	1994-06-15	Unused	ITGB2
Psoriasis	ENSG00000160712	TRUE	Approved	2004-02-24	Approved	IL6R
Psoriasis	ENSG00000160716	FALSE	Preclinical	2010-10-07	Absent	CHRNB2
Psoriasis	ENSG00000160791	FALSE	Phase II Clinical Trial	2004-11-23	Unused	CCR5
Psoriasis	ENSG00000160801	FALSE	Phase II Clinical Trial	1997-05-15	Unused	PTH1R
Psoriasis	ENSG00000160951	FALSE	unknown	1996-10-15	Unused	PTGER1
Psoriasis	ENSG00000161905	FALSE	Preclinical	NA	Unused	ALOX15
Psoriasis	ENSG00000162302	FALSE	Preclinical	2014-08-25	Absent	RPS6KA4
Psoriasis	ENSG00000162434	FALSE	Phase III Clinical Trial	2003-06-25	Phase III Clinical Trial	JAK1
Psoriasis	ENSG00000162594	FALSE	Preclinical	2010-07-09	Unused	IL23R
Psoriasis	ENSG00000162891	FALSE	Preclinical	2001-01-17	Unused	IL20
Psoriasis	ENSG00000163131	FALSE	Phase II Clinical Trial	1998-12-15	Unused	CTSS
Psoriasis	ENSG00000163235	FALSE	Preclinical	1992-03-15	Unused	TGFA
Psoriasis	ENSG00000163464	FALSE	Phase I Clinical Trial	1991-09-15	Unused	CXCR1
Psoriasis	ENSG00000163485	FALSE	Preclinical	2016-06-03	Absent	ADORA1
Psoriasis	ENSG00000163599	FALSE	Preclinical	2008-01-30	Preclinical	CTLA4
Psoriasis	ENSG00000163606	FALSE	Preclinical	2015-10-16	Absent	CD200R1
Psoriasis	ENSG00000163823	FALSE	Preclinical	2001-08-11	Unused	CCR1
Psoriasis	ENSG00000163932	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCD
Psoriasis	ENSG00000164136	FALSE	Preclinical	1999-05-26	Unused	IL15
Psoriasis	ENSG00000164400	FALSE	unknown	2002-04-15	Unused	CSF2
Psoriasis	ENSG00000164733	FALSE	Preclinical	2009-01-20	Preclinical	CTSB
Psoriasis	ENSG00000165025	FALSE	Preclinical	2006-07-25	Unused	SYK
Psoriasis	ENSG00000166333	FALSE	unknown	2010-06-08	Absent	ILK
Psoriasis	ENSG00000166501	FALSE	Phase II Clinical Trial	1995-09-15	Unused	PRKCB
Psoriasis	ENSG00000166603	FALSE	Preclinical	2004-11-02	Preclinical	MC4R
Psoriasis	ENSG00000166710	FALSE	Preclinical	2000-11-08	Unused	B2M
Psoriasis	ENSG00000166825	FALSE	Phase II Clinical Trial	2007-09-25	Unused	ANPEP
Psoriasis	ENSG00000167325	FALSE	Phase I Clinical Trial	1999-06-02	Unused	RRM1
Psoriasis	ENSG00000167658	FALSE	Phase II Clinical Trial	2000-03-30	Unused	EEF2
Psoriasis	ENSG00000168036	FALSE	Phase II Clinical Trial	2015-02-04	Absent	CTNNB1
Psoriasis	ENSG00000168522	FALSE	Preclinical	1997-06-15	Unused	FNTA
Psoriasis	ENSG00000168610	FALSE	Preclinical	2005-04-25	Absent	STAT3
Psoriasis	ENSG00000168811	FALSE	Phase III Clinical Trial	1997-06-15	Phase III Clinical Trial	IL12A
Psoriasis	ENSG00000169032	FALSE	unknown	2007-08-10	Phase II Clinical Trial	MAP2K1
Psoriasis	ENSG00000169047	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IRS1
Psoriasis	ENSG00000169245	FALSE	unknown	2008-01-14	Absent	CXCL10
Psoriasis	ENSG00000169403	FALSE	unknown	1992-07-15	Unused	PTAFR
Psoriasis	ENSG00000169429	FALSE	Approved	1996-09-15	Unused	CXCL8
Psoriasis	ENSG00000169432	FALSE	Preclinical	1992-05-15	Unused	SCN9A
Psoriasis	ENSG00000170312	FALSE	Preclinical	2004-08-16	Unused	CDK1
Psoriasis	ENSG00000170989	FALSE	Phase II Clinical Trial	2005-09-29	Phase II Clinical Trial	S1PR1
Psoriasis	ENSG00000171049	FALSE	Preclinical	2009-08-07	Preclinical	FPR2
Psoriasis	ENSG00000171132	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCE
Psoriasis	ENSG00000171408	FALSE	Preclinical	2004-07-06	Unused	PDE7B
Psoriasis	ENSG00000171552	FALSE	Preclinical	2003-06-02	Unused	BCL2L1
Psoriasis	ENSG00000171608	FALSE	Phase I Clinical Trial	2009-07-15	Phase I Clinical Trial	PIK3CD
Psoriasis	ENSG00000171848	FALSE	Phase I Clinical Trial	1999-06-02	Unused	RRM2
Psoriasis	ENSG00000172236	FALSE	Preclinical	1998-11-15	Unused	TPSAB1
Psoriasis	ENSG00000172819	TRUE	Approved	1991-02-15	Approved	RARG
Psoriasis	ENSG00000172936	FALSE	Preclinical	2000-03-01	Unused	MYD88
Psoriasis	ENSG00000173198	FALSE	Preclinical	1994-07-15	Unused	CYSLTR1
Psoriasis	ENSG00000174080	FALSE	Preclinical	2009-01-20	Preclinical	CTSF
Psoriasis	ENSG00000174175	FALSE	Phase I Clinical Trial	1994-02-15	Phase II Clinical Trial	SELP
Psoriasis	ENSG00000174600	FALSE	unknown	2010-04-08	Unused	CMKLR1
Psoriasis	ENSG00000175104	FALSE	Preclinical	2000-03-01	Unused	TRAF6
Psoriasis	ENSG00000175344	FALSE	Preclinical	2010-10-07	Absent	CHRNA7
Psoriasis	ENSG00000176136	FALSE	Preclinical	2004-11-02	Preclinical	MC5R
Psoriasis	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Psoriasis	ENSG00000177272	FALSE	Phase I Clinical Trial	2008-04-16	Unused	KCNA3
Psoriasis	ENSG00000177606	FALSE	Preclinical	1997-11-15	Unused	JUN
Psoriasis	ENSG00000177663	TRUE	Approved	2008-03-04	Phase III Clinical Trial	IL17RA
Psoriasis	ENSG00000178562	FALSE	Phase II Clinical Trial	2000-03-15	Unused	CD28
Psoriasis	ENSG00000178573	FALSE	Preclinical	1996-09-15	Unused	MAF
Psoriasis	ENSG00000179776	FALSE	Preclinical	2000-12-11	Unused	CDH5
Psoriasis	ENSG00000180739	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR5
Psoriasis	ENSG00000180871	FALSE	Phase I Clinical Trial	1991-09-15	Unused	CXCR2
Psoriasis	ENSG00000182782	FALSE	Preclinical	NA	Unused	HCAR2
Psoriasis	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Psoriasis	ENSG00000184216	FALSE	Preclinical	2000-03-01	Unused	IRAK1
Psoriasis	ENSG00000184588	TRUE	Approved	1999-01-08	Phase III Clinical Trial	PDE4B
Psoriasis	ENSG00000185532	FALSE	Phase II Clinical Trial	2005-12-13	Phase II Clinical Trial	PRKG1
Psoriasis	ENSG00000186350	FALSE	Phase II Clinical Trial	1992-09-15	Unused	RXRA
Psoriasis	ENSG00000186810	FALSE	Phase II Clinical Trial	NA	Unused	CXCR3
Psoriasis	ENSG00000186818	FALSE	Preclinical	2004-10-20	Unused	LILRB4
Psoriasis	ENSG00000188257	FALSE	Preclinical	1994-08-15	Unused	PLA2G2A
Psoriasis	ENSG00000188389	FALSE	Phase I Clinical Trial	2016-01-22	Absent	PDCD1
Psoriasis	ENSG00000188404	FALSE	Phase I Clinical Trial	1993-12-15	Phase II Clinical Trial	SELL
Psoriasis	ENSG00000189403	FALSE	Phase II Clinical Trial	2005-12-13	Phase II Clinical Trial	HMGB1
Psoriasis	ENSG00000196262	TRUE	Approved	1994-08-15	Approved	PPIA
Psoriasis	ENSG00000196591	FALSE	Preclinical	2007-12-18	Unused	HDAC2
Psoriasis	ENSG00000196639	FALSE	Approved	NA	Unused	HRH1
Psoriasis	ENSG00000196664	FALSE	Phase II Clinical Trial	2006-07-28	Phase II Clinical Trial	TLR7
Psoriasis	ENSG00000196689	FALSE	Preclinical	2005-01-31	Preclinical	TRPV1
Psoriasis	ENSG00000197122	FALSE	Phase I Clinical Trial	2007-04-25	Absent	SRC
Psoriasis	ENSG00000197249	FALSE	Phase I Clinical Trial	2008-03-11	Unused	SERPINA1
Psoriasis	ENSG00000197405	FALSE	Preclinical	2003-06-24	Unused	C5AR1
Psoriasis	ENSG00000197561	FALSE	Preclinical	1995-02-15	Unused	ELANE
Psoriasis	ENSG00000197632	FALSE	Phase II Clinical Trial	NA	Unused	SERPINB2
Psoriasis	ENSG00000197635	FALSE	Phase II Clinical Trial	1999-06-10	Unused	DPP4
Psoriasis	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
Psoriasis	ENSG00000198355	FALSE	Preclinical	NA	Absent	PIM3
Psoriasis	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	NTRK1
Psoriasis	ENSG00000198793	FALSE	Preclinical	2003-07-23	Unused	MTOR
Psoriasis	ENSG00000198805	FALSE	Phase III Clinical Trial	1989-07-15	Phase II Clinical Trial	PNP
Psoriasis	ENSG00000198851	FALSE	Phase II Clinical Trial	2002-11-07	Phase II Clinical Trial	CD3E
Psoriasis	ENSG00000204671	FALSE	Preclinical	2004-07-20	Unused	IL31
Psoriasis	ENSG00000205268	FALSE	Phase I Clinical Trial	2004-07-06	Unused	PDE7A
Psoriasis	ENSG00000205542	FALSE	unknown	2007-07-16	Unused	TMSB4X
Psoriasis	ENSG00000213903	TRUE	Approved	1993-01-15	Approved	LTB4R
Psoriasis	ENSG00000213949	FALSE	Preclinical	2002-11-29	Preclinical	ITGA1
Psoriasis	ENSG00000228716	TRUE	Approved	1990-05-15	Approved	DHFR
Psoriasis	ENSG00000239732	FALSE	Phase II Clinical Trial	1993-07-15	Phase II Clinical Trial	TLR9
Psoriasis	ENSG00000240972	FALSE	Preclinical	2012-06-15	Absent	MIF
Psoriasis	ENSG00000258839	FALSE	Preclinical	2001-01-15	Unused	MC1R
Psoriasis	ENSG00000259207	FALSE	unknown	NA	Phase II Clinical Trial	ITGB3
Psoriasis	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Psoriasis	ENSG00000271503	FALSE	Preclinical	2009-08-07	Preclinical	CCL5
Psoriasis	ENSG00000282608	FALSE	Phase III Clinical Trial	2001-07-24	Phase III Clinical Trial	ADORA3
Psychotic Disorders	ENSG00000011677	TRUE	Approved	2004-10-07	Approved	GABRA3
Psychotic Disorders	ENSG00000022355	TRUE	Approved	NA	Approved	GABRA1
Psychotic Disorders	ENSG00000059377	FALSE	unknown	NA	Unused	TBXAS1
Psychotic Disorders	ENSG00000060491	FALSE	unknown	NA	Unused	OGFR
Psychotic Disorders	ENSG00000069535	FALSE	unknown	NA	Unused	MAOB
Psychotic Disorders	ENSG00000069696	TRUE	Approved	1989-12-15	Approved	DRD4
Psychotic Disorders	ENSG00000075043	FALSE	Preclinical	2001-06-19	Absent	KCNQ2
Psychotic Disorders	ENSG00000075073	FALSE	Preclinical	2006-06-16	Unused	TACR2
Psychotic Disorders	ENSG00000082175	FALSE	unknown	2009-04-23	Absent	PGR
Psychotic Disorders	ENSG00000082701	FALSE	Preclinical	2004-08-16	Unused	GSK3B
Psychotic Disorders	ENSG00000100300	FALSE	Preclinical	2012-08-22	Preclinical	TSPO
Psychotic Disorders	ENSG00000101180	FALSE	Preclinical	2003-09-11	Unused	HRH3
Psychotic Disorders	ENSG00000102468	TRUE	Approved	1989-12-15	Approved	HTR2A
Psychotic Disorders	ENSG00000103546	FALSE	Phase II Clinical Trial	2008-05-29	Unused	SLC6A2
Psychotic Disorders	ENSG00000106688	FALSE	Preclinical	1999-06-02	Unused	SLC1A1
Psychotic Disorders	ENSG00000108576	FALSE	Phase II Clinical Trial	1992-12-15	Unused	SLC6A4
Psychotic Disorders	ENSG00000109163	FALSE	unknown	NA	Unused	GNRHR
Psychotic Disorders	ENSG00000110148	FALSE	Preclinical	1994-11-15	Unused	CCKBR
Psychotic Disorders	ENSG00000110436	FALSE	Preclinical	1999-06-02	Unused	SLC1A2
Psychotic Disorders	ENSG00000110887	FALSE	Preclinical	2007-06-15	Unused	DAO
Psychotic Disorders	ENSG00000112541	FALSE	Phase I Clinical Trial	2011-03-30	Unused	PDE10A
Psychotic Disorders	ENSG00000113580	FALSE	unknown	2002-02-05	Phase III Clinical Trial	NR3C1
Psychotic Disorders	ENSG00000115353	FALSE	Preclinical	1991-04-15	Unused	TACR1
Psychotic Disorders	ENSG00000117013	FALSE	Preclinical	2001-06-19	Absent	KCNQ4
Psychotic Disorders	ENSG00000118432	FALSE	Preclinical	2002-01-18	Unused	CNR1
Psychotic Disorders	ENSG00000120907	TRUE	Approved	2007-11-05	Approved	ADRA1A
Psychotic Disorders	ENSG00000123213	FALSE	Preclinical	1998-06-15	Unused	NLN
Psychotic Disorders	ENSG00000125384	FALSE	Preclinical	NA	Unused	PTGER2
Psychotic Disorders	ENSG00000126010	FALSE	Preclinical	1997-11-15	Unused	GRPR
Psychotic Disorders	ENSG00000128271	FALSE	unknown	1995-06-15	Absent	ADORA2A
Psychotic Disorders	ENSG00000129167	FALSE	Phase I Clinical Trial	1994-11-15	Unused	TPH1
Psychotic Disorders	ENSG00000130779	FALSE	Preclinical	NA	Unused	CLIP1
Psychotic Disorders	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Psychotic Disorders	ENSG00000135312	FALSE	Preclinical	1991-10-15	Unused	HTR1B
Psychotic Disorders	ENSG00000135577	FALSE	Preclinical	1997-11-15	Unused	NMBR
Psychotic Disorders	ENSG00000141551	FALSE	Preclinical	2011-09-08	Unused	CSNK1D
Psychotic Disorders	ENSG00000142319	FALSE	Preclinical	NA	Unused	SLC6A3
Psychotic Disorders	ENSG00000145936	FALSE	Preclinical	1992-04-15	Unused	KCNMB1
Psychotic Disorders	ENSG00000147246	TRUE	Approved	1989-12-15	Approved	HTR2C
Psychotic Disorders	ENSG00000147955	FALSE	Phase II Clinical Trial	1990-04-15	Unused	SIGMAR1
Psychotic Disorders	ENSG00000148408	FALSE	Preclinical	1992-04-15	Unused	CACNA1B
Psychotic Disorders	ENSG00000148680	TRUE	Approved	1996-01-15	Unused	HTR7
Psychotic Disorders	ENSG00000149295	TRUE	Approved	1989-07-15	Approved	DRD2
Psychotic Disorders	ENSG00000151577	TRUE	Approved	1989-12-15	Approved	DRD3
Psychotic Disorders	ENSG00000151834	TRUE	Approved	NA	Approved	GABRA2
Psychotic Disorders	ENSG00000155511	FALSE	Preclinical	1999-06-02	Unused	GRIA1
Psychotic Disorders	ENSG00000156113	FALSE	Preclinical	1992-04-15	Unused	KCNMA1
Psychotic Disorders	ENSG00000157103	FALSE	Preclinical	1996-11-15	Unused	SLC6A1
Psychotic Disorders	ENSG00000157219	FALSE	Preclinical	2006-11-24	Unused	HTR5A
Psychotic Disorders	ENSG00000158748	TRUE	Approved	2006-11-24	Approved	HTR6
Psychotic Disorders	ENSG00000163394	FALSE	unknown	1993-01-15	Unused	CCKAR
Psychotic Disorders	ENSG00000164082	FALSE	Phase I Clinical Trial	1996-10-15	Unused	GRM2
Psychotic Disorders	ENSG00000164270	FALSE	unknown	1995-03-15	Unused	HTR4
Psychotic Disorders	ENSG00000166736	TRUE	Approved	1990-10-15	Approved	HTR3A
Psychotic Disorders	ENSG00000168539	TRUE	Approved	2002-08-21	Approved	CHRM1
Psychotic Disorders	ENSG00000168959	FALSE	Preclinical	2008-09-25	Unused	GRM5
Psychotic Disorders	ENSG00000169676	FALSE	Preclinical	1990-07-15	Unused	DRD5
Psychotic Disorders	ENSG00000169836	FALSE	Preclinical	2011-04-08	Unused	TACR3
Psychotic Disorders	ENSG00000170214	FALSE	Preclinical	1990-06-15	Unused	ADRA1B
Psychotic Disorders	ENSG00000175344	FALSE	Preclinical	1996-06-15	Unused	CHRNA7
Psychotic Disorders	ENSG00000176884	FALSE	Preclinical	1996-07-15	Unused	GRIN1
Psychotic Disorders	ENSG00000178394	TRUE	Approved	1989-07-15	Approved	HTR1A
Psychotic Disorders	ENSG00000179546	TRUE	Approved	1992-10-15	Approved	HTR1D
Psychotic Disorders	ENSG00000180720	TRUE	Approved	1997-10-15	Approved	CHRM4
Psychotic Disorders	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Psychotic Disorders	ENSG00000184156	FALSE	Preclinical	2001-06-19	Absent	KCNQ3
Psychotic Disorders	ENSG00000184845	TRUE	Approved	1989-07-15	Approved	DRD1
Psychotic Disorders	ENSG00000185760	FALSE	Preclinical	2001-06-19	Absent	KCNQ5
Psychotic Disorders	ENSG00000186297	TRUE	Approved	NA	Approved	GABRA5
Psychotic Disorders	ENSG00000196218	FALSE	Preclinical	NA	Absent	RYR1
Psychotic Disorders	ENSG00000196639	TRUE	Approved	NA	Approved	HRH1
Psychotic Disorders	ENSG00000198822	FALSE	Phase I Clinical Trial	1996-10-15	Unused	GRM3
Psychotic Disorders	ENSG00000203737	FALSE	Preclinical	2014-04-09	Absent	GPR52
Psychotic Disorders	ENSG00000213923	FALSE	Preclinical	2011-09-08	Unused	CSNK1E
Pterygium	ENSG00000196611	FALSE	unknown	NA	Unused	MMP1
Puberty, Delayed	ENSG00000169083	FALSE	Preclinical	2013-09-19	Absent	AR
Puberty, Precocious	ENSG00000109163	TRUE	Approved	1995-07-15	Approved	GNRHR
Puberty, Precocious	ENSG00000137869	FALSE	Phase II Clinical Trial	1991-02-15	Unused	CYP19A1
Puberty, Precocious	ENSG00000147437	FALSE	Preclinical	2015-10-19	Absent	GNRH1
Pulmonary Alveolar Proteinosis	ENSG00000198223	FALSE	Phase III Clinical Trial	NA	Absent	CSF2RA
Pulmonary Disease, Chronic Obstructive	ENSG00000001626	FALSE	Phase II Clinical Trial	2013-04-22	Absent	CFTR
Pulmonary Disease, Chronic Obstructive	ENSG00000005381	FALSE	Preclinical	2005-01-28	Unused	MPO
Pulmonary Disease, Chronic Obstructive	ENSG00000007171	FALSE	Phase II Clinical Trial	1999-09-22	Unused	NOS2
Pulmonary Disease, Chronic Obstructive	ENSG00000007908	FALSE	Phase I Clinical Trial	1994-02-15	Phase II Clinical Trial	SELE
Pulmonary Disease, Chronic Obstructive	ENSG00000010810	FALSE	Preclinical	NA	Absent	FYN
Pulmonary Disease, Chronic Obstructive	ENSG00000012779	TRUE	Approved	1994-01-15	Approved	ALOX5
Pulmonary Disease, Chronic Obstructive	ENSG00000016490	FALSE	Preclinical	2001-04-30	Unused	CLCA1
Pulmonary Disease, Chronic Obstructive	ENSG00000043591	FALSE	Preclinical	2004-07-26	Preclinical	ADRB1
Pulmonary Disease, Chronic Obstructive	ENSG00000065989	TRUE	Approved	1992-06-15	Approved	PDE4A
Pulmonary Disease, Chronic Obstructive	ENSG00000067900	FALSE	Preclinical	2007-11-26	Unused	ROCK1
Pulmonary Disease, Chronic Obstructive	ENSG00000068078	FALSE	Preclinical	NA	Absent	FGFR3
Pulmonary Disease, Chronic Obstructive	ENSG00000069431	FALSE	unknown	1991-01-15	Unused	ABCC9
Pulmonary Disease, Chronic Obstructive	ENSG00000072694	FALSE	unknown	2006-07-31	Preclinical	FCGR2B
Pulmonary Disease, Chronic Obstructive	ENSG00000075073	FALSE	Phase II Clinical Trial	1998-10-15	Unused	TACR2
Pulmonary Disease, Chronic Obstructive	ENSG00000077238	FALSE	Phase I Clinical Trial	2006-11-17	Unused	IL4R
Pulmonary Disease, Chronic Obstructive	ENSG00000077782	FALSE	Preclinical	2009-03-03	Unused	FGFR1
Pulmonary Disease, Chronic Obstructive	ENSG00000078401	FALSE	Preclinical	2005-06-08	Unused	EDN1
Pulmonary Disease, Chronic Obstructive	ENSG00000081181	FALSE	Preclinical	2012-09-18	Preclinical	ARG2
Pulmonary Disease, Chronic Obstructive	ENSG00000083457	FALSE	Preclinical	2007-05-22	Unused	ITGAE
Pulmonary Disease, Chronic Obstructive	ENSG00000089041	FALSE	Phase II Clinical Trial	2001-12-04	Unused	P2RX7
Pulmonary Disease, Chronic Obstructive	ENSG00000091181	FALSE	Phase III Clinical Trial	2003-08-27	Phase II Clinical Trial	IL5RA
Pulmonary Disease, Chronic Obstructive	ENSG00000091831	FALSE	Preclinical	2001-05-09	Unused	ESR1
Pulmonary Disease, Chronic Obstructive	ENSG00000092009	FALSE	Preclinical	2003-08-14	Unused	CMA1
Pulmonary Disease, Chronic Obstructive	ENSG00000096717	FALSE	Phase I Clinical Trial	2008-10-21	Phase I Clinical Trial	SIRT1
Pulmonary Disease, Chronic Obstructive	ENSG00000100448	FALSE	Preclinical	1991-07-15	Unused	CTSG
Pulmonary Disease, Chronic Obstructive	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Pulmonary Disease, Chronic Obstructive	ENSG00000100985	FALSE	Phase II Clinical Trial	2008-11-03	Absent	MMP9
Pulmonary Disease, Chronic Obstructive	ENSG00000102265	FALSE	Preclinical	2003-08-14	Unused	TIMP1
Pulmonary Disease, Chronic Obstructive	ENSG00000102539	FALSE	Preclinical	2008-06-18	Absent	MLNR
Pulmonary Disease, Chronic Obstructive	ENSG00000104365	FALSE	Phase II Clinical Trial	2004-02-12	Unused	IKBKB
Pulmonary Disease, Chronic Obstructive	ENSG00000104774	FALSE	Preclinical	2017-03-22	Absent	MAN2B1
Pulmonary Disease, Chronic Obstructive	ENSG00000105639	FALSE	Preclinical	2009-06-10	Unused	JAK3
Pulmonary Disease, Chronic Obstructive	ENSG00000105650	TRUE	Approved	1992-06-15	Approved	PDE4C
Pulmonary Disease, Chronic Obstructive	ENSG00000105851	FALSE	Phase I Clinical Trial	2009-07-15	Phase I Clinical Trial	PIK3CG
Pulmonary Disease, Chronic Obstructive	ENSG00000106018	FALSE	Phase I Clinical Trial	2007-03-13	Unused	VIPR2
Pulmonary Disease, Chronic Obstructive	ENSG00000106366	FALSE	Phase II Clinical Trial	2006-08-29	Unused	SERPINE1
Pulmonary Disease, Chronic Obstructive	ENSG00000107485	FALSE	Phase II Clinical Trial	2011-11-01	Absent	GATA3
Pulmonary Disease, Chronic Obstructive	ENSG00000109320	FALSE	unknown	2001-07-18	Preclinical	NFKB1
Pulmonary Disease, Chronic Obstructive	ENSG00000109861	FALSE	Phase I Clinical Trial	2014-12-02	Absent	CTSC
Pulmonary Disease, Chronic Obstructive	ENSG00000110429	FALSE	Preclinical	2017-09-27	Absent	FBXO3
Pulmonary Disease, Chronic Obstructive	ENSG00000111319	FALSE	Preclinical	1990-02-15	Unused	SCNN1A
Pulmonary Disease, Chronic Obstructive	ENSG00000111424	FALSE	Preclinical	2006-10-23	Unused	VDR
Pulmonary Disease, Chronic Obstructive	ENSG00000112062	FALSE	Phase II Clinical Trial	2001-09-11	Phase II Clinical Trial	MAPK14
Pulmonary Disease, Chronic Obstructive	ENSG00000112096	FALSE	unknown	1999-10-20	Unused	SOD2
Pulmonary Disease, Chronic Obstructive	ENSG00000112115	FALSE	Phase II Clinical Trial	2006-02-01	Unused	IL17A
Pulmonary Disease, Chronic Obstructive	ENSG00000113448	TRUE	Approved	1992-06-15	Approved	PDE4D
Pulmonary Disease, Chronic Obstructive	ENSG00000113520	FALSE	Preclinical	2014-10-29	Absent	IL4
Pulmonary Disease, Chronic Obstructive	ENSG00000113525	FALSE	Pre-registration	1997-05-15	Absent	IL5
Pulmonary Disease, Chronic Obstructive	ENSG00000113580	TRUE	Approved	1991-09-15	Approved	NR3C1
Pulmonary Disease, Chronic Obstructive	ENSG00000113721	FALSE	Preclinical	NA	Absent	PDGFRB
Pulmonary Disease, Chronic Obstructive	ENSG00000114812	FALSE	Phase I Clinical Trial	2003-12-09	Unused	VIPR1
Pulmonary Disease, Chronic Obstructive	ENSG00000114859	FALSE	unknown	2002-09-25	Preclinical	CLCN2
Pulmonary Disease, Chronic Obstructive	ENSG00000115353	FALSE	Phase II Clinical Trial	1998-07-15	Unused	TACR1
Pulmonary Disease, Chronic Obstructive	ENSG00000115590	FALSE	Phase I Clinical Trial	2011-07-28	Phase II Clinical Trial	IL1R2
Pulmonary Disease, Chronic Obstructive	ENSG00000115594	FALSE	Phase I Clinical Trial	2011-07-28	Phase II Clinical Trial	IL1R1
Pulmonary Disease, Chronic Obstructive	ENSG00000115602	FALSE	Phase I Clinical Trial	2013-08-26	Absent	IL1RL1
Pulmonary Disease, Chronic Obstructive	ENSG00000115604	FALSE	Preclinical	2009-07-14	Unused	IL18R1
Pulmonary Disease, Chronic Obstructive	ENSG00000116044	FALSE	Preclinical	2009-02-23	Unused	NFE2L2
Pulmonary Disease, Chronic Obstructive	ENSG00000118520	FALSE	Preclinical	2012-09-18	Preclinical	ARG1
Pulmonary Disease, Chronic Obstructive	ENSG00000120915	FALSE	Phase I Clinical Trial	2012-12-15	Preclinical	EPHX2
Pulmonary Disease, Chronic Obstructive	ENSG00000121361	FALSE	unknown	1991-01-15	Unused	KCNJ8
Pulmonary Disease, Chronic Obstructive	ENSG00000121764	FALSE	Phase I Clinical Trial	2007-12-13	Phase I Clinical Trial	HCRTR1
Pulmonary Disease, Chronic Obstructive	ENSG00000121807	FALSE	Phase II Clinical Trial	2007-08-29	Phase II Clinical Trial	CCR2
Pulmonary Disease, Chronic Obstructive	ENSG00000123496	FALSE	Preclinical	2006-11-17	Unused	IL13RA2
Pulmonary Disease, Chronic Obstructive	ENSG00000124107	FALSE	Preclinical	2003-08-14	Unused	SLPI
Pulmonary Disease, Chronic Obstructive	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Pulmonary Disease, Chronic Obstructive	ENSG00000125730	FALSE	Phase I Clinical Trial	2007-03-26	Preclinical	C3
Pulmonary Disease, Chronic Obstructive	ENSG00000126934	FALSE	unknown	2006-05-01	Preclinical	MAP2K2
Pulmonary Disease, Chronic Obstructive	ENSG00000128271	TRUE	Approved	1998-08-15	Approved	ADORA2A
Pulmonary Disease, Chronic Obstructive	ENSG00000131471	FALSE	Phase I Clinical Trial	2006-06-01	Phase I Clinical Trial	AOC3
Pulmonary Disease, Chronic Obstructive	ENSG00000131724	FALSE	Preclinical	2006-11-17	Unused	IL13RA1
Pulmonary Disease, Chronic Obstructive	ENSG00000132170	FALSE	Preclinical	2011-08-05	Unused	PPARG
Pulmonary Disease, Chronic Obstructive	ENSG00000132703	FALSE	Preclinical	2009-07-24	Absent	APCS
Pulmonary Disease, Chronic Obstructive	ENSG00000132965	FALSE	unknown	2007-11-03	Unused	ALOX5AP
Pulmonary Disease, Chronic Obstructive	ENSG00000133019	TRUE	Approved	1994-08-15	Approved	CHRM3
Pulmonary Disease, Chronic Obstructive	ENSG00000134318	FALSE	Preclinical	2007-11-26	Unused	ROCK2
Pulmonary Disease, Chronic Obstructive	ENSG00000134489	FALSE	Phase II Clinical Trial	2009-11-09	Absent	HRH4
Pulmonary Disease, Chronic Obstructive	ENSG00000135914	FALSE	Preclinical	2003-05-30	Preclinical	HTR2B
Pulmonary Disease, Chronic Obstructive	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Pulmonary Disease, Chronic Obstructive	ENSG00000137033	FALSE	Phase I Clinical Trial	2017-04-03	Absent	IL33
Pulmonary Disease, Chronic Obstructive	ENSG00000137252	FALSE	Phase I Clinical Trial	2007-12-13	Phase I Clinical Trial	HCRTR2
Pulmonary Disease, Chronic Obstructive	ENSG00000138684	FALSE	Preclinical	2014-10-29	Absent	IL21
Pulmonary Disease, Chronic Obstructive	ENSG00000138735	FALSE	Phase II Clinical Trial	1994-12-15	Phase II Clinical Trial	PDE5A
Pulmonary Disease, Chronic Obstructive	ENSG00000138798	FALSE	Preclinical	2017-08-23	Absent	EGF
Pulmonary Disease, Chronic Obstructive	ENSG00000139610	FALSE	Phase III Clinical Trial	NA	Unused	CELA1
Pulmonary Disease, Chronic Obstructive	ENSG00000141736	FALSE	unknown	2006-06-05	Unused	ERBB2
Pulmonary Disease, Chronic Obstructive	ENSG00000143365	FALSE	Preclinical	2012-06-15	Absent	RORC
Pulmonary Disease, Chronic Obstructive	ENSG00000145839	FALSE	Preclinical	2014-10-29	Absent	IL9
Pulmonary Disease, Chronic Obstructive	ENSG00000146648	FALSE	unknown	2006-06-05	Unused	EGFR
Pulmonary Disease, Chronic Obstructive	ENSG00000149021	FALSE	Phase I Clinical Trial	1997-08-15	Unused	SCGB1A1
Pulmonary Disease, Chronic Obstructive	ENSG00000149295	FALSE	Preclinical	1994-03-15	Unused	DRD2
Pulmonary Disease, Chronic Obstructive	ENSG00000150782	FALSE	Phase I Clinical Trial	2011-03-26	Unused	IL18
Pulmonary Disease, Chronic Obstructive	ENSG00000151617	FALSE	unknown	1995-06-15	Unused	EDNRA
Pulmonary Disease, Chronic Obstructive	ENSG00000157404	FALSE	Preclinical	NA	Absent	KIT
Pulmonary Disease, Chronic Obstructive	ENSG00000158859	FALSE	Preclinical	2015-09-03	Absent	ADAMTS4
Pulmonary Disease, Chronic Obstructive	ENSG00000159110	FALSE	unknown	NA	Phase II Clinical Trial	IFNAR2
Pulmonary Disease, Chronic Obstructive	ENSG00000160013	FALSE	Phase I Clinical Trial	2015-10-05	Absent	PTGIR
Pulmonary Disease, Chronic Obstructive	ENSG00000160255	FALSE	Preclinical	2011-03-31	Unused	ITGB2
Pulmonary Disease, Chronic Obstructive	ENSG00000160791	FALSE	Phase I Clinical Trial	2007-12-31	Unused	CCR5
Pulmonary Disease, Chronic Obstructive	ENSG00000163106	FALSE	Phase I Clinical Trial	2014-08-23	Absent	HPGDS
Pulmonary Disease, Chronic Obstructive	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Pulmonary Disease, Chronic Obstructive	ENSG00000163464	FALSE	Phase I Clinical Trial	1998-08-15	Phase II Clinical Trial	CXCR1
Pulmonary Disease, Chronic Obstructive	ENSG00000163485	TRUE	Approved	2001-05-09	Approved	ADORA1
Pulmonary Disease, Chronic Obstructive	ENSG00000163737	FALSE	Preclinical	2009-12-01	Unused	PF4
Pulmonary Disease, Chronic Obstructive	ENSG00000163823	FALSE	Phase II Clinical Trial	2006-02-08	Unused	CCR1
Pulmonary Disease, Chronic Obstructive	ENSG00000164342	FALSE	Preclinical	2012-03-07	Absent	TLR3
Pulmonary Disease, Chronic Obstructive	ENSG00000164400	FALSE	unknown	2005-06-06	Absent	CSF2
Pulmonary Disease, Chronic Obstructive	ENSG00000165025	FALSE	Preclinical	1998-12-15	Unused	SYK
Pulmonary Disease, Chronic Obstructive	ENSG00000167642	FALSE	Phase II Clinical Trial	2005-12-10	Unused	SPINT2
Pulmonary Disease, Chronic Obstructive	ENSG00000167748	FALSE	Preclinical	2008-06-23	Preclinical	KLK1
Pulmonary Disease, Chronic Obstructive	ENSG00000168209	FALSE	Preclinical	2007-01-31	Unused	DDIT4
Pulmonary Disease, Chronic Obstructive	ENSG00000168229	FALSE	Phase I Clinical Trial	2008-08-20	Unused	PTGDR
Pulmonary Disease, Chronic Obstructive	ENSG00000168398	FALSE	unknown	2006-12-14	Unused	BDKRB2
Pulmonary Disease, Chronic Obstructive	ENSG00000168539	TRUE	Approved	2000-01-11	Approved	CHRM1
Pulmonary Disease, Chronic Obstructive	ENSG00000168918	FALSE	unknown	2009-10-12	Phase II Clinical Trial	INPP5D
Pulmonary Disease, Chronic Obstructive	ENSG00000169032	FALSE	unknown	2006-05-01	Preclinical	MAP2K1
Pulmonary Disease, Chronic Obstructive	ENSG00000169194	FALSE	unknown	2003-05-20	Unused	IL13
Pulmonary Disease, Chronic Obstructive	ENSG00000169252	TRUE	Approved	1992-03-15	Approved	ADRB2
Pulmonary Disease, Chronic Obstructive	ENSG00000169418	FALSE	Preclinical	1997-05-15	Unused	NPR1
Pulmonary Disease, Chronic Obstructive	ENSG00000169429	FALSE	unknown	1996-09-15	Phase I Clinical Trial	CXCL8
Pulmonary Disease, Chronic Obstructive	ENSG00000169836	FALSE	Phase II Clinical Trial	1996-03-15	Unused	TACR3
Pulmonary Disease, Chronic Obstructive	ENSG00000169896	FALSE	Preclinical	2011-03-31	Unused	ITGAM
Pulmonary Disease, Chronic Obstructive	ENSG00000170425	FALSE	Preclinical	2012-08-02	Preclinical	ADORA2B
Pulmonary Disease, Chronic Obstructive	ENSG00000171408	FALSE	Preclinical	2004-11-29	Preclinical	PDE7B
Pulmonary Disease, Chronic Obstructive	ENSG00000171608	FALSE	Phase II Clinical Trial	2009-07-15	Phase I Clinical Trial	PIK3CD
Pulmonary Disease, Chronic Obstructive	ENSG00000172236	FALSE	Preclinical	2003-08-14	Unused	TPSAB1
Pulmonary Disease, Chronic Obstructive	ENSG00000172572	FALSE	Phase II Clinical Trial	1999-08-11	Phase II Clinical Trial	PDE3A
Pulmonary Disease, Chronic Obstructive	ENSG00000172819	FALSE	Phase I Clinical Trial	2001-01-23	Unused	RARG
Pulmonary Disease, Chronic Obstructive	ENSG00000174175	FALSE	Phase I Clinical Trial	1994-02-15	Phase II Clinical Trial	SELP
Pulmonary Disease, Chronic Obstructive	ENSG00000180210	FALSE	Preclinical	2003-08-14	Unused	F2
Pulmonary Disease, Chronic Obstructive	ENSG00000180720	TRUE	Approved	2000-01-11	Approved	CHRM4
Pulmonary Disease, Chronic Obstructive	ENSG00000180871	FALSE	Phase II Clinical Trial	1998-08-15	Phase II Clinical Trial	CXCR2
Pulmonary Disease, Chronic Obstructive	ENSG00000181072	TRUE	Approved	2000-01-11	Approved	CHRM2
Pulmonary Disease, Chronic Obstructive	ENSG00000181104	FALSE	unknown	2006-10-20	Absent	F2R
Pulmonary Disease, Chronic Obstructive	ENSG00000183134	FALSE	Phase II Clinical Trial	2004-02-03	Phase I Clinical Trial	PTGDR2
Pulmonary Disease, Chronic Obstructive	ENSG00000183625	FALSE	unknown	2005-01-28	Unused	CCR3
Pulmonary Disease, Chronic Obstructive	ENSG00000183735	FALSE	Preclinical	2010-07-30	Absent	TBK1
Pulmonary Disease, Chronic Obstructive	ENSG00000184588	TRUE	Approved	1992-06-15	Approved	PDE4B
Pulmonary Disease, Chronic Obstructive	ENSG00000188404	FALSE	Phase I Clinical Trial	1994-02-15	Phase II Clinical Trial	SELL
Pulmonary Disease, Chronic Obstructive	ENSG00000196218	FALSE	Preclinical	2016-04-15	Absent	RYR1
Pulmonary Disease, Chronic Obstructive	ENSG00000196262	FALSE	Preclinical	2002-03-11	Unused	PPIA
Pulmonary Disease, Chronic Obstructive	ENSG00000196639	FALSE	Phase II Clinical Trial	2005-01-28	Phase II Clinical Trial	HRH1
Pulmonary Disease, Chronic Obstructive	ENSG00000196689	FALSE	Preclinical	2006-12-14	Preclinical	TRPV1
Pulmonary Disease, Chronic Obstructive	ENSG00000197249	FALSE	Phase I Clinical Trial	1990-06-15	Unused	SERPINA1
Pulmonary Disease, Chronic Obstructive	ENSG00000197405	FALSE	Phase I Clinical Trial	2007-08-09	Phase I Clinical Trial	C5AR1
Pulmonary Disease, Chronic Obstructive	ENSG00000197561	FALSE	Phase III Clinical Trial	1989-06-15	Unused	ELANE
Pulmonary Disease, Chronic Obstructive	ENSG00000197766	FALSE	Preclinical	2014-08-26	Absent	CFD
Pulmonary Disease, Chronic Obstructive	ENSG00000198223	FALSE	Preclinical	2006-11-27	Absent	CSF2RA
Pulmonary Disease, Chronic Obstructive	ENSG00000205542	FALSE	Preclinical	2007-07-16	Unused	TMSB4X
Pulmonary Disease, Chronic Obstructive	ENSG00000213316	FALSE	Preclinical	2008-08-27	Preclinical	LTC4S
Pulmonary Disease, Chronic Obstructive	ENSG00000213903	FALSE	Phase II Clinical Trial	1998-07-15	Unused	LTB4R
Pulmonary Disease, Chronic Obstructive	ENSG00000213918	FALSE	Phase III Clinical Trial	1990-07-15	Absent	DNASE1
Pulmonary Disease, Chronic Obstructive	ENSG00000239732	FALSE	Preclinical	2006-09-08	Preclinical	TLR9
Pulmonary Disease, Chronic Obstructive	ENSG00000254087	FALSE	Preclinical	NA	Absent	LYN
Pulmonary Disease, Chronic Obstructive	ENSG00000262406	FALSE	Phase II Clinical Trial	2000-10-19	Unused	MMP12
Pulmonary Disease, Chronic Obstructive	ENSG00000263528	FALSE	Preclinical	2010-07-30	Absent	IKBKE
Pulmonary Disease, Chronic Obstructive	ENSG00000271503	FALSE	Preclinical	2009-12-01	Unused	CCL5
Pulmonary Disease, Chronic Obstructive	ENSG00000277443	FALSE	Phase II Clinical Trial	NA	Unused	MARCKS
Pulmonary Disease, Chronic Obstructive	ENSG00000282608	FALSE	Preclinical	2002-11-11	Unused	ADORA3
Pulmonary Edema	ENSG00000067182	FALSE	Phase II Clinical Trial	2009-11-16	Phase II Clinical Trial	TNFRSF1A
Pulmonary Edema	ENSG00000111199	FALSE	Phase I Clinical Trial	2012-11-29	Preclinical	TRPV4
Pulmonary Edema	ENSG00000137672	FALSE	Preclinical	2015-05-27	Absent	TRPC6
Pulmonary Edema	ENSG00000164344	FALSE	Preclinical	2012-01-03	Absent	KLKB1
Pulmonary Embolism	ENSG00000057593	FALSE	unknown	1992-03-15	Unused	F7
Pulmonary Embolism	ENSG00000080618	FALSE	Phase II Clinical Trial	2013-05-16	Absent	CPB2
Pulmonary Embolism	ENSG00000095303	TRUE	Approved	1995-05-15	Approved	PTGS1
Pulmonary Embolism	ENSG00000101981	FALSE	Preclinical	2001-12-04	Unused	F9
Pulmonary Embolism	ENSG00000104368	TRUE	Approved	1989-07-15	Approved	PLAT
Pulmonary Embolism	ENSG00000115718	TRUE	Approved	NA	Absent	PROC
Pulmonary Embolism	ENSG00000117525	FALSE	unknown	1992-03-15	Unused	F3
Pulmonary Embolism	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Pulmonary Embolism	ENSG00000122194	TRUE	Approved	NA	Approved	PLG
Pulmonary Embolism	ENSG00000122861	TRUE	Approved	2010-06-09	Approved	PLAU
Pulmonary Embolism	ENSG00000126218	TRUE	Approved	1991-11-15	Approved	F10
Pulmonary Embolism	ENSG00000149131	FALSE	unknown	2012-09-27	Phase I Clinical Trial	SERPING1
Pulmonary Embolism	ENSG00000167711	FALSE	Phase I Clinical Trial	2013-11-28	Absent	SERPINF2
Pulmonary Embolism	ENSG00000180210	TRUE	Approved	1993-09-15	Approved	F2
Purpura Fulminans	ENSG00000005961	FALSE	unknown	2010-08-20	Absent	ITGA2B
Purpura Fulminans	ENSG00000115718	TRUE	Approved	NA	Approved	PROC
Purpura Fulminans	ENSG00000160013	FALSE	unknown	2010-08-20	Absent	PTGIR
Purpura Fulminans	ENSG00000259207	FALSE	unknown	2010-08-20	Absent	ITGB3
Purpura, Thrombocytopenic, Idiopathic	ENSG00000010671	FALSE	Phase II Clinical Trial	2012-11-06	Absent	BTK
Purpura, Thrombocytopenic, Idiopathic	ENSG00000072694	FALSE	unknown	2006-07-31	Phase II Clinical Trial	FCGR2B
Purpura, Thrombocytopenic, Idiopathic	ENSG00000101017	FALSE	Phase II Clinical Trial	2012-01-18	Absent	CD40
Purpura, Thrombocytopenic, Idiopathic	ENSG00000102245	FALSE	Phase II Clinical Trial	1994-06-15	Unused	CD40LG
Purpura, Thrombocytopenic, Idiopathic	ENSG00000102524	FALSE	Preclinical	2004-03-24	Preclinical	TNFSF13B
Purpura, Thrombocytopenic, Idiopathic	ENSG00000104870	FALSE	Phase II Clinical Trial	2011-11-19	Absent	FCGRT
Purpura, Thrombocytopenic, Idiopathic	ENSG00000117400	TRUE	Approved	1994-08-15	Approved	MPL
Purpura, Thrombocytopenic, Idiopathic	ENSG00000122025	FALSE	Pre-registration	2003-10-31	Unused	FLT3
Purpura, Thrombocytopenic, Idiopathic	ENSG00000150337	FALSE	unknown	1992-02-15	Unused	FCGR1A
Purpura, Thrombocytopenic, Idiopathic	ENSG00000156738	FALSE	Phase III Clinical Trial	1993-09-15	Phase II Clinical Trial	MS4A1
Purpura, Thrombocytopenic, Idiopathic	ENSG00000160712	FALSE	unknown	1998-08-15	Unused	IL6R
Purpura, Thrombocytopenic, Idiopathic	ENSG00000162747	FALSE	Preclinical	2006-07-31	Unused	FCGR3B
Purpura, Thrombocytopenic, Idiopathic	ENSG00000163485	FALSE	Preclinical	2016-06-03	Absent	ADORA1
Purpura, Thrombocytopenic, Idiopathic	ENSG00000163599	FALSE	unknown	1999-06-30	Unused	CTLA4
Purpura, Thrombocytopenic, Idiopathic	ENSG00000165025	FALSE	Pre-registration	2003-10-31	Phase I Clinical Trial	SYK
Purpura, Thrombocytopenic, Idiopathic	ENSG00000182326	FALSE	Phase I Clinical Trial	2012-05-21	Absent	C1S
Purpura, Thrombocytopenic, Idiopathic	ENSG00000187010	FALSE	unknown	2004-08-09	Phase II Clinical Trial	RHD
Purpura, Thrombocytopenic, Idiopathic	ENSG00000198223	FALSE	unknown	2004-03-23	Unused	CSF2RA
Purpura, Thrombocytopenic, Idiopathic	ENSG00000203747	FALSE	Phase I Clinical Trial	2001-10-24	Unused	FCGR3A
Purpura, Thrombocytopenic, Idiopathic	ENSG00000282608	FALSE	Preclinical	2016-06-03	Absent	ADORA3
Purpura, Thrombotic Thrombocytopenic	ENSG00000009724	FALSE	Phase II Clinical Trial	2008-01-15	Absent	MASP2
Purpura, Thrombotic Thrombocytopenic	ENSG00000110799	FALSE	Pre-registration	2003-07-09	Phase II Clinical Trial	VWF
Purpura, Thrombotic Thrombocytopenic	ENSG00000156738	FALSE	unknown	1993-09-15	Absent	MS4A1
Purpura, Thrombotic Thrombocytopenic	ENSG00000160323	FALSE	Phase III Clinical Trial	2007-10-18	Preclinical	ADAMTS13
Purpura, Thrombotic Thrombocytopenic	ENSG00000185245	FALSE	Preclinical	2009-10-08	Absent	GP1BA
Pyoderma Gangrenosum	ENSG00000115008	FALSE	Phase II Clinical Trial	2009-12-07	Absent	IL1A
Pyoderma Gangrenosum	ENSG00000125538	FALSE	Phase III Clinical Trial	2006-01-18	Absent	IL1B
Pyoderma Gangrenosum	ENSG00000125910	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR4
Pyoderma Gangrenosum	ENSG00000170989	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR1
Pyoderma Gangrenosum	ENSG00000180739	FALSE	Phase II Clinical Trial	2009-01-15	Absent	S1PR5
Pyruvate Metabolism, Inborn Errors	ENSG00000143627	FALSE	Phase II Clinical Trial	2009-07-14	Absent	PKLR
Rabies	ENSG00000121966	FALSE	unknown	2004-08-03	Unused	CXCR4
Rabies	ENSG00000160791	FALSE	unknown	2004-08-03	Unused	CCR5
Rabies	ENSG00000164342	FALSE	Phase II Clinical Trial	2015-03-24	Absent	TLR3
Rabies	ENSG00000197272	FALSE	unknown	2004-08-03	Unused	IL27
Rabies	ENSG00000239732	FALSE	Preclinical	2016-05-12	Absent	TLR9
Radiation Injuries	ENSG00000007171	FALSE	unknown	2001-05-09	Phase II Clinical Trial	NOS2
Radiation Injuries	ENSG00000012223	FALSE	unknown	NA	Preclinical	LTF
Radiation Injuries	ENSG00000017797	FALSE	Preclinical	2009-03-02	Unused	RALBP1
Radiation Injuries	ENSG00000065325	FALSE	Phase II Clinical Trial	1997-03-15	Phase II Clinical Trial	GLP2R
Radiation Injuries	ENSG00000085563	FALSE	Phase II Clinical Trial	1994-06-15	Unused	ABCB1
Radiation Injuries	ENSG00000087245	FALSE	unknown	2001-07-18	Unused	MMP2
Radiation Injuries	ENSG00000102539	FALSE	Preclinical	2004-08-20	Preclinical	MLNR
Radiation Injuries	ENSG00000103222	FALSE	Preclinical	1993-07-15	Unused	ABCC1
Radiation Injuries	ENSG00000105810	FALSE	Phase I Clinical Trial	2012-09-26	Absent	CDK6
Radiation Injuries	ENSG00000106128	FALSE	Phase I Clinical Trial	2015-07-27	Absent	GHRHR
Radiation Injuries	ENSG00000109320	FALSE	unknown	2001-07-18	Unused	NFKB1
Radiation Injuries	ENSG00000111424	FALSE	Preclinical	2012-05-17	Preclinical	VDR
Radiation Injuries	ENSG00000112115	FALSE	unknown	NA	Unused	IL17A
Radiation Injuries	ENSG00000113302	FALSE	Phase II Clinical Trial	2008-10-20	Phase I Clinical Trial	IL12B
Radiation Injuries	ENSG00000113580	FALSE	Phase I Clinical Trial	2001-09-28	Preclinical	NR3C1
Radiation Injuries	ENSG00000114812	FALSE	Preclinical	2007-05-04	Unused	VIPR1
Radiation Injuries	ENSG00000115232	FALSE	unknown	NA	Unused	ITGA4
Radiation Injuries	ENSG00000115263	FALSE	Preclinical	2017-02-03	Absent	GCG
Radiation Injuries	ENSG00000115353	FALSE	Preclinical	2001-07-18	Unused	TACR1
Radiation Injuries	ENSG00000115594	FALSE	unknown	NA	Unused	IL1R1
Radiation Injuries	ENSG00000116329	FALSE	unknown	2001-07-18	Unused	OPRD1
Radiation Injuries	ENSG00000119535	FALSE	Preclinical	2003-04-30	Unused	CSF3R
Radiation Injuries	ENSG00000121853	FALSE	Preclinical	2015-10-22	Absent	GHSR
Radiation Injuries	ENSG00000122025	FALSE	unknown	1996-01-15	Unused	FLT3
Radiation Injuries	ENSG00000130427	FALSE	Preclinical	2004-02-23	Unused	EPO
Radiation Injuries	ENSG00000135446	FALSE	Phase I Clinical Trial	2012-09-26	Absent	CDK4
Radiation Injuries	ENSG00000137070	FALSE	Preclinical	2016-09-12	Absent	IL11RA
Radiation Injuries	ENSG00000137462	FALSE	Phase II Clinical Trial	2007-01-30	Unused	TLR2
Radiation Injuries	ENSG00000137752	FALSE	unknown	NA	Unused	CASP1
Radiation Injuries	ENSG00000138448	FALSE	unknown	NA	Unused	ITGAV
Radiation Injuries	ENSG00000150782	FALSE	unknown	NA	Unused	IL18
Radiation Injuries	ENSG00000163823	FALSE	Preclinical	1990-06-15	Unused	CCR1
Radiation Injuries	ENSG00000168811	FALSE	Phase II Clinical Trial	2008-10-20	Phase I Clinical Trial	IL12A
Radiation Injuries	ENSG00000169919	FALSE	unknown	2001-07-18	Unused	GUSB
Radiation Injuries	ENSG00000170430	FALSE	Phase I Clinical Trial	2009-02-06	Phase I Clinical Trial	MGMT
Radiation Injuries	ENSG00000171862	FALSE	Preclinical	2004-02-09	Unused	PTEN
Radiation Injuries	ENSG00000172831	FALSE	Preclinical	2003-04-14	Unused	CES2
Radiation Injuries	ENSG00000172936	FALSE	unknown	2000-03-01	Unused	MYD88
Radiation Injuries	ENSG00000174130	FALSE	Phase II Clinical Trial	2007-01-30	Unused	TLR6
Radiation Injuries	ENSG00000175104	FALSE	unknown	2000-03-01	Unused	TRAF6
Radiation Injuries	ENSG00000178726	FALSE	unknown	1992-06-15	Preclinical	THBD
Radiation Injuries	ENSG00000179921	FALSE	Preclinical	2011-09-03	Absent	GPBAR1
Radiation Injuries	ENSG00000184216	FALSE	unknown	2000-03-01	Unused	IRAK1
Radiation Injuries	ENSG00000187266	FALSE	Preclinical	2001-01-23	Unused	EPOR
Radiation Injuries	ENSG00000187554	FALSE	Phase I Clinical Trial	2006-08-01	Phase I Clinical Trial	TLR5
Radiation Injuries	ENSG00000198223	FALSE	Approved	1990-03-15	Approved	CSF2RA
Radiation Injuries	ENSG00000259207	FALSE	unknown	NA	Unused	ITGB3
Radiodermatitis	ENSG00000073756	FALSE	Phase II Clinical Trial	2000-03-29	Absent	PTGS2
Radiodermatitis	ENSG00000095303	FALSE	Phase II Clinical Trial	2000-03-29	Absent	PTGS1
Radiodermatitis	ENSG00000111275	FALSE	Preclinical	2017-10-06	Absent	ALDH2
Radiodermatitis	ENSG00000113749	FALSE	unknown	NA	Unused	HRH2
Radiodermatitis	ENSG00000115353	FALSE	Preclinical	NA	Absent	TACR1
Radiodermatitis	ENSG00000116044	FALSE	Phase II Clinical Trial	2014-01-07	Absent	NFE2L2
Radiodermatitis	ENSG00000142168	FALSE	Phase II Clinical Trial	2005-08-18	Phase II Clinical Trial	SOD1
Raynaud Disease	ENSG00000095321	FALSE	Phase II Clinical Trial	NA	Unused	CRAT
Raynaud Disease	ENSG00000136160	FALSE	Preclinical	1997-10-15	Unused	EDNRB
Raynaud Disease	ENSG00000138735	FALSE	Phase II Clinical Trial	2005-05-24	Unused	PDE5A
Raynaud Disease	ENSG00000151067	TRUE	Approved	1997-05-15	Approved	CACNA1C
Raynaud Disease	ENSG00000151617	FALSE	Preclinical	1997-10-15	Unused	EDNRA
Raynaud Disease	ENSG00000160013	TRUE	Approved	2005-01-17	Approved	PTGIR
Raynaud Disease	ENSG00000160951	FALSE	Phase II Clinical Trial	1997-03-15	Preclinical	PTGER1
Raynaud Disease	ENSG00000166148	FALSE	Preclinical	2006-07-10	Unused	AVPR1A
Raynaud Disease	ENSG00000184160	FALSE	Phase II Clinical Trial	2008-06-24	Unused	ADRA2C
Rectal Fistula	ENSG00000067182	FALSE	Preclinical	2010-10-09	Absent	TNFRSF1A
Red-Cell Aplasia, Pure	ENSG00000124614	FALSE	Preclinical	2014-10-31	Absent	RPS10
Red-Cell Aplasia, Pure	ENSG00000185291	FALSE	unknown	NA	Absent	IL3RA
Red-Cell Aplasia, Pure	ENSG00000187266	FALSE	unknown	1996-10-15	Absent	EPOR
Red-Cell Aplasia, Pure	ENSG00000196262	TRUE	Approved	NA	Absent	PPIA
Renal Insufficiency	ENSG00000007171	FALSE	unknown	1989-10-15	Unused	NOS2
Renal Insufficiency	ENSG00000019186	FALSE	Preclinical	2012-06-11	Absent	CYP24A1
Renal Insufficiency	ENSG00000019991	FALSE	Phase II Clinical Trial	2007-09-21	Absent	HGF
Renal Insufficiency	ENSG00000036828	FALSE	Phase II Clinical Trial	1997-08-15	Phase I Clinical Trial	CASR
Renal Insufficiency	ENSG00000043591	TRUE	Approved	NA	Approved	ADRB1
Renal Insufficiency	ENSG00000063176	FALSE	Preclinical	2013-01-22	Absent	SPHK2
Renal Insufficiency	ENSG00000065989	FALSE	Preclinical	2016-06-23	Absent	PDE4A
Renal Insufficiency	ENSG00000066230	FALSE	Phase II Clinical Trial	2011-05-02	Phase II Clinical Trial	SLC9A3
Renal Insufficiency	ENSG00000070915	TRUE	Approved	NA	Approved	SLC12A3
Renal Insufficiency	ENSG00000073756	FALSE	Preclinical	2014-03-25	Absent	PTGS2
Renal Insufficiency	ENSG00000082701	FALSE	Preclinical	2009-02-05	Absent	GSK3B
Renal Insufficiency	ENSG00000088832	FALSE	Preclinical	2017-10-24	Absent	FKBP1A
Renal Insufficiency	ENSG00000096717	FALSE	Preclinical	2015-10-13	Absent	SIRT1
Renal Insufficiency	ENSG00000100170	FALSE	Phase II Clinical Trial	2011-08-04	Absent	SLC5A1
Renal Insufficiency	ENSG00000100292	FALSE	Preclinical	2017-11-27	Absent	HMOX1
Renal Insufficiency	ENSG00000100644	FALSE	Preclinical	2010-01-05	Preclinical	HIF1A
Renal Insufficiency	ENSG00000101144	FALSE	Preclinical	NA	Unused	BMP7
Renal Insufficiency	ENSG00000102524	FALSE	Phase II Clinical Trial	2007-02-02	Phase II Clinical Trial	TNFSF13B
Renal Insufficiency	ENSG00000105329	FALSE	Preclinical	2016-11-11	Absent	TGFB1
Renal Insufficiency	ENSG00000109320	FALSE	Preclinical	2010-04-24	Absent	NFKB1
Renal Insufficiency	ENSG00000111424	TRUE	Approved	2004-08-02	Phase III Clinical Trial	VDR
Renal Insufficiency	ENSG00000112033	FALSE	Preclinical	2015-03-10	Absent	PPARD
Renal Insufficiency	ENSG00000112062	FALSE	Phase II Clinical Trial	2008-12-03	Absent	MAPK14
Renal Insufficiency	ENSG00000112715	FALSE	Preclinical	2012-03-13	Preclinical	VEGFA
Renal Insufficiency	ENSG00000112964	FALSE	Phase II Clinical Trial	NA	Unused	GHR
Renal Insufficiency	ENSG00000113161	FALSE	unknown	1997-02-15	Unused	HMGCR
Renal Insufficiency	ENSG00000115718	FALSE	unknown	2007-05-03	Unused	PROC
Renal Insufficiency	ENSG00000116044	FALSE	Phase II Clinical Trial	2005-05-27	Unused	NFE2L2
Renal Insufficiency	ENSG00000116711	FALSE	Preclinical	2010-01-22	Absent	PLA2G4A
Renal Insufficiency	ENSG00000117298	FALSE	Preclinical	1996-10-15	Unused	ECE1
Renal Insufficiency	ENSG00000118432	FALSE	Preclinical	2017-03-24	Absent	CNR1
Renal Insufficiency	ENSG00000120156	FALSE	Preclinical	2017-04-12	Absent	TEK
Renal Insufficiency	ENSG00000123358	FALSE	Preclinical	2016-12-08	Absent	NR4A1
Renal Insufficiency	ENSG00000124089	FALSE	Preclinical	2004-11-02	Phase II Clinical Trial	MC3R
Renal Insufficiency	ENSG00000125730	FALSE	Phase I Clinical Trial	NA	Absent	C3
Renal Insufficiency	ENSG00000126895	FALSE	Phase II Clinical Trial	1992-04-15	Unused	AVPR2
Renal Insufficiency	ENSG00000131981	FALSE	unknown	1997-05-15	Phase II Clinical Trial	LGALS3
Renal Insufficiency	ENSG00000132170	FALSE	Preclinical	2013-11-04	Absent	PPARG
Renal Insufficiency	ENSG00000132693	FALSE	unknown	2006-05-02	Phase I Clinical Trial	CRP
Renal Insufficiency	ENSG00000132906	FALSE	unknown	1997-05-15	Phase II Clinical Trial	CASP9
Renal Insufficiency	ENSG00000134318	FALSE	Preclinical	2017-10-05	Absent	ROCK2
Renal Insufficiency	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Renal Insufficiency	ENSG00000136160	FALSE	Preclinical	1993-09-15	Unused	EDNRB
Renal Insufficiency	ENSG00000136869	FALSE	Preclinical	2011-11-27	Absent	TLR4
Renal Insufficiency	ENSG00000137764	FALSE	Preclinical	2014-12-17	Absent	MAP2K5
Renal Insufficiency	ENSG00000138735	FALSE	Phase I Clinical Trial	1996-06-15	Phase II Clinical Trial	PDE5A
Renal Insufficiency	ENSG00000140675	FALSE	Phase III Clinical Trial	2004-11-22	Absent	SLC5A2
Renal Insufficiency	ENSG00000141510	FALSE	Phase II Clinical Trial	2003-10-14	Phase II Clinical Trial	TP53
Renal Insufficiency	ENSG00000141867	FALSE	Phase I Clinical Trial	2005-03-04	Absent	BRD4
Renal Insufficiency	ENSG00000142208	FALSE	unknown	1997-05-15	Phase II Clinical Trial	AKT1
Renal Insufficiency	ENSG00000143839	FALSE	Phase III Clinical Trial	2000-11-23	Phase III Clinical Trial	REN
Renal Insufficiency	ENSG00000144891	FALSE	Phase III Clinical Trial	1999-10-05	Unused	AGTR1
Renal Insufficiency	ENSG00000146648	FALSE	Phase I Clinical Trial	2012-03-09	Absent	EGFR
Renal Insufficiency	ENSG00000148180	FALSE	Phase II Clinical Trial	2008-06-10	Unused	GSN
Renal Insufficiency	ENSG00000150281	FALSE	unknown	NA	Absent	CTF1
Renal Insufficiency	ENSG00000151617	FALSE	Phase II Clinical Trial	1994-08-15	Phase II Clinical Trial	EDNRA
Renal Insufficiency	ENSG00000151623	FALSE	Phase II Clinical Trial	2010-10-25	Phase II Clinical Trial	NR3C2
Renal Insufficiency	ENSG00000151704	FALSE	Phase I Clinical Trial	2011-06-13	Absent	KCNJ1
Renal Insufficiency	ENSG00000156110	FALSE	Preclinical	2016-08-11	Absent	ADK
Renal Insufficiency	ENSG00000159339	FALSE	Preclinical	2017-10-06	Absent	PADI4
Renal Insufficiency	ENSG00000159640	TRUE	Approved	1996-10-15	Approved	ACE
Renal Insufficiency	ENSG00000159899	FALSE	Preclinical	2008-06-20	Preclinical	NPR2
Renal Insufficiency	ENSG00000160013	FALSE	unknown	2005-11-25	Phase III Clinical Trial	PTGIR
Renal Insufficiency	ENSG00000160882	FALSE	Preclinical	2014-08-04	Absent	CYP11B1
Renal Insufficiency	ENSG00000163235	FALSE	Phase I Clinical Trial	2012-03-09	Absent	TGFA
Renal Insufficiency	ENSG00000163485	FALSE	Phase II Clinical Trial	1990-09-15	Unused	ADORA1
Renal Insufficiency	ENSG00000166603	FALSE	Preclinical	2004-11-02	Phase II Clinical Trial	MC4R
Renal Insufficiency	ENSG00000167601	FALSE	Preclinical	2012-08-28	Preclinical	AXL
Renal Insufficiency	ENSG00000169403	FALSE	Preclinical	1996-05-15	Unused	PTAFR
Renal Insufficiency	ENSG00000169418	FALSE	Phase I Clinical Trial	1990-02-15	Phase I Clinical Trial	NPR1
Renal Insufficiency	ENSG00000170820	FALSE	Preclinical	2012-09-18	Absent	FSHR
Renal Insufficiency	ENSG00000171509	FALSE	Preclinical	2012-03-13	Preclinical	RXFP1
Renal Insufficiency	ENSG00000171791	FALSE	Preclinical	2001-05-30	Phase II Clinical Trial	BCL2
Renal Insufficiency	ENSG00000176136	FALSE	Preclinical	2004-11-02	Phase II Clinical Trial	MC5R
Renal Insufficiency	ENSG00000178562	FALSE	Preclinical	2009-06-29	Absent	CD28
Renal Insufficiency	ENSG00000179142	FALSE	Phase I Clinical Trial	2014-02-04	Absent	CYP11B2
Renal Insufficiency	ENSG00000182326	FALSE	Phase I Clinical Trial	2012-05-21	Absent	C1S
Renal Insufficiency	ENSG00000183625	FALSE	Phase I Clinical Trial	2016-03-04	Absent	CCR3
Renal Insufficiency	ENSG00000184381	FALSE	Preclinical	1998-12-15	Unused	PLA2G6
Renal Insufficiency	ENSG00000184845	FALSE	Preclinical	NA	Unused	DRD1
Renal Insufficiency	ENSG00000185532	FALSE	Preclinical	1997-04-15	Unused	PRKG1
Renal Insufficiency	ENSG00000186951	FALSE	Preclinical	2015-10-13	Absent	PPARA
Renal Insufficiency	ENSG00000187266	FALSE	Pre-registration	NA	Unused	EPOR
Renal Insufficiency	ENSG00000188822	FALSE	Preclinical	2017-03-24	Absent	CNR2
Renal Insufficiency	ENSG00000196262	FALSE	unknown	2004-04-27	Absent	PPIA
Renal Insufficiency	ENSG00000196549	FALSE	Phase II Clinical Trial	1996-10-15	Unused	MME
Renal Insufficiency	ENSG00000197442	FALSE	Preclinical	2017-10-05	Absent	MAP3K5
Renal Insufficiency	ENSG00000198959	FALSE	Preclinical	2012-04-03	Preclinical	TGM2
Renal Insufficiency	ENSG00000258839	FALSE	Preclinical	2004-11-02	Phase II Clinical Trial	MC1R
Reperfusion Injury	ENSG00000007908	FALSE	Preclinical	1994-02-15	Unused	SELE
Reperfusion Injury	ENSG00000009724	FALSE	Phase I Clinical Trial	2008-01-15	Preclinical	MASP2
Reperfusion Injury	ENSG00000010610	FALSE	Preclinical	2005-10-18	Unused	CD4
Reperfusion Injury	ENSG00000026103	FALSE	Preclinical	2008-03-06	Unused	FAS
Reperfusion Injury	ENSG00000065989	FALSE	Phase II Clinical Trial	1996-01-15	Unused	PDE4A
Reperfusion Injury	ENSG00000067182	FALSE	Phase II Clinical Trial	2009-11-16	Phase I Clinical Trial	TNFRSF1A
Reperfusion Injury	ENSG00000069535	FALSE	Preclinical	2011-03-03	Unused	MAOB
Reperfusion Injury	ENSG00000090339	FALSE	Preclinical	1995-06-15	Unused	ICAM1
Reperfusion Injury	ENSG00000100448	FALSE	Preclinical	1995-02-15	Unused	CTSG
Reperfusion Injury	ENSG00000105650	FALSE	Phase II Clinical Trial	1996-01-15	Unused	PDE4C
Reperfusion Injury	ENSG00000106804	FALSE	unknown	2005-01-31	Unused	C5
Reperfusion Injury	ENSG00000109320	FALSE	Preclinical	1997-11-15	Unused	NFKB1
Reperfusion Injury	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Reperfusion Injury	ENSG00000112062	FALSE	unknown	1997-12-15	Unused	MAPK14
Reperfusion Injury	ENSG00000113070	FALSE	Preclinical	NA	Absent	HBEGF
Reperfusion Injury	ENSG00000113448	FALSE	Phase II Clinical Trial	1996-01-15	Unused	PDE4D
Reperfusion Injury	ENSG00000115008	FALSE	unknown	2009-12-07	Preclinical	IL1A
Reperfusion Injury	ENSG00000117335	FALSE	unknown	NA	Unused	CD46
Reperfusion Injury	ENSG00000122194	FALSE	Preclinical	1995-02-15	Unused	PLG
Reperfusion Injury	ENSG00000125730	FALSE	Preclinical	2011-09-15	Absent	C3
Reperfusion Injury	ENSG00000128271	FALSE	unknown	2000-04-03	Unused	ADORA2A
Reperfusion Injury	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Reperfusion Injury	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Reperfusion Injury	ENSG00000137070	FALSE	Preclinical	2016-09-12	Absent	IL11RA
Reperfusion Injury	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Reperfusion Injury	ENSG00000139610	FALSE	Preclinical	1995-02-15	Unused	CELA1
Reperfusion Injury	ENSG00000142168	FALSE	unknown	NA	Absent	SOD1
Reperfusion Injury	ENSG00000143799	FALSE	Preclinical	2008-04-10	Unused	PARP1
Reperfusion Injury	ENSG00000149131	FALSE	Preclinical	NA	Preclinical	SERPING1
Reperfusion Injury	ENSG00000150281	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	CTF1
Reperfusion Injury	ENSG00000151067	FALSE	Preclinical	1999-09-14	Unused	CACNA1C
Reperfusion Injury	ENSG00000158125	FALSE	Preclinical	2002-07-03	Absent	XDH
Reperfusion Injury	ENSG00000160255	FALSE	Phase II Clinical Trial	1997-04-15	Unused	ITGB2
Reperfusion Injury	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Reperfusion Injury	ENSG00000163464	FALSE	Preclinical	1997-03-15	Unused	CXCR1
Reperfusion Injury	ENSG00000163485	FALSE	Phase II Clinical Trial	1993-04-15	Unused	ADORA1
Reperfusion Injury	ENSG00000163719	FALSE	Preclinical	2016-10-24	Absent	MTMR14
Reperfusion Injury	ENSG00000163932	FALSE	Phase II Clinical Trial	2004-09-29	Unused	PRKCD
Reperfusion Injury	ENSG00000164111	FALSE	Preclinical	2003-11-10	Unused	ANXA5
Reperfusion Injury	ENSG00000167325	FALSE	Preclinical	1992-08-15	Unused	RRM1
Reperfusion Injury	ENSG00000169083	FALSE	Preclinical	NA	Unused	AR
Reperfusion Injury	ENSG00000169429	FALSE	unknown	2005-10-17	Unused	CXCL8
Reperfusion Injury	ENSG00000171049	FALSE	Preclinical	2014-08-06	Absent	FPR2
Reperfusion Injury	ENSG00000171497	FALSE	Preclinical	2010-11-15	Unused	PPID
Reperfusion Injury	ENSG00000171848	FALSE	Preclinical	1992-08-15	Unused	RRM2
Reperfusion Injury	ENSG00000174175	FALSE	Phase I Clinical Trial	1992-01-15	Unused	SELP
Reperfusion Injury	ENSG00000179776	FALSE	Phase II Clinical Trial	2003-02-26	Unused	CDH5
Reperfusion Injury	ENSG00000180210	TRUE	Approved	1995-02-15	Approved	F2
Reperfusion Injury	ENSG00000180871	FALSE	Preclinical	1997-03-15	Unused	CXCR2
Reperfusion Injury	ENSG00000181104	FALSE	Preclinical	2003-01-27	Unused	F2R
Reperfusion Injury	ENSG00000184588	FALSE	Phase II Clinical Trial	1996-01-15	Unused	PDE4B
Reperfusion Injury	ENSG00000188404	FALSE	Preclinical	1992-09-15	Unused	SELL
Reperfusion Injury	ENSG00000188822	FALSE	Preclinical	2011-05-06	Unused	CNR2
Reperfusion Injury	ENSG00000196262	FALSE	Preclinical	2004-04-27	Phase III Clinical Trial	PPIA
Reperfusion Injury	ENSG00000196352	FALSE	Preclinical	1995-06-15	Unused	CD55
Reperfusion Injury	ENSG00000197405	FALSE	Preclinical	2004-10-20	Preclinical	C5AR1
Reperfusion Injury	ENSG00000197561	FALSE	Preclinical	1995-02-15	Unused	ELANE
Reperfusion Injury	ENSG00000197635	FALSE	Preclinical	2011-07-04	Unused	DPP4
Reperfusion Injury	ENSG00000203710	FALSE	Preclinical	NA	Unused	CR1
Reperfusion Injury	ENSG00000239732	FALSE	Preclinical	2008-08-28	Unused	TLR9
Reperfusion Injury	ENSG00000259207	FALSE	Preclinical	1997-02-15	Unused	ITGB3
Reperfusion Injury	ENSG00000271503	FALSE	unknown	2009-06-04	Absent	CCL5
Reperfusion Injury	ENSG00000282608	FALSE	unknown	2001-08-07	Absent	ADORA3
Reproductive Tract Infections	ENSG00000100312	TRUE	Approved	2002-03-20	Phase III Clinical Trial	ACR
Reproductive Tract Infections	ENSG00000114378	TRUE	Approved	2002-03-20	Phase III Clinical Trial	HYAL1
Reproductive Tract Infections	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Reproductive Tract Infections	ENSG00000159110	FALSE	Approved	NA	Unused	IFNAR2
Respiratory Distress Syndrome, Adult	ENSG00000007908	FALSE	Phase I Clinical Trial	1994-02-15	Unused	SELE
Respiratory Distress Syndrome, Adult	ENSG00000057593	FALSE	Phase II Clinical Trial	1996-07-15	Unused	F7
Respiratory Distress Syndrome, Adult	ENSG00000067182	FALSE	Phase II Clinical Trial	2009-11-16	Phase II Clinical Trial	TNFRSF1A
Respiratory Distress Syndrome, Adult	ENSG00000067560	FALSE	Preclinical	2008-07-21	Unused	RHOA
Respiratory Distress Syndrome, Adult	ENSG00000069764	FALSE	unknown	1998-04-15	Unused	PLA2G10
Respiratory Distress Syndrome, Adult	ENSG00000090339	FALSE	unknown	1990-06-15	Unused	ICAM1
Respiratory Distress Syndrome, Adult	ENSG00000102245	FALSE	Preclinical	1993-11-15	Unused	CD40LG
Respiratory Distress Syndrome, Adult	ENSG00000112062	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	MAPK14
Respiratory Distress Syndrome, Adult	ENSG00000113580	FALSE	Preclinical	NA	Absent	NR3C1
Respiratory Distress Syndrome, Adult	ENSG00000114812	FALSE	Phase II Clinical Trial	2003-12-09	Phase I Clinical Trial	VIPR1
Respiratory Distress Syndrome, Adult	ENSG00000115718	FALSE	Preclinical	2008-07-25	Unused	PROC
Respiratory Distress Syndrome, Adult	ENSG00000117525	FALSE	Phase II Clinical Trial	2003-04-08	Phase II Clinical Trial	F3
Respiratory Distress Syndrome, Adult	ENSG00000124089	FALSE	unknown	2004-11-02	Unused	MC3R
Respiratory Distress Syndrome, Adult	ENSG00000124102	FALSE	Preclinical	NA	Unused	PI3
Respiratory Distress Syndrome, Adult	ENSG00000130234	FALSE	Phase II Clinical Trial	2007-07-13	Phase II Clinical Trial	ACE2
Respiratory Distress Syndrome, Adult	ENSG00000130368	FALSE	Preclinical	2008-12-16	Unused	MAS1
Respiratory Distress Syndrome, Adult	ENSG00000131471	FALSE	unknown	2000-08-17	Unused	AOC3
Respiratory Distress Syndrome, Adult	ENSG00000132693	FALSE	Preclinical	1997-01-15	Unused	CRP
Respiratory Distress Syndrome, Adult	ENSG00000134489	FALSE	unknown	2001-05-10	Unused	HRH4
Respiratory Distress Syndrome, Adult	ENSG00000136869	FALSE	Preclinical	2009-06-04	Preclinical	TLR4
Respiratory Distress Syndrome, Adult	ENSG00000142166	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	IFNAR1
Respiratory Distress Syndrome, Adult	ENSG00000146070	FALSE	unknown	1995-05-15	Unused	PLA2G7
Respiratory Distress Syndrome, Adult	ENSG00000149021	FALSE	Preclinical	1997-08-15	Unused	SCGB1A1
Respiratory Distress Syndrome, Adult	ENSG00000159110	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	IFNAR2
Respiratory Distress Syndrome, Adult	ENSG00000163464	FALSE	Preclinical	1998-08-15	Unused	CXCR1
Respiratory Distress Syndrome, Adult	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Respiratory Distress Syndrome, Adult	ENSG00000166603	FALSE	unknown	2004-11-02	Unused	MC4R
Respiratory Distress Syndrome, Adult	ENSG00000169418	FALSE	Phase II Clinical Trial	NA	Unused	NPR1
Respiratory Distress Syndrome, Adult	ENSG00000169429	FALSE	unknown	2005-10-17	Preclinical	CXCL8
Respiratory Distress Syndrome, Adult	ENSG00000170458	FALSE	Preclinical	1999-01-25	Absent	CD14
Respiratory Distress Syndrome, Adult	ENSG00000174175	FALSE	Phase I Clinical Trial	1994-02-15	Unused	SELP
Respiratory Distress Syndrome, Adult	ENSG00000176136	FALSE	unknown	2004-11-02	Unused	MC5R
Respiratory Distress Syndrome, Adult	ENSG00000177606	FALSE	Preclinical	2007-12-12	Preclinical	JUN
Respiratory Distress Syndrome, Adult	ENSG00000180210	FALSE	Preclinical	2006-02-07	Unused	F2
Respiratory Distress Syndrome, Adult	ENSG00000180871	FALSE	Preclinical	1998-08-15	Unused	CXCR2
Respiratory Distress Syndrome, Adult	ENSG00000184381	FALSE	unknown	1998-04-15	Unused	PLA2G6
Respiratory Distress Syndrome, Adult	ENSG00000188257	FALSE	unknown	1998-04-15	Unused	PLA2G2A
Respiratory Distress Syndrome, Adult	ENSG00000188404	FALSE	Phase I Clinical Trial	1992-09-15	Unused	SELL
Respiratory Distress Syndrome, Adult	ENSG00000196639	FALSE	unknown	2001-05-10	Unused	HRH1
Respiratory Distress Syndrome, Adult	ENSG00000197561	FALSE	Preclinical	1992-06-15	Unused	ELANE
Respiratory Distress Syndrome, Adult	ENSG00000198223	FALSE	Phase II Clinical Trial	NA	Absent	CSF2RA
Respiratory Distress Syndrome, Adult	ENSG00000203710	FALSE	Phase I Clinical Trial	NA	Unused	CR1
Respiratory Distress Syndrome, Adult	ENSG00000213918	FALSE	Preclinical	2014-11-21	Absent	DNASE1
Respiratory Distress Syndrome, Adult	ENSG00000258839	FALSE	unknown	2004-11-02	Unused	MC1R
Respiratory Distress Syndrome, Adult	ENSG00000262406	FALSE	unknown	2000-10-19	Absent	MMP12
Respiratory Distress Syndrome, Adult	ENSG00000277443	FALSE	Phase II Clinical Trial	NA	Absent	MARCKS
Respiratory Distress Syndrome, Newborn	ENSG00000132693	FALSE	Preclinical	1997-01-15	Unused	CRP
Respiratory Distress Syndrome, Newborn	ENSG00000134489	FALSE	unknown	2001-05-10	Unused	HRH4
Respiratory Distress Syndrome, Newborn	ENSG00000142166	FALSE	unknown	NA	Unused	IFNAR1
Respiratory Distress Syndrome, Newborn	ENSG00000149021	FALSE	Phase II Clinical Trial	2009-07-17	Phase II Clinical Trial	SCGB1A1
Respiratory Distress Syndrome, Newborn	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Respiratory Distress Syndrome, Newborn	ENSG00000174417	FALSE	unknown	NA	Absent	TRHR
Respiratory Distress Syndrome, Newborn	ENSG00000196639	FALSE	unknown	2001-05-10	Unused	HRH1
Respiratory Insufficiency	ENSG00000108576	FALSE	Phase II Clinical Trial	2014-02-14	Absent	SLC6A4
Respiratory Insufficiency	ENSG00000155511	FALSE	Phase II Clinical Trial	2002-11-15	Phase I Clinical Trial	GRIA1
Respiratory Syncytial Virus Infections	ENSG00000082898	FALSE	Preclinical	2013-09-05	Absent	XPO1
Respiratory Syncytial Virus Infections	ENSG00000106348	TRUE	Approved	NA	Approved	IMPDH1
Respiratory Syncytial Virus Infections	ENSG00000107201	FALSE	unknown	2008-07-29	Absent	DDX58
Respiratory Syncytial Virus Infections	ENSG00000133321	FALSE	Preclinical	2009-07-23	Preclinical	RARRES3
Respiratory Syncytial Virus Infections	ENSG00000143226	FALSE	Preclinical	2016-11-24	Absent	FCGR2A
Respiratory Syncytial Virus Infections	ENSG00000149021	FALSE	unknown	2011-02-22	Phase II Clinical Trial	SCGB1A1
Respiratory Syncytial Virus Infections	ENSG00000167207	FALSE	unknown	2008-07-29	Absent	NOD2
Respiratory Syncytial Virus Infections	ENSG00000169385	FALSE	Preclinical	1999-09-01	Unused	RNASE2
Respiratory Syncytial Virus Infections	ENSG00000180871	FALSE	Phase I Clinical Trial	2010-02-25	Absent	CXCR2
Respiratory Tract Diseases	ENSG00000007908	FALSE	Preclinical	1992-03-15	Unused	SELE
Respiratory Tract Diseases	ENSG00000011465	FALSE	Preclinical	1991-06-15	Unused	DCN
Respiratory Tract Diseases	ENSG00000012779	FALSE	Preclinical	1993-06-15	Unused	ALOX5
Respiratory Tract Diseases	ENSG00000065989	FALSE	Phase II Clinical Trial	1994-10-15	Phase I Clinical Trial	PDE4A
Respiratory Tract Diseases	ENSG00000073756	FALSE	Phase III Clinical Trial	1989-05-15	Unused	PTGS2
Respiratory Tract Diseases	ENSG00000075073	FALSE	Preclinical	1997-09-15	Unused	TACR2
Respiratory Tract Diseases	ENSG00000077238	FALSE	Phase II Clinical Trial	2002-01-15	Unused	IL4R
Respiratory Tract Diseases	ENSG00000081985	FALSE	Preclinical	2014-08-07	Absent	IL12RB2
Respiratory Tract Diseases	ENSG00000082556	FALSE	Preclinical	1998-08-15	Unused	OPRK1
Respiratory Tract Diseases	ENSG00000083444	FALSE	Preclinical	1993-12-15	Unused	PLOD1
Respiratory Tract Diseases	ENSG00000090339	FALSE	Preclinical	2008-07-31	Unused	ICAM1
Respiratory Tract Diseases	ENSG00000095303	FALSE	Phase III Clinical Trial	1989-05-15	Unused	PTGS1
Respiratory Tract Diseases	ENSG00000096996	FALSE	Preclinical	2014-08-07	Absent	IL12RB1
Respiratory Tract Diseases	ENSG00000101180	FALSE	Preclinical	1993-12-15	Unused	HRH3
Respiratory Tract Diseases	ENSG00000104321	FALSE	Preclinical	2009-11-09	Preclinical	TRPA1
Respiratory Tract Diseases	ENSG00000105329	FALSE	Preclinical	2017-09-21	Absent	TGFB1
Respiratory Tract Diseases	ENSG00000105650	FALSE	Preclinical	1994-10-15	Unused	PDE4C
Respiratory Tract Diseases	ENSG00000106799	FALSE	Preclinical	1991-06-15	Unused	TGFBR1
Respiratory Tract Diseases	ENSG00000106804	FALSE	unknown	NA	Unused	C5
Respiratory Tract Diseases	ENSG00000109991	FALSE	Preclinical	2014-08-21	Absent	P2RX3
Respiratory Tract Diseases	ENSG00000112038	FALSE	Phase III Clinical Trial	1989-05-15	Unused	OPRM1
Respiratory Tract Diseases	ENSG00000112062	FALSE	Preclinical	2003-07-07	Unused	MAPK14
Respiratory Tract Diseases	ENSG00000112096	FALSE	Preclinical	1995-06-15	Unused	SOD2
Respiratory Tract Diseases	ENSG00000113070	FALSE	Preclinical	1991-09-15	Unused	HBEGF
Respiratory Tract Diseases	ENSG00000113163	FALSE	unknown	2016-09-08	Absent	COL4A3BP
Respiratory Tract Diseases	ENSG00000113448	FALSE	Preclinical	1994-10-15	Unused	PDE4D
Respiratory Tract Diseases	ENSG00000113580	FALSE	Pre-registration	2012-07-28	Unused	NR3C1
Respiratory Tract Diseases	ENSG00000115221	FALSE	Phase I Clinical Trial	2014-02-04	Absent	ITGB6
Respiratory Tract Diseases	ENSG00000115353	FALSE	Preclinical	1997-09-15	Unused	TACR1
Respiratory Tract Diseases	ENSG00000116711	FALSE	Preclinical	2015-05-25	Absent	PLA2G4A
Respiratory Tract Diseases	ENSG00000121691	FALSE	Preclinical	1995-06-15	Unused	CAT
Respiratory Tract Diseases	ENSG00000121807	FALSE	Preclinical	2001-08-11	Unused	CCR2
Respiratory Tract Diseases	ENSG00000122420	FALSE	Preclinical	1994-08-15	Unused	PTGFR
Respiratory Tract Diseases	ENSG00000122884	FALSE	Preclinical	1993-12-15	Unused	P4HA1
Respiratory Tract Diseases	ENSG00000125571	FALSE	Preclinical	2014-08-07	Absent	IL37
Respiratory Tract Diseases	ENSG00000126010	FALSE	Preclinical	1992-05-15	Unused	GRPR
Respiratory Tract Diseases	ENSG00000128271	TRUE	Approved	NA	Approved	ADORA2A
Respiratory Tract Diseases	ENSG00000132170	FALSE	Preclinical	2013-01-04	Preclinical	PPARG
Respiratory Tract Diseases	ENSG00000133019	FALSE	Phase I Clinical Trial	1995-06-15	Unused	CHRM3
Respiratory Tract Diseases	ENSG00000133105	FALSE	Preclinical	2008-05-20	Preclinical	RXFP2
Respiratory Tract Diseases	ENSG00000134489	FALSE	unknown	2009-11-09	Absent	HRH4
Respiratory Tract Diseases	ENSG00000138448	FALSE	Phase I Clinical Trial	2014-02-04	Absent	ITGAV
Respiratory Tract Diseases	ENSG00000138735	FALSE	Phase I Clinical Trial	1994-09-15	Unused	PDE5A
Respiratory Tract Diseases	ENSG00000142168	FALSE	Phase I Clinical Trial	2006-12-15	Unused	SOD1
Respiratory Tract Diseases	ENSG00000146070	FALSE	Preclinical	1997-08-15	Unused	PLA2G7
Respiratory Tract Diseases	ENSG00000151694	FALSE	Preclinical	2002-12-02	Unused	ADAM17
Respiratory Tract Diseases	ENSG00000160013	FALSE	Phase III Clinical Trial	2014-06-26	Absent	PTGIR
Respiratory Tract Diseases	ENSG00000160255	FALSE	Phase I Clinical Trial	NA	Absent	ITGB2
Respiratory Tract Diseases	ENSG00000161905	FALSE	Preclinical	2003-10-20	Unused	ALOX15
Respiratory Tract Diseases	ENSG00000162896	FALSE	Preclinical	2004-03-30	Unused	PIGR
Respiratory Tract Diseases	ENSG00000163485	TRUE	Approved	NA	Approved	ADORA1
Respiratory Tract Diseases	ENSG00000163823	FALSE	Preclinical	2001-08-11	Unused	CCR1
Respiratory Tract Diseases	ENSG00000169252	FALSE	Preclinical	2002-05-01	Unused	ADRB2
Respiratory Tract Diseases	ENSG00000169403	FALSE	Preclinical	1990-01-15	Unused	PTAFR
Respiratory Tract Diseases	ENSG00000169429	FALSE	Preclinical	1994-07-15	Unused	CXCL8
Respiratory Tract Diseases	ENSG00000169836	FALSE	Preclinical	1997-09-15	Unused	TACR3
Respiratory Tract Diseases	ENSG00000170425	FALSE	unknown	2004-09-24	Unused	ADORA2B
Respiratory Tract Diseases	ENSG00000171509	FALSE	Preclinical	2008-05-20	Preclinical	RXFP1
Respiratory Tract Diseases	ENSG00000171557	FALSE	unknown	NA	Absent	FGG
Respiratory Tract Diseases	ENSG00000171560	FALSE	unknown	NA	Absent	FGA
Respiratory Tract Diseases	ENSG00000171564	FALSE	unknown	NA	Absent	FGB
Respiratory Tract Diseases	ENSG00000171608	FALSE	Preclinical	2016-09-09	Preclinical	PIK3CD
Respiratory Tract Diseases	ENSG00000172236	FALSE	Preclinical	2001-04-02	Unused	TPSAB1
Respiratory Tract Diseases	ENSG00000172572	FALSE	Preclinical	2011-07-28	Unused	PDE3A
Respiratory Tract Diseases	ENSG00000180871	FALSE	Phase I Clinical Trial	2000-04-05	Unused	CXCR2
Respiratory Tract Diseases	ENSG00000182326	FALSE	Preclinical	1990-06-15	Unused	C1S
Respiratory Tract Diseases	ENSG00000183134	FALSE	Phase I Clinical Trial	2009-11-06	Unused	PTGDR2
Respiratory Tract Diseases	ENSG00000183813	FALSE	Preclinical	2011-09-21	Preclinical	CCR4
Respiratory Tract Diseases	ENSG00000184588	FALSE	Preclinical	1994-10-15	Unused	PDE4B
Respiratory Tract Diseases	ENSG00000187848	FALSE	Preclinical	2014-08-21	Absent	P2RX2
Respiratory Tract Diseases	ENSG00000196639	FALSE	unknown	2009-11-09	Unused	HRH1
Respiratory Tract Diseases	ENSG00000197405	FALSE	Preclinical	1994-05-15	Unused	C5AR1
Respiratory Tract Diseases	ENSG00000197561	FALSE	Preclinical	1990-12-15	Unused	ELANE
Respiratory Tract Diseases	ENSG00000197635	FALSE	Preclinical	1995-09-15	Unused	DPP4
Respiratory Tract Diseases	ENSG00000198121	FALSE	Preclinical	2015-05-05	Absent	LPAR1
Respiratory Tract Diseases	ENSG00000203710	FALSE	Preclinical	1992-11-15	Unused	CR1
Respiratory Tract Infections	ENSG00000012223	FALSE	unknown	1998-09-15	Unused	LTF
Respiratory Tract Infections	ENSG00000027697	FALSE	Preclinical	2001-05-15	Unused	IFNGR1
Respiratory Tract Infections	ENSG00000065989	FALSE	Phase I Clinical Trial	2005-05-24	Absent	PDE4A
Respiratory Tract Infections	ENSG00000106348	TRUE	Approved	NA	Approved	IMPDH1
Respiratory Tract Infections	ENSG00000121879	FALSE	Phase II Clinical Trial	2006-12-07	Absent	PIK3CA
Respiratory Tract Infections	ENSG00000131747	FALSE	Phase I Clinical Trial	2007-09-07	Phase I Clinical Trial	TOP2A
Respiratory Tract Infections	ENSG00000135828	FALSE	Preclinical	1998-06-15	Unused	RNASEL
Respiratory Tract Infections	ENSG00000149021	FALSE	Preclinical	2009-07-17	Absent	SCGB1A1
Respiratory Tract Infections	ENSG00000159110	FALSE	Phase III Clinical Trial	2004-11-16	Phase II Clinical Trial	IFNAR2
Respiratory Tract Infections	ENSG00000169836	FALSE	unknown	1996-03-15	Unused	TACR3
Respiratory Tract Infections	ENSG00000170458	FALSE	unknown	1999-01-25	Unused	CD14
Respiratory Tract Infections	ENSG00000175591	FALSE	unknown	NA	Unused	P2RY2
Respiratory Tract Infections	ENSG00000198793	FALSE	Phase II Clinical Trial	2006-12-07	Absent	MTOR
Respiratory Tract Infections	ENSG00000205649	FALSE	unknown	1998-03-15	Unused	HTN3
Respiratory Tract Infections	ENSG00000239732	FALSE	unknown	2006-03-06	Unused	TLR9
Restless Legs Syndrome	ENSG00000069535	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	MAOB
Restless Legs Syndrome	ENSG00000082556	TRUE	Approved	2001-08-09	Phase III Clinical Trial	OPRK1
Restless Legs Syndrome	ENSG00000093010	FALSE	Phase II Clinical Trial	2000-10-02	Unused	COMT
Restless Legs Syndrome	ENSG00000103546	FALSE	unknown	2000-07-10	Unused	SLC6A2
Restless Legs Syndrome	ENSG00000108576	FALSE	unknown	2000-07-10	Unused	SLC6A4
Restless Legs Syndrome	ENSG00000112038	TRUE	Approved	2001-08-09	Phase III Clinical Trial	OPRM1
Restless Legs Syndrome	ENSG00000116329	TRUE	Approved	2001-08-09	Phase III Clinical Trial	OPRD1
Restless Legs Syndrome	ENSG00000128271	FALSE	Phase II Clinical Trial	1996-03-15	Unused	ADORA2A
Restless Legs Syndrome	ENSG00000132437	FALSE	Phase II Clinical Trial	2000-10-02	Unused	DDC
Restless Legs Syndrome	ENSG00000142319	FALSE	Phase II Clinical Trial	1995-08-15	Phase II Clinical Trial	SLC6A3
Restless Legs Syndrome	ENSG00000149295	TRUE	Approved	1991-06-15	Approved	DRD2
Restless Legs Syndrome	ENSG00000151577	TRUE	Approved	1991-06-15	Approved	DRD3
Restless Legs Syndrome	ENSG00000153956	TRUE	Approved	1993-06-15	Approved	CACNA2D1
Restless Legs Syndrome	ENSG00000158104	FALSE	Phase II Clinical Trial	1992-11-15	Unused	HPD
Restless Legs Syndrome	ENSG00000171408	FALSE	Preclinical	2009-01-09	Preclinical	PDE7B
Restless Legs Syndrome	ENSG00000176884	FALSE	Phase I Clinical Trial	2005-06-06	Unused	GRIN1
Restless Legs Syndrome	ENSG00000178394	FALSE	unknown	1995-08-15	Unused	HTR1A
Restless Legs Syndrome	ENSG00000179546	FALSE	unknown	1995-08-15	Unused	HTR1D
Restless Legs Syndrome	ENSG00000205268	FALSE	Preclinical	2009-01-09	Preclinical	PDE7A
Retinal Artery Occlusion	ENSG00000014216	FALSE	Preclinical	2016-04-28	Absent	CAPN1
Retinal Artery Occlusion	ENSG00000092439	FALSE	Preclinical	2011-09-28	Preclinical	TRPM7
Retinal Artery Occlusion	ENSG00000162909	FALSE	Preclinical	2016-04-28	Absent	CAPN2
Retinal Detachment	ENSG00000026103	FALSE	Preclinical	NA	Absent	FAS
Retinal Detachment	ENSG00000100644	FALSE	Preclinical	2009-02-18	Absent	HIF1A
Retinal Detachment	ENSG00000113721	FALSE	unknown	2004-02-09	Absent	PDGFRB
Retinal Detachment	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Retinal Diseases	ENSG00000067182	FALSE	unknown	NA	Unused	TNFRSF1A
Retinal Diseases	ENSG00000082781	FALSE	Phase II Clinical Trial	2011-12-02	Absent	ITGB5
Retinal Diseases	ENSG00000101425	FALSE	Preclinical	2001-05-01	Unused	BPI
Retinal Diseases	ENSG00000112062	FALSE	unknown	2000-10-25	Unused	MAPK14
Retinal Diseases	ENSG00000112715	FALSE	Phase III Clinical Trial	1999-11-02	Absent	VEGFA
Retinal Diseases	ENSG00000116678	FALSE	Preclinical	2017-03-22	Absent	LEPR
Retinal Diseases	ENSG00000116745	FALSE	Preclinical	2008-06-17	Absent	RPE65
Retinal Diseases	ENSG00000122194	TRUE	Approved	2000-10-30	Approved	PLG
Retinal Diseases	ENSG00000122420	FALSE	Preclinical	2011-08-17	Unused	PTGFR
Retinal Diseases	ENSG00000132646	FALSE	Phase II Clinical Trial	NA	Unused	PCNA
Retinal Diseases	ENSG00000132703	FALSE	Preclinical	2012-03-16	Preclinical	APCS
Retinal Diseases	ENSG00000138448	FALSE	Phase II Clinical Trial	2011-12-02	Absent	ITGAV
Retinal Diseases	ENSG00000140443	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IGF1R
Retinal Diseases	ENSG00000150093	FALSE	Phase II Clinical Trial	2003-01-24	Unused	ITGB1
Retinal Diseases	ENSG00000161638	FALSE	Phase II Clinical Trial	2003-01-24	Unused	ITGA5
Retinal Diseases	ENSG00000163513	FALSE	Preclinical	2005-06-29	Unused	TGFBR2
Retinal Diseases	ENSG00000164171	FALSE	Phase II Clinical Trial	2011-12-02	Absent	ITGA2
Retinal Diseases	ENSG00000169047	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IRS1
Retinal Diseases	ENSG00000180616	FALSE	Preclinical	1998-08-15	Unused	SSTR2
Retinal Diseases	ENSG00000186951	FALSE	Preclinical	2016-02-10	Absent	PPARA
Retinal Diseases	ENSG00000259207	FALSE	Phase II Clinical Trial	2011-12-02	Absent	ITGB3
Retinal Vein Occlusion	ENSG00000112715	TRUE	Approved	1993-05-15	Approved	VEGFA
Retinal Vein Occlusion	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Retinal Vein Occlusion	ENSG00000119630	TRUE	Approved	NA	Approved	PGF
Retinal Vein Occlusion	ENSG00000122194	FALSE	Phase I Clinical Trial	2000-10-30	Absent	PLG
Retinal Vein Occlusion	ENSG00000130427	FALSE	Phase I Clinical Trial	2014-11-04	Absent	EPO
Retinal Vein Occlusion	ENSG00000138685	FALSE	Phase II Clinical Trial	1993-05-15	Absent	FGF2
Retinal Vein Occlusion	ENSG00000145050	FALSE	Preclinical	2010-01-11	Absent	MANF
Retinal Vein Occlusion	ENSG00000164344	FALSE	Phase II Clinical Trial	2007-05-24	Absent	KLKB1
Retinal Vein Occlusion	ENSG00000169047	FALSE	Preclinical	NA	Absent	IRS1
Retinal Vein Occlusion	ENSG00000196396	FALSE	Phase II Clinical Trial	2009-06-04	Absent	PTPN1
Retinitis Pigmentosa	ENSG00000042781	FALSE	Preclinical	2016-06-08	Absent	USH2A
Retinitis Pigmentosa	ENSG00000064300	FALSE	Phase II Clinical Trial	2011-07-05	Absent	NGFR
Retinitis Pigmentosa	ENSG00000067900	FALSE	Preclinical	2015-04-29	Absent	ROCK1
Retinitis Pigmentosa	ENSG00000075043	FALSE	Preclinical	NA	Absent	KCNQ2
Retinitis Pigmentosa	ENSG00000092200	FALSE	Phase II Clinical Trial	2014-11-20	Absent	RPGRIP1
Retinitis Pigmentosa	ENSG00000116745	TRUE	Approved	2008-06-17	Absent	RPE65
Retinitis Pigmentosa	ENSG00000122756	FALSE	Phase III Clinical Trial	2000-05-31	Phase III Clinical Trial	CNTFR
Retinitis Pigmentosa	ENSG00000132386	FALSE	Phase I Clinical Trial	NA	Absent	SERPINF1
Retinitis Pigmentosa	ENSG00000140522	FALSE	Phase I Clinical Trial	2016-06-21	Absent	RLBP1
Retinitis Pigmentosa	ENSG00000145050	FALSE	Preclinical	2010-01-11	Absent	MANF
Retinitis Pigmentosa	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	ADRA2A
Retinitis Pigmentosa	ENSG00000156113	FALSE	Phase III Clinical Trial	1989-11-15	Phase II Clinical Trial	KCNMA1
Retinitis Pigmentosa	ENSG00000171105	FALSE	Preclinical	NA	Preclinical	INSR
Retinitis Pigmentosa	ENSG00000171119	FALSE	Preclinical	NA	Unused	NRTN
Retinitis Pigmentosa	ENSG00000171773	FALSE	Preclinical	2004-12-13	Unused	NXNL1
Retinitis Pigmentosa	ENSG00000178607	FALSE	Preclinical	2015-02-05	Absent	ERN1
Retinitis Pigmentosa	ENSG00000184156	FALSE	Preclinical	NA	Absent	KCNQ3
Retinitis Pigmentosa	ENSG00000184588	FALSE	Preclinical	2001-12-03	Unused	PDE4B
Retinitis Pigmentosa	ENSG00000198691	FALSE	Preclinical	2007-06-12	Absent	ABCA4
Retinoschisis	ENSG00000102104	FALSE	Phase II Clinical Trial	2009-07-01	Absent	RS1
Rett Syndrome	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Rett Syndrome	ENSG00000017427	FALSE	Preclinical	2009-09-04	Unused	IGF1
Rett Syndrome	ENSG00000022355	FALSE	Preclinical	2014-04-26	Absent	GABRA1
Rett Syndrome	ENSG00000069535	FALSE	Preclinical	NA	Absent	MAOB
Rett Syndrome	ENSG00000069696	FALSE	Phase III Clinical Trial	1995-03-15	Preclinical	DRD4
Rett Syndrome	ENSG00000094631	FALSE	Preclinical	2015-10-21	Absent	HDAC6
Rett Syndrome	ENSG00000103546	FALSE	Phase II Clinical Trial	NA	Absent	SLC6A2
Rett Syndrome	ENSG00000108576	FALSE	Phase II Clinical Trial	2014-02-14	Absent	SLC6A4
Rett Syndrome	ENSG00000133019	FALSE	Preclinical	2007-02-02	Absent	CHRM3
Rett Syndrome	ENSG00000142168	FALSE	Preclinical	2017-06-28	Absent	SOD1
Rett Syndrome	ENSG00000144285	FALSE	Preclinical	2013-12-23	Absent	SCN1A
Rett Syndrome	ENSG00000147955	FALSE	Preclinical	2007-02-02	Absent	SIGMAR1
Rett Syndrome	ENSG00000148053	FALSE	Preclinical	2016-10-24	Absent	NTRK2
Rett Syndrome	ENSG00000149295	FALSE	Phase III Clinical Trial	1995-03-15	Preclinical	DRD2
Rett Syndrome	ENSG00000151577	FALSE	Phase III Clinical Trial	1995-03-15	Preclinical	DRD3
Rett Syndrome	ENSG00000171132	FALSE	Preclinical	2009-05-01	Absent	PRKCE
Rett Syndrome	ENSG00000178394	FALSE	Phase III Clinical Trial	1995-03-15	Preclinical	HTR1A
Rett Syndrome	ENSG00000181072	FALSE	Preclinical	2007-02-02	Absent	CHRM2
Rett Syndrome	ENSG00000183454	FALSE	Preclinical	2011-11-15	Absent	GRIN2A
Rett Syndrome	ENSG00000196591	FALSE	Preclinical	2014-01-10	Absent	HDAC2
Rh Isoimmunization	ENSG00000187010	TRUE	Approved	2004-08-09	Approved	RHD
Rhabdomyosarcoma	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT4
Rhabdomyosarcoma	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Rhabdomyosarcoma	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR3
Rhabdomyosarcoma	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR1
Rhabdomyosarcoma	ENSG00000080824	FALSE	Phase II Clinical Trial	2014-03-10	Absent	HSP90AA1
Rhabdomyosarcoma	ENSG00000097007	FALSE	Phase II Clinical Trial	2002-11-12	Unused	ABL1
Rhabdomyosarcoma	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Rhabdomyosarcoma	ENSG00000102755	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT1
Rhabdomyosarcoma	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Rhabdomyosarcoma	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Rhabdomyosarcoma	ENSG00000121966	FALSE	Preclinical	2014-09-06	Absent	CXCR4
Rhabdomyosarcoma	ENSG00000128052	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KDR
Rhabdomyosarcoma	ENSG00000128602	FALSE	Phase II Clinical Trial	2008-11-24	Phase II Clinical Trial	SMO
Rhabdomyosarcoma	ENSG00000131747	FALSE	Approved	2007-03-05	Absent	TOP2A
Rhabdomyosarcoma	ENSG00000134323	FALSE	Preclinical	NA	Absent	MYCN
Rhabdomyosarcoma	ENSG00000134460	FALSE	Preclinical	2015-09-15	Absent	IL2RA
Rhabdomyosarcoma	ENSG00000136997	FALSE	Preclinical	NA	Absent	MYC
Rhabdomyosarcoma	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-09-24	Phase II Clinical Trial	IGF1R
Rhabdomyosarcoma	ENSG00000141736	FALSE	Phase I Clinical Trial	2006-06-05	Absent	ERBB2
Rhabdomyosarcoma	ENSG00000146648	FALSE	Phase I Clinical Trial	2006-06-05	Absent	EGFR
Rhabdomyosarcoma	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KIT
Rhabdomyosarcoma	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Rhabdomyosarcoma	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Rhabdomyosarcoma	ENSG00000165731	FALSE	Phase II Clinical Trial	2003-07-22	Absent	RET
Rhabdomyosarcoma	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Rhabdomyosarcoma	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Unused	PTEN
Rhabdomyosarcoma	ENSG00000174807	FALSE	Phase II Clinical Trial	2004-10-18	Phase II Clinical Trial	CD248
Rhabdomyosarcoma	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Rhabdomyosarcoma	ENSG00000197122	FALSE	Phase II Clinical Trial	2002-11-12	Unused	SRC
Rhabdomyosarcoma	ENSG00000198793	FALSE	Phase II Clinical Trial	1999-02-15	Unused	MTOR
Rhabdomyosarcoma	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Unused	TOP1
Rhabdomyosarcoma	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Rhinitis	ENSG00000006638	FALSE	Pre-registration	1999-02-15	Unused	TBXA2R
Rhinitis	ENSG00000007171	FALSE	unknown	1999-09-22	Unused	NOS2
Rhinitis	ENSG00000007908	FALSE	unknown	1992-01-15	Unused	SELE
Rhinitis	ENSG00000012779	FALSE	Phase I Clinical Trial	1998-10-15	Unused	ALOX5
Rhinitis	ENSG00000059377	FALSE	unknown	2002-09-18	Unused	TBXAS1
Rhinitis	ENSG00000065989	FALSE	Preclinical	1995-03-15	Unused	PDE4A
Rhinitis	ENSG00000072694	FALSE	Phase I Clinical Trial	2012-01-28	Absent	FCGR2B
Rhinitis	ENSG00000075073	FALSE	Phase II Clinical Trial	1998-10-15	Unused	TACR2
Rhinitis	ENSG00000077238	FALSE	Preclinical	1998-08-15	Unused	IL4R
Rhinitis	ENSG00000082556	TRUE	Approved	NA	Approved	OPRK1
Rhinitis	ENSG00000101180	FALSE	Phase II Clinical Trial	1991-05-15	Unused	HRH3
Rhinitis	ENSG00000104921	FALSE	unknown	1995-08-15	Unused	FCER2
Rhinitis	ENSG00000105329	FALSE	Approved	NA	Unused	TGFB1
Rhinitis	ENSG00000105650	FALSE	Preclinical	1995-03-15	Unused	PDE4C
Rhinitis	ENSG00000109320	FALSE	unknown	1994-03-15	Unused	NFKB1
Rhinitis	ENSG00000112038	TRUE	Approved	2010-03-05	Approved	OPRM1
Rhinitis	ENSG00000113448	FALSE	Preclinical	1995-03-15	Unused	PDE4D
Rhinitis	ENSG00000113580	TRUE	Approved	1995-12-15	Approved	NR3C1
Rhinitis	ENSG00000115232	FALSE	unknown	2002-04-04	Unused	ITGA4
Rhinitis	ENSG00000115353	FALSE	Phase II Clinical Trial	1998-10-15	Unused	TACR1
Rhinitis	ENSG00000115602	FALSE	Phase I Clinical Trial	2014-01-16	Absent	IL1RL1
Rhinitis	ENSG00000116329	TRUE	Approved	NA	Approved	OPRD1
Rhinitis	ENSG00000117586	FALSE	Phase I Clinical Trial	2007-03-23	Phase I Clinical Trial	TNFSF4
Rhinitis	ENSG00000120907	FALSE	Phase III Clinical Trial	2008-11-25	Unused	ADRA1A
Rhinitis	ENSG00000120915	FALSE	Preclinical	2016-10-27	Absent	EPHX2
Rhinitis	ENSG00000123496	FALSE	Preclinical	2002-07-30	Unused	IL13RA2
Rhinitis	ENSG00000134489	FALSE	Preclinical	2001-05-10	Phase I Clinical Trial	HRH4
Rhinitis	ENSG00000144481	FALSE	Preclinical	2016-02-01	Absent	TRPM8
Rhinitis	ENSG00000150594	FALSE	Preclinical	2012-08-23	Preclinical	ADRA2A
Rhinitis	ENSG00000158859	FALSE	Phase II Clinical Trial	2015-09-03	Absent	ADAMTS4
Rhinitis	ENSG00000160712	FALSE	Preclinical	1998-08-15	Unused	IL6R
Rhinitis	ENSG00000163106	FALSE	Preclinical	2008-02-12	Unused	HPGDS
Rhinitis	ENSG00000163131	FALSE	Preclinical	2003-05-22	Unused	CTSS
Rhinitis	ENSG00000165025	FALSE	Preclinical	1992-06-15	Unused	SYK
Rhinitis	ENSG00000167748	FALSE	Preclinical	2008-06-23	Preclinical	KLK1
Rhinitis	ENSG00000168229	FALSE	Phase I Clinical Trial	2003-07-10	Phase III Clinical Trial	PTGDR
Rhinitis	ENSG00000168398	FALSE	unknown	1989-08-15	Unused	BDKRB2
Rhinitis	ENSG00000169252	FALSE	unknown	1995-12-15	Unused	ADRB2
Rhinitis	ENSG00000169403	TRUE	Approved	NA	Approved	PTAFR
Rhinitis	ENSG00000170214	FALSE	Phase III Clinical Trial	2008-11-25	Unused	ADRA1B
Rhinitis	ENSG00000171608	FALSE	unknown	2008-07-18	Unused	PIK3CD
Rhinitis	ENSG00000171873	FALSE	Phase III Clinical Trial	2011-08-05	Unused	ADRA1D
Rhinitis	ENSG00000172156	FALSE	Preclinical	NA	Phase II Clinical Trial	CCL11
Rhinitis	ENSG00000172236	FALSE	Preclinical	2001-05-09	Unused	TPSAB1
Rhinitis	ENSG00000173198	FALSE	Approved	1999-02-15	Unused	CYSLTR1
Rhinitis	ENSG00000183134	FALSE	Phase I Clinical Trial	2004-03-03	Phase I Clinical Trial	PTGDR2
Rhinitis	ENSG00000183625	FALSE	Phase II Clinical Trial	2005-01-28	Unused	CCR3
Rhinitis	ENSG00000183813	FALSE	Preclinical	2003-05-20	Unused	CCR4
Rhinitis	ENSG00000184160	FALSE	Preclinical	2012-08-23	Preclinical	ADRA2C
Rhinitis	ENSG00000184588	FALSE	Preclinical	1995-03-15	Unused	PDE4B
Rhinitis	ENSG00000185149	FALSE	Preclinical	1997-06-15	Unused	NPY2R
Rhinitis	ENSG00000196639	TRUE	Approved	1990-05-15	Approved	HRH1
Rhinitis	ENSG00000196664	FALSE	Phase II Clinical Trial	2007-08-07	Phase II Clinical Trial	TLR7
Rhinitis	ENSG00000196689	FALSE	Phase II Clinical Trial	2004-08-16	Phase II Clinical Trial	TRPV1
Rhinitis	ENSG00000239732	FALSE	Preclinical	2001-08-07	Unused	TLR9
Rhinitis	ENSG00000274286	FALSE	Preclinical	2012-08-23	Preclinical	ADRA2B
Rhinitis, Allergic, Perennial	ENSG00000006638	FALSE	Approved	1989-11-15	Unused	TBXA2R
Rhinitis, Allergic, Perennial	ENSG00000101916	FALSE	unknown	2008-04-10	Absent	TLR8
Rhinitis, Allergic, Perennial	ENSG00000113580	TRUE	Approved	1991-09-15	Approved	NR3C1
Rhinitis, Allergic, Perennial	ENSG00000168229	FALSE	Phase III Clinical Trial	2007-04-02	Absent	PTGDR
Rhinitis, Allergic, Perennial	ENSG00000169403	TRUE	Approved	1993-08-15	Approved	PTAFR
Rhinitis, Allergic, Perennial	ENSG00000172236	FALSE	unknown	1993-10-15	Unused	TPSAB1
Rhinitis, Allergic, Perennial	ENSG00000173198	TRUE	Approved	1993-07-15	Approved	CYSLTR1
Rhinitis, Allergic, Perennial	ENSG00000175591	FALSE	unknown	NA	Unused	P2RY2
Rhinitis, Allergic, Perennial	ENSG00000196639	TRUE	Approved	1993-06-15	Approved	HRH1
Rhinitis, Allergic, Perennial	ENSG00000196664	FALSE	unknown	2008-04-10	Absent	TLR7
Rhinitis, Allergic, Seasonal	ENSG00000010671	FALSE	unknown	2007-12-12	Unused	BTK
Rhinitis, Allergic, Seasonal	ENSG00000012779	FALSE	Phase II Clinical Trial	NA	Unused	ALOX5
Rhinitis, Allergic, Seasonal	ENSG00000065989	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	PDE4A
Rhinitis, Allergic, Seasonal	ENSG00000073756	FALSE	Phase III Clinical Trial	2010-12-15	Unused	PTGS2
Rhinitis, Allergic, Seasonal	ENSG00000077238	FALSE	Preclinical	2009-11-19	Absent	IL4R
Rhinitis, Allergic, Seasonal	ENSG00000095303	FALSE	Phase III Clinical Trial	2010-12-15	Unused	PTGS1
Rhinitis, Allergic, Seasonal	ENSG00000101180	FALSE	Phase II Clinical Trial	2007-08-07	Unused	HRH3
Rhinitis, Allergic, Seasonal	ENSG00000101916	FALSE	unknown	2008-04-10	Unused	TLR8
Rhinitis, Allergic, Seasonal	ENSG00000105650	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	PDE4C
Rhinitis, Allergic, Seasonal	ENSG00000107317	FALSE	Phase II Clinical Trial	2011-06-04	Phase II Clinical Trial	PTGDS
Rhinitis, Allergic, Seasonal	ENSG00000113448	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	PDE4D
Rhinitis, Allergic, Seasonal	ENSG00000113520	FALSE	Phase II Clinical Trial	2007-09-17	Unused	IL4
Rhinitis, Allergic, Seasonal	ENSG00000113580	TRUE	Approved	1991-09-15	Approved	NR3C1
Rhinitis, Allergic, Seasonal	ENSG00000134489	FALSE	unknown	2007-07-30	Phase II Clinical Trial	HRH4
Rhinitis, Allergic, Seasonal	ENSG00000136869	FALSE	Phase I Clinical Trial	2003-03-05	Unused	TLR4
Rhinitis, Allergic, Seasonal	ENSG00000149021	FALSE	Phase II Clinical Trial	1997-08-15	Unused	SCGB1A1
Rhinitis, Allergic, Seasonal	ENSG00000158859	FALSE	Phase II Clinical Trial	2015-09-03	Absent	ADAMTS4
Rhinitis, Allergic, Seasonal	ENSG00000165025	FALSE	unknown	1999-09-22	Unused	SYK
Rhinitis, Allergic, Seasonal	ENSG00000168229	FALSE	Phase II Clinical Trial	2003-09-17	Phase II Clinical Trial	PTGDR
Rhinitis, Allergic, Seasonal	ENSG00000169194	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	IL13
Rhinitis, Allergic, Seasonal	ENSG00000169403	TRUE	Approved	1993-08-15	Approved	PTAFR
Rhinitis, Allergic, Seasonal	ENSG00000172572	FALSE	Phase II Clinical Trial	2007-06-06	Phase II Clinical Trial	PDE3A
Rhinitis, Allergic, Seasonal	ENSG00000173198	TRUE	Approved	1993-07-15	Approved	CYSLTR1
Rhinitis, Allergic, Seasonal	ENSG00000183134	FALSE	Phase II Clinical Trial	2005-06-01	Phase II Clinical Trial	PTGDR2
Rhinitis, Allergic, Seasonal	ENSG00000183625	FALSE	unknown	2001-02-09	Unused	CCR3
Rhinitis, Allergic, Seasonal	ENSG00000184588	FALSE	Phase II Clinical Trial	1999-01-08	Phase II Clinical Trial	PDE4B
Rhinitis, Allergic, Seasonal	ENSG00000196639	TRUE	Approved	1993-06-15	Approved	HRH1
Rhinitis, Allergic, Seasonal	ENSG00000196664	FALSE	Phase II Clinical Trial	2007-08-07	Phase II Clinical Trial	TLR7
Rhinitis, Allergic, Seasonal	ENSG00000196689	FALSE	Phase II Clinical Trial	2004-08-16	Phase II Clinical Trial	TRPV1
Rhinitis, Allergic, Seasonal	ENSG00000239732	FALSE	Phase III Clinical Trial	1999-08-25	Unused	TLR9
Rickets	ENSG00000019186	FALSE	Preclinical	2001-10-19	Unused	CYP24A1
Rosacea	ENSG00000065989	FALSE	unknown	2010-06-08	Absent	PDE4A
Rosacea	ENSG00000073756	FALSE	Approved	NA	Unused	PTGS2
Rosacea	ENSG00000095303	FALSE	Approved	NA	Unused	PTGS1
Rosacea	ENSG00000100644	FALSE	Preclinical	2009-02-18	Preclinical	HIF1A
Rosacea	ENSG00000109320	FALSE	Preclinical	2015-10-23	Absent	NFKB1
Rosacea	ENSG00000112715	FALSE	Phase II Clinical Trial	2009-10-02	Phase II Clinical Trial	VEGFA
Rosacea	ENSG00000115008	FALSE	Phase II Clinical Trial	2014-01-31	Absent	IL1A
Rosacea	ENSG00000132906	FALSE	unknown	2007-03-05	Preclinical	CASP9
Rosacea	ENSG00000150594	TRUE	Approved	2009-10-20	Absent	ADRA2A
Rosacea	ENSG00000166333	FALSE	unknown	2010-06-08	Absent	ILK
Rosacea	ENSG00000168229	FALSE	Phase I Clinical Trial	2003-09-17	Phase I Clinical Trial	PTGDR
Rosacea	ENSG00000169047	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IRS1
Rosacea	ENSG00000169429	FALSE	Phase II Clinical Trial	2014-01-31	Absent	CXCL8
Rosacea	ENSG00000196611	TRUE	Approved	1995-06-15	Approved	MMP1
Rosacea	ENSG00000196689	FALSE	Phase II Clinical Trial	2009-06-30	Absent	TRPV1
Rosacea	ENSG00000228716	FALSE	Phase II Clinical Trial	1999-03-08	Unused	DHFR
Sandhoff Disease	ENSG00000049860	FALSE	Preclinical	2005-12-21	Unused	HEXB
Sandhoff Disease	ENSG00000148154	FALSE	unknown	2000-11-29	Unused	UGCG
Sandhoff Disease	ENSG00000213614	FALSE	Preclinical	2005-12-21	Unused	HEXA
Sarcoidosis	ENSG00000065989	FALSE	Phase II Clinical Trial	2004-01-28	Unused	PDE4A
Sarcoidosis	ENSG00000067182	FALSE	Phase II Clinical Trial	2004-01-28	Unused	TNFRSF1A
Sarcoidosis	ENSG00000105650	FALSE	Phase II Clinical Trial	2004-01-28	Unused	PDE4C
Sarcoidosis	ENSG00000111012	FALSE	Preclinical	NA	Unused	CYP27B1
Sarcoidosis	ENSG00000113302	FALSE	Phase II Clinical Trial	2003-04-30	Phase II Clinical Trial	IL12B
Sarcoidosis	ENSG00000113448	FALSE	Phase II Clinical Trial	2004-01-28	Unused	PDE4D
Sarcoidosis	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Sarcoidosis	ENSG00000114812	FALSE	Phase III Clinical Trial	2003-12-09	Unused	VIPR1
Sarcoidosis	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Absent	IL1B
Sarcoidosis	ENSG00000134216	FALSE	Phase I Clinical Trial	2014-12-23	Absent	CHIA
Sarcoidosis	ENSG00000160013	FALSE	Preclinical	2014-09-06	Absent	PTGIR
Sarcoidosis	ENSG00000184371	FALSE	Phase II Clinical Trial	2006-12-21	Preclinical	CSF1
Sarcoidosis	ENSG00000184588	FALSE	Phase II Clinical Trial	2004-01-28	Unused	PDE4B
Sarcoma	ENSG00000012779	FALSE	unknown	1993-10-15	Unused	ALOX5
Sarcoma	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Sarcoma	ENSG00000026508	FALSE	unknown	1992-09-15	Unused	CD44
Sarcoma	ENSG00000037280	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	FLT4
Sarcoma	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Sarcoma	ENSG00000047936	FALSE	Phase I Clinical Trial	2006-12-05	Absent	ROS1
Sarcoma	ENSG00000049249	FALSE	Phase I Clinical Trial	2011-01-31	Absent	TNFRSF9
Sarcoma	ENSG00000051180	FALSE	unknown	2004-10-05	Unused	RAD51
Sarcoma	ENSG00000065361	FALSE	Phase I Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Sarcoma	ENSG00000066468	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR2
Sarcoma	ENSG00000067182	FALSE	Phase I Clinical Trial	2003-05-23	Phase I Clinical Trial	TNFRSF1A
Sarcoma	ENSG00000068078	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR3
Sarcoma	ENSG00000077782	FALSE	Phase I Clinical Trial	2003-07-22	Phase I Clinical Trial	FGFR1
Sarcoma	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-12-05	Absent	HSP90AA1
Sarcoma	ENSG00000082175	FALSE	Phase II Clinical Trial	NA	Absent	PGR
Sarcoma	ENSG00000082781	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB5
Sarcoma	ENSG00000085563	FALSE	unknown	1997-01-15	Unused	ABCB1
Sarcoma	ENSG00000087586	FALSE	unknown	2004-05-20	Phase I Clinical Trial	AURKA
Sarcoma	ENSG00000096968	FALSE	unknown	2004-05-20	Phase I Clinical Trial	JAK2
Sarcoma	ENSG00000097007	TRUE	Approved	1999-03-17	Approved	ABL1
Sarcoma	ENSG00000100311	FALSE	Phase I Clinical Trial	2003-07-22	Absent	PDGFB
Sarcoma	ENSG00000100644	FALSE	unknown	1997-04-15	Unused	HIF1A
Sarcoma	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Sarcoma	ENSG00000101868	FALSE	Phase II Clinical Trial	NA	Unused	POLA1
Sarcoma	ENSG00000102755	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	FLT1
Sarcoma	ENSG00000102967	FALSE	unknown	1994-12-15	Unused	DHODH
Sarcoma	ENSG00000105810	FALSE	unknown	1996-05-15	Unused	CDK6
Sarcoma	ENSG00000105835	FALSE	Phase I Clinical Trial	2014-01-22	Absent	NAMPT
Sarcoma	ENSG00000105851	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CG
Sarcoma	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Sarcoma	ENSG00000106128	FALSE	Preclinical	1996-07-15	Unused	GHRHR
Sarcoma	ENSG00000106683	FALSE	Preclinical	2014-04-03	Absent	LIMK1
Sarcoma	ENSG00000106991	FALSE	unknown	2006-05-01	Phase I Clinical Trial	ENG
Sarcoma	ENSG00000112715	FALSE	Phase I Clinical Trial	2003-11-26	Phase I Clinical Trial	VEGFA
Sarcoma	ENSG00000113070	FALSE	Phase I Clinical Trial	2004-02-04	Phase I Clinical Trial	HBEGF
Sarcoma	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB6
Sarcoma	ENSG00000116478	FALSE	Phase II Clinical Trial	2005-07-20	Phase II Clinical Trial	HDAC1
Sarcoma	ENSG00000120889	FALSE	unknown	1997-04-15	Unused	TNFRSF10B
Sarcoma	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	PIK3CA
Sarcoma	ENSG00000122025	FALSE	unknown	2002-03-21	Phase II Clinical Trial	FLT3
Sarcoma	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Sarcoma	ENSG00000128052	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	KDR
Sarcoma	ENSG00000130669	FALSE	Phase I Clinical Trial	2014-01-22	Absent	PAK4
Sarcoma	ENSG00000131747	TRUE	Approved	1992-09-15	Approved	TOP2A
Sarcoma	ENSG00000132155	FALSE	unknown	NA	Unused	RAF1
Sarcoma	ENSG00000132170	FALSE	unknown	1993-10-15	Unused	PPARG
Sarcoma	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Sarcoma	ENSG00000134853	TRUE	Approved	1994-12-15	Approved	PDGFRA
Sarcoma	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Sarcoma	ENSG00000135446	FALSE	unknown	1996-05-15	Phase I Clinical Trial	CDK4
Sarcoma	ENSG00000136807	FALSE	unknown	1996-05-15	Phase I Clinical Trial	CDK9
Sarcoma	ENSG00000136810	FALSE	unknown	2000-05-11	Unused	TXN
Sarcoma	ENSG00000136869	FALSE	Phase II Clinical Trial	2013-11-01	Absent	TLR4
Sarcoma	ENSG00000138160	FALSE	unknown	2008-01-15	Unused	KIF11
Sarcoma	ENSG00000138413	FALSE	Phase I Clinical Trial	2010-04-19	Absent	IDH1
Sarcoma	ENSG00000138448	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGAV
Sarcoma	ENSG00000140443	FALSE	Phase II Clinical Trial	2003-06-03	Phase I Clinical Trial	IGF1R
Sarcoma	ENSG00000141510	FALSE	Phase I Clinical Trial	2009-02-12	Phase I Clinical Trial	TP53
Sarcoma	ENSG00000141736	FALSE	Phase II Clinical Trial	2000-04-04	Phase I Clinical Trial	ERBB2
Sarcoma	ENSG00000141867	FALSE	Phase I Clinical Trial	2003-09-05	Absent	BRD4
Sarcoma	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Unused	AKT1
Sarcoma	ENSG00000146648	FALSE	Phase I Clinical Trial	2003-12-08	Phase I Clinical Trial	EGFR
Sarcoma	ENSG00000146904	FALSE	unknown	2005-06-27	Phase I Clinical Trial	EPHA1
Sarcoma	ENSG00000149294	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NCAM1
Sarcoma	ENSG00000157404	TRUE	Approved	1999-03-17	Approved	KIT
Sarcoma	ENSG00000160867	FALSE	Phase I Clinical Trial	2003-07-22	Absent	FGFR4
Sarcoma	ENSG00000164078	FALSE	Phase II Clinical Trial	2008-08-15	Phase I Clinical Trial	MST1R
Sarcoma	ENSG00000164305	FALSE	Phase I Clinical Trial	1994-07-15	Phase I Clinical Trial	CASP3
Sarcoma	ENSG00000164399	FALSE	Preclinical	1997-07-15	Unused	IL3
Sarcoma	ENSG00000164400	FALSE	Phase I Clinical Trial	1997-09-15	Phase I Clinical Trial	CSF2
Sarcoma	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Sarcoma	ENSG00000165731	FALSE	Phase I Clinical Trial	2002-03-21	Phase II Clinical Trial	RET
Sarcoma	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Sarcoma	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Sarcoma	ENSG00000166851	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	PLK1
Sarcoma	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Sarcoma	ENSG00000171094	FALSE	Phase I Clinical Trial	2006-12-05	Phase I Clinical Trial	ALK
Sarcoma	ENSG00000171608	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PIK3CD
Sarcoma	ENSG00000173638	FALSE	Preclinical	1996-12-15	Unused	SLC19A1
Sarcoma	ENSG00000174807	FALSE	Preclinical	2017-03-14	Absent	CD248
Sarcoma	ENSG00000176890	FALSE	unknown	NA	Unused	TYMS
Sarcoma	ENSG00000177606	FALSE	Preclinical	1994-06-15	Unused	JUN
Sarcoma	ENSG00000178562	FALSE	Phase II Clinical Trial	2008-02-13	Unused	CD28
Sarcoma	ENSG00000178568	FALSE	unknown	2003-12-08	Unused	ERBB4
Sarcoma	ENSG00000178999	FALSE	unknown	2004-05-20	Phase I Clinical Trial	AURKB
Sarcoma	ENSG00000179776	FALSE	unknown	2000-12-11	Phase I Clinical Trial	CDH5
Sarcoma	ENSG00000182054	FALSE	Phase II Clinical Trial	NA	Absent	IDH2
Sarcoma	ENSG00000182578	FALSE	unknown	2005-06-27	Phase I Clinical Trial	CSF1R
Sarcoma	ENSG00000182871	FALSE	unknown	1997-02-15	Unused	COL18A1
Sarcoma	ENSG00000184033	FALSE	Phase II Clinical Trial	2013-11-01	Absent	CTAG1B
Sarcoma	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Absent	WT1
Sarcoma	ENSG00000185686	FALSE	Preclinical	NA	Absent	PRAME
Sarcoma	ENSG00000186716	TRUE	Approved	1999-03-17	Approved	BCR
Sarcoma	ENSG00000187555	FALSE	Preclinical	2012-05-01	Absent	USP7
Sarcoma	ENSG00000188389	FALSE	Phase I Clinical Trial	2015-10-12	Absent	PDCD1
Sarcoma	ENSG00000196591	FALSE	Phase II Clinical Trial	2005-07-20	Phase II Clinical Trial	HDAC2
Sarcoma	ENSG00000197122	FALSE	unknown	2005-06-27	Phase I Clinical Trial	SRC
Sarcoma	ENSG00000198793	FALSE	Phase II Clinical Trial	2003-09-05	Phase II Clinical Trial	MTOR
Sarcoma	ENSG00000198900	FALSE	Phase I Clinical Trial	1996-06-15	Phase I Clinical Trial	TOP1
Sarcoma	ENSG00000213903	FALSE	unknown	1993-10-15	Unused	LTB4R
Sarcoma	ENSG00000228716	FALSE	unknown	NA	Unused	DHFR
Sarcoma	ENSG00000243955	FALSE	unknown	1994-07-15	Unused	GSTA1
Sarcoma	ENSG00000253729	FALSE	Phase I Clinical Trial	2003-09-05	Absent	PRKDC
Sarcoma	ENSG00000259207	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB3
Sarcoma, Ewing	ENSG00000002586	FALSE	Preclinical	2016-09-15	Absent	CD99
Sarcoma, Ewing	ENSG00000004487	FALSE	Preclinical	NA	Absent	KDM1A
Sarcoma, Ewing	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT4
Sarcoma, Ewing	ENSG00000065361	FALSE	Phase I Clinical Trial	2007-02-07	Absent	ERBB3
Sarcoma, Ewing	ENSG00000065883	FALSE	Preclinical	2016-09-06	Absent	CDK13
Sarcoma, Ewing	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Sarcoma, Ewing	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR3
Sarcoma, Ewing	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR1
Sarcoma, Ewing	ENSG00000080824	FALSE	Phase II Clinical Trial	2014-03-10	Absent	HSP90AA1
Sarcoma, Ewing	ENSG00000085563	FALSE	unknown	1997-01-15	Unused	ABCB1
Sarcoma, Ewing	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Sarcoma, Ewing	ENSG00000101557	FALSE	Preclinical	2014-10-08	Absent	USP14
Sarcoma, Ewing	ENSG00000102755	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FLT1
Sarcoma, Ewing	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Sarcoma, Ewing	ENSG00000105976	FALSE	Phase II Clinical Trial	2004-08-09	Absent	MET
Sarcoma, Ewing	ENSG00000116750	FALSE	Preclinical	2014-10-08	Absent	UCHL5
Sarcoma, Ewing	ENSG00000119630	FALSE	Phase II Clinical Trial	2003-07-24	Absent	PGF
Sarcoma, Ewing	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-08-09	Absent	TEK
Sarcoma, Ewing	ENSG00000122025	FALSE	Phase II Clinical Trial	2004-08-09	Absent	FLT3
Sarcoma, Ewing	ENSG00000128052	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KDR
Sarcoma, Ewing	ENSG00000129484	FALSE	Phase II Clinical Trial	2008-09-17	Absent	PARP2
Sarcoma, Ewing	ENSG00000131747	FALSE	Approved	2007-03-05	Absent	TOP2A
Sarcoma, Ewing	ENSG00000134460	FALSE	Preclinical	2015-09-15	Absent	IL2RA
Sarcoma, Ewing	ENSG00000140443	FALSE	Phase III Clinical Trial	2003-06-03	Phase II Clinical Trial	IGF1R
Sarcoma, Ewing	ENSG00000143799	FALSE	Phase II Clinical Trial	2008-09-17	Absent	PARP1
Sarcoma, Ewing	ENSG00000151702	FALSE	Phase I Clinical Trial	2005-05-13	Unused	FLI1
Sarcoma, Ewing	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Absent	KIT
Sarcoma, Ewing	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Sarcoma, Ewing	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Sarcoma, Ewing	ENSG00000164400	FALSE	Phase II Clinical Trial	2008-07-04	Phase II Clinical Trial	CSF2
Sarcoma, Ewing	ENSG00000165731	FALSE	Phase II Clinical Trial	2003-07-22	Absent	RET
Sarcoma, Ewing	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Sarcoma, Ewing	ENSG00000167258	FALSE	Preclinical	2016-09-06	Absent	CDK12
Sarcoma, Ewing	ENSG00000171862	FALSE	Preclinical	2017-09-05	Absent	PTEN
Sarcoma, Ewing	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Sarcoma, Ewing	ENSG00000177034	FALSE	Preclinical	2016-10-24	Absent	MTX3
Sarcoma, Ewing	ENSG00000182944	FALSE	Phase I Clinical Trial	2005-05-13	Unused	EWSR1
Sarcoma, Ewing	ENSG00000185591	FALSE	Preclinical	2011-12-03	Absent	SP1
Sarcoma, Ewing	ENSG00000197081	FALSE	Phase I Clinical Trial	2009-01-13	Phase I Clinical Trial	IGF2R
Sarcoma, Ewing	ENSG00000198793	FALSE	Phase I Clinical Trial	2011-01-24	Absent	MTOR
Sarcoma, Ewing	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Unused	TOP1
Sarcoma, Ewing	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Sarcoma, Ewing	ENSG00000253729	FALSE	Phase I Clinical Trial	2011-01-24	Absent	PRKDC
Sarcoma, Ewing	ENSG00000263761	FALSE	Preclinical	2017-02-10	Absent	GDF2
Sarcoma, Kaposi	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Unused	IFNGR1
Sarcoma, Kaposi	ENSG00000060491	FALSE	Preclinical	2012-09-01	Absent	OGFR
Sarcoma, Kaposi	ENSG00000063176	FALSE	Preclinical	2006-06-05	Absent	SPHK2
Sarcoma, Kaposi	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Sarcoma, Kaposi	ENSG00000074181	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH3
Sarcoma, Kaposi	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Sarcoma, Kaposi	ENSG00000077238	FALSE	unknown	NA	Unused	IL4R
Sarcoma, Kaposi	ENSG00000081985	FALSE	unknown	NA	Unused	IL12RB2
Sarcoma, Kaposi	ENSG00000082781	FALSE	unknown	1998-06-15	Unused	ITGB5
Sarcoma, Kaposi	ENSG00000087245	FALSE	unknown	1997-06-15	Unused	MMP2
Sarcoma, Kaposi	ENSG00000095596	FALSE	unknown	NA	Unused	CYP26A1
Sarcoma, Kaposi	ENSG00000096996	FALSE	unknown	NA	Unused	IL12RB1
Sarcoma, Kaposi	ENSG00000100985	FALSE	unknown	1997-06-15	Unused	MMP9
Sarcoma, Kaposi	ENSG00000112715	FALSE	unknown	2003-11-26	Phase II Clinical Trial	VEGFA
Sarcoma, Kaposi	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Sarcoma, Kaposi	ENSG00000128052	FALSE	unknown	1997-11-15	Unused	KDR
Sarcoma, Kaposi	ENSG00000131747	TRUE	Approved	1996-10-15	Approved	TOP2A
Sarcoma, Kaposi	ENSG00000134250	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	NOTCH2
Sarcoma, Kaposi	ENSG00000138039	FALSE	Preclinical	1997-05-15	Unused	LHCGR
Sarcoma, Kaposi	ENSG00000138448	FALSE	unknown	1998-06-15	Unused	ITGAV
Sarcoma, Kaposi	ENSG00000138685	FALSE	Preclinical	1989-07-15	Unused	FGF2
Sarcoma, Kaposi	ENSG00000143171	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRG
Sarcoma, Kaposi	ENSG00000146648	FALSE	Preclinical	2011-10-27	Unused	EGFR
Sarcoma, Kaposi	ENSG00000159110	TRUE	Approved	1991-09-15	Approved	IFNAR2
Sarcoma, Kaposi	ENSG00000160712	FALSE	Preclinical	1991-04-15	Unused	IL6R
Sarcoma, Kaposi	ENSG00000163737	FALSE	unknown	NA	Unused	PF4
Sarcoma, Kaposi	ENSG00000167658	FALSE	Preclinical	1991-04-15	Unused	EEF2
Sarcoma, Kaposi	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Sarcoma, Kaposi	ENSG00000169385	FALSE	Preclinical	1999-04-21	Unused	RNASE2
Sarcoma, Kaposi	ENSG00000186350	FALSE	Phase III Clinical Trial	1992-09-15	Unused	RXRA
Sarcoma, Kaposi	ENSG00000188379	FALSE	Approved	2017-01-05	Absent	IFNA2
Sarcoma, Kaposi	ENSG00000198223	FALSE	Phase III Clinical Trial	NA	Unused	CSF2RA
Sarcoma, Kaposi	ENSG00000259207	FALSE	unknown	1998-06-15	Unused	ITGB3
Sarcoma, Kaposi	ENSG00000260314	FALSE	Preclinical	2015-06-10	Absent	MRC1
Sarcoma, Synovial	ENSG00000037280	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT4
Sarcoma, Synovial	ENSG00000068078	FALSE	Phase III Clinical Trial	2001-04-03	Absent	FGFR3
Sarcoma, Synovial	ENSG00000077782	FALSE	Phase III Clinical Trial	2001-04-03	Absent	FGFR1
Sarcoma, Synovial	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	FLT1
Sarcoma, Synovial	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Sarcoma, Synovial	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Sarcoma, Synovial	ENSG00000113712	FALSE	Preclinical	2014-08-02	Absent	CSNK1A1
Sarcoma, Synovial	ENSG00000113721	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Sarcoma, Synovial	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-06-20	Absent	CD274
Sarcoma, Synovial	ENSG00000128052	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KDR
Sarcoma, Synovial	ENSG00000134323	FALSE	Preclinical	NA	Absent	MYCN
Sarcoma, Synovial	ENSG00000134853	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRA
Sarcoma, Synovial	ENSG00000136869	FALSE	Phase II Clinical Trial	2013-11-01	Absent	TLR4
Sarcoma, Synovial	ENSG00000136997	FALSE	Preclinical	NA	Absent	MYC
Sarcoma, Synovial	ENSG00000140443	FALSE	unknown	2003-09-24	Phase II Clinical Trial	IGF1R
Sarcoma, Synovial	ENSG00000157404	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	KIT
Sarcoma, Synovial	ENSG00000157764	FALSE	Phase III Clinical Trial	2001-04-03	Phase III Clinical Trial	BRAF
Sarcoma, Synovial	ENSG00000184033	FALSE	Phase III Clinical Trial	2009-04-09	Absent	CTAG1B
Sarcopenia	ENSG00000043591	FALSE	Preclinical	2010-11-24	Preclinical	ADRB1
Sarcopenia	ENSG00000096717	FALSE	Phase I Clinical Trial	2008-10-21	Phase I Clinical Trial	SIRT1
Sarcopenia	ENSG00000114739	FALSE	Phase II Clinical Trial	2010-07-02	Absent	ACVR2B
Sarcopenia	ENSG00000121853	FALSE	Phase II Clinical Trial	1998-10-15	Phase II Clinical Trial	GHSR
Sarcopenia	ENSG00000130368	FALSE	Phase II Clinical Trial	2016-02-10	Absent	MAS1
Sarcopenia	ENSG00000134569	FALSE	Preclinical	2016-07-28	Absent	LRP4
Sarcopenia	ENSG00000138379	FALSE	Phase II Clinical Trial	2007-05-29	Unused	MSTN
Sarcopenia	ENSG00000140564	FALSE	Preclinical	2015-02-06	Absent	FURIN
Sarcopenia	ENSG00000164099	FALSE	Preclinical	2007-11-16	Preclinical	PRSS12
Sarcopenia	ENSG00000169083	FALSE	Phase II Clinical Trial	2003-09-02	Phase II Clinical Trial	AR
Sarcopenia	ENSG00000188157	FALSE	Preclinical	2010-07-07	Preclinical	AGRN
Sarcopenia	ENSG00000196218	FALSE	Preclinical	2008-07-04	Absent	RYR1
Schistosomiasis	ENSG00000068903	FALSE	Preclinical	2015-08-26	Absent	SIRT2
Schistosomiasis	ENSG00000213614	FALSE	unknown	2013-11-20	Absent	HEXA
Schizophrenia	ENSG00000010322	FALSE	Phase III Clinical Trial	NA	Unused	NISCH
Schizophrenia	ENSG00000011677	FALSE	Phase II Clinical Trial	1989-09-15	Unused	GABRA3
Schizophrenia	ENSG00000065989	FALSE	Phase I Clinical Trial	1999-01-08	Absent	PDE4A
Schizophrenia	ENSG00000069696	TRUE	Approved	1989-12-15	Approved	DRD4
Schizophrenia	ENSG00000073756	FALSE	Phase II Clinical Trial	2000-05-24	Unused	PTGS2
Schizophrenia	ENSG00000075073	FALSE	Phase I Clinical Trial	2003-03-23	Unused	TACR2
Schizophrenia	ENSG00000080293	FALSE	Preclinical	1999-03-23	Unused	SCTR
Schizophrenia	ENSG00000082175	FALSE	unknown	2009-04-23	Unused	PGR
Schizophrenia	ENSG00000082556	FALSE	Phase III Clinical Trial	2013-01-09	Phase I Clinical Trial	OPRK1
Schizophrenia	ENSG00000082701	FALSE	Preclinical	2004-10-15	Unused	GSK3B
Schizophrenia	ENSG00000087085	FALSE	Phase II Clinical Trial	1989-06-15	Phase II Clinical Trial	ACHE
Schizophrenia	ENSG00000093010	FALSE	Preclinical	2012-04-05	Preclinical	COMT
Schizophrenia	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Schizophrenia	ENSG00000100985	FALSE	Preclinical	2014-12-06	Absent	MMP9
Schizophrenia	ENSG00000101126	FALSE	Preclinical	2003-06-17	Unused	ADNP
Schizophrenia	ENSG00000101180	FALSE	Phase II Clinical Trial	2006-01-23	Phase I Clinical Trial	HRH3
Schizophrenia	ENSG00000101204	FALSE	Phase II Clinical Trial	2000-12-12	Phase I Clinical Trial	CHRNA4
Schizophrenia	ENSG00000102468	TRUE	Approved	1989-12-15	Approved	HTR2A
Schizophrenia	ENSG00000103546	TRUE	Approved	2011-12-07	Approved	SLC6A2
Schizophrenia	ENSG00000105464	FALSE	Preclinical	2011-07-28	Absent	GRIN2D
Schizophrenia	ENSG00000105650	FALSE	Phase I Clinical Trial	1999-01-08	Absent	PDE4C
Schizophrenia	ENSG00000108576	FALSE	Phase II Clinical Trial	1998-05-15	Unused	SLC6A4
Schizophrenia	ENSG00000109576	FALSE	Preclinical	2010-12-30	Preclinical	AADAT
Schizophrenia	ENSG00000110148	FALSE	Preclinical	1996-03-15	Unused	CCKBR
Schizophrenia	ENSG00000110887	FALSE	Phase III Clinical Trial	2012-04-05	Preclinical	DAO
Schizophrenia	ENSG00000112038	FALSE	Phase III Clinical Trial	2013-01-09	Phase I Clinical Trial	OPRM1
Schizophrenia	ENSG00000112541	FALSE	Phase II Clinical Trial	2006-02-27	Phase I Clinical Trial	PDE10A
Schizophrenia	ENSG00000113448	FALSE	Phase I Clinical Trial	1999-01-08	Absent	PDE4D
Schizophrenia	ENSG00000115252	FALSE	Phase I Clinical Trial	2007-06-26	Phase I Clinical Trial	PDE1A
Schizophrenia	ENSG00000115353	FALSE	Preclinical	2009-03-06	Unused	TACR1
Schizophrenia	ENSG00000116329	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	OPRD1
Schizophrenia	ENSG00000117594	FALSE	Preclinical	2015-03-06	Absent	HSD11B1
Schizophrenia	ENSG00000118432	FALSE	Phase II Clinical Trial	1994-02-15	Unused	CNR1
Schizophrenia	ENSG00000120907	TRUE	Approved	2003-02-17	Approved	ADRA1A
Schizophrenia	ENSG00000124493	FALSE	Preclinical	2009-06-11	Unused	GRM4
Schizophrenia	ENSG00000125510	FALSE	Phase II Clinical Trial	2009-07-02	Unused	OPRL1
Schizophrenia	ENSG00000125730	FALSE	Preclinical	2016-06-28	Absent	C3
Schizophrenia	ENSG00000128271	FALSE	unknown	1995-06-15	Absent	ADORA2A
Schizophrenia	ENSG00000130876	FALSE	Preclinical	2014-12-12	Absent	SLC7A10
Schizophrenia	ENSG00000133019	TRUE	Approved	2008-04-30	Approved	CHRM3
Schizophrenia	ENSG00000135312	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	HTR1B
Schizophrenia	ENSG00000135519	FALSE	Phase I Clinical Trial	2008-05-13	Absent	KCNH3
Schizophrenia	ENSG00000135914	FALSE	Phase II Clinical Trial	2001-11-13	Unused	HTR2B
Schizophrenia	ENSG00000138039	FALSE	Preclinical	2005-12-06	Unused	LHCGR
Schizophrenia	ENSG00000142319	FALSE	Preclinical	2011-12-07	Unused	SLC6A3
Schizophrenia	ENSG00000143799	FALSE	Preclinical	2003-06-17	Unused	PARP1
Schizophrenia	ENSG00000144285	FALSE	Phase III Clinical Trial	2004-02-25	Unused	SCN1A
Schizophrenia	ENSG00000145335	FALSE	Preclinical	2017-02-15	Absent	SNCA
Schizophrenia	ENSG00000146399	FALSE	Phase I Clinical Trial	2012-07-25	Preclinical	TAAR1
Schizophrenia	ENSG00000147246	TRUE	Approved	1989-12-15	Approved	HTR2C
Schizophrenia	ENSG00000147955	FALSE	Phase III Clinical Trial	1992-11-15	Phase II Clinical Trial	SIGMAR1
Schizophrenia	ENSG00000148680	TRUE	Approved	1996-01-15	Approved	HTR7
Schizophrenia	ENSG00000149295	TRUE	Approved	1989-12-15	Approved	DRD2
Schizophrenia	ENSG00000151012	FALSE	Preclinical	2009-11-04	Absent	SLC7A11
Schizophrenia	ENSG00000151577	TRUE	Approved	1989-12-15	Approved	DRD3
Schizophrenia	ENSG00000151834	FALSE	Phase II Clinical Trial	2007-08-28	Unused	GABRA2
Schizophrenia	ENSG00000153253	FALSE	Phase III Clinical Trial	2004-02-25	Unused	SCN3A
Schizophrenia	ENSG00000154229	FALSE	Preclinical	2012-09-25	Preclinical	PRKCA
Schizophrenia	ENSG00000155511	FALSE	Phase I Clinical Trial	1994-02-15	Phase I Clinical Trial	GRIA1
Schizophrenia	ENSG00000157168	FALSE	Preclinical	2004-02-13	Unused	NRG1
Schizophrenia	ENSG00000158292	FALSE	Preclinical	2016-11-02	Absent	GPR153
Schizophrenia	ENSG00000158748	TRUE	Approved	1999-01-15	Approved	HTR6
Schizophrenia	ENSG00000160191	FALSE	Phase II Clinical Trial	2011-05-02	Absent	PDE9A
Schizophrenia	ENSG00000160716	FALSE	Phase II Clinical Trial	2000-12-12	Phase I Clinical Trial	CHRNB2
Schizophrenia	ENSG00000161509	FALSE	Preclinical	2011-07-28	Absent	GRIN2C
Schizophrenia	ENSG00000163394	FALSE	Preclinical	1996-03-15	Unused	CCKAR
Schizophrenia	ENSG00000163485	FALSE	unknown	2011-06-25	Preclinical	ADORA1
Schizophrenia	ENSG00000164082	FALSE	Phase II Clinical Trial	2005-01-18	Phase II Clinical Trial	GRM2
Schizophrenia	ENSG00000164270	FALSE	Phase I Clinical Trial	2001-06-14	Unused	HTR4
Schizophrenia	ENSG00000165646	FALSE	Preclinical	2009-05-05	Approved	SLC18A2
Schizophrenia	ENSG00000165970	FALSE	Preclinical	1998-12-15	Unused	SLC6A5
Schizophrenia	ENSG00000166736	TRUE	Approved	2008-04-30	Approved	HTR3A
Schizophrenia	ENSG00000168539	TRUE	Approved	1995-03-15	Approved	CHRM1
Schizophrenia	ENSG00000168959	FALSE	Phase I Clinical Trial	2006-09-20	Unused	GRM5
Schizophrenia	ENSG00000169432	FALSE	Phase II Clinical Trial	2007-03-09	Preclinical	SCN9A
Schizophrenia	ENSG00000169676	FALSE	Preclinical	2001-03-30	Unused	DRD5
Schizophrenia	ENSG00000169836	FALSE	Phase II Clinical Trial	1995-05-15	Unused	TACR3
Schizophrenia	ENSG00000171189	FALSE	Preclinical	2015-06-19	Absent	GRIK1
Schizophrenia	ENSG00000171873	FALSE	Phase I Clinical Trial	2013-12-07	Absent	ADRA1D
Schizophrenia	ENSG00000173250	FALSE	Preclinical	2015-03-18	Absent	GPR151
Schizophrenia	ENSG00000175344	FALSE	Phase II Clinical Trial	1997-10-15	Phase III Clinical Trial	CHRNA7
Schizophrenia	ENSG00000176884	FALSE	Phase II Clinical Trial	2008-01-16	Unused	GRIN1
Schizophrenia	ENSG00000178394	TRUE	Approved	1992-10-15	Approved	HTR1A
Schizophrenia	ENSG00000178568	FALSE	Preclinical	2010-10-27	Absent	ERBB4
Schizophrenia	ENSG00000179546	TRUE	Approved	1992-10-15	Approved	HTR1D
Schizophrenia	ENSG00000180269	FALSE	Phase II Clinical Trial	2016-05-02	Absent	GPR139
Schizophrenia	ENSG00000180720	TRUE	Approved	1995-03-15	Approved	CHRM4
Schizophrenia	ENSG00000180914	FALSE	unknown	NA	Absent	OXTR
Schizophrenia	ENSG00000181072	TRUE	Approved	2008-04-30	Approved	CHRM2
Schizophrenia	ENSG00000181656	FALSE	Preclinical	2012-03-14	Absent	GPR88
Schizophrenia	ENSG00000182326	FALSE	Preclinical	2016-06-27	Absent	C1S
Schizophrenia	ENSG00000184160	FALSE	Preclinical	2003-11-26	Phase I Clinical Trial	ADRA2C
Schizophrenia	ENSG00000184588	FALSE	Phase I Clinical Trial	1999-01-08	Absent	PDE4B
Schizophrenia	ENSG00000184845	TRUE	Approved	1989-12-15	Approved	DRD1
Schizophrenia	ENSG00000185313	FALSE	Phase II Clinical Trial	2007-03-09	Preclinical	SCN10A
Schizophrenia	ENSG00000186297	FALSE	Phase II Clinical Trial	2010-02-09	Absent	GABRA5
Schizophrenia	ENSG00000186642	FALSE	Preclinical	2009-09-18	Unused	PDE2A
Schizophrenia	ENSG00000187266	FALSE	Phase II Clinical Trial	2005-12-06	Unused	EPOR
Schizophrenia	ENSG00000196517	FALSE	Phase III Clinical Trial	1997-10-15	Phase III Clinical Trial	SLC6A9
Schizophrenia	ENSG00000196639	TRUE	Approved	2002-04-03	Approved	HRH1
Schizophrenia	ENSG00000198049	FALSE	Preclinical	2006-03-27	Unused	AVPR1B
Schizophrenia	ENSG00000198822	FALSE	Phase II Clinical Trial	2006-12-13	Unused	GRM3
Schizophrenia	ENSG00000242950	FALSE	Preclinical	2010-07-07	Preclinical	ERVW-1
Schizophrenia	ENSG00000273079	FALSE	Preclinical	2011-11-15	Preclinical	GRIN2B
Schnitzler Syndrome	ENSG00000125538	FALSE	Phase II Clinical Trial	2006-01-18	Absent	IL1B
Scleritis	ENSG00000113580	FALSE	Phase I Clinical Trial	2008-03-14	Phase I Clinical Trial	NR3C1
Scleritis	ENSG00000125538	FALSE	Phase II Clinical Trial	2006-01-18	Phase II Clinical Trial	IL1B
Scleroderma, Systemic	ENSG00000006638	FALSE	Phase II Clinical Trial	1991-10-15	Absent	TBXA2R
Scleroderma, Systemic	ENSG00000007952	FALSE	Preclinical	NA	Absent	NOX1
Scleroderma, Systemic	ENSG00000037280	FALSE	Phase III Clinical Trial	2001-10-30	Absent	FLT4
Scleroderma, Systemic	ENSG00000050748	FALSE	Preclinical	2001-01-23	Absent	MAPK9
Scleroderma, Systemic	ENSG00000067182	FALSE	Phase II Clinical Trial	NA	Unused	TNFRSF1A
Scleroderma, Systemic	ENSG00000082781	FALSE	Phase II Clinical Trial	2008-01-15	Unused	ITGB5
Scleroderma, Systemic	ENSG00000086991	FALSE	Preclinical	NA	Absent	NOX4
Scleroderma, Systemic	ENSG00000097007	FALSE	unknown	1999-03-17	Unused	ABL1
Scleroderma, Systemic	ENSG00000099985	FALSE	Phase II Clinical Trial	2015-03-12	Absent	OSM
Scleroderma, Systemic	ENSG00000100453	FALSE	Preclinical	2013-03-12	Absent	GZMB
Scleroderma, Systemic	ENSG00000102755	FALSE	Phase III Clinical Trial	2001-10-30	Absent	FLT1
Scleroderma, Systemic	ENSG00000104321	FALSE	Approved	2005-05-23	Absent	TRPA1
Scleroderma, Systemic	ENSG00000105329	FALSE	Phase II Clinical Trial	1997-06-15	Phase II Clinical Trial	TGFB1
Scleroderma, Systemic	ENSG00000106178	FALSE	Phase I Clinical Trial	NA	Absent	CCL24
Scleroderma, Systemic	ENSG00000107643	FALSE	Preclinical	2001-01-23	Absent	MAPK8
Scleroderma, Systemic	ENSG00000108821	FALSE	Phase II Clinical Trial	2007-08-17	Unused	COL1A1
Scleroderma, Systemic	ENSG00000109339	FALSE	Preclinical	2001-01-23	Absent	MAPK10
Scleroderma, Systemic	ENSG00000110799	FALSE	Phase II Clinical Trial	2016-10-31	Absent	VWF
Scleroderma, Systemic	ENSG00000112033	FALSE	Phase II Clinical Trial	2013-03-19	Absent	PPARD
Scleroderma, Systemic	ENSG00000112062	FALSE	Phase II Clinical Trial	NA	Unused	MAPK14
Scleroderma, Systemic	ENSG00000112715	FALSE	Preclinical	2012-03-13	Preclinical	VEGFA
Scleroderma, Systemic	ENSG00000113520	FALSE	Phase II Clinical Trial	2011-04-28	Absent	IL4
Scleroderma, Systemic	ENSG00000115221	FALSE	Phase II Clinical Trial	2008-01-15	Absent	ITGB6
Scleroderma, Systemic	ENSG00000116044	FALSE	Preclinical	2013-07-19	Absent	NFE2L2
Scleroderma, Systemic	ENSG00000116824	FALSE	Phase I Clinical Trial	1989-08-15	Unused	CD2
Scleroderma, Systemic	ENSG00000118523	FALSE	Preclinical	1998-10-15	Unused	CTGF
Scleroderma, Systemic	ENSG00000120949	FALSE	Preclinical	2002-10-28	Absent	TNFRSF8
Scleroderma, Systemic	ENSG00000121807	FALSE	unknown	2003-02-24	Unused	CCR2
Scleroderma, Systemic	ENSG00000122884	FALSE	Preclinical	2001-02-06	Unused	P4HA1
Scleroderma, Systemic	ENSG00000128052	FALSE	Phase III Clinical Trial	2001-10-30	Absent	KDR
Scleroderma, Systemic	ENSG00000132170	FALSE	Phase II Clinical Trial	2013-03-19	Absent	PPARG
Scleroderma, Systemic	ENSG00000134318	FALSE	Preclinical	2005-05-24	Absent	ROCK2
Scleroderma, Systemic	ENSG00000134853	FALSE	Phase III Clinical Trial	1999-03-17	Unused	PDGFRA
Scleroderma, Systemic	ENSG00000136869	FALSE	Preclinical	2013-01-02	Preclinical	TLR4
Scleroderma, Systemic	ENSG00000136960	FALSE	Preclinical	2014-10-09	Absent	ENPP2
Scleroderma, Systemic	ENSG00000138448	FALSE	Phase II Clinical Trial	2008-01-15	Unused	ITGAV
Scleroderma, Systemic	ENSG00000140937	FALSE	unknown	NA	Preclinical	CDH11
Scleroderma, Systemic	ENSG00000142166	FALSE	Phase I Clinical Trial	2004-11-23	Phase I Clinical Trial	IFNAR1
Scleroderma, Systemic	ENSG00000150093	FALSE	Phase II Clinical Trial	2008-01-15	Absent	ITGB1
Scleroderma, Systemic	ENSG00000156738	FALSE	Phase III Clinical Trial	2013-06-20	Absent	MS4A1
Scleroderma, Systemic	ENSG00000157404	FALSE	unknown	1999-03-17	Unused	KIT
Scleroderma, Systemic	ENSG00000160013	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PTGIR
Scleroderma, Systemic	ENSG00000160712	FALSE	Phase III Clinical Trial	1996-05-15	Phase III Clinical Trial	IL6R
Scleroderma, Systemic	ENSG00000163220	FALSE	Phase II Clinical Trial	2002-06-05	Phase II Clinical Trial	S100A9
Scleroderma, Systemic	ENSG00000168036	FALSE	unknown	2015-02-04	Absent	CTNNB1
Scleroderma, Systemic	ENSG00000168610	FALSE	unknown	2015-02-13	Absent	STAT3
Scleroderma, Systemic	ENSG00000169194	FALSE	Phase II Clinical Trial	2006-12-07	Phase II Clinical Trial	IL13
Scleroderma, Systemic	ENSG00000171509	FALSE	Phase I Clinical Trial	NA	Unused	RXFP1
Scleroderma, Systemic	ENSG00000171517	FALSE	Phase II Clinical Trial	2010-10-28	Phase II Clinical Trial	LPAR3
Scleroderma, Systemic	ENSG00000177455	FALSE	Phase I Clinical Trial	2007-08-07	Unused	CD19
Scleroderma, Systemic	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Scleroderma, Systemic	ENSG00000186716	FALSE	unknown	1999-03-17	Unused	BCR
Scleroderma, Systemic	ENSG00000186951	FALSE	Phase II Clinical Trial	2013-03-19	Absent	PPARA
Scleroderma, Systemic	ENSG00000188822	FALSE	Phase III Clinical Trial	2011-05-13	Absent	CNR2
Scleroderma, Systemic	ENSG00000196839	FALSE	Preclinical	NA	Absent	ADA
Scleroderma, Systemic	ENSG00000198121	FALSE	Phase II Clinical Trial	2010-02-10	Phase II Clinical Trial	LPAR1
Scleroderma, Systemic	ENSG00000239961	FALSE	Phase I Clinical Trial	2010-01-21	Absent	LILRA4
Scleroderma, Systemic	ENSG00000254087	FALSE	Phase III Clinical Trial	2001-10-30	Absent	LYN
Scleroderma, Systemic	ENSG00000259207	FALSE	Phase II Clinical Trial	2008-01-15	Absent	ITGB3
Scleroderma, Systemic	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Seasonal Affective Disorder	ENSG00000134640	FALSE	Preclinical	1993-10-15	Absent	MTNR1B
Seasonal Affective Disorder	ENSG00000168412	FALSE	Preclinical	1993-10-15	Absent	MTNR1A
Sepsis	ENSG00000003436	FALSE	Phase III Clinical Trial	1994-11-15	Unused	TFPI
Sepsis	ENSG00000005421	FALSE	Preclinical	2001-01-23	Unused	PON1
Sepsis	ENSG00000005961	FALSE	unknown	2010-08-20	Phase II Clinical Trial	ITGA2B
Sepsis	ENSG00000007171	FALSE	Preclinical	1992-09-15	Unused	NOS2
Sepsis	ENSG00000007908	FALSE	Preclinical	1992-01-15	Unused	SELE
Sepsis	ENSG00000012223	FALSE	Phase III Clinical Trial	1994-08-15	Phase III Clinical Trial	LTF
Sepsis	ENSG00000012779	FALSE	Preclinical	1996-08-15	Unused	ALOX5
Sepsis	ENSG00000023445	FALSE	Preclinical	1997-02-15	Unused	BIRC3
Sepsis	ENSG00000064012	FALSE	unknown	1999-01-15	Unused	CASP8
Sepsis	ENSG00000067182	FALSE	Phase III Clinical Trial	1992-05-15	Unused	TNFRSF1A
Sepsis	ENSG00000069764	FALSE	Phase I Clinical Trial	1994-12-15	Unused	PLA2G10
Sepsis	ENSG00000073756	FALSE	Preclinical	1996-08-15	Unused	PTGS2
Sepsis	ENSG00000082175	FALSE	Phase I Clinical Trial	2002-03-22	Unused	PGR
Sepsis	ENSG00000082556	TRUE	Approved	1993-01-15	Approved	OPRK1
Sepsis	ENSG00000082781	FALSE	Preclinical	NA	Unused	ITGB5
Sepsis	ENSG00000088926	FALSE	Preclinical	2017-04-11	Absent	F11
Sepsis	ENSG00000089250	FALSE	Preclinical	1996-11-15	Unused	NOS1
Sepsis	ENSG00000091879	FALSE	Preclinical	2015-08-07	Absent	ANGPT2
Sepsis	ENSG00000094631	FALSE	Preclinical	2016-09-20	Absent	HDAC6
Sepsis	ENSG00000096968	FALSE	Phase I Clinical Trial	2006-07-24	Unused	JAK2
Sepsis	ENSG00000100739	FALSE	Preclinical	1997-03-15	Unused	BDKRB1
Sepsis	ENSG00000100985	FALSE	Preclinical	1995-01-15	Unused	MMP9
Sepsis	ENSG00000101425	FALSE	Phase I Clinical Trial	2011-03-07	Phase I Clinical Trial	BPI
Sepsis	ENSG00000105639	FALSE	Preclinical	2000-11-07	Unused	JAK3
Sepsis	ENSG00000106804	FALSE	Preclinical	2008-03-20	Unused	C5
Sepsis	ENSG00000109320	FALSE	Phase I Clinical Trial	2006-07-24	Unused	NFKB1
Sepsis	ENSG00000111537	FALSE	Preclinical	2001-12-07	Unused	IFNG
Sepsis	ENSG00000112038	TRUE	Approved	1993-01-15	Approved	OPRM1
Sepsis	ENSG00000112062	FALSE	Preclinical	1995-11-15	Unused	MAPK14
Sepsis	ENSG00000114854	FALSE	unknown	1991-05-15	Absent	TNNC1
Sepsis	ENSG00000115415	FALSE	Phase I Clinical Trial	2006-07-24	Unused	STAT1
Sepsis	ENSG00000115590	FALSE	Preclinical	1995-11-15	Unused	IL1R2
Sepsis	ENSG00000115594	FALSE	Preclinical	1989-06-15	Unused	IL1R1
Sepsis	ENSG00000115718	TRUE	Approved	1995-09-15	Unused	PROC
Sepsis	ENSG00000117525	FALSE	Phase III Clinical Trial	1994-11-15	Unused	F3
Sepsis	ENSG00000117560	FALSE	Preclinical	2004-01-19	Unused	FASLG
Sepsis	ENSG00000118137	FALSE	Preclinical	1993-06-15	Unused	APOA1
Sepsis	ENSG00000120217	FALSE	unknown	2008-01-16	Absent	CD274
Sepsis	ENSG00000124731	FALSE	Phase II Clinical Trial	2002-06-25	Unused	TREM1
Sepsis	ENSG00000126218	FALSE	unknown	2003-04-15	Unused	F10
Sepsis	ENSG00000128271	FALSE	Preclinical	2000-04-03	Unused	ADORA2A
Sepsis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Sepsis	ENSG00000135744	TRUE	Approved	2013-03-05	Absent	AGT
Sepsis	ENSG00000136244	FALSE	Phase I Clinical Trial	2006-07-24	Unused	IL6
Sepsis	ENSG00000136869	FALSE	Phase III Clinical Trial	1993-08-15	Phase III Clinical Trial	TLR4
Sepsis	ENSG00000136960	FALSE	Preclinical	2014-10-08	Absent	ENPP2
Sepsis	ENSG00000137462	FALSE	Preclinical	2010-12-20	Absent	TLR2
Sepsis	ENSG00000137752	FALSE	Preclinical	1995-06-15	Unused	CASP1
Sepsis	ENSG00000138448	FALSE	Preclinical	1997-02-15	Unused	ITGAV
Sepsis	ENSG00000143226	FALSE	Preclinical	2016-11-24	Absent	FCGR2A
Sepsis	ENSG00000146070	FALSE	Phase III Clinical Trial	1995-05-15	Unused	PLA2G7
Sepsis	ENSG00000146469	FALSE	Preclinical	NA	Unused	VIP
Sepsis	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Sepsis	ENSG00000148926	FALSE	Phase II Clinical Trial	2013-01-04	Preclinical	ADM
Sepsis	ENSG00000151617	FALSE	unknown	1995-06-15	Unused	EDNRA
Sepsis	ENSG00000151694	FALSE	Preclinical	1992-08-15	Unused	ADAM17
Sepsis	ENSG00000154229	FALSE	Preclinical	1992-03-15	Unused	PRKCA
Sepsis	ENSG00000160013	FALSE	unknown	2010-08-20	Phase II Clinical Trial	PTGIR
Sepsis	ENSG00000160712	FALSE	Preclinical	1989-06-15	Unused	IL6R
Sepsis	ENSG00000163464	FALSE	Preclinical	1991-09-15	Unused	CXCR1
Sepsis	ENSG00000163485	FALSE	Preclinical	2002-06-25	Preclinical	ADORA1
Sepsis	ENSG00000164111	FALSE	Preclinical	2015-07-29	Absent	ANXA5
Sepsis	ENSG00000164251	FALSE	Preclinical	2003-04-08	Unused	F2RL1
Sepsis	ENSG00000164305	FALSE	Preclinical	2002-09-10	Unused	CASP3
Sepsis	ENSG00000164342	FALSE	Preclinical	2010-12-21	Absent	TLR3
Sepsis	ENSG00000164867	FALSE	Preclinical	1996-11-15	Unused	NOS3
Sepsis	ENSG00000165527	FALSE	Preclinical	2016-10-04	Absent	ARF6
Sepsis	ENSG00000166148	FALSE	Phase III Clinical Trial	2002-03-22	Phase II Clinical Trial	AVPR1A
Sepsis	ENSG00000166501	FALSE	Preclinical	1992-03-15	Unused	PRKCB
Sepsis	ENSG00000168398	FALSE	Preclinical	1997-03-15	Unused	BDKRB2
Sepsis	ENSG00000168685	FALSE	Phase II Clinical Trial	2004-01-19	Absent	IL7R
Sepsis	ENSG00000169174	FALSE	unknown	2011-10-25	Absent	PCSK9
Sepsis	ENSG00000169245	FALSE	Preclinical	2009-11-06	Preclinical	CXCL10
Sepsis	ENSG00000169403	FALSE	Pre-registration	1989-06-15	Unused	PTAFR
Sepsis	ENSG00000170458	FALSE	Phase II Clinical Trial	1992-12-15	Unused	CD14
Sepsis	ENSG00000172236	FALSE	Preclinical	NA	Absent	TPSAB1
Sepsis	ENSG00000174130	FALSE	Preclinical	2009-06-26	Unused	TLR6
Sepsis	ENSG00000174175	FALSE	Preclinical	1995-11-15	Unused	SELP
Sepsis	ENSG00000178562	FALSE	Preclinical	2009-06-29	Phase I Clinical Trial	CD28
Sepsis	ENSG00000180210	FALSE	Preclinical	2003-04-15	Unused	F2
Sepsis	ENSG00000180871	FALSE	Preclinical	1991-09-15	Unused	CXCR2
Sepsis	ENSG00000184381	FALSE	Phase I Clinical Trial	1998-04-15	Unused	PLA2G6
Sepsis	ENSG00000184845	FALSE	Preclinical	1993-02-15	Unused	DRD1
Sepsis	ENSG00000187010	FALSE	Preclinical	1989-12-15	Unused	RHD
Sepsis	ENSG00000187514	FALSE	Phase III Clinical Trial	NA	Absent	PTMA
Sepsis	ENSG00000188257	FALSE	Phase I Clinical Trial	1998-04-15	Unused	PLA2G2A
Sepsis	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Sepsis	ENSG00000188404	FALSE	Preclinical	2000-06-07	Unused	SELL
Sepsis	ENSG00000189403	FALSE	Preclinical	2003-08-06	Unused	HMGB1
Sepsis	ENSG00000196611	FALSE	Preclinical	1995-01-15	Unused	MMP1
Sepsis	ENSG00000197249	FALSE	Preclinical	NA	Unused	SERPINA1
Sepsis	ENSG00000197405	FALSE	Preclinical	2012-05-08	Preclinical	C5AR1
Sepsis	ENSG00000197561	FALSE	Preclinical	1991-04-15	Unused	ELANE
Sepsis	ENSG00000198001	FALSE	Preclinical	2011-09-05	Preclinical	IRAK4
Sepsis	ENSG00000198223	FALSE	Phase III Clinical Trial	1994-08-15	Phase III Clinical Trial	CSF2RA
Sepsis	ENSG00000205542	FALSE	Preclinical	1995-01-15	Unused	TMSB4X
Sepsis	ENSG00000239732	FALSE	Preclinical	2010-12-20	Absent	TLR9
Sepsis	ENSG00000259207	FALSE	Preclinical	1997-02-15	Phase II Clinical Trial	ITGB3
Serum Sickness	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Severe Acute Respiratory Syndrome	ENSG00000109320	FALSE	Preclinical	2008-02-11	Absent	NFKB1
Severe Acute Respiratory Syndrome	ENSG00000111537	FALSE	Approved	2016-11-08	Absent	IFNG
Severe Acute Respiratory Syndrome	ENSG00000135047	FALSE	Preclinical	2014-03-10	Absent	CTSL
Severe Acute Respiratory Syndrome	ENSG00000141736	FALSE	Preclinical	2012-03-28	Absent	ERBB2
Severe Acute Respiratory Syndrome	ENSG00000159110	FALSE	Preclinical	2004-09-10	Absent	IFNAR2
Severe Acute Respiratory Syndrome	ENSG00000159640	FALSE	unknown	2003-07-16	Absent	ACE
Severe Acute Respiratory Syndrome	ENSG00000196262	FALSE	Preclinical	NA	Absent	PPIA
Severe Acute Respiratory Syndrome	ENSG00000197635	FALSE	Preclinical	2008-07-31	Absent	DPP4
Severe Combined Immunodeficiency	ENSG00000147168	FALSE	Phase II Clinical Trial	2000-05-10	Unused	IL2RG
Severe Combined Immunodeficiency	ENSG00000152457	FALSE	Preclinical	2011-05-10	Preclinical	DCLRE1C
Severe Combined Immunodeficiency	ENSG00000196839	TRUE	Approved	1992-07-15	Approved	ADA
Sexual Dysfunction, Physiological	ENSG00000069696	TRUE	Approved	1994-08-15	Preclinical	DRD4
Sexual Dysfunction, Physiological	ENSG00000082175	TRUE	Approved	1990-06-15	Phase II Clinical Trial	PGR
Sexual Dysfunction, Physiological	ENSG00000091831	TRUE	Approved	1990-06-15	Phase II Clinical Trial	ESR1
Sexual Dysfunction, Physiological	ENSG00000102468	TRUE	Approved	1994-08-15	Preclinical	HTR2A
Sexual Dysfunction, Physiological	ENSG00000108576	FALSE	unknown	1996-08-15	Unused	SLC6A4
Sexual Dysfunction, Physiological	ENSG00000114812	FALSE	Preclinical	1999-12-08	Unused	VIPR1
Sexual Dysfunction, Physiological	ENSG00000138735	FALSE	Phase II Clinical Trial	1991-09-15	Unused	PDE5A
Sexual Dysfunction, Physiological	ENSG00000147955	FALSE	unknown	1996-08-15	Unused	SIGMAR1
Sexual Dysfunction, Physiological	ENSG00000149295	FALSE	unknown	1999-07-21	Unused	DRD2
Sexual Dysfunction, Physiological	ENSG00000153956	FALSE	Phase I Clinical Trial	2006-12-05	Unused	CACNA2D1
Sexual Dysfunction, Physiological	ENSG00000159723	FALSE	Preclinical	2009-08-13	Unused	AGRP
Sexual Dysfunction, Physiological	ENSG00000160951	TRUE	Approved	1996-10-15	Phase III Clinical Trial	PTGER1
Sexual Dysfunction, Physiological	ENSG00000166603	FALSE	Phase III Clinical Trial	2000-06-28	Phase II Clinical Trial	MC4R
Sexual Dysfunction, Physiological	ENSG00000169083	TRUE	Approved	1995-12-15	Approved	AR
Sexual Dysfunction, Physiological	ENSG00000175591	FALSE	Preclinical	2000-11-10	Unused	P2RY2
Sexual Dysfunction, Physiological	ENSG00000178394	TRUE	Approved	1994-08-15	Unused	HTR1A
Shock, Traumatic	ENSG00000057593	FALSE	unknown	2004-12-07	Unused	F7
Shock, Traumatic	ENSG00000073756	FALSE	Approved	NA	Unused	PTGS2
Shock, Traumatic	ENSG00000095303	FALSE	Approved	NA	Unused	PTGS1
Shock, Traumatic	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Shock, Traumatic	ENSG00000115718	FALSE	unknown	2007-05-03	Unused	PROC
Shock, Traumatic	ENSG00000117335	FALSE	Preclinical	1994-06-15	Unused	CD46
Shock, Traumatic	ENSG00000124731	FALSE	Preclinical	2012-01-19	Preclinical	TREM1
Shock, Traumatic	ENSG00000136160	FALSE	Preclinical	1997-10-15	Unused	EDNRB
Shock, Traumatic	ENSG00000148180	FALSE	Phase I Clinical Trial	NA	Absent	GSN
Shock, Traumatic	ENSG00000151067	FALSE	Preclinical	1998-10-15	Unused	CACNA1C
Shock, Traumatic	ENSG00000151617	FALSE	Preclinical	1997-10-15	Unused	EDNRA
Shock, Traumatic	ENSG00000166603	FALSE	Preclinical	2000-06-28	Preclinical	MC4R
Shock, Traumatic	ENSG00000169083	FALSE	unknown	2000-09-29	Unused	AR
Shock, Traumatic	ENSG00000171557	FALSE	Preclinical	1999-07-08	Preclinical	FGG
Shock, Traumatic	ENSG00000171560	FALSE	Preclinical	1999-07-08	Preclinical	FGA
Shock, Traumatic	ENSG00000171564	FALSE	Preclinical	1999-07-08	Preclinical	FGB
Shock, Traumatic	ENSG00000179776	FALSE	unknown	2003-02-26	Unused	CDH5
Shock, Traumatic	ENSG00000188404	FALSE	unknown	1993-12-15	Unused	SELL
Short Bowel Syndrome	ENSG00000001626	FALSE	Preclinical	1992-11-15	Absent	CFTR
Short Bowel Syndrome	ENSG00000065325	TRUE	Approved	1997-03-15	Approved	GLP2R
Short Bowel Syndrome	ENSG00000112164	FALSE	Preclinical	2015-01-09	Absent	GLP1R
Short Bowel Syndrome	ENSG00000112964	TRUE	Approved	NA	Approved	GHR
Short Bowel Syndrome	ENSG00000115263	FALSE	Preclinical	2014-06-07	Absent	GCG
Short Bowel Syndrome	ENSG00000134640	FALSE	Preclinical	NA	Absent	MTNR1B
Short Bowel Syndrome	ENSG00000140443	FALSE	Preclinical	NA	Unused	IGF1R
Short Bowel Syndrome	ENSG00000168412	FALSE	Preclinical	NA	Absent	MTNR1A
Short Bowel Syndrome	ENSG00000171105	FALSE	Phase III Clinical Trial	NA	Absent	INSR
Short Bowel Syndrome	ENSG00000179921	FALSE	Preclinical	2011-09-03	Absent	GPBAR1
Short Bowel Syndrome	ENSG00000204174	FALSE	Phase II Clinical Trial	2006-07-31	Absent	NPY4R
Sialorrhea	ENSG00000133019	TRUE	Approved	2001-11-12	Approved	CHRM3
Sialorrhea	ENSG00000168539	TRUE	Approved	2006-07-05	Phase II Clinical Trial	CHRM1
Sialorrhea	ENSG00000180720	FALSE	Phase II Clinical Trial	2006-07-05	Phase II Clinical Trial	CHRM4
Sialorrhea	ENSG00000181072	FALSE	Phase II Clinical Trial	2006-07-05	Phase II Clinical Trial	CHRM2
Sinusitis	ENSG00000077238	FALSE	Phase II Clinical Trial	2009-11-19	Absent	IL4R
Sinusitis	ENSG00000091181	FALSE	Phase II Clinical Trial	2003-08-27	Absent	IL5RA
Sinusitis	ENSG00000113580	TRUE	Approved	1996-10-15	Approved	NR3C1
Sinusitis	ENSG00000115602	FALSE	Phase I Clinical Trial	2013-08-26	Absent	IL1RL1
Sinusitis	ENSG00000120915	FALSE	Preclinical	2016-10-27	Absent	EPHX2
Sinusitis	ENSG00000122861	FALSE	Approved	NA	Absent	PLAU
Sinusitis	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Sinusitis	ENSG00000149021	FALSE	Phase II Clinical Trial	1997-08-15	Unused	SCGB1A1
Sinusitis	ENSG00000168918	FALSE	unknown	2009-10-12	Absent	INPP5D
Sinusitis	ENSG00000173198	FALSE	Phase III Clinical Trial	NA	Unused	CYSLTR1
Sinusitis	ENSG00000175591	FALSE	Phase I Clinical Trial	NA	Unused	P2RY2
Sjogren's Syndrome	ENSG00000010671	FALSE	Phase II Clinical Trial	2012-01-14	Absent	BTK
Sjogren's Syndrome	ENSG00000012124	FALSE	Phase II Clinical Trial	1993-08-15	Unused	CD22
Sjogren's Syndrome	ENSG00000059377	FALSE	Phase III Clinical Trial	1995-07-15	Unused	TBXAS1
Sjogren's Syndrome	ENSG00000087085	FALSE	Preclinical	2001-09-14	Unused	ACHE
Sjogren's Syndrome	ENSG00000091831	FALSE	Phase II Clinical Trial	2007-08-22	Phase II Clinical Trial	ESR1
Sjogren's Syndrome	ENSG00000101017	FALSE	Phase II Clinical Trial	2014-03-18	Absent	CD40
Sjogren's Syndrome	ENSG00000101916	FALSE	Preclinical	2013-04-30	Absent	TLR8
Sjogren's Syndrome	ENSG00000102245	FALSE	Phase I Clinical Trial	2014-06-04	Absent	CD40LG
Sjogren's Syndrome	ENSG00000102524	FALSE	Phase II Clinical Trial	1999-07-13	Phase II Clinical Trial	TNFSF13B
Sjogren's Syndrome	ENSG00000105639	FALSE	unknown	2006-07-25	Phase I Clinical Trial	JAK3
Sjogren's Syndrome	ENSG00000106804	FALSE	Phase I Clinical Trial	2005-01-31	Absent	C5
Sjogren's Syndrome	ENSG00000111319	FALSE	unknown	2007-08-18	Phase II Clinical Trial	SCNN1A
Sjogren's Syndrome	ENSG00000113520	FALSE	Preclinical	2014-10-29	Absent	IL4
Sjogren's Syndrome	ENSG00000114013	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD86
Sjogren's Syndrome	ENSG00000121594	FALSE	Phase III Clinical Trial	1992-11-15	Absent	CD80
Sjogren's Syndrome	ENSG00000133019	FALSE	Preclinical	2017-05-17	Absent	CHRM3
Sjogren's Syndrome	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Sjogren's Syndrome	ENSG00000138684	FALSE	Preclinical	2014-10-29	Absent	IL21
Sjogren's Syndrome	ENSG00000139219	FALSE	Preclinical	2016-11-24	Absent	COL2A1
Sjogren's Syndrome	ENSG00000145839	FALSE	Preclinical	2014-10-29	Absent	IL9
Sjogren's Syndrome	ENSG00000156738	FALSE	unknown	1993-09-15	Unused	MS4A1
Sjogren's Syndrome	ENSG00000159110	FALSE	unknown	NA	Unused	IFNAR2
Sjogren's Syndrome	ENSG00000159958	FALSE	Phase II Clinical Trial	2010-10-21	Absent	TNFRSF13C
Sjogren's Syndrome	ENSG00000160223	FALSE	Phase II Clinical Trial	2007-03-13	Absent	ICOSLG
Sjogren's Syndrome	ENSG00000162434	FALSE	Phase II Clinical Trial	2009-12-11	Absent	JAK1
Sjogren's Syndrome	ENSG00000163131	FALSE	Phase II Clinical Trial	2014-11-22	Absent	CTSS
Sjogren's Syndrome	ENSG00000163600	FALSE	unknown	2007-04-05	Unused	ICOS
Sjogren's Syndrome	ENSG00000165025	FALSE	Phase II Clinical Trial	2006-07-25	Phase I Clinical Trial	SYK
Sjogren's Syndrome	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Sjogren's Syndrome	ENSG00000168685	FALSE	Phase II Clinical Trial	2011-07-13	Absent	IL7R
Sjogren's Syndrome	ENSG00000171608	FALSE	Phase II Clinical Trial	2013-10-29	Absent	PIK3CD
Sjogren's Syndrome	ENSG00000173585	FALSE	Phase I Clinical Trial	2008-03-26	Absent	CCR9
Sjogren's Syndrome	ENSG00000175591	FALSE	unknown	NA	Approved	P2RY2
Sjogren's Syndrome	ENSG00000178562	FALSE	Phase II Clinical Trial	2010-02-16	Absent	CD28
Sjogren's Syndrome	ENSG00000183735	FALSE	Preclinical	2009-10-14	Unused	TBK1
Sjogren's Syndrome	ENSG00000196664	FALSE	Preclinical	2013-04-30	Absent	TLR7
Sjogren's Syndrome	ENSG00000213903	FALSE	Phase I Clinical Trial	2017-04-12	Absent	LTB4R
Sjogren's Syndrome	ENSG00000239732	FALSE	Preclinical	2001-09-14	Unused	TLR9
Sjogren's Syndrome	ENSG00000239961	FALSE	Phase I Clinical Trial	2010-01-21	Absent	LILRA4
Sjogren's Syndrome	ENSG00000263528	FALSE	Preclinical	2009-10-14	Unused	IKBKE
Skin Diseases	ENSG00000007908	FALSE	Preclinical	1989-06-15	Unused	SELE
Skin Diseases	ENSG00000065989	FALSE	unknown	1994-10-15	Phase I Clinical Trial	PDE4A
Skin Diseases	ENSG00000069431	FALSE	Preclinical	1990-10-15	Unused	ABCC9
Skin Diseases	ENSG00000077092	TRUE	Approved	1991-02-15	Absent	RARB
Skin Diseases	ENSG00000077498	TRUE	Approved	1998-05-15	Approved	TYR
Skin Diseases	ENSG00000082175	FALSE	Preclinical	1991-09-15	Unused	PGR
Skin Diseases	ENSG00000082898	FALSE	Preclinical	2011-08-20	Absent	XPO1
Skin Diseases	ENSG00000083444	FALSE	Preclinical	1993-12-15	Unused	PLOD1
Skin Diseases	ENSG00000087245	FALSE	Phase I Clinical Trial	NA	Unused	MMP2
Skin Diseases	ENSG00000100985	FALSE	Phase I Clinical Trial	NA	Unused	MMP9
Skin Diseases	ENSG00000105221	FALSE	Phase II Clinical Trial	2008-11-12	Absent	AKT2
Skin Diseases	ENSG00000105639	FALSE	Phase I Clinical Trial	2015-09-10	Absent	JAK3
Skin Diseases	ENSG00000105650	FALSE	unknown	1994-10-15	Phase I Clinical Trial	PDE4C
Skin Diseases	ENSG00000109320	FALSE	Preclinical	2016-02-12	Absent	NFKB1
Skin Diseases	ENSG00000111424	FALSE	Preclinical	1996-09-15	Unused	VDR
Skin Diseases	ENSG00000113161	FALSE	Phase I Clinical Trial	1998-12-15	Unused	HMGCR
Skin Diseases	ENSG00000113448	FALSE	unknown	1994-10-15	Phase I Clinical Trial	PDE4D
Skin Diseases	ENSG00000113580	TRUE	Approved	2010-05-27	Approved	NR3C1
Skin Diseases	ENSG00000114378	FALSE	Phase I Clinical Trial	NA	Unused	HYAL1
Skin Diseases	ENSG00000115008	FALSE	Preclinical	2014-01-31	Absent	IL1A
Skin Diseases	ENSG00000116044	FALSE	unknown	2014-01-07	Absent	NFE2L2
Skin Diseases	ENSG00000118972	FALSE	Phase II Clinical Trial	2009-01-30	Absent	FGF23
Skin Diseases	ENSG00000121361	FALSE	Preclinical	1990-10-15	Unused	KCNJ8
Skin Diseases	ENSG00000121879	FALSE	Phase II Clinical Trial	2008-11-12	Absent	PIK3CA
Skin Diseases	ENSG00000122884	FALSE	Preclinical	1993-12-15	Unused	P4HA1
Skin Diseases	ENSG00000131759	TRUE	Approved	1991-02-15	Unused	RARA
Skin Diseases	ENSG00000132965	FALSE	Preclinical	2008-08-20	Unused	ALOX5AP
Skin Diseases	ENSG00000138675	FALSE	Preclinical	1993-11-15	Unused	FGF5
Skin Diseases	ENSG00000143171	FALSE	Preclinical	2011-11-11	Unused	RXRG
Skin Diseases	ENSG00000143365	FALSE	Preclinical	2016-04-11	Absent	RORC
Skin Diseases	ENSG00000144381	FALSE	Preclinical	2015-09-01	Absent	HSPD1
Skin Diseases	ENSG00000145545	FALSE	Preclinical	1993-03-15	Unused	SRD5A1
Skin Diseases	ENSG00000146648	FALSE	Preclinical	1992-03-15	Unused	EGFR
Skin Diseases	ENSG00000151090	FALSE	unknown	NA	Unused	THRB
Skin Diseases	ENSG00000162434	FALSE	Phase I Clinical Trial	2015-09-10	Absent	JAK1
Skin Diseases	ENSG00000163464	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR1
Skin Diseases	ENSG00000165025	FALSE	Preclinical	2010-07-10	Absent	SYK
Skin Diseases	ENSG00000167723	FALSE	Phase I Clinical Trial	2008-10-28	Unused	TRPV3
Skin Diseases	ENSG00000167768	FALSE	Preclinical	1993-11-15	Unused	KRT1
Skin Diseases	ENSG00000169083	TRUE	Approved	1991-09-15	Approved	AR
Skin Diseases	ENSG00000169429	FALSE	Preclinical	2014-01-31	Absent	CXCL8
Skin Diseases	ENSG00000170989	FALSE	Preclinical	2011-09-21	Absent	S1PR1
Skin Diseases	ENSG00000172236	FALSE	Preclinical	2006-03-29	Unused	TPSAB1
Skin Diseases	ENSG00000172819	TRUE	Approved	1991-02-15	Absent	RARG
Skin Diseases	ENSG00000176136	FALSE	Preclinical	2005-08-10	Unused	MC5R
Skin Diseases	ENSG00000176890	FALSE	Preclinical	1992-11-15	Unused	TYMS
Skin Diseases	ENSG00000180871	FALSE	Phase I Clinical Trial	2014-05-30	Absent	CXCR2
Skin Diseases	ENSG00000184588	FALSE	unknown	1994-10-15	Phase I Clinical Trial	PDE4B
Skin Diseases	ENSG00000186350	FALSE	Preclinical	2011-11-11	Unused	RXRA
Skin Diseases	ENSG00000196639	FALSE	Approved	NA	Unused	HRH1
Skin Diseases	ENSG00000197894	FALSE	Preclinical	2015-07-28	Absent	ADH5
Skin Diseases	ENSG00000198793	FALSE	Preclinical	2013-07-09	Absent	MTOR
Skin Diseases	ENSG00000205542	FALSE	unknown	2007-07-16	Unused	TMSB4X
Skin Diseases	ENSG00000213903	FALSE	Preclinical	1993-08-15	Unused	LTB4R
Skin Diseases	ENSG00000258839	FALSE	Preclinical	2010-09-01	Preclinical	MC1R
Skin Diseases, Bacterial	ENSG00000065989	FALSE	Phase II Clinical Trial	2005-05-24	Absent	PDE4A
Skin Diseases, Bacterial	ENSG00000131747	FALSE	Phase II Clinical Trial	2012-06-15	Absent	TOP2A
Skin Diseases, Infectious	ENSG00000012223	FALSE	unknown	1996-06-15	Unused	LTF
Skin Diseases, Infectious	ENSG00000012779	FALSE	Preclinical	1996-03-15	Unused	ALOX5
Skin Diseases, Infectious	ENSG00000065989	FALSE	Phase II Clinical Trial	2005-05-24	Absent	PDE4A
Skin Diseases, Infectious	ENSG00000069764	FALSE	Preclinical	1998-07-15	Unused	PLA2G10
Skin Diseases, Infectious	ENSG00000073756	FALSE	Approved	2002-04-16	Unused	PTGS2
Skin Diseases, Infectious	ENSG00000095303	FALSE	Approved	2002-04-16	Unused	PTGS1
Skin Diseases, Infectious	ENSG00000112096	FALSE	Preclinical	2003-06-25	Unused	SOD2
Skin Diseases, Infectious	ENSG00000113580	TRUE	Approved	2007-04-26	Approved	NR3C1
Skin Diseases, Infectious	ENSG00000118432	FALSE	Preclinical	2015-07-23	Absent	CNR1
Skin Diseases, Infectious	ENSG00000131747	FALSE	unknown	2007-09-07	Unused	TOP2A
Skin Diseases, Infectious	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Skin Diseases, Infectious	ENSG00000136869	FALSE	Approved	NA	Unused	TLR4
Skin Diseases, Infectious	ENSG00000172236	FALSE	unknown	1996-06-15	Unused	TPSAB1
Skin Diseases, Infectious	ENSG00000174600	FALSE	Phase I Clinical Trial	2010-04-08	Unused	CMKLR1
Skin Diseases, Infectious	ENSG00000178562	FALSE	Phase III Clinical Trial	2009-06-29	Phase II Clinical Trial	CD28
Skin Neoplasms	ENSG00000026508	FALSE	Preclinical	2013-02-21	Preclinical	CD44
Skin Neoplasms	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Skin Neoplasms	ENSG00000081985	FALSE	Preclinical	2016-01-24	Absent	IL12RB2
Skin Neoplasms	ENSG00000085276	FALSE	Preclinical	2014-07-03	Absent	MECOM
Skin Neoplasms	ENSG00000089041	FALSE	unknown	2008-08-11	Preclinical	P2RX7
Skin Neoplasms	ENSG00000091831	FALSE	unknown	1999-05-19	Unused	ESR1
Skin Neoplasms	ENSG00000096996	FALSE	Preclinical	2016-01-24	Absent	IL12RB1
Skin Neoplasms	ENSG00000105329	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	TGFB1
Skin Neoplasms	ENSG00000110195	FALSE	Preclinical	2010-02-25	Preclinical	FOLR1
Skin Neoplasms	ENSG00000114013	FALSE	unknown	2002-01-11	Unused	CD86
Skin Neoplasms	ENSG00000115758	FALSE	unknown	1996-05-15	Unused	ODC1
Skin Neoplasms	ENSG00000121879	FALSE	Preclinical	2006-12-07	Phase II Clinical Trial	PIK3CA
Skin Neoplasms	ENSG00000131747	FALSE	unknown	NA	Unused	TOP2A
Skin Neoplasms	ENSG00000134460	FALSE	Preclinical	2012-09-25	Preclinical	IL2RA
Skin Neoplasms	ENSG00000140443	FALSE	unknown	2003-02-11	Unused	IGF1R
Skin Neoplasms	ENSG00000140992	FALSE	Preclinical	2009-11-25	Unused	PDPK1
Skin Neoplasms	ENSG00000141510	FALSE	Preclinical	1996-09-15	Unused	TP53
Skin Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	2011-08-06	Absent	ERBB2
Skin Neoplasms	ENSG00000142208	FALSE	Preclinical	2009-11-25	Unused	AKT1
Skin Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Absent	MCL1
Skin Neoplasms	ENSG00000146648	FALSE	Phase II Clinical Trial	2011-08-06	Absent	EGFR
Skin Neoplasms	ENSG00000149294	FALSE	unknown	NA	Phase I Clinical Trial	NCAM1
Skin Neoplasms	ENSG00000159110	FALSE	Approved	2014-01-17	Unused	IFNAR2
Skin Neoplasms	ENSG00000163932	FALSE	Phase II Clinical Trial	2002-10-14	Unused	PRKCD
Skin Neoplasms	ENSG00000164400	FALSE	unknown	2002-01-11	Unused	CSF2
Skin Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Absent	PLK1
Skin Neoplasms	ENSG00000177606	FALSE	Preclinical	2006-07-25	Unused	JUN
Skin Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2011-08-06	Absent	ERBB4
Skin Neoplasms	ENSG00000196664	FALSE	Preclinical	2009-12-23	Preclinical	TLR7
Skin Neoplasms	ENSG00000198223	FALSE	unknown	NA	Unused	CSF2RA
Skin Neoplasms	ENSG00000198793	FALSE	Preclinical	2006-12-07	Phase II Clinical Trial	MTOR
Skin Neoplasms	ENSG00000198900	FALSE	unknown	NA	Unused	TOP1
Skin Neoplasms	ENSG00000253729	FALSE	Phase II Clinical Trial	2006-11-29	Phase I Clinical Trial	PRKDC
Sleep Disorders, Circadian Rhythm	ENSG00000125510	FALSE	Preclinical	2004-10-25	Unused	OPRL1
Sleep Disorders, Circadian Rhythm	ENSG00000134640	TRUE	Approved	1997-06-15	Phase III Clinical Trial	MTNR1B
Sleep Disorders, Circadian Rhythm	ENSG00000168412	TRUE	Approved	1997-06-15	Phase III Clinical Trial	MTNR1A
Sleep Initiation and Maintenance Disorders	ENSG00000011677	TRUE	Approved	1989-09-15	Approved	GABRA3
Sleep Initiation and Maintenance Disorders	ENSG00000022355	TRUE	Approved	1991-09-15	Approved	GABRA1
Sleep Initiation and Maintenance Disorders	ENSG00000101180	FALSE	Preclinical	2013-10-22	Absent	HRH3
Sleep Initiation and Maintenance Disorders	ENSG00000102468	FALSE	Phase III Clinical Trial	1990-10-15	Phase II Clinical Trial	HTR2A
Sleep Initiation and Maintenance Disorders	ENSG00000106113	TRUE	Approved	NA	Approved	CRHR2
Sleep Initiation and Maintenance Disorders	ENSG00000106128	FALSE	unknown	1997-08-15	Unused	GHRHR
Sleep Initiation and Maintenance Disorders	ENSG00000113749	TRUE	Approved	2004-03-22	Approved	HRH2
Sleep Initiation and Maintenance Disorders	ENSG00000115353	FALSE	Phase II Clinical Trial	2001-03-07	Unused	TACR1
Sleep Initiation and Maintenance Disorders	ENSG00000117480	FALSE	Phase I Clinical Trial	2008-09-30	Unused	FAAH
Sleep Initiation and Maintenance Disorders	ENSG00000120088	TRUE	Approved	NA	Approved	CRHR1
Sleep Initiation and Maintenance Disorders	ENSG00000121764	TRUE	Approved	2000-07-05	Approved	HCRTR1
Sleep Initiation and Maintenance Disorders	ENSG00000134640	TRUE	Approved	1993-12-15	Approved	MTNR1B
Sleep Initiation and Maintenance Disorders	ENSG00000135914	FALSE	Phase II Clinical Trial	2008-01-15	Phase II Clinical Trial	HTR2B
Sleep Initiation and Maintenance Disorders	ENSG00000137252	TRUE	Approved	2000-07-05	Approved	HCRTR2
Sleep Initiation and Maintenance Disorders	ENSG00000142319	TRUE	Approved	2004-03-22	Approved	SLC6A3
Sleep Initiation and Maintenance Disorders	ENSG00000143839	FALSE	Preclinical	1998-03-15	Unused	REN
Sleep Initiation and Maintenance Disorders	ENSG00000147246	FALSE	Phase III Clinical Trial	1992-11-15	Unused	HTR2C
Sleep Initiation and Maintenance Disorders	ENSG00000148680	FALSE	Phase III Clinical Trial	2004-09-15	Unused	HTR7
Sleep Initiation and Maintenance Disorders	ENSG00000149295	FALSE	Phase III Clinical Trial	2004-09-15	Phase II Clinical Trial	DRD2
Sleep Initiation and Maintenance Disorders	ENSG00000151834	TRUE	Approved	1998-09-15	Approved	GABRA2
Sleep Initiation and Maintenance Disorders	ENSG00000153956	FALSE	Phase II Clinical Trial	2003-06-25	Unused	CACNA2D1
Sleep Initiation and Maintenance Disorders	ENSG00000168412	TRUE	Approved	1993-12-15	Approved	MTNR1A
Sleep Initiation and Maintenance Disorders	ENSG00000178394	FALSE	Phase II Clinical Trial	1996-01-15	Phase II Clinical Trial	HTR1A
Sleep Initiation and Maintenance Disorders	ENSG00000179546	FALSE	Phase II Clinical Trial	2008-01-15	Phase II Clinical Trial	HTR1D
Sleep Initiation and Maintenance Disorders	ENSG00000186297	TRUE	Approved	1996-07-15	Approved	GABRA5
Sleep Initiation and Maintenance Disorders	ENSG00000187730	FALSE	Phase III Clinical Trial	NA	Unused	GABRD
Sleep Initiation and Maintenance Disorders	ENSG00000196639	TRUE	Approved	1999-07-28	Approved	HRH1
Sleep Wake Disorders	ENSG00000011677	TRUE	Approved	1992-08-15	Approved	GABRA3
Sleep Wake Disorders	ENSG00000022355	TRUE	Approved	1993-06-15	Approved	GABRA1
Sleep Wake Disorders	ENSG00000069696	FALSE	unknown	1990-09-15	Unused	DRD4
Sleep Wake Disorders	ENSG00000101180	FALSE	Phase II Clinical Trial	2003-06-03	Phase I Clinical Trial	HRH3
Sleep Wake Disorders	ENSG00000102468	FALSE	Phase I Clinical Trial	1990-07-15	Unused	HTR2A
Sleep Wake Disorders	ENSG00000103546	FALSE	Preclinical	2015-09-03	Unused	SLC6A2
Sleep Wake Disorders	ENSG00000108576	FALSE	Preclinical	2015-09-03	Unused	SLC6A4
Sleep Wake Disorders	ENSG00000109158	FALSE	Preclinical	2013-06-12	Absent	GABRA4
Sleep Wake Disorders	ENSG00000109163	FALSE	Preclinical	1996-01-15	Unused	GNRHR
Sleep Wake Disorders	ENSG00000113580	FALSE	Preclinical	NA	Unused	NR3C1
Sleep Wake Disorders	ENSG00000115353	FALSE	Phase I Clinical Trial	1998-06-15	Unused	TACR1
Sleep Wake Disorders	ENSG00000117480	FALSE	Preclinical	1995-08-15	Unused	FAAH
Sleep Wake Disorders	ENSG00000118432	FALSE	Phase II Clinical Trial	2010-12-23	Absent	CNR1
Sleep Wake Disorders	ENSG00000121764	FALSE	Phase II Clinical Trial	2004-12-06	Phase II Clinical Trial	HCRTR1
Sleep Wake Disorders	ENSG00000125510	FALSE	Preclinical	2007-05-04	Unused	OPRL1
Sleep Wake Disorders	ENSG00000128271	FALSE	Preclinical	2007-08-24	Unused	ADORA2A
Sleep Wake Disorders	ENSG00000132164	FALSE	Preclinical	1997-04-15	Unused	SLC6A11
Sleep Wake Disorders	ENSG00000132437	FALSE	Preclinical	1989-06-15	Unused	DDC
Sleep Wake Disorders	ENSG00000134640	FALSE	Phase II Clinical Trial	1989-06-15	Unused	MTNR1B
Sleep Wake Disorders	ENSG00000137252	FALSE	Phase II Clinical Trial	2004-12-06	Phase II Clinical Trial	HCRTR2
Sleep Wake Disorders	ENSG00000141551	FALSE	Preclinical	2011-09-08	Unused	CSNK1D
Sleep Wake Disorders	ENSG00000143125	FALSE	Preclinical	2006-12-06	Unused	PROK1
Sleep Wake Disorders	ENSG00000144285	FALSE	Preclinical	NA	Unused	SCN1A
Sleep Wake Disorders	ENSG00000147246	FALSE	Phase II Clinical Trial	1992-11-15	Unused	HTR2C
Sleep Wake Disorders	ENSG00000148680	FALSE	Preclinical	2003-02-10	Unused	HTR7
Sleep Wake Disorders	ENSG00000151834	TRUE	Approved	1993-06-15	Approved	GABRA2
Sleep Wake Disorders	ENSG00000153253	FALSE	Preclinical	NA	Unused	SCN3A
Sleep Wake Disorders	ENSG00000155511	FALSE	Preclinical	2002-11-15	Unused	GRIA1
Sleep Wake Disorders	ENSG00000157103	FALSE	Preclinical	2006-10-13	Unused	SLC6A1
Sleep Wake Disorders	ENSG00000163421	FALSE	Preclinical	2006-12-06	Unused	PROK2
Sleep Wake Disorders	ENSG00000166736	FALSE	unknown	2004-02-04	Unused	HTR3A
Sleep Wake Disorders	ENSG00000168412	FALSE	Phase II Clinical Trial	1989-06-15	Unused	MTNR1A
Sleep Wake Disorders	ENSG00000169618	FALSE	Preclinical	2006-12-06	Unused	PROKR1
Sleep Wake Disorders	ENSG00000178394	FALSE	Preclinical	1989-09-15	Unused	HTR1A
Sleep Wake Disorders	ENSG00000184845	FALSE	unknown	NA	Unused	DRD1
Sleep Wake Disorders	ENSG00000186297	TRUE	Approved	1992-08-15	Approved	GABRA5
Sleep Wake Disorders	ENSG00000187258	FALSE	Preclinical	2009-08-26	Unused	NPSR1
Sleep Wake Disorders	ENSG00000187730	FALSE	Preclinical	2013-06-12	Absent	GABRD
Sleep Wake Disorders	ENSG00000196639	FALSE	Phase I Clinical Trial	1994-02-15	Unused	HRH1
Sleep Wake Disorders	ENSG00000213923	FALSE	Preclinical	2011-09-08	Unused	CSNK1E
Small Cell Lung Carcinoma	ENSG00000004487	FALSE	Phase II Clinical Trial	2008-07-31	Absent	KDM1A
Small Cell Lung Carcinoma	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Unused	HGF
Small Cell Lung Carcinoma	ENSG00000025708	FALSE	Phase II Clinical Trial	1998-06-15	Absent	TYMP
Small Cell Lung Carcinoma	ENSG00000026508	FALSE	Phase II Clinical Trial	2003-07-17	Phase II Clinical Trial	CD44
Small Cell Lung Carcinoma	ENSG00000027697	FALSE	unknown	NA	Unused	IFNGR1
Small Cell Lung Carcinoma	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Small Cell Lung Carcinoma	ENSG00000047936	FALSE	Phase II Clinical Trial	2010-05-17	Absent	ROS1
Small Cell Lung Carcinoma	ENSG00000051180	FALSE	Phase I Clinical Trial	2004-10-05	Unused	RAD51
Small Cell Lung Carcinoma	ENSG00000066468	FALSE	unknown	2003-07-22	Absent	FGFR2
Small Cell Lung Carcinoma	ENSG00000068078	FALSE	unknown	2003-07-22	Absent	FGFR3
Small Cell Lung Carcinoma	ENSG00000074181	FALSE	unknown	NA	Absent	NOTCH3
Small Cell Lung Carcinoma	ENSG00000077782	FALSE	unknown	2003-07-22	Phase I Clinical Trial	FGFR1
Small Cell Lung Carcinoma	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	HSP90AA1
Small Cell Lung Carcinoma	ENSG00000085563	FALSE	unknown	1994-04-15	Unused	ABCB1
Small Cell Lung Carcinoma	ENSG00000086548	FALSE	Preclinical	2008-05-30	Preclinical	CEACAM6
Small Cell Lung Carcinoma	ENSG00000087245	FALSE	unknown	1997-01-15	Unused	MMP2
Small Cell Lung Carcinoma	ENSG00000087586	FALSE	Phase II Clinical Trial	2006-11-20	Phase II Clinical Trial	AURKA
Small Cell Lung Carcinoma	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Small Cell Lung Carcinoma	ENSG00000090339	FALSE	unknown	2001-02-21	Unused	ICAM1
Small Cell Lung Carcinoma	ENSG00000090932	FALSE	Phase III Clinical Trial	2013-07-20	Absent	DLL3
Small Cell Lung Carcinoma	ENSG00000097007	FALSE	unknown	1999-03-17	Unused	ABL1
Small Cell Lung Carcinoma	ENSG00000100311	FALSE	Phase I Clinical Trial	1994-06-15	Phase I Clinical Trial	PDGFB
Small Cell Lung Carcinoma	ENSG00000100644	FALSE	Phase II Clinical Trial	2003-08-01	Phase II Clinical Trial	HIF1A
Small Cell Lung Carcinoma	ENSG00000100985	FALSE	unknown	1997-01-15	Unused	MMP9
Small Cell Lung Carcinoma	ENSG00000101188	FALSE	Preclinical	2016-02-23	Absent	NTSR1
Small Cell Lung Carcinoma	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Small Cell Lung Carcinoma	ENSG00000103222	FALSE	unknown	1994-04-15	Unused	ABCC1
Small Cell Lung Carcinoma	ENSG00000105146	FALSE	Phase II Clinical Trial	2007-02-06	Phase II Clinical Trial	AURKC
Small Cell Lung Carcinoma	ENSG00000105383	FALSE	unknown	1991-02-15	Unused	CD33
Small Cell Lung Carcinoma	ENSG00000105388	FALSE	Preclinical	2001-02-21	Unused	CEACAM5
Small Cell Lung Carcinoma	ENSG00000105810	FALSE	Phase II Clinical Trial	2012-09-26	Absent	CDK6
Small Cell Lung Carcinoma	ENSG00000105953	FALSE	Phase I Clinical Trial	2008-07-26	Absent	OGDH
Small Cell Lung Carcinoma	ENSG00000105976	FALSE	Phase II Clinical Trial	2004-08-09	Phase II Clinical Trial	MET
Small Cell Lung Carcinoma	ENSG00000106348	FALSE	unknown	NA	Unused	IMPDH1
Small Cell Lung Carcinoma	ENSG00000109320	FALSE	unknown	1997-11-15	Unused	NFKB1
Small Cell Lung Carcinoma	ENSG00000109471	FALSE	unknown	2000-07-26	Absent	IL2
Small Cell Lung Carcinoma	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Small Cell Lung Carcinoma	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Small Cell Lung Carcinoma	ENSG00000113721	FALSE	Phase I Clinical Trial	2007-06-08	Phase I Clinical Trial	PDGFRB
Small Cell Lung Carcinoma	ENSG00000115353	FALSE	unknown	NA	Unused	TACR1
Small Cell Lung Carcinoma	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Small Cell Lung Carcinoma	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Small Cell Lung Carcinoma	ENSG00000116478	FALSE	Phase II Clinical Trial	2008-01-07	Absent	HDAC1
Small Cell Lung Carcinoma	ENSG00000117091	FALSE	unknown	2001-02-21	Unused	CD48
Small Cell Lung Carcinoma	ENSG00000117601	FALSE	unknown	2007-05-19	Phase II Clinical Trial	SERPINC1
Small Cell Lung Carcinoma	ENSG00000119888	FALSE	Phase II Clinical Trial	2000-11-07	Phase I Clinical Trial	EPCAM
Small Cell Lung Carcinoma	ENSG00000120156	FALSE	unknown	2004-08-09	Phase II Clinical Trial	TEK
Small Cell Lung Carcinoma	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-04-27	Absent	CD274
Small Cell Lung Carcinoma	ENSG00000121594	FALSE	unknown	2001-02-21	Unused	CD80
Small Cell Lung Carcinoma	ENSG00000121966	FALSE	Phase II Clinical Trial	2008-07-14	Phase II Clinical Trial	CXCR4
Small Cell Lung Carcinoma	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Small Cell Lung Carcinoma	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Small Cell Lung Carcinoma	ENSG00000126010	FALSE	unknown	1994-07-15	Unused	GRPR
Small Cell Lung Carcinoma	ENSG00000128052	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Small Cell Lung Carcinoma	ENSG00000128602	FALSE	Phase II Clinical Trial	2004-07-21	Phase II Clinical Trial	SMO
Small Cell Lung Carcinoma	ENSG00000128917	FALSE	unknown	2012-04-23	Absent	DLL4
Small Cell Lung Carcinoma	ENSG00000129484	FALSE	Phase II Clinical Trial	2000-06-26	Absent	PARP2
Small Cell Lung Carcinoma	ENSG00000130816	FALSE	Preclinical	2005-12-02	Absent	DNMT1
Small Cell Lung Carcinoma	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Small Cell Lung Carcinoma	ENSG00000131747	TRUE	Approved	1989-05-15	Approved	TOP2A
Small Cell Lung Carcinoma	ENSG00000131759	FALSE	Phase II Clinical Trial	2018-01-09	Absent	RARA
Small Cell Lung Carcinoma	ENSG00000131828	FALSE	Phase I Clinical Trial	2008-07-26	Absent	PDHA1
Small Cell Lung Carcinoma	ENSG00000132155	FALSE	unknown	1992-11-15	Phase I Clinical Trial	RAF1
Small Cell Lung Carcinoma	ENSG00000132906	FALSE	Preclinical	2006-12-08	Preclinical	CASP9
Small Cell Lung Carcinoma	ENSG00000133019	FALSE	Preclinical	2011-05-18	Unused	CHRM3
Small Cell Lung Carcinoma	ENSG00000133703	FALSE	unknown	1992-11-15	Unused	KRAS
Small Cell Lung Carcinoma	ENSG00000134058	FALSE	Phase I Clinical Trial	2013-05-03	Absent	CDK7
Small Cell Lung Carcinoma	ENSG00000134250	FALSE	unknown	NA	Absent	NOTCH2
Small Cell Lung Carcinoma	ENSG00000134460	FALSE	Phase II Clinical Trial	2000-11-07	Unused	IL2RA
Small Cell Lung Carcinoma	ENSG00000134853	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	PDGFRA
Small Cell Lung Carcinoma	ENSG00000135446	FALSE	Phase II Clinical Trial	2012-09-26	Absent	CDK4
Small Cell Lung Carcinoma	ENSG00000138160	FALSE	Phase II Clinical Trial	2006-01-13	Phase II Clinical Trial	KIF11
Small Cell Lung Carcinoma	ENSG00000138735	FALSE	unknown	1994-12-15	Unused	PDE5A
Small Cell Lung Carcinoma	ENSG00000139874	FALSE	Phase II Clinical Trial	2010-07-30	Absent	SSTR1
Small Cell Lung Carcinoma	ENSG00000140443	FALSE	Phase II Clinical Trial	2005-03-08	Phase II Clinical Trial	IGF1R
Small Cell Lung Carcinoma	ENSG00000140538	FALSE	Phase II Clinical Trial	2010-05-17	Absent	NTRK3
Small Cell Lung Carcinoma	ENSG00000140545	FALSE	Phase II Clinical Trial	NA	Unused	MFGE8
Small Cell Lung Carcinoma	ENSG00000141510	FALSE	Phase II Clinical Trial	1996-05-15	Unused	TP53
Small Cell Lung Carcinoma	ENSG00000141867	FALSE	Phase II Clinical Trial	2017-10-04	Absent	BRD4
Small Cell Lung Carcinoma	ENSG00000142627	FALSE	Phase II Clinical Trial	2010-05-17	Absent	EPHA2
Small Cell Lung Carcinoma	ENSG00000143384	FALSE	unknown	1999-10-20	Phase II Clinical Trial	MCL1
Small Cell Lung Carcinoma	ENSG00000143799	FALSE	Phase II Clinical Trial	2000-06-26	Absent	PARP1
Small Cell Lung Carcinoma	ENSG00000146648	FALSE	Phase II Clinical Trial	1999-12-09	Unused	EGFR
Small Cell Lung Carcinoma	ENSG00000147099	FALSE	Preclinical	2008-07-31	Absent	HDAC8
Small Cell Lung Carcinoma	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Small Cell Lung Carcinoma	ENSG00000149294	FALSE	Phase I Clinical Trial	1991-01-15	Phase II Clinical Trial	NCAM1
Small Cell Lung Carcinoma	ENSG00000149554	FALSE	Phase II Clinical Trial	2010-03-02	Absent	CHEK1
Small Cell Lung Carcinoma	ENSG00000149968	FALSE	unknown	1997-01-15	Unused	MMP3
Small Cell Lung Carcinoma	ENSG00000154229	FALSE	Phase II Clinical Trial	1996-05-15	Unused	PRKCA
Small Cell Lung Carcinoma	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Small Cell Lung Carcinoma	ENSG00000157404	FALSE	Phase II Clinical Trial	1996-06-15	Phase II Clinical Trial	KIT
Small Cell Lung Carcinoma	ENSG00000159131	FALSE	unknown	1992-06-15	Unused	GART
Small Cell Lung Carcinoma	ENSG00000160867	FALSE	unknown	2003-07-22	Absent	FGFR4
Small Cell Lung Carcinoma	ENSG00000162009	FALSE	Phase II Clinical Trial	2010-07-30	Absent	SSTR5
Small Cell Lung Carcinoma	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase III Clinical Trial	CTLA4
Small Cell Lung Carcinoma	ENSG00000164400	FALSE	Phase I Clinical Trial	2008-07-04	Phase I Clinical Trial	CSF2
Small Cell Lung Carcinoma	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Small Cell Lung Carcinoma	ENSG00000166148	FALSE	Preclinical	2014-03-12	Absent	AVPR1A
Small Cell Lung Carcinoma	ENSG00000166483	FALSE	Phase II Clinical Trial	2008-04-09	Absent	WEE1
Small Cell Lung Carcinoma	ENSG00000166825	FALSE	Phase II Clinical Trial	2003-02-20	Phase II Clinical Trial	ANPEP
Small Cell Lung Carcinoma	ENSG00000166851	FALSE	Phase I Clinical Trial	2006-10-19	Unused	PLK1
Small Cell Lung Carcinoma	ENSG00000167325	FALSE	Phase I Clinical Trial	2015-07-24	Absent	RRM1
Small Cell Lung Carcinoma	ENSG00000167658	FALSE	Phase I Clinical Trial	2004-03-03	Unused	EEF2
Small Cell Lung Carcinoma	ENSG00000168398	FALSE	Preclinical	2008-06-03	Unused	BDKRB2
Small Cell Lung Carcinoma	ENSG00000168522	FALSE	unknown	NA	Unused	FNTA
Small Cell Lung Carcinoma	ENSG00000170430	FALSE	Phase II Clinical Trial	2000-05-03	Unused	MGMT
Small Cell Lung Carcinoma	ENSG00000171094	FALSE	Phase II Clinical Trial	2010-05-17	Absent	ALK
Small Cell Lung Carcinoma	ENSG00000171345	FALSE	unknown	2010-01-19	Unused	KRT19
Small Cell Lung Carcinoma	ENSG00000171552	FALSE	Phase I Clinical Trial	2005-11-21	Phase II Clinical Trial	BCL2L1
Small Cell Lung Carcinoma	ENSG00000171720	FALSE	Preclinical	2008-07-31	Absent	HDAC3
Small Cell Lung Carcinoma	ENSG00000171791	FALSE	Phase I Clinical Trial	1992-03-15	Phase II Clinical Trial	BCL2
Small Cell Lung Carcinoma	ENSG00000171862	FALSE	Phase I Clinical Trial	1999-02-15	Phase I Clinical Trial	PTEN
Small Cell Lung Carcinoma	ENSG00000175054	FALSE	Phase I Clinical Trial	2013-07-22	Absent	ATR
Small Cell Lung Carcinoma	ENSG00000176890	FALSE	unknown	1992-06-15	Unused	TYMS
Small Cell Lung Carcinoma	ENSG00000178999	FALSE	Phase II Clinical Trial	2007-02-06	Phase II Clinical Trial	AURKB
Small Cell Lung Carcinoma	ENSG00000179776	FALSE	unknown	2000-12-11	Phase II Clinical Trial	CDH5
Small Cell Lung Carcinoma	ENSG00000180616	FALSE	Phase II Clinical Trial	1999-09-02	Absent	SSTR2
Small Cell Lung Carcinoma	ENSG00000182578	FALSE	Phase I Clinical Trial	2007-06-08	Absent	CSF1R
Small Cell Lung Carcinoma	ENSG00000182871	FALSE	unknown	NA	Phase II Clinical Trial	COL18A1
Small Cell Lung Carcinoma	ENSG00000183765	FALSE	Phase II Clinical Trial	2010-03-02	Absent	CHEK2
Small Cell Lung Carcinoma	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Small Cell Lung Carcinoma	ENSG00000184937	FALSE	Phase II Clinical Trial	2005-12-05	Phase II Clinical Trial	WT1
Small Cell Lung Carcinoma	ENSG00000186642	FALSE	unknown	1994-12-15	Unused	PDE2A
Small Cell Lung Carcinoma	ENSG00000186716	FALSE	Phase II Clinical Trial	1999-03-17	Phase II Clinical Trial	BCR
Small Cell Lung Carcinoma	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Small Cell Lung Carcinoma	ENSG00000196591	FALSE	Preclinical	2008-07-31	Absent	HDAC2
Small Cell Lung Carcinoma	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Small Cell Lung Carcinoma	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Phase I Clinical Trial	MTOR
Small Cell Lung Carcinoma	ENSG00000198900	TRUE	Approved	1996-05-15	Approved	TOP1
Small Cell Lung Carcinoma	ENSG00000213918	FALSE	Preclinical	2014-11-21	Absent	DNASE1
Small Cell Lung Carcinoma	ENSG00000221867	FALSE	unknown	NA	Unused	MAGEA3
Small Cell Lung Carcinoma	ENSG00000228716	FALSE	unknown	1992-06-15	Unused	DHFR
Small Cell Lung Carcinoma	ENSG00000239732	FALSE	Phase II Clinical Trial	2008-05-07	Absent	TLR9
Small Cell Lung Carcinoma	ENSG00000253729	FALSE	Phase II Clinical Trial	1999-03-31	Unused	PRKDC
Small Cell Lung Carcinoma	ENSG00000278195	FALSE	Phase II Clinical Trial	2010-07-30	Absent	SSTR3
Smallpox	ENSG00000097007	FALSE	Preclinical	2009-05-28	Absent	ABL1
Smallpox	ENSG00000141736	FALSE	Preclinical	2012-03-28	Preclinical	ERBB2
Smallpox	ENSG00000186716	FALSE	Preclinical	2009-05-28	Absent	BCR
Smallpox	ENSG00000197461	FALSE	Preclinical	2009-05-28	Absent	PDGFA
Smith-Magenis Syndrome	ENSG00000043591	FALSE	Preclinical	2016-10-14	Absent	ADRB1
Smith-Magenis Syndrome	ENSG00000134640	FALSE	Phase III Clinical Trial	2006-01-04	Absent	MTNR1B
Smith-Magenis Syndrome	ENSG00000168412	FALSE	Phase III Clinical Trial	2006-01-04	Absent	MTNR1A
Soft Tissue Neoplasms	ENSG00000037280	TRUE	Approved	2001-04-03	Approved	FLT4
Soft Tissue Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	FGFR2
Soft Tissue Neoplasms	ENSG00000067182	FALSE	unknown	2003-05-23	Preclinical	TNFRSF1A
Soft Tissue Neoplasms	ENSG00000068024	FALSE	Phase II Clinical Trial	2002-06-10	Absent	HDAC4
Soft Tissue Neoplasms	ENSG00000068078	TRUE	Approved	2001-04-03	Phase II Clinical Trial	FGFR3
Soft Tissue Neoplasms	ENSG00000077782	TRUE	Approved	2001-04-03	Phase II Clinical Trial	FGFR1
Soft Tissue Neoplasms	ENSG00000080824	FALSE	Preclinical	2005-01-07	Phase I Clinical Trial	HSP90AA1
Soft Tissue Neoplasms	ENSG00000082781	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB5
Soft Tissue Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Soft Tissue Neoplasms	ENSG00000085563	FALSE	unknown	1994-04-15	Unused	ABCB1
Soft Tissue Neoplasms	ENSG00000087586	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	AURKA
Soft Tissue Neoplasms	ENSG00000089692	FALSE	Preclinical	2007-07-16	Absent	LAG3
Soft Tissue Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Unused	ANGPT2
Soft Tissue Neoplasms	ENSG00000094631	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC6
Soft Tissue Neoplasms	ENSG00000097007	FALSE	Phase I Clinical Trial	2003-01-13	Phase I Clinical Trial	ABL1
Soft Tissue Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Soft Tissue Neoplasms	ENSG00000100429	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC10
Soft Tissue Neoplasms	ENSG00000100644	FALSE	Preclinical	2006-09-15	Phase I Clinical Trial	HIF1A
Soft Tissue Neoplasms	ENSG00000102755	TRUE	Approved	2001-04-03	Approved	FLT1
Soft Tissue Neoplasms	ENSG00000103222	FALSE	unknown	1994-04-15	Unused	ABCC1
Soft Tissue Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Soft Tissue Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Soft Tissue Neoplasms	ENSG00000106462	FALSE	Phase II Clinical Trial	2010-12-03	Absent	EZH2
Soft Tissue Neoplasms	ENSG00000106991	FALSE	Phase III Clinical Trial	2006-05-01	Absent	ENG
Soft Tissue Neoplasms	ENSG00000109320	FALSE	Phase I Clinical Trial	1997-11-15	Phase I Clinical Trial	NFKB1
Soft Tissue Neoplasms	ENSG00000109471	FALSE	Phase II Clinical Trial	2000-07-26	Unused	IL2
Soft Tissue Neoplasms	ENSG00000110195	FALSE	unknown	NA	Phase I Clinical Trial	FOLR1
Soft Tissue Neoplasms	ENSG00000112715	FALSE	Phase III Clinical Trial	1995-04-15	Phase II Clinical Trial	VEGFA
Soft Tissue Neoplasms	ENSG00000113328	FALSE	Phase III Clinical Trial	2003-08-05	Phase II Clinical Trial	CCNG1
Soft Tissue Neoplasms	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Soft Tissue Neoplasms	ENSG00000113721	TRUE	Approved	2001-04-03	Approved	PDGFRB
Soft Tissue Neoplasms	ENSG00000113851	FALSE	Phase I Clinical Trial	2011-08-26	Absent	CRBN
Soft Tissue Neoplasms	ENSG00000115221	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB6
Soft Tissue Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC1
Soft Tissue Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-03-24	Unused	TEK
Soft Tissue Neoplasms	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Soft Tissue Neoplasms	ENSG00000120889	FALSE	Phase II Clinical Trial	2006-06-05	Unused	TNFRSF10B
Soft Tissue Neoplasms	ENSG00000121879	FALSE	unknown	2005-05-10	Phase II Clinical Trial	PIK3CA
Soft Tissue Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	2004-08-09	Phase II Clinical Trial	FLT3
Soft Tissue Neoplasms	ENSG00000128052	TRUE	Approved	2001-04-03	Approved	KDR
Soft Tissue Neoplasms	ENSG00000128917	FALSE	Phase I Clinical Trial	2012-10-11	Absent	DLL4
Soft Tissue Neoplasms	ENSG00000129484	FALSE	unknown	2000-06-26	Unused	PARP2
Soft Tissue Neoplasms	ENSG00000130368	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MAS1
Soft Tissue Neoplasms	ENSG00000131747	TRUE	Approved	1998-02-15	Approved	TOP2A
Soft Tissue Neoplasms	ENSG00000132906	FALSE	Preclinical	2006-12-08	Absent	CASP9
Soft Tissue Neoplasms	ENSG00000134323	FALSE	Preclinical	NA	Absent	MYCN
Soft Tissue Neoplasms	ENSG00000134853	TRUE	Approved	2001-04-03	Approved	PDGFRA
Soft Tissue Neoplasms	ENSG00000135218	FALSE	unknown	2001-03-14	Unused	CD36
Soft Tissue Neoplasms	ENSG00000135446	FALSE	unknown	2007-08-14	Phase I Clinical Trial	CDK4
Soft Tissue Neoplasms	ENSG00000135679	FALSE	Phase I Clinical Trial	2007-11-29	Phase I Clinical Trial	MDM2
Soft Tissue Neoplasms	ENSG00000136160	FALSE	Phase I Clinical Trial	2004-11-29	Phase I Clinical Trial	EDNRB
Soft Tissue Neoplasms	ENSG00000136869	FALSE	Phase II Clinical Trial	2012-08-06	Absent	TLR4
Soft Tissue Neoplasms	ENSG00000136997	FALSE	Preclinical	NA	Absent	MYC
Soft Tissue Neoplasms	ENSG00000138160	FALSE	Phase I Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Soft Tissue Neoplasms	ENSG00000138448	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGAV
Soft Tissue Neoplasms	ENSG00000140443	FALSE	unknown	2006-04-25	Phase I Clinical Trial	IGF1R
Soft Tissue Neoplasms	ENSG00000141510	FALSE	Preclinical	2006-12-08	Absent	TP53
Soft Tissue Neoplasms	ENSG00000143799	FALSE	Phase I Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Soft Tissue Neoplasms	ENSG00000146904	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	EPHA1
Soft Tissue Neoplasms	ENSG00000147099	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC8
Soft Tissue Neoplasms	ENSG00000151617	FALSE	Phase I Clinical Trial	2004-11-29	Phase I Clinical Trial	EDNRA
Soft Tissue Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Unused	ANGPT1
Soft Tissue Neoplasms	ENSG00000157404	TRUE	Approved	2001-04-03	Approved	KIT
Soft Tissue Neoplasms	ENSG00000157764	TRUE	Approved	2001-04-03	Approved	BRAF
Soft Tissue Neoplasms	ENSG00000159131	FALSE	unknown	1990-07-15	Unused	GART
Soft Tissue Neoplasms	ENSG00000163599	FALSE	Phase I Clinical Trial	2011-05-25	Absent	CTLA4
Soft Tissue Neoplasms	ENSG00000164342	FALSE	Phase II Clinical Trial	NA	Absent	TLR3
Soft Tissue Neoplasms	ENSG00000164400	FALSE	Phase II Clinical Trial	1999-06-15	Unused	CSF2
Soft Tissue Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	2004-08-09	Absent	RET
Soft Tissue Neoplasms	ENSG00000166825	FALSE	Approved	2003-02-20	Phase II Clinical Trial	ANPEP
Soft Tissue Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2011-04-18	Absent	PTK2
Soft Tissue Neoplasms	ENSG00000171720	FALSE	Phase II Clinical Trial	2003-03-06	Phase II Clinical Trial	HDAC3
Soft Tissue Neoplasms	ENSG00000171862	FALSE	Phase II Clinical Trial	1999-02-15	Phase II Clinical Trial	PTEN
Soft Tissue Neoplasms	ENSG00000173153	FALSE	Preclinical	2006-09-15	Preclinical	ESRRA
Soft Tissue Neoplasms	ENSG00000174807	FALSE	Phase II Clinical Trial	2004-10-18	Phase II Clinical Trial	CD248
Soft Tissue Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2005-06-27	Phase II Clinical Trial	CSF1R
Soft Tissue Neoplasms	ENSG00000184033	FALSE	Phase II Clinical Trial	2009-04-09	Absent	CTAG1B
Soft Tissue Neoplasms	ENSG00000185664	FALSE	unknown	1999-06-15	Unused	PMEL
Soft Tissue Neoplasms	ENSG00000186716	FALSE	Phase I Clinical Trial	2003-01-13	Phase I Clinical Trial	BCR
Soft Tissue Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Soft Tissue Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Soft Tissue Neoplasms	ENSG00000196776	FALSE	Phase I Clinical Trial	2011-05-14	Absent	CD47
Soft Tissue Neoplasms	ENSG00000197122	FALSE	Phase II Clinical Trial	2003-01-13	Phase II Clinical Trial	SRC
Soft Tissue Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2013-07-11	Absent	NTRK1
Soft Tissue Neoplasms	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Approved	MTOR
Soft Tissue Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1993-07-15	Unused	TOP1
Soft Tissue Neoplasms	ENSG00000203710	FALSE	unknown	1999-02-14	Absent	CR1
Soft Tissue Neoplasms	ENSG00000239732	FALSE	unknown	2002-09-30	Unused	TLR9
Soft Tissue Neoplasms	ENSG00000259207	FALSE	Phase I Clinical Trial	2002-11-26	Unused	ITGB3
Spasm	ENSG00000011677	FALSE	Approved	1994-10-15	Unused	GABRA3
Spasm	ENSG00000022355	FALSE	Approved	2000-05-24	Unused	GABRA1
Spasm	ENSG00000065989	TRUE	Approved	NA	Approved	PDE4A
Spasm	ENSG00000073756	TRUE	Approved	2011-01-15	Approved	PTGS2
Spasm	ENSG00000082556	FALSE	Preclinical	NA	Unused	OPRK1
Spasm	ENSG00000095303	TRUE	Approved	2011-01-15	Approved	PTGS1
Spasm	ENSG00000105650	FALSE	Preclinical	NA	Unused	PDE4C
Spasm	ENSG00000112038	FALSE	Preclinical	NA	Unused	OPRM1
Spasm	ENSG00000113448	FALSE	Preclinical	NA	Unused	PDE4D
Spasm	ENSG00000118432	FALSE	Preclinical	2008-03-04	Preclinical	CNR1
Spasm	ENSG00000123700	FALSE	Preclinical	2007-06-11	Unused	KCNJ2
Spasm	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Spasm	ENSG00000144285	FALSE	Preclinical	1989-11-15	Unused	SCN1A
Spasm	ENSG00000148408	FALSE	Preclinical	1995-10-15	Unused	CACNA1B
Spasm	ENSG00000151834	FALSE	Approved	1994-10-15	Unused	GABRA2
Spasm	ENSG00000153253	FALSE	Preclinical	1989-11-15	Unused	SCN3A
Spasm	ENSG00000155511	FALSE	Phase I Clinical Trial	2003-05-07	Unused	GRIA1
Spasm	ENSG00000157103	FALSE	Preclinical	2006-10-13	Unused	SLC6A1
Spasm	ENSG00000160013	FALSE	Preclinical	NA	Unused	PTGIR
Spasm	ENSG00000166148	FALSE	Preclinical	NA	Unused	AVPR1A
Spasm	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Spasm	ENSG00000169403	TRUE	Approved	NA	Approved	PTAFR
Spasm	ENSG00000178394	FALSE	Phase I Clinical Trial	2000-03-22	Unused	HTR1A
Spasm	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Spasm	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Spasm	ENSG00000184588	FALSE	Preclinical	NA	Unused	PDE4B
Spasm	ENSG00000186297	FALSE	Approved	1994-10-15	Unused	GABRA5
Spasm	ENSG00000189221	FALSE	Phase II Clinical Trial	1991-11-15	Unused	MAOA
Spasm	ENSG00000196689	FALSE	Preclinical	1991-09-15	Unused	TRPV1
Spasm	ENSG00000198049	FALSE	Preclinical	NA	Unused	AVPR1B
Spasms, Infantile	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Spasms, Infantile	ENSG00000124493	FALSE	Phase I Clinical Trial	NA	Absent	GRM4
Spasms, Infantile	ENSG00000185231	FALSE	Phase I Clinical Trial	2013-09-03	Absent	MC2R
Spasms, Infantile	ENSG00000196277	FALSE	Phase I Clinical Trial	NA	Absent	GRM7
Spinal Cord Injuries	ENSG00000004478	FALSE	Phase I Clinical Trial	2008-09-24	Unused	FKBP4
Spinal Cord Injuries	ENSG00000006071	FALSE	Phase II Clinical Trial	2010-06-10	Phase I Clinical Trial	ABCC8
Spinal Cord Injuries	ENSG00000014216	FALSE	Preclinical	1996-12-15	Unused	CAPN1
Spinal Cord Injuries	ENSG00000019991	FALSE	Phase II Clinical Trial	2007-09-21	Absent	HGF
Spinal Cord Injuries	ENSG00000050748	FALSE	Preclinical	2015-09-18	Absent	MAPK9
Spinal Cord Injuries	ENSG00000065989	FALSE	Preclinical	2000-06-28	Unused	PDE4A
Spinal Cord Injuries	ENSG00000073756	FALSE	Phase II Clinical Trial	NA	Absent	PTGS2
Spinal Cord Injuries	ENSG00000075213	FALSE	Preclinical	2011-09-26	Preclinical	SEMA3A
Spinal Cord Injuries	ENSG00000077092	FALSE	Preclinical	2001-02-06	Unused	RARB
Spinal Cord Injuries	ENSG00000077238	FALSE	Preclinical	2014-01-20	Absent	IL4R
Spinal Cord Injuries	ENSG00000077782	FALSE	Phase II Clinical Trial	NA	Preclinical	FGFR1
Spinal Cord Injuries	ENSG00000078018	FALSE	unknown	2010-08-21	Unused	MAP2
Spinal Cord Injuries	ENSG00000080824	FALSE	Preclinical	2001-12-11	Unused	HSP90AA1
Spinal Cord Injuries	ENSG00000102967	FALSE	Phase II Clinical Trial	NA	Absent	DHODH
Spinal Cord Injuries	ENSG00000105650	FALSE	Preclinical	2000-06-28	Unused	PDE4C
Spinal Cord Injuries	ENSG00000105695	FALSE	unknown	2007-11-05	Unused	MAG
Spinal Cord Injuries	ENSG00000109320	FALSE	Preclinical	1990-06-15	Unused	NFKB1
Spinal Cord Injuries	ENSG00000109339	FALSE	Preclinical	2015-09-18	Absent	MAPK10
Spinal Cord Injuries	ENSG00000112715	FALSE	Preclinical	1998-12-15	Unused	VEGFA
Spinal Cord Injuries	ENSG00000113448	FALSE	Preclinical	2000-06-28	Unused	PDE4D
Spinal Cord Injuries	ENSG00000113721	FALSE	Preclinical	2005-02-22	Preclinical	PDGFRB
Spinal Cord Injuries	ENSG00000115310	FALSE	Phase I Clinical Trial	2006-12-07	Phase I Clinical Trial	RTN4
Spinal Cord Injuries	ENSG00000115457	FALSE	Phase I Clinical Trial	2010-10-19	Absent	IGFBP2
Spinal Cord Injuries	ENSG00000118432	FALSE	unknown	1998-08-15	Phase III Clinical Trial	CNR1
Spinal Cord Injuries	ENSG00000119535	FALSE	Preclinical	2003-04-24	Phase I Clinical Trial	CSF3R
Spinal Cord Injuries	ENSG00000121966	FALSE	Preclinical	2005-07-06	Unused	CXCR4
Spinal Cord Injuries	ENSG00000122884	FALSE	unknown	NA	Unused	P4HA1
Spinal Cord Injuries	ENSG00000128271	FALSE	Preclinical	2000-04-03	Unused	ADORA2A
Spinal Cord Injuries	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Spinal Cord Injuries	ENSG00000132437	FALSE	unknown	2011-12-07	Preclinical	DDC
Spinal Cord Injuries	ENSG00000134318	FALSE	Phase III Clinical Trial	2002-06-17	Unused	ROCK2
Spinal Cord Injuries	ENSG00000135744	FALSE	Preclinical	2012-09-27	Absent	AGT
Spinal Cord Injuries	ENSG00000138685	FALSE	Phase II Clinical Trial	2011-04-04	Phase II Clinical Trial	FGF2
Spinal Cord Injuries	ENSG00000140443	FALSE	Phase I Clinical Trial	2010-10-19	Absent	IGF1R
Spinal Cord Injuries	ENSG00000147955	FALSE	unknown	1996-05-15	Unused	SIGMAR1
Spinal Cord Injuries	ENSG00000148053	FALSE	Preclinical	2009-12-09	Unused	NTRK2
Spinal Cord Injuries	ENSG00000149294	FALSE	Preclinical	2007-06-12	Unused	NCAM1
Spinal Cord Injuries	ENSG00000150594	FALSE	Preclinical	NA	Unused	ADRA2A
Spinal Cord Injuries	ENSG00000155511	FALSE	Preclinical	2002-11-15	Unused	GRIA1
Spinal Cord Injuries	ENSG00000157168	FALSE	Preclinical	1989-06-15	Absent	NRG1
Spinal Cord Injuries	ENSG00000162909	FALSE	Preclinical	1996-12-15	Unused	CAPN2
Spinal Cord Injuries	ENSG00000163464	FALSE	Preclinical	2007-07-04	Unused	CXCR1
Spinal Cord Injuries	ENSG00000164305	FALSE	Preclinical	2013-01-03	Preclinical	CASP3
Spinal Cord Injuries	ENSG00000165970	FALSE	Preclinical	1997-10-15	Unused	SLC6A5
Spinal Cord Injuries	ENSG00000168621	FALSE	Preclinical	2009-08-03	Absent	GDNF
Spinal Cord Injuries	ENSG00000169245	FALSE	Preclinical	2002-12-04	Unused	CXCL10
Spinal Cord Injuries	ENSG00000171497	FALSE	Preclinical	2009-07-28	Unused	PPID
Spinal Cord Injuries	ENSG00000171791	FALSE	Preclinical	1997-07-15	Unused	BCL2
Spinal Cord Injuries	ENSG00000171862	FALSE	Preclinical	2016-06-24	Absent	PTEN
Spinal Cord Injuries	ENSG00000176884	FALSE	Preclinical	1990-06-15	Unused	GRIN1
Spinal Cord Injuries	ENSG00000178394	FALSE	unknown	2011-12-07	Preclinical	HTR1A
Spinal Cord Injuries	ENSG00000180871	FALSE	Preclinical	2007-07-04	Unused	CXCR2
Spinal Cord Injuries	ENSG00000182175	FALSE	Phase I Clinical Trial	2015-11-13	Absent	RGMA
Spinal Cord Injuries	ENSG00000184588	FALSE	Preclinical	2000-06-28	Unused	PDE4B
Spinal Cord Injuries	ENSG00000188778	FALSE	Phase I Clinical Trial	2002-12-04	Absent	ADRB3
Spinal Cord Injuries	ENSG00000196262	FALSE	Phase I Clinical Trial	2004-04-27	Phase I Clinical Trial	PPIA
Spinal Cord Injuries	ENSG00000197971	FALSE	unknown	NA	Unused	MBP
Spinal Cord Injuries	ENSG00000242252	FALSE	Preclinical	2016-07-12	Absent	BGLAP
Spinal Cord Injuries	ENSG00000262655	FALSE	Preclinical	1992-08-15	Unused	SPON1
Spinal Cord Injuries	ENSG00000274286	FALSE	Preclinical	NA	Unused	ADRA2B
Spinal Stenosis	ENSG00000114859	FALSE	Phase I Clinical Trial	2005-12-31	Phase II Clinical Trial	CLCN2
Spinal Stenosis	ENSG00000156113	FALSE	unknown	2010-03-15	Absent	KCNMA1
Spinal Stenosis	ENSG00000160013	FALSE	unknown	2005-11-25	Phase II Clinical Trial	PTGIR
Spinal Stenosis	ENSG00000160951	FALSE	unknown	NA	Absent	PTGER1
Spinocerebellar Ataxias	ENSG00000080709	FALSE	Preclinical	NA	Absent	KCNN2
Spinocerebellar Ataxias	ENSG00000080824	FALSE	Phase I Clinical Trial	2016-01-29	Absent	HSP90AA1
Spinocerebellar Ataxias	ENSG00000110887	FALSE	Phase II Clinical Trial	2015-10-05	Absent	DAO
Spinocerebellar Ataxias	ENSG00000123454	FALSE	unknown	1989-06-15	Unused	DBH
Spinocerebellar Ataxias	ENSG00000143603	FALSE	Preclinical	NA	Absent	KCNN3
Spinocerebellar Ataxias	ENSG00000171759	FALSE	unknown	1989-06-15	Unused	PAH
Spinocerebellar Ataxias	ENSG00000174417	FALSE	Approved	1990-10-15	Unused	TRHR
Spinocerebellar Ataxias	ENSG00000204842	FALSE	Preclinical	2015-01-02	Absent	ATXN2
Spondylarthritis	ENSG00000110944	FALSE	Preclinical	2009-05-22	Absent	IL23A
Spondylarthritis	ENSG00000112115	FALSE	Phase III Clinical Trial	2006-02-01	Absent	IL17A
Spondylarthritis	ENSG00000113302	FALSE	Phase III Clinical Trial	2003-04-30	Absent	IL12B
Spondylarthritis	ENSG00000143365	FALSE	Preclinical	2016-06-14	Absent	RORC
Spondylarthritis	ENSG00000177663	FALSE	Phase III Clinical Trial	2008-03-04	Absent	IL17RA
Spondylitis, Ankylosing	ENSG00000065989	FALSE	Phase III Clinical Trial	2004-01-28	Phase III Clinical Trial	PDE4A
Spondylitis, Ankylosing	ENSG00000067182	FALSE	Phase III Clinical Trial	2004-01-28	Phase III Clinical Trial	TNFRSF1A
Spondylitis, Ankylosing	ENSG00000073756	TRUE	Approved	1996-10-15	Approved	PTGS2
Spondylitis, Ankylosing	ENSG00000095303	TRUE	Approved	2005-10-28	Approved	PTGS1
Spondylitis, Ankylosing	ENSG00000096968	FALSE	unknown	2007-10-10	Absent	JAK2
Spondylitis, Ankylosing	ENSG00000105639	FALSE	unknown	2003-06-25	Phase II Clinical Trial	JAK3
Spondylitis, Ankylosing	ENSG00000105650	FALSE	Phase III Clinical Trial	2004-01-28	Phase III Clinical Trial	PDE4C
Spondylitis, Ankylosing	ENSG00000105675	TRUE	Approved	2005-10-28	Approved	ATP4A
Spondylitis, Ankylosing	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Spondylitis, Ankylosing	ENSG00000110944	FALSE	Phase II Clinical Trial	2012-04-17	Absent	IL23A
Spondylitis, Ankylosing	ENSG00000112062	FALSE	Phase II Clinical Trial	2003-11-21	Unused	MAPK14
Spondylitis, Ankylosing	ENSG00000112115	TRUE	Approved	2006-02-01	Phase III Clinical Trial	IL17A
Spondylitis, Ankylosing	ENSG00000112116	FALSE	Phase II Clinical Trial	2012-03-21	Absent	IL17F
Spondylitis, Ankylosing	ENSG00000113302	FALSE	unknown	2003-04-30	Absent	IL12B
Spondylitis, Ankylosing	ENSG00000113448	FALSE	Phase III Clinical Trial	2004-01-28	Phase III Clinical Trial	PDE4D
Spondylitis, Ankylosing	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Spondylitis, Ankylosing	ENSG00000114013	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	CD86
Spondylitis, Ankylosing	ENSG00000121594	FALSE	Phase II Clinical Trial	1992-11-15	Phase II Clinical Trial	CD80
Spondylitis, Ankylosing	ENSG00000139219	FALSE	Preclinical	2016-11-23	Absent	COL2A1
Spondylitis, Ankylosing	ENSG00000143365	FALSE	Preclinical	2012-06-15	Preclinical	RORC
Spondylitis, Ankylosing	ENSG00000156738	FALSE	unknown	1993-09-15	Unused	MS4A1
Spondylitis, Ankylosing	ENSG00000160712	FALSE	Phase III Clinical Trial	1996-05-15	Phase III Clinical Trial	IL6R
Spondylitis, Ankylosing	ENSG00000160951	TRUE	Approved	NA	Unused	PTGER1
Spondylitis, Ankylosing	ENSG00000162434	FALSE	Phase III Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK1
Spondylitis, Ankylosing	ENSG00000163283	FALSE	unknown	2013-07-04	Absent	ALPP
Spondylitis, Ankylosing	ENSG00000164400	FALSE	Preclinical	2002-04-15	Absent	CSF2
Spondylitis, Ankylosing	ENSG00000184588	FALSE	Phase III Clinical Trial	2004-01-28	Phase III Clinical Trial	PDE4B
Spondylitis, Ankylosing	ENSG00000228716	FALSE	unknown	2008-03-27	Absent	DHFR
Staphylococcal Infections	ENSG00000012223	FALSE	unknown	1996-06-15	Unused	LTF
Staphylococcal Infections	ENSG00000065989	FALSE	Phase II Clinical Trial	2005-05-24	Absent	PDE4A
Staphylococcal Infections	ENSG00000101425	FALSE	unknown	2002-01-17	Unused	BPI
Staphylococcal Infections	ENSG00000115020	FALSE	Preclinical	2013-08-29	Absent	PIKFYVE
Staphylococcal Infections	ENSG00000118432	FALSE	Preclinical	2014-11-21	Absent	CNR1
Staphylococcal Infections	ENSG00000121879	FALSE	Preclinical	2004-08-10	Preclinical	PIK3CA
Staphylococcal Infections	ENSG00000131747	FALSE	Preclinical	2013-07-22	Absent	TOP2A
Staphylococcal Infections	ENSG00000156508	FALSE	Preclinical	2010-10-27	Unused	EEF1A1
Staphylococcal Infections	ENSG00000172236	FALSE	unknown	1996-06-15	Unused	TPSAB1
Staphylococcal Infections	ENSG00000188822	FALSE	Preclinical	2014-11-21	Absent	CNR2
Staphylococcal Infections	ENSG00000198793	FALSE	Preclinical	2004-08-10	Preclinical	MTOR
Staphylococcal Infections	ENSG00000203710	FALSE	Preclinical	2004-10-01	Unused	CR1
Status Epilepticus	ENSG00000011677	FALSE	unknown	2007-03-07	Absent	GABRA3
Status Epilepticus	ENSG00000022355	FALSE	Phase III Clinical Trial	2007-03-07	Absent	GABRA1
Status Epilepticus	ENSG00000124493	FALSE	Phase I Clinical Trial	NA	Absent	GRM4
Status Epilepticus	ENSG00000144285	TRUE	Approved	NA	Absent	SCN1A
Status Epilepticus	ENSG00000151067	FALSE	Preclinical	NA	Absent	CACNA1C
Status Epilepticus	ENSG00000151834	FALSE	unknown	2007-03-07	Absent	GABRA2
Status Epilepticus	ENSG00000153253	TRUE	Approved	NA	Absent	SCN3A
Status Epilepticus	ENSG00000155511	FALSE	unknown	1996-12-15	Absent	GRIA1
Status Epilepticus	ENSG00000186297	FALSE	unknown	2007-03-07	Absent	GABRA5
Status Epilepticus	ENSG00000196277	FALSE	Phase I Clinical Trial	NA	Absent	GRM7
Steatorrhea	ENSG00000175535	TRUE	Approved	2003-05-19	Approved	PNLIP
Stiff-Person Syndrome	ENSG00000136750	FALSE	Preclinical	NA	Unused	GAD2
Still's Disease, Adult-Onset	ENSG00000115594	FALSE	Phase III Clinical Trial	NA	Absent	IL1R1
Still's Disease, Adult-Onset	ENSG00000125538	TRUE	Approved	2003-12-08	Absent	IL1B
Still's Disease, Adult-Onset	ENSG00000150782	FALSE	Phase III Clinical Trial	2015-04-01	Absent	IL18
Stomach Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Stomach Neoplasms	ENSG00000010810	FALSE	Phase II Clinical Trial	NA	Absent	FYN
Stomach Neoplasms	ENSG00000019991	FALSE	Phase II Clinical Trial	2005-04-26	Phase III Clinical Trial	HGF
Stomach Neoplasms	ENSG00000020633	FALSE	Preclinical	2012-09-20	Preclinical	RUNX3
Stomach Neoplasms	ENSG00000025708	FALSE	Phase III Clinical Trial	1998-06-15	Absent	TYMP
Stomach Neoplasms	ENSG00000037280	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Stomach Neoplasms	ENSG00000044574	FALSE	Preclinical	2007-11-19	Preclinical	HSPA5
Stomach Neoplasms	ENSG00000051382	FALSE	Phase II Clinical Trial	2005-12-01	Phase II Clinical Trial	PIK3CB
Stomach Neoplasms	ENSG00000064012	FALSE	unknown	2004-01-30	Unused	CASP8
Stomach Neoplasms	ENSG00000065361	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	ERBB3
Stomach Neoplasms	ENSG00000066405	FALSE	Phase II Clinical Trial	2004-01-06	Absent	CLDN18
Stomach Neoplasms	ENSG00000066468	FALSE	Phase III Clinical Trial	2006-05-05	Phase II Clinical Trial	FGFR2
Stomach Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-23	Phase II Clinical Trial	FGFR3
Stomach Neoplasms	ENSG00000070019	FALSE	Phase II Clinical Trial	2012-02-17	Phase I Clinical Trial	GUCY2C
Stomach Neoplasms	ENSG00000074266	FALSE	Phase II Clinical Trial	2016-06-25	Absent	EED
Stomach Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-23	Phase II Clinical Trial	FGFR1
Stomach Neoplasms	ENSG00000079385	FALSE	Phase I Clinical Trial	2015-01-09	Absent	CEACAM1
Stomach Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2004-02-03	Phase II Clinical Trial	HSP90AA1
Stomach Neoplasms	ENSG00000081181	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG2
Stomach Neoplasms	ENSG00000085563	FALSE	Phase II Clinical Trial	2005-04-13	Phase II Clinical Trial	ABCB1
Stomach Neoplasms	ENSG00000087088	FALSE	unknown	2002-06-26	Unused	BAX
Stomach Neoplasms	ENSG00000087586	FALSE	unknown	2006-11-20	Phase II Clinical Trial	AURKA
Stomach Neoplasms	ENSG00000089692	FALSE	Phase II Clinical Trial	2007-07-16	Absent	LAG3
Stomach Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT2
Stomach Neoplasms	ENSG00000096968	FALSE	Phase I Clinical Trial	2007-08-07	Unused	JAK2
Stomach Neoplasms	ENSG00000096996	FALSE	Phase I Clinical Trial	2014-09-23	Absent	IL12RB1
Stomach Neoplasms	ENSG00000100311	FALSE	Phase I Clinical Trial	1994-06-15	Unused	PDGFB
Stomach Neoplasms	ENSG00000100644	FALSE	Phase II Clinical Trial	2003-08-01	Phase II Clinical Trial	HIF1A
Stomach Neoplasms	ENSG00000100985	FALSE	Phase III Clinical Trial	2013-03-05	Preclinical	MMP9
Stomach Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	2016-11-14	Absent	CD40
Stomach Neoplasms	ENSG00000101868	FALSE	unknown	2004-05-18	Unused	POLA1
Stomach Neoplasms	ENSG00000102312	FALSE	Preclinical	2011-05-14	Absent	PORCN
Stomach Neoplasms	ENSG00000102755	FALSE	Phase III Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Stomach Neoplasms	ENSG00000102854	FALSE	Phase II Clinical Trial	2004-01-30	Absent	MSLN
Stomach Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Stomach Neoplasms	ENSG00000105281	FALSE	Preclinical	2016-12-12	Absent	SLC1A5
Stomach Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2014-07-14	Absent	CEACAM5
Stomach Neoplasms	ENSG00000105639	FALSE	Preclinical	2017-07-24	Absent	JAK3
Stomach Neoplasms	ENSG00000105810	FALSE	unknown	1996-05-15	Unused	CDK6
Stomach Neoplasms	ENSG00000105851	FALSE	unknown	2005-12-01	Absent	PIK3CG
Stomach Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	1996-01-15	Phase III Clinical Trial	MET
Stomach Neoplasms	ENSG00000106799	FALSE	Phase I Clinical Trial	2003-09-17	Absent	TGFBR1
Stomach Neoplasms	ENSG00000107317	FALSE	Preclinical	2013-05-07	Absent	PTGDS
Stomach Neoplasms	ENSG00000107984	FALSE	Phase I Clinical Trial	2011-11-01	Absent	DKK1
Stomach Neoplasms	ENSG00000108654	FALSE	Preclinical	2006-08-30	Absent	DDX5
Stomach Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Stomach Neoplasms	ENSG00000110195	FALSE	Phase I Clinical Trial	2003-10-15	Phase I Clinical Trial	FOLR1
Stomach Neoplasms	ENSG00000112715	FALSE	Preclinical	1995-04-15	Unused	VEGFA
Stomach Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Stomach Neoplasms	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Stomach Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2003-07-16	Phase II Clinical Trial	PDGFRB
Stomach Neoplasms	ENSG00000114378	FALSE	Phase II Clinical Trial	NA	Absent	HYAL1
Stomach Neoplasms	ENSG00000114491	FALSE	Approved	2016-06-16	Absent	UMPS
Stomach Neoplasms	ENSG00000115053	FALSE	unknown	2003-03-13	Unused	NCL
Stomach Neoplasms	ENSG00000115758	FALSE	Preclinical	1994-03-15	Phase I Clinical Trial	ODC1
Stomach Neoplasms	ENSG00000116016	FALSE	Phase II Clinical Trial	2003-08-01	Absent	EPAS1
Stomach Neoplasms	ENSG00000116157	FALSE	Preclinical	2016-07-06	Absent	GPX7
Stomach Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC1
Stomach Neoplasms	ENSG00000118520	FALSE	Phase II Clinical Trial	2014-08-28	Absent	ARG1
Stomach Neoplasms	ENSG00000119888	FALSE	Phase II Clinical Trial	1999-04-28	Phase III Clinical Trial	EPCAM
Stomach Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	TEK
Stomach Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2008-01-16	Phase I Clinical Trial	CD274
Stomach Neoplasms	ENSG00000121858	FALSE	unknown	2006-07-10	Unused	TNFSF10
Stomach Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	2005-12-01	Phase I Clinical Trial	PIK3CA
Stomach Neoplasms	ENSG00000121966	FALSE	Phase II Clinical Trial	2009-03-27	Absent	CXCR4
Stomach Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Stomach Neoplasms	ENSG00000122861	FALSE	unknown	1999-03-10	Unused	PLAU
Stomach Neoplasms	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Stomach Neoplasms	ENSG00000124762	FALSE	unknown	1996-05-15	Unused	CDKN1A
Stomach Neoplasms	ENSG00000126934	FALSE	unknown	2003-06-09	Unused	MAP2K2
Stomach Neoplasms	ENSG00000128052	TRUE	Approved	1994-06-15	Phase III Clinical Trial	KDR
Stomach Neoplasms	ENSG00000128602	FALSE	Phase I Clinical Trial	2004-07-21	Phase I Clinical Trial	SMO
Stomach Neoplasms	ENSG00000129484	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP2
Stomach Neoplasms	ENSG00000130164	FALSE	unknown	2007-11-19	Absent	LDLR
Stomach Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase I Clinical Trial	PPT1
Stomach Neoplasms	ENSG00000131747	FALSE	Approved	1992-04-15	Phase II Clinical Trial	TOP2A
Stomach Neoplasms	ENSG00000131759	FALSE	Phase II Clinical Trial	2018-01-09	Absent	RARA
Stomach Neoplasms	ENSG00000132155	FALSE	unknown	1994-06-15	Unused	RAF1
Stomach Neoplasms	ENSG00000132906	FALSE	unknown	2004-01-30	Unused	CASP9
Stomach Neoplasms	ENSG00000134460	FALSE	Preclinical	2015-09-15	Absent	IL2RA
Stomach Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	1996-12-15	Phase II Clinical Trial	PDGFRA
Stomach Neoplasms	ENSG00000135446	FALSE	unknown	1996-05-15	Unused	CDK4
Stomach Neoplasms	ENSG00000136807	FALSE	unknown	1996-05-15	Phase I Clinical Trial	CDK9
Stomach Neoplasms	ENSG00000137462	FALSE	Preclinical	2006-02-15	Absent	TLR2
Stomach Neoplasms	ENSG00000138160	FALSE	unknown	1999-06-30	Phase II Clinical Trial	KIF11
Stomach Neoplasms	ENSG00000138778	FALSE	Phase I Clinical Trial	2006-02-03	Phase I Clinical Trial	CENPE
Stomach Neoplasms	ENSG00000140443	FALSE	unknown	2006-04-25	Phase I Clinical Trial	IGF1R
Stomach Neoplasms	ENSG00000140538	FALSE	Preclinical	2012-03-14	Absent	NTRK3
Stomach Neoplasms	ENSG00000141510	FALSE	unknown	1996-05-15	Unused	TP53
Stomach Neoplasms	ENSG00000141736	TRUE	Approved	1990-09-15	Approved	ERBB2
Stomach Neoplasms	ENSG00000142208	FALSE	Phase II Clinical Trial	2004-03-23	Preclinical	AKT1
Stomach Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Stomach Neoplasms	ENSG00000143226	FALSE	Phase II Clinical Trial	NA	Absent	FCGR2A
Stomach Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Stomach Neoplasms	ENSG00000143384	FALSE	unknown	2005-11-21	Unused	MCL1
Stomach Neoplasms	ENSG00000143799	FALSE	Phase III Clinical Trial	2000-06-26	Phase II Clinical Trial	PARP1
Stomach Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1993-07-15	Phase III Clinical Trial	EGFR
Stomach Neoplasms	ENSG00000147257	FALSE	Phase I Clinical Trial	2014-12-01	Absent	GPC3
Stomach Neoplasms	ENSG00000148400	FALSE	unknown	2009-02-06	Absent	NOTCH1
Stomach Neoplasms	ENSG00000150093	FALSE	Preclinical	2008-08-19	Preclinical	ITGB1
Stomach Neoplasms	ENSG00000150337	FALSE	Phase II Clinical Trial	NA	Absent	FCGR1A
Stomach Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase II Clinical Trial	ANGPT1
Stomach Neoplasms	ENSG00000154229	FALSE	Phase II Clinical Trial	2018-01-09	Absent	PRKCA
Stomach Neoplasms	ENSG00000155380	FALSE	Phase I Clinical Trial	2010-09-13	Absent	SLC16A1
Stomach Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase I Clinical Trial	EEF1A1
Stomach Neoplasms	ENSG00000157227	FALSE	Preclinical	2014-06-09	Absent	MMP14
Stomach Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-05-15	Phase II Clinical Trial	KIT
Stomach Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Stomach Neoplasms	ENSG00000160180	FALSE	Preclinical	2012-07-17	Preclinical	TFF3
Stomach Neoplasms	ENSG00000160182	FALSE	Preclinical	2012-07-17	Preclinical	TFF1
Stomach Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2006-05-05	Absent	FGFR4
Stomach Neoplasms	ENSG00000161011	FALSE	Preclinical	2015-11-04	Absent	SQSTM1
Stomach Neoplasms	ENSG00000162434	FALSE	Preclinical	2017-07-24	Absent	JAK1
Stomach Neoplasms	ENSG00000162747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3B
Stomach Neoplasms	ENSG00000163220	FALSE	Phase II Clinical Trial	2001-05-18	Phase II Clinical Trial	S100A9
Stomach Neoplasms	ENSG00000163513	FALSE	unknown	2002-06-26	Unused	TGFBR2
Stomach Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase II Clinical Trial	CTLA4
Stomach Neoplasms	ENSG00000163600	FALSE	Phase II Clinical Trial	2013-02-26	Absent	ICOS
Stomach Neoplasms	ENSG00000164078	FALSE	Phase II Clinical Trial	2001-12-18	Phase II Clinical Trial	MST1R
Stomach Neoplasms	ENSG00000164171	FALSE	Preclinical	2008-08-19	Preclinical	ITGA2
Stomach Neoplasms	ENSG00000164305	FALSE	unknown	2004-01-30	Unused	CASP3
Stomach Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	2013-05-28	Absent	TERT
Stomach Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Stomach Neoplasms	ENSG00000165025	FALSE	Phase I Clinical Trial	2013-12-06	Absent	SYK
Stomach Neoplasms	ENSG00000165731	FALSE	Approved	1994-06-15	Phase III Clinical Trial	RET
Stomach Neoplasms	ENSG00000166483	FALSE	Phase I Clinical Trial	2008-04-09	Phase I Clinical Trial	WEE1
Stomach Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Stomach Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	2009-04-21	Unused	PLK1
Stomach Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	1991-07-15	Absent	RRM1
Stomach Neoplasms	ENSG00000167601	FALSE	Preclinical	2004-06-18	Phase II Clinical Trial	AXL
Stomach Neoplasms	ENSG00000167653	FALSE	Preclinical	2017-06-29	Absent	PSCA
Stomach Neoplasms	ENSG00000167658	FALSE	Preclinical	1993-05-15	Unused	EEF2
Stomach Neoplasms	ENSG00000168522	FALSE	unknown	1997-06-15	Unused	FNTA
Stomach Neoplasms	ENSG00000168610	FALSE	Phase III Clinical Trial	2010-08-03	Absent	STAT3
Stomach Neoplasms	ENSG00000169032	FALSE	unknown	2003-06-09	Unused	MAP2K1
Stomach Neoplasms	ENSG00000169398	FALSE	Phase I Clinical Trial	2007-01-08	Unused	PTK2
Stomach Neoplasms	ENSG00000169710	FALSE	Preclinical	2008-06-20	Unused	FASN
Stomach Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Stomach Neoplasms	ENSG00000170558	FALSE	unknown	1999-06-30	Unused	CDH2
Stomach Neoplasms	ENSG00000171552	FALSE	unknown	2005-11-21	Unused	BCL2L1
Stomach Neoplasms	ENSG00000171608	FALSE	Phase I Clinical Trial	2005-12-01	Absent	PIK3CD
Stomach Neoplasms	ENSG00000171791	FALSE	unknown	2005-11-21	Unused	BCL2
Stomach Neoplasms	ENSG00000171848	FALSE	unknown	1991-07-15	Absent	RRM2
Stomach Neoplasms	ENSG00000174807	FALSE	Phase I Clinical Trial	2004-10-18	Phase I Clinical Trial	CD248
Stomach Neoplasms	ENSG00000175054	FALSE	Preclinical	2013-04-30	Absent	ATR
Stomach Neoplasms	ENSG00000176890	TRUE	Approved	1991-09-15	Approved	TYMS
Stomach Neoplasms	ENSG00000178568	FALSE	Phase III Clinical Trial	2003-11-21	Phase II Clinical Trial	ERBB4
Stomach Neoplasms	ENSG00000178999	FALSE	Phase I Clinical Trial	2013-01-21	Absent	AURKB
Stomach Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-08	Absent	CSF1R
Stomach Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Stomach Neoplasms	ENSG00000184502	FALSE	Phase III Clinical Trial	1994-08-15	Phase III Clinical Trial	GAST
Stomach Neoplasms	ENSG00000184937	FALSE	unknown	2005-12-05	Phase II Clinical Trial	WT1
Stomach Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2007-08-21	Phase I Clinical Trial	MUC1
Stomach Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Absent	PDCD1
Stomach Neoplasms	ENSG00000188641	FALSE	Approved	2016-06-16	Absent	DPYD
Stomach Neoplasms	ENSG00000196352	FALSE	Phase II Clinical Trial	1999-12-01	Phase II Clinical Trial	CD55
Stomach Neoplasms	ENSG00000196591	FALSE	Phase I Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC2
Stomach Neoplasms	ENSG00000197122	FALSE	Phase I Clinical Trial	2007-04-25	Phase I Clinical Trial	SRC
Stomach Neoplasms	ENSG00000197442	FALSE	Preclinical	2013-01-19	Preclinical	MAP3K5
Stomach Neoplasms	ENSG00000198400	FALSE	Preclinical	2012-03-14	Absent	NTRK1
Stomach Neoplasms	ENSG00000198793	FALSE	Phase III Clinical Trial	1997-08-15	Phase III Clinical Trial	MTOR
Stomach Neoplasms	ENSG00000198851	FALSE	Phase II Clinical Trial	2014-04-11	Absent	CD3E
Stomach Neoplasms	ENSG00000198900	TRUE	Approved	1995-06-15	Approved	TOP1
Stomach Neoplasms	ENSG00000203747	FALSE	Phase II Clinical Trial	NA	Absent	FCGR3A
Stomach Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Stomach Neoplasms	ENSG00000254087	FALSE	Phase II Clinical Trial	NA	Absent	LYN
Stomach Ulcer	ENSG00000050628	TRUE	Approved	NA	Approved	PTGER3
Stomach Ulcer	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Stomach Ulcer	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Stomach Ulcer	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Stomach Ulcer	ENSG00000110148	TRUE	Approved	1995-10-15	Approved	CCKBR
Stomach Ulcer	ENSG00000113749	TRUE	Approved	1989-05-15	Approved	HRH2
Stomach Ulcer	ENSG00000114859	FALSE	Phase I Clinical Trial	2002-09-25	Phase II Clinical Trial	CLCN2
Stomach Ulcer	ENSG00000125384	TRUE	Approved	NA	Approved	PTGER2
Stomach Ulcer	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Stomach Ulcer	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Stomach Ulcer	ENSG00000145545	TRUE	Approved	NA	Approved	SRD5A1
Stomach Ulcer	ENSG00000146648	FALSE	Pre-registration	1992-12-15	Unused	EGFR
Stomach Ulcer	ENSG00000160951	TRUE	Approved	NA	Approved	PTGER1
Stomach Ulcer	ENSG00000164120	FALSE	Approved	NA	Unused	HPGD
Stomach Ulcer	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Stomach Ulcer	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Stomach Ulcer	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Stomach Ulcer	ENSG00000184502	TRUE	Approved	2002-09-26	Approved	GAST
Stomach Ulcer	ENSG00000254087	FALSE	unknown	2007-04-05	Unused	LYN
Stomatitis	ENSG00000112096	FALSE	unknown	1999-10-20	Absent	SOD2
Stomatitis	ENSG00000116044	FALSE	Preclinical	2004-11-18	Absent	NFE2L2
Stomatitis	ENSG00000125384	FALSE	Preclinical	2009-07-18	Absent	PTGER2
Stomatitis	ENSG00000146648	FALSE	Phase III Clinical Trial	1997-11-15	Absent	EGFR
Stomatitis	ENSG00000205649	FALSE	Phase II Clinical Trial	1998-03-15	Absent	HTN3
Stomatitis, Aphthous	ENSG00000113580	TRUE	Approved	1996-04-15	Approved	NR3C1
Stomatitis, Aphthous	ENSG00000117594	FALSE	Preclinical	2016-10-26	Absent	HSD11B1
Stomatitis, Aphthous	ENSG00000159110	FALSE	unknown	NA	Phase II Clinical Trial	IFNAR2
Stomatitis, Aphthous	ENSG00000169432	FALSE	unknown	2008-06-06	Unused	SCN9A
Streptococcal Infections	ENSG00000131747	FALSE	Preclinical	2013-07-22	Absent	TOP2A
Streptococcal Infections	ENSG00000196664	FALSE	Preclinical	2011-09-08	Unused	TLR7
Stress Disorders, Post-Traumatic	ENSG00000011677	FALSE	Preclinical	2009-07-16	Absent	GABRA3
Stress Disorders, Post-Traumatic	ENSG00000022355	FALSE	Preclinical	2009-07-16	Absent	GABRA1
Stress Disorders, Post-Traumatic	ENSG00000043591	FALSE	Phase II Clinical Trial	NA	Unused	ADRB1
Stress Disorders, Post-Traumatic	ENSG00000082175	FALSE	unknown	2009-04-23	Unused	PGR
Stress Disorders, Post-Traumatic	ENSG00000102468	TRUE	Approved	1990-12-15	Unused	HTR2A
Stress Disorders, Post-Traumatic	ENSG00000103546	TRUE	Approved	NA	Unused	SLC6A2
Stress Disorders, Post-Traumatic	ENSG00000108576	TRUE	Approved	2015-02-05	Approved	SLC6A4
Stress Disorders, Post-Traumatic	ENSG00000112038	FALSE	Preclinical	NA	Absent	OPRM1
Stress Disorders, Post-Traumatic	ENSG00000115353	FALSE	Phase II Clinical Trial	2004-02-18	Unused	TACR1
Stress Disorders, Post-Traumatic	ENSG00000117480	FALSE	Phase I Clinical Trial	2008-09-30	Absent	FAAH
Stress Disorders, Post-Traumatic	ENSG00000117594	FALSE	Preclinical	2015-03-06	Absent	HSD11B1
Stress Disorders, Post-Traumatic	ENSG00000118432	FALSE	Preclinical	2017-02-09	Absent	CNR1
Stress Disorders, Post-Traumatic	ENSG00000120088	FALSE	Phase II Clinical Trial	2001-09-04	Phase II Clinical Trial	CRHR1
Stress Disorders, Post-Traumatic	ENSG00000123454	FALSE	unknown	1996-12-15	Phase II Clinical Trial	DBH
Stress Disorders, Post-Traumatic	ENSG00000142319	FALSE	Phase III Clinical Trial	NA	Unused	SLC6A3
Stress Disorders, Post-Traumatic	ENSG00000147246	TRUE	Approved	NA	Unused	HTR2C
Stress Disorders, Post-Traumatic	ENSG00000148053	FALSE	Preclinical	2014-05-29	Absent	NTRK2
Stress Disorders, Post-Traumatic	ENSG00000149295	FALSE	Phase III Clinical Trial	1990-12-15	Phase II Clinical Trial	DRD2
Stress Disorders, Post-Traumatic	ENSG00000150594	FALSE	Phase II Clinical Trial	NA	Unused	ADRA2A
Stress Disorders, Post-Traumatic	ENSG00000151577	FALSE	Phase III Clinical Trial	2008-12-08	Absent	DRD3
Stress Disorders, Post-Traumatic	ENSG00000151834	FALSE	Preclinical	2009-07-16	Absent	GABRA2
Stress Disorders, Post-Traumatic	ENSG00000154229	FALSE	Preclinical	2012-09-25	Preclinical	PRKCA
Stress Disorders, Post-Traumatic	ENSG00000155511	FALSE	unknown	NA	Unused	GRIA1
Stress Disorders, Post-Traumatic	ENSG00000157540	FALSE	Preclinical	2008-07-17	Preclinical	DYRK1A
Stress Disorders, Post-Traumatic	ENSG00000164270	FALSE	unknown	2004-12-21	Phase II Clinical Trial	HTR4
Stress Disorders, Post-Traumatic	ENSG00000166148	FALSE	Phase II Clinical Trial	2006-07-10	Phase I Clinical Trial	AVPR1A
Stress Disorders, Post-Traumatic	ENSG00000166736	FALSE	Phase II Clinical Trial	NA	Unused	HTR3A
Stress Disorders, Post-Traumatic	ENSG00000169252	FALSE	Phase II Clinical Trial	NA	Unused	ADRB2
Stress Disorders, Post-Traumatic	ENSG00000171720	FALSE	Preclinical	2011-01-21	Unused	HDAC3
Stress Disorders, Post-Traumatic	ENSG00000173250	FALSE	Preclinical	2015-03-18	Absent	GPR151
Stress Disorders, Post-Traumatic	ENSG00000175344	FALSE	Phase II Clinical Trial	2007-05-30	Absent	CHRNA7
Stress Disorders, Post-Traumatic	ENSG00000176884	FALSE	unknown	2007-09-03	Unused	GRIN1
Stress Disorders, Post-Traumatic	ENSG00000178394	FALSE	Phase III Clinical Trial	1992-10-15	Phase II Clinical Trial	HTR1A
Stress Disorders, Post-Traumatic	ENSG00000179142	FALSE	Preclinical	2009-07-16	Absent	CYP11B2
Stress Disorders, Post-Traumatic	ENSG00000183873	FALSE	unknown	NA	Unused	SCN5A
Stress Disorders, Post-Traumatic	ENSG00000186297	FALSE	Preclinical	2009-07-16	Absent	GABRA5
Stress Disorders, Post-Traumatic	ENSG00000196218	FALSE	Preclinical	2012-09-07	Absent	RYR1
Stress Disorders, Post-Traumatic	ENSG00000196277	FALSE	Preclinical	2008-06-09	Preclinical	GRM7
Stress Disorders, Post-Traumatic	ENSG00000196591	FALSE	Preclinical	2014-01-10	Absent	HDAC2
Stress Disorders, Post-Traumatic	ENSG00000273079	FALSE	Preclinical	2011-11-15	Preclinical	GRIN2B
Stuttering	ENSG00000011677	FALSE	Phase II Clinical Trial	1994-05-15	Unused	GABRA3
Stuttering	ENSG00000022355	FALSE	Phase II Clinical Trial	1994-05-15	Unused	GABRA1
Stuttering	ENSG00000151834	FALSE	Phase II Clinical Trial	1994-05-15	Unused	GABRA2
Stuttering	ENSG00000186297	FALSE	Phase II Clinical Trial	1994-05-15	Unused	GABRA5
Subarachnoid Hemorrhage	ENSG00000006071	FALSE	unknown	2010-06-10	Absent	ABCC8
Subarachnoid Hemorrhage	ENSG00000130203	FALSE	Preclinical	2008-06-19	Unused	APOE
Subarachnoid Hemorrhage	ENSG00000136160	FALSE	Phase I Clinical Trial	1994-08-15	Unused	EDNRB
Subarachnoid Hemorrhage	ENSG00000151067	TRUE	Approved	2010-07-16	Approved	CACNA1C
Subarachnoid Hemorrhage	ENSG00000151617	FALSE	Phase II Clinical Trial	1994-08-15	Unused	EDNRA
Subarachnoid Hemorrhage	ENSG00000213903	FALSE	unknown	NA	Unused	LTB4R
Subarachnoid Hemorrhage	ENSG00000273079	FALSE	Preclinical	2010-06-04	Preclinical	GRIN2B
Substance-Related Disorders	ENSG00000011677	FALSE	Phase II Clinical Trial	1990-08-15	Unused	GABRA3
Substance-Related Disorders	ENSG00000022355	FALSE	Phase II Clinical Trial	1990-08-15	Unused	GABRA1
Substance-Related Disorders	ENSG00000069431	FALSE	Preclinical	1991-12-15	Unused	ABCC9
Substance-Related Disorders	ENSG00000069696	FALSE	Preclinical	1995-03-15	Unused	DRD4
Substance-Related Disorders	ENSG00000080644	FALSE	Phase I Clinical Trial	2012-11-02	Preclinical	CHRNA3
Substance-Related Disorders	ENSG00000082556	TRUE	Approved	1997-10-15	Unused	OPRK1
Substance-Related Disorders	ENSG00000087085	FALSE	Phase II Clinical Trial	1994-04-15	Unused	ACHE
Substance-Related Disorders	ENSG00000101204	FALSE	Preclinical	1995-10-15	Unused	CHRNA4
Substance-Related Disorders	ENSG00000102468	FALSE	unknown	1991-06-15	Unused	HTR2A
Substance-Related Disorders	ENSG00000108576	FALSE	unknown	NA	Unused	SLC6A4
Substance-Related Disorders	ENSG00000110148	FALSE	Phase I Clinical Trial	1991-07-15	Unused	CCKBR
Substance-Related Disorders	ENSG00000111275	FALSE	Phase I Clinical Trial	2007-01-29	Absent	ALDH2
Substance-Related Disorders	ENSG00000112038	TRUE	Approved	1990-03-15	Unused	OPRM1
Substance-Related Disorders	ENSG00000115353	FALSE	unknown	2014-11-06	Absent	TACR1
Substance-Related Disorders	ENSG00000116329	TRUE	Approved	1993-05-15	Unused	OPRD1
Substance-Related Disorders	ENSG00000117971	FALSE	Phase I Clinical Trial	2012-11-02	Preclinical	CHRNB4
Substance-Related Disorders	ENSG00000118432	FALSE	Phase I Clinical Trial	1996-05-15	Unused	CNR1
Substance-Related Disorders	ENSG00000120088	FALSE	Preclinical	1996-05-15	Unused	CRHR1
Substance-Related Disorders	ENSG00000121361	FALSE	Preclinical	1991-12-15	Unused	KCNJ8
Substance-Related Disorders	ENSG00000121764	FALSE	Preclinical	2008-09-26	Unused	HCRTR1
Substance-Related Disorders	ENSG00000123454	FALSE	Preclinical	NA	Unused	DBH
Substance-Related Disorders	ENSG00000124493	FALSE	Preclinical	2004-05-24	Absent	GRM4
Substance-Related Disorders	ENSG00000125510	FALSE	Preclinical	2004-03-31	Unused	OPRL1
Substance-Related Disorders	ENSG00000128271	FALSE	Preclinical	2007-01-29	Unused	ADORA2A
Substance-Related Disorders	ENSG00000133019	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CHRM3
Substance-Related Disorders	ENSG00000134640	FALSE	Preclinical	1991-08-15	Unused	MTNR1B
Substance-Related Disorders	ENSG00000137252	FALSE	Preclinical	2008-09-26	Unused	HCRTR2
Substance-Related Disorders	ENSG00000142319	FALSE	Preclinical	1995-06-15	Unused	SLC6A3
Substance-Related Disorders	ENSG00000147955	FALSE	Preclinical	1994-08-15	Unused	SIGMAR1
Substance-Related Disorders	ENSG00000149295	TRUE	Approved	1994-08-15	Approved	DRD2
Substance-Related Disorders	ENSG00000151577	FALSE	Preclinical	1994-08-15	Unused	DRD3
Substance-Related Disorders	ENSG00000151834	FALSE	Phase II Clinical Trial	1990-08-15	Unused	GABRA2
Substance-Related Disorders	ENSG00000152822	FALSE	Preclinical	2007-01-15	Unused	GRM1
Substance-Related Disorders	ENSG00000157219	FALSE	Preclinical	2017-02-28	Absent	HTR5A
Substance-Related Disorders	ENSG00000160716	FALSE	Preclinical	1995-10-15	Unused	CHRNB2
Substance-Related Disorders	ENSG00000165092	TRUE	Approved	NA	Unused	ALDH1A1
Substance-Related Disorders	ENSG00000166736	FALSE	Preclinical	1990-12-15	Unused	HTR3A
Substance-Related Disorders	ENSG00000168412	FALSE	Preclinical	1991-08-15	Unused	MTNR1A
Substance-Related Disorders	ENSG00000168539	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CHRM1
Substance-Related Disorders	ENSG00000168959	FALSE	Preclinical	2005-10-03	Unused	GRM5
Substance-Related Disorders	ENSG00000169836	FALSE	unknown	2014-11-06	Absent	TACR3
Substance-Related Disorders	ENSG00000175344	FALSE	Preclinical	1996-06-15	Unused	CHRNA7
Substance-Related Disorders	ENSG00000176884	FALSE	Phase II Clinical Trial	1996-08-15	Unused	GRIN1
Substance-Related Disorders	ENSG00000178394	FALSE	Preclinical	1991-06-15	Unused	HTR1A
Substance-Related Disorders	ENSG00000180720	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CHRM4
Substance-Related Disorders	ENSG00000181072	FALSE	Phase II Clinical Trial	1994-04-15	Unused	CHRM2
Substance-Related Disorders	ENSG00000184845	FALSE	Preclinical	1993-08-15	Unused	DRD1
Substance-Related Disorders	ENSG00000186297	FALSE	Phase II Clinical Trial	1990-08-15	Unused	GABRA5
Substance-Related Disorders	ENSG00000196549	FALSE	Preclinical	1989-08-15	Unused	MME
Substance-Related Disorders	ENSG00000197406	FALSE	Preclinical	2014-12-08	Absent	DIO3
Supranuclear Palsy, Progressive	ENSG00000010810	FALSE	Phase III Clinical Trial	NA	Absent	FYN
Supranuclear Palsy, Progressive	ENSG00000022355	FALSE	Preclinical	2013-11-21	Absent	GABRA1
Supranuclear Palsy, Progressive	ENSG00000068078	FALSE	Phase III Clinical Trial	NA	Absent	FGFR3
Supranuclear Palsy, Progressive	ENSG00000082701	FALSE	Phase II Clinical Trial	2004-07-28	Phase II Clinical Trial	GSK3B
Supranuclear Palsy, Progressive	ENSG00000101126	FALSE	unknown	2003-06-17	Unused	ADNP
Supranuclear Palsy, Progressive	ENSG00000113721	FALSE	Phase III Clinical Trial	NA	Absent	PDGFRB
Supranuclear Palsy, Progressive	ENSG00000116329	FALSE	Phase II Clinical Trial	2008-01-16	Absent	OPRD1
Supranuclear Palsy, Progressive	ENSG00000122756	FALSE	unknown	NA	Absent	CNTFR
Supranuclear Palsy, Progressive	ENSG00000142192	FALSE	Phase I Clinical Trial	2010-05-29	Absent	APP
Supranuclear Palsy, Progressive	ENSG00000143799	FALSE	unknown	2003-06-17	Unused	PARP1
Supranuclear Palsy, Progressive	ENSG00000147955	FALSE	Phase II Clinical Trial	2008-01-16	Absent	SIGMAR1
Supranuclear Palsy, Progressive	ENSG00000157404	FALSE	Phase III Clinical Trial	NA	Absent	KIT
Supranuclear Palsy, Progressive	ENSG00000168539	FALSE	unknown	2003-11-20	Preclinical	CHRM1
Supranuclear Palsy, Progressive	ENSG00000176884	FALSE	Phase II Clinical Trial	2008-01-16	Absent	GRIN1
Supranuclear Palsy, Progressive	ENSG00000186868	FALSE	Phase II Clinical Trial	2008-08-08	Preclinical	MAPT
Supranuclear Palsy, Progressive	ENSG00000198408	FALSE	Phase I Clinical Trial	2010-08-11	Absent	OGA
Supranuclear Palsy, Progressive	ENSG00000254087	FALSE	Phase III Clinical Trial	NA	Absent	LYN
Synovitis, Pigmented Villonodular	ENSG00000122025	FALSE	Phase III Clinical Trial	2008-08-14	Absent	FLT3
Synovitis, Pigmented Villonodular	ENSG00000157404	FALSE	Phase III Clinical Trial	2008-08-14	Absent	KIT
Synovitis, Pigmented Villonodular	ENSG00000182578	FALSE	Phase III Clinical Trial	2008-08-14	Absent	CSF1R
Synovitis, Pigmented Villonodular	ENSG00000184371	FALSE	Phase II Clinical Trial	2008-09-30	Absent	CSF1
Systemic Inflammatory Response Syndrome	ENSG00000007908	FALSE	Phase I Clinical Trial	1992-01-15	Unused	SELE
Systemic Inflammatory Response Syndrome	ENSG00000132693	FALSE	unknown	1993-04-15	Unused	CRP
Systemic Inflammatory Response Syndrome	ENSG00000168398	FALSE	unknown	NA	Unused	BDKRB2
Systemic Inflammatory Response Syndrome	ENSG00000169174	FALSE	unknown	2011-10-25	Absent	PCSK9
Systemic Inflammatory Response Syndrome	ENSG00000197561	FALSE	Approved	1991-08-15	Unused	ELANE
Systemic Inflammatory Response Syndrome	ENSG00000276045	FALSE	Phase I Clinical Trial	2016-11-21	Absent	ORAI1
Tachycardia	ENSG00000043591	FALSE	Approved	1990-08-15	Unused	ADRB1
Tachycardia, Supraventricular	ENSG00000043591	TRUE	Approved	2011-03-15	Approved	ADRB1
Tachycardia, Supraventricular	ENSG00000053918	FALSE	unknown	1993-06-15	Phase III Clinical Trial	KCNQ1
Tachycardia, Supraventricular	ENSG00000055118	FALSE	unknown	1993-06-15	Phase III Clinical Trial	KCNH2
Tachycardia, Supraventricular	ENSG00000151067	TRUE	Approved	NA	Approved	CACNA1C
Tachycardia, Supraventricular	ENSG00000163485	FALSE	unknown	1998-03-15	Unused	ADORA1
Tachycardia, Supraventricular	ENSG00000169252	FALSE	Approved	NA	Approved	ADRB2
Tachycardia, Supraventricular	ENSG00000183873	FALSE	Approved	2012-05-24	Unused	SCN5A
Tachycardia, Ventricular	ENSG00000043591	FALSE	Approved	NA	Approved	ADRB1
Tachycardia, Ventricular	ENSG00000118729	FALSE	Preclinical	2015-09-02	Absent	CASQ2
Tachycardia, Ventricular	ENSG00000163485	FALSE	Preclinical	NA	Unused	ADORA1
Tachycardia, Ventricular	ENSG00000169252	FALSE	Approved	NA	Approved	ADRB2
Tachycardia, Ventricular	ENSG00000183873	TRUE	Approved	2007-10-09	Approved	SCN5A
Tachycardia, Ventricular	ENSG00000198626	FALSE	Preclinical	2008-07-04	Phase II Clinical Trial	RYR2
Tay-Sachs Disease	ENSG00000148154	FALSE	Preclinical	1989-06-15	Unused	UGCG
Tay-Sachs Disease	ENSG00000213614	FALSE	Phase I Clinical Trial	NA	Unused	HEXA
Telangiectasia, Hereditary Hemorrhagic	ENSG00000037280	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FLT4
Telangiectasia, Hereditary Hemorrhagic	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR3
Telangiectasia, Hereditary Hemorrhagic	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR1
Telangiectasia, Hereditary Hemorrhagic	ENSG00000102755	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FLT1
Telangiectasia, Hereditary Hemorrhagic	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Absent	PDGFRB
Telangiectasia, Hereditary Hemorrhagic	ENSG00000128052	FALSE	Phase II Clinical Trial	2001-04-03	Absent	KDR
Telangiectasia, Hereditary Hemorrhagic	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-04-03	Absent	PDGFRA
Telangiectasia, Hereditary Hemorrhagic	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-04-03	Absent	KIT
Telangiectasia, Hereditary Hemorrhagic	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Absent	BRAF
Telangiectasis	ENSG00000122756	FALSE	Phase III Clinical Trial	2000-05-31	Phase I Clinical Trial	CNTFR
Tendinopathy	ENSG00000026508	FALSE	Phase III Clinical Trial	1994-01-15	Phase III Clinical Trial	CD44
Tendinopathy	ENSG00000073756	TRUE	Approved	1996-12-15	Approved	PTGS2
Tendinopathy	ENSG00000095303	TRUE	Approved	1996-12-15	Approved	PTGS1
Tendinopathy	ENSG00000113580	FALSE	Phase III Clinical Trial	NA	Unused	NR3C1
Tendinopathy	ENSG00000169432	FALSE	unknown	2010-08-13	Phase III Clinical Trial	SCN9A
Tendinopathy	ENSG00000196689	FALSE	unknown	2002-08-30	Unused	TRPV1
Tennis Elbow	ENSG00000026508	FALSE	Phase III Clinical Trial	1994-01-15	Phase III Clinical Trial	CD44
Tennis Elbow	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Tennis Elbow	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Tennis Elbow	ENSG00000113721	FALSE	unknown	2012-01-20	Phase II Clinical Trial	PDGFRB
Teratoma	ENSG00000105810	FALSE	Phase II Clinical Trial	2009-12-10	Absent	CDK6
Teratoma	ENSG00000135446	FALSE	Phase II Clinical Trial	2009-12-10	Absent	CDK4
Testicular Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2008-09-16	Phase I Clinical Trial	FLT4
Testicular Neoplasms	ENSG00000065559	FALSE	Preclinical	1998-01-15	Unused	MAP2K4
Testicular Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2008-09-16	Absent	FGFR2
Testicular Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2008-09-16	Absent	FGFR3
Testicular Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2008-09-16	Phase I Clinical Trial	FGFR1
Testicular Neoplasms	ENSG00000081051	FALSE	Preclinical	2014-11-13	Absent	AFP
Testicular Neoplasms	ENSG00000086205	FALSE	Phase I Clinical Trial	2003-11-27	Absent	FOLH1
Testicular Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	2008-09-16	Phase I Clinical Trial	FLT1
Testicular Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	2004-10-06	Phase I Clinical Trial	CGB3
Testicular Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2003-07-18	Phase II Clinical Trial	MET
Testicular Neoplasms	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Testicular Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2008-09-16	Absent	PDGFRB
Testicular Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	2006-10-23	Unused	PIK3CA
Testicular Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	NA	Absent	MAP2K2
Testicular Neoplasms	ENSG00000128052	FALSE	Phase II Clinical Trial	2004-06-18	Phase I Clinical Trial	KDR
Testicular Neoplasms	ENSG00000130816	FALSE	unknown	NA	Unused	DNMT1
Testicular Neoplasms	ENSG00000131747	TRUE	Approved	1989-05-15	Approved	TOP2A
Testicular Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	2004-06-18	Unused	PDGFRA
Testicular Neoplasms	ENSG00000140443	FALSE	unknown	2005-08-05	Unused	IGF1R
Testicular Neoplasms	ENSG00000146648	FALSE	Preclinical	2007-04-11	Absent	EGFR
Testicular Neoplasms	ENSG00000157404	FALSE	Preclinical	2004-06-18	Unused	KIT
Testicular Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2009-04-21	Absent	BRAF
Testicular Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	NA	Absent	MAP2K1
Testicular Neoplasms	ENSG00000173638	FALSE	Preclinical	1996-12-15	Unused	SLC19A1
Testicular Neoplasms	ENSG00000185686	FALSE	Phase I Clinical Trial	2003-11-27	Absent	PRAME
Testicular Neoplasms	ENSG00000188389	FALSE	Phase I Clinical Trial	2014-11-15	Absent	PDCD1
Testicular Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2006-10-23	Unused	MTOR
Testicular Neoplasms	ENSG00000203747	FALSE	Preclinical	2007-04-11	Absent	FCGR3A
Tetanus	ENSG00000101017	FALSE	Preclinical	1998-12-15	Unused	CD40
Tetralogy of Fallot	ENSG00000120907	FALSE	Preclinical	NA	Unused	ADRA1A
Tetralogy of Fallot	ENSG00000170214	FALSE	Preclinical	NA	Unused	ADRA1B
Tetralogy of Fallot	ENSG00000171873	FALSE	Preclinical	NA	Unused	ADRA1D
Thalassemia	ENSG00000096968	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK2
Thalassemia	ENSG00000110911	FALSE	Preclinical	2016-09-29	Absent	SLC11A2
Thalassemia	ENSG00000116478	FALSE	Preclinical	2011-06-30	Preclinical	HDAC1
Thalassemia	ENSG00000130427	FALSE	Preclinical	1998-06-15	Unused	EPO
Thalassemia	ENSG00000139567	FALSE	Phase III Clinical Trial	2009-01-15	Absent	ACVRL1
Thalassemia	ENSG00000143627	FALSE	Preclinical	2009-07-14	Absent	PKLR
Thalassemia	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK1
Thalassemia	ENSG00000187045	FALSE	Phase I Clinical Trial	2012-01-18	Preclinical	TMPRSS6
Thalassemia	ENSG00000187266	FALSE	Preclinical	2003-11-10	Absent	EPOR
Thalassemia	ENSG00000196517	FALSE	Phase II Clinical Trial	2005-02-07	Absent	SLC6A9
Thalassemia	ENSG00000196591	FALSE	Preclinical	2011-06-30	Preclinical	HDAC2
Thalassemia	ENSG00000244734	FALSE	Phase III Clinical Trial	1993-07-15	Phase II Clinical Trial	HBB
Thrombasthenia	ENSG00000057593	TRUE	Approved	2011-11-11	Absent	F7
Thromboangiitis Obliterans	ENSG00000019991	FALSE	Phase III Clinical Trial	2001-01-31	Phase III Clinical Trial	HGF
Thromboangiitis Obliterans	ENSG00000105976	FALSE	Preclinical	2001-03-06	Unused	MET
Thromboangiitis Obliterans	ENSG00000112715	FALSE	unknown	1998-01-15	Unused	VEGFA
Thromboangiitis Obliterans	ENSG00000160013	TRUE	Approved	NA	Approved	PTGIR
Thromboangiitis Obliterans	ENSG00000160951	FALSE	Approved	NA	Unused	PTGER1
Thromboangiitis Obliterans	ENSG00000172572	TRUE	Approved	2008-10-20	Approved	PDE3A
Thrombocytopenia	ENSG00000005961	FALSE	Phase II Clinical Trial	1997-04-15	Unused	ITGA2B
Thrombocytopenia	ENSG00000084207	FALSE	unknown	1994-06-15	Unused	GSTP1
Thrombocytopenia	ENSG00000090534	FALSE	Preclinical	2008-07-19	Unused	THPO
Thrombocytopenia	ENSG00000102524	FALSE	Phase I Clinical Trial	1999-07-13	Phase I Clinical Trial	TNFSF13B
Thrombocytopenia	ENSG00000104368	FALSE	Preclinical	2015-05-27	Absent	PLAT
Thrombocytopenia	ENSG00000113302	FALSE	unknown	2008-10-20	Preclinical	IL12B
Thrombocytopenia	ENSG00000114812	FALSE	Preclinical	2007-05-04	Unused	VIPR1
Thrombocytopenia	ENSG00000115594	FALSE	Phase II Clinical Trial	NA	Unused	IL1R1
Thrombocytopenia	ENSG00000117400	TRUE	Approved	1994-08-15	Unused	MPL
Thrombocytopenia	ENSG00000117601	TRUE	Approved	NA	Approved	SERPINC1
Thrombocytopenia	ENSG00000126218	TRUE	Approved	NA	Approved	F10
Thrombocytopenia	ENSG00000130368	FALSE	Preclinical	2010-09-20	Preclinical	MAS1
Thrombocytopenia	ENSG00000137070	TRUE	Approved	1991-08-15	Approved	IL11RA
Thrombocytopenia	ENSG00000151694	FALSE	Preclinical	2012-01-02	Unused	ADAM17
Thrombocytopenia	ENSG00000159110	FALSE	Approved	2014-01-17	Absent	IFNAR2
Thrombocytopenia	ENSG00000160712	FALSE	Phase III Clinical Trial	1989-07-15	Unused	IL6R
Thrombocytopenia	ENSG00000168811	FALSE	unknown	2008-10-20	Preclinical	IL12A
Thrombocytopenia	ENSG00000168918	FALSE	Preclinical	2007-10-29	Unused	INPP5D
Thrombocytopenia	ENSG00000171557	FALSE	Preclinical	2008-10-16	Unused	FGG
Thrombocytopenia	ENSG00000171560	FALSE	Preclinical	2008-10-16	Unused	FGA
Thrombocytopenia	ENSG00000171564	FALSE	Preclinical	2008-10-16	Unused	FGB
Thrombocytopenia	ENSG00000180210	TRUE	Approved	1991-02-15	Approved	F2
Thrombocytopenia	ENSG00000185291	FALSE	unknown	NA	Unused	IL3RA
Thrombocytopenia	ENSG00000259207	FALSE	Phase II Clinical Trial	1997-04-15	Unused	ITGB3
Thrombocytopenia	ENSG00000282608	FALSE	Preclinical	2015-05-27	Absent	ADORA3
Thrombocytosis	ENSG00000027697	FALSE	unknown	2003-11-24	Unused	IFNGR1
Thrombocytosis	ENSG00000090534	FALSE	Phase II Clinical Trial	NA	Unused	THPO
Thrombocytosis	ENSG00000096968	FALSE	Phase III Clinical Trial	1999-03-17	Phase III Clinical Trial	JAK2
Thrombocytosis	ENSG00000115590	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	IL1R2
Thrombocytosis	ENSG00000116478	FALSE	Phase I Clinical Trial	2003-12-09	Absent	HDAC1
Thrombocytosis	ENSG00000121879	FALSE	Phase I Clinical Trial	2008-11-24	Phase I Clinical Trial	PIK3CA
Thrombocytosis	ENSG00000122025	FALSE	Phase II Clinical Trial	1999-03-17	Phase III Clinical Trial	FLT3
Thrombocytosis	ENSG00000132703	FALSE	Phase II Clinical Trial	2009-07-24	Absent	APCS
Thrombocytosis	ENSG00000159110	FALSE	Phase III Clinical Trial	2007-07-31	Absent	IFNAR2
Thrombocytosis	ENSG00000160712	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	IL6R
Thrombocytosis	ENSG00000162434	FALSE	Phase III Clinical Trial	2006-11-24	Phase II Clinical Trial	JAK1
Thrombocytosis	ENSG00000165731	FALSE	unknown	2007-01-10	Phase III Clinical Trial	RET
Thrombocytosis	ENSG00000171608	FALSE	Phase I Clinical Trial	2004-01-20	Absent	PIK3CD
Thrombocytosis	ENSG00000172572	TRUE	Approved	2014-01-20	Approved	PDE3A
Thrombocytosis	ENSG00000196591	FALSE	Phase I Clinical Trial	2003-12-09	Absent	HDAC2
Thrombocytosis	ENSG00000198400	FALSE	Phase II Clinical Trial	1999-03-17	Unused	NTRK1
Thrombocytosis	ENSG00000275302	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL4
Thrombocytosis	ENSG00000277632	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL3
Thrombophlebitis	ENSG00000115590	FALSE	unknown	1995-08-15	Unused	IL1R2
Thrombophlebitis	ENSG00000115594	FALSE	unknown	1995-08-15	Unused	IL1R1
Thrombophlebitis	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Thrombophlebitis	ENSG00000122861	FALSE	Approved	NA	Absent	PLAU
Thrombophlebitis	ENSG00000126218	TRUE	Approved	1992-11-15	Approved	F10
Thrombophlebitis	ENSG00000180210	TRUE	Approved	1992-11-15	Approved	F2
Thrombosis	ENSG00000003436	FALSE	unknown	1994-11-15	Unused	TFPI
Thrombosis	ENSG00000005961	FALSE	Phase III Clinical Trial	1989-09-15	Phase II Clinical Trial	ITGA2B
Thrombosis	ENSG00000006638	TRUE	Approved	1989-06-15	Approved	TBXA2R
Thrombosis	ENSG00000011422	FALSE	Preclinical	2000-09-06	Unused	PLAUR
Thrombosis	ENSG00000012779	FALSE	unknown	NA	Unused	ALOX5
Thrombosis	ENSG00000051382	FALSE	Phase I Clinical Trial	2008-06-11	Unused	PIK3CB
Thrombosis	ENSG00000057593	FALSE	Phase I Clinical Trial	1991-04-15	Unused	F7
Thrombosis	ENSG00000059377	TRUE	Approved	1989-10-15	Approved	TBXAS1
Thrombosis	ENSG00000065989	TRUE	Approved	1992-06-15	Approved	PDE4A
Thrombosis	ENSG00000073756	TRUE	Approved	1991-03-15	Approved	PTGS2
Thrombosis	ENSG00000079459	FALSE	Preclinical	1990-06-15	Unused	FDFT1
Thrombosis	ENSG00000080618	FALSE	Phase II Clinical Trial	2002-11-11	Unused	CPB2
Thrombosis	ENSG00000085662	FALSE	Preclinical	1993-02-15	Unused	AKR1B1
Thrombosis	ENSG00000088053	FALSE	Phase II Clinical Trial	2004-01-23	Phase II Clinical Trial	GP6
Thrombosis	ENSG00000088926	FALSE	Phase II Clinical Trial	2008-12-12	Phase II Clinical Trial	F11
Thrombosis	ENSG00000090534	FALSE	Phase II Clinical Trial	NA	Unused	THPO
Thrombosis	ENSG00000092445	FALSE	Preclinical	2011-04-01	Unused	TYRO3
Thrombosis	ENSG00000095303	TRUE	Approved	1991-03-15	Approved	PTGS1
Thrombosis	ENSG00000101981	FALSE	Preclinical	1997-07-15	Phase II Clinical Trial	F9
Thrombosis	ENSG00000102468	FALSE	Approved	1989-11-15	Unused	HTR2A
Thrombosis	ENSG00000104368	FALSE	Approved	1989-11-15	Unused	PLAT
Thrombosis	ENSG00000105650	TRUE	Approved	1992-06-15	Approved	PDE4C
Thrombosis	ENSG00000105675	FALSE	Approved	2007-11-22	Unused	ATP4A
Thrombosis	ENSG00000106366	FALSE	Phase I Clinical Trial	1994-08-15	Unused	SERPINE1
Thrombosis	ENSG00000109320	FALSE	Preclinical	2007-04-11	Unused	NFKB1
Thrombosis	ENSG00000110799	FALSE	Phase II Clinical Trial	1992-01-15	Phase II Clinical Trial	VWF
Thrombosis	ENSG00000111424	FALSE	Preclinical	2011-06-20	Unused	VDR
Thrombosis	ENSG00000113161	TRUE	Approved	2008-06-05	Unused	HMGCR
Thrombosis	ENSG00000113448	TRUE	Approved	1992-06-15	Approved	PDE4D
Thrombosis	ENSG00000115008	FALSE	unknown	2009-12-07	Preclinical	IL1A
Thrombosis	ENSG00000115252	FALSE	Preclinical	1990-02-15	Unused	PDE1A
Thrombosis	ENSG00000115414	FALSE	Preclinical	NA	Unused	FN1
Thrombosis	ENSG00000115718	TRUE	Approved	1995-09-15	Approved	PROC
Thrombosis	ENSG00000117525	FALSE	Phase I Clinical Trial	1994-11-15	Unused	F3
Thrombosis	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Thrombosis	ENSG00000121879	FALSE	Phase I Clinical Trial	2000-03-01	Unused	PIK3CA
Thrombosis	ENSG00000122194	FALSE	Phase III Clinical Trial	1995-02-15	Unused	PLG
Thrombosis	ENSG00000122861	TRUE	Approved	1991-09-15	Approved	PLAU
Thrombosis	ENSG00000124491	FALSE	Preclinical	1991-07-15	Unused	F13A1
Thrombosis	ENSG00000126218	TRUE	Approved	1990-08-15	Approved	F10
Thrombosis	ENSG00000127533	FALSE	Phase II Clinical Trial	2014-08-06	Absent	F2RL3
Thrombosis	ENSG00000127837	FALSE	Preclinical	1996-06-15	Unused	AAMP
Thrombosis	ENSG00000131187	FALSE	Phase I Clinical Trial	2010-02-23	Unused	F12
Thrombosis	ENSG00000138185	FALSE	Preclinical	1997-05-15	Unused	ENTPD1
Thrombosis	ENSG00000138448	FALSE	Preclinical	2006-11-01	Preclinical	ITGAV
Thrombosis	ENSG00000138735	FALSE	Preclinical	1996-11-15	Unused	PDE5A
Thrombosis	ENSG00000146070	FALSE	Preclinical	NA	Unused	PLA2G7
Thrombosis	ENSG00000150093	FALSE	Preclinical	2001-07-23	Unused	ITGB1
Thrombosis	ENSG00000151067	FALSE	Preclinical	1991-09-15	Unused	CACNA1C
Thrombosis	ENSG00000154229	FALSE	Preclinical	1994-10-15	Unused	PRKCA
Thrombosis	ENSG00000155511	FALSE	unknown	2003-05-07	Unused	GRIA1
Thrombosis	ENSG00000158769	FALSE	Preclinical	2009-09-30	Unused	F11R
Thrombosis	ENSG00000159640	TRUE	Approved	2008-06-05	Absent	ACE
Thrombosis	ENSG00000160013	FALSE	Preclinical	1990-05-15	Phase II Clinical Trial	PTGIR
Thrombosis	ENSG00000160951	FALSE	Preclinical	NA	Unused	PTGER1
Thrombosis	ENSG00000164111	FALSE	unknown	2003-11-10	Unused	ANXA5
Thrombosis	ENSG00000164120	FALSE	Preclinical	1992-03-15	Unused	HPGD
Thrombosis	ENSG00000164171	FALSE	Preclinical	2001-07-23	Unused	ITGA2
Thrombosis	ENSG00000164344	FALSE	Preclinical	1990-09-15	Absent	KLKB1
Thrombosis	ENSG00000167397	FALSE	Phase II Clinical Trial	2004-10-13	Unused	VKORC1
Thrombosis	ENSG00000167711	FALSE	Phase I Clinical Trial	2013-11-28	Unused	SERPINF2
Thrombosis	ENSG00000167748	FALSE	Preclinical	2007-03-06	Unused	KLK1
Thrombosis	ENSG00000168229	FALSE	Preclinical	1991-05-15	Unused	PTGDR
Thrombosis	ENSG00000169313	TRUE	Approved	1993-08-15	Approved	P2RY12
Thrombosis	ENSG00000169403	TRUE	Approved	1990-02-15	Approved	PTAFR
Thrombosis	ENSG00000169432	FALSE	Preclinical	NA	Unused	SCN9A
Thrombosis	ENSG00000169860	FALSE	Preclinical	2011-09-09	Preclinical	P2RY1
Thrombosis	ENSG00000170890	FALSE	Preclinical	NA	Unused	PLA2G1B
Thrombosis	ENSG00000171557	FALSE	Preclinical	1989-11-15	Unused	FGG
Thrombosis	ENSG00000171560	FALSE	Preclinical	1989-11-15	Unused	FGA
Thrombosis	ENSG00000171564	FALSE	Preclinical	1989-11-15	Unused	FGB
Thrombosis	ENSG00000172236	FALSE	Phase I Clinical Trial	2012-08-07	Absent	TPSAB1
Thrombosis	ENSG00000172572	FALSE	Preclinical	1989-06-15	Unused	PDE3A
Thrombosis	ENSG00000173198	FALSE	Preclinical	1997-06-15	Unused	CYSLTR1
Thrombosis	ENSG00000174175	FALSE	Preclinical	1999-02-15	Unused	SELP
Thrombosis	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Thrombosis	ENSG00000175899	FALSE	Preclinical	NA	Unused	A2M
Thrombosis	ENSG00000178394	FALSE	Preclinical	NA	Unused	HTR1A
Thrombosis	ENSG00000178726	FALSE	Pre-registration	1992-06-15	Unused	THBD
Thrombosis	ENSG00000180210	TRUE	Approved	1989-11-15	Approved	F2
Thrombosis	ENSG00000181104	TRUE	Approved	1991-11-15	Phase III Clinical Trial	F2R
Thrombosis	ENSG00000183087	FALSE	Preclinical	2001-07-10	Unused	GAS6
Thrombosis	ENSG00000183873	FALSE	Preclinical	NA	Unused	SCN5A
Thrombosis	ENSG00000184502	FALSE	unknown	NA	Unused	GAST
Thrombosis	ENSG00000184588	TRUE	Approved	1992-06-15	Approved	PDE4B
Thrombosis	ENSG00000185010	FALSE	Phase II Clinical Trial	2000-10-30	Unused	F8
Thrombosis	ENSG00000185245	FALSE	Phase II Clinical Trial	1989-11-15	Phase II Clinical Trial	GP1BA
Thrombosis	ENSG00000186642	FALSE	Preclinical	1996-11-15	Unused	PDE2A
Thrombosis	ENSG00000198668	FALSE	unknown	NA	Unused	CALM1
Thrombosis	ENSG00000204174	FALSE	Preclinical	2005-09-13	Absent	NPY4R
Thrombosis	ENSG00000259207	FALSE	Phase III Clinical Trial	1989-09-15	Phase II Clinical Trial	ITGB3
Thymoma	ENSG00000068024	FALSE	Preclinical	2002-06-10	Absent	HDAC4
Thymoma	ENSG00000113575	FALSE	Phase I Clinical Trial	2008-02-29	Absent	PPP2CA
Thymoma	ENSG00000116478	FALSE	Preclinical	2002-06-10	Absent	HDAC1
Thymoma	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-06-20	Absent	CD274
Thymoma	ENSG00000123374	FALSE	Phase II Clinical Trial	1997-05-15	Phase II Clinical Trial	CDK2
Thymoma	ENSG00000134058	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK7
Thymoma	ENSG00000135446	FALSE	Phase II Clinical Trial	2007-02-06	Phase II Clinical Trial	CDK4
Thymoma	ENSG00000136807	FALSE	Phase I Clinical Trial	1997-05-15	Absent	CDK9
Thymoma	ENSG00000138160	FALSE	Phase I Clinical Trial	2008-01-15	Unused	KIF11
Thymoma	ENSG00000146648	FALSE	unknown	1993-07-15	Phase II Clinical Trial	EGFR
Thymoma	ENSG00000170312	FALSE	Phase II Clinical Trial	2007-02-06	Phase II Clinical Trial	CDK1
Thymoma	ENSG00000196591	FALSE	Preclinical	2002-06-10	Absent	HDAC2
Thymoma	ENSG00000198400	FALSE	Phase II Clinical Trial	2007-02-06	Phase II Clinical Trial	NTRK1
Thymoma	ENSG00000198900	FALSE	Phase I Clinical Trial	2007-02-23	Unused	TOP1
Thymus Neoplasms	ENSG00000089685	FALSE	Phase I Clinical Trial	2003-11-19	Phase I Clinical Trial	BIRC5
Thymus Neoplasms	ENSG00000126934	FALSE	unknown	2003-06-09	Unused	MAP2K2
Thymus Neoplasms	ENSG00000139874	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR1
Thymus Neoplasms	ENSG00000140443	FALSE	unknown	2006-04-25	Phase I Clinical Trial	IGF1R
Thymus Neoplasms	ENSG00000146648	FALSE	Phase I Clinical Trial	2005-01-28	Phase I Clinical Trial	EGFR
Thymus Neoplasms	ENSG00000162009	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR5
Thymus Neoplasms	ENSG00000166851	FALSE	Phase I Clinical Trial	2009-04-21	Unused	PLK1
Thymus Neoplasms	ENSG00000169032	FALSE	unknown	2003-06-09	Unused	MAP2K1
Thymus Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR2
Thymus Neoplasms	ENSG00000278195	FALSE	Phase II Clinical Trial	2002-11-27	Absent	SSTR3
Thyroid Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Thyroid Neoplasms	ENSG00000012779	FALSE	unknown	1993-10-15	Unused	ALOX5
Thyroid Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Thyroid Neoplasms	ENSG00000026103	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	FAS
Thyroid Neoplasms	ENSG00000037280	TRUE	Approved	1994-06-15	Phase III Clinical Trial	FLT4
Thyroid Neoplasms	ENSG00000044574	FALSE	Preclinical	2009-07-23	Absent	HSPA5
Thyroid Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2013-07-31	Absent	ERBB3
Thyroid Neoplasms	ENSG00000066468	TRUE	Approved	2003-07-22	Absent	FGFR2
Thyroid Neoplasms	ENSG00000067182	FALSE	Phase II Clinical Trial	2002-06-26	Phase II Clinical Trial	TNFRSF1A
Thyroid Neoplasms	ENSG00000068078	TRUE	Approved	2001-04-03	Absent	FGFR3
Thyroid Neoplasms	ENSG00000077782	TRUE	Approved	2001-04-03	Phase III Clinical Trial	FGFR1
Thyroid Neoplasms	ENSG00000082781	FALSE	unknown	2001-11-05	Unused	ITGB5
Thyroid Neoplasms	ENSG00000082898	FALSE	Preclinical	2012-06-02	Absent	XPO1
Thyroid Neoplasms	ENSG00000089327	FALSE	Preclinical	2011-01-25	Absent	FXYD5
Thyroid Neoplasms	ENSG00000090932	FALSE	Phase II Clinical Trial	2013-07-20	Absent	DLL3
Thyroid Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Unused	ANGPT2
Thyroid Neoplasms	ENSG00000099250	FALSE	unknown	2008-09-09	Phase I Clinical Trial	NRP1
Thyroid Neoplasms	ENSG00000100311	TRUE	Approved	1994-06-15	Phase III Clinical Trial	PDGFB
Thyroid Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2001-02-02	Unused	E2F1
Thyroid Neoplasms	ENSG00000102755	TRUE	Approved	1994-03-15	Phase III Clinical Trial	FLT1
Thyroid Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	1993-06-15	Phase II Clinical Trial	CEACAM5
Thyroid Neoplasms	ENSG00000105976	TRUE	Approved	2001-12-18	Approved	MET
Thyroid Neoplasms	ENSG00000106991	FALSE	unknown	2006-05-01	Phase I Clinical Trial	ENG
Thyroid Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Thyroid Neoplasms	ENSG00000112715	FALSE	Phase I Clinical Trial	2000-08-30	Phase I Clinical Trial	VEGFA
Thyroid Neoplasms	ENSG00000113578	FALSE	Phase III Clinical Trial	2013-04-20	Absent	FGF1
Thyroid Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase III Clinical Trial	PDGFRB
Thyroid Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Thyroid Neoplasms	ENSG00000116044	FALSE	unknown	2005-05-27	Unused	NFE2L2
Thyroid Neoplasms	ENSG00000116478	FALSE	Phase I Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC1
Thyroid Neoplasms	ENSG00000120156	TRUE	Approved	2001-12-18	Approved	TEK
Thyroid Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	PIK3CA
Thyroid Neoplasms	ENSG00000122025	TRUE	Approved	1994-06-15	Approved	FLT3
Thyroid Neoplasms	ENSG00000126934	FALSE	Phase III Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K2
Thyroid Neoplasms	ENSG00000128052	TRUE	Approved	1994-06-15	Approved	KDR
Thyroid Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Thyroid Neoplasms	ENSG00000131747	FALSE	Approved	2007-03-05	Absent	TOP2A
Thyroid Neoplasms	ENSG00000132155	TRUE	Approved	1994-06-15	Phase III Clinical Trial	RAF1
Thyroid Neoplasms	ENSG00000132170	FALSE	Phase II Clinical Trial	1993-10-15	Phase II Clinical Trial	PPARG
Thyroid Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRA
Thyroid Neoplasms	ENSG00000138448	FALSE	unknown	2001-11-05	Unused	ITGAV
Thyroid Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Thyroid Neoplasms	ENSG00000141736	FALSE	unknown	2000-04-04	Unused	ERBB2
Thyroid Neoplasms	ENSG00000142208	FALSE	Phase I Clinical Trial	1992-08-15	Unused	AKT1
Thyroid Neoplasms	ENSG00000146648	TRUE	Approved	1999-12-09	Approved	EGFR
Thyroid Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Thyroid Neoplasms	ENSG00000150093	FALSE	unknown	2001-11-05	Unused	ITGB1
Thyroid Neoplasms	ENSG00000151090	FALSE	unknown	2005-04-25	Unused	THRB
Thyroid Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Unused	ANGPT1
Thyroid Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Thyroid Neoplasms	ENSG00000157404	TRUE	Approved	2001-04-03	Approved	KIT
Thyroid Neoplasms	ENSG00000157764	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	BRAF
Thyroid Neoplasms	ENSG00000157765	FALSE	Phase I Clinical Trial	2016-04-26	Absent	SLC34A2
Thyroid Neoplasms	ENSG00000160867	TRUE	Approved	2003-07-22	Absent	FGFR4
Thyroid Neoplasms	ENSG00000161638	FALSE	unknown	2001-11-05	Unused	ITGA5
Thyroid Neoplasms	ENSG00000163399	FALSE	Preclinical	2011-01-25	Absent	ATP1A1
Thyroid Neoplasms	ENSG00000164078	FALSE	Phase I Clinical Trial	2001-12-18	Phase I Clinical Trial	MST1R
Thyroid Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	1994-07-15	Unused	CASP3
Thyroid Neoplasms	ENSG00000165025	FALSE	unknown	2003-10-31	Phase II Clinical Trial	SYK
Thyroid Neoplasms	ENSG00000165409	TRUE	Approved	1990-07-15	Approved	TSHR
Thyroid Neoplasms	ENSG00000165731	TRUE	Approved	1994-06-15	Approved	RET
Thyroid Neoplasms	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Thyroid Neoplasms	ENSG00000167601	FALSE	Phase II Clinical Trial	2004-06-18	Unused	AXL
Thyroid Neoplasms	ENSG00000168522	FALSE	Phase II Clinical Trial	NA	Absent	FNTA
Thyroid Neoplasms	ENSG00000169032	FALSE	Phase III Clinical Trial	2003-06-09	Phase I Clinical Trial	MAP2K1
Thyroid Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Thyroid Neoplasms	ENSG00000171791	FALSE	Preclinical	2009-04-29	Absent	BCL2
Thyroid Neoplasms	ENSG00000178568	FALSE	unknown	2003-12-08	Unused	ERBB4
Thyroid Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Phase III Clinical Trial	CDH5
Thyroid Neoplasms	ENSG00000180616	FALSE	Phase II Clinical Trial	2012-08-24	Absent	SSTR2
Thyroid Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-08-14	Absent	CSF1R
Thyroid Neoplasms	ENSG00000186088	FALSE	Phase I Clinical Trial	2007-01-08	Absent	GSAP
Thyroid Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2011-02-17	Absent	PDCD1
Thyroid Neoplasms	ENSG00000196591	FALSE	Phase I Clinical Trial	2005-07-20	Phase I Clinical Trial	HDAC2
Thyroid Neoplasms	ENSG00000197122	FALSE	Phase I Clinical Trial	2007-04-25	Unused	SRC
Thyroid Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Thyroid Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	2006-10-23	Phase I Clinical Trial	MTOR
Thyroid Neoplasms	ENSG00000198900	FALSE	Phase I Clinical Trial	1998-06-15	Unused	TOP1
Thyroid Neoplasms	ENSG00000213903	FALSE	unknown	1993-10-15	Unused	LTB4R
Thyroid Neoplasms	ENSG00000239732	FALSE	unknown	2002-09-30	Unused	TLR9
Thyroid Neoplasms	ENSG00000243955	FALSE	Phase I Clinical Trial	1994-07-15	Unused	GSTA1
Thyroid Neoplasms	ENSG00000259207	FALSE	unknown	2001-11-05	Unused	ITGB3
Tinnitus	ENSG00000075043	FALSE	Preclinical	2012-11-15	Absent	KCNQ2
Tinnitus	ENSG00000108576	FALSE	unknown	NA	Unused	SLC6A4
Tinnitus	ENSG00000115353	FALSE	unknown	NA	Unused	TACR1
Tinnitus	ENSG00000169432	FALSE	Phase II Clinical Trial	1998-12-15	Unused	SCN9A
Tinnitus	ENSG00000176884	FALSE	Phase III Clinical Trial	1998-12-15	Phase III Clinical Trial	GRIN1
Tinnitus	ENSG00000184156	FALSE	Preclinical	2012-11-15	Absent	KCNQ3
Tissue Adhesions	ENSG00000050748	FALSE	Phase II Clinical Trial	2001-01-23	Phase II Clinical Trial	MAPK9
Tissue Adhesions	ENSG00000075073	FALSE	Preclinical	2013-04-19	Absent	TACR2
Tissue Adhesions	ENSG00000106366	FALSE	Phase II Clinical Trial	2009-01-23	Absent	SERPINE1
Tissue Adhesions	ENSG00000107643	FALSE	Phase II Clinical Trial	2001-01-23	Phase II Clinical Trial	MAPK8
Tissue Adhesions	ENSG00000109339	FALSE	Phase II Clinical Trial	2001-01-23	Phase II Clinical Trial	MAPK10
Tissue Adhesions	ENSG00000110492	FALSE	Preclinical	2009-05-19	Absent	MDK
Tissue Adhesions	ENSG00000111424	FALSE	unknown	2006-10-23	Unused	VDR
Tissue Adhesions	ENSG00000115353	FALSE	Preclinical	2013-04-19	Absent	TACR1
Tissue Adhesions	ENSG00000118523	FALSE	Preclinical	1998-10-15	Unused	CTGF
Tissue Adhesions	ENSG00000125538	FALSE	Phase II Clinical Trial	2009-01-23	Absent	IL1B
Tissue Adhesions	ENSG00000136244	FALSE	Phase II Clinical Trial	2009-01-23	Absent	IL6
Tissue Adhesions	ENSG00000169429	FALSE	Phase II Clinical Trial	2009-01-23	Absent	CXCL8
Tissue Adhesions	ENSG00000198900	FALSE	Phase I Clinical Trial	2002-11-04	Unused	TOP1
Tobacco Use Disorder	ENSG00000011677	FALSE	Preclinical	2009-07-16	Preclinical	GABRA3
Tobacco Use Disorder	ENSG00000022355	FALSE	Preclinical	2009-07-16	Preclinical	GABRA1
Tobacco Use Disorder	ENSG00000043591	FALSE	Phase II Clinical Trial	2004-07-26	Preclinical	ADRB1
Tobacco Use Disorder	ENSG00000069535	FALSE	Phase II Clinical Trial	1999-04-14	Unused	MAOB
Tobacco Use Disorder	ENSG00000080644	FALSE	Preclinical	2010-11-08	Unused	CHRNA3
Tobacco Use Disorder	ENSG00000082556	FALSE	Phase II Clinical Trial	2001-01-22	Phase II Clinical Trial	OPRK1
Tobacco Use Disorder	ENSG00000087085	FALSE	Preclinical	2002-07-03	Unused	ACHE
Tobacco Use Disorder	ENSG00000101204	TRUE	Approved	2000-12-12	Approved	CHRNA4
Tobacco Use Disorder	ENSG00000103546	FALSE	Phase I Clinical Trial	1997-07-15	Unused	SLC6A2
Tobacco Use Disorder	ENSG00000108576	FALSE	Phase I Clinical Trial	2003-03-31	Absent	SLC6A4
Tobacco Use Disorder	ENSG00000111275	FALSE	Phase I Clinical Trial	2007-01-29	Absent	ALDH2
Tobacco Use Disorder	ENSG00000112038	FALSE	Phase II Clinical Trial	2001-01-22	Phase II Clinical Trial	OPRM1
Tobacco Use Disorder	ENSG00000117971	FALSE	Preclinical	2010-11-08	Unused	CHRNB4
Tobacco Use Disorder	ENSG00000118432	FALSE	Approved	1994-02-15	Unused	CNR1
Tobacco Use Disorder	ENSG00000121764	FALSE	Preclinical	2012-03-22	Preclinical	HCRTR1
Tobacco Use Disorder	ENSG00000132170	FALSE	Phase II Clinical Trial	2009-09-28	Phase II Clinical Trial	PPARG
Tobacco Use Disorder	ENSG00000132437	FALSE	Phase I Clinical Trial	2011-01-18	Absent	DDC
Tobacco Use Disorder	ENSG00000133019	FALSE	Phase I Clinical Trial	1999-05-19	Unused	CHRM3
Tobacco Use Disorder	ENSG00000142319	FALSE	Phase I Clinical Trial	1997-07-15	Unused	SLC6A3
Tobacco Use Disorder	ENSG00000147246	FALSE	Phase II Clinical Trial	2001-02-02	Preclinical	HTR2C
Tobacco Use Disorder	ENSG00000147434	FALSE	Preclinical	2007-07-30	Unused	CHRNA6
Tobacco Use Disorder	ENSG00000151577	FALSE	Phase II Clinical Trial	1998-08-15	Unused	DRD3
Tobacco Use Disorder	ENSG00000151834	FALSE	Preclinical	2009-07-16	Preclinical	GABRA2
Tobacco Use Disorder	ENSG00000160716	TRUE	Approved	2000-12-12	Approved	CHRNB2
Tobacco Use Disorder	ENSG00000164082	FALSE	Preclinical	1996-10-15	Unused	GRM2
Tobacco Use Disorder	ENSG00000166736	FALSE	Phase I Clinical Trial	2011-05-26	Phase I Clinical Trial	HTR3A
Tobacco Use Disorder	ENSG00000168539	FALSE	Phase I Clinical Trial	1999-05-19	Unused	CHRM1
Tobacco Use Disorder	ENSG00000168959	FALSE	unknown	2005-10-04	Unused	GRM5
Tobacco Use Disorder	ENSG00000169252	FALSE	Phase II Clinical Trial	2004-07-26	Preclinical	ADRB2
Tobacco Use Disorder	ENSG00000171408	FALSE	Preclinical	2009-01-09	Preclinical	PDE7B
Tobacco Use Disorder	ENSG00000176884	FALSE	Preclinical	2001-02-28	Unused	GRIN1
Tobacco Use Disorder	ENSG00000179142	FALSE	Preclinical	2009-07-16	Preclinical	CYP11B2
Tobacco Use Disorder	ENSG00000180720	FALSE	Phase I Clinical Trial	1999-05-19	Unused	CHRM4
Tobacco Use Disorder	ENSG00000181072	FALSE	Phase I Clinical Trial	1999-05-19	Unused	CHRM2
Tobacco Use Disorder	ENSG00000184845	FALSE	unknown	1998-01-15	Unused	DRD1
Tobacco Use Disorder	ENSG00000186297	FALSE	Preclinical	2009-07-16	Preclinical	GABRA5
Tobacco Use Disorder	ENSG00000189221	FALSE	Preclinical	1990-04-15	Unused	MAOA
Tobacco Use Disorder	ENSG00000198822	FALSE	unknown	1996-10-15	Unused	GRM3
Tobacco Use Disorder	ENSG00000205268	FALSE	Preclinical	2009-01-09	Preclinical	PDE7A
Tobacco Use Disorder	ENSG00000255974	FALSE	Phase I Clinical Trial	2000-08-03	Unused	CYP2A6
Tourette Syndrome	ENSG00000069696	FALSE	Phase I Clinical Trial	2008-07-22	Unused	DRD4
Tourette Syndrome	ENSG00000074416	FALSE	Phase I Clinical Trial	2014-11-05	Absent	MGLL
Tourette Syndrome	ENSG00000101180	FALSE	Phase II Clinical Trial	2007-08-07	Unused	HRH3
Tourette Syndrome	ENSG00000102468	TRUE	Approved	1992-10-15	Approved	HTR2A
Tourette Syndrome	ENSG00000103546	FALSE	Phase II Clinical Trial	NA	Absent	SLC6A2
Tourette Syndrome	ENSG00000112541	FALSE	Preclinical	2011-08-10	Unused	PDE10A
Tourette Syndrome	ENSG00000118432	FALSE	Phase II Clinical Trial	2014-10-21	Approved	CNR1
Tourette Syndrome	ENSG00000148680	FALSE	Phase I Clinical Trial	2008-07-22	Absent	HTR7
Tourette Syndrome	ENSG00000149295	TRUE	Approved	1992-10-15	Approved	DRD2
Tourette Syndrome	ENSG00000151577	FALSE	Phase II Clinical Trial	2008-07-22	Unused	DRD3
Tourette Syndrome	ENSG00000158748	FALSE	Phase I Clinical Trial	2008-07-22	Absent	HTR6
Tourette Syndrome	ENSG00000165646	FALSE	Phase III Clinical Trial	2009-05-05	Phase I Clinical Trial	SLC18A2
Tourette Syndrome	ENSG00000169676	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DRD5
Tourette Syndrome	ENSG00000178394	TRUE	Approved	1992-10-15	Approved	HTR1A
Tourette Syndrome	ENSG00000179546	FALSE	Phase II Clinical Trial	1992-10-15	Phase II Clinical Trial	HTR1D
Tourette Syndrome	ENSG00000184845	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	DRD1
Toxoplasmosis	ENSG00000228716	FALSE	Preclinical	2017-01-12	Absent	DHFR
Tuberculosis	ENSG00000027697	FALSE	Approved	NA	Unused	IFNGR1
Tuberculosis	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Tuberculosis	ENSG00000086205	FALSE	Phase III Clinical Trial	NA	Absent	FOLH1
Tuberculosis	ENSG00000095303	TRUE	Approved	NA	Approved	PTGS1
Tuberculosis	ENSG00000106348	FALSE	Preclinical	2017-02-22	Absent	IMPDH1
Tuberculosis	ENSG00000124253	FALSE	Preclinical	2016-10-04	Absent	PCK1
Tuberculosis	ENSG00000124762	FALSE	Preclinical	2017-05-30	Absent	CDKN1A
Tuberculosis	ENSG00000131747	FALSE	Preclinical	2015-06-03	Preclinical	TOP2A
Tuberculosis	ENSG00000134460	FALSE	Approved	2013-01-18	Unused	IL2RA
Tuberculosis	ENSG00000136869	FALSE	Preclinical	2010-07-24	Unused	TLR4
Tuberculosis	ENSG00000137462	FALSE	Preclinical	2010-07-24	Unused	TLR2
Tuberculosis	ENSG00000160211	FALSE	unknown	1999-01-15	Phase II Clinical Trial	G6PD
Tuberculosis	ENSG00000164342	FALSE	Preclinical	2015-03-30	Absent	TLR3
Tuberculosis	ENSG00000169432	FALSE	Preclinical	2012-11-26	Preclinical	SCN9A
Tuberculosis	ENSG00000171608	FALSE	Preclinical	2013-04-24	Absent	PIK3CD
Tuberculosis	ENSG00000197249	FALSE	unknown	2009-06-04	Preclinical	SERPINA1
Tuberculosis	ENSG00000198900	FALSE	Preclinical	2012-04-17	Preclinical	TOP1
Tuberous Sclerosis	ENSG00000022355	FALSE	unknown	2014-04-26	Absent	GABRA1
Tuberous Sclerosis	ENSG00000036530	FALSE	Phase II Clinical Trial	2014-07-28	Absent	CYP46A1
Tuberous Sclerosis	ENSG00000198793	TRUE	Approved	1997-08-15	Approved	MTOR
Tularemia	ENSG00000082701	FALSE	Preclinical	2010-06-30	Unused	GSK3B
Tularemia	ENSG00000140992	FALSE	unknown	2008-04-09	Absent	PDPK1
Tumor Lysis Syndrome	ENSG00000158125	TRUE	Approved	2017-03-21	Absent	XDH
Turner Syndrome	ENSG00000091831	FALSE	Phase III Clinical Trial	NA	Unused	ESR1
Turner Syndrome	ENSG00000112964	TRUE	Approved	1995-07-15	Approved	GHR
Turner Syndrome	ENSG00000169083	TRUE	Approved	NA	Approved	AR
Tympanic Membrane Perforation	ENSG00000113070	FALSE	Preclinical	2017-02-02	Absent	HBEGF
Tympanic Membrane Perforation	ENSG00000122194	FALSE	Preclinical	NA	Absent	PLG
Tyrosinemias	ENSG00000158104	TRUE	Approved	1992-11-15	Approved	HPD
Ulcer	ENSG00000006638	FALSE	unknown	1991-10-15	Unused	TBXA2R
Ulcer	ENSG00000019991	FALSE	unknown	2007-09-21	Absent	HGF
Ulcer	ENSG00000095321	FALSE	unknown	NA	Unused	CRAT
Ulcer	ENSG00000100985	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP9
Ulcer	ENSG00000105675	FALSE	Approved	1992-01-15	Unused	ATP4A
Ulcer	ENSG00000112715	FALSE	Preclinical	2011-09-23	Unused	VEGFA
Ulcer	ENSG00000113749	TRUE	Approved	1990-06-15	Unused	HRH2
Ulcer	ENSG00000115718	FALSE	unknown	2008-09-30	Unused	PROC
Ulcer	ENSG00000136160	TRUE	Approved	1994-10-15	Approved	EDNRB
Ulcer	ENSG00000146648	FALSE	Preclinical	2003-08-05	Unused	EGFR
Ulcer	ENSG00000148344	FALSE	unknown	2006-12-19	Unused	PTGES
Ulcer	ENSG00000151617	TRUE	Approved	1994-10-15	Approved	EDNRA
Ulcer	ENSG00000160951	FALSE	unknown	NA	Unused	PTGER1
Ulcer	ENSG00000196611	FALSE	unknown	1995-01-15	Phase II Clinical Trial	MMP1
Ulcer	ENSG00000205542	FALSE	unknown	1995-01-15	Phase II Clinical Trial	TMSB4X
Unverricht-Lundborg Syndrome	ENSG00000159164	FALSE	unknown	2002-05-20	Unused	SV2A
Unverricht-Lundborg Syndrome	ENSG00000183023	FALSE	unknown	2002-05-20	Unused	SLC8A1
Urea Cycle Disorders, Inborn	ENSG00000103507	FALSE	Phase II Clinical Trial	NA	Absent	BCKDK
Urea Cycle Disorders, Inborn	ENSG00000110887	FALSE	Pre-registration	NA	Absent	DAO
Urethral Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FLT4
Urethral Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR2
Urethral Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FGFR3
Urethral Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	FGFR1
Urethral Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-02-11	Absent	HSP90AA1
Urethral Neoplasms	ENSG00000100311	FALSE	Phase II Clinical Trial	2003-07-22	Absent	PDGFB
Urethral Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	2002-12-02	Phase II Clinical Trial	FLT1
Urethral Neoplasms	ENSG00000105388	FALSE	Preclinical	2010-06-10	Absent	CEACAM5
Urethral Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2004-08-09	Absent	MET
Urethral Neoplasms	ENSG00000106211	FALSE	Phase II Clinical Trial	2005-04-26	Preclinical	HSPB1
Urethral Neoplasms	ENSG00000113721	FALSE	unknown	2003-07-23	Phase II Clinical Trial	PDGFRB
Urethral Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	NA	Absent	HDAC1
Urethral Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2004-08-09	Absent	TEK
Urethral Neoplasms	ENSG00000120217	FALSE	Phase III Clinical Trial	2011-06-20	Absent	CD274
Urethral Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	2003-07-23	Phase II Clinical Trial	FLT3
Urethral Neoplasms	ENSG00000126934	FALSE	Phase II Clinical Trial	2006-10-23	Absent	MAP2K2
Urethral Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	2003-07-22	Phase II Clinical Trial	KDR
Urethral Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2011-06-23	Absent	ADORA2A
Urethral Neoplasms	ENSG00000129484	FALSE	Preclinical	NA	Absent	PARP2
Urethral Neoplasms	ENSG00000131203	FALSE	Phase III Clinical Trial	2009-04-24	Absent	IDO1
Urethral Neoplasms	ENSG00000134258	FALSE	Preclinical	2016-12-17	Absent	VTCN1
Urethral Neoplasms	ENSG00000134460	FALSE	Phase II Clinical Trial	2007-08-23	Phase II Clinical Trial	IL2RA
Urethral Neoplasms	ENSG00000141736	FALSE	Preclinical	2010-06-10	Absent	ERBB2
Urethral Neoplasms	ENSG00000143217	FALSE	Phase II Clinical Trial	2004-10-18	Absent	NECTIN4
Urethral Neoplasms	ENSG00000143799	FALSE	Preclinical	NA	Absent	PARP1
Urethral Neoplasms	ENSG00000146648	FALSE	unknown	2003-07-23	Phase II Clinical Trial	EGFR
Urethral Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2003-07-22	Phase II Clinical Trial	KIT
Urethral Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Urethral Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2003-07-22	Absent	FGFR4
Urethral Neoplasms	ENSG00000163517	FALSE	Phase II Clinical Trial	NA	Absent	HDAC11
Urethral Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	2003-07-22	Absent	RET
Urethral Neoplasms	ENSG00000169032	FALSE	Phase II Clinical Trial	2006-10-23	Absent	MAP2K1
Urethral Neoplasms	ENSG00000171720	FALSE	Phase II Clinical Trial	NA	Absent	HDAC3
Urethral Neoplasms	ENSG00000176890	FALSE	Phase II Clinical Trial	1992-06-15	Unused	TYMS
Urethral Neoplasms	ENSG00000184564	FALSE	Phase I Clinical Trial	2013-05-03	Absent	SLITRK6
Urethral Neoplasms	ENSG00000184937	FALSE	Phase I Clinical Trial	2015-05-07	Absent	WT1
Urethral Neoplasms	ENSG00000186827	FALSE	unknown	2014-08-16	Absent	TNFRSF4
Urethral Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Urethral Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	NA	Absent	HDAC2
Urethral Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Unused	DHFR
Urinary Bladder Diseases	ENSG00000050628	FALSE	Phase I Clinical Trial	2012-01-19	Absent	PTGER3
Urinary Bladder Diseases	ENSG00000125384	FALSE	Phase I Clinical Trial	2012-01-19	Absent	PTGER2
Urinary Bladder Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2014-01-01	Absent	BTK
Urinary Bladder Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Urinary Bladder Neoplasms	ENSG00000027697	FALSE	Phase I Clinical Trial	NA	Absent	IFNGR1
Urinary Bladder Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT4
Urinary Bladder Neoplasms	ENSG00000039068	FALSE	Preclinical	2015-08-27	Absent	CDH1
Urinary Bladder Neoplasms	ENSG00000049249	FALSE	Phase I Clinical Trial	2015-07-15	Absent	TNFRSF9
Urinary Bladder Neoplasms	ENSG00000050165	FALSE	Preclinical	2010-07-26	Absent	DKK3
Urinary Bladder Neoplasms	ENSG00000054219	FALSE	unknown	2006-07-17	Phase II Clinical Trial	LY75
Urinary Bladder Neoplasms	ENSG00000063176	FALSE	Phase I Clinical Trial	2006-06-05	Absent	SPHK2
Urinary Bladder Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Urinary Bladder Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2006-05-05	Phase I Clinical Trial	FGFR2
Urinary Bladder Neoplasms	ENSG00000068024	FALSE	unknown	2002-06-10	Absent	HDAC4
Urinary Bladder Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR3
Urinary Bladder Neoplasms	ENSG00000073756	FALSE	Preclinical	1998-08-15	Unused	PTGS2
Urinary Bladder Neoplasms	ENSG00000077238	FALSE	Preclinical	1996-06-15	Absent	IL4R
Urinary Bladder Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	FGFR1
Urinary Bladder Neoplasms	ENSG00000078725	FALSE	Preclinical	1999-07-06	Unused	BRINP1
Urinary Bladder Neoplasms	ENSG00000079385	FALSE	Phase I Clinical Trial	2015-01-09	Absent	CEACAM1
Urinary Bladder Neoplasms	ENSG00000080824	FALSE	Phase II Clinical Trial	2005-02-11	Absent	HSP90AA1
Urinary Bladder Neoplasms	ENSG00000081181	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG2
Urinary Bladder Neoplasms	ENSG00000084774	FALSE	unknown	NA	Unused	CAD
Urinary Bladder Neoplasms	ENSG00000085563	FALSE	unknown	1994-12-15	Unused	ABCB1
Urinary Bladder Neoplasms	ENSG00000086205	FALSE	Phase II Clinical Trial	2008-03-04	Phase II Clinical Trial	FOLH1
Urinary Bladder Neoplasms	ENSG00000087586	FALSE	Preclinical	2006-11-20	Absent	AURKA
Urinary Bladder Neoplasms	ENSG00000090339	FALSE	Phase II Clinical Trial	2004-07-19	Unused	ICAM1
Urinary Bladder Neoplasms	ENSG00000091879	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT2
Urinary Bladder Neoplasms	ENSG00000095303	FALSE	Preclinical	1998-08-15	Unused	PTGS1
Urinary Bladder Neoplasms	ENSG00000097046	FALSE	Phase I Clinical Trial	2016-10-12	Absent	CDC7
Urinary Bladder Neoplasms	ENSG00000100311	FALSE	unknown	1994-06-15	Phase II Clinical Trial	PDGFB
Urinary Bladder Neoplasms	ENSG00000100385	FALSE	Phase II Clinical Trial	2012-05-28	Absent	IL2RB
Urinary Bladder Neoplasms	ENSG00000100823	FALSE	unknown	2007-02-13	Unused	APEX1
Urinary Bladder Neoplasms	ENSG00000101017	FALSE	Phase I Clinical Trial	1998-07-15	Unused	CD40
Urinary Bladder Neoplasms	ENSG00000101412	FALSE	Phase I Clinical Trial	2007-11-12	Absent	E2F1
Urinary Bladder Neoplasms	ENSG00000101868	FALSE	unknown	1993-08-15	Phase I Clinical Trial	POLA1
Urinary Bladder Neoplasms	ENSG00000102755	FALSE	Phase II Clinical Trial	1994-03-15	Phase II Clinical Trial	FLT1
Urinary Bladder Neoplasms	ENSG00000103222	FALSE	Preclinical	2011-09-28	Preclinical	ABCC1
Urinary Bladder Neoplasms	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Phase I Clinical Trial	CD276
Urinary Bladder Neoplasms	ENSG00000104827	FALSE	Phase I Clinical Trial	2004-10-06	Phase I Clinical Trial	CGB3
Urinary Bladder Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2003-09-10	Absent	CEACAM5
Urinary Bladder Neoplasms	ENSG00000105976	FALSE	Phase II Clinical Trial	2001-10-18	Phase I Clinical Trial	MET
Urinary Bladder Neoplasms	ENSG00000106211	FALSE	Phase II Clinical Trial	2005-04-26	Phase II Clinical Trial	HSPB1
Urinary Bladder Neoplasms	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Phase II Clinical Trial	ENG
Urinary Bladder Neoplasms	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Urinary Bladder Neoplasms	ENSG00000109163	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	GNRHR
Urinary Bladder Neoplasms	ENSG00000109471	FALSE	unknown	1997-10-15	Unused	IL2
Urinary Bladder Neoplasms	ENSG00000110375	FALSE	Preclinical	2001-08-09	Unused	UPK2
Urinary Bladder Neoplasms	ENSG00000111142	FALSE	Phase III Clinical Trial	2016-05-23	Absent	METAP2
Urinary Bladder Neoplasms	ENSG00000112062	FALSE	Preclinical	NA	Absent	MAPK14
Urinary Bladder Neoplasms	ENSG00000112715	FALSE	Preclinical	2008-04-02	Preclinical	VEGFA
Urinary Bladder Neoplasms	ENSG00000113721	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRB
Urinary Bladder Neoplasms	ENSG00000113916	FALSE	Preclinical	2017-04-13	Absent	BCL6
Urinary Bladder Neoplasms	ENSG00000114378	FALSE	Phase II Clinical Trial	NA	Absent	HYAL1
Urinary Bladder Neoplasms	ENSG00000115053	FALSE	Phase II Clinical Trial	2008-07-31	Phase II Clinical Trial	NCL
Urinary Bladder Neoplasms	ENSG00000115414	FALSE	Phase I Clinical Trial	2004-02-11	Unused	FN1
Urinary Bladder Neoplasms	ENSG00000115758	FALSE	unknown	1994-03-15	Phase II Clinical Trial	ODC1
Urinary Bladder Neoplasms	ENSG00000115884	FALSE	Phase II Clinical Trial	2006-07-11	Absent	SDC1
Urinary Bladder Neoplasms	ENSG00000116478	FALSE	unknown	2002-06-10	Absent	HDAC1
Urinary Bladder Neoplasms	ENSG00000117091	FALSE	Phase I Clinical Trial	2007-08-31	Unused	CD48
Urinary Bladder Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Urinary Bladder Neoplasms	ENSG00000118520	FALSE	Phase I Clinical Trial	2014-08-28	Absent	ARG1
Urinary Bladder Neoplasms	ENSG00000119630	FALSE	Preclinical	2014-07-12	Absent	PGF
Urinary Bladder Neoplasms	ENSG00000120156	FALSE	Phase II Clinical Trial	2001-12-18	Phase I Clinical Trial	TEK
Urinary Bladder Neoplasms	ENSG00000120217	TRUE	Approved	2011-04-27	Absent	CD274
Urinary Bladder Neoplasms	ENSG00000120885	FALSE	unknown	2001-12-07	Unused	CLU
Urinary Bladder Neoplasms	ENSG00000121594	FALSE	Phase I Clinical Trial	2007-08-31	Unused	CD80
Urinary Bladder Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	2009-09-01	Absent	PIK3CA
Urinary Bladder Neoplasms	ENSG00000122025	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	FLT3
Urinary Bladder Neoplasms	ENSG00000126934	FALSE	unknown	2003-06-09	Unused	MAP2K2
Urinary Bladder Neoplasms	ENSG00000128052	FALSE	Phase III Clinical Trial	1994-06-15	Phase II Clinical Trial	KDR
Urinary Bladder Neoplasms	ENSG00000128271	FALSE	Phase II Clinical Trial	2008-10-21	Absent	ADORA2A
Urinary Bladder Neoplasms	ENSG00000129484	FALSE	Phase I Clinical Trial	2006-08-16	Phase I Clinical Trial	PARP2
Urinary Bladder Neoplasms	ENSG00000130816	FALSE	Phase II Clinical Trial	2005-12-02	Absent	DNMT1
Urinary Bladder Neoplasms	ENSG00000131203	FALSE	Phase II Clinical Trial	2009-04-24	Phase II Clinical Trial	IDO1
Urinary Bladder Neoplasms	ENSG00000131238	FALSE	unknown	1994-03-15	Phase II Clinical Trial	PPT1
Urinary Bladder Neoplasms	ENSG00000131747	TRUE	Approved	1991-06-15	Approved	TOP2A
Urinary Bladder Neoplasms	ENSG00000132155	FALSE	Preclinical	1994-06-15	Phase II Clinical Trial	RAF1
Urinary Bladder Neoplasms	ENSG00000132646	FALSE	Preclinical	2011-03-30	Absent	PCNA
Urinary Bladder Neoplasms	ENSG00000134460	FALSE	Approved	2007-08-23	Unused	IL2RA
Urinary Bladder Neoplasms	ENSG00000134470	FALSE	Phase III Clinical Trial	2010-10-05	Preclinical	IL15RA
Urinary Bladder Neoplasms	ENSG00000134853	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	PDGFRA
Urinary Bladder Neoplasms	ENSG00000135218	FALSE	Phase I Clinical Trial	2001-03-14	Unused	CD36
Urinary Bladder Neoplasms	ENSG00000135446	FALSE	unknown	2012-01-04	Preclinical	CDK4
Urinary Bladder Neoplasms	ENSG00000137077	FALSE	Preclinical	2015-02-24	Absent	CCL21
Urinary Bladder Neoplasms	ENSG00000138160	FALSE	Phase II Clinical Trial	1999-06-30	Phase I Clinical Trial	KIF11
Urinary Bladder Neoplasms	ENSG00000138735	FALSE	unknown	1999-01-08	Preclinical	PDE5A
Urinary Bladder Neoplasms	ENSG00000139193	FALSE	unknown	2008-11-12	Absent	CD27
Urinary Bladder Neoplasms	ENSG00000139687	FALSE	Preclinical	1993-10-15	Unused	RB1
Urinary Bladder Neoplasms	ENSG00000140443	FALSE	Phase I Clinical Trial	2009-01-13	Phase I Clinical Trial	IGF1R
Urinary Bladder Neoplasms	ENSG00000140538	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK3
Urinary Bladder Neoplasms	ENSG00000141510	FALSE	Preclinical	1995-01-15	Unused	TP53
Urinary Bladder Neoplasms	ENSG00000141736	FALSE	Phase III Clinical Trial	1990-09-15	Phase II Clinical Trial	ERBB2
Urinary Bladder Neoplasms	ENSG00000142627	FALSE	unknown	2006-09-11	Unused	EPHA2
Urinary Bladder Neoplasms	ENSG00000143217	FALSE	Phase II Clinical Trial	2004-10-18	Unused	NECTIN4
Urinary Bladder Neoplasms	ENSG00000143365	FALSE	Phase II Clinical Trial	2014-11-11	Absent	RORC
Urinary Bladder Neoplasms	ENSG00000143537	FALSE	Preclinical	2017-12-22	Absent	ADAM15
Urinary Bladder Neoplasms	ENSG00000143799	FALSE	Phase I Clinical Trial	2006-08-16	Phase I Clinical Trial	PARP1
Urinary Bladder Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1993-07-15	Phase II Clinical Trial	EGFR
Urinary Bladder Neoplasms	ENSG00000148053	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK2
Urinary Bladder Neoplasms	ENSG00000148773	FALSE	Phase I Clinical Trial	2005-05-31	Unused	MKI67
Urinary Bladder Neoplasms	ENSG00000148795	FALSE	Preclinical	2008-10-27	Absent	CYP17A1
Urinary Bladder Neoplasms	ENSG00000149554	FALSE	Phase I Clinical Trial	NA	Phase II Clinical Trial	CHEK1
Urinary Bladder Neoplasms	ENSG00000150337	FALSE	unknown	1995-09-15	Unused	FCGR1A
Urinary Bladder Neoplasms	ENSG00000153563	FALSE	unknown	2007-07-23	Unused	CD8A
Urinary Bladder Neoplasms	ENSG00000154188	FALSE	Phase I Clinical Trial	2004-03-24	Phase I Clinical Trial	ANGPT1
Urinary Bladder Neoplasms	ENSG00000154229	FALSE	Preclinical	2003-02-26	Preclinical	PRKCA
Urinary Bladder Neoplasms	ENSG00000156508	FALSE	unknown	1994-03-15	Phase II Clinical Trial	EEF1A1
Urinary Bladder Neoplasms	ENSG00000156738	FALSE	Preclinical	NA	Absent	MS4A1
Urinary Bladder Neoplasms	ENSG00000157404	FALSE	Phase II Clinical Trial	2001-04-03	Phase II Clinical Trial	KIT
Urinary Bladder Neoplasms	ENSG00000157764	FALSE	Phase I Clinical Trial	2001-04-03	Absent	BRAF
Urinary Bladder Neoplasms	ENSG00000159110	FALSE	Approved	2013-01-08	Unused	IFNAR2
Urinary Bladder Neoplasms	ENSG00000159131	FALSE	Phase II Clinical Trial	1992-06-15	Unused	GART
Urinary Bladder Neoplasms	ENSG00000160867	FALSE	Phase II Clinical Trial	2006-05-05	Absent	FGFR4
Urinary Bladder Neoplasms	ENSG00000163517	FALSE	unknown	NA	Absent	HDAC11
Urinary Bladder Neoplasms	ENSG00000163599	FALSE	Phase III Clinical Trial	1998-09-15	Phase I Clinical Trial	CTLA4
Urinary Bladder Neoplasms	ENSG00000163932	FALSE	Preclinical	NA	Unused	PRKCD
Urinary Bladder Neoplasms	ENSG00000164078	FALSE	Phase I Clinical Trial	2001-10-18	Phase I Clinical Trial	MST1R
Urinary Bladder Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	2001-12-19	Phase I Clinical Trial	CASP3
Urinary Bladder Neoplasms	ENSG00000164362	FALSE	Phase I Clinical Trial	NA	Unused	TERT
Urinary Bladder Neoplasms	ENSG00000165731	FALSE	Phase II Clinical Trial	1994-06-15	Phase II Clinical Trial	RET
Urinary Bladder Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	PLK1
Urinary Bladder Neoplasms	ENSG00000167325	FALSE	Phase I Clinical Trial	2000-07-26	Unused	RRM1
Urinary Bladder Neoplasms	ENSG00000167653	FALSE	Preclinical	2000-07-26	Unused	PSCA
Urinary Bladder Neoplasms	ENSG00000167658	FALSE	Phase II Clinical Trial	1994-10-15	Unused	EEF2
Urinary Bladder Neoplasms	ENSG00000168522	FALSE	Phase I Clinical Trial	1999-01-15	Unused	FNTA
Urinary Bladder Neoplasms	ENSG00000168610	FALSE	Phase II Clinical Trial	2010-08-03	Absent	STAT3
Urinary Bladder Neoplasms	ENSG00000169032	FALSE	unknown	2003-06-09	Unused	MAP2K1
Urinary Bladder Neoplasms	ENSG00000169047	FALSE	Preclinical	NA	Preclinical	IRS1
Urinary Bladder Neoplasms	ENSG00000171094	FALSE	Phase II Clinical Trial	2011-03-24	Absent	ALK
Urinary Bladder Neoplasms	ENSG00000171720	FALSE	unknown	NA	Absent	HDAC3
Urinary Bladder Neoplasms	ENSG00000171791	FALSE	Preclinical	2017-04-12	Absent	BCL2
Urinary Bladder Neoplasms	ENSG00000171848	FALSE	unknown	1998-11-15	Unused	RRM2
Urinary Bladder Neoplasms	ENSG00000173638	FALSE	unknown	NA	Phase II Clinical Trial	SLC19A1
Urinary Bladder Neoplasms	ENSG00000175054	FALSE	Preclinical	2013-07-22	Absent	ATR
Urinary Bladder Neoplasms	ENSG00000176890	FALSE	Approved	1992-06-15	Unused	TYMS
Urinary Bladder Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Phase I Clinical Trial	ERBB4
Urinary Bladder Neoplasms	ENSG00000178999	FALSE	Preclinical	2007-02-14	Absent	AURKB
Urinary Bladder Neoplasms	ENSG00000181019	FALSE	Phase I Clinical Trial	2007-11-12	Absent	NQO1
Urinary Bladder Neoplasms	ENSG00000182578	FALSE	Phase II Clinical Trial	2008-08-14	Absent	CSF1R
Urinary Bladder Neoplasms	ENSG00000184033	FALSE	Preclinical	2002-10-10	Phase II Clinical Trial	CTAG1B
Urinary Bladder Neoplasms	ENSG00000184292	FALSE	Phase III Clinical Trial	2002-10-02	Absent	TACSTD2
Urinary Bladder Neoplasms	ENSG00000184564	FALSE	Phase I Clinical Trial	2013-05-03	Absent	SLITRK6
Urinary Bladder Neoplasms	ENSG00000185499	FALSE	Phase II Clinical Trial	2003-09-10	Phase II Clinical Trial	MUC1
Urinary Bladder Neoplasms	ENSG00000186642	FALSE	unknown	1999-01-08	Preclinical	PDE2A
Urinary Bladder Neoplasms	ENSG00000186827	FALSE	unknown	2014-08-16	Absent	TNFRSF4
Urinary Bladder Neoplasms	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Urinary Bladder Neoplasms	ENSG00000188379	FALSE	Approved	1999-05-19	Phase II Clinical Trial	IFNA2
Urinary Bladder Neoplasms	ENSG00000188389	TRUE	Approved	2005-05-12	Absent	PDCD1
Urinary Bladder Neoplasms	ENSG00000196352	FALSE	Phase II Clinical Trial	2004-07-19	Preclinical	CD55
Urinary Bladder Neoplasms	ENSG00000196591	FALSE	unknown	2002-06-10	Absent	HDAC2
Urinary Bladder Neoplasms	ENSG00000196664	FALSE	Phase II Clinical Trial	2008-07-21	Phase II Clinical Trial	TLR7
Urinary Bladder Neoplasms	ENSG00000196776	FALSE	Preclinical	2016-02-25	Absent	CD47
Urinary Bladder Neoplasms	ENSG00000197081	FALSE	Phase I Clinical Trial	2009-01-13	Phase I Clinical Trial	IGF2R
Urinary Bladder Neoplasms	ENSG00000198400	FALSE	Phase II Clinical Trial	2011-03-24	Absent	NTRK1
Urinary Bladder Neoplasms	ENSG00000198668	FALSE	unknown	2003-12-09	Absent	CALM1
Urinary Bladder Neoplasms	ENSG00000198793	FALSE	Phase II Clinical Trial	2007-01-26	Unused	MTOR
Urinary Bladder Neoplasms	ENSG00000198900	FALSE	Phase II Clinical Trial	1995-06-15	Unused	TOP1
Urinary Bladder Neoplasms	ENSG00000213809	FALSE	Preclinical	NA	Absent	KLRK1
Urinary Bladder Neoplasms	ENSG00000221867	FALSE	Phase II Clinical Trial	1998-07-15	Preclinical	MAGEA3
Urinary Bladder Neoplasms	ENSG00000228716	FALSE	Phase II Clinical Trial	1992-06-15	Phase II Clinical Trial	DHFR
Urinary Bladder Neoplasms	ENSG00000239732	FALSE	Preclinical	2015-02-21	Absent	TLR9
Urinary Bladder, Neurogenic	ENSG00000007171	FALSE	unknown	1996-08-15	Unused	NOS2
Urinary Bladder, Neurogenic	ENSG00000073756	FALSE	unknown	1996-08-15	Unused	PTGS2
Urinary Bladder, Neurogenic	ENSG00000095303	FALSE	unknown	1996-08-15	Unused	PTGS1
Urinary Bladder, Neurogenic	ENSG00000120907	FALSE	Phase III Clinical Trial	NA	Unused	ADRA1A
Urinary Bladder, Neurogenic	ENSG00000122420	FALSE	unknown	NA	Unused	PTGFR
Urinary Bladder, Neurogenic	ENSG00000133019	TRUE	Approved	1989-09-15	Approved	CHRM3
Urinary Bladder, Neurogenic	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Urinary Bladder, Neurogenic	ENSG00000168539	TRUE	Approved	1989-09-15	Approved	CHRM1
Urinary Bladder, Neurogenic	ENSG00000180720	TRUE	Approved	1989-09-15	Approved	CHRM4
Urinary Bladder, Neurogenic	ENSG00000181072	TRUE	Approved	1989-09-15	Approved	CHRM2
Urinary Bladder, Overactive	ENSG00000053918	FALSE	Preclinical	2001-05-10	Unused	KCNQ1
Urinary Bladder, Overactive	ENSG00000055118	FALSE	Preclinical	2001-05-10	Unused	KCNH2
Urinary Bladder, Overactive	ENSG00000065989	FALSE	Phase II Clinical Trial	2009-11-09	Absent	PDE4A
Urinary Bladder, Overactive	ENSG00000075043	FALSE	Phase II Clinical Trial	NA	Absent	KCNQ2
Urinary Bladder, Overactive	ENSG00000075073	FALSE	Preclinical	2001-01-03	Unused	TACR2
Urinary Bladder, Overactive	ENSG00000080644	FALSE	unknown	2005-12-06	Absent	CHRNA3
Urinary Bladder, Overactive	ENSG00000088832	FALSE	Preclinical	2011-06-27	Absent	FKBP1A
Urinary Bladder, Overactive	ENSG00000101204	FALSE	unknown	2005-12-06	Preclinical	CHRNA4
Urinary Bladder, Overactive	ENSG00000103546	FALSE	Phase II Clinical Trial	1990-07-15	Unused	SLC6A2
Urinary Bladder, Overactive	ENSG00000104321	FALSE	Preclinical	2009-11-09	Unused	TRPA1
Urinary Bladder, Overactive	ENSG00000108576	FALSE	Phase II Clinical Trial	NA	Unused	SLC6A4
Urinary Bladder, Overactive	ENSG00000109991	FALSE	Preclinical	2010-08-26	Unused	P2RX3
Urinary Bladder, Overactive	ENSG00000111424	FALSE	unknown	2002-03-27	Unused	VDR
Urinary Bladder, Overactive	ENSG00000112038	FALSE	unknown	2005-12-30	Unused	OPRM1
Urinary Bladder, Overactive	ENSG00000115353	FALSE	Phase II Clinical Trial	1999-06-01	Unused	TACR1
Urinary Bladder, Overactive	ENSG00000116329	FALSE	Phase I Clinical Trial	2009-12-09	Unused	OPRD1
Urinary Bladder, Overactive	ENSG00000117971	FALSE	unknown	2005-12-06	Absent	CHRNB4
Urinary Bladder, Overactive	ENSG00000120907	TRUE	Approved	2015-01-28	Approved	ADRA1A
Urinary Bladder, Overactive	ENSG00000121361	FALSE	Phase II Clinical Trial	1998-03-15	Unused	KCNJ8
Urinary Bladder, Overactive	ENSG00000126895	FALSE	Phase II Clinical Trial	2001-04-18	Unused	AVPR2
Urinary Bladder, Overactive	ENSG00000133019	TRUE	Approved	1989-09-15	Approved	CHRM3
Urinary Bladder, Overactive	ENSG00000134259	FALSE	Preclinical	2011-06-27	Preclinical	NGF
Urinary Bladder, Overactive	ENSG00000134489	FALSE	Phase II Clinical Trial	2009-11-09	Absent	HRH4
Urinary Bladder, Overactive	ENSG00000135898	FALSE	unknown	2009-11-14	Unused	GPR55
Urinary Bladder, Overactive	ENSG00000138735	FALSE	Phase II Clinical Trial	2001-05-31	Unused	PDE5A
Urinary Bladder, Overactive	ENSG00000144481	FALSE	Preclinical	2017-02-21	Absent	TRPM8
Urinary Bladder, Overactive	ENSG00000145936	FALSE	Phase II Clinical Trial	1999-01-15	Unused	KCNMB1
Urinary Bladder, Overactive	ENSG00000147955	FALSE	Preclinical	1997-03-15	Unused	SIGMAR1
Urinary Bladder, Overactive	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Urinary Bladder, Overactive	ENSG00000153956	FALSE	Phase II Clinical Trial	2004-01-07	Unused	CACNA2D1
Urinary Bladder, Overactive	ENSG00000156113	FALSE	Phase II Clinical Trial	1999-01-15	Phase I Clinical Trial	KCNMA1
Urinary Bladder, Overactive	ENSG00000160013	FALSE	Preclinical	2001-01-23	Unused	PTGIR
Urinary Bladder, Overactive	ENSG00000160716	FALSE	unknown	2005-12-06	Preclinical	CHRNB2
Urinary Bladder, Overactive	ENSG00000160951	FALSE	Phase II Clinical Trial	2003-07-10	Phase II Clinical Trial	PTGER1
Urinary Bladder, Overactive	ENSG00000166736	FALSE	Preclinical	1990-07-15	Unused	HTR3A
Urinary Bladder, Overactive	ENSG00000168539	TRUE	Approved	1989-09-15	Approved	CHRM1
Urinary Bladder, Overactive	ENSG00000169432	FALSE	unknown	2007-04-02	Unused	SCN9A
Urinary Bladder, Overactive	ENSG00000171873	FALSE	Phase I Clinical Trial	2011-08-01	Unused	ADRA1D
Urinary Bladder, Overactive	ENSG00000178394	FALSE	unknown	2001-01-12	Unused	HTR1A
Urinary Bladder, Overactive	ENSG00000180720	TRUE	Approved	1989-09-15	Approved	CHRM4
Urinary Bladder, Overactive	ENSG00000181072	TRUE	Approved	1989-09-15	Approved	CHRM2
Urinary Bladder, Overactive	ENSG00000184156	FALSE	Phase II Clinical Trial	NA	Absent	KCNQ3
Urinary Bladder, Overactive	ENSG00000188778	TRUE	Approved	1998-11-15	Approved	ADRB3
Urinary Bladder, Overactive	ENSG00000188822	FALSE	Phase I Clinical Trial	2011-05-13	Absent	CNR2
Urinary Bladder, Overactive	ENSG00000196639	FALSE	Phase II Clinical Trial	2009-11-09	Unused	HRH1
Urinary Bladder, Overactive	ENSG00000196689	FALSE	Phase II Clinical Trial	1996-12-15	Phase II Clinical Trial	TRPV1
Urinary Calculi	ENSG00000059377	FALSE	unknown	1995-07-15	Unused	TBXAS1
Urinary Calculi	ENSG00000120907	FALSE	Phase II Clinical Trial	1996-05-15	Phase II Clinical Trial	ADRA1A
Urinary Calculi	ENSG00000169252	FALSE	Phase II Clinical Trial	1998-05-15	Unused	ADRB2
Urinary Calculi	ENSG00000188778	FALSE	Phase II Clinical Trial	1998-05-15	Unused	ADRB3
Urinary Incontinence	ENSG00000007171	FALSE	unknown	1996-08-15	Unused	NOS2
Urinary Incontinence	ENSG00000064989	FALSE	unknown	1990-05-15	Unused	CALCRL
Urinary Incontinence	ENSG00000065989	FALSE	Phase II Clinical Trial	2009-11-09	Absent	PDE4A
Urinary Incontinence	ENSG00000069431	FALSE	Preclinical	1995-08-15	Unused	ABCC9
Urinary Incontinence	ENSG00000073756	FALSE	unknown	1996-08-15	Unused	PTGS2
Urinary Incontinence	ENSG00000075043	FALSE	Preclinical	2008-10-17	Unused	KCNQ2
Urinary Incontinence	ENSG00000075073	FALSE	Phase I Clinical Trial	1993-01-15	Unused	TACR2
Urinary Incontinence	ENSG00000095303	FALSE	unknown	1996-08-15	Unused	PTGS1
Urinary Incontinence	ENSG00000103546	TRUE	Approved	2000-05-02	Approved	SLC6A2
Urinary Incontinence	ENSG00000107562	FALSE	Preclinical	2009-03-25	Absent	CXCL12
Urinary Incontinence	ENSG00000108576	TRUE	Approved	2003-07-29	Approved	SLC6A4
Urinary Incontinence	ENSG00000111262	FALSE	Preclinical	2004-06-29	Unused	KCNA1
Urinary Incontinence	ENSG00000112038	FALSE	unknown	2005-12-30	Unused	OPRM1
Urinary Incontinence	ENSG00000115353	FALSE	Phase I Clinical Trial	1990-05-15	Unused	TACR1
Urinary Incontinence	ENSG00000116329	FALSE	Preclinical	1998-02-15	Unused	OPRD1
Urinary Incontinence	ENSG00000120907	TRUE	Approved	1994-07-15	Approved	ADRA1A
Urinary Incontinence	ENSG00000121361	FALSE	Phase II Clinical Trial	1993-03-15	Unused	KCNJ8
Urinary Incontinence	ENSG00000126895	TRUE	Approved	1998-03-15	Unused	AVPR2
Urinary Incontinence	ENSG00000132329	FALSE	unknown	1990-05-15	Unused	RAMP1
Urinary Incontinence	ENSG00000133019	TRUE	Approved	1989-09-15	Approved	CHRM3
Urinary Incontinence	ENSG00000134259	FALSE	Preclinical	1999-06-23	Unused	NGF
Urinary Incontinence	ENSG00000134489	FALSE	Phase II Clinical Trial	2009-11-09	Absent	HRH4
Urinary Incontinence	ENSG00000142319	FALSE	unknown	2000-05-02	Unused	SLC6A3
Urinary Incontinence	ENSG00000145936	FALSE	unknown	1999-01-15	Unused	KCNMB1
Urinary Incontinence	ENSG00000147246	FALSE	Preclinical	2009-08-12	Unused	HTR2C
Urinary Incontinence	ENSG00000147955	FALSE	Preclinical	1997-03-15	Unused	SIGMAR1
Urinary Incontinence	ENSG00000148408	FALSE	Preclinical	2005-08-23	Unused	CACNA1B
Urinary Incontinence	ENSG00000151067	TRUE	Approved	1989-09-15	Approved	CACNA1C
Urinary Incontinence	ENSG00000156113	FALSE	unknown	1999-01-15	Unused	KCNMA1
Urinary Incontinence	ENSG00000160951	FALSE	Preclinical	2003-07-10	Unused	PTGER1
Urinary Incontinence	ENSG00000164270	FALSE	unknown	1998-08-15	Unused	HTR4
Urinary Incontinence	ENSG00000168539	TRUE	Approved	1989-09-15	Approved	CHRM1
Urinary Incontinence	ENSG00000169083	FALSE	Phase II Clinical Trial	2003-09-02	Absent	AR
Urinary Incontinence	ENSG00000169836	FALSE	unknown	1996-03-15	Unused	TACR3
Urinary Incontinence	ENSG00000170214	TRUE	Approved	1999-04-21	Approved	ADRA1B
Urinary Incontinence	ENSG00000171873	TRUE	Approved	1999-04-21	Approved	ADRA1D
Urinary Incontinence	ENSG00000178394	FALSE	Phase I Clinical Trial	1996-06-15	Unused	HTR1A
Urinary Incontinence	ENSG00000180720	TRUE	Approved	1989-09-15	Approved	CHRM4
Urinary Incontinence	ENSG00000181072	TRUE	Approved	1989-09-15	Approved	CHRM2
Urinary Incontinence	ENSG00000184156	FALSE	Preclinical	2008-10-17	Unused	KCNQ3
Urinary Incontinence	ENSG00000185313	FALSE	Preclinical	2005-08-23	Unused	SCN10A
Urinary Incontinence	ENSG00000188778	TRUE	Approved	1998-11-15	Approved	ADRB3
Urinary Incontinence	ENSG00000196639	FALSE	Phase II Clinical Trial	2009-11-09	Unused	HRH1
Urinary Incontinence	ENSG00000196689	FALSE	unknown	1996-12-15	Unused	TRPV1
Urinary Retention	ENSG00000082556	FALSE	Preclinical	1997-01-15	Unused	OPRK1
Urinary Retention	ENSG00000087085	FALSE	Phase II Clinical Trial	2003-11-01	Unused	ACHE
Urinary Retention	ENSG00000112038	FALSE	Phase II Clinical Trial	NA	Unused	OPRM1
Urinary Retention	ENSG00000120907	TRUE	Approved	NA	Approved	ADRA1A
Urinary Retention	ENSG00000137869	FALSE	Phase II Clinical Trial	1992-09-15	Unused	CYP19A1
Urinary Tract Infections	ENSG00000005381	FALSE	Preclinical	2011-06-07	Absent	MPO
Urinary Tract Infections	ENSG00000065989	FALSE	Phase III Clinical Trial	2001-05-09	Phase I Clinical Trial	PDE4A
Urinary Tract Infections	ENSG00000088832	FALSE	Preclinical	2011-06-10	Preclinical	FKBP1A
Urinary Tract Infections	ENSG00000105650	FALSE	Phase III Clinical Trial	2002-07-12	Unused	PDE4C
Urinary Tract Infections	ENSG00000105668	FALSE	Preclinical	1997-05-15	Unused	UPK1A
Urinary Tract Infections	ENSG00000109991	FALSE	Phase II Clinical Trial	2006-02-13	Phase II Clinical Trial	P2RX3
Urinary Tract Infections	ENSG00000111424	FALSE	unknown	2002-03-27	Unused	VDR
Urinary Tract Infections	ENSG00000113070	FALSE	unknown	NA	Phase I Clinical Trial	HBEGF
Urinary Tract Infections	ENSG00000113448	FALSE	Phase III Clinical Trial	2002-07-12	Unused	PDE4D
Urinary Tract Infections	ENSG00000114638	FALSE	Preclinical	1997-05-15	Unused	UPK1B
Urinary Tract Infections	ENSG00000121807	FALSE	Preclinical	2015-09-03	Absent	CCR2
Urinary Tract Infections	ENSG00000133019	TRUE	Approved	NA	Approved	CHRM3
Urinary Tract Infections	ENSG00000134259	FALSE	Phase II Clinical Trial	2003-03-26	Phase II Clinical Trial	NGF
Urinary Tract Infections	ENSG00000134460	FALSE	Approved	NA	Unused	IL2RA
Urinary Tract Infections	ENSG00000153956	FALSE	Phase II Clinical Trial	2006-12-05	Unused	CACNA2D1
Urinary Tract Infections	ENSG00000159110	FALSE	Approved	NA	Unused	IFNAR2
Urinary Tract Infections	ENSG00000160712	FALSE	Preclinical	2004-04-05	Unused	IL6R
Urinary Tract Infections	ENSG00000162711	FALSE	Preclinical	2014-09-02	Absent	NLRP3
Urinary Tract Infections	ENSG00000163823	FALSE	Preclinical	2015-09-03	Absent	CCR1
Urinary Tract Infections	ENSG00000168539	TRUE	Approved	NA	Approved	CHRM1
Urinary Tract Infections	ENSG00000168918	FALSE	Phase III Clinical Trial	2009-10-12	Phase I Clinical Trial	INPP5D
Urinary Tract Infections	ENSG00000169432	TRUE	Approved	2005-10-04	Phase II Clinical Trial	SCN9A
Urinary Tract Infections	ENSG00000172572	FALSE	Phase III Clinical Trial	2001-05-09	Phase I Clinical Trial	PDE3A
Urinary Tract Infections	ENSG00000173198	FALSE	Phase III Clinical Trial	2001-05-09	Phase I Clinical Trial	CYSLTR1
Urinary Tract Infections	ENSG00000176884	FALSE	Preclinical	2004-04-05	Unused	GRIN1
Urinary Tract Infections	ENSG00000180720	TRUE	Approved	NA	Approved	CHRM4
Urinary Tract Infections	ENSG00000181072	TRUE	Approved	NA	Approved	CHRM2
Urinary Tract Infections	ENSG00000181104	FALSE	Preclinical	2007-08-24	Absent	F2R
Urinary Tract Infections	ENSG00000184588	FALSE	Phase III Clinical Trial	2001-05-09	Phase I Clinical Trial	PDE4B
Urinary Tract Infections	ENSG00000188822	FALSE	unknown	2011-05-13	Absent	CNR2
Urinary Tract Infections	ENSG00000196689	FALSE	Preclinical	1996-12-15	Preclinical	TRPV1
Urinary Tract Infections	ENSG00000228716	FALSE	Preclinical	NA	Absent	DHFR
Urinary Tract Infections	ENSG00000274286	FALSE	Phase II Clinical Trial	2004-11-02	Phase II Clinical Trial	ADRA2B
Urogenital Abnormalities	ENSG00000006638	FALSE	unknown	1990-09-15	Unused	TBXA2R
Urogenital Abnormalities	ENSG00000011465	FALSE	Preclinical	1991-06-15	Unused	DCN
Urogenital Abnormalities	ENSG00000012779	FALSE	unknown	1990-07-15	Unused	ALOX5
Urogenital Abnormalities	ENSG00000017427	FALSE	Preclinical	1993-11-15	Unused	IGF1
Urogenital Abnormalities	ENSG00000059377	FALSE	Preclinical	1990-07-15	Unused	TBXAS1
Urogenital Abnormalities	ENSG00000069431	FALSE	Preclinical	1990-10-15	Unused	ABCC9
Urogenital Abnormalities	ENSG00000069535	FALSE	Preclinical	2016-06-22	Absent	MAOB
Urogenital Abnormalities	ENSG00000073756	FALSE	Preclinical	2001-09-24	Unused	PTGS2
Urogenital Abnormalities	ENSG00000075073	FALSE	Preclinical	2000-03-08	Unused	TACR2
Urogenital Abnormalities	ENSG00000082175	FALSE	Preclinical	2000-02-16	Phase I Clinical Trial	PGR
Urogenital Abnormalities	ENSG00000091831	FALSE	Preclinical	1999-09-16	Unused	ESR1
Urogenital Abnormalities	ENSG00000095303	FALSE	Preclinical	2001-09-24	Unused	PTGS1
Urogenital Abnormalities	ENSG00000102468	FALSE	Preclinical	1990-07-15	Unused	HTR2A
Urogenital Abnormalities	ENSG00000103546	FALSE	Preclinical	1990-08-15	Unused	SLC6A2
Urogenital Abnormalities	ENSG00000105976	FALSE	Preclinical	2001-07-04	Unused	MET
Urogenital Abnormalities	ENSG00000106128	FALSE	Preclinical	NA	Unused	GHRHR
Urogenital Abnormalities	ENSG00000106799	FALSE	Preclinical	1991-06-15	Unused	TGFBR1
Urogenital Abnormalities	ENSG00000109163	FALSE	Preclinical	1989-11-15	Unused	GNRHR
Urogenital Abnormalities	ENSG00000109991	FALSE	Phase I Clinical Trial	2014-08-21	Absent	P2RX3
Urogenital Abnormalities	ENSG00000111424	FALSE	unknown	1996-08-15	Unused	VDR
Urogenital Abnormalities	ENSG00000112038	FALSE	Phase II Clinical Trial	1990-09-15	Unused	OPRM1
Urogenital Abnormalities	ENSG00000115353	FALSE	Preclinical	1995-12-15	Unused	TACR1
Urogenital Abnormalities	ENSG00000116014	FALSE	Preclinical	2004-05-20	Unused	KISS1R
Urogenital Abnormalities	ENSG00000116678	FALSE	Preclinical	1994-08-15	Unused	LEPR
Urogenital Abnormalities	ENSG00000117298	FALSE	Preclinical	1992-09-15	Unused	ECE1
Urogenital Abnormalities	ENSG00000117400	FALSE	Preclinical	2003-07-08	Unused	MPL
Urogenital Abnormalities	ENSG00000120907	FALSE	Preclinical	1995-09-15	Unused	ADRA1A
Urogenital Abnormalities	ENSG00000121361	FALSE	Preclinical	1990-10-15	Unused	KCNJ8
Urogenital Abnormalities	ENSG00000121853	FALSE	Preclinical	2003-09-16	Unused	GHSR
Urogenital Abnormalities	ENSG00000122420	FALSE	unknown	NA	Unused	PTGFR
Urogenital Abnormalities	ENSG00000123700	FALSE	Preclinical	2007-06-11	Unused	KCNJ2
Urogenital Abnormalities	ENSG00000126895	FALSE	Preclinical	1992-06-15	Unused	AVPR2
Urogenital Abnormalities	ENSG00000131981	FALSE	Preclinical	2013-08-19	Absent	LGALS3
Urogenital Abnormalities	ENSG00000132671	FALSE	Preclinical	2001-07-26	Unused	SSTR4
Urogenital Abnormalities	ENSG00000133019	TRUE	Approved	1992-05-15	Unused	CHRM3
Urogenital Abnormalities	ENSG00000133105	FALSE	Preclinical	2008-05-20	Preclinical	RXFP2
Urogenital Abnormalities	ENSG00000134640	FALSE	unknown	NA	Unused	MTNR1B
Urogenital Abnormalities	ENSG00000136160	FALSE	Preclinical	1992-09-15	Unused	EDNRB
Urogenital Abnormalities	ENSG00000137869	FALSE	Preclinical	NA	Unused	CYP19A1
Urogenital Abnormalities	ENSG00000138039	FALSE	Preclinical	2003-09-17	Unused	LHCGR
Urogenital Abnormalities	ENSG00000138735	FALSE	unknown	2001-12-18	Unused	PDE5A
Urogenital Abnormalities	ENSG00000139874	FALSE	Preclinical	2001-07-26	Unused	SSTR1
Urogenital Abnormalities	ENSG00000148408	FALSE	Preclinical	2002-01-14	Unused	CACNA1B
Urogenital Abnormalities	ENSG00000148680	FALSE	Preclinical	1997-03-15	Unused	HTR7
Urogenital Abnormalities	ENSG00000151617	FALSE	Preclinical	1992-04-15	Unused	EDNRA
Urogenital Abnormalities	ENSG00000158125	FALSE	Preclinical	1989-12-15	Unused	XDH
Urogenital Abnormalities	ENSG00000160013	FALSE	Preclinical	1998-09-15	Unused	PTGIR
Urogenital Abnormalities	ENSG00000163485	FALSE	Preclinical	1995-08-15	Unused	ADORA1
Urogenital Abnormalities	ENSG00000164270	FALSE	Preclinical	1994-05-15	Unused	HTR4
Urogenital Abnormalities	ENSG00000166148	FALSE	Preclinical	2002-04-10	Unused	AVPR1A
Urogenital Abnormalities	ENSG00000166603	FALSE	Preclinical	1994-08-15	Unused	MC4R
Urogenital Abnormalities	ENSG00000168412	FALSE	unknown	NA	Unused	MTNR1A
Urogenital Abnormalities	ENSG00000168539	TRUE	Approved	2005-06-13	Unused	CHRM1
Urogenital Abnormalities	ENSG00000169083	FALSE	Phase III Clinical Trial	1995-06-15	Unused	AR
Urogenital Abnormalities	ENSG00000169403	FALSE	Preclinical	1991-06-15	Unused	PTAFR
Urogenital Abnormalities	ENSG00000169418	FALSE	Preclinical	1991-07-15	Unused	NPR1
Urogenital Abnormalities	ENSG00000170820	FALSE	Preclinical	2000-01-19	Unused	FSHR
Urogenital Abnormalities	ENSG00000171509	FALSE	Preclinical	2008-05-20	Preclinical	RXFP1
Urogenital Abnormalities	ENSG00000175567	FALSE	Preclinical	1994-08-15	Unused	UCP2
Urogenital Abnormalities	ENSG00000178394	FALSE	Preclinical	1999-06-10	Unused	HTR1A
Urogenital Abnormalities	ENSG00000179142	FALSE	Preclinical	1990-04-15	Unused	CYP11B2
Urogenital Abnormalities	ENSG00000180720	TRUE	Approved	2005-06-13	Unused	CHRM4
Urogenital Abnormalities	ENSG00000180914	FALSE	Preclinical	2008-10-09	Unused	OXTR
Urogenital Abnormalities	ENSG00000181072	TRUE	Approved	2005-06-13	Unused	CHRM2
Urogenital Abnormalities	ENSG00000181408	FALSE	Preclinical	2004-11-29	Unused	UTS2R
Urogenital Abnormalities	ENSG00000184845	FALSE	Preclinical	1990-08-15	Unused	DRD1
Urogenital Abnormalities	ENSG00000185313	FALSE	Preclinical	2002-01-14	Unused	SCN10A
Urogenital Abnormalities	ENSG00000187266	FALSE	Preclinical	2003-07-08	Unused	EPOR
Urogenital Abnormalities	ENSG00000187848	FALSE	Preclinical	2014-08-21	Absent	P2RX2
Urogenital Abnormalities	ENSG00000189221	FALSE	Preclinical	2016-06-22	Absent	MAOA
Urogenital Abnormalities	ENSG00000196549	FALSE	Preclinical	1992-12-15	Unused	MME
Urogenital Abnormalities	ENSG00000197405	FALSE	Preclinical	2003-10-15	Unused	C5AR1
Urogenital Abnormalities	ENSG00000198959	FALSE	Preclinical	2003-12-01	Unused	TGM2
Urogenital Abnormalities	ENSG00000258839	FALSE	Preclinical	1997-08-15	Unused	MC1R
Urogenital Abnormalities	ENSG00000269858	FALSE	Preclinical	2007-11-09	Unused	EGLN2
Urogenital Abnormalities	ENSG00000282608	FALSE	Preclinical	1995-06-15	Unused	ADORA3
Urogenital Neoplasms	ENSG00000010671	FALSE	Phase II Clinical Trial	2007-12-12	Absent	BTK
Urogenital Neoplasms	ENSG00000072274	FALSE	Preclinical	2011-10-27	Unused	TFRC
Urogenital Neoplasms	ENSG00000075213	FALSE	Preclinical	2011-10-27	Unused	SEMA3A
Urogenital Neoplasms	ENSG00000102096	FALSE	Preclinical	NA	Absent	PIM2
Urogenital Neoplasms	ENSG00000113520	FALSE	Preclinical	2011-10-27	Unused	IL4
Urogenital Neoplasms	ENSG00000137193	FALSE	Preclinical	NA	Absent	PIM1
Urogenital Neoplasms	ENSG00000139193	FALSE	unknown	2008-11-12	Absent	CD27
Urogenital Neoplasms	ENSG00000139687	FALSE	Phase I Clinical Trial	2007-08-15	Absent	RB1
Urogenital Neoplasms	ENSG00000140443	FALSE	Phase II Clinical Trial	2005-05-13	Unused	IGF1R
Urogenital Neoplasms	ENSG00000146648	FALSE	Preclinical	2011-10-27	Unused	EGFR
Urogenital Neoplasms	ENSG00000148795	FALSE	Phase I Clinical Trial	2016-07-29	Absent	CYP17A1
Urogenital Neoplasms	ENSG00000163599	FALSE	Phase II Clinical Trial	2004-07-07	Phase II Clinical Trial	CTLA4
Urogenital Neoplasms	ENSG00000164305	FALSE	Phase I Clinical Trial	2014-07-15	Absent	CASP3
Urogenital Neoplasms	ENSG00000169194	FALSE	Preclinical	2011-10-27	Unused	IL13
Urogenital Neoplasms	ENSG00000198355	FALSE	Preclinical	NA	Absent	PIM3
Urticaria	ENSG00000010671	FALSE	Phase II Clinical Trial	2013-11-26	Absent	BTK
Urticaria	ENSG00000077238	FALSE	Preclinical	1998-08-15	Unused	IL4R
Urticaria	ENSG00000105366	FALSE	Preclinical	2016-06-24	Absent	SIGLEC8
Urticaria	ENSG00000140287	FALSE	Phase II Clinical Trial	2001-10-15	Phase II Clinical Trial	HDC
Urticaria	ENSG00000160712	FALSE	Preclinical	1998-08-15	Unused	IL6R
Urticaria	ENSG00000165025	FALSE	Phase I Clinical Trial	2015-03-17	Absent	SYK
Urticaria	ENSG00000169403	TRUE	Approved	1993-08-15	Approved	PTAFR
Urticaria	ENSG00000196639	TRUE	Approved	1990-05-15	Approved	HRH1
Urticaria	ENSG00000258839	FALSE	unknown	2003-06-05	Phase II Clinical Trial	MC1R
Usher Syndromes	ENSG00000042781	FALSE	Preclinical	2016-06-03	Absent	USH2A
Usher Syndromes	ENSG00000122756	FALSE	Phase II Clinical Trial	2000-05-31	Phase II Clinical Trial	CNTFR
Usher Syndromes	ENSG00000137474	FALSE	Phase II Clinical Trial	2009-04-15	Phase II Clinical Trial	MYO7A
Uterine Cervical Dysplasia	ENSG00000082175	FALSE	Preclinical	1998-03-15	Unused	PGR
Uterine Cervical Dysplasia	ENSG00000109471	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL2
Uterine Cervical Dysplasia	ENSG00000115758	FALSE	unknown	1996-05-15	Unused	ODC1
Uterine Cervical Dysplasia	ENSG00000128052	FALSE	Preclinical	2017-12-19	Absent	KDR
Uterine Cervical Dysplasia	ENSG00000134460	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IL2RA
Uterine Cervical Dysplasia	ENSG00000136869	FALSE	Phase II Clinical Trial	2015-11-18	Absent	TLR4
Uterine Cervical Dysplasia	ENSG00000159110	FALSE	Phase II Clinical Trial	1999-06-02	Phase II Clinical Trial	IFNAR2
Uterine Cervical Dysplasia	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Uterine Cervical Dysplasia	ENSG00000172819	FALSE	Preclinical	NA	Unused	RARG
Uterine Cervical Neoplasms	ENSG00000003402	FALSE	Phase I Clinical Trial	1998-11-15	Unused	CFLAR
Uterine Cervical Neoplasms	ENSG00000006327	FALSE	Phase I Clinical Trial	2008-03-17	Phase I Clinical Trial	TNFRSF12A
Uterine Cervical Neoplasms	ENSG00000037280	FALSE	Phase II Clinical Trial	2001-04-03	Unused	FLT4
Uterine Cervical Neoplasms	ENSG00000044574	FALSE	unknown	2009-07-23	Phase I Clinical Trial	HSPA5
Uterine Cervical Neoplasms	ENSG00000049249	FALSE	Preclinical	2016-06-28	Absent	TNFRSF9
Uterine Cervical Neoplasms	ENSG00000065361	FALSE	Phase I Clinical Trial	2002-06-10	Phase I Clinical Trial	ERBB3
Uterine Cervical Neoplasms	ENSG00000066468	FALSE	Phase II Clinical Trial	2009-09-28	Absent	FGFR2
Uterine Cervical Neoplasms	ENSG00000068024	FALSE	Phase II Clinical Trial	2002-06-10	Absent	HDAC4
Uterine Cervical Neoplasms	ENSG00000068078	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR3
Uterine Cervical Neoplasms	ENSG00000077782	FALSE	Phase II Clinical Trial	2001-04-03	Absent	FGFR1
Uterine Cervical Neoplasms	ENSG00000082898	FALSE	Phase II Clinical Trial	2012-06-02	Absent	XPO1
Uterine Cervical Neoplasms	ENSG00000086205	FALSE	Phase II Clinical Trial	2008-03-04	Absent	FOLH1
Uterine Cervical Neoplasms	ENSG00000089692	FALSE	Preclinical	2004-06-09	Unused	LAG3
Uterine Cervical Neoplasms	ENSG00000101966	FALSE	Phase I Clinical Trial	1998-11-15	Unused	XIAP
Uterine Cervical Neoplasms	ENSG00000102755	FALSE	Phase I Clinical Trial	2001-04-03	Unused	FLT1
Uterine Cervical Neoplasms	ENSG00000102854	FALSE	Phase I Clinical Trial	1999-04-21	Unused	MSLN
Uterine Cervical Neoplasms	ENSG00000105221	FALSE	Phase I Clinical Trial	2008-11-12	Absent	AKT2
Uterine Cervical Neoplasms	ENSG00000105388	FALSE	Phase II Clinical Trial	2014-07-14	Absent	CEACAM5
Uterine Cervical Neoplasms	ENSG00000105976	FALSE	unknown	2003-07-18	Phase I Clinical Trial	MET
Uterine Cervical Neoplasms	ENSG00000107159	FALSE	Preclinical	NA	Preclinical	CA9
Uterine Cervical Neoplasms	ENSG00000108691	FALSE	Phase I Clinical Trial	NA	Unused	CCL2
Uterine Cervical Neoplasms	ENSG00000108821	FALSE	unknown	2005-05-13	Unused	COL1A1
Uterine Cervical Neoplasms	ENSG00000109471	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL2
Uterine Cervical Neoplasms	ENSG00000112715	TRUE	Approved	1995-04-15	Absent	VEGFA
Uterine Cervical Neoplasms	ENSG00000113070	FALSE	unknown	2004-02-04	Unused	HBEGF
Uterine Cervical Neoplasms	ENSG00000113578	FALSE	Phase II Clinical Trial	2013-04-20	Absent	FGF1
Uterine Cervical Neoplasms	ENSG00000113721	FALSE	unknown	2001-04-03	Unused	PDGFRB
Uterine Cervical Neoplasms	ENSG00000116478	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC1
Uterine Cervical Neoplasms	ENSG00000117525	FALSE	Phase II Clinical Trial	2008-10-30	Absent	F3
Uterine Cervical Neoplasms	ENSG00000120217	FALSE	Phase II Clinical Trial	2011-04-27	Absent	CD274
Uterine Cervical Neoplasms	ENSG00000121879	FALSE	Phase I Clinical Trial	1992-08-15	Phase I Clinical Trial	PIK3CA
Uterine Cervical Neoplasms	ENSG00000128052	FALSE	Phase II Clinical Trial	2001-04-03	Unused	KDR
Uterine Cervical Neoplasms	ENSG00000129484	FALSE	Phase I Clinical Trial	2013-11-14	Absent	PARP2
Uterine Cervical Neoplasms	ENSG00000130816	FALSE	Preclinical	2005-12-02	Unused	DNMT1
Uterine Cervical Neoplasms	ENSG00000131203	FALSE	Preclinical	2009-04-24	Absent	IDO1
Uterine Cervical Neoplasms	ENSG00000131747	FALSE	Phase II Clinical Trial	1991-06-15	Unused	TOP2A
Uterine Cervical Neoplasms	ENSG00000132906	FALSE	Phase I Clinical Trial	2006-12-08	Absent	CASP9
Uterine Cervical Neoplasms	ENSG00000133083	FALSE	Preclinical	2014-07-24	Absent	DCLK1
Uterine Cervical Neoplasms	ENSG00000134460	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	IL2RA
Uterine Cervical Neoplasms	ENSG00000134853	FALSE	unknown	2001-04-03	Unused	PDGFRA
Uterine Cervical Neoplasms	ENSG00000135409	FALSE	Phase I Clinical Trial	2014-09-15	Absent	AMHR2
Uterine Cervical Neoplasms	ENSG00000135446	FALSE	unknown	NA	Unused	CDK4
Uterine Cervical Neoplasms	ENSG00000137462	FALSE	Preclinical	NA	Absent	TLR2
Uterine Cervical Neoplasms	ENSG00000141510	FALSE	Phase I Clinical Trial	1995-03-15	Unused	TP53
Uterine Cervical Neoplasms	ENSG00000141736	FALSE	Phase II Clinical Trial	2001-02-28	Phase I Clinical Trial	ERBB2
Uterine Cervical Neoplasms	ENSG00000142208	FALSE	unknown	1992-08-15	Unused	AKT1
Uterine Cervical Neoplasms	ENSG00000142627	FALSE	Phase I Clinical Trial	2006-09-11	Unused	EPHA2
Uterine Cervical Neoplasms	ENSG00000143384	FALSE	Phase II Clinical Trial	2002-05-27	Phase I Clinical Trial	MCL1
Uterine Cervical Neoplasms	ENSG00000143799	FALSE	Phase I Clinical Trial	2013-11-14	Absent	PARP1
Uterine Cervical Neoplasms	ENSG00000144285	FALSE	unknown	NA	Unused	SCN1A
Uterine Cervical Neoplasms	ENSG00000145545	FALSE	Phase I Clinical Trial	1998-11-15	Unused	SRD5A1
Uterine Cervical Neoplasms	ENSG00000146648	FALSE	Phase III Clinical Trial	1992-03-15	Phase III Clinical Trial	EGFR
Uterine Cervical Neoplasms	ENSG00000147889	FALSE	Phase II Clinical Trial	2011-11-11	Phase II Clinical Trial	CDKN2A
Uterine Cervical Neoplasms	ENSG00000149294	FALSE	Phase I Clinical Trial	NA	Unused	NCAM1
Uterine Cervical Neoplasms	ENSG00000151067	FALSE	unknown	NA	Unused	CACNA1C
Uterine Cervical Neoplasms	ENSG00000153253	FALSE	unknown	NA	Unused	SCN3A
Uterine Cervical Neoplasms	ENSG00000154229	FALSE	unknown	NA	Unused	PRKCA
Uterine Cervical Neoplasms	ENSG00000157404	FALSE	unknown	2001-04-03	Unused	KIT
Uterine Cervical Neoplasms	ENSG00000157764	FALSE	unknown	2001-04-03	Unused	BRAF
Uterine Cervical Neoplasms	ENSG00000159110	TRUE	Approved	1999-06-02	Unused	IFNAR2
Uterine Cervical Neoplasms	ENSG00000164400	FALSE	Phase III Clinical Trial	2008-07-04	Absent	CSF2
Uterine Cervical Neoplasms	ENSG00000165675	FALSE	Phase I Clinical Trial	1998-11-15	Unused	ENOX2
Uterine Cervical Neoplasms	ENSG00000166483	FALSE	unknown	2008-04-09	Unused	WEE1
Uterine Cervical Neoplasms	ENSG00000166851	FALSE	Phase II Clinical Trial	2002-05-27	Phase I Clinical Trial	PLK1
Uterine Cervical Neoplasms	ENSG00000167325	FALSE	Phase II Clinical Trial	1997-03-15	Preclinical	RRM1
Uterine Cervical Neoplasms	ENSG00000167658	FALSE	Phase I Clinical Trial	1999-04-21	Unused	EEF2
Uterine Cervical Neoplasms	ENSG00000168685	FALSE	Preclinical	2015-10-09	Absent	IL7R
Uterine Cervical Neoplasms	ENSG00000170312	FALSE	unknown	2004-08-16	Unused	CDK1
Uterine Cervical Neoplasms	ENSG00000171345	FALSE	unknown	2010-01-19	Unused	KRT19
Uterine Cervical Neoplasms	ENSG00000171848	FALSE	Phase II Clinical Trial	1997-03-15	Preclinical	RRM2
Uterine Cervical Neoplasms	ENSG00000174125	FALSE	Preclinical	NA	Absent	TLR1
Uterine Cervical Neoplasms	ENSG00000176890	FALSE	unknown	1993-08-15	Phase III Clinical Trial	TYMS
Uterine Cervical Neoplasms	ENSG00000178568	FALSE	Phase II Clinical Trial	2002-05-30	Phase I Clinical Trial	ERBB4
Uterine Cervical Neoplasms	ENSG00000179776	FALSE	unknown	2000-12-11	Phase I Clinical Trial	CDH5
Uterine Cervical Neoplasms	ENSG00000182578	FALSE	Phase I Clinical Trial	2007-08-14	Absent	CSF1R
Uterine Cervical Neoplasms	ENSG00000184292	FALSE	Phase II Clinical Trial	2007-11-12	Absent	TACSTD2
Uterine Cervical Neoplasms	ENSG00000187498	FALSE	unknown	2005-05-13	Unused	COL4A1
Uterine Cervical Neoplasms	ENSG00000188389	FALSE	Phase III Clinical Trial	2005-05-12	Absent	PDCD1
Uterine Cervical Neoplasms	ENSG00000196591	FALSE	Phase II Clinical Trial	2002-06-10	Phase II Clinical Trial	HDAC2
Uterine Cervical Neoplasms	ENSG00000196664	FALSE	unknown	NA	Unused	TLR7
Uterine Cervical Neoplasms	ENSG00000198793	FALSE	Phase I Clinical Trial	1997-08-15	Phase I Clinical Trial	MTOR
Uterine Cervical Neoplasms	ENSG00000198900	TRUE	Approved	1993-07-15	Approved	TOP1
Uterine Cervical Neoplasms	ENSG00000221867	FALSE	Preclinical	2014-12-09	Absent	MAGEA3
Uterine Cervical Neoplasms	ENSG00000228716	FALSE	unknown	1993-05-15	Unused	DHFR
Uveitis	ENSG00000007171	FALSE	Preclinical	2002-07-03	Unused	NOS2
Uveitis	ENSG00000007908	FALSE	Preclinical	1994-02-15	Unused	SELE
Uveitis	ENSG00000027075	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCH
Uveitis	ENSG00000065675	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCQ
Uveitis	ENSG00000081051	FALSE	unknown	2001-02-27	Unused	AFP
Uveitis	ENSG00000085662	FALSE	Preclinical	2011-02-22	Unused	AKR1B1
Uveitis	ENSG00000088832	FALSE	unknown	NA	Absent	FKBP1A
Uveitis	ENSG00000102967	FALSE	Preclinical	2013-12-24	Absent	DHODH
Uveitis	ENSG00000105397	FALSE	Preclinical	2017-05-30	Absent	TYK2
Uveitis	ENSG00000106804	FALSE	Phase II Clinical Trial	2007-04-30	Absent	C5
Uveitis	ENSG00000112115	FALSE	Phase II Clinical Trial	2001-07-24	Phase III Clinical Trial	IL17A
Uveitis	ENSG00000113580	TRUE	Approved	1997-03-15	Approved	NR3C1
Uveitis	ENSG00000118432	FALSE	Preclinical	2016-12-30	Absent	CNR1
Uveitis	ENSG00000121807	FALSE	Preclinical	2006-01-01	Unused	CCR2
Uveitis	ENSG00000125538	FALSE	unknown	2006-01-18	Phase III Clinical Trial	IL1B
Uveitis	ENSG00000125571	FALSE	Phase II Clinical Trial	2001-07-24	Absent	IL37
Uveitis	ENSG00000125910	FALSE	Preclinical	1997-12-15	Preclinical	S1PR4
Uveitis	ENSG00000130561	FALSE	Preclinical	NA	Unused	SAG
Uveitis	ENSG00000134460	FALSE	Phase II Clinical Trial	1992-04-15	Unused	IL2RA
Uveitis	ENSG00000136244	FALSE	Preclinical	2013-05-29	Absent	IL6
Uveitis	ENSG00000136869	FALSE	Preclinical	2010-12-20	Absent	TLR4
Uveitis	ENSG00000137462	FALSE	Preclinical	2010-12-20	Absent	TLR2
Uveitis	ENSG00000143365	FALSE	Phase I Clinical Trial	2012-06-15	Preclinical	RORC
Uveitis	ENSG00000154229	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCA
Uveitis	ENSG00000160712	FALSE	Phase II Clinical Trial	2007-11-29	Absent	IL6R
Uveitis	ENSG00000162434	FALSE	Phase II Clinical Trial	2009-12-11	Absent	JAK1
Uveitis	ENSG00000162711	FALSE	Preclinical	2014-09-02	Absent	NLRP3
Uveitis	ENSG00000163932	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCD
Uveitis	ENSG00000165025	FALSE	unknown	2006-12-19	Unused	SYK
Uveitis	ENSG00000166501	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCB
Uveitis	ENSG00000168610	FALSE	Preclinical	2007-11-27	Absent	STAT3
Uveitis	ENSG00000170989	FALSE	Preclinical	1997-12-15	Preclinical	S1PR1
Uveitis	ENSG00000171132	FALSE	Phase II Clinical Trial	2005-01-26	Unused	PRKCE
Uveitis	ENSG00000174175	FALSE	Preclinical	1994-02-15	Unused	SELP
Uveitis	ENSG00000175591	FALSE	Preclinical	NA	Unused	P2RY2
Uveitis	ENSG00000177272	FALSE	Preclinical	2008-06-18	Absent	KCNA3
Uveitis	ENSG00000178562	FALSE	Preclinical	2011-07-13	Absent	CD28
Uveitis	ENSG00000180739	FALSE	Preclinical	1997-12-15	Preclinical	S1PR5
Uveitis	ENSG00000182220	FALSE	Preclinical	2017-09-28	Absent	ATP6AP2
Uveitis	ENSG00000188404	FALSE	Preclinical	1994-02-15	Unused	SELL
Uveitis	ENSG00000188822	FALSE	Preclinical	2016-12-30	Absent	CNR2
Uveitis	ENSG00000196262	TRUE	Approved	2014-09-15	Approved	PPIA
Uveitis	ENSG00000198793	FALSE	Pre-registration	NA	Phase III Clinical Trial	MTOR
Uveitis	ENSG00000198851	FALSE	unknown	2004-02-24	Absent	CD3E
Uveitis	ENSG00000213694	FALSE	Preclinical	1997-12-15	Preclinical	S1PR3
Uveitis	ENSG00000228716	FALSE	unknown	2008-03-27	Absent	DHFR
Uveitis	ENSG00000239732	FALSE	Preclinical	2010-12-20	Absent	TLR9
Uveitis	ENSG00000258839	FALSE	Preclinical	2011-06-16	Unused	MC1R
Uveitis	ENSG00000282608	FALSE	Phase II Clinical Trial	2001-07-24	Preclinical	ADORA3
Vaginal Neoplasms	ENSG00000019991	FALSE	Phase I Clinical Trial	2006-04-28	Absent	HGF
Vaginal Neoplasms	ENSG00000120217	FALSE	Phase I Clinical Trial	2011-04-27	Absent	CD274
Vaginal Neoplasms	ENSG00000123374	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK2
Vaginal Neoplasms	ENSG00000136807	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK9
Vaginal Neoplasms	ENSG00000141736	FALSE	Phase I Clinical Trial	2008-11-10	Phase I Clinical Trial	ERBB2
Vaginal Neoplasms	ENSG00000146648	FALSE	Phase I Clinical Trial	2008-11-10	Phase I Clinical Trial	EGFR
Vaginal Neoplasms	ENSG00000147889	FALSE	Phase II Clinical Trial	2011-11-11	Phase II Clinical Trial	CDKN2A
Vaginal Neoplasms	ENSG00000164885	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK5
Vaginal Neoplasms	ENSG00000167325	FALSE	Phase II Clinical Trial	1997-03-15	Preclinical	RRM1
Vaginal Neoplasms	ENSG00000170312	FALSE	unknown	2005-03-14	Phase I Clinical Trial	CDK1
Vaginal Neoplasms	ENSG00000171848	FALSE	Phase II Clinical Trial	1997-03-15	Preclinical	RRM2
Vaginal Neoplasms	ENSG00000188389	FALSE	Phase II Clinical Trial	2005-05-12	Absent	PDCD1
Vaginal Neoplasms	ENSG00000198900	FALSE	Phase I Clinical Trial	2007-02-23	Unused	TOP1
Vaginitis	ENSG00000087085	TRUE	Approved	2014-08-25	Absent	ACHE
Vaginitis	ENSG00000091831	TRUE	Approved	1990-10-15	Approved	ESR1
Vaginitis	ENSG00000113580	FALSE	Approved	NA	Absent	NR3C1
Vaginitis	ENSG00000136869	FALSE	Phase II Clinical Trial	2015-11-18	Absent	TLR4
Vascular Calcification	ENSG00000162551	FALSE	Phase I Clinical Trial	2014-05-23	Absent	ALPL
Vascular Calcification	ENSG00000197594	FALSE	Preclinical	2011-03-02	Absent	ENPP1
Vascular Diseases	ENSG00000009724	FALSE	Phase III Clinical Trial	2008-01-15	Absent	MASP2
Vascular Diseases	ENSG00000043591	FALSE	Approved	1990-08-15	Absent	ADRB1
Vascular Diseases	ENSG00000049540	FALSE	Preclinical	2008-09-02	Absent	ELN
Vascular Diseases	ENSG00000088053	FALSE	Phase I Clinical Trial	2004-01-23	Absent	GP6
Vascular Diseases	ENSG00000100311	FALSE	Preclinical	2012-08-01	Absent	PDGFB
Vascular Diseases	ENSG00000106804	FALSE	unknown	2010-12-02	Absent	C5
Vascular Diseases	ENSG00000128271	TRUE	Approved	1997-11-15	Absent	ADORA2A
Vascular Diseases	ENSG00000159640	FALSE	Preclinical	2007-08-07	Absent	ACE
Vascular Diseases	ENSG00000163485	FALSE	unknown	2009-02-27	Unused	ADORA1
Vascular Diseases	ENSG00000164111	FALSE	Phase II Clinical Trial	1999-11-11	Absent	ANXA5
Vascular Diseases	ENSG00000171557	TRUE	Approved	1992-01-15	Absent	FGG
Vascular Diseases	ENSG00000171560	TRUE	Approved	1992-01-15	Absent	FGA
Vascular Diseases	ENSG00000171564	TRUE	Approved	1992-01-15	Absent	FGB
Vascular Diseases	ENSG00000180210	FALSE	unknown	2004-09-21	Unused	F2
Vascular Diseases	ENSG00000184845	FALSE	unknown	1990-12-15	Unused	DRD1
Vascular Diseases	ENSG00000260314	FALSE	Preclinical	2004-08-18	Absent	MRC1
Vascular Malformations	ENSG00000105221	FALSE	Phase II Clinical Trial	2008-11-12	Absent	AKT2
Vascular Malformations	ENSG00000121879	FALSE	Phase II Clinical Trial	2008-11-12	Absent	PIK3CA
Vasculitis	ENSG00000005381	FALSE	Preclinical	2010-05-22	Preclinical	MPO
Vasculitis	ENSG00000006638	TRUE	Approved	NA	Approved	TBXA2R
Vasculitis	ENSG00000010671	FALSE	Preclinical	2004-08-23	Unused	BTK
Vasculitis	ENSG00000059377	FALSE	unknown	2006-08-29	Phase I Clinical Trial	TBXAS1
Vasculitis	ENSG00000102524	FALSE	Phase III Clinical Trial	1999-07-13	Phase I Clinical Trial	TNFSF13B
Vasculitis	ENSG00000106804	FALSE	Phase I Clinical Trial	2008-03-20	Absent	C5
Vasculitis	ENSG00000109471	FALSE	Phase II Clinical Trial	2013-11-26	Absent	IL2
Vasculitis	ENSG00000111537	FALSE	unknown	2004-02-24	Absent	IFNG
Vasculitis	ENSG00000113580	TRUE	Approved	NA	Approved	NR3C1
Vasculitis	ENSG00000114013	FALSE	Preclinical	1992-11-15	Absent	CD86
Vasculitis	ENSG00000121594	FALSE	Preclinical	1992-11-15	Absent	CD80
Vasculitis	ENSG00000124102	FALSE	Phase II Clinical Trial	2004-07-21	Absent	PI3
Vasculitis	ENSG00000125538	FALSE	unknown	2006-01-18	Absent	IL1B
Vasculitis	ENSG00000131471	FALSE	Preclinical	2009-11-12	Preclinical	AOC3
Vasculitis	ENSG00000136244	FALSE	Phase III Clinical Trial	2007-08-23	Absent	IL6
Vasculitis	ENSG00000156738	TRUE	Approved	1993-09-15	Approved	MS4A1
Vasculitis	ENSG00000160255	FALSE	Phase I Clinical Trial	1996-03-15	Unused	ITGB2
Vasculitis	ENSG00000160712	TRUE	Approved	1996-05-15	Preclinical	IL6R
Vasculitis	ENSG00000162434	FALSE	Preclinical	2012-07-26	Absent	JAK1
Vasculitis	ENSG00000165527	FALSE	Preclinical	2014-10-21	Absent	ARF6
Vasculitis	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Vasculitis	ENSG00000177272	FALSE	Preclinical	2008-04-16	Preclinical	KCNA3
Vasculitis	ENSG00000197405	FALSE	Pre-registration	2006-07-25	Phase II Clinical Trial	C5AR1
Vasospasm, Intracranial	ENSG00000059377	FALSE	Approved	NA	Unused	TBXAS1
Vasospasm, Intracranial	ENSG00000067560	FALSE	Preclinical	1998-10-15	Unused	RHOA
Vasospasm, Intracranial	ENSG00000135312	FALSE	Preclinical	1998-01-15	Unused	HTR1B
Vasospasm, Intracranial	ENSG00000151067	FALSE	Preclinical	2017-03-23	Absent	CACNA1C
Vasospasm, Intracranial	ENSG00000151617	FALSE	Phase II Clinical Trial	1995-06-15	Unused	EDNRA
Vasospasm, Intracranial	ENSG00000167748	FALSE	Phase I Clinical Trial	1992-01-15	Unused	KLK1
Venous Insufficiency	ENSG00000006638	TRUE	Approved	NA	Approved	TBXA2R
Venous Insufficiency	ENSG00000102468	FALSE	Phase II Clinical Trial	NA	Unused	HTR2A
Venous Insufficiency	ENSG00000113580	TRUE	Approved	2011-07-20	Approved	NR3C1
Venous Insufficiency	ENSG00000117601	TRUE	Approved	2011-06-30	Approved	SERPINC1
Venous Insufficiency	ENSG00000122194	FALSE	Preclinical	2013-01-07	Preclinical	PLG
Venous Insufficiency	ENSG00000126218	TRUE	Approved	2011-06-30	Approved	F10
Venous Insufficiency	ENSG00000151617	FALSE	Preclinical	1996-12-15	Unused	EDNRA
Venous Insufficiency	ENSG00000160951	FALSE	Approved	1997-01-15	Unused	PTGER1
Venous Insufficiency	ENSG00000175445	TRUE	Approved	NA	Approved	LPL
Venous Insufficiency	ENSG00000180210	TRUE	Approved	2011-06-30	Approved	F2
Venous Thrombosis	ENSG00000005961	FALSE	Phase I Clinical Trial	1995-07-15	Unused	ITGA2B
Venous Thrombosis	ENSG00000007908	FALSE	Phase II Clinical Trial	2005-05-25	Unused	SELE
Venous Thrombosis	ENSG00000057593	FALSE	Preclinical	1992-03-15	Unused	F7
Venous Thrombosis	ENSG00000073756	TRUE	Approved	NA	Approved	PTGS2
Venous Thrombosis	ENSG00000088926	FALSE	Phase II Clinical Trial	2008-12-12	Phase II Clinical Trial	F11
Venous Thrombosis	ENSG00000095303	TRUE	Approved	1995-05-15	Approved	PTGS1
Venous Thrombosis	ENSG00000101981	FALSE	Phase II Clinical Trial	2001-12-04	Phase I Clinical Trial	F9
Venous Thrombosis	ENSG00000104368	FALSE	Phase III Clinical Trial	1994-07-15	Unused	PLAT
Venous Thrombosis	ENSG00000106366	FALSE	Preclinical	1991-11-15	Unused	SERPINE1
Venous Thrombosis	ENSG00000110799	FALSE	Phase II Clinical Trial	2003-07-09	Phase II Clinical Trial	VWF
Venous Thrombosis	ENSG00000115718	FALSE	Preclinical	1996-07-15	Unused	PROC
Venous Thrombosis	ENSG00000117525	FALSE	unknown	1992-03-15	Unused	F3
Venous Thrombosis	ENSG00000117601	TRUE	Approved	1989-11-15	Approved	SERPINC1
Venous Thrombosis	ENSG00000122194	TRUE	Approved	2000-10-30	Approved	PLG
Venous Thrombosis	ENSG00000122861	FALSE	Approved	2010-06-09	Unused	PLAU
Venous Thrombosis	ENSG00000126218	TRUE	Approved	1991-11-15	Approved	F10
Venous Thrombosis	ENSG00000136810	FALSE	Preclinical	NA	Unused	TXN
Venous Thrombosis	ENSG00000149131	FALSE	unknown	2012-09-27	Phase I Clinical Trial	SERPING1
Venous Thrombosis	ENSG00000167397	FALSE	Preclinical	2004-10-13	Unused	VKORC1
Venous Thrombosis	ENSG00000167711	FALSE	Phase I Clinical Trial	2013-11-28	Absent	SERPINF2
Venous Thrombosis	ENSG00000174175	FALSE	Phase II Clinical Trial	2002-01-03	Phase II Clinical Trial	SELP
Venous Thrombosis	ENSG00000178726	FALSE	Phase I Clinical Trial	1992-06-15	Unused	THBD
Venous Thrombosis	ENSG00000180210	TRUE	Approved	1989-08-15	Approved	F2
Venous Thrombosis	ENSG00000181104	FALSE	Phase I Clinical Trial	2008-08-15	Phase I Clinical Trial	F2R
Venous Thrombosis	ENSG00000185010	FALSE	Phase II Clinical Trial	2000-10-30	Unused	F8
Venous Thrombosis	ENSG00000188404	FALSE	unknown	2005-05-25	Unused	SELL
Venous Thrombosis	ENSG00000203710	FALSE	Preclinical	2005-02-01	Unused	CR1
Venous Thrombosis	ENSG00000204174	FALSE	Preclinical	2005-09-13	Absent	NPY4R
Venous Thrombosis	ENSG00000259207	FALSE	Phase I Clinical Trial	1995-07-15	Unused	ITGB3
Ventricular Fibrillation	ENSG00000043591	TRUE	Approved	1990-08-15	Approved	ADRB1
Ventricular Fibrillation	ENSG00000053918	FALSE	unknown	1993-06-15	Phase III Clinical Trial	KCNQ1
Ventricular Fibrillation	ENSG00000055118	TRUE	Approved	1993-06-15	Approved	KCNH2
Ventricular Fibrillation	ENSG00000096717	FALSE	Preclinical	2015-10-13	Absent	SIRT1
Ventricular Fibrillation	ENSG00000151067	FALSE	unknown	1998-05-15	Unused	CACNA1C
Ventricular Fibrillation	ENSG00000169252	TRUE	Approved	2005-02-02	Approved	ADRB2
Ventricular Fibrillation	ENSG00000183873	TRUE	Approved	2002-12-04	Approved	SCN5A
Ventricular Fibrillation	ENSG00000186951	FALSE	Preclinical	2015-10-13	Absent	PPARA
Vertigo	ENSG00000006283	TRUE	Approved	NA	Approved	CACNA1G
Vertigo	ENSG00000101180	FALSE	Preclinical	2013-02-23	Unused	HRH3
Vertigo	ENSG00000169432	FALSE	Phase II Clinical Trial	1998-12-15	Unused	SCN9A
Vertigo	ENSG00000196639	FALSE	Preclinical	2013-02-23	Unused	HRH1
Vestibular Diseases	ENSG00000125538	FALSE	unknown	2006-01-18	Absent	IL1B
Virus Diseases	ENSG00000004487	FALSE	Preclinical	2015-09-02	Absent	KDM1A
Virus Diseases	ENSG00000023445	FALSE	Preclinical	1997-02-15	Unused	BIRC3
Virus Diseases	ENSG00000027697	FALSE	Preclinical	2014-02-26	Absent	IFNGR1
Virus Diseases	ENSG00000070501	FALSE	Preclinical	NA	Unused	POLB
Virus Diseases	ENSG00000090339	FALSE	Preclinical	1990-01-15	Unused	ICAM1
Virus Diseases	ENSG00000101017	FALSE	Preclinical	2011-05-25	Unused	CD40
Virus Diseases	ENSG00000101444	FALSE	Preclinical	1992-06-15	Unused	AHCY
Virus Diseases	ENSG00000101868	FALSE	Preclinical	1993-05-15	Unused	POLA1
Virus Diseases	ENSG00000105675	FALSE	Preclinical	1990-11-15	Unused	ATP4A
Virus Diseases	ENSG00000106348	FALSE	unknown	NA	Unused	IMPDH1
Virus Diseases	ENSG00000107201	FALSE	Preclinical	2015-09-03	Absent	DDX58
Virus Diseases	ENSG00000115232	FALSE	Preclinical	2003-09-11	Unused	ITGA4
Virus Diseases	ENSG00000120217	FALSE	Preclinical	2014-11-21	Absent	CD274
Virus Diseases	ENSG00000132155	FALSE	Preclinical	2009-07-24	Unused	RAF1
Virus Diseases	ENSG00000132507	FALSE	Preclinical	2002-09-13	Unused	EIF5A
Virus Diseases	ENSG00000133321	FALSE	unknown	2014-10-18	Absent	RARRES3
Virus Diseases	ENSG00000133703	FALSE	Preclinical	2009-07-24	Unused	KRAS
Virus Diseases	ENSG00000134058	FALSE	Preclinical	2015-06-04	Absent	CDK7
Virus Diseases	ENSG00000143393	FALSE	Preclinical	2014-06-17	Absent	PI4KB
Virus Diseases	ENSG00000154229	FALSE	Preclinical	1994-10-15	Unused	PRKCA
Virus Diseases	ENSG00000156136	FALSE	Preclinical	2008-08-29	Unused	DCK
Virus Diseases	ENSG00000159110	FALSE	Preclinical	2006-02-17	Preclinical	IFNAR2
Virus Diseases	ENSG00000164342	FALSE	Preclinical	2013-03-19	Absent	TLR3
Virus Diseases	ENSG00000167207	FALSE	Preclinical	2015-09-03	Absent	NOD2
Virus Diseases	ENSG00000171298	FALSE	Preclinical	1995-11-15	Unused	GAA
Virus Diseases	ENSG00000176890	FALSE	Preclinical	NA	Unused	TYMS
Virus Diseases	ENSG00000177628	FALSE	Preclinical	1995-11-15	Unused	GBA
Virus Diseases	ENSG00000183696	FALSE	Preclinical	1994-04-15	Unused	UPP1
Virus Diseases	ENSG00000185436	FALSE	Preclinical	2013-05-16	Absent	IFNLR1
Virus Diseases	ENSG00000186818	FALSE	Preclinical	2004-10-20	Unused	LILRB4
Virus Diseases	ENSG00000186891	FALSE	unknown	2004-10-20	Unused	TNFRSF18
Virus Diseases	ENSG00000197249	FALSE	Preclinical	2002-07-23	Unused	SERPINA1
Virus Diseases	ENSG00000204577	FALSE	Preclinical	2010-02-15	Unused	LILRB3
Virus Diseases	ENSG00000213903	FALSE	Preclinical	1998-07-15	Unused	LTB4R
Vitamin D Deficiency	ENSG00000111424	TRUE	Approved	2007-09-21	Phase III Clinical Trial	VDR
Vitiligo	ENSG00000096968	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK2
Vitiligo	ENSG00000105639	FALSE	Phase II Clinical Trial	2012-08-17	Absent	JAK3
Vitiligo	ENSG00000111537	FALSE	Preclinical	1997-01-15	Unused	IFNG
Vitiligo	ENSG00000113263	FALSE	Preclinical	2012-08-17	Absent	ITK
Vitiligo	ENSG00000121691	FALSE	Phase III Clinical Trial	1996-02-15	Unused	CAT
Vitiligo	ENSG00000141510	FALSE	Preclinical	1996-09-15	Unused	TP53
Vitiligo	ENSG00000162434	FALSE	Phase II Clinical Trial	2006-12-01	Absent	JAK1
Vitiligo	ENSG00000197919	FALSE	Preclinical	1997-01-15	Unused	IFNA1
Vitiligo	ENSG00000258839	FALSE	Phase II Clinical Trial	2003-06-05	Phase II Clinical Trial	MC1R
von Hippel-Lindau Disease	ENSG00000116016	FALSE	Preclinical	2011-08-02	Absent	EPAS1
von Willebrand Diseases	ENSG00000003436	FALSE	unknown	2006-02-22	Unused	TFPI
von Willebrand Diseases	ENSG00000110799	TRUE	Approved	1995-06-15	Approved	VWF
von Willebrand Diseases	ENSG00000117525	FALSE	unknown	2009-06-11	Phase I Clinical Trial	F3
von Willebrand Diseases	ENSG00000122194	FALSE	Preclinical	2014-10-04	Absent	PLG
von Willebrand Diseases	ENSG00000126895	FALSE	unknown	NA	Absent	AVPR2
von Willebrand Diseases	ENSG00000185010	TRUE	Approved	2000-11-23	Approved	F8
Vulvodynia	ENSG00000073756	FALSE	Phase I Clinical Trial	1998-01-15	Unused	PTGS2
Vulvodynia	ENSG00000082556	FALSE	unknown	2011-08-11	Absent	OPRK1
Vulvodynia	ENSG00000095303	FALSE	Phase I Clinical Trial	1998-01-15	Unused	PTGS1
Vulvodynia	ENSG00000103546	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	SLC6A2
Vulvodynia	ENSG00000108576	FALSE	Phase III Clinical Trial	NA	Phase III Clinical Trial	SLC6A4
Vulvodynia	ENSG00000112038	FALSE	unknown	2011-08-11	Absent	OPRM1
Vulvodynia	ENSG00000150594	FALSE	unknown	2011-08-11	Absent	ADRA2A
Vulvodynia	ENSG00000184160	FALSE	unknown	2011-08-11	Absent	ADRA2C
Vulvodynia	ENSG00000274286	FALSE	unknown	2011-08-11	Absent	ADRA2B
Waldenstrom Macroglobulinemia	ENSG00000010671	TRUE	Approved	2007-12-12	Phase III Clinical Trial	BTK
Waldenstrom Macroglobulinemia	ENSG00000012124	FALSE	Phase II Clinical Trial	1993-08-15	Phase II Clinical Trial	CD22
Waldenstrom Macroglobulinemia	ENSG00000048462	FALSE	Phase I Clinical Trial	2012-01-25	Absent	TNFRSF17
Waldenstrom Macroglobulinemia	ENSG00000082898	FALSE	Phase I Clinical Trial	2012-06-02	Phase I Clinical Trial	XPO1
Waldenstrom Macroglobulinemia	ENSG00000087586	FALSE	unknown	2006-11-20	Phase I Clinical Trial	AURKA
Waldenstrom Macroglobulinemia	ENSG00000100823	FALSE	unknown	2007-02-13	Absent	APEX1
Waldenstrom Macroglobulinemia	ENSG00000101017	FALSE	unknown	1998-07-15	Unused	CD40
Waldenstrom Macroglobulinemia	ENSG00000101557	FALSE	Preclinical	2014-10-08	Absent	USP14
Waldenstrom Macroglobulinemia	ENSG00000101916	FALSE	unknown	2012-03-16	Absent	TLR8
Waldenstrom Macroglobulinemia	ENSG00000102524	FALSE	Phase II Clinical Trial	1999-07-13	Phase II Clinical Trial	TNFSF13B
Waldenstrom Macroglobulinemia	ENSG00000109320	FALSE	unknown	1997-11-15	Phase I Clinical Trial	NFKB1
Waldenstrom Macroglobulinemia	ENSG00000115419	FALSE	Phase I Clinical Trial	2013-05-02	Absent	GLS
Waldenstrom Macroglobulinemia	ENSG00000116750	FALSE	Preclinical	2014-10-08	Absent	UCHL5
Waldenstrom Macroglobulinemia	ENSG00000120217	FALSE	Preclinical	2011-06-20	Absent	CD274
Waldenstrom Macroglobulinemia	ENSG00000121879	FALSE	Phase III Clinical Trial	1992-08-15	Phase II Clinical Trial	PIK3CA
Waldenstrom Macroglobulinemia	ENSG00000125726	FALSE	unknown	2011-05-17	Absent	CD70
Waldenstrom Macroglobulinemia	ENSG00000136244	FALSE	Phase I Clinical Trial	NA	Phase I Clinical Trial	IL6
Waldenstrom Macroglobulinemia	ENSG00000142208	FALSE	unknown	1992-08-15	Unused	AKT1
Waldenstrom Macroglobulinemia	ENSG00000156738	FALSE	Phase II Clinical Trial	1993-09-15	Phase II Clinical Trial	MS4A1
Waldenstrom Macroglobulinemia	ENSG00000161955	FALSE	Phase I Clinical Trial	2000-05-03	Phase I Clinical Trial	TNFSF13
Waldenstrom Macroglobulinemia	ENSG00000166501	FALSE	Phase II Clinical Trial	2001-07-03	Phase II Clinical Trial	PRKCB
Waldenstrom Macroglobulinemia	ENSG00000171608	FALSE	Phase II Clinical Trial	2004-01-20	Absent	PIK3CD
Waldenstrom Macroglobulinemia	ENSG00000173638	FALSE	unknown	NA	Phase II Clinical Trial	SLC19A1
Waldenstrom Macroglobulinemia	ENSG00000196664	FALSE	unknown	2012-03-16	Absent	TLR7
Waldenstrom Macroglobulinemia	ENSG00000198793	FALSE	Phase I Clinical Trial	2009-07-15	Phase I Clinical Trial	MTOR
Waldenstrom Macroglobulinemia	ENSG00000228716	FALSE	unknown	NA	Phase II Clinical Trial	DHFR
Waldenstrom Macroglobulinemia	ENSG00000239732	FALSE	unknown	2012-03-16	Absent	TLR9
Waldenstrom Macroglobulinemia	ENSG00000275302	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL4
Waldenstrom Macroglobulinemia	ENSG00000277632	FALSE	Phase I Clinical Trial	2004-01-20	Absent	CCL3
Weight Gain	ENSG00000101180	FALSE	Phase II Clinical Trial	2007-02-07	Unused	HRH3
Weight Gain	ENSG00000113580	FALSE	Phase II Clinical Trial	2002-02-05	Phase II Clinical Trial	NR3C1
Weight Gain	ENSG00000143799	FALSE	unknown	2002-03-12	Unused	PARP1
Weight Gain	ENSG00000151623	FALSE	Phase I Clinical Trial	2014-02-01	Absent	NR3C2
Weight Gain	ENSG00000196639	FALSE	Phase II Clinical Trial	2007-02-07	Unused	HRH1
Werner Syndrome	ENSG00000165392	FALSE	Preclinical	1997-11-15	Unused	WRN
West Nile Fever	ENSG00000133321	FALSE	Preclinical	2009-07-23	Preclinical	RARRES3
West Nile Fever	ENSG00000159110	FALSE	Phase II Clinical Trial	2005-02-01	Unused	IFNAR2
West Nile Fever	ENSG00000159640	FALSE	unknown	2003-07-16	Unused	ACE
West Nile Fever	ENSG00000164342	FALSE	unknown	NA	Absent	TLR3
Wet Macular Degeneration	ENSG00000017427	FALSE	unknown	2004-08-17	Phase I Clinical Trial	IGF1
Wet Macular Degeneration	ENSG00000026103	FALSE	Preclinical	NA	Absent	FAS
Wet Macular Degeneration	ENSG00000026508	FALSE	unknown	1998-12-15	Unused	CD44
Wet Macular Degeneration	ENSG00000037280	FALSE	Phase II Clinical Trial	2000-07-05	Phase II Clinical Trial	FLT4
Wet Macular Degeneration	ENSG00000067560	FALSE	Preclinical	2004-08-11	Unused	RHOA
Wet Macular Degeneration	ENSG00000073756	FALSE	unknown	NA	Unused	PTGS2
Wet Macular Degeneration	ENSG00000082781	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGB5
Wet Macular Degeneration	ENSG00000091879	FALSE	Phase II Clinical Trial	2010-10-29	Unused	ANGPT2
Wet Macular Degeneration	ENSG00000092969	FALSE	Preclinical	2013-03-06	Absent	TGFB2
Wet Macular Degeneration	ENSG00000095303	FALSE	unknown	NA	Absent	PTGS1
Wet Macular Degeneration	ENSG00000096063	FALSE	Preclinical	2015-06-11	Absent	SRPK1
Wet Macular Degeneration	ENSG00000100311	FALSE	Preclinical	2012-08-22	Preclinical	PDGFB
Wet Macular Degeneration	ENSG00000100644	FALSE	Preclinical	2006-12-19	Unused	HIF1A
Wet Macular Degeneration	ENSG00000100739	FALSE	Preclinical	2012-07-12	Preclinical	BDKRB1
Wet Macular Degeneration	ENSG00000102755	FALSE	Phase II Clinical Trial	2000-07-05	Phase II Clinical Trial	FLT1
Wet Macular Degeneration	ENSG00000105329	FALSE	Preclinical	2006-10-13	Preclinical	TGFB1
Wet Macular Degeneration	ENSG00000106804	FALSE	Phase II Clinical Trial	2007-04-30	Phase I Clinical Trial	C5
Wet Macular Degeneration	ENSG00000106991	FALSE	Phase II Clinical Trial	2006-05-01	Absent	ENG
Wet Macular Degeneration	ENSG00000112715	TRUE	Approved	1993-05-15	Approved	VEGFA
Wet Macular Degeneration	ENSG00000113580	FALSE	Phase II Clinical Trial	1997-03-15	Phase II Clinical Trial	NR3C1
Wet Macular Degeneration	ENSG00000113721	FALSE	Phase III Clinical Trial	2004-02-09	Phase II Clinical Trial	PDGFRB
Wet Macular Degeneration	ENSG00000113889	FALSE	Preclinical	2004-12-13	Unused	KNG1
Wet Macular Degeneration	ENSG00000117318	FALSE	Preclinical	2015-01-06	Absent	ID3
Wet Macular Degeneration	ENSG00000117525	FALSE	Phase II Clinical Trial	2010-12-01	Phase II Clinical Trial	F3
Wet Macular Degeneration	ENSG00000118523	FALSE	Phase II Clinical Trial	2010-11-18	Absent	CTGF
Wet Macular Degeneration	ENSG00000119630	TRUE	Approved	2003-07-24	Approved	PGF
Wet Macular Degeneration	ENSG00000121966	FALSE	Preclinical	2015-09-22	Absent	CXCR4
Wet Macular Degeneration	ENSG00000122194	FALSE	Phase I Clinical Trial	2000-10-30	Phase II Clinical Trial	PLG
Wet Macular Degeneration	ENSG00000125538	FALSE	Phase I Clinical Trial	2003-12-08	Unused	IL1B
Wet Macular Degeneration	ENSG00000125730	FALSE	Phase II Clinical Trial	2007-03-26	Phase II Clinical Trial	C3
Wet Macular Degeneration	ENSG00000125968	FALSE	Preclinical	2015-01-06	Absent	ID1
Wet Macular Degeneration	ENSG00000128052	FALSE	Phase II Clinical Trial	2000-07-05	Phase II Clinical Trial	KDR
Wet Macular Degeneration	ENSG00000128917	FALSE	unknown	2013-09-24	Absent	DLL4
Wet Macular Degeneration	ENSG00000130427	FALSE	Phase I Clinical Trial	2014-11-04	Absent	EPO
Wet Macular Degeneration	ENSG00000132155	FALSE	Preclinical	2001-04-20	Preclinical	RAF1
Wet Macular Degeneration	ENSG00000132386	FALSE	unknown	1996-11-15	Unused	SERPINF1
Wet Macular Degeneration	ENSG00000134013	FALSE	unknown	2010-07-29	Unused	LOXL2
Wet Macular Degeneration	ENSG00000134853	FALSE	Phase III Clinical Trial	2000-07-05	Phase II Clinical Trial	PDGFRA
Wet Macular Degeneration	ENSG00000138448	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGAV
Wet Macular Degeneration	ENSG00000138685	FALSE	Phase III Clinical Trial	1993-05-15	Absent	FGF2
Wet Macular Degeneration	ENSG00000143537	FALSE	Preclinical	2015-06-24	Absent	ADAM15
Wet Macular Degeneration	ENSG00000150093	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGB1
Wet Macular Degeneration	ENSG00000150630	FALSE	Phase II Clinical Trial	2008-11-25	Preclinical	VEGFC
Wet Macular Degeneration	ENSG00000154229	FALSE	Preclinical	2015-02-19	Absent	PRKCA
Wet Macular Degeneration	ENSG00000157404	FALSE	Phase III Clinical Trial	2000-07-05	Phase II Clinical Trial	KIT
Wet Macular Degeneration	ENSG00000161638	FALSE	Phase II Clinical Trial	2000-02-02	Phase II Clinical Trial	ITGA5
Wet Macular Degeneration	ENSG00000163513	FALSE	Preclinical	2006-12-19	Unused	TGFBR2
Wet Macular Degeneration	ENSG00000164171	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGA2
Wet Macular Degeneration	ENSG00000165197	FALSE	Phase II Clinical Trial	2008-11-25	Preclinical	VEGFD
Wet Macular Degeneration	ENSG00000165731	FALSE	Phase III Clinical Trial	2014-07-19	Absent	RET
Wet Macular Degeneration	ENSG00000168209	FALSE	Phase II Clinical Trial	2003-10-14	Phase II Clinical Trial	DDIT4
Wet Macular Degeneration	ENSG00000168398	FALSE	Preclinical	2012-07-12	Preclinical	BDKRB2
Wet Macular Degeneration	ENSG00000168610	FALSE	Preclinical	2007-11-27	Preclinical	STAT3
Wet Macular Degeneration	ENSG00000170989	FALSE	Preclinical	2011-11-22	Preclinical	S1PR1
Wet Macular Degeneration	ENSG00000172156	FALSE	unknown	2000-08-02	Absent	CCL11
Wet Macular Degeneration	ENSG00000176105	FALSE	Preclinical	2011-06-04	Preclinical	YES1
Wet Macular Degeneration	ENSG00000179776	FALSE	unknown	2000-12-11	Phase II Clinical Trial	CDH5
Wet Macular Degeneration	ENSG00000181634	FALSE	Phase II Clinical Trial	2013-12-28	Absent	TNFSF15
Wet Macular Degeneration	ENSG00000182578	FALSE	Phase II Clinical Trial	2007-06-08	Absent	CSF1R
Wet Macular Degeneration	ENSG00000182871	FALSE	Phase I Clinical Trial	2002-08-29	Phase I Clinical Trial	COL18A1
Wet Macular Degeneration	ENSG00000183625	FALSE	unknown	2004-09-17	Phase I Clinical Trial	CCR3
Wet Macular Degeneration	ENSG00000185338	FALSE	Preclinical	2015-02-19	Absent	SOCS1
Wet Macular Degeneration	ENSG00000196396	FALSE	Preclinical	2009-06-04	Preclinical	PTPN1
Wet Macular Degeneration	ENSG00000197405	FALSE	Preclinical	2012-05-08	Preclinical	C5AR1
Wet Macular Degeneration	ENSG00000198793	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTOR
Wet Macular Degeneration	ENSG00000259207	FALSE	Phase II Clinical Trial	2011-12-02	Phase II Clinical Trial	ITGB3
Whooping Cough	ENSG00000101017	FALSE	Preclinical	1998-12-15	Unused	CD40
Wilms Tumor	ENSG00000049249	FALSE	Phase I Clinical Trial	2016-06-28	Absent	TNFRSF9
Wilms Tumor	ENSG00000103855	FALSE	Phase I Clinical Trial	2010-11-22	Absent	CD276
Wilms Tumor	ENSG00000131747	FALSE	Approved	2007-03-05	Absent	TOP2A
Wilms Tumor	ENSG00000140443	FALSE	Phase I Clinical Trial	2003-06-03	Absent	IGF1R
Wilms Tumor	ENSG00000166825	FALSE	Approved	2007-03-05	Absent	ANPEP
Wilms Tumor	ENSG00000184937	FALSE	Preclinical	2005-08-10	Absent	WT1
Wiskott-Aldrich Syndrome	ENSG00000015285	FALSE	Phase III Clinical Trial	2005-07-26	Phase II Clinical Trial	WAS
Wolfram Syndrome	ENSG00000265972	FALSE	Preclinical	2014-05-30	Absent	TXNIP
Wolman Disease	ENSG00000107798	TRUE	Approved	2010-05-06	Phase III Clinical Trial	LIPA
Wounds and Injuries	ENSG00000000971	FALSE	Preclinical	2009-10-27	Absent	CFH
Wounds and Injuries	ENSG00000005884	FALSE	Preclinical	1999-11-24	Absent	ITGA3
Wounds and Injuries	ENSG00000006638	FALSE	unknown	1991-10-15	Absent	TBXA2R
Wounds and Injuries	ENSG00000011465	FALSE	Preclinical	1991-06-15	Absent	DCN
Wounds and Injuries	ENSG00000012223	FALSE	Preclinical	1994-08-15	Absent	LTF
Wounds and Injuries	ENSG00000012779	FALSE	Preclinical	2006-07-31	Absent	ALOX5
Wounds and Injuries	ENSG00000017797	FALSE	Preclinical	2009-03-02	Absent	RALBP1
Wounds and Injuries	ENSG00000019991	FALSE	Phase II Clinical Trial	2007-09-21	Absent	HGF
Wounds and Injuries	ENSG00000026508	FALSE	Approved	NA	Absent	CD44
Wounds and Injuries	ENSG00000027697	FALSE	Phase II Clinical Trial	NA	Absent	IFNGR1
Wounds and Injuries	ENSG00000049540	FALSE	Preclinical	2004-08-11	Absent	ELN
Wounds and Injuries	ENSG00000055332	FALSE	Preclinical	1997-10-15	Unused	EIF2AK2
Wounds and Injuries	ENSG00000064300	FALSE	Approved	1997-06-15	Unused	NGFR
Wounds and Injuries	ENSG00000065320	FALSE	Preclinical	1998-01-15	Unused	NTN1
Wounds and Injuries	ENSG00000065989	FALSE	Preclinical	2017-06-19	Absent	PDE4A
Wounds and Injuries	ENSG00000066468	FALSE	Preclinical	2007-04-25	Absent	FGFR2
Wounds and Injuries	ENSG00000067182	FALSE	Approved	2005-06-27	Phase II Clinical Trial	TNFRSF1A
Wounds and Injuries	ENSG00000069702	FALSE	Preclinical	1992-03-15	Absent	TGFBR3
Wounds and Injuries	ENSG00000072571	FALSE	Preclinical	1998-07-15	Absent	HMMR
Wounds and Injuries	ENSG00000073756	FALSE	Phase II Clinical Trial	1998-07-15	Unused	PTGS2
Wounds and Injuries	ENSG00000077092	FALSE	Phase III Clinical Trial	1990-06-15	Absent	RARB
Wounds and Injuries	ENSG00000077238	FALSE	unknown	NA	Unused	IL4R
Wounds and Injuries	ENSG00000077782	FALSE	Approved	1989-09-15	Absent	FGFR1
Wounds and Injuries	ENSG00000081479	FALSE	Preclinical	2007-07-11	Unused	LRP2
Wounds and Injuries	ENSG00000082898	FALSE	Preclinical	2014-07-01	Absent	XPO1
Wounds and Injuries	ENSG00000085563	FALSE	Phase II Clinical Trial	1998-06-15	Unused	ABCB1
Wounds and Injuries	ENSG00000087085	FALSE	unknown	1989-06-15	Phase III Clinical Trial	ACHE
Wounds and Injuries	ENSG00000088832	FALSE	Preclinical	2011-06-10	Preclinical	FKBP1A
Wounds and Injuries	ENSG00000089250	FALSE	Phase II Clinical Trial	2015-08-19	Absent	NOS1
Wounds and Injuries	ENSG00000091831	FALSE	Phase III Clinical Trial	2005-12-12	Unused	ESR1
Wounds and Injuries	ENSG00000092969	FALSE	Preclinical	1993-03-15	Absent	TGFB2
Wounds and Injuries	ENSG00000095303	FALSE	Phase II Clinical Trial	1998-07-15	Unused	PTGS1
Wounds and Injuries	ENSG00000100311	FALSE	Phase II Clinical Trial	1994-01-15	Absent	PDGFB
Wounds and Injuries	ENSG00000100453	FALSE	Preclinical	2013-03-13	Absent	GZMB
Wounds and Injuries	ENSG00000100644	FALSE	unknown	2009-02-18	Absent	HIF1A
Wounds and Injuries	ENSG00000100739	FALSE	Preclinical	1997-10-15	Absent	BDKRB1
Wounds and Injuries	ENSG00000100985	FALSE	Preclinical	1995-01-15	Absent	MMP9
Wounds and Injuries	ENSG00000101017	FALSE	Preclinical	2015-01-11	Absent	CD40
Wounds and Injuries	ENSG00000102468	FALSE	Phase II Clinical Trial	2002-09-09	Absent	HTR2A
Wounds and Injuries	ENSG00000102755	FALSE	Preclinical	1990-07-15	Absent	FLT1
Wounds and Injuries	ENSG00000103319	FALSE	Preclinical	2009-01-23	Unused	EEF2K
Wounds and Injuries	ENSG00000105329	FALSE	Approved	1993-03-15	Phase II Clinical Trial	TGFB1
Wounds and Injuries	ENSG00000105810	FALSE	Preclinical	2013-04-17	Absent	CDK6
Wounds and Injuries	ENSG00000105894	FALSE	Preclinical	2002-02-11	Absent	PTN
Wounds and Injuries	ENSG00000106128	FALSE	Preclinical	NA	Absent	GHRHR
Wounds and Injuries	ENSG00000106799	FALSE	Preclinical	1991-06-15	Absent	TGFBR1
Wounds and Injuries	ENSG00000107562	FALSE	Phase II Clinical Trial	2009-03-25	Absent	CXCL12
Wounds and Injuries	ENSG00000110324	FALSE	unknown	2005-12-12	Preclinical	IL10RA
Wounds and Injuries	ENSG00000111679	FALSE	Preclinical	2001-07-24	Unused	PTPN6
Wounds and Injuries	ENSG00000112033	FALSE	Preclinical	2017-12-20	Absent	PPARD
Wounds and Injuries	ENSG00000112062	FALSE	Approved	2000-10-25	Phase II Clinical Trial	MAPK14
Wounds and Injuries	ENSG00000112096	FALSE	Preclinical	2004-03-29	Unused	SOD2
Wounds and Injuries	ENSG00000112715	FALSE	Preclinical	2002-08-09	Absent	VEGFA
Wounds and Injuries	ENSG00000112964	FALSE	Approved	NA	Absent	GHR
Wounds and Injuries	ENSG00000113070	FALSE	Preclinical	1991-09-15	Absent	HBEGF
Wounds and Injuries	ENSG00000113302	FALSE	Phase II Clinical Trial	2008-10-20	Absent	IL12B
Wounds and Injuries	ENSG00000113580	FALSE	Preclinical	1994-08-15	Absent	NR3C1
Wounds and Injuries	ENSG00000113721	FALSE	Preclinical	NA	Absent	PDGFRB
Wounds and Injuries	ENSG00000114378	FALSE	Preclinical	2004-08-27	Absent	HYAL1
Wounds and Injuries	ENSG00000114859	FALSE	Preclinical	2002-09-25	Absent	CLCN2
Wounds and Injuries	ENSG00000115310	FALSE	Preclinical	2000-02-09	Unused	RTN4
Wounds and Injuries	ENSG00000115353	FALSE	Preclinical	2007-07-16	Absent	TACR1
Wounds and Injuries	ENSG00000115414	FALSE	Preclinical	NA	Absent	FN1
Wounds and Injuries	ENSG00000115541	FALSE	Preclinical	2002-09-04	Absent	HSPE1
Wounds and Injuries	ENSG00000115590	FALSE	Phase II Clinical Trial	1998-12-15	Absent	IL1R2
Wounds and Injuries	ENSG00000115718	FALSE	Phase II Clinical Trial	2008-09-30	Absent	PROC
Wounds and Injuries	ENSG00000116044	FALSE	Preclinical	2017-04-17	Absent	NFE2L2
Wounds and Injuries	ENSG00000117525	FALSE	Preclinical	2003-12-05	Absent	F3
Wounds and Injuries	ENSG00000117601	TRUE	Approved	1997-05-15	Absent	SERPINC1
Wounds and Injuries	ENSG00000117632	FALSE	Preclinical	2017-04-26	Absent	STMN1
Wounds and Injuries	ENSG00000118523	FALSE	Phase II Clinical Trial	1997-08-15	Absent	CTGF
Wounds and Injuries	ENSG00000119535	FALSE	Phase III Clinical Trial	1996-12-15	Unused	CSF3R
Wounds and Injuries	ENSG00000119715	FALSE	Preclinical	2006-09-15	Absent	ESRRB
Wounds and Injuries	ENSG00000120156	FALSE	Preclinical	1995-08-15	Absent	TEK
Wounds and Injuries	ENSG00000120738	FALSE	Preclinical	2000-12-05	Absent	EGR1
Wounds and Injuries	ENSG00000121691	FALSE	Preclinical	NA	Absent	CAT
Wounds and Injuries	ENSG00000121966	FALSE	Phase II Clinical Trial	2005-01-18	Unused	CXCR4
Wounds and Injuries	ENSG00000121989	FALSE	Preclinical	1995-07-15	Absent	ACVR2A
Wounds and Injuries	ENSG00000122194	FALSE	Preclinical	NA	Absent	PLG
Wounds and Injuries	ENSG00000122861	FALSE	unknown	1993-05-15	Unused	PLAU
Wounds and Injuries	ENSG00000122884	FALSE	Preclinical	2001-02-06	Unused	P4HA1
Wounds and Injuries	ENSG00000124491	TRUE	Approved	NA	Absent	F13A1
Wounds and Injuries	ENSG00000124762	FALSE	Preclinical	1994-12-15	Absent	CDKN1A
Wounds and Injuries	ENSG00000126218	TRUE	Approved	1997-05-15	Absent	F10
Wounds and Injuries	ENSG00000127837	FALSE	Preclinical	1996-06-15	Absent	AAMP
Wounds and Injuries	ENSG00000128052	FALSE	unknown	1997-09-15	Absent	KDR
Wounds and Injuries	ENSG00000128271	FALSE	Preclinical	1998-04-15	Absent	ADORA2A
Wounds and Injuries	ENSG00000129521	FALSE	Phase I Clinical Trial	2008-09-16	Absent	EGLN3
Wounds and Injuries	ENSG00000130283	FALSE	Preclinical	1991-12-15	Unused	GDF1
Wounds and Injuries	ENSG00000130427	FALSE	Preclinical	1995-08-15	Unused	EPO
Wounds and Injuries	ENSG00000131747	TRUE	Approved	2002-06-10	Approved	TOP2A
Wounds and Injuries	ENSG00000131981	FALSE	unknown	1997-05-15	Preclinical	LGALS3
Wounds and Injuries	ENSG00000132646	FALSE	Phase I Clinical Trial	NA	Absent	PCNA
Wounds and Injuries	ENSG00000132671	FALSE	Preclinical	2001-07-26	Absent	SSTR4
Wounds and Injuries	ENSG00000132703	FALSE	Phase II Clinical Trial	2009-07-24	Absent	APCS
Wounds and Injuries	ENSG00000132906	FALSE	unknown	1997-05-15	Preclinical	CASP9
Wounds and Injuries	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Wounds and Injuries	ENSG00000133067	FALSE	Preclinical	2016-11-02	Absent	LGR6
Wounds and Injuries	ENSG00000134363	FALSE	Preclinical	1995-07-15	Absent	FST
Wounds and Injuries	ENSG00000134460	FALSE	Approved	1998-06-15	Unused	IL2RA
Wounds and Injuries	ENSG00000135446	FALSE	Preclinical	2013-04-17	Absent	CDK4
Wounds and Injuries	ENSG00000138448	FALSE	Preclinical	1997-02-15	Absent	ITGAV
Wounds and Injuries	ENSG00000138685	FALSE	Preclinical	1994-12-15	Absent	FGF2
Wounds and Injuries	ENSG00000138735	FALSE	Preclinical	2008-09-30	Absent	PDE5A
Wounds and Injuries	ENSG00000139874	FALSE	Preclinical	2001-07-26	Absent	SSTR1
Wounds and Injuries	ENSG00000140443	FALSE	Preclinical	NA	Absent	IGF1R
Wounds and Injuries	ENSG00000141510	FALSE	Preclinical	2003-07-15	Unused	TP53
Wounds and Injuries	ENSG00000141736	FALSE	Preclinical	2011-03-26	Absent	ERBB2
Wounds and Injuries	ENSG00000142168	FALSE	Phase II Clinical Trial	2005-08-18	Absent	SOD1
Wounds and Injuries	ENSG00000142192	FALSE	Preclinical	1996-01-15	Unused	APP
Wounds and Injuries	ENSG00000142208	FALSE	unknown	1997-05-15	Preclinical	AKT1
Wounds and Injuries	ENSG00000143799	FALSE	Preclinical	1996-06-15	Unused	PARP1
Wounds and Injuries	ENSG00000146648	FALSE	Approved	1997-11-15	Absent	EGFR
Wounds and Injuries	ENSG00000147246	FALSE	Phase II Clinical Trial	2002-09-09	Absent	HTR2C
Wounds and Injuries	ENSG00000147601	FALSE	Preclinical	2000-01-11	Absent	TERF1
Wounds and Injuries	ENSG00000148408	FALSE	Preclinical	1993-08-15	Unused	CACNA1B
Wounds and Injuries	ENSG00000148926	FALSE	Preclinical	1996-09-15	Absent	ADM
Wounds and Injuries	ENSG00000149968	FALSE	Preclinical	2002-09-03	Absent	MMP3
Wounds and Injuries	ENSG00000150093	FALSE	Preclinical	1999-11-24	Absent	ITGB1
Wounds and Injuries	ENSG00000154188	FALSE	Preclinical	2008-09-13	Absent	ANGPT1
Wounds and Injuries	ENSG00000154229	FALSE	Preclinical	1998-05-15	Absent	PRKCA
Wounds and Injuries	ENSG00000157404	FALSE	Phase I Clinical Trial	2007-03-05	Unused	KIT
Wounds and Injuries	ENSG00000159110	FALSE	unknown	NA	Absent	IFNAR2
Wounds and Injuries	ENSG00000160712	FALSE	Preclinical	1998-06-15	Unused	IL6R
Wounds and Injuries	ENSG00000160791	FALSE	Phase II Clinical Trial	2008-03-04	Absent	CCR5
Wounds and Injuries	ENSG00000160951	FALSE	Preclinical	1997-03-15	Absent	PTGER1
Wounds and Injuries	ENSG00000161638	FALSE	Preclinical	2012-01-09	Absent	ITGA5
Wounds and Injuries	ENSG00000161905	FALSE	Preclinical	2006-07-31	Absent	ALOX15
Wounds and Injuries	ENSG00000163513	FALSE	Preclinical	1992-03-15	Absent	TGFBR2
Wounds and Injuries	ENSG00000163736	FALSE	Preclinical	NA	Absent	PPBP
Wounds and Injuries	ENSG00000163932	FALSE	Phase II Clinical Trial	2002-10-14	Absent	PRKCD
Wounds and Injuries	ENSG00000164362	FALSE	Preclinical	1999-12-01	Absent	TERT
Wounds and Injuries	ENSG00000168036	FALSE	Phase I Clinical Trial	2014-10-20	Absent	CTNNB1
Wounds and Injuries	ENSG00000168487	FALSE	Preclinical	2004-03-28	Absent	BMP1
Wounds and Injuries	ENSG00000168522	FALSE	Preclinical	1997-02-15	Unused	FNTA
Wounds and Injuries	ENSG00000168811	FALSE	Phase II Clinical Trial	2008-10-20	Absent	IL12A
Wounds and Injuries	ENSG00000169083	FALSE	Phase III Clinical Trial	1996-11-15	Unused	AR
Wounds and Injuries	ENSG00000169194	FALSE	Phase II Clinical Trial	2006-12-07	Absent	IL13
Wounds and Injuries	ENSG00000169432	FALSE	Phase I Clinical Trial	2005-10-04	Phase I Clinical Trial	SCN9A
Wounds and Injuries	ENSG00000169919	FALSE	Preclinical	2015-11-27	Absent	GUSB
Wounds and Injuries	ENSG00000170027	FALSE	unknown	2006-08-09	Absent	YWHAG
Wounds and Injuries	ENSG00000170430	FALSE	Preclinical	1996-12-15	Unused	MGMT
Wounds and Injuries	ENSG00000170558	FALSE	Preclinical	1999-06-30	Unused	CDH2
Wounds and Injuries	ENSG00000171105	FALSE	Phase I Clinical Trial	1992-06-15	Absent	INSR
Wounds and Injuries	ENSG00000171557	TRUE	Approved	1992-05-15	Absent	FGG
Wounds and Injuries	ENSG00000171560	TRUE	Approved	1992-05-15	Absent	FGA
Wounds and Injuries	ENSG00000171564	TRUE	Approved	1992-05-15	Absent	FGB
Wounds and Injuries	ENSG00000171791	FALSE	Preclinical	1997-07-15	Unused	BCL2
Wounds and Injuries	ENSG00000173083	FALSE	Preclinical	1990-06-15	Absent	HPSE
Wounds and Injuries	ENSG00000173153	FALSE	Preclinical	2006-09-15	Absent	ESRRA
Wounds and Injuries	ENSG00000176884	FALSE	Preclinical	2007-10-09	Unused	GRIN1
Wounds and Injuries	ENSG00000178726	FALSE	Preclinical	NA	Absent	THBD
Wounds and Injuries	ENSG00000179218	FALSE	Preclinical	1997-05-15	Absent	CALR
Wounds and Injuries	ENSG00000179295	FALSE	Preclinical	2002-07-03	Unused	PTPN11
Wounds and Injuries	ENSG00000180210	TRUE	Approved	1992-06-15	Absent	F2
Wounds and Injuries	ENSG00000181104	TRUE	Approved	1992-05-15	Absent	F2R
Wounds and Injuries	ENSG00000185291	FALSE	Phase III Clinical Trial	1996-12-15	Unused	IL3RA
Wounds and Injuries	ENSG00000187514	FALSE	Preclinical	1999-01-15	Absent	PTMA
Wounds and Injuries	ENSG00000187554	FALSE	Preclinical	2006-08-01	Preclinical	TLR5
Wounds and Injuries	ENSG00000188641	FALSE	unknown	NA	Unused	DPYD
Wounds and Injuries	ENSG00000196396	FALSE	Preclinical	2009-06-04	Preclinical	PTPN1
Wounds and Injuries	ENSG00000196611	FALSE	Preclinical	1995-01-15	Absent	MMP1
Wounds and Injuries	ENSG00000197081	FALSE	Preclinical	NA	Absent	IGF2R
Wounds and Injuries	ENSG00000198121	FALSE	Preclinical	2009-06-17	Absent	LPAR1
Wounds and Injuries	ENSG00000198223	FALSE	Preclinical	1990-03-15	Unused	CSF2RA
Wounds and Injuries	ENSG00000198382	FALSE	Preclinical	1999-12-08	Unused	UVRAG
Wounds and Injuries	ENSG00000205542	FALSE	Preclinical	1995-01-15	Absent	TMSB4X
Wounds and Injuries	ENSG00000213903	FALSE	Phase I Clinical Trial	1995-11-15	Absent	LTB4R
Wounds and Injuries	ENSG00000214274	FALSE	Preclinical	NA	Absent	ANG
Wounds and Injuries	ENSG00000228716	FALSE	unknown	NA	Absent	DHFR
Wounds and Injuries	ENSG00000240583	FALSE	Phase I Clinical Trial	2014-06-17	Absent	AQP1
Wounds and Injuries	ENSG00000258839	FALSE	Preclinical	2003-06-05	Absent	MC1R
Wounds and Injuries	ENSG00000259207	FALSE	Preclinical	1997-02-15	Absent	ITGB3
Wounds and Injuries	ENSG00000269858	FALSE	Phase I Clinical Trial	2008-09-16	Absent	EGLN2
Wounds and Injuries	ENSG00000271503	FALSE	Preclinical	1999-01-15	Absent	CCL5
Xerophthalmia	ENSG00000001626	FALSE	Preclinical	2017-03-29	Absent	CFTR
Xerophthalmia	ENSG00000005844	TRUE	Approved	2007-03-12	Phase III Clinical Trial	ITGAL
Xerophthalmia	ENSG00000012223	FALSE	Phase I Clinical Trial	1998-09-15	Unused	LTF
Xerophthalmia	ENSG00000026508	TRUE	Approved	NA	Approved	CD44
Xerophthalmia	ENSG00000059377	FALSE	Phase III Clinical Trial	NA	Phase II Clinical Trial	TBXAS1
Xerophthalmia	ENSG00000064300	FALSE	Phase II Clinical Trial	2011-07-05	Unused	NGFR
Xerophthalmia	ENSG00000065989	FALSE	unknown	2009-05-11	Unused	PDE4A
Xerophthalmia	ENSG00000073756	FALSE	Phase III Clinical Trial	2010-08-24	Unused	PTGS2
Xerophthalmia	ENSG00000082175	FALSE	Preclinical	2007-05-11	Unused	PGR
Xerophthalmia	ENSG00000088832	FALSE	Phase II Clinical Trial	NA	Unused	FKBP1A
Xerophthalmia	ENSG00000090339	TRUE	Approved	2007-03-12	Phase III Clinical Trial	ICAM1
Xerophthalmia	ENSG00000095303	FALSE	Phase III Clinical Trial	2010-09-23	Unused	PTGS1
Xerophthalmia	ENSG00000100985	FALSE	Phase III Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP9
Xerophthalmia	ENSG00000102967	FALSE	Preclinical	2013-12-24	Absent	DHODH
Xerophthalmia	ENSG00000105329	FALSE	Preclinical	2006-10-13	Preclinical	TGFB1
Xerophthalmia	ENSG00000105639	FALSE	Phase II Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK3
Xerophthalmia	ENSG00000109320	FALSE	Preclinical	2015-10-23	Absent	NFKB1
Xerophthalmia	ENSG00000111319	FALSE	Phase II Clinical Trial	2007-08-18	Unused	SCNN1A
Xerophthalmia	ENSG00000112115	FALSE	Phase II Clinical Trial	2001-07-24	Phase II Clinical Trial	IL17A
Xerophthalmia	ENSG00000113580	FALSE	Phase III Clinical Trial	2004-03-30	Phase III Clinical Trial	NR3C1
Xerophthalmia	ENSG00000115008	FALSE	unknown	2012-05-09	Phase I Clinical Trial	IL1A
Xerophthalmia	ENSG00000118432	FALSE	Preclinical	2016-12-30	Absent	CNR1
Xerophthalmia	ENSG00000125538	FALSE	Phase II Clinical Trial	2003-12-08	Phase II Clinical Trial	IL1B
Xerophthalmia	ENSG00000125571	FALSE	unknown	2001-07-24	Absent	IL37
Xerophthalmia	ENSG00000132170	FALSE	Phase II Clinical Trial	1999-05-25	Absent	PPARG
Xerophthalmia	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Xerophthalmia	ENSG00000134489	FALSE	unknown	2001-05-10	Unused	HRH4
Xerophthalmia	ENSG00000144481	FALSE	Preclinical	2016-02-01	Absent	TRPM8
Xerophthalmia	ENSG00000147955	FALSE	Phase I Clinical Trial	1992-06-15	Unused	SIGMAR1
Xerophthalmia	ENSG00000150594	FALSE	Phase III Clinical Trial	2016-02-10	Absent	ADRA2A
Xerophthalmia	ENSG00000150782	FALSE	Preclinical	2015-04-01	Preclinical	IL18
Xerophthalmia	ENSG00000154229	FALSE	Preclinical	2010-06-15	Preclinical	PRKCA
Xerophthalmia	ENSG00000162434	FALSE	Phase II Clinical Trial	2003-06-25	Phase II Clinical Trial	JAK1
Xerophthalmia	ENSG00000165025	FALSE	Phase II Clinical Trial	2006-07-25	Phase I Clinical Trial	SYK
Xerophthalmia	ENSG00000166825	FALSE	Preclinical	NA	Absent	ANPEP
Xerophthalmia	ENSG00000168918	FALSE	Preclinical	2007-10-11	Unused	INPP5D
Xerophthalmia	ENSG00000169083	FALSE	Phase II Clinical Trial	2007-05-11	Unused	AR
Xerophthalmia	ENSG00000175591	FALSE	Approved	NA	Approved	P2RY2
Xerophthalmia	ENSG00000177272	FALSE	Preclinical	2016-03-01	Absent	KCNA3
Xerophthalmia	ENSG00000184502	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	GAST
Xerophthalmia	ENSG00000188257	FALSE	unknown	1997-11-15	Unused	PLA2G2A
Xerophthalmia	ENSG00000188822	FALSE	Preclinical	2016-11-29	Absent	CNR2
Xerophthalmia	ENSG00000196262	TRUE	Approved	1993-08-15	Approved	PPIA
Xerophthalmia	ENSG00000196549	FALSE	Preclinical	NA	Absent	MME
Xerophthalmia	ENSG00000196611	FALSE	Phase III Clinical Trial	1995-01-15	Phase II Clinical Trial	MMP1
Xerophthalmia	ENSG00000196639	FALSE	unknown	2001-05-10	Unused	HRH1
Xerophthalmia	ENSG00000196689	FALSE	Phase III Clinical Trial	2005-01-31	Phase II Clinical Trial	TRPV1
Xerophthalmia	ENSG00000198400	FALSE	Phase III Clinical Trial	2006-10-30	Phase II Clinical Trial	NTRK1
Xerophthalmia	ENSG00000198793	FALSE	Phase II Clinical Trial	NA	Phase II Clinical Trial	MTOR
Xerophthalmia	ENSG00000205542	FALSE	Phase III Clinical Trial	1995-01-15	Phase II Clinical Trial	TMSB4X
Xerophthalmia	ENSG00000258839	FALSE	Preclinical	2013-03-20	Absent	MC1R
Xerophthalmia	ENSG00000282608	FALSE	unknown	2001-07-24	Phase III Clinical Trial	ADORA3
Xerostomia	ENSG00000087085	FALSE	Phase II Clinical Trial	2008-10-16	Unused	ACHE
Xerostomia	ENSG00000111319	FALSE	unknown	2007-08-18	Phase II Clinical Trial	SCNN1A
Xerostomia	ENSG00000112096	FALSE	Preclinical	2004-03-29	Unused	SOD2
Xerostomia	ENSG00000133019	TRUE	Approved	1989-05-15	Approved	CHRM3
Xerostomia	ENSG00000168539	FALSE	Phase II Clinical Trial	2005-03-30	Unused	CHRM1
Xerostomia	ENSG00000240583	FALSE	Phase I Clinical Trial	2014-06-17	Absent	AQP1
Yellow Fever	ENSG00000164342	FALSE	unknown	NA	Absent	TLR3
Yersinia Infections	ENSG00000163485	FALSE	Preclinical	2002-06-25	Preclinical	ADORA1
Zika Virus Infection	ENSG00000100312	FALSE	Preclinical	2002-03-20	Absent	ACR
Zika Virus Infection	ENSG00000114378	FALSE	Preclinical	2002-03-20	Absent	HYAL1
Zika Virus Infection	ENSG00000166598	FALSE	Preclinical	2016-10-25	Absent	HSP90B1
Zika Virus Infection	ENSG00000167601	FALSE	Preclinical	2016-02-16	Absent	AXL
Zika Virus Infection	ENSG00000183087	FALSE	Preclinical	2016-02-16	Absent	GAS6
Zika Virus Infection	ENSG00000260314	FALSE	Preclinical	2017-08-16	Absent	MRC1
Zollinger-Ellison Syndrome	ENSG00000105675	TRUE	Approved	1989-09-15	Approved	ATP4A
Zollinger-Ellison Syndrome	ENSG00000113749	TRUE	Approved	NA	Approved	HRH2
Zollinger-Ellison Syndrome	ENSG00000184502	FALSE	Preclinical	2005-07-25	Unused	GAST
